The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
differential.report.sites | yes |
region.types | promoters, genes, cpgislands |
differential.permutations | 0 |
differential.comparison.columns | default |
differential.comparison.columns.all.pairwise | default |
columns.pairing | default |
differential.site.test.method | limma |
differential.variability | no |
differential.variability.method | diffVar |
covariate.adjustment.columns | default |
differential.adjustment.sva | yes |
differential.adjustment.celltype | yes |
differential.enrichment.go | yes |
differential.enrichment.lola | no |
differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
R01C01 vs. non.R01C01 (based on Sentrix position) | 22259 |
R01C02 vs. non.R01C02 (based on Sentrix position) | 108908 |
R02C01 vs. non.R02C01 (based on Sentrix position) | 90162 |
R02C02 vs. non.R02C02 (based on Sentrix position) | 3783 |
R03C01 vs. non.R03C01 (based on Sentrix position) | 162 |
R03C02 vs. non.R03C02 (based on Sentrix position) | 0 |
R04C01 vs. non.R04C01 (based on Sentrix position) | 80 |
R04C02 vs. non.R04C02 (based on Sentrix position) | 100032 |
R05C01 vs. non.R05C01 (based on Sentrix position) | 75110 |
R05C02 vs. non.R05C02 (based on Sentrix position) | 0 |
R06C01 vs. non.R06C01 (based on Sentrix position) | 45377 |
R06C02 vs. non.R06C02 (based on Sentrix position) | 49190 |
Primary solid Tumor vs. Recurrent Solid Tumor (based on Type) | 95056 |
FEMALE vs. MALE (based on Gender) | 92989 |
HISPANIC OR LATINO vs. NOT HISPANIC OR LATINO (based on Ethnicity) | 106449 |
BLACK OR AFRICAN AMERICAN vs. WHITE (based on Race) | 105040 |
DECEASED vs. LIVING (based on Vital status) | 0 |
mutated vs. wild type (based on IDH1) | 107977 |
negative vs. positive (based on G-CIMP status) | 97450 |
female vs. male (based on Predicted Gender) | 76805 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
promoters | genes | cpgislands | |
R01C01 vs. non.R01C01 (based on Sentrix position) | 6 | 63 | 59 |
R01C02 vs. non.R01C02 (based on Sentrix position) | 112 | 383 | 358 |
R02C01 vs. non.R02C01 (based on Sentrix position) | 8 | 0 | 41 |
R02C02 vs. non.R02C02 (based on Sentrix position) | 26 | 57 | 0 |
R03C01 vs. non.R03C01 (based on Sentrix position) | 0 | 24 | 31 |
R03C02 vs. non.R03C02 (based on Sentrix position) | 0 | 17 | 0 |
R04C01 vs. non.R04C01 (based on Sentrix position) | 100 | 15 | 0 |
R04C02 vs. non.R04C02 (based on Sentrix position) | 548 | 80 | 84 |
R05C01 vs. non.R05C01 (based on Sentrix position) | 117 | 0 | 61 |
R05C02 vs. non.R05C02 (based on Sentrix position) | 42 | 0 | 0 |
R06C01 vs. non.R06C01 (based on Sentrix position) | 56 | 0 | 0 |
R06C02 vs. non.R06C02 (based on Sentrix position) | 118 | 0 | 0 |
Primary solid Tumor vs. Recurrent Solid Tumor (based on Type) | 1167 | 311 | 2083 |
FEMALE vs. MALE (based on Gender) | 110 | 0 | 0 |
HISPANIC OR LATINO vs. NOT HISPANIC OR LATINO (based on Ethnicity) | 485 | 355 | 626 |
BLACK OR AFRICAN AMERICAN vs. WHITE (based on Race) | 2 | 0 | 28 |
DECEASED vs. LIVING (based on Vital status) | 55 | 35 | 18 |
mutated vs. wild type (based on IDH1) | 1761 | 3223 | 5247 |
negative vs. positive (based on G-CIMP status) | 3956 | 1133 | 5012 |
female vs. male (based on Predicted Gender) | 0 | 35 | 66 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
promoters | genes | cpgislands | |
R01C01 vs. non.R01C01 (based on Sentrix position) | csv | csv | csv |
R01C02 vs. non.R01C02 (based on Sentrix position) | csv | csv | csv |
R02C01 vs. non.R02C01 (based on Sentrix position) | csv | csv | csv |
R02C02 vs. non.R02C02 (based on Sentrix position) | csv | csv | csv |
R03C01 vs. non.R03C01 (based on Sentrix position) | csv | csv | csv |
R03C02 vs. non.R03C02 (based on Sentrix position) | csv | csv | csv |
R04C01 vs. non.R04C01 (based on Sentrix position) | csv | csv | csv |
R04C02 vs. non.R04C02 (based on Sentrix position) | csv | csv | csv |
R05C01 vs. non.R05C01 (based on Sentrix position) | csv | csv | csv |
R05C02 vs. non.R05C02 (based on Sentrix position) | csv | csv | csv |
R06C01 vs. non.R06C01 (based on Sentrix position) | csv | csv | csv |
R06C02 vs. non.R06C02 (based on Sentrix position) | csv | csv | csv |
Primary solid Tumor vs. Recurrent Solid Tumor (based on Type) | csv | csv | csv |
FEMALE vs. MALE (based on Gender) | csv | csv | csv |
HISPANIC OR LATINO vs. NOT HISPANIC OR LATINO (based on Ethnicity) | csv | csv | csv |
BLACK OR AFRICAN AMERICAN vs. WHITE (based on Race) | csv | csv | csv |
DECEASED vs. LIVING (based on Vital status) | csv | csv | csv |
mutated vs. wild type (based on IDH1) | csv | csv | csv |
negative vs. positive (based on G-CIMP status) | csv | csv | csv |
female vs. male (based on Predicted Gender) | csv | csv | csv |
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008037 | 0.001 | 17.681 | 0.1975 | 3 | 137 | cell recognition |
GO:0048850 | 0.0043 | 361.9773 | 0.0043 | 1 | 3 | hypophysis morphogenesis |
GO:0060370 | 0.0043 | 361.9773 | 0.0043 | 1 | 3 | susceptibility to T cell mediated cytotoxicity |
GO:0042271 | 0.0058 | 241.303 | 0.0058 | 1 | 4 | susceptibility to natural killer cell mediated cytotoxicity |
GO:0051464 | 0.0058 | 241.303 | 0.0058 | 1 | 4 | positive regulation of cortisol secretion |
GO:0060126 | 0.0058 | 241.303 | 0.0058 | 1 | 4 | somatotropin secreting cell differentiation |
GO:0007052 | 0.0084 | 16.0436 | 0.1384 | 2 | 96 | mitotic spindle organization |
GO:0021979 | 0.0086 | 144.7636 | 0.0087 | 1 | 6 | hypothalamus cell differentiation |
GO:0050911 | 0.0097 | 7.6076 | 0.4484 | 3 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000252 | 1e-04 | 212.2533 | 0.0135 | 2 | 8 | negative regulation of feeding behavior |
GO:0046887 | 0.001 | 17.4912 | 0.1963 | 3 | 116 | positive regulation of hormone secretion |
GO:0009914 | 0.0015 | 9.2144 | 0.5061 | 4 | 299 | hormone transport |
GO:0019358 | 0.0017 | Inf | 0.0017 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 0.0017 | Inf | 0.0017 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0051355 | 0.0017 | Inf | 0.0017 | 1 | 1 | proprioception involved in equilibrioception |
GO:0052182 | 0.0017 | Inf | 0.0017 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
GO:2000836 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of androgen secretion |
GO:2001208 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of transcription elongation from RNA polymerase I promoter |
GO:0044060 | 0.0023 | 31.77 | 0.0711 | 2 | 42 | regulation of endocrine process |
GO:0046903 | 0.0025 | 4.1065 | 2.5202 | 8 | 1489 | secretion |
GO:0060986 | 0.0027 | 28.8745 | 0.0779 | 2 | 46 | endocrine hormone secretion |
GO:0070265 | 0.0033 | 25.92 | 0.0863 | 2 | 51 | necrotic cell death |
GO:0052047 | 0.0034 | 612.4615 | 0.0034 | 1 | 2 | interaction with other organism via secreted substance involved in symbiotic interaction |
GO:1902957 | 0.0034 | 612.4615 | 0.0034 | 1 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
GO:0009593 | 0.0039 | 7.0385 | 0.6567 | 4 | 388 | detection of chemical stimulus |
GO:0090276 | 0.0042 | 10.2971 | 0.3284 | 3 | 194 | regulation of peptide hormone secretion |
GO:0023061 | 0.0045 | 6.75 | 0.6838 | 4 | 404 | signal release |
GO:0051705 | 0.0047 | 21.5132 | 0.1032 | 2 | 61 | multi-organism behavior |
GO:0021986 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | habenula development |
GO:0035483 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | gastric emptying |
GO:0071899 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | negative regulation of estrogen receptor binding |
GO:1901856 | 0.0051 | 306.2115 | 0.0051 | 1 | 3 | negative regulation of cellular respiration |
GO:0046888 | 0.0052 | 20.4684 | 0.1083 | 2 | 64 | negative regulation of hormone secretion |
GO:0050795 | 0.0055 | 19.8263 | 0.1117 | 2 | 66 | regulation of behavior |
GO:0001692 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | histamine metabolic process |
GO:0014054 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | positive regulation of gamma-aminobutyric acid secretion |
GO:0031064 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | negative regulation of histone deacetylation |
GO:0032497 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | detection of lipopolysaccharide |
GO:0051461 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | positive regulation of corticotropin secretion |
GO:0051919 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | positive regulation of fibrinolysis |
GO:2000048 | 0.0068 | 204.1282 | 0.0068 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
GO:0014050 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | negative regulation of glutamate secretion |
GO:0033132 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | negative regulation of glucokinase activity |
GO:0048880 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | sensory system development |
GO:0060455 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | negative regulation of gastric acid secretion |
GO:2000987 | 0.0084 | 153.0865 | 0.0085 | 1 | 5 | positive regulation of behavioral fear response |
GO:0071158 | 0.0092 | 15.0867 | 0.1456 | 2 | 86 | positive regulation of cell cycle arrest |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006333 | 0 | 58.8422 | 0.4661 | 16 | 169 | chromatin assembly or disassembly |
GO:0006323 | 0 | 52.9008 | 0.513 | 16 | 186 | DNA packaging |
GO:0006335 | 0 | 212.3797 | 0.0883 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0071824 | 0 | 39.1241 | 0.6758 | 16 | 245 | protein-DNA complex subunit organization |
GO:0000183 | 0 | 179.6606 | 0.0993 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 172.9956 | 0.1021 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 172.9956 | 0.1021 | 10 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 137.3183 | 0.1214 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 72.8125 | 0.2041 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 67.5149 | 0.2179 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 49.2243 | 0.3255 | 11 | 118 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 51.1215 | 0.2786 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 48.9567 | 0.2896 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 39.3569 | 0.3531 | 10 | 128 | regulation of gene silencing |
GO:0032200 | 0 | 30.2864 | 0.4496 | 10 | 163 | telomere organization |
GO:0035194 | 0 | 23.5526 | 0.6427 | 11 | 233 | posttranscriptional gene silencing by RNA |
GO:0002244 | 0 | 26.2901 | 0.513 | 10 | 186 | hematopoietic progenitor cell differentiation |
GO:0007596 | 0 | 19.015 | 0.7964 | 11 | 302 | blood coagulation |
GO:0050878 | 0 | 13.8963 | 1.3212 | 13 | 479 | regulation of body fluid levels |
GO:0009611 | 0 | 11.6241 | 1.7322 | 14 | 628 | response to wounding |
GO:0017148 | 0 | 16.8274 | 0.8826 | 11 | 320 | negative regulation of translation |
GO:0048863 | 0 | 18.6485 | 0.7089 | 10 | 257 | stem cell differentiation |
GO:0002227 | 0 | 135.8376 | 0.0552 | 5 | 20 | innate immune response in mucosa |
GO:0034622 | 0 | 8.9273 | 2.6838 | 16 | 973 | cellular macromolecular complex assembly |
GO:0002251 | 0 | 75.4084 | 0.0883 | 5 | 32 | organ or tissue specific immune response |
GO:0006334 | 0 | 38.4692 | 0.2008 | 6 | 94 | nucleosome assembly |
GO:0030099 | 0 | 12.5246 | 1.0344 | 10 | 375 | myeloid cell differentiation |
GO:0019731 | 0 | 61.6744 | 0.1048 | 5 | 38 | antibacterial humoral response |
GO:0034248 | 0 | 9.767 | 1.4784 | 11 | 536 | regulation of cellular amide metabolic process |
GO:1903706 | 0 | 10.8725 | 1.1833 | 10 | 429 | regulation of hemopoiesis |
GO:0061844 | 0 | 44.2085 | 0.1407 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0010608 | 0 | 8.3312 | 1.7184 | 11 | 623 | posttranscriptional regulation of gene expression |
GO:0043043 | 0 | 7.5263 | 2.1156 | 12 | 767 | peptide biosynthetic process |
GO:0051259 | 0 | 9.0635 | 1.4067 | 10 | 510 | protein oligomerization |
GO:0071345 | 0 | 6.7522 | 2.3418 | 12 | 849 | cellular response to cytokine stimulus |
GO:0050830 | 0 | 26.0191 | 0.2289 | 5 | 83 | defense response to Gram-positive bacterium |
GO:0048534 | 0 | 6.1176 | 2.2976 | 11 | 833 | hematopoietic or lymphoid organ development |
GO:0006959 | 0 | 12.5923 | 0.5599 | 6 | 203 | humoral immune response |
GO:0045892 | 0 | 5.1691 | 3.001 | 12 | 1088 | negative regulation of transcription, DNA-templated |
GO:0010033 | 0 | 3.7761 | 7.988 | 20 | 2896 | response to organic substance |
GO:0022607 | 0 | 3.7851 | 7.3894 | 19 | 2679 | cellular component assembly |
GO:1902679 | 0 | 4.9993 | 3.0948 | 12 | 1122 | negative regulation of RNA biosynthetic process |
GO:0051248 | 1e-04 | 4.5107 | 3.401 | 12 | 1233 | negative regulation of protein metabolic process |
GO:0071840 | 1e-04 | 3.2786 | 16.3566 | 29 | 5930 | cellular component organization or biogenesis |
GO:0002376 | 1e-04 | 3.5193 | 7.2625 | 18 | 2633 | immune system process |
GO:0045934 | 2e-04 | 4.0969 | 3.7126 | 12 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009890 | 2e-04 | 3.8352 | 4.3608 | 13 | 1581 | negative regulation of biosynthetic process |
GO:0070887 | 3e-04 | 3.2214 | 7.8114 | 18 | 2832 | cellular response to chemical stimulus |
GO:0007166 | 3e-04 | 3.2571 | 7.155 | 17 | 2594 | cell surface receptor signaling pathway |
GO:0009617 | 5e-04 | 5.7705 | 1.4122 | 7 | 512 | response to bacterium |
GO:1901564 | 5e-04 | 2.873 | 17.7302 | 29 | 6428 | organonitrogen compound metabolic process |
GO:0021542 | 8e-04 | 58.2234 | 0.0414 | 2 | 15 | dentate gyrus development |
GO:0071822 | 0.001 | 3.3581 | 4.4408 | 12 | 1610 | protein complex subunit organization |
GO:0032268 | 0.0019 | 2.81 | 6.8626 | 15 | 2488 | regulation of cellular protein metabolic process |
GO:0072378 | 0.0021 | 32.8882 | 0.069 | 2 | 25 | blood coagulation, fibrin clot formation |
GO:0030421 | 0.0028 | Inf | 0.0028 | 1 | 1 | defecation |
GO:0030844 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of intermediate filament depolymerization |
GO:0045108 | 0.0028 | Inf | 0.0028 | 1 | 1 | regulation of intermediate filament polymerization or depolymerization |
GO:0070392 | 0.0028 | Inf | 0.0028 | 1 | 1 | detection of lipoteichoic acid |
GO:1903082 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of C-C chemokine receptor CCR7 signaling pathway |
GO:2000350 | 0.0028 | Inf | 0.0028 | 1 | 1 | positive regulation of CD40 signaling pathway |
GO:0010604 | 0.0033 | 2.5784 | 8.0045 | 16 | 2902 | positive regulation of macromolecule metabolic process |
GO:0070271 | 0.0035 | 3.1411 | 3.7844 | 10 | 1372 | protein complex biogenesis |
GO:0051276 | 0.0037 | 4.0585 | 2.0522 | 7 | 953 | chromosome organization |
GO:0001662 | 0.0037 | 24.3886 | 0.091 | 2 | 33 | behavioral fear response |
GO:0045595 | 0.004 | 2.9359 | 4.5043 | 11 | 1633 | regulation of cell differentiation |
GO:0043207 | 0.0054 | 3.6644 | 2.1735 | 7 | 788 | response to external biotic stimulus |
GO:0090382 | 0.0054 | 19.8872 | 0.1103 | 2 | 40 | phagosome maturation |
GO:0002543 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | activation of blood coagulation via clotting cascade |
GO:0002588 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | positive regulation of antigen processing and presentation of peptide antigen via MHC class II |
GO:0007506 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | gonadal mesoderm development |
GO:0032499 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | detection of peptidoglycan |
GO:2000355 | 0.0055 | 369.9302 | 0.0055 | 1 | 2 | negative regulation of ovarian follicle development |
GO:0016567 | 0.0062 | 3.5681 | 2.2287 | 7 | 808 | protein ubiquitination |
GO:0098542 | 0.0067 | 4.6038 | 1.2026 | 5 | 436 | defense response to other organism |
GO:0008347 | 0.0068 | 17.5692 | 0.1241 | 2 | 45 | glial cell migration |
GO:2000179 | 0.0074 | 16.7862 | 0.1296 | 2 | 47 | positive regulation of neural precursor cell proliferation |
GO:0001546 | 0.0083 | 184.9535 | 0.0083 | 1 | 3 | preantral ovarian follicle growth |
GO:0002541 | 0.0083 | 184.9535 | 0.0083 | 1 | 3 | activation of plasma proteins involved in acute inflammatory response |
GO:0044267 | 0.0088 | 2.8029 | 5.2035 | 11 | 2418 | cellular protein metabolic process |
GO:2000242 | 0.009 | 15.1029 | 0.1434 | 2 | 52 | negative regulation of reproductive process |
GO:0008152 | 0.0093 | 2.6029 | 29.5025 | 37 | 10696 | metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 22.4467 | 0.8999 | 13 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 21.7339 | 0.9278 | 13 | 400 | detection of stimulus involved in sensory perception |
GO:0050911 | 0 | 25.0692 | 0.7214 | 12 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 21.3938 | 0.9417 | 13 | 406 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 7.6924 | 2.7393 | 14 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 7.0536 | 2.6627 | 13 | 1148 | nervous system process |
GO:0006683 | 0.0023 | Inf | 0.0023 | 1 | 1 | galactosylceramide catabolic process |
GO:0030200 | 0.0069 | 221.0139 | 0.007 | 1 | 3 | heparan sulfate proteoglycan catabolic process |
GO:0043137 | 0.0092 | 147.3333 | 0.0093 | 1 | 4 | DNA replication, removal of RNA primer |
GO:1902412 | 0.0092 | 147.3333 | 0.0093 | 1 | 4 | regulation of mitotic cytokinesis |
GO:1904340 | 0.0092 | 147.3333 | 0.0093 | 1 | 4 | positive regulation of dopaminergic neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0034120 | 0.0013 | Inf | 0.0013 | 1 | 1 | positive regulation of erythrocyte aggregation |
GO:0048685 | 0.0013 | Inf | 0.0013 | 1 | 1 | negative regulation of collateral sprouting of intact axon in response to injury |
GO:0060183 | 0.0013 | Inf | 0.0013 | 1 | 1 | apelin receptor signaling pathway |
GO:1904022 | 0.0013 | Inf | 0.0013 | 1 | 1 | positive regulation of G-protein coupled receptor internalization |
GO:0090134 | 0.0026 | 796.5 | 0.0026 | 1 | 2 | cell migration involved in mesendoderm migration |
GO:2000866 | 0.0026 | 796.5 | 0.0026 | 1 | 2 | positive regulation of estradiol secretion |
GO:0048678 | 0.0029 | 28.3176 | 0.0803 | 2 | 61 | response to axon injury |
GO:0002317 | 0.0039 | 398.225 | 0.0039 | 1 | 3 | plasma cell differentiation |
GO:0060337 | 0.0043 | 22.8666 | 0.0987 | 2 | 75 | type I interferon signaling pathway |
GO:0034340 | 0.0049 | 21.3941 | 0.1053 | 2 | 80 | response to type I interferon |
GO:0006710 | 0.0053 | 265.4667 | 0.0053 | 1 | 4 | androgen catabolic process |
GO:0048382 | 0.0066 | 199.0875 | 0.0066 | 1 | 5 | mesendoderm development |
GO:0070221 | 0.0066 | 199.0875 | 0.0066 | 1 | 5 | sulfide oxidation, using sulfide:quinone oxidoreductase |
GO:0035900 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | response to isolation stress |
GO:0070459 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | prolactin secretion |
GO:0071394 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | cellular response to testosterone stimulus |
GO:0090481 | 0.0079 | 159.26 | 0.0079 | 1 | 6 | pyrimidine nucleotide-sugar transmembrane transport |
GO:0034754 | 0.0092 | 15.2796 | 0.1461 | 2 | 111 | cellular hormone metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 264.023 | 0.1061 | 13 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 253.0061 | 0.109 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 253.0061 | 0.109 | 13 | 37 | response to interleukin-7 |
GO:0045652 | 0 | 99.3115 | 0.218 | 13 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 91.7589 | 0.2328 | 13 | 79 | positive regulation of gene expression, epigenetic |
GO:0006335 | 0 | 195.1229 | 0.0943 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:1902036 | 0 | 68.7236 | 0.2976 | 13 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 65.719 | 0.3094 | 13 | 105 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 57.535 | 0.3477 | 13 | 118 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 52.4987 | 0.3771 | 13 | 128 | regulation of gene silencing |
GO:0051290 | 0 | 126.1606 | 0.1296 | 10 | 44 | protein heterotetramerization |
GO:0006333 | 0 | 38.6005 | 0.4979 | 13 | 169 | chromatin assembly or disassembly |
GO:0002244 | 0 | 34.7698 | 0.548 | 13 | 186 | hematopoietic progenitor cell differentiation |
GO:0006323 | 0 | 34.7698 | 0.548 | 13 | 186 | DNA packaging |
GO:0035194 | 0 | 27.26 | 0.6865 | 13 | 233 | posttranscriptional gene silencing by RNA |
GO:0071824 | 0 | 25.8302 | 0.7219 | 13 | 245 | protein-DNA complex subunit organization |
GO:0048863 | 0 | 24.5411 | 0.7572 | 13 | 257 | stem cell differentiation |
GO:0017148 | 0 | 19.4265 | 0.9428 | 13 | 320 | negative regulation of translation |
GO:0007596 | 0 | 18.9849 | 0.9635 | 13 | 327 | blood coagulation |
GO:0032200 | 0 | 27.8255 | 0.4803 | 10 | 163 | telomere organization |
GO:0030099 | 0 | 16.4169 | 1.1049 | 13 | 375 | myeloid cell differentiation |
GO:0050911 | 0 | 17.8951 | 0.9163 | 12 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:1903706 | 0 | 14.2362 | 1.264 | 13 | 429 | regulation of hemopoiesis |
GO:0050878 | 0 | 12.6677 | 1.4113 | 13 | 479 | regulation of body fluid levels |
GO:0009593 | 0 | 14.1602 | 1.1432 | 12 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 13.7116 | 1.1785 | 12 | 400 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 13.4976 | 1.1962 | 12 | 406 | sensory perception of chemical stimulus |
GO:0034248 | 0 | 11.2454 | 1.5792 | 13 | 536 | regulation of cellular amide metabolic process |
GO:0010608 | 0 | 9.587 | 1.8356 | 13 | 623 | posttranscriptional regulation of gene expression |
GO:0009611 | 0 | 9.506 | 1.8503 | 13 | 628 | response to wounding |
GO:0071345 | 0 | 7.6567 | 2.5014 | 14 | 849 | cellular response to cytokine stimulus |
GO:0043043 | 0 | 7.6831 | 2.2598 | 13 | 767 | peptide biosynthetic process |
GO:0051248 | 0 | 6.2292 | 3.6328 | 16 | 1233 | negative regulation of protein metabolic process |
GO:0048534 | 0 | 7.0339 | 2.4543 | 13 | 833 | hematopoietic or lymphoid organ development |
GO:0051259 | 0 | 8.327 | 1.5026 | 10 | 510 | protein oligomerization |
GO:0034622 | 0 | 5.9524 | 2.8668 | 13 | 973 | cellular macromolecular complex assembly |
GO:0045892 | 0 | 5.2747 | 3.2056 | 13 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 5.1013 | 3.3058 | 13 | 1122 | negative regulation of RNA biosynthetic process |
GO:0050877 | 0 | 4.9756 | 3.3824 | 13 | 1148 | nervous system process |
GO:0045934 | 0 | 4.6415 | 3.9658 | 14 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0031424 | 0 | 11.5499 | 0.604 | 6 | 205 | keratinization |
GO:0007186 | 1e-04 | 4.3219 | 3.4796 | 12 | 1181 | G-protein coupled receptor signaling pathway |
GO:0009890 | 1e-04 | 3.8818 | 4.6582 | 14 | 1581 | negative regulation of biosynthetic process |
GO:0045595 | 2e-04 | 3.7435 | 4.8114 | 14 | 1633 | regulation of cell differentiation |
GO:0009913 | 4e-04 | 7.1046 | 0.9635 | 6 | 327 | epidermal cell differentiation |
GO:0023052 | 6e-04 | 2.705 | 17.5779 | 29 | 5966 | signaling |
GO:0007154 | 7e-04 | 2.6905 | 17.6368 | 29 | 5986 | cell communication |
GO:0007166 | 7e-04 | 2.9307 | 7.6428 | 17 | 2594 | cell surface receptor signaling pathway |
GO:0032501 | 9e-04 | 3.7277 | 7.8245 | 16 | 3927 | multicellular organismal process |
GO:0002376 | 9e-04 | 2.8786 | 7.7577 | 17 | 2633 | immune system process |
GO:0043588 | 9e-04 | 5.9788 | 1.1373 | 6 | 386 | skin development |
GO:0006334 | 0.0013 | 15.3122 | 0.2185 | 3 | 94 | nucleosome assembly |
GO:0032268 | 0.0014 | 2.8047 | 7.3305 | 16 | 2488 | regulation of cellular protein metabolic process |
GO:0050896 | 0.002 | 2.5604 | 23.7799 | 34 | 8071 | response to stimulus |
GO:0070887 | 0.002 | 2.6351 | 8.344 | 17 | 2832 | cellular response to chemical stimulus |
GO:0048869 | 0.0024 | 2.4413 | 11.7117 | 21 | 3975 | cellular developmental process |
GO:0048731 | 0.0034 | 2.3427 | 12.8608 | 22 | 4365 | system development |
GO:0070271 | 0.0058 | 2.8859 | 4.0424 | 10 | 1372 | protein complex biogenesis |
GO:1900176 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:0010033 | 0.0068 | 2.3342 | 8.5326 | 16 | 2896 | response to organic substance |
GO:1900108 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | negative regulation of nodal signaling pathway |
GO:0051239 | 0.0091 | 2.2905 | 8.0052 | 15 | 2717 | regulation of multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 6e-04 | 8.453 | 0.7054 | 5 | 388 | detection of chemical stimulus |
GO:0050906 | 7e-04 | 8.1899 | 0.7272 | 5 | 400 | detection of stimulus involved in sensory perception |
GO:0007606 | 7e-04 | 8.0642 | 0.7381 | 5 | 406 | sensory perception of chemical stimulus |
GO:0019358 | 0.0018 | Inf | 0.0018 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 0.0018 | Inf | 0.0018 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0050911 | 0.0023 | 8.1386 | 0.5654 | 4 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0014839 | 0.0036 | 568.6429 | 0.0036 | 1 | 2 | myoblast migration involved in skeletal muscle regeneration |
GO:0036292 | 0.0036 | 568.6429 | 0.0036 | 1 | 2 | DNA rewinding |
GO:0007186 | 0.0044 | 3.9973 | 2.147 | 7 | 1181 | G-protein coupled receptor signaling pathway |
GO:0018149 | 0.0045 | 22.1803 | 0.1 | 2 | 55 | peptide cross-linking |
GO:0051697 | 0.0054 | 284.3036 | 0.0055 | 1 | 3 | protein delipidation |
GO:1900138 | 0.0054 | 284.3036 | 0.0055 | 1 | 3 | negative regulation of phospholipase A2 activity |
GO:0031394 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0033031 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | positive regulation of neutrophil apoptotic process |
GO:0045629 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | negative regulation of T-helper 2 cell differentiation |
GO:0097350 | 0.0073 | 189.5238 | 0.0073 | 1 | 4 | neutrophil clearance |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052548 | 6e-04 | 12.8021 | 0.4028 | 4 | 378 | regulation of endopeptidase activity |
GO:0010952 | 7e-04 | 20.6067 | 0.178 | 3 | 167 | positive regulation of peptidase activity |
GO:0019731 | 7e-04 | 58.8852 | 0.0405 | 2 | 38 | antibacterial humoral response |
GO:0098542 | 0.001 | 11.042 | 0.4646 | 4 | 436 | defense response to other organism |
GO:0051878 | 0.0011 | Inf | 0.0011 | 1 | 1 | lateral element assembly |
GO:0045071 | 0.0013 | 44.1306 | 0.0533 | 2 | 50 | negative regulation of viral genome replication |
GO:0014839 | 0.0021 | 995.875 | 0.0021 | 1 | 2 | myoblast migration involved in skeletal muscle regeneration |
GO:0036292 | 0.0021 | 995.875 | 0.0021 | 1 | 2 | DNA rewinding |
GO:0032652 | 0.0025 | 31.1118 | 0.0746 | 2 | 70 | regulation of interleukin-1 production |
GO:0071103 | 0.0025 | 12.9697 | 0.2792 | 3 | 262 | DNA conformation change |
GO:0000711 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | meiotic DNA repair synthesis |
GO:1900005 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
GO:1900138 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | negative regulation of phospholipase A2 activity |
GO:1901318 | 0.0032 | 497.9062 | 0.0032 | 1 | 3 | negative regulation of flagellated sperm motility |
GO:0097722 | 0.0035 | 26.0971 | 0.0885 | 2 | 83 | sperm motility |
GO:0048525 | 0.0037 | 25.1603 | 0.0916 | 2 | 86 | negative regulation of viral process |
GO:0031394 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0033031 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | positive regulation of neutrophil apoptotic process |
GO:0045629 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | negative regulation of T-helper 2 cell differentiation |
GO:0097350 | 0.0043 | 331.9167 | 0.0043 | 1 | 4 | neutrophil clearance |
GO:0050790 | 0.005 | 4.4167 | 2.3307 | 7 | 2187 | regulation of catalytic activity |
GO:0051704 | 0.0061 | 4.2422 | 2.4127 | 7 | 2264 | multi-organism process |
GO:0045627 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | positive regulation of T-helper 1 cell differentiation |
GO:0070459 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | prolactin secretion |
GO:2000483 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | negative regulation of interleukin-8 secretion |
GO:2001279 | 0.0064 | 199.125 | 0.0064 | 1 | 6 | regulation of unsaturated fatty acid biosynthetic process |
GO:0030162 | 0.0067 | 6.3541 | 0.7886 | 4 | 740 | regulation of proteolysis |
GO:0048609 | 0.0074 | 6.1779 | 0.8099 | 4 | 760 | multicellular organismal reproductive process |
GO:0031340 | 0.0074 | 165.9271 | 0.0075 | 1 | 7 | positive regulation of vesicle fusion |
GO:0051026 | 0.0074 | 165.9271 | 0.0075 | 1 | 7 | chiasma assembly |
GO:2001056 | 0.0077 | 17.1404 | 0.1332 | 2 | 125 | positive regulation of cysteine-type endopeptidase activity |
GO:0050777 | 0.0078 | 17.0011 | 0.1343 | 2 | 126 | negative regulation of immune response |
GO:1903900 | 0.0078 | 17.0011 | 0.1343 | 2 | 126 | regulation of viral life cycle |
GO:0051346 | 0.008 | 8.4744 | 0.422 | 3 | 396 | negative regulation of hydrolase activity |
GO:0043207 | 0.0084 | 5.9462 | 0.8398 | 4 | 788 | response to external biotic stimulus |
GO:0000733 | 0.0085 | 142.2143 | 0.0085 | 1 | 8 | DNA strand renaturation |
GO:0051256 | 0.0085 | 142.2143 | 0.0085 | 1 | 8 | mitotic spindle midzone assembly |
GO:0045087 | 0.0093 | 5.768 | 0.8643 | 4 | 811 | innate immune response |
GO:0035457 | 0.0096 | 124.4297 | 0.0096 | 1 | 9 | cellular response to interferon-alpha |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 33.4659 | 0.7019 | 14 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 26.4448 | 0.8756 | 14 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 25.6029 | 0.9027 | 14 | 400 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 25.2013 | 0.9162 | 14 | 406 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 9.0358 | 2.6652 | 15 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 8.2952 | 2.5908 | 14 | 1148 | nervous system process |
GO:0031424 | 0 | 15.796 | 0.4626 | 6 | 205 | keratinization |
GO:0009913 | 1e-04 | 9.7165 | 0.738 | 6 | 327 | epidermal cell differentiation |
GO:0043588 | 2e-04 | 8.1768 | 0.8711 | 6 | 386 | skin development |
GO:0018149 | 3e-04 | 27.7343 | 0.1241 | 3 | 55 | peptide cross-linking |
GO:0042742 | 0.0016 | 8.7965 | 0.5123 | 4 | 227 | defense response to bacterium |
GO:0002152 | 0.0023 | Inf | 0.0023 | 1 | 1 | bile acid conjugation |
GO:0045189 | 0.0023 | Inf | 0.0023 | 1 | 1 | connective tissue growth factor biosynthetic process |
GO:0070351 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of white fat cell proliferation |
GO:1903488 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of lactation |
GO:0010831 | 0.0031 | 26.6908 | 0.0835 | 2 | 37 | positive regulation of myotube differentiation |
GO:0002296 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | T-helper 1 cell lineage commitment |
GO:2000424 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | positive regulation of eosinophil chemotaxis |
GO:0032501 | 0.0057 | 2.7591 | 12.6215 | 20 | 6625 | multicellular organismal process |
GO:0036112 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
GO:0071288 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | cellular response to mercury ion |
GO:1903660 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | negative regulation of complement-dependent cytotoxicity |
GO:0031296 | 0.009 | 151.5524 | 0.009 | 1 | 4 | B cell costimulation |
GO:0048295 | 0.009 | 151.5524 | 0.009 | 1 | 4 | positive regulation of isotype switching to IgE isotypes |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006600 | 1e-04 | 234.1912 | 0.0119 | 2 | 10 | creatine metabolic process |
GO:0052548 | 9e-04 | 11.0938 | 0.4502 | 4 | 378 | regulation of endopeptidase activity |
GO:0019731 | 9e-04 | 51.951 | 0.0453 | 2 | 38 | antibacterial humoral response |
GO:0051878 | 0.0012 | Inf | 0.0012 | 1 | 1 | lateral element assembly |
GO:0051336 | 0.0015 | 6.1101 | 1.34 | 6 | 1125 | regulation of hydrolase activity |
GO:0098542 | 0.0015 | 9.5685 | 0.5193 | 4 | 436 | defense response to other organism |
GO:0045071 | 0.0016 | 38.9338 | 0.0596 | 2 | 50 | negative regulation of viral genome replication |
GO:0043207 | 0.0019 | 6.9102 | 0.9386 | 5 | 788 | response to external biotic stimulus |
GO:0014839 | 0.0024 | 885.1111 | 0.0024 | 1 | 2 | myoblast migration involved in skeletal muscle regeneration |
GO:0036292 | 0.0024 | 885.1111 | 0.0024 | 1 | 2 | DNA rewinding |
GO:0010466 | 0.0028 | 12.2602 | 0.2894 | 3 | 243 | negative regulation of peptidase activity |
GO:0032481 | 0.0031 | 27.4481 | 0.0834 | 2 | 70 | positive regulation of type I interferon production |
GO:0032652 | 0.0031 | 27.4481 | 0.0834 | 2 | 70 | regulation of interleukin-1 production |
GO:0071103 | 0.0035 | 11.347 | 0.3121 | 3 | 262 | DNA conformation change |
GO:0000711 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | meiotic DNA repair synthesis |
GO:1900005 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
GO:1900138 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | negative regulation of phospholipase A2 activity |
GO:1901318 | 0.0036 | 442.5278 | 0.0036 | 1 | 3 | negative regulation of flagellated sperm motility |
GO:0097722 | 0.0043 | 23.024 | 0.0989 | 2 | 83 | sperm motility |
GO:0048525 | 0.0046 | 22.1975 | 0.1024 | 2 | 86 | negative regulation of viral process |
GO:0031394 | 0.0048 | 295 | 0.0048 | 1 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0033031 | 0.0048 | 295 | 0.0048 | 1 | 4 | positive regulation of neutrophil apoptotic process |
GO:0045629 | 0.0048 | 295 | 0.0048 | 1 | 4 | negative regulation of T-helper 2 cell differentiation |
GO:0097350 | 0.0048 | 295 | 0.0048 | 1 | 4 | neutrophil clearance |
GO:2000117 | 0.0066 | 18.4415 | 0.1227 | 2 | 103 | negative regulation of cysteine-type endopeptidase activity |
GO:0051098 | 0.0066 | 8.9764 | 0.3919 | 3 | 329 | regulation of binding |
GO:0045627 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | positive regulation of T-helper 1 cell differentiation |
GO:0070459 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | prolactin secretion |
GO:2000483 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | negative regulation of interleukin-8 secretion |
GO:2001279 | 0.0071 | 176.9778 | 0.0071 | 1 | 6 | regulation of unsaturated fatty acid biosynthetic process |
GO:0031340 | 0.0083 | 147.4722 | 0.0083 | 1 | 7 | positive regulation of vesicle fusion |
GO:0051026 | 0.0083 | 147.4722 | 0.0083 | 1 | 7 | chiasma assembly |
GO:0043900 | 0.0092 | 7.9085 | 0.4431 | 3 | 372 | regulation of multi-organism process |
GO:0000733 | 0.0095 | 126.3968 | 0.0095 | 1 | 8 | DNA strand renaturation |
GO:0051256 | 0.0095 | 126.3968 | 0.0095 | 1 | 8 | mitotic spindle midzone assembly |
GO:0050777 | 0.0097 | 14.9991 | 0.1501 | 2 | 126 | negative regulation of immune response |
GO:1903900 | 0.0097 | 14.9991 | 0.1501 | 2 | 126 | regulation of viral life cycle |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006333 | 0 | 92.7936 | 0.3814 | 17 | 169 | chromatin assembly or disassembly |
GO:0006323 | 0 | 83.3694 | 0.4198 | 17 | 186 | DNA packaging |
GO:0071824 | 0 | 61.5642 | 0.5529 | 17 | 245 | protein-DNA complex subunit organization |
GO:0006335 | 0 | 277.8671 | 0.0722 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 235.0592 | 0.0812 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 226.339 | 0.0835 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 226.339 | 0.0835 | 10 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 179.6606 | 0.0993 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 95.2644 | 0.167 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 88.3333 | 0.1783 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 65.009 | 0.2663 | 11 | 118 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 66.885 | 0.2279 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 64.0526 | 0.237 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 51.4928 | 0.2889 | 10 | 128 | regulation of gene silencing |
GO:0032200 | 0 | 39.6254 | 0.3679 | 10 | 163 | telomere organization |
GO:0035194 | 0 | 31.1052 | 0.5258 | 11 | 233 | posttranscriptional gene silencing by RNA |
GO:0034622 | 0 | 14.0013 | 2.1958 | 17 | 973 | cellular macromolecular complex assembly |
GO:0002244 | 0 | 34.3969 | 0.4198 | 10 | 186 | hematopoietic progenitor cell differentiation |
GO:0017148 | 0 | 22.2236 | 0.7222 | 11 | 320 | negative regulation of translation |
GO:0006334 | 0 | 66.9383 | 0.1535 | 7 | 94 | nucleosome assembly |
GO:0048863 | 0 | 24.3989 | 0.58 | 10 | 257 | stem cell differentiation |
GO:0002227 | 0 | 170.9785 | 0.0451 | 5 | 20 | innate immune response in mucosa |
GO:0007596 | 0 | 18.9262 | 0.738 | 10 | 327 | blood coagulation |
GO:0050878 | 0 | 14.5238 | 1.081 | 11 | 479 | regulation of body fluid levels |
GO:0030099 | 0 | 16.3867 | 0.8463 | 10 | 375 | myeloid cell differentiation |
GO:0002251 | 0 | 94.9164 | 0.0722 | 5 | 32 | organ or tissue specific immune response |
GO:0034248 | 0 | 12.8991 | 1.2096 | 11 | 536 | regulation of cellular amide metabolic process |
GO:0019731 | 0 | 77.6295 | 0.0858 | 5 | 38 | antibacterial humoral response |
GO:1903706 | 0 | 14.2253 | 0.9682 | 10 | 429 | regulation of hemopoiesis |
GO:0010608 | 0 | 11.0029 | 1.406 | 11 | 623 | posttranscriptional regulation of gene expression |
GO:0061844 | 0 | 55.6452 | 0.1151 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0051259 | 0 | 11.8585 | 1.151 | 10 | 510 | protein oligomerization |
GO:0045892 | 0 | 7.8032 | 2.4554 | 13 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 7.5466 | 2.5321 | 13 | 1122 | negative regulation of RNA biosynthetic process |
GO:0043043 | 0 | 8.8233 | 1.7309 | 11 | 767 | peptide biosynthetic process |
GO:0009611 | 0 | 9.5208 | 1.4173 | 10 | 628 | response to wounding |
GO:0050830 | 0 | 32.7502 | 0.1873 | 5 | 83 | defense response to Gram-positive bacterium |
GO:0048534 | 0 | 8.0795 | 1.8799 | 11 | 833 | hematopoietic or lymphoid organ development |
GO:0045934 | 0 | 6.1835 | 3.0376 | 13 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009890 | 0 | 5.8272 | 3.568 | 14 | 1581 | negative regulation of biosynthetic process |
GO:0051248 | 0 | 6.0176 | 2.7826 | 12 | 1233 | negative regulation of protein metabolic process |
GO:0071345 | 0 | 6.9116 | 1.916 | 10 | 849 | cellular response to cytokine stimulus |
GO:0002376 | 0 | 4.5489 | 5.9421 | 17 | 2633 | immune system process |
GO:0022607 | 0 | 4.4549 | 6.0459 | 17 | 2679 | cellular component assembly |
GO:0045595 | 0 | 4.9879 | 3.6853 | 13 | 1633 | regulation of cell differentiation |
GO:0006959 | 1e-04 | 12.8038 | 0.4581 | 5 | 203 | humoral immune response |
GO:0051276 | 1e-04 | 6.9691 | 1.5693 | 8 | 953 | chromosome organization |
GO:1903506 | 5e-04 | 3.2826 | 7.7317 | 17 | 3426 | regulation of nucleic acid-templated transcription |
GO:0070271 | 7e-04 | 4.1099 | 3.0963 | 10 | 1372 | protein complex biogenesis |
GO:2000112 | 8e-04 | 3.101 | 8.7991 | 18 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0051252 | 0.001 | 3.0654 | 8.1537 | 17 | 3613 | regulation of RNA metabolic process |
GO:0097275 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular ammonia homeostasis |
GO:0097276 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular creatinine homeostasis |
GO:0097277 | 0.0023 | Inf | 0.0023 | 1 | 1 | cellular urea homeostasis |
GO:0070887 | 0.0023 | 2.9578 | 6.3912 | 14 | 2832 | cellular response to chemical stimulus |
GO:0071822 | 0.0023 | 3.4413 | 3.6334 | 10 | 1610 | protein complex subunit organization |
GO:0098542 | 0.0028 | 5.7949 | 0.984 | 5 | 436 | defense response to other organism |
GO:0010033 | 0.0028 | 2.878 | 6.5356 | 14 | 2896 | response to organic substance |
GO:0048731 | 0.0032 | 2.6614 | 9.8508 | 18 | 4365 | system development |
GO:0034654 | 0.0036 | 2.6477 | 9.1106 | 17 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0006583 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | melanin biosynthetic process from tyrosine |
GO:0051239 | 0.0047 | 2.7617 | 6.1316 | 13 | 2717 | regulation of multicellular organismal process |
GO:0009617 | 0.0055 | 4.902 | 1.1555 | 5 | 512 | response to bacterium |
GO:0032268 | 0.0065 | 2.7141 | 5.6148 | 12 | 2488 | regulation of cellular protein metabolic process |
GO:0006726 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | eye pigment biosynthetic process |
GO:0043324 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | pigment metabolic process involved in developmental pigmentation |
GO:0016567 | 0.0088 | 3.7691 | 1.8235 | 6 | 808 | protein ubiquitination |
GO:1900738 | 0.009 | 151.5524 | 0.009 | 1 | 4 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 289 | 0.0702 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 244.4769 | 0.079 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 235.4074 | 0.0812 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 235.4074 | 0.0812 | 10 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 186.8588 | 0.0965 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 99.0812 | 0.1624 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 91.8725 | 0.1733 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 69.5648 | 0.2216 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 66.6189 | 0.2304 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0035194 | 0 | 37.0553 | 0.5112 | 12 | 233 | posttranscriptional gene silencing by RNA |
GO:0060968 | 0 | 53.5559 | 0.2808 | 10 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 46.7615 | 0.3181 | 10 | 145 | chromatin assembly |
GO:0034728 | 0 | 43.509 | 0.3401 | 10 | 155 | nucleosome organization |
GO:0032200 | 0 | 41.2131 | 0.3576 | 10 | 163 | telomere organization |
GO:0017148 | 0 | 26.441 | 0.7021 | 12 | 320 | negative regulation of translation |
GO:0002244 | 0 | 35.775 | 0.4081 | 10 | 186 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 30.8098 | 0.4695 | 10 | 214 | protein-DNA complex assembly |
GO:1903507 | 0 | 12.6722 | 2.4596 | 17 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:1903706 | 0 | 19.3932 | 0.9413 | 12 | 429 | regulation of hemopoiesis |
GO:0009890 | 0 | 10.9133 | 3.4688 | 19 | 1581 | negative regulation of biosynthetic process |
GO:0051253 | 0 | 11.8168 | 2.6219 | 17 | 1195 | negative regulation of RNA metabolic process |
GO:0048863 | 0 | 25.3765 | 0.5639 | 10 | 257 | stem cell differentiation |
GO:0071103 | 0 | 24.8651 | 0.5748 | 10 | 262 | DNA conformation change |
GO:0030099 | 0 | 19.5837 | 0.8228 | 11 | 375 | myeloid cell differentiation |
GO:0006342 | 0 | 81.95 | 0.1052 | 6 | 67 | chromatin silencing |
GO:0034248 | 0 | 15.3266 | 1.176 | 12 | 536 | regulation of cellular amide metabolic process |
GO:0007596 | 0 | 19.6845 | 0.7175 | 10 | 327 | blood coagulation |
GO:0031324 | 0 | 8.1272 | 5.4874 | 21 | 2501 | negative regulation of cellular metabolic process |
GO:0010608 | 0 | 13.0699 | 1.3669 | 12 | 623 | posttranscriptional regulation of gene expression |
GO:0040029 | 0 | 24.2244 | 0.4883 | 8 | 310 | regulation of gene expression, epigenetic |
GO:0043043 | 0 | 10.4776 | 1.6829 | 12 | 767 | peptide biosynthetic process |
GO:0050878 | 0 | 13.1753 | 1.051 | 10 | 479 | regulation of body fluid levels |
GO:0051259 | 0 | 12.3336 | 1.119 | 10 | 510 | protein oligomerization |
GO:0048534 | 0 | 9.5934 | 1.8277 | 12 | 833 | hematopoietic or lymphoid organ development |
GO:0051248 | 0 | 8.0383 | 2.7053 | 14 | 1233 | negative regulation of protein metabolic process |
GO:0071345 | 0 | 9.4 | 1.8628 | 12 | 849 | cellular response to cytokine stimulus |
GO:0048519 | 0 | 5.8039 | 10.5689 | 25 | 4817 | negative regulation of biological process |
GO:0009611 | 0 | 9.9023 | 1.3779 | 10 | 628 | response to wounding |
GO:0006355 | 0 | 5.5533 | 7.473 | 21 | 3406 | regulation of transcription, DNA-templated |
GO:2001141 | 0 | 5.4975 | 7.5323 | 21 | 3433 | regulation of RNA biosynthetic process |
GO:0034654 | 0 | 5.0166 | 8.8575 | 22 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0019219 | 0 | 4.5292 | 8.7346 | 21 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0045595 | 0 | 5.215 | 3.5829 | 13 | 1633 | regulation of cell differentiation |
GO:0032268 | 0 | 4.5801 | 5.4589 | 16 | 2488 | regulation of cellular protein metabolic process |
GO:0009059 | 0 | 4.2403 | 10.9221 | 23 | 4978 | macromolecule biosynthetic process |
GO:0065007 | 0 | 14.9046 | 24.3543 | 34 | 11100 | biological regulation |
GO:0050794 | 1e-04 | 15.5763 | 12.6441 | 21 | 8183 | regulation of cellular process |
GO:0044249 | 2e-04 | 3.6973 | 13.0131 | 24 | 5931 | cellular biosynthetic process |
GO:0002376 | 2e-04 | 3.8099 | 5.777 | 15 | 2633 | immune system process |
GO:0090304 | 3e-04 | 3.436 | 10.6589 | 21 | 4858 | nucleic acid metabolic process |
GO:0034641 | 4e-04 | 3.434 | 13.6209 | 24 | 6208 | cellular nitrogen compound metabolic process |
GO:0060255 | 4e-04 | 4.8379 | 4.5492 | 12 | 2827 | regulation of macromolecule metabolic process |
GO:0070271 | 5e-04 | 4.2746 | 3.0103 | 10 | 1372 | protein complex biogenesis |
GO:0051172 | 6e-04 | 6.1207 | 1.5937 | 7 | 1117 | negative regulation of nitrogen compound metabolic process |
GO:2000113 | 8e-04 | 5.7933 | 1.6229 | 7 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
GO:0046483 | 9e-04 | 3.0947 | 12.3944 | 22 | 5649 | heterocycle metabolic process |
GO:0051276 | 9e-04 | 6.4185 | 1.1801 | 6 | 735 | chromosome organization |
GO:0006725 | 9e-04 | 3.0643 | 12.4734 | 22 | 5685 | cellular aromatic compound metabolic process |
GO:0044260 | 0.0012 | 3.2834 | 17.7611 | 27 | 8095 | cellular macromolecule metabolic process |
GO:1901360 | 0.0016 | 2.8973 | 12.9253 | 22 | 5891 | organic cyclic compound metabolic process |
GO:0071822 | 0.0018 | 3.5792 | 3.5325 | 10 | 1610 | protein complex subunit organization |
GO:0010033 | 0.0021 | 3.0153 | 6.3541 | 14 | 2896 | response to organic substance |
GO:0010604 | 0.0021 | 3.0076 | 6.3672 | 14 | 2902 | positive regulation of macromolecule metabolic process |
GO:0002737 | 0.0022 | Inf | 0.0022 | 1 | 1 | negative regulation of plasmacytoid dendritic cell cytokine production |
GO:0065003 | 0.0029 | 3.3386 | 3.7585 | 10 | 1713 | macromolecular complex assembly |
GO:0051239 | 0.0035 | 2.8875 | 5.9613 | 13 | 2717 | regulation of multicellular organismal process |
GO:0010629 | 0.0037 | 4.3015 | 2.1305 | 7 | 1448 | negative regulation of gene expression |
GO:0048015 | 0.0043 | 10.0574 | 0.3291 | 3 | 150 | phosphatidylinositol-mediated signaling |
GO:0021569 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | rhombomere 3 development |
GO:0021570 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | rhombomere 4 development |
GO:0042231 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | interleukin-13 biosynthetic process |
GO:1901253 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | negative regulation of intracellular transport of viral material |
GO:0070887 | 0.0051 | 2.7456 | 6.2136 | 13 | 2832 | cellular response to chemical stimulus |
GO:0007166 | 0.0071 | 2.6946 | 5.6914 | 12 | 2594 | cell surface receptor signaling pathway |
GO:0019732 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | antifungal humoral response |
GO:0051142 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | positive regulation of NK T cell proliferation |
GO:0014068 | 0.0092 | 15.0123 | 0.1448 | 2 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 1686.4697 | 0.053 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:1904837 | 0 | 256.6164 | 0.1296 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:0006335 | 0 | 374.4411 | 0.0943 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 306.2837 | 0.1061 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 259.0979 | 0.1179 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0051290 | 0 | 224.4949 | 0.1296 | 14 | 44 | protein heterotetramerization |
GO:0034724 | 0 | 181.9427 | 0.1503 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 164.1508 | 0.162 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 115.9133 | 0.2121 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 110.1918 | 0.221 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 103.3846 | 0.2328 | 14 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 77.1341 | 0.2976 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 73.7249 | 0.3094 | 14 | 105 | regulation of gene silencing by miRNA |
GO:0031497 | 0 | 56.881 | 0.4272 | 15 | 145 | chromatin assembly |
GO:0045814 | 0 | 64.4563 | 0.3477 | 14 | 118 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 58.765 | 0.3771 | 14 | 128 | regulation of gene silencing |
GO:1903707 | 0 | 55.8056 | 0.3948 | 14 | 134 | negative regulation of hemopoiesis |
GO:0032200 | 0 | 44.8615 | 0.4803 | 14 | 163 | telomere organization |
GO:0065004 | 0 | 36.9959 | 0.6305 | 15 | 214 | protein-DNA complex assembly |
GO:0035194 | 0 | 33.7306 | 0.6865 | 15 | 233 | posttranscriptional gene silencing by RNA |
GO:0002244 | 0 | 38.8058 | 0.548 | 14 | 186 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 30.339 | 0.7572 | 15 | 257 | stem cell differentiation |
GO:0071103 | 0 | 29.7153 | 0.7719 | 15 | 262 | DNA conformation change |
GO:0006352 | 0 | 30.8145 | 0.6777 | 14 | 230 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 30.2466 | 0.6894 | 14 | 234 | regulation of myeloid cell differentiation |
GO:0017148 | 0 | 23.9754 | 0.9428 | 15 | 320 | negative regulation of translation |
GO:0051259 | 0 | 16.1013 | 1.5026 | 16 | 510 | protein oligomerization |
GO:0060249 | 0 | 18.6367 | 1.0843 | 14 | 368 | anatomical structure homeostasis |
GO:0006325 | 0 | 12.61 | 2.0654 | 17 | 701 | chromatin organization |
GO:0006281 | 0 | 14.8402 | 1.4791 | 15 | 502 | DNA repair |
GO:0034248 | 0 | 13.8412 | 1.5792 | 15 | 536 | regulation of cellular amide metabolic process |
GO:0048534 | 0 | 10.4785 | 2.4543 | 17 | 833 | hematopoietic or lymphoid organ development |
GO:0010608 | 0 | 11.7935 | 1.8356 | 15 | 623 | posttranscriptional regulation of gene expression |
GO:0045596 | 0 | 10.6012 | 1.8444 | 14 | 626 | negative regulation of cell differentiation |
GO:0043043 | 0 | 9.4454 | 2.2598 | 15 | 767 | peptide biosynthetic process |
GO:0045892 | 0 | 7.8487 | 3.2056 | 17 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 7.5897 | 3.3058 | 17 | 1122 | negative regulation of RNA biosynthetic process |
GO:0070271 | 0 | 6.6704 | 4.0424 | 18 | 1372 | protein complex biogenesis |
GO:0045934 | 0 | 6.215 | 3.9658 | 17 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0065003 | 0 | 5.6925 | 5.0471 | 19 | 1713 | macromolecular complex assembly |
GO:0009890 | 0 | 5.6954 | 4.6582 | 18 | 1581 | negative regulation of biosynthetic process |
GO:0051248 | 0 | 6.2292 | 3.6328 | 16 | 1233 | negative regulation of protein metabolic process |
GO:0071822 | 0 | 5.5804 | 4.7436 | 18 | 1610 | protein complex subunit organization |
GO:0033554 | 0 | 4.8577 | 5.3623 | 18 | 1820 | cellular response to stress |
GO:0002682 | 0 | 5.0867 | 3.9982 | 15 | 1357 | regulation of immune system process |
GO:2000026 | 0 | 4.1061 | 5.2798 | 16 | 1792 | regulation of multicellular organismal development |
GO:0032268 | 0 | 3.6927 | 7.3305 | 19 | 2488 | regulation of cellular protein metabolic process |
GO:0010604 | 1e-04 | 3.3472 | 8.5503 | 20 | 2902 | positive regulation of macromolecule metabolic process |
GO:1903506 | 1e-04 | 3.2318 | 10.0942 | 22 | 3426 | regulation of nucleic acid-templated transcription |
GO:0032501 | 1e-04 | 3.1586 | 20.1235 | 33 | 6830 | multicellular organismal process |
GO:0006996 | 1e-04 | 3.1281 | 10.3534 | 22 | 3514 | organelle organization |
GO:0051252 | 2e-04 | 3.0176 | 10.6451 | 22 | 3613 | regulation of RNA metabolic process |
GO:2000112 | 2e-04 | 2.9741 | 11.4878 | 23 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0048731 | 5e-04 | 2.7797 | 12.8608 | 24 | 4365 | system development |
GO:0065008 | 7e-04 | 2.7782 | 9.9233 | 20 | 3368 | regulation of biological quality |
GO:0080090 | 7e-04 | 2.6543 | 16.8118 | 28 | 5706 | regulation of primary metabolic process |
GO:0034654 | 0.0011 | 2.606 | 11.8944 | 22 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0048518 | 0.0014 | 2.5063 | 15.5714 | 26 | 5285 | positive regulation of biological process |
GO:0071840 | 0.0015 | 2.4977 | 17.4718 | 28 | 5930 | cellular component organization or biogenesis |
GO:0048523 | 0.0023 | 2.9239 | 8.053 | 16 | 3740 | negative regulation of cellular process |
GO:0048869 | 0.0025 | 2.5499 | 10.2114 | 19 | 3730 | cellular developmental process |
GO:0003106 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of glomerular filtration by angiotensin |
GO:1901208 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of heart looping |
GO:1901211 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of cardiac chamber formation |
GO:1901219 | 0.0029 | Inf | 0.0029 | 1 | 1 | regulation of cardiac chamber morphogenesis |
GO:0050896 | 0.005 | 2.307 | 23.7799 | 33 | 8071 | response to stimulus |
GO:0010467 | 0.0052 | 2.2184 | 15.0617 | 24 | 5112 | gene expression |
GO:0019731 | 0.0056 | 19.5914 | 0.112 | 2 | 38 | antibacterial humoral response |
GO:0045165 | 0.0058 | 6.0461 | 0.7219 | 4 | 245 | cell fate commitment |
GO:0007521 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | muscle cell fate determination |
GO:0014895 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | smooth muscle hypertrophy |
GO:0060465 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | pharynx development |
GO:1904044 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | response to aldosterone |
GO:1904808 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | positive regulation of protein oxidation |
GO:1904845 | 0.0059 | 345.7391 | 0.0059 | 1 | 2 | cellular response to L-glutamine |
GO:0009059 | 0.0082 | 2.1178 | 14.6669 | 23 | 4978 | macromolecule biosynthetic process |
GO:0002019 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | regulation of renal output by angiotensin |
GO:0009957 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | epidermal cell fate specification |
GO:0030538 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | embryonic genitalia morphogenesis |
GO:0044336 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process |
GO:0048619 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | embryonic hindgut morphogenesis |
GO:0060596 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | mammary placode formation |
GO:1900005 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
GO:1901318 | 0.0088 | 172.8587 | 0.0088 | 1 | 3 | negative regulation of flagellated sperm motility |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 27.3892 | 0.5069 | 9 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 21.7171 | 0.6324 | 9 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 21.0343 | 0.652 | 9 | 400 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 20.7084 | 0.6617 | 9 | 406 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 10.8202 | 1.9249 | 12 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050877 | 1e-04 | 6.8731 | 1.8711 | 9 | 1148 | nervous system process |
GO:0018191 | 0.0016 | Inf | 0.0016 | 1 | 1 | peptidyl-serine octanoylation |
GO:0032788 | 0.0016 | Inf | 0.0016 | 1 | 1 | saturated monocarboxylic acid metabolic process |
GO:0032789 | 0.0016 | Inf | 0.0016 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
GO:0006968 | 0.0035 | 25.4391 | 0.088 | 2 | 54 | cellular defense response |
GO:0006104 | 0.0065 | 212.3067 | 0.0065 | 1 | 4 | succinyl-CoA metabolic process |
GO:0060267 | 0.0097 | 127.368 | 0.0098 | 1 | 6 | positive regulation of respiratory burst |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003336 | 0.0013 | Inf | 0.0013 | 1 | 1 | corneocyte desquamation |
GO:0009956 | 0.0013 | Inf | 0.0013 | 1 | 1 | radial pattern formation |
GO:0061015 | 0.0013 | Inf | 0.0013 | 1 | 1 | snRNA import into nucleus |
GO:1902480 | 0.0013 | Inf | 0.0013 | 1 | 1 | protein localization to mitotic spindle |
GO:1905716 | 0.0013 | Inf | 0.0013 | 1 | 1 | negative regulation of cornification |
GO:0060849 | 0.0025 | 838.4737 | 0.0025 | 1 | 2 | regulation of transcription involved in lymphatic endothelial cell fate commitment |
GO:0007525 | 0.0038 | 419.2105 | 0.0038 | 1 | 3 | somatic muscle development |
GO:0070995 | 0.0038 | 419.2105 | 0.0038 | 1 | 3 | NADPH oxidation |
GO:0051464 | 0.005 | 279.4561 | 0.005 | 1 | 4 | positive regulation of cortisol secretion |
GO:0072592 | 0.005 | 279.4561 | 0.005 | 1 | 4 | oxygen metabolic process |
GO:1902416 | 0.0075 | 167.6526 | 0.0075 | 1 | 6 | positive regulation of mRNA binding |
GO:0060839 | 0.0087 | 139.7018 | 0.0088 | 1 | 7 | endothelial cell fate commitment |
GO:2000848 | 0.0087 | 139.7018 | 0.0088 | 1 | 7 | positive regulation of corticosteroid hormone secretion |
GO:0060836 | 0.01 | 119.7368 | 0.01 | 1 | 8 | lymphatic endothelial cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031424 | 3e-04 | 14.9026 | 0.3213 | 4 | 205 | keratinization |
GO:0035195 | 4e-04 | 13.4136 | 0.3558 | 4 | 227 | gene silencing by miRNA |
GO:0016441 | 4e-04 | 12.9996 | 0.3667 | 4 | 234 | posttranscriptional gene silencing |
GO:0043567 | 6e-04 | 65.8634 | 0.036 | 2 | 23 | regulation of insulin-like growth factor receptor signaling pathway |
GO:0031047 | 6e-04 | 11.8005 | 0.4028 | 4 | 257 | gene silencing by RNA |
GO:0009913 | 0.0016 | 9.2018 | 0.5125 | 4 | 327 | epidermal cell differentiation |
GO:0034249 | 0.0017 | 9.0026 | 0.5234 | 4 | 334 | negative regulation of cellular amide metabolic process |
GO:0045661 | 0.0027 | 29.3802 | 0.0768 | 2 | 49 | regulation of myoblast differentiation |
GO:0043588 | 0.0029 | 7.7512 | 0.6049 | 4 | 386 | skin development |
GO:0006742 | 0.0031 | 663.5833 | 0.0031 | 1 | 2 | NADP catabolic process |
GO:1904379 | 0.0031 | 663.5833 | 0.0031 | 1 | 2 | protein localization to cytosolic proteasome complex involved in ERAD pathway |
GO:0060221 | 0.0047 | 331.7708 | 0.0047 | 1 | 3 | retinal rod cell differentiation |
GO:0072034 | 0.0047 | 331.7708 | 0.0047 | 1 | 3 | renal vesicle induction |
GO:0072197 | 0.0047 | 331.7708 | 0.0047 | 1 | 3 | ureter morphogenesis |
GO:0019674 | 0.0052 | 20.584 | 0.1081 | 2 | 69 | NAD metabolic process |
GO:0043043 | 0.006 | 4.9754 | 1.202 | 5 | 767 | peptide biosynthetic process |
GO:0043456 | 0.0063 | 221.1667 | 0.0063 | 1 | 4 | regulation of pentose-phosphate shunt |
GO:0060018 | 0.0063 | 221.1667 | 0.0063 | 1 | 4 | astrocyte fate commitment |
GO:0072289 | 0.0063 | 221.1667 | 0.0063 | 1 | 4 | metanephric nephron tubule formation |
GO:0006417 | 0.0069 | 5.9882 | 0.7758 | 4 | 495 | regulation of translation |
GO:0006032 | 0.0078 | 165.8646 | 0.0078 | 1 | 5 | chitin catabolic process |
GO:0072526 | 0.0078 | 165.8646 | 0.0078 | 1 | 5 | pyridine-containing compound catabolic process |
GO:0046533 | 0.0094 | 132.6833 | 0.0094 | 1 | 6 | negative regulation of photoreceptor cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 277.8671 | 0.0722 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 235.0592 | 0.0812 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 226.339 | 0.0835 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 226.339 | 0.0835 | 10 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 179.6606 | 0.0993 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 95.2644 | 0.167 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 88.3333 | 0.1783 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 66.885 | 0.2279 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 64.0526 | 0.237 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 56.2963 | 0.2663 | 10 | 118 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 51.4928 | 0.2889 | 10 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 44.9601 | 0.3272 | 10 | 145 | chromatin assembly |
GO:0034728 | 0 | 41.8329 | 0.3498 | 10 | 155 | nucleosome organization |
GO:0032200 | 0 | 39.6254 | 0.3679 | 10 | 163 | telomere organization |
GO:0007596 | 0 | 24.7635 | 0.738 | 12 | 327 | blood coagulation |
GO:0002244 | 0 | 34.3969 | 0.4198 | 10 | 186 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 29.6229 | 0.4829 | 10 | 214 | protein-DNA complex assembly |
GO:0035194 | 0 | 27.0662 | 0.5258 | 10 | 233 | posttranscriptional gene silencing by RNA |
GO:0048863 | 0 | 24.3989 | 0.58 | 10 | 257 | stem cell differentiation |
GO:0071103 | 0 | 23.9072 | 0.5913 | 10 | 262 | DNA conformation change |
GO:0050878 | 0 | 16.5407 | 1.081 | 12 | 479 | regulation of body fluid levels |
GO:0030099 | 0 | 18.7991 | 0.8463 | 11 | 375 | myeloid cell differentiation |
GO:0009611 | 0 | 14.0624 | 1.4173 | 13 | 628 | response to wounding |
GO:0017148 | 0 | 19.3623 | 0.7222 | 10 | 320 | negative regulation of translation |
GO:1903706 | 0 | 14.2253 | 0.9682 | 10 | 429 | regulation of hemopoiesis |
GO:0051259 | 0 | 11.8585 | 1.151 | 10 | 510 | protein oligomerization |
GO:0034248 | 0 | 11.2533 | 1.2096 | 10 | 536 | regulation of cellular amide metabolic process |
GO:0045892 | 0 | 7.8032 | 2.4554 | 13 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 7.5466 | 2.5321 | 13 | 1122 | negative regulation of RNA biosynthetic process |
GO:0010608 | 0 | 9.6016 | 1.406 | 10 | 623 | posttranscriptional regulation of gene expression |
GO:0048534 | 0 | 8.0795 | 1.8799 | 11 | 833 | hematopoietic or lymphoid organ development |
GO:0071345 | 0 | 7.9168 | 1.916 | 11 | 849 | cellular response to cytokine stimulus |
GO:0045934 | 0 | 6.1835 | 3.0376 | 13 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0043043 | 0 | 7.702 | 1.7309 | 10 | 767 | peptide biosynthetic process |
GO:0007275 | 0 | 4.535 | 11.0469 | 24 | 4895 | multicellular organism development |
GO:0010604 | 0 | 4.5187 | 6.5491 | 18 | 2902 | positive regulation of macromolecule metabolic process |
GO:0009890 | 0 | 5.172 | 3.568 | 13 | 1581 | negative regulation of biosynthetic process |
GO:0050911 | 1e-04 | 10.2367 | 0.7019 | 6 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0023052 | 1e-04 | 3.8159 | 13.4639 | 25 | 5966 | signaling |
GO:0007154 | 1e-04 | 3.7955 | 13.509 | 25 | 5986 | cell communication |
GO:0048513 | 1e-04 | 5.0312 | 3.8891 | 12 | 2352 | animal organ development |
GO:0032502 | 2e-04 | 3.568 | 12.9561 | 24 | 5741 | developmental process |
GO:0050896 | 2e-04 | 4.0563 | 18.2144 | 29 | 8071 | response to stimulus |
GO:0009593 | 2e-04 | 8.133 | 0.8756 | 6 | 388 | detection of chemical stimulus |
GO:0050906 | 2e-04 | 7.8792 | 0.9027 | 6 | 400 | detection of stimulus involved in sensory perception |
GO:0007166 | 3e-04 | 3.6938 | 5.8541 | 15 | 2594 | cell surface receptor signaling pathway |
GO:0007606 | 3e-04 | 7.758 | 0.9162 | 6 | 406 | sensory perception of chemical stimulus |
GO:0032501 | 3e-04 | 9.3234 | 1.5729 | 7 | 1376 | multicellular organismal process |
GO:0051248 | 3e-04 | 4.6207 | 2.7826 | 10 | 1233 | negative regulation of protein metabolic process |
GO:0060134 | 4e-04 | 85.0535 | 0.0293 | 2 | 13 | prepulse inhibition |
GO:1903506 | 5e-04 | 3.2826 | 7.7317 | 17 | 3426 | regulation of nucleic acid-templated transcription |
GO:0045595 | 7e-04 | 3.8775 | 3.6853 | 11 | 1633 | regulation of cell differentiation |
GO:0070271 | 7e-04 | 4.1099 | 3.0963 | 10 | 1372 | protein complex biogenesis |
GO:0050877 | 8e-04 | 4.3246 | 2.5908 | 9 | 1148 | nervous system process |
GO:0048518 | 0.001 | 3.0379 | 11.5899 | 21 | 5281 | positive regulation of biological process |
GO:0051252 | 0.001 | 3.0654 | 8.1537 | 17 | 3613 | regulation of RNA metabolic process |
GO:0034654 | 0.0012 | 2.9602 | 9.1106 | 18 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0051239 | 0.0015 | 3.1107 | 6.1316 | 14 | 2717 | regulation of multicellular organismal process |
GO:0032268 | 0.0021 | 3.0695 | 5.6148 | 13 | 2488 | regulation of cellular protein metabolic process |
GO:0002152 | 0.0023 | Inf | 0.0023 | 1 | 1 | bile acid conjugation |
GO:0052182 | 0.0023 | Inf | 0.0023 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
GO:0060678 | 0.0023 | Inf | 0.0023 | 1 | 1 | dichotomous subdivision of terminal units involved in ureteric bud branching |
GO:0072127 | 0.0023 | Inf | 0.0023 | 1 | 1 | renal capsule development |
GO:0072129 | 0.0023 | Inf | 0.0023 | 1 | 1 | renal capsule formation |
GO:0072265 | 0.0023 | Inf | 0.0023 | 1 | 1 | metanephric capsule morphogenesis |
GO:0072267 | 0.0023 | Inf | 0.0023 | 1 | 1 | metanephric capsule specification |
GO:1902251 | 0.0023 | Inf | 0.0023 | 1 | 1 | negative regulation of erythrocyte apoptotic process |
GO:0070887 | 0.0023 | 2.9578 | 6.3912 | 14 | 2832 | cellular response to chemical stimulus |
GO:0071822 | 0.0023 | 3.4413 | 3.6334 | 10 | 1610 | protein complex subunit organization |
GO:2000112 | 0.0024 | 2.7736 | 8.7991 | 17 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0048523 | 0.0032 | 2.6605 | 9.8531 | 18 | 4366 | negative regulation of cellular process |
GO:0065003 | 0.0037 | 3.2099 | 3.8658 | 10 | 1713 | macromolecular complex assembly |
GO:0007186 | 0.0041 | 3.591 | 2.6652 | 8 | 1181 | G-protein coupled receptor signaling pathway |
GO:0046960 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | sensitization |
GO:0051877 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | pigment granule aggregation in cell center |
GO:0052047 | 0.0045 | 454.7143 | 0.0045 | 1 | 2 | interaction with other organism via secreted substance involved in symbiotic interaction |
GO:0030154 | 0.005 | 3.4641 | 3.5021 | 9 | 1978 | cell differentiation |
GO:0035106 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | operant conditioning |
GO:0038162 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | erythropoietin-mediated signaling pathway |
GO:0072076 | 0.0068 | 227.3429 | 0.0068 | 1 | 3 | nephrogenic mesenchyme development |
GO:0010033 | 0.0081 | 2.5551 | 6.5356 | 13 | 2896 | response to organic substance |
GO:0021853 | 0.009 | 151.5524 | 0.009 | 1 | 4 | cerebral cortex GABAergic interneuron migration |
GO:0046959 | 0.009 | 151.5524 | 0.009 | 1 | 4 | habituation |
GO:0051919 | 0.009 | 151.5524 | 0.009 | 1 | 4 | positive regulation of fibrinolysis |
GO:2000048 | 0.009 | 151.5524 | 0.009 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
GO:0060291 | 0.0091 | 15.0417 | 0.1444 | 2 | 64 | long-term synaptic potentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 1919.569 | 0.0485 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 426.1954 | 0.0863 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 348.6176 | 0.097 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 294.9098 | 0.1078 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0051290 | 0 | 255.5241 | 0.1186 | 14 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 255.5241 | 0.1186 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 207.0904 | 0.1375 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 186.8394 | 0.1483 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 131.9346 | 0.1941 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 125.4223 | 0.2022 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 117.6743 | 0.213 | 14 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 82.2087 | 0.3181 | 15 | 118 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 87.7955 | 0.2723 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 83.9151 | 0.283 | 14 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 66.8875 | 0.345 | 14 | 128 | regulation of gene silencing |
GO:1903707 | 0 | 63.519 | 0.3612 | 14 | 134 | negative regulation of hemopoiesis |
GO:0031497 | 0 | 58.1448 | 0.3909 | 14 | 145 | chromatin assembly |
GO:0032200 | 0 | 51.0623 | 0.4394 | 14 | 163 | telomere organization |
GO:0002244 | 0 | 44.1696 | 0.5014 | 14 | 186 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 36.4203 | 0.6689 | 15 | 254 | stem cell differentiation |
GO:0065004 | 0 | 37.9183 | 0.5769 | 14 | 214 | protein-DNA complex assembly |
GO:0006352 | 0 | 35.0738 | 0.62 | 14 | 230 | DNA-templated transcription, initiation |
GO:0035194 | 0 | 34.5867 | 0.6281 | 14 | 233 | posttranscriptional gene silencing by RNA |
GO:0045637 | 0 | 34.4273 | 0.6308 | 14 | 234 | regulation of myeloid cell differentiation |
GO:0071103 | 0 | 30.4858 | 0.7062 | 14 | 262 | DNA conformation change |
GO:0017148 | 0 | 24.616 | 0.8626 | 14 | 320 | negative regulation of translation |
GO:0045596 | 0 | 16.4267 | 1.6874 | 17 | 626 | negative regulation of cell differentiation |
GO:0060249 | 0 | 21.2127 | 0.992 | 14 | 368 | anatomical structure homeostasis |
GO:0006281 | 0 | 15.2554 | 1.3532 | 14 | 502 | DNA repair |
GO:0034248 | 0 | 14.2303 | 1.4448 | 14 | 536 | regulation of cellular amide metabolic process |
GO:0006325 | 0 | 11.888 | 1.8896 | 15 | 701 | chromatin organization |
GO:0010608 | 0 | 12.1284 | 1.6794 | 14 | 623 | posttranscriptional regulation of gene expression |
GO:0045892 | 0 | 9.0586 | 2.9328 | 17 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 8.7598 | 3.0244 | 17 | 1122 | negative regulation of RNA biosynthetic process |
GO:0070271 | 0 | 7.7397 | 3.6983 | 18 | 1372 | protein complex biogenesis |
GO:0043043 | 0 | 9.7167 | 2.0675 | 14 | 767 | peptide biosynthetic process |
GO:0048534 | 0 | 8.8948 | 2.2454 | 14 | 833 | hematopoietic or lymphoid organ development |
GO:0045934 | 0 | 7.1731 | 3.6283 | 17 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0002682 | 0 | 7.1089 | 3.6579 | 17 | 1357 | regulation of immune system process |
GO:0071822 | 0 | 6.475 | 4.3399 | 18 | 1610 | protein complex subunit organization |
GO:0065003 | 0 | 6.0378 | 4.6175 | 18 | 1713 | macromolecular complex assembly |
GO:0009890 | 0 | 5.9971 | 4.2617 | 17 | 1581 | negative regulation of biosynthetic process |
GO:0051248 | 0 | 6.4616 | 3.3237 | 15 | 1233 | negative regulation of protein metabolic process |
GO:2000026 | 0 | 5.8013 | 4.4937 | 17 | 1743 | regulation of multicellular organismal development |
GO:0048519 | 0 | 4.3344 | 12.9846 | 28 | 4817 | negative regulation of biological process |
GO:1903506 | 0 | 4.2262 | 9.2351 | 23 | 3426 | regulation of nucleic acid-templated transcription |
GO:0033554 | 0 | 4.6333 | 4.906 | 16 | 1820 | cellular response to stress |
GO:0051252 | 0 | 3.9462 | 9.7392 | 23 | 3613 | regulation of RNA metabolic process |
GO:2000112 | 0 | 3.5702 | 10.5101 | 23 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0048518 | 1e-04 | 3.4183 | 14.2462 | 27 | 5285 | positive regulation of biological process |
GO:0034654 | 1e-04 | 3.4079 | 10.8821 | 23 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0060179 | 1e-04 | 193.9634 | 0.0162 | 2 | 6 | male mating behavior |
GO:0051602 | 2e-04 | 29.7544 | 0.1159 | 3 | 43 | response to electrical stimulus |
GO:0010604 | 3e-04 | 3.2517 | 7.8226 | 18 | 2902 | positive regulation of macromolecule metabolic process |
GO:0032268 | 5e-04 | 3.2211 | 6.7066 | 16 | 2488 | regulation of cellular protein metabolic process |
GO:0048869 | 6e-04 | 2.8861 | 10.715 | 21 | 3975 | cellular developmental process |
GO:0015671 | 7e-04 | 59.6473 | 0.0404 | 2 | 15 | oxygen transport |
GO:0006996 | 0.001 | 2.8119 | 9.4723 | 19 | 3514 | organelle organization |
GO:0010467 | 0.0011 | 2.6864 | 13.7798 | 24 | 5112 | gene expression |
GO:0090304 | 0.0014 | 2.6339 | 13.0952 | 23 | 4858 | nucleic acid metabolic process |
GO:0090189 | 0.0014 | 40.7959 | 0.0566 | 2 | 21 | regulation of branching involved in ureteric bud morphogenesis |
GO:0042744 | 0.0016 | 38.7537 | 0.0593 | 2 | 22 | hydrogen peroxide catabolic process |
GO:0065008 | 0.0017 | 2.6992 | 9.0787 | 18 | 3368 | regulation of biological quality |
GO:0009059 | 0.0019 | 2.5423 | 13.4186 | 23 | 4978 | macromolecule biosynthetic process |
GO:0048731 | 0.0022 | 2.5413 | 11.7662 | 21 | 4365 | system development |
GO:0080090 | 0.0023 | 2.5005 | 15.381 | 25 | 5706 | regulation of primary metabolic process |
GO:0014739 | 0.0027 | Inf | 0.0027 | 1 | 1 | positive regulation of muscle hyperplasia |
GO:0060450 | 0.0027 | Inf | 0.0027 | 1 | 1 | positive regulation of hindgut contraction |
GO:0019098 | 0.0029 | 27.6672 | 0.0809 | 2 | 30 | reproductive behavior |
GO:0048048 | 0.0038 | 24.2027 | 0.0916 | 2 | 34 | embryonic eye morphogenesis |
GO:0097178 | 0.0038 | 24.2027 | 0.0916 | 2 | 34 | ruffle assembly |
GO:0030431 | 0.0042 | 22.7762 | 0.097 | 2 | 36 | sleep |
GO:0090596 | 0.0042 | 6.64 | 0.6631 | 4 | 246 | sensory organ morphogenesis |
GO:0007618 | 0.0047 | 21.5081 | 0.1024 | 2 | 38 | mating |
GO:0046483 | 0.0049 | 2.3094 | 15.2274 | 24 | 5649 | heterocycle metabolic process |
GO:0003404 | 0.0054 | 378.7619 | 0.0054 | 1 | 2 | optic vesicle morphogenesis |
GO:0097402 | 0.0054 | 378.7619 | 0.0054 | 1 | 2 | neuroblast migration |
GO:0015701 | 0.006 | 18.8792 | 0.1159 | 2 | 43 | bicarbonate transport |
GO:0090183 | 0.0077 | 16.4629 | 0.1321 | 2 | 49 | regulation of kidney development |
GO:0002125 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | maternal aggressive behavior |
GO:0009946 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | proximal/distal axis specification |
GO:0014016 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | neuroblast differentiation |
GO:0035880 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | embryonic nail plate morphogenesis |
GO:0038123 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | toll-like receptor TLR1:TLR2 signaling pathway |
GO:0045925 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | positive regulation of female receptivity |
GO:0071673 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:0071727 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | cellular response to triacyl bacterial lipopeptide |
GO:1902732 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | positive regulation of chondrocyte proliferation |
GO:1903237 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | negative regulation of leukocyte tethering or rolling |
GO:1904693 | 0.0081 | 189.369 | 0.0081 | 1 | 3 | midbrain morphogenesis |
GO:0051291 | 0.0086 | 15.6089 | 0.1404 | 2 | 77 | protein heterooligomerization |
GO:1901360 | 0.0089 | 2.162 | 15.8797 | 24 | 5891 | organic cyclic compound metabolic process |
GO:0071840 | 0.0098 | 2.1394 | 15.9848 | 24 | 5930 | cellular component organization or biogenesis |
GO:0044249 | 0.0098 | 2.1388 | 15.9875 | 24 | 5931 | cellular biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 289 | 0.0702 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 244.4769 | 0.079 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 235.4074 | 0.0812 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 235.4074 | 0.0812 | 10 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 186.8588 | 0.0965 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 99.0812 | 0.1624 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 91.8725 | 0.1733 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 69.5648 | 0.2216 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 66.6189 | 0.2304 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 58.5519 | 0.2589 | 10 | 118 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 53.5559 | 0.2808 | 10 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 46.7615 | 0.3181 | 10 | 145 | chromatin assembly |
GO:0034728 | 0 | 43.509 | 0.3401 | 10 | 155 | nucleosome organization |
GO:0032200 | 0 | 41.2131 | 0.3576 | 10 | 163 | telomere organization |
GO:0035194 | 0 | 32.4033 | 0.5112 | 11 | 233 | posttranscriptional gene silencing by RNA |
GO:0007596 | 0 | 25.8418 | 0.7175 | 12 | 327 | blood coagulation |
GO:0002244 | 0 | 35.775 | 0.4081 | 10 | 186 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 30.8098 | 0.4695 | 10 | 214 | protein-DNA complex assembly |
GO:0017148 | 0 | 23.151 | 0.7021 | 11 | 320 | negative regulation of translation |
GO:0048863 | 0 | 25.3765 | 0.5639 | 10 | 257 | stem cell differentiation |
GO:0071103 | 0 | 24.8651 | 0.5748 | 10 | 262 | DNA conformation change |
GO:0050878 | 0 | 17.261 | 1.051 | 12 | 479 | regulation of body fluid levels |
GO:0030099 | 0 | 19.5837 | 0.8228 | 11 | 375 | myeloid cell differentiation |
GO:0009611 | 0 | 14.7026 | 1.3779 | 13 | 628 | response to wounding |
GO:0034248 | 0 | 13.4375 | 1.176 | 11 | 536 | regulation of cellular amide metabolic process |
GO:1903706 | 0 | 14.7952 | 0.9413 | 10 | 429 | regulation of hemopoiesis |
GO:0010608 | 0 | 11.4621 | 1.3669 | 11 | 623 | posttranscriptional regulation of gene expression |
GO:0051259 | 0 | 12.3336 | 1.119 | 10 | 510 | protein oligomerization |
GO:0043043 | 0 | 9.1915 | 1.6829 | 11 | 767 | peptide biosynthetic process |
GO:0048534 | 0 | 8.4167 | 1.8277 | 11 | 833 | hematopoietic or lymphoid organ development |
GO:0071345 | 0 | 8.2473 | 1.8628 | 11 | 849 | cellular response to cytokine stimulus |
GO:0045892 | 0 | 7.1962 | 2.3872 | 12 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 6.9598 | 2.4618 | 12 | 1122 | negative regulation of RNA biosynthetic process |
GO:0050896 | 0 | 5.8769 | 17.7084 | 30 | 8071 | response to stimulus |
GO:0009890 | 0 | 5.4075 | 3.4688 | 13 | 1581 | negative regulation of biosynthetic process |
GO:0045934 | 0 | 5.7035 | 2.9532 | 12 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0051248 | 0 | 5.5116 | 2.7053 | 11 | 1233 | negative regulation of protein metabolic process |
GO:0050911 | 1e-04 | 10.5904 | 0.6824 | 6 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 2e-04 | 8.414 | 0.8513 | 6 | 388 | detection of chemical stimulus |
GO:0023052 | 2e-04 | 3.6627 | 13.0899 | 24 | 5966 | signaling |
GO:0007154 | 2e-04 | 3.6431 | 13.1338 | 24 | 5986 | cell communication |
GO:0050906 | 2e-04 | 8.1514 | 0.8776 | 6 | 400 | detection of stimulus involved in sensory perception |
GO:0007606 | 2e-04 | 8.026 | 0.8908 | 6 | 406 | sensory perception of chemical stimulus |
GO:0045595 | 5e-04 | 4.0394 | 3.5829 | 11 | 1633 | regulation of cell differentiation |
GO:0070271 | 5e-04 | 4.2746 | 3.0103 | 10 | 1372 | protein complex biogenesis |
GO:0050877 | 6e-04 | 4.4912 | 2.5188 | 9 | 1148 | nervous system process |
GO:0007166 | 7e-04 | 3.4463 | 5.6914 | 14 | 2594 | cell surface receptor signaling pathway |
GO:0048731 | 7e-04 | 3.1617 | 9.5772 | 19 | 4365 | system development |
GO:0032268 | 0.0016 | 3.2093 | 5.4589 | 13 | 2488 | regulation of cellular protein metabolic process |
GO:0032501 | 0.0016 | 3.8892 | 6.8392 | 14 | 4115 | multicellular organismal process |
GO:0071822 | 0.0018 | 3.5792 | 3.5325 | 10 | 1610 | protein complex subunit organization |
GO:0048869 | 0.0021 | 2.8536 | 8.7215 | 17 | 3975 | cellular developmental process |
GO:0010604 | 0.0021 | 3.0076 | 6.3672 | 14 | 2902 | positive regulation of macromolecule metabolic process |
GO:0052182 | 0.0022 | Inf | 0.0022 | 1 | 1 | modification by host of symbiont morphology or physiology via secreted substance |
GO:1902251 | 0.0022 | Inf | 0.0022 | 1 | 1 | negative regulation of erythrocyte apoptotic process |
GO:0002376 | 0.0027 | 2.999 | 5.777 | 13 | 2633 | immune system process |
GO:0065003 | 0.0029 | 3.3386 | 3.7585 | 10 | 1713 | macromolecular complex assembly |
GO:0007186 | 0.0034 | 3.7243 | 2.5912 | 8 | 1181 | G-protein coupled receptor signaling pathway |
GO:0051239 | 0.0035 | 2.8875 | 5.9613 | 13 | 2717 | regulation of multicellular organismal process |
GO:0051877 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | pigment granule aggregation in cell center |
GO:0052047 | 0.0044 | 468.1176 | 0.0044 | 1 | 2 | interaction with other organism via secreted substance involved in symbiotic interaction |
GO:0070887 | 0.0051 | 2.7456 | 6.2136 | 13 | 2832 | cellular response to chemical stimulus |
GO:0048523 | 0.006 | 2.5121 | 9.5794 | 17 | 4366 | negative regulation of cellular process |
GO:0038162 | 0.0066 | 234.0441 | 0.0066 | 1 | 3 | erythropoietin-mediated signaling pathway |
GO:0051919 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | positive regulation of fibrinolysis |
GO:2000048 | 0.0087 | 156.0196 | 0.0088 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004068 | 0.0016 | Inf | 0.0016 | 1 | 1 | aspartate 1-decarboxylase activity |
GO:0004782 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | sulfinoalanine decarboxylase activity |
GO:0004169 | 0.0078 | 165.8958 | 0.0078 | 1 | 5 | dolichyl-phosphate-mannose-protein mannosyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047963 | 0.0016 | Inf | 0.0016 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0052817 | 0.0016 | Inf | 0.0016 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0036461 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | BLOC-2 complex binding |
GO:0052815 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
GO:0071885 | 0.0031 | 663.7083 | 0.0031 | 1 | 2 | N-terminal protein N-methyltransferase activity |
GO:0032217 | 0.0047 | 331.8333 | 0.0047 | 1 | 3 | riboflavin transporter activity |
GO:0035651 | 0.0047 | 331.8333 | 0.0047 | 1 | 3 | AP-3 adaptor complex binding |
GO:0035650 | 0.0063 | 221.2083 | 0.0063 | 1 | 4 | AP-1 adaptor complex binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005540 | 6e-04 | 66.2875 | 0.0359 | 2 | 22 | hyaluronic acid binding |
GO:0004516 | 0.0016 | Inf | 0.0016 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0008437 | 0.0016 | Inf | 0.0016 | 1 | 1 | thyrotropin-releasing hormone activity |
GO:0097162 | 0.0016 | Inf | 0.0016 | 1 | 1 | MADS box domain binding |
GO:0004882 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | androgen receptor activity |
GO:0046811 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | histone deacetylase inhibitor activity |
GO:1904854 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | proteasome core complex binding |
GO:0004514 | 0.0049 | 318.54 | 0.0049 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0051430 | 0.0065 | 212.3467 | 0.0065 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
GO:0051431 | 0.0065 | 212.3467 | 0.0065 | 1 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0001875 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | lipopolysaccharide receptor activity |
GO:0030284 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | estrogen receptor activity |
GO:1990405 | 0.0097 | 127.392 | 0.0098 | 1 | 6 | protein antigen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 25.7888 | 0.4678 | 8 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 10.719 | 1.08 | 8 | 718 | G-protein coupled receptor activity |
GO:0099600 | 2e-04 | 6.4628 | 1.7329 | 8 | 1152 | transmembrane receptor activity |
GO:0038023 | 3e-04 | 6.1269 | 1.8201 | 8 | 1210 | signaling receptor activity |
GO:0031369 | 9e-04 | 53.5488 | 0.0436 | 2 | 29 | translation initiation factor binding |
GO:0060089 | 0.001 | 4.9671 | 2.2037 | 8 | 1465 | molecular transducer activity |
GO:0003743 | 0.0022 | 32.8244 | 0.0692 | 2 | 46 | translation initiation factor activity |
GO:0004649 | 0.003 | 692.6087 | 0.003 | 1 | 2 | poly(ADP-ribose) glycohydrolase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 137.3443 | 0.1213 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 23.8407 | 1.2879 | 18 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 26.6007 | 0.5074 | 10 | 184 | histone binding |
GO:0045296 | 0 | 15.8986 | 0.8246 | 10 | 299 | cadherin binding |
GO:0003682 | 0 | 9.8132 | 1.3044 | 10 | 473 | chromatin binding |
GO:0003677 | 0 | 4.0804 | 6.4145 | 18 | 2326 | DNA binding |
GO:0044877 | 0 | 5.3269 | 2.6144 | 11 | 948 | macromolecular complex binding |
GO:0031686 | 0.0028 | Inf | 0.0028 | 1 | 1 | A1 adenosine receptor binding |
GO:0045032 | 0.0028 | Inf | 0.0028 | 1 | 1 | ADP-activated adenosine receptor activity |
GO:0008260 | 0.0055 | 370 | 0.0055 | 1 | 2 | 3-oxoacid CoA-transferase activity |
GO:0045031 | 0.0055 | 370 | 0.0055 | 1 | 2 | ATP-activated adenosine receptor activity |
GO:0097110 | 0.0087 | 15.415 | 0.1406 | 2 | 51 | scaffold protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 1e-04 | 10.0659 | 0.761 | 6 | 467 | protein heterodimerization activity |
GO:0004984 | 1e-04 | 12.1561 | 0.5068 | 5 | 311 | olfactory receptor activity |
GO:0004930 | 9e-04 | 6.4117 | 1.17 | 6 | 718 | G-protein coupled receptor activity |
GO:0004508 | 0.0016 | Inf | 0.0016 | 1 | 1 | steroid 17-alpha-monooxygenase activity |
GO:0016412 | 0.0016 | Inf | 0.0016 | 1 | 1 | serine O-acyltransferase activity |
GO:0022852 | 0.0016 | Inf | 0.0016 | 1 | 1 | glycine-gated chloride ion channel activity |
GO:0047442 | 0.0016 | Inf | 0.0016 | 1 | 1 | 17-alpha-hydroxyprogesterone aldolase activity |
GO:0099600 | 0.002 | 4.757 | 1.8773 | 7 | 1152 | transmembrane receptor activity |
GO:0038023 | 0.0026 | 4.5099 | 1.9718 | 7 | 1210 | signaling receptor activity |
GO:0045519 | 0.0033 | 637.12 | 0.0033 | 1 | 2 | interleukin-23 receptor binding |
GO:0016934 | 0.0049 | 318.54 | 0.0049 | 1 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0030345 | 0.0065 | 212.3467 | 0.0065 | 1 | 4 | structural constituent of tooth enamel |
GO:0060089 | 0.0075 | 3.6567 | 2.3873 | 7 | 1465 | molecular transducer activity |
GO:0030883 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0081 | 159.25 | 0.0081 | 1 | 5 | exogenous lipid antigen binding |
GO:0004523 | 0.0097 | 127.392 | 0.0098 | 1 | 6 | RNA-DNA hybrid ribonuclease activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 26.1204 | 0.7017 | 12 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 12.1975 | 1.6201 | 13 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 7.3344 | 2.5993 | 13 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 6.9517 | 2.7302 | 13 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 5.6315 | 3.3055 | 13 | 1465 | molecular transducer activity |
GO:0005549 | 5e-04 | 21.1912 | 0.1602 | 3 | 71 | odorant binding |
GO:0004336 | 0.0023 | Inf | 0.0023 | 1 | 1 | galactosylceramidase activity |
GO:0043394 | 0.003 | 27.4827 | 0.0812 | 2 | 36 | proteoglycan binding |
GO:0001567 | 0.0045 | 454.8 | 0.0045 | 1 | 2 | cholesterol 25-hydroxylase activity |
GO:0030305 | 0.0045 | 454.8 | 0.0045 | 1 | 2 | heparanase activity |
GO:0004566 | 0.0068 | 227.3857 | 0.0068 | 1 | 3 | beta-glucuronidase activity |
GO:0034875 | 0.009 | 151.581 | 0.009 | 1 | 4 | caffeine oxidase activity |
GO:0042806 | 0.009 | 151.581 | 0.009 | 1 | 4 | fucose binding |
GO:0090722 | 0.009 | 151.581 | 0.009 | 1 | 4 | receptor-receptor interaction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031704 | 0.0014 | Inf | 0.0014 | 1 | 1 | apelin receptor binding |
GO:0050337 | 0.0014 | Inf | 0.0014 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0050840 | 0.0021 | 33.0938 | 0.0689 | 2 | 50 | extracellular matrix binding |
GO:0030395 | 0.0028 | 758.6667 | 0.0028 | 1 | 2 | lactose binding |
GO:0034987 | 0.0082 | 151.6952 | 0.0083 | 1 | 6 | immunoglobulin receptor binding |
GO:0015165 | 0.0096 | 126.4048 | 0.0097 | 1 | 7 | pyrimidine nucleotide-sugar transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 221.9925 | 0.1186 | 13 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 39.8895 | 0.4959 | 13 | 184 | histone binding |
GO:0004984 | 0 | 20.2132 | 0.8382 | 12 | 311 | olfactory receptor activity |
GO:0046982 | 0 | 14.7543 | 1.2586 | 13 | 467 | protein heterodimerization activity |
GO:0003682 | 0 | 14.5562 | 1.2748 | 13 | 473 | chromatin binding |
GO:0045296 | 0 | 16.3815 | 0.8058 | 10 | 299 | cadherin binding |
GO:0004930 | 0 | 8.3374 | 1.9351 | 12 | 718 | G-protein coupled receptor activity |
GO:0044877 | 0 | 6.9412 | 2.5549 | 13 | 948 | macromolecular complex binding |
GO:0038023 | 0 | 5.94 | 3.261 | 14 | 1210 | signaling receptor activity |
GO:0099600 | 0 | 5.6204 | 3.1047 | 13 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 4.8113 | 3.9483 | 14 | 1465 | molecular transducer activity |
GO:0004745 | 9e-04 | 51.6976 | 0.0458 | 2 | 17 | retinol dehydrogenase activity |
GO:0003677 | 0.0023 | 2.8398 | 6.2688 | 14 | 2326 | DNA binding |
GO:0001567 | 0.0054 | 378.8333 | 0.0054 | 1 | 2 | cholesterol 25-hydroxylase activity |
GO:0004866 | 0.0093 | 7.4782 | 0.4339 | 3 | 161 | endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0055102 | 3e-04 | 90.9371 | 0.0271 | 2 | 16 | lipase inhibitor activity |
GO:0004516 | 0.0017 | Inf | 0.0017 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0033676 | 0.0017 | Inf | 0.0017 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
GO:1990595 | 0.0017 | Inf | 0.0017 | 1 | 1 | mast cell secretagogue receptor activity |
GO:0004984 | 0.0017 | 8.8492 | 0.5263 | 4 | 311 | olfactory receptor activity |
GO:0005544 | 0.0025 | 30.259 | 0.0745 | 2 | 44 | calcium-dependent phospholipid binding |
GO:0038100 | 0.0034 | 612.5769 | 0.0034 | 1 | 2 | nodal binding |
GO:0004514 | 0.0051 | 306.2692 | 0.0051 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0004930 | 0.0054 | 5.0883 | 1.1685 | 5 | 717 | G-protein coupled receptor activity |
GO:0019834 | 0.0068 | 204.1667 | 0.0068 | 1 | 4 | phospholipase A2 inhibitor activity |
GO:0008508 | 0.0084 | 153.1154 | 0.0085 | 1 | 5 | bile acid:sodium symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033676 | 0.0011 | Inf | 0.0011 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
GO:0019834 | 0.0043 | 331.9792 | 0.0043 | 1 | 4 | phospholipase A2 inhibitor activity |
GO:0003677 | 0.007 | 4.111 | 2.4783 | 7 | 2326 | DNA binding |
GO:0036310 | 0.0074 | 165.9583 | 0.0075 | 1 | 7 | annealing helicase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031720 | 0 | 1179.6296 | 0.0055 | 2 | 3 | haptoglobin binding |
GO:0046982 | 0 | 10.6978 | 0.8488 | 7 | 467 | protein heterodimerization activity |
GO:0005344 | 3e-04 | 98.2346 | 0.0254 | 2 | 14 | oxygen carrier activity |
GO:0003692 | 0.0018 | Inf | 0.0018 | 1 | 1 | left-handed Z-DNA binding |
GO:0004601 | 0.0025 | 30.1747 | 0.0745 | 2 | 41 | peroxidase activity |
GO:0019825 | 0.0029 | 28.0141 | 0.08 | 2 | 44 | oxygen binding |
GO:0003726 | 0.0054 | 284.3571 | 0.0055 | 1 | 3 | double-stranded RNA adenosine deaminase activity |
GO:0004332 | 0.0054 | 284.3571 | 0.0055 | 1 | 3 | fructose-bisphosphate aldolase activity |
GO:0004886 | 0.0054 | 284.3571 | 0.0055 | 1 | 3 | 9-cis retinoic acid receptor activity |
GO:0003677 | 0.006 | 3.0929 | 4.2278 | 10 | 2326 | DNA binding |
GO:0015333 | 0.0073 | 189.5595 | 0.0073 | 1 | 4 | peptide:proton symporter activity |
GO:0015198 | 0.0091 | 142.1607 | 0.0091 | 1 | 5 | oligopeptide transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 40.9211 | 0.6238 | 14 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 19.103 | 1.4401 | 15 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 11.4745 | 2.3105 | 15 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 10.8747 | 2.4268 | 15 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 8.8071 | 2.9383 | 15 | 1465 | molecular transducer activity |
GO:0005549 | 4e-04 | 24.1202 | 0.1424 | 3 | 71 | odorant binding |
GO:0047963 | 0.002 | Inf | 0.002 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0052817 | 0.002 | Inf | 0.002 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0001567 | 0.004 | 513.6129 | 0.004 | 1 | 2 | cholesterol 25-hydroxylase activity |
GO:0052815 | 0.004 | 513.6129 | 0.004 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
GO:0005136 | 0.006 | 256.7903 | 0.006 | 1 | 3 | interleukin-4 receptor binding |
GO:0015333 | 0.008 | 171.1828 | 0.008 | 1 | 4 | peptide:proton symporter activity |
GO:0034875 | 0.008 | 171.1828 | 0.008 | 1 | 4 | caffeine oxidase activity |
GO:0015198 | 0.01 | 128.379 | 0.01 | 1 | 5 | oligopeptide transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 14.3855 | 0.5854 | 6 | 467 | protein heterodimerization activity |
GO:0042802 | 3e-04 | 6.2722 | 1.9292 | 8 | 1539 | identical protein binding |
GO:0031369 | 6e-04 | 65.465 | 0.0364 | 2 | 29 | translation initiation factor binding |
GO:0019115 | 0.0013 | Inf | 0.0013 | 1 | 1 | benzaldehyde dehydrogenase activity |
GO:0003743 | 0.0015 | 40.1288 | 0.0577 | 2 | 46 | translation initiation factor activity |
GO:0005503 | 0.0025 | 838.6316 | 0.0025 | 1 | 2 | all-trans retinal binding |
GO:0036505 | 0.0025 | 838.6316 | 0.0025 | 1 | 2 | prosaposin receptor activity |
GO:0035276 | 0.0038 | 419.2895 | 0.0038 | 1 | 3 | ethanol binding |
GO:0003960 | 0.005 | 279.5088 | 0.005 | 1 | 4 | NADPH:quinone reductase activity |
GO:0004024 | 0.0063 | 209.6184 | 0.0063 | 1 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0061578 | 0.0075 | 167.6842 | 0.0075 | 1 | 6 | Lys63-specific deubiquitinase activity |
GO:0004032 | 0.0087 | 139.7281 | 0.0088 | 1 | 7 | alditol:NADP+ 1-oxidoreductase activity |
GO:1990380 | 0.01 | 119.7594 | 0.01 | 1 | 8 | Lys48-specific deubiquitinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 32.3874 | 0.6228 | 14 | 184 | histone binding |
GO:0046982 | 0 | 13.1458 | 1.5806 | 15 | 467 | protein heterodimerization activity |
GO:0019904 | 0 | 10.2947 | 2.1826 | 16 | 657 | protein domain specific binding |
GO:0003723 | 0 | 4.0982 | 5.4829 | 17 | 1620 | RNA binding |
GO:0003677 | 4e-04 | 2.9448 | 7.8724 | 18 | 2326 | DNA binding |
GO:0008457 | 0.0034 | Inf | 0.0034 | 1 | 1 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity |
GO:0017174 | 0.0034 | Inf | 0.0034 | 1 | 1 | glycine N-methyltransferase activity |
GO:0031771 | 0.0034 | Inf | 0.0034 | 1 | 1 | type 1 hypocretin receptor binding |
GO:0031772 | 0.0034 | Inf | 0.0034 | 1 | 1 | type 2 hypocretin receptor binding |
GO:0047021 | 0.0034 | Inf | 0.0034 | 1 | 1 | 15-hydroxyprostaglandin dehydrogenase (NADP+) activity |
GO:0047256 | 0.0034 | Inf | 0.0034 | 1 | 1 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity |
GO:0050221 | 0.0034 | Inf | 0.0034 | 1 | 1 | prostaglandin-E2 9-reductase activity |
GO:0070976 | 0.0034 | Inf | 0.0034 | 1 | 1 | TIR domain binding |
GO:0003875 | 0.0068 | 300 | 0.0068 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
GO:0004657 | 0.0068 | 300 | 0.0068 | 1 | 2 | proline dehydrogenase activity |
GO:0008124 | 0.0068 | 300 | 0.0068 | 1 | 2 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity |
GO:0030395 | 0.0068 | 300 | 0.0068 | 1 | 2 | lactose binding |
GO:1901363 | 0.0083 | 1.998 | 18.9432 | 28 | 5597 | heterocyclic compound binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004111 | 0 | 442.5278 | 0.0075 | 2 | 6 | creatine kinase activity |
GO:0033676 | 0.0013 | Inf | 0.0013 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
GO:0035438 | 0.0013 | Inf | 0.0013 | 1 | 1 | cyclic-di-GMP binding |
GO:0061507 | 0.0013 | Inf | 0.0013 | 1 | 1 | cyclic-GMP-AMP binding |
GO:0019834 | 0.005 | 279.5088 | 0.005 | 1 | 4 | phospholipase A2 inhibitor activity |
GO:0036310 | 0.0087 | 139.7281 | 0.0088 | 1 | 7 | annealing helicase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 43.7481 | 0.9952 | 19 | 467 | protein heterodimerization activity |
GO:0031492 | 0 | 194.6936 | 0.0938 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 37.7083 | 0.3921 | 10 | 184 | histone binding |
GO:0003682 | 0 | 18.2923 | 1.008 | 12 | 473 | chromatin binding |
GO:0003677 | 0 | 9.5423 | 4.9567 | 21 | 2326 | DNA binding |
GO:0045296 | 0 | 22.5375 | 0.6372 | 10 | 299 | cadherin binding |
GO:0044877 | 0 | 6.6556 | 2.0202 | 10 | 948 | macromolecular complex binding |
GO:1901363 | 4e-04 | 3.4023 | 11.9272 | 22 | 5597 | heterocyclic compound binding |
GO:0097159 | 5e-04 | 3.3282 | 12.0976 | 22 | 5677 | organic cyclic compound binding |
GO:0004503 | 0.0021 | Inf | 0.0021 | 1 | 1 | monophenol monooxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 60.0051 | 0.6627 | 18 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 24.4623 | 1.5301 | 18 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 14.6696 | 2.4549 | 18 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 13.9011 | 2.5785 | 18 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 11.2531 | 3.1219 | 18 | 1465 | molecular transducer activity |
GO:0005549 | 0 | 52.2725 | 0.1513 | 6 | 71 | odorant binding |
GO:0030883 | 0 | 331.625 | 0.0107 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0 | 331.625 | 0.0107 | 2 | 5 | exogenous lipid antigen binding |
GO:0030881 | 2e-04 | 142.0893 | 0.0192 | 2 | 9 | beta-2-microglobulin binding |
GO:0003823 | 2e-04 | 32.002 | 0.1087 | 3 | 51 | antigen binding |
GO:0071723 | 2e-04 | 124.3203 | 0.0213 | 2 | 10 | lipopeptide binding |
GO:1904854 | 0.0043 | 482.4242 | 0.0043 | 1 | 2 | proteasome core complex binding |
GO:0005136 | 0.0064 | 241.197 | 0.0064 | 1 | 3 | interleukin-4 receptor binding |
GO:0046848 | 0.0064 | 241.197 | 0.0064 | 1 | 3 | hydroxyapatite binding |
GO:0030197 | 0.0085 | 160.7879 | 0.0085 | 1 | 4 | extracellular matrix constituent, lubricant activity |
GO:0030345 | 0.0085 | 160.7879 | 0.0085 | 1 | 4 | structural constituent of tooth enamel |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 57.0374 | 0.4483 | 12 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 23.5272 | 1.035 | 12 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 14.155 | 1.6607 | 12 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 10.8708 | 2.1119 | 12 | 1465 | molecular transducer activity |
GO:0038023 | 0 | 12.0563 | 1.4837 | 10 | 1121 | signaling receptor activity |
GO:0001591 | 0 | 303.3714 | 0.0101 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0035240 | 1e-04 | 168.4974 | 0.0159 | 2 | 11 | dopamine binding |
GO:0005549 | 0.0047 | 21.8951 | 0.1024 | 2 | 71 | odorant binding |
GO:0004867 | 0.0072 | 17.3454 | 0.1283 | 2 | 89 | serine-type endopeptidase inhibitor activity |
GO:0030594 | 0.0072 | 17.3454 | 0.1283 | 2 | 89 | neurotransmitter receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031720 | 0 | 1274.16 | 0.0051 | 2 | 3 | haptoglobin binding |
GO:0005506 | 1e-04 | 18.7993 | 0.2538 | 4 | 150 | iron ion binding |
GO:0005344 | 2e-04 | 106.1067 | 0.0237 | 2 | 14 | oxygen carrier activity |
GO:0003700 | 5e-04 | 5.3704 | 1.9732 | 8 | 1166 | DNA binding transcription factor activity |
GO:0043565 | 0.001 | 5.3795 | 1.6584 | 7 | 980 | sequence-specific DNA binding |
GO:0020037 | 0.0011 | 16.4667 | 0.2081 | 3 | 123 | heme binding |
GO:0008403 | 0.0017 | Inf | 0.0017 | 1 | 1 | 25-hydroxycholecalciferol-24-hydroxylase activity |
GO:0030342 | 0.0017 | Inf | 0.0017 | 1 | 1 | 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity |
GO:0000975 | 0.002 | 5.3816 | 1.369 | 6 | 809 | regulatory region DNA binding |
GO:0004601 | 0.0022 | 32.5928 | 0.0694 | 2 | 41 | peroxidase activity |
GO:0005544 | 0.0025 | 30.259 | 0.0745 | 2 | 44 | calcium-dependent phospholipid binding |
GO:0019825 | 0.0025 | 30.259 | 0.0745 | 2 | 44 | oxygen binding |
GO:0001012 | 0.0027 | 6.0034 | 0.9917 | 5 | 586 | RNA polymerase II regulatory region DNA binding |
GO:1901363 | 0.0029 | 3.1526 | 9.4716 | 17 | 5597 | heterocyclic compound binding |
GO:0097159 | 0.0034 | 3.084 | 9.607 | 17 | 5677 | organic cyclic compound binding |
GO:0001228 | 0.0041 | 6.9471 | 0.6651 | 4 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0000976 | 0.0046 | 5.2826 | 1.1203 | 5 | 662 | transcription regulatory region sequence-specific DNA binding |
GO:0017077 | 0.0051 | 306.2692 | 0.0051 | 1 | 3 | oxidative phosphorylation uncoupler activity |
GO:0000980 | 0.0059 | 19.2267 | 0.1151 | 2 | 68 | RNA polymerase II distal enhancer sequence-specific DNA binding |
GO:0004704 | 0.0068 | 204.1667 | 0.0068 | 1 | 4 | NF-kappaB-inducing kinase activity |
GO:0045569 | 0.0068 | 204.1667 | 0.0068 | 1 | 4 | TRAIL binding |
GO:0048248 | 0.0084 | 153.1154 | 0.0085 | 1 | 5 | CXCR3 chemokine receptor binding |
GO:1903136 | 0.0084 | 153.1154 | 0.0085 | 1 | 5 | cuprous ion binding |
GO:0003690 | 0.0089 | 4.4679 | 1.3132 | 5 | 776 | double-stranded DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 166.8382 | 0.1048 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 24.9401 | 1.1123 | 16 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 32.3132 | 0.4382 | 10 | 184 | histone binding |
GO:0045296 | 0 | 19.3129 | 0.7121 | 10 | 299 | cadherin binding |
GO:0003677 | 0 | 6.5583 | 5.5398 | 20 | 2326 | DNA binding |
GO:0003682 | 0 | 11.9207 | 1.1265 | 10 | 473 | chromatin binding |
GO:0044877 | 1e-04 | 5.7032 | 2.2579 | 10 | 948 | macromolecular complex binding |
GO:1901363 | 1e-04 | 3.5704 | 13.3304 | 25 | 5597 | heterocyclic compound binding |
GO:0097159 | 1e-04 | 3.4926 | 13.5209 | 25 | 5677 | organic cyclic compound binding |
GO:0016503 | 0.0071 | 215.0676 | 0.0071 | 1 | 3 | pheromone receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 35.9951 | 0.5766 | 14 | 184 | histone binding |
GO:0046982 | 0 | 17.6926 | 1.4635 | 17 | 467 | protein heterodimerization activity |
GO:0019904 | 0 | 10.1724 | 2.062 | 15 | 658 | protein domain specific binding |
GO:0003677 | 0 | 4.6382 | 7.2893 | 22 | 2326 | DNA binding |
GO:0003723 | 1e-04 | 3.8184 | 5.0768 | 15 | 1620 | RNA binding |
GO:0005119 | 0.0094 | 162.2755 | 0.0094 | 1 | 3 | smoothened binding |
GO:0008158 | 0.0094 | 162.2755 | 0.0094 | 1 | 3 | hedgehog receptor activity |
GO:0097108 | 0.0094 | 162.2755 | 0.0094 | 1 | 3 | hedgehog family protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 31.051 | 0.4678 | 9 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 18.2204 | 1.08 | 11 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 12.9746 | 1.7329 | 12 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 12.298 | 1.8201 | 12 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 9.9642 | 2.2037 | 12 | 1465 | molecular transducer activity |
GO:0004778 | 0.0015 | Inf | 0.0015 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0016412 | 0.0015 | Inf | 0.0015 | 1 | 1 | serine O-acyltransferase activity |
GO:0019862 | 0.0045 | 346.2826 | 0.0045 | 1 | 3 | IgA binding |
GO:0005549 | 0.0051 | 20.8986 | 0.1068 | 2 | 71 | odorant binding |
GO:0048248 | 0.0075 | 173.1196 | 0.0075 | 1 | 5 | CXCR3 chemokine receptor binding |
GO:0051373 | 0.0075 | 173.1196 | 0.0075 | 1 | 5 | FATZ binding |
GO:0034987 | 0.009 | 138.487 | 0.009 | 1 | 6 | immunoglobulin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031994 | 1e-04 | 187.3647 | 0.0143 | 2 | 12 | insulin-like growth factor I binding |
GO:0001968 | 5e-04 | 74.8753 | 0.0322 | 2 | 27 | fibronectin binding |
GO:0008160 | 0.0024 | 885.2778 | 0.0024 | 1 | 2 | protein tyrosine phosphatase activator activity |
GO:0016401 | 0.0024 | 885.2778 | 0.0024 | 1 | 2 | palmitoyl-CoA oxidase activity |
GO:1903231 | 0.0041 | 23.6143 | 0.0965 | 2 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004466 | 0.0059 | 221.2778 | 0.006 | 1 | 5 | long-chain-acyl-CoA dehydrogenase activity |
GO:0019960 | 0.0059 | 221.2778 | 0.006 | 1 | 5 | C-X3-C chemokine binding |
GO:0038132 | 0.0059 | 221.2778 | 0.006 | 1 | 5 | neuregulin binding |
GO:0043184 | 0.0083 | 147.5 | 0.0083 | 1 | 7 | vascular endothelial growth factor receptor 2 binding |
GO:0031995 | 0.0095 | 126.4206 | 0.0095 | 1 | 8 | insulin-like growth factor II binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031369 | 7e-04 | 62.0156 | 0.0382 | 2 | 29 | translation initiation factor binding |
GO:0003743 | 0.0016 | 38.0144 | 0.0605 | 2 | 46 | translation initiation factor activity |
GO:0004499 | 0.0066 | 199.125 | 0.0066 | 1 | 5 | N,N-dimethylaniline monooxygenase activity |
GO:0004966 | 0.0092 | 132.7333 | 0.0092 | 1 | 7 | galanin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 16.379 | 1.7269 | 19 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 28.7796 | 0.6804 | 14 | 184 | histone binding |
GO:0019904 | 0 | 9.6328 | 2.4332 | 17 | 658 | protein domain specific binding |
GO:0003677 | 0 | 5.9413 | 3.5579 | 15 | 1199 | DNA binding |
GO:0043565 | 0 | 5.2747 | 3.6239 | 15 | 980 | sequence-specific DNA binding |
GO:0140110 | 0 | 4.2636 | 5.5542 | 18 | 1502 | transcription regulator activity |
GO:0000976 | 0 | 5.3666 | 2.448 | 11 | 662 | transcription regulatory region sequence-specific DNA binding |
GO:0000975 | 0 | 4.837 | 2.9916 | 12 | 809 | regulatory region DNA binding |
GO:0001012 | 1e-04 | 5.428 | 2.167 | 10 | 586 | RNA polymerase II regulatory region DNA binding |
GO:0003690 | 1e-04 | 4.5327 | 2.8696 | 11 | 776 | double-stranded DNA binding |
GO:0097159 | 2e-04 | 2.6504 | 20.993 | 35 | 5677 | organic cyclic compound binding |
GO:0000978 | 3e-04 | 6.159 | 1.2832 | 7 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:1901363 | 3e-04 | 2.5261 | 20.6971 | 34 | 5597 | heterocyclic compound binding |
GO:0001159 | 4e-04 | 5.8931 | 1.3386 | 7 | 362 | core promoter proximal region DNA binding |
GO:0001228 | 6e-04 | 5.409 | 1.4533 | 7 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0003723 | 6e-04 | 3.0355 | 5.9906 | 15 | 1620 | RNA binding |
GO:0000981 | 8e-04 | 6.0374 | 1.1161 | 6 | 334 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0042813 | 0.0027 | 29.3204 | 0.0777 | 2 | 21 | Wnt-activated receptor activity |
GO:0008892 | 0.0037 | Inf | 0.0037 | 1 | 1 | guanine deaminase activity |
GO:0003713 | 0.0041 | 5.1267 | 1.0613 | 5 | 287 | transcription coactivator activity |
GO:0000989 | 0.0047 | 3.7002 | 2.0893 | 7 | 565 | transcription factor activity, transcription factor binding |
GO:0017147 | 0.0055 | 19.8847 | 0.1109 | 2 | 30 | Wnt-protein binding |
GO:0005200 | 0.0064 | 8.5482 | 0.3772 | 3 | 102 | structural constituent of cytoskeleton |
GO:0097604 | 0.0074 | 274.0517 | 0.0074 | 1 | 2 | temperature-gated cation channel activity |
GO:0070888 | 0.0078 | 16.3695 | 0.1331 | 2 | 36 | E-box binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004516 | 0.0023 | Inf | 0.0023 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004778 | 0.0023 | Inf | 0.0023 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0061501 | 0.0023 | Inf | 0.0023 | 1 | 1 | cyclic-GMP-AMP synthase activity |
GO:0008188 | 0.0042 | 22.6829 | 0.0974 | 2 | 42 | neuropeptide receptor activity |
GO:0031696 | 0.0046 | 442.1389 | 0.0046 | 1 | 2 | alpha-2C adrenergic receptor binding |
GO:0045145 | 0.0046 | 442.1389 | 0.0046 | 1 | 2 | single-stranded DNA 5'-3' exodeoxyribonuclease activity |
GO:0008227 | 0.0051 | 20.6156 | 0.1067 | 2 | 46 | G-protein coupled amine receptor activity |
GO:0004514 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0004938 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | alpha2-adrenergic receptor activity |
GO:0005275 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | amine transmembrane transporter activity |
GO:0031692 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | alpha-1B adrenergic receptor binding |
GO:0032795 | 0.0069 | 221.0556 | 0.007 | 1 | 3 | heterotrimeric G-protein binding |
GO:0015226 | 0.0092 | 147.3611 | 0.0093 | 1 | 4 | carnitine transmembrane transporter activity |
GO:0042806 | 0.0092 | 147.3611 | 0.0093 | 1 | 4 | fucose binding |
GO:0051380 | 0.0092 | 147.3611 | 0.0093 | 1 | 4 | norepinephrine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0 | 43.3493 | 0.1168 | 4 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0031995 | 1e-04 | 252.7937 | 0.0115 | 2 | 8 | insulin-like growth factor II binding |
GO:0031994 | 1e-04 | 151.6381 | 0.0173 | 2 | 12 | insulin-like growth factor I binding |
GO:0033735 | 0.0014 | Inf | 0.0014 | 1 | 1 | aspartate dehydrogenase activity |
GO:0008160 | 0.0029 | 724.1364 | 0.0029 | 1 | 2 | protein tyrosine phosphatase activator activity |
GO:0004082 | 0.0043 | 362.0455 | 0.0043 | 1 | 3 | bisphosphoglycerate mutase activity |
GO:0046538 | 0.0043 | 362.0455 | 0.0043 | 1 | 3 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
GO:0004568 | 0.0072 | 181 | 0.0072 | 1 | 5 | chitinase activity |
GO:0061578 | 0.0086 | 144.7909 | 0.0086 | 1 | 6 | Lys63-specific deubiquitinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 186.8941 | 0.0965 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 36.1977 | 0.4036 | 10 | 184 | histone binding |
GO:0045296 | 0 | 21.6346 | 0.6559 | 10 | 299 | cadherin binding |
GO:0003682 | 0 | 15.3353 | 1.0376 | 11 | 473 | chromatin binding |
GO:0046982 | 0 | 13.5344 | 1.0244 | 10 | 467 | protein heterodimerization activity |
GO:0044877 | 0 | 7.3289 | 2.0796 | 11 | 948 | macromolecular complex binding |
GO:0003677 | 0 | 4.4166 | 5.1025 | 15 | 2326 | DNA binding |
GO:0004984 | 1e-04 | 10.5924 | 0.6822 | 6 | 311 | olfactory receptor activity |
GO:0004930 | 1e-04 | 6.3474 | 1.5751 | 8 | 718 | G-protein coupled receptor activity |
GO:0047963 | 0.0022 | Inf | 0.0022 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0052817 | 0.0022 | Inf | 0.0022 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0099600 | 0.0029 | 3.827 | 2.5271 | 8 | 1152 | transmembrane receptor activity |
GO:0038023 | 0.004 | 3.628 | 2.6543 | 8 | 1210 | signaling receptor activity |
GO:0005128 | 0.0044 | 468.2059 | 0.0044 | 1 | 2 | erythropoietin receptor binding |
GO:0052815 | 0.0044 | 468.2059 | 0.0044 | 1 | 2 | medium-chain acyl-CoA hydrolase activity |
GO:1904854 | 0.0044 | 468.2059 | 0.0044 | 1 | 2 | proteasome core complex binding |
GO:0001588 | 0.0087 | 156.049 | 0.0088 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0015333 | 0.0087 | 156.049 | 0.0088 | 1 | 4 | peptide:proton symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004778 | 0.0014 | Inf | 0.0014 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0044730 | 0.0014 | Inf | 0.0014 | 1 | 1 | bone sialoprotein binding |
GO:1990081 | 0.0014 | Inf | 0.0014 | 1 | 1 | trimethylamine receptor activity |
GO:1990595 | 0.0014 | Inf | 0.0014 | 1 | 1 | mast cell secretagogue receptor activity |
GO:0005544 | 0.0017 | 37.8357 | 0.0607 | 2 | 44 | calcium-dependent phospholipid binding |
GO:0004500 | 0.0028 | 758.6667 | 0.0028 | 1 | 2 | dopamine beta-monooxygenase activity |
GO:0005094 | 0.0041 | 379.3095 | 0.0041 | 1 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0008823 | 0.0041 | 379.3095 | 0.0041 | 1 | 3 | cupric reductase activity |
GO:0052851 | 0.0041 | 379.3095 | 0.0041 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
GO:0030246 | 0.0048 | 9.9455 | 0.3475 | 3 | 252 | carbohydrate binding |
GO:0019834 | 0.0055 | 252.8571 | 0.0055 | 1 | 4 | phospholipase A2 inhibitor activity |
GO:0004859 | 0.0092 | 132.7 | 0.0092 | 1 | 7 | phospholipase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 40.5048 | 0.5305 | 14 | 184 | histone binding |
GO:0046982 | 0 | 14.9272 | 1.3464 | 14 | 467 | protein heterodimerization activity |
GO:0019904 | 0 | 10.3702 | 1.8971 | 14 | 658 | protein domain specific binding |
GO:0003677 | 0 | 4.9576 | 6.7061 | 21 | 2326 | DNA binding |
GO:0031720 | 0 | 723.0909 | 0.0086 | 2 | 3 | haptoglobin binding |
GO:0003723 | 1e-04 | 3.8964 | 4.6706 | 14 | 1620 | RNA binding |
GO:0005344 | 7e-04 | 60.2159 | 0.0404 | 2 | 14 | oxygen carrier activity |
GO:0031855 | 0.0029 | Inf | 0.0029 | 1 | 1 | oxytocin receptor binding |
GO:1990595 | 0.0029 | Inf | 0.0029 | 1 | 1 | mast cell secretagogue receptor activity |
GO:0005185 | 0.0058 | 353.5111 | 0.0058 | 1 | 2 | neurohypophyseal hormone activity |
GO:0004601 | 0.0062 | 18.4965 | 0.1182 | 2 | 41 | peroxidase activity |
GO:0019825 | 0.0071 | 17.1721 | 0.1269 | 2 | 44 | oxygen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 29.4356 | 0.6689 | 14 | 184 | histone binding |
GO:0046982 | 0 | 11.9199 | 1.6976 | 15 | 467 | protein heterodimerization activity |
GO:0019904 | 0 | 9.2879 | 2.3473 | 16 | 657 | protein domain specific binding |
GO:0003723 | 0 | 3.6973 | 5.8891 | 17 | 1620 | RNA binding |
GO:0003677 | 0.0029 | 2.44 | 8.4555 | 17 | 2326 | DNA binding |
GO:0005476 | 0.0036 | Inf | 0.0036 | 1 | 1 | carnitine:acyl carnitine antiporter activity |
GO:0008457 | 0.0036 | Inf | 0.0036 | 1 | 1 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity |
GO:0017174 | 0.0036 | Inf | 0.0036 | 1 | 1 | glycine N-methyltransferase activity |
GO:0031771 | 0.0036 | Inf | 0.0036 | 1 | 1 | type 1 hypocretin receptor binding |
GO:0031772 | 0.0036 | Inf | 0.0036 | 1 | 1 | type 2 hypocretin receptor binding |
GO:0047021 | 0.0036 | Inf | 0.0036 | 1 | 1 | 15-hydroxyprostaglandin dehydrogenase (NADP+) activity |
GO:0047256 | 0.0036 | Inf | 0.0036 | 1 | 1 | lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity |
GO:0050129 | 0.0036 | Inf | 0.0036 | 1 | 1 | N-formylglutamate deformylase activity |
GO:0050221 | 0.0036 | Inf | 0.0036 | 1 | 1 | prostaglandin-E2 9-reductase activity |
GO:0070976 | 0.0036 | Inf | 0.0036 | 1 | 1 | TIR domain binding |
GO:0003875 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | ADP-ribosylarginine hydrolase activity |
GO:0004657 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | proline dehydrogenase activity |
GO:0015227 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | acyl carnitine transmembrane transporter activity |
GO:0030395 | 0.0073 | 278.8772 | 0.0073 | 1 | 2 | lactose binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 194.6936 | 0.0938 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 37.7083 | 0.3921 | 10 | 184 | histone binding |
GO:0045296 | 0 | 22.5375 | 0.6372 | 10 | 299 | cadherin binding |
GO:0003682 | 0 | 16.0031 | 1.008 | 11 | 473 | chromatin binding |
GO:0046982 | 0 | 14.0992 | 0.9952 | 10 | 467 | protein heterodimerization activity |
GO:0044877 | 0 | 7.6481 | 2.0202 | 11 | 948 | macromolecular complex binding |
GO:0004984 | 0 | 10.9714 | 0.6627 | 6 | 311 | olfactory receptor activity |
GO:0004930 | 1e-04 | 6.592 | 1.5301 | 8 | 718 | G-protein coupled receptor activity |
GO:0003677 | 0.0022 | 3.2074 | 4.9567 | 12 | 2326 | DNA binding |
GO:0099600 | 0.0024 | 3.9744 | 2.4549 | 8 | 1152 | transmembrane receptor activity |
GO:0038023 | 0.0033 | 3.7678 | 2.5785 | 8 | 1210 | signaling receptor activity |
GO:0005128 | 0.0043 | 482.4242 | 0.0043 | 1 | 2 | erythropoietin receptor binding |
GO:1904854 | 0.0043 | 482.4242 | 0.0043 | 1 | 2 | proteasome core complex binding |
GO:0015333 | 0.0085 | 160.7879 | 0.0085 | 1 | 4 | peptide:proton symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0098911 | 0 | 64.3771 | 0.0609 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0007612 | 2e-04 | 10.9352 | 0.5117 | 5 | 126 | learning |
GO:0086073 | 2e-04 | 126.675 | 0.0244 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0009887 | 3e-04 | 4.7911 | 2.1831 | 9 | 593 | animal organ morphogenesis |
GO:0048167 | 3e-04 | 9.5078 | 0.5848 | 5 | 144 | regulation of synaptic plasticity |
GO:0071772 | 3e-04 | 9.305 | 0.597 | 5 | 147 | response to BMP |
GO:0098916 | 4e-04 | 4.5418 | 2.262 | 9 | 557 | anterograde trans-synaptic signaling |
GO:0099536 | 4e-04 | 4.5333 | 2.2661 | 9 | 558 | synaptic signaling |
GO:1903115 | 5e-04 | 22.0387 | 0.1543 | 3 | 38 | regulation of actin filament-based movement |
GO:0050890 | 5e-04 | 6.6247 | 1.0071 | 6 | 248 | cognition |
GO:0002934 | 6e-04 | 72.3714 | 0.0365 | 2 | 9 | desmosome organization |
GO:0042428 | 6e-04 | 72.3714 | 0.0365 | 2 | 9 | serotonin metabolic process |
GO:0032275 | 7e-04 | 63.3208 | 0.0406 | 2 | 10 | luteinizing hormone secretion |
GO:0008542 | 8e-04 | 18.8061 | 0.1787 | 3 | 44 | visual learning |
GO:0098900 | 8e-04 | 18.8061 | 0.1787 | 3 | 44 | regulation of action potential |
GO:0086002 | 8e-04 | 18.3571 | 0.1827 | 3 | 45 | cardiac muscle cell action potential involved in contraction |
GO:0003229 | 0.0012 | 16.0561 | 0.2071 | 3 | 51 | ventricular cardiac muscle tissue development |
GO:0007610 | 0.0013 | 4.1921 | 2.1402 | 8 | 527 | behavior |
GO:0060429 | 0.0019 | 2.9837 | 4.6458 | 12 | 1144 | epithelium development |
GO:0055008 | 0.0019 | 13.2791 | 0.2477 | 3 | 61 | cardiac muscle tissue morphogenesis |
GO:0055117 | 0.0021 | 12.8347 | 0.2558 | 3 | 63 | regulation of cardiac muscle contraction |
GO:0030509 | 0.0023 | 7.8154 | 0.5564 | 4 | 137 | BMP signaling pathway |
GO:0001501 | 0.0023 | 4.2117 | 1.8397 | 7 | 453 | skeletal system development |
GO:0048729 | 0.0023 | 3.7762 | 2.3635 | 8 | 582 | tissue morphogenesis |
GO:0061061 | 0.0024 | 3.7694 | 2.3676 | 8 | 583 | muscle structure development |
GO:0014706 | 0.0024 | 4.8295 | 1.3645 | 6 | 336 | striated muscle tissue development |
GO:0048148 | 0.0024 | 31.6438 | 0.0731 | 2 | 18 | behavioral response to cocaine |
GO:2000810 | 0.0024 | 31.6438 | 0.0731 | 2 | 18 | regulation of bicellular tight junction assembly |
GO:0007188 | 0.0025 | 7.6415 | 0.5685 | 4 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0003208 | 0.0026 | 11.8435 | 0.2762 | 3 | 68 | cardiac ventricle morphogenesis |
GO:0045109 | 0.0027 | 29.7804 | 0.0772 | 2 | 19 | intermediate filament organization |
GO:0086064 | 0.0027 | 29.7804 | 0.0772 | 2 | 19 | cell communication by electrical coupling involved in cardiac conduction |
GO:0098664 | 0.0027 | 29.7804 | 0.0772 | 2 | 19 | G-protein coupled serotonin receptor signaling pathway |
GO:0006937 | 0.0028 | 7.3681 | 0.5889 | 4 | 145 | regulation of muscle contraction |
GO:1901379 | 0.0032 | 10.9939 | 0.2965 | 3 | 73 | regulation of potassium ion transmembrane transport |
GO:0044057 | 0.0032 | 3.9554 | 1.9534 | 7 | 481 | regulation of system process |
GO:0048169 | 0.0036 | 25.3083 | 0.0893 | 2 | 22 | regulation of long-term neuronal synaptic plasticity |
GO:1903506 | 0.0038 | 2.1508 | 13.3811 | 23 | 3295 | regulation of nucleic acid-templated transcription |
GO:0001572 | 0.0041 | Inf | 0.0041 | 1 | 1 | lactosylceramide biosynthetic process |
GO:0007634 | 0.0041 | Inf | 0.0041 | 1 | 1 | optokinetic behavior |
GO:0019358 | 0.0041 | Inf | 0.0041 | 1 | 1 | nicotinate nucleotide salvage |
GO:0021509 | 0.0041 | Inf | 0.0041 | 1 | 1 | roof plate formation |
GO:0021757 | 0.0041 | Inf | 0.0041 | 1 | 1 | caudate nucleus development |
GO:0021758 | 0.0041 | Inf | 0.0041 | 1 | 1 | putamen development |
GO:0046497 | 0.0041 | Inf | 0.0041 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0060678 | 0.0041 | Inf | 0.0041 | 1 | 1 | dichotomous subdivision of terminal units involved in ureteric bud branching |
GO:0060806 | 0.0041 | Inf | 0.0041 | 1 | 1 | negative regulation of cell differentiation involved in embryonic placenta development |
GO:0072127 | 0.0041 | Inf | 0.0041 | 1 | 1 | renal capsule development |
GO:0072129 | 0.0041 | Inf | 0.0041 | 1 | 1 | renal capsule formation |
GO:0072265 | 0.0041 | Inf | 0.0041 | 1 | 1 | metanephric capsule morphogenesis |
GO:0072267 | 0.0041 | Inf | 0.0041 | 1 | 1 | metanephric capsule specification |
GO:0097326 | 0.0041 | Inf | 0.0041 | 1 | 1 | melanocyte adhesion |
GO:0120063 | 0.0041 | Inf | 0.0041 | 1 | 1 | stomach smooth muscle contraction |
GO:0120064 | 0.0041 | Inf | 0.0041 | 1 | 1 | stomach pylorus smooth muscle contraction |
GO:0120072 | 0.0041 | Inf | 0.0041 | 1 | 1 | positive regulation of pyloric antrum smooth muscle contraction |
GO:1903937 | 0.0041 | Inf | 0.0041 | 1 | 1 | response to acrylamide |
GO:1904343 | 0.0041 | Inf | 0.0041 | 1 | 1 | positive regulation of colon smooth muscle contraction |
GO:1904425 | 0.0041 | Inf | 0.0041 | 1 | 1 | negative regulation of GTP binding |
GO:1990708 | 0.0041 | Inf | 0.0041 | 1 | 1 | conditioned place preference |
GO:2001051 | 0.0041 | Inf | 0.0041 | 1 | 1 | positive regulation of tendon cell differentiation |
GO:0048644 | 0.0042 | 9.9899 | 0.3249 | 3 | 80 | muscle organ morphogenesis |
GO:0006366 | 0.0045 | 2.3588 | 8.0003 | 16 | 1970 | transcription from RNA polymerase II promoter |
GO:0048562 | 0.0047 | 4.9454 | 1.0965 | 5 | 270 | embryonic organ morphogenesis |
GO:0060021 | 0.0051 | 9.264 | 0.3493 | 3 | 86 | palate development |
GO:0018146 | 0.0053 | 20.24 | 0.1096 | 2 | 27 | keratan sulfate biosynthetic process |
GO:0045893 | 0.0059 | 2.5649 | 5.3322 | 12 | 1313 | positive regulation of transcription, DNA-templated |
GO:1902680 | 0.006 | 2.5628 | 5.3362 | 12 | 1314 | positive regulation of RNA biosynthetic process |
GO:0035637 | 0.006 | 5.9232 | 0.7269 | 4 | 179 | multicellular organismal signaling |
GO:0086019 | 0.0061 | 18.7383 | 0.1178 | 2 | 29 | cell-cell signaling involved in cardiac conduction |
GO:0007218 | 0.0062 | 8.6361 | 0.3736 | 3 | 92 | neuropeptide signaling pathway |
GO:0042417 | 0.0066 | 18.0679 | 0.1218 | 2 | 30 | dopamine metabolic process |
GO:0097009 | 0.0066 | 18.0679 | 0.1218 | 2 | 30 | energy homeostasis |
GO:0070252 | 0.0068 | 8.3528 | 0.3858 | 3 | 95 | actin-mediated cell contraction |
GO:0051930 | 0.007 | 17.4437 | 0.1259 | 2 | 31 | regulation of sensory perception of pain |
GO:0071804 | 0.0074 | 5.5688 | 0.7716 | 4 | 190 | cellular potassium ion transport |
GO:0051252 | 0.0075 | 2.0071 | 14.1162 | 23 | 3476 | regulation of RNA metabolic process |
GO:0098815 | 0.0079 | 16.3161 | 0.134 | 2 | 33 | modulation of excitatory postsynaptic potential |
GO:0043279 | 0.008 | 7.8383 | 0.4102 | 3 | 101 | response to alkaloid |
GO:0003220 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | left ventricular cardiac muscle tissue morphogenesis |
GO:0007509 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | mesoderm migration involved in gastrulation |
GO:0021560 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | abducens nerve development |
GO:0021599 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | abducens nerve formation |
GO:0030860 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | regulation of polarized epithelial cell differentiation |
GO:0031635 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
GO:0034334 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | adherens junction maintenance |
GO:0035992 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | tendon formation |
GO:0036215 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | response to stem cell factor |
GO:0038109 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | Kit signaling pathway |
GO:0060876 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | semicircular canal formation |
GO:0070352 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | positive regulation of white fat cell proliferation |
GO:0072560 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | type B pancreatic cell maturation |
GO:0097324 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | melanocyte migration |
GO:0098582 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | innate vocalization behavior |
GO:0098735 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | positive regulation of the force of heart contraction |
GO:0098907 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | regulation of SA node cell action potential |
GO:0098976 | 0.0081 | 249.2459 | 0.0081 | 1 | 2 | excitatory chemical synaptic transmission |
GO:0099565 | 0.0082 | 7.7586 | 0.4142 | 3 | 102 | chemical synaptic transmission, postsynaptic |
GO:0086091 | 0.0084 | 15.8052 | 0.1381 | 2 | 34 | regulation of heart rate by cardiac conduction |
GO:0003002 | 0.0089 | 4.2287 | 1.2752 | 5 | 314 | regionalization |
GO:0010959 | 0.0096 | 4.1465 | 1.2995 | 5 | 320 | regulation of metal ion transport |
GO:0035239 | 0.0097 | 4.1331 | 1.3036 | 5 | 321 | tube morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006333 | 0 | 49.5164 | 0.598 | 18 | 166 | chromatin assembly or disassembly |
GO:0006323 | 0 | 44.3646 | 0.6593 | 18 | 183 | DNA packaging |
GO:0071824 | 0 | 32.5512 | 0.8718 | 18 | 242 | protein-DNA complex subunit organization |
GO:0006335 | 0 | 160.7513 | 0.1117 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 129.7949 | 0.1297 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 129.7949 | 0.1297 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 129.7949 | 0.1297 | 10 | 36 | response to interleukin-7 |
GO:0051290 | 0 | 102.2155 | 0.1549 | 10 | 43 | protein heterotetramerization |
GO:0045652 | 0 | 55.1949 | 0.2558 | 10 | 71 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 49.4902 | 0.281 | 10 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 37.7603 | 0.3567 | 10 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 37.3383 | 0.3603 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 30.2322 | 0.4359 | 10 | 121 | regulation of gene silencing |
GO:0006342 | 0 | 56.3952 | 0.195 | 8 | 66 | chromatin silencing |
GO:0034622 | 0 | 8.8158 | 3.408 | 20 | 946 | cellular macromolecular complex assembly |
GO:0051276 | 0 | 10.4693 | 2.7395 | 18 | 920 | chromosome organization |
GO:0032200 | 0 | 23.0912 | 0.5584 | 10 | 155 | telomere organization |
GO:0006334 | 0 | 38.4254 | 0.2747 | 8 | 93 | nucleosome assembly |
GO:0002244 | 0 | 19.3179 | 0.6593 | 10 | 183 | hematopoietic progenitor cell differentiation |
GO:0002227 | 0 | 116.9154 | 0.0648 | 5 | 18 | innate immune response in mucosa |
GO:0051259 | 0 | 9.5615 | 1.7652 | 13 | 490 | protein oligomerization |
GO:0048863 | 0 | 14.1626 | 0.8826 | 10 | 245 | stem cell differentiation |
GO:1903507 | 0 | 6.5281 | 3.8655 | 18 | 1073 | negative regulation of nucleic acid-templated transcription |
GO:0035194 | 0 | 12.8297 | 0.9691 | 10 | 269 | posttranscriptional gene silencing by RNA |
GO:0002251 | 0 | 66.0391 | 0.1009 | 5 | 28 | organ or tissue specific immune response |
GO:0051253 | 0 | 6.0742 | 4.1285 | 18 | 1146 | negative regulation of RNA metabolic process |
GO:0007596 | 0 | 11.2759 | 1.0952 | 10 | 304 | blood coagulation |
GO:0019731 | 0 | 52.3552 | 0.1225 | 5 | 34 | antibacterial humoral response |
GO:0050878 | 0 | 8.5329 | 1.5995 | 11 | 444 | regulation of body fluid levels |
GO:0061844 | 0 | 39.9316 | 0.1549 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0017148 | 0 | 9.6047 | 1.2753 | 10 | 354 | negative regulation of translation |
GO:0030099 | 0 | 9.4917 | 1.2897 | 10 | 358 | myeloid cell differentiation |
GO:0010558 | 0 | 4.6137 | 5.2921 | 18 | 1469 | negative regulation of macromolecule biosynthetic process |
GO:1903706 | 0 | 8.0835 | 1.5023 | 10 | 417 | regulation of hemopoiesis |
GO:0022607 | 0 | 3.8588 | 9.2441 | 24 | 2566 | cellular component assembly |
GO:0031327 | 0 | 4.3631 | 5.5623 | 18 | 1544 | negative regulation of cellular biosynthetic process |
GO:0040029 | 0 | 9.5 | 1.0221 | 8 | 345 | regulation of gene expression, epigenetic |
GO:0050830 | 0 | 20.1827 | 0.2882 | 5 | 80 | defense response to Gram-positive bacterium |
GO:0016567 | 0 | 5.2702 | 2.7992 | 12 | 777 | protein ubiquitination |
GO:0034248 | 0 | 5.8468 | 2.0426 | 10 | 567 | regulation of cellular amide metabolic process |
GO:0009611 | 0 | 5.5961 | 2.1291 | 10 | 591 | response to wounding |
GO:0071840 | 1e-04 | 2.9675 | 20.4552 | 35 | 5678 | cellular component organization or biogenesis |
GO:0010608 | 1e-04 | 5.0351 | 2.3525 | 10 | 653 | posttranscriptional regulation of gene expression |
GO:0043043 | 1e-04 | 4.6256 | 2.8496 | 11 | 791 | peptide biosynthetic process |
GO:0071345 | 1e-04 | 4.5038 | 2.9217 | 11 | 811 | cellular response to cytokine stimulus |
GO:0070647 | 2e-04 | 3.92 | 3.6854 | 12 | 1023 | protein modification by small protein conjugation or removal |
GO:0044238 | 5e-04 | 3.1208 | 34.1917 | 46 | 9491 | primary metabolic process |
GO:0006959 | 5e-04 | 8.4944 | 0.6557 | 5 | 182 | humoral immune response |
GO:0006355 | 5e-04 | 2.6434 | 11.7983 | 23 | 3275 | regulation of transcription, DNA-templated |
GO:0048534 | 5e-04 | 4.0139 | 2.9109 | 10 | 808 | hematopoietic or lymphoid organ development |
GO:2001141 | 6e-04 | 2.6157 | 11.8956 | 23 | 3302 | regulation of RNA biosynthetic process |
GO:0070271 | 6e-04 | 3.3096 | 4.7337 | 13 | 1314 | protein complex biogenesis |
GO:0002376 | 7e-04 | 2.7452 | 8.9055 | 19 | 2472 | immune system process |
GO:0006807 | 9e-04 | 2.7737 | 32.5201 | 44 | 9027 | nitrogen compound metabolic process |
GO:0034654 | 0.001 | 2.4533 | 13.9851 | 25 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0009617 | 0.0014 | 4.6456 | 1.6932 | 7 | 470 | response to bacterium |
GO:0009892 | 0.002 | 2.4713 | 9.7125 | 19 | 2696 | negative regulation of metabolic process |
GO:0016338 | 0.0021 | 33.7292 | 0.0684 | 2 | 19 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0071822 | 0.0028 | 2.7659 | 5.5623 | 13 | 1544 | protein complex subunit organization |
GO:1901360 | 0.0028 | 2.1946 | 20.4156 | 31 | 5667 | organic cyclic compound metabolic process |
GO:0006725 | 0.0034 | 2.1556 | 19.7059 | 30 | 5470 | cellular aromatic compound metabolic process |
GO:0018874 | 0.0036 | Inf | 0.0036 | 1 | 1 | benzoate metabolic process |
GO:0019605 | 0.0036 | Inf | 0.0036 | 1 | 1 | butyrate metabolic process |
GO:0061772 | 0.0036 | Inf | 0.0036 | 1 | 1 | drug transport across blood-nerve barrier |
GO:1903545 | 0.0036 | Inf | 0.0036 | 1 | 1 | cellular response to butyrate |
GO:0051248 | 0.0036 | 2.9034 | 4.3843 | 11 | 1217 | negative regulation of protein metabolic process |
GO:0019219 | 0.0046 | 2.1608 | 13.7617 | 23 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0061028 | 0.0066 | 17.9009 | 0.1225 | 2 | 34 | establishment of endothelial barrier |
GO:0046483 | 0.0069 | 2.0215 | 19.5906 | 29 | 5438 | heterocycle metabolic process |
GO:0090304 | 0.0072 | 2.0289 | 16.8887 | 26 | 4688 | nucleic acid metabolic process |
GO:1902595 | 0.0072 | 281.6852 | 0.0072 | 1 | 2 | regulation of DNA replication origin binding |
GO:0044267 | 0.0075 | 2.0182 | 16.95 | 26 | 4705 | cellular protein metabolic process |
GO:0010467 | 0.0076 | 2.0087 | 17.8722 | 27 | 4961 | gene expression |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006333 | 0 | 43.4277 | 0.5763 | 16 | 166 | chromatin assembly or disassembly |
GO:0006323 | 0 | 38.9629 | 0.6353 | 16 | 183 | DNA packaging |
GO:0006335 | 0 | 168.2503 | 0.1076 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 135.8497 | 0.125 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 135.8497 | 0.125 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 135.8497 | 0.125 | 10 | 36 | response to interleukin-7 |
GO:0071824 | 0 | 28.6783 | 0.8401 | 16 | 242 | protein-DNA complex subunit organization |
GO:0051290 | 0 | 106.9838 | 0.1493 | 10 | 43 | protein heterotetramerization |
GO:0045652 | 0 | 57.7697 | 0.2465 | 10 | 71 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 51.7989 | 0.2708 | 10 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 39.5218 | 0.3437 | 10 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 39.0801 | 0.3472 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 32.8342 | 0.4062 | 10 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 31.6426 | 0.4201 | 10 | 121 | regulation of gene silencing |
GO:0032200 | 0 | 24.1684 | 0.5381 | 10 | 155 | telomere organization |
GO:0002244 | 0 | 20.2191 | 0.6353 | 10 | 183 | hematopoietic progenitor cell differentiation |
GO:0034622 | 0 | 7.9171 | 3.2841 | 18 | 946 | cellular macromolecular complex assembly |
GO:0002227 | 0 | 121.8029 | 0.0625 | 5 | 18 | innate immune response in mucosa |
GO:0048863 | 0 | 14.8234 | 0.8505 | 10 | 245 | stem cell differentiation |
GO:0035194 | 0 | 13.4282 | 0.9338 | 10 | 269 | posttranscriptional gene silencing by RNA |
GO:0017148 | 0 | 11.3551 | 1.2289 | 11 | 354 | negative regulation of translation |
GO:0002251 | 0 | 68.7998 | 0.0972 | 5 | 28 | organ or tissue specific immune response |
GO:0007596 | 0 | 11.8019 | 1.0553 | 10 | 304 | blood coagulation |
GO:0019731 | 0 | 54.5438 | 0.118 | 5 | 34 | antibacterial humoral response |
GO:0006334 | 0 | 28.1566 | 0.2625 | 6 | 93 | nucleosome assembly |
GO:0030099 | 0 | 9.9345 | 1.2428 | 10 | 358 | myeloid cell differentiation |
GO:0061844 | 0 | 41.6009 | 0.1493 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:1903706 | 0 | 8.4607 | 1.4476 | 10 | 417 | regulation of hemopoiesis |
GO:0050878 | 0 | 7.9198 | 1.5414 | 10 | 444 | regulation of body fluid levels |
GO:0071345 | 0 | 5.8712 | 2.8154 | 13 | 811 | cellular response to cytokine stimulus |
GO:0034248 | 0 | 6.9047 | 1.9684 | 11 | 567 | regulation of cellular amide metabolic process |
GO:0009611 | 0 | 6.6081 | 2.0517 | 11 | 591 | response to wounding |
GO:0051259 | 0 | 7.1386 | 1.7011 | 10 | 490 | protein oligomerization |
GO:0050830 | 0 | 21.0264 | 0.2777 | 5 | 80 | defense response to Gram-positive bacterium |
GO:0010608 | 0 | 5.9447 | 2.2669 | 11 | 653 | posttranscriptional regulation of gene expression |
GO:0045595 | 0 | 4.1719 | 5.4295 | 17 | 1564 | regulation of cell differentiation |
GO:0043043 | 1e-04 | 4.8466 | 2.746 | 11 | 791 | peptide biosynthetic process |
GO:0006996 | 2e-04 | 2.9197 | 11.7477 | 24 | 3384 | organelle organization |
GO:0051248 | 2e-04 | 3.7818 | 4.2249 | 13 | 1217 | negative regulation of protein metabolic process |
GO:0022607 | 2e-04 | 3.0155 | 8.908 | 20 | 2566 | cellular component assembly |
GO:0048534 | 4e-04 | 4.2012 | 2.805 | 10 | 808 | hematopoietic or lymphoid organ development |
GO:0006959 | 4e-04 | 8.8495 | 0.6318 | 5 | 182 | humoral immune response |
GO:0070647 | 7e-04 | 3.6755 | 3.5514 | 11 | 1023 | protein modification by small protein conjugation or removal |
GO:0045892 | 8e-04 | 3.6067 | 3.6139 | 11 | 1041 | negative regulation of transcription, DNA-templated |
GO:0090051 | 9e-04 | 54.1996 | 0.0451 | 2 | 13 | negative regulation of cell migration involved in sprouting angiogenesis |
GO:1902679 | 0.001 | 3.4866 | 3.7284 | 11 | 1074 | negative regulation of RNA biosynthetic process |
GO:0016567 | 0.0011 | 3.9424 | 2.6433 | 9 | 776 | protein ubiquitination |
GO:0002376 | 0.0012 | 2.6741 | 8.5816 | 18 | 2472 | immune system process |
GO:0071840 | 0.0013 | 2.3872 | 19.7114 | 31 | 5678 | cellular component organization or biogenesis |
GO:0051239 | 0.0019 | 2.5373 | 8.9635 | 18 | 2582 | regulation of multicellular organismal process |
GO:0007014 | 0.0035 | Inf | 0.0035 | 1 | 1 | actin ubiquitination |
GO:0030421 | 0.0035 | Inf | 0.0035 | 1 | 1 | defecation |
GO:0043251 | 0.0035 | Inf | 0.0035 | 1 | 1 | sodium-dependent organic anion transport |
GO:1903883 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of interleukin-17-mediated signaling pathway |
GO:1903886 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of chemokine (C-C motif) ligand 20 production |
GO:1905929 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of invadopodium disassembly |
GO:0045934 | 0.0041 | 2.8633 | 4.4644 | 11 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0010604 | 0.0043 | 2.3289 | 9.6162 | 18 | 2770 | positive regulation of macromolecule metabolic process |
GO:0070271 | 0.0048 | 2.7961 | 4.5616 | 11 | 1314 | protein complex biogenesis |
GO:1903506 | 0.0054 | 2.2094 | 11.4387 | 20 | 3295 | regulation of nucleic acid-templated transcription |
GO:0048869 | 0.006 | 2.1399 | 13.23 | 22 | 3811 | cellular developmental process |
GO:0032268 | 0.0061 | 2.3215 | 8.3491 | 16 | 2405 | regulation of cellular protein metabolic process |
GO:0009890 | 0.0062 | 2.5839 | 5.4156 | 12 | 1560 | negative regulation of biosynthetic process |
GO:0010025 | 0.0069 | 292.5577 | 0.0069 | 1 | 2 | wax biosynthetic process |
GO:0097498 | 0.0069 | 292.5577 | 0.0069 | 1 | 2 | endothelial tube lumen extension |
GO:1905863 | 0.0069 | 292.5577 | 0.0069 | 1 | 2 | invadopodium organization |
GO:0007166 | 0.0076 | 2.2595 | 8.54 | 16 | 2460 | cell surface receptor signaling pathway |
GO:0048731 | 0.0088 | 2.0358 | 14.5284 | 23 | 4185 | system development |
GO:0051252 | 0.0099 | 2.0619 | 12.0671 | 20 | 3476 | regulation of RNA metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 0.0023 | 12.5714 | 0.2623 | 3 | 89 | embryonic skeletal system morphogenesis |
GO:0019417 | 0.0029 | Inf | 0.0029 | 1 | 1 | sulfur oxidation |
GO:0045358 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of interferon-beta biosynthetic process |
GO:0060007 | 0.0029 | Inf | 0.0029 | 1 | 1 | linear vestibuloocular reflex |
GO:1903766 | 0.0029 | Inf | 0.0029 | 1 | 1 | positive regulation of potassium ion export across plasma membrane |
GO:1903815 | 0.0029 | Inf | 0.0029 | 1 | 1 | negative regulation of collecting lymphatic vessel constriction |
GO:0008016 | 0.0036 | 6.9742 | 0.6308 | 4 | 214 | regulation of heart contraction |
GO:0048598 | 0.0051 | 4.1829 | 1.6094 | 6 | 546 | embryonic morphogenesis |
GO:0003015 | 0.0055 | 6.1422 | 0.7133 | 4 | 242 | heart process |
GO:0045355 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | negative regulation of interferon-alpha biosynthetic process |
GO:1902269 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | positive regulation of polyamine transmembrane transport |
GO:1902524 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | positive regulation of protein K48-linked ubiquitination |
GO:1990186 | 0.0059 | 345.9318 | 0.0059 | 1 | 2 | regulation of lymphatic vessel size |
GO:0048568 | 0.006 | 4.729 | 1.1702 | 5 | 397 | embryonic organ development |
GO:0021545 | 0.0074 | 16.8106 | 0.1297 | 2 | 44 | cranial nerve development |
GO:0045933 | 0.0078 | 16.4186 | 0.1326 | 2 | 45 | positive regulation of muscle contraction |
GO:0060042 | 0.0081 | 16.0444 | 0.1356 | 2 | 46 | retina morphogenesis in camera-type eye |
GO:1901652 | 0.0087 | 4.3103 | 1.2792 | 5 | 434 | response to peptide |
GO:0001712 | 0.0088 | 172.9545 | 0.0088 | 1 | 3 | ectodermal cell fate commitment |
GO:0033387 | 0.0088 | 172.9545 | 0.0088 | 1 | 3 | putrescine biosynthetic process from ornithine |
GO:0043010 | 0.009 | 5.3027 | 0.8224 | 4 | 279 | camera-type eye development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018149 | 0 | 39.9816 | 0.1215 | 4 | 53 | peptide cross-linking |
GO:0050906 | 3e-04 | 7.5937 | 0.9399 | 6 | 410 | detection of stimulus involved in sensory perception |
GO:0050911 | 8e-04 | 7.742 | 0.7474 | 5 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0031424 | 0.0014 | 9.3201 | 0.486 | 4 | 212 | keratinization |
GO:0043588 | 0.0017 | 6.514 | 0.8826 | 5 | 385 | skin development |
GO:0009593 | 0.0021 | 6.2441 | 0.9193 | 5 | 401 | detection of chemical stimulus |
GO:0007606 | 0.0025 | 5.9802 | 0.9583 | 5 | 418 | sensory perception of chemical stimulus |
GO:0050877 | 0.0033 | 3.755 | 2.5722 | 8 | 1122 | nervous system process |
GO:0007186 | 0.0038 | 3.6626 | 2.6318 | 8 | 1148 | G-protein coupled receptor signaling pathway |
GO:0006775 | 0.004 | 23.6099 | 0.094 | 2 | 41 | fat-soluble vitamin metabolic process |
GO:0007468 | 0.0046 | 447.9706 | 0.0046 | 1 | 2 | regulation of rhodopsin gene expression |
GO:0031444 | 0.0046 | 447.9706 | 0.0046 | 1 | 2 | slow-twitch skeletal muscle fiber contraction |
GO:0070175 | 0.0046 | 447.9706 | 0.0046 | 1 | 2 | positive regulation of enamel mineralization |
GO:0009913 | 0.0062 | 6.0129 | 0.7428 | 4 | 324 | epidermal cell differentiation |
GO:0003010 | 0.0069 | 223.9706 | 0.0069 | 1 | 3 | voluntary skeletal muscle contraction |
GO:0030574 | 0.0086 | 15.586 | 0.1398 | 2 | 61 | collagen catabolic process |
GO:0002408 | 0.0091 | 149.3039 | 0.0092 | 1 | 4 | myeloid dendritic cell chemotaxis |
GO:0032914 | 0.0091 | 149.3039 | 0.0092 | 1 | 4 | positive regulation of transforming growth factor beta1 production |
GO:0098967 | 0.0091 | 149.3039 | 0.0092 | 1 | 4 | exocytic insertion of neurotransmitter receptor to postsynaptic membrane |
GO:0032501 | 0.0098 | 2.5054 | 13.0507 | 20 | 6338 | multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0034356 | 4e-04 | 86.7521 | 0.0285 | 2 | 15 | NAD biosynthesis via nicotinamide riboside salvage pathway |
GO:0019359 | 0.0015 | 40.2381 | 0.057 | 2 | 30 | nicotinamide nucleotide biosynthetic process |
GO:0072525 | 0.0018 | 36.3369 | 0.0627 | 2 | 33 | pyridine-containing compound biosynthetic process |
GO:0019677 | 0.0019 | Inf | 0.0019 | 1 | 1 | NAD catabolic process |
GO:0051041 | 0.0019 | Inf | 0.0019 | 1 | 1 | positive regulation of calcium-independent cell-cell adhesion |
GO:0071329 | 0.0019 | Inf | 0.0019 | 1 | 1 | cellular response to sucrose stimulus |
GO:0006742 | 0.0038 | 544.1786 | 0.0038 | 1 | 2 | NADP catabolic process |
GO:0050902 | 0.0038 | 544.1786 | 0.0038 | 1 | 2 | leukocyte adhesive activation |
GO:0055014 | 0.0057 | 272.0714 | 0.0057 | 1 | 3 | atrial cardiac muscle cell development |
GO:0032914 | 0.0076 | 181.369 | 0.0076 | 1 | 4 | positive regulation of transforming growth factor beta1 production |
GO:0042853 | 0.0076 | 181.369 | 0.0076 | 1 | 4 | L-alanine catabolic process |
GO:0090238 | 0.0076 | 181.369 | 0.0076 | 1 | 4 | positive regulation of arachidonic acid secretion |
GO:0006522 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | alanine metabolic process |
GO:0009080 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | pyruvate family amino acid catabolic process |
GO:0032049 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | cardiolipin biosynthetic process |
GO:0034285 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | response to disaccharide |
GO:0072526 | 0.0095 | 136.0179 | 0.0095 | 1 | 5 | pyridine-containing compound catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 1509.5177 | 0.0679 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 266.1402 | 0.1239 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 205.5861 | 0.1438 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 173.9116 | 0.1598 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 161.4681 | 0.1678 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0051290 | 0 | 155.8899 | 0.1718 | 14 | 43 | protein heterotetramerization |
GO:0016233 | 0 | 125.5201 | 0.1998 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 125.5201 | 0.1998 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0006303 | 0 | 86.8069 | 0.2637 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 76.4724 | 0.2917 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 70.4747 | 0.3117 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 52.9897 | 0.3956 | 14 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 52.3701 | 0.3996 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 43.6773 | 0.4675 | 14 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 42.0334 | 0.4835 | 14 | 121 | regulation of gene silencing |
GO:1903707 | 0 | 39.7857 | 0.5074 | 14 | 127 | negative regulation of hemopoiesis |
GO:0031497 | 0 | 34.8141 | 0.5714 | 14 | 143 | chromatin assembly |
GO:0032200 | 0 | 31.8259 | 0.6193 | 14 | 155 | telomere organization |
GO:0006352 | 0 | 23.2857 | 0.899 | 15 | 225 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 23.2857 | 0.899 | 15 | 225 | regulation of myeloid cell differentiation |
GO:0002244 | 0 | 26.5036 | 0.7312 | 14 | 183 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 21.2325 | 0.9789 | 15 | 245 | stem cell differentiation |
GO:0065004 | 0 | 22.6942 | 0.8431 | 14 | 211 | protein-DNA complex assembly |
GO:0051259 | 0 | 13.0672 | 1.9578 | 18 | 490 | protein oligomerization |
GO:0071103 | 0 | 18.4965 | 1.0189 | 14 | 255 | DNA conformation change |
GO:0035194 | 0 | 17.4647 | 1.0748 | 14 | 269 | posttranscriptional gene silencing by RNA |
GO:0017148 | 0 | 14.3007 | 1.4144 | 15 | 354 | negative regulation of translation |
GO:0060249 | 0 | 13.3863 | 1.3785 | 14 | 345 | anatomical structure homeostasis |
GO:0034248 | 0 | 9.4567 | 2.2655 | 16 | 567 | regulation of cellular amide metabolic process |
GO:0010608 | 0 | 8.132 | 2.6091 | 16 | 653 | posttranscriptional regulation of gene expression |
GO:0006281 | 0 | 9.3188 | 1.9378 | 14 | 485 | DNA repair |
GO:0045596 | 0 | 8.1355 | 2.4013 | 15 | 601 | negative regulation of cell differentiation |
GO:0006325 | 0 | 7.1415 | 2.713 | 15 | 679 | chromatin organization |
GO:0043043 | 0 | 6.6207 | 3.1605 | 16 | 791 | peptide biosynthetic process |
GO:2000026 | 0 | 4.8407 | 6.8444 | 23 | 1713 | regulation of multicellular organismal development |
GO:0048534 | 0 | 6.4709 | 3.2284 | 16 | 808 | hematopoietic or lymphoid organ development |
GO:0070271 | 0 | 5.2445 | 5.2501 | 20 | 1314 | protein complex biogenesis |
GO:0071822 | 0 | 4.3794 | 6.1691 | 20 | 1544 | protein complex subunit organization |
GO:0051248 | 0 | 4.8669 | 4.5784 | 17 | 1182 | negative regulation of protein metabolic process |
GO:0065003 | 0 | 4.0656 | 6.5887 | 20 | 1649 | macromolecular complex assembly |
GO:0002682 | 0 | 4.2616 | 5.1183 | 17 | 1281 | regulation of immune system process |
GO:0048869 | 0 | 2.9242 | 15.227 | 30 | 3811 | cellular developmental process |
GO:0045892 | 0 | 4.1125 | 4.1594 | 14 | 1041 | negative regulation of transcription, DNA-templated |
GO:1902679 | 1e-04 | 3.9752 | 4.2912 | 14 | 1074 | negative regulation of RNA biosynthetic process |
GO:0048731 | 1e-04 | 2.7493 | 16.7214 | 31 | 4185 | system development |
GO:0048519 | 1e-04 | 2.7182 | 18.5074 | 33 | 4632 | negative regulation of biological process |
GO:0033554 | 1e-04 | 3.265 | 6.9762 | 18 | 1746 | cellular response to stress |
GO:0032268 | 3e-04 | 2.8236 | 9.6093 | 21 | 2405 | regulation of cellular protein metabolic process |
GO:0097049 | 4e-04 | 85.8757 | 0.032 | 2 | 8 | motor neuron apoptotic process |
GO:0045934 | 4e-04 | 3.263 | 5.1383 | 14 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:1990001 | 6e-04 | 73.6029 | 0.036 | 2 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0097341 | 8e-04 | 57.2392 | 0.044 | 2 | 11 | zymogen inhibition |
GO:0009890 | 0.001 | 2.8833 | 6.2331 | 15 | 1560 | negative regulation of biosynthetic process |
GO:0060547 | 0.0012 | 46.8259 | 0.0519 | 2 | 13 | negative regulation of necrotic cell death |
GO:0021527 | 0.0014 | 42.9209 | 0.0559 | 2 | 14 | spinal cord association neuron differentiation |
GO:0071294 | 0.0016 | 39.6167 | 0.0599 | 2 | 15 | cellular response to zinc ion |
GO:0065008 | 0.0018 | 2.3119 | 12.6978 | 23 | 3178 | regulation of biological quality |
GO:0071241 | 0.0037 | 6.8143 | 0.6353 | 4 | 159 | cellular response to inorganic substance |
GO:0006211 | 0.004 | Inf | 0.004 | 1 | 1 | 5-methylcytosine catabolic process |
GO:0014876 | 0.004 | Inf | 0.004 | 1 | 1 | response to injury involved in regulation of muscle adaptation |
GO:0030421 | 0.004 | Inf | 0.004 | 1 | 1 | defecation |
GO:0070367 | 0.004 | Inf | 0.004 | 1 | 1 | negative regulation of hepatocyte differentiation |
GO:0010604 | 0.0043 | 2.2095 | 11.0677 | 20 | 2770 | positive regulation of macromolecule metabolic process |
GO:0048518 | 0.006 | 1.9789 | 20.0736 | 30 | 5024 | positive regulation of biological process |
GO:0017144 | 0.0072 | 17.148 | 0.1279 | 2 | 32 | drug metabolic process |
GO:0048665 | 0.0077 | 16.5938 | 0.1319 | 2 | 33 | neuron fate specification |
GO:0006788 | 0.008 | 253.4167 | 0.008 | 1 | 2 | heme oxidation |
GO:0009115 | 0.008 | 253.4167 | 0.008 | 1 | 2 | xanthine catabolic process |
GO:0010025 | 0.008 | 253.4167 | 0.008 | 1 | 2 | wax biosynthetic process |
GO:0014736 | 0.008 | 253.4167 | 0.008 | 1 | 2 | negative regulation of muscle atrophy |
GO:0021526 | 0.008 | 253.4167 | 0.008 | 1 | 2 | medial motor column neuron differentiation |
GO:0060163 | 0.008 | 253.4167 | 0.008 | 1 | 2 | subpallium neuron fate commitment |
GO:0097498 | 0.008 | 253.4167 | 0.008 | 1 | 2 | endothelial tube lumen extension |
GO:1900155 | 0.008 | 253.4167 | 0.008 | 1 | 2 | negative regulation of bone trabecula formation |
GO:0070266 | 0.0086 | 15.586 | 0.1398 | 2 | 35 | necroptotic process |
GO:1903318 | 0.0086 | 15.586 | 0.1398 | 2 | 35 | negative regulation of protein maturation |
GO:0002042 | 0.0091 | 15.1266 | 0.1438 | 2 | 36 | cell migration involved in sprouting angiogenesis |
GO:0046676 | 0.0096 | 14.6935 | 0.1478 | 2 | 37 | negative regulation of insulin secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0097120 | 0 | 51.6905 | 0.0715 | 3 | 21 | receptor localization to synapse |
GO:0060078 | 1e-04 | 13.8472 | 0.4121 | 5 | 121 | regulation of postsynaptic membrane potential |
GO:2000463 | 1e-04 | 46.5153 | 0.0783 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0003148 | 1e-04 | 42.2811 | 0.0852 | 3 | 25 | outflow tract septum morphogenesis |
GO:0021517 | 4e-04 | 23.8242 | 0.1431 | 3 | 42 | ventral spinal cord development |
GO:0099565 | 4e-04 | 12.8546 | 0.3474 | 4 | 102 | chemical synaptic transmission, postsynaptic |
GO:0046549 | 4e-04 | 86.9029 | 0.0307 | 2 | 9 | retinal cone cell development |
GO:0030182 | 4e-04 | 3.6865 | 3.9408 | 12 | 1157 | neuron differentiation |
GO:0120039 | 5e-04 | 4.9411 | 1.8665 | 8 | 548 | plasma membrane bounded cell projection morphogenesis |
GO:0032990 | 6e-04 | 4.7581 | 1.9346 | 8 | 568 | cell part morphogenesis |
GO:0003206 | 7e-04 | 11.1372 | 0.3985 | 4 | 117 | cardiac chamber morphogenesis |
GO:0021520 | 9e-04 | 55.2873 | 0.0443 | 2 | 13 | spinal cord motor neuron cell fate specification |
GO:0048667 | 0.0011 | 4.8801 | 1.6247 | 7 | 477 | cell morphogenesis involved in neuron differentiation |
GO:0071695 | 0.0012 | 9.3787 | 0.47 | 4 | 138 | anatomical structure maturation |
GO:2000026 | 0.0014 | 2.9309 | 5.8345 | 14 | 1713 | regulation of multicellular organismal development |
GO:0048167 | 0.0014 | 8.9732 | 0.4905 | 4 | 144 | regulation of synaptic plasticity |
GO:0060219 | 0.0015 | 40.5333 | 0.0579 | 2 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0006355 | 0.0015 | 2.49 | 11.1548 | 21 | 3275 | regulation of transcription, DNA-templated |
GO:2001141 | 0.0017 | 2.464 | 11.2467 | 21 | 3302 | regulation of RNA biosynthetic process |
GO:0010002 | 0.0019 | 35.76 | 0.0647 | 2 | 19 | cardioblast differentiation |
GO:0051240 | 0.0019 | 3.0366 | 4.7003 | 12 | 1380 | positive regulation of multicellular organismal process |
GO:0031016 | 0.002 | 13.2464 | 0.2486 | 3 | 73 | pancreas development |
GO:0048638 | 0.0022 | 5.9786 | 0.923 | 5 | 271 | regulation of developmental growth |
GO:0098916 | 0.0027 | 4.1477 | 1.8972 | 7 | 557 | anterograde trans-synaptic signaling |
GO:0099536 | 0.0027 | 4.1399 | 1.9006 | 7 | 558 | synaptic signaling |
GO:0010460 | 0.0027 | 28.941 | 0.0783 | 2 | 23 | positive regulation of heart rate |
GO:0097659 | 0.0029 | 2.3345 | 11.727 | 21 | 3443 | nucleic acid-templated transcription |
GO:0022603 | 0.003 | 3.385 | 3.0484 | 9 | 895 | regulation of anatomical structure morphogenesis |
GO:0021511 | 0.003 | 27.6236 | 0.0817 | 2 | 24 | spinal cord patterning |
GO:0061564 | 0.0031 | 4.6173 | 1.4442 | 6 | 424 | axon development |
GO:0003309 | 0.0032 | 26.4209 | 0.0852 | 2 | 25 | type B pancreatic cell differentiation |
GO:0048791 | 0.0032 | 26.4209 | 0.0852 | 2 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
GO:0006797 | 0.0034 | Inf | 0.0034 | 1 | 1 | polyphosphate metabolic process |
GO:0032912 | 0.0034 | Inf | 0.0034 | 1 | 1 | negative regulation of transforming growth factor beta2 production |
GO:0042404 | 0.0034 | Inf | 0.0034 | 1 | 1 | thyroid hormone catabolic process |
GO:0043354 | 0.0034 | Inf | 0.0034 | 1 | 1 | enucleate erythrocyte maturation |
GO:0060829 | 0.0034 | Inf | 0.0034 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation |
GO:0061931 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of erythrocyte enucleation |
GO:0090601 | 0.0034 | Inf | 0.0034 | 1 | 1 | enucleation |
GO:1902078 | 0.0034 | Inf | 0.0034 | 1 | 1 | positive regulation of lateral motor column neuron migration |
GO:1902838 | 0.0034 | Inf | 0.0034 | 1 | 1 | regulation of nuclear migration along microtubule |
GO:1903965 | 0.0034 | Inf | 0.0034 | 1 | 1 | monounsaturated fatty acid catabolic process |
GO:1905483 | 0.0034 | Inf | 0.0034 | 1 | 1 | regulation of motor neuron migration |
GO:0035418 | 0.0038 | 24.304 | 0.092 | 2 | 27 | protein localization to synapse |
GO:0003279 | 0.004 | 10.1754 | 0.3202 | 3 | 94 | cardiac septum development |
GO:0051094 | 0.0042 | 3.0109 | 3.8318 | 10 | 1125 | positive regulation of developmental process |
GO:0003203 | 0.0044 | 22.5007 | 0.0988 | 2 | 29 | endocardial cushion morphogenesis |
GO:0030513 | 0.005 | 20.9462 | 0.1056 | 2 | 31 | positive regulation of BMP signaling pathway |
GO:0061001 | 0.0053 | 20.2467 | 0.109 | 2 | 32 | regulation of dendritic spine morphogenesis |
GO:0045595 | 0.0054 | 2.641 | 5.327 | 12 | 1564 | regulation of cell differentiation |
GO:1900449 | 0.0056 | 19.5923 | 0.1124 | 2 | 33 | regulation of glutamate receptor signaling pathway |
GO:0050767 | 0.0057 | 3.5893 | 2.1765 | 7 | 639 | regulation of neurogenesis |
GO:0007411 | 0.0057 | 6.0419 | 0.7187 | 4 | 211 | axon guidance |
GO:0048468 | 0.0064 | 2.4921 | 6.1581 | 13 | 1808 | cell development |
GO:0001709 | 0.0068 | 17.7015 | 0.1236 | 2 | 37 | cell fate determination |
GO:0003220 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | left ventricular cardiac muscle tissue morphogenesis |
GO:0007493 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | endodermal cell fate determination |
GO:0035408 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | histone H3-T6 phosphorylation |
GO:0051793 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | medium-chain fatty acid catabolic process |
GO:0071657 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:0072560 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | type B pancreatic cell maturation |
GO:0098735 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | positive regulation of the force of heart contraction |
GO:0098886 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | modification of dendritic spine |
GO:0098887 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | neurotransmitter receptor transport, endosome to postsynaptic membrane |
GO:0098907 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | regulation of SA node cell action potential |
GO:2001055 | 0.0068 | 298.3137 | 0.0068 | 1 | 2 | positive regulation of mesenchymal cell apoptotic process |
GO:0007399 | 0.0069 | 2.4011 | 6.9415 | 14 | 2038 | nervous system development |
GO:0042461 | 0.007 | 17.3486 | 0.126 | 2 | 37 | photoreceptor cell development |
GO:0099601 | 0.007 | 17.3486 | 0.126 | 2 | 37 | regulation of neurotransmitter receptor activity |
GO:0000902 | 0.0071 | 3.1431 | 2.8611 | 8 | 840 | cell morphogenesis |
GO:0045927 | 0.0073 | 5.628 | 0.7698 | 4 | 226 | positive regulation of growth |
GO:0010769 | 0.0074 | 5.6024 | 0.7732 | 4 | 227 | regulation of cell morphogenesis involved in differentiation |
GO:0090287 | 0.0075 | 5.577 | 0.7766 | 4 | 228 | regulation of cellular response to growth factor stimulus |
GO:0050808 | 0.0078 | 5.5022 | 0.7868 | 4 | 231 | synapse organization |
GO:0035270 | 0.0079 | 7.9006 | 0.4087 | 3 | 120 | endocrine system development |
GO:1990138 | 0.0088 | 7.5743 | 0.4258 | 3 | 125 | neuron projection extension |
GO:0007612 | 0.009 | 7.5122 | 0.4292 | 3 | 126 | learning |
GO:0010975 | 0.0093 | 4.2099 | 1.2943 | 5 | 380 | regulation of neuron projection development |
GO:0001764 | 0.0094 | 7.391 | 0.436 | 3 | 128 | neuron migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045660 | 0.0016 | Inf | 0.0016 | 1 | 1 | positive regulation of neutrophil differentiation |
GO:0080058 | 0.0016 | Inf | 0.0016 | 1 | 1 | protein deglutathionylation |
GO:0039689 | 0.0049 | 317.5 | 0.0049 | 1 | 3 | negative stranded viral RNA replication |
GO:0061739 | 0.0065 | 211.6528 | 0.0066 | 1 | 4 | protein lipidation involved in autophagosome assembly |
GO:0048312 | 0.0098 | 126.975 | 0.0098 | 1 | 6 | intracellular distribution of mitochondria |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003206 | 0 | 19.6117 | 0.4292 | 7 | 117 | cardiac chamber morphogenesis |
GO:0003231 | 0 | 17.1 | 0.4108 | 6 | 112 | cardiac ventricle development |
GO:0007493 | 0 | Inf | 0.0073 | 2 | 2 | endodermal cell fate determination |
GO:0021794 | 0 | 78.2161 | 0.0514 | 3 | 14 | thalamus development |
GO:0007275 | 0 | 3.5473 | 12.2057 | 26 | 3710 | multicellular organism development |
GO:0007399 | 0 | 3.632 | 7.4755 | 20 | 2038 | nervous system development |
GO:0099565 | 0 | 15.2759 | 0.3741 | 5 | 102 | chemical synaptic transmission, postsynaptic |
GO:0060913 | 0 | 563.3333 | 0.011 | 2 | 3 | cardiac cell fate determination |
GO:2000463 | 1e-04 | 42.9934 | 0.0844 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0060078 | 1e-04 | 12.7578 | 0.4438 | 5 | 121 | regulation of postsynaptic membrane potential |
GO:0003148 | 1e-04 | 39.0798 | 0.0917 | 3 | 25 | outflow tract septum morphogenesis |
GO:0048646 | 1e-04 | 4.1976 | 3.448 | 12 | 940 | anatomical structure formation involved in morphogenesis |
GO:0048812 | 1e-04 | 5.3566 | 1.9587 | 9 | 534 | neuron projection morphogenesis |
GO:0071205 | 1e-04 | 187.7531 | 0.0183 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0048858 | 2e-04 | 5.1826 | 2.0211 | 9 | 551 | cell projection morphogenesis |
GO:0086073 | 2e-04 | 140.8056 | 0.022 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0048863 | 3e-04 | 7.5173 | 0.8987 | 6 | 245 | stem cell differentiation |
GO:0048286 | 3e-04 | 26.8496 | 0.1284 | 3 | 35 | lung alveolus development |
GO:0060537 | 3e-04 | 6.174 | 1.2875 | 7 | 351 | muscle tissue development |
GO:0007420 | 4e-04 | 4.6309 | 2.2485 | 9 | 613 | brain development |
GO:0003279 | 4e-04 | 12.9239 | 0.3448 | 4 | 94 | cardiac septum development |
GO:0072359 | 4e-04 | 3.9008 | 3.3306 | 11 | 908 | circulatory system development |
GO:0002934 | 5e-04 | 80.4444 | 0.033 | 2 | 9 | desmosome organization |
GO:0003151 | 6e-04 | 20.6523 | 0.1634 | 3 | 47 | outflow tract morphogenesis |
GO:0048699 | 6e-04 | 3.3359 | 4.6841 | 13 | 1277 | generation of neurons |
GO:0008284 | 6e-04 | 3.9737 | 2.9308 | 10 | 799 | positive regulation of cell proliferation |
GO:0007389 | 6e-04 | 5.4433 | 1.4525 | 7 | 396 | pattern specification process |
GO:0021903 | 6e-04 | 70.3843 | 0.0367 | 2 | 10 | rostrocaudal neural tube patterning |
GO:0060947 | 6e-04 | 70.3843 | 0.0367 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
GO:0032502 | 6e-04 | 3.0042 | 10.9379 | 21 | 3812 | developmental process |
GO:0055010 | 6e-04 | 19.9667 | 0.1687 | 3 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0060379 | 7e-04 | 62.5597 | 0.0403 | 2 | 11 | cardiac muscle cell myoblast differentiation |
GO:0098916 | 9e-04 | 4.4511 | 2.0431 | 8 | 557 | anterograde trans-synaptic signaling |
GO:0099536 | 9e-04 | 4.4427 | 2.0468 | 8 | 558 | synaptic signaling |
GO:1901213 | 0.001 | 51.1785 | 0.0477 | 2 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0032729 | 0.0011 | 16.1887 | 0.2054 | 3 | 56 | positive regulation of interferon-gamma production |
GO:0000122 | 0.0012 | 3.8937 | 2.6483 | 9 | 722 | negative regulation of transcription from RNA polymerase II promoter |
GO:0098911 | 0.0013 | 43.2991 | 0.055 | 2 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0061180 | 0.0014 | 14.7882 | 0.2238 | 3 | 61 | mammary gland epithelium development |
GO:0070848 | 0.0016 | 4.0376 | 2.2412 | 8 | 611 | response to growth factor |
GO:0043066 | 0.0017 | 3.6716 | 2.7987 | 9 | 763 | negative regulation of apoptotic process |
GO:0009887 | 0.0017 | 3.4164 | 3.3746 | 10 | 920 | animal organ morphogenesis |
GO:0120036 | 0.0017 | 3.0567 | 4.6144 | 12 | 1258 | plasma membrane bounded cell projection organization |
GO:0007517 | 0.0018 | 5.1555 | 1.2912 | 6 | 352 | muscle organ development |
GO:0032989 | 0.0019 | 3.3691 | 3.4186 | 10 | 932 | cellular component morphogenesis |
GO:0048167 | 0.0019 | 8.2808 | 0.5282 | 4 | 144 | regulation of synaptic plasticity |
GO:0023019 | 0.0019 | 35.1736 | 0.066 | 2 | 18 | signal transduction involved in regulation of gene expression |
GO:0045109 | 0.0022 | 33.1024 | 0.0697 | 2 | 19 | intermediate filament organization |
GO:0051094 | 0.0023 | 3.0933 | 4.1265 | 11 | 1125 | positive regulation of developmental process |
GO:0045844 | 0.0023 | 12.4217 | 0.2641 | 3 | 72 | positive regulation of striated muscle tissue development |
GO:0060444 | 0.0024 | 31.2613 | 0.0734 | 2 | 20 | branching involved in mammary gland duct morphogenesis |
GO:0035051 | 0.0024 | 31.1311 | 0.0734 | 2 | 21 | cardiocyte differentiation |
GO:0060415 | 0.0025 | 12.0702 | 0.2714 | 3 | 74 | muscle tissue morphogenesis |
GO:0050974 | 0.0029 | 28.1315 | 0.0807 | 2 | 22 | detection of mechanical stimulus involved in sensory perception |
GO:0043009 | 0.0029 | 4.0602 | 1.9221 | 7 | 524 | chordate embryonic development |
GO:0010575 | 0.0032 | 26.7901 | 0.0844 | 2 | 23 | positive regulation of vascular endothelial growth factor production |
GO:0060914 | 0.0032 | 26.7901 | 0.0844 | 2 | 23 | heart formation |
GO:0060548 | 0.0035 | 3.2761 | 3.1142 | 9 | 849 | negative regulation of cell death |
GO:0009952 | 0.0036 | 6.9099 | 0.63 | 4 | 178 | anterior/posterior pattern specification |
GO:0003142 | 0.0037 | Inf | 0.0037 | 1 | 1 | cardiogenic plate morphogenesis |
GO:0003167 | 0.0037 | Inf | 0.0037 | 1 | 1 | atrioventricular bundle cell differentiation |
GO:0021568 | 0.0037 | Inf | 0.0037 | 1 | 1 | rhombomere 2 development |
GO:0032912 | 0.0037 | Inf | 0.0037 | 1 | 1 | negative regulation of transforming growth factor beta2 production |
GO:0060807 | 0.0037 | Inf | 0.0037 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
GO:0060931 | 0.0037 | Inf | 0.0037 | 1 | 1 | sinoatrial node cell development |
GO:0061374 | 0.0037 | Inf | 0.0037 | 1 | 1 | mammillothalamic axonal tract development |
GO:0061381 | 0.0037 | Inf | 0.0037 | 1 | 1 | cell migration in diencephalon |
GO:1903965 | 0.0037 | Inf | 0.0037 | 1 | 1 | monounsaturated fatty acid catabolic process |
GO:1904425 | 0.0037 | Inf | 0.0037 | 1 | 1 | negative regulation of GTP binding |
GO:2000287 | 0.0037 | Inf | 0.0037 | 1 | 1 | positive regulation of myotome development |
GO:0070528 | 0.0038 | 24.4573 | 0.0917 | 2 | 25 | protein kinase C signaling |
GO:0048666 | 0.0038 | 3.2465 | 3.1544 | 9 | 890 | neuron development |
GO:0048738 | 0.0038 | 10.36 | 0.3146 | 3 | 90 | cardiac muscle tissue development |
GO:0035335 | 0.004 | 10.1934 | 0.3191 | 3 | 87 | peptidyl-tyrosine dephosphorylation |
GO:0035282 | 0.0041 | 10.0728 | 0.3228 | 3 | 88 | segmentation |
GO:0021761 | 0.0042 | 10.0285 | 0.3243 | 3 | 90 | limbic system development |
GO:0007178 | 0.0043 | 5.08 | 1.0747 | 5 | 293 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0035116 | 0.0044 | 22.4978 | 0.099 | 2 | 27 | embryonic hindlimb morphogenesis |
GO:0061311 | 0.0044 | 22.4978 | 0.099 | 2 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0003008 | 0.0044 | 2.52 | 6.5695 | 14 | 1791 | system process |
GO:0007154 | 0.0046 | 2.0825 | 20.9372 | 31 | 5708 | cell communication |
GO:0009790 | 0.0046 | 3.1298 | 3.2499 | 9 | 886 | embryo development |
GO:0003203 | 0.005 | 20.8285 | 0.1064 | 2 | 29 | endocardial cushion morphogenesis |
GO:0032735 | 0.005 | 20.8285 | 0.1064 | 2 | 29 | positive regulation of interleukin-12 production |
GO:0035115 | 0.0054 | 20.0833 | 0.11 | 2 | 30 | embryonic forelimb morphogenesis |
GO:0008038 | 0.0057 | 19.3895 | 0.1137 | 2 | 31 | neuron recognition |
GO:0030513 | 0.0057 | 19.3895 | 0.1137 | 2 | 31 | positive regulation of BMP signaling pathway |
GO:0035239 | 0.0063 | 4.6212 | 1.1774 | 5 | 321 | tube morphogenesis |
GO:0001944 | 0.0064 | 3.4849 | 2.2228 | 7 | 606 | vasculature development |
GO:0060795 | 0.0065 | 18.1362 | 0.121 | 2 | 33 | cell fate commitment involved in formation of primary germ layer |
GO:0055007 | 0.0067 | 8.3846 | 0.3851 | 3 | 105 | cardiac muscle cell differentiation |
GO:0051240 | 0.0068 | 2.6528 | 4.7715 | 11 | 1346 | positive regulation of multicellular organismal process |
GO:0086091 | 0.0069 | 17.5683 | 0.1247 | 2 | 34 | regulation of heart rate by cardiac conduction |
GO:1905209 | 0.0069 | 17.5683 | 0.1247 | 2 | 34 | positive regulation of cardiocyte differentiation |
GO:0051101 | 0.0071 | 8.2222 | 0.3925 | 3 | 107 | regulation of DNA binding |
GO:0001755 | 0.0073 | 17.0348 | 0.1284 | 2 | 35 | neural crest cell migration |
GO:0043954 | 0.0073 | 17.0348 | 0.1284 | 2 | 35 | cellular component maintenance |
GO:0030855 | 0.0073 | 3.4047 | 2.28 | 7 | 643 | epithelial cell differentiation |
GO:0001828 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | inner cell mass cellular morphogenesis |
GO:0003163 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | sinoatrial node development |
GO:0021767 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | mammillary body development |
GO:0034334 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | adherens junction maintenance |
GO:0051793 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | medium-chain fatty acid catabolic process |
GO:0061010 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | gall bladder development |
GO:0061379 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | inferior colliculus development |
GO:0070352 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | positive regulation of white fat cell proliferation |
GO:0071109 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | superior temporal gyrus development |
GO:0071657 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:2000043 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | regulation of cardiac cell fate specification |
GO:2001055 | 0.0073 | 276.5455 | 0.0073 | 1 | 2 | positive regulation of mesenchymal cell apoptotic process |
GO:0007411 | 0.0074 | 5.5756 | 0.774 | 4 | 211 | axon guidance |
GO:0030029 | 0.0076 | 3.3676 | 2.2962 | 7 | 626 | actin filament-based process |
GO:0046330 | 0.0078 | 7.9156 | 0.4072 | 3 | 111 | positive regulation of JNK cascade |
GO:0007611 | 0.0082 | 5.4164 | 0.796 | 4 | 217 | learning or memory |
GO:0007166 | 0.0084 | 2.2244 | 8.6209 | 16 | 2433 | cell surface receptor signaling pathway |
GO:0030857 | 0.0085 | 15.6121 | 0.1394 | 2 | 38 | negative regulation of epithelial cell differentiation |
GO:0045103 | 0.0085 | 15.6121 | 0.1394 | 2 | 38 | intermediate filament-based process |
GO:1903115 | 0.0085 | 15.6121 | 0.1394 | 2 | 38 | regulation of actin filament-based movement |
GO:0035113 | 0.0093 | 7.4304 | 0.4328 | 3 | 118 | embryonic appendage morphogenesis |
GO:0048565 | 0.0093 | 7.4304 | 0.4328 | 3 | 118 | digestive tract development |
GO:0023052 | 0.0093 | 1.9476 | 20.8675 | 30 | 5689 | signaling |
GO:0090287 | 0.0097 | 5.1466 | 0.8363 | 4 | 228 | regulation of cellular response to growth factor stimulus |
GO:0035987 | 0.0099 | 14.4084 | 0.1504 | 2 | 41 | endodermal cell differentiation |
GO:0048514 | 0.0099 | 3.5601 | 1.8414 | 6 | 502 | blood vessel morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018917 | 0.0025 | Inf | 0.0025 | 1 | 1 | fluorene metabolic process |
GO:0042489 | 0.005 | 411.5676 | 0.005 | 1 | 2 | negative regulation of odontogenesis of dentin-containing tooth |
GO:0070378 | 0.005 | 411.5676 | 0.005 | 1 | 2 | positive regulation of ERK5 cascade |
GO:0018879 | 0.0074 | 205.7703 | 0.0075 | 1 | 3 | biphenyl metabolic process |
GO:0060535 | 0.0099 | 137.1712 | 0.01 | 1 | 4 | trachea cartilage morphogenesis |
GO:1904340 | 0.0099 | 137.1712 | 0.01 | 1 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:2000852 | 0.0099 | 137.1712 | 0.01 | 1 | 4 | regulation of corticosterone secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007611 | 5e-04 | 8.6338 | 0.6538 | 5 | 217 | learning or memory |
GO:0071294 | 9e-04 | 53.1748 | 0.0452 | 2 | 15 | cellular response to zinc ion |
GO:0071241 | 0.0013 | 9.2571 | 0.4791 | 4 | 159 | cellular response to inorganic substance |
GO:0001525 | 0.0015 | 5.3649 | 1.2655 | 6 | 420 | angiogenesis |
GO:0090023 | 0.0025 | 30.0356 | 0.0753 | 2 | 25 | positive regulation of neutrophil chemotaxis |
GO:0048710 | 0.003 | 27.6291 | 0.0814 | 2 | 27 | regulation of astrocyte differentiation |
GO:0014013 | 0.003 | 11.3488 | 0.2893 | 3 | 96 | regulation of gliogenesis |
GO:0019242 | 0.003 | Inf | 0.003 | 1 | 1 | methylglyoxal biosynthetic process |
GO:0061889 | 0.003 | Inf | 0.003 | 1 | 1 | negative regulation of astrocyte activation |
GO:0071206 | 0.003 | Inf | 0.003 | 1 | 1 | establishment of protein localization to juxtaparanode region of axon |
GO:0001953 | 0.0039 | 23.8119 | 0.0934 | 2 | 31 | negative regulation of cell-matrix adhesion |
GO:1902622 | 0.0039 | 23.8119 | 0.0934 | 2 | 31 | regulation of neutrophil migration |
GO:0007616 | 0.0042 | 23.0167 | 0.0964 | 2 | 32 | long-term memory |
GO:0003165 | 0.006 | 338.2222 | 0.006 | 1 | 2 | Purkinje myocyte development |
GO:0010899 | 0.006 | 338.2222 | 0.006 | 1 | 2 | regulation of phosphatidylcholine catabolic process |
GO:0060163 | 0.006 | 338.2222 | 0.006 | 1 | 2 | subpallium neuron fate commitment |
GO:1903979 | 0.006 | 338.2222 | 0.006 | 1 | 2 | negative regulation of microglial cell activation |
GO:1904808 | 0.006 | 338.2222 | 0.006 | 1 | 2 | positive regulation of protein oxidation |
GO:1905167 | 0.006 | 338.2222 | 0.006 | 1 | 2 | positive regulation of lysosomal protein catabolic process |
GO:2000111 | 0.006 | 338.2222 | 0.006 | 1 | 2 | positive regulation of macrophage apoptotic process |
GO:0032570 | 0.0068 | 17.6946 | 0.1235 | 2 | 41 | response to progesterone |
GO:0071622 | 0.0074 | 16.8293 | 0.1296 | 2 | 43 | regulation of granulocyte chemotaxis |
GO:0001568 | 0.0075 | 3.8346 | 1.7445 | 6 | 579 | blood vessel development |
GO:0034113 | 0.0088 | 15.3293 | 0.1416 | 2 | 47 | heterotypic cell-cell adhesion |
GO:0031133 | 0.009 | 169.1 | 0.009 | 1 | 3 | regulation of axon diameter |
GO:0035986 | 0.009 | 169.1 | 0.009 | 1 | 3 | senescence-associated heterochromatin focus assembly |
GO:0045163 | 0.009 | 169.1 | 0.009 | 1 | 3 | clustering of voltage-gated potassium channels |
GO:0060168 | 0.009 | 169.1 | 0.009 | 1 | 3 | positive regulation of adenosine receptor signaling pathway |
GO:0061771 | 0.009 | 169.1 | 0.009 | 1 | 3 | response to caloric restriction |
GO:1905907 | 0.009 | 169.1 | 0.009 | 1 | 3 | negative regulation of amyloid fibril formation |
GO:0021879 | 0.0095 | 14.675 | 0.1476 | 2 | 49 | forebrain neuron differentiation |
GO:0046686 | 0.0095 | 14.675 | 0.1476 | 2 | 49 | response to cadmium ion |
GO:0072358 | 0.0097 | 3.6176 | 1.844 | 6 | 612 | cardiovascular system development |
GO:0043112 | 0.0098 | 7.3047 | 0.4429 | 3 | 147 | receptor metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0097120 | 1e-04 | 49.6569 | 0.0743 | 3 | 21 | receptor localization to synapse |
GO:0060078 | 1e-04 | 13.2803 | 0.428 | 5 | 121 | regulation of postsynaptic membrane potential |
GO:2000463 | 1e-04 | 44.6853 | 0.0814 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0003148 | 1e-04 | 40.6176 | 0.0884 | 3 | 25 | outflow tract septum morphogenesis |
GO:0006355 | 4e-04 | 2.7289 | 11.5838 | 23 | 3275 | regulation of transcription, DNA-templated |
GO:2001141 | 4e-04 | 2.7003 | 11.6793 | 23 | 3302 | regulation of RNA biosynthetic process |
GO:0046549 | 4e-04 | 83.5495 | 0.0318 | 2 | 9 | retinal cone cell development |
GO:0021517 | 4e-04 | 22.8869 | 0.1486 | 3 | 42 | ventral spinal cord development |
GO:0099565 | 5e-04 | 12.3388 | 0.3608 | 4 | 102 | chemical synaptic transmission, postsynaptic |
GO:0120039 | 6e-04 | 4.7256 | 1.9383 | 8 | 548 | plasma membrane bounded cell projection morphogenesis |
GO:0098916 | 7e-04 | 4.6453 | 1.9701 | 8 | 557 | anterograde trans-synaptic signaling |
GO:0099536 | 7e-04 | 4.6365 | 1.9737 | 8 | 558 | synaptic signaling |
GO:0003206 | 8e-04 | 10.6903 | 0.4138 | 4 | 117 | cardiac chamber morphogenesis |
GO:0097659 | 8e-04 | 2.5584 | 12.178 | 23 | 3443 | nucleic acid-templated transcription |
GO:0032990 | 8e-04 | 4.5506 | 2.009 | 8 | 568 | cell part morphogenesis |
GO:0021520 | 9e-04 | 53.1538 | 0.046 | 2 | 13 | spinal cord motor neuron cell fate specification |
GO:0048699 | 0.0014 | 3.1503 | 4.5168 | 12 | 1277 | generation of neurons |
GO:0071695 | 0.0014 | 9.0024 | 0.4881 | 4 | 138 | anatomical structure maturation |
GO:0019219 | 0.0014 | 2.4061 | 13.5115 | 24 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0060219 | 0.0016 | 38.9692 | 0.0601 | 2 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0048167 | 0.0017 | 8.6131 | 0.5093 | 4 | 144 | regulation of synaptic plasticity |
GO:0008306 | 0.0018 | 13.7086 | 0.2405 | 3 | 68 | associative learning |
GO:1904018 | 0.0019 | 8.2559 | 0.5306 | 4 | 150 | positive regulation of vasculature development |
GO:0010002 | 0.002 | 34.3801 | 0.0672 | 2 | 19 | cardioblast differentiation |
GO:0031016 | 0.0022 | 12.7252 | 0.2582 | 3 | 73 | pancreas development |
GO:0045664 | 0.0023 | 4.2592 | 1.8428 | 7 | 521 | regulation of neuron differentiation |
GO:0048638 | 0.0026 | 5.7338 | 0.9585 | 5 | 271 | regulation of developmental growth |
GO:0007389 | 0.0026 | 4.751 | 1.4007 | 6 | 396 | pattern specification process |
GO:0016070 | 0.0027 | 2.2575 | 14.9581 | 25 | 4229 | RNA metabolic process |
GO:0010460 | 0.003 | 27.8242 | 0.0814 | 2 | 23 | positive regulation of heart rate |
GO:0021511 | 0.0032 | 26.5577 | 0.0849 | 2 | 24 | spinal cord patterning |
GO:0003309 | 0.0035 | 25.4013 | 0.0884 | 2 | 25 | type B pancreatic cell differentiation |
GO:0048791 | 0.0035 | 25.4013 | 0.0884 | 2 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
GO:0021754 | 0.0035 | Inf | 0.0035 | 1 | 1 | facial nucleus development |
GO:0032912 | 0.0035 | Inf | 0.0035 | 1 | 1 | negative regulation of transforming growth factor beta2 production |
GO:0042404 | 0.0035 | Inf | 0.0035 | 1 | 1 | thyroid hormone catabolic process |
GO:0043354 | 0.0035 | Inf | 0.0035 | 1 | 1 | enucleate erythrocyte maturation |
GO:0060829 | 0.0035 | Inf | 0.0035 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation |
GO:0061931 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of erythrocyte enucleation |
GO:0090601 | 0.0035 | Inf | 0.0035 | 1 | 1 | enucleation |
GO:1902078 | 0.0035 | Inf | 0.0035 | 1 | 1 | positive regulation of lateral motor column neuron migration |
GO:1902838 | 0.0035 | Inf | 0.0035 | 1 | 1 | regulation of nuclear migration along microtubule |
GO:1903965 | 0.0035 | Inf | 0.0035 | 1 | 1 | monounsaturated fatty acid catabolic process |
GO:1905483 | 0.0035 | Inf | 0.0035 | 1 | 1 | regulation of motor neuron migration |
GO:0051960 | 0.0036 | 3.542 | 2.5467 | 8 | 720 | regulation of nervous system development |
GO:0022603 | 0.0039 | 3.2341 | 3.1657 | 9 | 895 | regulation of anatomical structure morphogenesis |
GO:0035418 | 0.0041 | 23.3662 | 0.0955 | 2 | 27 | protein localization to synapse |
GO:0035886 | 0.0041 | 23.3662 | 0.0955 | 2 | 27 | vascular smooth muscle cell differentiation |
GO:0034654 | 0.0043 | 2.1829 | 13.7308 | 23 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0009889 | 0.0044 | 2.1626 | 14.6151 | 24 | 4132 | regulation of biosynthetic process |
GO:0003279 | 0.0045 | 9.775 | 0.3325 | 3 | 94 | cardiac septum development |
GO:0003203 | 0.0047 | 21.6325 | 0.1026 | 2 | 29 | endocardial cushion morphogenesis |
GO:0032735 | 0.0047 | 21.6325 | 0.1026 | 2 | 29 | positive regulation of interleukin-12 production |
GO:0030513 | 0.0053 | 20.1379 | 0.1096 | 2 | 31 | positive regulation of BMP signaling pathway |
GO:0007420 | 0.0056 | 3.59 | 2.1682 | 7 | 613 | brain development |
GO:0061001 | 0.0057 | 19.4654 | 0.1132 | 2 | 32 | regulation of dendritic spine morphogenesis |
GO:1900449 | 0.006 | 18.8362 | 0.1167 | 2 | 33 | regulation of glutamate receptor signaling pathway |
GO:0051240 | 0.0062 | 2.8375 | 4.0683 | 10 | 1230 | positive regulation of multicellular organismal process |
GO:0048667 | 0.0065 | 3.9124 | 1.6872 | 6 | 477 | cell morphogenesis involved in neuron differentiation |
GO:0031175 | 0.007 | 3.1415 | 2.8509 | 8 | 806 | neuron projection development |
GO:0003220 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | left ventricular cardiac muscle tissue morphogenesis |
GO:0007493 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | endodermal cell fate determination |
GO:0021570 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | rhombomere 4 development |
GO:0021571 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | rhombomere 5 development |
GO:0035408 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | histone H3-T6 phosphorylation |
GO:0051793 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | medium-chain fatty acid catabolic process |
GO:0071657 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:0072560 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | type B pancreatic cell maturation |
GO:0098735 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | positive regulation of the force of heart contraction |
GO:0098886 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | modification of dendritic spine |
GO:0098887 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | neurotransmitter receptor transport, endosome to postsynaptic membrane |
GO:0098907 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | regulation of SA node cell action potential |
GO:2001055 | 0.0071 | 287.0189 | 0.0071 | 1 | 2 | positive regulation of mesenchymal cell apoptotic process |
GO:0007611 | 0.0072 | 5.6338 | 0.7675 | 4 | 217 | learning or memory |
GO:0001709 | 0.0073 | 17.005 | 0.1285 | 2 | 37 | cell fate determination |
GO:0042461 | 0.0076 | 16.6791 | 0.1309 | 2 | 37 | photoreceptor cell development |
GO:0099601 | 0.0076 | 16.6791 | 0.1309 | 2 | 37 | regulation of neurotransmitter receptor activity |
GO:0045597 | 0.0078 | 3.0844 | 2.9004 | 8 | 820 | positive regulation of cell differentiation |
GO:0045927 | 0.0083 | 5.4022 | 0.7994 | 4 | 226 | positive regulation of growth |
GO:0010769 | 0.0084 | 5.3776 | 0.8029 | 4 | 227 | regulation of cell morphogenesis involved in differentiation |
GO:0048731 | 0.0086 | 2.074 | 13.6869 | 22 | 4065 | system development |
GO:0035270 | 0.0088 | 7.5897 | 0.4244 | 3 | 120 | endocrine system development |
GO:0000902 | 0.0089 | 3.0061 | 2.9711 | 8 | 840 | cell morphogenesis |
GO:0050808 | 0.0089 | 5.2814 | 0.8171 | 4 | 231 | synapse organization |
GO:0048468 | 0.009 | 2.3702 | 6.395 | 13 | 1808 | cell development |
GO:1990138 | 0.0098 | 7.2763 | 0.4421 | 3 | 125 | neuron projection extension |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 1390.7582 | 0.0724 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 245.2018 | 0.132 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 189.4118 | 0.1533 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 160.2293 | 0.1703 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 148.7647 | 0.1788 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0051290 | 0 | 143.6254 | 0.1831 | 14 | 43 | protein heterotetramerization |
GO:0016233 | 0 | 115.6449 | 0.2129 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 115.6449 | 0.2129 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0006303 | 0 | 79.9774 | 0.281 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 70.456 | 0.3108 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 64.9301 | 0.3321 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 48.8208 | 0.4215 | 14 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 48.2499 | 0.4258 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 40.241 | 0.4981 | 14 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 38.7264 | 0.5152 | 14 | 121 | regulation of gene silencing |
GO:1903707 | 0 | 36.6556 | 0.5407 | 14 | 127 | negative regulation of hemopoiesis |
GO:0031497 | 0 | 32.0751 | 0.6088 | 14 | 143 | chromatin assembly |
GO:0032200 | 0 | 29.3219 | 0.6599 | 14 | 155 | telomere organization |
GO:0006352 | 0 | 21.4171 | 0.9579 | 15 | 225 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 21.4171 | 0.9579 | 15 | 225 | regulation of myeloid cell differentiation |
GO:0002244 | 0 | 24.4184 | 0.7791 | 14 | 183 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 19.5287 | 1.0431 | 15 | 245 | stem cell differentiation |
GO:0051259 | 0 | 12.9184 | 2.0862 | 19 | 490 | protein oligomerization |
GO:0065004 | 0 | 20.9087 | 0.8983 | 14 | 211 | protein-DNA complex assembly |
GO:0071103 | 0 | 17.0412 | 1.0857 | 14 | 255 | DNA conformation change |
GO:0035194 | 0 | 16.0906 | 1.1453 | 14 | 269 | posttranscriptional gene silencing by RNA |
GO:0017148 | 0 | 13.1531 | 1.5072 | 15 | 354 | negative regulation of translation |
GO:0060249 | 0 | 12.333 | 1.4689 | 14 | 345 | anatomical structure homeostasis |
GO:0034248 | 0 | 7.962 | 2.414 | 15 | 567 | regulation of cellular amide metabolic process |
GO:0006281 | 0 | 8.5856 | 2.0649 | 14 | 485 | DNA repair |
GO:0006325 | 0 | 7.1605 | 2.8909 | 16 | 679 | chromatin organization |
GO:0045596 | 0 | 7.4826 | 2.5588 | 15 | 601 | negative regulation of cell differentiation |
GO:2000026 | 0 | 4.6833 | 7.2932 | 24 | 1713 | regulation of multicellular organismal development |
GO:0010608 | 0 | 6.8483 | 2.7802 | 15 | 653 | posttranscriptional regulation of gene expression |
GO:0048534 | 0 | 5.941 | 3.4401 | 16 | 808 | hematopoietic or lymphoid organ development |
GO:0070271 | 0 | 4.7769 | 5.5944 | 20 | 1314 | protein complex biogenesis |
GO:0043043 | 0 | 5.5771 | 3.3677 | 15 | 791 | peptide biosynthetic process |
GO:0071822 | 0 | 3.9889 | 6.5737 | 20 | 1544 | protein complex subunit organization |
GO:0045892 | 0 | 4.5163 | 4.4321 | 16 | 1041 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 4.3653 | 4.5726 | 16 | 1074 | negative regulation of RNA biosynthetic process |
GO:0065003 | 0 | 3.7032 | 7.0207 | 20 | 1649 | macromolecular complex assembly |
GO:0051248 | 0 | 4.0883 | 4.8888 | 16 | 1182 | negative regulation of protein metabolic process |
GO:0048731 | 0 | 2.9199 | 17.8178 | 34 | 4185 | system development |
GO:0048869 | 0 | 2.9312 | 16.2255 | 32 | 3811 | cellular developmental process |
GO:0002682 | 1e-04 | 3.5975 | 5.4539 | 16 | 1281 | regulation of immune system process |
GO:0045934 | 1e-04 | 3.5821 | 5.4752 | 16 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0048519 | 2e-04 | 2.5294 | 19.721 | 34 | 4632 | negative regulation of biological process |
GO:0009890 | 2e-04 | 3.1352 | 6.6418 | 17 | 1560 | negative regulation of biosynthetic process |
GO:0097049 | 5e-04 | 80.4021 | 0.0341 | 2 | 8 | motor neuron apoptotic process |
GO:1990001 | 6e-04 | 68.9116 | 0.0383 | 2 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0010604 | 7e-04 | 2.4829 | 11.7934 | 23 | 2770 | positive regulation of macromolecule metabolic process |
GO:0033554 | 8e-04 | 2.7598 | 7.4337 | 17 | 1746 | cellular response to stress |
GO:0048518 | 9e-04 | 2.2445 | 21.3899 | 34 | 5024 | positive regulation of biological process |
GO:0097341 | 0.001 | 53.5908 | 0.0468 | 2 | 11 | zymogen inhibition |
GO:0060547 | 0.0014 | 43.8413 | 0.0553 | 2 | 13 | negative regulation of necrotic cell death |
GO:0021527 | 0.0016 | 40.1852 | 0.0596 | 2 | 14 | spinal cord association neuron differentiation |
GO:0032268 | 0.0018 | 2.3884 | 10.2394 | 20 | 2405 | regulation of cellular protein metabolic process |
GO:0071294 | 0.0018 | 37.0916 | 0.0639 | 2 | 15 | cellular response to zinc ion |
GO:0065008 | 0.002 | 2.236 | 13.5305 | 24 | 3178 | regulation of biological quality |
GO:2001236 | 0.0032 | 7.106 | 0.6088 | 4 | 143 | regulation of extrinsic apoptotic signaling pathway |
GO:0032501 | 0.004 | 2.0022 | 27.8869 | 39 | 6550 | multicellular organismal process |
GO:0006211 | 0.0043 | Inf | 0.0043 | 1 | 1 | 5-methylcytosine catabolic process |
GO:0014876 | 0.0043 | Inf | 0.0043 | 1 | 1 | response to injury involved in regulation of muscle adaptation |
GO:0030421 | 0.0043 | Inf | 0.0043 | 1 | 1 | defecation |
GO:0070367 | 0.0043 | Inf | 0.0043 | 1 | 1 | negative regulation of hepatocyte differentiation |
GO:1902045 | 0.0043 | Inf | 0.0043 | 1 | 1 | negative regulation of Fas signaling pathway |
GO:0071241 | 0.0047 | 6.3657 | 0.677 | 4 | 159 | cellular response to inorganic substance |
GO:0002040 | 0.0061 | 8.7085 | 0.3704 | 3 | 87 | sprouting angiogenesis |
GO:0036337 | 0.0084 | 241.2857 | 0.0084 | 1 | 2 | Fas signaling pathway |
GO:0006788 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | heme oxidation |
GO:0009115 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | xanthine catabolic process |
GO:0010025 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | wax biosynthetic process |
GO:0014736 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | negative regulation of muscle atrophy |
GO:0021526 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | medial motor column neuron differentiation |
GO:0060163 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | subpallium neuron fate commitment |
GO:0097498 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | endothelial tube lumen extension |
GO:1900155 | 0.0085 | 237.5156 | 0.0085 | 1 | 2 | negative regulation of bone trabecula formation |
GO:0048665 | 0.0087 | 15.5361 | 0.1405 | 2 | 33 | neuron fate specification |
GO:1902042 | 0.0092 | 15.0496 | 0.1448 | 2 | 34 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0070266 | 0.0097 | 14.5926 | 0.149 | 2 | 35 | necroptotic process |
GO:1903318 | 0.0097 | 14.5926 | 0.149 | 2 | 35 | negative regulation of protein maturation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032098 | 0.0014 | 42.1274 | 0.055 | 2 | 21 | regulation of appetite |
GO:0006536 | 0.0024 | 30.7713 | 0.0734 | 2 | 28 | glutamate metabolic process |
GO:0070378 | 0.0052 | 390.4103 | 0.0052 | 1 | 2 | positive regulation of ERK5 cascade |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004013 | 0.0032 | Inf | 0.0032 | 1 | 1 | adenosylhomocysteinase activity |
GO:0004068 | 0.0032 | Inf | 0.0032 | 1 | 1 | aspartate 1-decarboxylase activity |
GO:0004458 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
GO:0004782 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | sulfinoalanine decarboxylase activity |
GO:0004873 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | asialoglycoprotein receptor activity |
GO:0015275 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | stretch-activated, cation-selective, calcium channel activity |
GO:0023030 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | MHC class Ib protein binding, via antigen binding groove |
GO:0047710 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | bis(5'-adenosyl)-triphosphatase activity |
GO:0086056 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | voltage-gated calcium channel activity involved in AV node cell action potential |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005267 | 0.0031 | 11.3008 | 0.2932 | 3 | 121 | potassium channel activity |
GO:1901981 | 0.0032 | 11.2051 | 0.2957 | 3 | 122 | phosphatidylinositol phosphate binding |
GO:0005250 | 0.0073 | 211.5139 | 0.0073 | 1 | 3 | A-type (transient outward) potassium channel activity |
GO:0030348 | 0.0073 | 211.5139 | 0.0073 | 1 | 3 | syntaxin-3 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 30.749 | 1.6463 | 26 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 102.2222 | 0.1549 | 10 | 43 | nucleosomal DNA binding |
GO:0003677 | 0 | 6.528 | 8.1016 | 29 | 2249 | DNA binding |
GO:0042393 | 0 | 19.6641 | 0.6484 | 10 | 180 | histone binding |
GO:0045296 | 0 | 11.9384 | 1.0375 | 10 | 288 | cadherin binding |
GO:0003682 | 0 | 8.2775 | 1.6463 | 11 | 457 | chromatin binding |
GO:1901363 | 0 | 3.7483 | 19.5425 | 37 | 5425 | heterocyclic compound binding |
GO:0097159 | 0 | 3.6697 | 19.8091 | 37 | 5499 | organic cyclic compound binding |
GO:0044877 | 0.0013 | 3.5551 | 3.2601 | 10 | 905 | macromolecular complex binding |
GO:0004595 | 0.0036 | Inf | 0.0036 | 1 | 1 | pantetheine-phosphate adenylyltransferase activity |
GO:0018455 | 0.0036 | Inf | 0.0036 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0102522 | 0.0036 | Inf | 0.0036 | 1 | 1 | tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity |
GO:0004140 | 0.0072 | 281.7037 | 0.0072 | 1 | 2 | dephospho-CoA kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004516 | 0.0036 | Inf | 0.0036 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0008437 | 0.0036 | Inf | 0.0036 | 1 | 1 | thyrotropin-releasing hormone activity |
GO:0034189 | 0.0072 | 281.7037 | 0.0072 | 1 | 2 | very-low-density lipoprotein particle binding |
GO:0070780 | 0.0072 | 281.7037 | 0.0072 | 1 | 2 | dihydrosphingosine-1-phosphate phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0099600 | 2e-04 | 5.2731 | 2.2456 | 9 | 1106 | transmembrane receptor activity |
GO:0004930 | 3e-04 | 6.3381 | 1.3856 | 7 | 705 | G-protein coupled receptor activity |
GO:0042166 | 4e-04 | 87.5 | 0.0284 | 2 | 14 | acetylcholine binding |
GO:0004993 | 7e-04 | 61.7444 | 0.0386 | 2 | 19 | G-protein coupled serotonin receptor activity |
GO:0015464 | 7e-04 | 61.7444 | 0.0386 | 2 | 19 | acetylcholine receptor activity |
GO:0060089 | 0.0013 | 4.1013 | 2.8243 | 9 | 1391 | molecular transducer activity |
GO:0004871 | 0.0019 | 3.8927 | 2.9603 | 9 | 1458 | signal transducer activity |
GO:0004838 | 0.002 | Inf | 0.002 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
GO:0001641 | 0.0041 | 507.8667 | 0.0041 | 1 | 2 | group II metabotropic glutamate receptor activity |
GO:0004984 | 0.0041 | 6.8622 | 0.6619 | 4 | 326 | olfactory receptor activity |
GO:0005516 | 0.005 | 9.5528 | 0.3492 | 3 | 172 | calmodulin binding |
GO:0080130 | 0.0061 | 253.9167 | 0.0061 | 1 | 3 | L-phenylalanine:2-oxoglutarate aminotransferase activity |
GO:0030594 | 0.0065 | 18.1099 | 0.1217 | 2 | 64 | neurotransmitter receptor activity |
GO:0090722 | 0.0081 | 169.2667 | 0.0081 | 1 | 4 | receptor-receptor interaction |
GO:0098988 | 0.0081 | 169.2667 | 0.0081 | 1 | 4 | G-protein coupled glutamate receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 104.5523 | 0.1521 | 10 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 14.1048 | 1.6163 | 16 | 457 | protein heterodimerization activity |
GO:0045296 | 0 | 15.4638 | 1.0186 | 12 | 288 | cadherin binding |
GO:0042393 | 0 | 20.1123 | 0.6366 | 10 | 180 | histone binding |
GO:0003682 | 0 | 8.4705 | 1.6163 | 11 | 457 | chromatin binding |
GO:0044877 | 0 | 5.0909 | 3.2008 | 13 | 905 | macromolecular complex binding |
GO:0003677 | 0 | 3.7091 | 7.9543 | 21 | 2249 | DNA binding |
GO:0032027 | 2e-04 | 146.25 | 0.0212 | 2 | 6 | myosin light chain binding |
GO:0043250 | 0.0035 | Inf | 0.0035 | 1 | 1 | sodium-dependent organic anion transmembrane transporter activity |
GO:0005178 | 0.0062 | 8.6299 | 0.3749 | 3 | 106 | integrin binding |
GO:0001786 | 0.0068 | 17.6935 | 0.1238 | 2 | 35 | phosphatidylserine binding |
GO:0008389 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | coumarin 7-hydroxylase activity |
GO:0080019 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | fatty-acyl-CoA reductase (alcohol-forming) activity |
GO:0102965 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | alcohol-forming fatty acyl-CoA reductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 124.3898 | 0.1324 | 10 | 43 | nucleosomal DNA binding |
GO:0042393 | 0 | 23.9285 | 0.5541 | 10 | 180 | histone binding |
GO:0045296 | 0 | 16.4846 | 0.8866 | 11 | 288 | cadherin binding |
GO:0003682 | 0 | 10.1224 | 1.4068 | 11 | 457 | chromatin binding |
GO:0046982 | 0 | 10.1224 | 1.4068 | 11 | 457 | protein heterodimerization activity |
GO:0044877 | 1e-04 | 4.8967 | 2.7859 | 11 | 905 | macromolecular complex binding |
GO:0003677 | 2e-04 | 3.2977 | 6.9232 | 17 | 2249 | DNA binding |
GO:0045519 | 0.0061 | 330.8696 | 0.0062 | 1 | 2 | interleukin-23 receptor binding |
GO:0070851 | 0.0068 | 8.3692 | 0.3879 | 3 | 126 | growth factor receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008083 | 5e-04 | 12.1425 | 0.3729 | 4 | 146 | growth factor activity |
GO:0030545 | 7e-04 | 6.3333 | 1.1009 | 6 | 431 | receptor regulator activity |
GO:0005104 | 0.0018 | 35.7368 | 0.0639 | 2 | 25 | fibroblast growth factor receptor binding |
GO:0001616 | 0.0026 | Inf | 0.0026 | 1 | 1 | growth hormone secretagogue receptor activity |
GO:0004336 | 0.0026 | Inf | 0.0026 | 1 | 1 | galactosylceramidase activity |
GO:0005144 | 0.0026 | Inf | 0.0026 | 1 | 1 | interleukin-13 receptor binding |
GO:0008955 | 0.0026 | Inf | 0.0026 | 1 | 1 | peptidoglycan glycosyltransferase activity |
GO:0030272 | 0.0026 | Inf | 0.0026 | 1 | 1 | 5-formyltetrahydrofolate cyclo-ligase activity |
GO:0016303 | 0.0047 | 21.6088 | 0.1022 | 2 | 40 | 1-phosphatidylinositol-3-kinase activity |
GO:0016520 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | growth hormone-releasing hormone receptor activity |
GO:0047237 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity |
GO:0004713 | 0.0092 | 7.516 | 0.4342 | 3 | 170 | protein tyrosine kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005158 | 0.002 | 33.942 | 0.0668 | 2 | 30 | insulin receptor binding |
GO:0008613 | 0.0022 | Inf | 0.0022 | 1 | 1 | diuretic hormone activity |
GO:0008843 | 0.0022 | Inf | 0.0022 | 1 | 1 | endochitinase activity |
GO:0050337 | 0.0022 | Inf | 0.0022 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0005102 | 0.0053 | 3.4921 | 2.7993 | 8 | 1333 | receptor binding |
GO:0004351 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | glutamate decarboxylase activity |
GO:0001875 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | lipopolysaccharide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 14.0674 | 1.0249 | 11 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 6.1853 | 2.229 | 11 | 709 | G-protein coupled receptor activity |
GO:0031492 | 3e-04 | 25.3 | 0.1352 | 3 | 43 | nucleosomal DNA binding |
GO:0099600 | 5e-04 | 3.835 | 3.4771 | 11 | 1106 | transmembrane receptor activity |
GO:0046982 | 5e-04 | 5.6038 | 1.4367 | 7 | 457 | protein heterodimerization activity |
GO:0038023 | 8e-04 | 3.6271 | 3.6594 | 11 | 1164 | signaling receptor activity |
GO:0005549 | 0.0019 | 13.4622 | 0.2452 | 3 | 78 | odorant binding |
GO:0000210 | 0.0031 | Inf | 0.0031 | 1 | 1 | NAD+ diphosphatase activity |
GO:0004838 | 0.0031 | Inf | 0.0031 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
GO:0060089 | 0.0033 | 2.9816 | 4.3731 | 11 | 1391 | molecular transducer activity |
GO:0003872 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | 6-phosphofructokinase activity |
GO:0034714 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | type III transforming growth factor beta receptor binding |
GO:0035939 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | microsatellite binding |
GO:0080130 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | L-phenylalanine:2-oxoglutarate aminotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 39.6807 | 0.5423 | 14 | 180 | histone binding |
GO:0046982 | 0 | 14.5955 | 1.3769 | 14 | 457 | protein heterodimerization activity |
GO:0019904 | 0 | 10.5339 | 1.871 | 14 | 621 | protein domain specific binding |
GO:0003723 | 0 | 6.0164 | 4.8597 | 19 | 1613 | RNA binding |
GO:0003677 | 0 | 4.899 | 6.7759 | 21 | 2249 | DNA binding |
GO:1901363 | 0 | 3.4153 | 16.3446 | 30 | 5425 | heterocyclic compound binding |
GO:0097159 | 1e-04 | 3.3437 | 16.5676 | 30 | 5499 | organic cyclic compound binding |
GO:0004909 | 0.006 | 338.2444 | 0.006 | 1 | 2 | interleukin-1, Type I, activating receptor activity |
GO:0071791 | 0.006 | 338.2444 | 0.006 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045127 | 0.0024 | Inf | 0.0024 | 1 | 1 | N-acetylglucosamine kinase activity |
GO:0030246 | 0.0024 | 7.8709 | 0.5695 | 4 | 235 | carbohydrate binding |
GO:1990430 | 0.0073 | 211.5139 | 0.0073 | 1 | 3 | extracellular matrix protein binding |
GO:0005518 | 0.009 | 15.212 | 0.143 | 2 | 59 | collagen binding |
GO:0015333 | 0.0097 | 141 | 0.0097 | 1 | 4 | peptide:proton symporter activity |
GO:0034584 | 0.0097 | 141 | 0.0097 | 1 | 4 | piRNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000224 | 0.003 | Inf | 0.003 | 1 | 1 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity |
GO:0043914 | 0.003 | Inf | 0.003 | 1 | 1 | NADPH:sulfur oxidoreductase activity |
GO:0004021 | 0.006 | 338.2444 | 0.006 | 1 | 2 | L-alanine:2-oxoglutarate aminotransferase activity |
GO:0004674 | 0.0067 | 4.6016 | 1.1991 | 5 | 398 | protein serine/threonine kinase activity |
GO:0004689 | 0.009 | 169.1111 | 0.009 | 1 | 3 | phosphorylase kinase activity |
GO:0004937 | 0.009 | 169.1111 | 0.009 | 1 | 3 | alpha1-adrenergic receptor activity |
GO:0042978 | 0.009 | 169.1111 | 0.009 | 1 | 3 | ornithine decarboxylase activator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 8e-04 | 7.7425 | 0.7473 | 5 | 326 | olfactory receptor activity |
GO:0004744 | 0.0023 | Inf | 0.0023 | 1 | 1 | retinal isomerase activity |
GO:0050479 | 0.0023 | Inf | 0.0023 | 1 | 1 | glyceryl-ether monooxygenase activity |
GO:0052884 | 0.0023 | Inf | 0.0023 | 1 | 1 | all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity |
GO:0052885 | 0.0023 | Inf | 0.0023 | 1 | 1 | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity |
GO:1902118 | 0.0023 | Inf | 0.0023 | 1 | 1 | calcidiol binding |
GO:0005198 | 0.0028 | 4.8358 | 1.4465 | 6 | 631 | structural molecule activity |
GO:0004458 | 0.0046 | 448 | 0.0046 | 1 | 2 | D-lactate dehydrogenase (cytochrome) activity |
GO:0004930 | 0.005 | 4.2763 | 1.6253 | 6 | 709 | G-protein coupled receptor activity |
GO:0008607 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | phosphorylase kinase regulator activity |
GO:0010484 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | H3 histone acetyltransferase activity |
GO:0015016 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | [heparan sulfate]-glucosamine N-sulfotransferase activity |
GO:0031014 | 0.0091 | 149.3137 | 0.0092 | 1 | 4 | troponin T binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047961 | 1e-04 | 304.28 | 0.0136 | 2 | 4 | glycine N-acyltransferase activity |
GO:0034237 | 0.0017 | 38 | 0.0613 | 2 | 18 | protein kinase A regulatory subunit binding |
GO:0003677 | 0.0025 | 2.5841 | 7.6597 | 16 | 2249 | DNA binding |
GO:0046872 | 0.0032 | 2.2898 | 12.6458 | 22 | 3713 | metal ion binding |
GO:0015139 | 0.0034 | Inf | 0.0034 | 1 | 1 | alpha-ketoglutarate transmembrane transporter activity |
GO:0030351 | 0.0034 | Inf | 0.0034 | 1 | 1 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity |
GO:0033798 | 0.0034 | Inf | 0.0034 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0034417 | 0.0034 | Inf | 0.0034 | 1 | 1 | bisphosphoglycerate 3-phosphatase activity |
GO:0043924 | 0.0034 | Inf | 0.0034 | 1 | 1 | suramin binding |
GO:0047946 | 0.0034 | Inf | 0.0034 | 1 | 1 | glutamine N-acyltransferase activity |
GO:0052826 | 0.0034 | Inf | 0.0034 | 1 | 1 | inositol hexakisphosphate 2-phosphatase activity |
GO:0005217 | 0.0038 | 24.3056 | 0.092 | 2 | 27 | intracellular ligand-gated ion channel activity |
GO:0043167 | 0.0067 | 2.0692 | 18.7797 | 28 | 5514 | ion binding |
GO:0031894 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | V1A vasopressin receptor binding |
GO:0035403 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | histone kinase activity (H3-T6 specific) |
GO:0051717 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity |
GO:0005080 | 0.009 | 15.176 | 0.143 | 2 | 42 | protein kinase C binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030246 | 0.0018 | 8.6597 | 0.5233 | 4 | 235 | carbohydrate binding |
GO:0018455 | 0.0022 | Inf | 0.0022 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0035800 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | deubiquitinase activator activity |
GO:0004090 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | carbonyl reductase (NADPH) activity |
GO:0015252 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | hydrogen ion channel activity |
GO:1990430 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | extracellular matrix protein binding |
GO:0005518 | 0.0076 | 16.6414 | 0.1314 | 2 | 59 | collagen binding |
GO:0000253 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | 3-keto sterol reductase activity |
GO:0015333 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | peptide:proton symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009055 | 6e-04 | 20.8104 | 0.1662 | 3 | 94 | electron transfer activity |
GO:0004964 | 0.0018 | Inf | 0.0018 | 1 | 1 | luteinizing hormone receptor activity |
GO:0035472 | 0.0018 | Inf | 0.0018 | 1 | 1 | choriogonadotropin hormone receptor activity |
GO:0038106 | 0.0018 | Inf | 0.0018 | 1 | 1 | choriogonadotropin hormone binding |
GO:0004963 | 0.0035 | 586.1538 | 0.0035 | 1 | 2 | follicle-stimulating hormone receptor activity |
GO:0000979 | 0.0041 | 23.3677 | 0.0955 | 2 | 54 | RNA polymerase II core promoter sequence-specific DNA binding |
GO:0004471 | 0.0053 | 293.0577 | 0.0053 | 1 | 3 | malate dehydrogenase (decarboxylating) (NAD+) activity |
GO:0004473 | 0.0053 | 293.0577 | 0.0053 | 1 | 3 | malate dehydrogenase (decarboxylating) (NADP+) activity |
GO:0008948 | 0.0071 | 195.359 | 0.0071 | 1 | 4 | oxaloacetate decarboxylase activity |
GO:0046982 | 0.0081 | 5.6773 | 0.8082 | 4 | 457 | protein heterodimerization activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016805 | 5e-04 | 73.1779 | 0.0334 | 2 | 15 | dipeptidase activity |
GO:0043565 | 9e-04 | 4.6895 | 2.1066 | 8 | 946 | sequence-specific DNA binding |
GO:0004181 | 0.0011 | 47.5438 | 0.049 | 2 | 22 | metallocarboxypeptidase activity |
GO:0003721 | 0.0022 | Inf | 0.0022 | 1 | 1 | telomerase RNA reverse transcriptase activity |
GO:0004102 | 0.0022 | Inf | 0.0022 | 1 | 1 | choline O-acetyltransferase activity |
GO:0098680 | 0.0022 | Inf | 0.0022 | 1 | 1 | template-free RNA nucleotidyltransferase |
GO:1904492 | 0.0022 | Inf | 0.0022 | 1 | 1 | Ac-Asp-Glu binding |
GO:1904493 | 0.0022 | Inf | 0.0022 | 1 | 1 | tetrahydrofolyl-poly(glutamate) polymer binding |
GO:0003700 | 0.0027 | 3.8962 | 2.5008 | 8 | 1123 | DNA binding transcription factor activity |
GO:0070888 | 0.0027 | 28.7898 | 0.0779 | 2 | 35 | E-box binding |
GO:0003968 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | RNA-directed 5'-3' RNA polymerase activity |
GO:0052593 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | tryptamine:oxygen oxidoreductase (deaminating) activity |
GO:0052594 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | aminoacetone:oxygen oxidoreductase(deaminating) activity |
GO:0052595 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | aliphatic-amine oxidase activity |
GO:0052596 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | phenethylamine:oxygen oxidoreductase (deaminating) activity |
GO:0008237 | 0.0056 | 9.1173 | 0.363 | 3 | 163 | metallopeptidase activity |
GO:0008131 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | primary amine oxidase activity |
GO:0070139 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | SUMO-specific endopeptidase activity |
GO:0000975 | 0.0069 | 3.9979 | 1.7392 | 6 | 781 | regulatory region DNA binding |
GO:0001515 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | opioid peptide activity |
GO:0001588 | 0.0089 | 153.8485 | 0.0089 | 1 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 27.8916 | 0.8114 | 14 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 12.1996 | 1.7646 | 14 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 8.452 | 2.7527 | 15 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 7.9924 | 2.897 | 15 | 1164 | signaling receptor activity |
GO:0060089 | 0 | 6.5663 | 3.462 | 15 | 1391 | molecular transducer activity |
GO:0005549 | 0 | 24.0954 | 0.1941 | 4 | 78 | odorant binding |
GO:0039706 | 2e-04 | 120.8175 | 0.0224 | 2 | 9 | co-receptor binding |
GO:0004744 | 0.0025 | Inf | 0.0025 | 1 | 1 | retinal isomerase activity |
GO:0043250 | 0.0025 | Inf | 0.0025 | 1 | 1 | sodium-dependent organic anion transmembrane transporter activity |
GO:0043914 | 0.0025 | Inf | 0.0025 | 1 | 1 | NADPH:sulfur oxidoreductase activity |
GO:0052884 | 0.0025 | Inf | 0.0025 | 1 | 1 | all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity |
GO:0052885 | 0.0025 | Inf | 0.0025 | 1 | 1 | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity |
GO:0008454 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity |
GO:0070405 | 0.0097 | 14.5326 | 0.1493 | 2 | 60 | ammonium ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.5549 | 0.8114 | 7 | 326 | olfactory receptor activity |
GO:0001591 | 1e-04 | 211.4722 | 0.0149 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0004930 | 2e-04 | 5.7425 | 1.7112 | 8 | 706 | G-protein coupled receptor activity |
GO:0035240 | 3e-04 | 105.7083 | 0.0249 | 2 | 10 | dopamine binding |
GO:0099600 | 0.0013 | 3.9983 | 2.7527 | 9 | 1106 | transmembrane receptor activity |
GO:0060089 | 0.0017 | 3.5815 | 3.462 | 10 | 1391 | molecular transducer activity |
GO:0038023 | 0.0018 | 3.7819 | 2.897 | 9 | 1164 | signaling receptor activity |
GO:0001605 | 0.0025 | Inf | 0.0025 | 1 | 1 | adrenomedullin receptor activity |
GO:0001635 | 0.005 | 411.5946 | 0.005 | 1 | 2 | calcitonin gene-related peptide receptor activity |
GO:0016509 | 0.005 | 411.5946 | 0.005 | 1 | 2 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
GO:0004252 | 0.0073 | 8.2291 | 0.3982 | 3 | 160 | serine-type endopeptidase activity |
GO:0003872 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | 6-phosphofructokinase activity |
GO:0004948 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | calcitonin receptor activity |
GO:0004965 | 0.0074 | 205.7838 | 0.0075 | 1 | 3 | G-protein coupled GABA receptor activity |
GO:0004321 | 0.0099 | 137.1802 | 0.01 | 1 | 4 | fatty-acyl-CoA synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001616 | 0.0032 | Inf | 0.0032 | 1 | 1 | growth hormone secretagogue receptor activity |
GO:0005302 | 0.0032 | Inf | 0.0032 | 1 | 1 | L-tyrosine transmembrane transporter activity |
GO:0017064 | 0.0032 | Inf | 0.0032 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0030977 | 0.0032 | Inf | 0.0032 | 1 | 1 | taurine binding |
GO:0070287 | 0.0032 | Inf | 0.0032 | 1 | 1 | ferritin receptor activity |
GO:0102077 | 0.0032 | Inf | 0.0032 | 1 | 1 | oleamide hydrolase activity |
GO:0103073 | 0.0032 | Inf | 0.0032 | 1 | 1 | anandamide amidohydrolase activity |
GO:0019785 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | ISG15-specific protease activity |
GO:0031780 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | corticotropin hormone receptor binding |
GO:0031783 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | type 5 melanocortin receptor binding |
GO:0047057 | 0.0064 | 317.0417 | 0.0064 | 1 | 2 | vitamin-K-epoxide reductase (warfarin-sensitive) activity |
GO:0005544 | 0.0069 | 17.4606 | 0.1252 | 2 | 39 | calcium-dependent phospholipid binding |
GO:0052689 | 0.007 | 8.2755 | 0.3915 | 3 | 122 | carboxylic ester hydrolase activity |
GO:0003872 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | 6-phosphofructokinase activity |
GO:0004040 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | amidase activity |
GO:0016520 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | growth hormone-releasing hormone receptor activity |
GO:0016934 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0031781 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | type 4 melanocortin receptor binding |
GO:0070996 | 0.0096 | 158.5104 | 0.0096 | 1 | 3 | type 1 melanocortin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070905 | 0.0043 | 476.0625 | 0.0043 | 1 | 2 | serine binding |
GO:0001730 | 0.0065 | 238.0156 | 0.0065 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0032190 | 0.0086 | 158.6667 | 0.0086 | 1 | 4 | acrosin binding |
GO:0071987 | 0.0086 | 158.6667 | 0.0086 | 1 | 4 | WD40-repeat domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 32.5434 | 0.6248 | 14 | 180 | histone binding |
GO:0019904 | 0 | 13.5649 | 2.1557 | 19 | 621 | protein domain specific binding |
GO:0046982 | 0 | 15.857 | 1.5864 | 17 | 457 | protein heterodimerization activity |
GO:0003677 | 0 | 3.8253 | 7.807 | 21 | 2249 | DNA binding |
GO:0003723 | 1e-04 | 3.6875 | 5.5992 | 16 | 1613 | RNA binding |
GO:1901363 | 5e-04 | 2.5656 | 18.8319 | 31 | 5425 | heterocyclic compound binding |
GO:0097159 | 7e-04 | 2.5118 | 19.0887 | 31 | 5499 | organic cyclic compound binding |
GO:0043027 | 0.0026 | 29.7941 | 0.0764 | 2 | 22 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:0001191 | 0.0065 | 18.0416 | 0.1215 | 2 | 35 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
GO:0005515 | 0.0083 | 3.0942 | 22.1879 | 29 | 9454 | protein binding |
GO:0001228 | 0.0095 | 4.1793 | 1.3017 | 5 | 375 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 6e-04 | 3.3474 | 4.7375 | 13 | 1391 | molecular transducer activity |
GO:0099600 | 0.0011 | 3.4599 | 3.7668 | 11 | 1106 | transmembrane receptor activity |
GO:0038023 | 0.0016 | 3.2723 | 3.9644 | 11 | 1164 | signaling receptor activity |
GO:0034237 | 0.0017 | 38 | 0.0613 | 2 | 18 | protein kinase A regulatory subunit binding |
GO:0005516 | 0.0028 | 7.4643 | 0.5858 | 4 | 172 | calmodulin binding |
GO:0034986 | 0.0034 | Inf | 0.0034 | 1 | 1 | iron chaperone activity |
GO:0043924 | 0.0034 | Inf | 0.0034 | 1 | 1 | suramin binding |
GO:0045127 | 0.0034 | Inf | 0.0034 | 1 | 1 | N-acetylglucosamine kinase activity |
GO:0005427 | 0.0068 | 298.3333 | 0.0068 | 1 | 2 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
GO:0008188 | 0.0086 | 15.5662 | 0.1396 | 2 | 41 | neuropeptide receptor activity |
GO:0004930 | 0.0098 | 3.2161 | 2.4147 | 7 | 709 | G-protein coupled receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047453 | 0.0016 | Inf | 0.0016 | 1 | 1 | ATP-dependent NAD(P)H-hydrate dehydratase activity |
GO:0052855 | 0.0016 | Inf | 0.0016 | 1 | 1 | ADP-dependent NAD(P)H-hydrate dehydratase activity |
GO:0097573 | 0.0016 | Inf | 0.0016 | 1 | 1 | glutathione oxidoreductase activity |
GO:0008160 | 0.0033 | 635.0833 | 0.0033 | 1 | 2 | protein tyrosine phosphatase activator activity |
GO:0004656 | 0.0065 | 211.6667 | 0.0065 | 1 | 4 | procollagen-proline 4-dioxygenase activity |
GO:0015038 | 0.0065 | 211.6667 | 0.0065 | 1 | 4 | glutathione disulfide oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008331 | 3e-04 | 106.0488 | 0.0253 | 2 | 9 | high voltage-gated calcium channel activity |
GO:0042923 | 0.0014 | 41.2114 | 0.0563 | 2 | 20 | neuropeptide binding |
GO:0008843 | 0.0028 | Inf | 0.0028 | 1 | 1 | endochitinase activity |
GO:0038062 | 0.0028 | Inf | 0.0028 | 1 | 1 | protein tyrosine kinase collagen receptor activity |
GO:0047453 | 0.0028 | Inf | 0.0028 | 1 | 1 | ATP-dependent NAD(P)H-hydrate dehydratase activity |
GO:0052855 | 0.0028 | Inf | 0.0028 | 1 | 1 | ADP-dependent NAD(P)H-hydrate dehydratase activity |
GO:0086056 | 0.0056 | 362.4762 | 0.0056 | 1 | 2 | voltage-gated calcium channel activity involved in AV node cell action potential |
GO:0008188 | 0.0059 | 18.9944 | 0.1155 | 2 | 41 | neuropeptide receptor activity |
GO:0016618 | 0.0084 | 181.2262 | 0.0084 | 1 | 3 | hydroxypyruvate reductase activity |
GO:0030267 | 0.0084 | 181.2262 | 0.0084 | 1 | 3 | glyoxylate reductase (NADP) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003677 | 0.0028 | 2.6422 | 7.0705 | 15 | 2249 | DNA binding |
GO:0061501 | 0.0031 | Inf | 0.0031 | 1 | 1 | cyclic-GMP-AMP synthase activity |
GO:0061685 | 0.0031 | Inf | 0.0031 | 1 | 1 | diphthine methylesterase activity |
GO:0004137 | 0.0063 | 323.8085 | 0.0063 | 1 | 2 | deoxycytidine kinase activity |
GO:0045145 | 0.0063 | 323.8085 | 0.0063 | 1 | 2 | single-stranded DNA 5'-3' exodeoxyribonuclease activity |
GO:0046899 | 0.0063 | 323.8085 | 0.0063 | 1 | 2 | nucleoside triphosphate adenylate kinase activity |
GO:0003700 | 0.0075 | 2.9221 | 3.5305 | 9 | 1123 | DNA binding transcription factor activity |
GO:0050682 | 0.0094 | 161.8936 | 0.0094 | 1 | 3 | AF-2 domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031995 | 2e-04 | 133.5263 | 0.021 | 2 | 8 | insulin-like growth factor II binding |
GO:0031994 | 4e-04 | 80.0947 | 0.0314 | 2 | 12 | insulin-like growth factor I binding |
GO:0031737 | 0.0026 | Inf | 0.0026 | 1 | 1 | CX3C chemokine receptor binding |
GO:0036393 | 0.0026 | Inf | 0.0026 | 1 | 1 | thiocyanate peroxidase activity |
GO:0047402 | 0.0026 | Inf | 0.0026 | 1 | 1 | protein-glucosylgalactosylhydroxylysine glucosidase activity |
GO:0102797 | 0.0026 | Inf | 0.0026 | 1 | 1 | geranial:oxygen oxidoreductase activity |
GO:0102798 | 0.0026 | Inf | 0.0026 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
GO:0003989 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | acetyl-CoA carboxylase activity |
GO:0004021 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | L-alanine:2-oxoglutarate aminotransferase activity |
GO:0004031 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | aldehyde oxidase activity |
GO:0008160 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | protein tyrosine phosphatase activator activity |
GO:0008454 | 0.0078 | 195.2051 | 0.0079 | 1 | 3 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0017064 | 0.0026 | Inf | 0.0026 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0018585 | 0.0026 | Inf | 0.0026 | 1 | 1 | fluorene oxygenase activity |
GO:0050479 | 0.0026 | Inf | 0.0026 | 1 | 1 | glyceryl-ether monooxygenase activity |
GO:0070287 | 0.0026 | Inf | 0.0026 | 1 | 1 | ferritin receptor activity |
GO:0097655 | 0.0026 | Inf | 0.0026 | 1 | 1 | serpin family protein binding |
GO:0102077 | 0.0026 | Inf | 0.0026 | 1 | 1 | oleamide hydrolase activity |
GO:0103073 | 0.0026 | Inf | 0.0026 | 1 | 1 | anandamide amidohydrolase activity |
GO:0043394 | 0.0026 | 29.3456 | 0.0766 | 2 | 30 | proteoglycan binding |
GO:0001641 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | group II metabotropic glutamate receptor activity |
GO:0042284 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | sphingolipid delta-4 desaturase activity |
GO:0004040 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | amidase activity |
GO:0030298 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | receptor signaling protein tyrosine kinase activator activity |
GO:0031781 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 4 melanocortin receptor binding |
GO:0070996 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 1 melanocortin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050023 | 0.0022 | Inf | 0.0022 | 1 | 1 | L-fuconate dehydratase activity |
GO:0008396 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | oxysterol 7-alpha-hydroxylase activity |
GO:0008823 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | cupric reductase activity |
GO:0033872 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
GO:0052851 | 0.0044 | 461.6061 | 0.0045 | 1 | 2 | ferric-chelate reductase (NADPH) activity |
GO:0030943 | 0.0067 | 230.7879 | 0.0067 | 1 | 3 | mitochondrion targeting sequence binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 115.0379 | 0.1408 | 10 | 43 | nucleosomal DNA binding |
GO:0042393 | 0 | 22.1294 | 0.5895 | 10 | 180 | histone binding |
GO:0045296 | 0 | 15.2135 | 0.9431 | 11 | 288 | cadherin binding |
GO:0003682 | 0 | 9.3418 | 1.4966 | 11 | 457 | chromatin binding |
GO:0046982 | 0 | 8.2612 | 1.4966 | 10 | 457 | protein heterodimerization activity |
GO:0044877 | 0 | 5.0657 | 2.9637 | 12 | 905 | macromolecular complex binding |
GO:0008569 | 0.0014 | 42.2306 | 0.0557 | 2 | 17 | ATP-dependent microtubule motor activity, minus-end-directed |
GO:0003677 | 0.0016 | 2.7365 | 7.3651 | 16 | 2249 | DNA binding |
GO:0045503 | 0.0025 | 30.1528 | 0.0753 | 2 | 23 | dynein light chain binding |
GO:0045505 | 0.0032 | 26.3785 | 0.0851 | 2 | 26 | dynein intermediate chain binding |
GO:0000334 | 0.0033 | Inf | 0.0033 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0051959 | 0.0038 | 24.3462 | 0.0917 | 2 | 28 | dynein light intermediate chain binding |
GO:0004909 | 0.0065 | 310.551 | 0.0065 | 1 | 2 | interleukin-1, Type I, activating receptor activity |
GO:0008294 | 0.0065 | 310.551 | 0.0065 | 1 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
GO:0035800 | 0.0065 | 310.551 | 0.0065 | 1 | 2 | deubiquitinase activator activity |
GO:0002020 | 0.0081 | 7.8334 | 0.4126 | 3 | 126 | protease binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004347 | 0.0026 | Inf | 0.0026 | 1 | 1 | glucose-6-phosphate isomerase activity |
GO:0005509 | 0.0052 | 4.1931 | 1.6269 | 6 | 621 | calcium ion binding |
GO:0005153 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | interleukin-8 receptor binding |
GO:0008294 | 0.0052 | 390.4359 | 0.0052 | 1 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
GO:0008009 | 0.0056 | 19.4955 | 0.1127 | 2 | 43 | chemokine activity |
GO:0047223 | 0.0078 | 195.2051 | 0.0079 | 1 | 3 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
GO:0030276 | 0.0082 | 15.9768 | 0.1362 | 2 | 52 | clathrin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047961 | 1e-04 | 292.5385 | 0.0141 | 2 | 4 | glycine N-acyltransferase activity |
GO:0003677 | 5e-04 | 2.9097 | 7.9543 | 18 | 2249 | DNA binding |
GO:0003700 | 0.0016 | 3.2441 | 3.9718 | 11 | 1123 | DNA binding transcription factor activity |
GO:0034237 | 0.0018 | 36.5337 | 0.0637 | 2 | 18 | protein kinase A regulatory subunit binding |
GO:0046872 | 0.0024 | 2.3171 | 13.1322 | 23 | 3713 | metal ion binding |
GO:1990837 | 0.0024 | 3.787 | 2.3909 | 8 | 676 | sequence-specific double-stranded DNA binding |
GO:0000977 | 0.0035 | 3.9338 | 1.9877 | 7 | 562 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0015139 | 0.0035 | Inf | 0.0035 | 1 | 1 | alpha-ketoglutarate transmembrane transporter activity |
GO:0033798 | 0.0035 | Inf | 0.0035 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0043924 | 0.0035 | Inf | 0.0035 | 1 | 1 | suramin binding |
GO:0047946 | 0.0035 | Inf | 0.0035 | 1 | 1 | glutamine N-acyltransferase activity |
GO:0005217 | 0.0041 | 23.3677 | 0.0955 | 2 | 27 | intracellular ligand-gated ion channel activity |
GO:0044212 | 0.0057 | 3.2579 | 2.7552 | 8 | 779 | transcription regulatory region DNA binding |
GO:0001067 | 0.0058 | 3.249 | 2.7622 | 8 | 781 | regulatory region nucleic acid binding |
GO:0043167 | 0.0061 | 2.0575 | 19.502 | 29 | 5514 | ion binding |
GO:0031894 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | V1A vasopressin receptor binding |
GO:0035403 | 0.0071 | 287.0377 | 0.0071 | 1 | 2 | histone kinase activity (H3-T6 specific) |
GO:0097159 | 0.0089 | 1.9951 | 19.0865 | 28 | 5498 | organic cyclic compound binding |
GO:0000982 | 0.0096 | 4.1629 | 1.3051 | 5 | 369 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0005080 | 0.0097 | 14.5904 | 0.1485 | 2 | 42 | protein kinase C binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005184 | 0.0025 | 30.4344 | 0.0741 | 2 | 29 | neuropeptide hormone activity |
GO:0004042 | 0.0026 | Inf | 0.0026 | 1 | 1 | acetyl-CoA:L-glutamate N-acetyltransferase activity |
GO:0004838 | 0.0026 | Inf | 0.0026 | 1 | 1 | L-tyrosine:2-oxoglutarate aminotransferase activity |
GO:0017064 | 0.0026 | Inf | 0.0026 | 1 | 1 | fatty acid amide hydrolase activity |
GO:0097655 | 0.0026 | Inf | 0.0026 | 1 | 1 | serpin family protein binding |
GO:0102077 | 0.0026 | Inf | 0.0026 | 1 | 1 | oleamide hydrolase activity |
GO:0103045 | 0.0026 | Inf | 0.0026 | 1 | 1 | methione N-acyltransferase activity |
GO:0103073 | 0.0026 | Inf | 0.0026 | 1 | 1 | anandamide amidohydrolase activity |
GO:0043394 | 0.0026 | 29.3456 | 0.0766 | 2 | 30 | proteoglycan binding |
GO:0001641 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | group II metabotropic glutamate receptor activity |
GO:0042284 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | sphingolipid delta-4 desaturase activity |
GO:0098772 | 0.0058 | 2.9517 | 4.0946 | 10 | 1603 | molecular function regulator |
GO:0016597 | 0.0069 | 17.4606 | 0.1252 | 2 | 49 | amino acid binding |
GO:0004040 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | amidase activity |
GO:0030298 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | receptor signaling protein tyrosine kinase activator activity |
GO:0031781 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 4 melanocortin receptor binding |
GO:0070996 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | type 1 melanocortin receptor binding |
GO:0080130 | 0.0076 | 200.3553 | 0.0077 | 1 | 3 | L-phenylalanine:2-oxoglutarate aminotransferase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019731 | 1e-04 | 13.4712 | 0.4336 | 5 | 38 | antibacterial humoral response |
GO:0050832 | 1e-04 | 13.4712 | 0.4336 | 5 | 38 | defense response to fungus |
GO:0051852 | 1e-04 | Inf | 0.0226 | 2 | 2 | disruption by host of symbiont cells |
GO:0044657 | 1e-04 | Inf | 0.0228 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0052043 | 1e-04 | Inf | 0.0228 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 1e-04 | Inf | 0.0228 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 1e-04 | Inf | 0.0228 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0006955 | 3e-04 | 2.0322 | 19.9244 | 36 | 1782 | immune response |
GO:1903238 | 4e-04 | 175.2111 | 0.0342 | 2 | 3 | positive regulation of leukocyte tethering or rolling |
GO:0072676 | 4e-04 | 6.8584 | 0.9584 | 6 | 84 | lymphocyte migration |
GO:0031640 | 4e-04 | 8.8814 | 0.6275 | 5 | 55 | killing of cells of other organism |
GO:0002251 | 5e-04 | 12.634 | 0.3651 | 4 | 32 | organ or tissue specific immune response |
GO:0050755 | 6e-04 | 22.0084 | 0.1711 | 3 | 15 | chemokine metabolic process |
GO:0006952 | 0.001 | 1.9884 | 16.589 | 30 | 1454 | defense response |
GO:0002227 | 0.0014 | 15.5304 | 0.2282 | 3 | 20 | innate immune response in mucosa |
GO:0010818 | 0.0017 | 14.6667 | 0.2396 | 3 | 21 | T cell chemotaxis |
GO:0043207 | 0.0017 | 2.2738 | 8.9905 | 19 | 788 | response to external biotic stimulus |
GO:0001878 | 0.0019 | 43.7944 | 0.0685 | 2 | 6 | response to yeast |
GO:0051673 | 0.0019 | 43.7944 | 0.0685 | 2 | 6 | membrane disruption in other organism |
GO:0007606 | 0.0025 | 2.7547 | 4.6321 | 12 | 406 | sensory perception of chemical stimulus |
GO:0042758 | 0.0026 | 35.0333 | 0.0799 | 2 | 7 | long-chain fatty acid catabolic process |
GO:0070944 | 0.0026 | 35.0333 | 0.0799 | 2 | 7 | neutrophil mediated killing of bacterium |
GO:0061844 | 0.0027 | 7.5176 | 0.5819 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0045730 | 0.0028 | 11.997 | 0.2852 | 3 | 25 | respiratory burst |
GO:0050911 | 0.0031 | 2.9879 | 3.5483 | 10 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0070942 | 0.0035 | 29.1926 | 0.0913 | 2 | 8 | neutrophil mediated cytotoxicity |
GO:0034368 | 0.0039 | 10.5553 | 0.3195 | 3 | 28 | protein-lipid complex remodeling |
GO:0042742 | 0.0044 | 3.6403 | 2.0356 | 7 | 184 | defense response to bacterium |
GO:0042355 | 0.0044 | 25.0206 | 0.1027 | 2 | 9 | L-fucose catabolic process |
GO:0019730 | 0.0049 | 9.6583 | 0.3453 | 3 | 31 | antimicrobial humoral response |
GO:0009593 | 0.005 | 2.6265 | 4.4268 | 11 | 388 | detection of chemical stimulus |
GO:0070328 | 0.0057 | 9.0971 | 0.3651 | 3 | 32 | triglyceride homeostasis |
GO:0050906 | 0.0063 | 2.5435 | 4.5637 | 11 | 400 | detection of stimulus involved in sensory perception |
GO:0030595 | 0.0069 | 3.3333 | 2.2134 | 7 | 194 | leukocyte chemotaxis |
GO:0045321 | 0.0073 | 1.8721 | 12.5616 | 22 | 1101 | leukocyte activation |
GO:1904705 | 0.0073 | 8.2427 | 0.3993 | 3 | 35 | regulation of vascular smooth muscle cell proliferation |
GO:0050801 | 0.0076 | 2.0875 | 8.1234 | 16 | 712 | ion homeostasis |
GO:0051702 | 0.0076 | 5.5147 | 0.7758 | 4 | 68 | interaction with symbiont |
GO:0051873 | 0.0079 | 17.5111 | 0.1369 | 2 | 12 | killing by host of symbiont cells |
GO:0042119 | 0.0086 | 2.3285 | 5.4308 | 12 | 476 | neutrophil activation |
GO:0034105 | 0.0092 | 7.5347 | 0.4336 | 3 | 38 | positive regulation of tissue remodeling |
GO:0042398 | 0.0092 | 7.5347 | 0.4336 | 3 | 38 | cellular modified amino acid biosynthetic process |
GO:0034374 | 0.0093 | 15.9182 | 0.1483 | 2 | 13 | low-density lipoprotein particle remodeling |
GO:0045073 | 0.0093 | 15.9182 | 0.1483 | 2 | 13 | regulation of chemokine biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0098754 | 0 | 7.6542 | 1.1673 | 8 | 98 | detoxification |
GO:0097237 | 0 | 7.249 | 1.2268 | 8 | 103 | cellular response to toxic substance |
GO:0019430 | 1e-04 | 19.9178 | 0.2501 | 4 | 21 | removal of superoxide radicals |
GO:0042744 | 1e-04 | 18.81 | 0.262 | 4 | 22 | hydrogen peroxide catabolic process |
GO:0071450 | 1e-04 | 17.8189 | 0.2739 | 4 | 23 | cellular response to oxygen radical |
GO:0000303 | 2e-04 | 15.3861 | 0.3097 | 4 | 26 | response to superoxide |
GO:1902304 | 4e-04 | 167.6702 | 0.0357 | 2 | 3 | positive regulation of potassium ion export |
GO:0042448 | 7e-04 | 21.0561 | 0.1787 | 3 | 15 | progesterone metabolic process |
GO:0036293 | 7e-04 | 3.2122 | 4.002 | 12 | 336 | response to decreased oxygen levels |
GO:0032835 | 7e-04 | 7.7184 | 0.7146 | 5 | 60 | glomerulus development |
GO:1902949 | 8e-04 | 83.8298 | 0.0476 | 2 | 4 | positive regulation of tau-protein kinase activity |
GO:0032024 | 0.0012 | 6.8439 | 0.798 | 5 | 67 | positive regulation of insulin secretion |
GO:0070498 | 0.0016 | 14.8584 | 0.2382 | 3 | 20 | interleukin-1-mediated signaling pathway |
GO:0000820 | 0.0021 | 41.9096 | 0.0715 | 2 | 6 | regulation of glutamine family amino acid metabolic process |
GO:0007566 | 0.0025 | 7.6823 | 0.5717 | 4 | 48 | embryo implantation |
GO:0002793 | 0.0027 | 3.2712 | 2.9181 | 9 | 245 | positive regulation of peptide secretion |
GO:0033240 | 0.0028 | 33.5255 | 0.0834 | 2 | 7 | positive regulation of cellular amine metabolic process |
GO:0051126 | 0.0028 | 33.5255 | 0.0834 | 2 | 7 | negative regulation of actin nucleation |
GO:0071073 | 0.0028 | 33.5255 | 0.0834 | 2 | 7 | positive regulation of phospholipid biosynthetic process |
GO:0071453 | 0.0034 | 3.4376 | 2.4655 | 8 | 207 | cellular response to oxygen levels |
GO:0090594 | 0.0038 | 27.9362 | 0.0953 | 2 | 8 | inflammatory response to wounding |
GO:0006979 | 0.004 | 2.5825 | 4.9191 | 12 | 413 | response to oxidative stress |
GO:0042542 | 0.0046 | 4.1124 | 1.5484 | 6 | 130 | response to hydrogen peroxide |
GO:0061314 | 0.0048 | 23.9438 | 0.1072 | 2 | 9 | Notch signaling involved in heart development |
GO:0009749 | 0.0052 | 3.5293 | 2.0963 | 7 | 176 | response to glucose |
GO:1902624 | 0.0053 | 9.3494 | 0.3573 | 3 | 30 | positive regulation of neutrophil migration |
GO:0034284 | 0.007 | 3.33 | 2.2154 | 7 | 186 | response to monosaccharide |
GO:0071456 | 0.0072 | 3.3113 | 2.2273 | 7 | 187 | cellular response to hypoxia |
GO:1902514 | 0.0072 | 18.6206 | 0.131 | 2 | 11 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
GO:0006699 | 0.0076 | 8.1409 | 0.405 | 3 | 34 | bile acid biosynthetic process |
GO:1903532 | 0.0082 | 2.5741 | 4.0854 | 10 | 343 | positive regulation of secretion by cell |
GO:0002090 | 0.0082 | 7.886 | 0.4169 | 3 | 35 | regulation of receptor internalization |
GO:0051494 | 0.0084 | 4.2352 | 1.2498 | 5 | 106 | negative regulation of cytoskeleton organization |
GO:0003184 | 0.0086 | 16.7574 | 0.1429 | 2 | 12 | pulmonary valve morphogenesis |
GO:0098869 | 0.0086 | 5.3018 | 0.8056 | 4 | 69 | cellular oxidant detoxification |
GO:0090276 | 0.0087 | 3.1859 | 2.3107 | 7 | 194 | regulation of peptide hormone secretion |
GO:0047496 | 0.0089 | 7.6466 | 0.4288 | 3 | 36 | vesicle transport along microtubule |
GO:1901700 | 0.0096 | 1.7021 | 17.6398 | 28 | 1481 | response to oxygen-containing compound |
GO:0010817 | 0.0099 | 2.2783 | 5.5385 | 12 | 465 | regulation of hormone levels |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 235.8519 | 0.2787 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0034654 | 0 | 3.3001 | 62.5087 | 129 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0034645 | 0 | 3.0553 | 75.0817 | 140 | 4849 | cellular macromolecule biosynthetic process |
GO:0007389 | 0 | 10.2194 | 3.4413 | 28 | 230 | pattern specification process |
GO:0006335 | 0 | 52.3648 | 0.4955 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 42.833 | 0.5574 | 14 | 36 | chromatin silencing at rDNA |
GO:2001141 | 0 | 3.6092 | 30.8549 | 78 | 2311 | regulation of RNA biosynthetic process |
GO:0006355 | 0 | 3.6058 | 30.8776 | 78 | 2318 | regulation of transcription, DNA-templated |
GO:0034080 | 0 | 36.2341 | 0.6194 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0032502 | 0 | 3.2593 | 54.0503 | 107 | 3972 | developmental process |
GO:0051290 | 0 | 31.3948 | 0.6813 | 14 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 31.3948 | 0.6813 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0045944 | 0 | 4.0925 | 16.3975 | 54 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0009889 | 0 | 3.3257 | 35.3135 | 81 | 2671 | regulation of biosynthetic process |
GO:0034724 | 0 | 25.4439 | 0.7897 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0009952 | 0 | 9.2727 | 3.0194 | 23 | 195 | anterior/posterior pattern specification |
GO:0016233 | 0 | 22.9557 | 0.8516 | 14 | 55 | telomere capping |
GO:1903508 | 0 | 3.4775 | 21.0427 | 59 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0051254 | 0 | 3.3573 | 22.1421 | 60 | 1430 | positive regulation of RNA metabolic process |
GO:0019219 | 0 | 3.0642 | 35.3594 | 78 | 2635 | regulation of nucleobase-containing compound metabolic process |
GO:1901576 | 0 | 2.5054 | 93.1669 | 148 | 6017 | organic substance biosynthetic process |
GO:0097659 | 0 | 3.225 | 28.6109 | 68 | 2221 | nucleic acid-templated transcription |
GO:0006303 | 0 | 16.2097 | 1.1148 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0046483 | 0 | 2.4216 | 87.4688 | 140 | 5649 | heterocycle metabolic process |
GO:0048863 | 0 | 9.0531 | 2.51 | 19 | 168 | stem cell differentiation |
GO:0043044 | 0 | 15.4096 | 1.1613 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0010628 | 0 | 3.1056 | 24.4259 | 61 | 1664 | positive regulation of gene expression |
GO:0045596 | 0 | 4.371 | 9.693 | 36 | 626 | negative regulation of cell differentiation |
GO:0010557 | 0 | 3.0472 | 24.573 | 61 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0045815 | 0 | 14.4576 | 1.2232 | 14 | 79 | positive regulation of gene expression, epigenetic |
GO:0006725 | 0 | 2.3576 | 88.0263 | 139 | 5685 | cellular aromatic compound metabolic process |
GO:1902679 | 0 | 3.3747 | 17.373 | 49 | 1122 | negative regulation of RNA biosynthetic process |
GO:1903707 | 0 | 9.8475 | 2.0748 | 17 | 134 | negative regulation of hemopoiesis |
GO:1901360 | 0 | 2.342 | 91.216 | 142 | 5891 | organic cyclic compound metabolic process |
GO:0034641 | 0 | 2.2995 | 96.1244 | 146 | 6208 | cellular nitrogen compound metabolic process |
GO:0031497 | 0 | 8.9949 | 2.2452 | 17 | 145 | chromatin assembly |
GO:0060173 | 0 | 8.0966 | 2.6168 | 18 | 169 | limb development |
GO:0060255 | 0 | 2.6781 | 43.7501 | 83 | 3189 | regulation of macromolecule metabolic process |
GO:0031328 | 0 | 2.7748 | 26.6479 | 61 | 1721 | positive regulation of cellular biosynthetic process |
GO:0043009 | 0 | 4.2416 | 8.4388 | 31 | 545 | chordate embryonic development |
GO:1902036 | 0 | 10.7864 | 1.5639 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 10.3097 | 1.6258 | 14 | 105 | regulation of gene silencing by miRNA |
GO:0009890 | 0 | 2.7915 | 24.4801 | 57 | 1581 | negative regulation of biosynthetic process |
GO:0045934 | 0 | 2.8954 | 20.8414 | 51 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0045814 | 0 | 9.0135 | 1.8271 | 14 | 118 | negative regulation of gene expression, epigenetic |
GO:0001501 | 0 | 4.1796 | 7.3549 | 27 | 475 | skeletal system development |
GO:0035107 | 0 | 7.7462 | 2.2452 | 15 | 145 | appendage morphogenesis |
GO:0060968 | 0 | 8.2175 | 1.9819 | 14 | 128 | regulation of gene silencing |
GO:0065007 | 0 | 2.5095 | 171.8719 | 210 | 11100 | biological regulation |
GO:0000122 | 0 | 3.327 | 11.6594 | 34 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0035194 | 0 | 5.663 | 3.6078 | 18 | 233 | posttranscriptional gene silencing by RNA |
GO:0045637 | 0 | 5.6365 | 3.6232 | 18 | 234 | regulation of myeloid cell differentiation |
GO:0002244 | 0 | 6.3295 | 2.88 | 16 | 186 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 5.8185 | 3.3136 | 17 | 214 | protein-DNA complex assembly |
GO:0007399 | 0 | 2.7236 | 19.3677 | 45 | 1340 | nervous system development |
GO:0016070 | 0 | 2.327 | 37.9588 | 69 | 2948 | RNA metabolic process |
GO:0032200 | 0 | 6.2731 | 2.5239 | 14 | 163 | telomere organization |
GO:2000026 | 0 | 2.9128 | 13.7544 | 35 | 963 | regulation of multicellular organismal development |
GO:0071103 | 0 | 4.6641 | 4.0568 | 17 | 262 | DNA conformation change |
GO:0048562 | 0 | 5.6581 | 2.7708 | 14 | 187 | embryonic organ morphogenesis |
GO:0048731 | 0 | 2.8631 | 14.2544 | 34 | 1273 | system development |
GO:0021953 | 0 | 5.6846 | 2.5549 | 13 | 165 | central nervous system neuron differentiation |
GO:0051173 | 0 | 2.0037 | 43.2312 | 73 | 2792 | positive regulation of nitrogen compound metabolic process |
GO:0048534 | 0 | 2.7694 | 12.8981 | 32 | 833 | hematopoietic or lymphoid organ development |
GO:0030326 | 0 | 7.5719 | 1.5016 | 10 | 98 | embryonic limb morphogenesis |
GO:0017148 | 0 | 4.009 | 4.9549 | 18 | 320 | negative regulation of translation |
GO:0006352 | 0 | 4.6582 | 3.5613 | 15 | 230 | DNA-templated transcription, initiation |
GO:0021517 | 0 | 12.6948 | 0.6658 | 7 | 43 | ventral spinal cord development |
GO:0014031 | 0 | 9.3539 | 0.991 | 8 | 64 | mesenchymal cell development |
GO:0048864 | 0 | 9.3539 | 0.991 | 8 | 64 | stem cell development |
GO:0009954 | 0 | 15.6149 | 0.48 | 6 | 31 | proximal/distal pattern formation |
GO:0048704 | 0 | 11.3518 | 0.7302 | 7 | 48 | embryonic skeletal system morphogenesis |
GO:0021545 | 0 | 11.1431 | 0.7432 | 7 | 48 | cranial nerve development |
GO:0048729 | 0 | 2.9262 | 9.3988 | 25 | 607 | tissue morphogenesis |
GO:0014033 | 0 | 8.728 | 1.0529 | 8 | 68 | neural crest cell differentiation |
GO:0048699 | 0 | 2.348 | 18.115 | 38 | 1199 | generation of neurons |
GO:0010467 | 0 | 2.0228 | 40.791 | 66 | 3370 | gene expression |
GO:0021515 | 0 | 10.3813 | 0.7897 | 7 | 51 | cell differentiation in spinal cord |
GO:0007218 | 0 | 6.9491 | 1.4555 | 9 | 94 | neuropeptide signaling pathway |
GO:0043388 | 0 | 9.9287 | 0.8206 | 7 | 53 | positive regulation of DNA binding |
GO:0060485 | 0 | 4.2488 | 3.6078 | 14 | 233 | mesenchyme development |
GO:0023061 | 0 | 3.316 | 6.2555 | 19 | 404 | signal release |
GO:0051241 | 0 | 2.5253 | 13.1445 | 30 | 904 | negative regulation of multicellular organismal process |
GO:0050794 | 0 | 2.0974 | 60.1076 | 84 | 4993 | regulation of cellular process |
GO:0060850 | 0 | 32.5622 | 0.1843 | 4 | 12 | regulation of transcription involved in cell fate commitment |
GO:0042475 | 0 | 7.0705 | 1.2697 | 8 | 82 | odontogenesis of dentin-containing tooth |
GO:0006837 | 0 | 25.8354 | 0.2168 | 4 | 14 | serotonin transport |
GO:0009888 | 1e-04 | 2.5259 | 11.8163 | 27 | 855 | tissue development |
GO:0060537 | 1e-04 | 3.2713 | 5.6362 | 17 | 364 | muscle tissue development |
GO:0048598 | 1e-04 | 3.7642 | 4.0434 | 14 | 288 | embryonic morphogenesis |
GO:0044238 | 1e-04 | 1.7311 | 153.0898 | 182 | 9887 | primary metabolic process |
GO:0060249 | 1e-04 | 3.2332 | 5.6981 | 17 | 368 | anatomical structure homeostasis |
GO:0010605 | 1e-04 | 1.8285 | 39.3292 | 63 | 2540 | negative regulation of macromolecule metabolic process |
GO:0048646 | 1e-04 | 2.3165 | 14.681 | 31 | 962 | anatomical structure formation involved in morphogenesis |
GO:0051240 | 1e-04 | 2.1125 | 20.4676 | 39 | 1345 | positive regulation of multicellular organismal process |
GO:0045892 | 1e-04 | 3.4721 | 4.6947 | 15 | 335 | negative regulation of transcription, DNA-templated |
GO:0051094 | 1e-04 | 2.1493 | 18.4414 | 36 | 1191 | positive regulation of developmental process |
GO:0006325 | 1e-04 | 2.5036 | 10.8543 | 25 | 701 | chromatin organization |
GO:0034248 | 1e-04 | 2.7407 | 8.2994 | 21 | 536 | regulation of cellular amide metabolic process |
GO:0042472 | 1e-04 | 6.0792 | 1.4555 | 8 | 94 | inner ear morphogenesis |
GO:0003206 | 1e-04 | 5.2647 | 1.8736 | 9 | 121 | cardiac chamber morphogenesis |
GO:0021536 | 1e-04 | 7.1281 | 1.0994 | 7 | 71 | diencephalon development |
GO:0099537 | 1e-04 | 2.6249 | 9.0736 | 22 | 586 | trans-synaptic signaling |
GO:1902866 | 1e-04 | 48.2613 | 0.1084 | 3 | 7 | regulation of retina development in camera-type eye |
GO:0035050 | 1e-04 | 7.0179 | 1.1148 | 7 | 72 | embryonic heart tube development |
GO:0009893 | 1e-04 | 3.4634 | 4.4161 | 14 | 334 | positive regulation of metabolic process |
GO:0003215 | 2e-04 | 17.2181 | 0.2942 | 4 | 19 | cardiac right ventricle morphogenesis |
GO:0015837 | 2e-04 | 39.2435 | 0.1219 | 3 | 8 | amine transport |
GO:0035137 | 2e-04 | 39.0249 | 0.1226 | 3 | 8 | hindlimb morphogenesis |
GO:0007610 | 2e-04 | 2.6565 | 8.119 | 20 | 530 | behavior |
GO:0007492 | 2e-04 | 6.4224 | 1.2077 | 7 | 78 | endoderm development |
GO:0033693 | 2e-04 | Inf | 0.031 | 2 | 2 | neurofilament bundle assembly |
GO:0060577 | 2e-04 | Inf | 0.031 | 2 | 2 | pulmonary vein morphogenesis |
GO:0061379 | 2e-04 | Inf | 0.031 | 2 | 2 | inferior colliculus development |
GO:0002682 | 3e-04 | 1.983 | 21.0117 | 38 | 1357 | regulation of immune system process |
GO:0048468 | 3e-04 | 1.8589 | 27.445 | 46 | 1824 | cell development |
GO:0035136 | 3e-04 | 9.523 | 0.6039 | 5 | 39 | forelimb morphogenesis |
GO:0072359 | 4e-04 | 2.1305 | 14.7407 | 29 | 952 | circulatory system development |
GO:0021520 | 4e-04 | 27.7987 | 0.1536 | 3 | 10 | spinal cord motor neuron cell fate specification |
GO:0048935 | 4e-04 | 27.7987 | 0.1536 | 3 | 10 | peripheral nervous system neuron development |
GO:0007420 | 4e-04 | 2.375 | 9.9562 | 22 | 643 | brain development |
GO:0046887 | 4e-04 | 4.834 | 1.7961 | 8 | 116 | positive regulation of hormone secretion |
GO:0009790 | 5e-04 | 3.1748 | 4.3975 | 13 | 331 | embryo development |
GO:0003231 | 5e-04 | 4.7455 | 1.8271 | 8 | 118 | cardiac ventricle development |
GO:0022414 | 5e-04 | 1.9376 | 20.2375 | 36 | 1307 | reproductive process |
GO:0060573 | 6e-04 | 24.1245 | 0.1703 | 3 | 11 | cell fate specification involved in pattern specification |
GO:0048701 | 6e-04 | 8.2994 | 0.6813 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0033555 | 6e-04 | 6.3849 | 1.0374 | 6 | 67 | multicellular organismal response to stress |
GO:0019233 | 6e-04 | 5.2971 | 1.44 | 7 | 93 | sensory perception of pain |
GO:0030855 | 6e-04 | 2.2653 | 10.9007 | 23 | 704 | epithelial cell differentiation |
GO:0009953 | 7e-04 | 5.1761 | 1.471 | 7 | 95 | dorsal/ventral pattern formation |
GO:0050905 | 7e-04 | 5.1761 | 1.471 | 7 | 95 | neuromuscular process |
GO:0035270 | 7e-04 | 4.4983 | 1.92 | 8 | 124 | endocrine system development |
GO:0021524 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | visceral motor neuron differentiation |
GO:0021912 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035880 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0048936 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060913 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:1902869 | 7e-04 | 128.1959 | 0.0465 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0051960 | 7e-04 | 2.192 | 11.7523 | 24 | 759 | regulation of nervous system development |
GO:0060706 | 7e-04 | 11.2235 | 0.4181 | 4 | 27 | cell differentiation involved in embryonic placenta development |
GO:0045165 | 8e-04 | 3.65 | 2.9333 | 10 | 196 | cell fate commitment |
GO:0050432 | 9e-04 | 7.5255 | 0.7432 | 5 | 48 | catecholamine secretion |
GO:0060562 | 9e-04 | 2.974 | 4.6607 | 13 | 301 | epithelial tube morphogenesis |
GO:0008217 | 0.001 | 3.8186 | 2.5239 | 9 | 163 | regulation of blood pressure |
GO:0051259 | 0.001 | 2.4305 | 7.8968 | 18 | 510 | protein oligomerization |
GO:0090596 | 0.001 | 4.7923 | 1.5787 | 7 | 104 | sensory organ morphogenesis |
GO:0001755 | 0.0011 | 10.0057 | 0.461 | 4 | 30 | neural crest cell migration |
GO:0001764 | 0.0011 | 4.1721 | 2.0594 | 8 | 133 | neuron migration |
GO:0035150 | 0.0012 | 4.1387 | 2.0748 | 8 | 134 | regulation of tube size |
GO:0008284 | 0.0013 | 2.0681 | 12.9446 | 25 | 836 | positive regulation of cell proliferation |
GO:0001569 | 0.0013 | 9.5583 | 0.48 | 4 | 31 | branching involved in blood vessel morphogenesis |
GO:0009887 | 0.0013 | 2.4487 | 7.4166 | 17 | 533 | animal organ morphogenesis |
GO:0043583 | 0.0013 | 3.3736 | 3.1587 | 10 | 204 | ear development |
GO:0007198 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021855 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | hypothalamus cell migration |
GO:0021913 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0034287 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | detection of glucose |
GO:0061325 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0070253 | 0.0014 | 64.0939 | 0.0619 | 2 | 4 | somatostatin secretion |
GO:0060579 | 0.0015 | 16.0789 | 0.2323 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0001662 | 0.0016 | 8.898 | 0.511 | 4 | 33 | behavioral fear response |
GO:0061458 | 0.0017 | 2.539 | 6.271 | 15 | 405 | reproductive system development |
GO:0010608 | 0.0017 | 2.2066 | 9.6465 | 20 | 623 | posttranscriptional regulation of gene expression |
GO:0060413 | 0.0018 | 14.8411 | 0.2477 | 3 | 16 | atrial septum morphogenesis |
GO:0060841 | 0.0018 | 14.8411 | 0.2477 | 3 | 16 | venous blood vessel development |
GO:0048644 | 0.0018 | 5.053 | 1.2852 | 6 | 83 | muscle organ morphogenesis |
GO:0007519 | 0.0018 | 3.835 | 2.2277 | 8 | 145 | skeletal muscle tissue development |
GO:0007548 | 0.0018 | 3.0162 | 3.871 | 11 | 250 | sex differentiation |
GO:0001667 | 0.0018 | 2.8499 | 4.4672 | 12 | 295 | ameboidal-type cell migration |
GO:0001947 | 0.0019 | 6.2194 | 0.8826 | 5 | 57 | heart looping |
GO:0007268 | 0.0019 | 2.2944 | 8.3372 | 18 | 546 | chemical synaptic transmission |
GO:0007368 | 0.0019 | 4.2922 | 1.7497 | 7 | 113 | determination of left/right symmetry |
GO:0003230 | 0.002 | 8.3228 | 0.5419 | 4 | 35 | cardiac atrium development |
GO:0060795 | 0.002 | 8.3228 | 0.5419 | 4 | 35 | cell fate commitment involved in formation of primary germ layer |
GO:0045995 | 0.0021 | 4.2122 | 1.7807 | 7 | 115 | regulation of embryonic development |
GO:0033189 | 0.0021 | 13.7802 | 0.2632 | 3 | 17 | response to vitamin A |
GO:0048486 | 0.0021 | 13.7802 | 0.2632 | 3 | 17 | parasympathetic nervous system development |
GO:0051047 | 0.0021 | 2.5612 | 5.791 | 14 | 374 | positive regulation of secretion |
GO:0071542 | 0.0022 | 8.0622 | 0.5574 | 4 | 36 | dopaminergic neuron differentiation |
GO:0002074 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | extraocular skeletal muscle development |
GO:0014060 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | regulation of epinephrine secretion |
GO:0035609 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | C-terminal protein deglutamylation |
GO:0048880 | 0.0023 | 42.7265 | 0.0774 | 2 | 5 | sensory system development |
GO:0007498 | 0.0025 | 4.0607 | 1.8426 | 7 | 119 | mesoderm development |
GO:0051932 | 0.0027 | 7.587 | 0.5884 | 4 | 38 | synaptic transmission, GABAergic |
GO:0003018 | 0.0029 | 3.5427 | 2.4 | 8 | 155 | vascular process in circulatory system |
GO:0010002 | 0.003 | 12.0561 | 0.2942 | 3 | 19 | cardioblast differentiation |
GO:0009799 | 0.003 | 3.9196 | 1.9045 | 7 | 123 | specification of symmetry |
GO:0035282 | 0.003 | 4.5216 | 1.4245 | 6 | 92 | segmentation |
GO:0055008 | 0.0031 | 5.4791 | 0.991 | 5 | 64 | cardiac muscle tissue morphogenesis |
GO:0048665 | 0.0033 | 11.5777 | 0.3037 | 3 | 20 | neuron fate specification |
GO:1904888 | 0.0033 | 11.5548 | 0.3042 | 3 | 20 | cranial skeletal system development |
GO:0097746 | 0.0033 | 3.8527 | 1.9355 | 7 | 125 | regulation of blood vessel diameter |
GO:0003278 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0009996 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | negative regulation of cell fate specification |
GO:0010871 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | negative regulation of receptor biosynthetic process |
GO:0014062 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | regulation of serotonin secretion |
GO:0021546 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | rhombomere development |
GO:0038031 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
GO:0048241 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | epinephrine transport |
GO:0060022 | 0.0034 | 32.0429 | 0.0929 | 2 | 6 | hard palate development |
GO:0007210 | 0.0034 | 11.3462 | 0.3097 | 3 | 20 | serotonin receptor signaling pathway |
GO:0045109 | 0.0034 | 11.3462 | 0.3097 | 3 | 20 | intermediate filament organization |
GO:0060039 | 0.0034 | 11.3462 | 0.3097 | 3 | 20 | pericardium development |
GO:0021761 | 0.0036 | 4.3683 | 1.471 | 6 | 95 | limbic system development |
GO:0048565 | 0.0036 | 3.788 | 1.9665 | 7 | 127 | digestive tract development |
GO:0048514 | 0.0037 | 2.1933 | 8.191 | 17 | 529 | blood vessel morphogenesis |
GO:0007517 | 0.0038 | 2.7307 | 4.2523 | 11 | 280 | muscle organ development |
GO:0043433 | 0.0038 | 3.7565 | 1.9819 | 7 | 128 | negative regulation of DNA binding transcription factor activity |
GO:0008406 | 0.0039 | 3.0879 | 3.0813 | 9 | 199 | gonad development |
GO:0050768 | 0.0039 | 2.877 | 3.6697 | 10 | 237 | negative regulation of neurogenesis |
GO:0045103 | 0.004 | 6.7867 | 0.6503 | 4 | 42 | intermediate filament-based process |
GO:0003279 | 0.004 | 4.2718 | 1.5019 | 6 | 97 | cardiac septum development |
GO:0010842 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | retina layer formation |
GO:0015874 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | norepinephrine transport |
GO:0031290 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0048485 | 0.004 | 10.7152 | 0.3252 | 3 | 21 | sympathetic nervous system development |
GO:0043043 | 0.0041 | 1.9634 | 11.8762 | 22 | 767 | peptide biosynthetic process |
GO:0010594 | 0.0043 | 3.6649 | 2.0284 | 7 | 131 | regulation of endothelial cell migration |
GO:0050796 | 0.0045 | 3.2728 | 2.5858 | 8 | 167 | regulation of insulin secretion |
GO:0007422 | 0.0046 | 4.9714 | 1.0839 | 5 | 70 | peripheral nervous system development |
GO:0003253 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0003357 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | noradrenergic neuron differentiation |
GO:0033504 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | floor plate development |
GO:0098700 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
GO:1902513 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | regulation of organelle transport along microtubule |
GO:2000049 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:2000542 | 0.0048 | 25.6327 | 0.1084 | 2 | 7 | negative regulation of gastrulation |
GO:0014013 | 0.0048 | 4.0908 | 1.5639 | 6 | 101 | regulation of gliogenesis |
GO:0001707 | 0.0049 | 4.8958 | 1.0994 | 5 | 71 | mesoderm formation |
GO:0090132 | 0.0051 | 2.7657 | 3.8091 | 10 | 246 | epithelium migration |
GO:0003151 | 0.0051 | 6.2585 | 0.6991 | 4 | 46 | outflow tract morphogenesis |
GO:0045686 | 0.0052 | 9.6424 | 0.3561 | 3 | 23 | negative regulation of glial cell differentiation |
GO:0006281 | 0.0052 | 2.169 | 7.7729 | 16 | 502 | DNA repair |
GO:0042310 | 0.0055 | 4.7512 | 1.1303 | 5 | 73 | vasoconstriction |
GO:0051952 | 0.0055 | 4.7512 | 1.1303 | 5 | 73 | regulation of amine transport |
GO:0035987 | 0.0055 | 6.1387 | 0.7123 | 4 | 46 | endodermal cell differentiation |
GO:0030154 | 0.0055 | 1.905 | 13.0802 | 23 | 1081 | cell differentiation |
GO:0032101 | 0.0056 | 1.971 | 10.7149 | 20 | 692 | regulation of response to external stimulus |
GO:0035295 | 0.0056 | 2.3644 | 5.7882 | 13 | 387 | tube development |
GO:0048522 | 0.0058 | 1.4628 | 56.8071 | 74 | 3868 | positive regulation of cellular process |
GO:0009914 | 0.0058 | 2.5703 | 4.5018 | 11 | 293 | hormone transport |
GO:0021511 | 0.0058 | 9.1827 | 0.3716 | 3 | 24 | spinal cord patterning |
GO:0035640 | 0.0058 | 9.1827 | 0.3716 | 3 | 24 | exploration behavior |
GO:0042481 | 0.0058 | 9.1827 | 0.3716 | 3 | 24 | regulation of odontogenesis |
GO:0043279 | 0.0061 | 3.8851 | 1.6413 | 6 | 106 | response to alkaloid |
GO:0007187 | 0.0062 | 3.0956 | 2.7252 | 8 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0022603 | 0.0063 | 1.8098 | 14.6323 | 25 | 945 | regulation of anatomical structure morphogenesis |
GO:0045916 | 0.0063 | 21.3592 | 0.1239 | 2 | 8 | negative regulation of complement activation |
GO:0007267 | 0.0064 | 1.7694 | 16.248 | 27 | 1108 | cell-cell signaling |
GO:0008344 | 0.0065 | 4.5495 | 1.1768 | 5 | 76 | adult locomotory behavior |
GO:0031016 | 0.0065 | 4.5495 | 1.1768 | 5 | 76 | pancreas development |
GO:0001945 | 0.0066 | 8.7647 | 0.3871 | 3 | 25 | lymph vessel development |
GO:0003148 | 0.0066 | 8.7647 | 0.3871 | 3 | 25 | outflow tract septum morphogenesis |
GO:0048592 | 0.0067 | 3.3639 | 2.1987 | 7 | 142 | eye morphogenesis |
GO:0050886 | 0.0068 | 4.4861 | 1.1923 | 5 | 77 | endocrine process |
GO:0010575 | 0.0073 | 8.3831 | 0.4026 | 3 | 26 | positive regulation of vascular endothelial growth factor production |
GO:0007275 | 0.0076 | 2.7983 | 3.4512 | 9 | 365 | multicellular organism development |
GO:0002011 | 0.0079 | 5.4839 | 0.7897 | 4 | 51 | morphogenesis of an epithelial sheet |
GO:0003158 | 0.0079 | 3.6637 | 1.7342 | 6 | 112 | endothelium development |
GO:0001714 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | endodermal cell fate specification |
GO:0003266 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0008343 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | adult feeding behavior |
GO:0021603 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | cranial nerve formation |
GO:0042363 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | fat-soluble vitamin catabolic process |
GO:0048617 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | embryonic foregut morphogenesis |
GO:0060100 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | positive regulation of phagocytosis, engulfment |
GO:0060363 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | cranial suture morphogenesis |
GO:0070472 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | regulation of uterine smooth muscle contraction |
GO:2000543 | 0.008 | 18.3067 | 0.1394 | 2 | 9 | positive regulation of gastrulation |
GO:0034103 | 0.008 | 4.3058 | 1.2387 | 5 | 80 | regulation of tissue remodeling |
GO:0003016 | 0.0082 | 8.0333 | 0.4181 | 3 | 27 | respiratory system process |
GO:0061311 | 0.0082 | 8.0333 | 0.4181 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0071295 | 0.0082 | 8.0333 | 0.4181 | 3 | 27 | cellular response to vitamin |
GO:1903530 | 0.0086 | 1.9584 | 9.6642 | 18 | 629 | regulation of secretion by cell |
GO:0003008 | 0.0088 | 1.5746 | 26.5271 | 39 | 1759 | system process |
GO:0010634 | 0.009 | 3.5622 | 1.7807 | 6 | 115 | positive regulation of epithelial cell migration |
GO:0035116 | 0.009 | 7.7115 | 0.4336 | 3 | 28 | embryonic hindlimb morphogenesis |
GO:0009798 | 0.0093 | 4.1394 | 1.2852 | 5 | 83 | axis specification |
GO:0003263 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | cardioblast proliferation |
GO:0010960 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | magnesium ion homeostasis |
GO:0032769 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | negative regulation of monooxygenase activity |
GO:0045713 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | low-density lipoprotein particle receptor biosynthetic process |
GO:0061072 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | iris morphogenesis |
GO:1905205 | 0.0099 | 16.0173 | 0.1548 | 2 | 10 | positive regulation of connective tissue replacement |
GO:0048870 | 0.0099 | 1.6174 | 21.6775 | 33 | 1400 | cell motility |
GO:0003203 | 0.01 | 7.4144 | 0.449 | 3 | 29 | endocardial cushion morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2001141 | 0 | 4.7682 | 57.4606 | 149 | 3433 | regulation of RNA biosynthetic process |
GO:0019219 | 0 | 4.1571 | 66.6328 | 153 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0034654 | 0 | 4.0778 | 67.5701 | 153 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0060255 | 0 | 3.3552 | 95.8904 | 173 | 5729 | regulation of macromolecule metabolic process |
GO:0045944 | 0 | 4.8582 | 17.7252 | 66 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:1903508 | 0 | 4.2132 | 22.7466 | 73 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0009889 | 0 | 3.8504 | 38.2872 | 95 | 2671 | regulation of biosynthetic process |
GO:0051254 | 0 | 4.0516 | 23.9349 | 74 | 1430 | positive regulation of RNA metabolic process |
GO:0031328 | 0 | 3.5938 | 28.8056 | 79 | 1721 | positive regulation of cellular biosynthetic process |
GO:0009952 | 0 | 13.818 | 2.16 | 23 | 132 | anterior/posterior pattern specification |
GO:0046483 | 0 | 2.8675 | 94.5513 | 162 | 5649 | heterocycle metabolic process |
GO:0010557 | 0 | 3.6616 | 26.5628 | 75 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0006725 | 0 | 2.8388 | 95.1539 | 162 | 5685 | cellular aromatic compound metabolic process |
GO:1901360 | 0 | 2.8135 | 98.6019 | 165 | 5891 | organic cyclic compound metabolic process |
GO:0010628 | 0 | 3.4102 | 29.1738 | 77 | 1743 | positive regulation of gene expression |
GO:1901576 | 0 | 2.6321 | 100.7108 | 163 | 6017 | organic substance biosynthetic process |
GO:0034641 | 0 | 2.5811 | 103.9077 | 165 | 6208 | cellular nitrogen compound metabolic process |
GO:0034645 | 0 | 2.9073 | 49.3929 | 98 | 3436 | cellular macromolecule biosynthetic process |
GO:1903507 | 0 | 3.5578 | 18.763 | 55 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0000122 | 0 | 4.1677 | 12.6035 | 44 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0097659 | 0 | 3.7067 | 19.3346 | 54 | 1567 | nucleic acid-templated transcription |
GO:0051173 | 0 | 2.6598 | 46.7317 | 95 | 2792 | positive regulation of nitrogen compound metabolic process |
GO:0051253 | 0 | 3.3101 | 20.0016 | 55 | 1195 | negative regulation of RNA metabolic process |
GO:0048704 | 0 | 20.7291 | 0.7936 | 12 | 48 | embryonic skeletal system morphogenesis |
GO:0032502 | 0 | 2.7436 | 41.3415 | 80 | 3089 | developmental process |
GO:2000113 | 0 | 2.9113 | 23.8178 | 58 | 1423 | negative regulation of cellular macromolecule biosynthetic process |
GO:0006355 | 0 | 3.5457 | 15.7489 | 44 | 1351 | regulation of transcription, DNA-templated |
GO:0009890 | 0 | 2.7595 | 26.4623 | 61 | 1581 | negative regulation of biosynthetic process |
GO:0007498 | 0 | 8.9177 | 1.9918 | 15 | 119 | mesoderm development |
GO:0050793 | 0 | 2.352 | 38.6474 | 75 | 2309 | regulation of developmental process |
GO:0035295 | 0 | 4.3973 | 6.1806 | 24 | 387 | tube development |
GO:0035107 | 0 | 7.1223 | 2.427 | 15 | 145 | appendage morphogenesis |
GO:0010629 | 0 | 2.4248 | 29.5923 | 61 | 1768 | negative regulation of gene expression |
GO:0048729 | 0 | 3.8241 | 7.9684 | 27 | 491 | tissue morphogenesis |
GO:0044238 | 0 | 2.0944 | 165.4858 | 206 | 9887 | primary metabolic process |
GO:0060485 | 0 | 5.861 | 3.092 | 16 | 187 | mesenchyme development |
GO:0060173 | 0 | 6.003 | 2.8287 | 15 | 169 | limb development |
GO:0016070 | 0 | 2.4764 | 27.8197 | 55 | 2249 | RNA metabolic process |
GO:0048562 | 0 | 5.7044 | 2.9595 | 15 | 187 | embryonic organ morphogenesis |
GO:0010467 | 0 | 2.3638 | 28.5619 | 54 | 2303 | gene expression |
GO:0021546 | 0 | 119.2624 | 0.1004 | 4 | 6 | rhombomere development |
GO:0048935 | 0 | 37.3974 | 0.2176 | 5 | 13 | peripheral nervous system neuron development |
GO:0007399 | 0 | 3.183 | 9.1747 | 26 | 631 | nervous system development |
GO:0001763 | 0 | 5.244 | 2.9753 | 14 | 179 | morphogenesis of a branching structure |
GO:0045165 | 0 | 4.8254 | 3.4492 | 15 | 212 | cell fate commitment |
GO:0006837 | 0 | 33.24 | 0.2343 | 5 | 14 | serotonin transport |
GO:0045596 | 0 | 2.9557 | 10.4778 | 28 | 626 | negative regulation of cell differentiation |
GO:0021675 | 0 | 8.6501 | 1.2051 | 9 | 72 | nerve development |
GO:0072358 | 0 | 2.8854 | 10.7121 | 28 | 640 | cardiovascular system development |
GO:0019233 | 0 | 7.3142 | 1.5566 | 10 | 93 | sensory perception of pain |
GO:0007218 | 0 | 7.2267 | 1.5733 | 10 | 94 | neuropeptide signaling pathway |
GO:0001568 | 0 | 2.9298 | 10.1598 | 27 | 607 | blood vessel development |
GO:0003151 | 0 | 8.3828 | 1.2386 | 9 | 74 | outflow tract morphogenesis |
GO:0007420 | 0 | 3.0388 | 9.0611 | 25 | 555 | brain development |
GO:0023061 | 0 | 3.4106 | 6.762 | 21 | 404 | signal release |
GO:0022414 | 0 | 3.5252 | 6.2566 | 20 | 392 | reproductive process |
GO:0048870 | 0 | 2.203 | 23.4328 | 46 | 1400 | cell motility |
GO:0030855 | 0 | 2.7096 | 11.7834 | 29 | 704 | epithelial cell differentiation |
GO:0009887 | 0 | 3.6625 | 5.4078 | 18 | 376 | animal organ morphogenesis |
GO:0048565 | 0 | 5.7671 | 2.1257 | 11 | 127 | digestive tract development |
GO:0009798 | 0 | 7.3591 | 1.3892 | 9 | 83 | axis specification |
GO:0051172 | 0 | 1.9266 | 39.3336 | 66 | 2350 | negative regulation of nitrogen compound metabolic process |
GO:0048522 | 0 | 1.8976 | 47.8277 | 75 | 3257 | positive regulation of cellular process |
GO:0048598 | 0 | 4.6352 | 3.0832 | 13 | 209 | embryonic morphogenesis |
GO:0007268 | 0 | 2.7954 | 9.7748 | 25 | 584 | chemical synaptic transmission |
GO:0014033 | 0 | 8.0438 | 1.1382 | 8 | 68 | neural crest cell differentiation |
GO:0090596 | 0 | 3.9822 | 4.1175 | 15 | 246 | sensory organ morphogenesis |
GO:0099537 | 0 | 2.785 | 9.8083 | 25 | 586 | trans-synaptic signaling |
GO:0034287 | 0 | 178.2273 | 0.067 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0 | 178.2273 | 0.067 | 3 | 4 | detection of glucose |
GO:0060021 | 0 | 6.6377 | 1.5231 | 9 | 91 | palate development |
GO:0031324 | 0 | 1.8612 | 41.861 | 68 | 2501 | negative regulation of cellular metabolic process |
GO:0001707 | 0 | 7.6593 | 1.1884 | 8 | 71 | mesoderm formation |
GO:0030326 | 0 | 6.4913 | 1.5529 | 9 | 94 | embryonic limb morphogenesis |
GO:0048646 | 0 | 3.3481 | 5.8706 | 18 | 385 | anatomical structure formation involved in morphogenesis |
GO:0030182 | 0 | 2.3383 | 16.0414 | 34 | 994 | neuron differentiation |
GO:0008284 | 0 | 2.428 | 13.9927 | 31 | 836 | positive regulation of cell proliferation |
GO:0061061 | 0 | 2.7049 | 10.0761 | 25 | 602 | muscle structure development |
GO:0048754 | 0 | 5.0628 | 2.3935 | 11 | 143 | branching morphogenesis of an epithelial tube |
GO:0021510 | 0 | 7.3868 | 1.2263 | 8 | 74 | spinal cord development |
GO:0021761 | 0 | 6.3273 | 1.5901 | 9 | 95 | limbic system development |
GO:0021602 | 0 | 16.7361 | 0.3822 | 5 | 23 | cranial nerve morphogenesis |
GO:0030878 | 0 | 15.7352 | 0.4017 | 5 | 24 | thyroid gland development |
GO:0009914 | 0 | 3.4693 | 5.0046 | 16 | 299 | hormone transport |
GO:0060429 | 0 | 3.3223 | 5.5731 | 17 | 370 | epithelium development |
GO:0003002 | 0 | 10.5541 | 0.6603 | 6 | 46 | regionalization |
GO:0001655 | 1e-04 | 3.3959 | 5.105 | 16 | 305 | urogenital system development |
GO:0048483 | 1e-04 | 9.993 | 0.703 | 6 | 42 | autonomic nervous system development |
GO:0022008 | 1e-04 | 2.1298 | 19.1259 | 37 | 1188 | neurogenesis |
GO:0001764 | 1e-04 | 4.923 | 2.2261 | 10 | 133 | neuron migration |
GO:0050794 | 1e-04 | 1.944 | 63.7121 | 86 | 5193 | regulation of cellular process |
GO:0008595 | 1e-04 | 21.6716 | 0.2511 | 4 | 15 | anterior/posterior axis specification, embryo |
GO:0060581 | 1e-04 | 21.6716 | 0.2511 | 4 | 15 | cell fate commitment involved in pattern specification |
GO:0014031 | 1e-04 | 7.3816 | 1.0712 | 7 | 64 | mesenchymal cell development |
GO:0048864 | 1e-04 | 7.3816 | 1.0712 | 7 | 64 | stem cell development |
GO:0001892 | 1e-04 | 6.1804 | 1.4394 | 8 | 86 | embryonic placenta development |
GO:0043009 | 1e-04 | 3.1847 | 5.4279 | 16 | 355 | chordate embryonic development |
GO:0042472 | 1e-04 | 6.9661 | 1.1272 | 7 | 68 | inner ear morphogenesis |
GO:0035148 | 1e-04 | 4.62 | 2.36 | 10 | 141 | tube formation |
GO:0048608 | 1e-04 | 3.9086 | 3.3247 | 12 | 203 | reproductive structure development |
GO:0032890 | 1e-04 | 8.5621 | 0.8034 | 6 | 48 | regulation of organic acid transport |
GO:0050885 | 1e-04 | 8.5621 | 0.8034 | 6 | 48 | neuromuscular process controlling balance |
GO:0021522 | 2e-04 | 11.4937 | 0.5189 | 5 | 31 | spinal cord motor neuron differentiation |
GO:0021514 | 2e-04 | 18.3352 | 0.2845 | 4 | 17 | ventral spinal cord interneuron differentiation |
GO:0098700 | 2e-04 | 44.5483 | 0.1172 | 3 | 7 | neurotransmitter loading into synaptic vesicle |
GO:0003231 | 2e-04 | 4.9849 | 1.9751 | 9 | 118 | cardiac ventricle development |
GO:0043583 | 2e-04 | 3.7973 | 3.4145 | 12 | 204 | ear development |
GO:0007350 | 2e-04 | 17.0244 | 0.3013 | 4 | 18 | blastoderm segmentation |
GO:0051241 | 2e-04 | 2.1914 | 14.859 | 30 | 904 | negative regulation of multicellular organismal process |
GO:0009953 | 2e-04 | 6.4635 | 1.2052 | 7 | 73 | dorsal/ventral pattern formation |
GO:0048732 | 2e-04 | 3.0287 | 5.6821 | 16 | 350 | gland development |
GO:0009855 | 2e-04 | 4.8072 | 2.042 | 9 | 122 | determination of bilateral symmetry |
GO:0045597 | 2e-04 | 2.2433 | 13.508 | 28 | 817 | positive regulation of cell differentiation |
GO:0021560 | 3e-04 | Inf | 0.0335 | 2 | 2 | abducens nerve development |
GO:0021599 | 3e-04 | Inf | 0.0335 | 2 | 2 | abducens nerve formation |
GO:0060415 | 3e-04 | 6.0058 | 1.2888 | 7 | 77 | muscle tissue morphogenesis |
GO:0048857 | 3e-04 | 7.3357 | 0.9206 | 6 | 55 | neural nucleus development |
GO:0035137 | 3e-04 | 9.6368 | 0.6026 | 5 | 36 | hindlimb morphogenesis |
GO:0007267 | 3e-04 | 2.0504 | 17.5307 | 33 | 1108 | cell-cell signaling |
GO:0001755 | 4e-04 | 9.335 | 0.6193 | 5 | 37 | neural crest cell migration |
GO:0042698 | 4e-04 | 5.0158 | 1.7407 | 8 | 104 | ovulation cycle |
GO:0072048 | 4e-04 | 29.6951 | 0.1506 | 3 | 9 | renal system pattern specification |
GO:0007617 | 4e-04 | 14.0174 | 0.3515 | 4 | 21 | mating behavior |
GO:0048665 | 4e-04 | 13.4363 | 0.363 | 4 | 22 | neuron fate specification |
GO:0051090 | 4e-04 | 2.8094 | 6.0925 | 16 | 364 | regulation of DNA binding transcription factor activity |
GO:0051960 | 4e-04 | 2.2007 | 12.7039 | 26 | 759 | regulation of nervous system development |
GO:0021513 | 4e-04 | 13.2379 | 0.3682 | 4 | 22 | spinal cord dorsal/ventral patterning |
GO:0042475 | 4e-04 | 5.6036 | 1.3725 | 7 | 82 | odontogenesis of dentin-containing tooth |
GO:0035051 | 4e-04 | 4.3076 | 2.2596 | 9 | 135 | cardiocyte differentiation |
GO:0009888 | 5e-04 | 2.7864 | 6.1891 | 16 | 451 | tissue development |
GO:0032275 | 5e-04 | 25.4513 | 0.1674 | 3 | 10 | luteinizing hormone secretion |
GO:0001525 | 5e-04 | 2.5893 | 7.4315 | 18 | 444 | angiogenesis |
GO:0021983 | 5e-04 | 8.5333 | 0.6695 | 5 | 40 | pituitary gland development |
GO:0072210 | 5e-04 | 8.5333 | 0.6695 | 5 | 40 | metanephric nephron development |
GO:0045686 | 5e-04 | 12.5403 | 0.385 | 4 | 23 | negative regulation of glial cell differentiation |
GO:0030901 | 6e-04 | 5.387 | 1.4227 | 7 | 85 | midbrain development |
GO:0021879 | 6e-04 | 8.3558 | 0.6815 | 5 | 41 | forebrain neuron differentiation |
GO:0001501 | 6e-04 | 3.4904 | 3.3765 | 11 | 219 | skeletal system development |
GO:0072080 | 6e-04 | 5.2517 | 1.4562 | 7 | 87 | nephron tubule development |
GO:0060379 | 7e-04 | 22.2685 | 0.1841 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0090009 | 7e-04 | 22.2685 | 0.1841 | 3 | 11 | primitive streak formation |
GO:0006357 | 7e-04 | 3.4259 | 3.4521 | 11 | 277 | regulation of transcription from RNA polymerase II promoter |
GO:0007631 | 7e-04 | 6.1149 | 1.0824 | 6 | 66 | feeding behavior |
GO:0008283 | 8e-04 | 1.9878 | 16.9073 | 31 | 1083 | cell proliferation |
GO:0044706 | 8e-04 | 3.3782 | 3.4814 | 11 | 208 | multi-multicellular organism process |
GO:0060411 | 8e-04 | 5.9866 | 1.1047 | 6 | 66 | cardiac septum morphogenesis |
GO:0021912 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0060166 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | olfactory pit development |
GO:0060913 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:1902869 | 8e-04 | 118.3698 | 0.0502 | 2 | 3 | regulation of amacrine cell differentiation |
GO:0009954 | 8e-04 | 10.9091 | 0.4321 | 4 | 26 | proximal/distal pattern formation |
GO:0060536 | 9e-04 | 19.7929 | 0.2009 | 3 | 12 | cartilage morphogenesis |
GO:0060707 | 9e-04 | 19.7929 | 0.2009 | 3 | 12 | trophoblast giant cell differentiation |
GO:0048863 | 9e-04 | 3.5447 | 3.0173 | 10 | 185 | stem cell differentiation |
GO:0007188 | 0.001 | 3.8456 | 2.5107 | 9 | 150 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0060986 | 0.001 | 7.2817 | 0.7699 | 5 | 46 | endocrine hormone secretion |
GO:0043066 | 0.001 | 2.0643 | 13.4739 | 26 | 805 | negative regulation of apoptotic process |
GO:0007548 | 0.0011 | 3.0543 | 4.1844 | 12 | 250 | sex differentiation |
GO:0008306 | 0.0011 | 5.611 | 1.1716 | 6 | 70 | associative learning |
GO:0048468 | 0.0011 | 1.9569 | 16.5595 | 30 | 1061 | cell development |
GO:0072088 | 0.0012 | 5.5243 | 1.1884 | 6 | 71 | nephron epithelium morphogenesis |
GO:0060324 | 0.0012 | 6.9421 | 0.8034 | 5 | 48 | face development |
GO:0035050 | 0.0013 | 5.4403 | 1.2051 | 6 | 72 | embryonic heart tube development |
GO:0021772 | 0.0013 | 9.527 | 0.4854 | 4 | 29 | olfactory bulb development |
GO:0046545 | 0.0014 | 4.5632 | 1.657 | 7 | 99 | development of primary female sexual characteristics |
GO:0051952 | 0.0014 | 5.3587 | 1.2219 | 6 | 73 | regulation of amine transport |
GO:0061333 | 0.0014 | 5.3587 | 1.2219 | 6 | 73 | renal tubule morphogenesis |
GO:0032101 | 0.0014 | 2.1158 | 11.5825 | 23 | 692 | regulation of response to external stimulus |
GO:0003214 | 0.0015 | 16.1921 | 0.2343 | 3 | 14 | cardiac left ventricle morphogenesis |
GO:0042074 | 0.0015 | 16.1921 | 0.2343 | 3 | 14 | cell migration involved in gastrulation |
GO:0007409 | 0.0015 | 2.4739 | 6.8625 | 16 | 410 | axonogenesis |
GO:0042220 | 0.0016 | 6.4881 | 0.8536 | 5 | 51 | response to cocaine |
GO:0021536 | 0.0016 | 8.971 | 0.5104 | 4 | 31 | diencephalon development |
GO:0043388 | 0.0016 | 8.9111 | 0.5137 | 4 | 31 | positive regulation of DNA binding |
GO:0001992 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003257 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0007198 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021615 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0021855 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | hypothalamus cell migration |
GO:0021913 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0034653 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | retinoic acid catabolic process |
GO:0048866 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | stem cell fate specification |
GO:0061030 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
GO:0072086 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | specification of loop of Henle identity |
GO:0072268 | 0.0016 | 59.1811 | 0.067 | 2 | 4 | pattern specification involved in metanephros development |
GO:0051047 | 0.0016 | 2.5411 | 6.2599 | 15 | 374 | positive regulation of secretion |
GO:0050768 | 0.0017 | 6.3661 | 0.8672 | 5 | 53 | negative regulation of neurogenesis |
GO:0001829 | 0.0018 | 14.8419 | 0.2511 | 3 | 15 | trophectodermal cell differentiation |
GO:0007379 | 0.0018 | 14.8419 | 0.2511 | 3 | 15 | segment specification |
GO:0021783 | 0.0018 | 14.8419 | 0.2511 | 3 | 15 | preganglionic parasympathetic fiber development |
GO:0060284 | 0.0018 | 2.0038 | 13.2897 | 25 | 794 | regulation of cell development |
GO:0035150 | 0.0019 | 3.8142 | 2.2429 | 8 | 134 | regulation of tube size |
GO:0035115 | 0.0019 | 8.5046 | 0.5356 | 4 | 32 | embryonic forelimb morphogenesis |
GO:0042755 | 0.0019 | 8.5046 | 0.5356 | 4 | 32 | eating behavior |
GO:0001756 | 0.002 | 6.1338 | 0.8976 | 5 | 54 | somitogenesis |
GO:0060562 | 0.0021 | 3.7386 | 2.2838 | 8 | 142 | epithelial tube morphogenesis |
GO:0001541 | 0.0022 | 5.9676 | 0.9206 | 5 | 55 | ovarian follicle development |
GO:0048731 | 0.0023 | 2.1058 | 11.4634 | 22 | 980 | system development |
GO:0060548 | 0.0024 | 1.9111 | 15.0472 | 27 | 899 | negative regulation of cell death |
GO:2000027 | 0.0024 | 2.9001 | 4.0171 | 11 | 240 | regulation of organ morphogenesis |
GO:0007626 | 0.0026 | 4.0546 | 1.8483 | 7 | 112 | locomotory behavior |
GO:0007625 | 0.0026 | 12.72 | 0.2845 | 3 | 17 | grooming behavior |
GO:0061377 | 0.0026 | 12.72 | 0.2845 | 3 | 17 | mammary gland lobule development |
GO:0010040 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | response to iron(II) ion |
GO:0010957 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | negative regulation of vitamin D biosynthetic process |
GO:0048880 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | sensory system development |
GO:0061743 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | motor learning |
GO:0072047 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0097070 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | ductus arteriosus closure |
GO:1900086 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
GO:2000195 | 0.0027 | 39.4516 | 0.0837 | 2 | 5 | negative regulation of female gonad development |
GO:0048536 | 0.003 | 7.4396 | 0.6026 | 4 | 36 | spleen development |
GO:0071392 | 0.003 | 7.4396 | 0.6026 | 4 | 36 | cellular response to estradiol stimulus |
GO:0071542 | 0.003 | 7.4396 | 0.6026 | 4 | 36 | dopaminergic neuron differentiation |
GO:0001837 | 0.003 | 4.5423 | 1.4218 | 6 | 86 | epithelial to mesenchymal transition |
GO:0001824 | 0.003 | 5.5241 | 0.9875 | 5 | 59 | blastocyst development |
GO:0044703 | 0.003 | 1.8746 | 15.315 | 27 | 915 | multi-organism reproductive process |
GO:0014706 | 0.0031 | 3.5099 | 2.4238 | 8 | 148 | striated muscle tissue development |
GO:0030509 | 0.0032 | 3.4798 | 2.4437 | 8 | 146 | BMP signaling pathway |
GO:0046717 | 0.0032 | 3.8832 | 1.9248 | 7 | 115 | acid secretion |
GO:0090184 | 0.0033 | 7.2137 | 0.6193 | 4 | 37 | positive regulation of kidney development |
GO:0002520 | 0.0033 | 1.8852 | 14.6455 | 26 | 875 | immune system development |
GO:0033993 | 0.0033 | 1.8852 | 14.6455 | 26 | 875 | response to lipid |
GO:0046887 | 0.0034 | 3.8473 | 1.9416 | 7 | 116 | positive regulation of hormone secretion |
GO:0060993 | 0.0034 | 4.4286 | 1.4562 | 6 | 87 | kidney morphogenesis |
GO:0051239 | 0.0034 | 1.6756 | 25.8931 | 40 | 1679 | regulation of multicellular organismal process |
GO:0002573 | 0.0035 | 3.1462 | 3.0295 | 9 | 181 | myeloid leukocyte differentiation |
GO:0002673 | 0.0036 | 4.3743 | 1.4729 | 6 | 88 | regulation of acute inflammatory response |
GO:0060538 | 0.0036 | 3.4059 | 2.4931 | 8 | 150 | skeletal muscle organ development |
GO:0007530 | 0.0037 | 11.1286 | 0.318 | 3 | 19 | sex determination |
GO:0046641 | 0.0037 | 11.1286 | 0.318 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
GO:0072079 | 0.0037 | 11.1286 | 0.318 | 3 | 19 | nephron tubule formation |
GO:0072073 | 0.0038 | 6.9203 | 0.6419 | 4 | 39 | kidney epithelium development |
GO:0061371 | 0.0038 | 5.2324 | 1.0377 | 5 | 62 | determination of heart left/right asymmetry |
GO:0045665 | 0.0039 | 3.0917 | 3.0797 | 9 | 184 | negative regulation of neuron differentiation |
GO:0014048 | 0.004 | 29.7985 | 0.0997 | 2 | 6 | regulation of glutamate secretion |
GO:0015872 | 0.004 | 6.8007 | 0.6528 | 4 | 39 | dopamine transport |
GO:0021532 | 0.004 | 6.8007 | 0.6528 | 4 | 39 | neural tube patterning |
GO:0002865 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0014062 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | regulation of serotonin secretion |
GO:0016115 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | terpenoid catabolic process |
GO:0032229 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
GO:0090237 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | regulation of arachidonic acid secretion |
GO:1990869 | 0.004 | 29.5868 | 0.1004 | 2 | 6 | cellular response to chemokine |
GO:0031018 | 0.0042 | 10.5788 | 0.3315 | 3 | 20 | endocrine pancreas development |
GO:0030154 | 0.0042 | 2.0505 | 10.5216 | 20 | 827 | cell differentiation |
GO:0007130 | 0.0043 | 10.4733 | 0.3348 | 3 | 20 | synaptonemal complex assembly |
GO:0007210 | 0.0043 | 10.4733 | 0.3348 | 3 | 20 | serotonin receptor signaling pathway |
GO:0023019 | 0.0043 | 10.4733 | 0.3348 | 3 | 20 | signal transduction involved in regulation of gene expression |
GO:0034097 | 0.0043 | 1.8223 | 15.7167 | 27 | 939 | response to cytokine |
GO:0003008 | 0.0044 | 1.5886 | 31.1824 | 46 | 1863 | system process |
GO:0097485 | 0.0046 | 2.813 | 3.7492 | 10 | 224 | neuron projection guidance |
GO:0003018 | 0.0046 | 3.2649 | 2.5943 | 8 | 155 | vascular process in circulatory system |
GO:0007275 | 0.0047 | 2.4573 | 5.7176 | 13 | 530 | multicellular organism development |
GO:0001657 | 0.0047 | 4.1215 | 1.5566 | 6 | 93 | ureteric bud development |
GO:0007611 | 0.0049 | 2.7866 | 3.7827 | 10 | 226 | learning or memory |
GO:0021516 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | dorsal spinal cord development |
GO:0030539 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | male genitalia development |
GO:0031290 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0043586 | 0.0049 | 9.8908 | 0.3515 | 3 | 21 | tongue development |
GO:0072163 | 0.005 | 4.0745 | 1.5733 | 6 | 94 | mesonephric epithelium development |
GO:0071772 | 0.005 | 3.2206 | 2.6278 | 8 | 157 | response to BMP |
GO:0097746 | 0.0051 | 3.5518 | 2.0922 | 7 | 125 | regulation of blood vessel diameter |
GO:0006775 | 0.0052 | 6.2626 | 0.703 | 4 | 42 | fat-soluble vitamin metabolic process |
GO:1903793 | 0.0052 | 6.2626 | 0.703 | 4 | 42 | positive regulation of anion transport |
GO:0033555 | 0.0053 | 4.8089 | 1.1214 | 5 | 67 | multicellular organismal response to stress |
GO:0043067 | 0.0053 | 1.6466 | 23.9851 | 37 | 1433 | regulation of programmed cell death |
GO:0021521 | 0.0055 | 23.8449 | 0.1163 | 2 | 7 | ventral spinal cord interneuron specification |
GO:0090276 | 0.0055 | 2.9227 | 3.2471 | 9 | 194 | regulation of peptide hormone secretion |
GO:0021537 | 0.0055 | 2.7352 | 3.8497 | 10 | 230 | telencephalon development |
GO:0032504 | 0.0055 | 1.8771 | 12.9383 | 23 | 773 | multicellular organism reproduction |
GO:0001826 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | inner cell mass cell differentiation |
GO:0002069 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | columnar/cuboidal epithelial cell maturation |
GO:0048752 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | semicircular canal morphogenesis |
GO:1902866 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | regulation of retina development in camera-type eye |
GO:2000818 | 0.0055 | 23.6679 | 0.1172 | 2 | 7 | negative regulation of myoblast proliferation |
GO:0009966 | 0.0056 | 1.4687 | 49.075 | 66 | 2932 | regulation of signal transduction |
GO:2000679 | 0.0056 | 9.3696 | 0.3682 | 3 | 22 | positive regulation of transcription regulatory region DNA binding |
GO:0010648 | 0.0057 | 1.6856 | 20.8217 | 33 | 1244 | negative regulation of cell communication |
GO:0023057 | 0.0059 | 1.6795 | 20.8887 | 33 | 1248 | negative regulation of signaling |
GO:0031644 | 0.0059 | 4.658 | 1.1549 | 5 | 69 | regulation of neurological system process |
GO:0030073 | 0.006 | 2.8755 | 3.2973 | 9 | 197 | insulin secretion |
GO:0048701 | 0.0062 | 5.9487 | 0.7365 | 4 | 44 | embryonic cranial skeleton morphogenesis |
GO:0048738 | 0.0062 | 2.8601 | 3.3141 | 9 | 198 | cardiac muscle tissue development |
GO:0007422 | 0.0063 | 4.586 | 1.1716 | 5 | 70 | peripheral nervous system development |
GO:0051354 | 0.0064 | 8.9006 | 0.385 | 3 | 23 | negative regulation of oxidoreductase activity |
GO:0090103 | 0.0064 | 8.9006 | 0.385 | 3 | 23 | cochlea morphogenesis |
GO:0008406 | 0.0064 | 2.8449 | 3.3308 | 9 | 199 | gonad development |
GO:0051216 | 0.0065 | 3.0692 | 2.7493 | 8 | 166 | cartilage development |
GO:0031348 | 0.0067 | 3.055 | 2.7617 | 8 | 165 | negative regulation of defense response |
GO:0010718 | 0.0067 | 5.8032 | 0.7532 | 4 | 45 | positive regulation of epithelial to mesenchymal transition |
GO:0001838 | 0.0067 | 3.8125 | 1.6735 | 6 | 101 | embryonic epithelial tube formation |
GO:0015837 | 0.0071 | 20.0927 | 0.1315 | 2 | 8 | amine transport |
GO:0001570 | 0.0071 | 4.4486 | 1.2051 | 5 | 72 | vasculogenesis |
GO:0072132 | 0.0072 | 5.6647 | 0.7699 | 4 | 46 | mesenchyme morphogenesis |
GO:0048169 | 0.0072 | 8.4762 | 0.4017 | 3 | 24 | regulation of long-term neuronal synaptic plasticity |
GO:0042756 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | drinking behavior |
GO:0045647 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | negative regulation of erythrocyte differentiation |
GO:0045916 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | negative regulation of complement activation |
GO:0045924 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | regulation of female receptivity |
GO:0060539 | 0.0073 | 19.722 | 0.1339 | 2 | 8 | diaphragm development |
GO:0050900 | 0.0073 | 2.2049 | 6.6616 | 14 | 398 | leukocyte migration |
GO:1903707 | 0.0074 | 3.2982 | 2.2429 | 7 | 134 | negative regulation of hemopoiesis |
GO:0006954 | 0.0075 | 1.9097 | 11.0134 | 20 | 658 | inflammatory response |
GO:0016331 | 0.0075 | 8.3166 | 0.4074 | 3 | 25 | morphogenesis of embryonic epithelium |
GO:0071495 | 0.0076 | 1.6602 | 20.4367 | 32 | 1221 | cellular response to endogenous stimulus |
GO:0050789 | 0.0077 | 2.7491 | 4.1962 | 10 | 477 | regulation of biological process |
GO:0006342 | 0.0077 | 3.6943 | 1.724 | 6 | 103 | chromatin silencing |
GO:0002067 | 0.0078 | 5.5326 | 0.7867 | 4 | 47 | glandular epithelial cell differentiation |
GO:0120039 | 0.008 | 1.9707 | 9.5907 | 18 | 573 | plasma membrane bounded cell projection morphogenesis |
GO:0071363 | 0.0081 | 1.9295 | 10.3439 | 19 | 618 | cellular response to growth factor stimulus |
GO:0001945 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | lymph vessel development |
GO:0003309 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | type B pancreatic cell differentiation |
GO:0048643 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | positive regulation of skeletal muscle tissue development |
GO:0060037 | 0.0081 | 8.0904 | 0.4184 | 3 | 25 | pharyngeal system development |
GO:0055010 | 0.0084 | 5.4065 | 0.8034 | 4 | 48 | ventricular cardiac muscle tissue morphogenesis |
GO:0007610 | 0.0084 | 3.6159 | 1.7564 | 6 | 114 | behavior |
GO:0045995 | 0.0085 | 3.6088 | 1.7619 | 6 | 106 | regulation of embryonic development |
GO:0008344 | 0.0089 | 4.1969 | 1.2721 | 5 | 76 | adult locomotory behavior |
GO:0042693 | 0.0092 | 17.0244 | 0.1496 | 2 | 9 | muscle cell fate commitment |
GO:0001714 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | endodermal cell fate specification |
GO:0008354 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | germ cell migration |
GO:0010579 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0014049 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | positive regulation of glutamate secretion |
GO:0014807 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | regulation of somitogenesis |
GO:0021892 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0030917 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | midbrain-hindbrain boundary development |
GO:0042473 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | outer ear morphogenesis |
GO:0046877 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | regulation of saliva secretion |
GO:0048387 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | negative regulation of retinoic acid receptor signaling pathway |
GO:0048617 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | embryonic foregut morphogenesis |
GO:0048755 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | branching morphogenesis of a nerve |
GO:0060923 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | cardiac muscle cell fate commitment |
GO:2000543 | 0.0093 | 16.9035 | 0.1506 | 2 | 9 | positive regulation of gastrulation |
GO:0048706 | 0.0096 | 7.5406 | 0.4431 | 3 | 28 | embryonic skeletal system development |
GO:0007492 | 0.0099 | 4.0814 | 1.3055 | 5 | 78 | endoderm development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 265.3146 | 0.4052 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 176.8315 | 0.4559 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 106.0449 | 0.5572 | 24 | 44 | protein heterotetramerization |
GO:0006323 | 0 | 19.9057 | 2.3553 | 33 | 186 | DNA packaging |
GO:0045815 | 0 | 38.476 | 1.0004 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 29.1295 | 1.279 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0071824 | 0 | 14.3115 | 3.1024 | 33 | 245 | protein-DNA complex subunit organization |
GO:0045653 | 0 | 293.1436 | 0.2279 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 26.0824 | 1.3296 | 24 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 20.2844 | 1.6209 | 24 | 128 | regulation of gene silencing |
GO:0035194 | 0 | 12.7744 | 2.9505 | 29 | 233 | posttranscriptional gene silencing by RNA |
GO:0032200 | 0 | 15.1428 | 2.0641 | 24 | 163 | telomere organization |
GO:0002244 | 0 | 13.676 | 2.3553 | 25 | 186 | hematopoietic progenitor cell differentiation |
GO:0034080 | 0 | 45.036 | 0.5065 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0017148 | 0 | 8.9051 | 4.0522 | 29 | 320 | negative regulation of translation |
GO:1904837 | 0 | 39.0213 | 0.5572 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0006333 | 0 | 17.7315 | 1.3951 | 19 | 118 | chromatin assembly or disassembly |
GO:0048863 | 0 | 9.9246 | 3.2544 | 26 | 257 | stem cell differentiation |
GO:0034724 | 0 | 31.6248 | 0.6458 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 28.5322 | 0.6965 | 14 | 55 | telomere capping |
GO:0030099 | 0 | 7.1431 | 4.7486 | 28 | 375 | myeloid cell differentiation |
GO:1903507 | 0 | 4.2634 | 14.1952 | 48 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0009890 | 0 | 3.6695 | 20.0202 | 57 | 1581 | negative regulation of biosynthetic process |
GO:0006303 | 0 | 20.1475 | 0.9117 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0051253 | 0 | 3.9683 | 15.1323 | 48 | 1195 | negative regulation of RNA metabolic process |
GO:0043044 | 0 | 19.1529 | 0.9497 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0051259 | 0 | 5.3213 | 6.4581 | 29 | 510 | protein oligomerization |
GO:0038111 | 0 | 30.3299 | 0.4685 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 30.3299 | 0.4685 | 10 | 37 | response to interleukin-7 |
GO:0034248 | 0 | 5.0398 | 6.7874 | 29 | 536 | regulation of cellular amide metabolic process |
GO:1903707 | 0 | 10.5363 | 1.6968 | 15 | 134 | negative regulation of hemopoiesis |
GO:0034622 | 0 | 3.6714 | 12.3211 | 38 | 973 | cellular macromolecular complex assembly |
GO:0045652 | 0 | 19.1744 | 0.6607 | 10 | 56 | regulation of megakaryocyte differentiation |
GO:0010608 | 0 | 4.2771 | 7.889 | 29 | 623 | posttranscriptional regulation of gene expression |
GO:0043043 | 0 | 3.8454 | 9.7125 | 32 | 767 | peptide biosynthetic process |
GO:0002227 | 0 | 43.4552 | 0.2533 | 7 | 20 | innate immune response in mucosa |
GO:0048534 | 0 | 3.649 | 10.5483 | 33 | 833 | hematopoietic or lymphoid organ development |
GO:0051248 | 0 | 2.9169 | 15.6135 | 39 | 1233 | negative regulation of protein metabolic process |
GO:0002251 | 0 | 22.5795 | 0.4052 | 7 | 32 | organ or tissue specific immune response |
GO:0031324 | 0 | 2.3599 | 31.6701 | 61 | 2501 | negative regulation of cellular metabolic process |
GO:0019731 | 0 | 18.2023 | 0.4812 | 7 | 38 | antibacterial humoral response |
GO:0006342 | 0 | 12.5057 | 0.7493 | 8 | 67 | chromatin silencing |
GO:0002376 | 0 | 2.2166 | 33.3416 | 61 | 2633 | immune system process |
GO:0006334 | 0 | 9.8095 | 1.051 | 9 | 94 | nucleosome assembly |
GO:0006352 | 0 | 5.3555 | 2.9125 | 14 | 230 | DNA-templated transcription, initiation |
GO:0061844 | 0 | 12.8138 | 0.6458 | 7 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006355 | 0 | 1.9734 | 43.1301 | 70 | 3406 | regulation of transcription, DNA-templated |
GO:0050830 | 0 | 8.6186 | 1.051 | 8 | 83 | defense response to Gram-positive bacterium |
GO:2001141 | 0 | 1.9533 | 43.472 | 70 | 3433 | regulation of RNA biosynthetic process |
GO:0040029 | 0 | 4.441 | 3.4763 | 14 | 310 | regulation of gene expression, epigenetic |
GO:0060249 | 0 | 3.763 | 4.66 | 16 | 368 | anatomical structure homeostasis |
GO:0045596 | 0 | 2.9044 | 7.927 | 21 | 626 | negative regulation of cell differentiation |
GO:1903706 | 1e-04 | 4.0665 | 3.4875 | 13 | 295 | regulation of hemopoiesis |
GO:0034654 | 1e-04 | 1.757 | 51.1205 | 75 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0019219 | 1e-04 | 1.7524 | 50.4114 | 74 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0050911 | 2e-04 | 3.5666 | 3.9382 | 13 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 4e-04 | 3.0616 | 4.9132 | 14 | 388 | detection of chemical stimulus |
GO:0070271 | 5e-04 | 2.0242 | 17.3736 | 32 | 1372 | protein complex biogenesis |
GO:0050906 | 6e-04 | 2.9641 | 5.0652 | 14 | 400 | detection of stimulus involved in sensory perception |
GO:0010467 | 6e-04 | 1.6147 | 64.7332 | 87 | 5112 | gene expression |
GO:0006281 | 7e-04 | 2.7017 | 6.3568 | 16 | 502 | DNA repair |
GO:0006950 | 8e-04 | 1.6624 | 45.1056 | 65 | 3562 | response to stress |
GO:0050793 | 0.001 | 1.7574 | 29.2388 | 46 | 2309 | regulation of developmental process |
GO:0071822 | 0.001 | 1.8862 | 20.3874 | 35 | 1610 | protein complex subunit organization |
GO:0051276 | 0.0011 | 2.2237 | 10.7438 | 22 | 953 | chromosome organization |
GO:0009059 | 0.0011 | 1.5791 | 63.0364 | 84 | 4978 | macromolecule biosynthetic process |
GO:2000113 | 0.0011 | 2.1467 | 12.2069 | 24 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
GO:0031424 | 0.0012 | 3.7006 | 2.5959 | 9 | 205 | keratinization |
GO:0090304 | 0.0013 | 1.5701 | 61.5168 | 82 | 4858 | nucleic acid metabolic process |
GO:0007606 | 0.002 | 2.6878 | 5.1412 | 13 | 406 | sensory perception of chemical stimulus |
GO:0071677 | 0.0029 | 11.8568 | 0.2912 | 3 | 23 | positive regulation of mononuclear cell migration |
GO:0007596 | 0.0031 | 2.8129 | 4.1408 | 11 | 327 | blood coagulation |
GO:0043588 | 0.0038 | 2.5966 | 4.8879 | 12 | 386 | skin development |
GO:0044249 | 0.0039 | 1.4782 | 75.1042 | 94 | 5931 | cellular biosynthetic process |
GO:0006959 | 0.0044 | 3.2895 | 2.5706 | 8 | 203 | humoral immune response |
GO:0032268 | 0.0045 | 1.6069 | 31.5055 | 46 | 2488 | regulation of cellular protein metabolic process |
GO:0002690 | 0.0045 | 4.9714 | 1.0764 | 5 | 85 | positive regulation of leukocyte chemotaxis |
GO:1901360 | 0.0047 | 1.4645 | 74.5977 | 93 | 5891 | organic cyclic compound metabolic process |
GO:0043950 | 0.0054 | 22.49 | 0.114 | 2 | 9 | positive regulation of cAMP-mediated signaling |
GO:0000038 | 0.0057 | 9.1171 | 0.3672 | 3 | 29 | very long-chain fatty acid metabolic process |
GO:0051172 | 0.0059 | 1.9181 | 12.3698 | 22 | 1117 | negative regulation of nitrogen compound metabolic process |
GO:0048519 | 0.0062 | 1.4615 | 60.9976 | 78 | 4817 | negative regulation of biological process |
GO:0016458 | 0.0065 | 3.8195 | 1.6602 | 6 | 154 | gene silencing |
GO:0022607 | 0.0067 | 1.5542 | 33.9241 | 48 | 2679 | cellular component assembly |
GO:0071346 | 0.0075 | 3.7069 | 1.7095 | 6 | 135 | cellular response to interferon-gamma |
GO:0034641 | 0.0075 | 1.4281 | 78.6118 | 96 | 6208 | cellular nitrogen compound metabolic process |
GO:0014898 | 0.0076 | 8.1724 | 0.4052 | 3 | 32 | cardiac muscle hypertrophy in response to stress |
GO:0050878 | 0.0081 | 2.256 | 6.0656 | 13 | 479 | regulation of body fluid levels |
GO:0048731 | 0.0089 | 1.446 | 55.2739 | 71 | 4365 | system development |
GO:0009913 | 0.0089 | 2.5357 | 4.1408 | 10 | 327 | epidermal cell differentiation |
GO:0098542 | 0.0097 | 2.2829 | 5.5211 | 12 | 436 | defense response to other organism |
GO:0060255 | 0.0099 | 1.4118 | 72.5463 | 89 | 5729 | regulation of macromolecule metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 18.6854 | 3.9772 | 49 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 14.4535 | 5.1921 | 51 | 406 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 14.8025 | 4.9619 | 50 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 14.2839 | 5.1153 | 50 | 400 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 5.8469 | 15.1031 | 63 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 5.6143 | 14.681 | 60 | 1148 | nervous system process |
GO:0006335 | 0 | 36.8463 | 0.4092 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 31.1697 | 0.4604 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 30.0134 | 0.4732 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 30.0134 | 0.4732 | 10 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 23.8235 | 0.5627 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 12.6321 | 0.9463 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 11.713 | 1.0103 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:0031424 | 0 | 6.0016 | 2.6216 | 14 | 205 | keratinization |
GO:1902036 | 0 | 8.8688 | 1.2916 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 8.4932 | 1.3428 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0032501 | 0 | 1.9939 | 79.9359 | 112 | 6625 | multicellular organismal process |
GO:0031497 | 0 | 6.6412 | 1.8543 | 11 | 145 | chromatin assembly |
GO:0045814 | 0 | 7.4647 | 1.509 | 10 | 118 | negative regulation of gene expression, epigenetic |
GO:0034728 | 0 | 6.176 | 1.9822 | 11 | 155 | nucleosome organization |
GO:0060968 | 0 | 6.8277 | 1.6369 | 10 | 128 | regulation of gene silencing |
GO:0048863 | 0 | 4.3248 | 3.2866 | 13 | 257 | stem cell differentiation |
GO:0035194 | 0 | 4.3911 | 2.9797 | 12 | 233 | posttranscriptional gene silencing by RNA |
GO:0032200 | 0 | 5.254 | 2.0845 | 10 | 163 | telomere organization |
GO:0050896 | 1e-04 | 1.7647 | 103.2149 | 131 | 8071 | response to stimulus |
GO:0031640 | 1e-04 | 9.7087 | 0.7034 | 6 | 55 | killing of cells of other organism |
GO:0009913 | 1e-04 | 3.6336 | 4.1818 | 14 | 327 | epidermal cell differentiation |
GO:0065004 | 1e-04 | 4.3645 | 2.7367 | 11 | 214 | protein-DNA complex assembly |
GO:0002227 | 1e-04 | 19.665 | 0.2558 | 4 | 20 | innate immune response in mucosa |
GO:0050832 | 1e-04 | 11.9651 | 0.486 | 5 | 38 | defense response to fungus |
GO:0002244 | 1e-04 | 4.5607 | 2.3786 | 10 | 186 | hematopoietic progenitor cell differentiation |
GO:0044657 | 2e-04 | Inf | 0.0256 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0052043 | 2e-04 | Inf | 0.0256 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 2e-04 | Inf | 0.0256 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 2e-04 | Inf | 0.0256 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0042832 | 2e-04 | 16.5568 | 0.2941 | 4 | 23 | defense response to protozoan |
GO:0023052 | 4e-04 | 1.6198 | 76.2954 | 100 | 5966 | signaling |
GO:0043588 | 5e-04 | 3.0456 | 4.9363 | 14 | 386 | skin development |
GO:0007154 | 5e-04 | 1.6111 | 76.5512 | 100 | 5986 | cell communication |
GO:0071103 | 6e-04 | 3.5189 | 3.3506 | 11 | 262 | DNA conformation change |
GO:0002251 | 7e-04 | 11.2286 | 0.4092 | 4 | 32 | organ or tissue specific immune response |
GO:0017148 | 9e-04 | 3.1331 | 4.0923 | 12 | 320 | negative regulation of translation |
GO:0002361 | 0.001 | 77.9505 | 0.0512 | 2 | 4 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation |
GO:0007596 | 0.0011 | 3.0621 | 4.1818 | 12 | 327 | blood coagulation |
GO:0030099 | 0.0011 | 2.8929 | 4.7956 | 13 | 375 | myeloid cell differentiation |
GO:0019731 | 0.0014 | 9.2435 | 0.486 | 4 | 38 | antibacterial humoral response |
GO:0043303 | 0.0022 | 8.0559 | 0.5499 | 4 | 43 | mast cell degranulation |
GO:0051673 | 0.0024 | 38.9703 | 0.0767 | 2 | 6 | membrane disruption in other organism |
GO:0060267 | 0.0024 | 38.9703 | 0.0767 | 2 | 6 | positive regulation of respiratory burst |
GO:0042742 | 0.0027 | 3.5757 | 2.3753 | 8 | 189 | defense response to bacterium |
GO:0050878 | 0.0035 | 2.4218 | 6.1256 | 14 | 479 | regulation of body fluid levels |
GO:0061844 | 0.0041 | 6.6813 | 0.6522 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0045348 | 0.0043 | 25.9769 | 0.1023 | 2 | 8 | positive regulation of MHC class II biosynthetic process |
GO:0045576 | 0.0047 | 6.4078 | 0.6778 | 4 | 53 | mast cell activation |
GO:0002026 | 0.0048 | 9.7786 | 0.3453 | 3 | 27 | regulation of the force of heart contraction |
GO:0051259 | 0.006 | 2.2658 | 6.5221 | 14 | 510 | protein oligomerization |
GO:0051051 | 0.0067 | 2.3138 | 5.921 | 13 | 463 | negative regulation of transport |
GO:0019730 | 0.0067 | 8.5621 | 0.3882 | 3 | 31 | antimicrobial humoral response |
GO:0045080 | 0.0068 | 19.4802 | 0.1279 | 2 | 10 | positive regulation of chemokine biosynthetic process |
GO:0048304 | 0.0068 | 19.4802 | 0.1279 | 2 | 10 | positive regulation of isotype switching to IgG isotypes |
GO:0051937 | 0.0077 | 5.5056 | 0.7801 | 4 | 61 | catecholamine transport |
GO:0007565 | 0.0083 | 3.2178 | 2.2891 | 7 | 179 | female pregnancy |
GO:1903706 | 0.0093 | 2.2978 | 5.4862 | 12 | 429 | regulation of hemopoiesis |
GO:0033604 | 0.0099 | 15.5822 | 0.1535 | 2 | 12 | negative regulation of catecholamine secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 262.3333 | 0.4092 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 174.8444 | 0.4604 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 104.8533 | 0.5627 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 40.5907 | 1.0103 | 25 | 79 | positive regulation of gene expression, epigenetic |
GO:0006323 | 0 | 17.2325 | 2.3786 | 30 | 186 | DNA packaging |
GO:1902036 | 0 | 27.1359 | 1.2916 | 24 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0045653 | 0 | 290.0211 | 0.2302 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 25.7893 | 1.3428 | 24 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 21.2141 | 1.6369 | 25 | 128 | regulation of gene silencing |
GO:0071824 | 0 | 13.0072 | 3.1331 | 31 | 245 | protein-DNA complex subunit organization |
GO:0032200 | 0 | 16.6442 | 2.0845 | 26 | 163 | telomere organization |
GO:0035194 | 0 | 12.6268 | 2.9797 | 29 | 233 | posttranscriptional gene silencing by RNA |
GO:0002244 | 0 | 13.5215 | 2.3786 | 25 | 186 | hematopoietic progenitor cell differentiation |
GO:0017148 | 0 | 9.1902 | 4.0923 | 30 | 320 | negative regulation of translation |
GO:0048863 | 0 | 10.292 | 3.2866 | 27 | 257 | stem cell differentiation |
GO:0034080 | 0 | 44.5563 | 0.5115 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 38.6056 | 0.5627 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 31.2879 | 0.6522 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 28.2282 | 0.7034 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 19.9328 | 0.9208 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 18.9489 | 0.9591 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0006333 | 0 | 14.0717 | 1.41 | 16 | 118 | chromatin assembly or disassembly |
GO:0034248 | 0 | 5.1935 | 6.8546 | 30 | 536 | regulation of cellular amide metabolic process |
GO:0030099 | 0 | 6.1445 | 4.7956 | 25 | 375 | myeloid cell differentiation |
GO:1903707 | 0 | 11.273 | 1.7136 | 16 | 134 | negative regulation of hemopoiesis |
GO:0038111 | 0 | 30.0134 | 0.4732 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 30.0134 | 0.4732 | 10 | 37 | response to interleukin-7 |
GO:0051259 | 0 | 5.0388 | 6.5221 | 28 | 510 | protein oligomerization |
GO:0010608 | 0 | 4.5875 | 7.9672 | 31 | 623 | posttranscriptional regulation of gene expression |
GO:0048534 | 0 | 3.8799 | 10.6527 | 35 | 833 | hematopoietic or lymphoid organ development |
GO:0045652 | 0 | 18.9589 | 0.6678 | 10 | 56 | regulation of megakaryocyte differentiation |
GO:0010558 | 0 | 3.0713 | 18.9524 | 48 | 1482 | negative regulation of macromolecule biosynthetic process |
GO:1903507 | 0 | 3.3093 | 14.3358 | 40 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0043043 | 0 | 3.8002 | 9.8087 | 32 | 767 | peptide biosynthetic process |
GO:0051253 | 0 | 3.181 | 15.2821 | 41 | 1195 | negative regulation of RNA metabolic process |
GO:0031327 | 0 | 2.8928 | 19.9754 | 48 | 1562 | negative regulation of cellular biosynthetic process |
GO:0006352 | 0 | 6.6304 | 2.9413 | 17 | 230 | DNA-templated transcription, initiation |
GO:0034622 | 0 | 3.3872 | 12.4431 | 36 | 973 | cellular macromolecular complex assembly |
GO:0051248 | 0 | 3.0716 | 15.7681 | 41 | 1233 | negative regulation of protein metabolic process |
GO:0045596 | 0 | 3.52 | 8.0055 | 25 | 626 | negative regulation of cell differentiation |
GO:0006342 | 0 | 12.3587 | 0.7577 | 8 | 67 | chromatin silencing |
GO:0009892 | 0 | 2.1496 | 35.4621 | 63 | 2773 | negative regulation of metabolic process |
GO:0009611 | 0 | 3.343 | 8.0311 | 24 | 628 | response to wounding |
GO:0002227 | 0 | 26.3534 | 0.2558 | 5 | 20 | innate immune response in mucosa |
GO:0060249 | 0 | 3.7224 | 4.7061 | 16 | 368 | anatomical structure homeostasis |
GO:0002376 | 0 | 1.9827 | 33.6718 | 57 | 2633 | immune system process |
GO:2000179 | 0 | 11.609 | 0.6011 | 6 | 47 | positive regulation of neural precursor cell proliferation |
GO:0007596 | 0 | 4.0131 | 3.8113 | 14 | 302 | blood coagulation |
GO:0006355 | 0 | 1.8589 | 43.5572 | 68 | 3406 | regulation of transcription, DNA-templated |
GO:0002251 | 0 | 14.6296 | 0.4092 | 5 | 32 | organ or tissue specific immune response |
GO:0009889 | 1e-04 | 1.7901 | 54.3761 | 80 | 4252 | regulation of biosynthetic process |
GO:2001141 | 1e-04 | 1.84 | 43.9025 | 68 | 3433 | regulation of RNA biosynthetic process |
GO:0070271 | 1e-04 | 2.2323 | 17.5456 | 35 | 1372 | protein complex biogenesis |
GO:0051239 | 1e-04 | 1.9079 | 34.746 | 57 | 2717 | regulation of multicellular organismal process |
GO:0071822 | 1e-04 | 2.133 | 20.5893 | 39 | 1610 | protein complex subunit organization |
GO:0021796 | 1e-04 | 58.7463 | 0.0895 | 3 | 7 | cerebral cortex regionalization |
GO:0050830 | 1e-04 | 7.3273 | 1.0614 | 7 | 83 | defense response to Gram-positive bacterium |
GO:0019731 | 1e-04 | 11.9651 | 0.486 | 5 | 38 | antibacterial humoral response |
GO:0034645 | 1e-04 | 1.7155 | 62.0108 | 87 | 4849 | cellular macromolecule biosynthetic process |
GO:0050878 | 1e-04 | 3.0079 | 6.1256 | 17 | 479 | regulation of body fluid levels |
GO:0042704 | 2e-04 | Inf | 0.0256 | 2 | 2 | uterine wall breakdown |
GO:0032268 | 2e-04 | 1.8695 | 31.8175 | 52 | 2488 | regulation of cellular protein metabolic process |
GO:0040029 | 2e-04 | 3.7124 | 3.4959 | 12 | 310 | regulation of gene expression, epigenetic |
GO:0006996 | 2e-04 | 1.7452 | 44.9383 | 67 | 3514 | organelle organization |
GO:0048505 | 4e-04 | 26.1012 | 0.1535 | 3 | 12 | regulation of timing of cell differentiation |
GO:0061844 | 5e-04 | 8.5766 | 0.6522 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0045595 | 6e-04 | 2.2402 | 11.7176 | 24 | 1003 | regulation of cell differentiation |
GO:0006334 | 7e-04 | 6.1332 | 1.0628 | 6 | 94 | nucleosome assembly |
GO:0006281 | 7e-04 | 2.6726 | 6.4198 | 16 | 502 | DNA repair |
GO:0048665 | 8e-04 | 10.8407 | 0.422 | 4 | 33 | neuron fate specification |
GO:0021542 | 8e-04 | 19.5721 | 0.1918 | 3 | 15 | dentate gyrus development |
GO:0034654 | 9e-04 | 1.621 | 51.6266 | 72 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0022607 | 0.001 | 1.7087 | 34.26 | 52 | 2679 | cellular component assembly |
GO:0019219 | 0.001 | 1.6162 | 50.9105 | 71 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0010604 | 0.0012 | 1.6727 | 37.1118 | 55 | 2902 | positive regulation of macromolecule metabolic process |
GO:0048714 | 0.0012 | 16.774 | 0.2174 | 3 | 17 | positive regulation of oligodendrocyte differentiation |
GO:0045165 | 0.0012 | 3.4027 | 3.1331 | 10 | 245 | cell fate commitment |
GO:0010936 | 0.0016 | 51.9637 | 0.0639 | 2 | 5 | negative regulation of macrophage cytokine production |
GO:0021778 | 0.0016 | 51.9637 | 0.0639 | 2 | 5 | oligodendrocyte cell fate specification |
GO:0051891 | 0.0016 | 51.9637 | 0.0639 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0003278 | 0.0024 | 38.9703 | 0.0767 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0021513 | 0.0027 | 12.3559 | 0.2813 | 3 | 22 | spinal cord dorsal/ventral patterning |
GO:1903706 | 0.0028 | 3.0248 | 3.5061 | 10 | 295 | regulation of hemopoiesis |
GO:0021798 | 0.0033 | 31.1743 | 0.0895 | 2 | 7 | forebrain dorsal/ventral pattern formation |
GO:1901576 | 0.0038 | 1.4753 | 76.9476 | 96 | 6017 | organic substance biosynthetic process |
GO:0072378 | 0.0039 | 10.6689 | 0.3197 | 3 | 25 | blood coagulation, fibrin clot formation |
GO:0003310 | 0.0043 | 25.9769 | 0.1023 | 2 | 8 | pancreatic A cell differentiation |
GO:0035270 | 0.0052 | 4.0139 | 1.5858 | 6 | 124 | endocrine system development |
GO:1904753 | 0.0068 | 19.4802 | 0.1279 | 2 | 10 | negative regulation of vascular associated smooth muscle cell migration |
GO:0045685 | 0.0077 | 5.5056 | 0.7801 | 4 | 61 | regulation of glial cell differentiation |
GO:0090009 | 0.0083 | 17.3146 | 0.1407 | 2 | 11 | primitive streak formation |
GO:0048869 | 0.0085 | 1.4806 | 46.0699 | 61 | 3730 | cellular developmental process |
GO:0007435 | 0.0085 | 7.8199 | 0.422 | 3 | 33 | salivary gland morphogenesis |
GO:0045823 | 0.0092 | 7.5672 | 0.4348 | 3 | 34 | positive regulation of heart contraction |
GO:0017121 | 0.0099 | 15.5822 | 0.1535 | 2 | 12 | phospholipid scrambling |
GO:0060391 | 0.0099 | 15.5822 | 0.1535 | 2 | 12 | positive regulation of SMAD protein import into nucleus |
GO:0042596 | 0.01 | 7.3302 | 0.4476 | 3 | 35 | fear response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 27.9139 | 4.6595 | 72 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 21.4965 | 5.8132 | 73 | 388 | detection of chemical stimulus |
GO:0007606 | 0 | 20.7775 | 6.0829 | 74 | 406 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 20.6915 | 5.993 | 73 | 400 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 7.0679 | 17.4774 | 82 | 1176 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 7.0369 | 17.1998 | 81 | 1148 | nervous system process |
GO:0000183 | 0 | 39.2401 | 0.5394 | 13 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 37.6027 | 0.5544 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 37.6027 | 0.5544 | 13 | 37 | response to interleukin-7 |
GO:0031424 | 0 | 9.0866 | 3.0714 | 23 | 205 | keratinization |
GO:0032501 | 0 | 2.6231 | 90.8745 | 141 | 6625 | multicellular organismal process |
GO:0006335 | 0 | 31.1453 | 0.4794 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0009913 | 0 | 5.9614 | 4.8993 | 25 | 327 | epidermal cell differentiation |
GO:0045652 | 0 | 14.7596 | 1.1087 | 13 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 13.6371 | 1.1836 | 13 | 79 | positive regulation of gene expression, epigenetic |
GO:0043588 | 0 | 5.2058 | 5.7832 | 26 | 386 | skin development |
GO:0051290 | 0 | 20.1374 | 0.6592 | 10 | 44 | protein heterotetramerization |
GO:1902036 | 0 | 10.2134 | 1.5132 | 13 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 9.7669 | 1.5732 | 13 | 105 | regulation of gene silencing by miRNA |
GO:0007154 | 0 | 2.1137 | 89.6849 | 133 | 5986 | cell communication |
GO:0023052 | 0 | 2.089 | 89.3853 | 132 | 5966 | signaling |
GO:0031497 | 0 | 7.4011 | 2.1725 | 14 | 145 | chromatin assembly |
GO:0060968 | 0 | 7.802 | 1.9178 | 13 | 128 | regulation of gene silencing |
GO:0034728 | 0 | 6.8718 | 2.3223 | 14 | 155 | nucleosome organization |
GO:0051716 | 0 | 1.892 | 100.7869 | 138 | 6727 | cellular response to stimulus |
GO:0002244 | 0 | 5.6221 | 2.7867 | 14 | 186 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 4.8263 | 3.2062 | 14 | 214 | protein-DNA complex assembly |
GO:0035194 | 0 | 4.4022 | 3.4909 | 14 | 233 | posttranscriptional gene silencing by RNA |
GO:1903706 | 0 | 3.2235 | 6.4275 | 19 | 429 | regulation of hemopoiesis |
GO:0017148 | 0 | 3.6368 | 4.7944 | 16 | 320 | negative regulation of translation |
GO:0032200 | 0 | 4.9391 | 2.4421 | 11 | 163 | telomere organization |
GO:0071103 | 0 | 3.8801 | 3.9254 | 14 | 262 | DNA conformation change |
GO:0030099 | 1e-04 | 3.2845 | 5.6184 | 17 | 375 | myeloid cell differentiation |
GO:0007596 | 1e-04 | 3.3055 | 4.8993 | 15 | 327 | blood coagulation |
GO:0048863 | 1e-04 | 3.6468 | 3.8505 | 13 | 257 | stem cell differentiation |
GO:0018149 | 2e-04 | 8.2319 | 0.824 | 6 | 55 | peptide cross-linking |
GO:1904628 | 2e-04 | 39.9356 | 0.1199 | 3 | 8 | cellular response to phorbol 13-acetate 12-myristate |
GO:0009611 | 2e-04 | 2.5274 | 9.409 | 22 | 628 | response to wounding |
GO:0006342 | 4e-04 | 6.9876 | 0.9514 | 6 | 67 | chromatin silencing |
GO:0060429 | 8e-04 | 1.9521 | 17.7542 | 32 | 1185 | epithelium development |
GO:0051967 | 8e-04 | 19.9614 | 0.1948 | 3 | 13 | negative regulation of synaptic transmission, glutamatergic |
GO:0050878 | 9e-04 | 2.5279 | 7.1766 | 17 | 479 | regulation of body fluid levels |
GO:0051248 | 0.0016 | 1.8679 | 18.4734 | 32 | 1233 | negative regulation of protein metabolic process |
GO:0042699 | 0.0022 | 44.1913 | 0.0749 | 2 | 5 | follicle-stimulating hormone signaling pathway |
GO:0019730 | 0.0027 | 4.6251 | 1.3934 | 6 | 93 | antimicrobial humoral response |
GO:0010951 | 0.0028 | 3.0333 | 3.4909 | 10 | 233 | negative regulation of endopeptidase activity |
GO:0006067 | 0.0031 | 11.7368 | 0.2996 | 3 | 20 | ethanol metabolic process |
GO:0043152 | 0.0032 | 33.1414 | 0.0899 | 2 | 6 | induction of bacterial agglutination |
GO:0097647 | 0.0032 | 33.1414 | 0.0899 | 2 | 6 | amylin receptor signaling pathway |
GO:0071345 | 0.0044 | 1.9191 | 12.7201 | 23 | 849 | cellular response to cytokine stimulus |
GO:0006701 | 0.0045 | 26.5114 | 0.1049 | 2 | 7 | progesterone biosynthetic process |
GO:0035754 | 0.0045 | 26.5114 | 0.1049 | 2 | 7 | B cell chemotaxis |
GO:0030814 | 0.0056 | 3.4817 | 2.1275 | 7 | 142 | regulation of cAMP metabolic process |
GO:0071634 | 0.006 | 9.0664 | 0.3746 | 3 | 25 | regulation of transforming growth factor beta production |
GO:0034103 | 0.007 | 4.4553 | 1.1986 | 5 | 80 | regulation of tissue remodeling |
GO:0034248 | 0.007 | 2.0963 | 8.0306 | 16 | 536 | regulation of cellular amide metabolic process |
GO:0014059 | 0.0074 | 8.3099 | 0.4045 | 3 | 27 | regulation of dopamine secretion |
GO:0042554 | 0.0074 | 8.3099 | 0.4045 | 3 | 27 | superoxide anion generation |
GO:0007195 | 0.0075 | 18.9343 | 0.1348 | 2 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0048263 | 0.0075 | 18.9343 | 0.1348 | 2 | 9 | determination of dorsal identity |
GO:0002376 | 0.0086 | 1.4865 | 39.4488 | 54 | 2633 | immune system process |
GO:0050896 | 0.0092 | 1.8427 | 14.7148 | 24 | 1344 | response to stimulus |
GO:0032963 | 0.0094 | 3.5236 | 1.7979 | 6 | 120 | collagen metabolic process |
GO:0045861 | 0.0094 | 2.3893 | 4.8243 | 11 | 322 | negative regulation of proteolysis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045087 | 0 | 3.0613 | 8.4394 | 23 | 811 | innate immune response |
GO:0040029 | 1e-04 | 3.7852 | 4.048 | 14 | 389 | regulation of gene expression, epigenetic |
GO:0006342 | 1e-04 | 7.1954 | 1.0718 | 7 | 103 | chromatin silencing |
GO:0044663 | 1e-04 | Inf | 0.0208 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0070370 | 1e-04 | Inf | 0.0208 | 2 | 2 | cellular heat acclimation |
GO:0038166 | 2e-04 | 36.2991 | 0.1145 | 3 | 11 | angiotensin-activated signaling pathway |
GO:0090084 | 2e-04 | 36.2991 | 0.1145 | 3 | 11 | negative regulation of inclusion body assembly |
GO:0051707 | 2e-04 | 2.6861 | 8.1793 | 20 | 786 | response to other organism |
GO:0050778 | 2e-04 | 2.8458 | 6.9201 | 18 | 665 | positive regulation of immune response |
GO:0070434 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0051607 | 3e-04 | 4.4673 | 2.1749 | 9 | 209 | defense response to virus |
GO:0009607 | 4e-04 | 2.536 | 8.6268 | 20 | 829 | response to biotic stimulus |
GO:2000107 | 0.001 | 9.9696 | 0.4475 | 4 | 43 | negative regulation of leukocyte apoptotic process |
GO:0060414 | 0.0011 | 64.1585 | 0.052 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0007159 | 0.0011 | 3.2435 | 3.6318 | 11 | 349 | leukocyte cell-cell adhesion |
GO:0007606 | 0.0011 | 3.0441 | 4.2249 | 12 | 406 | sensory perception of chemical stimulus |
GO:0050863 | 0.0013 | 3.3896 | 3.1531 | 10 | 303 | regulation of T cell activation |
GO:0002376 | 0.0013 | 1.7812 | 27.3996 | 43 | 2633 | immune system process |
GO:1990776 | 0.0015 | 15.2732 | 0.2289 | 3 | 22 | response to angiotensin |
GO:0045071 | 0.0018 | 8.4487 | 0.5203 | 4 | 50 | negative regulation of viral genome replication |
GO:0042026 | 0.0019 | 13.8168 | 0.2497 | 3 | 24 | protein refolding |
GO:1900239 | 0.0022 | 38.4902 | 0.0728 | 2 | 7 | regulation of phenotypic switching |
GO:0001775 | 0.0024 | 2.0161 | 12.9557 | 24 | 1245 | cell activation |
GO:0009593 | 0.0025 | 2.9006 | 4.0376 | 11 | 388 | detection of chemical stimulus |
GO:0018149 | 0.0026 | 7.618 | 0.5723 | 4 | 55 | peptide cross-linking |
GO:0042742 | 0.0026 | 3.5991 | 2.3622 | 8 | 227 | defense response to bacterium |
GO:0036336 | 0.0027 | 12.0874 | 0.281 | 3 | 27 | dendritic cell migration |
GO:0002694 | 0.0028 | 2.7177 | 4.7036 | 12 | 452 | regulation of leukocyte activation |
GO:0002883 | 0.0029 | 32.0732 | 0.0832 | 2 | 8 | regulation of hypersensitivity |
GO:0070424 | 0.0029 | 32.0732 | 0.0832 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:1903265 | 0.0029 | 32.0732 | 0.0832 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0002757 | 0.0031 | 2.6801 | 4.766 | 12 | 458 | immune response-activating signal transduction |
GO:0050906 | 0.0032 | 2.809 | 4.1625 | 11 | 400 | detection of stimulus involved in sensory perception |
GO:0032677 | 0.0035 | 6.9356 | 0.6244 | 4 | 60 | regulation of interleukin-8 production |
GO:1902600 | 0.0036 | 5.2404 | 1.0198 | 5 | 98 | hydrogen ion transmembrane transport |
GO:0001768 | 0.0037 | 27.4895 | 0.0937 | 2 | 9 | establishment of T cell polarity |
GO:0006885 | 0.0037 | 5.1844 | 1.0302 | 5 | 99 | regulation of pH |
GO:0006600 | 0.0046 | 24.0518 | 0.1041 | 2 | 10 | creatine metabolic process |
GO:0050911 | 0.0053 | 2.9391 | 3.2363 | 9 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050851 | 0.0054 | 3.5018 | 2.1125 | 7 | 203 | antigen receptor-mediated signaling pathway |
GO:0001771 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | immunological synapse formation |
GO:0051451 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | myoblast migration |
GO:0097202 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | activation of cysteine-type endopeptidase activity |
GO:0098787 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | mRNA cleavage involved in mRNA processing |
GO:0052548 | 0.0063 | 2.6857 | 3.9336 | 10 | 378 | regulation of endopeptidase activity |
GO:0002829 | 0.0066 | 19.239 | 0.1249 | 2 | 12 | negative regulation of type 2 immune response |
GO:0019532 | 0.0066 | 19.239 | 0.1249 | 2 | 12 | oxalate transport |
GO:0045060 | 0.0066 | 19.239 | 0.1249 | 2 | 12 | negative thymic T cell selection |
GO:0045744 | 0.0071 | 8.2827 | 0.3954 | 3 | 38 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0006950 | 0.0073 | 1.5505 | 37.067 | 51 | 3562 | response to stress |
GO:1902358 | 0.0078 | 17.4889 | 0.1353 | 2 | 13 | sulfate transmembrane transport |
GO:0007155 | 0.0087 | 1.8212 | 13.5697 | 23 | 1304 | cell adhesion |
GO:0006954 | 0.0089 | 2.1656 | 6.8473 | 14 | 658 | inflammatory response |
GO:0010919 | 0.009 | 16.0305 | 0.1457 | 2 | 14 | regulation of inositol phosphate biosynthetic process |
GO:0022407 | 0.0095 | 2.5173 | 4.1833 | 10 | 402 | regulation of cell-cell adhesion |
GO:0002218 | 0.0096 | 2.8559 | 2.945 | 8 | 283 | activation of innate immune response |
GO:0051250 | 0.0099 | 4.0543 | 1.3008 | 5 | 125 | negative regulation of lymphocyte activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 40.4289 | 0.3751 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 29.7955 | 0.5158 | 11 | 44 | protein heterotetramerization |
GO:0000183 | 0 | 34.2003 | 0.422 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 32.9316 | 0.4337 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 32.9316 | 0.4337 | 10 | 37 | response to interleukin-7 |
GO:1902679 | 0 | 3.3374 | 13.1528 | 37 | 1122 | negative regulation of RNA biosynthetic process |
GO:0009890 | 0 | 2.9357 | 18.5335 | 45 | 1581 | negative regulation of biosynthetic process |
GO:0045652 | 0 | 13.8603 | 0.8675 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0031497 | 0 | 8.8484 | 1.6998 | 13 | 145 | chromatin assembly |
GO:0045815 | 0 | 12.8519 | 0.9261 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:0034728 | 0 | 8.22 | 1.817 | 13 | 155 | nucleosome organization |
GO:0035194 | 0 | 6.2195 | 2.7314 | 15 | 233 | posttranscriptional gene silencing by RNA |
GO:0045934 | 0 | 2.8188 | 15.7787 | 38 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:1902036 | 0 | 9.7312 | 1.184 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 9.3191 | 1.2309 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0017148 | 0 | 4.7587 | 3.7513 | 16 | 320 | negative regulation of translation |
GO:0065004 | 0 | 5.7852 | 2.5087 | 13 | 214 | protein-DNA complex assembly |
GO:0060968 | 0 | 7.4916 | 1.5005 | 10 | 128 | regulation of gene silencing |
GO:0002244 | 0 | 5.5679 | 2.1804 | 11 | 186 | hematopoietic progenitor cell differentiation |
GO:0071103 | 0 | 4.6556 | 3.0713 | 13 | 262 | DNA conformation change |
GO:0032200 | 0 | 5.7649 | 1.9108 | 10 | 163 | telomere organization |
GO:0034248 | 1e-04 | 3.135 | 6.2834 | 18 | 536 | regulation of cellular amide metabolic process |
GO:0006342 | 1e-04 | 9.0181 | 0.7451 | 6 | 67 | chromatin silencing |
GO:0007596 | 1e-04 | 3.6764 | 3.8333 | 13 | 327 | blood coagulation |
GO:0070370 | 1e-04 | Inf | 0.0234 | 2 | 2 | cellular heat acclimation |
GO:0014013 | 2e-04 | 6.4833 | 1.184 | 7 | 101 | regulation of gliogenesis |
GO:0048863 | 2e-04 | 3.9428 | 3.0127 | 11 | 257 | stem cell differentiation |
GO:0007274 | 3e-04 | 14.3361 | 0.3282 | 4 | 28 | neuromuscular synaptic transmission |
GO:0010608 | 4e-04 | 2.6689 | 7.3032 | 18 | 623 | posttranscriptional regulation of gene expression |
GO:0035054 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0061141 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | lung ciliated cell differentiation |
GO:0070434 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0071288 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | cellular response to mercury ion |
GO:0090063 | 4e-04 | 170.4216 | 0.0352 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0030099 | 5e-04 | 3.179 | 4.396 | 13 | 375 | myeloid cell differentiation |
GO:0050878 | 5e-04 | 2.8758 | 5.6152 | 15 | 479 | regulation of body fluid levels |
GO:1903706 | 5e-04 | 2.9932 | 5.029 | 14 | 429 | regulation of hemopoiesis |
GO:0048731 | 6e-04 | 1.6731 | 51.1694 | 72 | 4365 | system development |
GO:0045687 | 7e-04 | 11.094 | 0.4103 | 4 | 35 | positive regulation of glial cell differentiation |
GO:0040029 | 7e-04 | 3.4123 | 3.4568 | 11 | 310 | regulation of gene expression, epigenetic |
GO:1903506 | 8e-04 | 1.6973 | 40.1619 | 59 | 3426 | regulation of nucleic acid-templated transcription |
GO:0051259 | 9e-04 | 2.8305 | 5.3048 | 14 | 461 | protein oligomerization |
GO:2000112 | 9e-04 | 1.658 | 45.7067 | 65 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0048523 | 0.001 | 1.6346 | 51.1812 | 71 | 4366 | negative regulation of cellular process |
GO:0048708 | 0.001 | 7.1909 | 0.762 | 5 | 65 | astrocyte differentiation |
GO:0051239 | 0.001 | 1.743 | 31.8505 | 49 | 2717 | regulation of multicellular organismal process |
GO:0051248 | 0.0012 | 2.0372 | 14.454 | 27 | 1233 | negative regulation of protein metabolic process |
GO:0072009 | 0.0013 | 5.3544 | 1.2074 | 6 | 103 | nephron epithelium development |
GO:0015669 | 0.0013 | 16.0486 | 0.2227 | 3 | 19 | gas transport |
GO:0015701 | 0.0016 | 8.8138 | 0.5041 | 4 | 43 | bicarbonate transport |
GO:0045892 | 0.0022 | 2.1369 | 10.6275 | 21 | 985 | negative regulation of transcription, DNA-templated |
GO:0071345 | 0.0023 | 2.1577 | 9.9525 | 20 | 849 | cellular response to cytokine stimulus |
GO:0045662 | 0.0024 | 12.8356 | 0.2696 | 3 | 23 | negative regulation of myoblast differentiation |
GO:0070206 | 0.0026 | 7.6357 | 0.5744 | 4 | 49 | protein trimerization |
GO:0009611 | 0.003 | 2.3167 | 7.3618 | 16 | 628 | response to wounding |
GO:0051252 | 0.003 | 1.5837 | 42.354 | 59 | 3613 | regulation of RNA metabolic process |
GO:0060993 | 0.0036 | 5.2543 | 1.0199 | 5 | 87 | kidney morphogenesis |
GO:0061101 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | neuroendocrine cell differentiation |
GO:0070424 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0071493 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | cellular response to UV-B |
GO:0072201 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | negative regulation of mesenchymal cell proliferation |
GO:1903265 | 0.0037 | 28.3946 | 0.0938 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0010605 | 0.0038 | 1.9179 | 14.2075 | 25 | 1307 | negative regulation of macromolecule metabolic process |
GO:0061326 | 0.0039 | 5.1285 | 1.0433 | 5 | 89 | renal tubule development |
GO:0042542 | 0.0043 | 4.1813 | 1.5239 | 6 | 130 | response to hydrogen peroxide |
GO:0045595 | 0.0048 | 1.7568 | 19.1431 | 31 | 1633 | regulation of cell differentiation |
GO:0033690 | 0.0058 | 21.2932 | 0.1172 | 2 | 10 | positive regulation of osteoblast proliferation |
GO:0060236 | 0.0067 | 8.5516 | 0.3868 | 3 | 33 | regulation of mitotic spindle organization |
GO:0061614 | 0.0067 | 8.5516 | 0.3868 | 3 | 33 | pri-miRNA transcription from RNA polymerase II promoter |
GO:1901566 | 0.0068 | 1.6594 | 22.9295 | 35 | 1956 | organonitrogen compound biosynthetic process |
GO:0090084 | 0.007 | 18.9261 | 0.1289 | 2 | 11 | negative regulation of inclusion body assembly |
GO:0042221 | 0.0072 | 1.4933 | 47.6526 | 63 | 4065 | response to chemical |
GO:0051962 | 0.0074 | 2.3772 | 5.3221 | 12 | 454 | positive regulation of nervous system development |
GO:0014706 | 0.0078 | 2.5943 | 4.056 | 10 | 346 | striated muscle tissue development |
GO:0072078 | 0.0087 | 5.2795 | 0.8089 | 4 | 69 | nephron tubule morphogenesis |
GO:0007420 | 0.0088 | 2.102 | 7.5377 | 15 | 643 | brain development |
GO:0034654 | 0.0096 | 1.4712 | 47.3244 | 62 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0021781 | 0.0098 | 15.483 | 0.1524 | 2 | 13 | glial cell fate commitment |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 27.8729 | 3.7627 | 60 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 21.2236 | 4.6943 | 60 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 20.4586 | 4.8395 | 60 | 400 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 20.096 | 4.9121 | 60 | 406 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 7.5034 | 14.2887 | 70 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 7.0494 | 13.8894 | 66 | 1148 | nervous system process |
GO:0031424 | 0 | 25.873 | 1.0862 | 20 | 93 | keratinization |
GO:0009913 | 0 | 9.5817 | 3.9563 | 30 | 327 | epidermal cell differentiation |
GO:0043588 | 0 | 7.9632 | 4.6701 | 30 | 386 | skin development |
GO:0018149 | 0 | 29.9839 | 0.6654 | 14 | 55 | peptide cross-linking |
GO:0042742 | 0 | 5.2462 | 2.7464 | 13 | 227 | defense response to bacterium |
GO:0002548 | 0 | 11.5914 | 0.7017 | 7 | 58 | monocyte chemotaxis |
GO:0032501 | 0 | 1.9784 | 69.418 | 97 | 6625 | multicellular organismal process |
GO:0060429 | 0 | 2.4218 | 14.3371 | 31 | 1185 | epithelium development |
GO:0070268 | 1e-04 | 6.5094 | 1.3551 | 8 | 112 | cornification |
GO:0070098 | 3e-04 | 7.1913 | 0.9195 | 6 | 76 | chemokine-mediated signaling pathway |
GO:0046968 | 4e-04 | 165.0052 | 0.0363 | 2 | 3 | peptide antigen transport |
GO:0048247 | 4e-04 | 8.7051 | 0.6412 | 5 | 53 | lymphocyte chemotaxis |
GO:0097530 | 6e-04 | 5.354 | 1.4156 | 7 | 117 | granulocyte migration |
GO:0045087 | 0.002 | 2.1876 | 9.8121 | 20 | 811 | innate immune response |
GO:0016098 | 0.0021 | 41.2435 | 0.0726 | 2 | 6 | monoterpenoid metabolic process |
GO:0071677 | 0.0026 | 12.4255 | 0.2783 | 3 | 23 | positive regulation of mononuclear cell migration |
GO:0019062 | 0.0029 | 32.9927 | 0.0847 | 2 | 7 | virion attachment to host cell |
GO:0030593 | 0.0035 | 5.2788 | 1.0163 | 5 | 84 | neutrophil chemotaxis |
GO:0071347 | 0.0037 | 5.2124 | 1.0284 | 5 | 85 | cellular response to interleukin-1 |
GO:0060326 | 0.0037 | 3.1102 | 3.061 | 9 | 253 | cell chemotaxis |
GO:1904628 | 0.0039 | 27.4921 | 0.0968 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
GO:0031640 | 0.0044 | 6.5185 | 0.6654 | 4 | 55 | killing of cells of other organism |
GO:0007195 | 0.005 | 23.5632 | 0.1089 | 2 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0097267 | 0.005 | 23.5632 | 0.1089 | 2 | 9 | omega-hydroxylase P450 pathway |
GO:0019730 | 0.0054 | 4.7362 | 1.1252 | 5 | 93 | antimicrobial humoral response |
GO:0071624 | 0.0056 | 9.2 | 0.363 | 3 | 30 | positive regulation of granulocyte chemotaxis |
GO:0042482 | 0.0061 | 20.6165 | 0.121 | 2 | 10 | positive regulation of odontogenesis |
GO:0017144 | 0.0067 | 8.5644 | 0.3872 | 3 | 32 | drug metabolic process |
GO:0035821 | 0.0069 | 3.7697 | 1.6817 | 6 | 139 | modification of morphology or physiology of other organism |
GO:0050896 | 0.0072 | 1.446 | 97.6494 | 115 | 8071 | response to stimulus |
GO:0042738 | 0.0075 | 18.3246 | 0.1331 | 2 | 11 | exogenous drug catabolic process |
GO:0044406 | 0.0075 | 18.3246 | 0.1331 | 2 | 11 | adhesion of symbiont to host |
GO:0006805 | 0.0076 | 4.3393 | 1.222 | 5 | 101 | xenobiotic metabolic process |
GO:0060158 | 0.0089 | 16.4911 | 0.1452 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0070989 | 0.0089 | 16.4911 | 0.1452 | 2 | 12 | oxidative demethylation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007218 | 0 | 10.9289 | 1.1844 | 11 | 94 | neuropeptide signaling pathway |
GO:0007187 | 0 | 6.6128 | 2.2177 | 13 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0050877 | 0 | 2.675 | 14.4651 | 34 | 1148 | nervous system process |
GO:0050794 | 0 | 1.9118 | 124.7052 | 152 | 9897 | regulation of cellular process |
GO:0007268 | 1e-04 | 2.9754 | 7.3586 | 20 | 584 | chemical synaptic transmission |
GO:0099537 | 1e-04 | 2.9645 | 7.3838 | 20 | 586 | trans-synaptic signaling |
GO:0051241 | 1e-04 | 2.3997 | 12.9023 | 28 | 1034 | negative regulation of multicellular organismal process |
GO:0072507 | 1e-04 | 3.1725 | 5.4685 | 16 | 434 | divalent inorganic cation homeostasis |
GO:0006874 | 1e-04 | 3.2977 | 4.9267 | 15 | 391 | cellular calcium ion homeostasis |
GO:0046877 | 2e-04 | 39.7601 | 0.1134 | 3 | 9 | regulation of saliva secretion |
GO:0097746 | 2e-04 | 5.5388 | 1.575 | 8 | 125 | regulation of blood vessel diameter |
GO:0009952 | 2e-04 | 4.4053 | 2.4571 | 10 | 195 | anterior/posterior pattern specification |
GO:0033555 | 2e-04 | 7.9142 | 0.8442 | 6 | 67 | multicellular organismal response to stress |
GO:0007606 | 2e-04 | 3.1681 | 5.1157 | 15 | 406 | sensory perception of chemical stimulus |
GO:0007389 | 2e-04 | 3.1433 | 5.1535 | 15 | 409 | pattern specification process |
GO:0030799 | 3e-04 | 4.6261 | 2.1043 | 9 | 167 | regulation of cyclic nucleotide metabolic process |
GO:0035150 | 3e-04 | 5.1402 | 1.6884 | 8 | 134 | regulation of tube size |
GO:0021559 | 3e-04 | 29.8163 | 0.1386 | 3 | 11 | trigeminal nerve development |
GO:0042310 | 3e-04 | 7.2028 | 0.9198 | 6 | 73 | vasoconstriction |
GO:0007200 | 3e-04 | 5.8841 | 1.2978 | 7 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0050885 | 3e-04 | 9.3189 | 0.6048 | 5 | 48 | neuromuscular process controlling balance |
GO:0007631 | 3e-04 | 5.823 | 1.3104 | 7 | 104 | feeding behavior |
GO:0007267 | 4e-04 | 2.2014 | 13.4687 | 27 | 1108 | cell-cell signaling |
GO:0003203 | 5e-04 | 12.7724 | 0.3654 | 4 | 29 | endocardial cushion morphogenesis |
GO:0021524 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | visceral motor neuron differentiation |
GO:0060913 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | cardiac cell fate determination |
GO:0065007 | 5e-04 | 1.7706 | 139.8633 | 161 | 11100 | biological regulation |
GO:0019098 | 5e-04 | 12.2804 | 0.378 | 4 | 30 | reproductive behavior |
GO:0007204 | 6e-04 | 3.4904 | 3.3769 | 11 | 268 | positive regulation of cytosolic calcium ion concentration |
GO:0021545 | 6e-04 | 11.6292 | 0.3956 | 4 | 32 | cranial nerve development |
GO:0042711 | 6e-04 | 21.6804 | 0.1764 | 3 | 14 | maternal behavior |
GO:0001662 | 8e-04 | 11.0079 | 0.4158 | 4 | 33 | behavioral fear response |
GO:0048665 | 8e-04 | 11.0079 | 0.4158 | 4 | 33 | neuron fate specification |
GO:0003018 | 8e-04 | 4.4 | 1.953 | 8 | 155 | vascular process in circulatory system |
GO:0060253 | 8e-04 | 19.8725 | 0.189 | 3 | 15 | negative regulation of glial cell proliferation |
GO:0030816 | 9e-04 | 5.8083 | 1.1214 | 6 | 89 | positive regulation of cAMP metabolic process |
GO:0001992 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003308 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0007198 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021615 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0070253 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | somatostatin secretion |
GO:0098664 | 0.001 | 18.5275 | 0.1996 | 3 | 16 | G-protein coupled serotonin receptor signaling pathway |
GO:0045596 | 0.001 | 2.4498 | 7.8878 | 18 | 626 | negative regulation of cell differentiation |
GO:0060193 | 0.001 | 7.1497 | 0.7686 | 5 | 61 | positive regulation of lipase activity |
GO:0019932 | 0.0011 | 3.2342 | 3.6289 | 11 | 288 | second-messenger-mediated signaling |
GO:0045777 | 0.0013 | 9.3861 | 0.4788 | 4 | 38 | positive regulation of blood pressure |
GO:0009593 | 0.0013 | 2.8353 | 4.8889 | 13 | 388 | detection of chemical stimulus |
GO:0080090 | 0.0013 | 1.5553 | 71.8973 | 93 | 5706 | regulation of primary metabolic process |
GO:0050795 | 0.0014 | 6.5616 | 0.8316 | 5 | 66 | regulation of behavior |
GO:0048880 | 0.0015 | 52.7571 | 0.063 | 2 | 5 | sensory system development |
GO:0051970 | 0.0015 | 52.7571 | 0.063 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0007193 | 0.0017 | 6.3164 | 0.861 | 5 | 69 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0050906 | 0.0017 | 2.7452 | 5.0401 | 13 | 400 | detection of stimulus involved in sensory perception |
GO:0008306 | 0.0019 | 6.1562 | 0.882 | 5 | 70 | associative learning |
GO:0055065 | 0.0019 | 2.4223 | 7.0436 | 16 | 559 | metal ion homeostasis |
GO:0021536 | 0.002 | 6.0625 | 0.8946 | 5 | 71 | diencephalon development |
GO:0051171 | 0.0022 | 1.5231 | 70.0829 | 90 | 5562 | regulation of nitrogen compound metabolic process |
GO:0014821 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | phasic smooth muscle contraction |
GO:0031290 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0050951 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | sensory perception of temperature stimulus |
GO:0010840 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | regulation of circadian sleep/wake cycle, wakefulness |
GO:0021546 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | rhombomere development |
GO:0007611 | 0.0023 | 3.3556 | 2.8477 | 9 | 226 | learning or memory |
GO:0007186 | 0.0024 | 2.1572 | 9.9841 | 20 | 883 | G-protein coupled receptor signaling pathway |
GO:0030003 | 0.0025 | 2.3548 | 7.2326 | 16 | 574 | cellular cation homeostasis |
GO:0050886 | 0.0029 | 5.5552 | 0.9702 | 5 | 77 | endocrine process |
GO:0044062 | 0.0029 | 11.9174 | 0.2898 | 3 | 23 | regulation of excretion |
GO:0050768 | 0.0032 | 3.1914 | 2.9863 | 9 | 237 | negative regulation of neurogenesis |
GO:0060052 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | neurofilament cytoskeleton organization |
GO:2000542 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | negative regulation of gastrulation |
GO:0007202 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | activation of phospholipase C activity |
GO:0035640 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | exploration behavior |
GO:0046887 | 0.0035 | 4.3751 | 1.4616 | 6 | 116 | positive regulation of hormone secretion |
GO:0003073 | 0.0036 | 5.2615 | 1.0206 | 5 | 81 | regulation of systemic arterial blood pressure |
GO:0003148 | 0.0037 | 10.8326 | 0.315 | 3 | 25 | outflow tract septum morphogenesis |
GO:0002118 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | aggressive behavior |
GO:0045924 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | regulation of female receptivity |
GO:0051094 | 0.0042 | 1.8601 | 15.007 | 26 | 1191 | positive regulation of developmental process |
GO:0061311 | 0.0046 | 9.9287 | 0.3402 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0009914 | 0.0047 | 2.8011 | 3.7675 | 10 | 299 | hormone transport |
GO:0034767 | 0.0049 | 4.0764 | 1.5624 | 6 | 124 | positive regulation of ion transmembrane transport |
GO:0035270 | 0.0049 | 4.0764 | 1.5624 | 6 | 124 | endocrine system development |
GO:1900542 | 0.0049 | 2.9791 | 3.1879 | 9 | 253 | regulation of purine nucleotide metabolic process |
GO:0023061 | 0.0053 | 2.4877 | 5.0905 | 12 | 404 | signal release |
GO:0001993 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0010579 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0021562 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | vestibulocochlear nerve development |
GO:0043950 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | positive regulation of cAMP-mediated signaling |
GO:0046549 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | retinal cone cell development |
GO:0043266 | 0.0056 | 4.7017 | 1.134 | 5 | 90 | regulation of potassium ion transport |
GO:0032355 | 0.0057 | 3.9417 | 1.6128 | 6 | 128 | response to estradiol |
GO:0007417 | 0.0059 | 1.9689 | 10.7985 | 20 | 857 | central nervous system development |
GO:0019933 | 0.0059 | 4.6383 | 1.1483 | 5 | 92 | cAMP-mediated signaling |
GO:0050911 | 0.0062 | 2.6874 | 3.9187 | 10 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0019233 | 0.0064 | 4.5405 | 1.1718 | 5 | 93 | sensory perception of pain |
GO:0051006 | 0.0067 | 19.7776 | 0.126 | 2 | 10 | positive regulation of lipoprotein lipase activity |
GO:0032501 | 0.0071 | 1.4983 | 60.346 | 76 | 5469 | multicellular organismal process |
GO:0043278 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | response to morphine |
GO:0098801 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | regulation of renal system process |
GO:0051960 | 0.0075 | 1.9924 | 9.5636 | 18 | 759 | regulation of nervous system development |
GO:1901381 | 0.0081 | 7.9399 | 0.4158 | 3 | 33 | positive regulation of potassium ion transmembrane transport |
GO:0045981 | 0.0084 | 3.6132 | 1.7514 | 6 | 139 | positive regulation of nucleotide metabolic process |
GO:0055082 | 0.0085 | 2.0075 | 8.9462 | 17 | 710 | cellular chemical homeostasis |
GO:0055008 | 0.0086 | 5.31 | 0.8064 | 4 | 64 | cardiac muscle tissue morphogenesis |
GO:0007190 | 0.0088 | 7.6833 | 0.4284 | 3 | 34 | activation of adenylate cyclase activity |
GO:0048562 | 0.009 | 2.6877 | 3.5155 | 9 | 279 | embryonic organ morphogenesis |
GO:0014013 | 0.009 | 4.16 | 1.2726 | 5 | 101 | regulation of gliogenesis |
GO:1900274 | 0.0096 | 7.4427 | 0.441 | 3 | 35 | regulation of phospholipase C activity |
GO:0002862 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | negative regulation of inflammatory response to antigenic stimulus |
GO:0033605 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of catecholamine secretion |
GO:0035815 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of renal sodium excretion |
GO:0071361 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | cellular response to ethanol |
GO:0031326 | 0.0099 | 1.4443 | 52.7449 | 68 | 4186 | regulation of cellular biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038111 | 0 | 55.8023 | 0.385 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 55.8023 | 0.385 | 13 | 37 | response to interleukin-7 |
GO:0006333 | 0 | 13.4732 | 1.7587 | 19 | 169 | chromatin assembly or disassembly |
GO:0006323 | 0 | 12.0885 | 1.9356 | 19 | 186 | DNA packaging |
GO:0006335 | 0 | 45.9324 | 0.333 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 38.856 | 0.3746 | 10 | 36 | chromatin silencing at rDNA |
GO:0071824 | 0 | 8.8989 | 2.5495 | 19 | 245 | protein-DNA complex subunit organization |
GO:0051290 | 0 | 29.6983 | 0.4579 | 10 | 44 | protein heterotetramerization |
GO:0045814 | 0 | 11.5266 | 1.2279 | 12 | 118 | negative regulation of gene expression, epigenetic |
GO:0045652 | 0 | 15.7472 | 0.7701 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 14.6014 | 0.8221 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 11.0559 | 1.051 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 10.5877 | 1.0927 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0006334 | 0 | 11.2934 | 0.9211 | 9 | 94 | nucleosome assembly |
GO:0060968 | 0 | 8.5115 | 1.332 | 10 | 128 | regulation of gene silencing |
GO:0002227 | 0 | 32.6522 | 0.2081 | 5 | 20 | innate immune response in mucosa |
GO:0035194 | 0 | 5.488 | 2.4246 | 12 | 233 | posttranscriptional gene silencing by RNA |
GO:0032200 | 0 | 6.5498 | 1.6962 | 10 | 163 | telomere organization |
GO:0048863 | 0 | 4.9428 | 2.6744 | 12 | 257 | stem cell differentiation |
GO:0002251 | 0 | 18.1263 | 0.333 | 5 | 32 | organ or tissue specific immune response |
GO:0071345 | 0 | 2.913 | 8.8349 | 23 | 849 | cellular response to cytokine stimulus |
GO:0002244 | 0 | 5.6855 | 1.9356 | 10 | 186 | hematopoietic progenitor cell differentiation |
GO:0050878 | 0 | 3.5301 | 4.9846 | 16 | 479 | regulation of body fluid levels |
GO:0019731 | 0 | 14.825 | 0.3954 | 5 | 38 | antibacterial humoral response |
GO:0006583 | 1e-04 | Inf | 0.0208 | 2 | 2 | melanin biosynthetic process from tyrosine |
GO:0017148 | 1e-04 | 3.9158 | 3.33 | 12 | 320 | negative regulation of translation |
GO:0045892 | 2e-04 | 2.4557 | 11.322 | 25 | 1088 | negative regulation of transcription, DNA-templated |
GO:0061844 | 2e-04 | 10.6265 | 0.5307 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0034622 | 2e-04 | 2.5118 | 10.1253 | 23 | 973 | cellular macromolecular complex assembly |
GO:1902679 | 2e-04 | 2.3741 | 11.6758 | 25 | 1122 | negative regulation of RNA biosynthetic process |
GO:0003166 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | bundle of His development |
GO:0099566 | 3e-04 | 192.5 | 0.0312 | 2 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
GO:1903706 | 6e-04 | 3.1393 | 4.4643 | 13 | 429 | regulation of hemopoiesis |
GO:0030099 | 6e-04 | 3.3107 | 3.9023 | 12 | 375 | myeloid cell differentiation |
GO:0007596 | 6e-04 | 3.4743 | 3.4028 | 11 | 327 | blood coagulation |
GO:0060364 | 6e-04 | 96.2439 | 0.0416 | 2 | 4 | frontal suture morphogenesis |
GO:0045934 | 7e-04 | 2.1305 | 14.0068 | 27 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009890 | 9e-04 | 2.0245 | 16.4522 | 30 | 1581 | negative regulation of biosynthetic process |
GO:0097070 | 0.0011 | 64.1585 | 0.052 | 2 | 5 | ductus arteriosus closure |
GO:0050830 | 0.0017 | 6.2542 | 0.8637 | 5 | 83 | defense response to Gram-positive bacterium |
GO:0030879 | 0.0021 | 4.8549 | 1.3216 | 6 | 127 | mammary gland development |
GO:0051791 | 0.0022 | 38.4902 | 0.0728 | 2 | 7 | medium-chain fatty acid metabolic process |
GO:0051259 | 0.0026 | 2.6138 | 5.3072 | 13 | 510 | protein oligomerization |
GO:0034248 | 0.004 | 2.4796 | 5.5777 | 13 | 536 | regulation of cellular amide metabolic process |
GO:0035115 | 0.0044 | 10.0002 | 0.333 | 3 | 32 | embryonic forelimb morphogenesis |
GO:0007200 | 0.0044 | 4.9715 | 1.0718 | 5 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0060411 | 0.0049 | 6.262 | 0.6868 | 4 | 66 | cardiac septum morphogenesis |
GO:0003161 | 0.0056 | 21.378 | 0.1145 | 2 | 11 | cardiac conduction system development |
GO:0009611 | 0.006 | 2.2759 | 6.5351 | 14 | 628 | response to wounding |
GO:0035137 | 0.0061 | 8.7858 | 0.3746 | 3 | 36 | hindlimb morphogenesis |
GO:2000648 | 0.0071 | 8.2827 | 0.3954 | 3 | 38 | positive regulation of stem cell proliferation |
GO:0009593 | 0.0075 | 2.6129 | 4.0376 | 10 | 388 | detection of chemical stimulus |
GO:0003197 | 0.0077 | 8.0521 | 0.4058 | 3 | 39 | endocardial cushion development |
GO:0010033 | 0.008 | 1.5848 | 30.1364 | 43 | 2896 | response to organic substance |
GO:0001938 | 0.0081 | 5.3889 | 0.7909 | 4 | 76 | positive regulation of endothelial cell proliferation |
GO:0003214 | 0.009 | 16.0305 | 0.1457 | 2 | 14 | cardiac left ventricle morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 3.676 | 4.7673 | 16 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 3.5583 | 4.9147 | 16 | 400 | detection of stimulus involved in sensory perception |
GO:0007389 | 0 | 3.4748 | 5.0253 | 16 | 409 | pattern specification process |
GO:2000035 | 1e-04 | 61.2124 | 0.086 | 3 | 7 | regulation of stem cell division |
GO:0002686 | 1e-04 | 12.8632 | 0.4546 | 5 | 37 | negative regulation of leukocyte migration |
GO:0050911 | 1e-04 | 3.6849 | 3.8212 | 13 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0061032 | 2e-04 | Inf | 0.0246 | 2 | 2 | visceral serous pericardium development |
GO:0007606 | 2e-04 | 3.2566 | 4.9885 | 15 | 406 | sensory perception of chemical stimulus |
GO:0007501 | 6e-04 | 22.2492 | 0.172 | 3 | 14 | mesodermal cell fate specification |
GO:0060429 | 6e-04 | 2.103 | 14.5599 | 28 | 1185 | epithelium development |
GO:0048333 | 7e-04 | 11.2981 | 0.4055 | 4 | 33 | mesodermal cell differentiation |
GO:0001501 | 8e-04 | 2.7557 | 5.8363 | 15 | 475 | skeletal system development |
GO:0007186 | 8e-04 | 2.0948 | 14.0643 | 27 | 1161 | G-protein coupled receptor signaling pathway |
GO:0090027 | 9e-04 | 81.2062 | 0.0491 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:0030326 | 9e-04 | 4.8668 | 1.5481 | 7 | 126 | embryonic limb morphogenesis |
GO:0001657 | 0.001 | 5.6875 | 1.1427 | 6 | 93 | ureteric bud development |
GO:0010469 | 0.0011 | 2.5839 | 6.6349 | 16 | 540 | regulation of receptor activity |
GO:0072163 | 0.0011 | 5.6225 | 1.155 | 6 | 94 | mesonephric epithelium development |
GO:0060173 | 0.0012 | 4.1218 | 2.0765 | 8 | 169 | limb development |
GO:0097529 | 0.0013 | 4.0707 | 2.1011 | 8 | 171 | myeloid leukocyte migration |
GO:0048729 | 0.0014 | 2.4413 | 7.4581 | 17 | 607 | tissue morphogenesis |
GO:0035609 | 0.0015 | 54.134 | 0.0614 | 2 | 5 | C-terminal protein deglutamylation |
GO:0071504 | 0.0015 | 54.134 | 0.0614 | 2 | 5 | cellular response to heparin |
GO:0071672 | 0.0015 | 54.134 | 0.0614 | 2 | 5 | negative regulation of smooth muscle cell chemotaxis |
GO:0071305 | 0.0015 | 15.2915 | 0.2335 | 3 | 19 | cellular response to vitamin D |
GO:0071675 | 0.0016 | 8.8508 | 0.5038 | 4 | 41 | regulation of mononuclear cell migration |
GO:0048568 | 0.0017 | 2.7412 | 5.0499 | 13 | 411 | embryonic organ development |
GO:0002688 | 0.0018 | 5.0455 | 1.2778 | 6 | 104 | regulation of leukocyte chemotaxis |
GO:0098664 | 0.0018 | 14.391 | 0.2457 | 3 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0072088 | 0.0018 | 6.2232 | 0.8724 | 5 | 71 | nephron epithelium morphogenesis |
GO:2000401 | 0.0019 | 8.3958 | 0.5283 | 4 | 43 | regulation of lymphocyte migration |
GO:0061333 | 0.002 | 6.0394 | 0.8969 | 5 | 73 | renal tubule morphogenesis |
GO:0003008 | 0.0021 | 1.7752 | 22.8904 | 37 | 1863 | system process |
GO:0035107 | 0.0021 | 4.1916 | 1.7816 | 7 | 145 | appendage morphogenesis |
GO:0009952 | 0.0021 | 4.1788 | 1.7866 | 7 | 148 | anterior/posterior pattern specification |
GO:2000406 | 0.0024 | 12.8746 | 0.2703 | 3 | 22 | positive regulation of T cell migration |
GO:0032330 | 0.0024 | 7.7946 | 0.5652 | 4 | 46 | regulation of chondrocyte differentiation |
GO:0070098 | 0.0024 | 5.7831 | 0.9338 | 5 | 76 | chemokine-mediated signaling pathway |
GO:0009948 | 0.0026 | 7.6129 | 0.5775 | 4 | 47 | anterior/posterior axis specification |
GO:0003357 | 0.003 | 32.4763 | 0.086 | 2 | 7 | noradrenergic neuron differentiation |
GO:0061217 | 0.0031 | 11.6469 | 0.2949 | 3 | 24 | regulation of mesonephros development |
GO:0035239 | 0.0031 | 2.8143 | 4.1407 | 11 | 337 | tube morphogenesis |
GO:0001525 | 0.0034 | 2.5259 | 5.4554 | 13 | 444 | angiogenesis |
GO:0072273 | 0.0034 | 11.1168 | 0.3072 | 3 | 25 | metanephric nephron morphogenesis |
GO:0001656 | 0.0037 | 5.1948 | 1.0321 | 5 | 84 | metanephros development |
GO:0051093 | 0.0038 | 2.0592 | 10.3701 | 20 | 844 | negative regulation of developmental process |
GO:2000242 | 0.0038 | 6.8177 | 0.6389 | 4 | 52 | negative regulation of reproductive process |
GO:0071347 | 0.0039 | 5.1296 | 1.0444 | 5 | 85 | cellular response to interleukin-1 |
GO:2000270 | 0.004 | 27.0619 | 0.0983 | 2 | 8 | negative regulation of fibroblast apoptotic process |
GO:0006968 | 0.0043 | 6.5442 | 0.6635 | 4 | 54 | cellular defense response |
GO:2000146 | 0.0043 | 3.0344 | 3.1331 | 9 | 255 | negative regulation of cell motility |
GO:0060993 | 0.0044 | 5.0038 | 1.069 | 5 | 87 | kidney morphogenesis |
GO:0033273 | 0.0046 | 4.9432 | 1.0812 | 5 | 88 | response to vitamin |
GO:0048598 | 0.0046 | 3.008 | 3.1625 | 9 | 269 | embryonic morphogenesis |
GO:0001658 | 0.0046 | 6.4154 | 0.6758 | 4 | 55 | branching involved in ureteric bud morphogenesis |
GO:0033689 | 0.0051 | 23.1944 | 0.1106 | 2 | 9 | negative regulation of osteoblast proliferation |
GO:0048865 | 0.0051 | 23.1944 | 0.1106 | 2 | 9 | stem cell fate commitment |
GO:2000501 | 0.0051 | 23.1944 | 0.1106 | 2 | 9 | regulation of natural killer cell chemotaxis |
GO:0035051 | 0.0055 | 9.237 | 0.3616 | 3 | 30 | cardiocyte differentiation |
GO:0048704 | 0.0055 | 4.7147 | 1.1304 | 5 | 92 | embryonic skeletal system morphogenesis |
GO:0010667 | 0.0058 | 9.0553 | 0.3686 | 3 | 30 | negative regulation of cardiac muscle cell apoptotic process |
GO:0072006 | 0.0058 | 3.9173 | 1.6219 | 6 | 132 | nephron development |
GO:0072001 | 0.0063 | 2.8573 | 3.3175 | 9 | 270 | renal system development |
GO:0050905 | 0.0063 | 4.5567 | 1.1673 | 5 | 95 | neuromuscular process |
GO:0060346 | 0.0063 | 20.2938 | 0.1229 | 2 | 10 | bone trabecula formation |
GO:0006355 | 0.0063 | 1.5192 | 41.849 | 57 | 3406 | regulation of transcription, DNA-templated |
GO:0009954 | 0.0064 | 8.7313 | 0.3809 | 3 | 31 | proximal/distal pattern formation |
GO:0072171 | 0.0067 | 5.7379 | 0.7495 | 4 | 61 | mesonephric tubule morphogenesis |
GO:0007369 | 0.0071 | 3.3167 | 2.2239 | 7 | 181 | gastrulation |
GO:2001141 | 0.0075 | 1.5038 | 42.1808 | 57 | 3433 | regulation of RNA biosynthetic process |
GO:0000578 | 0.0076 | 8.1482 | 0.4055 | 3 | 33 | embryonic axis specification |
GO:0003156 | 0.0076 | 8.1482 | 0.4055 | 3 | 33 | regulation of animal organ formation |
GO:0003157 | 0.0077 | 18.0378 | 0.1352 | 2 | 11 | endocardium development |
GO:0055123 | 0.0077 | 3.6815 | 1.7202 | 6 | 140 | digestive system development |
GO:0065007 | 0.0079 | 1.5171 | 136.3842 | 152 | 11100 | biological regulation |
GO:0046888 | 0.0079 | 5.45 | 0.7864 | 4 | 64 | negative regulation of hormone secretion |
GO:0001568 | 0.0081 | 2.1228 | 7.4581 | 15 | 607 | blood vessel development |
GO:1901342 | 0.0082 | 2.7296 | 3.4649 | 9 | 282 | regulation of vasculature development |
GO:0051155 | 0.0083 | 5.3603 | 0.7986 | 4 | 65 | positive regulation of striated muscle cell differentiation |
GO:0051241 | 0.0088 | 1.8343 | 12.7538 | 22 | 1038 | negative regulation of multicellular organismal process |
GO:0060795 | 0.009 | 7.638 | 0.43 | 3 | 35 | cell fate commitment involved in formation of primary germ layer |
GO:0016331 | 0.0091 | 3.548 | 1.7816 | 6 | 145 | morphogenesis of embryonic epithelium |
GO:0003337 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0010454 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | negative regulation of cell fate commitment |
GO:0045835 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | negative regulation of meiotic nuclear division |
GO:0072017 | 0.0091 | 16.233 | 0.1474 | 2 | 12 | distal tubule development |
GO:0055007 | 0.0095 | 4.0984 | 1.2901 | 5 | 105 | cardiac muscle cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 27.024 | 3.3338 | 53 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 22.6596 | 4.1592 | 56 | 388 | detection of chemical stimulus |
GO:0007606 | 0 | 21.4692 | 4.3522 | 56 | 406 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 21.2139 | 4.2879 | 55 | 400 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 7.4963 | 12.3062 | 61 | 1148 | nervous system process |
GO:0007186 | 0 | 6.52 | 12.6599 | 57 | 1181 | G-protein coupled receptor signaling pathway |
GO:0008544 | 0 | 6.8773 | 4.5773 | 26 | 427 | epidermis development |
GO:0031424 | 0 | 16.7838 | 0.9629 | 13 | 93 | keratinization |
GO:0018149 | 0 | 24.5891 | 0.5896 | 11 | 55 | peptide cross-linking |
GO:0030855 | 0 | 3.9943 | 7.5466 | 26 | 704 | epithelial cell differentiation |
GO:0032501 | 0 | 2.289 | 63.528 | 94 | 6625 | multicellular organismal process |
GO:0019373 | 0 | 31.6586 | 0.2144 | 5 | 20 | epoxygenase P450 pathway |
GO:0052695 | 0 | 31.475 | 0.1715 | 4 | 16 | cellular glucuronidation |
GO:0042742 | 0 | 4.9541 | 2.4334 | 11 | 227 | defense response to bacterium |
GO:0001676 | 1e-04 | 8.0727 | 0.9648 | 7 | 90 | long-chain fatty acid metabolic process |
GO:0006063 | 1e-04 | 22.2106 | 0.2251 | 4 | 21 | uronic acid metabolic process |
GO:0042738 | 2e-04 | 35.2076 | 0.1179 | 3 | 11 | exogenous drug catabolic process |
GO:0070268 | 2e-04 | 6.3724 | 1.2006 | 7 | 112 | cornification |
GO:0010951 | 2e-04 | 4.3333 | 2.4977 | 10 | 233 | negative regulation of endopeptidase activity |
GO:0031640 | 3e-04 | 9.4765 | 0.5896 | 5 | 55 | killing of cells of other organism |
GO:0033559 | 5e-04 | 6.4847 | 1.0076 | 6 | 94 | unsaturated fatty acid metabolic process |
GO:0006690 | 8e-04 | 5.9413 | 1.0934 | 6 | 102 | icosanoid metabolic process |
GO:0008202 | 0.0014 | 3.3651 | 3.173 | 10 | 296 | steroid metabolic process |
GO:0071674 | 0.0015 | 6.4813 | 0.8361 | 5 | 78 | mononuclear cell migration |
GO:0016098 | 0.0017 | 46.6775 | 0.0643 | 2 | 6 | monoterpenoid metabolic process |
GO:0050896 | 0.0017 | 1.6003 | 86.5184 | 106 | 8071 | response to stimulus |
GO:0061844 | 0.0022 | 8.0183 | 0.5467 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0048007 | 0.0023 | 37.3396 | 0.075 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0045861 | 0.0025 | 3.0795 | 3.4517 | 10 | 322 | negative regulation of proteolysis |
GO:0034308 | 0.0028 | 7.3876 | 0.5896 | 4 | 55 | primary alcohol metabolic process |
GO:0035821 | 0.0039 | 4.2783 | 1.49 | 6 | 139 | modification of morphology or physiology of other organism |
GO:0007195 | 0.0039 | 26.6678 | 0.0965 | 2 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0090370 | 0.0039 | 26.6678 | 0.0965 | 2 | 9 | negative regulation of cholesterol efflux |
GO:0097267 | 0.0039 | 26.6678 | 0.0965 | 2 | 9 | omega-hydroxylase P450 pathway |
GO:0052547 | 0.0041 | 2.706 | 4.3093 | 11 | 402 | regulation of peptidase activity |
GO:0006805 | 0.0046 | 4.9212 | 1.0827 | 5 | 101 | xenobiotic metabolic process |
GO:0017144 | 0.0048 | 9.6995 | 0.343 | 3 | 32 | drug metabolic process |
GO:0002475 | 0.0049 | 23.3328 | 0.1072 | 2 | 10 | antigen processing and presentation via MHC class Ib |
GO:0030216 | 0.0053 | 6.1232 | 0.7 | 4 | 73 | keratinocyte differentiation |
GO:0006069 | 0.0059 | 20.739 | 0.1179 | 2 | 11 | ethanol oxidation |
GO:0048245 | 0.0059 | 20.739 | 0.1179 | 2 | 11 | eosinophil chemotaxis |
GO:0034754 | 0.0069 | 4.4541 | 1.1899 | 5 | 111 | cellular hormone metabolic process |
GO:0060158 | 0.007 | 18.6639 | 0.1286 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0009410 | 0.0071 | 4.4122 | 1.2006 | 5 | 112 | response to xenobiotic stimulus |
GO:0051481 | 0.0082 | 16.9661 | 0.1394 | 2 | 13 | negative regulation of cytosolic calcium ion concentration |
GO:0051967 | 0.0082 | 16.9661 | 0.1394 | 2 | 13 | negative regulation of synaptic transmission, glutamatergic |
GO:0048149 | 0.0096 | 15.5513 | 0.1501 | 2 | 14 | behavioral response to ethanol |
GO:1900003 | 0.0096 | 15.5513 | 0.1501 | 2 | 14 | regulation of serine-type endopeptidase activity |
GO:0045104 | 0.0096 | 7.398 | 0.4395 | 3 | 41 | intermediate filament cytoskeleton organization |
GO:0019730 | 0.0097 | 7.3616 | 0.4411 | 3 | 42 | antimicrobial humoral response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 305.129 | 0.3591 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 203.3677 | 0.404 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 121.9587 | 0.4937 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 44.2501 | 0.8865 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 33.5291 | 1.1333 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 29.9967 | 1.1782 | 24 | 105 | regulation of gene silencing by miRNA |
GO:0045653 | 0 | 334.4939 | 0.202 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0031497 | 0 | 22.3543 | 1.6271 | 26 | 145 | chromatin assembly |
GO:0060968 | 0 | 23.3285 | 1.4363 | 24 | 128 | regulation of gene silencing |
GO:0002244 | 0 | 16.5824 | 2.0871 | 26 | 186 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 17.4155 | 1.829 | 24 | 163 | telomere organization |
GO:0035194 | 0 | 13.4233 | 2.6145 | 27 | 233 | posttranscriptional gene silencing by RNA |
GO:0065004 | 0 | 14.0874 | 2.4013 | 26 | 214 | protein-DNA complex assembly |
GO:0048863 | 0 | 12.004 | 2.8838 | 27 | 257 | stem cell differentiation |
GO:0034080 | 0 | 51.3888 | 0.4488 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0071103 | 0 | 11.1876 | 2.9399 | 26 | 262 | DNA conformation change |
GO:0017148 | 0 | 9.831 | 3.5908 | 28 | 320 | negative regulation of translation |
GO:1904837 | 0 | 44.5257 | 0.4937 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 36.0858 | 0.5723 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 32.557 | 0.6172 | 14 | 55 | telomere capping |
GO:0030099 | 0 | 7.8735 | 4.2079 | 27 | 375 | myeloid cell differentiation |
GO:0006303 | 0 | 22.9896 | 0.8079 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 21.8547 | 0.8416 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:1903707 | 0 | 13.0228 | 1.5036 | 16 | 134 | negative regulation of hemopoiesis |
GO:1903507 | 0 | 4.1749 | 12.5789 | 42 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0038111 | 0 | 34.508 | 0.4152 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 34.508 | 0.4152 | 10 | 37 | response to interleukin-7 |
GO:0034248 | 0 | 5.572 | 6.0145 | 28 | 536 | regulation of cellular amide metabolic process |
GO:0051253 | 0 | 3.8873 | 13.4093 | 42 | 1195 | negative regulation of RNA metabolic process |
GO:0051259 | 0 | 5.368 | 5.7228 | 26 | 510 | protein oligomerization |
GO:0010558 | 0 | 3.4531 | 16.6298 | 46 | 1482 | negative regulation of macromolecule biosynthetic process |
GO:0048534 | 0 | 4.2304 | 9.3472 | 33 | 833 | hematopoietic or lymphoid organ development |
GO:0045652 | 0 | 22.0519 | 0.5799 | 10 | 56 | regulation of megakaryocyte differentiation |
GO:0010608 | 0 | 4.7302 | 6.9908 | 28 | 623 | posttranscriptional regulation of gene expression |
GO:0031327 | 0 | 3.2526 | 17.5275 | 46 | 1562 | negative regulation of cellular biosynthetic process |
GO:0034728 | 0 | 13.3367 | 1.0792 | 12 | 104 | nucleosome organization |
GO:0043043 | 0 | 4.1077 | 8.6066 | 30 | 767 | peptide biosynthetic process |
GO:0009593 | 0 | 5.2656 | 4.3538 | 20 | 388 | detection of chemical stimulus |
GO:0051248 | 0 | 3.1758 | 13.8357 | 37 | 1233 | negative regulation of protein metabolic process |
GO:0002376 | 0 | 2.5212 | 29.5453 | 59 | 2633 | immune system process |
GO:0050911 | 0 | 5.525 | 3.4898 | 17 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 4.7212 | 4.5558 | 19 | 406 | sensory perception of chemical stimulus |
GO:0006352 | 0 | 6.1111 | 2.5809 | 14 | 230 | DNA-templated transcription, initiation |
GO:0050906 | 0 | 4.5045 | 4.4885 | 18 | 400 | detection of stimulus involved in sensory perception |
GO:0006342 | 0 | 12.3769 | 0.6525 | 7 | 67 | chromatin silencing |
GO:0060249 | 0 | 4.3003 | 4.1294 | 16 | 368 | anatomical structure homeostasis |
GO:0007186 | 0 | 2.6634 | 13.2522 | 31 | 1181 | G-protein coupled receptor signaling pathway |
GO:0009892 | 0 | 2.1304 | 31.1163 | 55 | 2773 | negative regulation of metabolic process |
GO:1903706 | 0 | 4.7246 | 3.0399 | 13 | 295 | regulation of hemopoiesis |
GO:0051239 | 0 | 2.0699 | 30.4879 | 53 | 2717 | regulation of multicellular organismal process |
GO:0032268 | 0 | 2.0606 | 27.9183 | 49 | 2488 | regulation of cellular protein metabolic process |
GO:0045596 | 1e-04 | 2.967 | 7.0244 | 19 | 626 | negative regulation of cell differentiation |
GO:0070271 | 3e-04 | 2.1651 | 15.3954 | 30 | 1372 | protein complex biogenesis |
GO:0003099 | 4e-04 | 178.2147 | 0.0337 | 2 | 3 | positive regulation of the force of heart contraction by chemical signal |
GO:0071822 | 5e-04 | 2.0347 | 18.0661 | 33 | 1610 | protein complex subunit organization |
GO:0048523 | 5e-04 | 1.7735 | 39.0448 | 58 | 3740 | negative regulation of cellular process |
GO:0031424 | 5e-04 | 4.2075 | 2.3003 | 9 | 205 | keratinization |
GO:0071345 | 6e-04 | 2.399 | 9.5268 | 21 | 849 | cellular response to cytokine stimulus |
GO:0051790 | 7e-04 | 89.1017 | 0.0449 | 2 | 4 | short-chain fatty acid biosynthetic process |
GO:0072086 | 7e-04 | 89.1017 | 0.0449 | 2 | 4 | specification of loop of Henle identity |
GO:0040029 | 9e-04 | 3.5444 | 3.0272 | 10 | 310 | regulation of gene expression, epigenetic |
GO:0046641 | 0.0012 | 16.7866 | 0.2132 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
GO:0007596 | 0.0012 | 3.2027 | 3.6693 | 11 | 327 | blood coagulation |
GO:0009913 | 0.0012 | 3.2027 | 3.6693 | 11 | 327 | epidermal cell differentiation |
GO:0072047 | 0.0012 | 59.3974 | 0.0561 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0010604 | 0.0015 | 1.7069 | 32.5638 | 49 | 2902 | positive regulation of macromolecule metabolic process |
GO:0006281 | 0.0016 | 2.6576 | 5.633 | 14 | 502 | DNA repair |
GO:0002725 | 0.0018 | 44.5452 | 0.0673 | 2 | 6 | negative regulation of T cell cytokine production |
GO:0035744 | 0.0018 | 44.5452 | 0.0673 | 2 | 6 | T-helper 1 cell cytokine production |
GO:0071622 | 0.0019 | 8.3615 | 0.5274 | 4 | 47 | regulation of granulocyte chemotaxis |
GO:0006950 | 0.002 | 1.6353 | 39.9698 | 57 | 3562 | response to stress |
GO:0051716 | 0.002 | 1.5588 | 75.4848 | 95 | 6727 | cellular response to stimulus |
GO:0006355 | 0.002 | 1.6442 | 38.2193 | 55 | 3406 | regulation of transcription, DNA-templated |
GO:0097530 | 0.0021 | 4.8936 | 1.3129 | 6 | 117 | granulocyte migration |
GO:0048869 | 0.0022 | 1.6061 | 44.6041 | 62 | 3975 | cellular developmental process |
GO:2001141 | 0.0024 | 1.6275 | 38.5223 | 55 | 3433 | regulation of RNA biosynthetic process |
GO:0065003 | 0.0026 | 1.8249 | 19.2219 | 32 | 1713 | macromolecular complex assembly |
GO:0002690 | 0.0027 | 5.6369 | 0.9538 | 5 | 85 | positive regulation of leukocyte chemotaxis |
GO:0009889 | 0.0027 | 1.5778 | 47.7124 | 65 | 4252 | regulation of biosynthetic process |
GO:0003008 | 0.0028 | 1.7877 | 20.905 | 34 | 1863 | system process |
GO:0050878 | 0.003 | 2.5724 | 5.3749 | 13 | 479 | regulation of body fluid levels |
GO:0090023 | 0.0033 | 11.1854 | 0.303 | 3 | 27 | positive regulation of neutrophil chemotaxis |
GO:0018149 | 0.0033 | 7.0463 | 0.6172 | 4 | 55 | peptide cross-linking |
GO:0090281 | 0.0034 | 29.693 | 0.0898 | 2 | 8 | negative regulation of calcium ion import |
GO:1990403 | 0.0034 | 29.693 | 0.0898 | 2 | 8 | embryonic brain development |
GO:2001185 | 0.0034 | 29.693 | 0.0898 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
GO:0043588 | 0.0043 | 2.6885 | 4.3314 | 11 | 386 | skin development |
GO:0072048 | 0.0043 | 25.4496 | 0.101 | 2 | 9 | renal system pattern specification |
GO:0002385 | 0.0045 | 9.9407 | 0.3366 | 3 | 30 | mucosal immune response |
GO:0002701 | 0.0045 | 9.9407 | 0.3366 | 3 | 30 | negative regulation of production of molecular mediator of immune response |
GO:0042531 | 0.0049 | 6.3022 | 0.6845 | 4 | 61 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0042116 | 0.0052 | 6.1931 | 0.6957 | 4 | 62 | macrophage activation |
GO:0048731 | 0.0053 | 1.5213 | 48.9804 | 65 | 4365 | system development |
GO:0042535 | 0.0053 | 22.2669 | 0.1122 | 2 | 10 | positive regulation of tumor necrosis factor biosynthetic process |
GO:0048246 | 0.0059 | 8.9449 | 0.3703 | 3 | 33 | macrophage chemotaxis |
GO:1902622 | 0.0064 | 8.6558 | 0.3815 | 3 | 34 | regulation of neutrophil migration |
GO:0006959 | 0.0081 | 3.2344 | 2.2779 | 7 | 203 | humoral immune response |
GO:0019731 | 0.0088 | 7.6646 | 0.4264 | 3 | 38 | antibacterial humoral response |
GO:0045595 | 0.0088 | 1.9337 | 10.5129 | 19 | 1007 | regulation of cell differentiation |
GO:0050829 | 0.0091 | 5.2022 | 0.8191 | 4 | 73 | defense response to Gram-negative bacterium |
GO:1904064 | 0.0092 | 4.1295 | 1.2792 | 5 | 114 | positive regulation of cation transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 275.345 | 0.2415 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 61.1333 | 0.4293 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:1904837 | 0 | 40.8309 | 0.5903 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:0000183 | 0 | 50.0055 | 0.4829 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 42.3015 | 0.5366 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0051290 | 0 | 36.652 | 0.5903 | 14 | 44 | protein heterotetramerization |
GO:0034724 | 0 | 29.7046 | 0.6842 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 26.7998 | 0.7378 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 18.9241 | 0.9659 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 17.99 | 1.0061 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 16.8786 | 1.0598 | 14 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 12.3874 | 1.583 | 16 | 118 | negative regulation of gene expression, epigenetic |
GO:0060964 | 0 | 13.1055 | 1.4086 | 15 | 105 | regulation of gene silencing by miRNA |
GO:1903707 | 0 | 10.6968 | 1.7976 | 16 | 134 | negative regulation of hemopoiesis |
GO:0048863 | 0 | 7.1472 | 3.4477 | 21 | 257 | stem cell differentiation |
GO:0007389 | 0 | 5.5446 | 5.4868 | 26 | 409 | pattern specification process |
GO:1902036 | 0 | 12.5928 | 1.3549 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 10.4227 | 1.7172 | 15 | 128 | regulation of gene silencing |
GO:1902679 | 0 | 3.3141 | 15.0519 | 42 | 1122 | negative regulation of RNA biosynthetic process |
GO:0031497 | 0 | 9.0499 | 1.9452 | 15 | 145 | chromatin assembly |
GO:0009952 | 0 | 7.5435 | 2.616 | 17 | 195 | anterior/posterior pattern specification |
GO:0035194 | 0 | 6.6306 | 3.1258 | 18 | 233 | posttranscriptional gene silencing by RNA |
GO:0048704 | 0 | 11.6272 | 1.2342 | 12 | 92 | embryonic skeletal system morphogenesis |
GO:0065004 | 0 | 6.8076 | 2.8709 | 17 | 214 | protein-DNA complex assembly |
GO:0045934 | 0 | 2.9548 | 18.0569 | 45 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0006352 | 0 | 6.2898 | 3.0855 | 17 | 230 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 6.1722 | 3.1392 | 17 | 234 | regulation of myeloid cell differentiation |
GO:0002244 | 0 | 6.8619 | 2.4952 | 15 | 186 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 7.3237 | 2.1867 | 14 | 163 | telomere organization |
GO:0009890 | 0 | 2.6794 | 21.2095 | 48 | 1581 | negative regulation of biosynthetic process |
GO:0045892 | 0 | 5.1059 | 4.2319 | 19 | 335 | negative regulation of transcription, DNA-templated |
GO:0045596 | 0 | 3.6492 | 8.3979 | 27 | 626 | negative regulation of cell differentiation |
GO:0071103 | 0 | 5.457 | 3.5148 | 17 | 262 | DNA conformation change |
GO:0009792 | 0 | 3.8405 | 7.365 | 25 | 549 | embryo development ending in birth or egg hatching |
GO:0034654 | 0 | 2.085 | 54.1573 | 88 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0017148 | 0 | 4.694 | 4.2929 | 18 | 320 | negative regulation of translation |
GO:0080090 | 0 | 1.9169 | 76.5474 | 110 | 5706 | regulation of primary metabolic process |
GO:0060249 | 0 | 4.0377 | 4.9368 | 18 | 368 | anatomical structure homeostasis |
GO:0048536 | 0 | 15.1038 | 0.4829 | 6 | 36 | spleen development |
GO:0034248 | 0 | 3.2163 | 7.1906 | 21 | 536 | regulation of cellular amide metabolic process |
GO:0045944 | 0 | 2.5185 | 14.2067 | 32 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048736 | 0 | 5.3433 | 2.2672 | 11 | 169 | appendage development |
GO:0051259 | 0 | 3.2081 | 6.8418 | 20 | 510 | protein oligomerization |
GO:0035108 | 0 | 5.6656 | 1.9452 | 10 | 145 | limb morphogenesis |
GO:0048562 | 0 | 5.0661 | 2.3817 | 11 | 187 | embryonic organ morphogenesis |
GO:0010628 | 0 | 2.1627 | 20.9664 | 40 | 1664 | positive regulation of gene expression |
GO:0060255 | 0 | 1.7324 | 76.8559 | 105 | 5729 | regulation of macromolecule metabolic process |
GO:2000026 | 0 | 2.0715 | 24.0401 | 44 | 1792 | regulation of multicellular organismal development |
GO:0035113 | 1e-04 | 5.8615 | 1.6903 | 9 | 126 | embryonic appendage morphogenesis |
GO:0009893 | 1e-04 | 1.8476 | 41.9361 | 66 | 3126 | positive regulation of metabolic process |
GO:0031016 | 1e-04 | 7.6793 | 1.0196 | 7 | 76 | pancreas development |
GO:0048665 | 1e-04 | 13.4228 | 0.4427 | 5 | 33 | neuron fate specification |
GO:0097659 | 1e-04 | 1.9896 | 27.3934 | 47 | 2221 | nucleic acid-templated transcription |
GO:0010608 | 1e-04 | 2.7358 | 8.3577 | 21 | 623 | posttranscriptional regulation of gene expression |
GO:0034645 | 1e-04 | 1.7073 | 65.0505 | 91 | 4849 | cellular macromolecule biosynthetic process |
GO:0048534 | 1e-04 | 2.5201 | 10.4157 | 24 | 797 | hematopoietic or lymphoid organ development |
GO:0006325 | 2e-04 | 2.5413 | 9.4041 | 22 | 701 | chromatin organization |
GO:0050789 | 2e-04 | 1.7515 | 141.1016 | 165 | 10518 | regulation of biological process |
GO:0031323 | 2e-04 | 1.6847 | 66.2154 | 90 | 5289 | regulation of cellular metabolic process |
GO:1903508 | 3e-04 | 2.0547 | 18.2313 | 34 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0051171 | 3e-04 | 1.673 | 62.9228 | 86 | 5026 | regulation of nitrogen compound metabolic process |
GO:0051254 | 4e-04 | 2.0104 | 19.1838 | 35 | 1430 | positive regulation of RNA metabolic process |
GO:0048731 | 4e-04 | 1.671 | 53.0327 | 75 | 4125 | system development |
GO:0006281 | 4e-04 | 2.7139 | 6.7345 | 17 | 502 | DNA repair |
GO:0090596 | 5e-04 | 3.5747 | 3.3002 | 11 | 246 | sensory organ morphogenesis |
GO:0035116 | 5e-04 | 12.4714 | 0.3756 | 4 | 28 | embryonic hindlimb morphogenesis |
GO:0000122 | 5e-04 | 2.3523 | 10.1017 | 22 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0030855 | 5e-04 | 2.3984 | 9.4443 | 21 | 704 | epithelial cell differentiation |
GO:0036023 | 5e-04 | 148.4623 | 0.0402 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0055123 | 6e-04 | 4.5914 | 1.8781 | 8 | 140 | digestive system development |
GO:0051248 | 6e-04 | 2.0473 | 15.9913 | 30 | 1207 | negative regulation of protein metabolic process |
GO:0043043 | 7e-04 | 2.306 | 10.2895 | 22 | 767 | peptide biosynthetic process |
GO:1901576 | 7e-04 | 1.571 | 80.7195 | 104 | 6017 | organic substance biosynthetic process |
GO:0001709 | 7e-04 | 11.1852 | 0.4122 | 4 | 31 | cell fate determination |
GO:0021522 | 7e-04 | 11.0836 | 0.4159 | 4 | 31 | spinal cord motor neuron differentiation |
GO:0061448 | 0.0011 | 3.4418 | 3.0989 | 10 | 231 | connective tissue development |
GO:0002009 | 0.0013 | 2.5253 | 6.7613 | 16 | 504 | morphogenesis of an epithelium |
GO:0060021 | 0.0014 | 5.3121 | 1.2208 | 6 | 91 | palate development |
GO:0090304 | 0.0015 | 1.544 | 65.1713 | 86 | 4858 | nucleic acid metabolic process |
GO:0006111 | 0.0015 | 9.0649 | 0.4964 | 4 | 37 | regulation of gluconeogenesis |
GO:0035295 | 0.0015 | 2.4148 | 7.5125 | 17 | 560 | tube development |
GO:0045165 | 0.0015 | 3.5784 | 2.6797 | 9 | 205 | cell fate commitment |
GO:0042733 | 0.0015 | 6.4676 | 0.8452 | 5 | 63 | embryonic digit morphogenesis |
GO:0032682 | 0.0017 | 14.9033 | 0.2415 | 3 | 18 | negative regulation of chemokine production |
GO:0021778 | 0.0017 | 49.4811 | 0.0671 | 2 | 5 | oligodendrocyte cell fate specification |
GO:0034137 | 0.0017 | 49.4811 | 0.0671 | 2 | 5 | positive regulation of toll-like receptor 2 signaling pathway |
GO:0021510 | 0.0018 | 5.0721 | 1.2744 | 6 | 95 | spinal cord development |
GO:0007267 | 0.0019 | 1.8224 | 20.2839 | 34 | 1512 | cell-cell signaling |
GO:0042474 | 0.002 | 13.971 | 0.2549 | 3 | 19 | middle ear morphogenesis |
GO:0050678 | 0.002 | 2.9807 | 3.9173 | 11 | 292 | regulation of epithelial cell proliferation |
GO:0010557 | 0.0022 | 1.7872 | 21.29 | 35 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0065008 | 0.0024 | 1.5695 | 45.1825 | 63 | 3368 | regulation of biological quality |
GO:0048869 | 0.0025 | 1.5675 | 47.2573 | 65 | 3730 | cellular developmental process |
GO:0031328 | 0.0026 | 1.7446 | 23.0876 | 37 | 1721 | positive regulation of cellular biosynthetic process |
GO:0021902 | 0.0026 | 37.1085 | 0.0805 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:1904995 | 0.0026 | 37.1085 | 0.0805 | 2 | 6 | negative regulation of leukocyte adhesion to vascular endothelial cell |
GO:0007200 | 0.0026 | 4.6514 | 1.3818 | 6 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0021513 | 0.003 | 11.7628 | 0.2951 | 3 | 22 | spinal cord dorsal/ventral patterning |
GO:0009889 | 0.0043 | 1.6398 | 30.8528 | 45 | 2671 | regulation of biosynthetic process |
GO:0030168 | 0.0043 | 3.662 | 2.0257 | 7 | 151 | platelet activation |
GO:0048596 | 0.0044 | 10.1568 | 0.3354 | 3 | 25 | embryonic camera-type eye morphogenesis |
GO:0048546 | 0.0045 | 6.4977 | 0.6708 | 4 | 50 | digestive tract morphogenesis |
GO:0003310 | 0.0048 | 24.7358 | 0.1073 | 2 | 8 | pancreatic A cell differentiation |
GO:1900426 | 0.0048 | 24.7358 | 0.1073 | 2 | 8 | positive regulation of defense response to bacterium |
GO:0045778 | 0.0049 | 4.8658 | 1.1001 | 5 | 82 | positive regulation of ossification |
GO:0042036 | 0.0049 | 9.7146 | 0.3488 | 3 | 26 | negative regulation of cytokine biosynthetic process |
GO:0048706 | 0.0053 | 9.4269 | 0.3566 | 3 | 28 | embryonic skeletal system development |
GO:0043154 | 0.0054 | 4.742 | 1.1269 | 5 | 84 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0006355 | 0.0058 | 1.6388 | 26.9789 | 40 | 2318 | regulation of transcription, DNA-templated |
GO:0043010 | 0.006 | 2.6964 | 3.9038 | 10 | 291 | camera-type eye development |
GO:0048664 | 0.0061 | 21.2008 | 0.1207 | 2 | 9 | neuron fate determination |
GO:0060349 | 0.0063 | 4.5676 | 1.1671 | 5 | 87 | bone morphogenesis |
GO:0035270 | 0.0065 | 3.8184 | 1.6635 | 6 | 124 | endocrine system development |
GO:0007548 | 0.0067 | 2.8231 | 3.3538 | 9 | 250 | sex differentiation |
GO:0048646 | 0.0073 | 1.8374 | 13.2945 | 23 | 991 | anatomical structure formation involved in morphogenesis |
GO:0061072 | 0.0075 | 18.5495 | 0.1342 | 2 | 10 | iris morphogenesis |
GO:0035282 | 0.0079 | 4.3037 | 1.2342 | 5 | 92 | segmentation |
GO:0034641 | 0.008 | 1.4096 | 83.2818 | 101 | 6208 | cellular nitrogen compound metabolic process |
GO:0002062 | 0.0083 | 4.2546 | 1.2476 | 5 | 93 | chondrocyte differentiation |
GO:0021872 | 0.0085 | 5.334 | 0.8049 | 4 | 60 | forebrain generation of neurons |
GO:0046483 | 0.0087 | 1.4085 | 75.7827 | 93 | 5649 | heterocycle metabolic process |
GO:2001141 | 0.0088 | 1.5986 | 26.8032 | 39 | 2311 | regulation of RNA biosynthetic process |
GO:0003093 | 0.0091 | 16.4874 | 0.1476 | 2 | 11 | regulation of glomerular filtration |
GO:0009886 | 0.0091 | 16.4874 | 0.1476 | 2 | 11 | post-embryonic animal morphogenesis |
GO:0072567 | 0.0091 | 16.4874 | 0.1476 | 2 | 11 | chemokine (C-X-C motif) ligand 2 production |
GO:0051241 | 0.0096 | 1.873 | 11.3157 | 20 | 904 | negative regulation of multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007606 | 0 | 7.5839 | 4.1995 | 26 | 406 | sensory perception of chemical stimulus |
GO:0050911 | 0 | 8.2502 | 3.2168 | 22 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 7.2121 | 4.0133 | 24 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 6.2715 | 4.1374 | 22 | 400 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 3.4185 | 11.8744 | 34 | 1148 | nervous system process |
GO:0007186 | 0 | 3.0632 | 10.9673 | 29 | 1087 | G-protein coupled receptor signaling pathway |
GO:0036149 | 6e-04 | 22.4701 | 0.1655 | 3 | 16 | phosphatidylinositol acyl-chain remodeling |
GO:0006824 | 0.001 | 64.5562 | 0.0517 | 2 | 5 | cobalt ion transport |
GO:0031424 | 0.0013 | 4.0325 | 2.1204 | 8 | 205 | keratinization |
GO:0051716 | 0.0015 | 1.614 | 69.5809 | 89 | 6727 | cellular response to stimulus |
GO:0050830 | 0.0017 | 6.2937 | 0.8585 | 5 | 83 | defense response to Gram-positive bacterium |
GO:0060430 | 0.0022 | 38.7288 | 0.0724 | 2 | 7 | lung saccule development |
GO:0036152 | 0.0024 | 12.6924 | 0.2689 | 3 | 26 | phosphatidylethanolamine acyl-chain remodeling |
GO:0036151 | 0.0026 | 12.1628 | 0.2793 | 3 | 27 | phosphatidylcholine acyl-chain remodeling |
GO:0015889 | 0.0029 | 32.272 | 0.0827 | 2 | 8 | cobalamin transport |
GO:1904628 | 0.0029 | 32.272 | 0.0827 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
GO:0007218 | 0.0029 | 5.5119 | 0.9723 | 5 | 94 | neuropeptide signaling pathway |
GO:0070886 | 0.0037 | 27.6599 | 0.0931 | 2 | 9 | positive regulation of calcineurin-NFAT signaling cascade |
GO:0009954 | 0.0039 | 10.4226 | 0.3206 | 3 | 31 | proximal/distal pattern formation |
GO:0002430 | 0.0045 | 24.2009 | 0.1034 | 2 | 10 | complement receptor mediated signaling pathway |
GO:1905205 | 0.0045 | 24.2009 | 0.1034 | 2 | 10 | positive regulation of connective tissue replacement |
GO:1903244 | 0.0055 | 21.5106 | 0.1138 | 2 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0048469 | 0.0066 | 3.8057 | 1.6653 | 6 | 161 | cell maturation |
GO:0050850 | 0.007 | 8.3344 | 0.3931 | 3 | 38 | positive regulation of calcium-mediated signaling |
GO:0021520 | 0.0077 | 17.5973 | 0.1345 | 2 | 13 | spinal cord motor neuron cell fate specification |
GO:0014744 | 0.0089 | 16.1299 | 0.1448 | 2 | 14 | positive regulation of muscle adaptation |
GO:0032501 | 0.0098 | 1.4733 | 66.0523 | 81 | 6625 | multicellular organismal process |
GO:0007154 | 0.0098 | 1.4627 | 61.9164 | 77 | 5986 | cell communication |
GO:0001708 | 0.0099 | 5.069 | 0.8378 | 4 | 81 | cell fate specification |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 43.138 | 0.3531 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 36.4921 | 0.3972 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 35.1383 | 0.4082 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 35.1383 | 0.4082 | 10 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 27.8916 | 0.4855 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 16.6275 | 0.8164 | 11 | 74 | regulation of megakaryocyte differentiation |
GO:1902036 | 0 | 11.6193 | 1.1143 | 11 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0045815 | 0 | 13.7131 | 0.8716 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 9.9436 | 1.1585 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0035194 | 0 | 6.139 | 2.5707 | 14 | 233 | posttranscriptional gene silencing by RNA |
GO:0031497 | 0 | 7.7821 | 1.5998 | 11 | 145 | chromatin assembly |
GO:0045814 | 0 | 8.7394 | 1.3019 | 10 | 118 | negative regulation of gene expression, epigenetic |
GO:0002244 | 0 | 6.561 | 2.0522 | 12 | 186 | hematopoietic progenitor cell differentiation |
GO:1903706 | 0 | 4.259 | 4.7332 | 18 | 429 | regulation of hemopoiesis |
GO:0060968 | 0 | 7.9937 | 1.4122 | 10 | 128 | regulation of gene silencing |
GO:0032200 | 0 | 6.8526 | 1.7984 | 11 | 163 | telomere organization |
GO:0017148 | 0 | 4.7259 | 3.5306 | 15 | 320 | negative regulation of translation |
GO:0030099 | 0 | 4.2944 | 4.1374 | 16 | 375 | myeloid cell differentiation |
GO:0048863 | 0 | 5.0768 | 2.8355 | 13 | 257 | stem cell differentiation |
GO:0034728 | 0 | 6.494 | 1.7101 | 10 | 155 | nucleosome organization |
GO:0065004 | 0 | 5.1143 | 2.3611 | 11 | 214 | protein-DNA complex assembly |
GO:0071103 | 2e-04 | 4.1235 | 2.8907 | 11 | 262 | DNA conformation change |
GO:0034248 | 3e-04 | 2.9338 | 5.9137 | 16 | 536 | regulation of cellular amide metabolic process |
GO:0043043 | 3e-04 | 2.5794 | 8.4624 | 20 | 767 | peptide biosynthetic process |
GO:0048534 | 3e-04 | 2.4968 | 9.1906 | 21 | 833 | hematopoietic or lymphoid organ development |
GO:0045595 | 4e-04 | 2.0446 | 18.0171 | 33 | 1633 | regulation of cell differentiation |
GO:0051259 | 5e-04 | 2.8762 | 5.6269 | 15 | 510 | protein oligomerization |
GO:0009611 | 6e-04 | 2.6537 | 6.9288 | 17 | 628 | response to wounding |
GO:0008544 | 9e-04 | 2.9594 | 4.7111 | 13 | 427 | epidermis development |
GO:0007596 | 0.001 | 3.2616 | 3.6078 | 11 | 327 | blood coagulation |
GO:0010608 | 0.0015 | 2.499 | 6.8736 | 16 | 623 | posttranscriptional regulation of gene expression |
GO:0031327 | 0.0018 | 1.9105 | 17.2337 | 30 | 1562 | negative regulation of cellular biosynthetic process |
GO:0051450 | 0.002 | 13.6613 | 0.2538 | 3 | 23 | myoblast proliferation |
GO:2000112 | 0.0024 | 1.6083 | 43.0181 | 60 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0002327 | 0.0025 | 36.2552 | 0.0772 | 2 | 7 | immature B cell differentiation |
GO:0050878 | 0.0026 | 2.6203 | 5.2849 | 13 | 479 | regulation of body fluid levels |
GO:0044271 | 0.0027 | 1.569 | 52.33 | 70 | 4743 | cellular nitrogen compound biosynthetic process |
GO:0010558 | 0.0033 | 1.8635 | 16.3511 | 28 | 1482 | negative regulation of macromolecule biosynthetic process |
GO:0043588 | 0.0038 | 2.738 | 4.2588 | 11 | 386 | skin development |
GO:0045669 | 0.0038 | 6.7709 | 0.6399 | 4 | 58 | positive regulation of osteoblast differentiation |
GO:1903506 | 0.0044 | 1.5845 | 37.7994 | 53 | 3426 | regulation of nucleic acid-templated transcription |
GO:0002430 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | complement receptor mediated signaling pathway |
GO:0006600 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | creatine metabolic process |
GO:0009629 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | response to gravity |
GO:0043097 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | pyrimidine nucleoside salvage |
GO:1905065 | 0.0051 | 22.6552 | 0.1103 | 2 | 10 | positive regulation of vascular smooth muscle cell differentiation |
GO:0043094 | 0.0056 | 9.1017 | 0.3641 | 3 | 33 | cellular metabolic compound salvage |
GO:0032774 | 0.0074 | 1.5299 | 39.653 | 54 | 3594 | RNA biosynthetic process |
GO:0045892 | 0.0087 | 1.8677 | 12.004 | 21 | 1088 | negative regulation of transcription, DNA-templated |
GO:1901576 | 0.0096 | 1.4465 | 66.3862 | 82 | 6017 | organic substance biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 237.9242 | 0.2765 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 52.8249 | 0.4915 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 43.2094 | 0.5529 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 36.5524 | 0.6143 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0051290 | 0 | 31.6707 | 0.6758 | 14 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 31.6707 | 0.6758 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 25.6675 | 0.7833 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 23.1574 | 0.8447 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 16.3521 | 1.1058 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:1903507 | 0 | 3.504 | 17.217 | 50 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0043044 | 0 | 15.545 | 1.1519 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 14.5846 | 1.2133 | 14 | 79 | positive regulation of gene expression, epigenetic |
GO:1903707 | 0 | 9.9351 | 2.058 | 17 | 134 | negative regulation of hemopoiesis |
GO:1902036 | 0 | 11.8461 | 1.5512 | 15 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0051253 | 0 | 3.261 | 18.3535 | 50 | 1195 | negative regulation of RNA metabolic process |
GO:0060964 | 0 | 11.3167 | 1.6127 | 15 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 9 | 1.9659 | 15 | 128 | regulation of gene silencing |
GO:0048863 | 0 | 6.4564 | 3.3926 | 19 | 226 | stem cell differentiation |
GO:0002244 | 0 | 6.8552 | 2.8567 | 17 | 186 | hematopoietic progenitor cell differentiation |
GO:0006352 | 0 | 5.7957 | 3.5325 | 18 | 230 | DNA-templated transcription, initiation |
GO:0006355 | 0 | 2.1697 | 52.3113 | 90 | 3406 | regulation of transcription, DNA-templated |
GO:2001141 | 0 | 2.1475 | 52.726 | 90 | 3433 | regulation of RNA biosynthetic process |
GO:0031497 | 0 | 7.2061 | 2.227 | 14 | 145 | chromatin assembly |
GO:0009890 | 0 | 2.4984 | 24.2819 | 52 | 1581 | negative regulation of biosynthetic process |
GO:0045596 | 0 | 3.3742 | 9.3217 | 28 | 614 | negative regulation of cell differentiation |
GO:0032200 | 0 | 6.3282 | 2.5034 | 14 | 163 | telomere organization |
GO:0009952 | 0 | 5.6257 | 2.9949 | 15 | 195 | anterior/posterior pattern specification |
GO:0035194 | 0 | 4.9874 | 3.5785 | 16 | 233 | posttranscriptional gene silencing by RNA |
GO:0045637 | 0 | 4.9642 | 3.5939 | 16 | 234 | regulation of myeloid cell differentiation |
GO:0065004 | 0 | 5.0824 | 3.2867 | 15 | 214 | protein-DNA complex assembly |
GO:0007389 | 0 | 3.8164 | 5.8011 | 20 | 385 | pattern specification process |
GO:0045944 | 0 | 2.556 | 16.2647 | 37 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0034654 | 0 | 1.8573 | 62.0026 | 94 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0019219 | 0 | 1.8273 | 61.1425 | 92 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0032501 | 0 | 1.8031 | 88.7459 | 120 | 6312 | multicellular organismal process |
GO:2000113 | 0 | 2.4215 | 16.1583 | 35 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
GO:0000122 | 0 | 2.6664 | 11.565 | 28 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048731 | 0 | 1.888 | 47.9172 | 75 | 3323 | system development |
GO:0003206 | 0 | 5.9789 | 1.8584 | 10 | 121 | cardiac chamber morphogenesis |
GO:0051172 | 0 | 1.9434 | 36.0927 | 61 | 2350 | negative regulation of nitrogen compound metabolic process |
GO:0002682 | 0 | 2.1978 | 20.8416 | 41 | 1357 | regulation of immune system process |
GO:0060415 | 0 | 7.6502 | 1.1826 | 8 | 77 | muscle tissue morphogenesis |
GO:0050877 | 0 | 2.2608 | 17.6316 | 36 | 1148 | nervous system process |
GO:0048534 | 0 | 2.4886 | 12.7937 | 29 | 833 | hematopoietic or lymphoid organ development |
GO:0017148 | 0 | 3.5401 | 4.9147 | 16 | 320 | negative regulation of translation |
GO:0071103 | 1e-04 | 3.7779 | 4.0239 | 14 | 262 | DNA conformation change |
GO:0060249 | 1e-04 | 3.262 | 5.652 | 17 | 368 | anatomical structure homeostasis |
GO:0048869 | 1e-04 | 1.7361 | 58.1487 | 85 | 3894 | cellular developmental process |
GO:1904746 | 1e-04 | 64.8926 | 0.0922 | 3 | 6 | negative regulation of apoptotic process involved in development |
GO:0043009 | 1e-04 | 3.053 | 6.389 | 18 | 425 | chordate embryonic development |
GO:0003231 | 1e-04 | 5.4572 | 1.8123 | 9 | 118 | cardiac ventricle development |
GO:0048636 | 1e-04 | 7.4217 | 1.0597 | 7 | 69 | positive regulation of muscle organ development |
GO:0007498 | 1e-04 | 5.4073 | 1.8277 | 9 | 119 | mesoderm development |
GO:1901863 | 1e-04 | 7.3035 | 1.0751 | 7 | 70 | positive regulation of muscle tissue development |
GO:0007218 | 1e-04 | 6.1313 | 1.4437 | 8 | 94 | neuropeptide signaling pathway |
GO:1903508 | 1e-04 | 2.0634 | 20.8723 | 39 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0009593 | 1e-04 | 3.0821 | 5.9591 | 17 | 388 | detection of chemical stimulus |
GO:0048562 | 1e-04 | 3.5316 | 4.285 | 14 | 279 | embryonic organ morphogenesis |
GO:0031324 | 1e-04 | 1.8026 | 38.4118 | 61 | 2501 | negative regulation of cellular metabolic process |
GO:0007369 | 1e-04 | 4.2963 | 2.7799 | 11 | 181 | gastrulation |
GO:0051259 | 1e-04 | 2.7605 | 7.8329 | 20 | 510 | protein oligomerization |
GO:0050906 | 2e-04 | 2.9832 | 6.1434 | 17 | 400 | detection of stimulus involved in sensory perception |
GO:0001763 | 2e-04 | 4.1245 | 2.8874 | 11 | 188 | morphogenesis of a branching structure |
GO:0010002 | 2e-04 | 17.3632 | 0.2918 | 4 | 19 | cardioblast differentiation |
GO:0007606 | 2e-04 | 2.9361 | 6.2356 | 17 | 406 | sensory perception of chemical stimulus |
GO:0033278 | 2e-04 | 38.9306 | 0.1229 | 3 | 8 | cell proliferation in midbrain |
GO:0007492 | 2e-04 | 6.4772 | 1.198 | 7 | 78 | endoderm development |
GO:0007493 | 2e-04 | Inf | 0.0307 | 2 | 2 | endodermal cell fate determination |
GO:1902257 | 2e-04 | Inf | 0.0307 | 2 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
GO:2000026 | 3e-04 | 1.9157 | 24.2488 | 42 | 1637 | regulation of multicellular organismal development |
GO:0001714 | 3e-04 | 32.4401 | 0.1382 | 3 | 9 | endodermal cell fate specification |
GO:0030917 | 3e-04 | 32.4401 | 0.1382 | 3 | 9 | midbrain-hindbrain boundary development |
GO:0051254 | 3e-04 | 1.9485 | 21.9628 | 39 | 1430 | positive regulation of RNA metabolic process |
GO:0021532 | 3e-04 | 9.6036 | 0.599 | 5 | 39 | neural tube patterning |
GO:0050911 | 3e-04 | 3.1446 | 4.7765 | 14 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0048754 | 4e-04 | 4.432 | 2.1963 | 9 | 143 | branching morphogenesis of an epithelial tube |
GO:1902337 | 4e-04 | 27.804 | 0.1536 | 3 | 10 | regulation of apoptotic process involved in morphogenesis |
GO:0007187 | 4e-04 | 3.9839 | 2.7031 | 10 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0006342 | 4e-04 | 6.8302 | 0.9724 | 6 | 67 | chromatin silencing |
GO:0035295 | 4e-04 | 2.4966 | 8.6008 | 20 | 560 | tube development |
GO:0009893 | 4e-04 | 1.6559 | 48.0109 | 70 | 3126 | positive regulation of metabolic process |
GO:0010628 | 5e-04 | 1.8639 | 24.2162 | 41 | 1664 | positive regulation of gene expression |
GO:0003148 | 5e-04 | 12.3975 | 0.384 | 4 | 25 | outflow tract septum morphogenesis |
GO:0035282 | 5e-04 | 5.4055 | 1.413 | 7 | 92 | segmentation |
GO:0021521 | 5e-04 | 24.327 | 0.1689 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0019233 | 6e-04 | 5.3423 | 1.4283 | 7 | 93 | sensory perception of pain |
GO:0010629 | 6e-04 | 1.911 | 21.2124 | 37 | 1448 | negative regulation of gene expression |
GO:0060255 | 6e-04 | 1.5382 | 87.9893 | 113 | 5729 | regulation of macromolecule metabolic process |
GO:0048663 | 6e-04 | 6.3349 | 1.0444 | 6 | 68 | neuron fate commitment |
GO:0010557 | 6e-04 | 1.8409 | 24.3741 | 41 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0035987 | 7e-04 | 7.9604 | 0.7065 | 5 | 46 | endodermal cell differentiation |
GO:0055025 | 7e-04 | 7.9604 | 0.7065 | 5 | 46 | positive regulation of cardiac muscle tissue development |
GO:0002877 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | regulation of acute inflammatory response to non-antigenic stimulus |
GO:0021524 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | visceral motor neuron differentiation |
GO:0048936 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060913 | 7e-04 | 129.2675 | 0.0461 | 2 | 3 | cardiac cell fate determination |
GO:0010454 | 7e-04 | 21.6226 | 0.1843 | 3 | 12 | negative regulation of cell fate commitment |
GO:0065007 | 8e-04 | 1.6334 | 170.4802 | 193 | 11100 | biological regulation |
GO:0021536 | 8e-04 | 6.0413 | 1.0905 | 6 | 71 | diencephalon development |
GO:0055010 | 8e-04 | 7.5891 | 0.7372 | 5 | 48 | ventricular cardiac muscle tissue morphogenesis |
GO:0003151 | 8e-04 | 7.5318 | 0.7414 | 5 | 49 | outflow tract morphogenesis |
GO:0031328 | 9e-04 | 1.7797 | 26.4321 | 43 | 1721 | positive regulation of cellular biosynthetic process |
GO:0048934 | 9e-04 | 19.4591 | 0.1997 | 3 | 13 | peripheral nervous system neuron differentiation |
GO:0048608 | 0.001 | 3.5132 | 3.0412 | 10 | 203 | reproductive structure development |
GO:0032725 | 0.0011 | 17.689 | 0.215 | 3 | 14 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0043388 | 0.0013 | 6.7964 | 0.814 | 5 | 53 | positive regulation of DNA binding |
GO:0061047 | 0.0014 | 64.6296 | 0.0614 | 2 | 4 | positive regulation of branching involved in lung morphogenesis |
GO:0072095 | 0.0014 | 64.6296 | 0.0614 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:1904954 | 0.0014 | 64.6296 | 0.0614 | 2 | 4 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation |
GO:0060581 | 0.0014 | 16.2138 | 0.2304 | 3 | 15 | cell fate commitment involved in pattern specification |
GO:0008015 | 0.0015 | 2.4067 | 7.5103 | 17 | 489 | blood circulation |
GO:0040019 | 0.0016 | 8.973 | 0.5068 | 4 | 33 | positive regulation of embryonic development |
GO:0060795 | 0.0017 | 15.1381 | 0.243 | 3 | 16 | cell fate commitment involved in formation of primary germ layer |
GO:0021515 | 0.0017 | 8.7748 | 0.5163 | 4 | 34 | cell differentiation in spinal cord |
GO:0007548 | 0.0017 | 3.0424 | 3.8396 | 11 | 250 | sex differentiation |
GO:0060850 | 0.0017 | 14.9657 | 0.2457 | 3 | 16 | regulation of transcription involved in cell fate commitment |
GO:0009790 | 0.0019 | 2.1042 | 11.1627 | 22 | 756 | embryo development |
GO:2000826 | 0.002 | 8.393 | 0.5376 | 4 | 35 | regulation of heart morphogenesis |
GO:0021514 | 0.0021 | 13.8958 | 0.2611 | 3 | 17 | ventral spinal cord interneuron differentiation |
GO:1904948 | 0.0021 | 13.8958 | 0.2611 | 3 | 17 | midbrain dopaminergic neuron differentiation |
GO:2000738 | 0.0021 | 13.8958 | 0.2611 | 3 | 17 | positive regulation of stem cell differentiation |
GO:0001892 | 0.0021 | 4.9039 | 1.3208 | 6 | 86 | embryonic placenta development |
GO:0048286 | 0.0022 | 8.1302 | 0.5529 | 4 | 36 | lung alveolus development |
GO:0007507 | 0.0022 | 2.3155 | 7.7868 | 17 | 507 | heart development |
GO:0007519 | 0.0022 | 3.7 | 2.3038 | 8 | 150 | skeletal muscle tissue development |
GO:0014032 | 0.0023 | 5.9288 | 0.9215 | 5 | 60 | neural crest cell development |
GO:0045110 | 0.0023 | 43.0837 | 0.0768 | 2 | 5 | intermediate filament bundle assembly |
GO:0061743 | 0.0023 | 43.0837 | 0.0768 | 2 | 5 | motor learning |
GO:0072179 | 0.0023 | 43.0837 | 0.0768 | 2 | 5 | nephric duct formation |
GO:0048706 | 0.0025 | 4.0588 | 1.843 | 7 | 120 | embryonic skeletal system development |
GO:0014855 | 0.0026 | 5.72 | 0.9522 | 5 | 62 | striated muscle cell proliferation |
GO:0071542 | 0.0028 | 12.2989 | 0.2885 | 3 | 19 | dopaminergic neuron differentiation |
GO:0001710 | 0.0029 | 12.1573 | 0.2918 | 3 | 19 | mesodermal cell fate commitment |
GO:0060602 | 0.0029 | 12.1573 | 0.2918 | 3 | 19 | branch elongation of an epithelium |
GO:0001707 | 0.0029 | 5.5701 | 0.9754 | 5 | 64 | mesoderm formation |
GO:0001657 | 0.0031 | 4.5073 | 1.4283 | 6 | 93 | ureteric bud development |
GO:0072001 | 0.0031 | 2.8038 | 4.1468 | 11 | 270 | renal system development |
GO:0016202 | 0.0032 | 3.8856 | 1.9198 | 7 | 125 | regulation of striated muscle tissue development |
GO:0007186 | 0.0032 | 1.9193 | 13.8987 | 25 | 937 | G-protein coupled receptor signaling pathway |
GO:0042472 | 0.0033 | 4.4558 | 1.4437 | 6 | 94 | inner ear morphogenesis |
GO:0072163 | 0.0033 | 4.4558 | 1.4437 | 6 | 94 | mesonephric epithelium development |
GO:0007417 | 0.0033 | 1.9391 | 13.1623 | 24 | 857 | central nervous system development |
GO:0072010 | 0.0034 | 11.4414 | 0.3072 | 3 | 20 | glomerular epithelium development |
GO:0003180 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | aortic valve morphogenesis |
GO:0003278 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0021546 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | rhombomere development |
GO:0061218 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | negative regulation of mesonephros development |
GO:0086073 | 0.0034 | 32.3107 | 0.0922 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0050794 | 0.0034 | 1.4847 | 141.9913 | 162 | 9769 | regulation of cellular process |
GO:0048729 | 0.0035 | 2.267 | 7.4642 | 16 | 499 | tissue morphogenesis |
GO:0008406 | 0.0037 | 3.1145 | 3.0564 | 9 | 199 | gonad development |
GO:0031290 | 0.0039 | 10.8051 | 0.3225 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0034248 | 0.0039 | 2.182 | 8.2322 | 17 | 536 | regulation of cellular amide metabolic process |
GO:1901576 | 0.0041 | 1.4214 | 92.4126 | 113 | 6017 | organic substance biosynthetic process |
GO:0048699 | 0.0042 | 1.7265 | 20.4576 | 33 | 1332 | generation of neurons |
GO:0048646 | 0.0043 | 1.8479 | 14.9674 | 26 | 982 | anatomical structure formation involved in morphogenesis |
GO:0021513 | 0.0044 | 10.2358 | 0.3379 | 3 | 22 | spinal cord dorsal/ventral patterning |
GO:0001826 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | inner cell mass cell differentiation |
GO:0048341 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | paraxial mesoderm formation |
GO:0060687 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | regulation of branching involved in prostate gland morphogenesis |
GO:2000328 | 0.0047 | 25.8469 | 0.1075 | 2 | 7 | regulation of T-helper 17 cell lineage commitment |
GO:0090304 | 0.0047 | 1.4299 | 74.612 | 94 | 4858 | nucleic acid metabolic process |
GO:0001708 | 0.0047 | 4.9229 | 1.0929 | 5 | 72 | cell fate specification |
GO:0090596 | 0.0048 | 2.7896 | 3.7782 | 10 | 246 | sensory organ morphogenesis |
GO:0007517 | 0.0049 | 2.6304 | 4.4055 | 11 | 294 | muscle organ development |
GO:0031018 | 0.0049 | 6.3419 | 0.6911 | 4 | 45 | endocrine pancreas development |
GO:0007193 | 0.0053 | 4.7914 | 1.1212 | 5 | 73 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0072132 | 0.0053 | 6.1905 | 0.7065 | 4 | 46 | mesenchyme morphogenesis |
GO:0007267 | 0.0053 | 1.6608 | 23.2222 | 36 | 1512 | cell-cell signaling |
GO:0021871 | 0.0057 | 9.2597 | 0.3686 | 3 | 24 | forebrain regionalization |
GO:0060914 | 0.0057 | 9.2597 | 0.3686 | 3 | 24 | heart formation |
GO:0000003 | 0.0058 | 1.6991 | 20.089 | 32 | 1308 | reproduction |
GO:0040008 | 0.0061 | 2.0317 | 9.338 | 18 | 608 | regulation of growth |
GO:0060677 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | ureteric bud elongation |
GO:0061303 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | cornea development in camera-type eye |
GO:0071420 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | cellular response to histamine |
GO:0072217 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | negative regulation of metanephros development |
GO:1990403 | 0.0062 | 21.5377 | 0.1229 | 2 | 8 | embryonic brain development |
GO:0021545 | 0.0062 | 5.9083 | 0.7372 | 4 | 48 | cranial nerve development |
GO:0050885 | 0.0062 | 5.9083 | 0.7372 | 4 | 48 | neuromuscular process controlling balance |
GO:0046483 | 0.0063 | 1.3983 | 86.7606 | 106 | 5649 | heterocycle metabolic process |
GO:0060571 | 0.0064 | 8.8383 | 0.384 | 3 | 25 | morphogenesis of an epithelial fold |
GO:1905207 | 0.0067 | 5.7767 | 0.7526 | 4 | 49 | regulation of cardiocyte differentiation |
GO:0021517 | 0.0069 | 8.5519 | 0.3949 | 3 | 26 | ventral spinal cord development |
GO:0016331 | 0.0071 | 3.3182 | 2.227 | 7 | 145 | morphogenesis of embryonic epithelium |
GO:0060045 | 0.0072 | 8.4535 | 0.3993 | 3 | 26 | positive regulation of cardiac muscle cell proliferation |
GO:0048546 | 0.0072 | 5.6507 | 0.7679 | 4 | 50 | digestive tract morphogenesis |
GO:0048762 | 0.0076 | 2.9787 | 2.826 | 8 | 184 | mesenchymal cell differentiation |
GO:0055017 | 0.0077 | 4.3422 | 1.2287 | 5 | 80 | cardiac muscle tissue growth |
GO:0006725 | 0.0078 | 1.3844 | 87.3135 | 106 | 5685 | cellular aromatic compound metabolic process |
GO:0001574 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | ganglioside biosynthetic process |
GO:0003139 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | secondary heart field specification |
GO:0003149 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | membranous septum morphogenesis |
GO:0021603 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | cranial nerve formation |
GO:0061004 | 0.0079 | 18.4597 | 0.1382 | 2 | 9 | pattern specification involved in kidney development |
GO:0045995 | 0.0081 | 4.2926 | 1.2414 | 5 | 82 | regulation of embryonic development |
GO:0061053 | 0.0082 | 4.2848 | 1.244 | 5 | 81 | somite development |
GO:2000242 | 0.0083 | 5.4146 | 0.7986 | 4 | 52 | negative regulation of reproductive process |
GO:0010591 | 0.0088 | 7.7762 | 0.43 | 3 | 28 | regulation of lamellipodium assembly |
GO:0022602 | 0.009 | 4.1744 | 1.2748 | 5 | 83 | ovulation cycle process |
GO:0060429 | 0.0092 | 1.713 | 16.6946 | 27 | 1104 | epithelium development |
GO:0030510 | 0.0095 | 4.1213 | 1.2901 | 5 | 84 | regulation of BMP signaling pathway |
GO:0010092 | 0.0097 | 7.4766 | 0.4454 | 3 | 29 | specification of animal organ identity |
GO:0031128 | 0.0097 | 7.4766 | 0.4454 | 3 | 29 | developmental induction |
GO:0002430 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | complement receptor mediated signaling pathway |
GO:0002934 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | desmosome organization |
GO:0046838 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | phosphorylated carbohydrate dephosphorylation |
GO:0060502 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | epithelial cell proliferation involved in lung morphogenesis |
GO:0060947 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
GO:0061072 | 0.0097 | 16.1512 | 0.1536 | 2 | 10 | iris morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 306.3278 | 0.2189 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 68.0123 | 0.3892 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 55.6323 | 0.4378 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 47.0615 | 0.4865 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0051290 | 0 | 40.7763 | 0.5351 | 14 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 40.7763 | 0.5351 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 33.0471 | 0.6202 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 29.8154 | 0.6689 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 21.0536 | 0.8756 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 20.0144 | 0.9121 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 18.7779 | 0.9608 | 14 | 79 | positive regulation of gene expression, epigenetic |
GO:0016441 | 0 | 8.859 | 2.8458 | 21 | 234 | posttranscriptional gene silencing |
GO:0031047 | 0 | 7.9838 | 3.1255 | 21 | 257 | gene silencing by RNA |
GO:1903707 | 0 | 11.9139 | 1.6296 | 16 | 134 | negative regulation of hemopoiesis |
GO:0034249 | 0 | 6.6806 | 4.0619 | 23 | 334 | negative regulation of cellular amide metabolic process |
GO:1902036 | 0 | 14.0098 | 1.2283 | 14 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 13.3906 | 1.277 | 14 | 105 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 11.7071 | 1.4351 | 14 | 118 | negative regulation of gene expression, epigenetic |
GO:0031497 | 0 | 10.0739 | 1.7634 | 15 | 145 | chromatin assembly |
GO:0060968 | 0 | 10.6733 | 1.5567 | 14 | 128 | regulation of gene silencing |
GO:0002244 | 0 | 8.2422 | 2.262 | 16 | 186 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 8.8385 | 1.9823 | 15 | 163 | telomere organization |
GO:0048863 | 0 | 6.6409 | 3.1255 | 18 | 257 | stem cell differentiation |
GO:0006352 | 0 | 7.0095 | 2.7971 | 17 | 230 | DNA-templated transcription, initiation |
GO:0065004 | 0 | 7.0639 | 2.6026 | 16 | 214 | protein-DNA complex assembly |
GO:0045596 | 0 | 4.0916 | 7.6131 | 27 | 626 | negative regulation of cell differentiation |
GO:0071103 | 0 | 6.0814 | 3.1863 | 17 | 262 | DNA conformation change |
GO:0045637 | 0 | 5.9459 | 2.8458 | 15 | 234 | regulation of myeloid cell differentiation |
GO:0045892 | 0 | 2.8565 | 13.2317 | 33 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 2.761 | 13.6452 | 33 | 1122 | negative regulation of RNA biosynthetic process |
GO:0060249 | 0 | 4.2159 | 4.4754 | 17 | 368 | anatomical structure homeostasis |
GO:0032269 | 0 | 2.6134 | 14.3384 | 33 | 1179 | negative regulation of cellular protein metabolic process |
GO:1901566 | 0 | 2.2743 | 23.0621 | 45 | 1922 | organonitrogen compound biosynthetic process |
GO:0043604 | 0 | 2.8266 | 10.2643 | 26 | 844 | amide biosynthetic process |
GO:0006412 | 0 | 2.9529 | 9.036 | 24 | 743 | translation |
GO:0048869 | 0 | 1.8743 | 48.3419 | 74 | 3975 | cellular developmental process |
GO:0045934 | 0 | 2.3398 | 16.3694 | 34 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0032501 | 0 | 1.7991 | 83.0629 | 111 | 6830 | multicellular organismal process |
GO:0006518 | 0 | 2.626 | 10.9818 | 26 | 903 | peptide metabolic process |
GO:0048513 | 0 | 1.9003 | 38.7343 | 62 | 3185 | animal organ development |
GO:0048519 | 1e-04 | 1.7413 | 58.5819 | 83 | 4817 | negative regulation of biological process |
GO:0010605 | 1e-04 | 1.9013 | 30.8902 | 51 | 2540 | negative regulation of macromolecule metabolic process |
GO:0070370 | 1e-04 | Inf | 0.0243 | 2 | 2 | cellular heat acclimation |
GO:0051259 | 2e-04 | 2.9739 | 6.2024 | 17 | 510 | protein oligomerization |
GO:2000026 | 2e-04 | 2.0102 | 21.7934 | 39 | 1792 | regulation of multicellular organismal development |
GO:0006281 | 4e-04 | 2.8246 | 6.1051 | 16 | 502 | DNA repair |
GO:0070434 | 4e-04 | 164.1354 | 0.0365 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 4e-04 | 164.1354 | 0.0365 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0035195 | 5e-04 | 5.4719 | 1.3858 | 7 | 122 | gene silencing by miRNA |
GO:0009408 | 7e-04 | 4.5057 | 1.9094 | 8 | 157 | response to heat |
GO:0014706 | 0.0011 | 3.0448 | 4.2079 | 12 | 346 | striated muscle tissue development |
GO:0003241 | 0.0014 | 54.7049 | 0.0608 | 2 | 5 | growth involved in heart morphogenesis |
GO:0042816 | 0.0014 | 54.7049 | 0.0608 | 2 | 5 | vitamin B6 metabolic process |
GO:1903672 | 0.002 | 13.7347 | 0.2554 | 3 | 21 | positive regulation of sprouting angiogenesis |
GO:0003160 | 0.0021 | 41.026 | 0.073 | 2 | 6 | endocardium morphogenesis |
GO:0046533 | 0.0021 | 41.026 | 0.073 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0060956 | 0.0021 | 41.026 | 0.073 | 2 | 6 | endocardial cell differentiation |
GO:0009218 | 0.0023 | 13.011 | 0.2676 | 3 | 22 | pyrimidine ribonucleotide metabolic process |
GO:0003158 | 0.0025 | 4.7126 | 1.3621 | 6 | 112 | endothelium development |
GO:0051246 | 0.0025 | 1.6554 | 32.3374 | 48 | 2659 | regulation of protein metabolic process |
GO:0042692 | 0.0025 | 2.7421 | 4.6457 | 12 | 382 | muscle cell differentiation |
GO:0045662 | 0.0026 | 12.3597 | 0.2797 | 3 | 23 | negative regulation of myoblast differentiation |
GO:0045686 | 0.0026 | 12.3597 | 0.2797 | 3 | 23 | negative regulation of glial cell differentiation |
GO:0042026 | 0.003 | 11.7704 | 0.2919 | 3 | 24 | protein refolding |
GO:0060538 | 0.0032 | 3.869 | 1.9215 | 7 | 158 | skeletal muscle organ development |
GO:0046134 | 0.0033 | 11.2347 | 0.304 | 3 | 25 | pyrimidine nucleoside biosynthetic process |
GO:0060836 | 0.0039 | 27.3472 | 0.0973 | 2 | 8 | lymphatic endothelial cell differentiation |
GO:0070424 | 0.0039 | 27.3472 | 0.0973 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:1903265 | 0.0039 | 27.3472 | 0.0973 | 2 | 8 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0070271 | 0.0046 | 1.809 | 16.6856 | 28 | 1372 | protein complex biogenesis |
GO:0048731 | 0.0046 | 1.9822 | 12.2002 | 22 | 1180 | system development |
GO:0006221 | 0.0046 | 9.8846 | 0.3405 | 3 | 28 | pyrimidine nucleotide biosynthetic process |
GO:0006228 | 0.005 | 23.439 | 0.1095 | 2 | 9 | UTP biosynthetic process |
GO:0031652 | 0.005 | 23.439 | 0.1095 | 2 | 9 | positive regulation of heat generation |
GO:0090370 | 0.005 | 23.439 | 0.1095 | 2 | 9 | negative regulation of cholesterol efflux |
GO:0006325 | 0.0053 | 2.1166 | 8.5252 | 17 | 701 | chromatin organization |
GO:0046131 | 0.0056 | 9.1513 | 0.3648 | 3 | 30 | pyrimidine ribonucleoside metabolic process |
GO:0007565 | 0.0063 | 3.3921 | 2.1769 | 7 | 179 | female pregnancy |
GO:0042246 | 0.0064 | 5.7991 | 0.7419 | 4 | 61 | tissue regeneration |
GO:0033554 | 0.0071 | 1.6624 | 22.1339 | 34 | 1820 | cellular response to stress |
GO:0006183 | 0.0075 | 18.228 | 0.1338 | 2 | 11 | GTP biosynthetic process |
GO:0046689 | 0.0075 | 18.228 | 0.1338 | 2 | 11 | response to mercury ion |
GO:0090084 | 0.0075 | 18.228 | 0.1338 | 2 | 11 | negative regulation of inclusion body assembly |
GO:0009058 | 0.0075 | 1.4392 | 74.0026 | 91 | 6085 | biosynthetic process |
GO:0072525 | 0.008 | 7.9684 | 0.4135 | 3 | 34 | pyridine-containing compound biosynthetic process |
GO:0048754 | 0.0081 | 3.639 | 1.7391 | 6 | 143 | branching morphogenesis of an epithelial tube |
GO:0035914 | 0.0085 | 5.3297 | 0.8027 | 4 | 66 | skeletal muscle cell differentiation |
GO:0031327 | 0.0086 | 2.4342 | 4.7768 | 11 | 440 | negative regulation of cellular biosynthetic process |
GO:0006068 | 0.009 | 16.4042 | 0.1459 | 2 | 12 | ethanol catabolic process |
GO:0010666 | 0.009 | 16.4042 | 0.1459 | 2 | 12 | positive regulation of cardiac muscle cell apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 309.0784 | 0.4062 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 303.1538 | 0.3611 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 121.1692 | 0.4965 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 53.3484 | 0.8914 | 27 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 33.8423 | 1.3315 | 29 | 118 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 37.4356 | 1.1397 | 27 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 35.5068 | 1.1848 | 27 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 27.3809 | 1.4443 | 27 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 23.4108 | 1.6362 | 27 | 145 | chromatin assembly |
GO:0045653 | 0 | 332.4578 | 0.2031 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0035194 | 0 | 16.0366 | 2.6291 | 31 | 233 | posttranscriptional gene silencing by RNA |
GO:0002244 | 0 | 18.2042 | 2.0988 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0017148 | 0 | 11.6246 | 3.6108 | 32 | 320 | negative regulation of translation |
GO:0065004 | 0 | 14.7075 | 2.4147 | 27 | 214 | protein-DNA complex assembly |
GO:0032200 | 0 | 17.3027 | 1.8393 | 24 | 163 | telomere organization |
GO:0048863 | 0 | 12.503 | 2.8999 | 28 | 257 | stem cell differentiation |
GO:0071103 | 0 | 11.6673 | 2.9564 | 27 | 262 | DNA conformation change |
GO:0034080 | 0 | 51.076 | 0.4514 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 44.2546 | 0.4965 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0038111 | 0 | 51.0788 | 0.4175 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 51.0788 | 0.4175 | 13 | 37 | response to interleukin-7 |
GO:0034724 | 0 | 35.8662 | 0.5755 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 32.3588 | 0.6206 | 14 | 55 | telomere capping |
GO:0050911 | 0 | 9.1743 | 3.5093 | 26 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0030099 | 0 | 8.1886 | 4.2314 | 28 | 375 | myeloid cell differentiation |
GO:0034248 | 0 | 6.55 | 6.0481 | 32 | 536 | regulation of cellular amide metabolic process |
GO:0045652 | 0 | 31.0724 | 0.5834 | 13 | 56 | regulation of megakaryocyte differentiation |
GO:0006303 | 0 | 22.8496 | 0.8124 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0050906 | 0 | 7.2854 | 4.5135 | 27 | 400 | detection of stimulus involved in sensory perception |
GO:0043044 | 0 | 21.7217 | 0.8463 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0009593 | 0 | 7.187 | 4.3781 | 26 | 388 | detection of chemical stimulus |
GO:0010608 | 0 | 5.5539 | 7.0298 | 32 | 623 | posttranscriptional regulation of gene expression |
GO:0051259 | 0 | 6.1054 | 5.7548 | 29 | 510 | protein oligomerization |
GO:0007606 | 0 | 6.8386 | 4.5812 | 26 | 406 | sensory perception of chemical stimulus |
GO:0034728 | 0 | 14.6069 | 1.0857 | 13 | 104 | nucleosome organization |
GO:0043043 | 0 | 4.4235 | 8.6547 | 32 | 767 | peptide biosynthetic process |
GO:1903707 | 0 | 11.0004 | 1.512 | 14 | 134 | negative regulation of hemopoiesis |
GO:0007186 | 0 | 3.3085 | 13.3262 | 37 | 1181 | G-protein coupled receptor signaling pathway |
GO:0048534 | 0 | 3.7283 | 9.3994 | 30 | 833 | hematopoietic or lymphoid organ development |
GO:0032501 | 0 | 2.6453 | 41.3458 | 72 | 4115 | multicellular organismal process |
GO:0045892 | 0 | 3.1316 | 12.2768 | 33 | 1088 | negative regulation of transcription, DNA-templated |
GO:0050877 | 0 | 3.0642 | 12.9539 | 34 | 1148 | nervous system process |
GO:1902679 | 0 | 3.0268 | 12.6605 | 33 | 1122 | negative regulation of RNA biosynthetic process |
GO:0006352 | 0 | 6.0739 | 2.5953 | 14 | 230 | DNA-templated transcription, initiation |
GO:0009890 | 0 | 2.6385 | 17.8398 | 40 | 1581 | negative regulation of biosynthetic process |
GO:0051248 | 0 | 2.8305 | 13.913 | 34 | 1233 | negative regulation of protein metabolic process |
GO:0007596 | 0 | 4.8501 | 3.6898 | 16 | 327 | blood coagulation |
GO:0045934 | 0 | 2.5666 | 15.1881 | 34 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:1903706 | 0 | 4.631 | 3.0958 | 13 | 295 | regulation of hemopoiesis |
GO:0060249 | 0 | 3.9709 | 4.1525 | 15 | 368 | anatomical structure homeostasis |
GO:0048731 | 0 | 1.9118 | 49.254 | 75 | 4365 | system development |
GO:0070271 | 1e-04 | 2.3287 | 15.4814 | 32 | 1372 | protein complex biogenesis |
GO:0009611 | 1e-04 | 2.9383 | 7.0863 | 19 | 628 | response to wounding |
GO:0050878 | 1e-04 | 3.2258 | 5.405 | 16 | 479 | regulation of body fluid levels |
GO:0001694 | 1e-04 | Inf | 0.0226 | 2 | 2 | histamine biosynthetic process |
GO:0048869 | 2e-04 | 1.8 | 44.8533 | 67 | 3975 | cellular developmental process |
GO:0006281 | 2e-04 | 3.0686 | 5.6645 | 16 | 502 | DNA repair |
GO:0065003 | 4e-04 | 2.0274 | 19.3292 | 35 | 1713 | macromolecular complex assembly |
GO:0051716 | 6e-04 | 1.6484 | 75.9065 | 98 | 6727 | cellular response to stimulus |
GO:0015671 | 6e-04 | 22.2599 | 0.1693 | 3 | 15 | oxygen transport |
GO:0045596 | 7e-04 | 2.5967 | 7.0637 | 17 | 626 | negative regulation of cell differentiation |
GO:0021853 | 7e-04 | 88.5955 | 0.0451 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
GO:0071822 | 0.0011 | 1.9448 | 18.167 | 32 | 1610 | protein complex subunit organization |
GO:0048148 | 0.0012 | 16.6907 | 0.2144 | 3 | 19 | behavioral response to cocaine |
GO:0051239 | 0.0013 | 1.7341 | 30.6582 | 47 | 2717 | regulation of multicellular organismal process |
GO:0015701 | 0.0014 | 9.1684 | 0.4852 | 4 | 43 | bicarbonate transport |
GO:0050793 | 0.0018 | 1.7563 | 26.0544 | 41 | 2309 | regulation of developmental process |
GO:0021843 | 0.0026 | 35.4315 | 0.079 | 2 | 7 | substrate-independent telencephalic tangential interneuron migration |
GO:1903506 | 0.0026 | 1.6186 | 38.6585 | 55 | 3426 | regulation of nucleic acid-templated transcription |
GO:0051252 | 0.0032 | 1.592 | 40.7686 | 57 | 3613 | regulation of RNA metabolic process |
GO:2000112 | 0.0043 | 1.5542 | 43.9957 | 60 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0021892 | 0.0043 | 25.305 | 0.1016 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0010604 | 0.0051 | 1.5988 | 32.7457 | 47 | 2902 | positive regulation of macromolecule metabolic process |
GO:0021548 | 0.0054 | 22.1404 | 0.1128 | 2 | 10 | pons development |
GO:0070328 | 0.0055 | 9.2011 | 0.3611 | 3 | 32 | triglyceride homeostasis |
GO:0071345 | 0.0075 | 1.9977 | 9.58 | 18 | 849 | cellular response to cytokine stimulus |
GO:0052803 | 0.0078 | 17.7101 | 0.1354 | 2 | 12 | imidazole-containing compound metabolic process |
GO:0060158 | 0.0078 | 17.7101 | 0.1354 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0007618 | 0.0089 | 7.6208 | 0.4288 | 3 | 38 | mating |
GO:0060134 | 0.0091 | 16.0991 | 0.1467 | 2 | 13 | prepulse inhibition |
GO:0015872 | 0.0096 | 7.4087 | 0.4401 | 3 | 39 | dopamine transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 244.4611 | 0.4353 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 162.9326 | 0.4897 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 97.7098 | 0.5985 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 35.4517 | 1.0747 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 25.4801 | 1.4283 | 25 | 105 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 23.1458 | 1.6052 | 26 | 118 | negative regulation of gene expression, epigenetic |
GO:0045653 | 0 | 271.2241 | 0.2449 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:1902036 | 0 | 25.2871 | 1.3739 | 24 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 19.7613 | 1.7412 | 25 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 17.8633 | 1.9725 | 26 | 145 | chromatin assembly |
GO:0048863 | 0 | 11.9236 | 3.4961 | 32 | 257 | stem cell differentiation |
GO:0002244 | 0 | 13.921 | 2.5302 | 27 | 186 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 14.7164 | 2.2173 | 25 | 163 | telomere organization |
GO:0035194 | 0 | 11.2231 | 3.1696 | 28 | 233 | posttranscriptional gene silencing by RNA |
GO:0034080 | 0 | 46.6634 | 0.5441 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:0065004 | 0 | 11.2572 | 2.9111 | 26 | 214 | protein-DNA complex assembly |
GO:0071103 | 0 | 9.8139 | 3.5641 | 28 | 262 | DNA conformation change |
GO:0034724 | 0 | 32.3824 | 0.6938 | 15 | 51 | DNA replication-independent nucleosome organization |
GO:1904837 | 0 | 36.1034 | 0.5985 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0043044 | 0 | 21.1498 | 1.0202 | 16 | 75 | ATP-dependent chromatin remodeling |
GO:0017148 | 0 | 7.8351 | 4.3531 | 28 | 320 | negative regulation of translation |
GO:0016233 | 0 | 26.3987 | 0.7482 | 14 | 55 | telomere capping |
GO:0030099 | 0 | 6.8608 | 5.1012 | 29 | 375 | myeloid cell differentiation |
GO:0006303 | 0 | 20.4247 | 0.9794 | 15 | 72 | double-strand break repair via nonhomologous end joining |
GO:0038111 | 0 | 32.2627 | 0.5033 | 11 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 32.2627 | 0.5033 | 11 | 37 | response to interleukin-7 |
GO:0051259 | 0 | 5.0986 | 6.9377 | 30 | 510 | protein oligomerization |
GO:1902679 | 0 | 3.5608 | 15.2629 | 45 | 1122 | negative regulation of RNA biosynthetic process |
GO:1903707 | 0 | 10.5351 | 1.8228 | 16 | 134 | negative regulation of hemopoiesis |
GO:0048534 | 0 | 3.9895 | 11.3316 | 38 | 833 | hematopoietic or lymphoid organ development |
GO:0045892 | 0 | 3.579 | 14.8004 | 44 | 1088 | negative regulation of transcription, DNA-templated |
GO:0034248 | 0 | 4.4407 | 7.2914 | 28 | 536 | regulation of cellular amide metabolic process |
GO:0045652 | 0 | 17.6673 | 0.7134 | 10 | 56 | regulation of megakaryocyte differentiation |
GO:0009890 | 0 | 2.8524 | 21.5068 | 51 | 1581 | negative regulation of biosynthetic process |
GO:0045934 | 0 | 2.987 | 18.3101 | 46 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0010608 | 0 | 3.7697 | 8.4749 | 28 | 623 | posttranscriptional regulation of gene expression |
GO:0034728 | 0 | 9.6642 | 1.3212 | 11 | 104 | nucleosome organization |
GO:0097659 | 0 | 2.1684 | 48.6862 | 83 | 3579 | nucleic acid-templated transcription |
GO:0045596 | 0 | 3.5908 | 8.5157 | 27 | 626 | negative regulation of cell differentiation |
GO:0051252 | 0 | 2.1416 | 49.1488 | 83 | 3613 | regulation of RNA metabolic process |
GO:0031326 | 0 | 2.0928 | 56.9435 | 92 | 4186 | regulation of cellular biosynthetic process |
GO:0002376 | 0 | 2.1926 | 35.8175 | 65 | 2633 | immune system process |
GO:0034654 | 0 | 2.036 | 54.9166 | 88 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0006352 | 0 | 5.3603 | 3.1288 | 15 | 230 | DNA-templated transcription, initiation |
GO:0010556 | 0 | 2.0274 | 54.3044 | 87 | 3992 | regulation of macromolecule biosynthetic process |
GO:0070271 | 0 | 2.521 | 18.6637 | 41 | 1372 | protein complex biogenesis |
GO:0051248 | 0 | 2.583 | 16.7729 | 38 | 1233 | negative regulation of protein metabolic process |
GO:0043043 | 0 | 3.0063 | 10.4337 | 28 | 767 | peptide biosynthetic process |
GO:0048869 | 0 | 1.9873 | 49.3945 | 79 | 3730 | cellular developmental process |
GO:0060249 | 0 | 3.976 | 5.006 | 18 | 368 | anatomical structure homeostasis |
GO:0009952 | 0 | 5.3456 | 2.4817 | 12 | 184 | anterior/posterior pattern specification |
GO:0090191 | 0 | 220.5701 | 0.0544 | 3 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0080090 | 0 | 1.7942 | 77.6205 | 108 | 5706 | regulation of primary metabolic process |
GO:0010604 | 0 | 1.9442 | 39.4768 | 65 | 2902 | positive regulation of macromolecule metabolic process |
GO:0050878 | 0 | 3.262 | 6.3775 | 19 | 473 | regulation of body fluid levels |
GO:0009790 | 0 | 2.5456 | 12.6239 | 29 | 928 | embryo development |
GO:0048518 | 0 | 1.7721 | 71.8935 | 101 | 5285 | positive regulation of biological process |
GO:0007389 | 0 | 3.7962 | 4.3141 | 15 | 326 | pattern specification process |
GO:0007596 | 0 | 3.6707 | 4.4483 | 15 | 327 | blood coagulation |
GO:0021978 | 0 | 74.184 | 0.0809 | 3 | 6 | telencephalon regionalization |
GO:0065003 | 1e-04 | 2.0813 | 23.3025 | 43 | 1713 | macromolecular complex assembly |
GO:0071822 | 1e-04 | 2.1033 | 21.9013 | 41 | 1610 | protein complex subunit organization |
GO:0010467 | 1e-04 | 1.6954 | 69.5401 | 96 | 5112 | gene expression |
GO:0048519 | 2e-04 | 1.6901 | 63.833 | 89 | 4765 | negative regulation of biological process |
GO:0035107 | 2e-04 | 4.9629 | 1.9725 | 9 | 145 | appendage morphogenesis |
GO:0007166 | 2e-04 | 1.8086 | 35.287 | 56 | 2594 | cell surface receptor signaling pathway |
GO:0061217 | 3e-04 | 14.7559 | 0.3265 | 4 | 24 | regulation of mesonephros development |
GO:0048701 | 3e-04 | 9.492 | 0.5985 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0009611 | 4e-04 | 2.5259 | 8.5429 | 20 | 628 | response to wounding |
GO:0032330 | 4e-04 | 9.0278 | 0.6258 | 5 | 46 | regulation of chondrocyte differentiation |
GO:0010463 | 4e-04 | 8.8123 | 0.6394 | 5 | 47 | mesenchymal cell proliferation |
GO:0003337 | 5e-04 | 24.4953 | 0.1632 | 3 | 12 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0048505 | 5e-04 | 24.4953 | 0.1632 | 3 | 12 | regulation of timing of cell differentiation |
GO:0060173 | 5e-04 | 4.212 | 2.299 | 9 | 169 | limb development |
GO:0060441 | 5e-04 | 12.2934 | 0.3809 | 4 | 28 | epithelial tube branching involved in lung morphogenesis |
GO:0009946 | 5e-04 | 146.3628 | 0.0408 | 2 | 3 | proximal/distal axis specification |
GO:0060688 | 6e-04 | 8.2233 | 0.6802 | 5 | 50 | regulation of morphogenesis of a branching structure |
GO:0032268 | 8e-04 | 1.7205 | 33.845 | 52 | 2488 | regulation of cellular protein metabolic process |
GO:0016331 | 8e-04 | 4.358 | 1.9725 | 8 | 145 | morphogenesis of embryonic epithelium |
GO:0034645 | 9e-04 | 1.5724 | 65.9624 | 88 | 4849 | cellular macromolecule biosynthetic process |
GO:0090304 | 9e-04 | 1.5681 | 66.0849 | 88 | 4858 | nucleic acid metabolic process |
GO:0021764 | 0.0011 | 73.1767 | 0.0544 | 2 | 4 | amygdala development |
GO:0060235 | 0.0011 | 73.1767 | 0.0544 | 2 | 4 | lens induction in camera-type eye |
GO:0061325 | 0.0011 | 73.1767 | 0.0544 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0007420 | 0.0013 | 2.3238 | 8.7469 | 19 | 643 | brain development |
GO:0071345 | 0.0013 | 2.1399 | 11.5492 | 23 | 849 | cellular response to cytokine stimulus |
GO:0006281 | 0.0014 | 2.4976 | 6.8289 | 16 | 502 | DNA repair |
GO:0090185 | 0.0015 | 15.742 | 0.2313 | 3 | 17 | negative regulation of kidney development |
GO:0048729 | 0.0016 | 2.326 | 8.2572 | 18 | 607 | tissue morphogenesis |
GO:0030326 | 0.0017 | 5.1195 | 1.2636 | 6 | 94 | embryonic limb morphogenesis |
GO:0072077 | 0.0017 | 14.6916 | 0.2449 | 3 | 18 | renal vesicle morphogenesis |
GO:0035609 | 0.0018 | 48.7814 | 0.068 | 2 | 5 | C-terminal protein deglutamylation |
GO:0060455 | 0.0018 | 48.7814 | 0.068 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0051171 | 0.0019 | 1.5595 | 61.6187 | 81 | 5026 | regulation of nitrogen compound metabolic process |
GO:0001667 | 0.002 | 2.8198 | 4.5163 | 12 | 332 | ameboidal-type cell migration |
GO:0001710 | 0.002 | 13.7725 | 0.2585 | 3 | 19 | mesodermal cell fate commitment |
GO:0048557 | 0.002 | 13.7725 | 0.2585 | 3 | 19 | embryonic digestive tract morphogenesis |
GO:0048562 | 0.0021 | 3.725 | 2.2858 | 8 | 175 | embryonic organ morphogenesis |
GO:0001501 | 0.0022 | 2.4658 | 6.4616 | 15 | 475 | skeletal system development |
GO:0030183 | 0.0022 | 4.8351 | 1.3331 | 6 | 98 | B cell differentiation |
GO:0043009 | 0.0022 | 2.6623 | 5.1845 | 13 | 390 | chordate embryonic development |
GO:0060562 | 0.0023 | 3.6896 | 2.3068 | 8 | 173 | epithelial tube morphogenesis |
GO:0065007 | 0.0024 | 1.5901 | 150.9967 | 170 | 11100 | biological regulation |
GO:0072078 | 0.0025 | 5.775 | 0.9386 | 5 | 69 | nephron tubule morphogenesis |
GO:2000026 | 0.0025 | 1.8784 | 16.7708 | 29 | 1363 | regulation of multicellular organismal development |
GO:0021902 | 0.0027 | 36.5837 | 0.0816 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0060179 | 0.0027 | 36.5837 | 0.0816 | 2 | 6 | male mating behavior |
GO:0090186 | 0.0027 | 36.5837 | 0.0816 | 2 | 6 | regulation of pancreatic juice secretion |
GO:0015701 | 0.0027 | 7.558 | 0.5849 | 4 | 43 | bicarbonate transport |
GO:0061138 | 0.0027 | 3.5683 | 2.3806 | 8 | 175 | morphogenesis of a branching epithelium |
GO:0021536 | 0.0028 | 5.5993 | 0.9658 | 5 | 71 | diencephalon development |
GO:0055123 | 0.0031 | 3.9103 | 1.9045 | 7 | 140 | digestive system development |
GO:1901576 | 0.0031 | 1.4725 | 81.8511 | 102 | 6017 | organic substance biosynthetic process |
GO:1901360 | 0.0034 | 1.4676 | 80.1371 | 100 | 5891 | organic cyclic compound metabolic process |
GO:0003253 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0021796 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | cerebral cortex regionalization |
GO:0021798 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | forebrain dorsal/ventral pattern formation |
GO:0072161 | 0.0037 | 29.2651 | 0.0952 | 2 | 7 | mesenchymal cell differentiation involved in kidney development |
GO:0048762 | 0.0037 | 3.3839 | 2.503 | 8 | 184 | mesenchymal cell differentiation |
GO:0031016 | 0.0038 | 5.2033 | 1.0339 | 5 | 76 | pancreas development |
GO:0048704 | 0.0038 | 6.8409 | 0.6397 | 4 | 48 | embryonic skeletal system morphogenesis |
GO:0048856 | 0.0039 | 2.7687 | 4.322 | 11 | 455 | anatomical structure development |
GO:0060485 | 0.004 | 6.7269 | 0.6495 | 4 | 49 | mesenchyme development |
GO:0007492 | 0.0042 | 5.0601 | 1.0611 | 5 | 78 | endoderm development |
GO:0009798 | 0.0045 | 4.9711 | 1.0784 | 5 | 80 | axis specification |
GO:1903706 | 0.0045 | 2.8166 | 3.7486 | 10 | 295 | regulation of hemopoiesis |
GO:0048596 | 0.0046 | 10.0125 | 0.3401 | 3 | 25 | embryonic camera-type eye morphogenesis |
GO:0060571 | 0.0046 | 10.0125 | 0.3401 | 3 | 25 | morphogenesis of an epithelial fold |
GO:0072273 | 0.0046 | 10.0125 | 0.3401 | 3 | 25 | metanephric nephron morphogenesis |
GO:0030334 | 0.0046 | 2.0519 | 9.8216 | 19 | 722 | regulation of cell migration |
GO:0002118 | 0.0049 | 24.386 | 0.1088 | 2 | 8 | aggressive behavior |
GO:0072205 | 0.0049 | 24.386 | 0.1088 | 2 | 8 | metanephric collecting duct development |
GO:0021846 | 0.0051 | 9.5766 | 0.3537 | 3 | 26 | cell proliferation in forebrain |
GO:0021915 | 0.0053 | 3.5106 | 2.1085 | 7 | 155 | neural tube development |
GO:0072359 | 0.0054 | 1.8895 | 12.9504 | 23 | 952 | circulatory system development |
GO:2000242 | 0.0054 | 6.1373 | 0.7074 | 4 | 52 | negative regulation of reproductive process |
GO:0007498 | 0.0057 | 3.9312 | 1.6188 | 6 | 119 | mesoderm development |
GO:0051270 | 0.0058 | 1.9339 | 11.522 | 21 | 847 | regulation of cellular component movement |
GO:0009954 | 0.0062 | 8.8919 | 0.3775 | 3 | 28 | proximal/distal pattern formation |
GO:0046483 | 0.0063 | 1.4274 | 76.8451 | 95 | 5649 | heterocycle metabolic process |
GO:0045165 | 0.0065 | 2.8417 | 3.3328 | 9 | 245 | cell fate commitment |
GO:0048513 | 0.0065 | 1.7768 | 17.2361 | 28 | 1609 | animal organ development |
GO:0051716 | 0.0066 | 1.4166 | 91.5095 | 110 | 6727 | cellular response to stimulus |
GO:0090596 | 0.0066 | 2.8295 | 3.3464 | 9 | 246 | sensory organ morphogenesis |
GO:0060993 | 0.0067 | 4.5021 | 1.1835 | 5 | 87 | kidney morphogenesis |
GO:0009953 | 0.0067 | 4.4885 | 1.1866 | 5 | 88 | dorsal/ventral pattern formation |
GO:0061326 | 0.0073 | 4.3944 | 1.2107 | 5 | 89 | renal tubule development |
GO:0060021 | 0.008 | 4.2916 | 1.2379 | 5 | 91 | palate development |
GO:0072175 | 0.0081 | 3.6391 | 1.7412 | 6 | 128 | epithelial tube formation |
GO:0048546 | 0.0081 | 7.9677 | 0.4164 | 3 | 31 | digestive tract morphogenesis |
GO:0007275 | 0.0083 | 1.6259 | 26.9087 | 39 | 2541 | multicellular organism development |
GO:0014020 | 0.0084 | 4.242 | 1.2515 | 5 | 92 | primary neural tube formation |
GO:0001893 | 0.0084 | 7.864 | 0.4217 | 3 | 31 | maternal placenta development |
GO:0030858 | 0.0085 | 5.3538 | 0.8026 | 4 | 59 | positive regulation of epithelial cell differentiation |
GO:0048645 | 0.0085 | 5.3538 | 0.8026 | 4 | 59 | animal organ formation |
GO:0060393 | 0.0085 | 5.3538 | 0.8026 | 4 | 59 | regulation of pathway-restricted SMAD protein phosphorylation |
GO:0048870 | 0.0085 | 1.6821 | 19.0446 | 30 | 1400 | cell motility |
GO:0034641 | 0.0089 | 1.3987 | 84.4493 | 102 | 6208 | cellular nitrogen compound metabolic process |
GO:0021872 | 0.009 | 5.2579 | 0.8162 | 4 | 60 | forebrain generation of neurons |
GO:0060675 | 0.009 | 5.2579 | 0.8162 | 4 | 60 | ureteric bud morphogenesis |
GO:0001655 | 0.0091 | 2.5285 | 4.149 | 10 | 305 | urogenital system development |
GO:0035115 | 0.0092 | 7.5923 | 0.4353 | 3 | 32 | embryonic forelimb morphogenesis |
GO:0021903 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | rostrocaudal neural tube patterning |
GO:0061308 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | cardiac neural crest cell development involved in heart development |
GO:0071223 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | cellular response to lipoteichoic acid |
GO:0090009 | 0.0093 | 16.2543 | 0.1496 | 2 | 11 | primitive streak formation |
GO:0045595 | 0.0094 | 1.8499 | 12.0771 | 21 | 983 | regulation of cell differentiation |
GO:0045944 | 0.0097 | 1.7662 | 14.4059 | 24 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0006355 | 0.0098 | 1.5851 | 26.9789 | 39 | 2318 | regulation of transcription, DNA-templated |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 37.4322 | 0.4032 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 27.5754 | 0.5544 | 11 | 44 | protein heterotetramerization |
GO:0000183 | 0 | 31.6653 | 0.4536 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 30.4906 | 0.4662 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 30.4906 | 0.4662 | 10 | 37 | response to interleukin-7 |
GO:0045652 | 0 | 12.833 | 0.9324 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 11.8992 | 0.9954 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 10.0743 | 1.2726 | 11 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 8.6283 | 1.323 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0007596 | 0 | 4.602 | 4.1203 | 17 | 327 | blood coagulation |
GO:0032200 | 0 | 6.5594 | 2.0538 | 12 | 163 | telomere organization |
GO:0071310 | 0 | 2.2315 | 29.3587 | 55 | 2330 | cellular response to organic substance |
GO:0031497 | 0 | 6.7473 | 1.827 | 11 | 145 | chromatin assembly |
GO:0045814 | 0 | 7.5834 | 1.4868 | 10 | 118 | negative regulation of gene expression, epigenetic |
GO:0002244 | 0 | 5.684 | 2.3437 | 12 | 186 | hematopoietic progenitor cell differentiation |
GO:0034728 | 0 | 6.2747 | 1.953 | 11 | 155 | nucleosome organization |
GO:0048863 | 0 | 4.7779 | 3.2383 | 14 | 257 | stem cell differentiation |
GO:0060968 | 0 | 6.9363 | 1.6128 | 10 | 128 | regulation of gene silencing |
GO:0051259 | 0 | 3.4414 | 6.4262 | 20 | 510 | protein oligomerization |
GO:0002376 | 0 | 2.0754 | 33.1766 | 58 | 2633 | immune system process |
GO:0050878 | 0 | 3.4702 | 6.0355 | 19 | 479 | regulation of body fluid levels |
GO:0009611 | 0 | 3.0716 | 7.913 | 22 | 628 | response to wounding |
GO:0030099 | 0 | 3.7081 | 4.7251 | 16 | 375 | myeloid cell differentiation |
GO:0035194 | 0 | 4.4617 | 2.9359 | 12 | 233 | posttranscriptional gene silencing by RNA |
GO:0048534 | 1e-04 | 2.627 | 10.4961 | 25 | 833 | hematopoietic or lymphoid organ development |
GO:0065004 | 1e-04 | 4.4342 | 2.6965 | 11 | 214 | protein-DNA complex assembly |
GO:1903706 | 1e-04 | 3.2119 | 5.4055 | 16 | 429 | regulation of hemopoiesis |
GO:0071103 | 1e-04 | 3.9368 | 3.3013 | 12 | 262 | DNA conformation change |
GO:0003165 | 2e-04 | Inf | 0.0252 | 2 | 2 | Purkinje myocyte development |
GO:0051094 | 2e-04 | 2.2047 | 15.007 | 30 | 1191 | positive regulation of developmental process |
GO:0022037 | 2e-04 | 6.3497 | 1.2096 | 7 | 96 | metencephalon development |
GO:0090023 | 3e-04 | 13.8848 | 0.3402 | 4 | 27 | positive regulation of neutrophil chemotaxis |
GO:0051248 | 4e-04 | 2.1216 | 15.5362 | 30 | 1233 | negative regulation of protein metabolic process |
GO:0002457 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | T cell antigen processing and presentation |
GO:1900138 | 5e-04 | 158.2915 | 0.0378 | 2 | 3 | negative regulation of phospholipase A2 activity |
GO:0021527 | 6e-04 | 21.6804 | 0.1764 | 3 | 14 | spinal cord association neuron differentiation |
GO:0050896 | 7e-04 | 1.6574 | 78.6759 | 100 | 6644 | response to stimulus |
GO:0017148 | 8e-04 | 3.1835 | 4.0321 | 12 | 320 | negative regulation of translation |
GO:1902622 | 8e-04 | 10.6403 | 0.4284 | 4 | 34 | regulation of neutrophil migration |
GO:0009913 | 9e-04 | 3.1113 | 4.1203 | 12 | 327 | epidermal cell differentiation |
GO:1904431 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | positive regulation of t-circle formation |
GO:0002697 | 9e-04 | 3.1013 | 4.1329 | 12 | 328 | regulation of immune effector process |
GO:0051270 | 0.001 | 2.2236 | 10.6725 | 22 | 847 | regulation of cellular component movement |
GO:0050777 | 0.0011 | 4.7398 | 1.5876 | 7 | 126 | negative regulation of immune response |
GO:0014855 | 0.0011 | 7.0238 | 0.7812 | 5 | 62 | striated muscle cell proliferation |
GO:0071294 | 0.0012 | 17.0314 | 0.2142 | 3 | 17 | cellular response to zinc ion |
GO:0031424 | 0.0012 | 3.7201 | 2.5831 | 9 | 205 | keratinization |
GO:0046649 | 0.0014 | 2.4385 | 7.4594 | 17 | 592 | lymphocyte activation |
GO:0021697 | 0.0014 | 15.8949 | 0.2268 | 3 | 18 | cerebellar cortex formation |
GO:0001819 | 0.0014 | 2.8122 | 4.9267 | 13 | 391 | positive regulation of cytokine production |
GO:0010604 | 0.0014 | 1.6643 | 36.5661 | 54 | 2902 | positive regulation of macromolecule metabolic process |
GO:0042743 | 0.0016 | 8.8635 | 0.504 | 4 | 40 | hydrogen peroxide metabolic process |
GO:0048519 | 0.0016 | 1.5771 | 56.5434 | 76 | 4614 | negative regulation of biological process |
GO:0060043 | 0.0017 | 8.6234 | 0.5166 | 4 | 41 | regulation of cardiac muscle cell proliferation |
GO:0090278 | 0.0019 | 8.3959 | 0.5292 | 4 | 42 | negative regulation of peptide hormone secretion |
GO:0045766 | 0.0019 | 4.2695 | 1.7514 | 7 | 139 | positive regulation of angiogenesis |
GO:0030334 | 0.002 | 2.2346 | 9.0974 | 19 | 722 | regulation of cell migration |
GO:0001890 | 0.002 | 4.2371 | 1.764 | 7 | 140 | placenta development |
GO:0040012 | 0.0021 | 2.1326 | 10.5591 | 21 | 838 | regulation of locomotion |
GO:0019221 | 0.0022 | 2.5678 | 5.8121 | 14 | 495 | cytokine-mediated signaling pathway |
GO:0048869 | 0.0022 | 1.5778 | 47.94 | 66 | 3878 | cellular developmental process |
GO:0002583 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | regulation of antigen processing and presentation of peptide antigen |
GO:0003278 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0010792 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | DNA double-strand break processing involved in repair via single-strand annealing |
GO:0021937 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0086073 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0051240 | 0.0024 | 2.0065 | 12.9151 | 24 | 1069 | positive regulation of multicellular organismal process |
GO:0060337 | 0.0026 | 5.7147 | 0.945 | 5 | 75 | type I interferon signaling pathway |
GO:0006952 | 0.0026 | 1.8361 | 18.3208 | 31 | 1454 | defense response |
GO:0022408 | 0.0026 | 4.0235 | 1.8522 | 7 | 147 | negative regulation of cell-cell adhesion |
GO:0071622 | 0.0029 | 7.4173 | 0.5922 | 4 | 47 | regulation of granulocyte chemotaxis |
GO:0031579 | 0.0029 | 11.9174 | 0.2898 | 3 | 23 | membrane raft organization |
GO:0046631 | 0.0029 | 4.5414 | 1.4112 | 6 | 112 | alpha-beta T cell activation |
GO:0050709 | 0.0029 | 4.5414 | 1.4112 | 6 | 112 | negative regulation of protein secretion |
GO:0012501 | 0.0032 | 1.7139 | 24.243 | 38 | 1924 | programmed cell death |
GO:0031340 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | positive regulation of vesicle fusion |
GO:0051048 | 0.0032 | 3.4687 | 2.4445 | 8 | 194 | negative regulation of secretion |
GO:0021871 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | forebrain regionalization |
GO:0002821 | 0.0034 | 5.332 | 1.008 | 5 | 80 | positive regulation of adaptive immune response |
GO:0034340 | 0.0034 | 5.332 | 1.008 | 5 | 80 | response to type I interferon |
GO:0055017 | 0.0034 | 5.332 | 1.008 | 5 | 80 | cardiac muscle tissue growth |
GO:0007165 | 0.0036 | 1.4907 | 69.2135 | 88 | 5493 | signal transduction |
GO:0030073 | 0.0036 | 3.413 | 2.4823 | 8 | 197 | insulin secretion |
GO:0050670 | 0.0036 | 3.413 | 2.4823 | 8 | 197 | regulation of lymphocyte proliferation |
GO:0043588 | 0.0037 | 2.6105 | 4.8637 | 12 | 386 | skin development |
GO:0002687 | 0.0038 | 4.2964 | 1.4868 | 6 | 118 | positive regulation of leukocyte migration |
GO:0002822 | 0.0038 | 4.2964 | 1.4868 | 6 | 118 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0032479 | 0.0038 | 4.2964 | 1.4868 | 6 | 118 | regulation of type I interferon production |
GO:0022610 | 0.004 | 1.8267 | 16.5064 | 28 | 1310 | biological adhesion |
GO:0002483 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | antigen processing and presentation of endogenous peptide antigen |
GO:0021702 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | cerebellar Purkinje cell differentiation |
GO:1900122 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | positive regulation of receptor binding |
GO:1904996 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | positive regulation of leukocyte adhesion to vascular endothelial cell |
GO:2000252 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | negative regulation of feeding behavior |
GO:2001185 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
GO:1904950 | 0.0043 | 3.3067 | 2.5579 | 8 | 203 | negative regulation of establishment of protein localization |
GO:0045595 | 0.0043 | 1.7373 | 20.5763 | 33 | 1633 | regulation of cell differentiation |
GO:0048522 | 0.0043 | 1.4929 | 59.2718 | 77 | 4704 | positive regulation of cellular process |
GO:0060706 | 0.0046 | 9.9287 | 0.3402 | 3 | 27 | cell differentiation involved in embryonic placenta development |
GO:0070663 | 0.0048 | 3.2394 | 2.6083 | 8 | 207 | regulation of leukocyte proliferation |
GO:0007159 | 0.0048 | 2.64 | 4.3975 | 11 | 349 | leukocyte cell-cell adhesion |
GO:0048518 | 0.0049 | 2.5423 | 5.0961 | 12 | 465 | positive regulation of biological process |
GO:0018149 | 0.0051 | 6.2506 | 0.693 | 4 | 55 | peptide cross-linking |
GO:0051607 | 0.0051 | 3.2068 | 2.6335 | 8 | 209 | defense response to virus |
GO:0048731 | 0.0051 | 1.4897 | 55.0003 | 72 | 4365 | system development |
GO:0050863 | 0.0052 | 2.7622 | 3.8179 | 10 | 303 | regulation of T cell activation |
GO:0048870 | 0.0053 | 1.7684 | 17.6404 | 29 | 1400 | cell motility |
GO:0061179 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | negative regulation of insulin secretion involved in cellular response to glucose stimulus |
GO:0061820 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | telomeric D-loop disassembly |
GO:0032892 | 0.0057 | 9.1638 | 0.3654 | 3 | 29 | positive regulation of organic acid transport |
GO:0050727 | 0.0063 | 2.6783 | 3.9313 | 10 | 312 | regulation of inflammatory response |
GO:0043066 | 0.0064 | 1.9876 | 10.1432 | 19 | 805 | negative regulation of apoptotic process |
GO:0021936 | 0.0067 | 19.7776 | 0.126 | 2 | 10 | regulation of cerebellar granule cell precursor proliferation |
GO:1903530 | 0.0067 | 2.1142 | 8.0012 | 16 | 635 | regulation of secretion by cell |
GO:0032835 | 0.0069 | 5.6907 | 0.756 | 4 | 60 | glomerulus development |
GO:0060420 | 0.0069 | 5.6907 | 0.756 | 4 | 60 | regulation of heart growth |
GO:0009719 | 0.0069 | 1.731 | 17.9806 | 29 | 1427 | response to endogenous stimulus |
GO:0009749 | 0.007 | 3.3268 | 2.2177 | 7 | 176 | response to glucose |
GO:0042102 | 0.007 | 4.4391 | 1.197 | 5 | 95 | positive regulation of T cell proliferation |
GO:0032101 | 0.0071 | 2.4974 | 4.6407 | 11 | 380 | regulation of response to external stimulus |
GO:0030155 | 0.0074 | 2.0896 | 8.0894 | 16 | 642 | regulation of cell adhesion |
GO:0001775 | 0.0075 | 1.7712 | 15.6874 | 26 | 1245 | cell activation |
GO:0045907 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | positive regulation of vasoconstriction |
GO:0007569 | 0.0076 | 4.342 | 1.2222 | 5 | 97 | cell aging |
GO:0007565 | 0.0076 | 3.2682 | 2.2555 | 7 | 179 | female pregnancy |
GO:0070887 | 0.0078 | 2.3733 | 5.3804 | 12 | 502 | cellular response to chemical stimulus |
GO:0051047 | 0.008 | 2.4542 | 4.7125 | 11 | 374 | positive regulation of secretion |
GO:0002791 | 0.008 | 2.3463 | 5.3803 | 12 | 427 | regulation of peptide secretion |
GO:0003161 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | cardiac conduction system development |
GO:0021681 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | cerebellar granular layer development |
GO:0043374 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | CD8-positive, alpha-beta T cell differentiation |
GO:2000774 | 0.0081 | 17.579 | 0.1386 | 2 | 11 | positive regulation of cellular senescence |
GO:0007369 | 0.0081 | 3.2302 | 2.2807 | 7 | 181 | gastrulation |
GO:0043122 | 0.0082 | 2.9398 | 2.8603 | 8 | 227 | regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0098742 | 0.0086 | 2.9128 | 2.8855 | 8 | 229 | cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0034284 | 0.0093 | 3.139 | 2.3437 | 7 | 186 | response to monosaccharide |
GO:0010035 | 0.0095 | 2.2094 | 6.1867 | 13 | 491 | response to inorganic substance |
GO:0021587 | 0.0096 | 7.4427 | 0.441 | 3 | 35 | cerebellum morphogenesis |
GO:0021692 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | cerebellar Purkinje cell layer morphogenesis |
GO:0044090 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of vacuole organization |
GO:0060670 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | branching involved in labyrinthine layer morphogenesis |
GO:0090197 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of chemokine secretion |
GO:1901298 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | regulation of hydrogen peroxide-mediated programmed cell death |
GO:0050795 | 0.0096 | 5.138 | 0.8316 | 4 | 66 | regulation of behavior |
GO:0060548 | 0.0097 | 1.8695 | 11.3277 | 20 | 899 | negative regulation of cell death |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0021675 | 0 | 11.6726 | 0.9072 | 9 | 72 | nerve development |
GO:0050877 | 0 | 2.8723 | 14.4651 | 36 | 1148 | nervous system process |
GO:0021524 | 0 | Inf | 0.0378 | 3 | 3 | visceral motor neuron differentiation |
GO:0009593 | 0 | 4.0889 | 4.8889 | 18 | 388 | detection of chemical stimulus |
GO:0050911 | 0 | 4.5313 | 3.9187 | 16 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 3.9573 | 5.0401 | 18 | 400 | detection of stimulus involved in sensory perception |
GO:0007389 | 0 | 3.864 | 5.1535 | 18 | 409 | pattern specification process |
GO:0009952 | 0 | 5.4013 | 2.4571 | 12 | 195 | anterior/posterior pattern specification |
GO:0048935 | 0 | 35.5149 | 0.1638 | 4 | 13 | peripheral nervous system neuron development |
GO:0032501 | 1e-04 | 1.8545 | 60.7209 | 85 | 5469 | multicellular organismal process |
GO:0021570 | 2e-04 | Inf | 0.0252 | 2 | 2 | rhombomere 4 development |
GO:0033555 | 2e-04 | 7.9142 | 0.8442 | 6 | 67 | multicellular organismal response to stress |
GO:0048663 | 2e-04 | 7.7861 | 0.8568 | 6 | 68 | neuron fate commitment |
GO:0007186 | 2e-04 | 2.2981 | 12.935 | 27 | 1067 | G-protein coupled receptor signaling pathway |
GO:0021559 | 3e-04 | 29.8163 | 0.1386 | 3 | 11 | trigeminal nerve development |
GO:0001501 | 3e-04 | 2.8814 | 5.9851 | 16 | 475 | skeletal system development |
GO:0021515 | 4e-04 | 8.7095 | 0.6426 | 5 | 51 | cell differentiation in spinal cord |
GO:0003203 | 5e-04 | 12.7724 | 0.3654 | 4 | 29 | endocardial cushion morphogenesis |
GO:0021520 | 5e-04 | 23.85 | 0.1638 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0001662 | 8e-04 | 11.0079 | 0.4158 | 4 | 33 | behavioral fear response |
GO:0060253 | 8e-04 | 19.8725 | 0.189 | 3 | 15 | negative regulation of glial cell proliferation |
GO:0001992 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0021615 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0070253 | 9e-04 | 79.1407 | 0.0504 | 2 | 4 | somatostatin secretion |
GO:0050789 | 0.001 | 1.6689 | 129.6137 | 150 | 10452 | regulation of biological process |
GO:0048704 | 0.0011 | 5.6047 | 1.1592 | 6 | 92 | embryonic skeletal system morphogenesis |
GO:0007268 | 0.0012 | 2.4742 | 7.3586 | 17 | 584 | chemical synaptic transmission |
GO:0007218 | 0.0012 | 5.4766 | 1.1844 | 6 | 94 | neuropeptide signaling pathway |
GO:0099537 | 0.0012 | 2.4652 | 7.3838 | 17 | 586 | trans-synaptic signaling |
GO:0045777 | 0.0013 | 9.3861 | 0.4788 | 4 | 38 | positive regulation of blood pressure |
GO:0051241 | 0.0014 | 2.0666 | 13.0791 | 25 | 1038 | negative regulation of multicellular organismal process |
GO:0048880 | 0.0015 | 52.7571 | 0.063 | 2 | 5 | sensory system development |
GO:0021983 | 0.0016 | 8.8635 | 0.504 | 4 | 40 | pituitary gland development |
GO:0098664 | 0.0019 | 14.0232 | 0.252 | 3 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0021517 | 0.0021 | 8.1801 | 0.5418 | 4 | 43 | ventral spinal cord development |
GO:0031290 | 0.0022 | 13.2433 | 0.2646 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0042310 | 0.0023 | 5.8835 | 0.9198 | 5 | 73 | vasoconstriction |
GO:0010840 | 0.0023 | 39.5653 | 0.0756 | 2 | 6 | regulation of circadian sleep/wake cycle, wakefulness |
GO:0045596 | 0.0025 | 2.2972 | 7.8878 | 17 | 626 | negative regulation of cell differentiation |
GO:0021602 | 0.0028 | 12.0375 | 0.287 | 3 | 23 | cranial nerve morphogenesis |
GO:0044062 | 0.0029 | 11.9174 | 0.2898 | 3 | 23 | regulation of excretion |
GO:0007608 | 0.0031 | 11.5639 | 0.2957 | 3 | 25 | sensory perception of smell |
GO:0050768 | 0.0032 | 3.1914 | 2.9863 | 9 | 237 | negative regulation of neurogenesis |
GO:0021612 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | facial nerve structural organization |
GO:0060052 | 0.0032 | 31.6503 | 0.0882 | 2 | 7 | neurofilament cytoskeleton organization |
GO:0035640 | 0.0033 | 11.3492 | 0.3024 | 3 | 24 | exploration behavior |
GO:0072507 | 0.0035 | 2.5179 | 5.4685 | 13 | 434 | divalent inorganic cation homeostasis |
GO:0046887 | 0.0035 | 4.3751 | 1.4616 | 6 | 116 | positive regulation of hormone secretion |
GO:0001708 | 0.0036 | 5.2615 | 1.0206 | 5 | 81 | cell fate specification |
GO:0003148 | 0.0037 | 10.8326 | 0.315 | 3 | 25 | outflow tract septum morphogenesis |
GO:0002011 | 0.0039 | 6.7843 | 0.6426 | 4 | 51 | morphogenesis of an epithelial sheet |
GO:0006874 | 0.0041 | 2.5752 | 4.9267 | 12 | 391 | cellular calcium ion homeostasis |
GO:0002118 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | aggressive behavior |
GO:0045924 | 0.0042 | 26.3735 | 0.1008 | 2 | 8 | regulation of female receptivity |
GO:0006355 | 0.0045 | 1.5398 | 42.9166 | 59 | 3406 | regulation of transcription, DNA-templated |
GO:0007267 | 0.0046 | 1.757 | 19.0517 | 31 | 1512 | cell-cell signaling |
GO:0097746 | 0.005 | 4.0419 | 1.575 | 6 | 125 | regulation of blood vessel diameter |
GO:0048857 | 0.0051 | 6.2506 | 0.693 | 4 | 55 | neural nucleus development |
GO:2001141 | 0.0053 | 1.5242 | 43.2568 | 59 | 3433 | regulation of RNA biosynthetic process |
GO:0010579 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0021561 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | facial nerve development |
GO:0021562 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | vestibulocochlear nerve development |
GO:0046549 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | retinal cone cell development |
GO:0046877 | 0.0054 | 22.6045 | 0.1134 | 2 | 9 | regulation of saliva secretion |
GO:0007417 | 0.0059 | 1.9689 | 10.7985 | 20 | 857 | central nervous system development |
GO:0009889 | 0.0062 | 1.4782 | 53.5765 | 70 | 4252 | regulation of biosynthetic process |
GO:0019098 | 0.0062 | 8.8238 | 0.378 | 3 | 30 | reproductive behavior |
GO:0051006 | 0.0067 | 19.7776 | 0.126 | 2 | 10 | positive regulation of lipoprotein lipase activity |
GO:0009790 | 0.0068 | 1.9094 | 11.6931 | 21 | 928 | embryo development |
GO:0035150 | 0.007 | 3.7555 | 1.6884 | 6 | 134 | regulation of tube size |
GO:0060193 | 0.0073 | 5.5905 | 0.7686 | 4 | 61 | positive regulation of lipase activity |
GO:0098801 | 0.0075 | 8.2142 | 0.4032 | 3 | 32 | regulation of renal system process |
GO:0051960 | 0.0075 | 1.9924 | 9.5636 | 18 | 759 | regulation of nervous system development |
GO:0080090 | 0.0075 | 1.4337 | 71.8973 | 89 | 5706 | regulation of primary metabolic process |
GO:0003156 | 0.0081 | 7.9399 | 0.4158 | 3 | 33 | regulation of animal organ formation |
GO:0051094 | 0.0082 | 1.7768 | 15.007 | 25 | 1191 | positive regulation of developmental process |
GO:0055008 | 0.0086 | 5.31 | 0.8064 | 4 | 64 | cardiac muscle tissue morphogenesis |
GO:0014013 | 0.009 | 4.16 | 1.2726 | 5 | 101 | regulation of gliogenesis |
GO:0048699 | 0.0094 | 1.7177 | 16.7836 | 27 | 1332 | generation of neurons |
GO:0031323 | 0.0094 | 1.4161 | 73.3968 | 90 | 5825 | regulation of cellular metabolic process |
GO:0035815 | 0.0096 | 15.8201 | 0.1512 | 2 | 12 | positive regulation of renal sodium excretion |
GO:0050795 | 0.0096 | 5.138 | 0.8316 | 4 | 66 | regulation of behavior |
GO:0009887 | 0.01 | 1.8362 | 12.1215 | 21 | 962 | animal organ morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 291.7407 | 0.4265 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 286.4545 | 0.3791 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 114.4945 | 0.5213 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 50.3558 | 0.936 | 27 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 31.9204 | 1.3981 | 29 | 118 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 35.3356 | 1.1967 | 27 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 33.515 | 1.244 | 27 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 25.8449 | 1.5165 | 27 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 22.0975 | 1.718 | 27 | 145 | chromatin assembly |
GO:0045653 | 0 | 315.18 | 0.2133 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0035194 | 0 | 15.1144 | 2.7606 | 31 | 233 | posttranscriptional gene silencing by RNA |
GO:0002244 | 0 | 17.1767 | 2.2037 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0017148 | 0 | 11.4069 | 3.7914 | 33 | 320 | negative regulation of translation |
GO:0048863 | 0 | 12.3496 | 3.0449 | 29 | 257 | stem cell differentiation |
GO:0065004 | 0 | 13.8824 | 2.5355 | 27 | 214 | protein-DNA complex assembly |
GO:0032200 | 0 | 16.3495 | 1.9312 | 24 | 163 | telomere organization |
GO:0071103 | 0 | 11.0128 | 3.1042 | 27 | 262 | DNA conformation change |
GO:0034080 | 0 | 48.4215 | 0.4739 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 41.9547 | 0.5213 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0038111 | 0 | 48.4392 | 0.4384 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 48.4392 | 0.4384 | 13 | 37 | response to interleukin-7 |
GO:0034724 | 0 | 34.0022 | 0.6043 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0030099 | 0 | 8.0761 | 4.443 | 29 | 375 | myeloid cell differentiation |
GO:0016233 | 0 | 30.6771 | 0.6516 | 14 | 55 | telomere capping |
GO:0050911 | 0 | 8.6627 | 3.6847 | 26 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0034248 | 0 | 6.4176 | 6.3506 | 33 | 536 | regulation of cellular amide metabolic process |
GO:0045652 | 0 | 29.3293 | 0.615 | 13 | 56 | regulation of megakaryocyte differentiation |
GO:0050906 | 0 | 7.1954 | 4.7392 | 28 | 400 | detection of stimulus involved in sensory perception |
GO:0006303 | 0 | 21.6621 | 0.8531 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0009593 | 0 | 7.1108 | 4.597 | 27 | 388 | detection of chemical stimulus |
GO:0043044 | 0 | 20.5928 | 0.8886 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0007606 | 0 | 6.7652 | 4.8103 | 27 | 406 | sensory perception of chemical stimulus |
GO:0010608 | 0 | 5.4401 | 7.3813 | 33 | 623 | posttranscriptional regulation of gene expression |
GO:0051259 | 0 | 5.7585 | 6.0425 | 29 | 510 | protein oligomerization |
GO:1903707 | 0 | 11.3329 | 1.5876 | 15 | 134 | negative regulation of hemopoiesis |
GO:0043043 | 0 | 4.3314 | 9.0874 | 33 | 767 | peptide biosynthetic process |
GO:0034728 | 0 | 13.7875 | 1.1446 | 13 | 104 | nucleosome organization |
GO:0032501 | 0 | 2.742 | 43.5219 | 77 | 4115 | multicellular organismal process |
GO:0048534 | 0 | 3.6601 | 9.8694 | 31 | 833 | hematopoietic or lymphoid organ development |
GO:0045892 | 0 | 3.1749 | 12.8907 | 35 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 0 | 3.0685 | 13.2935 | 35 | 1122 | negative regulation of RNA biosynthetic process |
GO:0009890 | 0 | 2.724 | 18.7318 | 43 | 1581 | negative regulation of biosynthetic process |
GO:0050877 | 0 | 2.9915 | 13.6016 | 35 | 1148 | nervous system process |
GO:0007186 | 0 | 2.8988 | 13.9925 | 35 | 1181 | G-protein coupled receptor signaling pathway |
GO:0006352 | 0 | 5.7581 | 2.7251 | 14 | 230 | DNA-templated transcription, initiation |
GO:0051248 | 0 | 2.7631 | 14.6086 | 35 | 1233 | negative regulation of protein metabolic process |
GO:0045934 | 0 | 2.6879 | 15.9475 | 37 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0007596 | 0 | 4.5951 | 3.8743 | 16 | 327 | blood coagulation |
GO:0048731 | 0 | 1.966 | 51.7167 | 80 | 4365 | system development |
GO:0060249 | 0 | 4.0491 | 4.3601 | 16 | 368 | anatomical structure homeostasis |
GO:1903706 | 0 | 4.3986 | 3.245 | 13 | 295 | regulation of hemopoiesis |
GO:0048869 | 0 | 1.87 | 47.096 | 72 | 3975 | cellular developmental process |
GO:0070271 | 2e-04 | 2.1938 | 16.2555 | 32 | 1372 | protein complex biogenesis |
GO:0009611 | 2e-04 | 2.7811 | 7.4406 | 19 | 628 | response to wounding |
GO:0050878 | 2e-04 | 3.0562 | 5.6752 | 16 | 479 | regulation of body fluid levels |
GO:0010604 | 3e-04 | 1.8139 | 34.383 | 54 | 2902 | positive regulation of macromolecule metabolic process |
GO:0006281 | 3e-04 | 2.9072 | 5.9477 | 16 | 502 | DNA repair |
GO:0051716 | 4e-04 | 1.6524 | 79.7018 | 103 | 6727 | cellular response to stimulus |
GO:0065003 | 4e-04 | 1.9764 | 20.2957 | 36 | 1713 | macromolecular complex assembly |
GO:0015671 | 7e-04 | 21.1707 | 0.1777 | 3 | 15 | oxygen transport |
GO:0021853 | 8e-04 | 84.2834 | 0.0474 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
GO:0015872 | 0.0011 | 9.7161 | 0.4621 | 4 | 39 | dopamine transport |
GO:0051239 | 0.0013 | 1.7179 | 32.1911 | 49 | 2717 | regulation of multicellular organismal process |
GO:0045596 | 0.0013 | 2.4594 | 7.4169 | 17 | 626 | negative regulation of cell differentiation |
GO:0048148 | 0.0014 | 15.874 | 0.2251 | 3 | 19 | behavioral response to cocaine |
GO:0050793 | 0.0015 | 1.7543 | 27.3571 | 43 | 2309 | regulation of developmental process |
GO:0015701 | 0.0016 | 8.7174 | 0.5095 | 4 | 43 | bicarbonate transport |
GO:0048518 | 0.002 | 1.5554 | 62.6169 | 82 | 5285 | positive regulation of biological process |
GO:0021546 | 0.002 | 42.1364 | 0.0711 | 2 | 6 | rhombomere development |
GO:0071822 | 0.0024 | 1.8322 | 19.0754 | 32 | 1610 | protein complex subunit organization |
GO:0021843 | 0.0028 | 33.707 | 0.0829 | 2 | 7 | substrate-independent telencephalic tangential interneuron migration |
GO:0021884 | 0.0035 | 11.0379 | 0.308 | 3 | 26 | forebrain neuron development |
GO:0014059 | 0.0039 | 10.5773 | 0.3199 | 3 | 27 | regulation of dopamine secretion |
GO:0021892 | 0.0048 | 24.0733 | 0.1066 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0021548 | 0.0059 | 21.0628 | 0.1185 | 2 | 10 | pons development |
GO:0070328 | 0.0063 | 8.7508 | 0.3791 | 3 | 32 | triglyceride homeostasis |
GO:1903506 | 0.0081 | 1.5088 | 40.5914 | 55 | 3426 | regulation of nucleic acid-templated transcription |
GO:0060158 | 0.0085 | 16.8481 | 0.1422 | 2 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0060536 | 0.0085 | 16.8481 | 0.1422 | 2 | 12 | cartilage morphogenesis |
GO:0009952 | 0.0087 | 3.1864 | 2.3104 | 7 | 195 | anterior/posterior pattern specification |
GO:2000112 | 0.0087 | 1.4807 | 46.1955 | 61 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0002376 | 0.0097 | 1.5441 | 31.1959 | 44 | 2633 | immune system process |
GO:0032268 | 0.0098 | 1.5555 | 29.4779 | 42 | 2488 | regulation of cellular protein metabolic process |
GO:0051252 | 0.0099 | 1.4823 | 42.807 | 57 | 3613 | regulation of RNA metabolic process |
GO:0060134 | 0.01 | 15.3155 | 0.154 | 2 | 13 | prepulse inhibition |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 3e-04 | 2.1387 | 16.1605 | 31 | 1465 | molecular transducer activity |
GO:0030246 | 5e-04 | 3.8676 | 2.7798 | 10 | 252 | carbohydrate binding |
GO:0099600 | 9e-04 | 2.1525 | 12.7077 | 25 | 1152 | transmembrane receptor activity |
GO:0019825 | 0.0014 | 9.1506 | 0.4854 | 4 | 44 | oxygen binding |
GO:0038023 | 0.002 | 2.0479 | 12.7383 | 24 | 1172 | signaling receptor activity |
GO:0004984 | 0.0024 | 3.0977 | 3.4306 | 10 | 311 | olfactory receptor activity |
GO:0004966 | 0.0025 | 36.2621 | 0.0772 | 2 | 7 | galanin receptor activity |
GO:0032393 | 0.0025 | 36.2621 | 0.0772 | 2 | 7 | MHC class I receptor activity |
GO:0002020 | 0.0031 | 4.4924 | 1.423 | 6 | 129 | protease binding |
GO:0001968 | 0.0032 | 11.3837 | 0.2978 | 3 | 27 | fibronectin binding |
GO:0046920 | 0.0032 | 30.2165 | 0.0882 | 2 | 8 | alpha-(1->3)-fucosyltransferase activity |
GO:0015926 | 0.0074 | 18.1253 | 0.1324 | 2 | 12 | glucosidase activity |
GO:0015026 | 0.0084 | 7.8005 | 0.4192 | 3 | 38 | coreceptor activity |
GO:0004866 | 0.0089 | 3.5576 | 1.776 | 6 | 161 | endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004601 | 1e-04 | 11.7443 | 0.4908 | 5 | 41 | peroxidase activity |
GO:0031720 | 4e-04 | 166.8042 | 0.0359 | 2 | 3 | haptoglobin binding |
GO:0016918 | 6e-04 | 22.8525 | 0.1676 | 3 | 14 | retinal binding |
GO:0019841 | 6e-04 | 22.8525 | 0.1676 | 3 | 14 | retinol binding |
GO:0004887 | 0.0029 | 33.3524 | 0.0838 | 2 | 7 | thyroid hormone receptor activity |
GO:0005507 | 0.0032 | 7.153 | 0.6105 | 4 | 51 | copper ion binding |
GO:0004866 | 0.0033 | 3.8562 | 1.9274 | 7 | 161 | endopeptidase inhibitor activity |
GO:0032052 | 0.0049 | 23.8201 | 0.1077 | 2 | 9 | bile acid binding |
GO:0019840 | 0.0077 | 8.0987 | 0.407 | 3 | 34 | isoprenoid binding |
GO:0005246 | 0.009 | 7.6069 | 0.431 | 3 | 36 | calcium channel regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 9.9025 | 6.0003 | 44 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 14.3339 | 2.3641 | 26 | 184 | histone binding |
GO:0031492 | 0 | 23.7044 | 0.5653 | 10 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 2.6441 | 29.8859 | 63 | 2326 | DNA binding |
GO:0102991 | 1e-04 | 46.7673 | 0.1028 | 3 | 8 | myristoyl-CoA hydrolase activity |
GO:0004984 | 2e-04 | 3.5108 | 3.9959 | 13 | 311 | olfactory receptor activity |
GO:0016290 | 3e-04 | 29.224 | 0.1413 | 3 | 11 | palmitoyl-CoA hydrolase activity |
GO:0000253 | 0.001 | 77.5764 | 0.0514 | 2 | 4 | 3-keto sterol reductase activity |
GO:1901363 | 0.0014 | 1.5458 | 71.9138 | 93 | 5597 | heterocyclic compound binding |
GO:0008508 | 0.0016 | 51.7143 | 0.0642 | 2 | 5 | bile acid:sodium symporter activity |
GO:0016289 | 0.0017 | 14.6046 | 0.2441 | 3 | 19 | CoA hydrolase activity |
GO:0019904 | 0.0021 | 2.2726 | 8.4544 | 18 | 658 | protein domain specific binding |
GO:0097159 | 0.0023 | 1.5117 | 72.9417 | 93 | 5677 | organic cyclic compound binding |
GO:1903231 | 0.0039 | 5.1559 | 1.0407 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004930 | 0.0053 | 2.0695 | 9.2253 | 18 | 718 | G-protein coupled receptor activity |
GO:0045296 | 0.0054 | 2.7435 | 3.8417 | 10 | 299 | cadherin binding |
GO:0003682 | 0.0083 | 2.2506 | 6.0774 | 13 | 473 | chromatin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 6.1884 | 5.4442 | 28 | 467 | protein heterodimerization activity |
GO:0004930 | 0 | 3.8728 | 8.3703 | 28 | 718 | G-protein coupled receptor activity |
GO:0004984 | 0 | 5.6592 | 3.6256 | 18 | 311 | olfactory receptor activity |
GO:0042393 | 0 | 7.4687 | 2.145 | 14 | 184 | histone binding |
GO:0003677 | 0 | 2.6702 | 14.8307 | 34 | 1346 | DNA binding |
GO:0038023 | 0 | 2.475 | 14.1059 | 31 | 1210 | signaling receptor activity |
GO:0019904 | 0 | 3.0234 | 7.6708 | 21 | 658 | protein domain specific binding |
GO:0099600 | 1e-04 | 2.409 | 13.4298 | 29 | 1152 | transmembrane receptor activity |
GO:0033872 | 1e-04 | Inf | 0.0233 | 2 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
GO:0048018 | 1e-04 | 3.2861 | 4.9546 | 15 | 425 | receptor ligand activity |
GO:0001664 | 2e-04 | 4.033 | 2.9494 | 11 | 253 | G-protein coupled receptor binding |
GO:0060089 | 4e-04 | 2.0788 | 17.0787 | 32 | 1465 | molecular transducer activity |
GO:0008201 | 0.0025 | 4.072 | 1.8303 | 7 | 157 | heparin binding |
GO:0004966 | 0.0027 | 34.2696 | 0.0816 | 2 | 7 | galanin receptor activity |
GO:0008467 | 0.0027 | 34.2696 | 0.0816 | 2 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GO:0005184 | 0.0046 | 9.9262 | 0.3381 | 3 | 29 | neuropeptide hormone activity |
GO:0031369 | 0.0046 | 9.9262 | 0.3381 | 3 | 29 | translation initiation factor binding |
GO:0043565 | 0.0051 | 1.9655 | 11.4246 | 21 | 980 | sequence-specific DNA binding |
GO:0001228 | 0.0065 | 2.5319 | 4.5815 | 11 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 21.978 | 3.5281 | 49 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 9.6758 | 8.1453 | 54 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 6.1622 | 13.0688 | 57 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 5.8291 | 13.7267 | 57 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 5.2028 | 16.6196 | 61 | 1465 | molecular transducer activity |
GO:0005549 | 0 | 25.3625 | 0.8055 | 15 | 71 | odorant binding |
GO:0031492 | 0 | 27.0726 | 0.4992 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 5.243 | 2.0874 | 10 | 184 | histone binding |
GO:0046982 | 9e-04 | 2.8353 | 5.2978 | 14 | 467 | protein heterodimerization activity |
GO:0019865 | 0.0022 | 13.2758 | 0.2609 | 3 | 23 | immunoglobulin binding |
GO:0045296 | 0.0022 | 3.1334 | 3.392 | 10 | 299 | cadherin binding |
GO:0030414 | 0.003 | 3.9259 | 1.8945 | 7 | 167 | peptidase inhibitor activity |
GO:0061135 | 0.003 | 3.9259 | 1.8945 | 7 | 167 | endopeptidase regulator activity |
GO:0004869 | 0.0033 | 7.1069 | 0.6126 | 4 | 54 | cysteine-type endopeptidase inhibitor activity |
GO:0003682 | 0.0078 | 2.3586 | 5.3659 | 12 | 473 | chromatin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 10.0925 | 5.9125 | 44 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 13.1402 | 2.3296 | 24 | 184 | histone binding |
GO:0031492 | 0 | 24.0794 | 0.5571 | 10 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 2.6386 | 29.4486 | 62 | 2326 | DNA binding |
GO:0019904 | 3e-04 | 2.6034 | 8.3307 | 20 | 658 | protein domain specific binding |
GO:0045296 | 4e-04 | 3.4035 | 3.7855 | 12 | 299 | cadherin binding |
GO:0034714 | 5e-04 | 157.52 | 0.038 | 2 | 3 | type III transforming growth factor beta receptor binding |
GO:0004583 | 9e-04 | 78.755 | 0.0506 | 2 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
GO:0030151 | 9e-04 | 78.755 | 0.0506 | 2 | 4 | molybdenum ion binding |
GO:0003682 | 0.001 | 2.6788 | 5.9885 | 15 | 473 | chromatin binding |
GO:0004459 | 0.0016 | 52.5 | 0.0633 | 2 | 5 | L-lactate dehydrogenase activity |
GO:0032027 | 0.0023 | 39.3725 | 0.076 | 2 | 6 | myosin light chain binding |
GO:0043546 | 0.0023 | 39.3725 | 0.076 | 2 | 6 | molybdopterin cofactor binding |
GO:0005114 | 0.0032 | 31.496 | 0.0886 | 2 | 7 | type II transforming growth factor beta receptor binding |
GO:1901363 | 0.0034 | 1.4933 | 70.111 | 89 | 5591 | heterocyclic compound binding |
GO:0097159 | 0.0035 | 1.4906 | 71.1142 | 90 | 5671 | organic cyclic compound binding |
GO:0030548 | 0.0067 | 19.6812 | 0.1266 | 2 | 10 | acetylcholine receptor regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.823 | 3.5866 | 28 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 4.6294 | 8.2803 | 32 | 718 | G-protein coupled receptor activity |
GO:0031492 | 0 | 26.6007 | 0.5074 | 10 | 44 | nucleosomal DNA binding |
GO:0099600 | 0 | 3.7833 | 13.2854 | 41 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 3.1738 | 16.895 | 44 | 1465 | molecular transducer activity |
GO:0038023 | 0 | 3.3332 | 12.0425 | 34 | 1083 | signaling receptor activity |
GO:0005549 | 0 | 13.0305 | 0.8188 | 9 | 71 | odorant binding |
GO:0046982 | 0 | 3.9385 | 5.3856 | 19 | 467 | protein heterodimerization activity |
GO:0042393 | 1e-04 | 5.1516 | 2.122 | 10 | 184 | histone binding |
GO:0005125 | 1e-04 | 4.7382 | 2.295 | 10 | 199 | cytokine activity |
GO:0016934 | 4e-04 | 173.2967 | 0.0346 | 2 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0030545 | 8e-04 | 2.8829 | 5.2127 | 14 | 452 | receptor regulator activity |
GO:0030345 | 8e-04 | 86.6429 | 0.0461 | 2 | 4 | structural constituent of tooth enamel |
GO:0045569 | 8e-04 | 86.6429 | 0.0461 | 2 | 4 | TRAIL binding |
GO:1903231 | 0.0024 | 5.7685 | 0.9341 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0045296 | 0.0025 | 3.0788 | 3.4482 | 10 | 299 | cadherin binding |
GO:0099589 | 0.0036 | 10.875 | 0.3114 | 3 | 27 | serotonin receptor activity |
GO:0030594 | 0.0037 | 5.2165 | 1.0264 | 5 | 89 | neurotransmitter receptor activity |
GO:0019911 | 0.0045 | 24.7473 | 0.1038 | 2 | 9 | structural constituent of myelin sheath |
GO:0005154 | 0.0064 | 8.6967 | 0.3806 | 3 | 33 | epidermal growth factor receptor binding |
GO:0004062 | 0.0081 | 17.3198 | 0.1384 | 2 | 12 | aryl sulfotransferase activity |
GO:0016594 | 0.0081 | 17.3198 | 0.1384 | 2 | 12 | glycine binding |
GO:0015026 | 0.0095 | 7.4519 | 0.4382 | 3 | 38 | coreceptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 13.0512 | 4.0739 | 39 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 6.7085 | 9.4053 | 48 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 4.7692 | 15.0904 | 55 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 4.6281 | 15.8502 | 56 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 4.1102 | 19.1905 | 60 | 1465 | molecular transducer activity |
GO:0046982 | 0 | 4.7044 | 6.1174 | 25 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 7.6871 | 2.4103 | 16 | 184 | histone binding |
GO:0005549 | 0 | 9.9079 | 0.9301 | 8 | 71 | odorant binding |
GO:0019904 | 0.0021 | 2.2695 | 8.4622 | 18 | 652 | protein domain specific binding |
GO:0055131 | 0.0025 | 38.0242 | 0.0786 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0042813 | 0.0025 | 12.7249 | 0.2751 | 3 | 21 | Wnt-activated receptor activity |
GO:0001591 | 0.0034 | 30.4174 | 0.0917 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0044183 | 0.0051 | 9.54 | 0.3537 | 3 | 27 | protein binding involved in protein folding |
GO:0031419 | 0.0058 | 21.7239 | 0.1179 | 2 | 9 | cobalamin binding |
GO:0017147 | 0.0069 | 8.4784 | 0.393 | 3 | 30 | Wnt-protein binding |
GO:0008395 | 0.0083 | 7.8927 | 0.4192 | 3 | 32 | steroid hydroxylase activity |
GO:0035240 | 0.0087 | 16.8943 | 0.1441 | 2 | 11 | dopamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 1e-04 | 9.9194 | 0.6752 | 6 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0050840 | 8e-04 | 10.6343 | 0.4168 | 4 | 50 | extracellular matrix binding |
GO:0034987 | 0.001 | 60.374 | 0.05 | 2 | 6 | immunoglobulin receptor binding |
GO:0102991 | 0.0019 | 40.2443 | 0.0667 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0005549 | 0.0029 | 7.2914 | 0.5919 | 4 | 71 | odorant binding |
GO:0016290 | 0.0036 | 26.8244 | 0.0917 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0016614 | 0.0044 | 4.9857 | 1.067 | 5 | 128 | oxidoreductase activity, acting on CH-OH group of donors |
GO:0004984 | 0.0046 | 3.2779 | 2.5925 | 8 | 311 | olfactory receptor activity |
GO:0015172 | 0.0059 | 20.1145 | 0.1167 | 2 | 14 | acidic amino acid transmembrane transporter activity |
GO:0008106 | 0.0077 | 17.2388 | 0.1334 | 2 | 16 | alcohol dehydrogenase (NADP+) activity |
GO:0004070 | 0.0083 | Inf | 0.0083 | 1 | 1 | aspartate carbamoyltransferase activity |
GO:0004151 | 0.0083 | Inf | 0.0083 | 1 | 1 | dihydroorotase activity |
GO:0008336 | 0.0083 | Inf | 0.0083 | 1 | 1 | gamma-butyrobetaine dioxygenase activity |
GO:0008859 | 0.0083 | Inf | 0.0083 | 1 | 1 | exoribonuclease II activity |
GO:0008891 | 0.0083 | Inf | 0.0083 | 1 | 1 | glycolate oxidase activity |
GO:0015327 | 0.0083 | Inf | 0.0083 | 1 | 1 | cystine:glutamate antiporter activity |
GO:0018455 | 0.0083 | Inf | 0.0083 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0019115 | 0.0083 | Inf | 0.0083 | 1 | 1 | benzaldehyde dehydrogenase activity |
GO:0031686 | 0.0083 | Inf | 0.0083 | 1 | 1 | A1 adenosine receptor binding |
GO:0031704 | 0.0083 | Inf | 0.0083 | 1 | 1 | apelin receptor binding |
GO:0045032 | 0.0083 | Inf | 0.0083 | 1 | 1 | ADP-activated adenosine receptor activity |
GO:0047963 | 0.0083 | Inf | 0.0083 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0047969 | 0.0083 | Inf | 0.0083 | 1 | 1 | glyoxylate oxidase activity |
GO:0050337 | 0.0083 | Inf | 0.0083 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0052817 | 0.0083 | Inf | 0.0083 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:0070335 | 0.0083 | Inf | 0.0083 | 1 | 1 | aspartate binding |
GO:1901680 | 0.0083 | Inf | 0.0083 | 1 | 1 | sulfur-containing amino acid secondary active transmembrane transporter activity |
GO:0004745 | 0.0086 | 16.0885 | 0.1417 | 2 | 17 | retinol dehydrogenase activity |
GO:0005149 | 0.0086 | 16.0885 | 0.1417 | 2 | 17 | interleukin-1 receptor binding |
GO:0005507 | 0.0088 | 7.5837 | 0.4251 | 3 | 51 | copper ion binding |
GO:0008157 | 0.0097 | 15.0821 | 0.15 | 2 | 18 | protein phosphatase 1 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 28.0893 | 4.6392 | 72 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 11.0159 | 10.7104 | 76 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 7.0553 | 17.1843 | 81 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 6.7984 | 18.0495 | 82 | 1210 | signaling receptor activity |
GO:0005549 | 0 | 39.9852 | 1.0591 | 25 | 71 | odorant binding |
GO:0060089 | 0 | 5.448 | 21.8533 | 82 | 1465 | molecular transducer activity |
GO:0031492 | 0 | 29.2356 | 0.6563 | 13 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 5.2527 | 2.7447 | 13 | 184 | histone binding |
GO:0046982 | 0 | 3.134 | 6.9662 | 20 | 467 | protein heterodimerization activity |
GO:0004867 | 1e-04 | 6.7143 | 1.3276 | 8 | 89 | serine-type endopeptidase inhibitor activity |
GO:0030414 | 2e-04 | 4.3469 | 2.4911 | 10 | 167 | peptidase inhibitor activity |
GO:0061135 | 2e-04 | 4.3469 | 2.4911 | 10 | 167 | endopeptidase regulator activity |
GO:0004024 | 0.0022 | 44.3898 | 0.0746 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0005134 | 0.0022 | 44.3898 | 0.0746 | 2 | 5 | interleukin-2 receptor binding |
GO:0019103 | 0.0022 | 44.3898 | 0.0746 | 2 | 5 | pyrimidine nucleotide binding |
GO:0001591 | 0.0044 | 26.6305 | 0.1044 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0048018 | 0.0048 | 2.3276 | 6.3397 | 14 | 425 | receptor ligand activity |
GO:0045296 | 0.0054 | 2.596 | 4.4602 | 11 | 299 | cadherin binding |
GO:0031628 | 0.0058 | 22.1907 | 0.1193 | 2 | 8 | opioid receptor binding |
GO:0015143 | 0.0092 | 16.6409 | 0.1492 | 2 | 10 | urate transmembrane transporter activity |
GO:0036122 | 0.0092 | 16.6409 | 0.1492 | 2 | 10 | BMP binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 16.2781 | 1.9374 | 24 | 184 | histone binding |
GO:0046982 | 0 | 6.6791 | 4.9173 | 27 | 467 | protein heterodimerization activity |
GO:0031492 | 0 | 29.3243 | 0.4633 | 10 | 44 | nucleosomal DNA binding |
GO:0004984 | 0 | 6.3457 | 3.2747 | 18 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 3.2672 | 7.5603 | 22 | 718 | G-protein coupled receptor activity |
GO:0019904 | 1e-04 | 3.0229 | 6.9285 | 19 | 658 | protein domain specific binding |
GO:0003677 | 1e-04 | 2.0348 | 24.4919 | 43 | 2326 | DNA binding |
GO:0099600 | 2e-04 | 2.384 | 12.1301 | 26 | 1152 | transmembrane receptor activity |
GO:0004522 | 7e-04 | 95.0904 | 0.0421 | 2 | 4 | ribonuclease A activity |
GO:0045296 | 7e-04 | 3.6903 | 2.9093 | 10 | 281 | cadherin binding |
GO:1901618 | 8e-04 | 10.6714 | 0.4212 | 4 | 40 | organic hydroxy compound transmembrane transporter activity |
GO:0098641 | 8e-04 | 19.1176 | 0.1895 | 3 | 18 | cadherin binding involved in cell-cell adhesion |
GO:0038023 | 9e-04 | 2.1543 | 12.7408 | 25 | 1210 | signaling receptor activity |
GO:0008508 | 0.0011 | 63.3896 | 0.0526 | 2 | 5 | bile acid:sodium symporter activity |
GO:0004993 | 0.0011 | 16.8663 | 0.2106 | 3 | 20 | G-protein coupled serotonin receptor activity |
GO:0003682 | 0.0015 | 2.7945 | 4.9805 | 13 | 473 | chromatin binding |
GO:0016894 | 0.0015 | 15.089 | 0.2317 | 3 | 22 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters |
GO:0004468 | 0.0016 | 47.5392 | 0.0632 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0016628 | 0.002 | 13.6502 | 0.2527 | 3 | 24 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor |
GO:0060089 | 0.0029 | 1.9108 | 15.4259 | 27 | 1465 | molecular transducer activity |
GO:0003723 | 0.0031 | 1.8616 | 17.058 | 29 | 1620 | RNA binding |
GO:0004859 | 0.0057 | 21.1218 | 0.1158 | 2 | 11 | phospholipase inhibitor activity |
GO:0098631 | 0.0069 | 8.4241 | 0.3896 | 3 | 37 | cell adhesion mediator activity |
GO:0008028 | 0.0097 | 7.3417 | 0.4422 | 3 | 42 | monocarboxylic acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 0.0014 | 6.544 | 0.8275 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004111 | 0.0015 | 49.0311 | 0.0613 | 2 | 6 | creatine kinase activity |
GO:0055131 | 0.0015 | 49.0311 | 0.0613 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0004129 | 0.0016 | 14.7863 | 0.235 | 3 | 23 | cytochrome-c oxidase activity |
GO:0016675 | 0.0018 | 14.0813 | 0.2452 | 3 | 24 | oxidoreductase activity, acting on a heme group of donors |
GO:0060089 | 0.0038 | 1.8929 | 14.9668 | 26 | 1465 | molecular transducer activity |
GO:0004984 | 0.0047 | 2.9975 | 3.1772 | 9 | 311 | olfactory receptor activity |
GO:0019531 | 0.0054 | 21.7847 | 0.1124 | 2 | 11 | oxalate transmembrane transporter activity |
GO:0038023 | 0.0059 | 1.918 | 12.3616 | 22 | 1210 | signaling receptor activity |
GO:0099600 | 0.0069 | 1.917 | 11.7691 | 21 | 1152 | transmembrane receptor activity |
GO:0008271 | 0.0075 | 17.8216 | 0.1328 | 2 | 13 | secondary active sulfate transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 27.2336 | 0.4964 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 5.3245 | 5.2686 | 24 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 6.4797 | 2.0758 | 12 | 184 | histone binding |
GO:0045296 | 2e-04 | 3.8547 | 3.3732 | 12 | 299 | cadherin binding |
GO:0003682 | 3e-04 | 3.0403 | 5.3363 | 15 | 473 | chromatin binding |
GO:0031720 | 4e-04 | 177.236 | 0.0338 | 2 | 3 | haptoglobin binding |
GO:0055131 | 0.0018 | 44.3006 | 0.0677 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0003677 | 0.0021 | 1.7414 | 26.2413 | 41 | 2326 | DNA binding |
GO:0042043 | 0.0026 | 35.4382 | 0.079 | 2 | 7 | neurexin family protein binding |
GO:0005125 | 0.0075 | 3.284 | 2.2451 | 7 | 199 | cytokine activity |
GO:0004062 | 0.0078 | 17.7135 | 0.1354 | 2 | 12 | aryl sulfotransferase activity |
GO:0005092 | 0.0078 | 17.7135 | 0.1354 | 2 | 12 | GDP-dissociation inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 29.2066 | 3.6451 | 60 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 11.4261 | 8.4153 | 62 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 7.3742 | 13.502 | 66 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 7.144 | 14.1818 | 67 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 6.02 | 17.1705 | 69 | 1465 | molecular transducer activity |
GO:0005549 | 0 | 16.3625 | 0.8322 | 11 | 71 | odorant binding |
GO:0048020 | 7e-04 | 11.0961 | 0.4102 | 4 | 35 | CCR chemokine receptor binding |
GO:0034875 | 8e-04 | 85.2216 | 0.0469 | 2 | 4 | caffeine oxidase activity |
GO:0008009 | 0.0017 | 8.5945 | 0.5157 | 4 | 44 | chemokine activity |
GO:0005198 | 0.0022 | 2.3221 | 7.8293 | 17 | 668 | structural molecule activity |
GO:0001591 | 0.0028 | 34.0822 | 0.082 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0030414 | 0.0036 | 3.7936 | 1.9573 | 7 | 167 | peptidase inhibitor activity |
GO:0061135 | 0.0036 | 3.7936 | 1.9573 | 7 | 167 | endopeptidase regulator activity |
GO:0046790 | 0.0037 | 28.4 | 0.0938 | 2 | 8 | virion binding |
GO:0004867 | 0.0039 | 5.1295 | 1.0431 | 5 | 89 | serine-type endopeptidase inhibitor activity |
GO:0042056 | 0.0046 | 9.8717 | 0.3399 | 3 | 29 | chemoattractant activity |
GO:0016725 | 0.0047 | 24.3413 | 0.1055 | 2 | 9 | oxidoreductase activity, acting on CH or CH2 groups |
GO:0035240 | 0.007 | 18.9297 | 0.1289 | 2 | 11 | dopamine binding |
GO:0004062 | 0.0083 | 17.0357 | 0.1406 | 2 | 12 | aryl sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 33.3728 | 0.4109 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 5.6502 | 4.3612 | 21 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 6.4632 | 1.7183 | 10 | 184 | histone binding |
GO:1903231 | 0 | 10.48 | 0.7564 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0045296 | 5e-04 | 3.8627 | 2.7923 | 10 | 299 | cadherin binding |
GO:0061578 | 0.0013 | 53.7483 | 0.056 | 2 | 6 | Lys63-specific deubiquitinase activity |
GO:0004683 | 0.0016 | 14.7422 | 0.2335 | 3 | 25 | calmodulin-dependent protein kinase activity |
GO:0102991 | 0.0023 | 35.8277 | 0.0747 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:1990380 | 0.0023 | 35.8277 | 0.0747 | 2 | 8 | Lys48-specific deubiquitinase activity |
GO:0071723 | 0.0037 | 26.8673 | 0.0934 | 2 | 10 | lipopeptide binding |
GO:0016782 | 0.0039 | 6.6805 | 0.6444 | 4 | 69 | transferase activity, transferring sulfur-containing groups |
GO:0016290 | 0.0045 | 23.8806 | 0.1027 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0003682 | 0.0049 | 2.6473 | 4.4172 | 11 | 473 | chromatin binding |
GO:0045504 | 0.0073 | 17.907 | 0.1307 | 2 | 14 | dynein heavy chain binding |
GO:0004984 | 0.0089 | 2.903 | 2.9044 | 8 | 311 | olfactory receptor activity |
GO:0000210 | 0.0093 | Inf | 0.0093 | 1 | 1 | NAD+ diphosphatase activity |
GO:0003692 | 0.0093 | Inf | 0.0093 | 1 | 1 | left-handed Z-DNA binding |
GO:0004587 | 0.0093 | Inf | 0.0093 | 1 | 1 | ornithine-oxo-acid transaminase activity |
GO:0004607 | 0.0093 | Inf | 0.0093 | 1 | 1 | phosphatidylcholine-sterol O-acyltransferase activity |
GO:0008459 | 0.0093 | Inf | 0.0093 | 1 | 1 | chondroitin 6-sulfotransferase activity |
GO:0008891 | 0.0093 | Inf | 0.0093 | 1 | 1 | glycolate oxidase activity |
GO:0019115 | 0.0093 | Inf | 0.0093 | 1 | 1 | benzaldehyde dehydrogenase activity |
GO:0033735 | 0.0093 | Inf | 0.0093 | 1 | 1 | aspartate dehydrogenase activity |
GO:0047963 | 0.0093 | Inf | 0.0093 | 1 | 1 | glycine N-choloyltransferase activity |
GO:0047969 | 0.0093 | Inf | 0.0093 | 1 | 1 | glyoxylate oxidase activity |
GO:0050337 | 0.0093 | Inf | 0.0093 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
GO:0052817 | 0.0093 | Inf | 0.0093 | 1 | 1 | very long chain acyl-CoA hydrolase activity |
GO:1904265 | 0.0093 | Inf | 0.0093 | 1 | 1 | ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 10.6241 | 2.9408 | 25 | 184 | histone binding |
GO:0031492 | 0 | 18.8067 | 0.7032 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.9285 | 7.4638 | 26 | 467 | protein heterodimerization activity |
GO:0005123 | 1e-04 | 22.7294 | 0.2397 | 4 | 15 | death receptor binding |
GO:0019904 | 4e-04 | 2.352 | 10.5165 | 23 | 658 | protein domain specific binding |
GO:0045296 | 0.0011 | 2.8952 | 4.7788 | 13 | 299 | cadherin binding |
GO:0047617 | 0.0023 | 13.3384 | 0.2717 | 3 | 17 | acyl-CoA hydrolase activity |
GO:0017108 | 0.0037 | 31.0198 | 0.0959 | 2 | 6 | 5'-flap endonuclease activity |
GO:0043546 | 0.0037 | 31.0198 | 0.0959 | 2 | 6 | molybdopterin cofactor binding |
GO:0030742 | 0.0056 | 9.3333 | 0.3676 | 3 | 23 | GTP-dependent protein binding |
GO:0102991 | 0.0067 | 20.6772 | 0.1279 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0050840 | 0.0083 | 5.4232 | 0.7991 | 4 | 50 | extracellular matrix binding |
GO:0008821 | 0.0085 | 17.7222 | 0.1438 | 2 | 9 | crossover junction endodeoxyribonuclease activity |
GO:0030881 | 0.0085 | 17.7222 | 0.1438 | 2 | 9 | beta-2-microglobulin binding |
GO:0003682 | 0.0093 | 2.08 | 7.5597 | 15 | 473 | chromatin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0099600 | 0 | 3.3099 | 13.6464 | 38 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 2.6146 | 17.3541 | 39 | 1465 | molecular transducer activity |
GO:0004993 | 0 | 28.5344 | 0.2369 | 5 | 20 | G-protein coupled serotonin receptor activity |
GO:0004930 | 0 | 3.5309 | 6.6553 | 21 | 585 | G-protein coupled receptor activity |
GO:0051378 | 0 | 56.7928 | 0.1185 | 4 | 10 | serotonin binding |
GO:0030594 | 0 | 8.5588 | 1.0543 | 8 | 89 | neurotransmitter receptor activity |
GO:0038023 | 0 | 2.5496 | 12.7884 | 29 | 1121 | signaling receptor activity |
GO:0043565 | 0 | 2.5906 | 11.6089 | 27 | 980 | sequence-specific DNA binding |
GO:0003700 | 3e-04 | 2.2355 | 13.8122 | 28 | 1166 | DNA binding transcription factor activity |
GO:0005184 | 4e-04 | 13.6138 | 0.3435 | 4 | 29 | neuropeptide hormone activity |
GO:0008528 | 6e-04 | 5.3278 | 1.4215 | 7 | 120 | G-protein coupled peptide receptor activity |
GO:0001664 | 0.0013 | 3.6547 | 2.6276 | 9 | 225 | G-protein coupled receptor binding |
GO:0048248 | 0.0014 | 56.1961 | 0.0592 | 2 | 5 | CXCR3 chemokine receptor binding |
GO:0008009 | 0.0018 | 8.5005 | 0.5212 | 4 | 44 | chemokine activity |
GO:0042923 | 0.0019 | 14.1111 | 0.2488 | 3 | 21 | neuropeptide binding |
GO:0001228 | 0.0026 | 2.7377 | 4.6554 | 12 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0003676 | 0.0033 | 1.5637 | 45.1681 | 62 | 3813 | nucleic acid binding |
GO:0070405 | 0.0038 | 6.8071 | 0.6381 | 4 | 55 | ammonium ion binding |
GO:0004984 | 0.004 | 2.8703 | 3.684 | 10 | 311 | olfactory receptor activity |
GO:0071855 | 0.0043 | 10.1555 | 0.3317 | 3 | 28 | neuropeptide receptor binding |
GO:0048018 | 0.0048 | 2.5203 | 5.0345 | 12 | 425 | receptor ligand activity |
GO:0039706 | 0.0059 | 21.0668 | 0.1185 | 2 | 10 | co-receptor binding |
GO:0000982 | 0.0064 | 2.5363 | 4.5725 | 11 | 386 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0045125 | 0.01 | 15.3184 | 0.154 | 2 | 13 | bioactive lipid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 1e-04 | 8.3861 | 0.792 | 6 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004111 | 0.0014 | 51.2825 | 0.0587 | 2 | 6 | creatine kinase activity |
GO:0004129 | 0.0014 | 15.4696 | 0.2249 | 3 | 23 | cytochrome-c oxidase activity |
GO:0016675 | 0.0016 | 14.732 | 0.2347 | 3 | 24 | oxidoreductase activity, acting on a heme group of donors |
GO:0004872 | 0.0028 | 1.969 | 13.8938 | 25 | 1421 | receptor activity |
GO:0019531 | 0.0049 | 22.785 | 0.1076 | 2 | 11 | oxalate transmembrane transporter activity |
GO:0004888 | 0.0057 | 1.9904 | 10.8237 | 20 | 1107 | transmembrane signaling receptor activity |
GO:0008271 | 0.0069 | 18.6399 | 0.1271 | 2 | 13 | secondary active sulfate transmembrane transporter activity |
GO:0004336 | 0.0098 | Inf | 0.0098 | 1 | 1 | galactosylceramidase activity |
GO:0004352 | 0.0098 | Inf | 0.0098 | 1 | 1 | glutamate dehydrogenase (NAD+) activity |
GO:0018455 | 0.0098 | Inf | 0.0098 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0031370 | 0.0098 | Inf | 0.0098 | 1 | 1 | eukaryotic initiation factor 4G binding |
GO:0031687 | 0.0098 | Inf | 0.0098 | 1 | 1 | A2A adenosine receptor binding |
GO:0032003 | 0.0098 | Inf | 0.0098 | 1 | 1 | interleukin-28 receptor binding |
GO:0033676 | 0.0098 | Inf | 0.0098 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
GO:0035438 | 0.0098 | Inf | 0.0098 | 1 | 1 | cyclic-di-GMP binding |
GO:0035757 | 0.0098 | Inf | 0.0098 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.0098 | Inf | 0.0098 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.0098 | Inf | 0.0098 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.0098 | Inf | 0.0098 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0046817 | 0.0098 | Inf | 0.0098 | 1 | 1 | chemokine receptor antagonist activity |
GO:0061507 | 0.0098 | Inf | 0.0098 | 1 | 1 | cyclic-GMP-AMP binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 6.9786 | 4.7417 | 27 | 467 | protein heterodimerization activity |
GO:0031492 | 0 | 30.4934 | 0.4468 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 5.9056 | 1.8683 | 10 | 184 | histone binding |
GO:0003677 | 0 | 2.2077 | 23.6172 | 44 | 2326 | DNA binding |
GO:0003682 | 1e-04 | 3.4166 | 4.8026 | 15 | 473 | chromatin binding |
GO:0099583 | 3e-04 | 197.4 | 0.0305 | 2 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
GO:0047961 | 6e-04 | 98.6937 | 0.0406 | 2 | 4 | glycine N-acyltransferase activity |
GO:0045296 | 0.001 | 3.5294 | 3.0359 | 10 | 299 | cadherin binding |
GO:0038023 | 0.0026 | 2.0361 | 12.2858 | 23 | 1210 | signaling receptor activity |
GO:0004930 | 0.0026 | 2.3559 | 7.2903 | 16 | 718 | G-protein coupled receptor activity |
GO:0001102 | 0.0062 | 8.7453 | 0.3757 | 3 | 37 | RNA polymerase II activating transcription factor binding |
GO:0099600 | 0.0064 | 1.9308 | 11.6969 | 21 | 1152 | transmembrane receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 3.2752 | 8.5953 | 25 | 718 | G-protein coupled receptor activity |
GO:0043565 | 0 | 2.9057 | 11.7317 | 30 | 980 | sequence-specific DNA binding |
GO:0000981 | 0 | 2.9287 | 8.703 | 23 | 727 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0004984 | 1e-04 | 3.7904 | 3.723 | 13 | 311 | olfactory receptor activity |
GO:0099600 | 1e-04 | 2.3339 | 13.7908 | 29 | 1152 | transmembrane receptor activity |
GO:0005125 | 1e-04 | 4.5529 | 2.3823 | 10 | 199 | cytokine activity |
GO:0140110 | 2e-04 | 2.109 | 17.9807 | 34 | 1502 | transcription regulator activity |
GO:0060089 | 3e-04 | 2.0904 | 17.5378 | 33 | 1465 | molecular transducer activity |
GO:0000978 | 0.001 | 3.0876 | 4.154 | 12 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0030545 | 0.0011 | 2.7676 | 5.411 | 14 | 452 | receptor regulator activity |
GO:0001077 | 0.0013 | 3.4009 | 3.1364 | 10 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0019960 | 0.0014 | 55.5944 | 0.0599 | 2 | 5 | C-X3-C chemokine binding |
GO:0001159 | 0.0014 | 2.9524 | 4.3336 | 12 | 362 | core promoter proximal region DNA binding |
GO:0038023 | 0.0014 | 2.0662 | 13.1417 | 25 | 1121 | signaling receptor activity |
GO:0004993 | 0.0017 | 14.7813 | 0.2394 | 3 | 20 | G-protein coupled serotonin receptor activity |
GO:0030594 | 0.0043 | 5.0179 | 1.0654 | 5 | 89 | neurotransmitter receptor activity |
GO:0019864 | 0.0073 | 18.5244 | 0.1317 | 2 | 11 | IgG binding |
GO:0000975 | 0.0085 | 1.9695 | 9.6847 | 18 | 809 | regulatory region DNA binding |
GO:0005126 | 0.0095 | 2.864 | 2.9329 | 8 | 245 | cytokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 27.4988 | 3.2942 | 53 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 10.6939 | 7.6053 | 54 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 6.6423 | 12.2023 | 56 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 6.2836 | 12.8167 | 56 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 5.0567 | 15.5177 | 56 | 1465 | molecular transducer activity |
GO:0005549 | 0 | 18.2475 | 0.7521 | 11 | 71 | odorant binding |
GO:0008395 | 0 | 27.2412 | 0.339 | 7 | 32 | steroid hydroxylase activity |
GO:0019825 | 0 | 18.3922 | 0.4661 | 7 | 44 | oxygen binding |
GO:0008392 | 0 | 43.7223 | 0.1695 | 5 | 16 | arachidonic acid epoxygenase activity |
GO:0020037 | 0 | 7.7329 | 1.3029 | 9 | 123 | heme binding |
GO:0005506 | 0 | 6.2414 | 1.5888 | 9 | 150 | iron ion binding |
GO:0030414 | 1e-04 | 5.5638 | 1.7689 | 9 | 167 | peptidase inhibitor activity |
GO:0061135 | 1e-04 | 5.5638 | 1.7689 | 9 | 167 | endopeptidase regulator activity |
GO:0015020 | 3e-04 | 14.1495 | 0.3284 | 4 | 31 | glucuronosyltransferase activity |
GO:0004867 | 4e-04 | 6.9642 | 0.9427 | 6 | 89 | serine-type endopeptidase inhibitor activity |
GO:0005198 | 7e-04 | 2.6002 | 7.0757 | 17 | 668 | structural molecule activity |
GO:0004024 | 0.0011 | 63.006 | 0.053 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0030883 | 0.0011 | 63.006 | 0.053 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0011 | 63.006 | 0.053 | 2 | 5 | exogenous lipid antigen binding |
GO:0016712 | 0.002 | 13.5671 | 0.2542 | 3 | 24 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO:0001591 | 0.0023 | 37.7988 | 0.0741 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0030881 | 0.0038 | 26.9957 | 0.0953 | 2 | 9 | beta-2-microglobulin binding |
GO:0071723 | 0.0047 | 23.6198 | 0.1059 | 2 | 10 | lipopeptide binding |
GO:0035240 | 0.0058 | 20.994 | 0.1165 | 2 | 11 | dopamine binding |
GO:0016705 | 0.0093 | 4.1181 | 1.2817 | 5 | 123 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 23.8315 | 3.1772 | 47 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 10.9601 | 7.3353 | 53 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 7.2174 | 11.7691 | 57 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 6.1286 | 14.9668 | 61 | 1465 | molecular transducer activity |
GO:0038023 | 0 | 6.9862 | 11.0927 | 53 | 1121 | signaling receptor activity |
GO:0005549 | 0 | 18.975 | 0.7254 | 11 | 71 | odorant binding |
GO:0030594 | 3e-04 | 7.2331 | 0.9092 | 6 | 89 | neurotransmitter receptor activity |
GO:1903231 | 0.0014 | 6.544 | 0.8275 | 5 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0034987 | 0.0015 | 49.0311 | 0.0613 | 2 | 6 | immunoglobulin receptor binding |
GO:0001591 | 0.0021 | 39.2224 | 0.0715 | 2 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0052689 | 0.0024 | 4.7139 | 1.3588 | 6 | 133 | carboxylic ester hydrolase activity |
GO:0035240 | 0.0054 | 21.7847 | 0.1124 | 2 | 11 | dopamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005506 | 0 | 6.5693 | 1.6923 | 10 | 150 | iron ion binding |
GO:0004984 | 0 | 4.3952 | 3.5086 | 14 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 3.1048 | 7.893 | 22 | 707 | G-protein coupled receptor activity |
GO:0038023 | 0 | 2.4737 | 13.6509 | 30 | 1210 | signaling receptor activity |
GO:0099600 | 0 | 2.5058 | 12.9966 | 29 | 1152 | transmembrane receptor activity |
GO:0016015 | 0 | 66.8263 | 0.079 | 3 | 7 | morphogen activity |
GO:0060089 | 2e-04 | 2.164 | 16.5277 | 32 | 1465 | molecular transducer activity |
GO:0031720 | 4e-04 | 177.236 | 0.0338 | 2 | 3 | haptoglobin binding |
GO:0005125 | 4e-04 | 4.3172 | 2.2451 | 9 | 199 | cytokine activity |
GO:0020037 | 5e-04 | 5.4621 | 1.3877 | 7 | 123 | heme binding |
GO:0030545 | 6e-04 | 2.9532 | 5.0993 | 14 | 452 | receptor regulator activity |
GO:0045236 | 7e-04 | 20.5502 | 0.1805 | 3 | 16 | CXCR chemokine receptor binding |
GO:0016705 | 0.0014 | 4.5188 | 1.6584 | 7 | 147 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0140110 | 0.0014 | 1.9433 | 16.9452 | 30 | 1502 | transcription regulator activity |
GO:0043565 | 0.0016 | 2.1536 | 11.0561 | 22 | 980 | sequence-specific DNA binding |
GO:0055131 | 0.0018 | 44.3006 | 0.0677 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0000975 | 0.002 | 2.2385 | 9.1269 | 19 | 809 | regulatory region DNA binding |
GO:0043208 | 0.0034 | 29.53 | 0.0903 | 2 | 8 | glycosphingolipid binding |
GO:0004497 | 0.0039 | 6.7189 | 0.6447 | 4 | 58 | monooxygenase activity |
GO:0003810 | 0.0043 | 25.3098 | 0.1015 | 2 | 9 | protein-glutamine gamma-glutamyltransferase activity |
GO:0039706 | 0.0054 | 22.1447 | 0.1128 | 2 | 10 | co-receptor binding |
GO:0008395 | 0.0055 | 9.2028 | 0.361 | 3 | 32 | steroid hydroxylase activity |
GO:0004952 | 0.0065 | 19.6829 | 0.1241 | 2 | 11 | dopamine neurotransmitter receptor activity |
GO:0008239 | 0.0065 | 19.6829 | 0.1241 | 2 | 11 | dipeptidyl-peptidase activity |
GO:0035240 | 0.0065 | 19.6829 | 0.1241 | 2 | 11 | dopamine binding |
GO:0000977 | 0.0066 | 2.2456 | 6.5998 | 14 | 585 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0070888 | 0.0077 | 8.0853 | 0.4061 | 3 | 36 | E-box binding |
GO:0008236 | 0.0081 | 3.2328 | 2.2789 | 7 | 202 | serine-type peptidase activity |
GO:0000981 | 0.0082 | 2.067 | 8.2018 | 16 | 727 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0070696 | 0.0091 | 16.1021 | 0.1467 | 2 | 13 | transmembrane receptor protein serine/threonine kinase binding |
GO:0005539 | 0.0094 | 3.1351 | 2.3466 | 7 | 208 | glycosaminoglycan binding |
GO:0001077 | 0.0099 | 2.8422 | 2.9558 | 8 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.2844 | 5.4149 | 35 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 14.5435 | 2.1335 | 24 | 184 | histone binding |
GO:0031492 | 0 | 26.4471 | 0.5102 | 10 | 44 | nucleosomal DNA binding |
GO:0004984 | 0 | 5.3266 | 3.6061 | 17 | 311 | olfactory receptor activity |
GO:0005549 | 0 | 11.2686 | 0.8233 | 8 | 71 | odorant binding |
GO:0004930 | 0 | 2.9232 | 8.3253 | 22 | 718 | G-protein coupled receptor activity |
GO:0003677 | 0 | 2.0751 | 26.9702 | 48 | 2326 | DNA binding |
GO:0038023 | 3e-04 | 2.2011 | 14.0301 | 28 | 1210 | signaling receptor activity |
GO:0060089 | 3e-04 | 2.0925 | 16.9868 | 32 | 1465 | molecular transducer activity |
GO:0099600 | 0.0018 | 2.0301 | 13.3576 | 25 | 1152 | transmembrane receptor activity |
GO:0045296 | 0.0026 | 3.061 | 3.4669 | 10 | 299 | cadherin binding |
GO:0003682 | 0.0035 | 2.5155 | 5.4845 | 13 | 473 | chromatin binding |
GO:1990459 | 0.0036 | 28.714 | 0.0928 | 2 | 8 | transferrin receptor binding |
GO:0019904 | 0.0042 | 2.2309 | 7.6296 | 16 | 658 | protein domain specific binding |
GO:0048020 | 0.0076 | 8.1068 | 0.4058 | 3 | 35 | CCR chemokine receptor binding |
GO:0005125 | 0.0086 | 3.1907 | 2.3074 | 7 | 199 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038023 | 0 | 4.4958 | 12.0583 | 42 | 1210 | signaling receptor activity |
GO:0004984 | 0 | 8.6165 | 3.0993 | 22 | 311 | olfactory receptor activity |
GO:0099600 | 0 | 4.4387 | 11.4803 | 40 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 3.8705 | 14.5995 | 44 | 1465 | molecular transducer activity |
GO:0004930 | 0 | 5.408 | 5.778 | 26 | 598 | G-protein coupled receptor activity |
GO:0005549 | 0 | 13.2307 | 0.7076 | 8 | 71 | odorant binding |
GO:0001847 | 3e-04 | 202.5 | 0.0297 | 2 | 3 | opsonin receptor activity |
GO:0019862 | 3e-04 | 201.2102 | 0.0299 | 2 | 3 | IgA binding |
GO:0016019 | 0.001 | 67.0616 | 0.0498 | 2 | 5 | peptidoglycan receptor activity |
GO:0008528 | 0.0013 | 5.3946 | 1.1959 | 6 | 120 | G-protein coupled peptide receptor activity |
GO:0004966 | 0.002 | 40.2318 | 0.0698 | 2 | 7 | galanin receptor activity |
GO:0031419 | 0.0034 | 28.7334 | 0.0897 | 2 | 9 | cobalamin binding |
GO:0004623 | 0.0043 | 10.1064 | 0.3289 | 3 | 33 | phospholipase A2 activity |
GO:0001228 | 0.0061 | 2.7009 | 3.9165 | 10 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0042834 | 0.0072 | 18.2803 | 0.1296 | 2 | 13 | peptidoglycan binding |
GO:0043565 | 0.0089 | 1.9685 | 9.7662 | 18 | 980 | sequence-specific DNA binding |
GO:0001605 | 0.01 | Inf | 0.01 | 1 | 1 | adrenomedullin receptor activity |
GO:0001856 | 0.01 | Inf | 0.01 | 1 | 1 | complement component C5a binding |
GO:0001861 | 0.01 | Inf | 0.01 | 1 | 1 | complement component C4b receptor activity |
GO:0004131 | 0.01 | Inf | 0.01 | 1 | 1 | cytosine deaminase activity |
GO:0004778 | 0.01 | Inf | 0.01 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0004877 | 0.01 | Inf | 0.01 | 1 | 1 | complement component C3b receptor activity |
GO:0016412 | 0.01 | Inf | 0.01 | 1 | 1 | serine O-acyltransferase activity |
GO:0047444 | 0.01 | Inf | 0.01 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.01 | Inf | 0.01 | 1 | 1 | N-acetylneuraminate synthase activity |
GO:0099038 | 0.01 | Inf | 0.01 | 1 | 1 | ceramide-translocating ATPase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 4.127 | 4.8881 | 18 | 467 | protein heterodimerization activity |
GO:0004111 | 0.0016 | 47.8303 | 0.0628 | 2 | 6 | creatine kinase activity |
GO:0055131 | 0.0016 | 47.8303 | 0.0628 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0015450 | 0.0029 | 31.8828 | 0.0837 | 2 | 8 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity |
GO:0003677 | 0.003 | 1.7381 | 24.3461 | 38 | 2326 | DNA binding |
GO:0004984 | 0.0055 | 2.9209 | 3.2552 | 9 | 311 | olfactory receptor activity |
GO:0015266 | 0.0056 | 21.2512 | 0.1151 | 2 | 11 | protein channel activity |
GO:0001077 | 0.0064 | 3.0771 | 2.7423 | 8 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0031994 | 0.0067 | 19.1248 | 0.1256 | 2 | 12 | insulin-like growth factor I binding |
GO:0005179 | 0.008 | 4.2814 | 1.2351 | 5 | 118 | hormone activity |
GO:0034236 | 0.0091 | 15.9354 | 0.1465 | 2 | 14 | protein kinase A catalytic subunit binding |
GO:0050700 | 0.0091 | 15.9354 | 0.1465 | 2 | 14 | CARD domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 28.7724 | 0.4716 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 5.5722 | 1.972 | 10 | 184 | histone binding |
GO:0003677 | 7e-04 | 1.8632 | 24.9292 | 41 | 2326 | DNA binding |
GO:0045296 | 0.0015 | 3.3302 | 3.2046 | 10 | 299 | cadherin binding |
GO:0046982 | 0.0016 | 2.7783 | 5.0051 | 13 | 467 | protein heterodimerization activity |
GO:0004111 | 0.0017 | 46.6864 | 0.0643 | 2 | 6 | creatine kinase activity |
GO:0004875 | 0.0039 | 26.6729 | 0.0965 | 2 | 9 | complement receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 22.6456 | 0.5902 | 10 | 44 | nucleosomal DNA binding |
GO:0042393 | 0 | 4.8762 | 2.4679 | 11 | 184 | histone binding |
GO:0003677 | 1e-04 | 2.2381 | 17.0778 | 34 | 1346 | DNA binding |
GO:0004966 | 1e-04 | 55.9372 | 0.0939 | 3 | 7 | galanin receptor activity |
GO:0004983 | 1e-04 | 44.7469 | 0.1073 | 3 | 8 | neuropeptide Y receptor activity |
GO:0003700 | 2e-04 | 2.1799 | 15.6392 | 31 | 1166 | DNA binding transcription factor activity |
GO:0008528 | 2e-04 | 5.4192 | 1.6095 | 8 | 120 | G-protein coupled peptide receptor activity |
GO:0003682 | 2e-04 | 2.8926 | 6.3442 | 17 | 473 | chromatin binding |
GO:0046982 | 6e-04 | 2.7396 | 6.2637 | 16 | 467 | protein heterodimerization activity |
GO:0045296 | 7e-04 | 3.1988 | 4.0104 | 12 | 299 | cadherin binding |
GO:0017046 | 8e-04 | 10.6891 | 0.4292 | 4 | 32 | peptide hormone binding |
GO:0045569 | 0.0011 | 74.2406 | 0.0537 | 2 | 4 | TRAIL binding |
GO:0051380 | 0.0011 | 74.2406 | 0.0537 | 2 | 4 | norepinephrine binding |
GO:0008310 | 0.0017 | 49.4906 | 0.0671 | 2 | 5 | single-stranded DNA 3'-5' exodeoxyribonuclease activity |
GO:0055131 | 0.0026 | 37.1156 | 0.0805 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0043565 | 0.0032 | 1.9535 | 13.1445 | 24 | 980 | sequence-specific DNA binding |
GO:0051379 | 0.0036 | 29.6906 | 0.0939 | 2 | 7 | epinephrine binding |
GO:0001106 | 0.0044 | 10.1588 | 0.3353 | 3 | 25 | RNA polymerase II transcription corepressor activity |
GO:0004935 | 0.0061 | 21.2049 | 0.1207 | 2 | 9 | adrenergic receptor activity |
GO:0001228 | 0.0069 | 2.3949 | 5.2712 | 12 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0072349 | 0.0091 | 16.4906 | 0.1475 | 2 | 11 | modified amino acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 4.7681 | 5.7954 | 24 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 7.5604 | 2.2834 | 15 | 184 | histone binding |
GO:1903231 | 1e-04 | 7.7672 | 1.0052 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0019904 | 0.0012 | 2.4115 | 8.0125 | 18 | 652 | protein domain specific binding |
GO:0008483 | 0.0021 | 13.4521 | 0.2606 | 3 | 21 | transaminase activity |
GO:0055131 | 0.0022 | 40.1862 | 0.0745 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0005160 | 0.0029 | 7.3632 | 0.5957 | 4 | 48 | transforming growth factor beta receptor binding |
GO:0030170 | 0.0039 | 6.7479 | 0.6453 | 4 | 52 | pyridoxal phosphate binding |
GO:0031995 | 0.0041 | 26.7874 | 0.0993 | 2 | 8 | insulin-like growth factor II binding |
GO:0044183 | 0.0044 | 10.0853 | 0.3351 | 3 | 27 | protein binding involved in protein folding |
GO:0004062 | 0.0093 | 16.0684 | 0.1489 | 2 | 12 | aryl sulfotransferase activity |
GO:0005092 | 0.0093 | 16.0684 | 0.1489 | 2 | 12 | GDP-dissociation inhibitor activity |
GO:0031994 | 0.0093 | 16.0684 | 0.1489 | 2 | 12 | insulin-like growth factor I binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 19.6252 | 1.8913 | 27 | 184 | histone binding |
GO:0046982 | 0 | 8.2087 | 4.8003 | 31 | 467 | protein heterodimerization activity |
GO:0004984 | 0 | 10.2506 | 3.1967 | 26 | 311 | olfactory receptor activity |
GO:0031492 | 0 | 43.7684 | 0.4523 | 13 | 44 | nucleosomal DNA binding |
GO:0004930 | 0 | 4.8575 | 7.1835 | 29 | 707 | G-protein coupled receptor activity |
GO:0003677 | 0 | 2.6814 | 23.9087 | 51 | 2326 | DNA binding |
GO:0099600 | 0 | 3.1755 | 11.8413 | 32 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 3.0073 | 12.4375 | 32 | 1210 | signaling receptor activity |
GO:0003682 | 0 | 3.8891 | 4.8619 | 17 | 473 | chromatin binding |
GO:0060089 | 0 | 2.5259 | 15.0586 | 33 | 1465 | molecular transducer activity |
GO:0019904 | 1e-04 | 2.9186 | 6.7635 | 18 | 658 | protein domain specific binding |
GO:0031720 | 3e-04 | 194.9383 | 0.0308 | 2 | 3 | haptoglobin binding |
GO:0005344 | 4e-04 | 26.7307 | 0.1439 | 3 | 14 | oxygen carrier activity |
GO:0045296 | 0.0011 | 3.4831 | 3.0734 | 10 | 299 | cadherin binding |
GO:0102991 | 0.0028 | 32.4794 | 0.0822 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0004952 | 0.0054 | 21.6488 | 0.1131 | 2 | 11 | dopamine neurotransmitter receptor activity |
GO:0016290 | 0.0054 | 21.6488 | 0.1131 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0035240 | 0.0054 | 21.6488 | 0.1131 | 2 | 11 | dopamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 4.7553 | 6.2274 | 25 | 658 | calcium ion binding |
GO:0004930 | 0 | 3.5337 | 6.7413 | 21 | 717 | G-protein coupled receptor activity |
GO:0038023 | 0 | 2.8161 | 11.4516 | 28 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 2.5887 | 13.8649 | 31 | 1465 | molecular transducer activity |
GO:0099600 | 0 | 2.7114 | 10.9027 | 26 | 1152 | transmembrane receptor activity |
GO:0004984 | 0 | 4.4768 | 2.9433 | 12 | 311 | olfactory receptor activity |
GO:0055102 | 4e-04 | 24.6221 | 0.1514 | 3 | 16 | lipase inhibitor activity |
GO:0019834 | 5e-04 | 106.0537 | 0.0379 | 2 | 4 | phospholipase A2 inhibitor activity |
GO:0005329 | 9e-04 | 70.698 | 0.0473 | 2 | 5 | dopamine transmembrane transporter activity |
GO:0015651 | 0.0024 | 35.3423 | 0.0757 | 2 | 8 | quaternary ammonium group transmembrane transporter activity |
GO:0031406 | 0.0066 | 3.8054 | 1.6657 | 6 | 176 | carboxylic acid binding |
GO:0005544 | 0.0083 | 7.7932 | 0.4164 | 3 | 44 | calcium-dependent phospholipid binding |
GO:0004778 | 0.0095 | Inf | 0.0095 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0005307 | 0.0095 | Inf | 0.0095 | 1 | 1 | choline:sodium symporter activity |
GO:0008265 | 0.0095 | Inf | 0.0095 | 1 | 1 | Mo-molybdopterin cofactor sulfurase activity |
GO:0030977 | 0.0095 | Inf | 0.0095 | 1 | 1 | taurine binding |
GO:0031857 | 0.0095 | Inf | 0.0095 | 1 | 1 | type 1 parathyroid hormone receptor binding |
GO:0033676 | 0.0095 | Inf | 0.0095 | 1 | 1 | double-stranded DNA-dependent ATPase activity |
GO:0035438 | 0.0095 | Inf | 0.0095 | 1 | 1 | cyclic-di-GMP binding |
GO:0035757 | 0.0095 | Inf | 0.0095 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
GO:0035758 | 0.0095 | Inf | 0.0095 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
GO:0038117 | 0.0095 | Inf | 0.0095 | 1 | 1 | C-C motif chemokine 19 receptor activity |
GO:0038121 | 0.0095 | Inf | 0.0095 | 1 | 1 | C-C motif chemokine 21 receptor activity |
GO:0044730 | 0.0095 | Inf | 0.0095 | 1 | 1 | bone sialoprotein binding |
GO:0047444 | 0.0095 | Inf | 0.0095 | 1 | 1 | N-acylneuraminate-9-phosphate synthase activity |
GO:0050462 | 0.0095 | Inf | 0.0095 | 1 | 1 | N-acetylneuraminate synthase activity |
GO:0061507 | 0.0095 | Inf | 0.0095 | 1 | 1 | cyclic-GMP-AMP binding |
GO:0102867 | 0.0095 | Inf | 0.0095 | 1 | 1 | molybdenum cofactor sulfurtransferase activity |
GO:1990081 | 0.0095 | Inf | 0.0095 | 1 | 1 | trimethylamine receptor activity |
GO:1990595 | 0.0095 | Inf | 0.0095 | 1 | 1 | mast cell secretagogue receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 13.2466 | 2.4218 | 25 | 184 | histone binding |
GO:0046982 | 0 | 5.8383 | 6.1467 | 30 | 467 | protein heterodimerization activity |
GO:0031492 | 0 | 23.1044 | 0.5791 | 10 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 2.5538 | 15.8194 | 35 | 1346 | DNA binding |
GO:0000977 | 0 | 2.9907 | 7.6998 | 21 | 585 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0043565 | 2e-04 | 3.751 | 3.4628 | 12 | 281 | sequence-specific DNA binding |
GO:0000981 | 3e-04 | 2.8096 | 6.5335 | 17 | 509 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0019904 | 4e-04 | 2.4925 | 8.6606 | 20 | 658 | protein domain specific binding |
GO:0031720 | 5e-04 | 151.3846 | 0.0395 | 2 | 3 | haptoglobin binding |
GO:1990837 | 7e-04 | 2.3889 | 9.0129 | 20 | 691 | sequence-specific double-stranded DNA binding |
GO:0000253 | 0.001 | 75.6875 | 0.0526 | 2 | 4 | 3-keto sterol reductase activity |
GO:0070891 | 0.001 | 75.6875 | 0.0526 | 2 | 4 | lipoteichoic acid binding |
GO:0008508 | 0.0017 | 50.4551 | 0.0658 | 2 | 5 | bile acid:sodium symporter activity |
GO:0045296 | 0.0021 | 2.9667 | 3.9354 | 11 | 299 | cadherin binding |
GO:0044212 | 0.0023 | 2.1146 | 10.6217 | 21 | 807 | transcription regulatory region DNA binding |
GO:0140110 | 0.0023 | 1.8119 | 19.7694 | 33 | 1502 | transcription regulator activity |
GO:0001067 | 0.0024 | 2.1062 | 10.6612 | 21 | 810 | regulatory region nucleic acid binding |
GO:0016015 | 0.0035 | 30.2692 | 0.0921 | 2 | 7 | morphogen activity |
GO:0043184 | 0.0035 | 30.2692 | 0.0921 | 2 | 7 | vascular endothelial growth factor receptor 2 binding |
GO:0005160 | 0.0036 | 6.9289 | 0.6318 | 4 | 48 | transforming growth factor beta receptor binding |
GO:0003682 | 0.004 | 2.3788 | 6.2256 | 14 | 473 | chromatin binding |
GO:0004181 | 0.0042 | 10.3577 | 0.3291 | 3 | 25 | metallocarboxypeptidase activity |
GO:0003680 | 0.0046 | 25.2228 | 0.1053 | 2 | 8 | AT DNA binding |
GO:0019869 | 0.0046 | 25.2228 | 0.1053 | 2 | 8 | chloride channel inhibitor activity |
GO:1901363 | 0.0052 | 1.4503 | 73.6678 | 92 | 5597 | heterocyclic compound binding |
GO:0097159 | 0.0054 | 1.4464 | 74.7208 | 93 | 5677 | organic cyclic compound binding |
GO:0099106 | 0.0064 | 4.5473 | 1.1714 | 5 | 89 | ion channel regulator activity |
GO:0044877 | 0.007 | 1.8727 | 12.4776 | 22 | 948 | macromolecular complex binding |
GO:0001077 | 0.008 | 2.7418 | 3.4484 | 9 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0001227 | 0.0083 | 2.9298 | 2.8693 | 8 | 218 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0004952 | 0.0088 | 16.812 | 0.1448 | 2 | 11 | dopamine neurotransmitter receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 24.4662 | 0.5488 | 10 | 44 | nucleosomal DNA binding |
GO:0045296 | 0 | 4.108 | 3.7293 | 14 | 299 | cadherin binding |
GO:0042393 | 1e-04 | 4.7382 | 2.295 | 10 | 184 | histone binding |
GO:0038100 | 2e-04 | Inf | 0.0249 | 2 | 2 | nodal binding |
GO:0046982 | 3e-04 | 2.9671 | 5.8247 | 16 | 467 | protein heterodimerization activity |
GO:0003682 | 3e-04 | 2.927 | 5.8995 | 16 | 473 | chromatin binding |
GO:0031720 | 5e-04 | 159.9492 | 0.0374 | 2 | 3 | haptoglobin binding |
GO:0098632 | 5e-04 | 12.4103 | 0.3742 | 4 | 30 | cell-cell adhesion mediator activity |
GO:0019834 | 9e-04 | 79.9695 | 0.0499 | 2 | 4 | phospholipase A2 inhibitor activity |
GO:0017108 | 0.0022 | 39.9797 | 0.0748 | 2 | 6 | 5'-flap endonuclease activity |
GO:0032027 | 0.0022 | 39.9797 | 0.0748 | 2 | 6 | myosin light chain binding |
GO:0086083 | 0.0022 | 39.9797 | 0.0748 | 2 | 6 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
GO:0008821 | 0.0053 | 22.8412 | 0.1123 | 2 | 9 | crossover junction endodeoxyribonuclease activity |
GO:0030881 | 0.0053 | 22.8412 | 0.1123 | 2 | 9 | beta-2-microglobulin binding |
GO:0046703 | 0.0053 | 22.8412 | 0.1123 | 2 | 9 | natural killer cell lectin-like receptor binding |
GO:0004062 | 0.0094 | 15.9858 | 0.1497 | 2 | 12 | aryl sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 3.3318 | 11.5475 | 33 | 980 | sequence-specific DNA binding |
GO:0099600 | 0 | 2.8928 | 13.5742 | 34 | 1152 | transmembrane receptor activity |
GO:0004930 | 0 | 3.4426 | 8.2254 | 25 | 705 | G-protein coupled receptor activity |
GO:0004984 | 0 | 4.8788 | 3.6646 | 16 | 311 | olfactory receptor activity |
GO:0060089 | 0 | 2.2935 | 17.2623 | 35 | 1465 | molecular transducer activity |
GO:0038023 | 1e-04 | 2.4114 | 12.9297 | 28 | 1121 | signaling receptor activity |
GO:0000981 | 4e-04 | 2.5359 | 8.5663 | 20 | 727 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0001012 | 6e-04 | 2.6554 | 6.9049 | 17 | 586 | RNA polymerase II regulatory region DNA binding |
GO:0000976 | 8e-04 | 2.4864 | 7.8004 | 18 | 662 | transcription regulatory region sequence-specific DNA binding |
GO:0004993 | 0.0016 | 15.0238 | 0.2357 | 3 | 20 | G-protein coupled serotonin receptor activity |
GO:0000975 | 0.0033 | 2.1314 | 9.5326 | 19 | 809 | regulatory region DNA binding |
GO:0003700 | 0.0035 | 2.6361 | 4.8432 | 12 | 439 | DNA binding transcription factor activity |
GO:0070405 | 0.0038 | 6.7692 | 0.6416 | 4 | 55 | ammonium ion binding |
GO:0001077 | 0.0039 | 3.0831 | 3.0872 | 9 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0030594 | 0.004 | 5.1012 | 1.0487 | 5 | 89 | neurotransmitter receptor activity |
GO:0071855 | 0.0042 | 10.211 | 0.3299 | 3 | 28 | neuropeptide receptor binding |
GO:0005184 | 0.0047 | 9.8177 | 0.3417 | 3 | 29 | neuropeptide hormone activity |
GO:0003690 | 0.0048 | 2.0966 | 9.1437 | 18 | 776 | double-stranded DNA binding |
GO:0039706 | 0.0058 | 21.1815 | 0.1178 | 2 | 10 | co-receptor binding |
GO:0051378 | 0.0058 | 21.1815 | 0.1178 | 2 | 10 | serotonin binding |
GO:0003677 | 0.0068 | 1.8967 | 12.5334 | 22 | 1199 | DNA binding |
GO:0000978 | 0.0082 | 2.5723 | 4.0887 | 10 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0045125 | 0.0099 | 15.4018 | 0.1532 | 2 | 13 | bioactive lipid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 10.7187 | 2.9177 | 25 | 184 | histone binding |
GO:0031492 | 0 | 18.9639 | 0.6977 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.9636 | 7.4053 | 26 | 467 | protein heterodimerization activity |
GO:0005123 | 1e-04 | 22.9149 | 0.2379 | 4 | 15 | death receptor binding |
GO:0019904 | 3e-04 | 2.3728 | 10.434 | 23 | 658 | protein domain specific binding |
GO:0047617 | 0.0023 | 13.4469 | 0.2696 | 3 | 17 | acyl-CoA hydrolase activity |
GO:0045296 | 0.003 | 2.6744 | 4.7413 | 12 | 299 | cadherin binding |
GO:0017108 | 0.0036 | 31.2709 | 0.0951 | 2 | 6 | 5'-flap endonuclease activity |
GO:0043546 | 0.0036 | 31.2709 | 0.0951 | 2 | 6 | molybdopterin cofactor binding |
GO:0003682 | 0.0037 | 2.2521 | 7.5004 | 16 | 473 | chromatin binding |
GO:0102991 | 0.0066 | 20.8446 | 0.1269 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0008821 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | crossover junction endodeoxyribonuclease activity |
GO:0016208 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | AMP binding |
GO:0019911 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | structural constituent of myelin sheath |
GO:0030881 | 0.0084 | 17.8657 | 0.1427 | 2 | 9 | beta-2-microglobulin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 17.4398 | 2.0874 | 27 | 184 | histone binding |
GO:0031492 | 0 | 39.297 | 0.4992 | 13 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 7.2703 | 5.2978 | 31 | 467 | protein heterodimerization activity |
GO:0004984 | 0 | 9.1163 | 3.5281 | 26 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 4.3021 | 7.9373 | 29 | 707 | G-protein coupled receptor activity |
GO:0003677 | 0 | 2.3931 | 26.3871 | 52 | 2326 | DNA binding |
GO:0099600 | 0 | 2.9202 | 13.0688 | 33 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 2.7653 | 13.7267 | 33 | 1210 | signaling receptor activity |
GO:0003682 | 0 | 3.4821 | 5.3659 | 17 | 473 | chromatin binding |
GO:0060089 | 0 | 2.3183 | 16.6196 | 34 | 1465 | molecular transducer activity |
GO:0019904 | 1e-04 | 2.9471 | 7.4646 | 20 | 658 | protein domain specific binding |
GO:0031720 | 4e-04 | 176.2346 | 0.034 | 2 | 3 | haptoglobin binding |
GO:0005344 | 5e-04 | 24.1517 | 0.1588 | 3 | 14 | oxygen carrier activity |
GO:0045296 | 0.0022 | 3.1334 | 3.392 | 10 | 299 | cadherin binding |
GO:0102991 | 0.0034 | 29.3631 | 0.0908 | 2 | 8 | myristoyl-CoA hydrolase activity |
GO:0044877 | 0.0055 | 1.9873 | 10.7545 | 20 | 948 | macromolecular complex binding |
GO:0004952 | 0.0066 | 19.5717 | 0.1248 | 2 | 11 | dopamine neurotransmitter receptor activity |
GO:0016290 | 0.0066 | 19.5717 | 0.1248 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0035240 | 0.0066 | 19.5717 | 0.1248 | 2 | 11 | dopamine binding |
GO:0008195 | 0.0092 | 16.0112 | 0.1475 | 2 | 13 | phosphatidate phosphatase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 230.9845 | 0.3519 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 40.7238 | 0.6416 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 31.4579 | 0.7451 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 26.6111 | 0.8279 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 24.707 | 0.8693 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0051290 | 0 | 23.8534 | 0.89 | 14 | 43 | protein heterotetramerization |
GO:0016233 | 0 | 19.2062 | 1.0349 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 19.2062 | 1.0349 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0006303 | 0 | 13.2823 | 1.3661 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0032501 | 0 | 2.1339 | 121.3992 | 175 | 6203 | multicellular organismal process |
GO:0043044 | 0 | 11.701 | 1.511 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0048863 | 0 | 5.4782 | 5.0711 | 24 | 245 | stem cell differentiation |
GO:0045815 | 0 | 10.7832 | 1.6145 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 8.82 | 2.0491 | 15 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 8.0129 | 2.0698 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 7.2547 | 2.4217 | 15 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 6.9791 | 2.5045 | 15 | 121 | regulation of gene silencing |
GO:1903707 | 0 | 6.6025 | 2.6287 | 15 | 127 | negative regulation of hemopoiesis |
GO:0097659 | 0 | 1.8881 | 71.264 | 111 | 3443 | nucleic acid-templated transcription |
GO:0099537 | 0 | 3.09 | 11.5496 | 32 | 558 | trans-synaptic signaling |
GO:0031497 | 0 | 5.771 | 2.9598 | 15 | 143 | chromatin assembly |
GO:0034654 | 0 | 1.7713 | 80.3506 | 118 | 3882 | nucleobase-containing compound biosynthetic process |
GO:1902679 | 0 | 2.3075 | 22.2299 | 46 | 1074 | negative regulation of RNA biosynthetic process |
GO:0045934 | 0 | 2.1895 | 26.6179 | 52 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0048731 | 0 | 2.1762 | 29.701 | 55 | 1748 | system development |
GO:2000026 | 0 | 2.4132 | 18.0064 | 39 | 928 | regulation of multicellular organismal development |
GO:0006837 | 0 | 30.0301 | 0.2691 | 5 | 13 | serotonin transport |
GO:0032200 | 0 | 4.8692 | 3.2082 | 14 | 155 | telomere organization |
GO:0006352 | 0 | 4.03 | 4.6571 | 17 | 225 | DNA-templated transcription, initiation |
GO:0002244 | 0 | 4.3851 | 3.7878 | 15 | 183 | hematopoietic progenitor cell differentiation |
GO:0045596 | 0 | 2.6417 | 12.4396 | 30 | 601 | negative regulation of cell differentiation |
GO:0007267 | 0 | 2.2174 | 20.9681 | 42 | 1054 | cell-cell signaling |
GO:0035194 | 0 | 3.5375 | 5.5678 | 18 | 269 | posttranscriptional gene silencing by RNA |
GO:0015837 | 0 | 8.1612 | 1.146 | 8 | 56 | amine transport |
GO:0045637 | 0 | 3.7619 | 4.6571 | 16 | 225 | regulation of myeloid cell differentiation |
GO:0065004 | 0 | 3.7515 | 4.3673 | 15 | 211 | protein-DNA complex assembly |
GO:0007198 | 0 | 143.2907 | 0.0828 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 0 | 143.2907 | 0.0828 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0 | 143.2907 | 0.0828 | 3 | 4 | detection of glucose |
GO:0003013 | 0 | 2.7043 | 9.6247 | 24 | 465 | circulatory system process |
GO:0031644 | 0 | 6.9086 | 1.3247 | 8 | 64 | regulation of neurological system process |
GO:0060255 | 1e-04 | 1.5718 | 114.2129 | 148 | 5518 | regulation of macromolecule metabolic process |
GO:0050880 | 1e-04 | 4.5726 | 2.6494 | 11 | 128 | regulation of blood vessel size |
GO:0006325 | 1e-04 | 2.3116 | 14.0541 | 30 | 679 | chromatin organization |
GO:0007218 | 1e-04 | 5.2514 | 1.9042 | 9 | 92 | neuropeptide signaling pathway |
GO:0006355 | 1e-04 | 1.7504 | 42.5569 | 66 | 2234 | regulation of transcription, DNA-templated |
GO:0009952 | 2e-04 | 3.6226 | 3.8913 | 13 | 188 | anterior/posterior pattern specification |
GO:0003206 | 2e-04 | 4.5336 | 2.4217 | 10 | 117 | cardiac chamber morphogenesis |
GO:0007188 | 2e-04 | 4.1439 | 2.8978 | 11 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0016070 | 2e-04 | 1.5498 | 87.5328 | 117 | 4229 | RNA metabolic process |
GO:0023061 | 2e-04 | 2.6775 | 8.0309 | 20 | 388 | signal release |
GO:0007268 | 2e-04 | 3.7626 | 3.4604 | 12 | 174 | chemical synaptic transmission |
GO:0035270 | 2e-04 | 4.4091 | 2.4838 | 10 | 120 | endocrine system development |
GO:0009890 | 2e-04 | 1.7978 | 32.2893 | 53 | 1560 | negative regulation of biosynthetic process |
GO:2001141 | 2e-04 | 1.7239 | 42.3843 | 65 | 2228 | regulation of RNA biosynthetic process |
GO:0045892 | 2e-04 | 2.8987 | 6.3164 | 17 | 319 | negative regulation of transcription, DNA-templated |
GO:0035296 | 2e-04 | 4.3298 | 2.5252 | 10 | 122 | regulation of tube diameter |
GO:0051259 | 2e-04 | 2.4346 | 10.1421 | 23 | 490 | protein oligomerization |
GO:0050433 | 2e-04 | 7.8016 | 0.89 | 6 | 43 | regulation of catecholamine secretion |
GO:0051046 | 3e-04 | 2.2027 | 13.6608 | 28 | 660 | regulation of secretion |
GO:0071103 | 3e-04 | 3.0546 | 5.2781 | 15 | 255 | DNA conformation change |
GO:0051584 | 3e-04 | 35.8155 | 0.1449 | 3 | 7 | regulation of dopamine uptake involved in synaptic transmission |
GO:0006936 | 3e-04 | 2.7957 | 6.5199 | 17 | 315 | muscle contraction |
GO:0060249 | 3e-04 | 2.7013 | 7.1409 | 18 | 345 | anatomical structure homeostasis |
GO:0007399 | 3e-04 | 2.1751 | 13.9325 | 28 | 746 | nervous system development |
GO:0035637 | 4e-04 | 3.4945 | 3.705 | 12 | 179 | multicellular organismal signaling |
GO:0006812 | 4e-04 | 1.9457 | 20.512 | 37 | 991 | cation transport |
GO:0034645 | 4e-04 | 1.4984 | 97.5508 | 126 | 4713 | cellular macromolecule biosynthetic process |
GO:0007517 | 4e-04 | 2.6434 | 7.2858 | 18 | 352 | muscle organ development |
GO:0017148 | 4e-04 | 2.6273 | 7.3272 | 18 | 354 | negative regulation of translation |
GO:0042391 | 5e-04 | 3.0378 | 4.9415 | 14 | 243 | regulation of membrane potential |
GO:0003231 | 5e-04 | 4.2261 | 2.3182 | 9 | 112 | cardiac ventricle development |
GO:0007210 | 5e-04 | 12.7658 | 0.3933 | 4 | 19 | serotonin receptor signaling pathway |
GO:0015844 | 6e-04 | 6.5128 | 1.0398 | 6 | 51 | monoamine transport |
GO:0009889 | 6e-04 | 1.618 | 49.3497 | 71 | 2572 | regulation of biosynthetic process |
GO:0030154 | 6e-04 | 1.6544 | 42.4788 | 63 | 2247 | cell differentiation |
GO:0009887 | 7e-04 | 2.148 | 12.4399 | 25 | 625 | animal organ morphogenesis |
GO:0009893 | 8e-04 | 1.5337 | 61.6394 | 85 | 2978 | positive regulation of metabolic process |
GO:0035295 | 8e-04 | 2.2137 | 11.0736 | 23 | 535 | tube development |
GO:0065008 | 8e-04 | 1.6476 | 40.2961 | 60 | 2130 | regulation of biological quality |
GO:0051953 | 8e-04 | 11.2624 | 0.4347 | 4 | 21 | negative regulation of amine transport |
GO:0060415 | 8e-04 | 5.0325 | 1.5317 | 7 | 74 | muscle tissue morphogenesis |
GO:0050794 | 0.001 | 1.48 | 186.1725 | 212 | 9368 | regulation of cellular process |
GO:0009914 | 0.001 | 2.6694 | 5.9818 | 15 | 289 | hormone transport |
GO:0060537 | 0.0011 | 2.4882 | 7.2651 | 17 | 351 | muscle tissue development |
GO:0000122 | 0.0011 | 1.9973 | 14.9441 | 28 | 722 | negative regulation of transcription from RNA polymerase II promoter |
GO:0019219 | 0.0012 | 1.5829 | 47.8489 | 68 | 2534 | regulation of nucleobase-containing compound metabolic process |
GO:2000463 | 0.0012 | 10.0756 | 0.4761 | 4 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0002009 | 0.0012 | 2.2275 | 10.0179 | 21 | 484 | morphogenesis of an epithelium |
GO:0021524 | 0.0013 | 95.2229 | 0.0621 | 2 | 3 | visceral motor neuron differentiation |
GO:0061364 | 0.0013 | 95.2229 | 0.0621 | 2 | 3 | apoptotic process involved in luteolysis |
GO:1905333 | 0.0013 | 95.2229 | 0.0621 | 2 | 3 | regulation of gastric motility |
GO:0051580 | 0.0013 | 17.903 | 0.2277 | 3 | 11 | regulation of neurotransmitter uptake |
GO:0051934 | 0.0013 | 17.903 | 0.2277 | 3 | 11 | catecholamine uptake involved in synaptic transmission |
GO:0090494 | 0.0013 | 17.903 | 0.2277 | 3 | 11 | dopamine uptake |
GO:0001708 | 0.0013 | 4.617 | 1.6559 | 7 | 80 | cell fate specification |
GO:0015872 | 0.0013 | 9.6589 | 0.4924 | 4 | 24 | dopamine transport |
GO:0048699 | 0.0013 | 2.1223 | 11.5443 | 23 | 580 | generation of neurons |
GO:0001764 | 0.0014 | 3.6539 | 2.6494 | 9 | 128 | neuron migration |
GO:0045666 | 0.0014 | 2.5829 | 6.1681 | 15 | 298 | positive regulation of neuron differentiation |
GO:0048534 | 0.0014 | 1.9109 | 16.7242 | 30 | 808 | hematopoietic or lymphoid organ development |
GO:0048562 | 0.0015 | 2.661 | 5.5885 | 14 | 270 | embryonic organ morphogenesis |
GO:0048666 | 0.0016 | 1.8785 | 17.5891 | 31 | 860 | neuron development |
GO:0003148 | 0.0016 | 9.1148 | 0.5175 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0016 | 9.1148 | 0.5175 | 4 | 25 | type B pancreatic cell differentiation |
GO:0099531 | 0.0016 | 3.5633 | 2.7115 | 9 | 131 | presynaptic process involved in chemical synaptic transmission |
GO:0021517 | 0.0017 | 6.4804 | 0.8693 | 5 | 42 | ventral spinal cord development |
GO:1901576 | 0.0018 | 1.4058 | 120.381 | 146 | 5816 | organic substance biosynthetic process |
GO:0090276 | 0.0018 | 3.0277 | 3.8706 | 11 | 187 | regulation of peptide hormone secretion |
GO:0022603 | 0.0018 | 1.8394 | 18.5249 | 32 | 895 | regulation of anatomical structure morphogenesis |
GO:0033555 | 0.0019 | 5.0574 | 1.304 | 6 | 63 | multicellular organismal response to stress |
GO:0045944 | 0.0021 | 1.7718 | 21.0501 | 35 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0003214 | 0.0022 | 14.3204 | 0.2691 | 3 | 13 | cardiac left ventricle morphogenesis |
GO:0021520 | 0.0022 | 14.3204 | 0.2691 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0003016 | 0.0022 | 8.3211 | 0.5589 | 4 | 27 | respiratory system process |
GO:0048754 | 0.0022 | 3.3949 | 2.8357 | 9 | 137 | branching morphogenesis of an epithelial tube |
GO:0002067 | 0.0023 | 5.9932 | 0.9314 | 5 | 45 | glandular epithelial cell differentiation |
GO:0031016 | 0.0023 | 4.8331 | 1.3581 | 6 | 66 | pancreas development |
GO:0021675 | 0.0024 | 4.8035 | 1.3661 | 6 | 66 | nerve development |
GO:0032024 | 0.0024 | 4.8035 | 1.3661 | 6 | 66 | positive regulation of insulin secretion |
GO:0000038 | 0.0025 | 7.9738 | 0.5796 | 4 | 28 | very long-chain fatty acid metabolic process |
GO:0002865 | 0.0025 | 47.6083 | 0.0828 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0032100 | 0.0025 | 47.6083 | 0.0828 | 2 | 4 | positive regulation of appetite |
GO:0051414 | 0.0025 | 47.6083 | 0.0828 | 2 | 4 | response to cortisol |
GO:0055010 | 0.0025 | 5.8466 | 0.9521 | 5 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0040011 | 0.0026 | 1.6133 | 31.9167 | 48 | 1542 | locomotion |
GO:0014048 | 0.0027 | 13.0177 | 0.2898 | 3 | 14 | regulation of glutamate secretion |
GO:0021794 | 0.0027 | 13.0177 | 0.2898 | 3 | 14 | thalamus development |
GO:0042711 | 0.0027 | 13.0177 | 0.2898 | 3 | 14 | maternal behavior |
GO:0007417 | 0.0027 | 2.8635 | 4.0789 | 11 | 204 | central nervous system development |
GO:0042472 | 0.0028 | 4.0094 | 1.8835 | 7 | 91 | inner ear morphogenesis |
GO:0008306 | 0.0028 | 4.648 | 1.4075 | 6 | 68 | associative learning |
GO:0048663 | 0.0028 | 4.648 | 1.4075 | 6 | 68 | neuron fate commitment |
GO:0001525 | 0.003 | 2.1861 | 8.6933 | 18 | 420 | angiogenesis |
GO:0042755 | 0.0032 | 7.3595 | 0.6209 | 4 | 30 | eating behavior |
GO:0042310 | 0.0032 | 4.5021 | 1.4489 | 6 | 70 | vasoconstriction |
GO:0098911 | 0.0033 | 11.9321 | 0.3105 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0051962 | 0.0034 | 2.1585 | 8.7968 | 18 | 425 | positive regulation of nervous system development |
GO:0019932 | 0.0035 | 2.5127 | 5.4643 | 13 | 264 | second-messenger-mediated signaling |
GO:0034248 | 0.0036 | 1.978 | 11.7359 | 22 | 567 | regulation of cellular amide metabolic process |
GO:0010517 | 0.0036 | 5.3255 | 1.0349 | 5 | 50 | regulation of phospholipase activity |
GO:0060078 | 0.0037 | 3.4106 | 2.5045 | 8 | 121 | regulation of postsynaptic membrane potential |
GO:0048646 | 0.0038 | 2.086 | 9.6148 | 19 | 481 | anatomical structure formation involved in morphogenesis |
GO:0048812 | 0.0038 | 2.0035 | 11.0529 | 21 | 534 | neuron projection morphogenesis |
GO:0048598 | 0.004 | 2.4684 | 5.5579 | 13 | 276 | embryonic morphogenesis |
GO:0060413 | 0.004 | 11.0135 | 0.3312 | 3 | 16 | atrial septum morphogenesis |
GO:1904018 | 0.004 | 3.0792 | 3.1047 | 9 | 150 | positive regulation of vasculature development |
GO:0043270 | 0.0041 | 2.7043 | 4.3002 | 11 | 209 | positive regulation of ion transport |
GO:0010040 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | response to iron(II) ion |
GO:0035609 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | C-terminal protein deglutamylation |
GO:0045110 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | intermediate filament bundle assembly |
GO:0051891 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0051970 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0070100 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:0090237 | 0.0041 | 31.7367 | 0.1035 | 2 | 5 | regulation of arachidonic acid secretion |
GO:0001662 | 0.0041 | 6.8329 | 0.6623 | 4 | 32 | behavioral fear response |
GO:0008344 | 0.0043 | 4.2361 | 1.5317 | 6 | 74 | adult locomotory behavior |
GO:0007420 | 0.0045 | 1.9107 | 12.688 | 23 | 613 | brain development |
GO:0032879 | 0.0045 | 1.471 | 49.2411 | 67 | 2379 | regulation of localization |
GO:0008284 | 0.0046 | 1.7881 | 16.5379 | 28 | 799 | positive regulation of cell proliferation |
GO:0015849 | 0.0046 | 2.4243 | 5.6506 | 13 | 273 | organic acid transport |
GO:0042053 | 0.0048 | 10.2262 | 0.3519 | 3 | 17 | regulation of dopamine metabolic process |
GO:1901700 | 0.005 | 1.5908 | 28.7706 | 43 | 1390 | response to oxygen-containing compound |
GO:0043279 | 0.005 | 3.5805 | 2.0905 | 7 | 101 | response to alkaloid |
GO:0007626 | 0.0051 | 3.5585 | 2.1016 | 7 | 103 | locomotory behavior |
GO:0048856 | 0.0052 | 1.89 | 13.7966 | 24 | 938 | anatomical structure development |
GO:0099565 | 0.0053 | 3.5426 | 2.1112 | 7 | 102 | chemical synaptic transmission, postsynaptic |
GO:0048858 | 0.0054 | 1.9369 | 11.4047 | 21 | 551 | cell projection morphogenesis |
GO:0007611 | 0.0056 | 2.5815 | 4.4915 | 11 | 217 | learning or memory |
GO:0051094 | 0.0056 | 2.9156 | 3.2679 | 9 | 167 | positive regulation of developmental process |
GO:0061041 | 0.0057 | 3.1571 | 2.6908 | 8 | 130 | regulation of wound healing |
GO:0043954 | 0.0057 | 6.1704 | 0.7244 | 4 | 35 | cellular component maintenance |
GO:0021854 | 0.0057 | 9.5438 | 0.3726 | 3 | 18 | hypothalamus development |
GO:0048148 | 0.0057 | 9.5438 | 0.3726 | 3 | 18 | behavioral response to cocaine |
GO:0097755 | 0.0059 | 4.6971 | 1.1591 | 5 | 56 | positive regulation of blood vessel diameter |
GO:0014062 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | regulation of serotonin secretion |
GO:0021800 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | cerebral cortex tangential migration |
GO:0032109 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | positive regulation of response to nutrient levels |
GO:0032229 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
GO:0033603 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | positive regulation of dopamine secretion |
GO:0060430 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | lung saccule development |
GO:0071313 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | cellular response to caffeine |
GO:0086073 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0110022 | 0.0061 | 23.801 | 0.1242 | 2 | 6 | regulation of cardiac muscle myoblast proliferation |
GO:0090066 | 0.0061 | 2.0736 | 8.6105 | 17 | 416 | regulation of anatomical structure size |
GO:0021537 | 0.0062 | 2.5439 | 4.5536 | 11 | 220 | telencephalon development |
GO:0006725 | 0.0062 | 1.3444 | 113.2194 | 135 | 5470 | cellular aromatic compound metabolic process |
GO:0048645 | 0.0064 | 4.6064 | 1.1798 | 5 | 57 | animal organ formation |
GO:0010628 | 0.0064 | 1.545 | 31.7528 | 46 | 1597 | positive regulation of gene expression |
GO:1904064 | 0.0065 | 3.3985 | 2.194 | 7 | 106 | positive regulation of cation transmembrane transport |
GO:0045597 | 0.0065 | 1.7381 | 16.9726 | 28 | 820 | positive regulation of cell differentiation |
GO:0051384 | 0.0065 | 3.0756 | 2.7567 | 8 | 134 | response to glucocorticoid |
GO:0034505 | 0.0067 | 8.9467 | 0.3933 | 3 | 19 | tooth mineralization |
GO:0032844 | 0.0067 | 2.0525 | 8.6933 | 17 | 420 | regulation of homeostatic process |
GO:0051960 | 0.0067 | 5.8455 | 0.7582 | 4 | 38 | regulation of nervous system development |
GO:0046483 | 0.0069 | 1.3391 | 112.557 | 134 | 5438 | heterocycle metabolic process |
GO:0050804 | 0.007 | 2.2982 | 5.9404 | 13 | 287 | modulation of chemical synaptic transmission |
GO:0006835 | 0.007 | 3.7882 | 1.6973 | 6 | 82 | dicarboxylic acid transport |
GO:0006813 | 0.0071 | 2.4955 | 4.6364 | 11 | 224 | potassium ion transport |
GO:0050767 | 0.0073 | 1.8267 | 13.2262 | 23 | 639 | regulation of neurogenesis |
GO:0048545 | 0.0073 | 2.1415 | 7.3479 | 15 | 355 | response to steroid hormone |
GO:0061564 | 0.0073 | 2.0317 | 8.7761 | 17 | 424 | axon development |
GO:0048738 | 0.0075 | 2.6084 | 4.0362 | 10 | 195 | cardiac muscle tissue development |
GO:0007214 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | gamma-aminobutyric acid signaling pathway |
GO:0015874 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | norepinephrine transport |
GO:0031290 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | retinal ganglion cell axon guidance |
GO:0051968 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | positive regulation of synaptic transmission, glutamatergic |
GO:0060039 | 0.0077 | 8.4198 | 0.414 | 3 | 20 | pericardium development |
GO:0046717 | 0.0079 | 3.2657 | 2.2768 | 7 | 110 | acid secretion |
GO:0043583 | 0.008 | 2.5801 | 4.0776 | 10 | 197 | ear development |
GO:0045995 | 0.0083 | 3.234 | 2.2975 | 7 | 111 | regulation of embryonic development |
GO:0001676 | 0.0084 | 3.6436 | 1.7594 | 6 | 85 | long-chain fatty acid metabolic process |
GO:0001574 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | ganglioside biosynthetic process |
GO:0010700 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | negative regulation of norepinephrine secretion |
GO:0031017 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | exocrine pancreas development |
GO:0035385 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | Roundabout signaling pathway |
GO:0071420 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | cellular response to histamine |
GO:0072608 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | interleukin-10 secretion |
GO:0098700 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | neurotransmitter loading into synaptic vesicle |
GO:2000049 | 0.0084 | 19.0395 | 0.1449 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0003197 | 0.0084 | 5.4637 | 0.8072 | 4 | 39 | endocardial cushion development |
GO:0003002 | 0.0084 | 3.2205 | 2.3049 | 7 | 115 | regionalization |
GO:0006940 | 0.0085 | 4.2762 | 1.2626 | 5 | 61 | regulation of smooth muscle contraction |
GO:0021954 | 0.0085 | 4.2762 | 1.2626 | 5 | 61 | central nervous system neuron development |
GO:0009719 | 0.0085 | 1.5499 | 28.0047 | 41 | 1353 | response to endogenous stimulus |
GO:0030534 | 0.0086 | 5.4044 | 0.8142 | 4 | 40 | adult behavior |
GO:0046887 | 0.0087 | 3.203 | 2.3182 | 7 | 112 | positive regulation of hormone secretion |
GO:0072358 | 0.0087 | 1.8214 | 12.6673 | 22 | 612 | cardiovascular system development |
GO:0014821 | 0.0089 | 7.9515 | 0.4347 | 3 | 21 | phasic smooth muscle contraction |
GO:1903672 | 0.0089 | 7.9515 | 0.4347 | 3 | 21 | positive regulation of sprouting angiogenesis |
GO:2000191 | 0.0089 | 7.9515 | 0.4347 | 3 | 21 | regulation of fatty acid transport |
GO:0015711 | 0.0091 | 2.0286 | 8.2586 | 16 | 399 | organic anion transport |
GO:0034105 | 0.0092 | 5.3116 | 0.8279 | 4 | 40 | positive regulation of tissue remodeling |
GO:0010608 | 0.0093 | 1.7844 | 13.5159 | 23 | 653 | posttranscriptional regulation of gene expression |
GO:0001568 | 0.0093 | 1.8362 | 11.9843 | 21 | 579 | blood vessel development |
GO:0002793 | 0.0094 | 2.3928 | 4.8227 | 11 | 233 | positive regulation of peptide secretion |
GO:0019233 | 0.0098 | 3.5096 | 1.8214 | 6 | 88 | sensory perception of pain |
GO:0035282 | 0.0098 | 3.5096 | 1.8214 | 6 | 88 | segmentation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009952 | 0 | 10.5192 | 2.5076 | 21 | 125 | anterior/posterior pattern specification |
GO:0007389 | 0 | 7.2551 | 4.491 | 27 | 226 | pattern specification process |
GO:0034654 | 0 | 2.3927 | 79.5877 | 139 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0009790 | 0 | 3.3059 | 17.321 | 49 | 854 | embryo development |
GO:0045944 | 0 | 2.9583 | 20.8503 | 53 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0035107 | 0 | 7.6716 | 2.7882 | 18 | 136 | appendage morphogenesis |
GO:0060255 | 0 | 2.026 | 113.1286 | 166 | 5518 | regulation of macromolecule metabolic process |
GO:1902679 | 0 | 2.7818 | 22.0189 | 53 | 1074 | negative regulation of RNA biosynthetic process |
GO:0034645 | 0 | 1.9884 | 96.6247 | 146 | 4713 | cellular macromolecule biosynthetic process |
GO:2001141 | 0 | 2.3488 | 40.8145 | 78 | 2228 | regulation of RNA biosynthetic process |
GO:0060173 | 0 | 6.3647 | 3.2803 | 18 | 160 | limb development |
GO:1903508 | 0 | 2.5377 | 26.9188 | 59 | 1313 | positive regulation of nucleic acid-templated transcription |
GO:0019219 | 0 | 2.2213 | 46.7615 | 84 | 2534 | regulation of nucleobase-containing compound metabolic process |
GO:0003206 | 0 | 7.3293 | 2.3987 | 15 | 117 | cardiac chamber morphogenesis |
GO:0009889 | 0 | 2.2045 | 47.8485 | 85 | 2572 | regulation of biosynthetic process |
GO:0031328 | 0 | 2.2908 | 33.9509 | 67 | 1656 | positive regulation of cellular biosynthetic process |
GO:0051254 | 0 | 2.3913 | 28.3539 | 59 | 1383 | positive regulation of RNA metabolic process |
GO:0097659 | 0 | 2.2368 | 38.7871 | 72 | 2131 | nucleic acid-templated transcription |
GO:0006355 | 0 | 2.2736 | 35.8469 | 68 | 1998 | regulation of transcription, DNA-templated |
GO:0045934 | 0 | 2.3765 | 26.3652 | 55 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0010557 | 0 | 2.259 | 31.4907 | 62 | 1536 | positive regulation of macromolecule biosynthetic process |
GO:0048332 | 0 | 8.8928 | 1.4761 | 11 | 72 | mesoderm morphogenesis |
GO:0072359 | 0 | 2.594 | 18.6156 | 43 | 908 | circulatory system development |
GO:0051173 | 0 | 1.9384 | 54.6781 | 90 | 2667 | positive regulation of nitrogen compound metabolic process |
GO:1901576 | 0 | 1.7647 | 119.2381 | 162 | 5816 | organic substance biosynthetic process |
GO:0010628 | 0 | 2.1288 | 34.3404 | 64 | 1675 | positive regulation of gene expression |
GO:0000122 | 0 | 2.7031 | 14.8023 | 36 | 722 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048562 | 0 | 5.0461 | 3.3319 | 15 | 169 | embryonic organ morphogenesis |
GO:0007267 | 0 | 2.337 | 21.0389 | 44 | 1054 | cell-cell signaling |
GO:0048935 | 0 | 34.6637 | 0.246 | 5 | 12 | peripheral nervous system neuron development |
GO:0032502 | 0 | 1.8493 | 66.7493 | 99 | 3812 | developmental process |
GO:0048704 | 0 | 9.885 | 0.9741 | 8 | 48 | embryonic skeletal system morphogenesis |
GO:0009890 | 0 | 2.0371 | 31.9827 | 58 | 1560 | negative regulation of biosynthetic process |
GO:0001944 | 0 | 2.6461 | 12.4241 | 30 | 606 | vasculature development |
GO:0060021 | 0 | 6.4608 | 1.7631 | 10 | 86 | palate development |
GO:0001708 | 0 | 7.4183 | 1.4021 | 9 | 69 | cell fate specification |
GO:2000027 | 0 | 4.1388 | 3.9902 | 15 | 198 | regulation of organ morphogenesis |
GO:0099537 | 0 | 2.6738 | 11.44 | 28 | 558 | trans-synaptic signaling |
GO:0048468 | 0 | 1.9075 | 37.0671 | 63 | 1808 | cell development |
GO:0003151 | 0 | 6.9977 | 1.4761 | 9 | 72 | outflow tract morphogenesis |
GO:0042472 | 0 | 6.06 | 1.8657 | 10 | 91 | inner ear morphogenesis |
GO:0006725 | 0 | 1.6234 | 112.1445 | 148 | 5470 | cellular aromatic compound metabolic process |
GO:0001763 | 0 | 4.2488 | 3.6288 | 14 | 177 | morphogenesis of a branching structure |
GO:0021517 | 0 | 9.751 | 0.8611 | 7 | 42 | ventral spinal cord development |
GO:0046483 | 0 | 1.5962 | 111.4884 | 146 | 5438 | heterocycle metabolic process |
GO:0090596 | 0 | 3.575 | 4.8794 | 16 | 238 | sensory organ morphogenesis |
GO:0007275 | 0 | 1.888 | 39.718 | 64 | 2343 | multicellular organism development |
GO:0048646 | 0 | 3.0141 | 7.2161 | 20 | 379 | anatomical structure formation involved in morphogenesis |
GO:0001756 | 0 | 7.1053 | 1.2916 | 8 | 63 | somitogenesis |
GO:0071772 | 1e-04 | 4.3762 | 3.0138 | 12 | 147 | response to BMP |
GO:0034641 | 1e-04 | 1.5645 | 123.2359 | 157 | 6011 | cellular nitrogen compound metabolic process |
GO:0021953 | 1e-04 | 4.61 | 2.6275 | 11 | 130 | central nervous system neuron differentiation |
GO:0035050 | 1e-04 | 6.511 | 1.3941 | 8 | 68 | embryonic heart tube development |
GO:0030154 | 1e-04 | 2.0753 | 22.1263 | 41 | 1248 | cell differentiation |
GO:0010454 | 1e-04 | 24.1845 | 0.246 | 4 | 12 | negative regulation of cell fate commitment |
GO:0021515 | 1e-04 | 9.8112 | 0.7317 | 6 | 36 | cell differentiation in spinal cord |
GO:1901360 | 1e-04 | 1.5536 | 116.1833 | 149 | 5667 | organic cyclic compound metabolic process |
GO:0065007 | 1e-04 | 1.737 | 140.9537 | 168 | 7441 | biological regulation |
GO:0003231 | 1e-04 | 4.8055 | 2.2962 | 10 | 112 | cardiac ventricle development |
GO:0003214 | 1e-04 | 21.4959 | 0.2665 | 4 | 13 | cardiac left ventricle morphogenesis |
GO:0008595 | 1e-04 | 21.4959 | 0.2665 | 4 | 13 | anterior/posterior axis specification, embryo |
GO:0051094 | 1e-04 | 3.2107 | 5.3973 | 16 | 280 | positive regulation of developmental process |
GO:0060537 | 1e-04 | 2.8463 | 7.1961 | 19 | 351 | muscle tissue development |
GO:0001704 | 1e-04 | 4.5794 | 2.3987 | 10 | 117 | formation of primary germ layer |
GO:0048732 | 1e-04 | 2.7131 | 7.9342 | 20 | 387 | gland development |
GO:0009887 | 2e-04 | 3.1151 | 5.5484 | 16 | 308 | animal organ morphogenesis |
GO:0016331 | 2e-04 | 4.1534 | 2.8907 | 11 | 141 | morphogenesis of embryonic epithelium |
GO:0007611 | 2e-04 | 3.4024 | 4.4489 | 14 | 217 | learning or memory |
GO:0086073 | 2e-04 | 48.229 | 0.123 | 3 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0048699 | 2e-04 | 2.3064 | 12.6483 | 27 | 638 | generation of neurons |
GO:0048729 | 2e-04 | 2.541 | 9.318 | 22 | 474 | tissue morphogenesis |
GO:0061311 | 2e-04 | 11.0183 | 0.5535 | 5 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0007350 | 2e-04 | 17.5852 | 0.3075 | 4 | 15 | blastoderm segmentation |
GO:0061377 | 2e-04 | 17.5852 | 0.3075 | 4 | 15 | mammary gland lobule development |
GO:0098911 | 2e-04 | 17.5852 | 0.3075 | 4 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0016477 | 2e-04 | 1.8974 | 24.6226 | 43 | 1201 | cell migration |
GO:0072001 | 2e-04 | 3.0991 | 5.2074 | 15 | 254 | renal system development |
GO:0072132 | 3e-04 | 7.287 | 0.9431 | 6 | 46 | mesenchyme morphogenesis |
GO:0016070 | 4e-04 | 1.6414 | 52.0805 | 75 | 2847 | RNA metabolic process |
GO:0060429 | 4e-04 | 2.0142 | 17.6758 | 33 | 910 | epithelium development |
GO:0051892 | 4e-04 | Inf | 0.041 | 2 | 2 | negative regulation of cardioblast differentiation |
GO:0061032 | 4e-04 | Inf | 0.041 | 2 | 2 | visceral serous pericardium development |
GO:2000043 | 4e-04 | Inf | 0.041 | 2 | 2 | regulation of cardiac cell fate specification |
GO:0001710 | 4e-04 | 13.8141 | 0.369 | 4 | 18 | mesodermal cell fate commitment |
GO:0033278 | 4e-04 | 28.9335 | 0.164 | 3 | 8 | cell proliferation in midbrain |
GO:0048754 | 5e-04 | 4.3194 | 2.2706 | 9 | 112 | branching morphogenesis of an epithelial tube |
GO:0008306 | 5e-04 | 5.5851 | 1.3941 | 7 | 68 | associative learning |
GO:2000026 | 5e-04 | 1.7792 | 28.7805 | 47 | 1482 | regulation of multicellular organismal development |
GO:0030509 | 5e-04 | 3.8531 | 2.8087 | 10 | 137 | BMP signaling pathway |
GO:0061448 | 6e-04 | 3.1332 | 4.4489 | 13 | 217 | connective tissue development |
GO:0030539 | 6e-04 | 12.0858 | 0.41 | 4 | 20 | male genitalia development |
GO:0002934 | 7e-04 | 24.1097 | 0.1845 | 3 | 9 | desmosome organization |
GO:0060923 | 7e-04 | 24.1097 | 0.1845 | 3 | 9 | cardiac muscle cell fate commitment |
GO:1905770 | 7e-04 | 24.1097 | 0.1845 | 3 | 9 | regulation of mesodermal cell differentiation |
GO:1905330 | 7e-04 | 3.4551 | 3.4238 | 11 | 167 | regulation of morphogenesis of an epithelium |
GO:0035137 | 7e-04 | 8.0758 | 0.7176 | 5 | 35 | hindlimb morphogenesis |
GO:0043583 | 8e-04 | 3.1827 | 4.0388 | 12 | 197 | ear development |
GO:0002065 | 8e-04 | 4.431 | 1.9682 | 8 | 96 | columnar/cuboidal epithelial cell differentiation |
GO:0001947 | 8e-04 | 6.0692 | 1.1071 | 6 | 54 | heart looping |
GO:0090287 | 9e-04 | 2.9707 | 4.6744 | 13 | 228 | regulation of cellular response to growth factor stimulus |
GO:0021520 | 9e-04 | 20.7968 | 0.2037 | 3 | 10 | spinal cord motor neuron cell fate specification |
GO:0001841 | 9e-04 | 4.3319 | 2.0092 | 8 | 98 | neural tube formation |
GO:0032275 | 9e-04 | 20.6641 | 0.205 | 3 | 10 | luteinizing hormone secretion |
GO:0051674 | 0.001 | 1.7444 | 27.1853 | 44 | 1326 | localization of cell |
GO:0007399 | 0.001 | 1.8408 | 21.7423 | 37 | 1168 | nervous system development |
GO:0060828 | 0.001 | 2.9292 | 4.7359 | 13 | 231 | regulation of canonical Wnt signaling pathway |
GO:0048483 | 0.001 | 7.3401 | 0.7791 | 5 | 38 | autonomic nervous system development |
GO:0010467 | 0.001 | 1.5533 | 60.2121 | 82 | 3287 | gene expression |
GO:0008284 | 0.001 | 1.9554 | 16.3809 | 30 | 799 | positive regulation of cell proliferation |
GO:0042733 | 0.001 | 5.7481 | 1.1614 | 6 | 57 | embryonic digit morphogenesis |
GO:0009798 | 0.0011 | 4.7952 | 1.5991 | 7 | 78 | axis specification |
GO:0001525 | 0.0011 | 2.3454 | 8.6107 | 19 | 420 | angiogenesis |
GO:0042127 | 0.0011 | 2.0854 | 12.8102 | 25 | 657 | regulation of cell proliferation |
GO:0060571 | 0.0011 | 10.1754 | 0.4715 | 4 | 23 | morphogenesis of an epithelial fold |
GO:0060914 | 0.0011 | 10.1754 | 0.4715 | 4 | 23 | heart formation |
GO:0035637 | 0.0012 | 3.2057 | 3.6698 | 11 | 179 | multicellular organismal signaling |
GO:0045892 | 0.0012 | 2.6298 | 6.0751 | 15 | 319 | negative regulation of transcription, DNA-templated |
GO:0021912 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035880 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0044691 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | tooth eruption |
GO:0060913 | 0.0012 | 96.1608 | 0.0615 | 2 | 3 | cardiac cell fate determination |
GO:0060379 | 0.0012 | 18.0798 | 0.2255 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060536 | 0.0012 | 18.0798 | 0.2255 | 3 | 11 | cartilage morphogenesis |
GO:0060573 | 0.0012 | 18.0798 | 0.2255 | 3 | 11 | cell fate specification involved in pattern specification |
GO:0030326 | 0.0013 | 6.9216 | 0.8178 | 5 | 41 | embryonic limb morphogenesis |
GO:0021511 | 0.0013 | 9.666 | 0.492 | 4 | 24 | spinal cord patterning |
GO:0072089 | 0.0013 | 4.0596 | 2.1322 | 8 | 104 | stem cell proliferation |
GO:0044238 | 0.0015 | 1.4501 | 194.582 | 220 | 9491 | primary metabolic process |
GO:0097485 | 0.0015 | 2.9262 | 4.3669 | 12 | 213 | neuron projection guidance |
GO:0061180 | 0.0015 | 5.2943 | 1.2506 | 6 | 61 | mammary gland epithelium development |
GO:0045597 | 0.0015 | 1.9006 | 16.8114 | 30 | 820 | positive regulation of cell differentiation |
GO:0006928 | 0.0016 | 1.6651 | 31.1317 | 48 | 1557 | movement of cell or subcellular component |
GO:0060292 | 0.0016 | 9.2051 | 0.5125 | 4 | 25 | long term synaptic depression |
GO:0060441 | 0.0016 | 9.2051 | 0.5125 | 4 | 25 | epithelial tube branching involved in lung morphogenesis |
GO:0007368 | 0.0016 | 3.9358 | 2.1937 | 8 | 107 | determination of left/right symmetry |
GO:0060291 | 0.0017 | 5.1994 | 1.2711 | 6 | 62 | long-term synaptic potentiation |
GO:0048863 | 0.0017 | 2.7498 | 5.0229 | 13 | 245 | stem cell differentiation |
GO:0035051 | 0.0017 | 3.5407 | 2.7267 | 9 | 133 | cardiocyte differentiation |
GO:0048546 | 0.0018 | 8.8627 | 0.5286 | 4 | 26 | digestive tract morphogenesis |
GO:0048706 | 0.0019 | 8.698 | 0.5354 | 4 | 27 | embryonic skeletal system development |
GO:0007420 | 0.0019 | 2.0254 | 12.5676 | 24 | 613 | brain development |
GO:0048333 | 0.002 | 14.6353 | 0.2635 | 3 | 13 | mesodermal cell differentiation |
GO:0006837 | 0.0021 | 14.4619 | 0.2665 | 3 | 13 | serotonin transport |
GO:0042074 | 0.0021 | 14.4619 | 0.2665 | 3 | 13 | cell migration involved in gastrulation |
GO:0007422 | 0.0021 | 4.934 | 1.3326 | 6 | 65 | peripheral nervous system development |
GO:0050905 | 0.0022 | 4.2004 | 1.8042 | 7 | 88 | neuromuscular process |
GO:0009712 | 0.0022 | 6.0528 | 0.9226 | 5 | 45 | catechol-containing compound metabolic process |
GO:0031018 | 0.0022 | 6.0528 | 0.9226 | 5 | 45 | endocrine pancreas development |
GO:0086002 | 0.0022 | 6.0528 | 0.9226 | 5 | 45 | cardiac muscle cell action potential involved in contraction |
GO:0000902 | 0.0022 | 1.8511 | 17.2215 | 30 | 840 | cell morphogenesis |
GO:0003008 | 0.0023 | 1.5865 | 36.7186 | 54 | 1791 | system process |
GO:0031175 | 0.0024 | 1.8631 | 16.5244 | 29 | 806 | neuron projection development |
GO:0007188 | 0.0024 | 3.3499 | 2.8702 | 9 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0003164 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | His-Purkinje system development |
GO:0021913 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0034287 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | detection of monosaccharide stimulus |
GO:0042662 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0048105 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | establishment of body hair planar orientation |
GO:0051594 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | detection of glucose |
GO:0060214 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | endocardium formation |
GO:0061030 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
GO:0061183 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | regulation of dermatome development |
GO:0097070 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | ductus arteriosus closure |
GO:0097476 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | spinal cord motor neuron migration |
GO:1905903 | 0.0024 | 48.0772 | 0.082 | 2 | 4 | negative regulation of mesoderm formation |
GO:0007519 | 0.0025 | 3.3243 | 2.8907 | 9 | 141 | skeletal muscle tissue development |
GO:0007517 | 0.0026 | 2.3438 | 7.2166 | 16 | 352 | muscle organ development |
GO:0021527 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | spinal cord association neuron differentiation |
GO:0021794 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | thalamus development |
GO:0071625 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | vocalization behavior |
GO:0099054 | 0.0026 | 13.1463 | 0.287 | 3 | 14 | presynapse assembly |
GO:0072164 | 0.0026 | 4.0496 | 1.8657 | 7 | 91 | mesonephric tubule development |
GO:0035295 | 0.0028 | 2.4857 | 5.9577 | 14 | 309 | tube development |
GO:0042330 | 0.0028 | 2.0619 | 10.7634 | 21 | 525 | taxis |
GO:0021761 | 0.0028 | 4.0017 | 1.8862 | 7 | 92 | limbic system development |
GO:0009799 | 0.0028 | 3.5723 | 2.3987 | 8 | 117 | specification of symmetry |
GO:0035115 | 0.0031 | 7.4324 | 0.6151 | 4 | 30 | embryonic forelimb morphogenesis |
GO:0003156 | 0.0032 | 12.1555 | 0.3049 | 3 | 15 | regulation of animal organ formation |
GO:0007632 | 0.0032 | 5.501 | 1.0046 | 5 | 49 | visual behavior |
GO:0086065 | 0.0032 | 5.501 | 1.0046 | 5 | 49 | cell communication involved in cardiac conduction |
GO:0060579 | 0.0032 | 12.05 | 0.3075 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0007215 | 0.0033 | 4.4768 | 1.4556 | 6 | 71 | glutamate receptor signaling pathway |
GO:0001823 | 0.0034 | 3.8645 | 1.9477 | 7 | 95 | mesonephros development |
GO:0048565 | 0.0035 | 4.4325 | 1.4675 | 6 | 73 | digestive tract development |
GO:0010517 | 0.0035 | 5.3784 | 1.0251 | 5 | 50 | regulation of phospholipase activity |
GO:0043009 | 0.0035 | 2.3331 | 6.7858 | 15 | 352 | chordate embryonic development |
GO:0007626 | 0.0036 | 2.9223 | 3.6288 | 10 | 177 | locomotory behavior |
GO:0010647 | 0.0036 | 1.5996 | 30.7526 | 46 | 1500 | positive regulation of cell communication |
GO:0045165 | 0.0036 | 3.1324 | 3.0532 | 9 | 154 | cell fate commitment |
GO:0023056 | 0.0038 | 1.5948 | 30.8346 | 46 | 1504 | positive regulation of signaling |
GO:0001837 | 0.0038 | 3.3845 | 2.5217 | 8 | 123 | epithelial to mesenchymal transition |
GO:0036342 | 0.0039 | 11.1223 | 0.328 | 3 | 16 | post-anal tail morphogenesis |
GO:1904948 | 0.0039 | 11.1223 | 0.328 | 3 | 16 | midbrain dopaminergic neuron differentiation |
GO:2000380 | 0.0039 | 11.1223 | 0.328 | 3 | 16 | regulation of mesoderm development |
GO:0040019 | 0.004 | 6.9006 | 0.6561 | 4 | 32 | positive regulation of embryonic development |
GO:0010040 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | response to iron(II) ion |
GO:0010957 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | negative regulation of vitamin D biosynthetic process |
GO:0045110 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | intermediate filament bundle assembly |
GO:0060374 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | mast cell differentiation |
GO:0060539 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | diaphragm development |
GO:0071205 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0090237 | 0.004 | 32.0493 | 0.1025 | 2 | 5 | regulation of arachidonic acid secretion |
GO:0043066 | 0.0041 | 1.8237 | 15.6428 | 27 | 763 | negative regulation of apoptotic process |
GO:0007167 | 0.0042 | 1.7476 | 18.7796 | 31 | 916 | enzyme linked receptor protein signaling pathway |
GO:0048519 | 0.0042 | 1.3802 | 94.964 | 117 | 4632 | negative regulation of biological process |
GO:0016055 | 0.0044 | 2.1012 | 9.0208 | 18 | 440 | Wnt signaling pathway |
GO:0072175 | 0.0044 | 3.2978 | 2.5832 | 8 | 126 | epithelial tube formation |
GO:0098815 | 0.0044 | 6.6622 | 0.6766 | 4 | 33 | modulation of excitatory postsynaptic potential |
GO:0120039 | 0.0046 | 1.9688 | 11.235 | 21 | 548 | plasma membrane bounded cell projection morphogenesis |
GO:0045778 | 0.0046 | 4.1556 | 1.5581 | 6 | 76 | positive regulation of ossification |
GO:0042053 | 0.0047 | 10.3272 | 0.3485 | 3 | 17 | regulation of dopamine metabolic process |
GO:0044342 | 0.0047 | 10.3272 | 0.3485 | 3 | 17 | type B pancreatic cell proliferation |
GO:0072074 | 0.0047 | 10.3272 | 0.3485 | 3 | 17 | kidney mesenchyme development |
GO:0043279 | 0.0047 | 3.6163 | 2.0707 | 7 | 101 | response to alkaloid |
GO:0001738 | 0.0049 | 3.2424 | 2.6242 | 8 | 128 | morphogenesis of a polarized epithelium |
GO:0072073 | 0.0049 | 3.2424 | 2.6242 | 8 | 128 | kidney epithelium development |
GO:0060548 | 0.0049 | 1.7601 | 17.406 | 29 | 849 | negative regulation of cell death |
GO:0046189 | 0.0049 | 6.4397 | 0.6971 | 4 | 34 | phenol-containing compound biosynthetic process |
GO:0086091 | 0.0049 | 6.4397 | 0.6971 | 4 | 34 | regulation of heart rate by cardiac conduction |
GO:0099565 | 0.005 | 3.578 | 2.0912 | 7 | 102 | chemical synaptic transmission, postsynaptic |
GO:0051090 | 0.005 | 2.2376 | 7.0526 | 15 | 344 | regulation of DNA binding transcription factor activity |
GO:0060562 | 0.0051 | 4.8694 | 1.1185 | 5 | 57 | epithelial tube morphogenesis |
GO:0050794 | 0.0054 | 1.4925 | 78.8282 | 96 | 4736 | regulation of cellular process |
GO:0007417 | 0.0055 | 2.9285 | 3.2524 | 9 | 168 | central nervous system development |
GO:0001755 | 0.0055 | 6.2315 | 0.7176 | 4 | 35 | neural crest cell migration |
GO:0010464 | 0.0055 | 6.2315 | 0.7176 | 4 | 35 | regulation of mesenchymal cell proliferation |
GO:0001759 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | organ induction |
GO:0010884 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | positive regulation of lipid storage |
GO:0023019 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | signal transduction involved in regulation of gene expression |
GO:0030318 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | melanocyte differentiation |
GO:0048148 | 0.0055 | 9.6381 | 0.369 | 3 | 18 | behavioral response to cocaine |
GO:0048514 | 0.0057 | 3.9685 | 1.6238 | 6 | 82 | blood vessel morphogenesis |
GO:0050804 | 0.0058 | 2.4515 | 5.152 | 12 | 254 | modulation of chemical synaptic transmission |
GO:0035136 | 0.0058 | 24.3062 | 0.1217 | 2 | 6 | forelimb morphogenesis |
GO:0065008 | 0.0059 | 1.4061 | 65.1545 | 84 | 3178 | regulation of biological quality |
GO:0002069 | 0.006 | 24.0354 | 0.123 | 2 | 6 | columnar/cuboidal epithelial cell maturation |
GO:0002318 | 0.006 | 24.0354 | 0.123 | 2 | 6 | myeloid progenitor cell differentiation |
GO:0003402 | 0.006 | 24.0354 | 0.123 | 2 | 6 | planar cell polarity pathway involved in axis elongation |
GO:0042297 | 0.006 | 24.0354 | 0.123 | 2 | 6 | vocal learning |
GO:0060501 | 0.006 | 24.0354 | 0.123 | 2 | 6 | positive regulation of epithelial cell proliferation involved in lung morphogenesis |
GO:0050731 | 0.006 | 2.883 | 3.3008 | 9 | 161 | positive regulation of peptidyl-tyrosine phosphorylation |
GO:0018212 | 0.006 | 2.1899 | 7.1961 | 15 | 351 | peptidyl-tyrosine modification |
GO:0071363 | 0.0061 | 2.1894 | 7.2013 | 15 | 361 | cellular response to growth factor stimulus |
GO:0010470 | 0.0061 | 6.0364 | 0.7381 | 4 | 36 | regulation of gastrulation |
GO:0040012 | 0.0062 | 1.7631 | 16.1349 | 27 | 787 | regulation of locomotion |
GO:0009888 | 0.0064 | 2.5369 | 4.5736 | 11 | 254 | tissue development |
GO:0051101 | 0.0065 | 3.398 | 2.1937 | 7 | 107 | regulation of DNA binding |
GO:0034505 | 0.0065 | 9.0351 | 0.3895 | 3 | 19 | tooth mineralization |
GO:0042423 | 0.0065 | 9.0351 | 0.3895 | 3 | 19 | catecholamine biosynthetic process |
GO:0048557 | 0.0065 | 9.0351 | 0.3895 | 3 | 19 | embryonic digestive tract morphogenesis |
GO:0050767 | 0.0065 | 1.846 | 13.1006 | 23 | 639 | regulation of neurogenesis |
GO:0023061 | 0.0065 | 2.1117 | 7.9547 | 16 | 388 | signal release |
GO:0006836 | 0.0065 | 2.8452 | 3.3418 | 9 | 163 | neurotransmitter transport |
GO:0007268 | 0.0067 | 2.5193 | 4.5959 | 11 | 232 | chemical synaptic transmission |
GO:0060349 | 0.0067 | 3.826 | 1.6811 | 6 | 82 | bone morphogenesis |
GO:0060840 | 0.0067 | 3.826 | 1.6811 | 6 | 82 | artery development |
GO:0032990 | 0.0068 | 1.8942 | 11.645 | 21 | 568 | cell part morphogenesis |
GO:0030534 | 0.0068 | 3.3605 | 2.2159 | 7 | 109 | adult behavior |
GO:0060675 | 0.0071 | 4.4793 | 1.2096 | 5 | 59 | ureteric bud morphogenesis |
GO:1903115 | 0.0074 | 5.6806 | 0.7791 | 4 | 38 | regulation of actin filament-based movement |
GO:0031290 | 0.0075 | 8.503 | 0.41 | 3 | 20 | retinal ganglion cell axon guidance |
GO:0043586 | 0.0075 | 8.503 | 0.41 | 3 | 20 | tongue development |
GO:0050951 | 0.0075 | 8.503 | 0.41 | 3 | 20 | sensory perception of temperature stimulus |
GO:0072080 | 0.0075 | 3.7274 | 1.7221 | 6 | 84 | nephron tubule development |
GO:0098655 | 0.0077 | 1.7703 | 14.8433 | 25 | 724 | cation transmembrane transport |
GO:0003197 | 0.0081 | 5.5179 | 0.7996 | 4 | 39 | endocardial cushion development |
GO:0022414 | 0.0082 | 1.5809 | 25.4222 | 38 | 1240 | reproductive process |
GO:0055008 | 0.0082 | 4.3188 | 1.2506 | 5 | 61 | cardiac muscle tissue morphogenesis |
GO:0001826 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | inner cell mass cell differentiation |
GO:0048341 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | paraxial mesoderm formation |
GO:0060028 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | convergent extension involved in axis elongation |
GO:0098597 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | observational learning |
GO:2000035 | 0.0082 | 19.227 | 0.1435 | 2 | 7 | regulation of stem cell division |
GO:0050808 | 0.0083 | 2.4394 | 4.7359 | 11 | 231 | synapse organization |
GO:0048522 | 0.0083 | 1.491 | 39.4151 | 54 | 2141 | positive regulation of cellular process |
GO:0009966 | 0.0085 | 1.4063 | 56.0638 | 73 | 2764 | regulation of signal transduction |
GO:0010842 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | retina layer formation |
GO:0048103 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | somatic stem cell division |
GO:0051953 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | negative regulation of amine transport |
GO:0097120 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | receptor localization to synapse |
GO:2000191 | 0.0086 | 8.0301 | 0.4305 | 3 | 21 | regulation of fatty acid transport |
GO:0045596 | 0.0089 | 1.8458 | 11.9306 | 21 | 589 | negative regulation of cell differentiation |
GO:0072210 | 0.0089 | 5.3643 | 0.8201 | 4 | 40 | metanephric nephron development |
GO:0060541 | 0.0094 | 2.6706 | 3.5457 | 9 | 174 | respiratory system development |
GO:0043303 | 0.0097 | 5.2189 | 0.8406 | 4 | 41 | mast cell degranulation |
GO:0048701 | 0.0097 | 5.2189 | 0.8406 | 4 | 41 | embryonic cranial skeleton morphogenesis |
GO:0048705 | 0.0098 | 5.1904 | 0.8422 | 4 | 43 | skeletal system morphogenesis |
GO:0048169 | 0.0098 | 7.607 | 0.451 | 3 | 22 | regulation of long-term neuronal synaptic plasticity |
GO:0051354 | 0.0098 | 7.607 | 0.451 | 3 | 22 | negative regulation of oxidoreductase activity |
GO:2000679 | 0.0098 | 7.607 | 0.451 | 3 | 22 | positive regulation of transcription regulatory region DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 246.5126 | 0.4731 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 143.7512 | 0.5494 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 90.7479 | 0.6563 | 24 | 43 | protein heterotetramerization |
GO:0006323 | 0 | 16.3724 | 2.7929 | 33 | 183 | DNA packaging |
GO:0045815 | 0 | 31.8554 | 1.1904 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 24.2983 | 1.5109 | 25 | 99 | regulation of gene silencing by miRNA |
GO:0045653 | 0 | 320.2953 | 0.2594 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 12.1783 | 3.6933 | 34 | 242 | protein-DNA complex subunit organization |
GO:1902036 | 0 | 22.6009 | 1.5262 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 18.7024 | 1.8467 | 25 | 121 | regulation of gene silencing |
GO:0035194 | 0 | 9.1483 | 4.1054 | 30 | 269 | posttranscriptional gene silencing by RNA |
GO:0032200 | 0 | 13.0637 | 2.3656 | 24 | 155 | telomere organization |
GO:0002244 | 0 | 11.3163 | 2.7929 | 25 | 183 | hematopoietic progenitor cell differentiation |
GO:0034080 | 0 | 36.9006 | 0.6105 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 34.2603 | 0.641 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0006333 | 0 | 14.5938 | 1.6694 | 19 | 116 | chromatin assembly or disassembly |
GO:0016233 | 0 | 26.6327 | 0.7631 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 26.6327 | 0.7631 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0017148 | 0 | 6.7095 | 5.4026 | 30 | 354 | negative regulation of translation |
GO:0034622 | 0 | 4.0843 | 14.4375 | 48 | 946 | cellular macromolecular complex assembly |
GO:0051259 | 0 | 5.4621 | 7.4782 | 34 | 490 | protein oligomerization |
GO:0048863 | 0 | 7.6969 | 3.7391 | 24 | 245 | stem cell differentiation |
GO:0006303 | 0 | 18.4183 | 1.0073 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 16.2255 | 1.1141 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0030099 | 0 | 5.5621 | 5.4637 | 26 | 358 | myeloid cell differentiation |
GO:0038111 | 0 | 25.8848 | 0.5494 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 25.8848 | 0.5494 | 10 | 36 | response to interleukin-7 |
GO:1903507 | 0 | 3.355 | 16.3758 | 46 | 1073 | negative regulation of nucleic acid-templated transcription |
GO:0034248 | 0 | 4.3146 | 8.6534 | 32 | 567 | regulation of cellular amide metabolic process |
GO:1903707 | 0 | 9.1673 | 1.9382 | 15 | 127 | negative regulation of hemopoiesis |
GO:0051253 | 0 | 3.116 | 17.4899 | 46 | 1146 | negative regulation of RNA metabolic process |
GO:0010608 | 0 | 3.836 | 9.9659 | 33 | 653 | posttranscriptional regulation of gene expression |
GO:0006342 | 0 | 15.1182 | 0.9057 | 11 | 66 | chromatin silencing |
GO:0045652 | 0 | 16.2973 | 0.7755 | 10 | 54 | regulation of megakaryocyte differentiation |
GO:0010558 | 0 | 2.7608 | 22.4194 | 52 | 1469 | negative regulation of macromolecule biosynthetic process |
GO:0043043 | 0 | 3.3385 | 12.072 | 35 | 791 | peptide biosynthetic process |
GO:0031327 | 0 | 2.6076 | 23.564 | 52 | 1544 | negative regulation of cellular biosynthetic process |
GO:0070271 | 0 | 2.6706 | 20.0538 | 46 | 1314 | protein complex biogenesis |
GO:0071822 | 0 | 2.285 | 23.564 | 47 | 1544 | protein complex subunit organization |
GO:0006334 | 0 | 8.0052 | 1.2757 | 9 | 93 | nucleosome assembly |
GO:0002227 | 0 | 25.3391 | 0.2747 | 5 | 18 | innate immune response in mucosa |
GO:0040029 | 0 | 3.9552 | 4.7472 | 17 | 345 | regulation of gene expression, epigenetic |
GO:0048534 | 0 | 2.708 | 12.3314 | 30 | 808 | hematopoietic or lymphoid organ development |
GO:0006352 | 0 | 4.4909 | 3.4339 | 14 | 225 | DNA-templated transcription, initiation |
GO:0006355 | 0 | 1.8632 | 49.982 | 78 | 3275 | regulation of transcription, DNA-templated |
GO:2001141 | 0 | 1.8434 | 50.3941 | 78 | 3302 | regulation of RNA biosynthetic process |
GO:0022607 | 1e-04 | 1.8553 | 39.1615 | 63 | 2566 | cellular component assembly |
GO:0002251 | 1e-04 | 14.3125 | 0.4273 | 5 | 28 | organ or tissue specific immune response |
GO:0060249 | 1e-04 | 3.2956 | 5.2653 | 16 | 345 | anatomical structure homeostasis |
GO:0051248 | 1e-04 | 2.1435 | 18.5735 | 36 | 1217 | negative regulation of protein metabolic process |
GO:0019219 | 1e-04 | 1.7049 | 58.2996 | 84 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0019731 | 2e-04 | 11.3468 | 0.5189 | 5 | 34 | antibacterial humoral response |
GO:0051276 | 2e-04 | 2.3274 | 12.7237 | 27 | 920 | chromosome organization |
GO:0009889 | 2e-04 | 1.6493 | 63.0612 | 88 | 4132 | regulation of biosynthetic process |
GO:0034654 | 3e-04 | 1.6364 | 59.2458 | 83 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0061844 | 5e-04 | 8.6542 | 0.6563 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006281 | 5e-04 | 2.6115 | 7.4019 | 18 | 485 | DNA repair |
GO:1903706 | 0.001 | 3.0685 | 4.1757 | 12 | 290 | regulation of hemopoiesis |
GO:0090304 | 0.001 | 1.5368 | 71.5467 | 94 | 4688 | nucleic acid metabolic process |
GO:0010467 | 0.0013 | 1.5183 | 75.7132 | 98 | 4961 | gene expression |
GO:0050830 | 0.0014 | 5.3435 | 1.2209 | 6 | 80 | defense response to Gram-positive bacterium |
GO:0034645 | 0.002 | 1.4974 | 71.9283 | 93 | 4713 | cellular macromolecule biosynthetic process |
GO:0045596 | 0.0022 | 2.2047 | 9.1723 | 19 | 601 | negative regulation of cell differentiation |
GO:0034641 | 0.004 | 1.4334 | 91.7379 | 112 | 6011 | cellular nitrogen compound metabolic process |
GO:0006725 | 0.0048 | 1.4271 | 83.4814 | 103 | 5470 | cellular aromatic compound metabolic process |
GO:1901360 | 0.0051 | 1.4218 | 86.4879 | 106 | 5667 | organic cyclic compound metabolic process |
GO:0009892 | 0.0052 | 1.5211 | 41.1455 | 57 | 2696 | negative regulation of metabolic process |
GO:0002376 | 0.0054 | 1.5355 | 37.7269 | 53 | 2472 | immune system process |
GO:0046483 | 0.0058 | 1.4151 | 82.993 | 102 | 5438 | heterocycle metabolic process |
GO:0014888 | 0.0065 | 5.8181 | 0.7478 | 4 | 49 | striated muscle adaptation |
GO:0060045 | 0.0087 | 7.8308 | 0.4273 | 3 | 28 | positive regulation of cardiac muscle cell proliferation |
GO:0050793 | 0.0096 | 1.5126 | 33.5604 | 47 | 2199 | regulation of developmental process |
GO:0000098 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | sulfur amino acid catabolic process |
GO:0014819 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | regulation of skeletal muscle contraction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 242.9757 | 0.4792 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 141.6887 | 0.5565 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 89.4459 | 0.6647 | 24 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 510.0339 | 0.2628 | 15 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 31.3983 | 1.2057 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 23.9481 | 1.5304 | 25 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 23.6272 | 1.5458 | 25 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0031497 | 0 | 17.4602 | 2.2105 | 28 | 143 | chromatin assembly |
GO:0045814 | 0 | 20.3265 | 1.8086 | 26 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 18.4328 | 1.8704 | 25 | 121 | regulation of gene silencing |
GO:0032200 | 0 | 14.3024 | 2.396 | 26 | 155 | telomere organization |
GO:0065004 | 0 | 10.9222 | 3.2617 | 28 | 211 | protein-DNA complex assembly |
GO:0034080 | 0 | 40.7403 | 0.6183 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 37.7174 | 0.6492 | 15 | 42 | beta-catenin-TCF complex assembly |
GO:0002244 | 0 | 11.1532 | 2.8288 | 25 | 183 | hematopoietic progenitor cell differentiation |
GO:0030099 | 0 | 7.3558 | 5.534 | 33 | 358 | myeloid cell differentiation |
GO:0071103 | 0 | 8.7791 | 3.9418 | 28 | 255 | DNA conformation change |
GO:0034724 | 0 | 29.0808 | 0.7729 | 15 | 50 | DNA replication-independent nucleosome organization |
GO:0048863 | 0 | 8.7782 | 3.7873 | 27 | 245 | stem cell differentiation |
GO:0016233 | 0 | 26.2675 | 0.7729 | 14 | 50 | telomere capping |
GO:0035194 | 0 | 7.5345 | 4.1582 | 26 | 269 | posttranscriptional gene silencing by RNA |
GO:0017148 | 0 | 6.3393 | 5.4722 | 29 | 354 | negative regulation of translation |
GO:0043044 | 0 | 17.5218 | 1.1284 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 18.1658 | 1.0202 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:1903707 | 0 | 10.5296 | 1.9632 | 17 | 127 | negative regulation of hemopoiesis |
GO:0038111 | 0 | 25.5361 | 0.5565 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 25.5361 | 0.5565 | 10 | 36 | response to interleukin-7 |
GO:1902679 | 0 | 3.2979 | 16.6021 | 46 | 1074 | negative regulation of RNA biosynthetic process |
GO:0045892 | 0 | 3.32 | 16.092 | 45 | 1041 | negative regulation of transcription, DNA-templated |
GO:0045934 | 0 | 3.0795 | 19.8792 | 51 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0034728 | 0 | 11.3281 | 1.4959 | 14 | 103 | nucleosome organization |
GO:0048534 | 0 | 3.5545 | 12.4902 | 38 | 808 | hematopoietic or lymphoid organ development |
GO:0051259 | 0 | 4.245 | 7.5745 | 28 | 490 | protein oligomerization |
GO:0034248 | 0 | 3.9307 | 8.7648 | 30 | 567 | regulation of cellular amide metabolic process |
GO:0045652 | 0 | 16.1407 | 0.7826 | 10 | 54 | regulation of megakaryocyte differentiation |
GO:0010608 | 0 | 3.6399 | 10.0942 | 32 | 653 | posttranscriptional regulation of gene expression |
GO:0051252 | 0 | 2.1989 | 53.7326 | 92 | 3476 | regulation of RNA metabolic process |
GO:0006352 | 0 | 5.913 | 3.4781 | 18 | 225 | DNA-templated transcription, initiation |
GO:0051239 | 0 | 2.2809 | 39.913 | 74 | 2582 | regulation of multicellular organismal process |
GO:1903506 | 0 | 2.1519 | 50.9347 | 87 | 3295 | regulation of nucleic acid-templated transcription |
GO:0045596 | 0 | 3.5414 | 9.2904 | 29 | 601 | negative regulation of cell differentiation |
GO:0009890 | 0 | 2.5343 | 24.1148 | 52 | 1560 | negative regulation of biosynthetic process |
GO:0043043 | 0 | 3.061 | 12.2274 | 33 | 791 | peptide biosynthetic process |
GO:0034654 | 0 | 2.0005 | 60.0086 | 95 | 3882 | nucleobase-containing compound biosynthetic process |
GO:2000112 | 0 | 1.9496 | 58.772 | 92 | 3802 | regulation of cellular macromolecule biosynthetic process |
GO:1903706 | 0 | 4.2133 | 4.1948 | 16 | 290 | regulation of hemopoiesis |
GO:0060249 | 0 | 3.7128 | 5.3331 | 18 | 345 | anatomical structure homeostasis |
GO:0048869 | 0 | 1.8396 | 58.9111 | 89 | 3811 | cellular developmental process |
GO:0010604 | 0 | 1.9259 | 42.8192 | 70 | 2770 | positive regulation of macromolecule metabolic process |
GO:0009059 | 0 | 1.7148 | 74.7557 | 104 | 4836 | macromolecule biosynthetic process |
GO:0048731 | 1e-04 | 1.7527 | 58.3903 | 85 | 3931 | system development |
GO:0044249 | 1e-04 | 1.6774 | 88.6063 | 118 | 5732 | cellular biosynthetic process |
GO:0002376 | 2e-04 | 1.7836 | 38.2126 | 60 | 2472 | immune system process |
GO:0065003 | 2e-04 | 1.917 | 25.4905 | 44 | 1649 | macromolecular complex assembly |
GO:0090304 | 3e-04 | 1.6154 | 72.4679 | 98 | 4688 | nucleic acid metabolic process |
GO:0070271 | 3e-04 | 2.0026 | 20.312 | 37 | 1314 | protein complex biogenesis |
GO:0051248 | 3e-04 | 2.0402 | 18.8126 | 35 | 1217 | negative regulation of protein metabolic process |
GO:0007596 | 3e-04 | 3.2056 | 4.6993 | 14 | 304 | blood coagulation |
GO:1901360 | 4e-04 | 1.5676 | 87.6015 | 113 | 5667 | organic cyclic compound metabolic process |
GO:0007218 | 6e-04 | 5.3749 | 1.4222 | 7 | 92 | neuropeptide signaling pathway |
GO:0065008 | 8e-04 | 1.6729 | 40.5775 | 60 | 2734 | regulation of biological quality |
GO:0046483 | 8e-04 | 1.5357 | 84.0616 | 108 | 5438 | heterocycle metabolic process |
GO:0080090 | 8e-04 | 1.5347 | 85.02 | 109 | 5500 | regulation of primary metabolic process |
GO:0006725 | 0.001 | 1.5215 | 84.5562 | 108 | 5470 | cellular aromatic compound metabolic process |
GO:0007268 | 0.0011 | 2.3587 | 8.6102 | 19 | 557 | chemical synaptic transmission |
GO:0045595 | 0.0011 | 2.073 | 13.592 | 26 | 963 | regulation of cell differentiation |
GO:0099537 | 0.0011 | 2.3541 | 8.6257 | 19 | 558 | trans-synaptic signaling |
GO:0060535 | 0.0014 | 64.2265 | 0.0618 | 2 | 4 | trachea cartilage morphogenesis |
GO:0071651 | 0.0014 | 64.2265 | 0.0618 | 2 | 4 | positive regulation of chemokine (C-C motif) ligand 5 production |
GO:0072268 | 0.0014 | 64.2265 | 0.0618 | 2 | 4 | pattern specification involved in metanephros development |
GO:0001662 | 0.0014 | 9.2383 | 0.4947 | 4 | 32 | behavioral fear response |
GO:0072001 | 0.0014 | 3.1177 | 3.7574 | 11 | 245 | renal system development |
GO:0006281 | 0.0015 | 2.4155 | 7.4972 | 17 | 485 | DNA repair |
GO:0050878 | 0.0015 | 2.4814 | 6.8634 | 16 | 444 | regulation of body fluid levels |
GO:0001819 | 0.0016 | 2.6452 | 5.6268 | 14 | 364 | positive regulation of cytokine production |
GO:0009914 | 0.0018 | 2.8534 | 4.4674 | 12 | 289 | hormone transport |
GO:0060008 | 0.0021 | 13.8109 | 0.2628 | 3 | 17 | Sertoli cell differentiation |
GO:0045666 | 0.0024 | 2.7619 | 4.6065 | 12 | 298 | positive regulation of neuron differentiation |
GO:0032268 | 0.0025 | 1.6003 | 37.1769 | 54 | 2405 | regulation of cellular protein metabolic process |
GO:0051716 | 0.0025 | 1.4582 | 99.257 | 121 | 6421 | cellular response to stimulus |
GO:0060438 | 0.0025 | 12.8893 | 0.2782 | 3 | 18 | trachea development |
GO:1900120 | 0.0025 | 12.8893 | 0.2782 | 3 | 18 | regulation of receptor binding |
GO:0071822 | 0.0026 | 1.7236 | 23.8674 | 38 | 1544 | protein complex subunit organization |
GO:0019932 | 0.0027 | 2.8557 | 4.081 | 11 | 264 | second-messenger-mediated signaling |
GO:0048519 | 0.0029 | 1.4978 | 62.701 | 82 | 4186 | negative regulation of biological process |
GO:0023061 | 0.0029 | 2.4714 | 5.9978 | 14 | 388 | signal release |
GO:0048518 | 0.0034 | 1.5315 | 51.4074 | 69 | 3520 | positive regulation of biological process |
GO:0002793 | 0.0034 | 2.9382 | 3.6018 | 10 | 233 | positive regulation of peptide secretion |
GO:0072073 | 0.0038 | 3.7666 | 1.9786 | 7 | 128 | kidney epithelium development |
GO:0010468 | 0.0042 | 1.5192 | 49.0852 | 66 | 3512 | regulation of gene expression |
GO:0034641 | 0.0046 | 1.4226 | 92.9191 | 113 | 6011 | cellular nitrogen compound metabolic process |
GO:0060986 | 0.0047 | 6.4616 | 0.6802 | 4 | 44 | endocrine hormone secretion |
GO:0031666 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | positive regulation of lipopolysaccharide-mediated signaling pathway |
GO:0034127 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | regulation of MyD88-independent toll-like receptor signaling pathway |
GO:0035385 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | Roundabout signaling pathway |
GO:0048007 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0050957 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | equilibrioception |
GO:0060290 | 0.0047 | 25.6855 | 0.1082 | 2 | 7 | transdifferentiation |
GO:0002761 | 0.0048 | 4.1014 | 1.5613 | 6 | 101 | regulation of myeloid leukocyte differentiation |
GO:0009611 | 0.0049 | 2.0834 | 9.1358 | 18 | 591 | response to wounding |
GO:0002067 | 0.005 | 6.3036 | 0.6956 | 4 | 45 | glandular epithelial cell differentiation |
GO:0060384 | 0.0051 | 9.6637 | 0.3555 | 3 | 23 | innervation |
GO:1903532 | 0.0052 | 2.4866 | 5.0857 | 12 | 329 | positive regulation of secretion by cell |
GO:0051384 | 0.0057 | 3.4768 | 2.1332 | 7 | 138 | response to glucocorticoid |
GO:0015824 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | proline transport |
GO:0070445 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
GO:0090557 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | establishment of endothelial intestinal barrier |
GO:2000252 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | negative regulation of feeding behavior |
GO:2000833 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | positive regulation of steroid hormone secretion |
GO:0006357 | 0.0063 | 1.5967 | 27.6701 | 41 | 1790 | regulation of transcription from RNA polymerase II promoter |
GO:0048588 | 0.0063 | 3.0856 | 2.7361 | 8 | 177 | developmental cell growth |
GO:0048791 | 0.0065 | 8.784 | 0.3865 | 3 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
GO:0071345 | 0.0075 | 1.8557 | 12.5366 | 22 | 811 | cellular response to cytokine stimulus |
GO:0001714 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | endodermal cell fate specification |
GO:0002024 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | diet induced thermogenesis |
GO:0010579 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0072048 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | renal system pattern specification |
GO:0007166 | 0.0081 | 1.5024 | 37.6148 | 52 | 2453 | cell surface receptor signaling pathway |
GO:0030816 | 0.0084 | 4.2592 | 1.2521 | 5 | 81 | positive regulation of cAMP metabolic process |
GO:0051966 | 0.0084 | 5.3818 | 0.8038 | 4 | 52 | regulation of synaptic transmission, glutamatergic |
GO:0090276 | 0.0087 | 2.9113 | 2.8907 | 8 | 187 | regulation of peptide hormone secretion |
GO:0010647 | 0.0089 | 1.6124 | 23.1873 | 35 | 1500 | positive regulation of cell communication |
GO:0048265 | 0.009 | 7.7284 | 0.4328 | 3 | 28 | response to pain |
GO:0023056 | 0.0092 | 1.6076 | 23.2491 | 35 | 1504 | positive regulation of signaling |
GO:0006351 | 0.0093 | 1.5553 | 30.2521 | 43 | 2242 | transcription, DNA-templated |
GO:0002250 | 0.0094 | 2.3925 | 4.823 | 11 | 312 | adaptive immune response |
GO:0051051 | 0.0097 | 2.1312 | 6.8943 | 14 | 446 | negative regulation of transport |
GO:0002475 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | antigen processing and presentation via MHC class Ib |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 246.5126 | 0.4731 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 143.7512 | 0.5494 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 90.7479 | 0.6563 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 31.8554 | 1.1904 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0006323 | 0 | 15.0255 | 2.7929 | 31 | 183 | DNA packaging |
GO:0045653 | 0 | 320.2953 | 0.2594 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 22.9037 | 1.5109 | 24 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 22.6009 | 1.5262 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 17.683 | 1.8467 | 24 | 121 | regulation of gene silencing |
GO:0071824 | 0 | 10.7811 | 3.6933 | 31 | 242 | protein-DNA complex subunit organization |
GO:0032200 | 0 | 14.5126 | 2.3656 | 26 | 155 | telomere organization |
GO:0002244 | 0 | 11.3163 | 2.7929 | 25 | 183 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 9.3262 | 3.7391 | 28 | 245 | stem cell differentiation |
GO:0034080 | 0 | 36.9006 | 0.6105 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 34.2603 | 0.641 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 26.6327 | 0.7631 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 26.6327 | 0.7631 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0035194 | 0 | 7.2854 | 4.1054 | 25 | 269 | posttranscriptional gene silencing by RNA |
GO:0006333 | 0 | 12.6654 | 1.6694 | 17 | 116 | chromatin assembly or disassembly |
GO:0006303 | 0 | 18.4183 | 1.0073 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0030099 | 0 | 6.0859 | 5.4637 | 28 | 358 | myeloid cell differentiation |
GO:0043044 | 0 | 16.2255 | 1.1141 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0017148 | 0 | 5.6315 | 5.4026 | 26 | 354 | negative regulation of translation |
GO:0038111 | 0 | 25.8848 | 0.5494 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 25.8848 | 0.5494 | 10 | 36 | response to interleukin-7 |
GO:1903707 | 0 | 9.1673 | 1.9382 | 15 | 127 | negative regulation of hemopoiesis |
GO:0051259 | 0 | 4.3081 | 7.4782 | 28 | 490 | protein oligomerization |
GO:0045652 | 0 | 16.2973 | 0.7755 | 10 | 54 | regulation of megakaryocyte differentiation |
GO:0034622 | 0 | 3.1312 | 14.4375 | 39 | 946 | cellular macromolecular complex assembly |
GO:0034248 | 0 | 3.6731 | 8.6534 | 28 | 567 | regulation of cellular amide metabolic process |
GO:0006352 | 0 | 5.6099 | 3.4339 | 17 | 225 | DNA-templated transcription, initiation |
GO:0048534 | 0 | 3.0358 | 12.3314 | 33 | 808 | hematopoietic or lymphoid organ development |
GO:1903507 | 0 | 2.7219 | 16.3758 | 39 | 1073 | negative regulation of nucleic acid-templated transcription |
GO:0051253 | 0 | 2.61 | 17.4899 | 40 | 1146 | negative regulation of RNA metabolic process |
GO:0051248 | 0 | 2.5164 | 18.5735 | 41 | 1217 | negative regulation of protein metabolic process |
GO:0006281 | 0 | 3.4545 | 7.4019 | 23 | 485 | DNA repair |
GO:0010608 | 0 | 3.0167 | 9.9659 | 27 | 653 | posttranscriptional regulation of gene expression |
GO:0006996 | 0 | 1.9294 | 51.6455 | 82 | 3384 | organelle organization |
GO:0045596 | 0 | 3.0169 | 9.1723 | 25 | 601 | negative regulation of cell differentiation |
GO:0002227 | 0 | 25.3391 | 0.2747 | 5 | 18 | innate immune response in mucosa |
GO:0060249 | 0 | 3.7654 | 5.2653 | 18 | 345 | anatomical structure homeostasis |
GO:0043043 | 0 | 2.5547 | 12.072 | 28 | 791 | peptide biosynthetic process |
GO:0006342 | 0 | 8.7885 | 0.9057 | 7 | 66 | chromatin silencing |
GO:0031327 | 0 | 2.1005 | 23.564 | 44 | 1544 | negative regulation of cellular biosynthetic process |
GO:0010558 | 0 | 2.0968 | 22.4194 | 42 | 1469 | negative regulation of macromolecule biosynthetic process |
GO:0002251 | 1e-04 | 14.3125 | 0.4273 | 5 | 28 | organ or tissue specific immune response |
GO:0051239 | 1e-04 | 1.8412 | 39.4056 | 63 | 2582 | regulation of multicellular organismal process |
GO:0010604 | 1e-04 | 1.7635 | 42.2748 | 65 | 2770 | positive regulation of macromolecule metabolic process |
GO:0019731 | 2e-04 | 11.3468 | 0.5189 | 5 | 34 | antibacterial humoral response |
GO:0070271 | 2e-04 | 2.0337 | 20.0538 | 37 | 1314 | protein complex biogenesis |
GO:0048731 | 2e-04 | 1.6505 | 63.8701 | 89 | 4185 | system development |
GO:0071840 | 2e-04 | 1.6023 | 86.6558 | 113 | 5678 | cellular component organization or biogenesis |
GO:0006334 | 3e-04 | 6.0204 | 1.2757 | 7 | 93 | nucleosome assembly |
GO:2001141 | 3e-04 | 1.668 | 50.3941 | 73 | 3302 | regulation of RNA biosynthetic process |
GO:0002376 | 4e-04 | 1.7327 | 37.7269 | 58 | 2472 | immune system process |
GO:0009892 | 4e-04 | 1.7069 | 41.1455 | 62 | 2696 | negative regulation of metabolic process |
GO:0006355 | 4e-04 | 1.6519 | 49.982 | 72 | 3275 | regulation of transcription, DNA-templated |
GO:0061844 | 5e-04 | 8.6542 | 0.6563 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0071822 | 6e-04 | 1.8645 | 23.564 | 40 | 1544 | protein complex subunit organization |
GO:0003285 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | septum secundum development |
GO:0019249 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | lactate biosynthetic process |
GO:0042126 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | nitrate metabolic process |
GO:0048869 | 8e-04 | 1.584 | 58.1622 | 80 | 3811 | cellular developmental process |
GO:0007596 | 8e-04 | 2.9937 | 4.6395 | 13 | 304 | blood coagulation |
GO:0022607 | 0.001 | 1.6553 | 39.1615 | 58 | 2566 | cellular component assembly |
GO:0032268 | 0.0011 | 1.6678 | 36.7043 | 55 | 2405 | regulation of cellular protein metabolic process |
GO:0050878 | 0.0013 | 2.5162 | 6.7762 | 16 | 444 | regulation of body fluid levels |
GO:0034654 | 0.0014 | 1.5447 | 59.2458 | 80 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0045595 | 0.0021 | 2.0589 | 12.0202 | 23 | 867 | regulation of cell differentiation |
GO:0019219 | 0.0022 | 1.5186 | 58.2996 | 78 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0051410 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | detoxification of nitrogen compound |
GO:0051891 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:1902961 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
GO:0055001 | 0.0028 | 3.552 | 2.3961 | 8 | 157 | muscle cell development |
GO:0021902 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0032808 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | lacrimal gland development |
GO:0061061 | 0.0037 | 2.144 | 8.8976 | 18 | 583 | muscle structure development |
GO:1902991 | 0.0038 | 10.8812 | 0.3205 | 3 | 21 | regulation of amyloid precursor protein catabolic process |
GO:0009611 | 0.0042 | 2.1129 | 9.0197 | 18 | 591 | response to wounding |
GO:0021796 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | cerebral cortex regionalization |
GO:0043652 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | engulfment of apoptotic cell |
GO:1905245 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | regulation of aspartic-type peptidase activity |
GO:0009889 | 0.0056 | 1.4448 | 63.0612 | 81 | 4132 | regulation of biosynthetic process |
GO:0051147 | 0.0073 | 3.0016 | 2.8081 | 8 | 184 | regulation of muscle cell differentiation |
GO:0050830 | 0.0075 | 4.374 | 1.2209 | 5 | 80 | defense response to Gram-positive bacterium |
GO:0006089 | 0.0077 | 18.7473 | 0.1362 | 2 | 9 | lactate metabolic process |
GO:0008354 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | germ cell migration |
GO:0051639 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | actin filament network formation |
GO:1903706 | 0.0094 | 2.5141 | 4.1757 | 10 | 290 | regulation of hemopoiesis |
GO:0051764 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | actin crosslink formation |
GO:1902004 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | positive regulation of amyloid-beta formation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 32.0585 | 0.4731 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 23.2294 | 0.6563 | 11 | 43 | protein heterotetramerization |
GO:0000183 | 0 | 25.8848 | 0.5494 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 25.8848 | 0.5494 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 25.8848 | 0.5494 | 10 | 36 | response to interleukin-7 |
GO:0006333 | 0 | 7.8624 | 2.5334 | 17 | 166 | chromatin assembly or disassembly |
GO:0006323 | 0 | 7.0492 | 2.7929 | 17 | 183 | DNA packaging |
GO:0045652 | 0 | 12.3659 | 1.0836 | 11 | 71 | regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 5.1801 | 3.6933 | 17 | 242 | protein-DNA complex subunit organization |
GO:0045814 | 0 | 7.7202 | 1.7856 | 12 | 117 | negative regulation of gene expression, epigenetic |
GO:0045815 | 0 | 9.8694 | 1.1904 | 10 | 78 | positive regulation of gene expression, epigenetic |
GO:0002244 | 0 | 5.6229 | 2.7929 | 14 | 183 | hematopoietic progenitor cell differentiation |
GO:0007596 | 0 | 4.3172 | 4.6395 | 18 | 304 | blood coagulation |
GO:0050878 | 0 | 3.6103 | 6.7762 | 22 | 444 | regulation of body fluid levels |
GO:0060964 | 0 | 7.5301 | 1.5109 | 10 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 7.4459 | 1.5262 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0002251 | 0 | 18.036 | 0.4273 | 6 | 28 | organ or tissue specific immune response |
GO:0002227 | 0 | 25.3391 | 0.2747 | 5 | 18 | innate immune response in mucosa |
GO:0048534 | 0 | 2.708 | 12.3314 | 30 | 808 | hematopoietic or lymphoid organ development |
GO:0002376 | 0 | 1.9856 | 37.7269 | 64 | 2472 | immune system process |
GO:0060968 | 0 | 6.0288 | 1.8467 | 10 | 121 | regulation of gene silencing |
GO:1903706 | 0 | 3.265 | 6.3641 | 19 | 417 | regulation of hemopoiesis |
GO:0061844 | 0 | 10.7134 | 0.6563 | 6 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0048863 | 1e-04 | 3.7701 | 3.7391 | 13 | 245 | stem cell differentiation |
GO:0030099 | 1e-04 | 3.1675 | 5.4637 | 16 | 358 | myeloid cell differentiation |
GO:0032200 | 1e-04 | 4.6046 | 2.3656 | 10 | 155 | telomere organization |
GO:0019731 | 2e-04 | 11.3468 | 0.5189 | 5 | 34 | antibacterial humoral response |
GO:0034622 | 3e-04 | 2.1885 | 14.4375 | 29 | 946 | cellular macromolecular complex assembly |
GO:0009611 | 3e-04 | 2.5136 | 9.0197 | 21 | 591 | response to wounding |
GO:0006334 | 4e-04 | 5.6249 | 1.3612 | 7 | 93 | nucleosome assembly |
GO:0002215 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | defense response to nematode |
GO:0016339 | 7e-04 | 11.4 | 0.4121 | 4 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0002369 | 0.0011 | 10.0826 | 0.4579 | 4 | 30 | T cell cytokine production |
GO:0048486 | 0.0011 | 17.8138 | 0.2137 | 3 | 14 | parasympathetic nervous system development |
GO:0050830 | 0.0014 | 5.3435 | 1.2209 | 6 | 80 | defense response to Gram-positive bacterium |
GO:0060696 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | regulation of phospholipid catabolic process |
GO:0032613 | 0.0026 | 7.7061 | 0.5799 | 4 | 38 | interleukin-10 production |
GO:0002825 | 0.0028 | 12.2429 | 0.29 | 3 | 19 | regulation of T-helper 1 type immune response |
GO:0035194 | 0.0029 | 2.8378 | 4.1054 | 11 | 269 | posttranscriptional gene silencing by RNA |
GO:0002250 | 0.0031 | 2.6668 | 4.7616 | 12 | 312 | adaptive immune response |
GO:0043382 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | positive regulation of memory T cell differentiation |
GO:0002606 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | positive regulation of dendritic cell antigen processing and presentation |
GO:0021610 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | facial nerve morphogenesis |
GO:0032615 | 0.0048 | 6.3875 | 0.6868 | 4 | 45 | interleukin-12 production |
GO:0009617 | 0.0058 | 2.2047 | 7.173 | 15 | 470 | response to bacterium |
GO:0006570 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | tyrosine metabolic process |
GO:0090023 | 0.0063 | 8.9004 | 0.3815 | 3 | 25 | positive regulation of neutrophil chemotaxis |
GO:0045621 | 0.0064 | 4.5571 | 1.1751 | 5 | 77 | positive regulation of lymphocyte differentiation |
GO:0051901 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | positive regulation of mitochondrial depolarization |
GO:0090331 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | negative regulation of platelet aggregation |
GO:0090715 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | immunological memory formation process |
GO:0007166 | 0.0078 | 1.5064 | 37.5437 | 52 | 2460 | cell surface receptor signaling pathway |
GO:0098609 | 0.0079 | 1.9056 | 11.08 | 20 | 726 | cell-cell adhesion |
GO:0045595 | 0.008 | 1.6152 | 23.8693 | 36 | 1564 | regulation of cell differentiation |
GO:0017148 | 0.0083 | 2.3326 | 5.4026 | 12 | 354 | negative regulation of translation |
GO:0051259 | 0.0084 | 2.109 | 7.4782 | 15 | 490 | protein oligomerization |
GO:0050866 | 0.0085 | 3.2027 | 2.3045 | 7 | 151 | negative regulation of cell activation |
GO:0018149 | 0.0086 | 5.3418 | 0.8089 | 4 | 53 | peptide cross-linking |
GO:0002449 | 0.0094 | 2.8696 | 2.9302 | 8 | 192 | lymphocyte mediated immunity |
GO:0045580 | 0.0095 | 3.5216 | 1.8009 | 6 | 118 | regulation of T cell differentiation |
GO:0031115 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | negative regulation of microtubule polymerization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 6.7541 | 4.9753 | 28 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 5.8083 | 6.3794 | 31 | 418 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 5.603 | 6.1199 | 29 | 401 | detection of chemical stimulus |
GO:0050906 | 0 | 5.4673 | 6.2573 | 29 | 410 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 2.8411 | 17.1236 | 42 | 1122 | nervous system process |
GO:0007186 | 0 | 2.6865 | 17.5204 | 41 | 1148 | G-protein coupled receptor signaling pathway |
GO:0045919 | 0 | 54.9269 | 0.1679 | 5 | 11 | positive regulation of cytolysis |
GO:0032501 | 0 | 1.786 | 99.964 | 133 | 6550 | multicellular organismal process |
GO:2000821 | 0 | 98.0348 | 0.0763 | 3 | 5 | regulation of grooming behavior |
GO:2000252 | 2e-04 | 39.2061 | 0.1221 | 3 | 8 | negative regulation of feeding behavior |
GO:0051729 | 2e-04 | Inf | 0.0305 | 2 | 2 | germline cell cycle switching, mitotic to meiotic cell cycle |
GO:0060184 | 2e-04 | Inf | 0.0305 | 2 | 2 | cell cycle switching |
GO:0015844 | 4e-04 | 6.8249 | 0.9767 | 6 | 64 | monoamine transport |
GO:0051952 | 6e-04 | 6.2811 | 1.0531 | 6 | 69 | regulation of amine transport |
GO:0071673 | 7e-04 | 130.1558 | 0.0458 | 2 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:0001963 | 0.0011 | 10.0826 | 0.4579 | 4 | 30 | synaptic transmission, dopaminergic |
GO:0014744 | 0.0011 | 17.8138 | 0.2137 | 3 | 14 | positive regulation of muscle adaptation |
GO:0007356 | 0.0014 | 65.0736 | 0.061 | 2 | 4 | thorax and anterior abdomen determination |
GO:0015872 | 0.0019 | 8.4536 | 0.5342 | 4 | 35 | dopamine transport |
GO:0007155 | 0.002 | 1.8437 | 18.7261 | 32 | 1227 | cell adhesion |
GO:0044117 | 0.002 | 13.9938 | 0.2594 | 3 | 17 | growth of symbiont in host |
GO:0051446 | 0.002 | 13.9938 | 0.2594 | 3 | 17 | positive regulation of meiotic cell cycle |
GO:0002309 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | T cell proliferation involved in immune response |
GO:0006824 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | cobalt ion transport |
GO:0014805 | 0.0022 | 43.3795 | 0.0763 | 2 | 5 | smooth muscle adaptation |
GO:0044110 | 0.0024 | 13.06 | 0.2747 | 3 | 18 | growth involved in symbiotic interaction |
GO:0018108 | 0.0028 | 2.5849 | 5.3263 | 13 | 349 | peptidyl-tyrosine phosphorylation |
GO:0050778 | 0.0028 | 2.1546 | 9.3707 | 19 | 614 | positive regulation of immune response |
GO:0002697 | 0.0029 | 2.6943 | 4.7159 | 12 | 309 | regulation of immune effector process |
GO:0034105 | 0.0031 | 7.277 | 0.6105 | 4 | 40 | positive regulation of tissue remodeling |
GO:0051716 | 0.0032 | 1.4464 | 97.9952 | 119 | 6421 | cellular response to stimulus |
GO:0001878 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | response to yeast |
GO:0042536 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | negative regulation of tumor necrosis factor biosynthetic process |
GO:2001179 | 0.0033 | 32.5325 | 0.0916 | 2 | 6 | regulation of interleukin-10 secretion |
GO:0014821 | 0.0038 | 10.8812 | 0.3205 | 3 | 21 | phasic smooth muscle contraction |
GO:0009607 | 0.0039 | 1.9719 | 11.8583 | 22 | 777 | response to biotic stimulus |
GO:0023052 | 0.0042 | 1.4939 | 61.1322 | 79 | 4247 | signaling |
GO:0032496 | 0.0043 | 2.6791 | 4.3343 | 11 | 284 | response to lipopolysaccharide |
GO:0051707 | 0.0044 | 1.9838 | 11.2326 | 21 | 736 | response to other organism |
GO:0071447 | 0.0046 | 26.0242 | 0.1068 | 2 | 7 | cellular response to hydroperoxide |
GO:0050432 | 0.0048 | 6.3875 | 0.6868 | 4 | 45 | catecholamine secretion |
GO:0002366 | 0.005 | 2.0789 | 9.157 | 18 | 600 | leukocyte activation involved in immune response |
GO:0042633 | 0.0052 | 4.0284 | 1.5872 | 6 | 104 | hair cycle |
GO:0002709 | 0.0052 | 6.235 | 0.702 | 4 | 46 | regulation of T cell mediated immunity |
GO:0014059 | 0.0056 | 9.3248 | 0.3663 | 3 | 24 | regulation of dopamine secretion |
GO:0034698 | 0.0056 | 9.3248 | 0.3663 | 3 | 24 | response to gonadotropin |
GO:0002443 | 0.0059 | 2.0001 | 10.0422 | 19 | 658 | leukocyte mediated immunity |
GO:0007195 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0033860 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | regulation of NAD(P)H oxidase activity |
GO:0045630 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
GO:0061140 | 0.0061 | 21.6854 | 0.1221 | 2 | 8 | lung secretory cell differentiation |
GO:0043588 | 0.0063 | 2.329 | 5.8757 | 13 | 385 | skin development |
GO:0032649 | 0.0064 | 4.5571 | 1.1751 | 5 | 77 | regulation of interferon-gamma production |
GO:0032635 | 0.0065 | 3.8316 | 1.6635 | 6 | 109 | interleukin-6 production |
GO:0002283 | 0.0067 | 2.2353 | 6.593 | 14 | 432 | neutrophil activation involved in immune response |
GO:0007267 | 0.007 | 1.6535 | 22.0073 | 34 | 1442 | cell-cell signaling |
GO:1903428 | 0.007 | 5.6913 | 0.7631 | 4 | 50 | positive regulation of reactive oxygen species biosynthetic process |
GO:0007610 | 0.0071 | 2.0955 | 8.0429 | 16 | 527 | behavior |
GO:0007154 | 0.0072 | 1.4527 | 61.4057 | 78 | 4266 | cell communication |
GO:0002218 | 0.0076 | 2.599 | 4.0443 | 10 | 265 | activation of innate immune response |
GO:0007088 | 0.0077 | 3.2715 | 2.2587 | 7 | 148 | regulation of mitotic nuclear division |
GO:0046877 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | regulation of saliva secretion |
GO:0072124 | 0.0078 | 18.5863 | 0.1374 | 2 | 9 | regulation of glomerular mesangial cell proliferation |
GO:0007160 | 0.0078 | 2.9675 | 2.8387 | 8 | 186 | cell-matrix adhesion |
GO:0050670 | 0.0081 | 2.9507 | 2.8539 | 8 | 187 | regulation of lymphocyte proliferation |
GO:0036230 | 0.0087 | 2.1608 | 6.8067 | 14 | 446 | granulocyte activation |
GO:0002224 | 0.0091 | 3.5535 | 1.7856 | 6 | 117 | toll-like receptor signaling pathway |
GO:0006600 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | creatine metabolic process |
GO:0021559 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | trigeminal nerve development |
GO:0035878 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | nail development |
GO:0070486 | 0.0096 | 16.2619 | 0.1526 | 2 | 10 | leukocyte aggregation |
GO:0022600 | 0.0097 | 4.0992 | 1.2972 | 5 | 85 | digestive system process |
GO:0031532 | 0.0097 | 4.0992 | 1.2972 | 5 | 85 | actin cytoskeleton reorganization |
GO:0051896 | 0.01 | 2.8383 | 2.9608 | 8 | 194 | regulation of protein kinase B signaling |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2000026 | 1e-04 | 2.0942 | 21.6551 | 40 | 1713 | regulation of multicellular organismal development |
GO:0010594 | 2e-04 | 5.5281 | 1.5802 | 8 | 125 | regulation of endothelial cell migration |
GO:0070527 | 4e-04 | 8.8824 | 0.6321 | 5 | 50 | platelet aggregation |
GO:0001973 | 5e-04 | 23.7853 | 0.1643 | 3 | 13 | adenosine receptor signaling pathway |
GO:0006026 | 6e-04 | 8.1551 | 0.6826 | 5 | 54 | aminoglycan catabolic process |
GO:0043537 | 6e-04 | 11.7946 | 0.3919 | 4 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0010469 | 8e-04 | 2.6679 | 6.4472 | 16 | 510 | regulation of receptor activity |
GO:0090132 | 8e-04 | 3.6391 | 2.9455 | 10 | 233 | epithelium migration |
GO:0048295 | 9e-04 | 78.911 | 0.0506 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
GO:0045765 | 9e-04 | 3.5424 | 3.0214 | 10 | 239 | regulation of angiogenesis |
GO:0040012 | 0.001 | 2.2806 | 9.949 | 21 | 787 | regulation of locomotion |
GO:0030334 | 0.001 | 2.3772 | 8.609 | 19 | 681 | regulation of cell migration |
GO:0051270 | 0.0011 | 2.2588 | 10.0375 | 21 | 794 | regulation of cellular component movement |
GO:0007178 | 0.0013 | 3.1703 | 3.704 | 11 | 293 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:2000181 | 0.0014 | 5.3419 | 1.2136 | 6 | 96 | negative regulation of blood vessel morphogenesis |
GO:0010633 | 0.0014 | 6.6551 | 0.8217 | 5 | 65 | negative regulation of epithelial cell migration |
GO:0097709 | 0.0014 | 15.8516 | 0.2275 | 3 | 18 | connective tissue replacement |
GO:0035025 | 0.0017 | 14.8599 | 0.2402 | 3 | 19 | positive regulation of Rho protein signal transduction |
GO:0048646 | 0.0018 | 2.0887 | 11.8831 | 23 | 940 | anatomical structure formation involved in morphogenesis |
GO:0001667 | 0.0022 | 2.9464 | 3.9695 | 11 | 314 | ameboidal-type cell migration |
GO:0045595 | 0.0022 | 1.8245 | 19.7715 | 33 | 1564 | regulation of cell differentiation |
GO:0043382 | 0.0023 | 39.4503 | 0.0758 | 2 | 6 | positive regulation of memory T cell differentiation |
GO:0042330 | 0.0028 | 2.4065 | 6.6369 | 15 | 525 | taxis |
GO:0042692 | 0.0028 | 2.7021 | 4.7153 | 12 | 373 | muscle cell differentiation |
GO:0042346 | 0.0029 | 11.8847 | 0.2908 | 3 | 23 | positive regulation of NF-kappaB import into nucleus |
GO:0097090 | 0.0032 | 31.5581 | 0.0885 | 2 | 7 | presynaptic membrane organization |
GO:0034308 | 0.0034 | 7.0683 | 0.6194 | 4 | 49 | primary alcohol metabolic process |
GO:0009611 | 0.0035 | 2.2794 | 7.4712 | 16 | 591 | response to wounding |
GO:0032733 | 0.0037 | 10.8029 | 0.316 | 3 | 25 | positive regulation of interleukin-10 production |
GO:1903671 | 0.0042 | 10.3325 | 0.3287 | 3 | 26 | negative regulation of sprouting angiogenesis |
GO:1900182 | 0.0042 | 4.2105 | 1.517 | 6 | 120 | positive regulation of protein localization to nucleus |
GO:0032071 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | regulation of endodeoxyribonuclease activity |
GO:2000544 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | regulation of endothelial cell chemotaxis to fibroblast growth factor |
GO:0035587 | 0.0047 | 9.9013 | 0.3413 | 3 | 27 | purinergic receptor signaling pathway |
GO:0048710 | 0.0047 | 9.9013 | 0.3413 | 3 | 27 | regulation of astrocyte differentiation |
GO:0072358 | 0.0048 | 2.1959 | 7.7367 | 16 | 612 | cardiovascular system development |
GO:0048870 | 0.0049 | 1.801 | 16.7628 | 28 | 1326 | cell motility |
GO:0030198 | 0.005 | 2.776 | 3.8051 | 10 | 301 | extracellular matrix organization |
GO:0035766 | 0.0054 | 22.5385 | 0.1138 | 2 | 9 | cell chemotaxis to fibroblast growth factor |
GO:0090715 | 0.0054 | 22.5385 | 0.1138 | 2 | 9 | immunological memory formation process |
GO:0035303 | 0.0055 | 3.9651 | 1.6055 | 6 | 127 | regulation of dephosphorylation |
GO:0032735 | 0.0057 | 9.1385 | 0.3666 | 3 | 29 | positive regulation of interleukin-12 production |
GO:0042221 | 0.0061 | 1.4987 | 49.0496 | 65 | 3880 | response to chemical |
GO:0002312 | 0.0062 | 5.8867 | 0.7332 | 4 | 58 | B cell activation involved in immune response |
GO:0043122 | 0.0062 | 3.0906 | 2.7306 | 8 | 216 | regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0070306 | 0.0063 | 8.7994 | 0.3792 | 3 | 30 | lens fiber cell differentiation |
GO:0045664 | 0.0065 | 2.2472 | 6.5863 | 14 | 521 | regulation of neuron differentiation |
GO:0007165 | 0.0069 | 1.454 | 66.1537 | 83 | 5233 | signal transduction |
GO:0071363 | 0.0079 | 2.1288 | 7.4459 | 15 | 589 | cellular response to growth factor stimulus |
GO:0006068 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | ethanol catabolic process |
GO:0030207 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | chondroitin sulfate catabolic process |
GO:0032700 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | negative regulation of interleukin-17 production |
GO:0046607 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | positive regulation of centrosome cycle |
GO:0035307 | 0.0089 | 7.662 | 0.4298 | 3 | 34 | positive regulation of protein dephosphorylation |
GO:0050922 | 0.0089 | 7.662 | 0.4298 | 3 | 34 | negative regulation of chemotaxis |
GO:0007167 | 0.0091 | 2.0954 | 7.5722 | 15 | 623 | enzyme linked receptor protein signaling pathway |
GO:0001937 | 0.0097 | 7.422 | 0.4425 | 3 | 35 | negative regulation of endothelial cell proliferation |
GO:1903510 | 0.0099 | 4.0643 | 1.3021 | 5 | 103 | mucopolysaccharide metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 15.39 | 4.9967 | 52 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 11.7673 | 6.4068 | 53 | 418 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 12.0213 | 6.1462 | 52 | 401 | detection of chemical stimulus |
GO:0050906 | 0 | 11.7119 | 6.2841 | 52 | 410 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 4.6865 | 17.1038 | 61 | 1129 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 4.5363 | 17.1971 | 60 | 1122 | nervous system process |
GO:0000183 | 0 | 38.3887 | 0.5518 | 13 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 38.3887 | 0.5518 | 13 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 38.3887 | 0.5518 | 13 | 36 | response to interleukin-7 |
GO:0045815 | 0 | 14.8839 | 1.1955 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0006335 | 0 | 31.9133 | 0.4751 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0045652 | 0 | 15.1876 | 1.0882 | 13 | 71 | regulation of megakaryocyte differentiation |
GO:0032501 | 0 | 2.3863 | 93.0608 | 140 | 6243 | multicellular organismal process |
GO:1902036 | 0 | 11.0601 | 1.5327 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0051290 | 0 | 20.2922 | 0.6591 | 10 | 43 | protein heterotetramerization |
GO:0060964 | 0 | 10.2237 | 1.5174 | 13 | 99 | regulation of gene silencing by miRNA |
GO:0006333 | 0 | 7.2822 | 2.5443 | 16 | 166 | chromatin assembly or disassembly |
GO:0002244 | 0 | 6.5334 | 2.8049 | 16 | 183 | hematopoietic progenitor cell differentiation |
GO:0006323 | 0 | 6.5334 | 2.8049 | 16 | 183 | DNA packaging |
GO:0045814 | 0 | 8.444 | 1.7933 | 13 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 8.1291 | 1.8546 | 13 | 121 | regulation of gene silencing |
GO:0007154 | 0 | 1.9753 | 87.4875 | 126 | 5708 | cell communication |
GO:0071824 | 0 | 5.1559 | 3.7092 | 17 | 242 | protein-DNA complex subunit organization |
GO:0023052 | 0 | 1.9179 | 87.1963 | 124 | 5689 | signaling |
GO:0048863 | 0 | 4.7447 | 3.7552 | 16 | 245 | stem cell differentiation |
GO:0051716 | 0 | 1.8314 | 98.4158 | 133 | 6421 | cellular response to stimulus |
GO:0030099 | 0 | 3.6012 | 5.4871 | 18 | 358 | myeloid cell differentiation |
GO:0050878 | 0 | 3.2201 | 6.8053 | 20 | 444 | regulation of body fluid levels |
GO:0007596 | 1e-04 | 3.4943 | 4.6595 | 15 | 304 | blood coagulation |
GO:1903706 | 1e-04 | 3.0564 | 6.3914 | 18 | 417 | regulation of hemopoiesis |
GO:0032200 | 1e-04 | 4.5837 | 2.3757 | 10 | 155 | telomere organization |
GO:0035194 | 3e-04 | 3.3955 | 4.123 | 13 | 269 | posttranscriptional gene silencing by RNA |
GO:0048534 | 3e-04 | 2.278 | 12.3844 | 26 | 808 | hematopoietic or lymphoid organ development |
GO:0061383 | 6e-04 | 8.184 | 0.6897 | 5 | 45 | trabecula morphogenesis |
GO:0009611 | 8e-04 | 2.3671 | 9.0584 | 20 | 591 | response to wounding |
GO:0060347 | 0.0011 | 17.7355 | 0.2146 | 3 | 14 | heart trabecula formation |
GO:0017148 | 0.0012 | 2.75 | 5.4258 | 14 | 354 | negative regulation of translation |
GO:0018149 | 0.0013 | 6.8163 | 0.8123 | 5 | 53 | peptide cross-linking |
GO:0035910 | 0.0014 | 64.7888 | 0.0613 | 2 | 4 | ascending aorta morphogenesis |
GO:0055093 | 0.0021 | 13.9323 | 0.2606 | 3 | 17 | response to hyperoxia |
GO:0061436 | 0.0021 | 13.9323 | 0.2606 | 3 | 17 | establishment of skin barrier |
GO:0006334 | 0.0025 | 4.7216 | 1.3673 | 6 | 93 | nucleosome assembly |
GO:0098664 | 0.0029 | 12.1891 | 0.2912 | 3 | 19 | G-protein coupled serotonin receptor signaling pathway |
GO:0006701 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | progesterone biosynthetic process |
GO:0036018 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | cellular response to erythropoietin |
GO:2001258 | 0.0038 | 6.8627 | 0.6437 | 4 | 42 | negative regulation of cation channel activity |
GO:0032410 | 0.0046 | 4.9514 | 1.0882 | 5 | 71 | negative regulation of transporter activity |
GO:0006953 | 0.0049 | 6.3593 | 0.6897 | 4 | 45 | acute-phase response |
GO:0007009 | 0.0049 | 4.8771 | 1.1036 | 5 | 72 | plasma membrane organization |
GO:0007195 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0097084 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | vascular smooth muscle cell development |
GO:0046320 | 0.0064 | 8.8613 | 0.3832 | 3 | 25 | regulation of fatty acid oxidation |
GO:0065007 | 0.0072 | 1.4669 | 162.7593 | 180 | 10619 | biological regulation |
GO:0002682 | 0.0076 | 1.8575 | 12.5673 | 22 | 864 | regulation of immune system process |
GO:0034766 | 0.0077 | 4.3546 | 1.2262 | 5 | 80 | negative regulation of ion transmembrane transport |
GO:0048871 | 0.0079 | 2.4559 | 4.7054 | 11 | 307 | multicellular organismal homeostasis |
GO:0051259 | 0.0087 | 2.0992 | 7.5103 | 15 | 490 | protein oligomerization |
GO:0051926 | 0.01 | 5.109 | 0.843 | 4 | 55 | negative regulation of calcium ion transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 231.8764 | 0.4995 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 135.2162 | 0.5801 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 94.2873 | 0.6929 | 25 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 29.964 | 1.2568 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 22.8492 | 1.5952 | 25 | 99 | regulation of gene silencing by miRNA |
GO:0045653 | 0 | 302.0862 | 0.2739 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006323 | 0 | 14.1046 | 2.9487 | 31 | 183 | DNA packaging |
GO:0060968 | 0 | 18.5682 | 1.9497 | 26 | 121 | regulation of gene silencing |
GO:1902036 | 0 | 21.2589 | 1.6113 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0032200 | 0 | 14.3447 | 2.4975 | 27 | 155 | telomere organization |
GO:0045814 | 0 | 17.3531 | 1.8852 | 24 | 117 | negative regulation of gene expression, epigenetic |
GO:0002244 | 0 | 12.3187 | 2.9487 | 28 | 183 | hematopoietic progenitor cell differentiation |
GO:0071824 | 0 | 10.1204 | 3.8994 | 31 | 242 | protein-DNA complex subunit organization |
GO:0048863 | 0 | 9.9765 | 3.9477 | 31 | 245 | stem cell differentiation |
GO:0016233 | 0 | 30.6639 | 0.8057 | 16 | 50 | telomere capping |
GO:0035194 | 0 | 8.5902 | 4.3344 | 30 | 269 | posttranscriptional gene silencing by RNA |
GO:0034080 | 0 | 34.8027 | 0.6445 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 32.3125 | 0.6768 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0030099 | 0 | 7.762 | 4.2225 | 27 | 267 | myeloid cell differentiation |
GO:0034724 | 0 | 25.1185 | 0.8057 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0017148 | 0 | 6.3002 | 5.7041 | 30 | 354 | negative regulation of translation |
GO:0048534 | 0 | 4.0648 | 13.0195 | 44 | 808 | hematopoietic or lymphoid organ development |
GO:0051248 | 0 | 3.4344 | 19.6097 | 55 | 1217 | negative regulation of protein metabolic process |
GO:0006333 | 0 | 11.8892 | 1.7685 | 17 | 116 | chromatin assembly or disassembly |
GO:0006303 | 0 | 17.3712 | 1.0635 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0034248 | 0 | 4.5176 | 9.1362 | 35 | 567 | regulation of cellular amide metabolic process |
GO:0043044 | 0 | 15.303 | 1.1763 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:1903707 | 0 | 10.063 | 2.0464 | 17 | 127 | negative regulation of hemopoiesis |
GO:0034622 | 0 | 3.5085 | 15.2431 | 45 | 946 | cellular macromolecular complex assembly |
GO:0051259 | 0 | 4.5744 | 7.8955 | 31 | 490 | protein oligomerization |
GO:0038111 | 0 | 24.4377 | 0.5801 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 24.4377 | 0.5801 | 10 | 36 | response to interleukin-7 |
GO:0006352 | 0 | 6.0195 | 3.6255 | 19 | 225 | DNA-templated transcription, initiation |
GO:0010608 | 0 | 3.5986 | 10.5219 | 33 | 653 | posttranscriptional regulation of gene expression |
GO:0045652 | 0 | 15.3296 | 0.8215 | 10 | 54 | regulation of megakaryocyte differentiation |
GO:0043043 | 0 | 3.2392 | 12.7455 | 36 | 791 | peptide biosynthetic process |
GO:0060249 | 0 | 4.2337 | 5.559 | 21 | 345 | anatomical structure homeostasis |
GO:0006950 | 0 | 2.4723 | 24.6224 | 51 | 1624 | response to stress |
GO:0071360 | 0 | 38.9341 | 0.2095 | 5 | 13 | cellular response to exogenous dsRNA |
GO:0032268 | 0 | 2.0734 | 38.7522 | 68 | 2405 | regulation of cellular protein metabolic process |
GO:0022607 | 0 | 2.0247 | 40.9172 | 70 | 2559 | cellular component assembly |
GO:0097659 | 0 | 1.8676 | 55.4777 | 86 | 3443 | nucleic acid-templated transcription |
GO:0070271 | 0 | 2.2916 | 21.1727 | 43 | 1314 | protein complex biogenesis |
GO:0002227 | 0 | 23.9515 | 0.29 | 5 | 18 | innate immune response in mucosa |
GO:0010604 | 0 | 1.89 | 44.6335 | 72 | 2770 | positive regulation of macromolecule metabolic process |
GO:0045596 | 0 | 2.8369 | 9.684 | 25 | 601 | negative regulation of cell differentiation |
GO:0019731 | 0 | 13.3866 | 0.5478 | 6 | 34 | antibacterial humoral response |
GO:0048869 | 0 | 1.7835 | 61.4073 | 91 | 3811 | cellular developmental process |
GO:0034645 | 0 | 1.7406 | 75.9414 | 107 | 4713 | cellular macromolecule biosynthetic process |
GO:0006996 | 0 | 1.8079 | 54.527 | 83 | 3384 | organelle organization |
GO:1902679 | 0 | 2.3093 | 17.3056 | 36 | 1074 | negative regulation of RNA biosynthetic process |
GO:0016070 | 0 | 1.7456 | 68.1427 | 98 | 4229 | RNA metabolic process |
GO:0071822 | 0 | 2.0763 | 24.8788 | 46 | 1544 | protein complex subunit organization |
GO:0034654 | 0 | 1.7391 | 62.5514 | 91 | 3882 | nucleobase-containing compound biosynthetic process |
GO:1901564 | 0 | 1.6775 | 99.0316 | 130 | 6146 | organonitrogen compound metabolic process |
GO:0045892 | 0 | 2.2715 | 16.5183 | 34 | 1033 | negative regulation of transcription, DNA-templated |
GO:0002251 | 1e-04 | 13.5288 | 0.4512 | 5 | 28 | organ or tissue specific immune response |
GO:0045934 | 1e-04 | 2.0811 | 20.7216 | 39 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0002682 | 1e-04 | 2.3675 | 12.5091 | 27 | 864 | regulation of immune system process |
GO:1903706 | 1e-04 | 3.4528 | 4.3864 | 14 | 290 | regulation of hemopoiesis |
GO:0006725 | 2e-04 | 1.6111 | 88.1391 | 116 | 5470 | cellular aromatic compound metabolic process |
GO:0006959 | 2e-04 | 4.0649 | 2.9326 | 11 | 182 | humoral immune response |
GO:0046483 | 2e-04 | 1.5994 | 87.6235 | 115 | 5438 | heterocycle metabolic process |
GO:0048519 | 2e-04 | 1.6126 | 74.6363 | 101 | 4632 | negative regulation of biological process |
GO:0009889 | 2e-04 | 1.792 | 38.0912 | 59 | 2572 | regulation of biosynthetic process |
GO:1901360 | 3e-04 | 1.5736 | 91.3134 | 118 | 5667 | organic cyclic compound metabolic process |
GO:0009890 | 3e-04 | 1.8856 | 25.1366 | 43 | 1560 | negative regulation of biosynthetic process |
GO:0006281 | 3e-04 | 2.6143 | 7.8149 | 19 | 485 | DNA repair |
GO:0098542 | 4e-04 | 2.7704 | 6.5903 | 17 | 409 | defense response to other organism |
GO:0034641 | 4e-04 | 1.5511 | 96.8564 | 123 | 6011 | cellular nitrogen compound metabolic process |
GO:0071345 | 4e-04 | 2.2071 | 12.7274 | 26 | 799 | cellular response to cytokine stimulus |
GO:0050793 | 5e-04 | 1.7295 | 35.4329 | 55 | 2199 | regulation of developmental process |
GO:0070887 | 5e-04 | 1.666 | 43.2156 | 64 | 2682 | cellular response to chemical stimulus |
GO:0010033 | 6e-04 | 1.6529 | 44.2468 | 65 | 2746 | response to organic substance |
GO:0061844 | 6e-04 | 8.1803 | 0.6929 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0034344 | 8e-04 | 123.1148 | 0.0483 | 2 | 3 | regulation of type III interferon production |
GO:0045658 | 8e-04 | 123.1148 | 0.0483 | 2 | 3 | regulation of neutrophil differentiation |
GO:0070340 | 8e-04 | 123.1148 | 0.0483 | 2 | 3 | detection of bacterial lipopeptide |
GO:0032481 | 8e-04 | 6.0319 | 1.0957 | 6 | 68 | positive regulation of type I interferon production |
GO:0071840 | 8e-04 | 1.5175 | 91.4907 | 116 | 5678 | cellular component organization or biogenesis |
GO:0033160 | 8e-04 | 20.5926 | 0.1934 | 3 | 12 | positive regulation of protein import into nucleus, translocation |
GO:0035458 | 8e-04 | 20.5926 | 0.1934 | 3 | 12 | cellular response to interferon-beta |
GO:1901576 | 9e-04 | 1.5084 | 93.7143 | 118 | 5816 | organic substance biosynthetic process |
GO:0051239 | 0.001 | 1.6349 | 41.6042 | 61 | 2582 | regulation of multicellular organismal process |
GO:0045838 | 0.001 | 18.5321 | 0.2095 | 3 | 13 | positive regulation of membrane potential |
GO:0042987 | 0.0011 | 9.9147 | 0.4673 | 4 | 29 | amyloid precursor protein catabolic process |
GO:0032675 | 0.0012 | 4.7013 | 1.6113 | 7 | 100 | regulation of interleukin-6 production |
GO:0042107 | 0.0013 | 4.6017 | 1.6435 | 7 | 102 | cytokine metabolic process |
GO:2001141 | 0.0013 | 1.6938 | 32.9655 | 50 | 2228 | regulation of RNA biosynthetic process |
GO:0006355 | 0.0013 | 1.693 | 32.9776 | 50 | 2234 | regulation of transcription, DNA-templated |
GO:1990511 | 0.0015 | 61.5533 | 0.0645 | 2 | 4 | piRNA biosynthetic process |
GO:0051348 | 0.0016 | 2.6454 | 5.6235 | 14 | 349 | negative regulation of transferase activity |
GO:0043508 | 0.0016 | 15.4414 | 0.2417 | 3 | 15 | negative regulation of JUN kinase activity |
GO:0006955 | 0.0017 | 1.7757 | 23.2599 | 38 | 1492 | immune response |
GO:0030888 | 0.0017 | 6.3392 | 0.8701 | 5 | 54 | regulation of B cell proliferation |
GO:0060333 | 0.0018 | 5.0497 | 1.2891 | 6 | 80 | interferon-gamma-mediated signaling pathway |
GO:0044238 | 0.0018 | 1.5094 | 152.9302 | 175 | 9491 | primary metabolic process |
GO:0043331 | 0.002 | 4.982 | 1.3052 | 6 | 81 | response to dsRNA |
GO:0002076 | 0.002 | 14.2526 | 0.2578 | 3 | 16 | osteoblast development |
GO:0032677 | 0.002 | 6.0898 | 0.9023 | 5 | 56 | regulation of interleukin-8 production |
GO:0048731 | 0.0024 | 1.4851 | 67.4337 | 88 | 4185 | system development |
GO:0006334 | 0.0024 | 4.766 | 1.3551 | 6 | 93 | nucleosome assembly |
GO:0009597 | 0.0025 | 41.0328 | 0.0806 | 2 | 5 | detection of virus |
GO:0042035 | 0.0031 | 4.4994 | 1.4341 | 6 | 89 | regulation of cytokine biosynthetic process |
GO:0031324 | 0.0032 | 1.8389 | 17.0267 | 29 | 1150 | negative regulation of cellular metabolic process |
GO:0034123 | 0.0033 | 11.5779 | 0.3062 | 3 | 19 | positive regulation of toll-like receptor signaling pathway |
GO:0002757 | 0.0034 | 2.3434 | 6.7675 | 15 | 420 | immune response-activating signal transduction |
GO:0002262 | 0.0035 | 3.8299 | 1.9497 | 7 | 121 | myeloid cell homeostasis |
GO:0032944 | 0.0035 | 3.1487 | 3.0293 | 9 | 188 | regulation of mononuclear cell proliferation |
GO:0030218 | 0.0035 | 4.3929 | 1.4663 | 6 | 91 | erythrocyte differentiation |
GO:0000395 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | mRNA 5'-splice site recognition |
GO:0002371 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | dendritic cell cytokine production |
GO:0071221 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | cellular response to bacterial lipopeptide |
GO:2000483 | 0.0037 | 30.7725 | 0.0967 | 2 | 6 | negative regulation of interleukin-8 secretion |
GO:0007596 | 0.0039 | 2.5868 | 4.8984 | 12 | 304 | blood coagulation |
GO:0043207 | 0.0041 | 1.9622 | 11.8915 | 22 | 738 | response to external biotic stimulus |
GO:0019219 | 0.0044 | 1.5665 | 37.5179 | 53 | 2534 | regulation of nucleobase-containing compound metabolic process |
GO:0001816 | 0.0046 | 2.0509 | 9.7968 | 19 | 608 | cytokine production |
GO:0050871 | 0.0048 | 4.9259 | 1.0957 | 5 | 68 | positive regulation of B cell activation |
GO:0006469 | 0.005 | 2.7739 | 3.8027 | 10 | 236 | negative regulation of protein kinase activity |
GO:0032493 | 0.0051 | 24.6164 | 0.1128 | 2 | 7 | response to bacterial lipoprotein |
GO:0051026 | 0.0051 | 24.6164 | 0.1128 | 2 | 7 | chiasma assembly |
GO:0002252 | 0.0053 | 1.7958 | 15.9843 | 27 | 992 | immune effector process |
GO:0045577 | 0.0058 | 9.2599 | 0.3706 | 3 | 23 | regulation of B cell differentiation |
GO:0045736 | 0.0058 | 9.2599 | 0.3706 | 3 | 23 | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
GO:0032608 | 0.0063 | 5.8949 | 0.7412 | 4 | 46 | interferon-beta production |
GO:0010629 | 0.0065 | 2.3258 | 5.9051 | 13 | 401 | negative regulation of gene expression |
GO:0010944 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | negative regulation of transcription by competitive promoter binding |
GO:0034135 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | regulation of toll-like receptor 2 signaling pathway |
GO:0042135 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | neurotransmitter catabolic process |
GO:0045410 | 0.0068 | 20.5123 | 0.1289 | 2 | 8 | positive regulation of interleukin-6 biosynthetic process |
GO:0045088 | 0.0068 | 2.305 | 5.9297 | 13 | 368 | regulation of innate immune response |
GO:0048518 | 0.0069 | 1.4087 | 75.6983 | 94 | 4807 | positive regulation of biological process |
GO:0070661 | 0.0076 | 2.5986 | 4.0444 | 10 | 251 | leukocyte proliferation |
GO:0033554 | 0.0085 | 1.562 | 28.1336 | 41 | 1746 | cellular response to stress |
GO:0045861 | 0.0087 | 2.4202 | 4.7695 | 11 | 296 | negative regulation of proteolysis |
GO:0051091 | 0.0087 | 2.7044 | 3.4966 | 9 | 217 | positive regulation of DNA binding transcription factor activity |
GO:0045321 | 0.0091 | 1.7139 | 16.6771 | 27 | 1035 | leukocyte activation |
GO:0065008 | 0.0092 | 1.433 | 51.2077 | 67 | 3178 | regulation of biological quality |
GO:0009617 | 0.0094 | 2.0788 | 7.5732 | 15 | 470 | response to bacterium |
GO:0050830 | 0.0094 | 4.1344 | 1.2891 | 5 | 80 | defense response to Gram-positive bacterium |
GO:0001824 | 0.0097 | 5.156 | 0.8379 | 4 | 52 | blastocyst development |
GO:1903902 | 0.0097 | 5.156 | 0.8379 | 4 | 52 | positive regulation of viral life cycle |
GO:0044092 | 0.0098 | 1.703 | 16.7738 | 27 | 1041 | negative regulation of molecular function |
GO:0034341 | 0.0098 | 3.1132 | 2.3686 | 7 | 147 | response to interferon-gamma |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 6.8192 | 1.9891 | 12 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0018003 | 2e-04 | Inf | 0.0272 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0001816 | 2e-04 | 2.6181 | 8.2835 | 20 | 608 | cytokine production |
GO:0002764 | 4e-04 | 2.8216 | 6.1036 | 16 | 448 | immune response-regulating signaling pathway |
GO:0045658 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | regulation of neutrophil differentiation |
GO:0060244 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | negative regulation of cell proliferation involved in contact inhibition |
GO:0022610 | 6e-04 | 2.0227 | 16.7713 | 31 | 1231 | biological adhesion |
GO:0045354 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | regulation of interferon-alpha biosynthetic process |
GO:0045087 | 0.0016 | 2.1854 | 10.3135 | 21 | 757 | innate immune response |
GO:0048584 | 0.0017 | 1.7475 | 25.8314 | 41 | 1896 | positive regulation of response to stimulus |
GO:0051607 | 0.0018 | 3.502 | 2.7385 | 9 | 201 | defense response to virus |
GO:0045409 | 0.0018 | 48.7249 | 0.0681 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0007130 | 0.0021 | 13.7588 | 0.2589 | 3 | 19 | synaptonemal complex assembly |
GO:0098609 | 0.0022 | 2.1628 | 9.8911 | 20 | 726 | cell-cell adhesion |
GO:0002253 | 0.0026 | 2.4231 | 6.5805 | 15 | 483 | activation of immune response |
GO:0032687 | 0.0027 | 36.5413 | 0.0817 | 2 | 6 | negative regulation of interferon-alpha production |
GO:0045357 | 0.0027 | 36.5413 | 0.0817 | 2 | 6 | regulation of interferon-beta biosynthetic process |
GO:0002684 | 0.0035 | 1.9971 | 11.7713 | 22 | 864 | positive regulation of immune system process |
GO:0039536 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | negative regulation of RIG-I signaling pathway |
GO:0045656 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | negative regulation of monocyte differentiation |
GO:0046598 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | positive regulation of viral entry into host cell |
GO:2000035 | 0.0037 | 29.2311 | 0.0954 | 2 | 7 | regulation of stem cell division |
GO:0045621 | 0.004 | 5.1269 | 1.0491 | 5 | 77 | positive regulation of lymphocyte differentiation |
GO:0090023 | 0.0046 | 10.0024 | 0.3406 | 3 | 25 | positive regulation of neutrophil chemotaxis |
GO:0002792 | 0.0047 | 4.1119 | 1.5532 | 6 | 114 | negative regulation of peptide secretion |
GO:0043124 | 0.0047 | 6.3994 | 0.6812 | 4 | 50 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0009607 | 0.0048 | 2.0099 | 10.586 | 20 | 777 | response to biotic stimulus |
GO:0050710 | 0.0051 | 6.2628 | 0.6948 | 4 | 51 | negative regulation of cytokine secretion |
GO:0032479 | 0.0051 | 4.0366 | 1.5804 | 6 | 116 | regulation of type I interferon production |
GO:0006950 | 0.0054 | 1.5085 | 45.9134 | 62 | 3370 | response to stress |
GO:1901222 | 0.0054 | 6.1319 | 0.7085 | 4 | 52 | regulation of NIK/NF-kappaB signaling |
GO:0050900 | 0.0056 | 2.4647 | 5.1363 | 12 | 377 | leukocyte migration |
GO:0051707 | 0.0057 | 2.0109 | 10.0274 | 19 | 736 | response to other organism |
GO:0002429 | 0.0062 | 2.6853 | 3.9238 | 10 | 288 | immune response-activating cell surface receptor signaling pathway |
GO:0032728 | 0.0064 | 8.8004 | 0.3815 | 3 | 28 | positive regulation of interferon-beta production |
GO:0007585 | 0.0075 | 5.5516 | 0.7766 | 4 | 57 | respiratory gaseous exchange |
GO:0097009 | 0.0077 | 8.1474 | 0.4087 | 3 | 30 | energy homeostasis |
GO:1903131 | 0.0077 | 8.1474 | 0.4087 | 3 | 30 | mononuclear cell differentiation |
GO:0045351 | 0.0077 | 18.2658 | 0.1362 | 2 | 10 | type I interferon biosynthetic process |
GO:0042742 | 0.0078 | 2.9718 | 2.8338 | 8 | 208 | defense response to bacterium |
GO:0048147 | 0.0085 | 7.8559 | 0.4223 | 3 | 31 | negative regulation of fibroblast proliferation |
GO:1902622 | 0.0085 | 7.8559 | 0.4223 | 3 | 31 | regulation of neutrophil migration |
GO:0050776 | 0.0086 | 2.4292 | 4.7679 | 11 | 368 | regulation of immune response |
GO:0050435 | 0.0092 | 7.5845 | 0.436 | 3 | 32 | amyloid-beta metabolic process |
GO:0070897 | 0.0092 | 7.5845 | 0.436 | 3 | 32 | DNA-templated transcriptional preinitiation complex assembly |
GO:0034384 | 0.0094 | 16.2352 | 0.1499 | 2 | 11 | high-density lipoprotein particle clearance |
GO:0044546 | 0.0094 | 16.2352 | 0.1499 | 2 | 11 | NLRP3 inflammasome complex assembly |
GO:1903827 | 0.0099 | 2.0698 | 7.6295 | 15 | 560 | regulation of cellular protein localization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070370 | 2e-04 | Inf | 0.0301 | 2 | 2 | cellular heat acclimation |
GO:0070434 | 7e-04 | 131.8947 | 0.0452 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 7e-04 | 131.8947 | 0.0452 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0089711 | 0.0011 | 18.0529 | 0.2109 | 3 | 14 | L-glutamate transmembrane transport |
GO:0043010 | 0.0011 | 3.045 | 4.2032 | 12 | 279 | camera-type eye development |
GO:1902261 | 0.0013 | 65.943 | 0.0603 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:2000741 | 0.0013 | 65.943 | 0.0603 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0003407 | 0.0018 | 6.2826 | 0.8738 | 5 | 58 | neural retina development |
GO:0030049 | 0.0018 | 8.5675 | 0.5273 | 4 | 35 | muscle filament sliding |
GO:0048706 | 0.0019 | 4.299 | 1.7476 | 7 | 116 | embryonic skeletal system development |
GO:0046604 | 0.0022 | 43.9591 | 0.0753 | 2 | 5 | positive regulation of mitotic centrosome separation |
GO:0015800 | 0.0023 | 13.2352 | 0.2712 | 3 | 18 | acidic amino acid transport |
GO:0007218 | 0.0027 | 4.6567 | 1.386 | 6 | 92 | neuropeptide signaling pathway |
GO:0048562 | 0.0027 | 2.8659 | 4.0676 | 11 | 270 | embryonic organ morphogenesis |
GO:0050808 | 0.0027 | 3.0473 | 3.4801 | 10 | 231 | synapse organization |
GO:0048701 | 0.0033 | 7.1753 | 0.6177 | 4 | 41 | embryonic cranial skeleton morphogenesis |
GO:0060047 | 0.0033 | 2.9524 | 3.5855 | 10 | 238 | heart contraction |
GO:0006342 | 0.0044 | 4.1688 | 1.5366 | 6 | 102 | chromatin silencing |
GO:0060463 | 0.0045 | 26.3719 | 0.1055 | 2 | 7 | lung lobe morphogenesis |
GO:1903265 | 0.0045 | 26.3719 | 0.1055 | 2 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0001964 | 0.0048 | 9.9231 | 0.3465 | 3 | 23 | startle response |
GO:1901379 | 0.0049 | 4.8918 | 1.0998 | 5 | 73 | regulation of potassium ion transmembrane transport |
GO:0060042 | 0.005 | 6.319 | 0.693 | 4 | 46 | retina morphogenesis in camera-type eye |
GO:0007399 | 0.005 | 1.592 | 30.7028 | 45 | 2038 | nervous system development |
GO:0031112 | 0.0054 | 9.45 | 0.3616 | 3 | 24 | positive regulation of microtubule polymerization or depolymerization |
GO:0042026 | 0.0054 | 9.45 | 0.3616 | 3 | 24 | protein refolding |
GO:1900034 | 0.0055 | 4.7514 | 1.1299 | 5 | 75 | regulation of cellular response to heat |
GO:0018210 | 0.0059 | 3.922 | 1.627 | 6 | 108 | peptidyl-threonine modification |
GO:0006776 | 0.006 | 21.9751 | 0.1205 | 2 | 8 | vitamin A metabolic process |
GO:0070424 | 0.006 | 21.9751 | 0.1205 | 2 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0070207 | 0.0068 | 8.6271 | 0.3917 | 3 | 26 | protein homotrimerization |
GO:0038003 | 0.0076 | 18.8346 | 0.1356 | 2 | 9 | opioid receptor signaling pathway |
GO:0042574 | 0.0076 | 18.8346 | 0.1356 | 2 | 9 | retinal metabolic process |
GO:0009408 | 0.0077 | 3.2694 | 2.2598 | 7 | 150 | response to heat |
GO:0051965 | 0.0083 | 5.4138 | 0.7985 | 4 | 53 | positive regulation of synapse assembly |
GO:0010959 | 0.0094 | 2.3941 | 4.8209 | 11 | 320 | regulation of metal ion transport |
GO:0090084 | 0.0094 | 16.4792 | 0.1507 | 2 | 10 | negative regulation of inclusion body assembly |
GO:0051239 | 0.0098 | 1.481 | 38.8983 | 53 | 2582 | regulation of multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 17.1749 | 4.6977 | 53 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 13.4839 | 6.0234 | 55 | 418 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 13.4242 | 5.9082 | 54 | 410 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 13.405 | 5.7785 | 53 | 401 | detection of chemical stimulus |
GO:0050877 | 0 | 5.5504 | 16.1682 | 65 | 1122 | nervous system process |
GO:0007186 | 0 | 5.2845 | 16.5429 | 64 | 1148 | G-protein coupled receptor signaling pathway |
GO:0018149 | 0 | 21.1154 | 0.7637 | 12 | 53 | peptide cross-linking |
GO:0009913 | 0 | 4.5689 | 4.6689 | 19 | 324 | epidermal cell differentiation |
GO:0032501 | 0 | 1.9599 | 86.3029 | 120 | 6338 | multicellular organismal process |
GO:1901750 | 0 | 69.6435 | 0.1153 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0043588 | 0 | 3.7917 | 5.5479 | 19 | 385 | skin development |
GO:0006751 | 0 | 55.7111 | 0.1297 | 4 | 9 | glutathione catabolic process |
GO:0070268 | 1e-04 | 5.7563 | 1.5275 | 8 | 106 | cornification |
GO:0050896 | 6e-04 | 1.5788 | 110.6845 | 135 | 7681 | response to stimulus |
GO:0031424 | 7e-04 | 5.122 | 1.4822 | 7 | 106 | keratinization |
GO:0006691 | 8e-04 | 11.1274 | 0.4179 | 4 | 29 | leukotriene metabolic process |
GO:0046604 | 0.002 | 46.0061 | 0.0721 | 2 | 5 | positive regulation of mitotic centrosome separation |
GO:0046456 | 0.0036 | 6.9477 | 0.634 | 4 | 44 | icosanoid biosynthetic process |
GO:1901568 | 0.0043 | 3.6575 | 2.0318 | 7 | 141 | fatty acid derivative metabolic process |
GO:0007601 | 0.0049 | 3.2255 | 2.6227 | 8 | 182 | visual perception |
GO:1904628 | 0.0055 | 22.9985 | 0.1153 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
GO:0023052 | 0.0074 | 1.4102 | 81.9794 | 100 | 5689 | signaling |
GO:0007154 | 0.0082 | 1.4026 | 82.2532 | 100 | 5708 | cell communication |
GO:0042340 | 0.0086 | 17.2466 | 0.1441 | 2 | 10 | keratan sulfate catabolic process |
GO:0002548 | 0.0097 | 5.1416 | 0.8358 | 4 | 58 | monocyte chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1901750 | 0 | 79.7354 | 0.1011 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 0 | 63.7841 | 0.1138 | 4 | 9 | glutathione catabolic process |
GO:0006742 | 2e-04 | Inf | 0.0253 | 2 | 2 | NADP catabolic process |
GO:0060326 | 2e-04 | 3.9355 | 3.0214 | 11 | 239 | cell chemotaxis |
GO:0032501 | 3e-04 | 1.6667 | 82.8028 | 107 | 6550 | multicellular organismal process |
GO:0006691 | 5e-04 | 12.7399 | 0.3666 | 4 | 29 | leukotriene metabolic process |
GO:0032914 | 9e-04 | 78.911 | 0.0506 | 2 | 4 | positive regulation of transforming growth factor beta1 production |
GO:2000741 | 9e-04 | 78.911 | 0.0506 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0006790 | 0.0012 | 3.0182 | 4.2476 | 12 | 336 | sulfur compound metabolic process |
GO:0072526 | 0.0016 | 52.6038 | 0.0632 | 2 | 5 | pyridine-containing compound catabolic process |
GO:0035025 | 0.0017 | 14.8599 | 0.2402 | 3 | 19 | positive regulation of Rho protein signal transduction |
GO:0007420 | 0.002 | 2.3464 | 7.7493 | 17 | 613 | brain development |
GO:0008347 | 0.0023 | 7.9545 | 0.5562 | 4 | 44 | glial cell migration |
GO:0046456 | 0.0023 | 7.9545 | 0.5562 | 4 | 44 | icosanoid biosynthetic process |
GO:0070098 | 0.0024 | 5.7836 | 0.9355 | 5 | 74 | chemokine-mediated signaling pathway |
GO:2000179 | 0.0027 | 7.5747 | 0.5815 | 4 | 46 | positive regulation of neural precursor cell proliferation |
GO:0021801 | 0.0029 | 11.8847 | 0.2908 | 3 | 23 | cerebral cortex radial glia guided migration |
GO:0071604 | 0.0033 | 11.318 | 0.3034 | 3 | 24 | transforming growth factor beta production |
GO:0048731 | 0.0033 | 1.5697 | 45.3463 | 62 | 3732 | system development |
GO:0032502 | 0.0034 | 1.5019 | 69.3647 | 88 | 5487 | developmental process |
GO:0009435 | 0.0042 | 10.3325 | 0.3287 | 3 | 26 | NAD biosynthetic process |
GO:0006570 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | tyrosine metabolic process |
GO:2000304 | 0.0042 | 26.2967 | 0.1011 | 2 | 8 | positive regulation of ceramide biosynthetic process |
GO:0032370 | 0.0045 | 6.4896 | 0.67 | 4 | 53 | positive regulation of lipid transport |
GO:0001501 | 0.0051 | 2.402 | 5.7267 | 13 | 453 | skeletal system development |
GO:0007186 | 0.0053 | 1.8487 | 14.5126 | 25 | 1148 | G-protein coupled receptor signaling pathway |
GO:0034145 | 0.0054 | 22.5385 | 0.1138 | 2 | 9 | positive regulation of toll-like receptor 4 signaling pathway |
GO:0002548 | 0.0062 | 5.8867 | 0.7332 | 4 | 58 | monocyte chemotaxis |
GO:0019363 | 0.0063 | 8.7994 | 0.3792 | 3 | 30 | pyridine nucleotide biosynthetic process |
GO:0042340 | 0.0067 | 19.7199 | 0.1264 | 2 | 10 | keratan sulfate catabolic process |
GO:1904627 | 0.0067 | 19.7199 | 0.1264 | 2 | 10 | response to phorbol 13-acetate 12-myristate |
GO:0008038 | 0.0069 | 8.4846 | 0.3919 | 3 | 31 | neuron recognition |
GO:0042330 | 0.007 | 2.229 | 6.6369 | 14 | 525 | taxis |
GO:0045665 | 0.0071 | 3.3192 | 2.2249 | 7 | 176 | negative regulation of neuron differentiation |
GO:0060322 | 0.0071 | 8.3514 | 0.3963 | 3 | 33 | head development |
GO:0031345 | 0.0074 | 3.7172 | 1.7066 | 6 | 135 | negative regulation of cell projection organization |
GO:0051962 | 0.0079 | 2.3535 | 5.3727 | 12 | 425 | positive regulation of nervous system development |
GO:0009109 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | coenzyme catabolic process |
GO:0055057 | 0.0081 | 17.5276 | 0.1391 | 2 | 11 | neuroblast division |
GO:0018107 | 0.0095 | 4.1064 | 1.2894 | 5 | 102 | peptidyl-threonine phosphorylation |
GO:0002523 | 0.0097 | 15.7738 | 0.1517 | 2 | 12 | leukocyte migration involved in inflammatory response |
GO:0006047 | 0.0097 | 15.7738 | 0.1517 | 2 | 12 | UDP-N-acetylglucosamine metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 256.0171 | 0.3196 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 45.1373 | 0.5828 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 34.8671 | 0.6768 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 29.4951 | 0.7519 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 27.3846 | 0.7895 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0051290 | 0 | 26.4385 | 0.8083 | 14 | 43 | protein heterotetramerization |
GO:0016233 | 0 | 21.2877 | 0.9399 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 21.2877 | 0.9399 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0043044 | 0 | 14.188 | 1.3723 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 14.7219 | 1.2407 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0045815 | 0 | 11.9519 | 1.4663 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0031497 | 0 | 7.4226 | 2.6882 | 17 | 143 | chromatin assembly |
GO:0060964 | 0 | 8.9864 | 1.8611 | 14 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 8.8813 | 1.8799 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:1903707 | 0 | 7.3208 | 2.3874 | 15 | 127 | negative regulation of hemopoiesis |
GO:0045814 | 0 | 7.407 | 2.1994 | 14 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 7.1282 | 2.2746 | 14 | 121 | regulation of gene silencing |
GO:0045637 | 0 | 4.7755 | 4.2297 | 18 | 225 | regulation of myeloid cell differentiation |
GO:0032200 | 0 | 5.397 | 2.9138 | 14 | 155 | telomere organization |
GO:0065004 | 0 | 4.4765 | 3.9665 | 16 | 211 | protein-DNA complex assembly |
GO:0006352 | 0 | 4.1727 | 4.2297 | 16 | 225 | DNA-templated transcription, initiation |
GO:0071103 | 0 | 3.9 | 4.7937 | 17 | 255 | DNA conformation change |
GO:0002244 | 0 | 4.4943 | 3.4402 | 14 | 183 | hematopoietic progenitor cell differentiation |
GO:0051259 | 0 | 2.8422 | 9.2114 | 24 | 490 | protein oligomerization |
GO:0045596 | 0 | 2.6063 | 11.298 | 27 | 601 | negative regulation of cell differentiation |
GO:0048863 | 1e-04 | 3.5366 | 4.6057 | 15 | 245 | stem cell differentiation |
GO:0035194 | 2e-04 | 3.1972 | 5.0569 | 15 | 269 | posttranscriptional gene silencing by RNA |
GO:0043652 | 2e-04 | 39.5493 | 0.1316 | 3 | 7 | engulfment of apoptotic cell |
GO:2000026 | 3e-04 | 1.7743 | 32.2022 | 52 | 1713 | regulation of multicellular organismal development |
GO:0010812 | 4e-04 | 6.9321 | 0.9775 | 6 | 52 | negative regulation of cell-substrate adhesion |
GO:0045602 | 5e-04 | 26.3627 | 0.1692 | 3 | 9 | negative regulation of endothelial cell differentiation |
GO:0030198 | 6e-04 | 2.8333 | 5.6584 | 15 | 301 | extracellular matrix organization |
GO:0060249 | 9e-04 | 2.6292 | 6.4856 | 16 | 345 | anatomical structure homeostasis |
GO:0035987 | 0.001 | 7.3601 | 0.7707 | 5 | 41 | endodermal cell differentiation |
GO:0030574 | 0.001 | 5.7942 | 1.1467 | 6 | 61 | collagen catabolic process |
GO:0036337 | 0.001 | 105.1158 | 0.0564 | 2 | 3 | Fas signaling pathway |
GO:0017148 | 0.0011 | 2.5576 | 6.6547 | 16 | 354 | negative regulation of translation |
GO:2000108 | 0.0011 | 10.0683 | 0.47 | 4 | 25 | positive regulation of leukocyte apoptotic process |
GO:1901606 | 0.0016 | 4.4333 | 1.7107 | 7 | 91 | alpha-amino acid catabolic process |
GO:0051895 | 0.0021 | 14.3748 | 0.2632 | 3 | 14 | negative regulation of focal adhesion assembly |
GO:0044571 | 0.0021 | 52.5544 | 0.0752 | 2 | 4 | [2Fe-2S] cluster assembly |
GO:0006281 | 0.0021 | 2.2081 | 9.1174 | 19 | 485 | DNA repair |
GO:0007492 | 0.0023 | 4.825 | 1.3535 | 6 | 72 | endoderm development |
GO:0071294 | 0.0025 | 13.1761 | 0.282 | 3 | 15 | cellular response to zinc ion |
GO:0043537 | 0.0026 | 7.8278 | 0.5828 | 4 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:1902041 | 0.0037 | 5.2943 | 1.0339 | 5 | 55 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0032502 | 0.0044 | 1.3841 | 103.1486 | 125 | 5487 | developmental process |
GO:0070482 | 0.0047 | 2.3344 | 6.3164 | 14 | 336 | response to oxygen levels |
GO:0002578 | 0.005 | 26.2737 | 0.1128 | 2 | 6 | negative regulation of antigen processing and presentation |
GO:0002040 | 0.0059 | 3.9275 | 1.6355 | 6 | 87 | sprouting angiogenesis |
GO:0007264 | 0.006 | 2.0806 | 8.591 | 17 | 457 | small GTPase mediated signal transduction |
GO:0001666 | 0.0061 | 2.3376 | 5.8464 | 13 | 311 | response to hypoxia |
GO:0051716 | 0.0063 | 1.3571 | 120.7066 | 142 | 6421 | cellular response to stimulus |
GO:0045926 | 0.0067 | 2.6544 | 3.9665 | 10 | 211 | negative regulation of growth |
GO:0006538 | 0.0069 | 21.0175 | 0.1316 | 2 | 7 | glutamate catabolic process |
GO:0097428 | 0.0069 | 21.0175 | 0.1316 | 2 | 7 | protein maturation by iron-sulfur cluster transfer |
GO:0001952 | 0.0077 | 3.6979 | 1.7295 | 6 | 92 | regulation of cell-matrix adhesion |
GO:0017015 | 0.0086 | 3.6134 | 1.7671 | 6 | 94 | regulation of transforming growth factor beta receptor signaling pathway |
GO:0033860 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | regulation of NAD(P)H oxidase activity |
GO:0060155 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | platelet dense granule organization |
GO:0097049 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | motor neuron apoptotic process |
GO:0098711 | 0.0091 | 17.5135 | 0.1504 | 2 | 8 | iron ion import across plasma membrane |
GO:0034109 | 0.0096 | 4.1323 | 1.2971 | 5 | 69 | homotypic cell-cell adhesion |
GO:0048731 | 0.0096 | 1.3602 | 78.6726 | 97 | 4185 | system development |
GO:0006584 | 0.01 | 5.15 | 0.8459 | 4 | 45 | catecholamine metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060322 | 0 | 3.0826 | 9.7744 | 27 | 646 | head development |
GO:0007389 | 0 | 3.6957 | 5.9917 | 20 | 396 | pattern specification process |
GO:0099537 | 0 | 3.1487 | 8.4429 | 24 | 558 | trans-synaptic signaling |
GO:0007218 | 0 | 7.3036 | 1.392 | 9 | 92 | neuropeptide signaling pathway |
GO:0021517 | 0 | 11.1111 | 0.6355 | 6 | 42 | ventral spinal cord development |
GO:0002067 | 1e-04 | 10.2544 | 0.6809 | 6 | 45 | glandular epithelial cell differentiation |
GO:0060078 | 1e-04 | 5.402 | 1.8308 | 9 | 121 | regulation of postsynaptic membrane potential |
GO:0060219 | 1e-04 | 20.3633 | 0.2572 | 4 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0045597 | 1e-04 | 2.3772 | 12.4072 | 27 | 820 | positive regulation of cell differentiation |
GO:0048665 | 1e-04 | 11.8584 | 0.4993 | 5 | 33 | neuron fate specification |
GO:0009952 | 1e-04 | 4.1975 | 2.8446 | 11 | 188 | anterior/posterior pattern specification |
GO:0021953 | 1e-04 | 4.5518 | 2.3906 | 10 | 158 | central nervous system neuron differentiation |
GO:0099565 | 2e-04 | 5.7025 | 1.5433 | 8 | 102 | chemical synaptic transmission, postsynaptic |
GO:0048699 | 2e-04 | 2.1363 | 17.0009 | 33 | 1149 | generation of neurons |
GO:0048644 | 2e-04 | 6.4054 | 1.2105 | 7 | 80 | muscle organ morphogenesis |
GO:0120039 | 3e-04 | 2.6045 | 8.2916 | 20 | 548 | plasma membrane bounded cell projection morphogenesis |
GO:0046877 | 3e-04 | 32.9605 | 0.1362 | 3 | 9 | regulation of saliva secretion |
GO:0007417 | 3e-04 | 2.4733 | 9.6392 | 22 | 659 | central nervous system development |
GO:0007267 | 3e-04 | 2.1483 | 15.301 | 30 | 1054 | cell-cell signaling |
GO:0055008 | 3e-04 | 7.2635 | 0.923 | 6 | 61 | cardiac muscle tissue morphogenesis |
GO:0021559 | 4e-04 | 28.25 | 0.1513 | 3 | 10 | trigeminal nerve development |
GO:0007187 | 4e-04 | 13.5927 | 0.3538 | 4 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0032990 | 4e-04 | 2.506 | 8.5942 | 20 | 568 | cell part morphogenesis |
GO:0009914 | 5e-04 | 3.1891 | 4.3728 | 13 | 289 | hormone transport |
GO:0021675 | 5e-04 | 6.656 | 0.9986 | 6 | 66 | nerve development |
GO:0003148 | 5e-04 | 12.5991 | 0.3783 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 5e-04 | 12.5991 | 0.3783 | 4 | 25 | type B pancreatic cell differentiation |
GO:0008306 | 6e-04 | 6.4404 | 1.0289 | 6 | 68 | associative learning |
GO:0061061 | 6e-04 | 2.4367 | 8.8212 | 20 | 583 | muscle structure development |
GO:0006813 | 6e-04 | 3.4796 | 3.3893 | 11 | 224 | potassium ion transport |
GO:0010159 | 7e-04 | 131.31 | 0.0454 | 2 | 3 | specification of animal organ position |
GO:0021524 | 7e-04 | 131.31 | 0.0454 | 2 | 3 | visceral motor neuron differentiation |
GO:0003016 | 7e-04 | 11.502 | 0.4085 | 4 | 27 | respiratory system process |
GO:0003206 | 8e-04 | 7.6764 | 0.7286 | 5 | 49 | cardiac chamber morphogenesis |
GO:0023061 | 9e-04 | 2.7299 | 5.8707 | 15 | 388 | signal release |
GO:0021819 | 9e-04 | 19.7711 | 0.1967 | 3 | 13 | layer formation in cerebral cortex |
GO:0021515 | 9e-04 | 7.3702 | 0.7565 | 5 | 50 | cell differentiation in spinal cord |
GO:0007409 | 9e-04 | 2.7076 | 5.9161 | 15 | 391 | axonogenesis |
GO:0006355 | 9e-04 | 1.605 | 49.553 | 70 | 3275 | regulation of transcription, DNA-templated |
GO:0003229 | 0.001 | 7.2095 | 0.7717 | 5 | 51 | ventricular cardiac muscle tissue development |
GO:0048593 | 0.001 | 4.8128 | 1.5736 | 7 | 104 | camera-type eye morphogenesis |
GO:0050793 | 0.001 | 1.7 | 33.2724 | 51 | 2199 | regulation of developmental process |
GO:0030900 | 0.0011 | 3.4718 | 3.0788 | 10 | 209 | forebrain development |
GO:0021794 | 0.0011 | 17.9725 | 0.2118 | 3 | 14 | thalamus development |
GO:0050884 | 0.0011 | 17.9725 | 0.2118 | 3 | 14 | neuromuscular process controlling posture |
GO:0007268 | 0.0011 | 2.5652 | 6.6622 | 16 | 453 | chemical synaptic transmission |
GO:2001141 | 0.0012 | 1.5879 | 49.9615 | 70 | 3302 | regulation of RNA biosynthetic process |
GO:0071695 | 0.0012 | 4.1134 | 2.088 | 8 | 138 | anatomical structure maturation |
GO:0031175 | 0.0012 | 2.1133 | 12.1953 | 24 | 806 | neuron projection development |
GO:0043388 | 0.0012 | 6.9082 | 0.8019 | 5 | 53 | positive regulation of DNA binding |
GO:0050794 | 0.0013 | 1.563 | 140.0563 | 162 | 9416 | regulation of cellular process |
GO:0007188 | 0.0013 | 4.0506 | 2.1183 | 8 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0001992 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0007198 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | detection of monosaccharide stimulus |
GO:0048880 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | sensory system development |
GO:0051594 | 0.0013 | 65.6507 | 0.0605 | 2 | 4 | detection of glucose |
GO:0048646 | 0.0015 | 2.0178 | 13.8558 | 26 | 927 | anatomical structure formation involved in morphogenesis |
GO:0035637 | 0.0016 | 3.5452 | 2.7084 | 9 | 179 | multicellular organismal signaling |
GO:0060428 | 0.0017 | 8.8141 | 0.5144 | 4 | 34 | lung epithelium development |
GO:0071396 | 0.002 | 2.3434 | 7.7166 | 17 | 510 | cellular response to lipid |
GO:0051241 | 0.0021 | 1.9406 | 14.934 | 27 | 987 | negative regulation of multicellular organismal process |
GO:0048639 | 0.0022 | 3.71 | 2.2999 | 8 | 152 | positive regulation of developmental growth |
GO:0051970 | 0.0022 | 43.7642 | 0.0757 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060012 | 0.0022 | 43.7642 | 0.0757 | 2 | 5 | synaptic transmission, glycinergic |
GO:0071205 | 0.0022 | 43.7642 | 0.0757 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0061180 | 0.0023 | 5.9181 | 0.923 | 5 | 61 | mammary gland epithelium development |
GO:0035270 | 0.0023 | 4.1269 | 1.8157 | 7 | 120 | endocrine system development |
GO:0050768 | 0.0024 | 3.1046 | 3.4195 | 10 | 226 | negative regulation of neurogenesis |
GO:0007631 | 0.0025 | 4.7307 | 1.3657 | 6 | 91 | feeding behavior |
GO:0019219 | 0.0027 | 1.5085 | 57.7992 | 77 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0021761 | 0.0027 | 4.6357 | 1.392 | 6 | 92 | limbic system development |
GO:0007210 | 0.0028 | 12.352 | 0.2875 | 3 | 19 | serotonin receptor signaling pathway |
GO:0010002 | 0.0028 | 12.352 | 0.2875 | 3 | 19 | cardioblast differentiation |
GO:0048562 | 0.0028 | 2.8527 | 4.0853 | 11 | 270 | embryonic organ morphogenesis |
GO:0001709 | 0.0028 | 7.5524 | 0.5901 | 4 | 39 | cell fate determination |
GO:0031644 | 0.0028 | 5.6161 | 0.9684 | 5 | 64 | regulation of neurological system process |
GO:0051960 | 0.0031 | 2.0511 | 10.8941 | 21 | 720 | regulation of nervous system development |
GO:0031290 | 0.0032 | 11.6246 | 0.3026 | 3 | 20 | retinal ganglion cell axon guidance |
GO:0050951 | 0.0032 | 11.6246 | 0.3026 | 3 | 20 | sensory perception of temperature stimulus |
GO:0051482 | 0.0032 | 11.6246 | 0.3026 | 3 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0048705 | 0.0032 | 3.1847 | 2.9959 | 9 | 198 | skeletal system morphogenesis |
GO:0002069 | 0.0033 | 32.821 | 0.0908 | 2 | 6 | columnar/cuboidal epithelial cell maturation |
GO:0060430 | 0.0033 | 32.821 | 0.0908 | 2 | 6 | lung saccule development |
GO:0001764 | 0.0033 | 3.852 | 1.9367 | 7 | 128 | neuron migration |
GO:0090596 | 0.0034 | 2.9388 | 3.6011 | 10 | 238 | sensory organ morphogenesis |
GO:0003208 | 0.0037 | 5.2581 | 1.0289 | 5 | 68 | cardiac ventricle morphogenesis |
GO:0097659 | 0.0037 | 1.5034 | 52.0949 | 70 | 3443 | nucleic acid-templated transcription |
GO:0097120 | 0.0037 | 10.9781 | 0.3177 | 3 | 21 | receptor localization to synapse |
GO:0042310 | 0.0041 | 5.0956 | 1.0591 | 5 | 70 | vasoconstriction |
GO:0050877 | 0.0042 | 1.8353 | 15.7277 | 27 | 1058 | nervous system process |
GO:0060479 | 0.0043 | 10.3996 | 0.3329 | 3 | 22 | lung cell differentiation |
GO:0006811 | 0.0043 | 1.7147 | 21.3191 | 34 | 1409 | ion transport |
GO:0060986 | 0.0043 | 6.6062 | 0.6657 | 4 | 44 | endocrine hormone secretion |
GO:0090066 | 0.0045 | 2.3486 | 6.2944 | 14 | 416 | regulation of anatomical structure size |
GO:0001574 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | ganglioside biosynthetic process |
GO:0003223 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | ventricular compact myocardium morphogenesis |
GO:0044851 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | hair cycle phase |
GO:0048819 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | regulation of hair follicle maturation |
GO:0090394 | 0.0046 | 26.255 | 0.1059 | 2 | 7 | negative regulation of excitatory postsynaptic potential |
GO:0050885 | 0.0047 | 6.4446 | 0.6809 | 4 | 45 | neuromuscular process controlling balance |
GO:0019935 | 0.0048 | 4.1069 | 1.5585 | 6 | 103 | cyclic-nucleotide-mediated signaling |
GO:0010460 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | positive regulation of heart rate |
GO:0021602 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | cranial nerve morphogenesis |
GO:0022030 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | telencephalon glial cell migration |
GO:0045662 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | negative regulation of myoblast differentiation |
GO:2000463 | 0.0048 | 9.8789 | 0.348 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0031016 | 0.005 | 4.8699 | 1.1045 | 5 | 73 | pancreas development |
GO:1901379 | 0.005 | 4.8699 | 1.1045 | 5 | 73 | regulation of potassium ion transmembrane transport |
GO:0048869 | 0.005 | 1.4841 | 52.8811 | 70 | 3625 | cellular developmental process |
GO:0051384 | 0.005 | 3.5556 | 2.088 | 7 | 138 | response to glucocorticoid |
GO:0014706 | 0.0052 | 2.4881 | 5.0839 | 12 | 336 | striated muscle tissue development |
GO:0021511 | 0.0055 | 9.4079 | 0.3631 | 3 | 24 | spinal cord patterning |
GO:0003310 | 0.006 | 21.8777 | 0.121 | 2 | 8 | pancreatic A cell differentiation |
GO:0008343 | 0.006 | 21.8777 | 0.121 | 2 | 8 | adult feeding behavior |
GO:0045924 | 0.006 | 21.8777 | 0.121 | 2 | 8 | regulation of female receptivity |
GO:0061140 | 0.006 | 21.8777 | 0.121 | 2 | 8 | lung secretory cell differentiation |
GO:0060441 | 0.0062 | 8.9797 | 0.3783 | 3 | 25 | epithelial tube branching involved in lung morphogenesis |
GO:0048666 | 0.0062 | 3.8738 | 1.6462 | 6 | 115 | neuron development |
GO:0015837 | 0.0062 | 4.5981 | 1.1651 | 5 | 77 | amine transport |
GO:0061387 | 0.0062 | 4.5981 | 1.1651 | 5 | 77 | regulation of extent of cell growth |
GO:0055025 | 0.0064 | 5.8702 | 0.7414 | 4 | 49 | positive regulation of cardiac muscle tissue development |
GO:0060485 | 0.0064 | 2.8484 | 3.3287 | 9 | 220 | mesenchyme development |
GO:0046887 | 0.0071 | 3.756 | 1.6946 | 6 | 112 | positive regulation of hormone secretion |
GO:1901701 | 0.0073 | 1.8104 | 14.0564 | 24 | 929 | cellular response to oxygen-containing compound |
GO:0021562 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | vestibulocochlear nerve development |
GO:0046549 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | retinal cone cell development |
GO:0046855 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | inositol phosphate dephosphorylation |
GO:0098598 | 0.0077 | 18.7511 | 0.1362 | 2 | 9 | learned vocalization behavior or vocal learning |
GO:0010769 | 0.0078 | 2.7556 | 3.4347 | 9 | 227 | regulation of cell morphogenesis involved in differentiation |
GO:0065008 | 0.0078 | 1.4986 | 40.2983 | 55 | 2757 | regulation of biological quality |
GO:0046530 | 0.0078 | 5.5022 | 0.7868 | 4 | 52 | photoreceptor cell differentiation |
GO:1904018 | 0.0079 | 3.2546 | 2.2696 | 7 | 150 | positive regulation of vasculature development |
GO:0071805 | 0.0081 | 3.6504 | 1.7403 | 6 | 117 | potassium ion transmembrane transport |
GO:0021885 | 0.0084 | 5.3896 | 0.8019 | 4 | 53 | forebrain cell migration |
GO:0060045 | 0.0085 | 7.9005 | 0.4237 | 3 | 28 | positive regulation of cardiac muscle cell proliferation |
GO:0000902 | 0.0087 | 1.8296 | 12.7098 | 22 | 840 | cell morphogenesis |
GO:0048469 | 0.0087 | 3.1871 | 2.315 | 7 | 153 | cell maturation |
GO:0030073 | 0.0089 | 2.8957 | 2.9051 | 8 | 192 | insulin secretion |
GO:0050886 | 0.009 | 7.7112 | 0.4324 | 3 | 29 | endocrine process |
GO:0021543 | 0.009 | 3.1652 | 2.3301 | 7 | 154 | pallium development |
GO:0003203 | 0.0093 | 7.5962 | 0.4388 | 3 | 29 | endocardial cushion morphogenesis |
GO:0019098 | 0.0093 | 7.5962 | 0.4388 | 3 | 29 | reproductive behavior |
GO:0021799 | 0.0093 | 7.5962 | 0.4388 | 3 | 29 | cerebral cortex radially oriented cell migration |
GO:0006874 | 0.0094 | 2.2925 | 5.4924 | 12 | 363 | cellular calcium ion homeostasis |
GO:0032275 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | luteinizing hormone secretion |
GO:0048845 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | venous blood vessel morphogenesis |
GO:0060947 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
GO:0097050 | 0.0095 | 16.4061 | 0.1513 | 2 | 10 | type B pancreatic cell apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 7.0751 | 1.9222 | 12 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0045658 | 5e-04 | 151.407 | 0.0395 | 2 | 3 | regulation of neutrophil differentiation |
GO:0002376 | 5e-04 | 1.7758 | 32.5455 | 51 | 2472 | immune system process |
GO:0045354 | 0.001 | 75.6985 | 0.0527 | 2 | 4 | regulation of interferon-alpha biosynthetic process |
GO:0050776 | 0.0011 | 3.7822 | 2.5503 | 9 | 202 | regulation of immune response |
GO:0022610 | 0.0016 | 1.9447 | 16.2069 | 29 | 1231 | biological adhesion |
GO:0045409 | 0.0017 | 50.4623 | 0.0658 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0002761 | 0.0022 | 4.8489 | 1.3297 | 6 | 101 | regulation of myeloid leukocyte differentiation |
GO:0045087 | 0.0024 | 2.1483 | 9.9664 | 20 | 757 | innate immune response |
GO:0032687 | 0.0025 | 37.8442 | 0.079 | 2 | 6 | negative regulation of interferon-alpha production |
GO:0045357 | 0.0025 | 37.8442 | 0.079 | 2 | 6 | regulation of interferon-beta biosynthetic process |
GO:0098609 | 0.0034 | 2.1202 | 9.5583 | 19 | 726 | cell-cell adhesion |
GO:0045656 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | negative regulation of monocyte differentiation |
GO:0046598 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | positive regulation of viral entry into host cell |
GO:0051256 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | mitotic spindle midzone assembly |
GO:2000035 | 0.0035 | 30.2734 | 0.0922 | 2 | 7 | regulation of stem cell division |
GO:0006950 | 0.0037 | 1.5481 | 44.3682 | 61 | 3370 | response to stress |
GO:0002757 | 0.0038 | 2.4906 | 5.5296 | 13 | 420 | immune response-activating signal transduction |
GO:0060333 | 0.0041 | 5.099 | 1.0533 | 5 | 80 | interferon-gamma-mediated signaling pathway |
GO:0080154 | 0.0042 | 10.3609 | 0.3291 | 3 | 25 | regulation of fertilization |
GO:0090023 | 0.0042 | 10.3609 | 0.3291 | 3 | 25 | positive regulation of neutrophil chemotaxis |
GO:0051607 | 0.0052 | 3.1943 | 2.6463 | 8 | 201 | defense response to virus |
GO:1902107 | 0.0053 | 4.0003 | 1.593 | 6 | 121 | positive regulation of leukocyte differentiation |
GO:0000910 | 0.0057 | 3.9314 | 1.6194 | 6 | 123 | cytokinesis |
GO:0032728 | 0.0058 | 9.1158 | 0.3686 | 3 | 28 | positive regulation of interferon-beta production |
GO:0097529 | 0.006 | 3.4265 | 2.1592 | 7 | 164 | myeloid leukocyte migration |
GO:0007585 | 0.0067 | 5.7516 | 0.7504 | 4 | 57 | respiratory gaseous exchange |
GO:0009607 | 0.007 | 1.9706 | 10.2297 | 19 | 777 | response to biotic stimulus |
GO:0097009 | 0.007 | 8.4394 | 0.395 | 3 | 30 | energy homeostasis |
GO:1903131 | 0.007 | 8.4394 | 0.395 | 3 | 30 | mononuclear cell differentiation |
GO:0001818 | 0.0071 | 3.0198 | 2.7911 | 8 | 212 | negative regulation of cytokine production |
GO:0045351 | 0.0072 | 18.9171 | 0.1317 | 2 | 10 | type I interferon biosynthetic process |
GO:0051231 | 0.0072 | 18.9171 | 0.1317 | 2 | 10 | spindle elongation |
GO:1900004 | 0.0072 | 18.9171 | 0.1317 | 2 | 10 | negative regulation of serine-type endopeptidase activity |
GO:0050778 | 0.0073 | 2.0925 | 8.0837 | 16 | 614 | positive regulation of immune response |
GO:0048147 | 0.0077 | 8.1374 | 0.4081 | 3 | 31 | negative regulation of fibroblast proliferation |
GO:1902622 | 0.0077 | 8.1374 | 0.4081 | 3 | 31 | regulation of neutrophil migration |
GO:0043122 | 0.0079 | 2.9609 | 2.8438 | 8 | 216 | regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0070897 | 0.0084 | 7.8563 | 0.4213 | 3 | 32 | DNA-templated transcriptional preinitiation complex assembly |
GO:0051707 | 0.0086 | 1.9656 | 9.6899 | 18 | 736 | response to other organism |
GO:0034384 | 0.0088 | 16.8141 | 0.1448 | 2 | 11 | high-density lipoprotein particle clearance |
GO:0051246 | 0.0097 | 1.5216 | 33.7567 | 47 | 2564 | regulation of protein metabolic process |
GO:0071621 | 0.0099 | 4.0632 | 1.3034 | 5 | 99 | granulocyte chemotaxis |
GO:0019731 | 0.01 | 7.3485 | 0.4476 | 3 | 34 | antibacterial humoral response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 41.2206 | 0.3736 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 33.2825 | 0.4339 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 33.2825 | 0.4339 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 33.2825 | 0.4339 | 10 | 36 | response to interleukin-7 |
GO:0051290 | 0 | 26.2104 | 0.5182 | 10 | 43 | protein heterotetramerization |
GO:0006333 | 0 | 9.4813 | 2.0007 | 16 | 166 | chromatin assembly or disassembly |
GO:0006323 | 0 | 8.5064 | 2.2055 | 16 | 183 | DNA packaging |
GO:0045652 | 0 | 15.9203 | 0.8557 | 11 | 71 | regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 6.7222 | 2.9166 | 17 | 242 | protein-DNA complex subunit organization |
GO:0045815 | 0 | 12.6902 | 0.9401 | 10 | 78 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 10.7121 | 1.2052 | 11 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 8.9839 | 1.4101 | 11 | 117 | negative regulation of gene expression, epigenetic |
GO:0060964 | 0 | 9.6823 | 1.1932 | 10 | 99 | regulation of gene silencing by miRNA |
GO:0002244 | 0 | 6.669 | 2.2055 | 13 | 183 | hematopoietic progenitor cell differentiation |
GO:0030099 | 0 | 4.7019 | 4.3147 | 18 | 358 | myeloid cell differentiation |
GO:0048863 | 0 | 5.2948 | 2.9528 | 14 | 245 | stem cell differentiation |
GO:0060968 | 0 | 7.7519 | 1.4583 | 10 | 121 | regulation of gene silencing |
GO:1903706 | 0 | 3.9906 | 5.0257 | 18 | 417 | regulation of hemopoiesis |
GO:0032200 | 0 | 5.9207 | 1.8681 | 10 | 155 | telomere organization |
GO:0035194 | 0 | 4.4031 | 3.242 | 13 | 269 | posttranscriptional gene silencing by RNA |
GO:0048534 | 0 | 2.7358 | 9.7381 | 24 | 808 | hematopoietic or lymphoid organ development |
GO:0050878 | 1e-04 | 3.261 | 5.3511 | 16 | 444 | regulation of body fluid levels |
GO:0097274 | 1e-04 | Inf | 0.0241 | 2 | 2 | urea homeostasis |
GO:0072505 | 3e-04 | 31.2327 | 0.1326 | 3 | 11 | divalent inorganic anion homeostasis |
GO:0072506 | 3e-04 | 31.2327 | 0.1326 | 3 | 11 | trivalent inorganic anion homeostasis |
GO:0007596 | 3e-04 | 3.534 | 3.6639 | 12 | 304 | blood coagulation |
GO:0017148 | 4e-04 | 3.2866 | 4.2665 | 13 | 354 | negative regulation of translation |
GO:1902679 | 5e-04 | 2.2038 | 12.944 | 26 | 1074 | negative regulation of RNA biosynthetic process |
GO:0006334 | 7e-04 | 6.1474 | 1.0621 | 6 | 93 | nucleosome assembly |
GO:0045892 | 7e-04 | 2.177 | 12.5463 | 25 | 1041 | negative regulation of transcription, DNA-templated |
GO:0045934 | 7e-04 | 2.0579 | 15.4991 | 29 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0071345 | 8e-04 | 2.3309 | 9.7743 | 21 | 811 | cellular response to cytokine stimulus |
GO:0055083 | 9e-04 | 19.2138 | 0.1928 | 3 | 16 | monovalent inorganic anion homeostasis |
GO:0051259 | 9e-04 | 2.7296 | 5.9055 | 15 | 490 | protein oligomerization |
GO:0045595 | 0.001 | 1.9345 | 18.8495 | 33 | 1564 | regulation of cell differentiation |
GO:0072507 | 0.0012 | 2.8641 | 4.857 | 13 | 403 | divalent inorganic cation homeostasis |
GO:0007611 | 0.0013 | 3.6779 | 2.6153 | 9 | 217 | learning or memory |
GO:0030539 | 0.0017 | 14.689 | 0.241 | 3 | 20 | male genitalia development |
GO:0021902 | 0.0021 | 41.4258 | 0.0723 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0034248 | 0.0036 | 2.3365 | 6.8336 | 15 | 567 | regulation of cellular amide metabolic process |
GO:1902253 | 0.0037 | 10.8528 | 0.3134 | 3 | 26 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
GO:0055065 | 0.0042 | 2.3724 | 6.2671 | 14 | 520 | metal ion homeostasis |
GO:0071230 | 0.0043 | 6.5499 | 0.6629 | 4 | 55 | cellular response to amino acid stimulus |
GO:0048731 | 0.0046 | 1.5248 | 50.4382 | 67 | 4185 | system development |
GO:0006935 | 0.0046 | 2.3484 | 6.3274 | 14 | 525 | chemotaxis |
GO:0006874 | 0.0046 | 2.6609 | 4.3749 | 11 | 363 | cellular calcium ion homeostasis |
GO:0042472 | 0.0049 | 4.8711 | 1.0967 | 5 | 91 | inner ear morphogenesis |
GO:0030643 | 0.0049 | 23.6672 | 0.1085 | 2 | 9 | cellular phosphate ion homeostasis |
GO:0060546 | 0.0049 | 23.6672 | 0.1085 | 2 | 9 | negative regulation of necroptotic process |
GO:0070232 | 0.005 | 9.5986 | 0.3495 | 3 | 29 | regulation of T cell apoptotic process |
GO:0009611 | 0.0053 | 2.2354 | 7.1228 | 15 | 591 | response to wounding |
GO:0010608 | 0.0056 | 2.1598 | 7.87 | 16 | 653 | posttranscriptional regulation of gene expression |
GO:0017144 | 0.0066 | 8.6039 | 0.3857 | 3 | 32 | drug metabolic process |
GO:0006873 | 0.0066 | 2.2437 | 6.6046 | 14 | 548 | cellular ion homeostasis |
GO:0070227 | 0.007 | 5.6588 | 0.7593 | 4 | 63 | lymphocyte apoptotic process |
GO:0002756 | 0.0072 | 8.3166 | 0.3977 | 3 | 33 | MyD88-independent toll-like receptor signaling pathway |
GO:0019725 | 0.0075 | 1.9992 | 9.5694 | 18 | 794 | cellular homeostasis |
GO:0002761 | 0.0075 | 4.3607 | 1.2173 | 5 | 101 | regulation of myeloid leukocyte differentiation |
GO:0043604 | 0.0082 | 1.9403 | 10.413 | 19 | 864 | amide biosynthetic process |
GO:0043029 | 0.0085 | 7.7958 | 0.4218 | 3 | 35 | T cell homeostasis |
GO:0006140 | 0.0085 | 2.9225 | 2.8805 | 8 | 239 | regulation of nucleotide metabolic process |
GO:0048663 | 0.0091 | 5.2149 | 0.8195 | 4 | 68 | neuron fate commitment |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009952 | 0 | 4.947 | 2.6722 | 12 | 188 | anterior/posterior pattern specification |
GO:0048704 | 0 | 7.0738 | 1.265 | 8 | 89 | embryonic skeletal system morphogenesis |
GO:0007156 | 0 | 5.2977 | 2.0752 | 10 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0009889 | 1e-04 | 1.7166 | 58.7309 | 84 | 4132 | regulation of biosynthetic process |
GO:0007416 | 1e-04 | 5.1663 | 1.9046 | 9 | 134 | synapse assembly |
GO:0044657 | 2e-04 | Inf | 0.0284 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0046960 | 2e-04 | Inf | 0.0284 | 2 | 2 | sensitization |
GO:0052043 | 2e-04 | Inf | 0.0284 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 2e-04 | Inf | 0.0284 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 2e-04 | Inf | 0.0284 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:1902957 | 2e-04 | Inf | 0.0284 | 2 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
GO:0009790 | 2e-04 | 2.3602 | 11.5548 | 25 | 829 | embryo development |
GO:0007389 | 3e-04 | 3.1923 | 4.725 | 14 | 339 | pattern specification process |
GO:0032501 | 3e-04 | 1.6431 | 81.9375 | 106 | 6154 | multicellular organismal process |
GO:0032502 | 4e-04 | 1.7673 | 41.2776 | 61 | 3211 | developmental process |
GO:0009712 | 4e-04 | 8.8502 | 0.6396 | 5 | 45 | catechol-containing compound metabolic process |
GO:0051934 | 4e-04 | 26.3586 | 0.1564 | 3 | 11 | catecholamine uptake involved in synaptic transmission |
GO:0090494 | 4e-04 | 26.3586 | 0.1564 | 3 | 11 | dopamine uptake |
GO:1901856 | 6e-04 | 139.9907 | 0.0426 | 2 | 3 | negative regulation of cellular respiration |
GO:0006355 | 7e-04 | 1.6488 | 46.5497 | 67 | 3275 | regulation of transcription, DNA-templated |
GO:0048731 | 7e-04 | 2.1374 | 14.0661 | 27 | 1083 | system development |
GO:0001501 | 8e-04 | 2.6618 | 6.4388 | 16 | 453 | skeletal system development |
GO:0001963 | 8e-04 | 10.8516 | 0.4264 | 4 | 30 | synaptic transmission, dopaminergic |
GO:2001141 | 9e-04 | 1.6313 | 46.9335 | 67 | 3302 | regulation of RNA biosynthetic process |
GO:0009653 | 9e-04 | 1.7249 | 32.3503 | 50 | 2276 | anatomical structure morphogenesis |
GO:0071867 | 9e-04 | 10.449 | 0.4406 | 4 | 31 | response to monoamine |
GO:0009617 | 0.0011 | 2.5592 | 6.6804 | 16 | 470 | response to bacterium |
GO:2000249 | 0.0012 | 9.7271 | 0.4691 | 4 | 33 | regulation of actin cytoskeleton reorganization |
GO:0009880 | 0.0013 | 6.8024 | 0.8102 | 5 | 57 | embryonic pattern specification |
GO:0019731 | 0.0013 | 9.4022 | 0.4833 | 4 | 34 | antibacterial humoral response |
GO:0043009 | 0.0014 | 2.4382 | 7.448 | 17 | 524 | chordate embryonic development |
GO:0060021 | 0.0014 | 5.3211 | 1.2224 | 6 | 86 | palate development |
GO:0060255 | 0.0015 | 1.5195 | 78.431 | 100 | 5518 | regulation of macromolecule metabolic process |
GO:0019219 | 0.0016 | 1.5616 | 54.2962 | 74 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0042053 | 0.0017 | 15.0561 | 0.2416 | 3 | 17 | regulation of dopamine metabolic process |
GO:0035609 | 0.002 | 46.6574 | 0.0711 | 2 | 5 | C-terminal protein deglutamylation |
GO:0045409 | 0.002 | 46.6574 | 0.0711 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0051673 | 0.002 | 46.6574 | 0.0711 | 2 | 5 | membrane disruption in other organism |
GO:0002227 | 0.002 | 14.0514 | 0.2558 | 3 | 18 | innate immune response in mucosa |
GO:0042423 | 0.0023 | 13.1723 | 0.2701 | 3 | 19 | catecholamine biosynthetic process |
GO:0032496 | 0.0025 | 2.8903 | 4.0367 | 11 | 284 | response to lipopolysaccharide |
GO:0097659 | 0.0027 | 1.5445 | 48.9376 | 67 | 3443 | nucleic acid-templated transcription |
GO:0001504 | 0.0027 | 12.3966 | 0.2843 | 3 | 20 | neurotransmitter uptake |
GO:0009888 | 0.0028 | 1.7104 | 24.8455 | 39 | 1748 | tissue development |
GO:0006771 | 0.0029 | 34.9907 | 0.0853 | 2 | 6 | riboflavin metabolic process |
GO:0090324 | 0.0029 | 34.9907 | 0.0853 | 2 | 6 | negative regulation of oxidative phosphorylation |
GO:1905446 | 0.0029 | 34.9907 | 0.0853 | 2 | 6 | regulation of mitochondrial ATP synthesis coupled electron transport |
GO:0021545 | 0.0035 | 7.0469 | 0.6254 | 4 | 44 | cranial nerve development |
GO:0048562 | 0.0036 | 3.404 | 2.4924 | 8 | 181 | embryonic organ morphogenesis |
GO:0044249 | 0.0039 | 1.4564 | 81.4727 | 101 | 5732 | cellular biosynthetic process |
GO:0051584 | 0.004 | 27.9907 | 0.0995 | 2 | 7 | regulation of dopamine uptake involved in synaptic transmission |
GO:0001964 | 0.0041 | 10.535 | 0.3269 | 3 | 23 | startle response |
GO:0042220 | 0.0051 | 6.2619 | 0.6965 | 4 | 49 | response to cocaine |
GO:0007191 | 0.0053 | 23.324 | 0.1137 | 2 | 8 | adenylate cyclase-activating dopamine receptor signaling pathway |
GO:0021603 | 0.0053 | 23.324 | 0.1137 | 2 | 8 | cranial nerve formation |
GO:0018149 | 0.0067 | 5.7492 | 0.7533 | 4 | 53 | peptide cross-linking |
GO:0001714 | 0.0068 | 19.9907 | 0.1279 | 2 | 9 | endodermal cell fate specification |
GO:0010579 | 0.0068 | 19.9907 | 0.1279 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0010764 | 0.0068 | 19.9907 | 0.1279 | 2 | 9 | negative regulation of fibroblast migration |
GO:0002251 | 0.0071 | 8.4252 | 0.398 | 3 | 28 | organ or tissue specific immune response |
GO:0009059 | 0.0076 | 1.4235 | 68.7373 | 86 | 4836 | macromolecule biosynthetic process |
GO:0001906 | 0.0076 | 3.693 | 1.7199 | 6 | 121 | cell killing |
GO:0071870 | 0.0079 | 8.1006 | 0.4122 | 3 | 29 | cellular response to catecholamine stimulus |
GO:0030432 | 0.0084 | 17.4907 | 0.1421 | 2 | 10 | peristalsis |
GO:0031115 | 0.0084 | 17.4907 | 0.1421 | 2 | 10 | negative regulation of microtubule polymerization |
GO:0051937 | 0.0087 | 5.3138 | 0.8102 | 4 | 57 | catecholamine transport |
GO:0043207 | 0.0091 | 1.9127 | 10.4897 | 19 | 738 | response to external biotic stimulus |
GO:0034654 | 0.0093 | 1.4341 | 55.1774 | 71 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0042472 | 0.0096 | 4.1038 | 1.2934 | 5 | 91 | inner ear morphogenesis |
GO:0035295 | 0.0096 | 2.0749 | 7.6043 | 15 | 535 | tube development |
GO:0048513 | 0.01 | 1.4646 | 43.4796 | 58 | 3059 | animal organ development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 11.2547 | 4.2493 | 36 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 9.123 | 5.4485 | 38 | 418 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 8.998 | 5.3442 | 37 | 410 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 8.8967 | 5.2269 | 36 | 401 | detection of chemical stimulus |
GO:0050877 | 0 | 4.2607 | 14.6249 | 49 | 1122 | nervous system process |
GO:0007186 | 0 | 3.8103 | 14.9638 | 46 | 1148 | G-protein coupled receptor signaling pathway |
GO:0051716 | 0 | 1.7873 | 83.6955 | 112 | 6421 | cellular response to stimulus |
GO:0023052 | 1e-04 | 1.7484 | 74.1541 | 101 | 5689 | signaling |
GO:0007154 | 1e-04 | 1.739 | 74.4018 | 101 | 5708 | cell communication |
GO:0060513 | 2e-04 | 38.4235 | 0.1173 | 3 | 9 | prostatic bud formation |
GO:0051967 | 4e-04 | 25.6105 | 0.1564 | 3 | 12 | negative regulation of synaptic transmission, glutamatergic |
GO:0060603 | 4e-04 | 12.8581 | 0.365 | 4 | 28 | mammary gland duct morphogenesis |
GO:0048807 | 5e-04 | 152.9645 | 0.0391 | 2 | 3 | female genitalia morphogenesis |
GO:0060750 | 5e-04 | 152.9645 | 0.0391 | 2 | 3 | epithelial cell proliferation involved in mammary gland duct elongation |
GO:0050891 | 8e-04 | 7.5889 | 0.7299 | 5 | 56 | multicellular organismal water homeostasis |
GO:0061436 | 0.0013 | 16.4585 | 0.2216 | 3 | 17 | establishment of skin barrier |
GO:0060602 | 0.0015 | 15.3602 | 0.2346 | 3 | 18 | branch elongation of an epithelium |
GO:0021983 | 0.0016 | 8.8105 | 0.5084 | 4 | 39 | pituitary gland development |
GO:0060157 | 0.0016 | 50.9814 | 0.0652 | 2 | 5 | urinary bladder development |
GO:0060744 | 0.0016 | 50.9814 | 0.0652 | 2 | 5 | mammary gland branching involved in thelarche |
GO:0032501 | 0.002 | 1.5254 | 85.377 | 106 | 6550 | multicellular organismal process |
GO:0060571 | 0.0032 | 11.5163 | 0.2998 | 3 | 23 | morphogenesis of an epithelial fold |
GO:0046543 | 0.0034 | 30.5848 | 0.0912 | 2 | 7 | development of secondary female sexual characteristics |
GO:0060907 | 0.0034 | 30.5848 | 0.0912 | 2 | 7 | positive regulation of macrophage cytokine production |
GO:0042221 | 0.0034 | 1.6708 | 31.5499 | 46 | 3033 | response to chemical |
GO:1900542 | 0.0035 | 3.139 | 3.0371 | 9 | 233 | regulation of purine nucleotide metabolic process |
GO:0015758 | 0.0036 | 4.3468 | 1.4729 | 6 | 113 | glucose transport |
GO:0030799 | 0.0038 | 3.7522 | 1.9813 | 7 | 152 | regulation of cyclic nucleotide metabolic process |
GO:0051450 | 0.0041 | 10.468 | 0.3259 | 3 | 25 | myoblast proliferation |
GO:0048146 | 0.0043 | 6.5558 | 0.6648 | 4 | 51 | positive regulation of fibroblast proliferation |
GO:0030817 | 0.0045 | 4.1514 | 1.5381 | 6 | 118 | regulation of cAMP biosynthetic process |
GO:0007195 | 0.0045 | 25.4856 | 0.1043 | 2 | 8 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0043455 | 0.0045 | 25.4856 | 0.1043 | 2 | 8 | regulation of secondary metabolic process |
GO:0060638 | 0.0045 | 25.4856 | 0.1043 | 2 | 8 | mesenchymal-epithelial cell signaling |
GO:0060512 | 0.0045 | 10.0122 | 0.3389 | 3 | 26 | prostate gland morphogenesis |
GO:0015749 | 0.0051 | 4.0423 | 1.5772 | 6 | 121 | monosaccharide transport |
GO:0031279 | 0.0056 | 4.7102 | 1.134 | 5 | 87 | regulation of cyclase activity |
GO:0045740 | 0.0057 | 6.04 | 0.7169 | 4 | 55 | positive regulation of DNA replication |
GO:0006857 | 0.0057 | 21.8434 | 0.1173 | 2 | 9 | oligopeptide transport |
GO:0010838 | 0.0057 | 21.8434 | 0.1173 | 2 | 9 | positive regulation of keratinocyte proliferation |
GO:0051339 | 0.0061 | 4.5974 | 1.1601 | 5 | 89 | regulation of lyase activity |
GO:0009954 | 0.0062 | 8.8552 | 0.378 | 3 | 29 | proximal/distal pattern formation |
GO:0007194 | 0.0068 | 8.5266 | 0.391 | 3 | 30 | negative regulation of adenylate cyclase activity |
GO:0007494 | 0.0071 | 19.1117 | 0.1303 | 2 | 10 | midgut development |
GO:0010035 | 0.0074 | 2.2861 | 5.9959 | 13 | 460 | response to inorganic substance |
GO:0019932 | 0.0079 | 2.7516 | 3.4411 | 9 | 264 | second-messenger-mediated signaling |
GO:1901385 | 0.0082 | 7.9375 | 0.4171 | 3 | 32 | regulation of voltage-gated calcium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:2001141 | 0 | 1.7957 | 50.6103 | 77 | 3302 | regulation of RNA biosynthetic process |
GO:0001826 | 1e-04 | 48.7955 | 0.1073 | 3 | 7 | inner cell mass cell differentiation |
GO:0010453 | 1e-04 | 11.7007 | 0.5058 | 5 | 33 | regulation of cell fate commitment |
GO:0099537 | 1e-04 | 2.6614 | 8.5526 | 21 | 558 | trans-synaptic signaling |
GO:0055123 | 2e-04 | 4.971 | 1.9772 | 9 | 129 | digestive system development |
GO:0045944 | 2e-04 | 2.1756 | 15.5877 | 31 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0019219 | 2e-04 | 1.6615 | 58.5498 | 83 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0009889 | 3e-04 | 1.6379 | 63.3319 | 88 | 4132 | regulation of biosynthetic process |
GO:0048562 | 3e-04 | 3.382 | 4.1383 | 13 | 270 | embryonic organ morphogenesis |
GO:0034654 | 4e-04 | 1.6254 | 59.5001 | 83 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0001964 | 4e-04 | 13.7428 | 0.3525 | 4 | 23 | startle response |
GO:0060562 | 6e-04 | 3.1221 | 4.4602 | 13 | 291 | epithelial tube morphogenesis |
GO:0006355 | 6e-04 | 1.7611 | 32.6636 | 51 | 2234 | regulation of transcription, DNA-templated |
GO:0035295 | 6e-04 | 2.4862 | 8.2 | 19 | 535 | tube development |
GO:0009952 | 7e-04 | 3.7257 | 2.8815 | 10 | 188 | anterior/posterior pattern specification |
GO:0009653 | 8e-04 | 2.0422 | 15.5144 | 29 | 1075 | anatomical structure morphogenesis |
GO:0048384 | 9e-04 | 10.4403 | 0.4445 | 4 | 29 | retinoic acid receptor signaling pathway |
GO:0048705 | 0.001 | 3.5251 | 3.0348 | 10 | 198 | skeletal system morphogenesis |
GO:0001963 | 0.0011 | 10.0381 | 0.4598 | 4 | 30 | synaptic transmission, dopaminergic |
GO:0007267 | 0.0012 | 1.8218 | 22.1018 | 37 | 1442 | cell-cell signaling |
GO:0051142 | 0.0014 | 64.7888 | 0.0613 | 2 | 4 | positive regulation of NK T cell proliferation |
GO:2000330 | 0.0014 | 64.7888 | 0.0613 | 2 | 4 | positive regulation of T-helper 17 cell lineage commitment |
GO:0048729 | 0.0016 | 2.2713 | 8.9204 | 19 | 582 | tissue morphogenesis |
GO:0045986 | 0.0017 | 15.005 | 0.2452 | 3 | 16 | negative regulation of smooth muscle contraction |
GO:0060008 | 0.0021 | 13.9323 | 0.2606 | 3 | 17 | Sertoli cell differentiation |
GO:0060023 | 0.0023 | 43.1897 | 0.0766 | 2 | 5 | soft palate development |
GO:0031328 | 0.0024 | 1.7119 | 25.3818 | 40 | 1656 | positive regulation of cellular biosynthetic process |
GO:0048148 | 0.0024 | 13.0026 | 0.2759 | 3 | 18 | behavioral response to cocaine |
GO:0007268 | 0.0027 | 2.2687 | 7.955 | 17 | 527 | chemical synaptic transmission |
GO:0010002 | 0.0029 | 12.1891 | 0.2912 | 3 | 19 | cardioblast differentiation |
GO:0007218 | 0.0029 | 4.5737 | 1.4101 | 6 | 92 | neuropeptide signaling pathway |
GO:0006811 | 0.0029 | 1.7484 | 21.596 | 35 | 1409 | ion transport |
GO:0019226 | 0.0032 | 5.4487 | 0.9963 | 5 | 65 | transmission of nerve impulse |
GO:0003279 | 0.0032 | 4.4692 | 1.4408 | 6 | 94 | cardiac septum development |
GO:1903508 | 0.0032 | 1.764 | 20.1246 | 33 | 1313 | positive regulation of nucleic acid-templated transcription |
GO:0010536 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | positive regulation of activation of Janus kinase activity |
GO:0043382 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | positive regulation of memory T cell differentiation |
GO:0060956 | 0.0034 | 32.3901 | 0.092 | 2 | 6 | endocardial cell differentiation |
GO:0007507 | 0.0035 | 2.2692 | 7.4643 | 16 | 487 | heart development |
GO:0001914 | 0.0039 | 10.8333 | 0.3219 | 3 | 21 | regulation of T cell mediated cytotoxicity |
GO:0045624 | 0.0039 | 10.8333 | 0.3219 | 3 | 21 | positive regulation of T-helper cell differentiation |
GO:0051952 | 0.0041 | 5.1068 | 1.0576 | 5 | 69 | regulation of amine transport |
GO:0032680 | 0.0042 | 4.2275 | 1.5174 | 6 | 99 | regulation of tumor necrosis factor production |
GO:0007399 | 0.0042 | 1.6018 | 31.2368 | 46 | 2038 | nervous system development |
GO:0045672 | 0.0044 | 10.2625 | 0.3372 | 3 | 22 | positive regulation of osteoclast differentiation |
GO:0001708 | 0.0045 | 4.9927 | 1.0796 | 5 | 71 | cell fate specification |
GO:0097659 | 0.0045 | 1.6135 | 30.6937 | 45 | 2131 | nucleic acid-templated transcription |
GO:0002573 | 0.0046 | 3.2698 | 2.5903 | 8 | 169 | myeloid leukocyte differentiation |
GO:0001766 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | membrane raft polarization |
GO:0002291 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0021826 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | substrate-independent telencephalic tangential migration |
GO:0021830 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | interneuron migration from the subpallium to the cortex |
GO:0032819 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | positive regulation of natural killer cell proliferation |
GO:0051584 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | regulation of dopamine uptake involved in synaptic transmission |
GO:2000318 | 0.0047 | 25.9103 | 0.1073 | 2 | 7 | positive regulation of T-helper 17 type immune response |
GO:0040012 | 0.0048 | 1.9355 | 12.0625 | 22 | 787 | regulation of locomotion |
GO:0048546 | 0.0049 | 6.3593 | 0.6897 | 4 | 45 | digestive tract morphogenesis |
GO:0030878 | 0.005 | 9.7487 | 0.3525 | 3 | 23 | thyroid gland development |
GO:0042832 | 0.005 | 9.7487 | 0.3525 | 3 | 23 | defense response to protozoan |
GO:0007275 | 0.0053 | 1.4985 | 50.4964 | 67 | 3525 | multicellular organism development |
GO:0046633 | 0.0057 | 9.2839 | 0.3679 | 3 | 24 | alpha-beta T cell proliferation |
GO:0051239 | 0.0057 | 1.5206 | 39.5748 | 55 | 2582 | regulation of multicellular organismal process |
GO:0014706 | 0.0058 | 2.454 | 5.1499 | 12 | 336 | striated muscle tissue development |
GO:0071706 | 0.0058 | 3.9297 | 1.6247 | 6 | 106 | tumor necrosis factor superfamily cytokine production |
GO:0007626 | 0.006 | 3.1134 | 2.7129 | 8 | 177 | locomotory behavior |
GO:0007368 | 0.0061 | 3.8906 | 1.64 | 6 | 107 | determination of left/right symmetry |
GO:0051133 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | regulation of NK T cell activation |
GO:0051665 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | membrane raft localization |
GO:1903715 | 0.0062 | 21.5905 | 0.1226 | 2 | 8 | regulation of aerobic respiration |
GO:0003148 | 0.0064 | 8.8613 | 0.3832 | 3 | 25 | outflow tract septum morphogenesis |
GO:0060292 | 0.0064 | 8.8613 | 0.3832 | 3 | 25 | long term synaptic depression |
GO:0048468 | 0.0064 | 1.5949 | 27.7115 | 41 | 1808 | cell development |
GO:0032649 | 0.0065 | 4.5369 | 1.1802 | 5 | 77 | regulation of interferon-gamma production |
GO:0048870 | 0.0068 | 1.682 | 20.3238 | 32 | 1326 | cell motility |
GO:0006937 | 0.007 | 3.3284 | 2.2224 | 7 | 145 | regulation of muscle contraction |
GO:0051254 | 0.0071 | 1.664 | 21.1975 | 33 | 1383 | positive regulation of RNA metabolic process |
GO:0016358 | 0.0073 | 3.0054 | 2.8049 | 8 | 183 | dendrite development |
GO:0048513 | 0.0075 | 1.533 | 34.9635 | 49 | 2411 | animal organ development |
GO:0045597 | 0.0077 | 1.8511 | 12.5683 | 22 | 820 | positive regulation of cell differentiation |
GO:0003018 | 0.0078 | 3.2569 | 2.2684 | 7 | 148 | vascular process in circulatory system |
GO:0001714 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | endodermal cell fate specification |
GO:0048617 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | embryonic foregut morphogenesis |
GO:0090715 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | immunological memory formation process |
GO:2001054 | 0.0078 | 18.5049 | 0.1379 | 2 | 9 | negative regulation of mesenchymal cell apoptotic process |
GO:0043467 | 0.0079 | 3.6709 | 1.732 | 6 | 113 | regulation of generation of precursor metabolites and energy |
GO:0098660 | 0.008 | 1.9022 | 11.0969 | 20 | 724 | inorganic ion transmembrane transport |
GO:0030816 | 0.0081 | 4.297 | 1.2415 | 5 | 81 | positive regulation of cAMP metabolic process |
GO:0001824 | 0.0082 | 5.4293 | 0.797 | 4 | 52 | blastocyst development |
GO:0048869 | 0.0082 | 1.5823 | 28.3063 | 41 | 1981 | cellular developmental process |
GO:0030001 | 0.0084 | 1.8619 | 11.9092 | 21 | 777 | metal ion transport |
GO:0021885 | 0.0088 | 5.3182 | 0.8123 | 4 | 53 | forebrain cell migration |
GO:0090022 | 0.0088 | 7.7964 | 0.4292 | 3 | 28 | regulation of neutrophil chemotaxis |
GO:2000516 | 0.0088 | 7.7964 | 0.4292 | 3 | 28 | positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0048706 | 0.0089 | 3.5701 | 1.778 | 6 | 116 | embryonic skeletal system development |
GO:0003206 | 0.0093 | 3.5377 | 1.7933 | 6 | 117 | cardiac chamber morphogenesis |
GO:0009799 | 0.0093 | 3.5377 | 1.7933 | 6 | 117 | specification of symmetry |
GO:0008406 | 0.0093 | 2.8725 | 2.9275 | 8 | 191 | gonad development |
GO:0001843 | 0.0094 | 4.133 | 1.2875 | 5 | 84 | neural tube closure |
GO:0009790 | 0.0094 | 1.7898 | 13.5799 | 23 | 886 | embryo development |
GO:0045892 | 0.0095 | 1.7264 | 15.9556 | 26 | 1041 | negative regulation of transcription, DNA-templated |
GO:0001838 | 0.0097 | 3.5059 | 1.8086 | 6 | 118 | embryonic epithelial tube formation |
GO:0043368 | 0.0097 | 7.496 | 0.4445 | 3 | 29 | positive T cell selection |
GO:0071888 | 0.0097 | 16.1907 | 0.1533 | 2 | 10 | macrophage apoptotic process |
GO:0048646 | 0.0098 | 1.7613 | 14.4075 | 24 | 940 | anatomical structure formation involved in morphogenesis |
GO:0007389 | 0.0098 | 2.4987 | 4.1988 | 10 | 279 | pattern specification process |
GO:1900542 | 0.0099 | 2.6445 | 3.5712 | 9 | 233 | regulation of purine nucleotide metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 214.9857 | 0.4905 | 26 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 280.472 | 0.4223 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 103.2494 | 0.5858 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 43.8973 | 1.0627 | 27 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 29.3268 | 1.3488 | 26 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 28.9286 | 1.3624 | 26 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 23.4976 | 1.594 | 26 | 117 | negative regulation of gene expression, epigenetic |
GO:0045653 | 0 | 362.1718 | 0.2316 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060968 | 0 | 22.5023 | 1.6485 | 26 | 121 | regulation of gene silencing |
GO:0031497 | 0 | 18.2442 | 1.9483 | 26 | 143 | chromatin assembly |
GO:0034728 | 0 | 16.7964 | 2.0845 | 26 | 153 | nucleosome organization |
GO:0002244 | 0 | 14.2506 | 2.4932 | 27 | 183 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 15.3812 | 2.0514 | 24 | 152 | telomere organization |
GO:0048863 | 0 | 10.6394 | 3.3379 | 28 | 245 | stem cell differentiation |
GO:0065004 | 0 | 11.4857 | 2.8747 | 26 | 211 | protein-DNA complex assembly |
GO:0034080 | 0 | 41.7252 | 0.545 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0030099 | 0 | 7.8905 | 4.8774 | 31 | 358 | myeloid cell differentiation |
GO:1904837 | 0 | 38.7397 | 0.5722 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0035194 | 0 | 9.1334 | 3.6649 | 27 | 269 | posttranscriptional gene silencing by RNA |
GO:0071103 | 0 | 9.2514 | 3.4742 | 26 | 255 | DNA conformation change |
GO:0016233 | 0 | 30.1148 | 0.6812 | 14 | 50 | telomere capping |
GO:0043044 | 0 | 20.1014 | 0.9946 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0045652 | 0 | 26.3031 | 0.687 | 13 | 54 | regulation of megakaryocyte differentiation |
GO:0006303 | 0 | 20.8265 | 0.8992 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0017148 | 0 | 6.7205 | 4.823 | 27 | 354 | negative regulation of translation |
GO:0051259 | 0 | 5.1302 | 6.6758 | 29 | 490 | protein oligomerization |
GO:0038111 | 0 | 29.2016 | 0.4905 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 29.2016 | 0.4905 | 10 | 36 | response to interleukin-7 |
GO:0034248 | 0 | 4.6799 | 7.5466 | 30 | 559 | regulation of cellular amide metabolic process |
GO:1903707 | 0 | 10.3722 | 1.7303 | 15 | 127 | negative regulation of hemopoiesis |
GO:0010608 | 0 | 4.2272 | 8.8966 | 32 | 653 | posttranscriptional regulation of gene expression |
GO:0045892 | 0 | 3.3438 | 14.1827 | 40 | 1041 | negative regulation of transcription, DNA-templated |
GO:0048534 | 0 | 3.6064 | 11.0083 | 34 | 808 | hematopoietic or lymphoid organ development |
GO:1902679 | 0 | 3.2295 | 14.6323 | 40 | 1074 | negative regulation of RNA biosynthetic process |
GO:0007596 | 0 | 5.5345 | 4.1417 | 20 | 304 | blood coagulation |
GO:0045596 | 0 | 3.7644 | 8.1881 | 27 | 601 | negative regulation of cell differentiation |
GO:0045934 | 0 | 2.8098 | 17.5207 | 42 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0006352 | 0 | 5.9211 | 3.0654 | 16 | 225 | DNA-templated transcription, initiation |
GO:0043043 | 0 | 3.2952 | 10.7767 | 31 | 791 | peptide biosynthetic process |
GO:0050878 | 0 | 4.1025 | 6.0491 | 22 | 444 | regulation of body fluid levels |
GO:0048869 | 0 | 2.0597 | 51.9217 | 84 | 3811 | cellular developmental process |
GO:0070271 | 0 | 2.5763 | 17.9021 | 40 | 1314 | protein complex biogenesis |
GO:0009611 | 0 | 3.3338 | 8.0519 | 24 | 591 | response to wounding |
GO:1903706 | 0 | 4.496 | 3.6968 | 15 | 290 | regulation of hemopoiesis |
GO:0060249 | 0 | 3.9974 | 4.7003 | 17 | 345 | anatomical structure homeostasis |
GO:0051248 | 0 | 2.4595 | 16.5806 | 36 | 1217 | negative regulation of protein metabolic process |
GO:0009890 | 0 | 2.2569 | 21.2537 | 42 | 1560 | negative regulation of biosynthetic process |
GO:0048731 | 0 | 1.8471 | 57.0171 | 85 | 4185 | system development |
GO:0065003 | 0 | 2.183 | 22.4662 | 43 | 1649 | macromolecular complex assembly |
GO:0071822 | 0 | 2.1459 | 21.0357 | 40 | 1544 | protein complex subunit organization |
GO:0048518 | 1e-04 | 1.7278 | 68.4478 | 95 | 5024 | positive regulation of biological process |
GO:0045595 | 1e-04 | 2.4254 | 11.8848 | 26 | 963 | regulation of cell differentiation |
GO:1902340 | 2e-04 | Inf | 0.0272 | 2 | 2 | negative regulation of chromosome condensation |
GO:0031509 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | telomeric heterochromatin assembly |
GO:2000566 | 5e-04 | 146.1942 | 0.0409 | 2 | 3 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
GO:0007166 | 6e-04 | 1.7512 | 33.5154 | 52 | 2460 | cell surface receptor signaling pathway |
GO:0022610 | 6e-04 | 2.0227 | 16.7713 | 31 | 1231 | biological adhesion |
GO:0006950 | 7e-04 | 1.7463 | 34.8416 | 53 | 2779 | response to stress |
GO:0098657 | 9e-04 | 2.3976 | 8.5151 | 19 | 625 | import into cell |
GO:0048646 | 0.001 | 2.1117 | 12.8067 | 25 | 940 | anatomical structure formation involved in morphogenesis |
GO:0010604 | 0.0011 | 1.6758 | 37.7389 | 56 | 2770 | positive regulation of macromolecule metabolic process |
GO:0003164 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | His-Purkinje system development |
GO:0031508 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | pericentric heterochromatin assembly |
GO:2000360 | 0.0011 | 73.0922 | 0.0545 | 2 | 4 | negative regulation of binding of sperm to zona pellucida |
GO:0048856 | 0.0014 | 2.2546 | 10.4109 | 21 | 938 | anatomical structure development |
GO:0001775 | 0.0016 | 4.4399 | 1.694 | 7 | 131 | cell activation |
GO:0002263 | 0.0016 | 2.3398 | 8.229 | 18 | 604 | cell activation involved in immune response |
GO:0002682 | 0.0016 | 2.1942 | 10.3564 | 21 | 864 | regulation of immune system process |
GO:0051891 | 0.0018 | 48.7249 | 0.0681 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0003197 | 0.0019 | 8.4168 | 0.5313 | 4 | 39 | endocardial cushion development |
GO:0032268 | 0.002 | 1.6616 | 32.7661 | 49 | 2405 | regulation of cellular protein metabolic process |
GO:0043090 | 0.0021 | 13.7588 | 0.2589 | 3 | 19 | amino acid import |
GO:0070527 | 0.0022 | 8.0359 | 0.5535 | 4 | 41 | platelet aggregation |
GO:0098609 | 0.0022 | 2.1628 | 9.8911 | 20 | 726 | cell-cell adhesion |
GO:0070661 | 0.0024 | 3.1053 | 3.4197 | 10 | 251 | leukocyte proliferation |
GO:0045603 | 0.0024 | 12.9486 | 0.2725 | 3 | 20 | positive regulation of endothelial cell differentiation |
GO:0002275 | 0.0024 | 2.4447 | 6.526 | 15 | 479 | myeloid cell activation involved in immune response |
GO:0002444 | 0.0026 | 2.4178 | 6.5941 | 15 | 484 | myeloid leukocyte mediated immunity |
GO:0090230 | 0.0027 | 36.5413 | 0.0817 | 2 | 6 | regulation of centromere complex assembly |
GO:0006281 | 0.0027 | 2.4125 | 6.6077 | 15 | 485 | DNA repair |
GO:0046640 | 0.0032 | 11.5841 | 0.2997 | 3 | 22 | regulation of alpha-beta T cell proliferation |
GO:1903506 | 0.0032 | 1.5534 | 44.8916 | 62 | 3295 | regulation of nucleic acid-templated transcription |
GO:0045055 | 0.0036 | 2.1555 | 8.883 | 18 | 652 | regulated exocytosis |
GO:0002703 | 0.0043 | 3.6584 | 2.03 | 7 | 149 | regulation of leukocyte mediated immunity |
GO:2000242 | 0.0044 | 6.542 | 0.6676 | 4 | 49 | negative regulation of reproductive process |
GO:0051252 | 0.0045 | 1.5171 | 47.3576 | 64 | 3476 | regulation of RNA metabolic process |
GO:0002449 | 0.0049 | 3.2337 | 2.6158 | 8 | 192 | lymphocyte mediated immunity |
GO:0098712 | 0.0049 | 24.3576 | 0.109 | 2 | 8 | L-glutamate import across plasma membrane |
GO:1904714 | 0.0049 | 24.3576 | 0.109 | 2 | 8 | regulation of chaperone-mediated autophagy |
GO:2001185 | 0.0049 | 24.3576 | 0.109 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
GO:0046651 | 0.005 | 2.9683 | 3.2017 | 9 | 235 | lymphocyte proliferation |
GO:0002460 | 0.005 | 3.216 | 2.6295 | 8 | 193 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0045137 | 0.0053 | 3.1812 | 2.6567 | 8 | 195 | development of primary sexual characteristics |
GO:0006336 | 0.0055 | 22.3601 | 0.1147 | 2 | 9 | DNA replication-independent nucleosome assembly |
GO:0016192 | 0.0057 | 1.6748 | 22.5889 | 35 | 1658 | vesicle-mediated transport |
GO:0034219 | 0.0057 | 9.1677 | 0.3679 | 3 | 27 | carbohydrate transmembrane transport |
GO:0043304 | 0.0057 | 9.1677 | 0.3679 | 3 | 27 | regulation of mast cell degranulation |
GO:0019755 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | one-carbon compound transport |
GO:0045602 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | negative regulation of endothelial cell differentiation |
GO:0051938 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | L-glutamate import |
GO:0090331 | 0.0062 | 20.8766 | 0.1226 | 2 | 9 | negative regulation of platelet aggregation |
GO:0043312 | 0.0063 | 2.3351 | 5.872 | 13 | 431 | neutrophil degranulation |
GO:2000026 | 0.0063 | 1.8051 | 15.5345 | 26 | 1296 | regulation of multicellular organismal development |
GO:0002699 | 0.0066 | 3.3706 | 2.1935 | 7 | 161 | positive regulation of immune effector process |
GO:0051241 | 0.0068 | 1.9415 | 10.963 | 20 | 860 | negative regulation of multicellular organismal process |
GO:0006909 | 0.0069 | 3.0333 | 2.7793 | 8 | 204 | phagocytosis |
GO:0002711 | 0.007 | 8.4614 | 0.3951 | 3 | 29 | positive regulation of T cell mediated immunity |
GO:0007169 | 0.0072 | 2.0453 | 8.7876 | 17 | 645 | transmembrane receptor protein tyrosine kinase signaling pathway |
GO:0045321 | 0.0074 | 1.8124 | 14.101 | 24 | 1035 | leukocyte activation |
GO:0071345 | 0.0075 | 1.9189 | 11.0492 | 20 | 811 | cellular response to cytokine stimulus |
GO:0042119 | 0.0075 | 2.279 | 6.0083 | 13 | 441 | neutrophil activation |
GO:0006996 | 0.0092 | 1.4656 | 46.1041 | 61 | 3384 | organelle organization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 219.8095 | 0.5239 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 128.1795 | 0.6084 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 80.9177 | 0.7267 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 30.2778 | 1.3181 | 25 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 24.2484 | 1.673 | 27 | 99 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 18.5459 | 2.0448 | 27 | 121 | regulation of gene silencing |
GO:0045653 | 0 | 287 | 0.2873 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:1902036 | 0 | 20.1525 | 1.6899 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 17.3971 | 1.9772 | 25 | 117 | negative regulation of gene expression, epigenetic |
GO:0031497 | 0 | 14.2644 | 2.4166 | 26 | 143 | chromatin assembly |
GO:0002244 | 0 | 11.1286 | 3.0926 | 27 | 183 | hematopoietic progenitor cell differentiation |
GO:0065004 | 0 | 9.8629 | 3.5657 | 28 | 211 | protein-DNA complex assembly |
GO:1904837 | 0 | 34.2524 | 0.7098 | 15 | 42 | beta-catenin-TCF complex assembly |
GO:0032200 | 0 | 11.6485 | 2.6194 | 24 | 155 | telomere organization |
GO:0035194 | 0 | 8.1315 | 4.5459 | 30 | 269 | posttranscriptional gene silencing by RNA |
GO:0034080 | 0 | 33.0646 | 0.676 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0048863 | 0 | 8.3978 | 3.7795 | 26 | 226 | stem cell differentiation |
GO:0071103 | 0 | 7.5774 | 4.3093 | 27 | 255 | DNA conformation change |
GO:0016233 | 0 | 23.8641 | 0.845 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 23.8641 | 0.845 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0030099 | 0 | 6.1316 | 6.0499 | 31 | 358 | myeloid cell differentiation |
GO:0006303 | 0 | 18.1046 | 1.1153 | 15 | 66 | double-strand break repair via nonhomologous end joining |
GO:0017148 | 0 | 5.9637 | 5.9823 | 30 | 354 | negative regulation of translation |
GO:0002520 | 0 | 3.9563 | 14.3136 | 47 | 847 | immune system development |
GO:0043044 | 0 | 15.9121 | 1.2336 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0038111 | 0 | 26.6921 | 0.6084 | 11 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 26.6921 | 0.6084 | 11 | 36 | response to interleukin-7 |
GO:1902679 | 0 | 3.283 | 18.1497 | 50 | 1074 | negative regulation of RNA biosynthetic process |
GO:1903707 | 0 | 9.5542 | 2.1462 | 17 | 127 | negative regulation of hemopoiesis |
GO:0051259 | 0 | 4.4985 | 8.2806 | 32 | 490 | protein oligomerization |
GO:0045892 | 0 | 3.2262 | 17.5921 | 48 | 1041 | negative regulation of transcription, DNA-templated |
GO:0034248 | 0 | 3.9757 | 9.5818 | 33 | 567 | regulation of cellular amide metabolic process |
GO:0045652 | 0 | 16.4281 | 0.864 | 11 | 54 | regulation of megakaryocyte differentiation |
GO:0007275 | 0 | 2.2383 | 66.0237 | 109 | 4084 | multicellular organism development |
GO:0045934 | 0 | 2.8178 | 21.7324 | 52 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009890 | 0 | 2.6079 | 26.3627 | 58 | 1560 | negative regulation of biosynthetic process |
GO:0045596 | 0 | 3.5933 | 10.1564 | 32 | 601 | negative regulation of cell differentiation |
GO:0051248 | 0 | 2.7061 | 20.5663 | 48 | 1217 | negative regulation of protein metabolic process |
GO:0006352 | 0 | 5.363 | 3.8023 | 18 | 225 | DNA-templated transcription, initiation |
GO:0034728 | 0 | 8.4589 | 1.6516 | 12 | 103 | nucleosome organization |
GO:0048513 | 0 | 2.0606 | 51.6946 | 87 | 3059 | animal organ development |
GO:0007156 | 0 | 6.4667 | 2.4673 | 14 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0032268 | 0 | 2.1451 | 40.6426 | 73 | 2405 | regulation of cellular protein metabolic process |
GO:0010608 | 0 | 3.1588 | 11.0352 | 31 | 653 | posttranscriptional regulation of gene expression |
GO:0043043 | 0 | 2.7574 | 13.3673 | 33 | 791 | peptide biosynthetic process |
GO:0070271 | 0 | 2.2875 | 22.2055 | 45 | 1314 | protein complex biogenesis |
GO:1903506 | 0 | 1.8386 | 55.6828 | 86 | 3295 | regulation of nucleic acid-templated transcription |
GO:0051252 | 0 | 1.807 | 58.7416 | 89 | 3476 | regulation of RNA metabolic process |
GO:0071822 | 0 | 2.1193 | 26.0924 | 49 | 1544 | protein complex subunit organization |
GO:0065003 | 0 | 2.0677 | 27.8668 | 51 | 1649 | macromolecular complex assembly |
GO:0045165 | 0 | 4.0743 | 4.0389 | 15 | 239 | cell fate commitment |
GO:0080090 | 0 | 1.7114 | 92.9456 | 126 | 5500 | regulation of primary metabolic process |
GO:0048869 | 0 | 1.8083 | 57.7586 | 87 | 3572 | cellular developmental process |
GO:0007399 | 0 | 1.9521 | 34.4406 | 59 | 2038 | nervous system development |
GO:2000112 | 0 | 1.7172 | 64.2507 | 93 | 3802 | regulation of cellular macromolecule biosynthetic process |
GO:0060037 | 1e-04 | 14.8113 | 0.4225 | 5 | 25 | pharyngeal system development |
GO:0010604 | 1e-04 | 1.7663 | 46.8108 | 72 | 2770 | positive regulation of macromolecule metabolic process |
GO:0045595 | 1e-04 | 2.3041 | 14.8396 | 31 | 963 | regulation of cell differentiation |
GO:0060249 | 1e-04 | 3.1573 | 5.8302 | 17 | 345 | anatomical structure homeostasis |
GO:0034654 | 2e-04 | 1.6406 | 65.6027 | 92 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0060538 | 2e-04 | 4.3772 | 2.4842 | 10 | 147 | skeletal muscle organ development |
GO:0022610 | 2e-04 | 2.0003 | 20.8029 | 38 | 1231 | biological adhesion |
GO:0007596 | 2e-04 | 3.1441 | 5.1374 | 15 | 304 | blood coagulation |
GO:0006281 | 2e-04 | 2.6284 | 8.1961 | 20 | 485 | DNA repair |
GO:1903706 | 2e-04 | 3.2676 | 4.6162 | 14 | 290 | regulation of hemopoiesis |
GO:0003165 | 3e-04 | Inf | 0.0338 | 2 | 2 | Purkinje myocyte development |
GO:1902963 | 3e-04 | Inf | 0.0338 | 2 | 2 | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
GO:1901861 | 3e-04 | 4.5226 | 2.1631 | 9 | 128 | regulation of muscle tissue development |
GO:0048518 | 4e-04 | 1.5517 | 84.9016 | 111 | 5024 | positive regulation of biological process |
GO:0048634 | 4e-04 | 4.3744 | 2.2307 | 9 | 132 | regulation of muscle organ development |
GO:0009611 | 5e-04 | 2.3657 | 9.9874 | 22 | 591 | response to wounding |
GO:0050878 | 6e-04 | 2.5674 | 7.5032 | 18 | 444 | regulation of body fluid levels |
GO:0021884 | 8e-04 | 11.2396 | 0.4225 | 4 | 25 | forebrain neuron development |
GO:0032502 | 8e-04 | 1.9558 | 20.3645 | 35 | 1513 | developmental process |
GO:0003350 | 8e-04 | 117.25 | 0.0507 | 2 | 3 | pulmonary myocardium development |
GO:0007045 | 9e-04 | 5.8345 | 1.1322 | 6 | 67 | cell-substrate adherens junction assembly |
GO:0048641 | 9e-04 | 7.3958 | 0.7605 | 5 | 45 | regulation of skeletal muscle tissue development |
GO:0031589 | 0.001 | 2.9075 | 4.7656 | 13 | 282 | cell-substrate adhesion |
GO:0034113 | 0.0011 | 7.0426 | 0.7943 | 5 | 47 | heterotypic cell-cell adhesion |
GO:0030097 | 0.0012 | 3.7318 | 2.5842 | 9 | 170 | hemopoiesis |
GO:0051893 | 0.0013 | 6.8784 | 0.8112 | 5 | 48 | regulation of focal adhesion assembly |
GO:0010467 | 0.0014 | 1.4825 | 83.8369 | 107 | 4961 | gene expression |
GO:1901888 | 0.0015 | 5.3099 | 1.2336 | 6 | 73 | regulation of cell junction assembly |
GO:0021953 | 0.0015 | 3.6048 | 2.6701 | 9 | 158 | central nervous system neuron differentiation |
GO:0014706 | 0.0015 | 2.6639 | 5.5849 | 14 | 333 | striated muscle tissue development |
GO:0048699 | 0.0016 | 1.7991 | 21.5803 | 36 | 1277 | generation of neurons |
GO:0051454 | 0.0017 | 58.6211 | 0.0676 | 2 | 4 | intracellular pH elevation |
GO:0090191 | 0.0017 | 58.6211 | 0.0676 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:2000275 | 0.0017 | 58.6211 | 0.0676 | 2 | 4 | regulation of oxidative phosphorylation uncoupler activity |
GO:0035295 | 0.0019 | 2.2329 | 9.0411 | 19 | 535 | tube development |
GO:0048523 | 0.002 | 1.5374 | 55.4907 | 75 | 3601 | negative regulation of cellular process |
GO:0001568 | 0.002 | 2.1722 | 9.7846 | 20 | 579 | blood vessel development |
GO:0001525 | 0.0021 | 2.3901 | 7.0977 | 16 | 420 | angiogenesis |
GO:0098609 | 0.0022 | 2.0744 | 11.2869 | 22 | 679 | cell-cell adhesion |
GO:2000811 | 0.0023 | 13.571 | 0.2704 | 3 | 16 | negative regulation of anoikis |
GO:0030509 | 0.0023 | 3.6912 | 2.3152 | 8 | 137 | BMP signaling pathway |
GO:0016043 | 0.0024 | 1.4448 | 92.6414 | 115 | 5482 | cellular component organization |
GO:0051241 | 0.0027 | 1.9494 | 13.6896 | 25 | 860 | negative regulation of multicellular organismal process |
GO:0065008 | 0.0027 | 1.5527 | 44.2663 | 62 | 2734 | regulation of biological quality |
GO:0003002 | 0.0027 | 2.5928 | 5.3063 | 13 | 314 | regionalization |
GO:0031947 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | negative regulation of glucocorticoid biosynthetic process |
GO:0032353 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | negative regulation of hormone biosynthetic process |
GO:0033864 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | positive regulation of NAD(P)H oxidase activity |
GO:0061196 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | fungiform papilla development |
GO:1900086 | 0.0028 | 39.0781 | 0.0845 | 2 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
GO:0072080 | 0.003 | 4.5577 | 1.4195 | 6 | 84 | nephron tubule development |
GO:0023052 | 0.003 | 1.4279 | 96.1395 | 118 | 5689 | signaling |
GO:0033135 | 0.0031 | 3.921 | 1.9096 | 7 | 113 | regulation of peptidyl-serine phosphorylation |
GO:0072171 | 0.0034 | 5.3733 | 1.014 | 5 | 60 | mesonephric tubule morphogenesis |
GO:0007154 | 0.0034 | 1.4202 | 96.4606 | 118 | 5708 | cell communication |
GO:0071772 | 0.0035 | 3.4233 | 2.4842 | 8 | 147 | response to BMP |
GO:0048589 | 0.0038 | 2.1365 | 8.9059 | 18 | 527 | developmental growth |
GO:0010002 | 0.0038 | 11.0243 | 0.3211 | 3 | 19 | cardioblast differentiation |
GO:0072358 | 0.0038 | 2.0465 | 10.3423 | 20 | 612 | cardiovascular system development |
GO:0009792 | 0.0038 | 2.1322 | 8.9228 | 18 | 528 | embryo development ending in birth or egg hatching |
GO:0007256 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | activation of JNKK activity |
GO:0060676 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | ureteric bud formation |
GO:0070257 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | positive regulation of mucus secretion |
GO:0071676 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | negative regulation of mononuclear cell migration |
GO:1902959 | 0.0041 | 29.3066 | 0.1014 | 2 | 6 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
GO:0010894 | 0.0044 | 10.3751 | 0.338 | 3 | 20 | negative regulation of steroid biosynthetic process |
GO:0051093 | 0.0046 | 3.0139 | 3.1592 | 9 | 205 | negative regulation of developmental process |
GO:0051239 | 0.0053 | 1.6592 | 24.1261 | 37 | 1595 | regulation of multicellular organismal process |
GO:0048598 | 0.0054 | 2.057 | 9.227 | 18 | 546 | embryonic morphogenesis |
GO:0002866 | 0.0056 | 23.4438 | 0.1183 | 2 | 7 | positive regulation of acute inflammatory response to antigenic stimulus |
GO:0061564 | 0.0058 | 2.2035 | 7.1653 | 15 | 424 | axon development |
GO:0043524 | 0.0058 | 3.4603 | 2.1462 | 7 | 127 | negative regulation of neuron apoptotic process |
GO:0072006 | 0.0058 | 3.4603 | 2.1462 | 7 | 127 | nephron development |
GO:0048736 | 0.0059 | 3.1278 | 2.7039 | 8 | 160 | appendage development |
GO:0001952 | 0.006 | 5.9944 | 0.7315 | 4 | 44 | regulation of cell-matrix adhesion |
GO:0072073 | 0.0061 | 3.4314 | 2.1631 | 7 | 128 | kidney epithelium development |
GO:0009059 | 0.0063 | 1.3959 | 81.7245 | 101 | 4836 | macromolecule biosynthetic process |
GO:0072088 | 0.0066 | 4.5436 | 1.1829 | 5 | 70 | nephron epithelium morphogenesis |
GO:0030878 | 0.0066 | 8.8171 | 0.3887 | 3 | 23 | thyroid gland development |
GO:0055067 | 0.0069 | 3.3477 | 2.2138 | 7 | 131 | monovalent inorganic cation homeostasis |
GO:0061383 | 0.0069 | 5.7492 | 0.7605 | 4 | 45 | trabecula morphogenesis |
GO:0061333 | 0.007 | 4.4745 | 1.1998 | 5 | 71 | renal tubule morphogenesis |
GO:0014902 | 0.007 | 3.7779 | 1.6899 | 6 | 100 | myotube differentiation |
GO:0090304 | 0.0071 | 1.3903 | 79.2234 | 98 | 4688 | nucleic acid metabolic process |
GO:0048666 | 0.0071 | 1.7673 | 15.5642 | 26 | 921 | neuron development |
GO:0035630 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | bone mineralization involved in bone maturation |
GO:0048743 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | positive regulation of skeletal muscle fiber development |
GO:0060346 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | bone trabecula formation |
GO:0090030 | 0.0074 | 19.5352 | 0.1352 | 2 | 8 | regulation of steroid hormone biosynthetic process |
GO:0032768 | 0.0075 | 5.6119 | 0.7774 | 4 | 46 | regulation of monooxygenase activity |
GO:0071310 | 0.0076 | 1.5024 | 37.3641 | 52 | 2211 | cellular response to organic substance |
GO:0051716 | 0.0081 | 1.3637 | 108.5097 | 128 | 6421 | cellular response to stimulus |
GO:0008344 | 0.0083 | 4.2791 | 1.2505 | 5 | 74 | adult locomotory behavior |
GO:0035108 | 0.0084 | 3.2169 | 2.2983 | 7 | 136 | limb morphogenesis |
GO:0048754 | 0.0087 | 3.1919 | 2.3152 | 7 | 137 | branching morphogenesis of an epithelial tube |
GO:0071695 | 0.009 | 3.1674 | 2.3321 | 7 | 138 | anatomical structure maturation |
GO:0061756 | 0.0093 | 7.6655 | 0.4394 | 3 | 26 | leukocyte adhesion to vascular endothelial cell |
GO:1903671 | 0.0093 | 7.6655 | 0.4394 | 3 | 26 | negative regulation of sprouting angiogenesis |
GO:0001714 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | endodermal cell fate specification |
GO:0007262 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | STAT protein import into nucleus |
GO:0031943 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | regulation of glucocorticoid metabolic process |
GO:0033689 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | negative regulation of osteoblast proliferation |
GO:0048263 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | determination of dorsal identity |
GO:0051956 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | negative regulation of amino acid transport |
GO:2000288 | 0.0095 | 16.7433 | 0.1521 | 2 | 9 | positive regulation of myoblast proliferation |
GO:0070997 | 0.0096 | 2.3861 | 4.8332 | 11 | 286 | neuron death |
GO:0031623 | 0.0098 | 4.1 | 1.3012 | 5 | 77 | receptor internalization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 255.0657 | 0.3207 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 44.9695 | 0.5848 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 29.3387 | 0.8112 | 15 | 43 | protein heterotetramerization |
GO:0000183 | 0 | 34.7376 | 0.6791 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 29.3855 | 0.7546 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 27.2828 | 0.7923 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 21.2086 | 0.9432 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 21.2086 | 0.9432 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0006303 | 0 | 14.6672 | 1.245 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 12.9209 | 1.3771 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 11.9075 | 1.4714 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0099537 | 0 | 3.8238 | 10.5262 | 35 | 558 | trans-synaptic signaling |
GO:1903707 | 0 | 7.8792 | 2.3958 | 16 | 127 | negative regulation of hemopoiesis |
GO:0060964 | 0 | 8.953 | 1.8676 | 14 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 8.8483 | 1.8864 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0048863 | 0 | 5.4483 | 4.1945 | 20 | 226 | stem cell differentiation |
GO:0007268 | 0 | 3.7105 | 9.1591 | 30 | 492 | chemical synaptic transmission |
GO:0045814 | 0 | 7.3795 | 2.2071 | 14 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 7.1017 | 2.2826 | 14 | 121 | regulation of gene silencing |
GO:0045596 | 0 | 3.1656 | 11.3374 | 32 | 601 | negative regulation of cell differentiation |
GO:0048731 | 0 | 2.3059 | 32.1076 | 61 | 1989 | system development |
GO:0006352 | 0 | 4.7575 | 4.2444 | 18 | 225 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 4.7575 | 4.2444 | 18 | 225 | regulation of myeloid cell differentiation |
GO:0002244 | 0 | 5.2173 | 3.4522 | 16 | 183 | hematopoietic progenitor cell differentiation |
GO:0031497 | 0 | 5.8819 | 2.6976 | 14 | 143 | chromatin assembly |
GO:0032200 | 0 | 5.3769 | 2.924 | 14 | 155 | telomere organization |
GO:0007389 | 0 | 3.3986 | 7.4702 | 23 | 396 | pattern specification process |
GO:0023061 | 0 | 3.3022 | 7.3193 | 22 | 388 | signal release |
GO:0007267 | 0 | 2.3737 | 18.8429 | 40 | 1054 | cell-cell signaling |
GO:0032502 | 0 | 2.3179 | 23.0459 | 45 | 1464 | developmental process |
GO:0032501 | 0 | 1.9563 | 53.7165 | 82 | 3487 | multicellular organismal process |
GO:0045934 | 0 | 2.1627 | 24.2594 | 47 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0065008 | 0 | 1.8708 | 48.1752 | 77 | 2711 | regulation of biological quality |
GO:0007218 | 0 | 6.5349 | 1.7355 | 10 | 92 | neuropeptide signaling pathway |
GO:0009914 | 0 | 3.6182 | 5.4518 | 18 | 289 | hormone transport |
GO:1902679 | 0 | 2.241 | 20.2602 | 41 | 1074 | negative regulation of RNA biosynthetic process |
GO:0003206 | 0 | 5.5719 | 2.2071 | 11 | 117 | cardiac chamber morphogenesis |
GO:0045892 | 0 | 2.2523 | 19.6376 | 40 | 1041 | negative regulation of transcription, DNA-templated |
GO:0007188 | 0 | 5.0445 | 2.641 | 12 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0051259 | 0 | 2.8313 | 9.2435 | 24 | 490 | protein oligomerization |
GO:2000026 | 0 | 1.9406 | 32.3144 | 56 | 1713 | regulation of multicellular organismal development |
GO:0048869 | 0 | 1.702 | 65.6023 | 95 | 3572 | cellular developmental process |
GO:0007548 | 0 | 3.6357 | 4.4897 | 15 | 238 | sex differentiation |
GO:0065004 | 0 | 3.8339 | 3.9803 | 14 | 211 | protein-DNA complex assembly |
GO:0046887 | 1e-04 | 5.2465 | 2.1128 | 10 | 112 | positive regulation of hormone secretion |
GO:0007215 | 1e-04 | 6.7646 | 1.3394 | 8 | 71 | glutamate receptor signaling pathway |
GO:0009952 | 1e-04 | 3.999 | 3.5465 | 13 | 188 | anterior/posterior pattern specification |
GO:0048534 | 1e-04 | 2.2879 | 15.2423 | 32 | 808 | hematopoietic or lymphoid organ development |
GO:0003148 | 1e-04 | 13.2147 | 0.4716 | 5 | 25 | outflow tract septum morphogenesis |
GO:0007399 | 1e-04 | 2.4021 | 11.7954 | 26 | 672 | nervous system development |
GO:0035194 | 2e-04 | 3.1853 | 5.0745 | 15 | 269 | posttranscriptional gene silencing by RNA |
GO:0021953 | 2e-04 | 4.0068 | 2.9805 | 11 | 158 | central nervous system neuron differentiation |
GO:0007420 | 3e-04 | 2.3265 | 11.5638 | 25 | 613 | brain development |
GO:0003231 | 3e-04 | 4.6589 | 2.1128 | 9 | 112 | cardiac ventricle development |
GO:0022008 | 3e-04 | 1.8629 | 25.7685 | 44 | 1366 | neurogenesis |
GO:0021515 | 3e-04 | 7.222 | 0.9432 | 6 | 50 | cell differentiation in spinal cord |
GO:0007493 | 4e-04 | Inf | 0.0377 | 2 | 2 | endodermal cell fate determination |
GO:2000043 | 4e-04 | Inf | 0.0377 | 2 | 2 | regulation of cardiac cell fate specification |
GO:0071103 | 4e-04 | 3.1246 | 4.8104 | 14 | 255 | DNA conformation change |
GO:0003279 | 4e-04 | 4.9478 | 1.7732 | 8 | 94 | cardiac septum development |
GO:0048167 | 4e-04 | 3.985 | 2.7164 | 10 | 144 | regulation of synaptic plasticity |
GO:0048636 | 4e-04 | 5.7157 | 1.3582 | 7 | 72 | positive regulation of muscle organ development |
GO:1901863 | 4e-04 | 5.7157 | 1.3582 | 7 | 72 | positive regulation of muscle tissue development |
GO:0030539 | 5e-04 | 13.1717 | 0.3773 | 4 | 20 | male genitalia development |
GO:0019932 | 5e-04 | 3.0103 | 4.9802 | 14 | 264 | second-messenger-mediated signaling |
GO:0060923 | 5e-04 | 26.2684 | 0.1698 | 3 | 9 | cardiac muscle cell fate commitment |
GO:0045956 | 6e-04 | 12.396 | 0.3961 | 4 | 21 | positive regulation of calcium ion-dependent exocytosis |
GO:0048639 | 6e-04 | 3.7585 | 2.8674 | 10 | 152 | positive regulation of developmental growth |
GO:0009790 | 7e-04 | 1.9926 | 16.7137 | 31 | 886 | embryo development |
GO:0120039 | 7e-04 | 2.2725 | 10.3376 | 22 | 548 | plasma membrane bounded cell projection morphogenesis |
GO:0045944 | 8e-04 | 1.9059 | 19.1849 | 34 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0060914 | 8e-04 | 11.0897 | 0.4339 | 4 | 23 | heart formation |
GO:0003008 | 8e-04 | 2.7387 | 5.8658 | 15 | 342 | system process |
GO:0072210 | 9e-04 | 7.5437 | 0.7546 | 5 | 40 | metanephric nephron development |
GO:0002009 | 9e-04 | 2.3345 | 9.1303 | 20 | 484 | morphogenesis of an epithelium |
GO:0060173 | 9e-04 | 3.5561 | 3.0183 | 10 | 160 | limb development |
GO:0008406 | 0.001 | 3.2649 | 3.6031 | 11 | 191 | gonad development |
GO:0042391 | 0.001 | 2.6755 | 5.9699 | 15 | 320 | regulation of membrane potential |
GO:0001560 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | regulation of cell growth by extracellular stimulus |
GO:0003166 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | bundle of His development |
GO:0021524 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | visceral motor neuron differentiation |
GO:0035880 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0060913 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | cardiac cell fate determination |
GO:0061364 | 0.0011 | 104.7413 | 0.0566 | 2 | 3 | apoptotic process involved in luteolysis |
GO:0021517 | 0.0011 | 7.1349 | 0.7923 | 5 | 42 | ventral spinal cord development |
GO:0048791 | 0.0011 | 10.0322 | 0.4716 | 4 | 25 | calcium ion-regulated exocytosis of neurotransmitter |
GO:0017148 | 0.0012 | 2.548 | 6.6779 | 16 | 354 | negative regulation of translation |
GO:0032990 | 0.0012 | 2.1863 | 10.7149 | 22 | 568 | cell part morphogenesis |
GO:0007610 | 0.0013 | 2.4433 | 7.3976 | 17 | 400 | behavior |
GO:0051047 | 0.0013 | 2.5175 | 6.7534 | 16 | 358 | positive regulation of secretion |
GO:0035282 | 0.0014 | 4.5818 | 1.6601 | 7 | 88 | segmentation |
GO:0060986 | 0.0014 | 6.7681 | 0.83 | 5 | 44 | endocrine hormone secretion |
GO:0031175 | 0.0014 | 1.9657 | 15.2046 | 28 | 806 | neuron projection development |
GO:0009893 | 0.0016 | 1.5193 | 56.1776 | 77 | 2978 | positive regulation of metabolic process |
GO:0003214 | 0.0017 | 15.7568 | 0.2452 | 3 | 13 | cardiac left ventricle morphogenesis |
GO:0042472 | 0.0017 | 4.4173 | 1.7166 | 7 | 91 | inner ear morphogenesis |
GO:0009888 | 0.0017 | 1.6432 | 32.9747 | 50 | 1748 | tissue development |
GO:0021761 | 0.0018 | 4.365 | 1.7355 | 7 | 92 | limbic system development |
GO:0035113 | 0.0018 | 3.8621 | 2.226 | 8 | 118 | embryonic appendage morphogenesis |
GO:0045165 | 0.002 | 2.8255 | 4.5085 | 12 | 239 | cell fate commitment |
GO:0010002 | 0.002 | 14.4218 | 0.2624 | 3 | 14 | cardioblast differentiation |
GO:0009887 | 0.002 | 2.218 | 9.0959 | 19 | 506 | animal organ morphogenesis |
GO:0021794 | 0.0021 | 14.3234 | 0.2641 | 3 | 14 | thalamus development |
GO:0002865 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0007198 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | detection of monosaccharide stimulus |
GO:0048880 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | sensory system development |
GO:0051414 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | response to cortisol |
GO:0051594 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | detection of glucose |
GO:0070253 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | somatostatin secretion |
GO:0072268 | 0.0021 | 52.3671 | 0.0755 | 2 | 4 | pattern specification involved in metanephros development |
GO:0030879 | 0.0021 | 3.7588 | 2.2826 | 8 | 121 | mammary gland development |
GO:0055025 | 0.0022 | 5.997 | 0.9243 | 5 | 49 | positive regulation of cardiac muscle tissue development |
GO:0035239 | 0.0023 | 3.1239 | 3.4052 | 10 | 184 | tube morphogenesis |
GO:0035115 | 0.0023 | 8.1002 | 0.5659 | 4 | 30 | embryonic forelimb morphogenesis |
GO:0060249 | 0.0024 | 2.4391 | 6.5082 | 15 | 345 | anatomical structure homeostasis |
GO:0008284 | 0.0025 | 1.9037 | 15.0725 | 27 | 799 | positive regulation of cell proliferation |
GO:1903530 | 0.0025 | 2.0459 | 11.394 | 22 | 604 | regulation of secretion by cell |
GO:1990138 | 0.0026 | 3.6293 | 2.358 | 8 | 125 | neuron projection extension |
GO:0071371 | 0.0026 | 13.1289 | 0.283 | 3 | 15 | cellular response to gonadotropin stimulus |
GO:0098911 | 0.0026 | 13.1289 | 0.283 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0030534 | 0.0028 | 3.5678 | 2.3958 | 8 | 127 | adult behavior |
GO:0032753 | 0.0031 | 12.1182 | 0.3018 | 3 | 16 | positive regulation of interleukin-4 production |
GO:0060413 | 0.0031 | 12.1182 | 0.3018 | 3 | 16 | atrial septum morphogenesis |
GO:0050877 | 0.0032 | 1.847 | 16.1194 | 28 | 874 | nervous system process |
GO:0003156 | 0.0033 | 7.2608 | 0.6225 | 4 | 33 | regulation of animal organ formation |
GO:0048646 | 0.0034 | 1.7977 | 17.7324 | 30 | 940 | anatomical structure formation involved in morphogenesis |
GO:0051891 | 0.0034 | 34.9091 | 0.0943 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0070100 | 0.0034 | 34.9091 | 0.0943 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:0071205 | 0.0034 | 34.9091 | 0.0943 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0014706 | 0.0035 | 2.9351 | 3.6097 | 10 | 195 | striated muscle tissue development |
GO:0061061 | 0.0036 | 2.0177 | 10.9978 | 21 | 583 | muscle structure development |
GO:0051716 | 0.0037 | 1.3863 | 121.1271 | 144 | 6421 | cellular response to stimulus |
GO:0006836 | 0.0038 | 3.1054 | 3.0749 | 9 | 163 | neurotransmitter transport |
GO:0048644 | 0.004 | 4.2855 | 1.5091 | 6 | 80 | muscle organ morphogenesis |
GO:0001755 | 0.0041 | 6.7915 | 0.6602 | 4 | 35 | neural crest cell migration |
GO:0035137 | 0.0041 | 6.7915 | 0.6602 | 4 | 35 | hindlimb morphogenesis |
GO:0009890 | 0.0043 | 1.6014 | 29.4282 | 44 | 1560 | negative regulation of biosynthetic process |
GO:0048846 | 0.0044 | 10.5011 | 0.3396 | 3 | 18 | axon extension involved in axon guidance |
GO:0051252 | 0.0044 | 1.4309 | 65.572 | 85 | 3476 | regulation of RNA metabolic process |
GO:0048754 | 0.0045 | 3.289 | 2.5844 | 8 | 137 | branching morphogenesis of an epithelial tube |
GO:0044057 | 0.0046 | 2.0901 | 9.0737 | 18 | 481 | regulation of system process |
GO:0003143 | 0.005 | 4.8832 | 1.113 | 5 | 59 | embryonic heart tube morphogenesis |
GO:0009996 | 0.0051 | 26.1801 | 0.1132 | 2 | 6 | negative regulation of cell fate specification |
GO:0086073 | 0.0051 | 26.1801 | 0.1132 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0007210 | 0.0051 | 9.8441 | 0.3584 | 3 | 19 | serotonin receptor signaling pathway |
GO:1903508 | 0.0053 | 1.6337 | 24.7687 | 38 | 1313 | positive regulation of nucleic acid-templated transcription |
GO:0007519 | 0.0053 | 3.1893 | 2.6599 | 8 | 141 | skeletal muscle tissue development |
GO:0090596 | 0.0056 | 2.5807 | 4.4897 | 11 | 238 | sensory organ morphogenesis |
GO:0055008 | 0.0058 | 4.7082 | 1.1507 | 5 | 61 | cardiac muscle tissue morphogenesis |
GO:0002861 | 0.006 | 9.2644 | 0.3773 | 3 | 20 | regulation of inflammatory response to antigenic stimulus |
GO:0031290 | 0.006 | 9.2644 | 0.3773 | 3 | 20 | retinal ganglion cell axon guidance |
GO:0060039 | 0.006 | 9.2644 | 0.3773 | 3 | 20 | pericardium development |
GO:0022603 | 0.006 | 1.7529 | 16.8835 | 28 | 895 | regulation of anatomical structure morphogenesis |
GO:0003197 | 0.0061 | 6.0137 | 0.7357 | 4 | 39 | endocardial cushion development |
GO:0051240 | 0.0061 | 1.6277 | 24.1887 | 37 | 1308 | positive regulation of multicellular organismal process |
GO:0048562 | 0.0062 | 2.6833 | 3.9264 | 10 | 211 | embryonic organ morphogenesis |
GO:0001763 | 0.0065 | 2.8439 | 3.339 | 9 | 177 | morphogenesis of a branching structure |
GO:0060421 | 0.0066 | 5.8462 | 0.7546 | 4 | 40 | positive regulation of heart growth |
GO:0008015 | 0.0067 | 2.0536 | 8.6964 | 17 | 461 | blood circulation |
GO:0071773 | 0.0068 | 3.0504 | 2.773 | 8 | 147 | cellular response to BMP stimulus |
GO:0001574 | 0.007 | 20.9427 | 0.132 | 2 | 7 | ganglioside biosynthetic process |
GO:0001766 | 0.007 | 20.9427 | 0.132 | 2 | 7 | membrane raft polarization |
GO:0035385 | 0.007 | 20.9427 | 0.132 | 2 | 7 | Roundabout signaling pathway |
GO:0042661 | 0.007 | 20.9427 | 0.132 | 2 | 7 | regulation of mesodermal cell fate specification |
GO:0071415 | 0.007 | 20.9427 | 0.132 | 2 | 7 | cellular response to purine-containing compound |
GO:1902668 | 0.007 | 20.9427 | 0.132 | 2 | 7 | negative regulation of axon guidance |
GO:2000049 | 0.007 | 20.9427 | 0.132 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0006812 | 0.0071 | 1.6961 | 18.6944 | 30 | 991 | cation transport |
GO:0097485 | 0.0073 | 2.6183 | 4.0181 | 10 | 213 | neuron projection guidance |
GO:0050805 | 0.0076 | 4.3931 | 1.2262 | 5 | 65 | negative regulation of synaptic transmission |
GO:0032102 | 0.0076 | 2.4701 | 4.6783 | 11 | 248 | negative regulation of response to external stimulus |
GO:0050890 | 0.0076 | 2.4701 | 4.6783 | 11 | 248 | cognition |
GO:0002790 | 0.0077 | 1.9796 | 9.5453 | 18 | 506 | peptide secretion |
GO:0035270 | 0.0077 | 3.2772 | 2.2637 | 7 | 120 | endocrine system development |
GO:0060079 | 0.0078 | 4.3612 | 1.2339 | 5 | 66 | excitatory postsynaptic potential |
GO:1901700 | 0.0078 | 1.5799 | 26.2213 | 39 | 1390 | response to oxygen-containing compound |
GO:0006821 | 0.0079 | 3.6846 | 1.7355 | 6 | 92 | chloride transport |
GO:0019933 | 0.0079 | 3.6846 | 1.7355 | 6 | 92 | cAMP-mediated signaling |
GO:0060976 | 0.0079 | 5.5378 | 0.7923 | 4 | 42 | coronary vasculature development |
GO:0090278 | 0.0079 | 5.5378 | 0.7923 | 4 | 42 | negative regulation of peptide hormone secretion |
GO:0010628 | 0.008 | 1.5554 | 28.8089 | 42 | 1597 | positive regulation of gene expression |
GO:0071322 | 0.008 | 3.2483 | 2.2826 | 7 | 121 | cellular response to carbohydrate stimulus |
GO:0032024 | 0.0081 | 4.3208 | 1.245 | 5 | 66 | positive regulation of insulin secretion |
GO:1900543 | 0.0081 | 4.3208 | 1.245 | 5 | 66 | negative regulation of purine nucleotide metabolic process |
GO:0001655 | 0.0085 | 2.3247 | 5.414 | 12 | 287 | urogenital system development |
GO:0045471 | 0.0088 | 3.1918 | 2.3203 | 7 | 123 | response to ethanol |
GO:0001964 | 0.0089 | 7.8732 | 0.4339 | 3 | 23 | startle response |
GO:2000463 | 0.0089 | 7.8732 | 0.4339 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0003056 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | regulation of vascular smooth muscle contraction |
GO:0007196 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
GO:0033278 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | cell proliferation in midbrain |
GO:0045630 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
GO:0051665 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | membrane raft localization |
GO:0070445 | 0.0092 | 17.451 | 0.1509 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
GO:0098900 | 0.0093 | 5.2602 | 0.83 | 4 | 44 | regulation of action potential |
GO:0030182 | 0.0095 | 1.6711 | 18.3151 | 29 | 999 | neuron differentiation |
GO:0001678 | 0.0095 | 3.1373 | 2.358 | 7 | 125 | cellular glucose homeostasis |
GO:0000904 | 0.0097 | 1.8593 | 11.2808 | 20 | 598 | cell morphogenesis involved in differentiation |
GO:0006325 | 0.0097 | 1.8029 | 12.8088 | 22 | 679 | chromatin organization |
GO:0007612 | 0.0099 | 3.1107 | 2.3769 | 7 | 126 | learning |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 5.624 | 2.3812 | 12 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0045199 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | maintenance of epithelial cell apical/basal polarity |
GO:0010159 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | specification of animal organ position |
GO:0051030 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | snRNA transport |
GO:0060197 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | cloacal septation |
GO:0007267 | 0.0011 | 1.8022 | 23.5186 | 39 | 1442 | cell-cell signaling |
GO:0007198 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0098609 | 0.0018 | 2.0723 | 11.8408 | 23 | 726 | cell-cell adhesion |
GO:0030011 | 0.0021 | 14.076 | 0.261 | 3 | 16 | maintenance of cell polarity |
GO:0060438 | 0.0029 | 12.1976 | 0.2936 | 3 | 18 | trachea development |
GO:0043648 | 0.0037 | 4.3378 | 1.4842 | 6 | 91 | dicarboxylic acid metabolic process |
GO:0009952 | 0.0038 | 3.1087 | 3.0662 | 9 | 188 | anterior/posterior pattern specification |
GO:0007218 | 0.0039 | 4.2871 | 1.5005 | 6 | 92 | neuropeptide signaling pathway |
GO:0007157 | 0.0048 | 6.4361 | 0.685 | 4 | 42 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0006678 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | glucosylceramide metabolic process |
GO:0048341 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | paraxial mesoderm formation |
GO:0072201 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | negative regulation of mesenchymal cell proliferation |
GO:0019935 | 0.0068 | 3.7981 | 1.6799 | 6 | 103 | cyclic-nucleotide-mediated signaling |
GO:0060441 | 0.0076 | 8.3126 | 0.4077 | 3 | 25 | epithelial tube branching involved in lung morphogenesis |
GO:0007188 | 0.0081 | 3.2373 | 2.2834 | 7 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0007399 | 0.0083 | 1.5224 | 33.2391 | 47 | 2038 | nervous system development |
GO:0048570 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | notochord morphogenesis |
GO:0061004 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | pattern specification involved in kidney development |
GO:0030510 | 0.0094 | 4.1382 | 1.2885 | 5 | 79 | regulation of BMP signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1901750 | 0 | 68.0452 | 0.1179 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 0 | 54.4326 | 0.1326 | 4 | 9 | glutathione catabolic process |
GO:0006691 | 1e-04 | 14.2216 | 0.4274 | 5 | 29 | leukotriene metabolic process |
GO:1901568 | 2e-04 | 4.7064 | 2.078 | 9 | 141 | fatty acid derivative metabolic process |
GO:0046456 | 5e-04 | 8.743 | 0.6485 | 5 | 44 | icosanoid biosynthetic process |
GO:0009109 | 5e-04 | 25.3953 | 0.1621 | 3 | 11 | coenzyme catabolic process |
GO:0051966 | 0.001 | 7.251 | 0.7664 | 5 | 52 | regulation of synaptic transmission, glutamatergic |
GO:0016053 | 0.0011 | 3.0365 | 4.215 | 12 | 286 | organic acid biosynthetic process |
GO:0032914 | 0.0013 | 67.4439 | 0.059 | 2 | 4 | positive regulation of transforming growth factor beta1 production |
GO:0060591 | 0.0021 | 44.9596 | 0.0737 | 2 | 5 | chondroblast differentiation |
GO:0016338 | 0.0026 | 12.6909 | 0.28 | 3 | 19 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0001502 | 0.003 | 11.9436 | 0.2948 | 3 | 20 | cartilage condensation |
GO:0048169 | 0.004 | 10.6849 | 0.3242 | 3 | 22 | regulation of long-term neuronal synaptic plasticity |
GO:1990776 | 0.004 | 10.6849 | 0.3242 | 3 | 22 | response to angiotensin |
GO:0071634 | 0.0045 | 10.15 | 0.339 | 3 | 23 | regulation of transforming growth factor beta production |
GO:0060042 | 0.0046 | 6.4641 | 0.6779 | 4 | 46 | retina morphogenesis in camera-type eye |
GO:0008652 | 0.005 | 4.861 | 1.1053 | 5 | 75 | cellular amino acid biosynthetic process |
GO:0048167 | 0.0055 | 3.4934 | 2.1222 | 7 | 144 | regulation of synaptic plasticity |
GO:0006776 | 0.0057 | 22.4753 | 0.1179 | 2 | 8 | vitamin A metabolic process |
GO:1904714 | 0.0057 | 22.4753 | 0.1179 | 2 | 8 | regulation of chaperone-mediated autophagy |
GO:2000544 | 0.0057 | 22.4753 | 0.1179 | 2 | 8 | regulation of endothelial cell chemotaxis to fibroblast growth factor |
GO:0034308 | 0.0058 | 6.032 | 0.7221 | 4 | 49 | primary alcohol metabolic process |
GO:0044282 | 0.0061 | 2.4361 | 5.1877 | 12 | 352 | small molecule catabolic process |
GO:0009435 | 0.0064 | 8.8243 | 0.3832 | 3 | 26 | NAD biosynthetic process |
GO:1904018 | 0.0068 | 3.3455 | 2.2107 | 7 | 150 | positive regulation of vasculature development |
GO:0006766 | 0.0071 | 3.7534 | 1.6948 | 6 | 115 | vitamin metabolic process |
GO:0071805 | 0.0072 | 3.0101 | 2.8002 | 8 | 190 | potassium ion transmembrane transport |
GO:0007168 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | receptor guanylyl cyclase signaling pathway |
GO:0014842 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | regulation of skeletal muscle satellite cell proliferation |
GO:0035766 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | cell chemotaxis to fibroblast growth factor |
GO:0042574 | 0.0073 | 19.2633 | 0.1326 | 2 | 9 | retinal metabolic process |
GO:0006536 | 0.0079 | 8.1173 | 0.4127 | 3 | 28 | glutamate metabolic process |
GO:0051588 | 0.0093 | 5.2175 | 0.8253 | 4 | 56 | regulation of neurotransmitter transport |
GO:0019363 | 0.0096 | 7.515 | 0.4421 | 3 | 30 | pyridine nucleotide biosynthetic process |
GO:0060419 | 0.0097 | 4.0961 | 1.2969 | 5 | 88 | heart growth |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 242.9757 | 0.4792 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 141.6887 | 0.5565 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 89.4459 | 0.6647 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 31.3983 | 1.2057 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 315.9039 | 0.2628 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 22.5751 | 1.5304 | 24 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 22.2766 | 1.5458 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 18.1838 | 1.8086 | 24 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 17.4293 | 1.8704 | 24 | 121 | regulation of gene silencing |
GO:0031497 | 0 | 14.1861 | 2.2105 | 24 | 143 | chromatin assembly |
GO:0032200 | 0 | 12.8763 | 2.396 | 24 | 155 | telomere organization |
GO:0002244 | 0 | 11.1532 | 2.8288 | 25 | 183 | hematopoietic progenitor cell differentiation |
GO:0034080 | 0 | 36.3947 | 0.6183 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 33.7905 | 0.6492 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0065004 | 0 | 9.4564 | 3.2617 | 25 | 211 | protein-DNA complex assembly |
GO:0016233 | 0 | 26.2675 | 0.7729 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 26.2675 | 0.7729 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0048863 | 0 | 7.9766 | 3.7873 | 25 | 245 | stem cell differentiation |
GO:0051259 | 0 | 5.3799 | 7.5745 | 34 | 490 | protein oligomerization |
GO:0006303 | 0 | 18.1658 | 1.0202 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0071103 | 0 | 7.2531 | 3.9418 | 24 | 255 | DNA conformation change |
GO:0030099 | 0 | 5.9969 | 5.534 | 28 | 358 | myeloid cell differentiation |
GO:0035194 | 0 | 6.8322 | 4.1582 | 24 | 269 | posttranscriptional gene silencing by RNA |
GO:0043044 | 0 | 16.0031 | 1.1284 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0038111 | 0 | 25.5361 | 0.5565 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 25.5361 | 0.5565 | 10 | 36 | response to interleukin-7 |
GO:0017148 | 0 | 5.0432 | 5.4722 | 24 | 354 | negative regulation of translation |
GO:0045652 | 0 | 16.0635 | 0.7861 | 10 | 54 | regulation of megakaryocyte differentiation |
GO:1903707 | 0 | 8.3254 | 1.9632 | 14 | 127 | negative regulation of hemopoiesis |
GO:0051239 | 0 | 2.2352 | 39.913 | 73 | 2582 | regulation of multicellular organismal process |
GO:0006352 | 0 | 5.1577 | 3.4781 | 16 | 225 | DNA-templated transcription, initiation |
GO:1902679 | 0 | 2.6771 | 16.6021 | 39 | 1074 | negative regulation of RNA biosynthetic process |
GO:0045892 | 0 | 2.6842 | 16.092 | 38 | 1041 | negative regulation of transcription, DNA-templated |
GO:0048534 | 0 | 2.8815 | 12.4902 | 32 | 808 | hematopoietic or lymphoid organ development |
GO:0034248 | 0 | 3.246 | 8.5724 | 25 | 559 | regulation of cellular amide metabolic process |
GO:0034728 | 0 | 7.5583 | 1.5027 | 10 | 103 | nucleosome organization |
GO:0045934 | 0 | 2.2578 | 19.8792 | 40 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0048731 | 0 | 1.7702 | 64.6925 | 94 | 4185 | system development |
GO:0070271 | 0 | 2.2037 | 20.312 | 40 | 1314 | protein complex biogenesis |
GO:0010608 | 0 | 2.7174 | 10.0942 | 25 | 653 | posttranscriptional regulation of gene expression |
GO:0045596 | 1e-04 | 2.7001 | 9.2904 | 23 | 601 | negative regulation of cell differentiation |
GO:0060249 | 1e-04 | 3.25 | 5.3331 | 16 | 345 | anatomical structure homeostasis |
GO:0071822 | 1e-04 | 2.0083 | 23.8674 | 43 | 1544 | protein complex subunit organization |
GO:0050911 | 2e-04 | 3.2125 | 5.0394 | 15 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0043043 | 2e-04 | 2.3088 | 12.2274 | 26 | 791 | peptide biosynthetic process |
GO:0051248 | 3e-04 | 2.0402 | 18.8126 | 35 | 1217 | negative regulation of protein metabolic process |
GO:0050877 | 3e-04 | 2.0812 | 17.3441 | 33 | 1122 | nervous system process |
GO:0048869 | 3e-04 | 1.6448 | 58.9111 | 83 | 3811 | cellular developmental process |
GO:0007606 | 3e-04 | 2.8321 | 6.4615 | 17 | 418 | sensory perception of chemical stimulus |
GO:0007596 | 3e-04 | 3.2056 | 4.6993 | 14 | 304 | blood coagulation |
GO:0065007 | 5e-04 | 1.6824 | 164.1504 | 187 | 10619 | biological regulation |
GO:0051252 | 5e-04 | 1.6249 | 53.7326 | 76 | 3476 | regulation of RNA metabolic process |
GO:0009593 | 5e-04 | 2.7667 | 6.1987 | 16 | 401 | detection of chemical stimulus |
GO:0048518 | 5e-04 | 1.5634 | 77.6619 | 102 | 5024 | positive regulation of biological process |
GO:0032501 | 6e-04 | 1.7072 | 51.0058 | 71 | 3970 | multicellular organismal process |
GO:0010604 | 7e-04 | 1.6579 | 42.8192 | 63 | 2770 | positive regulation of macromolecule metabolic process |
GO:1903506 | 8e-04 | 1.6084 | 50.9347 | 72 | 3295 | regulation of nucleic acid-templated transcription |
GO:0009890 | 9e-04 | 1.814 | 24.1148 | 40 | 1560 | negative regulation of biosynthetic process |
GO:1903706 | 0.0012 | 3.0092 | 4.2523 | 12 | 290 | regulation of hemopoiesis |
GO:0065003 | 0.0014 | 1.7551 | 25.4905 | 41 | 1649 | macromolecular complex assembly |
GO:0045595 | 0.0016 | 2.0056 | 13.986 | 26 | 963 | regulation of cell differentiation |
GO:0050906 | 0.0018 | 2.5149 | 6.3379 | 15 | 410 | detection of stimulus involved in sensory perception |
GO:0019800 | 0.0023 | 42.8148 | 0.0773 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0050896 | 0.0032 | 1.4485 | 118.7343 | 140 | 7681 | response to stimulus |
GO:0042359 | 0.0034 | 11.3714 | 0.3092 | 3 | 20 | vitamin D metabolic process |
GO:0060372 | 0.0034 | 32.109 | 0.0927 | 2 | 6 | regulation of atrial cardiac muscle cell membrane repolarization |
GO:0071345 | 0.0037 | 1.9517 | 12.5366 | 23 | 811 | cellular response to cytokine stimulus |
GO:0050878 | 0.0039 | 2.3102 | 6.8634 | 15 | 444 | regulation of body fluid levels |
GO:0007186 | 0.006 | 1.7418 | 17.746 | 29 | 1148 | G-protein coupled receptor signaling pathway |
GO:0006570 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | tyrosine metabolic process |
GO:0070445 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
GO:1904714 | 0.0063 | 21.4031 | 0.1237 | 2 | 8 | regulation of chaperone-mediated autophagy |
GO:0070207 | 0.0073 | 8.4016 | 0.4019 | 3 | 26 | protein homotrimerization |
GO:0001714 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | endodermal cell fate specification |
GO:0007168 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | receptor guanylyl cyclase signaling pathway |
GO:0019896 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | axonal transport of mitochondrion |
GO:0086015 | 0.008 | 18.3443 | 0.1391 | 2 | 9 | SA node cell action potential |
GO:0006813 | 0.0082 | 2.7322 | 3.4626 | 9 | 224 | potassium ion transport |
GO:0006281 | 0.0086 | 2.1028 | 7.4972 | 15 | 485 | DNA repair |
GO:0071805 | 0.0095 | 2.8627 | 2.9371 | 8 | 190 | potassium ion transmembrane transport |
GO:0006768 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | biotin metabolic process |
GO:0071888 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | macrophage apoptotic process |
GO:0086070 | 0.0099 | 16.0502 | 0.1546 | 2 | 10 | SA node cell to atrial cardiac muscle cell communication |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 10.5726 | 1.817 | 16 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0098609 | 0 | 3.7162 | 9.0352 | 29 | 726 | cell-cell adhesion |
GO:0022610 | 1e-04 | 2.3442 | 15.32 | 32 | 1231 | biological adhesion |
GO:1902715 | 1e-04 | 60.4532 | 0.0871 | 3 | 7 | positive regulation of interferon-gamma secretion |
GO:0002374 | 1e-04 | 21.5943 | 0.2365 | 4 | 19 | cytokine secretion involved in immune response |
GO:0002440 | 1e-04 | 5.2672 | 1.8668 | 9 | 150 | production of molecular mediator of immune response |
GO:0002407 | 1e-04 | 17.9916 | 0.2738 | 4 | 22 | dendritic cell chemotaxis |
GO:0050710 | 4e-04 | 8.8314 | 0.6347 | 5 | 51 | negative regulation of cytokine secretion |
GO:0043309 | 5e-04 | 160.383 | 0.0373 | 2 | 3 | regulation of eosinophil degranulation |
GO:0030101 | 8e-04 | 7.519 | 0.7343 | 5 | 59 | natural killer cell activation |
GO:0035459 | 0.0011 | 17.2609 | 0.2116 | 3 | 17 | cargo loading into vesicle |
GO:0002278 | 0.0015 | 53.4539 | 0.0622 | 2 | 5 | eosinophil activation involved in immune response |
GO:0002447 | 0.0015 | 53.4539 | 0.0622 | 2 | 5 | eosinophil mediated immunity |
GO:0070945 | 0.0015 | 53.4539 | 0.0622 | 2 | 5 | neutrophil mediated killing of gram-negative bacterium |
GO:0002250 | 0.0019 | 3.0167 | 3.8829 | 11 | 312 | adaptive immune response |
GO:0050900 | 0.0027 | 2.7173 | 4.6918 | 12 | 377 | leukocyte migration |
GO:0045577 | 0.0028 | 12.0778 | 0.2862 | 3 | 23 | regulation of B cell differentiation |
GO:0002521 | 0.0028 | 2.5885 | 5.339 | 13 | 429 | leukocyte differentiation |
GO:0002792 | 0.003 | 4.5196 | 1.4187 | 6 | 114 | negative regulation of peptide secretion |
GO:0034141 | 0.0031 | 32.0681 | 0.0871 | 2 | 7 | positive regulation of toll-like receptor 3 signaling pathway |
GO:0070943 | 0.0031 | 32.0681 | 0.0871 | 2 | 7 | neutrophil mediated killing of symbiont cell |
GO:0007267 | 0.0035 | 1.8146 | 17.9459 | 30 | 1442 | cell-cell signaling |
GO:0048247 | 0.0037 | 6.8771 | 0.6347 | 4 | 51 | lymphocyte chemotaxis |
GO:0098711 | 0.0041 | 26.7216 | 0.0996 | 2 | 8 | iron ion import across plasma membrane |
GO:0032501 | 0.0042 | 1.4861 | 81.5157 | 100 | 6550 | multicellular organismal process |
GO:0070661 | 0.0042 | 3.0481 | 3.1237 | 9 | 251 | leukocyte proliferation |
GO:0032609 | 0.0044 | 5.0037 | 1.0703 | 5 | 86 | interferon-gamma production |
GO:0016339 | 0.0045 | 10.0622 | 0.336 | 3 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:1903531 | 0.0046 | 3.6118 | 2.0534 | 7 | 165 | negative regulation of secretion by cell |
GO:0050865 | 0.0049 | 2.415 | 5.6999 | 13 | 458 | regulation of cell activation |
GO:0002718 | 0.0052 | 6.2138 | 0.6969 | 4 | 56 | regulation of cytokine production involved in immune response |
GO:0032817 | 0.0052 | 22.9027 | 0.112 | 2 | 9 | regulation of natural killer cell proliferation |
GO:0034145 | 0.0052 | 22.9027 | 0.112 | 2 | 9 | positive regulation of toll-like receptor 4 signaling pathway |
GO:0002369 | 0.006 | 8.9424 | 0.3734 | 3 | 30 | T cell cytokine production |
GO:0048311 | 0.0065 | 20.0386 | 0.1245 | 2 | 10 | mitochondrion distribution |
GO:0072672 | 0.0065 | 20.0386 | 0.1245 | 2 | 10 | neutrophil extravasation |
GO:0046329 | 0.0072 | 8.3245 | 0.3982 | 3 | 32 | negative regulation of JNK cascade |
GO:0002696 | 0.0074 | 2.7793 | 3.41 | 9 | 274 | positive regulation of leukocyte activation |
GO:0044272 | 0.0078 | 3.2573 | 2.265 | 7 | 182 | sulfur compound biosynthetic process |
GO:0035745 | 0.0079 | 17.8109 | 0.1369 | 2 | 11 | T-helper 2 cell cytokine production |
GO:0002443 | 0.0082 | 2.0675 | 8.1889 | 16 | 658 | leukocyte mediated immunity |
GO:0048856 | 0.0082 | 1.447 | 63.7565 | 80 | 5123 | anatomical structure development |
GO:0006970 | 0.0083 | 5.3824 | 0.7965 | 4 | 64 | response to osmotic stress |
GO:0046649 | 0.009 | 2.6931 | 3.5169 | 9 | 293 | lymphocyte activation |
GO:0046651 | 0.0093 | 2.8755 | 2.9246 | 8 | 235 | lymphocyte proliferation |
GO:0061158 | 0.0094 | 16.0287 | 0.1493 | 2 | 12 | 3'-UTR-mediated mRNA destabilization |
GO:2000484 | 0.0094 | 16.0287 | 0.1493 | 2 | 12 | positive regulation of interleukin-8 secretion |
GO:0050863 | 0.0095 | 2.6665 | 3.5469 | 9 | 285 | regulation of T cell activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009719 | 0 | 4.8328 | 2.9809 | 13 | 192 | response to endogenous stimulus |
GO:0007166 | 0 | 1.8619 | 40.1218 | 65 | 2460 | cell surface receptor signaling pathway |
GO:0023052 | 1e-04 | 1.6308 | 92.7858 | 122 | 5689 | signaling |
GO:0007154 | 1e-04 | 1.622 | 93.0957 | 122 | 5708 | cell communication |
GO:0030308 | 1e-04 | 4.7185 | 2.316 | 10 | 142 | negative regulation of cell growth |
GO:0030198 | 1e-04 | 3.302 | 4.9092 | 15 | 301 | extracellular matrix organization |
GO:1902622 | 1e-04 | 11.8159 | 0.5056 | 5 | 31 | regulation of neutrophil migration |
GO:0051716 | 2e-04 | 1.5918 | 104.7245 | 133 | 6421 | cellular response to stimulus |
GO:0071310 | 4e-04 | 1.7319 | 36.0607 | 56 | 2211 | cellular response to organic substance |
GO:0042345 | 5e-04 | 8.528 | 0.6687 | 5 | 41 | regulation of NF-kappaB import into nucleus |
GO:0001525 | 5e-04 | 2.6574 | 6.8501 | 17 | 420 | angiogenesis |
GO:0007039 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | protein catabolic process in the vacuole |
GO:0032536 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | regulation of cell projection size |
GO:2000774 | 6e-04 | 22.8811 | 0.1794 | 3 | 11 | positive regulation of cellular senescence |
GO:0090023 | 7e-04 | 11.6595 | 0.4077 | 4 | 25 | positive regulation of neutrophil chemotaxis |
GO:0070340 | 8e-04 | 121.5951 | 0.0489 | 2 | 3 | detection of bacterial lipopeptide |
GO:0006584 | 8e-04 | 7.6732 | 0.7339 | 5 | 45 | catecholamine metabolic process |
GO:0022610 | 9e-04 | 1.8901 | 20.0772 | 35 | 1231 | biological adhesion |
GO:0006790 | 0.0013 | 2.719 | 5.4801 | 14 | 336 | sulfur compound metabolic process |
GO:0044236 | 0.0014 | 3.9872 | 2.1529 | 8 | 132 | multicellular organism metabolic process |
GO:0040008 | 0.0015 | 2.2382 | 9.5249 | 20 | 584 | regulation of growth |
GO:0044571 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | [2Fe-2S] cluster assembly |
GO:1901668 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | regulation of superoxide dismutase activity |
GO:1902731 | 0.0016 | 60.7935 | 0.0652 | 2 | 4 | negative regulation of chondrocyte proliferation |
GO:0048545 | 0.0021 | 2.5641 | 5.7899 | 14 | 355 | response to steroid hormone |
GO:0002687 | 0.0023 | 4.148 | 1.8104 | 7 | 111 | positive regulation of leukocyte migration |
GO:0042246 | 0.0023 | 5.8977 | 0.9297 | 5 | 57 | tissue regeneration |
GO:0006637 | 0.0023 | 4.7911 | 1.3537 | 6 | 83 | acyl-CoA metabolic process |
GO:0018958 | 0.0023 | 4.7911 | 1.3537 | 6 | 83 | phenol-containing compound metabolic process |
GO:1901700 | 0.0024 | 2.3628 | 7.2021 | 16 | 461 | response to oxygen-containing compound |
GO:0009438 | 0.0026 | 40.5263 | 0.0815 | 2 | 5 | methylglyoxal metabolic process |
GO:0033993 | 0.0029 | 2.3205 | 7.3122 | 16 | 464 | response to lipid |
GO:0001568 | 0.0031 | 2.1328 | 9.4433 | 19 | 579 | blood vessel development |
GO:0043434 | 0.0032 | 2.4396 | 6.0672 | 14 | 372 | response to peptide hormone |
GO:0006925 | 0.0034 | 11.4345 | 0.3099 | 3 | 19 | inflammatory cell apoptotic process |
GO:0030325 | 0.0034 | 11.4345 | 0.3099 | 3 | 19 | adrenal gland development |
GO:0051239 | 0.0036 | 1.5379 | 42.1116 | 59 | 2582 | regulation of multicellular organismal process |
GO:0032637 | 0.0036 | 5.2855 | 1.0275 | 5 | 63 | interleukin-8 production |
GO:0071221 | 0.0038 | 30.3927 | 0.0979 | 2 | 6 | cellular response to bacterial lipopeptide |
GO:0086073 | 0.0038 | 30.3927 | 0.0979 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:1905165 | 0.0038 | 30.3927 | 0.0979 | 2 | 6 | regulation of lysosomal protein catabolic process |
GO:0001952 | 0.0039 | 4.2871 | 1.5005 | 6 | 92 | regulation of cell-matrix adhesion |
GO:0070613 | 0.0039 | 4.2871 | 1.5005 | 6 | 92 | regulation of protein processing |
GO:0009653 | 0.0041 | 1.5564 | 37.1208 | 53 | 2276 | anatomical structure morphogenesis |
GO:0002274 | 0.0043 | 2.1094 | 9.0193 | 18 | 553 | myeloid leukocyte activation |
GO:0010469 | 0.0043 | 2.1589 | 8.3179 | 17 | 510 | regulation of receptor activity |
GO:0090342 | 0.0044 | 6.6105 | 0.6687 | 4 | 41 | regulation of cell aging |
GO:0046688 | 0.0046 | 10.1626 | 0.3425 | 3 | 21 | response to copper ion |
GO:0031667 | 0.0046 | 2.3391 | 6.3118 | 14 | 387 | response to nutrient levels |
GO:0009409 | 0.0048 | 6.4361 | 0.685 | 4 | 42 | response to cold |
GO:0007179 | 0.0048 | 3.2466 | 2.6096 | 8 | 160 | transforming growth factor beta receptor signaling pathway |
GO:0007566 | 0.0052 | 6.2706 | 0.7013 | 4 | 43 | embryo implantation |
GO:0071622 | 0.0052 | 6.2706 | 0.7013 | 4 | 43 | regulation of granulocyte chemotaxis |
GO:0032493 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | response to bacterial lipoprotein |
GO:0048752 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | semicircular canal morphogenesis |
GO:0097428 | 0.0053 | 24.3126 | 0.1142 | 2 | 7 | protein maturation by iron-sulfur cluster transfer |
GO:0048870 | 0.0055 | 1.68 | 21.6266 | 34 | 1326 | cell motility |
GO:0072358 | 0.0056 | 2.0095 | 9.9815 | 19 | 612 | cardiovascular system development |
GO:0010226 | 0.006 | 9.1451 | 0.3751 | 3 | 23 | response to lithium ion |
GO:0090103 | 0.006 | 9.1451 | 0.3751 | 3 | 23 | cochlea morphogenesis |
GO:0006954 | 0.0062 | 1.9885 | 10.0794 | 19 | 618 | inflammatory response |
GO:0034135 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | regulation of toll-like receptor 2 signaling pathway |
GO:0045410 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | positive regulation of interleukin-6 biosynthetic process |
GO:1901299 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | negative regulation of hydrogen peroxide-mediated programmed cell death |
GO:1904996 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | positive regulation of leukocyte adhesion to vascular endothelial cell |
GO:2000252 | 0.007 | 20.2591 | 0.1305 | 2 | 8 | negative regulation of feeding behavior |
GO:1901343 | 0.0074 | 3.7209 | 1.7125 | 6 | 105 | negative regulation of vasculature development |
GO:0051384 | 0.0075 | 3.2871 | 2.2507 | 7 | 138 | response to glucocorticoid |
GO:0000303 | 0.0076 | 8.3126 | 0.4077 | 3 | 25 | response to superoxide |
GO:0035235 | 0.0076 | 8.3126 | 0.4077 | 3 | 25 | ionotropic glutamate receptor signaling pathway |
GO:0071495 | 0.0081 | 1.682 | 18.9355 | 30 | 1161 | cellular response to endogenous stimulus |
GO:0009605 | 0.0084 | 1.6686 | 19.8181 | 31 | 1260 | response to external stimulus |
GO:0010035 | 0.0087 | 2.0993 | 7.5025 | 15 | 460 | response to inorganic substance |
GO:0010243 | 0.0087 | 1.8025 | 13.4686 | 23 | 832 | response to organonitrogen compound |
GO:0018158 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | protein oxidation |
GO:0034776 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | response to histamine |
GO:1990001 | 0.0088 | 17.3638 | 0.1468 | 2 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0051272 | 0.0089 | 2.155 | 6.8174 | 14 | 418 | positive regulation of cellular component movement |
GO:0003158 | 0.0093 | 3.5408 | 1.7941 | 6 | 110 | endothelium development |
GO:0070482 | 0.0093 | 2.2963 | 5.4801 | 12 | 336 | response to oxygen levels |
GO:0030155 | 0.0093 | 1.9397 | 9.7532 | 18 | 598 | regulation of cell adhesion |
GO:0032101 | 0.0094 | 1.9024 | 10.5034 | 19 | 644 | regulation of response to external stimulus |
GO:1901701 | 0.0096 | 1.7425 | 15.1517 | 25 | 929 | cellular response to oxygen-containing compound |
GO:0032963 | 0.0097 | 3.5069 | 1.8104 | 6 | 111 | collagen metabolic process |
GO:0048731 | 0.0098 | 1.4219 | 56.0757 | 72 | 3573 | system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 4.0872 | 5.7583 | 21 | 396 | pattern specification process |
GO:0099537 | 0 | 3.2938 | 8.114 | 24 | 558 | trans-synaptic signaling |
GO:0007218 | 0 | 7.6168 | 1.3378 | 9 | 92 | neuropeptide signaling pathway |
GO:0060078 | 0 | 6.3463 | 1.7595 | 10 | 121 | regulation of postsynaptic membrane potential |
GO:0050877 | 0 | 2.4563 | 15.0318 | 33 | 1058 | nervous system process |
GO:0099565 | 0 | 6.7933 | 1.4832 | 9 | 102 | chemical synaptic transmission, postsynaptic |
GO:0009952 | 0 | 4.8276 | 2.7337 | 12 | 188 | anterior/posterior pattern specification |
GO:0021517 | 0 | 11.581 | 0.6107 | 6 | 42 | ventral spinal cord development |
GO:0048699 | 0 | 2.2266 | 18.5691 | 37 | 1277 | generation of neurons |
GO:0048646 | 0 | 2.427 | 13.6687 | 30 | 940 | anatomical structure formation involved in morphogenesis |
GO:0009593 | 1e-04 | 3.1661 | 5.831 | 17 | 401 | detection of chemical stimulus |
GO:0050911 | 1e-04 | 3.4331 | 4.7404 | 15 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0060219 | 1e-04 | 21.2167 | 0.2472 | 4 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0007267 | 1e-04 | 2.0722 | 20.9684 | 39 | 1442 | cell-cell signaling |
GO:0048665 | 1e-04 | 12.3576 | 0.4799 | 5 | 33 | neuron fate specification |
GO:0021953 | 1e-04 | 4.7479 | 2.2975 | 10 | 158 | central nervous system neuron differentiation |
GO:0030900 | 1e-04 | 3.3028 | 4.9149 | 15 | 338 | forebrain development |
GO:0007606 | 1e-04 | 3.0284 | 6.0782 | 17 | 418 | sensory perception of chemical stimulus |
GO:0048644 | 2e-04 | 6.6775 | 1.1633 | 7 | 80 | muscle organ morphogenesis |
GO:0071695 | 2e-04 | 4.8857 | 2.0067 | 9 | 138 | anatomical structure maturation |
GO:0060322 | 2e-04 | 2.5422 | 9.3936 | 22 | 646 | head development |
GO:0007188 | 2e-04 | 4.8105 | 2.0358 | 9 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0055008 | 3e-04 | 7.5707 | 0.887 | 6 | 61 | cardiac muscle tissue morphogenesis |
GO:0007610 | 3e-04 | 2.7125 | 7.1572 | 18 | 498 | behavior |
GO:0007187 | 3e-04 | 14.2526 | 0.3379 | 4 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0031644 | 3e-04 | 7.1777 | 0.9306 | 6 | 64 | regulation of neurological system process |
GO:0050906 | 3e-04 | 2.8882 | 5.9619 | 16 | 410 | detection of stimulus involved in sensory perception |
GO:0021559 | 3e-04 | 29.4286 | 0.1454 | 3 | 10 | trigeminal nerve development |
GO:0031960 | 3e-04 | 4.4663 | 2.1812 | 9 | 150 | response to corticosteroid |
GO:0021675 | 4e-04 | 6.9375 | 0.9597 | 6 | 66 | nerve development |
GO:0120039 | 4e-04 | 2.5683 | 7.9686 | 19 | 548 | plasma membrane bounded cell projection morphogenesis |
GO:0003148 | 4e-04 | 13.1271 | 0.3635 | 4 | 25 | outflow tract septum morphogenesis |
GO:0008306 | 5e-04 | 6.7128 | 0.9888 | 6 | 68 | associative learning |
GO:0060379 | 5e-04 | 25.7483 | 0.16 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0006355 | 5e-04 | 1.6654 | 47.6223 | 69 | 3275 | regulation of transcription, DNA-templated |
GO:0003016 | 6e-04 | 11.984 | 0.3926 | 4 | 27 | respiratory system process |
GO:2001141 | 6e-04 | 1.6477 | 48.0149 | 69 | 3302 | regulation of RNA biosynthetic process |
GO:0048636 | 6e-04 | 6.3043 | 1.047 | 6 | 72 | positive regulation of muscle organ development |
GO:1901863 | 6e-04 | 6.3043 | 1.047 | 6 | 72 | positive regulation of muscle tissue development |
GO:0010159 | 6e-04 | 136.7636 | 0.0436 | 2 | 3 | specification of animal organ position |
GO:0021524 | 6e-04 | 136.7636 | 0.0436 | 2 | 3 | visceral motor neuron differentiation |
GO:0061364 | 6e-04 | 136.7636 | 0.0436 | 2 | 3 | apoptotic process involved in luteolysis |
GO:0032990 | 7e-04 | 2.4713 | 8.2594 | 19 | 568 | cell part morphogenesis |
GO:0050886 | 7e-04 | 6.2098 | 1.0615 | 6 | 73 | endocrine process |
GO:0031175 | 7e-04 | 2.2108 | 11.7202 | 24 | 806 | neuron projection development |
GO:0055025 | 7e-04 | 7.8556 | 0.7125 | 5 | 49 | positive regulation of cardiac muscle tissue development |
GO:0021515 | 8e-04 | 7.6805 | 0.7271 | 5 | 50 | cell differentiation in spinal cord |
GO:1901213 | 8e-04 | 20.5959 | 0.189 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0003229 | 8e-04 | 7.513 | 0.7416 | 5 | 51 | ventricular cardiac muscle tissue development |
GO:0045597 | 9e-04 | 2.8257 | 5.3035 | 14 | 378 | positive regulation of cell differentiation |
GO:0021794 | 0.001 | 18.7223 | 0.2036 | 3 | 14 | thalamus development |
GO:0050884 | 0.001 | 18.7223 | 0.2036 | 3 | 14 | neuromuscular process controlling posture |
GO:0048598 | 0.0011 | 2.426 | 7.9395 | 18 | 546 | embryonic morphogenesis |
GO:0001763 | 0.0011 | 3.7417 | 2.5738 | 9 | 177 | morphogenesis of a branching structure |
GO:0065007 | 0.0012 | 1.6403 | 154.4127 | 175 | 10619 | biological regulation |
GO:0001992 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003257 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0007198 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0048880 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | sensory system development |
GO:0051414 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | response to cortisol |
GO:0070253 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | somatostatin secretion |
GO:0090027 | 0.0012 | 68.3773 | 0.0582 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:0060428 | 0.0014 | 9.1835 | 0.4944 | 4 | 34 | lung epithelium development |
GO:0060485 | 0.0014 | 3.3322 | 3.1991 | 10 | 220 | mesenchyme development |
GO:0071385 | 0.0015 | 6.5177 | 0.8434 | 5 | 58 | cellular response to glucocorticoid stimulus |
GO:0048639 | 0.0017 | 3.8684 | 2.2103 | 8 | 152 | positive regulation of developmental growth |
GO:0007409 | 0.0018 | 2.6188 | 5.6856 | 14 | 391 | axonogenesis |
GO:0007268 | 0.0019 | 2.51 | 6.3635 | 15 | 453 | chemical synaptic transmission |
GO:0061180 | 0.0019 | 6.1673 | 0.887 | 5 | 61 | mammary gland epithelium development |
GO:0097659 | 0.0019 | 1.56 | 50.0652 | 69 | 3443 | nucleic acid-templated transcription |
GO:0019219 | 0.002 | 1.5395 | 55.5473 | 75 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0051970 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060012 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | synaptic transmission, glycinergic |
GO:0070100 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:0071205 | 0.002 | 45.5818 | 0.0727 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0048846 | 0.0021 | 13.726 | 0.2617 | 3 | 18 | axon extension involved in axon guidance |
GO:0019933 | 0.0022 | 4.8317 | 1.3378 | 6 | 92 | cAMP-mediated signaling |
GO:1990138 | 0.0023 | 4.1186 | 1.8176 | 7 | 125 | neuron projection extension |
GO:0001709 | 0.0024 | 7.8689 | 0.5671 | 4 | 39 | cell fate determination |
GO:0007210 | 0.0025 | 12.8673 | 0.2763 | 3 | 19 | serotonin receptor signaling pathway |
GO:0050794 | 0.0027 | 1.5281 | 131.1652 | 151 | 9261 | regulation of cellular process |
GO:0031290 | 0.0029 | 12.1096 | 0.2908 | 3 | 20 | retinal ganglion cell axon guidance |
GO:0002069 | 0.003 | 34.1841 | 0.0872 | 2 | 6 | columnar/cuboidal epithelial cell maturation |
GO:0021800 | 0.003 | 34.1841 | 0.0872 | 2 | 6 | cerebral cortex tangential migration |
GO:0060430 | 0.003 | 34.1841 | 0.0872 | 2 | 6 | lung saccule development |
GO:0003208 | 0.0031 | 5.4795 | 0.9888 | 5 | 68 | cardiac ventricle morphogenesis |
GO:0008015 | 0.0031 | 2.372 | 6.7035 | 15 | 461 | blood circulation |
GO:0042692 | 0.0033 | 2.5373 | 5.4239 | 13 | 373 | muscle cell differentiation |
GO:0097120 | 0.0033 | 11.4361 | 0.3054 | 3 | 21 | receptor localization to synapse |
GO:0009914 | 0.0034 | 2.7692 | 4.2024 | 11 | 289 | hormone transport |
GO:0042310 | 0.0035 | 5.3102 | 1.0179 | 5 | 70 | vasoconstriction |
GO:0060479 | 0.0038 | 10.8335 | 0.3199 | 3 | 22 | lung cell differentiation |
GO:0014706 | 0.0038 | 2.5963 | 4.8858 | 12 | 336 | striated muscle tissue development |
GO:0051240 | 0.0038 | 1.8308 | 16.4344 | 28 | 1167 | positive regulation of multicellular organismal process |
GO:0045664 | 0.004 | 2.2363 | 7.5759 | 16 | 521 | regulation of neuron differentiation |
GO:0002067 | 0.0041 | 6.7147 | 0.6544 | 4 | 45 | glandular epithelial cell differentiation |
GO:0048593 | 0.0041 | 4.2367 | 1.5123 | 6 | 104 | camera-type eye morphogenesis |
GO:0003223 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | ventricular compact myocardium morphogenesis |
GO:0035385 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | Roundabout signaling pathway |
GO:0044851 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | hair cycle phase |
GO:0048819 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | regulation of hair follicle maturation |
GO:0090394 | 0.0042 | 27.3455 | 0.1018 | 2 | 7 | negative regulation of excitatory postsynaptic potential |
GO:0010460 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | positive regulation of heart rate |
GO:0021602 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | cranial nerve morphogenesis |
GO:0045662 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | negative regulation of myoblast differentiation |
GO:2000463 | 0.0043 | 10.2911 | 0.3344 | 3 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0035637 | 0.0047 | 3.2517 | 2.6029 | 8 | 179 | multicellular organismal signaling |
GO:0051241 | 0.0048 | 1.8578 | 14.3521 | 25 | 987 | negative regulation of multicellular organismal process |
GO:0021511 | 0.0049 | 9.8004 | 0.349 | 3 | 24 | spinal cord patterning |
GO:0007399 | 0.005 | 1.7779 | 17.581 | 29 | 1282 | nervous system development |
GO:0048729 | 0.005 | 2.1253 | 8.463 | 17 | 582 | tissue morphogenesis |
GO:0003206 | 0.0052 | 6.2335 | 0.6996 | 4 | 49 | cardiac chamber morphogenesis |
GO:0040008 | 0.0052 | 2.1175 | 8.492 | 17 | 584 | regulation of growth |
GO:0010720 | 0.0053 | 2.2987 | 6.4272 | 14 | 442 | positive regulation of cell development |
GO:0060441 | 0.0055 | 9.3543 | 0.3635 | 3 | 25 | epithelial tube branching involved in lung morphogenesis |
GO:0000902 | 0.0055 | 1.9132 | 12.2146 | 22 | 840 | cell morphogenesis |
GO:0048754 | 0.0056 | 3.9641 | 1.6092 | 6 | 112 | branching morphogenesis of an epithelial tube |
GO:0008343 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | adult feeding behavior |
GO:0045924 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | regulation of female receptivity |
GO:0060346 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | bone trabecula formation |
GO:0061140 | 0.0056 | 22.7864 | 0.1163 | 2 | 8 | lung secretory cell differentiation |
GO:0006813 | 0.0056 | 2.9145 | 3.2572 | 9 | 224 | potassium ion transport |
GO:0022603 | 0.0057 | 1.8785 | 13.0143 | 23 | 895 | regulation of anatomical structure morphogenesis |
GO:0003018 | 0.0059 | 3.4415 | 2.1521 | 7 | 148 | vascular process in circulatory system |
GO:0010769 | 0.0061 | 2.8738 | 3.3008 | 9 | 227 | regulation of cell morphogenesis involved in differentiation |
GO:0090287 | 0.0062 | 2.8605 | 3.3154 | 9 | 228 | regulation of cellular response to growth factor stimulus |
GO:1904018 | 0.0064 | 3.3929 | 2.1812 | 7 | 150 | positive regulation of vasculature development |
GO:0071805 | 0.0067 | 3.0529 | 2.7628 | 8 | 190 | potassium ion transmembrane transport |
GO:0046530 | 0.0068 | 5.7328 | 0.7561 | 4 | 52 | photoreceptor cell differentiation |
GO:0048469 | 0.0071 | 3.3225 | 2.2248 | 7 | 153 | cell maturation |
GO:0010579 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0021562 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | vestibulocochlear nerve development |
GO:0046549 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | retinal cone cell development |
GO:0046855 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | inositol phosphate dephosphorylation |
GO:0046877 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | regulation of saliva secretion |
GO:0098598 | 0.0071 | 19.5299 | 0.1309 | 2 | 9 | learned vocalization behavior or vocal learning |
GO:0009889 | 0.0072 | 1.4392 | 60.0841 | 77 | 4132 | regulation of biosynthetic process |
GO:0030326 | 0.0076 | 3.7036 | 1.7159 | 6 | 118 | embryonic limb morphogenesis |
GO:0010092 | 0.0076 | 8.2301 | 0.4072 | 3 | 28 | specification of animal organ identity |
GO:0031128 | 0.0076 | 8.2301 | 0.4072 | 3 | 28 | developmental induction |
GO:0060045 | 0.0076 | 8.2301 | 0.4072 | 3 | 28 | positive regulation of cardiac muscle cell proliferation |
GO:0046883 | 0.008 | 2.7459 | 3.4463 | 9 | 237 | regulation of hormone secretion |
GO:0090596 | 0.0082 | 2.7337 | 3.4608 | 9 | 238 | sensory organ morphogenesis |
GO:0035270 | 0.0082 | 3.6382 | 1.7449 | 6 | 120 | endocrine system development |
GO:0045165 | 0.0082 | 2.9401 | 2.8631 | 8 | 200 | cell fate commitment |
GO:0003203 | 0.0084 | 7.9131 | 0.4217 | 3 | 29 | endocardial cushion morphogenesis |
GO:0019098 | 0.0084 | 7.9131 | 0.4217 | 3 | 29 | reproductive behavior |
GO:1905332 | 0.0084 | 7.9131 | 0.4217 | 3 | 29 | positive regulation of morphogenesis of an epithelium |
GO:0032275 | 0.0088 | 17.0875 | 0.1454 | 2 | 10 | luteinizing hormone secretion |
GO:0048845 | 0.0088 | 17.0875 | 0.1454 | 2 | 10 | venous blood vessel morphogenesis |
GO:0060947 | 0.0088 | 17.0875 | 0.1454 | 2 | 10 | cardiac vascular smooth muscle cell differentiation |
GO:0097746 | 0.0088 | 3.575 | 1.774 | 6 | 122 | regulation of blood vessel diameter |
GO:0051960 | 0.009 | 1.9152 | 10.4696 | 19 | 720 | regulation of nervous system development |
GO:0051954 | 0.0092 | 7.6195 | 0.4362 | 3 | 30 | positive regulation of amine transport |
GO:0048704 | 0.0096 | 4.1039 | 1.2942 | 5 | 89 | embryonic skeletal system morphogenesis |
GO:0048863 | 0.0098 | 2.6514 | 3.5626 | 9 | 245 | stem cell differentiation |
GO:0003008 | 0.0099 | 2.0765 | 7.6479 | 15 | 605 | system process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 263.8868 | 0.3107 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 46.5248 | 0.5665 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 35.9389 | 0.6579 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 30.4017 | 0.731 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 28.2264 | 0.7675 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0051290 | 0 | 27.2513 | 0.7858 | 14 | 43 | protein heterotetramerization |
GO:0016233 | 0 | 21.9421 | 0.9137 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 21.9421 | 0.9137 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0043044 | 0 | 14.6258 | 1.3341 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 15.1745 | 1.2061 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0045815 | 0 | 12.3193 | 1.4254 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0031497 | 0 | 7.6534 | 2.6133 | 17 | 143 | chromatin assembly |
GO:0060964 | 0 | 9.2627 | 1.8092 | 14 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 9.1544 | 1.8275 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:1903707 | 0 | 7.5467 | 2.3209 | 15 | 127 | negative regulation of hemopoiesis |
GO:0045814 | 0 | 7.6347 | 2.1381 | 14 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 7.3473 | 2.2112 | 14 | 121 | regulation of gene silencing |
GO:0065004 | 0 | 4.948 | 3.856 | 17 | 211 | protein-DNA complex assembly |
GO:0006352 | 0 | 4.6106 | 4.1118 | 17 | 225 | DNA-templated transcription, initiation |
GO:0045637 | 0 | 4.6106 | 4.1118 | 17 | 225 | regulation of myeloid cell differentiation |
GO:0032200 | 0 | 5.5629 | 2.8326 | 14 | 155 | telomere organization |
GO:0071103 | 0 | 4.0213 | 4.6601 | 17 | 255 | DNA conformation change |
GO:0002244 | 0 | 4.6325 | 3.3443 | 14 | 183 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 3.6458 | 4.4773 | 15 | 245 | stem cell differentiation |
GO:0051259 | 1e-04 | 2.6559 | 8.9546 | 22 | 490 | protein oligomerization |
GO:0045596 | 1e-04 | 2.4627 | 10.9831 | 25 | 601 | negative regulation of cell differentiation |
GO:0035194 | 1e-04 | 3.2959 | 4.9159 | 15 | 269 | posttranscriptional gene silencing by RNA |
GO:0043652 | 2e-04 | 40.7174 | 0.1279 | 3 | 7 | engulfment of apoptotic cell |
GO:0060249 | 2e-04 | 2.9001 | 6.3048 | 17 | 345 | anatomical structure homeostasis |
GO:0045602 | 5e-04 | 27.1413 | 0.1645 | 3 | 9 | negative regulation of endothelial cell differentiation |
GO:0017148 | 8e-04 | 2.6368 | 6.4692 | 16 | 354 | negative regulation of translation |
GO:2000026 | 0.001 | 1.7059 | 31.3046 | 49 | 1713 | regulation of multicellular organismal development |
GO:0036337 | 0.001 | 108.2094 | 0.0548 | 2 | 3 | Fas signaling pathway |
GO:0002040 | 0.0011 | 4.7958 | 1.5899 | 7 | 87 | sprouting angiogenesis |
GO:0017015 | 0.0017 | 4.4078 | 1.7178 | 7 | 94 | regulation of transforming growth factor beta receptor signaling pathway |
GO:0045926 | 0.0018 | 3.0349 | 3.856 | 11 | 211 | negative regulation of growth |
GO:0051895 | 0.0019 | 14.7994 | 0.2558 | 3 | 14 | negative regulation of focal adhesion assembly |
GO:0007264 | 0.0019 | 2.2856 | 8.3515 | 18 | 457 | small GTPase mediated signal transduction |
GO:0032502 | 0.0019 | 1.4358 | 100.2733 | 124 | 5487 | developmental process |
GO:0043537 | 0.0023 | 8.0598 | 0.5665 | 4 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0071294 | 0.0023 | 13.5652 | 0.2741 | 3 | 15 | cellular response to zinc ion |
GO:0010812 | 0.0025 | 5.801 | 0.9503 | 5 | 52 | negative regulation of cell-substrate adhesion |
GO:0055114 | 0.003 | 1.8555 | 16.0452 | 28 | 878 | oxidation-reduction process |
GO:0009438 | 0.0032 | 36.065 | 0.0914 | 2 | 5 | methylglyoxal metabolic process |
GO:1902041 | 0.0032 | 5.4518 | 1.0051 | 5 | 55 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0006281 | 0.0036 | 2.1444 | 8.8632 | 18 | 485 | DNA repair |
GO:0070482 | 0.0036 | 2.4062 | 6.1403 | 14 | 336 | response to oxygen levels |
GO:0030198 | 0.0037 | 2.4945 | 5.5007 | 13 | 301 | extracellular matrix organization |
GO:0002578 | 0.0048 | 27.0469 | 0.1096 | 2 | 6 | negative regulation of antigen processing and presentation |
GO:0001666 | 0.0049 | 2.4092 | 5.6834 | 13 | 311 | response to hypoxia |
GO:0030574 | 0.0051 | 4.8657 | 1.1148 | 5 | 61 | collagen catabolic process |
GO:0048514 | 0.0051 | 2.0667 | 9.1739 | 18 | 502 | blood vessel morphogenesis |
GO:0035987 | 0.0065 | 5.8775 | 0.7493 | 4 | 41 | endodermal cell differentiation |
GO:0001952 | 0.0068 | 3.8083 | 1.6813 | 6 | 92 | regulation of cell-matrix adhesion |
GO:0048731 | 0.0082 | 1.3757 | 76.4797 | 95 | 4185 | system development |
GO:0034248 | 0.0083 | 1.9256 | 10.3618 | 19 | 567 | regulation of cellular amide metabolic process |
GO:0035912 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | dorsal aorta morphogenesis |
GO:0060155 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | platelet dense granule organization |
GO:0097049 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | motor neuron apoptotic process |
GO:0098711 | 0.0087 | 18.0289 | 0.1462 | 2 | 8 | iron ion import across plasma membrane |
GO:0010608 | 0.0088 | 1.8489 | 11.9334 | 21 | 653 | posttranscriptional regulation of gene expression |
GO:0042692 | 0.0089 | 2.1528 | 6.8165 | 14 | 373 | muscle cell differentiation |
GO:0090287 | 0.0093 | 2.5187 | 4.1666 | 10 | 228 | regulation of cellular response to growth factor stimulus |
GO:0010038 | 0.0093 | 2.294 | 5.4824 | 12 | 300 | response to metal ion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 229.7755 | 0.5036 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 133.9911 | 0.5848 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 84.5865 | 0.6985 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 29.6925 | 1.267 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 299.4644 | 0.2762 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 21.3486 | 1.6082 | 24 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 21.0663 | 1.6244 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 17.1959 | 1.9006 | 24 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 16.4823 | 1.9655 | 24 | 121 | regulation of gene silencing |
GO:0031497 | 0 | 13.4154 | 2.3229 | 24 | 143 | chromatin assembly |
GO:0032200 | 0 | 12.1767 | 2.5178 | 24 | 155 | telomere organization |
GO:0002244 | 0 | 10.5445 | 2.9727 | 25 | 183 | hematopoietic progenitor cell differentiation |
GO:0034080 | 0 | 34.5007 | 0.6498 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 32.0321 | 0.6823 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 24.9005 | 0.8122 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 24.9005 | 0.8122 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0065004 | 0 | 8.4981 | 3.4275 | 24 | 211 | protein-DNA complex assembly |
GO:0048863 | 0 | 7.5413 | 3.9798 | 25 | 245 | stem cell differentiation |
GO:0006303 | 0 | 17.2204 | 1.0721 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0071103 | 0 | 6.859 | 4.1423 | 24 | 255 | DNA conformation change |
GO:0030099 | 0 | 5.6652 | 5.8154 | 28 | 358 | myeloid cell differentiation |
GO:0043044 | 0 | 15.1702 | 1.1858 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0035194 | 0 | 6.4609 | 4.3697 | 24 | 269 | posttranscriptional gene silencing by RNA |
GO:0038111 | 0 | 24.2292 | 0.5848 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 24.2292 | 0.5848 | 10 | 36 | response to interleukin-7 |
GO:0017148 | 0 | 5.0057 | 5.7504 | 25 | 354 | negative regulation of translation |
GO:1903707 | 0 | 8.5686 | 2.063 | 15 | 127 | negative regulation of hemopoiesis |
GO:0045652 | 0 | 15.1907 | 0.8286 | 10 | 54 | regulation of megakaryocyte differentiation |
GO:0006352 | 0 | 4.887 | 3.6549 | 16 | 225 | DNA-templated transcription, initiation |
GO:0032501 | 0 | 1.8616 | 106.3994 | 144 | 6550 | multicellular organismal process |
GO:0034248 | 0 | 3.2106 | 9.012 | 26 | 559 | regulation of cellular amide metabolic process |
GO:0045892 | 0 | 2.5286 | 16.9102 | 38 | 1041 | negative regulation of transcription, DNA-templated |
GO:0034728 | 0 | 7.1477 | 1.5839 | 10 | 103 | nucleosome organization |
GO:1902679 | 0 | 2.4423 | 17.4463 | 38 | 1074 | negative regulation of RNA biosynthetic process |
GO:0048534 | 0 | 2.6185 | 13.1253 | 31 | 808 | hematopoietic or lymphoid organ development |
GO:0010608 | 0 | 2.6883 | 10.6075 | 26 | 653 | posttranscriptional regulation of gene expression |
GO:0070271 | 0 | 2.1388 | 21.3449 | 41 | 1314 | protein complex biogenesis |
GO:0048731 | 0 | 1.7177 | 67.9819 | 97 | 4185 | system development |
GO:0045596 | 0 | 2.6817 | 9.7628 | 24 | 601 | negative regulation of cell differentiation |
GO:0050911 | 1e-04 | 3.2723 | 5.2956 | 16 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0045934 | 1e-04 | 2.0609 | 20.89 | 39 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0071822 | 2e-04 | 1.9439 | 25.081 | 44 | 1544 | protein complex subunit organization |
GO:0051248 | 2e-04 | 2.0566 | 19.7692 | 37 | 1217 | negative regulation of protein metabolic process |
GO:0060249 | 2e-04 | 3.0793 | 5.6042 | 16 | 345 | anatomical structure homeostasis |
GO:0048518 | 3e-04 | 1.5854 | 81.6108 | 108 | 5024 | positive regulation of biological process |
GO:0009593 | 3e-04 | 2.8048 | 6.5139 | 17 | 401 | detection of chemical stimulus |
GO:0007606 | 5e-04 | 2.6828 | 6.7901 | 17 | 418 | sensory perception of chemical stimulus |
GO:0043043 | 5e-04 | 2.1822 | 12.8492 | 26 | 791 | peptide biosynthetic process |
GO:0048869 | 6e-04 | 1.5805 | 61.9066 | 85 | 3811 | cellular developmental process |
GO:0045595 | 8e-04 | 2.0637 | 14.7083 | 28 | 963 | regulation of cell differentiation |
GO:0050906 | 0.0011 | 2.56 | 6.6601 | 16 | 410 | detection of stimulus involved in sensory perception |
GO:0065007 | 0.0013 | 1.5832 | 172.497 | 194 | 10619 | biological regulation |
GO:0051716 | 0.0014 | 1.4791 | 104.3039 | 128 | 6421 | cellular response to stimulus |
GO:0007596 | 0.0014 | 2.7998 | 4.9382 | 13 | 304 | blood coagulation |
GO:0015803 | 0.0015 | 61.0447 | 0.065 | 2 | 4 | branched-chain amino acid transport |
GO:0065003 | 0.0021 | 1.7016 | 26.7867 | 42 | 1649 | macromolecular complex assembly |
GO:0051252 | 0.0024 | 1.51 | 56.4648 | 76 | 3476 | regulation of RNA metabolic process |
GO:0019800 | 0.0025 | 40.6938 | 0.0812 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0060591 | 0.0025 | 40.6938 | 0.0812 | 2 | 5 | chondroblast differentiation |
GO:0010604 | 0.0025 | 1.5488 | 44.9964 | 63 | 2770 | positive regulation of macromolecule metabolic process |
GO:0030574 | 0.0031 | 5.4979 | 0.9909 | 5 | 61 | collagen catabolic process |
GO:2000026 | 0.0033 | 1.7807 | 19.3745 | 32 | 1296 | regulation of multicellular organismal development |
GO:1903506 | 0.0033 | 1.4972 | 53.5246 | 72 | 3295 | regulation of nucleic acid-templated transcription |
GO:0006813 | 0.0037 | 2.9068 | 3.6387 | 10 | 224 | potassium ion transport |
GO:0060372 | 0.0038 | 30.5183 | 0.0975 | 2 | 6 | regulation of atrial cardiac muscle cell membrane repolarization |
GO:0007218 | 0.0039 | 4.3051 | 1.4945 | 6 | 92 | neuropeptide signaling pathway |
GO:0071805 | 0.0039 | 3.087 | 3.0864 | 9 | 190 | potassium ion transmembrane transport |
GO:0042359 | 0.0039 | 10.8058 | 0.3249 | 3 | 20 | vitamin D metabolic process |
GO:0051962 | 0.0041 | 2.2939 | 6.9038 | 15 | 425 | positive regulation of nervous system development |
GO:0009890 | 0.0042 | 1.656 | 25.3409 | 39 | 1560 | negative regulation of biosynthetic process |
GO:0051291 | 0.0044 | 5.0134 | 1.0741 | 5 | 73 | protein heterooligomerization |
GO:0050877 | 0.0048 | 1.7551 | 18.226 | 30 | 1122 | nervous system process |
GO:0061337 | 0.0049 | 3.5762 | 2.0793 | 7 | 128 | cardiac conduction |
GO:0021796 | 0.0052 | 24.413 | 0.1137 | 2 | 7 | cerebral cortex regionalization |
GO:1903706 | 0.0054 | 2.5979 | 4.463 | 11 | 290 | regulation of hemopoiesis |
GO:0050878 | 0.0061 | 2.1894 | 7.2124 | 15 | 444 | regulation of body fluid levels |
GO:0071345 | 0.0067 | 1.8461 | 13.174 | 23 | 811 | cellular response to cytokine stimulus |
GO:0006570 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | tyrosine metabolic process |
GO:0060534 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | trachea cartilage development |
GO:0070445 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | regulation of oligodendrocyte progenitor proliferation |
GO:1904714 | 0.0069 | 20.3428 | 0.13 | 2 | 8 | regulation of chaperone-mediated autophagy |
GO:0009611 | 0.008 | 1.973 | 9.6003 | 18 | 591 | response to wounding |
GO:0002828 | 0.0084 | 7.9837 | 0.4223 | 3 | 26 | regulation of type 2 immune response |
GO:0070207 | 0.0084 | 7.9837 | 0.4223 | 3 | 26 | protein homotrimerization |
GO:0007168 | 0.0088 | 17.4355 | 0.1462 | 2 | 9 | receptor guanylyl cyclase signaling pathway |
GO:0072520 | 0.0088 | 17.4355 | 0.1462 | 2 | 9 | seminiferous tubule development |
GO:0086015 | 0.0088 | 17.4355 | 0.1462 | 2 | 9 | SA node cell action potential |
GO:0034121 | 0.01 | 5.113 | 0.8447 | 4 | 52 | regulation of toll-like receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 1e-04 | 2.0787 | 19.7323 | 37 | 1351 | receptor activity |
GO:0017034 | 0.0012 | 68.0679 | 0.0584 | 2 | 4 | Rap guanyl-nucleotide exchange factor activity |
GO:0005328 | 0.0018 | 14.6406 | 0.2483 | 3 | 17 | neurotransmitter:sodium symporter activity |
GO:0004468 | 0.0031 | 34.0294 | 0.0876 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0004888 | 0.0036 | 1.857 | 15.5697 | 27 | 1066 | transmembrane signaling receptor activity |
GO:0004966 | 0.0042 | 27.2217 | 0.1022 | 2 | 7 | galanin receptor activity |
GO:0022890 | 0.0054 | 2.2266 | 7.113 | 15 | 487 | inorganic cation transmembrane transporter activity |
GO:0005215 | 0.007 | 1.7231 | 17.965 | 29 | 1230 | transporter activity |
GO:0008331 | 0.0071 | 19.4415 | 0.1315 | 2 | 9 | high voltage-gated calcium channel activity |
GO:0015085 | 0.0083 | 3.6214 | 1.7527 | 6 | 120 | calcium ion transmembrane transporter activity |
GO:0035240 | 0.0088 | 17.0102 | 0.1461 | 2 | 10 | dopamine binding |
GO:0022891 | 0.0094 | 1.8438 | 12.0351 | 21 | 824 | substrate-specific transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.1308 | 3.0417 | 14 | 180 | histone binding |
GO:0046982 | 3e-04 | 2.6448 | 7.7224 | 19 | 457 | protein heterodimerization activity |
GO:0019863 | 0.0028 | 39.0807 | 0.0845 | 2 | 5 | IgE binding |
GO:0019904 | 0.0045 | 2.0147 | 10.4937 | 20 | 621 | protein domain specific binding |
GO:0008432 | 0.0074 | 19.5365 | 0.1352 | 2 | 8 | JUN kinase binding |
GO:0008066 | 0.0083 | 8.015 | 0.4225 | 3 | 25 | glutamate receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 8.7793 | 6.7945 | 45 | 457 | protein heterodimerization activity |
GO:0042393 | 0 | 11.2808 | 2.6762 | 24 | 180 | histone binding |
GO:0003677 | 0 | 2.7448 | 33.4375 | 72 | 2249 | DNA binding |
GO:0031492 | 0 | 20.958 | 0.6393 | 10 | 43 | nucleosomal DNA binding |
GO:1901363 | 0 | 1.9503 | 80.6573 | 117 | 5425 | heterocyclic compound binding |
GO:0097159 | 0 | 1.9434 | 81.7575 | 118 | 5499 | organic cyclic compound binding |
GO:0045296 | 4e-04 | 3.2618 | 4.2819 | 13 | 288 | cadherin binding |
GO:0003682 | 0.0035 | 2.337 | 6.7945 | 15 | 457 | chromatin binding |
GO:0019904 | 0.0054 | 2.0621 | 9.2328 | 18 | 621 | protein domain specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 6.4299 | 7.3034 | 38 | 457 | protein heterodimerization activity |
GO:0042393 | 0 | 10.3972 | 2.8766 | 24 | 180 | histone binding |
GO:0031492 | 0 | 19.4134 | 0.6872 | 10 | 43 | nucleosomal DNA binding |
GO:0003677 | 0 | 2.0678 | 32.6384 | 58 | 2153 | DNA binding |
GO:0019904 | 0 | 2.7635 | 9.9243 | 25 | 621 | protein domain specific binding |
GO:0016508 | 8e-04 | 124.157 | 0.0479 | 2 | 3 | long-chain-enoyl-CoA hydratase activity |
GO:0005184 | 0.0011 | 9.9993 | 0.4635 | 4 | 29 | neuropeptide hormone activity |
GO:0005237 | 0.0015 | 62.0744 | 0.0639 | 2 | 4 | inhibitory extracellular ligand-gated ion channel activity |
GO:0044323 | 0.0015 | 62.0744 | 0.0639 | 2 | 4 | retinoic acid-responsive element binding |
GO:0000981 | 0.002 | 2.0936 | 11.2028 | 22 | 701 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0005328 | 0.0023 | 13.3462 | 0.2717 | 3 | 17 | neurotransmitter:sodium symporter activity |
GO:0045296 | 0.0024 | 2.7639 | 4.6026 | 12 | 288 | cadherin binding |
GO:0030883 | 0.0025 | 41.3802 | 0.0799 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0025 | 41.3802 | 0.0799 | 2 | 5 | exogenous lipid antigen binding |
GO:1901363 | 0.0028 | 1.4498 | 86.6977 | 108 | 5425 | heterocyclic compound binding |
GO:0051428 | 0.0032 | 11.6763 | 0.3036 | 3 | 19 | peptide hormone receptor binding |
GO:0004957 | 0.0037 | 31.0331 | 0.0959 | 2 | 6 | prostaglandin E receptor activity |
GO:0097159 | 0.0046 | 1.419 | 87.8803 | 108 | 5499 | organic cyclic compound binding |
GO:0003857 | 0.0051 | 24.8248 | 0.1119 | 2 | 7 | 3-hydroxyacyl-CoA dehydrogenase activity |
GO:0030371 | 0.0056 | 9.3386 | 0.3676 | 3 | 23 | translation repressor activity |
GO:0004983 | 0.0067 | 20.686 | 0.1278 | 2 | 8 | neuropeptide Y receptor activity |
GO:0030881 | 0.0067 | 20.686 | 0.1278 | 2 | 8 | beta-2-microglobulin binding |
GO:0071855 | 0.008 | 8.1189 | 0.4155 | 3 | 26 | neuropeptide receptor binding |
GO:0070700 | 0.0085 | 17.7296 | 0.1438 | 2 | 9 | BMP receptor binding |
GO:0031490 | 0.0088 | 5.3033 | 0.8146 | 4 | 53 | chromatin DNA binding |
GO:0005539 | 0.0096 | 2.8598 | 2.9405 | 8 | 184 | glycosaminoglycan binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 7.6253 | 7.0639 | 42 | 457 | protein heterodimerization activity |
GO:0042393 | 0 | 10.7954 | 2.7823 | 24 | 180 | histone binding |
GO:0031492 | 0 | 20.1113 | 0.6647 | 10 | 43 | nucleosomal DNA binding |
GO:0003677 | 0 | 2.2361 | 34.7632 | 65 | 2249 | DNA binding |
GO:0045296 | 0 | 4.2282 | 4.4517 | 17 | 288 | cadherin binding |
GO:0043546 | 1e-04 | 64.5021 | 0.0927 | 3 | 6 | molybdopterin cofactor binding |
GO:1901363 | 2e-04 | 1.6089 | 82.7301 | 109 | 5419 | heterocyclic compound binding |
GO:0005178 | 2e-04 | 5.3469 | 1.6385 | 8 | 106 | integrin binding |
GO:0097159 | 4e-04 | 1.5747 | 83.8598 | 109 | 5493 | organic cyclic compound binding |
GO:0008940 | 7e-04 | 128.4701 | 0.0464 | 2 | 3 | nitrate reductase activity |
GO:0016836 | 8e-04 | 7.5451 | 0.7419 | 5 | 48 | hydro-lyase activity |
GO:0004459 | 0.0014 | 64.2308 | 0.0618 | 2 | 4 | L-lactate dehydrogenase activity |
GO:0030151 | 0.0014 | 64.2308 | 0.0618 | 2 | 4 | molybdenum ion binding |
GO:0019904 | 0.0016 | 2.2233 | 9.5989 | 20 | 621 | protein domain specific binding |
GO:0050072 | 0.0023 | 42.8177 | 0.0773 | 2 | 5 | m7G(5')pppN diphosphatase activity |
GO:0032027 | 0.0034 | 32.1111 | 0.0927 | 2 | 6 | myosin light chain binding |
GO:0016829 | 0.004 | 3.3459 | 2.535 | 8 | 164 | lyase activity |
GO:0003682 | 0.0051 | 2.2404 | 7.0639 | 15 | 457 | chromatin binding |
GO:0030170 | 0.0068 | 5.7421 | 0.7574 | 4 | 49 | pyridoxal phosphate binding |
GO:0070410 | 0.008 | 18.3455 | 0.1391 | 2 | 9 | co-SMAD binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 20.668 | 0.6478 | 10 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.3651 | 6.8843 | 21 | 457 | protein heterodimerization activity |
GO:0042393 | 1e-04 | 4.4192 | 2.7116 | 11 | 180 | histone binding |
GO:0045296 | 4e-04 | 3.2161 | 4.3385 | 13 | 288 | cadherin binding |
GO:0005509 | 5e-04 | 2.4178 | 9.3549 | 21 | 621 | calcium ion binding |
GO:0005412 | 0.0033 | 32.9693 | 0.0904 | 2 | 6 | glucose:sodium symporter activity |
GO:0003682 | 0.004 | 2.3039 | 6.8843 | 15 | 457 | chromatin binding |
GO:0004222 | 0.0053 | 4.0012 | 1.5968 | 6 | 106 | metalloendopeptidase activity |
GO:0060089 | 0.0059 | 1.6875 | 20.9543 | 33 | 1391 | molecular transducer activity |
GO:0030414 | 0.008 | 3.2467 | 2.2747 | 7 | 151 | peptidase inhibitor activity |
GO:0099600 | 0.0088 | 1.7207 | 16.661 | 27 | 1106 | transmembrane receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 6.961 | 4.8469 | 28 | 326 | olfactory receptor activity |
GO:0060089 | 0 | 2.9628 | 20.681 | 51 | 1391 | molecular transducer activity |
GO:0004930 | 0 | 3.7493 | 10.5412 | 34 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 2.9823 | 16.4437 | 42 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 2.9022 | 16.8738 | 42 | 1149 | signaling receptor activity |
GO:0008329 | 0.0013 | 16.7734 | 0.223 | 3 | 15 | signaling pattern recognition receptor activity |
GO:0046870 | 0.0021 | 44.557 | 0.0743 | 2 | 5 | cadmium ion binding |
GO:0001591 | 0.0032 | 33.4156 | 0.0892 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0004111 | 0.0032 | 33.4156 | 0.0892 | 2 | 6 | creatine kinase activity |
GO:0005104 | 0.0059 | 9.1431 | 0.3717 | 3 | 25 | fibroblast growth factor receptor binding |
GO:0005549 | 0.0061 | 4.618 | 1.1597 | 5 | 78 | odorant binding |
GO:0048018 | 0.0076 | 2.2761 | 6.0065 | 13 | 404 | receptor ligand activity |
GO:0035240 | 0.0092 | 16.7033 | 0.1487 | 2 | 10 | dopamine binding |
GO:0035325 | 0.0092 | 16.7033 | 0.1487 | 2 | 10 | Toll-like receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005102 | 0 | 2.3379 | 17.9436 | 37 | 1363 | receptor binding |
GO:0001609 | 0.0035 | 30.2754 | 0.0922 | 2 | 7 | G-protein coupled adenosine receptor activity |
GO:0005125 | 0.0037 | 3.3901 | 2.5013 | 8 | 190 | cytokine activity |
GO:0030545 | 0.0047 | 2.4234 | 5.674 | 13 | 431 | receptor regulator activity |
GO:0004629 | 0.0064 | 8.7652 | 0.3818 | 3 | 29 | phospholipase C activity |
GO:0030957 | 0.0072 | 18.9183 | 0.1316 | 2 | 10 | Tat protein binding |
GO:0004062 | 0.0088 | 16.8152 | 0.1448 | 2 | 11 | aryl sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 15.8312 | 4.8896 | 52 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 7.3126 | 10.6341 | 57 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 4.6381 | 16.5886 | 59 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 4.4201 | 15.9463 | 55 | 1081 | signaling receptor activity |
GO:0060089 | 0 | 3.7426 | 20.8632 | 61 | 1391 | molecular transducer activity |
GO:0031492 | 0 | 30.1106 | 0.6449 | 13 | 43 | nucleosomal DNA binding |
GO:0005549 | 0 | 15.2362 | 1.1699 | 14 | 78 | odorant binding |
GO:0046982 | 0 | 3.7573 | 6.8544 | 23 | 457 | protein heterodimerization activity |
GO:0042393 | 0 | 5.3597 | 2.6998 | 13 | 180 | histone binding |
GO:0003682 | 0.0015 | 2.4865 | 6.8544 | 16 | 457 | chromatin binding |
GO:0004993 | 0.0027 | 12.4638 | 0.285 | 3 | 19 | G-protein coupled serotonin receptor activity |
GO:0001591 | 0.0032 | 33.1167 | 0.09 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0045296 | 0.0042 | 2.6891 | 4.3196 | 11 | 288 | cadherin binding |
GO:0030594 | 0.0082 | 4.2814 | 1.2449 | 5 | 83 | neurotransmitter receptor activity |
GO:0035240 | 0.0093 | 16.554 | 0.15 | 2 | 10 | dopamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 13.2427 | 2.7705 | 28 | 180 | histone binding |
GO:0046982 | 0 | 6.2788 | 7.034 | 36 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 23.0205 | 0.6618 | 11 | 43 | nucleosomal DNA binding |
GO:0003677 | 0 | 2.3488 | 34.6159 | 67 | 2249 | DNA binding |
GO:0045296 | 0 | 3.9648 | 4.4328 | 16 | 288 | cadherin binding |
GO:1901363 | 0 | 1.7246 | 83.4998 | 114 | 5425 | heterocyclic compound binding |
GO:0019904 | 0 | 2.7504 | 9.5582 | 24 | 621 | protein domain specific binding |
GO:0097159 | 1e-04 | 1.688 | 84.6388 | 114 | 5499 | organic cyclic compound binding |
GO:0003723 | 1e-04 | 2.0339 | 24.8268 | 45 | 1613 | RNA binding |
GO:0035663 | 7e-04 | 129.03 | 0.0462 | 2 | 3 | Toll-like receptor 2 binding |
GO:0044877 | 0.0016 | 2.0032 | 13.9295 | 26 | 905 | macromolecular complex binding |
GO:0005078 | 0.0047 | 25.7991 | 0.1077 | 2 | 7 | MAP-kinase scaffold activity |
GO:0019864 | 0.0047 | 25.7991 | 0.1077 | 2 | 7 | IgG binding |
GO:0019900 | 0.0047 | 2.0893 | 9.1148 | 18 | 597 | kinase binding |
GO:0003682 | 0.0049 | 2.2508 | 7.034 | 15 | 457 | chromatin binding |
GO:0008432 | 0.0062 | 21.4979 | 0.1231 | 2 | 8 | JUN kinase binding |
GO:0016667 | 0.0083 | 5.4058 | 0.8004 | 4 | 52 | oxidoreductase activity, acting on a sulfur group of donors |
GO:0043236 | 0.0089 | 7.7628 | 0.431 | 3 | 28 | laminin binding |
GO:0031625 | 0.0096 | 2.5057 | 4.1865 | 10 | 272 | ubiquitin protein ligase binding |
GO:0008484 | 0.0098 | 16.1212 | 0.1539 | 2 | 10 | sulfuric ester hydrolase activity |
GO:0071723 | 0.0098 | 16.1212 | 0.1539 | 2 | 10 | lipopeptide binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 6e-04 | 2.4808 | 8.2567 | 19 | 621 | calcium ion binding |
GO:0030492 | 0.001 | 74.9403 | 0.0532 | 2 | 4 | hemoglobin binding |
GO:0004468 | 0.0025 | 37.4652 | 0.0798 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0005488 | 0.0088 | 1.8056 | 174.4008 | 186 | 13117 | binding |
GO:0050664 | 0.0089 | 16.6457 | 0.1463 | 2 | 11 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor |
GO:0005547 | 0.0094 | 7.5175 | 0.4388 | 3 | 33 | phosphatidylinositol-3,4,5-trisphosphate binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008528 | 0.001 | 4.8609 | 1.557 | 7 | 108 | G-protein coupled peptide receptor activity |
GO:0005313 | 0.001 | 18.7235 | 0.2036 | 3 | 14 | L-glutamate transmembrane transporter activity |
GO:0042923 | 0.0029 | 12.1104 | 0.2908 | 3 | 20 | neuropeptide binding |
GO:0055131 | 0.003 | 34.1864 | 0.0872 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0004972 | 0.0042 | 27.3473 | 0.1018 | 2 | 7 | NMDA glutamate receptor activity |
GO:0004683 | 0.0043 | 10.2918 | 0.3344 | 3 | 23 | calmodulin-dependent protein kinase activity |
GO:0004985 | 0.0056 | 22.7879 | 0.1163 | 2 | 8 | opioid receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 17.936 | 4.5479 | 53 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 8.4905 | 9.8911 | 59 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 5.5104 | 15.4295 | 62 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 5.3231 | 16.2387 | 63 | 1164 | signaling receptor activity |
GO:0005549 | 0 | 18.0279 | 1.0882 | 15 | 78 | odorant binding |
GO:0036374 | 1e-04 | 71.6762 | 0.0837 | 3 | 6 | glutathione hydrolase activity |
GO:0005198 | 0.0014 | 2.3113 | 8.8029 | 19 | 631 | structural molecule activity |
GO:0004252 | 0.0018 | 3.8262 | 2.2321 | 8 | 160 | serine-type endopeptidase activity |
GO:0005044 | 0.0025 | 7.7683 | 0.572 | 4 | 41 | scavenger receptor activity |
GO:0004872 | 0.0051 | 4.0414 | 1.5784 | 6 | 148 | receptor activity |
GO:0017171 | 0.0051 | 3.2069 | 2.6367 | 8 | 189 | serine hydrolase activity |
GO:0004497 | 0.0058 | 4.6759 | 1.144 | 5 | 82 | monooxygenase activity |
GO:0042056 | 0.0068 | 8.5886 | 0.3906 | 3 | 28 | chemoattractant activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036374 | 0 | 85.226 | 0.0707 | 3 | 6 | glutathione hydrolase activity |
GO:0008528 | 1e-04 | 6.4513 | 1.3676 | 8 | 116 | G-protein coupled peptide receptor activity |
GO:0004872 | 2e-04 | 2.1701 | 15.9274 | 31 | 1351 | receptor activity |
GO:0004888 | 3e-04 | 2.2805 | 12.5675 | 26 | 1066 | transmembrane signaling receptor activity |
GO:0004871 | 0.0018 | 1.9132 | 17.1889 | 30 | 1458 | signal transducer activity |
GO:0004683 | 0.0024 | 12.7695 | 0.2712 | 3 | 23 | calmodulin-dependent protein kinase activity |
GO:0008020 | 0.0037 | 28.2434 | 0.0943 | 2 | 8 | G-protein coupled photoreceptor activity |
GO:0017171 | 0.0072 | 3.3139 | 2.2282 | 7 | 189 | serine hydrolase activity |
GO:0005201 | 0.0076 | 5.5081 | 0.7781 | 4 | 66 | extracellular matrix structural constituent |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.7893 | 3.3482 | 17 | 180 | histone binding |
GO:0050431 | 3e-04 | 15.2755 | 0.3348 | 4 | 18 | transforming growth factor beta binding |
GO:0019904 | 6e-04 | 2.2245 | 11.5512 | 24 | 621 | protein domain specific binding |
GO:0046982 | 9e-04 | 2.3811 | 8.5007 | 19 | 457 | protein heterodimerization activity |
GO:0016829 | 0.001 | 3.5146 | 3.0506 | 10 | 164 | lyase activity |
GO:0004351 | 0.001 | 106.2624 | 0.0558 | 2 | 3 | glutamate decarboxylase activity |
GO:0016836 | 0.0019 | 6.227 | 0.8928 | 5 | 48 | hydro-lyase activity |
GO:0005123 | 0.0025 | 13.3203 | 0.279 | 3 | 15 | death receptor binding |
GO:0016661 | 0.0033 | 35.4161 | 0.093 | 2 | 5 | oxidoreductase activity, acting on other nitrogenous compounds as donors |
GO:0004222 | 0.0036 | 3.7995 | 1.9717 | 7 | 106 | metalloendopeptidase activity |
GO:0043546 | 0.0049 | 26.5603 | 0.1116 | 2 | 6 | molybdopterin cofactor binding |
GO:0016723 | 0.0068 | 21.2468 | 0.1302 | 2 | 7 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
GO:0005201 | 0.0076 | 4.3842 | 1.2277 | 5 | 66 | extracellular matrix structural constituent |
GO:0019842 | 0.0081 | 3.239 | 2.2879 | 7 | 123 | vitamin binding |
GO:0005089 | 0.0092 | 4.1779 | 1.2835 | 5 | 69 | Rho guanyl-nucleotide exchange factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030492 | 0.001 | 78.0881 | 0.0511 | 2 | 4 | hemoglobin binding |
GO:0005509 | 0.001 | 2.4403 | 7.9313 | 18 | 621 | calcium ion binding |
GO:0005488 | 0.0082 | 1.8461 | 167.5278 | 179 | 13117 | binding |
GO:0050664 | 0.0083 | 17.3448 | 0.1405 | 2 | 11 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor |
GO:0005547 | 0.0084 | 7.8349 | 0.4215 | 3 | 33 | phosphatidylinositol-3,4,5-trisphosphate binding |
GO:0005092 | 0.0098 | 15.6093 | 0.1533 | 2 | 12 | GDP-dissociation inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 25.9108 | 0.5238 | 10 | 43 | nucleosomal DNA binding |
GO:0042393 | 0 | 7.3138 | 2.1928 | 14 | 180 | histone binding |
GO:0003682 | 0 | 3.5738 | 5.5673 | 18 | 457 | chromatin binding |
GO:0046982 | 0 | 3.5738 | 5.5673 | 18 | 457 | protein heterodimerization activity |
GO:0045296 | 2e-04 | 3.6997 | 3.5085 | 12 | 288 | cadherin binding |
GO:0003677 | 8e-04 | 1.8095 | 27.3981 | 44 | 2249 | DNA binding |
GO:0008528 | 0.003 | 4.537 | 1.4132 | 6 | 116 | G-protein coupled peptide receptor activity |
GO:0004065 | 0.003 | 32.7761 | 0.0853 | 2 | 7 | arylsulfatase activity |
GO:0000979 | 0.0042 | 6.6075 | 0.6578 | 4 | 54 | RNA polymerase II core promoter sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 20.0839 | 4.5479 | 57 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 9.5962 | 9.8911 | 64 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 6.3328 | 15.4295 | 68 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 5.2027 | 19.4055 | 71 | 1391 | molecular transducer activity |
GO:0038023 | 0 | 5.7573 | 14.6649 | 61 | 1081 | signaling receptor activity |
GO:0005549 | 0 | 14.99 | 1.0882 | 13 | 78 | odorant binding |
GO:0008392 | 0 | 43.6087 | 0.2232 | 6 | 16 | arachidonic acid epoxygenase activity |
GO:0005506 | 0 | 5.5269 | 1.995 | 10 | 143 | iron ion binding |
GO:0008395 | 1e-04 | 13.3796 | 0.4464 | 5 | 32 | steroid hydroxylase activity |
GO:0030594 | 2e-04 | 6.6973 | 1.1579 | 7 | 83 | neurotransmitter receptor activity |
GO:0008389 | 2e-04 | Inf | 0.0279 | 2 | 2 | coumarin 7-hydroxylase activity |
GO:0020037 | 2e-04 | 5.5035 | 1.5904 | 8 | 114 | heme binding |
GO:0019825 | 2e-04 | 10.6201 | 0.5441 | 5 | 39 | oxygen binding |
GO:0005198 | 2e-04 | 2.59 | 8.8029 | 21 | 631 | structural molecule activity |
GO:0003779 | 5e-04 | 2.9996 | 5.0083 | 14 | 359 | actin binding |
GO:0016709 | 8e-04 | 11.0629 | 0.4185 | 4 | 30 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0070330 | 0.0019 | 14.3238 | 0.2511 | 3 | 18 | aromatase activity |
GO:0019863 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | IgE binding |
GO:0030883 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | exogenous lipid antigen binding |
GO:0001591 | 0.0028 | 35.6659 | 0.0837 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0016705 | 0.0031 | 4.5017 | 1.4266 | 6 | 105 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0030881 | 0.0051 | 23.7741 | 0.1116 | 2 | 8 | beta-2-microglobulin binding |
GO:0039706 | 0.0065 | 20.3764 | 0.1256 | 2 | 9 | co-receptor binding |
GO:0035240 | 0.0081 | 17.8282 | 0.1395 | 2 | 10 | dopamine binding |
GO:0071723 | 0.0081 | 17.8282 | 0.1395 | 2 | 10 | lipopeptide binding |
GO:0005518 | 0.0092 | 5.2197 | 0.8231 | 4 | 59 | collagen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 11.3257 | 4.2277 | 36 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 5.4497 | 9.1945 | 40 | 709 | G-protein coupled receptor activity |
GO:0060089 | 0 | 3.7513 | 18.0389 | 53 | 1391 | molecular transducer activity |
GO:0038023 | 0 | 3.9657 | 14.8596 | 47 | 1157 | signaling receptor activity |
GO:0099600 | 0 | 3.9999 | 14.3429 | 46 | 1106 | transmembrane receptor activity |
GO:0005549 | 0 | 13.1721 | 1.0115 | 11 | 78 | odorant binding |
GO:0004028 | 0.0016 | 51.2483 | 0.0648 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0015198 | 0.0016 | 51.2483 | 0.0648 | 2 | 5 | oligopeptide transporter activity |
GO:0001591 | 0.0024 | 38.4337 | 0.0778 | 2 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0004887 | 0.0034 | 30.7449 | 0.0908 | 2 | 7 | thyroid hormone receptor activity |
GO:0035240 | 0.007 | 19.2117 | 0.1297 | 2 | 10 | dopamine binding |
GO:0035325 | 0.007 | 19.2117 | 0.1297 | 2 | 10 | Toll-like receptor binding |
GO:0042887 | 0.0074 | 8.2648 | 0.402 | 3 | 31 | amide transmembrane transporter activity |
GO:0015250 | 0.0085 | 17.076 | 0.1427 | 2 | 11 | water channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 14.062 | 2.5229 | 27 | 180 | histone binding |
GO:0031492 | 0 | 32.39 | 0.6027 | 13 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 5.3568 | 6.4054 | 29 | 457 | protein heterodimerization activity |
GO:0045296 | 2e-04 | 3.4758 | 4.0367 | 13 | 288 | cadherin binding |
GO:0003682 | 2e-04 | 2.8662 | 6.4054 | 17 | 457 | chromatin binding |
GO:0003677 | 3e-04 | 1.83 | 31.5225 | 51 | 2249 | DNA binding |
GO:0044877 | 9e-04 | 2.1305 | 12.6847 | 25 | 905 | macromolecular complex binding |
GO:0030492 | 0.0012 | 71 | 0.0561 | 2 | 4 | hemoglobin binding |
GO:0019904 | 0.0012 | 2.3391 | 8.7041 | 19 | 621 | protein domain specific binding |
GO:0015144 | 0.0023 | 7.946 | 0.5606 | 4 | 40 | carbohydrate transmembrane transporter activity |
GO:0016801 | 0.0066 | 20.279 | 0.1261 | 2 | 9 | hydrolase activity, acting on ether bonds |
GO:0022857 | 0.0078 | 1.8523 | 12.6006 | 22 | 899 | transmembrane transporter activity |
GO:0042887 | 0.0091 | 7.63 | 0.4345 | 3 | 31 | amide transmembrane transporter activity |
GO:0015250 | 0.0099 | 15.7704 | 0.1542 | 2 | 11 | water channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 11.4506 | 3.0181 | 27 | 180 | histone binding |
GO:0046982 | 0 | 5.2822 | 7.6626 | 34 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 18.4516 | 0.721 | 10 | 43 | nucleosomal DNA binding |
GO:0045296 | 0 | 4.1294 | 4.8289 | 18 | 288 | cadherin binding |
GO:0003677 | 0 | 2.0414 | 37.7092 | 66 | 2249 | DNA binding |
GO:0003682 | 0 | 2.9875 | 7.6626 | 21 | 457 | chromatin binding |
GO:0019904 | 0 | 2.6177 | 10.4124 | 25 | 621 | protein domain specific binding |
GO:0005488 | 4e-04 | 2.1994 | 200.871 | 218 | 12660 | binding |
GO:0005088 | 0.0018 | 3.0328 | 3.8564 | 11 | 230 | Ras guanyl-nucleotide exchange factor activity |
GO:0003700 | 0.0022 | 1.8228 | 18.8294 | 32 | 1123 | DNA binding transcription factor activity |
GO:0001190 | 0.0024 | 5.8437 | 0.939 | 5 | 56 | transcriptional activator activity, RNA polymerase II transcription factor binding |
GO:0001191 | 0.0027 | 7.6708 | 0.5868 | 4 | 35 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
GO:0022853 | 0.0036 | 3.8085 | 1.9618 | 7 | 117 | active ion transmembrane transporter activity |
GO:0030215 | 0.0073 | 19.6929 | 0.1341 | 2 | 8 | semaphorin receptor binding |
GO:0016208 | 0.0093 | 16.8785 | 0.1509 | 2 | 9 | AMP binding |
GO:0016846 | 0.0093 | 16.8785 | 0.1509 | 2 | 9 | carbon-sulfur lyase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 4.1908 | 5.3877 | 20 | 457 | protein heterodimerization activity |
GO:0019838 | 5e-04 | 5.3622 | 1.4147 | 7 | 120 | growth factor binding |
GO:0004656 | 8e-04 | 84.7528 | 0.0472 | 2 | 4 | procollagen-proline 4-dioxygenase activity |
GO:0055131 | 0.002 | 42.3708 | 0.0707 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0008331 | 0.0047 | 24.2071 | 0.1061 | 2 | 9 | high voltage-gated calcium channel activity |
GO:0015932 | 0.0057 | 9.1162 | 0.3655 | 3 | 31 | nucleobase-containing compound transmembrane transporter activity |
GO:0032036 | 0.0058 | 21.1798 | 0.1179 | 2 | 10 | myosin heavy chain binding |
GO:0048029 | 0.0061 | 5.8895 | 0.7309 | 4 | 62 | monosaccharide binding |
GO:0046332 | 0.008 | 5.4203 | 0.7899 | 4 | 67 | SMAD binding |
GO:0031543 | 0.0099 | 15.4004 | 0.1533 | 2 | 13 | peptidyl-proline dioxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008188 | 0.0039 | 6.8377 | 0.6472 | 4 | 41 | neuropeptide receptor activity |
GO:0004683 | 0.0054 | 9.4582 | 0.363 | 3 | 23 | calmodulin-dependent protein kinase activity |
GO:0000340 | 0.0065 | 20.9498 | 0.1263 | 2 | 8 | RNA 7-methylguanosine cap binding |
GO:0004435 | 0.0077 | 8.2229 | 0.4104 | 3 | 26 | phosphatidylinositol phospholipase C activity |
GO:0008331 | 0.0083 | 17.9558 | 0.1421 | 2 | 9 | high voltage-gated calcium channel activity |
GO:0016832 | 0.0083 | 17.9558 | 0.1421 | 2 | 9 | aldehyde-lyase activity |
GO:0035250 | 0.0095 | 7.564 | 0.442 | 3 | 28 | UDP-galactosyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003700 | 0.0013 | 1.8914 | 18.241 | 32 | 1123 | DNA binding transcription factor activity |
GO:0005509 | 0.0029 | 2.1045 | 10.087 | 20 | 621 | calcium ion binding |
GO:0004983 | 0.0069 | 20.3442 | 0.1299 | 2 | 8 | neuropeptide Y receptor activity |
GO:0071933 | 0.0069 | 20.3442 | 0.1299 | 2 | 8 | Arp2/3 complex binding |
GO:0036312 | 0.0088 | 17.4367 | 0.1462 | 2 | 9 | phosphatidylinositol 3-kinase regulatory subunit binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036374 | 1e-04 | 71.6762 | 0.0837 | 3 | 6 | glutathione hydrolase activity |
GO:0008503 | 0.0011 | 71.3412 | 0.0558 | 2 | 4 | benzodiazepine receptor activity |
GO:0015277 | 0.0019 | 47.5577 | 0.0698 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0005201 | 0.0023 | 5.9087 | 0.9207 | 5 | 66 | extracellular matrix structural constituent |
GO:0001228 | 0.0024 | 2.6382 | 5.2315 | 13 | 375 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0016702 | 0.003 | 11.9341 | 0.293 | 3 | 21 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0005104 | 0.0049 | 9.7617 | 0.3488 | 3 | 25 | fibroblast growth factor receptor binding |
GO:0008066 | 0.0049 | 9.7617 | 0.3488 | 3 | 25 | glutamate receptor activity |
GO:0031995 | 0.0051 | 23.7741 | 0.1116 | 2 | 8 | insulin-like growth factor II binding |
GO:0001653 | 0.006 | 3.9023 | 1.6322 | 6 | 117 | peptide receptor activity |
GO:0019842 | 0.0076 | 3.7007 | 1.7159 | 6 | 123 | vitamin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 11.427 | 2.7705 | 25 | 180 | histone binding |
GO:0031492 | 0 | 20.202 | 0.6618 | 10 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 4.4083 | 7.034 | 27 | 457 | protein heterodimerization activity |
GO:0003677 | 0 | 1.9206 | 34.6159 | 58 | 2249 | DNA binding |
GO:0045296 | 2e-04 | 3.4123 | 4.4328 | 14 | 288 | cadherin binding |
GO:0004984 | 2e-04 | 3.2276 | 5.0177 | 15 | 326 | olfactory receptor activity |
GO:0019904 | 6e-04 | 2.3605 | 9.5582 | 21 | 621 | protein domain specific binding |
GO:0004930 | 0.0014 | 2.1568 | 10.9127 | 22 | 709 | G-protein coupled receptor activity |
GO:0015079 | 0.0022 | 3.7222 | 2.2934 | 8 | 149 | potassium ion transmembrane transporter activity |
GO:0005249 | 0.0022 | 4.8365 | 1.3391 | 6 | 87 | voltage-gated potassium channel activity |
GO:0009374 | 0.0023 | 43.0043 | 0.077 | 2 | 5 | biotin binding |
GO:0004872 | 0.0029 | 1.7617 | 20.7941 | 34 | 1351 | receptor activity |
GO:0005201 | 0.0035 | 5.3357 | 1.0159 | 5 | 66 | extracellular matrix structural constituent |
GO:0005044 | 0.0035 | 7.0181 | 0.6311 | 4 | 41 | scavenger receptor activity |
GO:0003682 | 0.0049 | 2.2508 | 7.034 | 15 | 457 | chromatin binding |
GO:0004683 | 0.0051 | 9.7067 | 0.354 | 3 | 23 | calmodulin-dependent protein kinase activity |
GO:0008061 | 0.0062 | 21.4979 | 0.1231 | 2 | 8 | chitin binding |
GO:0004303 | 0.0098 | 16.1212 | 0.1539 | 2 | 10 | estradiol 17-beta-dehydrogenase activity |
GO:0005184 | 0.0098 | 7.4637 | 0.4464 | 3 | 29 | neuropeptide hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 1e-04 | 2.9208 | 7.5246 | 20 | 621 | calcium ion binding |
GO:0016493 | 0.0089 | 16.4732 | 0.1454 | 2 | 12 | C-C chemokine receptor activity |
GO:0019894 | 0.0093 | 7.5175 | 0.4362 | 3 | 36 | kinesin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 11.3177 | 2.7941 | 25 | 180 | histone binding |
GO:0046982 | 0 | 5.1592 | 7.0939 | 31 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 22.8137 | 0.6675 | 11 | 43 | nucleosomal DNA binding |
GO:0003682 | 0 | 3.078 | 7.0939 | 20 | 457 | chromatin binding |
GO:0003677 | 1e-04 | 1.8548 | 34.9105 | 57 | 2249 | DNA binding |
GO:0019904 | 3e-04 | 2.4654 | 9.6396 | 22 | 621 | protein domain specific binding |
GO:0022853 | 5e-04 | 4.7825 | 1.8162 | 8 | 117 | active ion transmembrane transporter activity |
GO:0045296 | 6e-04 | 3.1141 | 4.4705 | 13 | 288 | cadherin binding |
GO:0030492 | 0.0014 | 63.9532 | 0.0621 | 2 | 4 | hemoglobin binding |
GO:1990837 | 0.002 | 2.1338 | 10.4933 | 21 | 676 | sequence-specific double-stranded DNA binding |
GO:0015057 | 0.0023 | 42.6326 | 0.0776 | 2 | 5 | thrombin-activated receptor activity |
GO:0001965 | 0.003 | 12.0312 | 0.2949 | 3 | 19 | G-protein alpha-subunit binding |
GO:0043184 | 0.0048 | 25.5762 | 0.1087 | 2 | 7 | vascular endothelial growth factor receptor 2 binding |
GO:0044212 | 0.005 | 1.9295 | 12.0922 | 22 | 779 | transcription regulatory region DNA binding |
GO:0001067 | 0.0051 | 1.9241 | 12.1232 | 22 | 781 | regulatory region nucleic acid binding |
GO:0031681 | 0.0063 | 21.3121 | 0.1242 | 2 | 8 | G-protein beta-subunit binding |
GO:0000977 | 0.0068 | 2.0539 | 8.7237 | 17 | 562 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0044877 | 0.0073 | 1.8097 | 14.048 | 24 | 905 | macromolecular complex binding |
GO:0008510 | 0.008 | 18.2663 | 0.1397 | 2 | 9 | sodium:bicarbonate symporter activity |
GO:0036312 | 0.008 | 18.2663 | 0.1397 | 2 | 9 | phosphatidylinositol 3-kinase regulatory subunit binding |
GO:0005436 | 0.0099 | 15.9819 | 0.1552 | 2 | 10 | sodium:phosphate symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0098631 | 2e-04 | 10.6369 | 0.5502 | 5 | 35 | cell adhesion mediator activity |
GO:0035663 | 7e-04 | 126.2773 | 0.0472 | 2 | 3 | Toll-like receptor 2 binding |
GO:0043120 | 7e-04 | 126.2773 | 0.0472 | 2 | 3 | tumor necrosis factor binding |
GO:0098641 | 0.0018 | 14.6203 | 0.2515 | 3 | 16 | cadherin binding involved in cell-cell adhesion |
GO:0048018 | 0.0019 | 2.5088 | 6.3505 | 15 | 404 | receptor ligand activity |
GO:0003996 | 0.0024 | 42.0868 | 0.0786 | 2 | 5 | acyl-CoA ligase activity |
GO:0022849 | 0.0024 | 42.0868 | 0.0786 | 2 | 5 | glutamate-gated calcium ion channel activity |
GO:0019001 | 0.0034 | 2.5195 | 5.4545 | 13 | 347 | guanyl nucleotide binding |
GO:0050839 | 0.0035 | 2.3417 | 6.775 | 15 | 431 | cell adhesion molecule binding |
GO:0086083 | 0.0035 | 31.563 | 0.0943 | 2 | 6 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
GO:0004972 | 0.0049 | 25.2487 | 0.11 | 2 | 7 | NMDA glutamate receptor activity |
GO:0030306 | 0.0049 | 25.2487 | 0.11 | 2 | 7 | ADP-ribosylation factor binding |
GO:0050840 | 0.0058 | 6.0476 | 0.7231 | 4 | 46 | extracellular matrix binding |
GO:0005525 | 0.0061 | 2.4346 | 5.1873 | 12 | 330 | GTP binding |
GO:0019966 | 0.0065 | 21.0392 | 0.1258 | 2 | 8 | interleukin-1 binding |
GO:0001883 | 0.0066 | 2.4114 | 5.2345 | 12 | 333 | purine nucleoside binding |
GO:0032549 | 0.0069 | 2.3961 | 5.2659 | 12 | 335 | ribonucleoside binding |
GO:0017124 | 0.0085 | 3.6096 | 1.7605 | 6 | 112 | SH3 domain binding |
GO:0030594 | 0.0099 | 4.078 | 1.3047 | 5 | 83 | neurotransmitter receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.9248 | 3.2774 | 17 | 180 | histone binding |
GO:0050431 | 0 | 21.1003 | 0.3277 | 5 | 18 | transforming growth factor beta binding |
GO:0016723 | 2e-04 | 40.8709 | 0.1275 | 3 | 7 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
GO:0046982 | 3e-04 | 2.5816 | 8.3211 | 20 | 457 | protein heterodimerization activity |
GO:0019904 | 0.001 | 2.1707 | 11.3072 | 23 | 621 | protein domain specific binding |
GO:0004864 | 0.0023 | 8.0903 | 0.5644 | 4 | 31 | protein phosphatase inhibitor activity |
GO:0005123 | 0.0023 | 13.6164 | 0.2731 | 3 | 15 | death receptor binding |
GO:0004222 | 0.0032 | 3.8852 | 1.93 | 7 | 106 | metalloendopeptidase activity |
GO:0016491 | 0.0034 | 1.9918 | 11.6895 | 22 | 642 | oxidoreductase activity |
GO:0043546 | 0.0047 | 27.1486 | 0.1092 | 2 | 6 | molybdopterin cofactor binding |
GO:0019842 | 0.0073 | 3.3121 | 2.2396 | 7 | 123 | vitamin binding |
GO:0050660 | 0.0074 | 4.4098 | 1.2199 | 5 | 67 | flavin adenine dinucleotide binding |
GO:0005024 | 0.0086 | 18.0966 | 0.1457 | 2 | 8 | transforming growth factor beta-activated receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 10.6066 | 2.9591 | 25 | 180 | histone binding |
GO:0046982 | 0 | 4.4527 | 7.5129 | 29 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 18.8407 | 0.7069 | 10 | 43 | nucleosomal DNA binding |
GO:0004984 | 1e-04 | 3.2301 | 5.3593 | 16 | 326 | olfactory receptor activity |
GO:0003677 | 3e-04 | 1.7592 | 36.9727 | 58 | 2249 | DNA binding |
GO:0004930 | 3e-04 | 2.318 | 11.6557 | 25 | 709 | G-protein coupled receptor activity |
GO:0005249 | 6e-04 | 5.3565 | 1.4302 | 7 | 87 | voltage-gated potassium channel activity |
GO:0019904 | 6e-04 | 2.3124 | 10.209 | 22 | 621 | protein domain specific binding |
GO:0015079 | 8e-04 | 3.952 | 2.4495 | 9 | 149 | potassium ion transmembrane transporter activity |
GO:0045296 | 0.001 | 2.9281 | 4.7346 | 13 | 288 | cadherin binding |
GO:0090722 | 0.0016 | 60.3012 | 0.0658 | 2 | 4 | receptor-receptor interaction |
GO:0060089 | 0.0023 | 1.7447 | 22.8675 | 37 | 1391 | molecular transducer activity |
GO:0099600 | 0.0025 | 1.8275 | 18.1822 | 31 | 1106 | transmembrane receptor activity |
GO:0038023 | 0.0028 | 1.7923 | 19.1357 | 32 | 1164 | signaling receptor activity |
GO:0004683 | 0.0061 | 9.0708 | 0.3781 | 3 | 23 | calmodulin-dependent protein kinase activity |
GO:0005261 | 0.0067 | 2.5128 | 4.6031 | 11 | 280 | cation channel activity |
GO:0003682 | 0.0088 | 2.0959 | 7.5129 | 15 | 457 | chromatin binding |
GO:0005244 | 0.0093 | 2.8752 | 2.9263 | 8 | 178 | voltage-gated ion channel activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007606 | 0 | 3.1377 | 10.206 | 29 | 406 | sensory perception of chemical stimulus |
GO:0006955 | 0 | 1.9447 | 39.5871 | 69 | 1611 | immune response |
GO:0050906 | 0 | 2.9376 | 10.0552 | 27 | 400 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 2.9091 | 9.7535 | 26 | 388 | detection of chemical stimulus |
GO:0007186 | 0 | 2.0364 | 29.6879 | 55 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050911 | 0 | 2.9082 | 7.8179 | 21 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0031338 | 2e-04 | 5.5333 | 1.634 | 8 | 65 | regulation of vesicle fusion |
GO:0090630 | 3e-04 | 4.7376 | 2.1116 | 9 | 84 | activation of GTPase activity |
GO:0051673 | 3e-04 | 39.0653 | 0.1508 | 3 | 6 | membrane disruption in other organism |
GO:0051852 | 3e-04 | 15.6584 | 0.3519 | 4 | 14 | disruption by host of symbiont cells |
GO:0050832 | 3e-04 | 7.3666 | 0.9552 | 6 | 38 | defense response to fungus |
GO:0001775 | 4e-04 | 1.7521 | 31.2967 | 51 | 1245 | cell activation |
GO:0051707 | 4e-04 | 1.9464 | 19.7584 | 36 | 786 | response to other organism |
GO:0031640 | 4e-04 | 5.7382 | 1.3826 | 7 | 55 | killing of cells of other organism |
GO:0009607 | 5e-04 | 1.8942 | 20.8393 | 37 | 829 | response to biotic stimulus |
GO:0042231 | 6e-04 | Inf | 0.0503 | 2 | 2 | interleukin-13 biosynthetic process |
GO:0044657 | 6e-04 | Inf | 0.0503 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0052043 | 6e-04 | Inf | 0.0503 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 6e-04 | Inf | 0.0503 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 6e-04 | Inf | 0.0503 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0006959 | 6e-04 | 2.9404 | 5.103 | 14 | 203 | humoral immune response |
GO:0048671 | 8e-04 | 23.4362 | 0.2011 | 3 | 8 | negative regulation of collateral sprouting |
GO:0042742 | 9e-04 | 2.9588 | 4.703 | 13 | 189 | defense response to bacterium |
GO:0030814 | 9e-04 | 3.32 | 3.5696 | 11 | 142 | regulation of cAMP metabolic process |
GO:0006954 | 0.001 | 2.3765 | 8.4951 | 19 | 346 | inflammatory response |
GO:0072676 | 0.0012 | 4.1449 | 2.1116 | 8 | 84 | lymphocyte migration |
GO:0042107 | 0.0013 | 3.6962 | 2.6395 | 9 | 105 | cytokine metabolic process |
GO:0010818 | 0.0017 | 9.2067 | 0.5279 | 4 | 21 | T cell chemotaxis |
GO:1903238 | 0.0019 | 77.9449 | 0.0754 | 2 | 3 | positive regulation of leukocyte tethering or rolling |
GO:1903413 | 0.0019 | 77.9449 | 0.0754 | 2 | 3 | cellular response to bile acid |
GO:0035036 | 0.0019 | 5.12 | 1.3072 | 6 | 52 | sperm-egg recognition |
GO:0050877 | 0.002 | 1.6557 | 28.8583 | 45 | 1148 | nervous system process |
GO:0042119 | 0.0022 | 2.028 | 11.9656 | 23 | 476 | neutrophil activation |
GO:0002274 | 0.0024 | 1.9009 | 14.9822 | 27 | 596 | myeloid leukocyte activation |
GO:0042832 | 0.0024 | 8.2365 | 0.5782 | 4 | 23 | defense response to protozoan |
GO:0050727 | 0.0024 | 2.2895 | 7.843 | 17 | 312 | regulation of inflammatory response |
GO:0008037 | 0.0024 | 3.1061 | 3.4439 | 10 | 137 | cell recognition |
GO:0051607 | 0.0025 | 2.6249 | 5.2538 | 13 | 209 | defense response to virus |
GO:0019731 | 0.0025 | 5.9374 | 0.9552 | 5 | 38 | antibacterial humoral response |
GO:0034105 | 0.0025 | 5.9374 | 0.9552 | 5 | 38 | positive regulation of tissue remodeling |
GO:0070098 | 0.003 | 3.9864 | 1.9105 | 7 | 76 | chemokine-mediated signaling pathway |
GO:0043312 | 0.0035 | 1.9796 | 11.6891 | 22 | 465 | neutrophil degranulation |
GO:2000360 | 0.0037 | 38.9699 | 0.1006 | 2 | 4 | negative regulation of binding of sperm to zona pellucida |
GO:0030802 | 0.0037 | 2.9205 | 3.645 | 10 | 145 | regulation of cyclic nucleotide biosynthetic process |
GO:0030819 | 0.004 | 3.767 | 2.011 | 7 | 80 | positive regulation of cAMP biosynthetic process |
GO:0048660 | 0.0041 | 3.0817 | 3.1171 | 9 | 124 | regulation of smooth muscle cell proliferation |
GO:0070528 | 0.0044 | 6.8023 | 0.6787 | 4 | 27 | protein kinase C signaling |
GO:0042033 | 0.0047 | 10.6487 | 0.3519 | 3 | 14 | chemokine biosynthetic process |
GO:1900371 | 0.0054 | 2.7557 | 3.8461 | 10 | 153 | regulation of purine nucleotide biosynthetic process |
GO:0001866 | 0.006 | 25.9783 | 0.1257 | 2 | 5 | NK T cell proliferation |
GO:0010951 | 0.0062 | 2.3349 | 5.8571 | 13 | 233 | negative regulation of endopeptidase activity |
GO:0030801 | 0.0062 | 3.1139 | 2.74 | 8 | 109 | positive regulation of cyclic nucleotide metabolic process |
GO:0002366 | 0.0063 | 1.7563 | 16.1134 | 27 | 641 | leukocyte activation involved in immune response |
GO:0052652 | 0.0064 | 2.68 | 3.9467 | 10 | 157 | cyclic purine nucleotide metabolic process |
GO:0002385 | 0.0064 | 6.0163 | 0.7541 | 4 | 30 | mucosal immune response |
GO:0002444 | 0.0066 | 1.8392 | 13.0969 | 23 | 521 | myeloid leukocyte mediated immunity |
GO:0010518 | 0.0069 | 4.5537 | 1.2066 | 5 | 48 | positive regulation of phospholipase activity |
GO:0010744 | 0.0069 | 9.0093 | 0.4022 | 3 | 16 | positive regulation of macrophage derived foam cell differentiation |
GO:0032611 | 0.0077 | 3.7343 | 1.7345 | 6 | 69 | interleukin-1 beta production |
GO:0050794 | 0.0085 | 1.2982 | 248.7899 | 272 | 9897 | regulation of cellular process |
GO:0001547 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | antral ovarian follicle growth |
GO:0001878 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | response to yeast |
GO:0007256 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | activation of JNKK activity |
GO:0045416 | 0.0088 | 19.4825 | 0.1508 | 2 | 6 | positive regulation of interleukin-8 biosynthetic process |
GO:0010771 | 0.0094 | 3.5639 | 1.8099 | 6 | 72 | negative regulation of cell morphogenesis involved in differentiation |
GO:0042454 | 0.0097 | 7.807 | 0.4525 | 3 | 18 | ribonucleoside catabolic process |
GO:0002687 | 0.0099 | 2.8575 | 2.9663 | 8 | 118 | positive regulation of leukocyte migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 98.617 | 0.991 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 65.7277 | 1.1148 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 39.4162 | 1.3626 | 24 | 44 | protein heterotetramerization |
GO:0034654 | 0 | 2.6214 | 125.0174 | 228 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0009952 | 0 | 8.1215 | 6.0387 | 38 | 195 | anterior/posterior pattern specification |
GO:0048863 | 0 | 8.412 | 5.5322 | 36 | 183 | stem cell differentiation |
GO:0009790 | 0 | 3.7223 | 24.6924 | 76 | 813 | embryo development |
GO:0034645 | 0 | 2.2619 | 150.1634 | 242 | 4849 | cellular macromolecule biosynthetic process |
GO:0045653 | 0 | 112.6854 | 0.5574 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 14.3007 | 2.4465 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:0097659 | 0 | 2.6805 | 61.4831 | 128 | 2221 | nucleic acid-templated transcription |
GO:0006355 | 0 | 2.6414 | 63.3146 | 130 | 2318 | regulation of transcription, DNA-templated |
GO:2001141 | 0 | 2.6225 | 63.1123 | 129 | 2311 | regulation of RNA biosynthetic process |
GO:1902679 | 0 | 3.0687 | 34.746 | 89 | 1122 | negative regulation of RNA biosynthetic process |
GO:0009889 | 0 | 2.5421 | 72.8573 | 141 | 2671 | regulation of biosynthetic process |
GO:0045814 | 0 | 9.279 | 3.6542 | 26 | 118 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 10.2002 | 3.1278 | 24 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0031497 | 0 | 7.8784 | 4.4903 | 28 | 145 | chromatin assembly |
GO:0060964 | 0 | 9.6939 | 3.2516 | 24 | 105 | regulation of gene silencing by miRNA |
GO:0045934 | 0 | 2.7039 | 41.6828 | 95 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0045944 | 0 | 2.9038 | 32.795 | 81 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:1901576 | 0 | 1.9859 | 186.3339 | 267 | 6017 | organic substance biosynthetic process |
GO:0019219 | 0 | 2.3117 | 71.9817 | 132 | 2635 | regulation of nucleobase-containing compound metabolic process |
GO:0009890 | 0 | 2.4594 | 48.9603 | 102 | 1581 | negative regulation of biosynthetic process |
GO:0060968 | 0 | 7.5388 | 3.9639 | 24 | 128 | regulation of gene silencing |
GO:1904837 | 0 | 16.6608 | 1.3626 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:1903508 | 0 | 2.4909 | 42.0854 | 90 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0002244 | 0 | 5.8184 | 5.76 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0060255 | 0 | 2.1528 | 88.9268 | 148 | 3189 | regulation of macromolecule metabolic process |
GO:0034080 | 0 | 17.3115 | 1.2387 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0035194 | 0 | 5.0567 | 7.2155 | 31 | 233 | posttranscriptional gene silencing by RNA |
GO:0045892 | 0 | 4.2876 | 9.7421 | 36 | 335 | negative regulation of transcription, DNA-templated |
GO:0043009 | 0 | 3.8694 | 11.8997 | 40 | 390 | chordate embryonic development |
GO:0051254 | 0 | 2.381 | 44.2841 | 91 | 1430 | positive regulation of RNA metabolic process |
GO:0010628 | 0 | 2.2962 | 49.2711 | 97 | 1664 | positive regulation of gene expression |
GO:0032200 | 0 | 5.9176 | 5.0478 | 25 | 163 | telomere organization |
GO:0046483 | 0 | 1.8306 | 174.9377 | 245 | 5649 | heterocycle metabolic process |
GO:0006725 | 0 | 1.8272 | 176.0525 | 246 | 5685 | cellular aromatic compound metabolic process |
GO:0010557 | 0 | 2.2595 | 49.1461 | 96 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0065004 | 0 | 4.9335 | 6.6271 | 28 | 214 | protein-DNA complex assembly |
GO:1901360 | 0 | 1.7981 | 182.4319 | 251 | 5891 | organic cyclic compound metabolic process |
GO:0031328 | 0 | 2.1953 | 53.2958 | 101 | 1721 | positive regulation of cellular biosynthetic process |
GO:0034724 | 0 | 12.1562 | 1.5794 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0060173 | 0 | 5.3927 | 5.2336 | 24 | 169 | limb development |
GO:0030099 | 0 | 3.6218 | 11.613 | 37 | 375 | myeloid cell differentiation |
GO:0071103 | 0 | 4.2433 | 8.1136 | 30 | 262 | DNA conformation change |
GO:0016233 | 0 | 10.9674 | 1.7032 | 14 | 55 | telomere capping |
GO:0001501 | 0 | 3.2243 | 14.7098 | 42 | 475 | skeletal system development |
GO:0048704 | 0 | 12.0304 | 1.4725 | 13 | 48 | embryonic skeletal system morphogenesis |
GO:0048731 | 0 | 2.4034 | 36.4961 | 74 | 1476 | system development |
GO:0048562 | 0 | 5.1542 | 5.1899 | 23 | 175 | embryonic organ morphogenesis |
GO:0034641 | 0 | 1.7179 | 192.2487 | 256 | 6208 | cellular nitrogen compound metabolic process |
GO:0007218 | 0 | 7.1191 | 2.911 | 17 | 94 | neuropeptide signaling pathway |
GO:0021517 | 0 | 12.3895 | 1.3316 | 12 | 43 | ventral spinal cord development |
GO:0007399 | 0 | 2.309 | 35.4679 | 72 | 1208 | nervous system development |
GO:0009893 | 0 | 3.7234 | 9.4921 | 31 | 334 | positive regulation of metabolic process |
GO:0065007 | 0 | 1.959 | 217.5086 | 267 | 7732 | biological regulation |
GO:0016070 | 0 | 1.8874 | 81.8043 | 129 | 2948 | RNA metabolic process |
GO:0017148 | 0 | 3.5143 | 9.9097 | 31 | 320 | negative regulation of translation |
GO:0035107 | 0 | 5.1757 | 4.4903 | 20 | 145 | appendage morphogenesis |
GO:1903707 | 0 | 5.3367 | 4.1497 | 19 | 134 | negative regulation of hemopoiesis |
GO:0006303 | 0 | 7.7443 | 2.2297 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0021515 | 0 | 9.843 | 1.5794 | 12 | 51 | cell differentiation in spinal cord |
GO:0021953 | 0 | 4.7215 | 5.1097 | 21 | 165 | central nervous system neuron differentiation |
GO:0000122 | 0 | 2.4766 | 23.3188 | 52 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0043044 | 0 | 7.362 | 2.3226 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0048729 | 0 | 2.7846 | 16.3439 | 41 | 534 | tissue morphogenesis |
GO:0022414 | 0 | 2.0669 | 40.4751 | 75 | 1307 | reproductive process |
GO:0038111 | 0 | 11.8082 | 1.1458 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 11.8082 | 1.1458 | 10 | 37 | response to interleukin-7 |
GO:0051954 | 0 | 13.6409 | 0.929 | 9 | 30 | positive regulation of amine transport |
GO:0051259 | 0 | 2.7274 | 15.7936 | 39 | 510 | protein oligomerization |
GO:0048534 | 0 | 2.345 | 24.4869 | 52 | 797 | hematopoietic or lymphoid organ development |
GO:0009954 | 0 | 13.0201 | 0.96 | 9 | 31 | proximal/distal pattern formation |
GO:0050794 | 0 | 1.7973 | 129.9608 | 171 | 4917 | regulation of cellular process |
GO:0014033 | 0 | 6.8474 | 2.1058 | 12 | 68 | neural crest cell differentiation |
GO:0045165 | 0 | 4.1525 | 4.8695 | 18 | 162 | cell fate commitment |
GO:0099537 | 0 | 2.4063 | 18.1472 | 40 | 586 | trans-synaptic signaling |
GO:0090596 | 0 | 3.3361 | 7.6181 | 23 | 246 | sensory organ morphogenesis |
GO:0048608 | 0 | 2.7228 | 12.4491 | 31 | 402 | reproductive structure development |
GO:0023061 | 0 | 2.7078 | 12.511 | 31 | 404 | signal release |
GO:0045596 | 0 | 2.3679 | 18.4145 | 40 | 601 | negative regulation of cell differentiation |
GO:0014031 | 0 | 6.6196 | 1.9819 | 11 | 64 | mesenchymal cell development |
GO:0048864 | 0 | 6.6196 | 1.9819 | 11 | 64 | stem cell development |
GO:0030154 | 0 | 2.3218 | 20.0616 | 42 | 771 | cell differentiation |
GO:0007267 | 0 | 1.9942 | 32.9949 | 60 | 1108 | cell-cell signaling |
GO:0032501 | 0 | 1.6956 | 94.7588 | 132 | 3872 | multicellular organismal process |
GO:0045652 | 0 | 7.1267 | 1.687 | 10 | 56 | regulation of megakaryocyte differentiation |
GO:0021520 | 0 | 31.729 | 0.3085 | 5 | 10 | spinal cord motor neuron cell fate specification |
GO:0048935 | 0 | 31.729 | 0.3085 | 5 | 10 | peripheral nervous system neuron development |
GO:0001763 | 0 | 3.6187 | 5.822 | 19 | 188 | morphogenesis of a branching structure |
GO:0048646 | 0 | 2.1091 | 25.2964 | 49 | 836 | anatomical structure formation involved in morphogenesis |
GO:0010467 | 0 | 1.6452 | 88.4595 | 125 | 3370 | gene expression |
GO:0051241 | 0 | 2.0433 | 27.1463 | 51 | 904 | negative regulation of multicellular organismal process |
GO:0034248 | 0 | 2.3515 | 16.5988 | 36 | 536 | regulation of cellular amide metabolic process |
GO:0035050 | 0 | 5.7485 | 2.2297 | 11 | 72 | embryonic heart tube development |
GO:0001755 | 0 | 8.7578 | 1.1458 | 8 | 37 | neural crest cell migration |
GO:0034728 | 0 | 4.6895 | 3.1394 | 13 | 104 | nucleosome organization |
GO:0035150 | 0 | 4.0365 | 4.1497 | 15 | 134 | regulation of tube size |
GO:0060850 | 0 | 22.6591 | 0.3702 | 5 | 12 | regulation of transcription involved in cell fate commitment |
GO:0008344 | 0 | 5.3933 | 2.3536 | 11 | 76 | adult locomotory behavior |
GO:0010605 | 0 | 1.8244 | 38.9818 | 65 | 1307 | negative regulation of macromolecule metabolic process |
GO:0002125 | 0 | Inf | 0.0929 | 3 | 3 | maternal aggressive behavior |
GO:0021524 | 0 | Inf | 0.0929 | 3 | 3 | visceral motor neuron differentiation |
GO:0050433 | 0 | 7.7245 | 1.2649 | 8 | 41 | regulation of catecholamine secretion |
GO:0097746 | 0 | 4.0326 | 3.871 | 14 | 125 | regulation of blood vessel diameter |
GO:0048565 | 0 | 3.9607 | 3.9329 | 14 | 127 | digestive tract development |
GO:0016331 | 0 | 3.6923 | 4.4903 | 15 | 145 | morphogenesis of embryonic epithelium |
GO:0042711 | 0 | 17.5517 | 0.4336 | 5 | 14 | maternal behavior |
GO:0009914 | 1e-04 | 2.6861 | 9.2594 | 23 | 299 | hormone transport |
GO:0007389 | 1e-04 | 10.5692 | 0.7264 | 6 | 26 | pattern specification process |
GO:0051173 | 1e-04 | 1.5354 | 86.4624 | 120 | 2792 | positive regulation of nitrogen compound metabolic process |
GO:0003018 | 1e-04 | 3.4263 | 4.8 | 15 | 155 | vascular process in circulatory system |
GO:0060485 | 1e-04 | 3.1025 | 5.9615 | 17 | 194 | mesenchyme development |
GO:0008284 | 1e-04 | 1.9064 | 25.8892 | 46 | 836 | positive regulation of cell proliferation |
GO:0001992 | 1e-04 | 94.442 | 0.1239 | 3 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0007198 | 1e-04 | 94.442 | 0.1239 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 1e-04 | 94.442 | 0.1239 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 1e-04 | 94.442 | 0.1239 | 3 | 4 | detection of glucose |
GO:0007268 | 1e-04 | 2.134 | 16.5609 | 33 | 541 | chemical synaptic transmission |
GO:0048754 | 2e-04 | 3.8571 | 3.44 | 12 | 112 | branching morphogenesis of an epithelial tube |
GO:0030326 | 2e-04 | 4.542 | 2.4748 | 10 | 81 | embryonic limb morphogenesis |
GO:0043388 | 2e-04 | 5.638 | 1.6413 | 8 | 53 | positive regulation of DNA binding |
GO:0042475 | 2e-04 | 4.4152 | 2.5394 | 10 | 82 | odontogenesis of dentin-containing tooth |
GO:0007420 | 2e-04 | 1.9843 | 19.9124 | 37 | 643 | brain development |
GO:0048557 | 2e-04 | 11.2796 | 0.5884 | 5 | 19 | embryonic digestive tract morphogenesis |
GO:0001764 | 2e-04 | 3.4545 | 4.1187 | 13 | 133 | neuron migration |
GO:0010608 | 3e-04 | 1.9913 | 19.293 | 36 | 623 | posttranscriptional regulation of gene expression |
GO:0003084 | 3e-04 | 18.0187 | 0.3406 | 4 | 11 | positive regulation of systemic arterial blood pressure |
GO:0060573 | 3e-04 | 18.0187 | 0.3406 | 4 | 11 | cell fate specification involved in pattern specification |
GO:0001656 | 3e-04 | 4.2953 | 2.6013 | 10 | 84 | metanephros development |
GO:0009887 | 3e-04 | 2.2313 | 12.9376 | 27 | 465 | animal organ morphogenesis |
GO:0061061 | 3e-04 | 2.0026 | 18.6427 | 35 | 602 | muscle structure development |
GO:0060021 | 3e-04 | 4.2633 | 2.6173 | 10 | 85 | palate development |
GO:0048665 | 3e-04 | 10.6757 | 0.6111 | 5 | 20 | neuron fate specification |
GO:0051970 | 3e-04 | 47.2179 | 0.1548 | 3 | 5 | negative regulation of transmission of nerve impulse |
GO:0097070 | 3e-04 | 47.2179 | 0.1548 | 3 | 5 | ductus arteriosus closure |
GO:0009888 | 3e-04 | 2.2225 | 13.0099 | 27 | 464 | tissue development |
GO:0003151 | 3e-04 | 4.7027 | 2.1595 | 9 | 70 | outflow tract morphogenesis |
GO:0008015 | 3e-04 | 2.1128 | 15.1433 | 30 | 489 | blood circulation |
GO:0042472 | 3e-04 | 4.6506 | 2.1796 | 9 | 71 | inner ear morphogenesis |
GO:0003044 | 3e-04 | 6.1575 | 1.3316 | 7 | 43 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0015844 | 3e-04 | 5.2272 | 1.7488 | 8 | 57 | monoamine transport |
GO:0001947 | 3e-04 | 5.1765 | 1.7652 | 8 | 57 | heart looping |
GO:0051047 | 4e-04 | 2.2976 | 11.1507 | 24 | 362 | positive regulation of secretion |
GO:0007617 | 4e-04 | 9.8684 | 0.6503 | 5 | 21 | mating behavior |
GO:0015874 | 4e-04 | 9.8684 | 0.6503 | 5 | 21 | norepinephrine transport |
GO:0035115 | 4e-04 | 7.2976 | 0.991 | 6 | 32 | embryonic forelimb morphogenesis |
GO:0042755 | 4e-04 | 7.2976 | 0.991 | 6 | 32 | eating behavior |
GO:0003407 | 4e-04 | 5.0726 | 1.7961 | 8 | 58 | neural retina development |
GO:0019233 | 5e-04 | 4.8258 | 1.8737 | 8 | 61 | sensory perception of pain |
GO:0044238 | 5e-04 | 1.3803 | 306.1797 | 341 | 9887 | primary metabolic process |
GO:0031016 | 5e-04 | 4.2628 | 2.3536 | 9 | 76 | pancreas development |
GO:0021546 | 6e-04 | 31.4766 | 0.1858 | 3 | 6 | rhombomere development |
GO:0033603 | 6e-04 | 31.4766 | 0.1858 | 3 | 6 | positive regulation of dopamine secretion |
GO:0042713 | 6e-04 | 31.4766 | 0.1858 | 3 | 6 | sperm ejaculation |
GO:0060022 | 6e-04 | 31.4766 | 0.1858 | 3 | 6 | hard palate development |
GO:0030855 | 6e-04 | 1.8649 | 21.6542 | 38 | 702 | epithelial cell differentiation |
GO:0007492 | 6e-04 | 8.8515 | 0.706 | 5 | 23 | endoderm development |
GO:0044062 | 6e-04 | 8.7707 | 0.7123 | 5 | 23 | regulation of excretion |
GO:0090103 | 6e-04 | 8.7707 | 0.7123 | 5 | 23 | cochlea morphogenesis |
GO:0007626 | 6e-04 | 3.5285 | 3.4074 | 11 | 112 | locomotory behavior |
GO:0043583 | 6e-04 | 2.7188 | 6.3175 | 16 | 204 | ear development |
GO:0045137 | 6e-04 | 2.7188 | 6.3175 | 16 | 204 | development of primary sexual characteristics |
GO:0051240 | 6e-04 | 1.6009 | 43.4267 | 65 | 1422 | positive regulation of multicellular organismal process |
GO:0050885 | 6e-04 | 5.4049 | 1.4865 | 7 | 48 | neuromuscular process controlling balance |
GO:0060795 | 6e-04 | 6.5414 | 1.0839 | 6 | 35 | cell fate commitment involved in formation of primary germ layer |
GO:0009953 | 7e-04 | 3.7368 | 2.942 | 10 | 95 | dorsal/ventral pattern formation |
GO:0030878 | 7e-04 | 8.3086 | 0.7432 | 5 | 24 | thyroid gland development |
GO:0007368 | 8e-04 | 3.4287 | 3.4994 | 11 | 113 | determination of left/right symmetry |
GO:0072001 | 8e-04 | 2.4234 | 8.3613 | 19 | 270 | renal system development |
GO:0006352 | 8e-04 | 2.5508 | 7.1226 | 17 | 230 | DNA-templated transcription, initiation |
GO:0015837 | 8e-04 | 5.1232 | 1.5535 | 7 | 51 | amine transport |
GO:0001654 | 8e-04 | 2.2407 | 10.4362 | 22 | 337 | eye development |
GO:0021545 | 9e-04 | 6.1532 | 1.1396 | 6 | 37 | cranial nerve development |
GO:0048732 | 9e-04 | 2.1496 | 11.8505 | 24 | 386 | gland development |
GO:0060561 | 9e-04 | 7.8926 | 0.7742 | 5 | 25 | apoptotic process involved in morphogenesis |
GO:0042220 | 9e-04 | 5.0354 | 1.5794 | 7 | 51 | response to cocaine |
GO:0001826 | 9e-04 | 23.6059 | 0.2168 | 3 | 7 | inner cell mass cell differentiation |
GO:0098700 | 9e-04 | 23.6059 | 0.2168 | 3 | 7 | neurotransmitter loading into synaptic vesicle |
GO:1902866 | 9e-04 | 23.6059 | 0.2168 | 3 | 7 | regulation of retina development in camera-type eye |
GO:0008595 | 9e-04 | 11.4635 | 0.4645 | 4 | 15 | anterior/posterior axis specification, embryo |
GO:0060579 | 9e-04 | 11.4635 | 0.4645 | 4 | 15 | ventral spinal cord interneuron fate commitment |
GO:0090177 | 9e-04 | 11.4635 | 0.4645 | 4 | 15 | establishment of planar polarity involved in neural tube closure |
GO:0060411 | 9e-04 | 4.3707 | 2.0439 | 8 | 66 | cardiac septum morphogenesis |
GO:0033693 | 0.001 | Inf | 0.0619 | 2 | 2 | neurofilament bundle assembly |
GO:0042137 | 0.001 | Inf | 0.0619 | 2 | 2 | sequestering of neurotransmitter |
GO:0043134 | 0.001 | Inf | 0.0619 | 2 | 2 | regulation of hindgut contraction |
GO:0060577 | 0.001 | Inf | 0.0619 | 2 | 2 | pulmonary vein morphogenesis |
GO:0061017 | 0.001 | Inf | 0.0619 | 2 | 2 | hepatoblast differentiation |
GO:0061379 | 0.001 | Inf | 0.0619 | 2 | 2 | inferior colliculus development |
GO:0072272 | 0.001 | Inf | 0.0619 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0009798 | 0.001 | 3.8578 | 2.5703 | 9 | 83 | axis specification |
GO:0003231 | 0.0011 | 3.2674 | 3.6542 | 11 | 118 | cardiac ventricle development |
GO:0048514 | 0.0011 | 1.9382 | 16.382 | 30 | 529 | blood vessel morphogenesis |
GO:0051094 | 0.0011 | 1.6134 | 36.8828 | 56 | 1191 | positive regulation of developmental process |
GO:0015872 | 0.0012 | 5.747 | 1.2077 | 6 | 39 | dopamine transport |
GO:0060249 | 0.0012 | 2.1391 | 11.3962 | 23 | 368 | anatomical structure homeostasis |
GO:2000026 | 0.0012 | 1.9322 | 16.48 | 30 | 590 | regulation of multicellular organismal development |
GO:0014706 | 0.0012 | 2.1772 | 10.7149 | 22 | 346 | striated muscle tissue development |
GO:0060562 | 0.0012 | 3.028 | 4.2709 | 12 | 142 | epithelial tube morphogenesis |
GO:0050886 | 0.0012 | 7.2581 | 0.8269 | 5 | 27 | endocrine process |
GO:0060841 | 0.0012 | 10.5075 | 0.4955 | 4 | 16 | venous blood vessel development |
GO:0045777 | 0.0012 | 7.2301 | 0.8299 | 5 | 27 | positive regulation of blood pressure |
GO:0003016 | 0.0013 | 7.1742 | 0.8361 | 5 | 27 | respiratory system process |
GO:0035295 | 0.0013 | 2.3672 | 8.0804 | 18 | 274 | tube development |
GO:0007422 | 0.0014 | 4.0876 | 2.1678 | 8 | 70 | peripheral nervous system development |
GO:0035137 | 0.0014 | 19.0494 | 0.2457 | 3 | 8 | hindlimb morphogenesis |
GO:0050878 | 0.0015 | 1.9715 | 14.4747 | 27 | 470 | regulation of body fluid levels |
GO:0042310 | 0.0015 | 5.4644 | 1.2594 | 6 | 41 | vasoconstriction |
GO:0035116 | 0.0015 | 6.8618 | 0.8671 | 5 | 28 | embryonic hindlimb morphogenesis |
GO:0009799 | 0.0015 | 3.1205 | 3.8091 | 11 | 123 | specification of symmetry |
GO:0021536 | 0.0015 | 4.0225 | 2.1987 | 8 | 71 | diencephalon development |
GO:0007625 | 0.0016 | 9.6986 | 0.5265 | 4 | 17 | grooming behavior |
GO:0048486 | 0.0016 | 9.6986 | 0.5265 | 4 | 17 | parasympathetic nervous system development |
GO:0045595 | 0.0017 | 1.6571 | 29.436 | 46 | 1007 | regulation of cell differentiation |
GO:0044060 | 0.0017 | 5.2671 | 1.3007 | 6 | 42 | regulation of endocrine process |
GO:0055078 | 0.0017 | 5.2671 | 1.3007 | 6 | 42 | sodium ion homeostasis |
GO:1903793 | 0.0017 | 5.2671 | 1.3007 | 6 | 42 | positive regulation of anion transport |
GO:0032892 | 0.0018 | 6.5755 | 0.8981 | 5 | 29 | positive regulation of organic acid transport |
GO:0048332 | 0.0018 | 3.8982 | 2.2607 | 8 | 73 | mesoderm morphogenesis |
GO:0035282 | 0.0019 | 3.8672 | 2.2756 | 8 | 74 | segmentation |
GO:0007350 | 0.002 | 9.0052 | 0.5574 | 4 | 18 | blastoderm segmentation |
GO:0032095 | 0.002 | 9.0052 | 0.5574 | 4 | 18 | regulation of response to food |
GO:0032928 | 0.002 | 9.0052 | 0.5574 | 4 | 18 | regulation of superoxide anion generation |
GO:1905276 | 0.002 | 9.0052 | 0.5574 | 4 | 18 | regulation of epithelial tube formation |
GO:0002376 | 0.0021 | 1.398 | 81.5385 | 106 | 2633 | immune system process |
GO:0001714 | 0.0022 | 15.7352 | 0.2787 | 3 | 9 | endodermal cell fate specification |
GO:0008343 | 0.0022 | 15.7352 | 0.2787 | 3 | 9 | adult feeding behavior |
GO:0014049 | 0.0022 | 15.7352 | 0.2787 | 3 | 9 | positive regulation of glutamate secretion |
GO:0021603 | 0.0022 | 15.7352 | 0.2787 | 3 | 9 | cranial nerve formation |
GO:0046877 | 0.0022 | 15.7352 | 0.2787 | 3 | 9 | regulation of saliva secretion |
GO:0048617 | 0.0022 | 15.7352 | 0.2787 | 3 | 9 | embryonic foregut morphogenesis |
GO:0070472 | 0.0022 | 15.7352 | 0.2787 | 3 | 9 | regulation of uterine smooth muscle contraction |
GO:0009611 | 0.0022 | 1.7881 | 19.4478 | 33 | 628 | response to wounding |
GO:0048701 | 0.0022 | 4.9892 | 1.3626 | 6 | 44 | embryonic cranial skeleton morphogenesis |
GO:0045995 | 0.0023 | 3.7559 | 2.3354 | 8 | 76 | regulation of embryonic development |
GO:0048699 | 0.0023 | 1.5676 | 36.4574 | 54 | 1199 | generation of neurons |
GO:0003215 | 0.0024 | 8.4044 | 0.5884 | 4 | 19 | cardiac right ventricle morphogenesis |
GO:0072079 | 0.0024 | 8.4044 | 0.5884 | 4 | 19 | nephron tubule formation |
GO:0001569 | 0.0024 | 6.0689 | 0.96 | 5 | 31 | branching involved in blood vessel morphogenesis |
GO:0060429 | 0.0025 | 2.1231 | 9.9537 | 20 | 341 | epithelium development |
GO:0019953 | 0.0025 | 1.7008 | 23.5356 | 38 | 760 | sexual reproduction |
GO:0046661 | 0.0026 | 2.7438 | 4.6762 | 12 | 151 | male sex differentiation |
GO:0060541 | 0.0027 | 2.5037 | 5.9458 | 14 | 192 | respiratory system development |
GO:0051705 | 0.0027 | 4.1002 | 1.889 | 7 | 61 | multi-organism behavior |
GO:0021761 | 0.0027 | 3.3169 | 2.942 | 9 | 95 | limbic system development |
GO:0060986 | 0.0028 | 4.7391 | 1.4245 | 6 | 46 | endocrine hormone secretion |
GO:0014707 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0021912 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035880 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0048936 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060741 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | prostate gland stromal morphogenesis |
GO:0060743 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | epithelial cell maturation involved in prostate gland development |
GO:0060913 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | cardiac cell fate determination |
GO:0061010 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | gall bladder development |
GO:0061031 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:1902869 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | regulation of amacrine cell differentiation |
GO:1903237 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | negative regulation of leukocyte tethering or rolling |
GO:1905333 | 0.0028 | 62.8333 | 0.0929 | 2 | 3 | regulation of gastric motility |
GO:0045907 | 0.0028 | 5.8437 | 0.991 | 5 | 32 | positive regulation of vasoconstriction |
GO:0051930 | 0.0028 | 5.8437 | 0.991 | 5 | 32 | regulation of sensory perception of pain |
GO:0060538 | 0.0028 | 2.7152 | 4.7204 | 12 | 153 | skeletal muscle organ development |
GO:1904888 | 0.0029 | 7.9566 | 0.6135 | 4 | 20 | cranial skeletal system development |
GO:0007210 | 0.003 | 7.8786 | 0.6194 | 4 | 20 | serotonin receptor signaling pathway |
GO:0023019 | 0.003 | 7.8786 | 0.6194 | 4 | 20 | signal transduction involved in regulation of gene expression |
GO:0001820 | 0.003 | 13.4865 | 0.3097 | 3 | 10 | serotonin secretion |
GO:0032275 | 0.003 | 13.4865 | 0.3097 | 3 | 10 | luteinizing hormone secretion |
GO:1905205 | 0.003 | 13.4865 | 0.3097 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0046717 | 0.003 | 3.0211 | 3.5613 | 10 | 115 | acid secretion |
GO:0046887 | 0.0032 | 2.9924 | 3.5923 | 10 | 116 | positive regulation of hormone secretion |
GO:0021915 | 0.0032 | 2.6663 | 4.8 | 12 | 155 | neural tube development |
GO:0001662 | 0.0032 | 5.6347 | 1.0219 | 5 | 33 | behavioral fear response |
GO:0003156 | 0.0032 | 5.6347 | 1.0219 | 5 | 33 | regulation of animal organ formation |
GO:0048333 | 0.0032 | 5.6347 | 1.0219 | 5 | 33 | mesodermal cell differentiation |
GO:0021510 | 0.0034 | 5.5592 | 1.0313 | 5 | 34 | spinal cord development |
GO:0098801 | 0.0035 | 7.4565 | 0.6468 | 4 | 21 | regulation of renal system process |
GO:0014821 | 0.0036 | 7.4146 | 0.6503 | 4 | 21 | phasic smooth muscle contraction |
GO:0031290 | 0.0036 | 7.4146 | 0.6503 | 4 | 21 | retinal ganglion cell axon guidance |
GO:0043586 | 0.0036 | 7.4146 | 0.6503 | 4 | 21 | tongue development |
GO:0048485 | 0.0036 | 7.4146 | 0.6503 | 4 | 21 | sympathetic nervous system development |
GO:0007338 | 0.0038 | 2.7492 | 4.2736 | 11 | 138 | single fertilization |
GO:0051248 | 0.0039 | 1.5187 | 38.1834 | 55 | 1233 | negative regulation of protein metabolic process |
GO:0002087 | 0.004 | 11.7999 | 0.3406 | 3 | 11 | regulation of respiratory gaseous exchange by neurological system process |
GO:0003093 | 0.004 | 11.7999 | 0.3406 | 3 | 11 | regulation of glomerular filtration |
GO:0021559 | 0.004 | 11.7999 | 0.3406 | 3 | 11 | trigeminal nerve development |
GO:0048484 | 0.004 | 11.7999 | 0.3406 | 3 | 11 | enteric nervous system development |
GO:0090009 | 0.004 | 11.7999 | 0.3406 | 3 | 11 | primitive streak formation |
GO:1903244 | 0.004 | 11.7999 | 0.3406 | 3 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:2000047 | 0.004 | 11.7999 | 0.3406 | 3 | 11 | regulation of cell-cell adhesion mediated by cadherin |
GO:0007565 | 0.0041 | 2.8827 | 3.7151 | 10 | 121 | female pregnancy |
GO:0048644 | 0.0041 | 3.3762 | 2.5703 | 8 | 83 | muscle organ morphogenesis |
GO:1903530 | 0.0042 | 1.757 | 17.9225 | 30 | 589 | regulation of secretion by cell |
GO:0050795 | 0.0042 | 3.7515 | 2.0439 | 7 | 66 | regulation of behavior |
GO:0007416 | 0.0042 | 2.7063 | 4.3355 | 11 | 140 | synapse assembly |
GO:0035148 | 0.0044 | 2.6853 | 4.3665 | 11 | 141 | tube formation |
GO:0072507 | 0.0046 | 1.8742 | 13.4401 | 24 | 434 | divalent inorganic cation homeostasis |
GO:0033555 | 0.0046 | 3.6888 | 2.0748 | 7 | 67 | multicellular organismal response to stress |
GO:0050764 | 0.0046 | 3.6888 | 2.0748 | 7 | 67 | regulation of phagocytosis |
GO:0003002 | 0.0047 | 5.0762 | 1.1077 | 5 | 39 | regionalization |
GO:0060425 | 0.0047 | 4.2112 | 1.5794 | 6 | 51 | lung morphogenesis |
GO:0048286 | 0.0048 | 5.0884 | 1.1148 | 5 | 36 | lung alveolus development |
GO:0048536 | 0.0048 | 5.0884 | 1.1148 | 5 | 36 | spleen development |
GO:0071392 | 0.0048 | 5.0884 | 1.1148 | 5 | 36 | cellular response to estradiol stimulus |
GO:0071542 | 0.0048 | 5.0884 | 1.1148 | 5 | 36 | dopaminergic neuron differentiation |
GO:0048856 | 0.0049 | 1.9376 | 12.1042 | 22 | 573 | anatomical structure development |
GO:0032368 | 0.005 | 3.0009 | 3.2207 | 9 | 104 | regulation of lipid transport |
GO:0015850 | 0.005 | 2.3176 | 6.3817 | 14 | 208 | organic hydroxy compound transport |
GO:0043043 | 0.0051 | 1.6335 | 23.7524 | 37 | 767 | peptide biosynthetic process |
GO:0051969 | 0.0052 | 10.5512 | 0.3695 | 3 | 12 | regulation of transmission of nerve impulse |
GO:0010454 | 0.0053 | 10.4881 | 0.3716 | 3 | 12 | negative regulation of cell fate commitment |
GO:0032099 | 0.0053 | 10.4881 | 0.3716 | 3 | 12 | negative regulation of appetite |
GO:0035815 | 0.0053 | 10.4881 | 0.3716 | 3 | 12 | positive regulation of renal sodium excretion |
GO:0042659 | 0.0053 | 10.4881 | 0.3716 | 3 | 12 | regulation of cell fate specification |
GO:0070493 | 0.0053 | 10.4881 | 0.3716 | 3 | 12 | thrombin-activated receptor signaling pathway |
GO:0001709 | 0.0053 | 4.949 | 1.1414 | 5 | 37 | cell fate determination |
GO:0032675 | 0.0053 | 2.9695 | 3.2516 | 9 | 105 | regulation of interleukin-6 production |
GO:0006874 | 0.0053 | 1.906 | 12.1085 | 22 | 391 | cellular calcium ion homeostasis |
GO:0007166 | 0.0053 | 1.3539 | 80.3307 | 102 | 2594 | cell surface receptor signaling pathway |
GO:0032611 | 0.0054 | 3.5693 | 2.1368 | 7 | 69 | interleukin-1 beta production |
GO:0006837 | 0.0055 | 31.593 | 0.1232 | 2 | 4 | serotonin transport |
GO:0045924 | 0.0055 | 31.5388 | 0.1234 | 2 | 4 | regulation of female receptivity |
GO:0030072 | 0.0055 | 2.2187 | 7.1264 | 15 | 231 | peptide hormone secretion |
GO:0060993 | 0.0055 | 3.2045 | 2.6942 | 8 | 87 | kidney morphogenesis |
GO:0072080 | 0.0055 | 3.2045 | 2.6942 | 8 | 87 | nephron tubule development |
GO:1902476 | 0.0055 | 3.2045 | 2.6942 | 8 | 87 | chloride transmembrane transport |
GO:0007621 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | negative regulation of female receptivity |
GO:0010701 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | positive regulation of norepinephrine secretion |
GO:0021615 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0021855 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | hypothalamus cell migration |
GO:0021913 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0031394 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0032100 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | positive regulation of appetite |
GO:0032849 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | positive regulation of cellular pH reduction |
GO:0035811 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | negative regulation of urine volume |
GO:0048370 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | lateral mesoderm formation |
GO:0060406 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | positive regulation of penile erection |
GO:0061030 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
GO:0061325 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0070253 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | somatostatin secretion |
GO:0072086 | 0.0055 | 31.4146 | 0.1239 | 2 | 4 | specification of loop of Henle identity |
GO:0065008 | 0.0057 | 1.3441 | 86.1396 | 108 | 2884 | regulation of biological quality |
GO:0048468 | 0.0058 | 1.4114 | 55.4641 | 74 | 1824 | cell development |
GO:0032504 | 0.0058 | 1.6195 | 23.9382 | 37 | 773 | multicellular organism reproduction |
GO:0050796 | 0.0059 | 2.458 | 5.1716 | 12 | 167 | regulation of insulin secretion |
GO:0051048 | 0.0059 | 2.3561 | 5.8311 | 13 | 189 | negative regulation of secretion |
GO:0001975 | 0.0059 | 6.3012 | 0.7432 | 4 | 24 | response to amphetamine |
GO:0021511 | 0.0059 | 6.3012 | 0.7432 | 4 | 24 | spinal cord patterning |
GO:0032104 | 0.0059 | 6.3012 | 0.7432 | 4 | 24 | regulation of response to extracellular stimulus |
GO:0042481 | 0.0059 | 6.3012 | 0.7432 | 4 | 24 | regulation of odontogenesis |
GO:0048593 | 0.006 | 2.9085 | 3.3136 | 9 | 107 | camera-type eye morphogenesis |
GO:0051932 | 0.006 | 4.7794 | 1.1768 | 5 | 38 | synaptic transmission, GABAergic |
GO:0072088 | 0.0063 | 3.4573 | 2.1987 | 7 | 71 | nephron epithelium morphogenesis |
GO:0040011 | 0.0063 | 1.4231 | 50.3848 | 68 | 1627 | locomotion |
GO:0008584 | 0.0065 | 2.686 | 3.9639 | 10 | 128 | male gonad development |
GO:0043433 | 0.0065 | 2.686 | 3.9639 | 10 | 128 | negative regulation of DNA binding transcription factor activity |
GO:0072593 | 0.0066 | 2.169 | 7.2775 | 15 | 235 | reactive oxygen species metabolic process |
GO:0007596 | 0.0066 | 1.9675 | 10.1265 | 19 | 327 | blood coagulation |
GO:0010745 | 0.0067 | 9.4387 | 0.4026 | 3 | 13 | negative regulation of macrophage derived foam cell differentiation |
GO:0060456 | 0.0067 | 9.4387 | 0.4026 | 3 | 13 | positive regulation of digestive system process |
GO:0090179 | 0.0067 | 9.4387 | 0.4026 | 3 | 13 | planar cell polarity pathway involved in neural tube closure |
GO:0003197 | 0.0067 | 4.6385 | 1.2077 | 5 | 39 | endocardial cushion development |
GO:0010470 | 0.0067 | 4.6385 | 1.2077 | 5 | 39 | regulation of gastrulation |
GO:0007610 | 0.0067 | 2.1035 | 7.9904 | 16 | 271 | behavior |
GO:0001945 | 0.0069 | 6.0008 | 0.7742 | 4 | 25 | lymph vessel development |
GO:0045730 | 0.0069 | 6.0008 | 0.7742 | 4 | 25 | respiratory burst |
GO:0001706 | 0.0069 | 3.8664 | 1.7032 | 6 | 55 | endoderm formation |
GO:0048857 | 0.0069 | 3.8664 | 1.7032 | 6 | 55 | neural nucleus development |
GO:0007188 | 0.007 | 2.5099 | 4.6452 | 11 | 150 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0032355 | 0.0073 | 3.0379 | 2.8266 | 8 | 92 | response to estradiol |
GO:0061333 | 0.0073 | 3.3521 | 2.2607 | 7 | 73 | renal tubule morphogenesis |
GO:0051960 | 0.0074 | 1.6019 | 23.5046 | 36 | 759 | regulation of nervous system development |
GO:0048523 | 0.0075 | 1.3048 | 109.3253 | 132 | 3740 | negative regulation of cellular process |
GO:0014014 | 0.0075 | 4.5057 | 1.2387 | 5 | 40 | negative regulation of gliogenesis |
GO:0007187 | 0.0076 | 5.8064 | 0.7947 | 4 | 26 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0007156 | 0.0077 | 2.474 | 4.7071 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0072006 | 0.008 | 2.5972 | 4.0878 | 10 | 132 | nephron development |
GO:1903706 | 0.008 | 2.0114 | 8.8586 | 17 | 295 | regulation of hemopoiesis |
GO:0001657 | 0.0082 | 2.9771 | 2.88 | 8 | 93 | ureteric bud development |
GO:0014744 | 0.0083 | 8.5801 | 0.4336 | 3 | 14 | positive regulation of muscle adaptation |
GO:0032108 | 0.0083 | 8.5801 | 0.4336 | 3 | 14 | negative regulation of response to nutrient levels |
GO:1904994 | 0.0083 | 8.5801 | 0.4336 | 3 | 14 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0007548 | 0.0084 | 5.6116 | 0.8171 | 4 | 27 | sex differentiation |
GO:0007586 | 0.0085 | 2.4391 | 4.7691 | 11 | 154 | digestion |
GO:0072163 | 0.0087 | 2.9423 | 2.911 | 8 | 94 | mesonephric epithelium development |
GO:0060135 | 0.0089 | 3.6427 | 1.7961 | 6 | 58 | maternal process involved in female pregnancy |
GO:0031960 | 0.0089 | 2.422 | 4.8 | 11 | 155 | response to corticosteroid |
GO:0043084 | 0.0089 | 21.0245 | 0.1543 | 2 | 5 | penile erection |
GO:0002074 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | extraocular skeletal muscle development |
GO:0003150 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | muscular septum morphogenesis |
GO:0010040 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | response to iron(II) ion |
GO:0014060 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | regulation of epinephrine secretion |
GO:0034137 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | positive regulation of toll-like receptor 2 signaling pathway |
GO:0035609 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | C-terminal protein deglutamylation |
GO:0048880 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | sensory system development |
GO:0060012 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | synaptic transmission, glycinergic |
GO:0060455 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0061009 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | common bile duct development |
GO:0090296 | 0.009 | 20.9417 | 0.1548 | 2 | 5 | regulation of mitochondrial DNA replication |
GO:0051955 | 0.0091 | 5.4783 | 0.8361 | 4 | 27 | regulation of amino acid transport |
GO:0060706 | 0.0091 | 5.4783 | 0.8361 | 4 | 27 | cell differentiation involved in embryonic placenta development |
GO:0072358 | 0.0094 | 1.6325 | 19.8195 | 31 | 640 | cardiovascular system development |
GO:0007204 | 0.0095 | 2.0198 | 8.2994 | 16 | 268 | positive regulation of cytosolic calcium ion concentration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0034654 | 0 | 2.92 | 143.2386 | 275 | 4037 | nucleobase-containing compound biosynthetic process |
GO:2001141 | 0 | 3.1629 | 72.4622 | 166 | 2311 | regulation of RNA biosynthetic process |
GO:0009952 | 0 | 14.624 | 3.9902 | 38 | 116 | anterior/posterior pattern specification |
GO:0034645 | 0 | 2.5325 | 172.0495 | 292 | 4849 | cellular macromolecule biosynthetic process |
GO:0045944 | 0 | 3.7614 | 37.5748 | 112 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:1903508 | 0 | 3.3604 | 48.2193 | 128 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0051254 | 0 | 3.1959 | 50.7385 | 129 | 1430 | positive regulation of RNA metabolic process |
GO:0010557 | 0 | 3.0058 | 56.3091 | 135 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0019219 | 0 | 2.7877 | 82.806 | 170 | 2635 | regulation of nucleobase-containing compound metabolic process |
GO:0009889 | 0 | 2.7825 | 83.4513 | 170 | 2671 | regulation of biosynthetic process |
GO:0031328 | 0 | 2.8696 | 61.0636 | 140 | 1721 | positive regulation of cellular biosynthetic process |
GO:0010628 | 0 | 2.8257 | 61.8442 | 140 | 1743 | positive regulation of gene expression |
GO:1901576 | 0 | 2.2123 | 213.4919 | 320 | 6017 | organic substance biosynthetic process |
GO:0060255 | 0 | 2.5197 | 103.6687 | 188 | 3189 | regulation of macromolecule metabolic process |
GO:0097659 | 0 | 2.696 | 66.6574 | 139 | 2221 | nucleic acid-templated transcription |
GO:1902679 | 0 | 3.056 | 39.8102 | 101 | 1122 | negative regulation of RNA biosynthetic process |
GO:0000122 | 0 | 3.4265 | 26.7175 | 77 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048704 | 0 | 27.0848 | 1.2894 | 18 | 37 | embryonic skeletal system morphogenesis |
GO:0046483 | 0 | 2.0099 | 200.4347 | 293 | 5649 | heterocycle metabolic process |
GO:1901360 | 0 | 2.0052 | 209.0212 | 302 | 5891 | organic cyclic compound metabolic process |
GO:0006725 | 0 | 2.004 | 201.712 | 294 | 5685 | cellular aromatic compound metabolic process |
GO:0045934 | 0 | 2.6617 | 47.758 | 107 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0060173 | 0 | 6.9425 | 5.9964 | 33 | 169 | limb development |
GO:0032502 | 0 | 2.2625 | 107.9968 | 181 | 3592 | developmental process |
GO:0035107 | 0 | 7.4323 | 5.1448 | 30 | 145 | appendage morphogenesis |
GO:0009890 | 0 | 2.478 | 56.0962 | 117 | 1581 | negative regulation of biosynthetic process |
GO:0034641 | 0 | 1.9052 | 220.2688 | 307 | 6208 | cellular nitrogen compound metabolic process |
GO:0051173 | 0 | 2.0713 | 99.0642 | 169 | 2792 | positive regulation of nitrogen compound metabolic process |
GO:0060485 | 0 | 5.4285 | 6.3984 | 29 | 183 | mesenchyme development |
GO:0009954 | 0 | 23.9098 | 0.9179 | 12 | 26 | proximal/distal pattern formation |
GO:0022414 | 0 | 2.5327 | 34.2805 | 76 | 983 | reproductive process |
GO:0006355 | 0 | 2.6968 | 30.0853 | 69 | 1117 | regulation of transcription, DNA-templated |
GO:0048608 | 0 | 3.6017 | 13.0371 | 41 | 372 | reproductive structure development |
GO:0016070 | 0 | 1.9774 | 88.7059 | 144 | 2948 | RNA metabolic process |
GO:0048729 | 0 | 3.1559 | 16.8979 | 47 | 491 | tissue morphogenesis |
GO:0065007 | 0 | 1.8904 | 393.844 | 458 | 11100 | biological regulation |
GO:0001568 | 0 | 2.829 | 21.5372 | 54 | 607 | blood vessel development |
GO:0072358 | 0 | 2.7232 | 22.7081 | 55 | 640 | cardiovascular system development |
GO:0021953 | 0 | 6.7839 | 3.4462 | 19 | 99 | central nervous system neuron differentiation |
GO:0060322 | 0 | 2.7312 | 22.2183 | 54 | 631 | head development |
GO:0021515 | 0 | 10.5212 | 1.8096 | 14 | 51 | cell differentiation in spinal cord |
GO:0021517 | 0 | 12.033 | 1.5257 | 13 | 43 | ventral spinal cord development |
GO:0010467 | 0 | 1.8802 | 101.0289 | 155 | 3370 | gene expression |
GO:0007218 | 0 | 6.6169 | 3.3353 | 18 | 94 | neuropeptide signaling pathway |
GO:0030855 | 0 | 2.5511 | 24.9789 | 57 | 704 | epithelial cell differentiation |
GO:0007498 | 0 | 5.6562 | 4.2223 | 20 | 119 | mesoderm development |
GO:0048935 | 0 | 64.4369 | 0.3536 | 7 | 10 | peripheral nervous system neuron development |
GO:0009887 | 0 | 3.5777 | 10.1053 | 32 | 321 | animal organ morphogenesis |
GO:0030326 | 0 | 13.5643 | 1.1791 | 11 | 34 | embryonic limb morphogenesis |
GO:0007267 | 0 | 2.5662 | 22.6342 | 52 | 672 | cell-cell signaling |
GO:0007399 | 0 | 3.6153 | 9.3896 | 30 | 304 | nervous system development |
GO:0009953 | 0 | 6.0772 | 3.3707 | 17 | 95 | dorsal/ventral pattern formation |
GO:0007275 | 0 | 1.9316 | 66.3243 | 108 | 2439 | multicellular organism development |
GO:0072080 | 0 | 6.275 | 3.0869 | 16 | 87 | nephron tubule development |
GO:0030878 | 0 | 16.5576 | 0.8516 | 9 | 24 | thyroid gland development |
GO:0048598 | 0 | 8.5964 | 1.7593 | 12 | 56 | embryonic morphogenesis |
GO:0060429 | 0 | 3.2823 | 10.2119 | 30 | 313 | epithelium development |
GO:0001657 | 0 | 5.7838 | 3.2998 | 16 | 93 | ureteric bud development |
GO:0072088 | 0 | 6.8207 | 2.5192 | 14 | 71 | nephron epithelium morphogenesis |
GO:0022008 | 0 | 2.3292 | 25.6425 | 54 | 752 | neurogenesis |
GO:0072163 | 0 | 5.7093 | 3.3353 | 16 | 94 | mesonephric epithelium development |
GO:0048665 | 0 | 18.6291 | 0.7002 | 8 | 20 | neuron fate specification |
GO:0061333 | 0 | 6.5886 | 2.5901 | 14 | 73 | renal tubule morphogenesis |
GO:0060537 | 0 | 3.5146 | 8.2969 | 26 | 237 | muscle tissue development |
GO:0045137 | 0 | 3.7407 | 7.2382 | 24 | 204 | development of primary sexual characteristics |
GO:0014031 | 0 | 7.0686 | 2.2708 | 13 | 64 | mesenchymal cell development |
GO:0001892 | 0 | 5.8722 | 3.0514 | 15 | 86 | embryonic placenta development |
GO:0021520 | 0 | 41.3468 | 0.3536 | 6 | 10 | spinal cord motor neuron cell fate specification |
GO:0003151 | 0 | 8.792 | 1.6148 | 11 | 46 | outflow tract morphogenesis |
GO:0007156 | 0 | 4.233 | 5.3932 | 20 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0060415 | 0 | 6.1687 | 2.7321 | 14 | 77 | muscle tissue morphogenesis |
GO:0048565 | 0 | 4.6037 | 4.5061 | 18 | 127 | digestive tract development |
GO:0048732 | 0 | 3.0378 | 10.9338 | 30 | 317 | gland development |
GO:0001501 | 0 | 3.5591 | 7.2135 | 23 | 219 | skeletal system development |
GO:0003206 | 0 | 5.6095 | 2.9504 | 14 | 84 | cardiac chamber morphogenesis |
GO:0007517 | 0 | 3.3298 | 8.0113 | 24 | 230 | muscle organ development |
GO:0070848 | 0 | 2.2551 | 22.7436 | 47 | 641 | response to growth factor |
GO:0014033 | 0 | 6.4097 | 2.2634 | 12 | 64 | neural crest cell differentiation |
GO:0060993 | 0 | 5.3202 | 3.0869 | 14 | 87 | kidney morphogenesis |
GO:0048864 | 0 | 6.3874 | 2.2708 | 12 | 64 | stem cell development |
GO:0090596 | 0 | 3.1767 | 8.3544 | 24 | 237 | sensory organ morphogenesis |
GO:0060021 | 0 | 5.0425 | 3.2288 | 14 | 91 | palate development |
GO:0003231 | 0 | 4.3591 | 4.1868 | 16 | 118 | cardiac ventricle development |
GO:0001755 | 0 | 8.8627 | 1.3128 | 9 | 37 | neural crest cell migration |
GO:2000026 | 0 | 1.9076 | 38.4451 | 67 | 1152 | regulation of multicellular organismal development |
GO:0010605 | 0 | 1.6054 | 90.1229 | 130 | 2540 | negative regulation of macromolecule metabolic process |
GO:0001756 | 0 | 6.3553 | 2.0865 | 11 | 59 | somitogenesis |
GO:0009798 | 0 | 5.1436 | 2.945 | 13 | 83 | axis specification |
GO:0048870 | 0 | 1.7811 | 49.674 | 81 | 1400 | cell motility |
GO:0045995 | 0 | 4.3511 | 3.9255 | 15 | 111 | regulation of embryonic development |
GO:0060688 | 0 | 6.9002 | 1.7741 | 10 | 50 | regulation of morphogenesis of a branching structure |
GO:0001525 | 0 | 2.7609 | 10.6855 | 27 | 305 | angiogenesis |
GO:0007369 | 0 | 3.476 | 6.0739 | 19 | 172 | gastrulation |
GO:0035115 | 0 | 9.1768 | 1.1354 | 8 | 32 | embryonic forelimb morphogenesis |
GO:0042755 | 0 | 9.1768 | 1.1354 | 8 | 32 | eating behavior |
GO:0061217 | 0 | 11.321 | 0.8516 | 7 | 24 | regulation of mesonephros development |
GO:0045597 | 0 | 1.9636 | 29.7487 | 54 | 845 | positive regulation of cell differentiation |
GO:0048645 | 0 | 6.3045 | 1.9064 | 10 | 54 | animal organ formation |
GO:0008284 | 0 | 1.9739 | 28.4657 | 52 | 808 | positive regulation of cell proliferation |
GO:0023061 | 0 | 2.4186 | 14.3345 | 32 | 404 | signal release |
GO:0009111 | 0 | 22.8461 | 0.3903 | 5 | 11 | vitamin catabolic process |
GO:0060573 | 0 | 22.8461 | 0.3903 | 5 | 11 | cell fate specification involved in pattern specification |
GO:0003278 | 0 | 54.7473 | 0.2129 | 4 | 6 | apoptotic process involved in heart morphogenesis |
GO:0021546 | 0 | 54.7473 | 0.2129 | 4 | 6 | rhombomere development |
GO:0086073 | 0 | 54.7473 | 0.2129 | 4 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0001838 | 0 | 3.9619 | 4.2578 | 15 | 120 | embryonic epithelial tube formation |
GO:0007268 | 0 | 2.1347 | 20.7212 | 41 | 584 | chemical synaptic transmission |
GO:0046661 | 0 | 3.5245 | 5.3577 | 17 | 151 | male sex differentiation |
GO:0099537 | 0 | 2.1266 | 20.7921 | 41 | 586 | trans-synaptic signaling |
GO:0098609 | 0 | 1.968 | 27.3917 | 50 | 772 | cell-cell adhesion |
GO:0008585 | 0 | 4.3874 | 3.3707 | 13 | 95 | female gonad development |
GO:0021761 | 0 | 4.3874 | 3.3707 | 13 | 95 | limbic system development |
GO:0044238 | 0 | 1.4468 | 350.805 | 396 | 9887 | primary metabolic process |
GO:0050767 | 0 | 2.0298 | 23.879 | 45 | 673 | regulation of neurogenesis |
GO:0071542 | 0 | 12.7504 | 0.6701 | 6 | 19 | dopaminergic neuron differentiation |
GO:0048562 | 0 | 3.5893 | 4.9393 | 16 | 148 | embryonic organ morphogenesis |
GO:0090184 | 0 | 7.5921 | 1.3128 | 8 | 37 | positive regulation of kidney development |
GO:0035148 | 0 | 3.5517 | 5.0029 | 16 | 141 | tube formation |
GO:0035050 | 0 | 4.9793 | 2.5547 | 11 | 72 | embryonic heart tube development |
GO:0014707 | 0 | Inf | 0.1064 | 3 | 3 | branchiomeric skeletal muscle development |
GO:0046660 | 0 | 3.9163 | 4.0094 | 14 | 113 | female sex differentiation |
GO:0003002 | 0 | 7.1825 | 1.3445 | 8 | 43 | regionalization |
GO:0060017 | 1e-04 | 36.4958 | 0.2484 | 4 | 7 | parathyroid gland development |
GO:0048485 | 1e-04 | 10.9793 | 0.7451 | 6 | 21 | sympathetic nervous system development |
GO:0072210 | 1e-04 | 6.879 | 1.4193 | 8 | 40 | metanephric nephron development |
GO:0009914 | 1e-04 | 2.5487 | 10.609 | 25 | 299 | hormone transport |
GO:0019098 | 1e-04 | 8.3644 | 1.0644 | 7 | 30 | reproductive behavior |
GO:0009719 | 1e-04 | 1.6632 | 50.632 | 78 | 1427 | response to endogenous stimulus |
GO:0007492 | 1e-04 | 4.5316 | 2.7676 | 11 | 78 | endoderm development |
GO:0051094 | 1e-04 | 2.5451 | 10.1872 | 24 | 307 | positive regulation of developmental process |
GO:0048468 | 1e-04 | 1.9193 | 25.786 | 46 | 781 | cell development |
GO:0051090 | 1e-04 | 2.3312 | 12.9152 | 28 | 364 | regulation of DNA binding transcription factor activity |
GO:0021602 | 1e-04 | 9.7379 | 0.812 | 6 | 23 | cranial nerve morphogenesis |
GO:0001707 | 1e-04 | 4.8537 | 2.3695 | 10 | 67 | mesoderm formation |
GO:0007417 | 1e-04 | 1.9571 | 22.986 | 42 | 683 | central nervous system development |
GO:0060579 | 1e-04 | 13.7041 | 0.5322 | 5 | 15 | ventral spinal cord interneuron fate commitment |
GO:0043583 | 1e-04 | 2.8541 | 7.2382 | 19 | 204 | ear development |
GO:0050794 | 1e-04 | 1.6461 | 76.7643 | 104 | 2813 | regulation of cellular process |
GO:0051961 | 1e-04 | 2.6073 | 9.1187 | 22 | 257 | negative regulation of nervous system development |
GO:0048701 | 1e-04 | 6.1131 | 1.5612 | 8 | 44 | embryonic cranial skeleton morphogenesis |
GO:0010721 | 1e-04 | 2.5336 | 9.7929 | 23 | 276 | negative regulation of cell development |
GO:0043009 | 1e-04 | 2.7361 | 7.9033 | 20 | 243 | chordate embryonic development |
GO:0051240 | 1e-04 | 1.6412 | 49.179 | 75 | 1409 | positive regulation of multicellular organismal process |
GO:0042475 | 1e-04 | 4.2752 | 2.9095 | 11 | 82 | odontogenesis of dentin-containing tooth |
GO:0048522 | 2e-04 | 1.4703 | 105.5353 | 139 | 3257 | positive regulation of cellular process |
GO:0007422 | 2e-04 | 4.5941 | 2.4837 | 10 | 70 | peripheral nervous system development |
GO:0043587 | 2e-04 | 21.8947 | 0.3193 | 4 | 9 | tongue morphogenesis |
GO:0072048 | 2e-04 | 21.8947 | 0.3193 | 4 | 9 | renal system pattern specification |
GO:0072172 | 2e-04 | 21.8947 | 0.3193 | 4 | 9 | mesonephric tubule formation |
GO:0001992 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0021615 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | glossopharyngeal nerve morphogenesis |
GO:0021913 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0034287 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | detection of monosaccharide stimulus |
GO:0034653 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | retinoic acid catabolic process |
GO:0051594 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | detection of glucose |
GO:0072268 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | pattern specification involved in metanephros development |
GO:0090191 | 2e-04 | 81.9805 | 0.1419 | 3 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0008584 | 2e-04 | 3.3977 | 4.5416 | 14 | 128 | male gonad development |
GO:0033993 | 2e-04 | 1.7902 | 31.0463 | 52 | 875 | response to lipid |
GO:0072132 | 2e-04 | 5.7906 | 1.6321 | 8 | 46 | mesenchyme morphogenesis |
GO:0001945 | 2e-04 | 8.6656 | 0.887 | 6 | 25 | lymph vessel development |
GO:0060037 | 2e-04 | 8.6656 | 0.887 | 6 | 25 | pharyngeal system development |
GO:0007631 | 2e-04 | 4.9457 | 2.0933 | 9 | 60 | feeding behavior |
GO:0007565 | 2e-04 | 2.91 | 6.3512 | 17 | 179 | female pregnancy |
GO:0072001 | 2e-04 | 2.5652 | 8.8219 | 21 | 251 | renal system development |
GO:0009790 | 2e-04 | 2.4408 | 10.11 | 23 | 331 | embryo development |
GO:0048536 | 2e-04 | 6.6312 | 1.2773 | 7 | 36 | spleen development |
GO:0071392 | 2e-04 | 6.6312 | 1.2773 | 7 | 36 | cellular response to estradiol stimulus |
GO:0090185 | 2e-04 | 11.4186 | 0.6032 | 5 | 17 | negative regulation of kidney development |
GO:0090190 | 2e-04 | 11.4186 | 0.6032 | 5 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:2000738 | 2e-04 | 11.4186 | 0.6032 | 5 | 17 | positive regulation of stem cell differentiation |
GO:0055010 | 3e-04 | 5.5004 | 1.7031 | 8 | 48 | ventricular cardiac muscle tissue morphogenesis |
GO:0007507 | 3e-04 | 2.5275 | 8.939 | 21 | 259 | heart development |
GO:0019233 | 3e-04 | 4.7994 | 2.1496 | 9 | 61 | sensory perception of pain |
GO:0001764 | 3e-04 | 3.2538 | 4.719 | 14 | 133 | neuron migration |
GO:0032275 | 3e-04 | 18.2444 | 0.3548 | 4 | 10 | luteinizing hormone secretion |
GO:0042127 | 3e-04 | 2.9537 | 5.8816 | 16 | 180 | regulation of cell proliferation |
GO:0031018 | 3e-04 | 10.6191 | 0.6341 | 5 | 18 | endocrine pancreas development |
GO:0042698 | 3e-04 | 3.6008 | 3.6901 | 12 | 104 | ovulation cycle |
GO:1905276 | 3e-04 | 10.5396 | 0.6387 | 5 | 18 | regulation of epithelial tube formation |
GO:0007618 | 3e-04 | 6.2026 | 1.3483 | 7 | 38 | mating |
GO:2000027 | 4e-04 | 2.689 | 7.2253 | 18 | 205 | regulation of organ morphogenesis |
GO:0035116 | 4e-04 | 7.4825 | 0.9935 | 6 | 28 | embryonic hindlimb morphogenesis |
GO:0071310 | 4e-04 | 1.4646 | 82.6718 | 112 | 2330 | cellular response to organic substance |
GO:0048523 | 4e-04 | 1.4037 | 123.6629 | 157 | 3615 | negative regulation of cellular process |
GO:0045595 | 4e-04 | 1.8137 | 25.8725 | 44 | 770 | regulation of cell differentiation |
GO:0048880 | 4e-04 | 40.9876 | 0.1774 | 3 | 5 | sensory system development |
GO:0060431 | 4e-04 | 40.9876 | 0.1774 | 3 | 5 | primary lung bud formation |
GO:0072047 | 4e-04 | 40.9876 | 0.1774 | 3 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0060525 | 4e-04 | 15.637 | 0.3903 | 4 | 11 | prostate glandular acinus development |
GO:0090009 | 4e-04 | 15.637 | 0.3903 | 4 | 11 | primitive streak formation |
GO:0007530 | 4e-04 | 9.7861 | 0.6741 | 5 | 19 | sex determination |
GO:0009799 | 4e-04 | 3.2646 | 4.3642 | 13 | 123 | specification of symmetry |
GO:0072171 | 4e-04 | 5.0335 | 1.833 | 8 | 52 | mesonephric tubule morphogenesis |
GO:0002062 | 4e-04 | 3.6991 | 3.2998 | 11 | 93 | chondrocyte differentiation |
GO:0030154 | 4e-04 | 1.9186 | 20.7374 | 37 | 723 | cell differentiation |
GO:0010469 | 5e-04 | 1.9423 | 19.16 | 35 | 540 | regulation of receptor activity |
GO:0021983 | 5e-04 | 5.8259 | 1.4193 | 7 | 40 | pituitary gland development |
GO:0035914 | 5e-04 | 4.3454 | 2.3418 | 9 | 66 | skeletal muscle cell differentiation |
GO:0045892 | 5e-04 | 2.2777 | 10.778 | 23 | 335 | negative regulation of transcription, DNA-templated |
GO:0002520 | 6e-04 | 1.7102 | 31.0463 | 50 | 875 | immune system development |
GO:0048646 | 6e-04 | 2.2603 | 10.8531 | 23 | 334 | anatomical structure formation involved in morphogenesis |
GO:0060850 | 6e-04 | 13.754 | 0.4236 | 4 | 12 | regulation of transcription involved in cell fate commitment |
GO:0002070 | 6e-04 | 13.7295 | 0.4244 | 4 | 12 | epithelial cell maturation |
GO:0010454 | 6e-04 | 13.6815 | 0.4258 | 4 | 12 | negative regulation of cell fate commitment |
GO:0060272 | 6e-04 | 13.6815 | 0.4258 | 4 | 12 | embryonic skeletal joint morphogenesis |
GO:0060536 | 6e-04 | 13.6815 | 0.4258 | 4 | 12 | cartilage morphogenesis |
GO:0060707 | 6e-04 | 13.6815 | 0.4258 | 4 | 12 | trophoblast giant cell differentiation |
GO:0007368 | 7e-04 | 3.278 | 4.0094 | 12 | 113 | determination of left/right symmetry |
GO:0030509 | 7e-04 | 2.9309 | 5.1803 | 14 | 146 | BMP signaling pathway |
GO:0031290 | 7e-04 | 8.5617 | 0.7451 | 5 | 21 | retinal ganglion cell axon guidance |
GO:0045844 | 7e-04 | 4.1273 | 2.4482 | 9 | 69 | positive regulation of striated muscle tissue development |
GO:0043069 | 8e-04 | 1.7143 | 29.0593 | 47 | 819 | negative regulation of programmed cell death |
GO:0030182 | 8e-04 | 3.0209 | 4.6643 | 13 | 142 | neuron differentiation |
GO:0016115 | 8e-04 | 27.3233 | 0.2129 | 3 | 6 | terpenoid catabolic process |
GO:0032109 | 8e-04 | 27.3233 | 0.2129 | 3 | 6 | positive regulation of response to nutrient levels |
GO:0046137 | 8e-04 | 27.3233 | 0.2129 | 3 | 6 | negative regulation of vitamin metabolic process |
GO:0060527 | 8e-04 | 27.3233 | 0.2129 | 3 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0001967 | 9e-04 | 12.1605 | 0.4613 | 4 | 13 | suckling behavior |
GO:0061548 | 9e-04 | 12.1605 | 0.4613 | 4 | 13 | ganglion development |
GO:0045665 | 9e-04 | 2.6352 | 6.5286 | 16 | 184 | negative regulation of neuron differentiation |
GO:0001837 | 0.001 | 3.927 | 2.5535 | 9 | 73 | epithelial to mesenchymal transition |
GO:0048513 | 0.001 | 1.5835 | 43.5044 | 64 | 1528 | animal organ development |
GO:0001503 | 0.001 | 2.0953 | 12.6669 | 25 | 357 | ossification |
GO:0060349 | 0.001 | 3.5759 | 3.0869 | 10 | 87 | bone morphogenesis |
GO:0030900 | 0.001 | 2.5096 | 7.2519 | 17 | 210 | forebrain development |
GO:0007389 | 0.001 | 7.5858 | 0.7983 | 5 | 26 | pattern specification process |
GO:0060562 | 0.0011 | 2.9035 | 4.8373 | 13 | 142 | epithelial tube morphogenesis |
GO:1901342 | 0.0012 | 2.2329 | 10.0058 | 21 | 282 | regulation of vasculature development |
GO:0042733 | 0.0012 | 4.2427 | 2.1218 | 8 | 60 | embryonic digit morphogenesis |
GO:0003214 | 0.0012 | 10.9438 | 0.4967 | 4 | 14 | cardiac left ventricle morphogenesis |
GO:0042362 | 0.0012 | 10.9438 | 0.4967 | 4 | 14 | fat-soluble vitamin biosynthetic process |
GO:0007611 | 0.0012 | 2.3969 | 8.0188 | 18 | 226 | learning or memory |
GO:0048486 | 0.0012 | Inf | 0.0705 | 2 | 2 | parasympathetic nervous system development |
GO:0002067 | 0.0013 | 4.8042 | 1.6676 | 7 | 47 | glandular epithelial cell differentiation |
GO:0021915 | 0.0013 | 2.7422 | 5.4996 | 14 | 155 | neural tube development |
GO:0003165 | 0.0013 | Inf | 0.071 | 2 | 2 | Purkinje myocyte development |
GO:0007493 | 0.0013 | Inf | 0.071 | 2 | 2 | endodermal cell fate determination |
GO:0021560 | 0.0013 | Inf | 0.071 | 2 | 2 | abducens nerve development |
GO:0021599 | 0.0013 | Inf | 0.071 | 2 | 2 | abducens nerve formation |
GO:0022601 | 0.0013 | Inf | 0.071 | 2 | 2 | menstrual cycle phase |
GO:0038060 | 0.0013 | Inf | 0.071 | 2 | 2 | nitric oxide-cGMP-mediated signaling pathway |
GO:0060932 | 0.0013 | Inf | 0.071 | 2 | 2 | His-Purkinje system cell differentiation |
GO:0061032 | 0.0013 | Inf | 0.071 | 2 | 2 | visceral serous pericardium development |
GO:0061379 | 0.0013 | Inf | 0.071 | 2 | 2 | inferior colliculus development |
GO:0072166 | 0.0013 | Inf | 0.071 | 2 | 2 | posterior mesonephric tubule development |
GO:1902257 | 0.0013 | Inf | 0.071 | 2 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
GO:2000041 | 0.0013 | Inf | 0.071 | 2 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:2001037 | 0.0013 | Inf | 0.071 | 2 | 2 | positive regulation of tongue muscle cell differentiation |
GO:0021511 | 0.0013 | 7.2085 | 0.8516 | 5 | 24 | spinal cord patterning |
GO:0043269 | 0.0014 | 1.795 | 21.1824 | 36 | 597 | regulation of ion transport |
GO:0060430 | 0.0014 | 20.4911 | 0.2484 | 3 | 7 | lung saccule development |
GO:0098700 | 0.0014 | 20.4911 | 0.2484 | 3 | 7 | neurotransmitter loading into synaptic vesicle |
GO:1902866 | 0.0014 | 20.4911 | 0.2484 | 3 | 7 | regulation of retina development in camera-type eye |
GO:0050885 | 0.0014 | 4.6867 | 1.7031 | 7 | 48 | neuromuscular process controlling balance |
GO:0035239 | 0.0015 | 6.9254 | 0.871 | 5 | 26 | tube morphogenesis |
GO:0045165 | 0.0015 | 3.1253 | 3.819 | 11 | 114 | cell fate commitment |
GO:0001759 | 0.0015 | 9.9831 | 0.5304 | 4 | 15 | organ induction |
GO:0007379 | 0.0016 | 9.9482 | 0.5322 | 4 | 15 | segment specification |
GO:0008595 | 0.0016 | 9.9482 | 0.5322 | 4 | 15 | anterior/posterior axis specification, embryo |
GO:0014048 | 0.0016 | 9.9482 | 0.5322 | 4 | 15 | regulation of glutamate secretion |
GO:0015671 | 0.0016 | 9.9482 | 0.5322 | 4 | 15 | oxygen transport |
GO:0021783 | 0.0016 | 9.9482 | 0.5322 | 4 | 15 | preganglionic parasympathetic fiber development |
GO:0072075 | 0.0016 | 9.9482 | 0.5322 | 4 | 15 | metanephric mesenchyme development |
GO:0032890 | 0.0016 | 6.8882 | 0.882 | 5 | 25 | regulation of organic acid transport |
GO:0048641 | 0.0016 | 4.5748 | 1.7386 | 7 | 49 | regulation of skeletal muscle tissue development |
GO:0003148 | 0.0016 | 6.8476 | 0.887 | 5 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0016 | 6.8476 | 0.887 | 5 | 25 | type B pancreatic cell differentiation |
GO:0060571 | 0.0016 | 6.8476 | 0.887 | 5 | 25 | morphogenesis of an epithelial fold |
GO:0048844 | 0.0017 | 3.9964 | 2.2353 | 8 | 63 | artery morphogenesis |
GO:0048754 | 0.0017 | 3.961 | 2.248 | 8 | 65 | branching morphogenesis of an epithelial tube |
GO:1901861 | 0.0019 | 2.8763 | 4.5061 | 12 | 127 | regulation of muscle tissue development |
GO:0061180 | 0.002 | 3.8556 | 2.3063 | 8 | 65 | mammary gland epithelium development |
GO:0019935 | 0.0021 | 2.9995 | 3.9739 | 11 | 112 | cyclic-nucleotide-mediated signaling |
GO:0035137 | 0.0021 | 16.5447 | 0.2813 | 3 | 8 | hindlimb morphogenesis |
GO:0010002 | 0.0021 | 16.4711 | 0.2825 | 3 | 8 | cardioblast differentiation |
GO:0001654 | 0.0022 | 2.0331 | 11.9572 | 23 | 337 | eye development |
GO:0002158 | 0.0022 | 16.3918 | 0.2839 | 3 | 8 | osteoclast proliferation |
GO:0003310 | 0.0022 | 16.3918 | 0.2839 | 3 | 8 | pancreatic A cell differentiation |
GO:0048743 | 0.0022 | 16.3918 | 0.2839 | 3 | 8 | positive regulation of skeletal muscle fiber development |
GO:0060539 | 0.0022 | 16.3918 | 0.2839 | 3 | 8 | diaphragm development |
GO:0048706 | 0.0022 | 6.2642 | 0.9463 | 5 | 28 | embryonic skeletal system development |
GO:0048634 | 0.0023 | 2.8027 | 4.6126 | 12 | 130 | regulation of muscle organ development |
GO:0003279 | 0.0023 | 3.1628 | 3.4417 | 10 | 97 | cardiac septum development |
GO:0022610 | 0.0023 | 1.5006 | 46.4807 | 66 | 1310 | biological adhesion |
GO:0008285 | 0.0023 | 1.7083 | 23.4178 | 38 | 660 | negative regulation of cell proliferation |
GO:0006357 | 0.0023 | 2.3018 | 7.832 | 17 | 275 | regulation of transcription from RNA polymerase II promoter |
GO:0042249 | 0.0026 | 8.4166 | 0.6032 | 4 | 17 | establishment of planar polarity of embryonic epithelium |
GO:0061377 | 0.0026 | 8.4166 | 0.6032 | 4 | 17 | mammary gland lobule development |
GO:0098911 | 0.0026 | 8.4166 | 0.6032 | 4 | 17 | regulation of ventricular cardiac muscle cell action potential |
GO:1904948 | 0.0026 | 8.4166 | 0.6032 | 4 | 17 | midbrain dopaminergic neuron differentiation |
GO:0030901 | 0.0026 | 3.6854 | 2.3982 | 8 | 68 | midbrain development |
GO:0010646 | 0.0027 | 1.332 | 113.86 | 141 | 3209 | regulation of cell communication |
GO:0002053 | 0.0028 | 5.9533 | 0.9935 | 5 | 28 | positive regulation of mesenchymal cell proliferation |
GO:0010719 | 0.0028 | 5.9533 | 0.9935 | 5 | 28 | negative regulation of epithelial to mesenchymal transition |
GO:0048638 | 0.0028 | 2.1063 | 10.0412 | 20 | 283 | regulation of developmental growth |
GO:0046887 | 0.0028 | 2.8844 | 4.1158 | 11 | 116 | positive regulation of hormone secretion |
GO:0021879 | 0.003 | 4.7227 | 1.4478 | 6 | 41 | forebrain neuron differentiation |
GO:0031644 | 0.003 | 3.6019 | 2.4482 | 8 | 69 | regulation of neurological system process |
GO:0021536 | 0.0031 | 5.7746 | 1.0171 | 5 | 29 | diencephalon development |
GO:0042693 | 0.0031 | 13.7268 | 0.3178 | 3 | 9 | muscle cell fate commitment |
GO:0003266 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0021892 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0038003 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | opioid receptor signaling pathway |
GO:0048387 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | negative regulation of retinoic acid receptor signaling pathway |
GO:0048755 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | branching morphogenesis of a nerve |
GO:0060180 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | female mating behavior |
GO:0060556 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | regulation of vitamin D biosynthetic process |
GO:0060923 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | cardiac muscle cell fate commitment |
GO:0072239 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | metanephric glomerulus vasculature development |
GO:2000543 | 0.0032 | 13.659 | 0.3193 | 3 | 9 | positive regulation of gastrulation |
GO:0007188 | 0.0032 | 3.2413 | 3.0258 | 9 | 86 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0007350 | 0.0032 | 7.8149 | 0.6387 | 4 | 18 | blastoderm segmentation |
GO:0001825 | 0.0032 | 5.7048 | 1.029 | 5 | 29 | blastocyst formation |
GO:0021772 | 0.0032 | 5.7048 | 1.029 | 5 | 29 | olfactory bulb development |
GO:0060070 | 0.0032 | 2.0742 | 10.1832 | 20 | 287 | canonical Wnt signaling pathway |
GO:0008306 | 0.0033 | 3.5435 | 2.4837 | 8 | 70 | associative learning |
GO:0090092 | 0.0034 | 2.2781 | 7.4511 | 16 | 210 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0050982 | 0.0034 | 4.5685 | 1.4902 | 6 | 42 | detection of mechanical stimulus |
GO:1903793 | 0.0034 | 4.5685 | 1.4902 | 6 | 42 | positive regulation of anion transport |
GO:0042472 | 0.0034 | 3.5079 | 2.505 | 8 | 71 | inner ear morphogenesis |
GO:0023051 | 0.0035 | 1.3198 | 115.5276 | 142 | 3256 | regulation of signaling |
GO:0001546 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | preantral ovarian follicle growth |
GO:0003166 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | bundle of His development |
GO:0003350 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | pulmonary myocardium development |
GO:0003358 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | noradrenergic neuron development |
GO:0010159 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | specification of animal organ position |
GO:0010956 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | negative regulation of calcidiol 1-monooxygenase activity |
GO:0021524 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | visceral motor neuron differentiation |
GO:0021759 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | globus pallidus development |
GO:0021912 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035880 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0036378 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | calcitriol biosynthetic process from calciol |
GO:0038162 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | erythropoietin-mediated signaling pathway |
GO:0042369 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | vitamin D catabolic process |
GO:0048936 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0055014 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060166 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | olfactory pit development |
GO:0060423 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | foregut regionalization |
GO:0060435 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | bronchiole development |
GO:0060492 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | lung induction |
GO:0060743 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | epithelial cell maturation involved in prostate gland development |
GO:0060913 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | cardiac cell fate determination |
GO:0060926 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | cardiac pacemaker cell development |
GO:0061010 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | gall bladder development |
GO:0061031 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0071422 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | succinate transmembrane transport |
GO:1902809 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | regulation of skeletal muscle fiber differentiation |
GO:1902869 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | regulation of amacrine cell differentiation |
GO:1904349 | 0.0037 | 54.5567 | 0.1064 | 2 | 3 | positive regulation of small intestine smooth muscle contraction |
GO:0040012 | 0.0037 | 1.5894 | 29.7335 | 45 | 838 | regulation of locomotion |
GO:0060541 | 0.0037 | 7.4446 | 0.6611 | 4 | 19 | respiratory system development |
GO:0001708 | 0.0038 | 4.4656 | 1.515 | 6 | 44 | cell fate specification |
GO:0001667 | 0.0038 | 2.0427 | 10.3245 | 20 | 295 | ameboidal-type cell migration |
GO:0007519 | 0.0038 | 3.8424 | 2.0187 | 7 | 58 | skeletal muscle tissue development |
GO:0001947 | 0.0039 | 3.8409 | 2.0224 | 7 | 57 | heart looping |
GO:0046850 | 0.0039 | 4.4447 | 1.5257 | 6 | 43 | regulation of bone remodeling |
GO:0001570 | 0.0039 | 3.4323 | 2.5547 | 8 | 72 | vasculogenesis |
GO:0090276 | 0.0039 | 2.3128 | 6.8834 | 15 | 194 | regulation of peptide hormone secretion |
GO:0050678 | 0.0039 | 2.0354 | 10.3606 | 20 | 292 | regulation of epithelial cell proliferation |
GO:0045766 | 0.004 | 2.6025 | 4.9319 | 12 | 139 | positive regulation of angiogenesis |
GO:0050954 | 0.004 | 2.4883 | 5.5706 | 13 | 157 | sensory perception of mechanical stimulus |
GO:0001710 | 0.004 | 7.2935 | 0.6741 | 4 | 19 | mesodermal cell fate commitment |
GO:0042474 | 0.004 | 7.2935 | 0.6741 | 4 | 19 | middle ear morphogenesis |
GO:0048557 | 0.004 | 7.2935 | 0.6741 | 4 | 19 | embryonic digestive tract morphogenesis |
GO:0043388 | 0.0043 | 5.2969 | 1.0937 | 5 | 31 | positive regulation of DNA binding |
GO:0061138 | 0.0043 | 5.2657 | 1.0951 | 5 | 32 | morphogenesis of a branching epithelium |
GO:0003209 | 0.0044 | 5.2653 | 1.0999 | 5 | 31 | cardiac atrium morphogenesis |
GO:0048771 | 0.0044 | 2.4539 | 5.6415 | 13 | 159 | tissue remodeling |
GO:0001820 | 0.0044 | 11.7069 | 0.3548 | 3 | 10 | serotonin secretion |
GO:0002934 | 0.0044 | 11.7069 | 0.3548 | 3 | 10 | desmosome organization |
GO:0003263 | 0.0044 | 11.7069 | 0.3548 | 3 | 10 | cardioblast proliferation |
GO:0060346 | 0.0044 | 11.7069 | 0.3548 | 3 | 10 | bone trabecula formation |
GO:0061072 | 0.0044 | 11.7069 | 0.3548 | 3 | 10 | iris morphogenesis |
GO:0061140 | 0.0044 | 11.7069 | 0.3548 | 3 | 10 | lung secretory cell differentiation |
GO:0051270 | 0.0045 | 1.5706 | 30.0528 | 45 | 847 | regulation of cellular component movement |
GO:0072006 | 0.0045 | 3.0588 | 3.1857 | 9 | 91 | nephron development |
GO:0051216 | 0.0048 | 3.3 | 2.642 | 8 | 76 | cartilage development |
GO:0007130 | 0.0048 | 6.8372 | 0.7096 | 4 | 20 | synaptonemal complex assembly |
GO:0023019 | 0.0048 | 6.8372 | 0.7096 | 4 | 20 | signal transduction involved in regulation of gene expression |
GO:0060065 | 0.0048 | 6.8372 | 0.7096 | 4 | 20 | uterus development |
GO:0048538 | 0.0049 | 4.2162 | 1.5967 | 6 | 45 | thymus development |
GO:0051930 | 0.005 | 5.07 | 1.1354 | 5 | 32 | regulation of sensory perception of pain |
GO:0060317 | 0.005 | 5.07 | 1.1354 | 5 | 32 | cardiac epithelial to mesenchymal transition |
GO:1902742 | 0.005 | 5.07 | 1.1354 | 5 | 32 | apoptotic process involved in development |
GO:0051093 | 0.005 | 1.7003 | 19.7287 | 32 | 574 | negative regulation of developmental process |
GO:0016331 | 0.0053 | 6.6016 | 0.7271 | 4 | 21 | morphogenesis of embryonic epithelium |
GO:0050877 | 0.0054 | 1.4948 | 37.9073 | 54 | 1079 | nervous system process |
GO:0008344 | 0.0054 | 3.2296 | 2.6966 | 8 | 76 | adult locomotory behavior |
GO:0060986 | 0.0054 | 4.1105 | 1.6321 | 6 | 46 | endocrine hormone secretion |
GO:0003013 | 0.0055 | 1.7367 | 17.4924 | 29 | 493 | circulatory system process |
GO:0021545 | 0.0055 | 6.5316 | 0.7345 | 4 | 21 | cranial nerve development |
GO:0030324 | 0.0056 | 2.3803 | 5.7995 | 13 | 164 | lung development |
GO:0051937 | 0.0057 | 3.5554 | 2.1644 | 7 | 61 | catecholamine transport |
GO:0071773 | 0.0057 | 10.4139 | 0.3842 | 3 | 11 | cellular response to BMP stimulus |
GO:0021516 | 0.0058 | 6.4346 | 0.7451 | 4 | 21 | dorsal spinal cord development |
GO:0003161 | 0.0059 | 10.2429 | 0.3903 | 3 | 11 | cardiac conduction system development |
GO:0021903 | 0.0059 | 10.2429 | 0.3903 | 3 | 11 | rostrocaudal neural tube patterning |
GO:0048484 | 0.0059 | 10.2429 | 0.3903 | 3 | 11 | enteric nervous system development |
GO:0060379 | 0.0059 | 10.2429 | 0.3903 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0022412 | 0.006 | 1.9181 | 11.496 | 21 | 324 | cellular process involved in reproduction in multicellular organism |
GO:0030097 | 0.0061 | 1.5642 | 28.1013 | 42 | 792 | hemopoiesis |
GO:0007610 | 0.0063 | 2.1253 | 7.9337 | 16 | 234 | behavior |
GO:0097485 | 0.0063 | 2.1228 | 7.9478 | 16 | 224 | neuron projection guidance |
GO:0001655 | 0.0065 | 4.7169 | 1.203 | 5 | 35 | urogenital system development |
GO:0048048 | 0.0066 | 4.7197 | 1.2064 | 5 | 34 | embryonic eye morphogenesis |
GO:0048738 | 0.0067 | 2.2413 | 6.6044 | 14 | 187 | cardiac muscle tissue development |
GO:0060324 | 0.0067 | 3.9143 | 1.7031 | 6 | 48 | face development |
GO:0051963 | 0.0068 | 3.0925 | 2.803 | 8 | 79 | regulation of synapse assembly |
GO:0010894 | 0.0069 | 6.0767 | 0.7806 | 4 | 22 | negative regulation of steroid biosynthetic process |
GO:0033688 | 0.0069 | 6.0767 | 0.7806 | 4 | 22 | regulation of osteoblast proliferation |
GO:0051953 | 0.0069 | 6.0767 | 0.7806 | 4 | 22 | negative regulation of amine transport |
GO:2000679 | 0.0069 | 6.0767 | 0.7806 | 4 | 22 | positive regulation of transcription regulatory region DNA binding |
GO:0043524 | 0.007 | 2.5214 | 4.6481 | 11 | 131 | negative regulation of neuron apoptotic process |
GO:0061351 | 0.007 | 2.5214 | 4.6481 | 11 | 131 | neural precursor cell proliferation |
GO:0090288 | 0.007 | 2.5214 | 4.6481 | 11 | 131 | negative regulation of cellular response to growth factor stimulus |
GO:0006837 | 0.0071 | 27.41 | 0.1413 | 2 | 4 | serotonin transport |
GO:0003357 | 0.0071 | 27.3719 | 0.1415 | 2 | 4 | noradrenergic neuron differentiation |
GO:0003219 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | cardiac right ventricle formation |
GO:0003257 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0007198 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0014034 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | neural crest cell fate commitment |
GO:0015746 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | citrate transport |
GO:0021797 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | forebrain anterior/posterior pattern specification |
GO:0021855 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | hypothalamus cell migration |
GO:0032100 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | positive regulation of appetite |
GO:0042662 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0048866 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | stem cell fate specification |
GO:0060040 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | retinal bipolar neuron differentiation |
GO:0060486 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | Clara cell differentiation |
GO:0060708 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | spongiotrophoblast differentiation |
GO:0060800 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | regulation of cell differentiation involved in embryonic placenta development |
GO:0061030 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
GO:0061055 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | myotome development |
GO:0061056 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | sclerotome development |
GO:0061325 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0072086 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | specification of loop of Henle identity |
GO:0072107 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0090244 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
GO:0090403 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | oxidative stress-induced premature senescence |
GO:0110022 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | regulation of cardiac muscle myoblast proliferation |
GO:1900738 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:1905903 | 0.0072 | 27.2766 | 0.1419 | 2 | 4 | negative regulation of mesoderm formation |
GO:0048593 | 0.0073 | 2.8228 | 3.4256 | 9 | 97 | camera-type eye morphogenesis |
GO:0007189 | 0.0074 | 3.3676 | 2.2708 | 7 | 64 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0086091 | 0.0074 | 4.5621 | 1.2419 | 5 | 35 | regulation of heart rate by cardiac conduction |
GO:2000826 | 0.0074 | 4.5621 | 1.2419 | 5 | 35 | regulation of heart morphogenesis |
GO:0043586 | 0.0076 | 9.1664 | 0.423 | 3 | 12 | tongue development |
GO:0003207 | 0.0077 | 9.1042 | 0.4258 | 3 | 12 | cardiac chamber formation |
GO:0033605 | 0.0077 | 9.1042 | 0.4258 | 3 | 12 | positive regulation of catecholamine secretion |
GO:0055015 | 0.0077 | 9.1042 | 0.4258 | 3 | 12 | ventricular cardiac muscle cell development |
GO:0060766 | 0.0077 | 9.1042 | 0.4258 | 3 | 12 | negative regulation of androgen receptor signaling pathway |
GO:2000095 | 0.0077 | 9.1042 | 0.4258 | 3 | 12 | regulation of Wnt signaling pathway, planar cell polarity pathway |
GO:0046717 | 0.0078 | 2.6175 | 4.0804 | 10 | 115 | acid secretion |
GO:0050880 | 0.0078 | 2.4798 | 4.719 | 11 | 133 | regulation of blood vessel size |
GO:0198738 | 0.0079 | 1.7217 | 16.3924 | 27 | 462 | cell-cell signaling by wnt |
GO:0060441 | 0.008 | 5.7866 | 0.812 | 4 | 23 | epithelial tube branching involved in lung morphogenesis |
GO:0001658 | 0.0081 | 4.4586 | 1.2653 | 5 | 36 | branching involved in ureteric bud morphogenesis |
GO:0045686 | 0.0081 | 5.7565 | 0.8161 | 4 | 23 | negative regulation of glial cell differentiation |
GO:0051354 | 0.0081 | 5.7565 | 0.8161 | 4 | 23 | negative regulation of oxidoreductase activity |
GO:0051450 | 0.0081 | 5.7565 | 0.8161 | 4 | 23 | myoblast proliferation |
GO:0090103 | 0.0081 | 5.7565 | 0.8161 | 4 | 23 | cochlea morphogenesis |
GO:2000191 | 0.0081 | 5.7565 | 0.8161 | 4 | 23 | regulation of fatty acid transport |
GO:0001709 | 0.0082 | 4.4381 | 1.2709 | 5 | 36 | cell fate determination |
GO:0051046 | 0.0086 | 1.573 | 24.5532 | 37 | 692 | regulation of secretion |
GO:0051952 | 0.0088 | 3.6746 | 1.7992 | 6 | 51 | regulation of amine transport |
GO:0042220 | 0.009 | 3.6526 | 1.8096 | 6 | 51 | response to cocaine |
GO:0048666 | 0.0091 | 1.4886 | 32.981 | 47 | 947 | neuron development |
GO:0031076 | 0.0094 | 4.2764 | 1.3128 | 5 | 37 | embryonic camera-type eye development |
GO:0060412 | 0.0094 | 4.2764 | 1.3128 | 5 | 37 | ventricular septum morphogenesis |
GO:0033555 | 0.0094 | 3.1986 | 2.3773 | 7 | 67 | multicellular organismal response to stress |
GO:0061448 | 0.0094 | 3.6097 | 1.8245 | 6 | 53 | connective tissue development |
GO:0030178 | 0.0094 | 2.1426 | 6.8834 | 14 | 194 | negative regulation of Wnt signaling pathway |
GO:0032104 | 0.0095 | 5.4683 | 0.8516 | 4 | 24 | regulation of response to extracellular stimulus |
GO:0072202 | 0.0095 | 5.4683 | 0.8516 | 4 | 24 | cell differentiation involved in metanephros development |
GO:0007320 | 0.0097 | 8.1933 | 0.4613 | 3 | 13 | insemination |
GO:0021978 | 0.0097 | 8.1933 | 0.4613 | 3 | 13 | telencephalon regionalization |
GO:0042574 | 0.0097 | 8.1933 | 0.4613 | 3 | 13 | retinal metabolic process |
GO:0072189 | 0.0097 | 8.1933 | 0.4613 | 3 | 13 | ureter development |
GO:0090179 | 0.0097 | 8.1933 | 0.4613 | 3 | 13 | planar cell polarity pathway involved in neural tube closure |
GO:1901213 | 0.0097 | 8.1933 | 0.4613 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0048857 | 0.0098 | 3.5856 | 1.8389 | 6 | 52 | neural nucleus development |
GO:0030334 | 0.01 | 1.5469 | 25.6176 | 38 | 722 | regulation of cell migration |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 119.7763 | 0.8285 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 79.8303 | 0.932 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 47.8735 | 1.1392 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 19.6302 | 2.0453 | 26 | 79 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 195.1759 | 0.466 | 15 | 18 | negative regulation of megakaryocyte differentiation |
GO:1902036 | 0 | 13.1096 | 2.6149 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 12.4509 | 2.7185 | 25 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 10.6917 | 3.3139 | 27 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 8.2791 | 3.7541 | 25 | 145 | chromatin assembly |
GO:0032200 | 0 | 7.553 | 4.2201 | 26 | 163 | telomere organization |
GO:0035194 | 0 | 5.9175 | 6.0324 | 30 | 233 | posttranscriptional gene silencing by RNA |
GO:0048863 | 0 | 5.6026 | 6.5455 | 31 | 254 | stem cell differentiation |
GO:0034080 | 0 | 20.9352 | 1.0356 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0009593 | 0 | 4.3976 | 10.0454 | 38 | 388 | detection of chemical stimulus |
GO:0002244 | 0 | 6.4576 | 4.8156 | 26 | 186 | hematopoietic progenitor cell differentiation |
GO:1904837 | 0 | 18.1392 | 1.1392 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0017148 | 0 | 4.615 | 8.2849 | 33 | 320 | negative regulation of translation |
GO:0034724 | 0 | 14.7008 | 1.3204 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0007606 | 0 | 4.0455 | 10.5114 | 37 | 406 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 3.981 | 10.3561 | 36 | 400 | detection of stimulus involved in sensory perception |
GO:0016233 | 0 | 13.2632 | 1.424 | 14 | 55 | telomere capping |
GO:1903507 | 0 | 2.6612 | 29.0229 | 67 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0050911 | 0 | 4.4225 | 8.0518 | 31 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0065004 | 0 | 5.233 | 5.5405 | 25 | 214 | protein-DNA complex assembly |
GO:0009890 | 0 | 2.3203 | 40.9324 | 82 | 1581 | negative regulation of biosynthetic process |
GO:0051253 | 0 | 2.4739 | 30.9388 | 67 | 1195 | negative regulation of RNA metabolic process |
GO:0038111 | 0 | 16.3263 | 0.9579 | 11 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 16.3263 | 0.9579 | 11 | 37 | response to interleukin-7 |
GO:0030099 | 0 | 3.721 | 9.7088 | 32 | 375 | myeloid cell differentiation |
GO:0006303 | 0 | 9.3654 | 1.8641 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0050877 | 0 | 2.4454 | 29.7219 | 64 | 1148 | nervous system process |
GO:0071103 | 0 | 4.3564 | 6.7832 | 26 | 262 | DNA conformation change |
GO:0043044 | 0 | 8.9031 | 1.9418 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:1903707 | 0 | 6.0588 | 3.4693 | 18 | 134 | negative regulation of hemopoiesis |
GO:0034248 | 0 | 3.0606 | 13.8771 | 38 | 536 | regulation of cellular amide metabolic process |
GO:0007186 | 0 | 2.3777 | 27.4108 | 58 | 1078 | G-protein coupled receptor signaling pathway |
GO:0045596 | 0 | 2.8174 | 16.2072 | 41 | 626 | negative regulation of cell differentiation |
GO:0045652 | 0 | 9.7847 | 1.3988 | 11 | 56 | regulation of megakaryocyte differentiation |
GO:0010608 | 0 | 2.751 | 16.1296 | 40 | 623 | posttranscriptional regulation of gene expression |
GO:2000026 | 0 | 1.9718 | 46.3952 | 81 | 1792 | regulation of multicellular organismal development |
GO:0051259 | 0 | 2.7422 | 13.204 | 33 | 510 | protein oligomerization |
GO:0043043 | 0 | 2.3781 | 19.8578 | 43 | 767 | peptide biosynthetic process |
GO:0031324 | 0 | 1.7244 | 64.7513 | 99 | 2501 | negative regulation of cellular metabolic process |
GO:0032501 | 0 | 1.5489 | 169.5299 | 212 | 6681 | multicellular organismal process |
GO:0034728 | 0 | 5.1938 | 2.6096 | 12 | 104 | nucleosome organization |
GO:0002070 | 0 | 19.0306 | 0.3884 | 5 | 15 | epithelial cell maturation |
GO:0006342 | 0 | 6.3167 | 1.6375 | 9 | 67 | chromatin silencing |
GO:0006355 | 0 | 1.5645 | 88.1819 | 122 | 3406 | regulation of transcription, DNA-templated |
GO:2001141 | 1e-04 | 1.5483 | 88.881 | 122 | 3433 | regulation of RNA biosynthetic process |
GO:0048869 | 1e-04 | 1.5133 | 102.9134 | 137 | 3975 | cellular developmental process |
GO:0034654 | 1e-04 | 1.4981 | 104.5186 | 138 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0048534 | 1e-04 | 1.9941 | 21.5665 | 40 | 833 | hematopoietic or lymphoid organ development |
GO:0007200 | 3e-04 | 4.1212 | 2.6667 | 10 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0006352 | 3e-04 | 2.8861 | 5.9547 | 16 | 230 | DNA-templated transcription, initiation |
GO:0030855 | 4e-04 | 1.9909 | 18.2267 | 34 | 704 | epithelial cell differentiation |
GO:0009611 | 5e-04 | 2.0311 | 16.259 | 31 | 628 | response to wounding |
GO:0010817 | 5e-04 | 2.2111 | 12.0389 | 25 | 465 | regulation of hormone levels |
GO:0051172 | 5e-04 | 1.7827 | 27.7751 | 46 | 1117 | negative regulation of nitrogen compound metabolic process |
GO:0014827 | 6e-04 | 28.4177 | 0.1812 | 3 | 7 | intestine smooth muscle contraction |
GO:0061138 | 6e-04 | 3.0849 | 4.5308 | 13 | 175 | morphogenesis of a branching epithelium |
GO:0009098 | 7e-04 | Inf | 0.0518 | 2 | 2 | leucine biosynthetic process |
GO:0009099 | 7e-04 | Inf | 0.0518 | 2 | 2 | valine biosynthetic process |
GO:0019219 | 7e-04 | 1.4267 | 103.0688 | 132 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0071773 | 8e-04 | 3.177 | 4.0648 | 12 | 157 | cellular response to BMP stimulus |
GO:0009059 | 9e-04 | 1.3925 | 128.8813 | 159 | 4978 | macromolecule biosynthetic process |
GO:0048598 | 9e-04 | 2.0123 | 14.7574 | 28 | 570 | embryonic morphogenesis |
GO:0043500 | 0.0011 | 3.7817 | 2.589 | 9 | 100 | muscle adaptation |
GO:0007178 | 0.0012 | 2.3878 | 8.0001 | 18 | 309 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0045933 | 0.0013 | 5.5725 | 1.2168 | 6 | 47 | positive regulation of muscle contraction |
GO:0060317 | 0.0013 | 7.0407 | 0.8285 | 5 | 32 | cardiac epithelial to mesenchymal transition |
GO:0051716 | 0.0016 | 1.3491 | 174.1632 | 204 | 6727 | cellular response to stimulus |
GO:0030879 | 0.0017 | 3.2708 | 3.2881 | 10 | 127 | mammary gland development |
GO:0009946 | 0.002 | 75.6107 | 0.0777 | 2 | 3 | proximal/distal axis specification |
GO:0010513 | 0.002 | 75.6107 | 0.0777 | 2 | 3 | positive regulation of phosphatidylinositol biosynthetic process |
GO:0014016 | 0.002 | 75.6107 | 0.0777 | 2 | 3 | neuroblast differentiation |
GO:0060435 | 0.002 | 75.6107 | 0.0777 | 2 | 3 | bronchiole development |
GO:0060596 | 0.002 | 75.6107 | 0.0777 | 2 | 3 | mammary placode formation |
GO:0090310 | 0.002 | 75.6107 | 0.0777 | 2 | 3 | negative regulation of methylation-dependent chromatin silencing |
GO:1902304 | 0.002 | 75.6107 | 0.0777 | 2 | 3 | positive regulation of potassium ion export |
GO:0009887 | 0.0021 | 1.7001 | 24.9063 | 40 | 962 | animal organ morphogenesis |
GO:1903792 | 0.0022 | 8.433 | 0.5696 | 4 | 22 | negative regulation of anion transport |
GO:0050880 | 0.0024 | 3.11 | 3.4434 | 10 | 133 | regulation of blood vessel size |
GO:2000113 | 0.0025 | 1.662 | 26.8129 | 42 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
GO:1901018 | 0.0027 | 7.9887 | 0.5955 | 4 | 23 | positive regulation of potassium ion transmembrane transporter activity |
GO:0051147 | 0.0027 | 2.7216 | 4.6861 | 12 | 181 | regulation of muscle cell differentiation |
GO:0043616 | 0.0028 | 5.7583 | 0.9838 | 5 | 38 | keratinocyte proliferation |
GO:0044249 | 0.0029 | 1.3282 | 153.5546 | 181 | 5931 | cellular biosynthetic process |
GO:0060259 | 0.0031 | 7.5888 | 0.6214 | 4 | 24 | regulation of feeding behavior |
GO:0043268 | 0.0032 | 5.5886 | 1.0097 | 5 | 39 | positive regulation of potassium ion transport |
GO:0060421 | 0.0032 | 5.5886 | 1.0097 | 5 | 39 | positive regulation of heart growth |
GO:0061051 | 0.0032 | 12.626 | 0.3107 | 3 | 12 | positive regulation of cell growth involved in cardiac muscle cell development |
GO:0045597 | 0.0032 | 1.7009 | 22.3173 | 36 | 862 | positive regulation of cell differentiation |
GO:0050878 | 0.0034 | 1.9507 | 12.4014 | 23 | 479 | regulation of body fluid levels |
GO:0060249 | 0.0035 | 2.0989 | 9.5276 | 19 | 368 | anatomical structure homeostasis |
GO:0003309 | 0.0036 | 7.2269 | 0.6473 | 4 | 25 | type B pancreatic cell differentiation |
GO:0048519 | 0.0036 | 1.3341 | 123.5377 | 149 | 4802 | negative regulation of biological process |
GO:0001692 | 0.0039 | 37.8029 | 0.1036 | 2 | 4 | histamine metabolic process |
GO:0001994 | 0.0039 | 37.8029 | 0.1036 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0034287 | 0.0039 | 37.8029 | 0.1036 | 2 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0.0039 | 37.8029 | 0.1036 | 2 | 4 | detection of glucose |
GO:0060535 | 0.0039 | 37.8029 | 0.1036 | 2 | 4 | trachea cartilage morphogenesis |
GO:0098904 | 0.0039 | 37.8029 | 0.1036 | 2 | 4 | regulation of AV node cell action potential |
GO:1902261 | 0.0039 | 37.8029 | 0.1036 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:0051384 | 0.0039 | 2.8963 | 3.6764 | 10 | 142 | response to glucocorticoid |
GO:0090343 | 0.0041 | 11.3627 | 0.3366 | 3 | 13 | positive regulation of cell aging |
GO:0035265 | 0.0042 | 2.8663 | 3.7113 | 10 | 144 | organ growth |
GO:0048608 | 0.0042 | 2.0192 | 10.4078 | 20 | 402 | reproductive structure development |
GO:0071310 | 0.0044 | 1.4189 | 60.3241 | 80 | 2330 | cellular response to organic substance |
GO:0048729 | 0.0046 | 1.8041 | 15.7153 | 27 | 607 | tissue morphogenesis |
GO:0007154 | 0.0046 | 1.3082 | 154.9786 | 181 | 5986 | cell communication |
GO:0051248 | 0.0048 | 1.5541 | 31.9226 | 47 | 1233 | negative regulation of protein metabolic process |
GO:0003301 | 0.0048 | 6.5976 | 0.699 | 4 | 27 | physiological cardiac muscle hypertrophy |
GO:0035270 | 0.005 | 2.9879 | 3.2104 | 9 | 124 | endocrine system development |
GO:0003073 | 0.005 | 3.6032 | 2.0971 | 7 | 81 | regulation of systemic arterial blood pressure |
GO:0032108 | 0.0051 | 10.329 | 0.3625 | 3 | 14 | negative regulation of response to nutrient levels |
GO:0007596 | 0.0052 | 2.1089 | 8.4661 | 17 | 327 | blood coagulation |
GO:0009187 | 0.0053 | 2.4836 | 5.1004 | 12 | 197 | cyclic nucleotide metabolic process |
GO:0060562 | 0.0054 | 2.1571 | 7.7929 | 16 | 301 | epithelial tube morphogenesis |
GO:0060441 | 0.0055 | 6.3223 | 0.7249 | 4 | 28 | epithelial tube branching involved in lung morphogenesis |
GO:0006939 | 0.0056 | 3.1776 | 2.6926 | 8 | 104 | smooth muscle contraction |
GO:0030510 | 0.0061 | 3.4622 | 2.1748 | 7 | 84 | regulation of BMP signaling pathway |
GO:0007611 | 0.0061 | 2.3385 | 5.8512 | 13 | 226 | learning or memory |
GO:0048521 | 0.0062 | 9.4677 | 0.3884 | 3 | 15 | negative regulation of behavior |
GO:1901700 | 0.0063 | 1.4875 | 38.3433 | 54 | 1481 | response to oxygen-containing compound |
GO:0014050 | 0.0063 | 25.2003 | 0.1295 | 2 | 5 | negative regulation of glutamate secretion |
GO:0015677 | 0.0063 | 25.2003 | 0.1295 | 2 | 5 | copper ion import |
GO:0035482 | 0.0063 | 25.2003 | 0.1295 | 2 | 5 | gastric motility |
GO:0035926 | 0.0063 | 25.2003 | 0.1295 | 2 | 5 | chemokine (C-C motif) ligand 2 secretion |
GO:0060437 | 0.0063 | 25.2003 | 0.1295 | 2 | 5 | lung growth |
GO:0060455 | 0.0063 | 25.2003 | 0.1295 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0060510 | 0.0063 | 25.2003 | 0.1295 | 2 | 5 | Type II pneumocyte differentiation |
GO:0055025 | 0.0065 | 4.6324 | 1.1909 | 5 | 46 | positive regulation of cardiac muscle tissue development |
GO:0060986 | 0.0065 | 4.6324 | 1.1909 | 5 | 46 | endocrine hormone secretion |
GO:0051155 | 0.0066 | 3.8679 | 1.6829 | 6 | 65 | positive regulation of striated muscle cell differentiation |
GO:0045667 | 0.007 | 3.0497 | 2.7961 | 8 | 108 | regulation of osteoblast differentiation |
GO:0002682 | 0.007 | 1.4999 | 35.133 | 50 | 1357 | regulation of immune system process |
GO:0002067 | 0.0071 | 4.5218 | 1.2168 | 5 | 47 | glandular epithelial cell differentiation |
GO:0055013 | 0.0071 | 3.8032 | 1.7088 | 6 | 66 | cardiac muscle cell development |
GO:0010467 | 0.0072 | 1.2962 | 132.3506 | 156 | 5112 | gene expression |
GO:0032891 | 0.0075 | 8.7388 | 0.4142 | 3 | 16 | negative regulation of organic acid transport |
GO:1900116 | 0.0075 | 8.7388 | 0.4142 | 3 | 16 | extracellular negative regulation of signal transduction |
GO:0052652 | 0.0078 | 2.5982 | 4.0648 | 10 | 157 | cyclic purine nucleotide metabolic process |
GO:0014897 | 0.0088 | 3.2106 | 2.3301 | 7 | 90 | striated muscle hypertrophy |
GO:0048636 | 0.0088 | 3.6214 | 1.7864 | 6 | 69 | positive regulation of muscle organ development |
GO:0072359 | 0.0089 | 1.5727 | 24.6474 | 37 | 952 | circulatory system development |
GO:0030540 | 0.0089 | 8.1141 | 0.4401 | 3 | 17 | female genitalia development |
GO:0045907 | 0.009 | 5.4177 | 0.8285 | 4 | 32 | positive regulation of vasoconstriction |
GO:0060664 | 0.0094 | 18.899 | 0.1553 | 2 | 6 | epithelial cell proliferation involved in salivary gland morphogenesis |
GO:0071694 | 0.0094 | 18.899 | 0.1553 | 2 | 6 | maintenance of protein location in extracellular region |
GO:1901863 | 0.0094 | 3.5646 | 1.8123 | 6 | 70 | positive regulation of muscle tissue development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 121.375 | 0.8185 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 80.8958 | 0.9208 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 48.5125 | 1.1254 | 24 | 44 | protein heterotetramerization |
GO:0006323 | 0 | 10.3044 | 4.7573 | 37 | 186 | DNA packaging |
GO:0045815 | 0 | 19.8936 | 2.0206 | 26 | 79 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 138.0457 | 0.4604 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0071824 | 0 | 7.6094 | 6.2663 | 38 | 245 | protein-DNA complex subunit organization |
GO:1902036 | 0 | 13.285 | 2.5832 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 11.9313 | 2.6856 | 24 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 9.7854 | 3.2738 | 25 | 128 | regulation of gene silencing |
GO:0032200 | 0 | 8.0287 | 4.169 | 27 | 163 | telomere organization |
GO:0002244 | 0 | 7.1753 | 4.7573 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 5.7944 | 6.5732 | 32 | 257 | stem cell differentiation |
GO:0006333 | 0 | 9.4938 | 2.9238 | 22 | 118 | chromatin assembly or disassembly |
GO:0035194 | 0 | 5.9977 | 5.9594 | 30 | 233 | posttranscriptional gene silencing by RNA |
GO:0034080 | 0 | 21.2077 | 1.0231 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 18.3753 | 1.1254 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 14.8922 | 1.3044 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0017148 | 0 | 4.5083 | 8.1846 | 32 | 320 | negative regulation of translation |
GO:0016233 | 0 | 13.4358 | 1.4067 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 9.4873 | 1.8415 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 9.019 | 1.9183 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0038111 | 0 | 14.4398 | 0.9463 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 14.4398 | 0.9463 | 10 | 37 | response to interleukin-7 |
GO:0030099 | 0 | 3.4964 | 9.5913 | 30 | 375 | myeloid cell differentiation |
GO:1903707 | 0 | 5.7328 | 3.4273 | 17 | 134 | negative regulation of hemopoiesis |
GO:0045652 | 0 | 8.7715 | 1.3847 | 10 | 56 | regulation of megakaryocyte differentiation |
GO:0051259 | 0 | 2.7797 | 13.0441 | 33 | 510 | protein oligomerization |
GO:0010608 | 0 | 2.5457 | 15.9343 | 37 | 623 | posttranscriptional regulation of gene expression |
GO:0048534 | 0 | 2.33 | 20.7393 | 44 | 816 | hematopoietic or lymphoid organ development |
GO:0006334 | 0 | 6.0795 | 2.2673 | 12 | 94 | nucleosome assembly |
GO:0034248 | 0 | 2.6314 | 13.7091 | 33 | 536 | regulation of cellular amide metabolic process |
GO:1903507 | 0 | 2.0697 | 28.6715 | 54 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0006352 | 0 | 3.5493 | 5.8826 | 19 | 230 | DNA-templated transcription, initiation |
GO:0045596 | 0 | 2.3741 | 16.011 | 35 | 626 | negative regulation of cell differentiation |
GO:0051253 | 0 | 1.9686 | 30.5642 | 55 | 1195 | negative regulation of RNA metabolic process |
GO:0010558 | 0 | 1.8534 | 37.9047 | 64 | 1482 | negative regulation of macromolecule biosynthetic process |
GO:0051248 | 0 | 1.9001 | 31.5361 | 55 | 1233 | negative regulation of protein metabolic process |
GO:0034622 | 0 | 2.0037 | 24.8862 | 46 | 973 | cellular macromolecular complex assembly |
GO:0031327 | 1e-04 | 1.7782 | 39.9509 | 65 | 1562 | negative regulation of cellular biosynthetic process |
GO:0060249 | 1e-04 | 2.6319 | 9.4122 | 23 | 368 | anatomical structure homeostasis |
GO:0007596 | 1e-04 | 2.7022 | 8.3636 | 21 | 327 | blood coagulation |
GO:0002227 | 1e-04 | 12.8445 | 0.5115 | 5 | 20 | innate immune response in mucosa |
GO:0043043 | 2e-04 | 2.0238 | 19.6174 | 37 | 767 | peptide biosynthetic process |
GO:0009611 | 2e-04 | 2.1345 | 16.0622 | 32 | 628 | response to wounding |
GO:0006342 | 2e-04 | 5.5799 | 1.6165 | 8 | 67 | chromatin silencing |
GO:0040034 | 3e-04 | 17.0902 | 0.3325 | 4 | 13 | regulation of development, heterochronic |
GO:2001141 | 3e-04 | 1.4826 | 87.8049 | 117 | 3433 | regulation of RNA biosynthetic process |
GO:0002376 | 3e-04 | 1.5334 | 67.3435 | 94 | 2633 | immune system process |
GO:0006355 | 4e-04 | 1.4796 | 87.1143 | 116 | 3406 | regulation of transcription, DNA-templated |
GO:0021542 | 5e-04 | 13.9811 | 0.3837 | 4 | 15 | dentate gyrus development |
GO:0021796 | 5e-04 | 28.7778 | 0.179 | 3 | 7 | cerebral cortex regionalization |
GO:0009072 | 5e-04 | 8.7537 | 0.6906 | 5 | 27 | aromatic amino acid family metabolic process |
GO:0048869 | 6e-04 | 1.4394 | 101.6675 | 131 | 3975 | cellular developmental process |
GO:0003051 | 7e-04 | Inf | 0.0512 | 2 | 2 | angiotensin-mediated drinking behavior |
GO:0042704 | 7e-04 | Inf | 0.0512 | 2 | 2 | uterine wall breakdown |
GO:0051793 | 7e-04 | Inf | 0.0512 | 2 | 2 | medium-chain fatty acid catabolic process |
GO:1901383 | 7e-04 | Inf | 0.0512 | 2 | 2 | negative regulation of chorionic trophoblast cell proliferation |
GO:2000179 | 0.0012 | 5.6436 | 1.2021 | 6 | 47 | positive regulation of neural precursor cell proliferation |
GO:0002251 | 0.0012 | 7.1303 | 0.8185 | 5 | 32 | organ or tissue specific immune response |
GO:0050878 | 0.0014 | 2.0727 | 12.2513 | 24 | 479 | regulation of body fluid levels |
GO:0009892 | 0.0019 | 1.4376 | 70.9243 | 94 | 2773 | negative regulation of metabolic process |
GO:0002317 | 0.0019 | 76.5665 | 0.0767 | 2 | 3 | plasma cell differentiation |
GO:0006083 | 0.0019 | 76.5665 | 0.0767 | 2 | 3 | acetate metabolic process |
GO:1904752 | 0.0021 | 8.5402 | 0.5627 | 4 | 22 | regulation of vascular associated smooth muscle cell migration |
GO:0051239 | 0.0022 | 1.4328 | 69.492 | 92 | 2717 | regulation of multicellular organismal process |
GO:0006559 | 0.0024 | 14.3852 | 0.2813 | 3 | 11 | L-phenylalanine catabolic process |
GO:1902221 | 0.0024 | 14.3852 | 0.2813 | 3 | 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process |
GO:0031424 | 0.0024 | 2.6315 | 5.2432 | 13 | 205 | keratinization |
GO:0050793 | 0.0025 | 1.4602 | 58.1959 | 79 | 2296 | regulation of developmental process |
GO:0019731 | 0.0027 | 5.8316 | 0.9719 | 5 | 38 | antibacterial humoral response |
GO:0009889 | 0.0029 | 1.3569 | 108.7523 | 134 | 4252 | regulation of biosynthetic process |
GO:0021871 | 0.003 | 7.6851 | 0.6138 | 4 | 24 | forebrain regionalization |
GO:1900004 | 0.0031 | 12.786 | 0.3069 | 3 | 12 | negative regulation of serine-type endopeptidase activity |
GO:0060164 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | regulation of timing of neuron differentiation |
GO:1901164 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | negative regulation of trophoblast cell migration |
GO:0006089 | 0.0039 | 11.5067 | 0.3325 | 3 | 13 | lactate metabolic process |
GO:0021781 | 0.0039 | 11.5067 | 0.3325 | 3 | 13 | glial cell fate commitment |
GO:0009913 | 0.0046 | 2.1366 | 8.3636 | 17 | 327 | epidermal cell differentiation |
GO:1902571 | 0.0049 | 10.4599 | 0.3581 | 3 | 14 | regulation of serine-type peptidase activity |
GO:0048731 | 0.005 | 1.3357 | 106.6136 | 130 | 4225 | system development |
GO:0014812 | 0.0053 | 3.5528 | 2.1229 | 7 | 83 | muscle cell migration |
GO:0050830 | 0.0053 | 3.5528 | 2.1229 | 7 | 83 | defense response to Gram-positive bacterium |
GO:0032570 | 0.0056 | 4.8089 | 1.151 | 5 | 45 | response to progesterone |
GO:0009888 | 0.0056 | 1.4524 | 46.7798 | 64 | 1829 | tissue development |
GO:0034654 | 0.0058 | 1.329 | 103.2533 | 126 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0072148 | 0.006 | 9.5877 | 0.3837 | 3 | 15 | epithelial cell fate commitment |
GO:0010936 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | negative regulation of macrophage cytokine production |
GO:0021778 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | oligodendrocyte cell fate specification |
GO:0051891 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0072126 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | positive regulation of glomerular mesangial cell proliferation |
GO:0019219 | 0.0068 | 1.323 | 101.821 | 124 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:1903706 | 0.0068 | 2.1581 | 7.292 | 15 | 295 | regulation of hemopoiesis |
GO:2000241 | 0.0072 | 2.805 | 3.4017 | 9 | 133 | regulation of reproductive process |
GO:0010832 | 0.0073 | 8.8496 | 0.4092 | 3 | 16 | negative regulation of myotube differentiation |
GO:0033002 | 0.0075 | 2.4763 | 4.6805 | 11 | 183 | muscle cell proliferation |
GO:0034645 | 0.0077 | 1.2987 | 124.0216 | 147 | 4849 | cellular macromolecule biosynthetic process |
GO:0032268 | 0.0082 | 1.3735 | 63.6349 | 82 | 2488 | regulation of cellular protein metabolic process |
GO:0007597 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | blood coagulation, intrinsic pathway |
GO:0048535 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | lymph node development |
GO:0048714 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | positive regulation of oligodendrocyte differentiation |
GO:0002583 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | regulation of antigen processing and presentation of peptide antigen |
GO:0003278 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0032534 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | regulation of microvillus assembly |
GO:0042373 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | vitamin K metabolic process |
GO:0048541 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | Peyer's patch development |
GO:0061844 | 0.0096 | 4.1801 | 1.3044 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0048665 | 0.0096 | 5.297 | 0.844 | 4 | 33 | neuron fate specification |
GO:0055123 | 0.0099 | 2.6539 | 3.5807 | 9 | 140 | digestive system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 10.2888 | 7.9349 | 59 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 8.3896 | 9.8994 | 62 | 388 | detection of chemical stimulus |
GO:0007606 | 0 | 8.1169 | 10.3587 | 63 | 406 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 8.0854 | 10.2056 | 62 | 400 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 3.5913 | 30.1321 | 87 | 1181 | G-protein coupled receptor signaling pathway |
GO:0045653 | 0 | 138.4059 | 0.4593 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0050877 | 0 | 3.3714 | 29.2901 | 81 | 1148 | nervous system process |
GO:0006335 | 0 | 30.7291 | 0.8164 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0034080 | 0 | 23.7551 | 1.0206 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:0000183 | 0 | 25.1356 | 0.9185 | 14 | 36 | chromatin silencing at rDNA |
GO:0034724 | 0 | 16.4849 | 1.3012 | 15 | 51 | DNA replication-independent nucleosome organization |
GO:0051290 | 0 | 18.4232 | 1.1226 | 14 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 18.4232 | 1.1226 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 13.4709 | 1.4033 | 14 | 55 | telomere capping |
GO:0043044 | 0 | 9.8756 | 1.9136 | 15 | 75 | ATP-dependent chromatin remodeling |
GO:0045815 | 0 | 9.256 | 2.0156 | 15 | 79 | positive regulation of gene expression, epigenetic |
GO:0051716 | 0 | 1.8283 | 171.633 | 231 | 6727 | cellular response to stimulus |
GO:0006303 | 0 | 9.5121 | 1.837 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:1902036 | 0 | 7.4428 | 2.5769 | 16 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0032501 | 0 | 1.8192 | 153.6276 | 208 | 6302 | multicellular organismal process |
GO:1903707 | 0 | 6.1546 | 3.4189 | 18 | 134 | negative regulation of hemopoiesis |
GO:0060964 | 0 | 6.571 | 2.679 | 15 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 5.6387 | 3.2658 | 16 | 128 | regulation of gene silencing |
GO:0045637 | 0 | 3.9161 | 5.9703 | 21 | 234 | regulation of myeloid cell differentiation |
GO:0031497 | 0 | 4.8902 | 3.6995 | 16 | 145 | chromatin assembly |
GO:0002244 | 0 | 4.2353 | 4.7456 | 18 | 186 | hematopoietic progenitor cell differentiation |
GO:0035194 | 0 | 3.5082 | 5.9448 | 19 | 233 | posttranscriptional gene silencing by RNA |
GO:0048534 | 0 | 2.2064 | 21.2532 | 43 | 833 | hematopoietic or lymphoid organ development |
GO:0065004 | 0 | 3.6237 | 5.46 | 18 | 214 | protein-DNA complex assembly |
GO:0023052 | 0 | 1.5421 | 152.2168 | 194 | 5966 | signaling |
GO:0007154 | 0 | 1.5337 | 152.7271 | 194 | 5986 | cell communication |
GO:0002682 | 0 | 2.572 | 11.8209 | 28 | 479 | regulation of immune system process |
GO:0060249 | 0 | 2.769 | 9.3892 | 24 | 368 | anatomical structure homeostasis |
GO:0048863 | 0 | 3.1495 | 6.5571 | 19 | 257 | stem cell differentiation |
GO:0045087 | 1e-04 | 2.0885 | 20.6919 | 40 | 811 | innate immune response |
GO:0032200 | 1e-04 | 3.6809 | 4.1588 | 14 | 163 | telomere organization |
GO:0002580 | 2e-04 | 57.7092 | 0.1276 | 3 | 5 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
GO:2000821 | 2e-04 | 57.7092 | 0.1276 | 3 | 5 | regulation of grooming behavior |
GO:0050432 | 2e-04 | 6.6176 | 1.2247 | 7 | 48 | catecholamine secretion |
GO:0017148 | 2e-04 | 2.6262 | 8.1645 | 20 | 320 | negative regulation of translation |
GO:0006342 | 2e-04 | 5.4463 | 1.6544 | 8 | 67 | chromatin silencing |
GO:0006352 | 3e-04 | 2.9316 | 5.8682 | 16 | 230 | DNA-templated transcription, initiation |
GO:0051248 | 4e-04 | 1.7408 | 31.4588 | 51 | 1233 | negative regulation of protein metabolic process |
GO:0071103 | 4e-04 | 2.7221 | 6.6847 | 17 | 262 | DNA conformation change |
GO:0019835 | 6e-04 | 6.446 | 1.0716 | 6 | 42 | cytolysis |
GO:0002588 | 6e-04 | Inf | 0.051 | 2 | 2 | positive regulation of antigen processing and presentation of peptide antigen via MHC class II |
GO:0019376 | 6e-04 | Inf | 0.051 | 2 | 2 | galactolipid catabolic process |
GO:0070370 | 6e-04 | Inf | 0.051 | 2 | 2 | cellular heat acclimation |
GO:1901475 | 6e-04 | Inf | 0.051 | 2 | 2 | pyruvate transmembrane transport |
GO:1904313 | 6e-04 | Inf | 0.051 | 2 | 2 | response to methamphetamine hydrochloride |
GO:0042742 | 7e-04 | 2.7676 | 5.7917 | 15 | 227 | defense response to bacterium |
GO:0035094 | 0.0012 | 5.658 | 1.1992 | 6 | 47 | response to nicotine |
GO:0009607 | 0.0013 | 1.8051 | 21.1511 | 36 | 829 | response to biotic stimulus |
GO:0010608 | 0.0014 | 1.931 | 15.8952 | 29 | 623 | posttranscriptional regulation of gene expression |
GO:0038034 | 0.0018 | 4.3702 | 1.7605 | 7 | 69 | signal transduction in absence of ligand |
GO:0006950 | 0.0019 | 1.3996 | 90.881 | 116 | 3562 | response to stress |
GO:0070434 | 0.0019 | 76.7605 | 0.0765 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0071673 | 0.0019 | 76.7605 | 0.0765 | 2 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:0090063 | 0.0019 | 76.7605 | 0.0765 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0045321 | 0.002 | 1.6614 | 28.091 | 44 | 1101 | leukocyte activation |
GO:0015844 | 0.0022 | 4.2331 | 1.8115 | 7 | 71 | monoamine transport |
GO:0048871 | 0.0023 | 2.2445 | 8.4707 | 18 | 332 | multicellular organismal homeostasis |
GO:0044406 | 0.0023 | 14.4217 | 0.2807 | 3 | 11 | adhesion of symbiont to host |
GO:0031424 | 0.0024 | 2.6384 | 5.2304 | 13 | 205 | keratinization |
GO:0051952 | 0.0026 | 4.1043 | 1.8625 | 7 | 73 | regulation of amine transport |
GO:0006911 | 0.0026 | 5.8465 | 0.9695 | 5 | 38 | phagocytosis, engulfment |
GO:0031640 | 0.0027 | 4.7318 | 1.4033 | 6 | 55 | killing of cells of other organism |
GO:0045596 | 0.0029 | 1.8466 | 15.9718 | 28 | 626 | negative regulation of cell differentiation |
GO:0031112 | 0.003 | 7.7047 | 0.6123 | 4 | 24 | positive regulation of microtubule polymerization or depolymerization |
GO:0060259 | 0.003 | 7.7047 | 0.6123 | 4 | 24 | regulation of feeding behavior |
GO:0032780 | 0.0031 | 12.8185 | 0.3062 | 3 | 12 | negative regulation of ATPase activity |
GO:0071356 | 0.0031 | 2.37 | 6.6847 | 15 | 262 | cellular response to tumor necrosis factor |
GO:0051592 | 0.0032 | 3.2023 | 3.0107 | 9 | 118 | response to calcium ion |
GO:0065008 | 0.0034 | 1.3789 | 85.9313 | 109 | 3368 | regulation of biological quality |
GO:0002275 | 0.0035 | 1.9172 | 13.1652 | 24 | 516 | myeloid cell activation involved in immune response |
GO:1902412 | 0.0038 | 38.3778 | 0.1021 | 2 | 4 | regulation of mitotic cytokinesis |
GO:0019627 | 0.0039 | 11.5359 | 0.3317 | 3 | 13 | urea metabolic process |
GO:0051481 | 0.0039 | 11.5359 | 0.3317 | 3 | 13 | negative regulation of cytosolic calcium ion concentration |
GO:0002444 | 0.004 | 1.8973 | 13.2928 | 24 | 521 | myeloid leukocyte mediated immunity |
GO:0055078 | 0.0041 | 5.2131 | 1.0716 | 5 | 42 | sodium ion homeostasis |
GO:0043312 | 0.0042 | 1.948 | 11.864 | 22 | 465 | neutrophil degranulation |
GO:0009913 | 0.0045 | 2.1422 | 8.3431 | 17 | 327 | epidermal cell differentiation |
GO:0032757 | 0.0046 | 5.0756 | 1.0971 | 5 | 43 | positive regulation of interleukin-8 production |
GO:0014059 | 0.0046 | 6.6985 | 0.6889 | 4 | 27 | regulation of dopamine secretion |
GO:0043252 | 0.0046 | 6.6985 | 0.6889 | 4 | 27 | sodium-independent organic anion transport |
GO:2001236 | 0.0047 | 2.8122 | 3.7761 | 10 | 148 | regulation of extrinsic apoptotic signaling pathway |
GO:0042572 | 0.0053 | 6.4189 | 0.7144 | 4 | 28 | retinol metabolic process |
GO:0045471 | 0.0053 | 2.9564 | 3.2403 | 9 | 127 | response to ethanol |
GO:0042119 | 0.0055 | 1.8994 | 12.1447 | 22 | 476 | neutrophil activation |
GO:0034248 | 0.0056 | 1.8399 | 13.6755 | 24 | 536 | regulation of cellular amide metabolic process |
GO:1904035 | 0.0057 | 3.9953 | 1.6329 | 6 | 64 | regulation of epithelial cell apoptotic process |
GO:0042221 | 0.0058 | 1.3736 | 79.5889 | 100 | 3633 | response to chemical |
GO:0015671 | 0.006 | 9.612 | 0.3827 | 3 | 15 | oxygen transport |
GO:0034310 | 0.006 | 9.612 | 0.3827 | 3 | 15 | primary alcohol catabolic process |
GO:0048521 | 0.006 | 9.612 | 0.3827 | 3 | 15 | negative regulation of behavior |
GO:0050776 | 0.006 | 1.6409 | 22.4013 | 35 | 878 | regulation of immune response |
GO:0051259 | 0.0061 | 1.852 | 13.0122 | 23 | 510 | protein oligomerization |
GO:0006824 | 0.0062 | 25.5835 | 0.1276 | 2 | 5 | cobalt ion transport |
GO:0014060 | 0.0062 | 25.5835 | 0.1276 | 2 | 5 | regulation of epinephrine secretion |
GO:0050900 | 0.0069 | 1.9595 | 10.1546 | 19 | 398 | leukocyte migration |
GO:0050794 | 0.007 | 1.312 | 241.3852 | 265 | 9769 | regulation of cellular process |
GO:0032273 | 0.0072 | 3.0356 | 2.8065 | 8 | 110 | positive regulation of protein polymerization |
GO:0015721 | 0.0085 | 5.5005 | 0.8164 | 4 | 32 | bile acid and bile salt transport |
GO:0070665 | 0.0085 | 2.7236 | 3.4954 | 9 | 137 | positive regulation of leukocyte proliferation |
GO:0002583 | 0.0091 | 19.1864 | 0.1531 | 2 | 6 | regulation of antigen processing and presentation of peptide antigen |
GO:0016098 | 0.0091 | 19.1864 | 0.1531 | 2 | 6 | monoterpenoid metabolic process |
GO:0048241 | 0.0091 | 19.1864 | 0.1531 | 2 | 6 | epinephrine transport |
GO:0051673 | 0.0091 | 19.1864 | 0.1531 | 2 | 6 | membrane disruption in other organism |
GO:0051902 | 0.0091 | 19.1864 | 0.1531 | 2 | 6 | negative regulation of mitochondrial depolarization |
GO:0042220 | 0.0095 | 4.1907 | 1.3012 | 5 | 51 | response to cocaine |
GO:0060236 | 0.0095 | 5.3105 | 0.842 | 4 | 33 | regulation of mitotic spindle organization |
GO:2001240 | 0.0095 | 5.3105 | 0.842 | 4 | 33 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0019730 | 0.0097 | 3.1457 | 2.3728 | 7 | 93 | antimicrobial humoral response |
GO:0051707 | 0.0098 | 1.6745 | 17.479 | 28 | 693 | response to other organism |
GO:0043604 | 0.0099 | 1.603 | 21.5339 | 33 | 844 | amide biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 25.1539 | 8.9682 | 113 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 19.1587 | 11.1886 | 117 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 18.3318 | 11.5346 | 117 | 400 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 17.9442 | 11.7076 | 117 | 406 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 5.8008 | 33.7749 | 135 | 1176 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 5.6673 | 33.1043 | 131 | 1148 | nervous system process |
GO:0031424 | 0 | 12.5701 | 2.6303 | 24 | 93 | keratinization |
GO:0009913 | 0 | 5.3613 | 9.4295 | 42 | 327 | epidermal cell differentiation |
GO:0043588 | 0 | 4.6854 | 11.1309 | 44 | 386 | skin development |
GO:0032501 | 0 | 2.1423 | 178.3832 | 256 | 6625 | multicellular organismal process |
GO:0000183 | 0 | 19.5601 | 1.0381 | 13 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 18.7438 | 1.067 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 18.7438 | 1.067 | 13 | 37 | response to interleukin-7 |
GO:0007154 | 0 | 1.7067 | 172.6153 | 231 | 5986 | cell communication |
GO:0006335 | 0 | 15.6263 | 0.9228 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0023052 | 0 | 1.6856 | 172.0386 | 229 | 5966 | signaling |
GO:0051290 | 0 | 11.4766 | 1.2688 | 11 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 7.357 | 2.1339 | 13 | 74 | regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 6.7974 | 2.2781 | 13 | 79 | positive regulation of gene expression, epigenetic |
GO:0018149 | 0 | 8.6013 | 1.586 | 11 | 55 | peptide cross-linking |
GO:0051716 | 0 | 1.5698 | 193.9832 | 244 | 6727 | cellular response to stimulus |
GO:1902036 | 0 | 5.0908 | 2.9125 | 13 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 4.8682 | 3.0278 | 13 | 105 | regulation of gene silencing by miRNA |
GO:0050829 | 0 | 5.4423 | 2.1051 | 10 | 73 | defense response to Gram-negative bacterium |
GO:0010951 | 0 | 3.0759 | 6.7189 | 19 | 233 | negative regulation of endopeptidase activity |
GO:0060429 | 0 | 1.839 | 34.1713 | 58 | 1185 | epithelium development |
GO:0050896 | 1e-04 | 1.9439 | 31.4693 | 53 | 1344 | response to stimulus |
GO:0031497 | 1e-04 | 3.6808 | 4.1813 | 14 | 145 | chromatin assembly |
GO:0060968 | 1e-04 | 3.8887 | 3.6911 | 13 | 128 | regulation of gene silencing |
GO:0070268 | 1e-04 | 4.1229 | 3.2297 | 12 | 112 | cornification |
GO:0034728 | 2e-04 | 3.4175 | 4.4697 | 14 | 155 | nucleosome organization |
GO:0006959 | 3e-04 | 2.9494 | 5.8538 | 16 | 203 | humoral immune response |
GO:0032740 | 4e-04 | 15.0906 | 0.3749 | 4 | 13 | positive regulation of interleukin-17 production |
GO:0045861 | 4e-04 | 2.4142 | 9.2854 | 21 | 322 | negative regulation of proteolysis |
GO:0002376 | 5e-04 | 1.4782 | 75.9265 | 103 | 2633 | immune system process |
GO:0061844 | 6e-04 | 5.4252 | 1.4707 | 7 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0006954 | 8e-04 | 1.9017 | 18.9744 | 34 | 658 | inflammatory response |
GO:0019062 | 8e-04 | 25.4179 | 0.2019 | 3 | 7 | virion attachment to host cell |
GO:0002244 | 0.001 | 2.7959 | 5.3636 | 14 | 186 | hematopoietic progenitor cell differentiation |
GO:0045617 | 0.0012 | 20.333 | 0.2307 | 3 | 8 | negative regulation of keratinocyte differentiation |
GO:1904628 | 0.0012 | 20.333 | 0.2307 | 3 | 8 | cellular response to phorbol 13-acetate 12-myristate |
GO:0045683 | 0.0012 | 10.4447 | 0.4902 | 4 | 17 | negative regulation of epidermis development |
GO:0009611 | 0.0014 | 1.8687 | 18.1093 | 32 | 628 | response to wounding |
GO:0031343 | 0.0014 | 5.5203 | 1.24 | 6 | 43 | positive regulation of cell killing |
GO:0003095 | 0.0024 | 67.6463 | 0.0865 | 2 | 3 | pressure natriuresis |
GO:0046968 | 0.0024 | 67.6463 | 0.0865 | 2 | 3 | peptide antigen transport |
GO:0070175 | 0.0024 | 67.6463 | 0.0865 | 2 | 3 | positive regulation of enamel mineralization |
GO:2000097 | 0.0024 | 67.6463 | 0.0865 | 2 | 3 | regulation of smooth muscle cell-matrix adhesion |
GO:0010820 | 0.0025 | 14.5217 | 0.2884 | 3 | 10 | positive regulation of T cell chemotaxis |
GO:0051346 | 0.0027 | 2.0304 | 11.4193 | 22 | 396 | negative regulation of hydrolase activity |
GO:0006342 | 0.0027 | 4.0857 | 1.8817 | 7 | 67 | chromatin silencing |
GO:0030099 | 0.003 | 2.0456 | 10.8137 | 21 | 375 | myeloid cell differentiation |
GO:0035194 | 0.0032 | 2.3617 | 6.7189 | 15 | 233 | posttranscriptional gene silencing by RNA |
GO:0050878 | 0.0032 | 1.9036 | 13.8127 | 25 | 479 | regulation of body fluid levels |
GO:0006069 | 0.0033 | 12.7057 | 0.3172 | 3 | 11 | ethanol oxidation |
GO:0044406 | 0.0033 | 12.7057 | 0.3172 | 3 | 11 | adhesion of symbiont to host |
GO:1903706 | 0.0033 | 1.9557 | 12.3709 | 23 | 429 | regulation of hemopoiesis |
GO:0065004 | 0.0038 | 2.4001 | 6.171 | 14 | 214 | protein-DNA complex assembly |
GO:0002250 | 0.004 | 2.0691 | 9.6602 | 19 | 335 | adaptive immune response |
GO:2000319 | 0.0043 | 11.2932 | 0.346 | 3 | 12 | regulation of T-helper 17 cell differentiation |
GO:0019731 | 0.0045 | 5.1479 | 1.0958 | 5 | 38 | antibacterial humoral response |
GO:0036101 | 0.0048 | 33.821 | 0.1153 | 2 | 4 | leukotriene B4 catabolic process |
GO:2000330 | 0.0048 | 33.821 | 0.1153 | 2 | 4 | positive regulation of T-helper 17 cell lineage commitment |
GO:0071634 | 0.0053 | 6.4624 | 0.7209 | 4 | 25 | regulation of transforming growth factor beta production |
GO:0002708 | 0.0054 | 3.5575 | 2.1339 | 7 | 74 | positive regulation of lymphocyte mediated immunity |
GO:0051967 | 0.0055 | 10.1632 | 0.3749 | 3 | 13 | negative regulation of synaptic transmission, glutamatergic |
GO:0030857 | 0.0056 | 4.8531 | 1.1535 | 5 | 40 | negative regulation of epithelial cell differentiation |
GO:0002703 | 0.0056 | 2.593 | 4.4985 | 11 | 156 | regulation of leukocyte mediated immunity |
GO:0002548 | 0.0063 | 3.9241 | 1.6725 | 6 | 58 | monocyte chemotaxis |
GO:0052547 | 0.0066 | 1.8972 | 11.5923 | 21 | 402 | regulation of peptidase activity |
GO:0007596 | 0.0069 | 2.001 | 9.4295 | 18 | 327 | blood coagulation |
GO:0042554 | 0.0071 | 5.8997 | 0.7786 | 4 | 27 | superoxide anion generation |
GO:0010469 | 0.0076 | 1.7457 | 15.5717 | 26 | 540 | regulation of receptor activity |
GO:0032200 | 0.0077 | 2.4725 | 4.7004 | 11 | 163 | telomere organization |
GO:0006526 | 0.0078 | 22.5459 | 0.1442 | 2 | 5 | arginine biosynthetic process |
GO:0042699 | 0.0078 | 22.5459 | 0.1442 | 2 | 5 | follicle-stimulating hormone signaling pathway |
GO:1901523 | 0.0078 | 22.5459 | 0.1442 | 2 | 5 | icosanoid catabolic process |
GO:0032963 | 0.0079 | 2.7652 | 3.4604 | 9 | 120 | collagen metabolic process |
GO:0042104 | 0.0081 | 5.6535 | 0.8074 | 4 | 28 | positive regulation of activated T cell proliferation |
GO:0001916 | 0.0084 | 8.4683 | 0.4325 | 3 | 15 | positive regulation of T cell mediated cytotoxicity |
GO:0002827 | 0.0084 | 8.4683 | 0.4325 | 3 | 15 | positive regulation of T-helper 1 type immune response |
GO:0003417 | 0.0084 | 8.4683 | 0.4325 | 3 | 15 | growth plate cartilage development |
GO:0042448 | 0.0084 | 8.4683 | 0.4325 | 3 | 15 | progesterone metabolic process |
GO:2000404 | 0.0092 | 5.427 | 0.8363 | 4 | 29 | regulation of T cell migration |
GO:0050794 | 0.0096 | 1.2733 | 275.957 | 300 | 9769 | regulation of cellular process |
GO:0042742 | 0.0099 | 2.662 | 3.5812 | 9 | 127 | defense response to bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 147.227 | 0.4333 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 32.6877 | 0.7703 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0034080 | 0 | 25.2732 | 0.9629 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:0000183 | 0 | 26.7376 | 0.8666 | 14 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 21.7816 | 1.0592 | 15 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 21.7816 | 1.0592 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 17.5384 | 1.2277 | 15 | 51 | DNA replication-independent nucleosome organization |
GO:0043044 | 0 | 11.4289 | 1.8054 | 16 | 75 | ATP-dependent chromatin remodeling |
GO:0016233 | 0 | 14.3295 | 1.324 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 11.0619 | 1.7332 | 15 | 72 | double-strand break repair via nonhomologous end joining |
GO:1903707 | 0 | 6.9948 | 3.2257 | 19 | 134 | negative regulation of hemopoiesis |
GO:0045815 | 0 | 9.8476 | 1.9017 | 15 | 79 | positive regulation of gene expression, epigenetic |
GO:0031047 | 0 | 4.8219 | 6.1866 | 26 | 257 | gene silencing by RNA |
GO:1902036 | 0 | 7.9197 | 2.4313 | 16 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0016441 | 0 | 4.8756 | 5.6329 | 24 | 234 | posttranscriptional gene silencing |
GO:0060964 | 0 | 7.5618 | 2.5276 | 16 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 6 | 3.0812 | 16 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 5.2036 | 3.4905 | 16 | 145 | chromatin assembly |
GO:0002244 | 0 | 4.5082 | 4.4774 | 18 | 186 | hematopoietic progenitor cell differentiation |
GO:0045637 | 0 | 3.9422 | 5.6329 | 20 | 234 | regulation of myeloid cell differentiation |
GO:0002682 | 0 | 3.8241 | 5.7977 | 20 | 261 | regulation of immune system process |
GO:0034249 | 0 | 3.2813 | 8.0401 | 24 | 334 | negative regulation of cellular amide metabolic process |
GO:0006959 | 0 | 4.0894 | 4.8867 | 18 | 203 | humoral immune response |
GO:0006352 | 0 | 3.7887 | 5.5366 | 19 | 230 | DNA-templated transcription, initiation |
GO:0050776 | 0 | 2.2249 | 21.1354 | 43 | 878 | regulation of immune response |
GO:0065004 | 0 | 3.6143 | 5.1515 | 17 | 214 | protein-DNA complex assembly |
GO:0050900 | 0 | 2.8297 | 8.8062 | 23 | 371 | leukocyte migration |
GO:0051246 | 0 | 1.6672 | 64.008 | 95 | 2659 | regulation of protein metabolic process |
GO:0032200 | 0 | 3.9156 | 3.9238 | 14 | 163 | telomere organization |
GO:0045087 | 0 | 2.1543 | 19.0978 | 38 | 799 | innate immune response |
GO:0002684 | 0 | 2.3131 | 14.9624 | 32 | 637 | positive regulation of immune system process |
GO:0048534 | 1e-04 | 2.1034 | 20.0522 | 39 | 833 | hematopoietic or lymphoid organ development |
GO:0071103 | 1e-04 | 3.0887 | 6.3069 | 18 | 262 | DNA conformation change |
GO:0009890 | 1e-04 | 1.7808 | 38.0582 | 62 | 1581 | negative regulation of biosynthetic process |
GO:0060249 | 1e-04 | 2.6737 | 8.8586 | 22 | 368 | anatomical structure homeostasis |
GO:0048870 | 1e-04 | 1.8069 | 33.7011 | 56 | 1400 | cell motility |
GO:0051259 | 1e-04 | 2.3621 | 12.2768 | 27 | 510 | protein oligomerization |
GO:0052547 | 1e-04 | 2.5534 | 9.677 | 23 | 402 | regulation of peptidase activity |
GO:0097530 | 1e-04 | 4.3017 | 2.8164 | 11 | 117 | granulocyte migration |
GO:0072376 | 1e-04 | 5.1653 | 1.9498 | 9 | 81 | protein activation cascade |
GO:0045060 | 1e-04 | 20.4737 | 0.2889 | 4 | 12 | negative thymic T cell selection |
GO:0050865 | 1e-04 | 2.3694 | 11.7713 | 26 | 489 | regulation of cell activation |
GO:0048863 | 2e-04 | 2.9584 | 6.1866 | 17 | 257 | stem cell differentiation |
GO:0006952 | 2e-04 | 3.2812 | 4.6109 | 14 | 208 | defense response |
GO:0032269 | 2e-04 | 1.8235 | 28.3811 | 48 | 1179 | negative regulation of cellular protein metabolic process |
GO:0006412 | 3e-04 | 2.0359 | 17.8857 | 34 | 743 | translation |
GO:1990869 | 3e-04 | 40.853 | 0.1444 | 3 | 6 | cellular response to chemokine |
GO:0045596 | 3e-04 | 2.1289 | 15.0692 | 30 | 626 | negative regulation of cell differentiation |
GO:0002757 | 3e-04 | 2.3247 | 11.0251 | 24 | 458 | immune response-activating signal transduction |
GO:0051707 | 3e-04 | 1.9786 | 18.9208 | 35 | 786 | response to other organism |
GO:0050817 | 5e-04 | 2.537 | 7.992 | 19 | 332 | coagulation |
GO:2000107 | 5e-04 | 6.6628 | 1.0351 | 6 | 43 | negative regulation of leukocyte apoptotic process |
GO:0050707 | 6e-04 | 3.3157 | 3.8997 | 12 | 162 | regulation of cytokine secretion |
GO:0019724 | 6e-04 | Inf | 0.0474 | 2 | 2 | B cell mediated immunity |
GO:0001776 | 6e-04 | 4.7106 | 1.8776 | 8 | 78 | leukocyte homeostasis |
GO:0018003 | 6e-04 | Inf | 0.0481 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0044663 | 6e-04 | Inf | 0.0481 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0070370 | 6e-04 | Inf | 0.0481 | 2 | 2 | cellular heat acclimation |
GO:0050727 | 6e-04 | 2.555 | 7.5105 | 18 | 312 | regulation of inflammatory response |
GO:0070374 | 7e-04 | 3.0644 | 4.5496 | 13 | 189 | positive regulation of ERK1 and ERK2 cascade |
GO:0048584 | 8e-04 | 2.1005 | 13.2052 | 26 | 572 | positive regulation of response to stimulus |
GO:0002695 | 8e-04 | 3.3713 | 3.5145 | 11 | 146 | negative regulation of leukocyte activation |
GO:0030449 | 9e-04 | 6.0112 | 1.1314 | 6 | 47 | regulation of complement activation |
GO:0009607 | 9e-04 | 1.866 | 19.9559 | 35 | 829 | response to biotic stimulus |
GO:0002253 | 9e-04 | 4.982 | 1.5567 | 7 | 67 | activation of immune response |
GO:0006342 | 9e-04 | 4.9771 | 1.5576 | 7 | 67 | chromatin silencing |
GO:2000113 | 9e-04 | 1.6594 | 34.2548 | 53 | 1423 | negative regulation of cellular macromolecule biosynthetic process |
GO:0002526 | 0.001 | 3.2974 | 3.5868 | 11 | 149 | acute inflammatory response |
GO:0002443 | 0.001 | 1.9346 | 17.0191 | 31 | 707 | leukocyte mediated immunity |
GO:0040029 | 0.001 | 3.8619 | 2.5266 | 9 | 110 | regulation of gene expression, epigenetic |
GO:0010950 | 0.001 | 3.2735 | 3.6108 | 11 | 150 | positive regulation of endopeptidase activity |
GO:0046598 | 0.001 | 20.4226 | 0.2166 | 3 | 9 | positive regulation of viral entry into host cell |
GO:0001816 | 0.0011 | 1.9695 | 15.6229 | 29 | 649 | cytokine production |
GO:0030168 | 0.0011 | 3.2499 | 3.6349 | 11 | 151 | platelet activation |
GO:0010604 | 0.0011 | 1.4729 | 69.8576 | 94 | 2902 | positive regulation of macromolecule metabolic process |
GO:2000116 | 0.0011 | 2.7539 | 5.4162 | 14 | 225 | regulation of cysteine-type endopeptidase activity |
GO:0007599 | 0.0012 | 2.397 | 7.9679 | 18 | 331 | hemostasis |
GO:0006518 | 0.0012 | 1.8358 | 20.2623 | 35 | 850 | peptide metabolic process |
GO:0043604 | 0.0012 | 1.8296 | 20.317 | 35 | 844 | amide biosynthetic process |
GO:0042742 | 0.0012 | 2.7277 | 5.4644 | 14 | 227 | defense response to bacterium |
GO:0060326 | 0.0013 | 2.6184 | 6.0903 | 15 | 253 | cell chemotaxis |
GO:0002250 | 0.0013 | 2.3661 | 8.0642 | 18 | 335 | adaptive immune response |
GO:0061844 | 0.0014 | 5.4755 | 1.2277 | 6 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0002430 | 0.0015 | 17.5039 | 0.2407 | 3 | 10 | complement receptor mediated signaling pathway |
GO:0006600 | 0.0015 | 17.5039 | 0.2407 | 3 | 10 | creatine metabolic process |
GO:0010629 | 0.0015 | 1.5645 | 42.5597 | 62 | 1768 | negative regulation of gene expression |
GO:0050709 | 0.0015 | 3.6035 | 2.6961 | 9 | 112 | negative regulation of protein secretion |
GO:0002696 | 0.0015 | 2.4728 | 6.8606 | 16 | 285 | positive regulation of leukocyte activation |
GO:0051607 | 0.0017 | 2.7482 | 5.0311 | 13 | 209 | defense response to virus |
GO:0002317 | 0.0017 | 81.5026 | 0.0722 | 2 | 3 | plasma cell differentiation |
GO:0070434 | 0.0017 | 81.5026 | 0.0722 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0017 | 81.5026 | 0.0722 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0002366 | 0.0018 | 1.9188 | 15.4303 | 28 | 641 | leukocyte activation involved in immune response |
GO:0038166 | 0.002 | 15.315 | 0.2648 | 3 | 11 | angiotensin-activated signaling pathway |
GO:0090084 | 0.002 | 15.315 | 0.2648 | 3 | 11 | negative regulation of inclusion body assembly |
GO:1903037 | 0.002 | 2.3337 | 7.7031 | 17 | 320 | regulation of leukocyte cell-cell adhesion |
GO:0002407 | 0.002 | 8.6144 | 0.5537 | 4 | 23 | dendritic cell chemotaxis |
GO:0045744 | 0.0021 | 6.2105 | 0.9147 | 5 | 38 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0016064 | 0.0023 | 3.7005 | 2.335 | 8 | 97 | immunoglobulin mediated immune response |
GO:0006957 | 0.0026 | 13.6124 | 0.2889 | 3 | 12 | complement activation, alternative pathway |
GO:0043069 | 0.0027 | 1.7681 | 19.7151 | 33 | 819 | negative regulation of programmed cell death |
GO:1903507 | 0.0029 | 1.6491 | 26.985 | 42 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0051253 | 0.0031 | 1.621 | 28.7663 | 44 | 1195 | negative regulation of RNA metabolic process |
GO:0050870 | 0.0032 | 2.6533 | 4.7904 | 12 | 199 | positive regulation of T cell activation |
GO:0036336 | 0.0033 | 41.1296 | 0.0954 | 2 | 4 | dendritic cell migration |
GO:0002864 | 0.0033 | 12.2504 | 0.3129 | 3 | 13 | regulation of acute inflammatory response to antigenic stimulus |
GO:0050711 | 0.0033 | 12.2504 | 0.3129 | 3 | 13 | negative regulation of interleukin-1 secretion |
GO:0019805 | 0.0034 | 40.7487 | 0.0963 | 2 | 4 | quinolinate biosynthetic process |
GO:1902714 | 0.0034 | 40.7487 | 0.0963 | 2 | 4 | negative regulation of interferon-gamma secretion |
GO:0050911 | 0.0037 | 2.251 | 7.4865 | 16 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051239 | 0.0037 | 1.419 | 65.4042 | 86 | 2717 | regulation of multicellular organismal process |
GO:0042981 | 0.004 | 1.5527 | 34.1585 | 50 | 1419 | regulation of apoptotic process |
GO:0030593 | 0.0041 | 3.7355 | 2.0221 | 7 | 84 | neutrophil chemotaxis |
GO:0010919 | 0.0041 | 11.136 | 0.337 | 3 | 14 | regulation of inositol phosphate biosynthetic process |
GO:0030852 | 0.0041 | 11.136 | 0.337 | 3 | 14 | regulation of granulocyte differentiation |
GO:0010951 | 0.0043 | 2.4445 | 5.6088 | 13 | 233 | negative regulation of endopeptidase activity |
GO:0007606 | 0.0046 | 2.042 | 9.7733 | 19 | 406 | sensory perception of chemical stimulus |
GO:0002768 | 0.0048 | 2.1258 | 8.4012 | 17 | 349 | immune response-regulating cell surface receptor signaling pathway |
GO:0002577 | 0.0051 | 10.2073 | 0.3611 | 3 | 15 | regulation of antigen processing and presentation |
GO:0010759 | 0.0051 | 10.2073 | 0.3611 | 3 | 15 | positive regulation of macrophage chemotaxis |
GO:0051546 | 0.0051 | 10.2073 | 0.3611 | 3 | 15 | keratinocyte migration |
GO:0060044 | 0.0051 | 10.2073 | 0.3611 | 3 | 15 | negative regulation of cardiac muscle cell proliferation |
GO:0002274 | 0.0052 | 1.829 | 14.347 | 25 | 596 | myeloid leukocyte activation |
GO:0050792 | 0.0053 | 2.6091 | 4.4534 | 11 | 185 | regulation of viral process |
GO:0002885 | 0.0055 | 27.164 | 0.1204 | 2 | 5 | positive regulation of hypersensitivity |
GO:0045409 | 0.0055 | 27.164 | 0.1204 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0060414 | 0.0055 | 27.164 | 0.1204 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:2001268 | 0.0055 | 27.164 | 0.1204 | 2 | 5 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0071624 | 0.0055 | 6.2923 | 0.7222 | 4 | 30 | positive regulation of granulocyte chemotaxis |
GO:0070665 | 0.0059 | 2.895 | 3.2979 | 9 | 137 | positive regulation of leukocyte proliferation |
GO:0035855 | 0.0061 | 9.4216 | 0.3852 | 3 | 16 | megakaryocyte development |
GO:0006958 | 0.0062 | 6.0589 | 0.7462 | 4 | 31 | complement activation, classical pathway |
GO:0009593 | 0.0062 | 2.0201 | 9.34 | 18 | 388 | detection of chemical stimulus |
GO:0051249 | 0.0064 | 2.5378 | 4.5693 | 11 | 193 | regulation of lymphocyte activation |
GO:0030098 | 0.0064 | 2.1721 | 7.2457 | 15 | 301 | lymphocyte differentiation |
GO:0006909 | 0.0064 | 2.4175 | 5.2237 | 12 | 217 | phagocytosis |
GO:0035821 | 0.0065 | 2.8501 | 3.346 | 9 | 139 | modification of morphology or physiology of other organism |
GO:0043280 | 0.0066 | 3.0744 | 2.7683 | 8 | 115 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0045055 | 0.0067 | 1.73 | 16.9709 | 28 | 705 | regulated exocytosis |
GO:0032652 | 0.0067 | 3.8452 | 1.6851 | 6 | 70 | regulation of interleukin-1 production |
GO:0045071 | 0.0069 | 4.5509 | 1.2036 | 5 | 50 | negative regulation of viral genome replication |
GO:0007186 | 0.0072 | 1.5708 | 26.8082 | 40 | 1134 | G-protein coupled receptor signaling pathway |
GO:0051048 | 0.0074 | 2.4793 | 4.67 | 11 | 194 | negative regulation of secretion |
GO:0035195 | 0.0076 | 2.9951 | 2.8331 | 8 | 122 | gene silencing by miRNA |
GO:0030216 | 0.0076 | 2.1934 | 6.6921 | 14 | 278 | keratinocyte differentiation |
GO:0050868 | 0.008 | 3.2662 | 2.2869 | 7 | 95 | negative regulation of T cell activation |
GO:0002606 | 0.0081 | 20.3717 | 0.1444 | 2 | 6 | positive regulation of dendritic cell antigen processing and presentation |
GO:0034112 | 0.0081 | 20.3717 | 0.1444 | 2 | 6 | positive regulation of homotypic cell-cell adhesion |
GO:0045345 | 0.0081 | 20.3717 | 0.1444 | 2 | 6 | positive regulation of MHC class I biosynthetic process |
GO:0019222 | 0.0083 | 1.2909 | 149.7292 | 173 | 6220 | regulation of metabolic process |
GO:0050670 | 0.0083 | 2.4388 | 4.7422 | 11 | 197 | regulation of lymphocyte proliferation |
GO:0010941 | 0.0084 | 1.4744 | 37.2397 | 52 | 1547 | regulation of cell death |
GO:0050906 | 0.0084 | 1.9551 | 9.6289 | 18 | 400 | detection of stimulus involved in sensory perception |
GO:0009605 | 0.0085 | 1.4197 | 48.6018 | 65 | 2019 | response to external stimulus |
GO:0009967 | 0.0085 | 1.4896 | 34.6881 | 49 | 1441 | positive regulation of signal transduction |
GO:0006749 | 0.0088 | 4.2656 | 1.2758 | 5 | 53 | glutathione metabolic process |
GO:0090303 | 0.0088 | 4.2656 | 1.2758 | 5 | 53 | positive regulation of wound healing |
GO:0006954 | 0.0092 | 2.1425 | 6.8424 | 14 | 293 | inflammatory response |
GO:0051716 | 0.0094 | 1.2826 | 161.9338 | 185 | 6727 | cellular response to stimulus |
GO:0048523 | 0.0094 | 1.3335 | 86.3865 | 106 | 3740 | negative regulation of cellular process |
GO:1902600 | 0.0094 | 3.1579 | 2.3591 | 7 | 98 | hydrogen ion transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038111 | 0 | 17.1625 | 1.0322 | 12 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 17.1625 | 1.0322 | 12 | 37 | response to interleukin-7 |
GO:0051290 | 0 | 13.4021 | 1.2274 | 12 | 44 | protein heterotetramerization |
GO:0006335 | 0 | 16.1808 | 0.8927 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 13.6879 | 1.0043 | 10 | 36 | chromatin silencing at rDNA |
GO:0007275 | 0 | 1.5398 | 136.5518 | 179 | 4895 | multicellular organism development |
GO:0009890 | 0 | 1.7906 | 44.1039 | 72 | 1581 | negative regulation of biosynthetic process |
GO:0045662 | 0 | 12.4534 | 0.6416 | 6 | 23 | negative regulation of myoblast differentiation |
GO:0045652 | 0 | 5.5471 | 2.0643 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:1903507 | 1e-04 | 1.869 | 31.2716 | 54 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0045815 | 1e-04 | 5.1434 | 2.2038 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:0051253 | 2e-04 | 1.7773 | 33.3359 | 55 | 1195 | negative regulation of RNA metabolic process |
GO:0001654 | 2e-04 | 2.5083 | 9.401 | 22 | 337 | eye development |
GO:0051239 | 2e-04 | 1.5246 | 75.7939 | 105 | 2717 | regulation of multicellular organismal process |
GO:0031497 | 2e-04 | 3.5051 | 4.0449 | 13 | 145 | chromatin assembly |
GO:0017148 | 3e-04 | 2.5192 | 8.9268 | 21 | 320 | negative regulation of translation |
GO:0061448 | 3e-04 | 2.8385 | 6.444 | 17 | 231 | connective tissue development |
GO:2000179 | 3e-04 | 6.1797 | 1.3111 | 7 | 47 | positive regulation of neural precursor cell proliferation |
GO:0035194 | 3e-04 | 2.8118 | 6.4998 | 17 | 233 | posttranscriptional gene silencing by RNA |
GO:0072006 | 3e-04 | 3.5536 | 3.6823 | 12 | 132 | nephron development |
GO:0007399 | 3e-04 | 1.627 | 45.9086 | 69 | 1686 | nervous system development |
GO:0060842 | 4e-04 | 35.0769 | 0.1674 | 3 | 6 | arterial endothelial cell differentiation |
GO:0034728 | 4e-04 | 3.2561 | 4.3239 | 13 | 155 | nucleosome organization |
GO:1902036 | 5e-04 | 3.8944 | 2.8175 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0045766 | 5e-04 | 3.3562 | 3.8776 | 12 | 139 | positive regulation of angiogenesis |
GO:0051147 | 6e-04 | 2.9837 | 5.0492 | 14 | 181 | regulation of muscle cell differentiation |
GO:0072148 | 6e-04 | 12.7776 | 0.4184 | 4 | 15 | epithelial cell fate commitment |
GO:0014816 | 7e-04 | 26.306 | 0.1953 | 3 | 7 | skeletal muscle satellite cell differentiation |
GO:0060964 | 7e-04 | 3.7295 | 2.9291 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0072080 | 7e-04 | 4.0832 | 2.427 | 9 | 87 | nephron tubule development |
GO:0060322 | 7e-04 | 1.9061 | 18.9415 | 34 | 679 | head development |
GO:0002663 | 8e-04 | Inf | 0.0558 | 2 | 2 | positive regulation of B cell tolerance induction |
GO:0070370 | 8e-04 | Inf | 0.0558 | 2 | 2 | cellular heat acclimation |
GO:0050793 | 8e-04 | 1.4963 | 64.4123 | 89 | 2309 | regulation of developmental process |
GO:0061061 | 8e-04 | 1.9587 | 16.7935 | 31 | 602 | muscle structure development |
GO:0003222 | 8e-04 | 11.712 | 0.4463 | 4 | 16 | ventricular trabecula myocardium morphogenesis |
GO:0048513 | 0.001 | 1.4364 | 82.8893 | 109 | 3014 | animal organ development |
GO:0061101 | 0.0011 | 21.0434 | 0.2232 | 3 | 8 | neuroendocrine cell differentiation |
GO:0007565 | 0.0016 | 2.781 | 4.9934 | 13 | 179 | female pregnancy |
GO:0090257 | 0.0016 | 2.5534 | 6.2487 | 15 | 224 | regulation of muscle system process |
GO:0048635 | 0.0019 | 5.1556 | 1.3111 | 6 | 47 | negative regulation of muscle organ development |
GO:1901862 | 0.0019 | 5.1556 | 1.3111 | 6 | 47 | negative regulation of muscle tissue development |
GO:0055123 | 0.0019 | 3.0214 | 3.9055 | 11 | 140 | digestive system development |
GO:0051172 | 0.002 | 1.4434 | 65.556 | 88 | 2350 | negative regulation of nitrogen compound metabolic process |
GO:0050878 | 0.0021 | 1.9736 | 13.3623 | 25 | 479 | regulation of body fluid levels |
GO:0048699 | 0.0021 | 1.5715 | 37.1577 | 55 | 1332 | generation of neurons |
GO:0048708 | 0.0022 | 4.2569 | 1.8133 | 7 | 65 | astrocyte differentiation |
GO:1903706 | 0.0022 | 2.0272 | 11.9675 | 23 | 429 | regulation of hemopoiesis |
GO:0021530 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0035054 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | embryonic heart tube anterior/posterior pattern specification |
GO:0045608 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | negative regulation of auditory receptor cell differentiation |
GO:0060689 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | cell differentiation involved in salivary gland development |
GO:0061141 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | lung ciliated cell differentiation |
GO:0070434 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0071288 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | cellular response to mercury ion |
GO:0090063 | 0.0023 | 70.0045 | 0.0837 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0048518 | 0.0023 | 1.3316 | 147.4314 | 176 | 5285 | positive regulation of biological process |
GO:0034248 | 0.0023 | 1.9033 | 14.9524 | 27 | 536 | regulation of cellular amide metabolic process |
GO:0048863 | 0.0024 | 2.3625 | 7.1693 | 16 | 257 | stem cell differentiation |
GO:0045687 | 0.0027 | 5.8625 | 0.9764 | 5 | 35 | positive regulation of glial cell differentiation |
GO:0031324 | 0.0027 | 1.417 | 69.7684 | 92 | 2501 | negative regulation of cellular metabolic process |
GO:0010033 | 0.0029 | 1.3889 | 80.7874 | 104 | 2896 | response to organic substance |
GO:0035239 | 0.003 | 2.1303 | 9.401 | 19 | 337 | tube morphogenesis |
GO:0014003 | 0.0031 | 5.673 | 1.0043 | 5 | 36 | oligodendrocyte development |
GO:0060968 | 0.0031 | 2.9981 | 3.5707 | 10 | 128 | regulation of gene silencing |
GO:0048468 | 0.0037 | 1.4516 | 52.7796 | 72 | 1892 | cell development |
GO:0003008 | 0.0038 | 1.4529 | 51.9706 | 71 | 1863 | system process |
GO:0002517 | 0.0039 | 11.6878 | 0.3348 | 3 | 12 | T cell tolerance induction |
GO:0048505 | 0.0039 | 11.6878 | 0.3348 | 3 | 12 | regulation of timing of cell differentiation |
GO:0072358 | 0.004 | 1.7654 | 17.8536 | 30 | 640 | cardiovascular system development |
GO:0003171 | 0.0041 | 7.0236 | 0.6695 | 4 | 24 | atrioventricular valve development |
GO:0031112 | 0.0041 | 7.0236 | 0.6695 | 4 | 24 | positive regulation of microtubule polymerization or depolymerization |
GO:0072073 | 0.0041 | 2.8752 | 3.7102 | 10 | 133 | kidney epithelium development |
GO:0051962 | 0.0045 | 1.9064 | 12.6649 | 23 | 454 | positive regulation of nervous system development |
GO:0003002 | 0.0045 | 2.0941 | 9.0384 | 18 | 324 | regionalization |
GO:0014722 | 0.0045 | 35 | 0.1116 | 2 | 4 | regulation of skeletal muscle contraction by calcium ion signaling |
GO:0031296 | 0.0045 | 35 | 0.1116 | 2 | 4 | B cell costimulation |
GO:0045632 | 0.0045 | 35 | 0.1116 | 2 | 4 | negative regulation of mechanoreceptor differentiation |
GO:1902261 | 0.0045 | 35 | 0.1116 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:0009612 | 0.0047 | 2.4259 | 5.6629 | 13 | 203 | response to mechanical stimulus |
GO:0051259 | 0.0047 | 1.8436 | 14.2271 | 25 | 510 | protein oligomerization |
GO:0045600 | 0.005 | 4.142 | 1.5901 | 6 | 57 | positive regulation of fat cell differentiation |
GO:1900103 | 0.005 | 10.5183 | 0.3627 | 3 | 13 | positive regulation of endoplasmic reticulum unfolded protein response |
GO:0035924 | 0.0054 | 4.8835 | 1.1437 | 5 | 41 | cellular response to vascular endothelial growth factor stimulus |
GO:0050807 | 0.0058 | 2.916 | 3.2918 | 9 | 118 | regulation of synapse organization |
GO:0002244 | 0.0061 | 2.4421 | 5.1887 | 12 | 186 | hematopoietic progenitor cell differentiation |
GO:0060041 | 0.0062 | 2.8807 | 3.3281 | 9 | 120 | retina development in camera-type eye |
GO:0010604 | 0.0062 | 1.3496 | 80.9547 | 102 | 2902 | positive regulation of macromolecule metabolic process |
GO:0010880 | 0.0063 | 6.1063 | 0.7532 | 4 | 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO:0006941 | 0.0064 | 2.5435 | 4.575 | 11 | 164 | striated muscle contraction |
GO:0010830 | 0.0064 | 3.9112 | 1.6738 | 6 | 60 | regulation of myotube differentiation |
GO:2000113 | 0.0065 | 1.547 | 29.9176 | 44 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
GO:0042246 | 0.0069 | 3.8398 | 1.7017 | 6 | 61 | tissue regeneration |
GO:0065004 | 0.0072 | 2.2915 | 5.9698 | 13 | 214 | protein-DNA complex assembly |
GO:0007274 | 0.0072 | 5.8515 | 0.7811 | 4 | 28 | neuromuscular synaptic transmission |
GO:1901522 | 0.0072 | 5.8515 | 0.7811 | 4 | 28 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
GO:0014013 | 0.0073 | 3.0342 | 2.8175 | 8 | 101 | regulation of gliogenesis |
GO:0003186 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | tricuspid valve morphogenesis |
GO:0006524 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | alanine catabolic process |
GO:0007386 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | compartment pattern specification |
GO:0009078 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | pyruvate family amino acid metabolic process |
GO:0021779 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | glial cell fate specification |
GO:0035482 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | gastric motility |
GO:0043415 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | positive regulation of skeletal muscle tissue regeneration |
GO:0045409 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0048631 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | regulation of skeletal muscle tissue growth |
GO:0061743 | 0.0073 | 23.3318 | 0.1395 | 2 | 5 | motor learning |
GO:0048514 | 0.0074 | 1.7719 | 14.7571 | 25 | 529 | blood vessel morphogenesis |
GO:0007165 | 0.0075 | 1.2784 | 153.2338 | 178 | 5493 | signal transduction |
GO:0034310 | 0.0076 | 8.7641 | 0.4184 | 3 | 15 | primary alcohol catabolic process |
GO:0061298 | 0.0076 | 8.7641 | 0.4184 | 3 | 15 | retina vasculature development in camera-type eye |
GO:0070293 | 0.0076 | 8.7641 | 0.4184 | 3 | 15 | renal absorption |
GO:0032502 | 0.0077 | 1.3409 | 89.574 | 110 | 3433 | developmental process |
GO:1901019 | 0.0079 | 3.2884 | 2.2875 | 7 | 82 | regulation of calcium ion transmembrane transporter activity |
GO:0003203 | 0.0082 | 5.6171 | 0.809 | 4 | 29 | endocardial cushion morphogenesis |
GO:0055026 | 0.0082 | 5.6171 | 0.809 | 4 | 29 | negative regulation of cardiac muscle tissue development |
GO:0045926 | 0.0083 | 2.2462 | 6.0814 | 13 | 218 | negative regulation of growth |
GO:0016202 | 0.0084 | 2.7388 | 3.487 | 9 | 125 | regulation of striated muscle tissue development |
GO:0030323 | 0.0086 | 2.4311 | 4.7702 | 11 | 171 | respiratory tube development |
GO:0055008 | 0.0087 | 3.6405 | 1.7854 | 6 | 64 | cardiac muscle tissue morphogenesis |
GO:0002313 | 0.0092 | 8.0895 | 0.4463 | 3 | 16 | mature B cell differentiation involved in immune response |
GO:0002643 | 0.0092 | 8.0895 | 0.4463 | 3 | 16 | regulation of tolerance induction |
GO:0030099 | 0.0093 | 1.8982 | 10.4611 | 19 | 375 | myeloid cell differentiation |
GO:0007519 | 0.0094 | 2.5233 | 4.1844 | 10 | 150 | skeletal muscle tissue development |
GO:0002067 | 0.0097 | 4.1843 | 1.3111 | 5 | 47 | glandular epithelial cell differentiation |
GO:0045933 | 0.0097 | 4.1843 | 1.3111 | 5 | 47 | positive regulation of muscle contraction |
GO:0071622 | 0.0097 | 4.1843 | 1.3111 | 5 | 47 | regulation of granulocyte chemotaxis |
GO:0006342 | 0.0099 | 3.5355 | 1.8312 | 6 | 67 | chromatin silencing |
GO:0030900 | 0.0099 | 1.9209 | 9.7916 | 18 | 351 | forebrain development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 21.7712 | 8.1103 | 97 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 16.5438 | 10.5878 | 103 | 406 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 16.7546 | 10.1184 | 100 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 16.0717 | 10.4313 | 100 | 400 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 5.7214 | 29.9378 | 120 | 1148 | nervous system process |
GO:0007186 | 0 | 5.3913 | 30.7984 | 118 | 1181 | G-protein coupled receptor signaling pathway |
GO:0031424 | 0 | 17.7551 | 2.3544 | 28 | 93 | keratinization |
GO:0009913 | 0 | 6.561 | 8.5276 | 45 | 327 | epidermal cell differentiation |
GO:0018149 | 0 | 24.2399 | 1.4343 | 21 | 55 | peptide cross-linking |
GO:0043588 | 0 | 5.5566 | 10.0662 | 46 | 386 | skin development |
GO:0070268 | 0 | 5.9538 | 2.9208 | 15 | 112 | cornification |
GO:0032501 | 0 | 1.6831 | 156.9267 | 204 | 6625 | multicellular organismal process |
GO:0042742 | 0 | 4.8766 | 3.7114 | 16 | 144 | defense response to bacterium |
GO:0060429 | 0 | 1.9423 | 30.9027 | 55 | 1185 | epithelium development |
GO:0019730 | 0 | 5.1188 | 2.4253 | 11 | 93 | antimicrobial humoral response |
GO:0045087 | 1e-04 | 2.0022 | 20.9246 | 39 | 806 | innate immune response |
GO:0050896 | 2e-04 | 1.426 | 210.4774 | 246 | 8071 | response to stimulus |
GO:0006968 | 5e-04 | 5.6403 | 1.4082 | 7 | 54 | cellular defense response |
GO:0002765 | 6e-04 | 28.2058 | 0.1825 | 3 | 7 | immune response-inhibiting signal transduction |
GO:0051923 | 6e-04 | 12.5599 | 0.4173 | 4 | 16 | sulfation |
GO:0002548 | 7e-04 | 5.1966 | 1.5125 | 7 | 58 | monocyte chemotaxis |
GO:0070098 | 8e-04 | 4.4602 | 1.9819 | 8 | 76 | chemokine-mediated signaling pathway |
GO:0007195 | 0.0013 | 18.8015 | 0.2347 | 3 | 9 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0097267 | 0.0013 | 18.8015 | 0.2347 | 3 | 9 | omega-hydroxylase P450 pathway |
GO:0043207 | 0.0015 | 1.8035 | 20.5496 | 35 | 788 | response to external biotic stimulus |
GO:0019373 | 0.0016 | 9.4175 | 0.5216 | 4 | 20 | epoxygenase P450 pathway |
GO:1904627 | 0.0018 | 16.1145 | 0.2608 | 3 | 10 | response to phorbol 13-acetate 12-myristate |
GO:0002774 | 0.002 | 75.0483 | 0.0782 | 2 | 3 | Fc receptor mediated inhibitory signaling pathway |
GO:0003095 | 0.002 | 75.0483 | 0.0782 | 2 | 3 | pressure natriuresis |
GO:0046968 | 0.002 | 75.0483 | 0.0782 | 2 | 3 | peptide antigen transport |
GO:1904100 | 0.002 | 75.0483 | 0.0782 | 2 | 3 | positive regulation of protein O-linked glycosylation |
GO:0009620 | 0.002 | 5.0377 | 1.33 | 6 | 51 | response to fungus |
GO:0048247 | 0.0025 | 4.8227 | 1.3821 | 6 | 53 | lymphocyte chemotaxis |
GO:0044406 | 0.0025 | 14.0993 | 0.2869 | 3 | 11 | adhesion of symbiont to host |
GO:0045919 | 0.0025 | 14.0993 | 0.2869 | 3 | 11 | positive regulation of cytolysis |
GO:0031640 | 0.003 | 4.6253 | 1.4343 | 6 | 55 | killing of cells of other organism |
GO:0034308 | 0.003 | 4.6253 | 1.4343 | 6 | 55 | primary alcohol metabolic process |
GO:0006068 | 0.0033 | 12.5319 | 0.3129 | 3 | 12 | ethanol catabolic process |
GO:0060158 | 0.0033 | 12.5319 | 0.3129 | 3 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0050427 | 0.0037 | 7.1729 | 0.652 | 4 | 25 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process |
GO:0036101 | 0.0039 | 37.5217 | 0.1043 | 2 | 4 | leukotriene B4 catabolic process |
GO:0051481 | 0.0041 | 11.278 | 0.339 | 3 | 13 | negative regulation of cytosolic calcium ion concentration |
GO:0051967 | 0.0041 | 11.278 | 0.339 | 3 | 13 | negative regulation of synaptic transmission, glutamatergic |
GO:0051926 | 0.0046 | 4.1957 | 1.5647 | 6 | 60 | negative regulation of calcium ion transport |
GO:0002674 | 0.0052 | 10.252 | 0.3651 | 3 | 14 | negative regulation of acute inflammatory response |
GO:0045721 | 0.0052 | 10.252 | 0.3651 | 3 | 14 | negative regulation of gluconeogenesis |
GO:0048149 | 0.0052 | 10.252 | 0.3651 | 3 | 14 | behavioral response to ethanol |
GO:0050830 | 0.0059 | 3.4815 | 2.1645 | 7 | 83 | defense response to Gram-positive bacterium |
GO:0071466 | 0.0062 | 3.1209 | 2.7382 | 8 | 105 | cellular response to xenobiotic stimulus |
GO:1901386 | 0.0063 | 9.3971 | 0.3912 | 3 | 15 | negative regulation of voltage-gated calcium channel activity |
GO:0006824 | 0.0064 | 25.0129 | 0.1304 | 2 | 5 | cobalt ion transport |
GO:0061760 | 0.0064 | 25.0129 | 0.1304 | 2 | 5 | antifungal innate immune response |
GO:1901523 | 0.0064 | 25.0129 | 0.1304 | 2 | 5 | icosanoid catabolic process |
GO:2000359 | 0.0064 | 25.0129 | 0.1304 | 2 | 5 | regulation of binding of sperm to zona pellucida |
GO:0060326 | 0.0068 | 2.229 | 6.5978 | 14 | 253 | cell chemotaxis |
GO:0071624 | 0.0073 | 5.7916 | 0.7823 | 4 | 30 | positive regulation of granulocyte chemotaxis |
GO:0052695 | 0.0077 | 8.6737 | 0.4173 | 3 | 16 | cellular glucuronidation |
GO:0001895 | 0.0079 | 3.7125 | 1.7472 | 6 | 67 | retina homeostasis |
GO:0017144 | 0.0092 | 5.3773 | 0.8345 | 4 | 32 | drug metabolic process |
GO:0006072 | 0.0095 | 18.7585 | 0.1565 | 2 | 6 | glycerol-3-phosphate metabolic process |
GO:0016098 | 0.0095 | 18.7585 | 0.1565 | 2 | 6 | monoterpenoid metabolic process |
GO:0019236 | 0.0095 | 18.7585 | 0.1565 | 2 | 6 | response to pheromone |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 19.7588 | 0.7382 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 14.5201 | 1.015 | 11 | 44 | protein heterotetramerization |
GO:0000183 | 0 | 16.7147 | 0.8305 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 16.0946 | 0.8536 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 16.0946 | 0.8536 | 10 | 37 | response to interleukin-7 |
GO:0006333 | 0 | 5.6016 | 3.8987 | 19 | 169 | chromatin assembly or disassembly |
GO:0006323 | 0 | 5.0259 | 4.2909 | 19 | 186 | DNA packaging |
GO:0045652 | 0 | 8.4389 | 1.7071 | 12 | 74 | regulation of megakaryocyte differentiation |
GO:0016441 | 0 | 4.1277 | 5.3982 | 20 | 234 | posttranscriptional gene silencing |
GO:0045815 | 0 | 7.0306 | 1.8225 | 11 | 79 | positive regulation of gene expression, epigenetic |
GO:0031047 | 0 | 3.7216 | 5.9288 | 20 | 257 | gene silencing by RNA |
GO:0071824 | 0 | 3.6996 | 5.652 | 19 | 245 | protein-DNA complex subunit organization |
GO:0002227 | 1e-04 | 14.2966 | 0.4614 | 5 | 20 | innate immune response in mucosa |
GO:0002251 | 1e-04 | 9.918 | 0.7382 | 6 | 32 | organ or tissue specific immune response |
GO:0034249 | 1e-04 | 2.7949 | 7.7051 | 20 | 334 | negative regulation of cellular amide metabolic process |
GO:0048863 | 1e-04 | 3.0965 | 5.9288 | 17 | 257 | stem cell differentiation |
GO:1902036 | 1e-04 | 4.7557 | 2.33 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 2e-04 | 4.5542 | 2.4223 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0006334 | 3e-04 | 4.6955 | 2.1138 | 9 | 94 | nucleosome assembly |
GO:0045814 | 4e-04 | 4.0027 | 2.7222 | 10 | 118 | negative regulation of gene expression, epigenetic |
GO:0032200 | 4e-04 | 3.4451 | 3.7603 | 12 | 163 | telomere organization |
GO:0035195 | 4e-04 | 3.9452 | 2.7561 | 10 | 122 | gene silencing by miRNA |
GO:0006742 | 5e-04 | Inf | 0.0461 | 2 | 2 | NADP catabolic process |
GO:0061104 | 5e-04 | Inf | 0.0461 | 2 | 2 | adrenal chromaffin cell differentiation |
GO:2000179 | 7e-04 | 6.2834 | 1.0843 | 6 | 47 | positive regulation of neural precursor cell proliferation |
GO:0060968 | 8e-04 | 3.6611 | 2.9529 | 10 | 128 | regulation of gene silencing |
GO:1905205 | 0.0013 | 18.29 | 0.2307 | 3 | 10 | positive regulation of connective tissue replacement |
GO:0002244 | 0.0013 | 2.9853 | 4.2909 | 12 | 186 | hematopoietic progenitor cell differentiation |
GO:0007389 | 0.0014 | 2.2449 | 9.4353 | 20 | 409 | pattern specification process |
GO:0003358 | 0.0016 | 85.153 | 0.0692 | 2 | 3 | noradrenergic neuron development |
GO:0007596 | 0.0016 | 2.3863 | 7.5436 | 17 | 327 | blood coagulation |
GO:0019731 | 0.0017 | 6.4909 | 0.8766 | 5 | 38 | antibacterial humoral response |
GO:0007606 | 0.0029 | 2.1378 | 9.3661 | 19 | 406 | sensory perception of chemical stimulus |
GO:0021978 | 0.0029 | 12.8005 | 0.2999 | 3 | 13 | telencephalon regionalization |
GO:0042853 | 0.0031 | 42.5738 | 0.0923 | 2 | 4 | L-alanine catabolic process |
GO:0060480 | 0.0031 | 42.5738 | 0.0923 | 2 | 4 | lung goblet cell differentiation |
GO:0007274 | 0.0037 | 7.1245 | 0.6459 | 4 | 28 | neuromuscular synaptic transmission |
GO:0050878 | 0.0038 | 1.9987 | 11.0502 | 21 | 479 | regulation of body fluid levels |
GO:0009593 | 0.0041 | 2.1147 | 8.9509 | 18 | 388 | detection of chemical stimulus |
GO:0010862 | 0.0044 | 5.0971 | 1.0843 | 5 | 47 | positive regulation of pathway-restricted SMAD protein phosphorylation |
GO:0034356 | 0.0045 | 10.6658 | 0.346 | 3 | 15 | NAD biosynthesis via nicotinamide riboside salvage pathway |
GO:0060563 | 0.0048 | 4.9782 | 1.1073 | 5 | 48 | neuroepithelial cell differentiation |
GO:0006522 | 0.0051 | 28.3807 | 0.1153 | 2 | 5 | alanine metabolic process |
GO:0009080 | 0.0051 | 28.3807 | 0.1153 | 2 | 5 | pyruvate family amino acid catabolic process |
GO:0048631 | 0.0051 | 28.3807 | 0.1153 | 2 | 5 | regulation of skeletal muscle tissue growth |
GO:0072526 | 0.0051 | 28.3807 | 0.1153 | 2 | 5 | pyridine-containing compound catabolic process |
GO:0019359 | 0.0054 | 6.3317 | 0.7151 | 4 | 31 | nicotinamide nucleotide biosynthetic process |
GO:0009952 | 0.0057 | 2.5789 | 4.4985 | 11 | 195 | anterior/posterior pattern specification |
GO:0050911 | 0.0059 | 2.1947 | 7.1745 | 15 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0061844 | 0.0063 | 4.6527 | 1.1765 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0030099 | 0.0064 | 2.0599 | 8.651 | 17 | 375 | myeloid cell differentiation |
GO:0048665 | 0.0067 | 5.8943 | 0.7613 | 4 | 33 | neuron fate specification |
GO:0048513 | 0.0071 | 1.3663 | 73.4754 | 93 | 3185 | animal organ development |
GO:0072525 | 0.0075 | 5.6974 | 0.7844 | 4 | 34 | pyridine-containing compound biosynthetic process |
GO:0060482 | 0.0075 | 21.2842 | 0.1384 | 2 | 6 | lobar bronchus development |
GO:0060395 | 0.0086 | 4.2793 | 1.2688 | 5 | 55 | SMAD protein signal transduction |
GO:0032501 | 0.0086 | 1.3036 | 143.763 | 166 | 6421 | multicellular organismal process |
GO:1903242 | 0.009 | 7.9973 | 0.4383 | 3 | 19 | regulation of cardiac muscle hypertrophy in response to stress |
GO:0007186 | 0.0093 | 1.5437 | 27.2447 | 40 | 1181 | G-protein coupled receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007218 | 0 | 12.2476 | 2.4042 | 22 | 94 | neuropeptide signaling pathway |
GO:0007187 | 0 | 5.0846 | 4.5015 | 20 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0009952 | 0 | 4.2649 | 4.9875 | 19 | 195 | anterior/posterior pattern specification |
GO:0050877 | 0 | 2.1513 | 29.3621 | 57 | 1148 | nervous system process |
GO:0007606 | 0 | 2.8356 | 10.3842 | 27 | 406 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 2.2001 | 20.86 | 42 | 880 | G-protein coupled receptor signaling pathway |
GO:0021524 | 0 | Inf | 0.0767 | 3 | 3 | visceral motor neuron differentiation |
GO:0046877 | 0 | 30.7703 | 0.2302 | 4 | 9 | regulation of saliva secretion |
GO:0050911 | 1e-04 | 2.8543 | 7.9544 | 21 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 1e-04 | 2.6065 | 9.9238 | 24 | 388 | detection of chemical stimulus |
GO:0043269 | 1e-04 | 2.2563 | 15.2693 | 32 | 597 | regulation of ion transport |
GO:0050906 | 1e-04 | 2.5213 | 10.2307 | 24 | 400 | detection of stimulus involved in sensory perception |
GO:0007268 | 1e-04 | 2.2291 | 14.9368 | 31 | 584 | chemical synaptic transmission |
GO:0099537 | 1e-04 | 2.2208 | 14.988 | 31 | 586 | trans-synaptic signaling |
GO:0009887 | 1e-04 | 1.9259 | 24.6048 | 44 | 962 | animal organ morphogenesis |
GO:0019935 | 1e-04 | 4.2366 | 2.8646 | 11 | 112 | cyclic-nucleotide-mediated signaling |
GO:0072507 | 1e-04 | 2.4155 | 11.1003 | 25 | 434 | divalent inorganic cation homeostasis |
GO:0071799 | 2e-04 | 57.563 | 0.1279 | 3 | 5 | cellular response to prostaglandin D stimulus |
GO:0006874 | 2e-04 | 2.4636 | 10.0005 | 23 | 391 | cellular calcium ion homeostasis |
GO:0065007 | 2e-04 | 1.5161 | 283.9017 | 316 | 11100 | biological regulation |
GO:0007267 | 2e-04 | 1.8458 | 27.4632 | 47 | 1103 | cell-cell signaling |
GO:0007389 | 2e-04 | 2.601 | 8.2378 | 20 | 326 | pattern specification process |
GO:0021545 | 3e-04 | 7.5212 | 0.94 | 6 | 37 | cranial nerve development |
GO:0006812 | 5e-04 | 1.7953 | 26.83 | 45 | 1049 | cation transport |
GO:0002070 | 5e-04 | 13.9811 | 0.3837 | 4 | 15 | epithelial cell maturation |
GO:0021983 | 5e-04 | 6.8086 | 1.0231 | 6 | 40 | pituitary gland development |
GO:0050794 | 5e-04 | 1.43 | 253.1329 | 285 | 9897 | regulation of cellular process |
GO:2000818 | 5e-04 | 28.7778 | 0.179 | 3 | 7 | negative regulation of myoblast proliferation |
GO:0007204 | 6e-04 | 2.6491 | 6.8546 | 17 | 268 | positive regulation of cytosolic calcium ion concentration |
GO:0021570 | 7e-04 | Inf | 0.0512 | 2 | 2 | rhombomere 4 development |
GO:0033693 | 7e-04 | Inf | 0.0512 | 2 | 2 | neurofilament bundle assembly |
GO:0060577 | 7e-04 | Inf | 0.0512 | 2 | 2 | pulmonary vein morphogenesis |
GO:0034762 | 8e-04 | 2.1996 | 11.1003 | 23 | 434 | regulation of transmembrane transport |
GO:0032026 | 0.001 | 10.983 | 0.4604 | 4 | 18 | response to magnesium ion |
GO:0032501 | 0.0011 | 1.4061 | 130.0626 | 158 | 5469 | multicellular organismal process |
GO:0014807 | 0.0012 | 19.1827 | 0.2302 | 3 | 9 | regulation of somitogenesis |
GO:0038003 | 0.0012 | 19.1827 | 0.2302 | 3 | 9 | opioid receptor signaling pathway |
GO:0046549 | 0.0012 | 19.1827 | 0.2302 | 3 | 9 | retinal cone cell development |
GO:0007200 | 0.0013 | 3.7074 | 2.6344 | 9 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0097746 | 0.0014 | 3.371 | 3.1971 | 10 | 125 | regulation of blood vessel diameter |
GO:0048665 | 0.0014 | 9.6746 | 0.5082 | 4 | 20 | neuron fate specification |
GO:1905207 | 0.0015 | 5.3804 | 1.2533 | 6 | 49 | regulation of cardiocyte differentiation |
GO:0046883 | 0.0017 | 2.5413 | 6.2663 | 15 | 245 | regulation of hormone secretion |
GO:0032355 | 0.0017 | 3.2846 | 3.2738 | 10 | 128 | response to estradiol |
GO:0051283 | 0.0017 | 3.5552 | 2.7367 | 9 | 107 | negative regulation of sequestering of calcium ion |
GO:0048935 | 0.0017 | 16.5218 | 0.2546 | 3 | 10 | peripheral nervous system neuron development |
GO:0031290 | 0.0018 | 9.0431 | 0.5371 | 4 | 21 | retinal ganglion cell axon guidance |
GO:0008015 | 0.0018 | 2.0267 | 12.507 | 24 | 489 | blood circulation |
GO:0007193 | 0.0018 | 4.3803 | 1.7566 | 7 | 69 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:1904705 | 0.0018 | 6.416 | 0.8952 | 5 | 35 | regulation of vascular smooth muscle cell proliferation |
GO:2000021 | 0.0019 | 2.7175 | 5.0898 | 13 | 199 | regulation of ion homeostasis |
GO:0048936 | 0.0019 | 76.5665 | 0.0767 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060435 | 0.0019 | 76.5665 | 0.0767 | 2 | 3 | bronchiole development |
GO:0060913 | 0.0019 | 76.5665 | 0.0767 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 0.0019 | 76.5665 | 0.0767 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0035150 | 0.0023 | 3.1245 | 3.4273 | 10 | 134 | regulation of tube size |
GO:0021559 | 0.0024 | 14.3852 | 0.2813 | 3 | 11 | trigeminal nerve development |
GO:0055065 | 0.0025 | 1.9169 | 14.2974 | 26 | 559 | metal ion homeostasis |
GO:0006688 | 0.0025 | 8.0902 | 0.5883 | 4 | 23 | glycosphingolipid biosynthetic process |
GO:0042749 | 0.0025 | 8.0902 | 0.5883 | 4 | 23 | regulation of circadian sleep/wake cycle |
GO:0042310 | 0.0026 | 4.0938 | 1.8671 | 7 | 73 | vasoconstriction |
GO:0001501 | 0.0027 | 1.9947 | 12.1489 | 23 | 475 | skeletal system development |
GO:0051281 | 0.0027 | 5.8316 | 0.9719 | 5 | 38 | positive regulation of release of sequestered calcium ion into cytosol |
GO:0071805 | 0.0027 | 2.8671 | 4.0859 | 11 | 161 | potassium ion transmembrane transport |
GO:0098660 | 0.0028 | 1.763 | 19.7452 | 33 | 772 | inorganic ion transmembrane transport |
GO:0003151 | 0.0028 | 4.0324 | 1.8927 | 7 | 74 | outflow tract morphogenesis |
GO:0008284 | 0.0029 | 1.7271 | 21.3821 | 35 | 836 | positive regulation of cell proliferation |
GO:0030878 | 0.003 | 7.6851 | 0.6138 | 4 | 24 | thyroid gland development |
GO:0045760 | 0.0031 | 12.786 | 0.3069 | 3 | 12 | positive regulation of action potential |
GO:0034767 | 0.0032 | 3.2094 | 3.0044 | 9 | 118 | positive regulation of ion transmembrane transport |
GO:0061061 | 0.0035 | 1.8449 | 15.3972 | 27 | 602 | muscle structure development |
GO:0030003 | 0.0036 | 1.8625 | 14.681 | 26 | 574 | cellular cation homeostasis |
GO:0045104 | 0.0038 | 5.3446 | 1.0486 | 5 | 41 | intermediate filament cytoskeleton organization |
GO:0001992 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003308 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0007198 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021615 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0060126 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | somatotropin secreting cell differentiation |
GO:0070253 | 0.0038 | 38.2808 | 0.1023 | 2 | 4 | somatostatin secretion |
GO:0030799 | 0.0038 | 2.7331 | 4.2713 | 11 | 167 | regulation of cyclic nucleotide metabolic process |
GO:0007399 | 0.0039 | 1.4454 | 54.7342 | 74 | 2140 | nervous system development |
GO:0023061 | 0.0039 | 2.035 | 10.333 | 20 | 404 | signal release |
GO:0007320 | 0.0039 | 11.5067 | 0.3325 | 3 | 13 | insemination |
GO:0021520 | 0.0039 | 11.5067 | 0.3325 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:1904062 | 0.004 | 2.2976 | 6.8801 | 15 | 269 | regulation of cation transmembrane transport |
GO:0097553 | 0.0041 | 3.0802 | 3.1204 | 9 | 122 | calcium ion transmembrane import into cytosol |
GO:0009914 | 0.0045 | 2.2011 | 7.6474 | 16 | 299 | hormone transport |
GO:0051928 | 0.0046 | 3.2872 | 2.6088 | 8 | 102 | positive regulation of calcium ion transport |
GO:0002675 | 0.0046 | 6.6814 | 0.6906 | 4 | 27 | positive regulation of acute inflammatory response |
GO:0003016 | 0.0046 | 6.6814 | 0.6906 | 4 | 27 | respiratory system process |
GO:0022410 | 0.0046 | 6.6814 | 0.6906 | 4 | 27 | circadian sleep/wake cycle process |
GO:0042634 | 0.0046 | 6.6814 | 0.6906 | 4 | 27 | regulation of hair cycle |
GO:2001141 | 0.0048 | 1.3575 | 87.8049 | 110 | 3433 | regulation of RNA biosynthetic process |
GO:0042711 | 0.0049 | 10.4599 | 0.3581 | 3 | 14 | maternal behavior |
GO:0019219 | 0.0049 | 1.3388 | 101.821 | 125 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0006355 | 0.0052 | 1.3541 | 87.1143 | 109 | 3406 | regulation of transcription, DNA-templated |
GO:0009798 | 0.0053 | 3.5528 | 2.1229 | 7 | 83 | axis specification |
GO:0030879 | 0.0054 | 2.9488 | 3.2482 | 9 | 127 | mammary gland development |
GO:0014902 | 0.0055 | 3.1849 | 2.6856 | 8 | 105 | myotube differentiation |
GO:0007189 | 0.0058 | 3.9851 | 1.6369 | 6 | 64 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0055008 | 0.0058 | 3.9851 | 1.6369 | 6 | 64 | cardiac muscle tissue morphogenesis |
GO:0008595 | 0.006 | 9.5877 | 0.3837 | 3 | 15 | anterior/posterior axis specification, embryo |
GO:0014048 | 0.006 | 9.5877 | 0.3837 | 3 | 15 | regulation of glutamate secretion |
GO:0048532 | 0.006 | 9.5877 | 0.3837 | 3 | 15 | anatomical structure arrangement |
GO:0051546 | 0.006 | 9.5877 | 0.3837 | 3 | 15 | keratinocyte migration |
GO:0060253 | 0.006 | 9.5877 | 0.3837 | 3 | 15 | negative regulation of glial cell proliferation |
GO:0003203 | 0.006 | 6.1461 | 0.7417 | 4 | 29 | endocardial cushion morphogenesis |
GO:0055026 | 0.006 | 6.1461 | 0.7417 | 4 | 29 | negative regulation of cardiac muscle tissue development |
GO:0010841 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0035609 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | C-terminal protein deglutamylation |
GO:0038170 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | somatostatin signaling pathway |
GO:0048880 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | sensory system development |
GO:0051970 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0061743 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | motor learning |
GO:1905032 | 0.0062 | 25.5189 | 0.1279 | 2 | 5 | negative regulation of membrane repolarization during cardiac muscle cell action potential |
GO:0048598 | 0.0064 | 1.7964 | 14.5787 | 25 | 570 | embryonic morphogenesis |
GO:0003018 | 0.0066 | 2.6683 | 3.9644 | 10 | 155 | vascular process in circulatory system |
GO:0002067 | 0.0068 | 4.5793 | 1.2021 | 5 | 47 | glandular epithelial cell differentiation |
GO:0019098 | 0.0068 | 5.9094 | 0.7673 | 4 | 30 | reproductive behavior |
GO:0060603 | 0.0068 | 5.9094 | 0.7673 | 4 | 30 | mammary gland duct morphogenesis |
GO:0098664 | 0.0072 | 8.8923 | 0.4073 | 3 | 16 | G-protein coupled serotonin receptor signaling pathway |
GO:0033555 | 0.0072 | 3.7884 | 1.7136 | 6 | 67 | multicellular organismal response to stress |
GO:0090277 | 0.0073 | 3.3324 | 2.2508 | 7 | 88 | positive regulation of peptide hormone secretion |
GO:1903532 | 0.0074 | 2.0296 | 8.7728 | 17 | 343 | positive regulation of secretion by cell |
GO:0050885 | 0.0074 | 4.4726 | 1.2277 | 5 | 48 | neuromuscular process controlling balance |
GO:0030816 | 0.0078 | 3.2916 | 2.2763 | 7 | 89 | positive regulation of cAMP metabolic process |
GO:0043266 | 0.0082 | 3.2517 | 2.3019 | 7 | 90 | regulation of potassium ion transport |
GO:0048646 | 0.0082 | 1.5724 | 25.3465 | 38 | 991 | anatomical structure formation involved in morphogenesis |
GO:0042755 | 0.0086 | 5.4866 | 0.8185 | 4 | 32 | eating behavior |
GO:0001573 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | ganglioside metabolic process |
GO:0045683 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | negative regulation of epidermis development |
GO:0060219 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0060644 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | mammary gland epithelial cell differentiation |
GO:0098911 | 0.0086 | 8.2169 | 0.4348 | 3 | 17 | regulation of ventricular cardiac muscle cell action potential |
GO:0051094 | 0.0087 | 1.5173 | 30.4619 | 44 | 1191 | positive regulation of developmental process |
GO:0008306 | 0.0089 | 3.6101 | 1.7904 | 6 | 70 | associative learning |
GO:0055082 | 0.009 | 1.67 | 18.1595 | 29 | 710 | cellular chemical homeostasis |
GO:0051241 | 0.009 | 1.5536 | 26.3233 | 39 | 1034 | negative regulation of multicellular organismal process |
GO:0002865 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0032351 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | negative regulation of hormone metabolic process |
GO:0038001 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | paracrine signaling |
GO:0038031 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
GO:1903961 | 0.0091 | 19.1379 | 0.1535 | 2 | 6 | positive regulation of anion transmembrane transport |
GO:0006813 | 0.0092 | 2.6868 | 3.5393 | 9 | 140 | potassium ion transport |
GO:0035282 | 0.0093 | 3.1748 | 2.3531 | 7 | 92 | segmentation |
GO:0048704 | 0.0093 | 3.1748 | 2.3531 | 7 | 92 | embryonic skeletal system morphogenesis |
GO:0032103 | 0.0093 | 2.139 | 6.8546 | 14 | 268 | positive regulation of response to external stimulus |
GO:1900543 | 0.0095 | 3.5543 | 1.8159 | 6 | 71 | negative regulation of purine nucleotide metabolic process |
GO:0001662 | 0.0096 | 5.297 | 0.844 | 4 | 33 | behavioral fear response |
GO:1901381 | 0.0096 | 5.297 | 0.844 | 4 | 33 | positive regulation of potassium ion transmembrane transport |
GO:0019233 | 0.0098 | 3.1377 | 2.3786 | 7 | 93 | sensory perception of pain |
GO:0007631 | 0.0098 | 3.529 | 1.8271 | 6 | 72 | feeding behavior |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 148.8743 | 0.4288 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 33.0534 | 0.7623 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0034080 | 0 | 25.5567 | 0.9529 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:0000183 | 0 | 27.0368 | 0.8576 | 14 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 22.026 | 1.0481 | 15 | 44 | protein heterotetramerization |
GO:1904837 | 0 | 22.026 | 1.0481 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 17.7352 | 1.2149 | 15 | 51 | DNA replication-independent nucleosome organization |
GO:0043044 | 0 | 11.5575 | 1.7866 | 16 | 75 | ATP-dependent chromatin remodeling |
GO:0016233 | 0 | 14.4898 | 1.3102 | 14 | 55 | telomere capping |
GO:0006303 | 0 | 11.186 | 1.7151 | 15 | 72 | double-strand break repair via nonhomologous end joining |
GO:0016441 | 0 | 5.1766 | 5.5742 | 25 | 234 | posttranscriptional gene silencing |
GO:1903707 | 0 | 7.0741 | 3.1921 | 19 | 134 | negative regulation of hemopoiesis |
GO:0045815 | 0 | 9.958 | 1.8819 | 15 | 79 | positive regulation of gene expression, epigenetic |
GO:0031047 | 0 | 4.8777 | 6.1221 | 26 | 257 | gene silencing by RNA |
GO:1902036 | 0 | 8.0088 | 2.406 | 16 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 7.6469 | 2.5013 | 16 | 105 | regulation of gene silencing by miRNA |
GO:0034249 | 0 | 3.8032 | 7.9564 | 27 | 334 | negative regulation of cellular amide metabolic process |
GO:0045637 | 0 | 4.4524 | 5.5742 | 22 | 234 | regulation of myeloid cell differentiation |
GO:0050776 | 0 | 2.5679 | 20.9152 | 48 | 878 | regulation of immune response |
GO:0060968 | 0 | 6.0675 | 3.0491 | 16 | 128 | regulation of gene silencing |
GO:0002684 | 0 | 2.4925 | 21.9634 | 49 | 922 | positive regulation of immune system process |
GO:0002682 | 0 | 4.1552 | 5.6571 | 21 | 261 | regulation of immune system process |
GO:0031497 | 0 | 5.2621 | 3.4541 | 16 | 145 | chromatin assembly |
GO:0006959 | 0 | 4.4016 | 4.8358 | 19 | 203 | humoral immune response |
GO:0002244 | 0 | 4.5592 | 4.4308 | 18 | 186 | hematopoietic progenitor cell differentiation |
GO:0009890 | 0 | 1.9132 | 37.6617 | 65 | 1581 | negative regulation of biosynthetic process |
GO:0065004 | 0 | 3.655 | 5.0978 | 17 | 214 | protein-DNA complex assembly |
GO:0060249 | 0 | 2.8435 | 8.7663 | 23 | 368 | anatomical structure homeostasis |
GO:2000113 | 0 | 1.8747 | 33.8979 | 58 | 1423 | negative regulation of cellular macromolecule biosynthetic process |
GO:0032200 | 0 | 3.9594 | 3.8829 | 14 | 163 | telomere organization |
GO:0006352 | 0 | 3.377 | 5.4789 | 17 | 230 | DNA-templated transcription, initiation |
GO:0002757 | 0 | 2.574 | 10.9102 | 26 | 458 | immune response-activating signal transduction |
GO:0048534 | 0 | 2.1287 | 19.8433 | 39 | 833 | hematopoietic or lymphoid organ development |
GO:0048863 | 0 | 3.19 | 6.1221 | 18 | 257 | stem cell differentiation |
GO:0006952 | 1e-04 | 2.326 | 14.4389 | 31 | 643 | defense response |
GO:0002526 | 1e-04 | 4.0204 | 3.5494 | 13 | 149 | acute inflammatory response |
GO:0071103 | 1e-04 | 3.1236 | 6.2412 | 18 | 262 | DNA conformation change |
GO:0050900 | 1e-04 | 3.5017 | 4.6591 | 15 | 200 | leukocyte migration |
GO:0048870 | 1e-04 | 1.8297 | 33.3501 | 56 | 1400 | cell motility |
GO:0032269 | 1e-04 | 1.892 | 28.0855 | 49 | 1179 | negative regulation of cellular protein metabolic process |
GO:0006412 | 1e-04 | 2.1299 | 17.6993 | 35 | 743 | translation |
GO:0030449 | 1e-04 | 7.2871 | 1.1196 | 7 | 47 | regulation of complement activation |
GO:0072376 | 1e-04 | 5.2224 | 1.9295 | 9 | 81 | protein activation cascade |
GO:0006957 | 1e-04 | 20.6968 | 0.2859 | 4 | 12 | complement activation, alternative pathway |
GO:0045060 | 1e-04 | 20.6968 | 0.2859 | 4 | 12 | negative thymic T cell selection |
GO:0010629 | 1e-04 | 1.7129 | 42.1163 | 66 | 1768 | negative regulation of gene expression |
GO:0002253 | 1e-04 | 5.9101 | 1.5308 | 8 | 67 | activation of immune response |
GO:0051246 | 1e-04 | 1.5945 | 63.3413 | 91 | 2659 | regulation of protein metabolic process |
GO:0045087 | 2e-04 | 2.054 | 18.8472 | 36 | 799 | innate immune response |
GO:0002250 | 2e-04 | 2.6908 | 7.9802 | 20 | 335 | adaptive immune response |
GO:0002443 | 2e-04 | 2.1021 | 16.8418 | 33 | 707 | leukocyte mediated immunity |
GO:0050727 | 2e-04 | 2.7446 | 7.4323 | 19 | 312 | regulation of inflammatory response |
GO:0002695 | 2e-04 | 3.7568 | 3.4779 | 12 | 146 | negative regulation of leukocyte activation |
GO:0060548 | 2e-04 | 1.9565 | 21.4155 | 39 | 899 | negative regulation of cell death |
GO:0045596 | 2e-04 | 2.1538 | 14.9122 | 30 | 626 | negative regulation of cell differentiation |
GO:0006518 | 2e-04 | 1.9469 | 21.5108 | 39 | 903 | peptide metabolic process |
GO:0051253 | 2e-04 | 1.8183 | 28.4666 | 48 | 1195 | negative regulation of RNA metabolic process |
GO:1990869 | 3e-04 | 41.2971 | 0.1429 | 3 | 6 | cellular response to chemokine |
GO:0043604 | 3e-04 | 1.9736 | 20.1053 | 37 | 844 | amide biosynthetic process |
GO:0002768 | 3e-04 | 2.574 | 8.3137 | 20 | 349 | immune response-regulating cell surface receptor signaling pathway |
GO:0051707 | 3e-04 | 2.0021 | 18.7237 | 35 | 786 | response to other organism |
GO:0051249 | 4e-04 | 4.8956 | 1.8104 | 8 | 78 | regulation of lymphocyte activation |
GO:0070663 | 5e-04 | 3.048 | 4.931 | 14 | 207 | regulation of leukocyte proliferation |
GO:0097530 | 5e-04 | 3.9063 | 2.7871 | 10 | 117 | granulocyte migration |
GO:2000107 | 5e-04 | 6.7358 | 1.0243 | 6 | 43 | negative regulation of leukocyte apoptotic process |
GO:0019724 | 5e-04 | Inf | 0.0469 | 2 | 2 | B cell mediated immunity |
GO:0051259 | 5e-04 | 2.1906 | 12.1489 | 25 | 510 | protein oligomerization |
GO:0018003 | 6e-04 | Inf | 0.0476 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0021882 | 6e-04 | Inf | 0.0476 | 2 | 2 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment |
GO:0021893 | 6e-04 | Inf | 0.0476 | 2 | 2 | cerebral cortex GABAergic interneuron fate commitment |
GO:0044663 | 6e-04 | Inf | 0.0476 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0070370 | 6e-04 | Inf | 0.0476 | 2 | 2 | cellular heat acclimation |
GO:1902868 | 6e-04 | Inf | 0.0476 | 2 | 2 | positive regulation of retina development in camera-type eye |
GO:1902871 | 6e-04 | Inf | 0.0476 | 2 | 2 | positive regulation of amacrine cell differentiation |
GO:1903507 | 7e-04 | 1.7624 | 26.7039 | 44 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0009607 | 8e-04 | 1.8882 | 19.748 | 35 | 829 | response to biotic stimulus |
GO:0050867 | 8e-04 | 2.567 | 7.0512 | 17 | 296 | positive regulation of cell activation |
GO:0071622 | 8e-04 | 6.0771 | 1.1196 | 6 | 47 | regulation of granulocyte chemotaxis |
GO:0006342 | 9e-04 | 5.0339 | 1.5407 | 7 | 67 | chromatin silencing |
GO:0040029 | 9e-04 | 3.919 | 2.4915 | 9 | 110 | regulation of gene expression, epigenetic |
GO:0050670 | 9e-04 | 2.9624 | 4.6928 | 13 | 197 | regulation of lymphocyte proliferation |
GO:0021895 | 9e-04 | 11.0333 | 0.4526 | 4 | 19 | cerebral cortex neuron differentiation |
GO:0030168 | 0.001 | 3.2859 | 3.597 | 11 | 151 | platelet activation |
GO:0050817 | 0.0011 | 2.4162 | 7.9087 | 18 | 332 | coagulation |
GO:0001776 | 0.0011 | 10.4757 | 0.4706 | 4 | 20 | leukocyte homeostasis |
GO:0042742 | 0.0011 | 2.7582 | 5.4075 | 14 | 227 | defense response to bacterium |
GO:0051251 | 0.0012 | 2.6365 | 6.0507 | 15 | 254 | positive regulation of lymphocyte activation |
GO:0061844 | 0.0013 | 5.5355 | 1.2149 | 6 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0002430 | 0.0014 | 17.6942 | 0.2382 | 3 | 10 | complement receptor mediated signaling pathway |
GO:0006600 | 0.0014 | 17.6942 | 0.2382 | 3 | 10 | creatine metabolic process |
GO:0010820 | 0.0014 | 17.6942 | 0.2382 | 3 | 10 | positive regulation of T cell chemotaxis |
GO:0051607 | 0.0015 | 2.7788 | 4.9787 | 13 | 209 | defense response to virus |
GO:0090303 | 0.0016 | 5.2992 | 1.2625 | 6 | 53 | positive regulation of wound healing |
GO:0070434 | 0.0017 | 82.3862 | 0.0715 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0017 | 82.3862 | 0.0715 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0001817 | 0.0019 | 1.9652 | 13.9832 | 26 | 587 | regulation of cytokine production |
GO:0050865 | 0.0019 | 2.8544 | 4.4749 | 12 | 193 | regulation of cell activation |
GO:0038166 | 0.0019 | 15.4814 | 0.262 | 3 | 11 | angiotensin-activated signaling pathway |
GO:0090084 | 0.0019 | 15.4814 | 0.262 | 3 | 11 | negative regulation of inclusion body assembly |
GO:0045577 | 0.002 | 8.7083 | 0.5479 | 4 | 23 | regulation of B cell differentiation |
GO:0045744 | 0.002 | 6.2784 | 0.9052 | 5 | 38 | negative regulation of G-protein coupled receptor protein signaling pathway |
GO:0035195 | 0.002 | 3.4483 | 2.8023 | 9 | 122 | gene silencing by miRNA |
GO:0006909 | 0.0022 | 2.6685 | 5.1693 | 13 | 217 | phagocytosis |
GO:0016064 | 0.0022 | 3.7412 | 2.3107 | 8 | 97 | immunoglobulin mediated immune response |
GO:0002274 | 0.0023 | 1.9331 | 14.1976 | 26 | 596 | myeloid leukocyte activation |
GO:0030595 | 0.0024 | 2.7574 | 4.6214 | 12 | 194 | leukocyte chemotaxis |
GO:0002260 | 0.0025 | 4.7882 | 1.3816 | 6 | 58 | lymphocyte homeostasis |
GO:0007599 | 0.0026 | 2.2757 | 7.8849 | 17 | 331 | hemostasis |
GO:0048519 | 0.0029 | 1.3589 | 114.748 | 140 | 4817 | negative regulation of biological process |
GO:0070371 | 0.0029 | 2.3829 | 6.6462 | 15 | 279 | ERK1 and ERK2 cascade |
GO:2000116 | 0.003 | 2.5664 | 5.3598 | 13 | 225 | regulation of cysteine-type endopeptidase activity |
GO:0002366 | 0.0031 | 1.8633 | 15.2696 | 27 | 641 | leukocyte activation involved in immune response |
GO:0045055 | 0.0031 | 1.8206 | 16.7941 | 29 | 705 | regulated exocytosis |
GO:0002864 | 0.0032 | 12.3836 | 0.3097 | 3 | 13 | regulation of acute inflammatory response to antigenic stimulus |
GO:0034097 | 0.0033 | 1.7 | 22.3684 | 36 | 939 | response to cytokine |
GO:0048584 | 0.0035 | 1.5216 | 40.7211 | 58 | 1745 | positive regulation of response to stimulus |
GO:0050851 | 0.0035 | 2.6259 | 4.8358 | 12 | 203 | antigen receptor-mediated signaling pathway |
GO:0036336 | 0.0036 | 7.192 | 0.6432 | 4 | 27 | dendritic cell migration |
GO:0090023 | 0.0036 | 7.192 | 0.6432 | 4 | 27 | positive regulation of neutrophil chemotaxis |
GO:2000403 | 0.0036 | 7.192 | 0.6432 | 4 | 27 | positive regulation of lymphocyte migration |
GO:0052547 | 0.0037 | 2.0873 | 9.5762 | 19 | 402 | regulation of peptidase activity |
GO:0010919 | 0.004 | 11.2571 | 0.3335 | 3 | 14 | regulation of inositol phosphate biosynthetic process |
GO:0030852 | 0.004 | 11.2571 | 0.3335 | 3 | 14 | regulation of granulocyte differentiation |
GO:0043066 | 0.0041 | 1.7636 | 17.9136 | 30 | 762 | negative regulation of apoptotic process |
GO:0050869 | 0.0041 | 6.8918 | 0.667 | 4 | 28 | negative regulation of B cell activation |
GO:0032946 | 0.0041 | 3.0721 | 3.1206 | 9 | 131 | positive regulation of mononuclear cell proliferation |
GO:1903039 | 0.0044 | 2.545 | 4.9787 | 12 | 209 | positive regulation of leukocyte cell-cell adhesion |
GO:0006281 | 0.0046 | 1.9322 | 11.9584 | 22 | 502 | DNA repair |
GO:0042110 | 0.0047 | 2.8104 | 3.7706 | 10 | 162 | T cell activation |
GO:2000404 | 0.0047 | 6.6157 | 0.6908 | 4 | 29 | regulation of T cell migration |
GO:0002577 | 0.0049 | 10.3183 | 0.3573 | 3 | 15 | regulation of antigen processing and presentation |
GO:0051546 | 0.0049 | 10.3183 | 0.3573 | 3 | 15 | keratinocyte migration |
GO:0032103 | 0.0051 | 2.3068 | 6.3842 | 14 | 268 | positive regulation of response to external stimulus |
GO:0042119 | 0.0052 | 1.9435 | 11.339 | 21 | 476 | neutrophil activation |
GO:0002885 | 0.0054 | 27.4586 | 0.1191 | 2 | 5 | positive regulation of hypersensitivity |
GO:0060414 | 0.0054 | 27.4586 | 0.1191 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0030217 | 0.0059 | 2.4444 | 5.1693 | 12 | 217 | T cell differentiation |
GO:0097192 | 0.006 | 3.9493 | 1.6437 | 6 | 69 | extrinsic apoptotic signaling pathway in absence of ligand |
GO:0033630 | 0.006 | 9.524 | 0.3811 | 3 | 16 | positive regulation of cell adhesion mediated by integrin |
GO:0035855 | 0.006 | 9.524 | 0.3811 | 3 | 16 | megakaryocyte development |
GO:0002755 | 0.006 | 6.1249 | 0.7385 | 4 | 31 | MyD88-dependent toll-like receptor signaling pathway |
GO:0006958 | 0.006 | 6.1249 | 0.7385 | 4 | 31 | complement activation, classical pathway |
GO:0030335 | 0.0062 | 1.9811 | 10.0527 | 19 | 422 | positive regulation of cell migration |
GO:0045071 | 0.0066 | 4.6006 | 1.1911 | 5 | 50 | negative regulation of viral genome replication |
GO:0006935 | 0.0073 | 1.8214 | 13.2209 | 23 | 555 | chemotaxis |
GO:0042102 | 0.0076 | 3.3021 | 2.263 | 7 | 95 | positive regulation of T cell proliferation |
GO:0050868 | 0.0076 | 3.3021 | 2.263 | 7 | 95 | negative regulation of T cell activation |
GO:0010604 | 0.008 | 1.3663 | 69.1299 | 88 | 2902 | positive regulation of macromolecule metabolic process |
GO:0002606 | 0.008 | 20.5926 | 0.1429 | 2 | 6 | positive regulation of dendritic cell antigen processing and presentation |
GO:0046533 | 0.008 | 20.5926 | 0.1429 | 2 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0061074 | 0.008 | 20.5926 | 0.1429 | 2 | 6 | regulation of neural retina development |
GO:0022407 | 0.008 | 1.9667 | 9.5762 | 18 | 402 | regulation of cell-cell adhesion |
GO:0043312 | 0.0082 | 1.8885 | 11.077 | 20 | 465 | neutrophil degranulation |
GO:1902622 | 0.0084 | 5.5113 | 0.8099 | 4 | 34 | regulation of neutrophil migration |
GO:1902600 | 0.0089 | 3.1926 | 2.3345 | 7 | 98 | hydrogen ion transmembrane transport |
GO:0019222 | 0.0091 | 1.2881 | 148.1695 | 171 | 6220 | regulation of metabolic process |
GO:0050710 | 0.0091 | 4.2239 | 1.2864 | 5 | 54 | negative regulation of cytokine secretion |
GO:0090307 | 0.0091 | 4.2239 | 1.2864 | 5 | 54 | mitotic spindle assembly |
GO:0010595 | 0.0095 | 3.5528 | 1.8104 | 6 | 76 | positive regulation of endothelial cell migration |
GO:0010950 | 0.0098 | 2.6549 | 3.5732 | 9 | 150 | positive regulation of endopeptidase activity |
GO:0043067 | 0.0099 | 1.481 | 34.1362 | 48 | 1433 | regulation of programmed cell death |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038111 | 0 | 22.8839 | 0.8837 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 22.8839 | 0.8837 | 13 | 37 | response to interleukin-7 |
GO:0006333 | 0 | 6.0789 | 4.0364 | 21 | 169 | chromatin assembly or disassembly |
GO:0006335 | 0 | 19.0505 | 0.7643 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0006323 | 0 | 5.4466 | 4.4425 | 21 | 186 | DNA packaging |
GO:0051290 | 0 | 13.9982 | 1.0509 | 11 | 44 | protein heterotetramerization |
GO:0000183 | 0 | 16.1155 | 0.8598 | 10 | 36 | chromatin silencing at rDNA |
GO:0071824 | 0 | 3.9966 | 5.8516 | 21 | 245 | protein-DNA complex subunit organization |
GO:0045652 | 0 | 6.5309 | 1.7674 | 10 | 74 | regulation of megakaryocyte differentiation |
GO:0006334 | 0 | 5.6936 | 2.1906 | 11 | 94 | nucleosome assembly |
GO:0045815 | 0 | 6.0557 | 1.8868 | 10 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 4.7446 | 2.8183 | 12 | 118 | negative regulation of gene expression, epigenetic |
GO:0002227 | 1e-04 | 13.7908 | 0.4777 | 5 | 20 | innate immune response in mucosa |
GO:1902036 | 1e-04 | 4.5852 | 2.4123 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0035194 | 2e-04 | 3.1016 | 5.565 | 16 | 233 | posttranscriptional gene silencing by RNA |
GO:0060964 | 2e-04 | 4.391 | 2.5078 | 10 | 105 | regulation of gene silencing by miRNA |
GO:0071345 | 3e-04 | 1.955 | 20.2776 | 37 | 849 | cellular response to cytokine stimulus |
GO:0046543 | 4e-04 | 30.8869 | 0.1672 | 3 | 7 | development of secondary female sexual characteristics |
GO:0060441 | 5e-04 | 8.9894 | 0.6688 | 5 | 28 | epithelial tube branching involved in lung morphogenesis |
GO:0006583 | 6e-04 | Inf | 0.0478 | 2 | 2 | melanin biosynthetic process from tyrosine |
GO:0060749 | 6e-04 | 12.6978 | 0.406 | 4 | 17 | mammary gland alveolus development |
GO:0017148 | 7e-04 | 2.5071 | 7.6429 | 18 | 320 | negative regulation of translation |
GO:0002251 | 9e-04 | 7.6556 | 0.7643 | 5 | 32 | organ or tissue specific immune response |
GO:0060968 | 0.001 | 3.5299 | 3.0572 | 10 | 128 | regulation of gene silencing |
GO:0061138 | 0.001 | 3.0741 | 4.1797 | 12 | 175 | morphogenesis of a branching epithelium |
GO:0048598 | 0.0013 | 2.0231 | 13.614 | 26 | 570 | embryonic morphogenesis |
GO:0003166 | 0.0017 | 82.1636 | 0.0717 | 2 | 3 | bundle of His development |
GO:0070458 | 0.0017 | 82.1636 | 0.0717 | 2 | 3 | cellular detoxification of nitrogen compound |
GO:0099566 | 0.0017 | 82.1636 | 0.0717 | 2 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
GO:0019731 | 0.002 | 6.2613 | 0.9076 | 5 | 38 | antibacterial humoral response |
GO:0007186 | 0.0022 | 1.6575 | 28.2072 | 44 | 1181 | G-protein coupled receptor signaling pathway |
GO:0055062 | 0.0025 | 13.7231 | 0.2866 | 3 | 12 | phosphate ion homeostasis |
GO:0018916 | 0.0033 | 41.0792 | 0.0955 | 2 | 4 | nitrobenzene metabolic process |
GO:0031394 | 0.0033 | 41.0792 | 0.0955 | 2 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0048370 | 0.0033 | 41.0792 | 0.0955 | 2 | 4 | lateral mesoderm formation |
GO:0060364 | 0.0033 | 41.0792 | 0.0955 | 2 | 4 | frontal suture morphogenesis |
GO:0060750 | 0.0033 | 41.0792 | 0.0955 | 2 | 4 | epithelial cell proliferation involved in mammary gland duct elongation |
GO:0030879 | 0.0034 | 3.1683 | 3.0333 | 9 | 127 | mammary gland development |
GO:0035295 | 0.0043 | 1.8857 | 13.3751 | 24 | 560 | tube development |
GO:0002244 | 0.0052 | 2.6155 | 4.4425 | 11 | 186 | hematopoietic progenitor cell differentiation |
GO:0045923 | 0.0054 | 6.3436 | 0.7165 | 4 | 30 | positive regulation of fatty acid metabolic process |
GO:0060603 | 0.0054 | 6.3436 | 0.7165 | 4 | 30 | mammary gland duct morphogenesis |
GO:0032792 | 0.0054 | 27.3843 | 0.1194 | 2 | 5 | negative regulation of CREB transcription factor activity |
GO:0045110 | 0.0054 | 27.3843 | 0.1194 | 2 | 5 | intermediate filament bundle assembly |
GO:0060744 | 0.0054 | 27.3843 | 0.1194 | 2 | 5 | mammary gland branching involved in thelarche |
GO:0097070 | 0.0054 | 27.3843 | 0.1194 | 2 | 5 | ductus arteriosus closure |
GO:0010171 | 0.0056 | 4.8021 | 1.1464 | 5 | 48 | body morphogenesis |
GO:0051259 | 0.0057 | 1.8941 | 12.1809 | 22 | 510 | protein oligomerization |
GO:0032200 | 0.0058 | 2.7162 | 3.8931 | 10 | 163 | telomere organization |
GO:0097067 | 0.006 | 9.4982 | 0.3821 | 3 | 16 | cellular response to thyroid hormone stimulus |
GO:0021522 | 0.0061 | 6.1083 | 0.7404 | 4 | 31 | spinal cord motor neuron differentiation |
GO:0034622 | 0.0061 | 1.6297 | 23.2393 | 36 | 973 | cellular macromolecular complex assembly |
GO:0022612 | 0.0067 | 3.0708 | 2.7706 | 8 | 116 | gland morphogenesis |
GO:0061844 | 0.0072 | 4.488 | 1.2181 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:1903706 | 0.0075 | 1.9408 | 10.2463 | 19 | 429 | regulation of hemopoiesis |
GO:0048665 | 0.0076 | 5.6863 | 0.7882 | 4 | 33 | neuron fate specification |
GO:0042536 | 0.008 | 20.5369 | 0.1433 | 2 | 6 | negative regulation of tumor necrosis factor biosynthetic process |
GO:0060426 | 0.008 | 20.5369 | 0.1433 | 2 | 6 | lung vasculature development |
GO:2000503 | 0.008 | 20.5369 | 0.1433 | 2 | 6 | positive regulation of natural killer cell chemotaxis |
GO:2001279 | 0.008 | 20.5369 | 0.1433 | 2 | 6 | regulation of unsaturated fatty acid biosynthetic process |
GO:0032502 | 0.0082 | 1.2959 | 137.1189 | 160 | 5741 | developmental process |
GO:0048863 | 0.009 | 2.219 | 6.1382 | 13 | 257 | stem cell differentiation |
GO:0098754 | 0.009 | 3.1839 | 2.3406 | 7 | 98 | detoxification |
GO:0006656 | 0.0093 | 5.3187 | 0.8359 | 4 | 35 | phosphatidylcholine biosynthetic process |
GO:0031016 | 0.0096 | 3.5431 | 1.8152 | 6 | 76 | pancreas development |
GO:0003008 | 0.0096 | 1.4273 | 44.4962 | 60 | 1863 | system process |
GO:0009887 | 0.0099 | 1.6291 | 19.9266 | 31 | 846 | animal organ morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007186 | 0 | 2.3471 | 25.606 | 54 | 947 | G-protein coupled receptor signaling pathway |
GO:0007389 | 0 | 2.8168 | 11.2557 | 29 | 409 | pattern specification process |
GO:0060429 | 0 | 2.0222 | 29.7785 | 55 | 1096 | epithelium development |
GO:0050877 | 0 | 1.9309 | 31.593 | 56 | 1148 | nervous system process |
GO:0048568 | 0 | 2.5819 | 11.3107 | 27 | 411 | embryonic organ development |
GO:0048729 | 0 | 2.2629 | 16.7047 | 35 | 607 | tissue morphogenesis |
GO:0001763 | 1e-04 | 3.3737 | 5.1738 | 16 | 188 | morphogenesis of a branching structure |
GO:0001992 | 1e-04 | 106.7339 | 0.1101 | 3 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0048598 | 1e-04 | 2.8466 | 7.2015 | 19 | 269 | embryonic morphogenesis |
GO:0043270 | 2e-04 | 2.9356 | 6.2471 | 17 | 227 | positive regulation of ion transport |
GO:0009593 | 2e-04 | 2.4068 | 10.6778 | 24 | 388 | detection of chemical stimulus |
GO:0051241 | 2e-04 | 1.8177 | 28.3332 | 48 | 1034 | negative regulation of multicellular organismal process |
GO:2000406 | 3e-04 | 10.5015 | 0.6054 | 5 | 22 | positive regulation of T cell migration |
GO:2000241 | 3e-04 | 3.5749 | 3.6602 | 12 | 133 | regulation of reproductive process |
GO:0050906 | 3e-04 | 2.3282 | 11.008 | 24 | 400 | detection of stimulus involved in sensory perception |
GO:0001501 | 3e-04 | 2.2037 | 13.072 | 27 | 475 | skeletal system development |
GO:0034103 | 3e-04 | 4.5522 | 2.2016 | 9 | 80 | regulation of tissue remodeling |
GO:0009887 | 4e-04 | 1.9696 | 18.9681 | 35 | 702 | animal organ morphogenesis |
GO:0007606 | 4e-04 | 2.2907 | 11.1731 | 24 | 406 | sensory perception of chemical stimulus |
GO:0042713 | 4e-04 | 35.5734 | 0.1651 | 3 | 6 | sperm ejaculation |
GO:0046851 | 5e-04 | 14.2556 | 0.3853 | 4 | 14 | negative regulation of bone remodeling |
GO:0002686 | 5e-04 | 6.9204 | 1.0182 | 6 | 37 | negative regulation of leukocyte migration |
GO:0071347 | 5e-04 | 4.2513 | 2.3392 | 9 | 85 | cellular response to interleukin-1 |
GO:0031424 | 6e-04 | 2.8531 | 5.6416 | 15 | 205 | keratinization |
GO:0048754 | 6e-04 | 3.2999 | 3.9354 | 12 | 143 | branching morphogenesis of an epithelial tube |
GO:1900239 | 7e-04 | 26.6783 | 0.1926 | 3 | 7 | regulation of phenotypic switching |
GO:2000035 | 7e-04 | 26.6783 | 0.1926 | 3 | 7 | regulation of stem cell division |
GO:0030326 | 7e-04 | 3.4412 | 3.4675 | 11 | 126 | embryonic limb morphogenesis |
GO:0021570 | 8e-04 | Inf | 0.055 | 2 | 2 | rhombomere 4 development |
GO:0044663 | 8e-04 | Inf | 0.055 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0061032 | 8e-04 | Inf | 0.055 | 2 | 2 | visceral serous pericardium development |
GO:0048565 | 8e-04 | 3.4114 | 3.495 | 11 | 127 | digestive tract development |
GO:0090280 | 8e-04 | 11.8782 | 0.4403 | 4 | 16 | positive regulation of calcium ion import |
GO:0050794 | 8e-04 | 1.3918 | 270.4321 | 302 | 9890 | regulation of cellular process |
GO:0010469 | 0.001 | 1.996 | 14.8608 | 28 | 540 | regulation of receptor activity |
GO:0045924 | 0.001 | 21.3413 | 0.2202 | 3 | 8 | regulation of female receptivity |
GO:2000401 | 0.0011 | 5.7959 | 1.1834 | 6 | 43 | regulation of lymphocyte migration |
GO:0070098 | 0.0011 | 4.2159 | 2.0915 | 8 | 76 | chemokine-mediated signaling pathway |
GO:0060562 | 0.0012 | 3.0175 | 4.2676 | 12 | 158 | epithelial tube morphogenesis |
GO:0032502 | 0.0013 | 1.3766 | 130.3014 | 159 | 4897 | developmental process |
GO:0009952 | 0.0013 | 3.6927 | 2.6517 | 9 | 98 | anterior/posterior pattern specification |
GO:0006940 | 0.0015 | 4.5541 | 1.7062 | 7 | 62 | regulation of smooth muscle contraction |
GO:0086015 | 0.0015 | 17.7833 | 0.2477 | 3 | 9 | SA node cell action potential |
GO:0071305 | 0.0016 | 9.5007 | 0.5229 | 4 | 19 | cellular response to vitamin D |
GO:0009948 | 0.0017 | 5.2291 | 1.2934 | 6 | 47 | anterior/posterior axis specification |
GO:0009913 | 0.0019 | 2.2333 | 8.9991 | 19 | 327 | epidermal cell differentiation |
GO:0048704 | 0.0019 | 5.1509 | 1.3095 | 6 | 48 | embryonic skeletal system morphogenesis |
GO:0065007 | 0.0019 | 1.3848 | 305.4727 | 333 | 11100 | biological regulation |
GO:0008015 | 0.0019 | 2.0206 | 12.5402 | 24 | 459 | blood circulation |
GO:0007620 | 0.0019 | 8.9063 | 0.5504 | 4 | 20 | copulation |
GO:0072009 | 0.0021 | 3.4332 | 2.8346 | 9 | 103 | nephron epithelium development |
GO:0086070 | 0.0022 | 15.2418 | 0.2752 | 3 | 10 | SA node cell to atrial cardiac muscle cell communication |
GO:0002125 | 0.0022 | 70.9931 | 0.0826 | 2 | 3 | maternal aggressive behavior |
GO:0002434 | 0.0022 | 70.9931 | 0.0826 | 2 | 3 | immune complex clearance |
GO:0042631 | 0.0022 | 70.9931 | 0.0826 | 2 | 3 | cellular response to water deprivation |
GO:0061010 | 0.0022 | 70.9931 | 0.0826 | 2 | 3 | gall bladder development |
GO:0090264 | 0.0022 | 70.9931 | 0.0826 | 2 | 3 | regulation of immune complex clearance by monocytes and macrophages |
GO:0035107 | 0.0023 | 2.9497 | 3.9904 | 11 | 145 | appendage morphogenesis |
GO:0015874 | 0.0023 | 8.3819 | 0.5779 | 4 | 21 | norepinephrine transport |
GO:1901739 | 0.0023 | 8.3819 | 0.5779 | 4 | 21 | regulation of myoblast fusion |
GO:0016477 | 0.0024 | 1.5812 | 34.8679 | 52 | 1267 | cell migration |
GO:0043588 | 0.0024 | 2.085 | 10.6227 | 21 | 386 | skin development |
GO:0032501 | 0.0025 | 1.3687 | 128.194 | 154 | 5225 | multicellular organismal process |
GO:0050911 | 0.0025 | 2.2209 | 8.5587 | 18 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0060173 | 0.0025 | 2.7487 | 4.6509 | 12 | 169 | limb development |
GO:0043279 | 0.0026 | 3.3264 | 2.9171 | 9 | 106 | response to alkaloid |
GO:0072078 | 0.0028 | 4.0381 | 1.8989 | 7 | 69 | nephron tubule morphogenesis |
GO:0030431 | 0.0029 | 5.7537 | 0.9907 | 5 | 36 | sleep |
GO:0010819 | 0.0029 | 13.3357 | 0.3027 | 3 | 11 | regulation of T cell chemotaxis |
GO:0061326 | 0.0031 | 3.5363 | 2.4493 | 8 | 89 | renal tubule development |
GO:0048247 | 0.0032 | 4.5598 | 1.4586 | 6 | 53 | lymphocyte chemotaxis |
GO:0044062 | 0.0033 | 7.4986 | 0.633 | 4 | 23 | regulation of excretion |
GO:0043009 | 0.0034 | 1.9216 | 13.1353 | 24 | 482 | chordate embryonic development |
GO:0002548 | 0.0035 | 4.4846 | 1.4797 | 6 | 54 | monocyte chemotaxis |
GO:2000021 | 0.0035 | 2.5147 | 5.4765 | 13 | 199 | regulation of ion homeostasis |
GO:0042592 | 0.0036 | 1.4932 | 44.0596 | 62 | 1601 | homeostatic process |
GO:0002027 | 0.0036 | 3.4506 | 2.5043 | 8 | 91 | regulation of heart rate |
GO:0045777 | 0.0037 | 5.4043 | 1.0458 | 5 | 38 | positive regulation of blood pressure |
GO:0035815 | 0.0038 | 11.8532 | 0.3302 | 3 | 12 | positive regulation of renal sodium excretion |
GO:0045835 | 0.0038 | 11.8532 | 0.3302 | 3 | 12 | negative regulation of meiotic nuclear division |
GO:0007267 | 0.0038 | 1.5024 | 41.6103 | 59 | 1512 | cell-cell signaling |
GO:0001975 | 0.0039 | 7.1232 | 0.6605 | 4 | 24 | response to amphetamine |
GO:0061217 | 0.0039 | 7.1232 | 0.6605 | 4 | 24 | regulation of mesonephros development |
GO:0072028 | 0.0039 | 3.7924 | 2.009 | 7 | 73 | nephron morphogenesis |
GO:0035295 | 0.004 | 2.1161 | 8.9512 | 18 | 336 | tube development |
GO:0009889 | 0.0042 | 1.3265 | 117.0153 | 142 | 4252 | regulation of biosynthetic process |
GO:0045765 | 0.0043 | 2.2803 | 6.9351 | 15 | 252 | regulation of angiogenesis |
GO:0055082 | 0.0043 | 1.7203 | 19.5392 | 32 | 710 | cellular chemical homeostasis |
GO:0072164 | 0.0044 | 3.3296 | 2.5869 | 8 | 94 | mesonephric tubule development |
GO:0003257 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0010701 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | positive regulation of norepinephrine secretion |
GO:0035811 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | negative regulation of urine volume |
GO:0060406 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | positive regulation of penile erection |
GO:0090027 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:0090191 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:1901164 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | negative regulation of trophoblast cell migration |
GO:1902564 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | negative regulation of neutrophil activation |
GO:2000563 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | positive regulation of CD4-positive, alpha-beta T cell proliferation |
GO:2000724 | 0.0044 | 35.4943 | 0.1101 | 2 | 4 | positive regulation of cardiac vascular smooth muscle cell differentiation |
GO:0007369 | 0.0044 | 2.5516 | 4.9811 | 12 | 181 | gastrulation |
GO:0045730 | 0.0045 | 6.7836 | 0.688 | 4 | 25 | respiratory burst |
GO:0044058 | 0.0046 | 5.0948 | 1.1008 | 5 | 40 | regulation of digestive system process |
GO:0019229 | 0.0047 | 4.2011 | 1.5686 | 6 | 57 | regulation of vasoconstriction |
GO:0061061 | 0.0049 | 1.7731 | 16.5671 | 28 | 602 | muscle structure development |
GO:0007588 | 0.005 | 4.9929 | 1.1197 | 5 | 41 | excretion |
GO:0071675 | 0.0051 | 4.953 | 1.1283 | 5 | 41 | regulation of mononuclear cell migration |
GO:0008284 | 0.0053 | 1.6429 | 23.0068 | 36 | 836 | positive regulation of cell proliferation |
GO:0048645 | 0.0055 | 4.042 | 1.6237 | 6 | 59 | animal organ formation |
GO:0030183 | 0.0056 | 3.1808 | 2.697 | 8 | 98 | B cell differentiation |
GO:0055078 | 0.0057 | 4.8188 | 1.1558 | 5 | 42 | sodium ion homeostasis |
GO:0006355 | 0.0059 | 1.3343 | 93.7333 | 116 | 3406 | regulation of transcription, DNA-templated |
GO:0060675 | 0.006 | 3.9669 | 1.6512 | 6 | 60 | ureteric bud morphogenesis |
GO:0007501 | 0.006 | 9.6968 | 0.3853 | 3 | 14 | mesodermal cell fate specification |
GO:0042711 | 0.006 | 9.6968 | 0.3853 | 3 | 14 | maternal behavior |
GO:0003016 | 0.006 | 6.1929 | 0.743 | 4 | 27 | respiratory system process |
GO:0070542 | 0.006 | 3.475 | 2.1741 | 7 | 79 | response to fatty acid |
GO:0003044 | 0.0063 | 4.6917 | 1.1834 | 5 | 43 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0097756 | 0.0064 | 3.4272 | 2.2016 | 7 | 80 | negative regulation of blood vessel diameter |
GO:1904427 | 0.0065 | 3.8945 | 1.6787 | 6 | 61 | positive regulation of calcium ion transmembrane transport |
GO:0030324 | 0.0066 | 2.5301 | 4.5959 | 11 | 167 | lung development |
GO:2000027 | 0.0068 | 2.2282 | 6.6048 | 14 | 240 | regulation of organ morphogenesis |
GO:0016331 | 0.0069 | 2.6553 | 3.9904 | 10 | 145 | morphogenesis of embryonic epithelium |
GO:0048701 | 0.0069 | 4.5711 | 1.2109 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0051924 | 0.0069 | 2.3015 | 5.9443 | 13 | 216 | regulation of calcium ion transport |
GO:0035609 | 0.0072 | 23.6613 | 0.1376 | 2 | 5 | C-terminal protein deglutamylation |
GO:0060414 | 0.0072 | 23.6613 | 0.1376 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0060455 | 0.0072 | 23.6613 | 0.1376 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0061009 | 0.0072 | 23.6613 | 0.1376 | 2 | 5 | common bile duct development |
GO:0071504 | 0.0072 | 23.6613 | 0.1376 | 2 | 5 | cellular response to heparin |
GO:0071672 | 0.0072 | 23.6613 | 0.1376 | 2 | 5 | negative regulation of smooth muscle cell chemotaxis |
GO:0072223 | 0.0072 | 23.6613 | 0.1376 | 2 | 5 | metanephric glomerular mesangium development |
GO:0003018 | 0.0073 | 2.7995 | 3.4151 | 9 | 125 | vascular process in circulatory system |
GO:0045445 | 0.0074 | 3.3354 | 2.2566 | 7 | 82 | myoblast differentiation |
GO:0006910 | 0.0074 | 8.8882 | 0.4128 | 3 | 15 | phagocytosis, recognition |
GO:0071636 | 0.0074 | 8.8882 | 0.4128 | 3 | 15 | positive regulation of transforming growth factor beta production |
GO:0007204 | 0.0075 | 2.1338 | 7.3754 | 15 | 268 | positive regulation of cytosolic calcium ion concentration |
GO:0007200 | 0.0075 | 3.0124 | 2.8346 | 8 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0001756 | 0.0076 | 3.7574 | 1.7338 | 6 | 63 | somitogenesis |
GO:2001141 | 0.0076 | 1.3205 | 94.4764 | 116 | 3433 | regulation of RNA biosynthetic process |
GO:0050766 | 0.0076 | 4.4565 | 1.2384 | 5 | 45 | positive regulation of phagocytosis |
GO:0035296 | 0.0077 | 2.7781 | 3.44 | 9 | 125 | regulation of tube diameter |
GO:0098771 | 0.008 | 1.6849 | 17.9981 | 29 | 654 | inorganic ion homeostasis |
GO:0055074 | 0.0081 | 1.8907 | 11.0631 | 20 | 402 | calcium ion homeostasis |
GO:1903531 | 0.0081 | 2.4507 | 4.7335 | 11 | 172 | negative regulation of secretion by cell |
GO:0001656 | 0.0084 | 3.2483 | 2.3117 | 7 | 84 | metanephros development |
GO:0072359 | 0.0084 | 1.5591 | 26.1991 | 39 | 952 | circulatory system development |
GO:0010667 | 0.0088 | 5.4773 | 0.8256 | 4 | 30 | negative regulation of cardiac muscle cell apoptotic process |
GO:0019098 | 0.0088 | 5.4773 | 0.8256 | 4 | 30 | reproductive behavior |
GO:0043114 | 0.0088 | 5.4773 | 0.8256 | 4 | 30 | regulation of vascular permeability |
GO:0002237 | 0.0088 | 1.9887 | 8.944 | 17 | 325 | response to molecule of bacterial origin |
GO:0051155 | 0.0088 | 3.6295 | 1.7888 | 6 | 65 | positive regulation of striated muscle cell differentiation |
GO:0002690 | 0.0089 | 3.2065 | 2.3392 | 7 | 85 | positive regulation of leukocyte chemotaxis |
GO:0051093 | 0.0091 | 1.5905 | 23.0173 | 35 | 840 | negative regulation of developmental process |
GO:0009991 | 0.0093 | 1.8323 | 11.9712 | 21 | 435 | response to extracellular stimulus |
GO:0003014 | 0.0094 | 2.89 | 2.9446 | 8 | 107 | renal system process |
GO:0051051 | 0.0094 | 1.8031 | 12.7418 | 22 | 463 | negative regulation of transport |
GO:0007187 | 0.0096 | 2.3907 | 4.8435 | 11 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0050885 | 0.01 | 4.1448 | 1.321 | 5 | 48 | neuromuscular process controlling balance |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 15.605 | 7.0575 | 71 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 12.7548 | 8.8049 | 75 | 388 | detection of chemical stimulus |
GO:0007606 | 0 | 12.2882 | 9.2134 | 76 | 406 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 12.2742 | 9.0772 | 75 | 400 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 4.6797 | 26.8005 | 94 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 4.4024 | 26.0517 | 88 | 1148 | nervous system process |
GO:0023052 | 0 | 1.548 | 135.3869 | 173 | 5966 | signaling |
GO:0007154 | 1e-04 | 1.5222 | 135.8408 | 172 | 5986 | cell communication |
GO:0032501 | 4e-04 | 1.4452 | 146.8296 | 178 | 6625 | multicellular organismal process |
GO:0031424 | 8e-04 | 2.9873 | 4.6521 | 13 | 205 | keratinization |
GO:0050896 | 0.0015 | 1.7708 | 26.6615 | 42 | 1344 | response to stimulus |
GO:0006069 | 0.0017 | 16.2765 | 0.2496 | 3 | 11 | ethanol oxidation |
GO:0006959 | 0.0024 | 2.7642 | 4.6067 | 12 | 203 | humoral immune response |
GO:0051967 | 0.0028 | 13.0195 | 0.295 | 3 | 13 | negative regulation of synaptic transmission, glutamatergic |
GO:0051716 | 0.0028 | 1.3507 | 152.6563 | 179 | 6727 | cellular response to stimulus |
GO:0043207 | 0.004 | 1.7681 | 17.8821 | 30 | 788 | response to external biotic stimulus |
GO:1990266 | 0.0055 | 3.5137 | 2.1331 | 7 | 94 | neutrophil migration |
GO:0017144 | 0.0057 | 6.2099 | 0.7262 | 4 | 32 | drug metabolic process |
GO:0061844 | 0.0058 | 4.7327 | 1.1573 | 5 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0043299 | 0.0063 | 1.9058 | 11.5508 | 21 | 509 | leukocyte degranulation |
GO:0009617 | 0.0067 | 1.8938 | 11.6189 | 21 | 512 | response to bacterium |
GO:0006578 | 0.0073 | 21.6472 | 0.1362 | 2 | 6 | amino-acid betaine biosynthetic process |
GO:0019236 | 0.0073 | 21.6472 | 0.1362 | 2 | 6 | response to pheromone |
GO:0034154 | 0.0073 | 21.6472 | 0.1362 | 2 | 6 | toll-like receptor 7 signaling pathway |
GO:0002275 | 0.0073 | 1.878 | 11.7096 | 21 | 516 | myeloid cell activation involved in immune response |
GO:0034308 | 0.008 | 4.3529 | 1.2481 | 5 | 55 | primary alcohol metabolic process |
GO:0002444 | 0.0081 | 1.8586 | 11.8231 | 21 | 521 | myeloid leukocyte mediated immunity |
GO:0051781 | 0.0096 | 3.5339 | 1.8154 | 6 | 80 | positive regulation of cell division |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 4.4617 | 8.2663 | 32 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 3.8011 | 10.7914 | 36 | 406 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 3.8679 | 10.3129 | 35 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 3.7378 | 10.6319 | 35 | 400 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 2.3382 | 31.3907 | 65 | 1181 | G-protein coupled receptor signaling pathway |
GO:0003008 | 0 | 1.7356 | 49.5181 | 78 | 1863 | system process |
GO:0010469 | 1e-04 | 2.3275 | 14.3531 | 31 | 540 | regulation of receptor activity |
GO:1900175 | 2e-04 | 55.3183 | 0.1329 | 3 | 5 | regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry |
GO:0043588 | 3e-04 | 2.3962 | 10.2598 | 23 | 386 | skin development |
GO:0031424 | 4e-04 | 2.9606 | 5.4488 | 15 | 205 | keratinization |
GO:0060571 | 4e-04 | 9.253 | 0.6645 | 5 | 25 | morphogenesis of an epithelial fold |
GO:0042110 | 6e-04 | 2.2235 | 11.4824 | 24 | 432 | T cell activation |
GO:0038107 | 6e-04 | 27.6556 | 0.1861 | 3 | 7 | nodal signaling pathway involved in determination of left/right asymmetry |
GO:1900107 | 6e-04 | 27.6556 | 0.1861 | 3 | 7 | regulation of nodal signaling pathway |
GO:0009952 | 6e-04 | 2.9589 | 5.0802 | 14 | 192 | anterior/posterior pattern specification |
GO:0006952 | 7e-04 | 1.6376 | 38.6469 | 59 | 1454 | defense response |
GO:0051353 | 7e-04 | 6.3539 | 1.0898 | 6 | 41 | positive regulation of oxidoreductase activity |
GO:0046960 | 7e-04 | Inf | 0.0532 | 2 | 2 | sensitization |
GO:0051612 | 7e-04 | Inf | 0.0532 | 2 | 2 | negative regulation of serotonin uptake |
GO:0070370 | 7e-04 | Inf | 0.0532 | 2 | 2 | cellular heat acclimation |
GO:0023052 | 7e-04 | 1.4286 | 113.2007 | 142 | 4454 | signaling |
GO:0007154 | 8e-04 | 1.4679 | 87.7206 | 114 | 3507 | cell communication |
GO:0031128 | 9e-04 | 7.7088 | 0.7708 | 5 | 29 | developmental induction |
GO:0003140 | 9e-04 | 22.123 | 0.2126 | 3 | 8 | determination of left/right asymmetry in lateral mesoderm |
GO:0019098 | 0.0011 | 7.4 | 0.7974 | 5 | 30 | reproductive behavior |
GO:0042693 | 0.0011 | 10.5537 | 0.4784 | 4 | 18 | muscle cell fate commitment |
GO:0009913 | 0.0012 | 2.3183 | 8.6916 | 19 | 327 | epidermal cell differentiation |
GO:0009617 | 0.0013 | 2.0219 | 13.6088 | 26 | 512 | response to bacterium |
GO:0048148 | 0.0014 | 9.8495 | 0.505 | 4 | 19 | behavioral response to cocaine |
GO:0032496 | 0.0016 | 2.3214 | 8.2131 | 18 | 309 | response to lipopolysaccharide |
GO:0003156 | 0.0017 | 6.6059 | 0.8771 | 5 | 33 | regulation of animal organ formation |
GO:0048732 | 0.0017 | 2.2001 | 9.6143 | 20 | 365 | gland development |
GO:0032691 | 0.0017 | 9.2333 | 0.5316 | 4 | 20 | negative regulation of interleukin-1 beta production |
GO:0042359 | 0.0017 | 9.2333 | 0.5316 | 4 | 20 | vitamin D metabolic process |
GO:0050727 | 0.0018 | 2.2973 | 8.2929 | 18 | 312 | regulation of inflammatory response |
GO:0032502 | 0.002 | 1.3441 | 150.3063 | 179 | 5712 | developmental process |
GO:0046697 | 0.0021 | 8.6896 | 0.5582 | 4 | 21 | decidualization |
GO:0009946 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | proximal/distal axis specification |
GO:0033861 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | negative regulation of NAD(P)H oxidase activity |
GO:0045963 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | negative regulation of dopamine metabolic process |
GO:0060166 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | olfactory pit development |
GO:0060423 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | foregut regionalization |
GO:0060459 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | left lung development |
GO:0060492 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | lung induction |
GO:0065001 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | specification of axis polarity |
GO:0070434 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0100012 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | regulation of heart induction by canonical Wnt signaling pathway |
GO:1904339 | 0.0021 | 73.5877 | 0.0797 | 2 | 3 | negative regulation of dopaminergic neuron differentiation |
GO:0050805 | 0.0021 | 4.2564 | 1.8074 | 7 | 68 | negative regulation of synaptic transmission |
GO:0050776 | 0.0021 | 1.7214 | 23.337 | 38 | 878 | regulation of immune response |
GO:0048584 | 0.0022 | 1.4817 | 53.505 | 74 | 2013 | positive regulation of response to stimulus |
GO:0042744 | 0.0025 | 8.2063 | 0.5848 | 4 | 22 | hydrogen peroxide catabolic process |
GO:0032768 | 0.0025 | 4.8311 | 1.3821 | 6 | 52 | regulation of monooxygenase activity |
GO:0015844 | 0.0027 | 4.0561 | 1.8872 | 7 | 71 | monoamine transport |
GO:0060021 | 0.0029 | 3.5785 | 2.4188 | 8 | 91 | palate development |
GO:0051716 | 0.003 | 1.3179 | 178.8019 | 207 | 6727 | cellular response to stimulus |
GO:0048839 | 0.0032 | 2.663 | 4.7844 | 12 | 180 | inner ear development |
GO:0051952 | 0.0032 | 3.9326 | 1.9403 | 7 | 73 | regulation of amine transport |
GO:0045321 | 0.0033 | 1.8106 | 16.874 | 29 | 649 | leukocyte activation |
GO:0048562 | 0.0033 | 2.2762 | 7.4157 | 16 | 279 | embryonic organ morphogenesis |
GO:0001975 | 0.0034 | 7.3848 | 0.6379 | 4 | 24 | response to amphetamine |
GO:0051482 | 0.0034 | 7.3848 | 0.6379 | 4 | 24 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0060158 | 0.0034 | 12.2874 | 0.319 | 3 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0015872 | 0.0035 | 5.438 | 1.0366 | 5 | 39 | dopamine transport |
GO:0045944 | 0.0037 | 1.612 | 28.1479 | 43 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0042102 | 0.0038 | 3.4131 | 2.5251 | 8 | 95 | positive regulation of T cell proliferation |
GO:0002250 | 0.0038 | 2.1274 | 8.9042 | 18 | 335 | adaptive immune response |
GO:0001961 | 0.004 | 5.2823 | 1.0632 | 5 | 40 | positive regulation of cytokine-mediated signaling pathway |
GO:0048643 | 0.004 | 7.0327 | 0.6645 | 4 | 25 | positive regulation of skeletal muscle tissue development |
GO:0043315 | 0.0041 | 36.7915 | 0.1063 | 2 | 4 | positive regulation of neutrophil degranulation |
GO:0060662 | 0.0041 | 36.7915 | 0.1063 | 2 | 4 | salivary gland cavitation |
GO:0061056 | 0.0041 | 36.7915 | 0.1063 | 2 | 4 | sclerotome development |
GO:1900226 | 0.0041 | 36.7915 | 0.1063 | 2 | 4 | negative regulation of NLRP3 inflammasome complex assembly |
GO:1904340 | 0.0041 | 36.7915 | 0.1063 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0051580 | 0.0044 | 11.058 | 0.3455 | 3 | 13 | regulation of neurotransmitter uptake |
GO:0007626 | 0.0045 | 2.5406 | 4.997 | 12 | 188 | locomotory behavior |
GO:0050679 | 0.0049 | 2.6416 | 4.4122 | 11 | 166 | positive regulation of epithelial cell proliferation |
GO:0009855 | 0.0053 | 2.9584 | 3.2427 | 9 | 122 | determination of bilateral symmetry |
GO:0014059 | 0.0053 | 6.4203 | 0.7177 | 4 | 27 | regulation of dopamine secretion |
GO:0007600 | 0.0054 | 2.052 | 9.2113 | 18 | 369 | sensory perception |
GO:0007501 | 0.0055 | 10.052 | 0.3721 | 3 | 14 | mesodermal cell fate specification |
GO:0021527 | 0.0055 | 10.052 | 0.3721 | 3 | 14 | spinal cord association neuron differentiation |
GO:0002252 | 0.0056 | 1.5771 | 28.015 | 42 | 1054 | immune effector process |
GO:0030595 | 0.0058 | 2.4559 | 5.1565 | 12 | 194 | leukocyte chemotaxis |
GO:0035270 | 0.0059 | 2.9066 | 3.2959 | 9 | 124 | endocrine system development |
GO:0042127 | 0.0059 | 1.4775 | 40.7733 | 57 | 1534 | regulation of cell proliferation |
GO:0007389 | 0.0059 | 1.9515 | 10.7425 | 20 | 406 | pattern specification process |
GO:0097529 | 0.0061 | 2.5582 | 4.5451 | 11 | 171 | myeloid leukocyte migration |
GO:0048538 | 0.0066 | 4.6205 | 1.1961 | 5 | 45 | thymus development |
GO:0001661 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | conditioned taste aversion |
GO:0003129 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | heart induction |
GO:0015870 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | acetylcholine transport |
GO:0019800 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0048859 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | formation of anatomical boundary |
GO:0060431 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | primary lung bud formation |
GO:0060745 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | mammary gland branching involved in pregnancy |
GO:0061317 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
GO:0061743 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | motor learning |
GO:0061760 | 0.0067 | 24.5261 | 0.1329 | 2 | 5 | antifungal innate immune response |
GO:0098915 | 0.0067 | 9.2138 | 0.3987 | 3 | 15 | membrane repolarization during ventricular cardiac muscle cell action potential |
GO:0010092 | 0.0069 | 5.9059 | 0.7708 | 4 | 29 | specification of animal organ identity |
GO:0048634 | 0.0079 | 2.7614 | 3.4554 | 9 | 130 | regulation of muscle organ development |
GO:0050789 | 0.008 | 1.3024 | 279.5657 | 303 | 10518 | regulation of biological process |
GO:0030154 | 0.008 | 1.3124 | 101.2688 | 123 | 3810 | cell differentiation |
GO:0030322 | 0.0081 | 8.5045 | 0.4253 | 3 | 16 | stabilization of membrane potential |
GO:0098810 | 0.0081 | 8.5045 | 0.4253 | 3 | 16 | neurotransmitter reuptake |
GO:0032946 | 0.0083 | 2.7386 | 3.4819 | 9 | 131 | positive regulation of mononuclear cell proliferation |
GO:0033555 | 0.0087 | 3.6396 | 1.7808 | 6 | 67 | multicellular organismal response to stress |
GO:0007566 | 0.0087 | 4.2973 | 1.2758 | 5 | 48 | embryo implantation |
GO:0050432 | 0.0087 | 4.2973 | 1.2758 | 5 | 48 | catecholamine secretion |
GO:0007267 | 0.0087 | 1.4535 | 39.8553 | 55 | 1506 | cell-cell signaling |
GO:0060325 | 0.0088 | 5.4677 | 0.824 | 4 | 31 | face morphogenesis |
GO:2000379 | 0.0089 | 3.2013 | 2.339 | 7 | 88 | positive regulation of reactive oxygen species metabolic process |
GO:0035239 | 0.0089 | 1.9851 | 8.9574 | 17 | 337 | tube morphogenesis |
GO:0009790 | 0.009 | 1.5706 | 24.666 | 37 | 928 | embryo development |
GO:1902533 | 0.009 | 1.5706 | 24.666 | 37 | 928 | positive regulation of intracellular signal transduction |
GO:0050900 | 0.0091 | 2.4089 | 4.8052 | 11 | 184 | leukocyte migration |
GO:0032501 | 0.0091 | 1.3322 | 101.9429 | 122 | 4427 | multicellular organismal process |
GO:0034754 | 0.0095 | 2.8799 | 2.9504 | 8 | 111 | cellular hormone metabolic process |
GO:0032225 | 0.0096 | 7.8965 | 0.4519 | 3 | 17 | regulation of synaptic transmission, dopaminergic |
GO:0042069 | 0.0096 | 7.8965 | 0.4519 | 3 | 17 | regulation of catecholamine metabolic process |
GO:1904948 | 0.0096 | 7.8965 | 0.4519 | 3 | 17 | midbrain dopaminergic neuron differentiation |
GO:0002694 | 0.0097 | 1.8253 | 12.014 | 21 | 452 | regulation of leukocyte activation |
GO:0010647 | 0.0097 | 1.4355 | 41.8099 | 57 | 1573 | positive regulation of cell communication |
GO:0060429 | 0.0098 | 1.4985 | 31.497 | 45 | 1185 | epithelium development |
GO:0009996 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | negative regulation of cell fate specification |
GO:0021937 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0033239 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | negative regulation of cellular amine metabolic process |
GO:0035655 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | interleukin-18-mediated signaling pathway |
GO:0035744 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | T-helper 1 cell cytokine production |
GO:0060179 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | male mating behavior |
GO:0060353 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | regulation of cell adhesion molecule production |
GO:0061046 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | regulation of branching involved in lung morphogenesis |
GO:0061074 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | regulation of neural retina development |
GO:2000348 | 0.0098 | 18.3934 | 0.1595 | 2 | 6 | regulation of CD40 signaling pathway |
GO:0002449 | 0.0099 | 2.2784 | 5.5286 | 12 | 208 | lymphocyte mediated immunity |
GO:0048705 | 0.0099 | 2.2784 | 5.5286 | 12 | 208 | skeletal system morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 126.0811 | 0.7904 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 84.0324 | 0.8892 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 55.4094 | 1.0868 | 25 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 18.2836 | 1.9512 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 143.2605 | 0.4446 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0016441 | 0 | 7.8009 | 5.7796 | 36 | 234 | posttranscriptional gene silencing |
GO:0031497 | 0 | 10.5767 | 3.5814 | 29 | 145 | chromatin assembly |
GO:1902036 | 0 | 13.8015 | 2.4946 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 13.1081 | 2.5934 | 25 | 105 | regulation of gene silencing by miRNA |
GO:0031047 | 0 | 6.9786 | 6.3477 | 36 | 257 | gene silencing by RNA |
GO:0060968 | 0 | 10.1659 | 3.1615 | 25 | 128 | regulation of gene silencing |
GO:0034249 | 0 | 5.5037 | 8.2495 | 38 | 334 | negative regulation of cellular amide metabolic process |
GO:0002244 | 0 | 7.4566 | 4.594 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0034080 | 0 | 22.0089 | 0.988 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0065004 | 0 | 6.3226 | 5.2856 | 28 | 214 | protein-DNA complex assembly |
GO:1904837 | 0 | 19.0695 | 1.0868 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0048863 | 0 | 5.5663 | 6.3477 | 30 | 257 | stem cell differentiation |
GO:0032200 | 0 | 7.1953 | 4.026 | 24 | 163 | telomere organization |
GO:0034724 | 0 | 15.4548 | 1.2597 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0071103 | 0 | 5.2258 | 6.4712 | 29 | 262 | DNA conformation change |
GO:0016233 | 0 | 13.9434 | 1.3585 | 14 | 55 | telomere capping |
GO:0030099 | 0 | 4.2145 | 9.2622 | 34 | 375 | myeloid cell differentiation |
GO:0006303 | 0 | 10.7631 | 1.7783 | 15 | 72 | double-strand break repair via nonhomologous end joining |
GO:1903707 | 0 | 6.8039 | 3.3097 | 19 | 134 | negative regulation of hemopoiesis |
GO:0043044 | 0 | 9.3597 | 1.8524 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0051259 | 0 | 3.3054 | 12.5965 | 37 | 510 | protein oligomerization |
GO:0048534 | 0 | 2.6764 | 20.5743 | 49 | 833 | hematopoietic or lymphoid organ development |
GO:0038111 | 0 | 14.9797 | 0.9139 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 14.9797 | 0.9139 | 10 | 37 | response to interleukin-7 |
GO:0032269 | 0 | 2.318 | 29.1202 | 60 | 1179 | negative regulation of cellular protein metabolic process |
GO:0045652 | 0 | 10.274 | 1.3355 | 11 | 56 | regulation of megakaryocyte differentiation |
GO:0034728 | 0 | 6.5584 | 2.4854 | 14 | 104 | nucleosome organization |
GO:2000113 | 0 | 2.1058 | 35.1468 | 66 | 1423 | negative regulation of cellular macromolecule biosynthetic process |
GO:0006412 | 0 | 2.5288 | 18.3514 | 42 | 743 | translation |
GO:0007186 | 0 | 2.172 | 29.1696 | 57 | 1181 | G-protein coupled receptor signaling pathway |
GO:0009890 | 0 | 1.9723 | 39.0493 | 69 | 1581 | negative regulation of biosynthetic process |
GO:0009593 | 0 | 2.9658 | 9.5832 | 26 | 388 | detection of chemical stimulus |
GO:0060249 | 0 | 3.0053 | 9.0893 | 25 | 368 | anatomical structure homeostasis |
GO:0043604 | 0 | 2.257 | 20.846 | 43 | 844 | amide biosynthetic process |
GO:0006518 | 0 | 2.2091 | 22.3033 | 45 | 903 | peptide metabolic process |
GO:0010629 | 0 | 1.86 | 43.668 | 73 | 1768 | negative regulation of gene expression |
GO:1903507 | 0 | 2.0608 | 27.6877 | 52 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0007606 | 0 | 2.822 | 10.0278 | 26 | 406 | sensory perception of chemical stimulus |
GO:0050911 | 0 | 2.9641 | 7.6814 | 21 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051253 | 0 | 1.9175 | 29.5154 | 52 | 1195 | negative regulation of RNA metabolic process |
GO:0050793 | 0 | 1.6749 | 57.0302 | 86 | 2309 | regulation of developmental process |
GO:0051239 | 1e-04 | 1.6128 | 67.1074 | 97 | 2717 | regulation of multicellular organismal process |
GO:0035195 | 1e-04 | 4.2538 | 2.8408 | 11 | 122 | gene silencing by miRNA |
GO:0097530 | 2e-04 | 4.1867 | 2.8898 | 11 | 117 | granulocyte migration |
GO:0006342 | 2e-04 | 5.8009 | 1.5576 | 8 | 67 | chromatin silencing |
GO:0050906 | 2e-04 | 2.4964 | 9.8796 | 23 | 400 | detection of stimulus involved in sensory perception |
GO:0031424 | 2e-04 | 3.2012 | 5.0633 | 15 | 205 | keratinization |
GO:0002690 | 2e-04 | 4.7621 | 2.0994 | 9 | 85 | positive regulation of leukocyte chemotaxis |
GO:1903706 | 2e-04 | 2.7605 | 6.9936 | 18 | 295 | regulation of hemopoiesis |
GO:0032103 | 4e-04 | 2.7499 | 6.6194 | 17 | 268 | positive regulation of response to external stimulus |
GO:0045596 | 4e-04 | 2.069 | 15.4616 | 30 | 626 | negative regulation of cell differentiation |
GO:0090023 | 5e-04 | 9.0769 | 0.6669 | 5 | 27 | positive regulation of neutrophil chemotaxis |
GO:0051246 | 5e-04 | 1.5192 | 65.6749 | 91 | 2659 | regulation of protein metabolic process |
GO:0006352 | 6e-04 | 2.8244 | 5.6808 | 15 | 230 | DNA-templated transcription, initiation |
GO:0071622 | 0.001 | 5.8525 | 1.1609 | 6 | 47 | regulation of granulocyte chemotaxis |
GO:0070271 | 0.0012 | 1.64 | 33.8872 | 52 | 1372 | protein complex biogenesis |
GO:0009913 | 0.0013 | 2.3625 | 8.0766 | 18 | 327 | epidermal cell differentiation |
GO:1902622 | 0.0014 | 6.8828 | 0.8398 | 5 | 34 | regulation of neutrophil migration |
GO:2000147 | 0.0014 | 2.1473 | 10.8429 | 22 | 439 | positive regulation of cell motility |
GO:0042535 | 0.0016 | 17.0453 | 0.247 | 3 | 10 | positive regulation of tumor necrosis factor biosynthetic process |
GO:0048869 | 0.0017 | 1.3961 | 98.1789 | 124 | 3975 | cellular developmental process |
GO:0003099 | 0.0018 | 79.3724 | 0.0741 | 2 | 3 | positive regulation of the force of heart contraction by chemical signal |
GO:0035803 | 0.0018 | 79.3724 | 0.0741 | 2 | 3 | egg coat formation |
GO:0060168 | 0.0018 | 79.3724 | 0.0741 | 2 | 3 | positive regulation of adenosine receptor signaling pathway |
GO:0048519 | 0.0019 | 1.3721 | 118.9756 | 146 | 4817 | negative regulation of biological process |
GO:0019730 | 0.0021 | 3.7728 | 2.297 | 8 | 93 | antimicrobial humoral response |
GO:1901566 | 0.0021 | 1.5103 | 48.3114 | 68 | 1956 | organonitrogen compound biosynthetic process |
GO:0006950 | 0.0025 | 1.3939 | 87.9782 | 112 | 3562 | response to stress |
GO:1904894 | 0.0027 | 4.0603 | 1.8771 | 7 | 76 | positive regulation of STAT cascade |
GO:0010614 | 0.0031 | 7.5883 | 0.6175 | 4 | 25 | negative regulation of cardiac muscle hypertrophy |
GO:0043588 | 0.0035 | 2.0972 | 9.5339 | 19 | 386 | skin development |
GO:0051790 | 0.0035 | 39.6837 | 0.0988 | 2 | 4 | short-chain fatty acid biosynthetic process |
GO:0072086 | 0.0035 | 39.6837 | 0.0988 | 2 | 4 | specification of loop of Henle identity |
GO:0019835 | 0.0036 | 5.3919 | 1.0374 | 5 | 42 | cytolysis |
GO:0040029 | 0.0037 | 3.4091 | 2.5126 | 8 | 110 | regulation of gene expression, epigenetic |
GO:0048871 | 0.0038 | 2.1821 | 8.2001 | 17 | 332 | multicellular organismal homeostasis |
GO:0003008 | 0.0038 | 1.4833 | 46.0144 | 64 | 1863 | system process |
GO:0051250 | 0.0039 | 3.1119 | 3.0874 | 9 | 125 | negative regulation of lymphocyte activation |
GO:0050920 | 0.0039 | 2.7295 | 4.2729 | 11 | 173 | regulation of chemotaxis |
GO:0014743 | 0.0039 | 4.3589 | 1.5066 | 6 | 61 | regulation of muscle hypertrophy |
GO:0042531 | 0.0039 | 4.3589 | 1.5066 | 6 | 61 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0060326 | 0.0042 | 2.3614 | 6.2489 | 14 | 253 | cell chemotaxis |
GO:1900003 | 0.0044 | 10.8442 | 0.3458 | 3 | 14 | regulation of serine-type endopeptidase activity |
GO:0051716 | 0.0046 | 1.3124 | 166.1508 | 192 | 6727 | cellular response to stimulus |
GO:0046636 | 0.0047 | 6.6385 | 0.6916 | 4 | 28 | negative regulation of alpha-beta T cell activation |
GO:0071822 | 0.0053 | 1.493 | 39.7655 | 56 | 1610 | protein complex subunit organization |
GO:0002830 | 0.0055 | 9.9399 | 0.3705 | 3 | 15 | positive regulation of type 2 immune response |
GO:0009404 | 0.0055 | 9.9399 | 0.3705 | 3 | 15 | toxin metabolic process |
GO:0002885 | 0.0058 | 26.4541 | 0.1235 | 2 | 5 | positive regulation of hypersensitivity |
GO:0042636 | 0.0058 | 26.4541 | 0.1235 | 2 | 5 | negative regulation of hair cycle |
GO:0072047 | 0.0058 | 26.4541 | 0.1235 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0070372 | 0.0059 | 2.2651 | 6.4959 | 14 | 263 | regulation of ERK1 and ERK2 cascade |
GO:0010667 | 0.006 | 6.127 | 0.741 | 4 | 30 | negative regulation of cardiac muscle cell apoptotic process |
GO:0002029 | 0.0066 | 9.1747 | 0.3952 | 3 | 16 | desensitization of G-protein coupled receptor protein signaling pathway |
GO:0023058 | 0.0066 | 9.1747 | 0.3952 | 3 | 16 | adaptation of signaling pathway |
GO:0046635 | 0.007 | 4.532 | 1.2103 | 5 | 49 | positive regulation of alpha-beta T cell activation |
GO:0001501 | 0.0075 | 1.873 | 11.7321 | 21 | 475 | skeletal system development |
GO:0006955 | 0.0075 | 1.4426 | 44.8042 | 61 | 1814 | immune response |
GO:0090279 | 0.0076 | 5.6886 | 0.7904 | 4 | 32 | regulation of calcium ion import |
GO:0002709 | 0.0076 | 4.431 | 1.235 | 5 | 50 | regulation of T cell mediated immunity |
GO:0065003 | 0.008 | 1.4501 | 42.3096 | 58 | 1713 | macromolecular complex assembly |
GO:0002687 | 0.008 | 5.5944 | 0.8007 | 4 | 33 | positive regulation of leukocyte migration |
GO:0032943 | 0.0081 | 2.254 | 6.0513 | 13 | 245 | mononuclear cell proliferation |
GO:0050900 | 0.0081 | 2.178 | 6.7374 | 14 | 280 | leukocyte migration |
GO:0002062 | 0.0082 | 3.2541 | 2.297 | 7 | 93 | chondrocyte differentiation |
GO:0048246 | 0.0085 | 5.4921 | 0.8151 | 4 | 33 | macrophage chemotaxis |
GO:0002725 | 0.0085 | 19.8393 | 0.1482 | 2 | 6 | negative regulation of T cell cytokine production |
GO:0003278 | 0.0085 | 19.8393 | 0.1482 | 2 | 6 | apoptotic process involved in heart morphogenesis |
GO:0035744 | 0.0085 | 19.8393 | 0.1482 | 2 | 6 | T-helper 1 cell cytokine production |
GO:0051902 | 0.0085 | 19.8393 | 0.1482 | 2 | 6 | negative regulation of mitochondrial depolarization |
GO:0060267 | 0.0085 | 19.8393 | 0.1482 | 2 | 6 | positive regulation of respiratory burst |
GO:0072014 | 0.0085 | 19.8393 | 0.1482 | 2 | 6 | proximal tubule development |
GO:2000416 | 0.0085 | 19.8393 | 0.1482 | 2 | 6 | regulation of eosinophil migration |
GO:0002682 | 0.0086 | 1.6241 | 21.3423 | 33 | 928 | regulation of immune system process |
GO:0050817 | 0.0086 | 2.0417 | 8.2001 | 16 | 332 | coagulation |
GO:0045321 | 0.0091 | 1.5439 | 27.1937 | 40 | 1101 | leukocyte activation |
GO:0050670 | 0.01 | 2.3736 | 4.8657 | 11 | 197 | regulation of lymphocyte proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 105.5455 | 0.9308 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 70.3455 | 1.0471 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 42.1855 | 1.2798 | 24 | 44 | protein heterotetramerization |
GO:0045653 | 0 | 120.4311 | 0.5236 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0031497 | 0 | 9.6551 | 4.2177 | 31 | 145 | chromatin assembly |
GO:0045815 | 0 | 15.3055 | 2.2979 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 11.5783 | 3.0542 | 26 | 105 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 9.9339 | 3.4323 | 26 | 118 | negative regulation of gene expression, epigenetic |
GO:0065004 | 0 | 6.7244 | 6.2247 | 34 | 214 | protein-DNA complex assembly |
GO:1902036 | 0 | 10.9169 | 2.9378 | 24 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0048863 | 0 | 6.1343 | 6.9281 | 35 | 240 | stem cell differentiation |
GO:0060968 | 0 | 8.9542 | 3.7232 | 26 | 128 | regulation of gene silencing |
GO:0007389 | 0 | 5.4228 | 7.9248 | 36 | 278 | pattern specification process |
GO:1904837 | 0 | 19.7194 | 1.2798 | 16 | 44 | beta-catenin-TCF complex assembly |
GO:0034080 | 0 | 20.6633 | 1.1635 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:0002244 | 0 | 6.231 | 5.4102 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0071103 | 0 | 5.1018 | 7.6209 | 33 | 262 | DNA conformation change |
GO:1902679 | 0 | 2.7044 | 32.6359 | 76 | 1122 | negative regulation of RNA biosynthetic process |
GO:0048704 | 0 | 15.7821 | 1.385 | 15 | 48 | embryonic skeletal system morphogenesis |
GO:0034724 | 0 | 14.3393 | 1.4835 | 15 | 51 | DNA replication-independent nucleosome organization |
GO:0035194 | 0 | 4.9948 | 6.7773 | 29 | 233 | posttranscriptional gene silencing by RNA |
GO:0032200 | 0 | 6.0232 | 4.7412 | 24 | 163 | telomere organization |
GO:0009952 | 0 | 5.3808 | 5.672 | 26 | 195 | anterior/posterior pattern specification |
GO:0032502 | 0 | 1.8243 | 165.6326 | 231 | 5726 | developmental process |
GO:0045892 | 0 | 4.0554 | 9.3233 | 33 | 335 | negative regulation of transcription, DNA-templated |
GO:0016233 | 0 | 11.7213 | 1.5998 | 14 | 55 | telomere capping |
GO:0045934 | 0 | 2.3404 | 39.1515 | 80 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0043044 | 0 | 8.5902 | 2.1815 | 15 | 75 | ATP-dependent chromatin remodeling |
GO:0030099 | 0 | 3.5122 | 10.9077 | 34 | 375 | myeloid cell differentiation |
GO:0009890 | 0 | 2.1295 | 45.987 | 86 | 1581 | negative regulation of biosynthetic process |
GO:0006303 | 0 | 8.2766 | 2.0943 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0017148 | 0 | 3.6226 | 9.3079 | 30 | 320 | negative regulation of translation |
GO:0043009 | 0 | 2.8816 | 15.8526 | 41 | 545 | chordate embryonic development |
GO:0034728 | 0 | 6.4514 | 2.9367 | 16 | 104 | nucleosome organization |
GO:0038111 | 0 | 12.613 | 1.0762 | 10 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 12.613 | 1.0762 | 10 | 37 | response to interleukin-7 |
GO:0021953 | 0 | 4.7664 | 4.7994 | 20 | 165 | central nervous system neuron differentiation |
GO:0034654 | 0 | 1.688 | 117.4253 | 167 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0045944 | 0 | 2.1977 | 30.8034 | 61 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0051259 | 0 | 2.7507 | 14.8345 | 37 | 510 | protein oligomerization |
GO:1903707 | 0 | 4.9964 | 3.8977 | 17 | 134 | negative regulation of hemopoiesis |
GO:0045652 | 0 | 8.5968 | 1.5815 | 11 | 56 | regulation of megakaryocyte differentiation |
GO:0001501 | 0 | 3.4061 | 8.4728 | 26 | 297 | skeletal system development |
GO:0048536 | 0 | 11.3267 | 1.0471 | 9 | 36 | spleen development |
GO:2000026 | 0 | 1.8655 | 52.1244 | 87 | 1792 | regulation of multicellular organismal development |
GO:0035107 | 0 | 4.5638 | 4.2177 | 17 | 145 | appendage morphogenesis |
GO:0060173 | 0 | 4.0992 | 4.9157 | 18 | 169 | limb development |
GO:0010628 | 0 | 1.8812 | 46.1261 | 78 | 1664 | positive regulation of gene expression |
GO:0021517 | 0 | 8.9907 | 1.2508 | 9 | 43 | ventral spinal cord development |
GO:0048534 | 0 | 2.1468 | 22.7843 | 45 | 797 | hematopoietic or lymphoid organ development |
GO:0050878 | 0 | 2.4925 | 13.9328 | 32 | 479 | regulation of body fluid levels |
GO:0021515 | 0 | 7.2744 | 1.4835 | 9 | 51 | cell differentiation in spinal cord |
GO:0009893 | 0 | 1.5871 | 90.9268 | 128 | 3126 | positive regulation of metabolic process |
GO:0048665 | 0 | 14.5988 | 0.5772 | 6 | 20 | neuron fate specification |
GO:0002227 | 0 | 14.4797 | 0.5817 | 6 | 20 | innate immune response in mucosa |
GO:0001709 | 0 | 8.4737 | 1.1635 | 8 | 40 | cell fate determination |
GO:0034248 | 0 | 2.3604 | 15.5908 | 34 | 536 | regulation of cellular amide metabolic process |
GO:0048731 | 0 | 1.5601 | 105.4112 | 143 | 3858 | system development |
GO:0002251 | 0 | 9.474 | 0.9308 | 7 | 32 | organ or tissue specific immune response |
GO:0045596 | 0 | 2.1919 | 18.2086 | 37 | 626 | negative regulation of cell differentiation |
GO:1903508 | 0 | 1.7869 | 39.5296 | 65 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0006352 | 0 | 3.0914 | 6.6901 | 19 | 230 | DNA-templated transcription, initiation |
GO:0002072 | 0 | 33.6609 | 0.2327 | 4 | 8 | optic cup morphogenesis involved in camera-type eye development |
GO:0048562 | 0 | 4.8245 | 2.566 | 11 | 93 | embryonic organ morphogenesis |
GO:0048596 | 1e-04 | 10.6658 | 0.7272 | 6 | 25 | embryonic camera-type eye morphogenesis |
GO:0009611 | 1e-04 | 2.1164 | 18.2668 | 36 | 628 | response to wounding |
GO:0000122 | 1e-04 | 2.0115 | 21.9027 | 41 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0045165 | 1e-04 | 3.2772 | 5.318 | 16 | 187 | cell fate commitment |
GO:0097659 | 1e-04 | 1.6244 | 60.7221 | 89 | 2221 | nucleic acid-templated transcription |
GO:0080090 | 1e-04 | 1.437 | 165.9719 | 205 | 5706 | regulation of primary metabolic process |
GO:0009953 | 1e-04 | 4.453 | 2.7633 | 11 | 95 | dorsal/ventral pattern formation |
GO:0019731 | 1e-04 | 7.6374 | 1.1053 | 7 | 38 | antibacterial humoral response |
GO:0051254 | 1e-04 | 1.7171 | 41.5948 | 66 | 1430 | positive regulation of RNA metabolic process |
GO:0042693 | 1e-04 | 12.9672 | 0.5236 | 5 | 18 | muscle cell fate commitment |
GO:0035116 | 1e-04 | 9.2096 | 0.8144 | 6 | 28 | embryonic hindlimb morphogenesis |
GO:0042474 | 2e-04 | 12.0401 | 0.5527 | 5 | 19 | middle ear morphogenesis |
GO:0007596 | 2e-04 | 3.2305 | 5.0458 | 15 | 176 | blood coagulation |
GO:0007423 | 2e-04 | 2.152 | 14.8927 | 30 | 512 | sensory organ development |
GO:0021675 | 2e-04 | 4.843 | 2.0943 | 9 | 72 | nerve development |
GO:0072162 | 2e-04 | 50.3883 | 0.1454 | 3 | 5 | metanephric mesenchymal cell differentiation |
GO:0021872 | 3e-04 | 5.2078 | 1.7452 | 8 | 60 | forebrain generation of neurons |
GO:0010608 | 3e-04 | 2.0001 | 18.1214 | 34 | 623 | posttranscriptional regulation of gene expression |
GO:0021520 | 4e-04 | 14.9556 | 0.3781 | 4 | 13 | spinal cord motor neuron cell fate specification |
GO:0010557 | 4e-04 | 1.6076 | 46.1615 | 69 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0021602 | 4e-04 | 9.4019 | 0.6663 | 5 | 23 | cranial nerve morphogenesis |
GO:0060255 | 5e-04 | 1.377 | 166.6409 | 201 | 5729 | regulation of macromolecule metabolic process |
GO:0030326 | 5e-04 | 3.9007 | 2.8186 | 10 | 98 | embryonic limb morphogenesis |
GO:0034645 | 5e-04 | 1.3878 | 141.0441 | 174 | 4849 | cellular macromolecule biosynthetic process |
GO:0071542 | 5e-04 | 6.7502 | 1.0471 | 6 | 36 | dopaminergic neuron differentiation |
GO:0021511 | 5e-04 | 8.8688 | 0.6981 | 5 | 24 | spinal cord patterning |
GO:0030878 | 5e-04 | 8.8688 | 0.6981 | 5 | 24 | thyroid gland development |
GO:0051248 | 6e-04 | 1.6689 | 35.8646 | 56 | 1233 | negative regulation of protein metabolic process |
GO:0051216 | 7e-04 | 2.907 | 5.1775 | 14 | 178 | cartilage development |
GO:0060579 | 7e-04 | 12.2348 | 0.4363 | 4 | 15 | ventral spinal cord interneuron fate commitment |
GO:0002376 | 7e-04 | 1.4613 | 76.5868 | 103 | 2633 | immune system process |
GO:0051971 | 8e-04 | 25.1909 | 0.2036 | 3 | 7 | positive regulation of transmission of nerve impulse |
GO:2001012 | 8e-04 | 25.1909 | 0.2036 | 3 | 7 | mesenchymal cell differentiation involved in renal system development |
GO:0035136 | 8e-04 | 6.1354 | 1.1344 | 6 | 39 | forelimb morphogenesis |
GO:0048592 | 9e-04 | 3.1364 | 4.1304 | 12 | 142 | eye morphogenesis |
GO:0031328 | 0.001 | 1.5415 | 50.0592 | 72 | 1721 | positive regulation of cellular biosynthetic process |
GO:0072224 | 0.001 | 11.2145 | 0.4654 | 4 | 16 | metanephric glomerulus development |
GO:0048519 | 0.0011 | 1.3619 | 140.1133 | 171 | 4817 | negative regulation of biological process |
GO:1901576 | 0.0012 | 1.3417 | 175.0181 | 207 | 6017 | organic substance biosynthetic process |
GO:0048793 | 0.0012 | 20.1514 | 0.2327 | 3 | 8 | pronephros development |
GO:1903251 | 0.0012 | 20.1514 | 0.2327 | 3 | 8 | multi-ciliated epithelial cell differentiation |
GO:0048332 | 0.0012 | 4.1628 | 2.1234 | 8 | 73 | mesoderm morphogenesis |
GO:0007625 | 0.0012 | 10.3512 | 0.4945 | 4 | 17 | grooming behavior |
GO:0090185 | 0.0012 | 10.3512 | 0.4945 | 4 | 17 | negative regulation of kidney development |
GO:2000738 | 0.0012 | 10.3512 | 0.4945 | 4 | 17 | positive regulation of stem cell differentiation |
GO:0035295 | 0.0013 | 1.9387 | 15.8208 | 29 | 547 | tube development |
GO:0060021 | 0.0013 | 3.7163 | 2.6469 | 9 | 91 | palate development |
GO:0042471 | 0.0015 | 3.6209 | 2.708 | 9 | 94 | ear morphogenesis |
GO:0072074 | 0.0016 | 9.6112 | 0.5236 | 4 | 18 | kidney mesenchyme development |
GO:0007368 | 0.0017 | 3.2901 | 3.2869 | 10 | 113 | determination of left/right symmetry |
GO:0042135 | 0.0018 | 16.7918 | 0.2618 | 3 | 9 | neurotransmitter catabolic process |
GO:0072048 | 0.0018 | 16.7918 | 0.2618 | 3 | 9 | renal system pattern specification |
GO:2000543 | 0.0018 | 16.7918 | 0.2618 | 3 | 9 | positive regulation of gastrulation |
GO:0043043 | 0.0018 | 1.7518 | 22.3099 | 37 | 767 | peptide biosynthetic process |
GO:0001710 | 0.0019 | 8.9699 | 0.5527 | 4 | 19 | mesodermal cell fate commitment |
GO:0022008 | 0.0022 | 1.5366 | 41.4493 | 60 | 1425 | neurogenesis |
GO:0007420 | 0.0022 | 1.8036 | 18.7031 | 32 | 643 | brain development |
GO:0023019 | 0.0024 | 8.4087 | 0.5817 | 4 | 20 | signal transduction involved in regulation of gene expression |
GO:0070271 | 0.0024 | 1.541 | 39.9077 | 58 | 1372 | protein complex biogenesis |
GO:0003350 | 0.0025 | 67.0433 | 0.0873 | 2 | 3 | pulmonary myocardium development |
GO:0014707 | 0.0025 | 67.0433 | 0.0873 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0036023 | 0.0025 | 67.0433 | 0.0873 | 2 | 3 | embryonic skeletal limb joint morphogenesis |
GO:0060166 | 0.0025 | 67.0433 | 0.0873 | 2 | 3 | olfactory pit development |
GO:0060168 | 0.0025 | 67.0433 | 0.0873 | 2 | 3 | positive regulation of adenosine receptor signaling pathway |
GO:0070634 | 0.0025 | 67.0433 | 0.0873 | 2 | 3 | transepithelial ammonium transport |
GO:1903237 | 0.0025 | 67.0433 | 0.0873 | 2 | 3 | negative regulation of leukocyte tethering or rolling |
GO:0048598 | 0.0025 | 2.2828 | 7.8724 | 17 | 291 | embryonic morphogenesis |
GO:0065007 | 0.0028 | 1.3532 | 322.8686 | 350 | 11100 | biological regulation |
GO:0009888 | 0.0028 | 1.5027 | 45.2838 | 64 | 1596 | tissue development |
GO:0050830 | 0.0028 | 3.6054 | 2.4142 | 8 | 83 | defense response to Gram-positive bacterium |
GO:0061564 | 0.0029 | 1.9521 | 12.9438 | 24 | 445 | axon development |
GO:0007200 | 0.0031 | 3.2393 | 2.996 | 9 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0009799 | 0.0032 | 2.997 | 3.5777 | 10 | 123 | specification of symmetry |
GO:0065003 | 0.0032 | 1.471 | 49.8265 | 69 | 1713 | macromolecular complex assembly |
GO:0003093 | 0.0034 | 12.5922 | 0.32 | 3 | 11 | regulation of glomerular filtration |
GO:0009886 | 0.0034 | 12.5922 | 0.32 | 3 | 11 | post-embryonic animal morphogenesis |
GO:0060573 | 0.0034 | 12.5922 | 0.32 | 3 | 11 | cell fate specification involved in pattern specification |
GO:0072178 | 0.0034 | 12.5922 | 0.32 | 3 | 11 | nephric duct morphogenesis |
GO:0072182 | 0.0034 | 12.5922 | 0.32 | 3 | 11 | regulation of nephron tubule epithelial cell differentiation |
GO:0090009 | 0.0034 | 12.5922 | 0.32 | 3 | 11 | primitive streak formation |
GO:0061844 | 0.0035 | 4.4958 | 1.4835 | 6 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0072080 | 0.0038 | 3.4219 | 2.5306 | 8 | 87 | nephron tubule development |
GO:0060485 | 0.0039 | 2.3852 | 6.2069 | 14 | 215 | mesenchyme development |
GO:0090103 | 0.004 | 7.0796 | 0.669 | 4 | 23 | cochlea morphogenesis |
GO:0090304 | 0.0041 | 1.3067 | 141.3059 | 168 | 4858 | nucleic acid metabolic process |
GO:0003207 | 0.0044 | 11.1923 | 0.349 | 3 | 12 | cardiac chamber formation |
GO:0030307 | 0.0044 | 2.6814 | 4.3631 | 11 | 150 | positive regulation of cell growth |
GO:0072088 | 0.0045 | 3.6915 | 2.0652 | 7 | 71 | nephron epithelium morphogenesis |
GO:0045777 | 0.0046 | 5.1017 | 1.1053 | 5 | 38 | positive regulation of blood pressure |
GO:0030168 | 0.0047 | 2.6621 | 4.3922 | 11 | 151 | platelet activation |
GO:0061217 | 0.0047 | 6.7252 | 0.6981 | 4 | 24 | regulation of mesonephros development |
GO:0021615 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0021913 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0032058 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | positive regulation of translational initiation in response to stress |
GO:0042662 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0072268 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | pattern specification involved in metanephros development |
GO:0090191 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0090244 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
GO:0097476 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | spinal cord motor neuron migration |
GO:1905903 | 0.0049 | 33.5195 | 0.1163 | 2 | 4 | negative regulation of mesoderm formation |
GO:0043010 | 0.0052 | 2.1117 | 8.4644 | 17 | 291 | camera-type eye development |
GO:0061333 | 0.0053 | 3.5791 | 2.1234 | 7 | 73 | renal tubule morphogenesis |
GO:0035282 | 0.0053 | 3.2172 | 2.676 | 8 | 92 | segmentation |
GO:0050678 | 0.0054 | 2.1039 | 8.4935 | 17 | 292 | regulation of epithelial cell proliferation |
GO:0001764 | 0.0055 | 2.7515 | 3.8686 | 10 | 133 | neuron migration |
GO:0007411 | 0.0056 | 2.2855 | 6.4574 | 14 | 222 | axon guidance |
GO:0072189 | 0.0056 | 10.0725 | 0.3781 | 3 | 13 | ureter development |
GO:0001657 | 0.0057 | 3.1792 | 2.7051 | 8 | 93 | ureteric bud development |
GO:0031323 | 0.0057 | 1.2974 | 146.7492 | 172 | 5284 | regulation of cellular metabolic process |
GO:0048858 | 0.0057 | 1.7508 | 16.7543 | 28 | 576 | cell projection morphogenesis |
GO:0072163 | 0.0061 | 3.142 | 2.7342 | 8 | 94 | mesonephric epithelium development |
GO:0071773 | 0.0062 | 2.5517 | 4.5667 | 11 | 157 | cellular response to BMP stimulus |
GO:0021884 | 0.0064 | 6.113 | 0.7563 | 4 | 26 | forebrain neuron development |
GO:0051171 | 0.0064 | 1.2951 | 139.4451 | 164 | 5021 | regulation of nitrogen compound metabolic process |
GO:0060538 | 0.0065 | 2.5341 | 4.5958 | 11 | 158 | skeletal muscle organ development |
GO:0048667 | 0.0067 | 1.7883 | 14.6309 | 25 | 503 | cell morphogenesis involved in neuron differentiation |
GO:0048468 | 0.0069 | 1.403 | 55.0331 | 73 | 1892 | cell development |
GO:0060788 | 0.007 | 9.1562 | 0.4072 | 3 | 14 | ectodermal placode formation |
GO:1904994 | 0.007 | 9.1562 | 0.4072 | 3 | 14 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0048812 | 0.0071 | 1.7369 | 16.2598 | 27 | 559 | neuron projection morphogenesis |
GO:0048483 | 0.0071 | 4.549 | 1.2217 | 5 | 42 | autonomic nervous system development |
GO:0002009 | 0.0073 | 1.8474 | 12.4602 | 22 | 433 | morphogenesis of an epithelium |
GO:0006355 | 0.0076 | 1.3881 | 60.8194 | 79 | 2318 | regulation of transcription, DNA-templated |
GO:0030154 | 0.0076 | 1.5392 | 30.308 | 44 | 1196 | cell differentiation |
GO:0003044 | 0.0079 | 4.429 | 1.2508 | 5 | 43 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0021650 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | vestibulocochlear nerve formation |
GO:0021778 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | oligodendrocyte cell fate specification |
GO:0034137 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | positive regulation of toll-like receptor 2 signaling pathway |
GO:0048625 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | myoblast fate commitment |
GO:0051970 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0072081 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | specification of nephron tubule identity |
GO:1904956 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | regulation of midbrain dopaminergic neuron differentiation |
GO:2000609 | 0.008 | 22.3449 | 0.1454 | 2 | 5 | regulation of thyroid hormone generation |
GO:0072171 | 0.0084 | 3.676 | 1.7743 | 6 | 61 | mesonephric tubule morphogenesis |
GO:0002115 | 0.0086 | 8.3926 | 0.4363 | 3 | 15 | store-operated calcium entry |
GO:0021783 | 0.0086 | 8.3926 | 0.4363 | 3 | 15 | preganglionic parasympathetic fiber development |
GO:0048532 | 0.0086 | 8.3926 | 0.4363 | 3 | 15 | anatomical structure arrangement |
GO:0071696 | 0.0086 | 8.3926 | 0.4363 | 3 | 15 | ectodermal placode development |
GO:0048701 | 0.0087 | 4.3151 | 1.2798 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0071822 | 0.009 | 1.4158 | 46.8305 | 63 | 1610 | protein complex subunit organization |
GO:0048754 | 0.009 | 2.543 | 4.1595 | 10 | 143 | branching morphogenesis of an epithelial tube |
GO:0001704 | 0.0093 | 2.6913 | 3.5486 | 9 | 122 | formation of primary germ layer |
GO:2001141 | 0.0094 | 1.3757 | 60.4631 | 78 | 2311 | regulation of RNA biosynthetic process |
GO:0007129 | 0.0096 | 4.207 | 1.3089 | 5 | 45 | synapsis |
GO:0031018 | 0.0096 | 4.207 | 1.3089 | 5 | 45 | endocrine pancreas development |
GO:0007275 | 0.0097 | 1.8661 | 11.3043 | 20 | 474 | multicellular organism development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007606 | 0 | 6.0327 | 9.8242 | 48 | 406 | sensory perception of chemical stimulus |
GO:0050911 | 0 | 6.3196 | 7.5255 | 39 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 5.5309 | 9.3887 | 43 | 388 | detection of chemical stimulus |
GO:0050906 | 0 | 5.034 | 9.679 | 41 | 400 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 2.8682 | 27.7788 | 68 | 1148 | nervous system process |
GO:0007186 | 0 | 3.0579 | 22.0709 | 58 | 937 | G-protein coupled receptor signaling pathway |
GO:0050830 | 0 | 6.3124 | 2.0084 | 11 | 83 | defense response to Gram-positive bacterium |
GO:0034382 | 0 | 32.5885 | 0.2178 | 4 | 9 | chylomicron remnant clearance |
GO:0032501 | 1e-04 | 1.4747 | 156.0853 | 191 | 6625 | multicellular organismal process |
GO:0031424 | 1e-04 | 3.272 | 4.9605 | 15 | 205 | keratinization |
GO:0007218 | 4e-04 | 4.3479 | 2.2746 | 9 | 94 | neuropeptide signaling pathway |
GO:0034368 | 5e-04 | 8.8685 | 0.6775 | 5 | 28 | protein-lipid complex remodeling |
GO:0033693 | 6e-04 | Inf | 0.0484 | 2 | 2 | neurofilament bundle assembly |
GO:0036345 | 6e-04 | Inf | 0.0484 | 2 | 2 | platelet maturation |
GO:1905461 | 6e-04 | Inf | 0.0484 | 2 | 2 | positive regulation of vascular associated smooth muscle cell apoptotic process |
GO:0032375 | 6e-04 | 12.5276 | 0.4114 | 4 | 17 | negative regulation of cholesterol transport |
GO:0034375 | 6e-04 | 12.5276 | 0.4114 | 4 | 17 | high-density lipoprotein particle remodeling |
GO:0034371 | 0.0011 | 20.3133 | 0.2178 | 3 | 9 | chylomicron remodeling |
GO:0051006 | 0.0015 | 17.4103 | 0.242 | 3 | 10 | positive regulation of lipoprotein lipase activity |
GO:0032264 | 0.0017 | 81.0677 | 0.0726 | 2 | 3 | IMP salvage |
GO:1905563 | 0.0017 | 81.0677 | 0.0726 | 2 | 3 | negative regulation of vascular endothelial cell proliferation |
GO:2000502 | 0.0017 | 81.0677 | 0.0726 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
GO:0006968 | 0.0019 | 5.1046 | 1.3067 | 6 | 54 | cellular defense response |
GO:0050829 | 0.0019 | 4.3376 | 1.7664 | 7 | 73 | defense response to Gram-negative bacterium |
GO:1903244 | 0.002 | 15.233 | 0.2662 | 3 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0007154 | 0.0025 | 1.3481 | 144.8468 | 172 | 5986 | cell communication |
GO:0033700 | 0.0026 | 13.5396 | 0.2904 | 3 | 12 | phospholipid efflux |
GO:0010916 | 0.0034 | 40.5312 | 0.0968 | 2 | 4 | negative regulation of very-low-density lipoprotein particle clearance |
GO:0050896 | 0.0034 | 1.3309 | 195.2988 | 222 | 8071 | response to stimulus |
GO:0060191 | 0.0034 | 3.8666 | 1.96 | 7 | 81 | regulation of lipase activity |
GO:0007187 | 0.0038 | 2.738 | 4.2588 | 11 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0014744 | 0.0042 | 11.0764 | 0.3388 | 3 | 14 | positive regulation of muscle adaptation |
GO:0034433 | 0.0042 | 11.0764 | 0.3388 | 3 | 14 | steroid esterification |
GO:0034435 | 0.0042 | 11.0764 | 0.3388 | 3 | 14 | cholesterol esterification |
GO:0060080 | 0.0042 | 11.0764 | 0.3388 | 3 | 14 | inhibitory postsynaptic potential |
GO:0034377 | 0.0044 | 6.781 | 0.6775 | 4 | 28 | plasma lipoprotein particle assembly |
GO:0015748 | 0.0048 | 3.6208 | 2.081 | 7 | 86 | organophosphate ester transport |
GO:1905952 | 0.0048 | 2.9973 | 3.1941 | 9 | 132 | regulation of lipid localization |
GO:0032369 | 0.005 | 6.5093 | 0.7017 | 4 | 29 | negative regulation of lipid transport |
GO:0023052 | 0.0054 | 1.3124 | 144.3628 | 169 | 5966 | signaling |
GO:0006824 | 0.0056 | 27.0191 | 0.121 | 2 | 5 | cobalt ion transport |
GO:0010901 | 0.0056 | 27.0191 | 0.121 | 2 | 5 | regulation of very-low-density lipoprotein particle remodeling |
GO:0061760 | 0.0056 | 27.0191 | 0.121 | 2 | 5 | antifungal innate immune response |
GO:0003002 | 0.0057 | 2.1422 | 7.84 | 16 | 324 | regionalization |
GO:0009913 | 0.0062 | 2.1211 | 7.9126 | 16 | 327 | epidermal cell differentiation |
GO:0036149 | 0.0062 | 9.3712 | 0.3872 | 3 | 16 | phosphatidylinositol acyl-chain remodeling |
GO:0043588 | 0.0063 | 2.0201 | 9.3403 | 18 | 386 | skin development |
GO:0071222 | 0.0064 | 2.6792 | 3.9442 | 10 | 163 | cellular response to lipopolysaccharide |
GO:0042632 | 0.0064 | 3.8855 | 1.6696 | 6 | 69 | cholesterol homeostasis |
GO:0006641 | 0.0065 | 3.4041 | 2.202 | 7 | 91 | triglyceride metabolic process |
GO:0009617 | 0.0069 | 1.8596 | 12.3892 | 22 | 512 | response to bacterium |
GO:0070328 | 0.0071 | 5.8108 | 0.7743 | 4 | 32 | triglyceride homeostasis |
GO:0009996 | 0.0082 | 20.263 | 0.1452 | 2 | 6 | negative regulation of cell fate specification |
GO:0016098 | 0.0082 | 20.263 | 0.1452 | 2 | 6 | monoterpenoid metabolic process |
GO:0060696 | 0.0082 | 20.263 | 0.1452 | 2 | 6 | regulation of phospholipid catabolic process |
GO:0032026 | 0.0088 | 8.1206 | 0.4356 | 3 | 18 | response to magnesium ion |
GO:0043691 | 0.0088 | 8.1206 | 0.4356 | 3 | 18 | reverse cholesterol transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 116.6918 | 0.5394 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 25.908 | 0.9589 | 14 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 21.192 | 1.0787 | 14 | 36 | chromatin silencing at rDNA |
GO:1904837 | 0 | 17.2544 | 1.3185 | 15 | 44 | beta-catenin-TCF complex assembly |
GO:0034080 | 0 | 17.9271 | 1.1986 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0051290 | 0 | 15.5328 | 1.3185 | 14 | 44 | protein heterotetramerization |
GO:0034724 | 0 | 12.5884 | 1.5282 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0045814 | 0 | 6.8514 | 3.5359 | 20 | 118 | negative regulation of gene expression, epigenetic |
GO:0016233 | 0 | 11.3573 | 1.6481 | 14 | 55 | telomere capping |
GO:0003008 | 0 | 2.1124 | 55.8246 | 102 | 1863 | system process |
GO:1903707 | 0 | 5.8837 | 4.0153 | 20 | 134 | negative regulation of hemopoiesis |
GO:0051606 | 0 | 2.9929 | 16.5107 | 44 | 551 | detection of stimulus |
GO:1902679 | 0 | 2.2691 | 33.6206 | 68 | 1122 | negative regulation of RNA biosynthetic process |
GO:0006303 | 0 | 8.0196 | 2.1575 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 7.6237 | 2.2474 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0007187 | 0 | 4.5415 | 5.2738 | 21 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0045815 | 0 | 7.1527 | 2.3672 | 14 | 79 | positive regulation of gene expression, epigenetic |
GO:0007186 | 0 | 2.3366 | 26.6645 | 56 | 926 | G-protein coupled receptor signaling pathway |
GO:0007600 | 0 | 2.4839 | 21.3948 | 48 | 725 | sensory perception |
GO:0050911 | 0 | 3.34 | 9.3191 | 28 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:1902036 | 0 | 5.7969 | 3.0265 | 15 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 5.5378 | 3.1463 | 15 | 105 | regulation of gene silencing by miRNA |
GO:0048863 | 0 | 4.3398 | 4.9458 | 19 | 168 | stem cell differentiation |
GO:0045934 | 0 | 2.0232 | 37.7868 | 69 | 1274 | negative regulation of nucleobase-containing compound metabolic process |
GO:0007218 | 0 | 5.8059 | 2.8167 | 14 | 94 | neuropeptide signaling pathway |
GO:0045892 | 0 | 3.0904 | 9.6319 | 27 | 335 | negative regulation of transcription, DNA-templated |
GO:0045596 | 0 | 2.3912 | 18.2582 | 40 | 614 | negative regulation of cell differentiation |
GO:0060968 | 0 | 4.404 | 3.8355 | 15 | 128 | regulation of gene silencing |
GO:0007193 | 0 | 5.8552 | 2.1874 | 11 | 73 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0045944 | 0 | 1.9555 | 31.7328 | 57 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048729 | 0 | 2.2623 | 18.1887 | 38 | 607 | tissue morphogenesis |
GO:0009952 | 0 | 3.4958 | 5.6713 | 18 | 190 | anterior/posterior pattern specification |
GO:0065007 | 0 | 1.572 | 332.6103 | 373 | 11100 | biological regulation |
GO:0072010 | 0 | 14.0375 | 0.5993 | 6 | 20 | glomerular epithelium development |
GO:0007389 | 0 | 2.6446 | 11.0724 | 27 | 375 | pattern specification process |
GO:0048562 | 0 | 2.8566 | 8.3602 | 22 | 279 | embryonic organ morphogenesis |
GO:0009890 | 0 | 1.7261 | 47.3745 | 75 | 1581 | negative regulation of biosynthetic process |
GO:0051239 | 0 | 1.5672 | 81.4146 | 115 | 2717 | regulation of multicellular organismal process |
GO:0002244 | 0 | 3.3396 | 5.5735 | 17 | 186 | hematopoietic progenitor cell differentiation |
GO:0002682 | 1e-04 | 1.7599 | 40.6624 | 66 | 1357 | regulation of immune system process |
GO:0006352 | 1e-04 | 2.9943 | 6.8919 | 19 | 230 | DNA-templated transcription, initiation |
GO:0060795 | 1e-04 | 8.1985 | 1.0488 | 7 | 35 | cell fate commitment involved in formation of primary germ layer |
GO:0045637 | 1e-04 | 2.9378 | 7.0118 | 19 | 234 | regulation of myeloid cell differentiation |
GO:0072048 | 1e-04 | 26.108 | 0.2697 | 4 | 9 | renal system pattern specification |
GO:0048754 | 1e-04 | 3.5891 | 4.285 | 14 | 143 | branching morphogenesis of an epithelial tube |
GO:0072112 | 1e-04 | 13.6205 | 0.5094 | 5 | 17 | glomerular visceral epithelial cell differentiation |
GO:0032200 | 1e-04 | 3.3549 | 4.8843 | 15 | 163 | telomere organization |
GO:0031497 | 1e-04 | 3.5339 | 4.3449 | 14 | 145 | chromatin assembly |
GO:0021515 | 1e-04 | 6.1083 | 1.5282 | 8 | 51 | cell differentiation in spinal cord |
GO:0000122 | 2e-04 | 1.9452 | 22.5636 | 41 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0001763 | 2e-04 | 3.081 | 5.6334 | 16 | 188 | morphogenesis of a branching structure |
GO:0035295 | 2e-04 | 2.1033 | 16.7803 | 33 | 560 | tube development |
GO:1903508 | 2e-04 | 1.6926 | 40.7223 | 64 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0061458 | 2e-04 | 2.291 | 12.1358 | 26 | 405 | reproductive system development |
GO:0003205 | 2e-04 | 3.2811 | 4.6446 | 14 | 155 | cardiac chamber development |
GO:0061760 | 3e-04 | 48.8589 | 0.1498 | 3 | 5 | antifungal innate immune response |
GO:0010628 | 3e-04 | 1.6215 | 48.6421 | 73 | 1664 | positive regulation of gene expression |
GO:0009792 | 3e-04 | 2.0757 | 16.4507 | 32 | 549 | embryo development ending in birth or egg hatching |
GO:0010454 | 3e-04 | 16.3143 | 0.3596 | 4 | 12 | negative regulation of cell fate commitment |
GO:0019233 | 5e-04 | 3.9623 | 2.7867 | 10 | 93 | sensory perception of pain |
GO:0048869 | 5e-04 | 1.4145 | 114.5799 | 146 | 3894 | cellular developmental process |
GO:1904746 | 5e-04 | 32.5705 | 0.1798 | 3 | 6 | negative regulation of apoptotic process involved in development |
GO:0010469 | 5e-04 | 2.0713 | 14.8918 | 29 | 501 | regulation of receptor activity |
GO:0007548 | 6e-04 | 2.5708 | 7.4912 | 18 | 250 | sex differentiation |
GO:0003151 | 6e-04 | 5.5122 | 1.4552 | 7 | 49 | outflow tract morphogenesis |
GO:0014031 | 6e-04 | 4.6863 | 1.9178 | 8 | 64 | mesenchymal cell development |
GO:0048864 | 6e-04 | 4.6863 | 1.9178 | 8 | 64 | stem cell development |
GO:0045995 | 7e-04 | 3.4811 | 3.446 | 11 | 115 | regulation of embryonic development |
GO:0048534 | 7e-04 | 1.7881 | 24.9608 | 42 | 833 | hematopoietic or lymphoid organ development |
GO:0034654 | 7e-04 | 1.3909 | 120.9683 | 152 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0051254 | 7e-04 | 1.5966 | 42.8498 | 64 | 1430 | positive regulation of RNA metabolic process |
GO:0001755 | 7e-04 | 6.3326 | 1.1087 | 6 | 37 | neural crest cell migration |
GO:0060249 | 8e-04 | 2.2167 | 11.0271 | 23 | 368 | anatomical structure homeostasis |
GO:0051259 | 8e-04 | 2.0132 | 15.2821 | 29 | 510 | protein oligomerization |
GO:0003148 | 8e-04 | 8.1681 | 0.7491 | 5 | 25 | outflow tract septum morphogenesis |
GO:0048644 | 8e-04 | 3.9935 | 2.4871 | 9 | 83 | muscle organ morphogenesis |
GO:0001826 | 9e-04 | 24.4263 | 0.2098 | 3 | 7 | inner cell mass cell differentiation |
GO:0009187 | 9e-04 | 2.7221 | 5.9031 | 15 | 197 | cyclic nucleotide metabolic process |
GO:0007498 | 9e-04 | 3.3513 | 3.5658 | 11 | 119 | mesoderm development |
GO:0007493 | 9e-04 | Inf | 0.0599 | 2 | 2 | endodermal cell fate determination |
GO:0021623 | 9e-04 | Inf | 0.0599 | 2 | 2 | oculomotor nerve formation |
GO:0035990 | 9e-04 | Inf | 0.0599 | 2 | 2 | tendon cell differentiation |
GO:1902257 | 9e-04 | Inf | 0.0599 | 2 | 2 | negative regulation of apoptotic process involved in outflow tract morphogenesis |
GO:2001037 | 9e-04 | Inf | 0.0599 | 2 | 2 | positive regulation of tongue muscle cell differentiation |
GO:2001076 | 9e-04 | Inf | 0.0599 | 2 | 2 | positive regulation of metanephric ureteric bud development |
GO:0023052 | 9e-04 | 1.3463 | 178.7706 | 212 | 5966 | signaling |
GO:0014033 | 9e-04 | 4.3728 | 2.0376 | 8 | 68 | neural crest cell differentiation |
GO:0048706 | 0.001 | 3.3203 | 3.5958 | 11 | 120 | embryonic skeletal system development |
GO:0007631 | 0.0011 | 3.4961 | 3.1163 | 10 | 104 | feeding behavior |
GO:0007154 | 0.0011 | 1.3389 | 179.3699 | 212 | 5986 | cell communication |
GO:0023061 | 0.0012 | 2.0998 | 12.1058 | 24 | 404 | signal release |
GO:2000027 | 0.0012 | 2.6294 | 6.0919 | 15 | 205 | regulation of organ morphogenesis |
GO:0033002 | 0.0013 | 2.7325 | 5.4836 | 14 | 183 | muscle cell proliferation |
GO:0035270 | 0.0013 | 3.202 | 3.7156 | 11 | 124 | endocrine system development |
GO:0060429 | 0.0013 | 1.6151 | 35.5084 | 54 | 1185 | epithelium development |
GO:0033278 | 0.0013 | 19.5398 | 0.2397 | 3 | 8 | cell proliferation in midbrain |
GO:0060539 | 0.0013 | 19.5398 | 0.2397 | 3 | 8 | diaphragm development |
GO:0072217 | 0.0013 | 19.5398 | 0.2397 | 3 | 8 | negative regulation of metanephros development |
GO:0003208 | 0.0014 | 4.0984 | 2.1575 | 8 | 72 | cardiac ventricle morphogenesis |
GO:0021675 | 0.0014 | 4.0984 | 2.1575 | 8 | 72 | nerve development |
GO:0031328 | 0.0014 | 1.5122 | 51.5696 | 73 | 1721 | positive regulation of cellular biosynthetic process |
GO:1904948 | 0.0014 | 10.0364 | 0.5094 | 4 | 17 | midbrain dopaminergic neuron differentiation |
GO:0016331 | 0.0014 | 2.9703 | 4.3449 | 12 | 145 | morphogenesis of embryonic epithelium |
GO:0030802 | 0.0014 | 2.9703 | 4.3449 | 12 | 145 | regulation of cyclic nucleotide biosynthetic process |
GO:1901861 | 0.0015 | 3.1185 | 3.8055 | 11 | 127 | regulation of muscle tissue development |
GO:0010557 | 0.0016 | 1.5237 | 47.5543 | 68 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0021953 | 0.0016 | 2.9269 | 4.4024 | 12 | 148 | central nervous system neuron differentiation |
GO:0006171 | 0.0016 | 3.0917 | 3.8355 | 11 | 128 | cAMP biosynthetic process |
GO:0009893 | 0.0016 | 1.3903 | 93.6703 | 120 | 3126 | positive regulation of metabolic process |
GO:0050794 | 0.0017 | 1.3687 | 230.1591 | 259 | 8254 | regulation of cellular process |
GO:0021517 | 0.0017 | 5.3036 | 1.2885 | 6 | 43 | ventral spinal cord development |
GO:0072074 | 0.0017 | 9.3189 | 0.5394 | 4 | 18 | kidney mesenchyme development |
GO:0008015 | 0.0018 | 1.9453 | 14.6528 | 27 | 489 | blood circulation |
GO:0009914 | 0.0018 | 2.2462 | 8.9595 | 19 | 299 | hormone transport |
GO:0035194 | 0.0018 | 2.4349 | 6.9818 | 16 | 233 | posttranscriptional gene silencing by RNA |
GO:0048634 | 0.0018 | 3.0393 | 3.8954 | 11 | 130 | regulation of muscle organ development |
GO:0001657 | 0.0019 | 3.5158 | 2.7867 | 9 | 93 | ureteric bud development |
GO:0001714 | 0.002 | 16.2821 | 0.2697 | 3 | 9 | endodermal cell fate specification |
GO:0030917 | 0.002 | 16.2821 | 0.2697 | 3 | 9 | midbrain-hindbrain boundary development |
GO:0042363 | 0.002 | 16.2821 | 0.2697 | 3 | 9 | fat-soluble vitamin catabolic process |
GO:0051171 | 0.002 | 1.321 | 166.6647 | 197 | 5562 | regulation of nitrogen compound metabolic process |
GO:0042472 | 0.002 | 3.4743 | 2.8167 | 9 | 94 | inner ear morphogenesis |
GO:0072163 | 0.002 | 3.4743 | 2.8167 | 9 | 94 | mesonephric epithelium development |
GO:0065004 | 0.002 | 2.4868 | 6.4125 | 15 | 214 | protein-DNA complex assembly |
GO:0010002 | 0.0022 | 8.697 | 0.5693 | 4 | 19 | cardioblast differentiation |
GO:0060231 | 0.0022 | 8.697 | 0.5693 | 4 | 19 | mesenchymal to epithelial transition |
GO:1900371 | 0.0022 | 2.8003 | 4.5846 | 12 | 153 | regulation of purine nucleotide biosynthetic process |
GO:0050793 | 0.0023 | 1.615 | 31.5438 | 48 | 1091 | regulation of developmental process |
GO:0048662 | 0.0024 | 4.9049 | 1.3784 | 6 | 46 | negative regulation of smooth muscle cell proliferation |
GO:0061061 | 0.0025 | 1.8101 | 18.0389 | 31 | 602 | muscle structure development |
GO:0098664 | 0.0026 | 8.153 | 0.5993 | 4 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0002877 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | regulation of acute inflammatory response to non-antigenic stimulus |
GO:0003095 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | pressure natriuresis |
GO:0021524 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | visceral motor neuron differentiation |
GO:0044336 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process |
GO:0048619 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | embryonic hindgut morphogenesis |
GO:0048936 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060913 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | cardiac cell fate determination |
GO:1902809 | 0.0026 | 65.0126 | 0.0899 | 2 | 3 | regulation of skeletal muscle fiber differentiation |
GO:1902337 | 0.0027 | 13.9552 | 0.2996 | 3 | 10 | regulation of apoptotic process involved in morphogenesis |
GO:0008406 | 0.0027 | 2.4935 | 5.963 | 14 | 199 | gonad development |
GO:0055008 | 0.003 | 4.0198 | 1.9178 | 7 | 64 | cardiac muscle tissue morphogenesis |
GO:0046883 | 0.003 | 2.3055 | 7.3414 | 16 | 245 | regulation of hormone secretion |
GO:0001708 | 0.0031 | 3.9809 | 1.9334 | 7 | 65 | cell fate specification |
GO:2000112 | 0.0032 | 1.3317 | 116.8331 | 143 | 3899 | regulation of cellular macromolecule biosynthetic process |
GO:0030815 | 0.0033 | 4.5618 | 1.4683 | 6 | 49 | negative regulation of cAMP metabolic process |
GO:0051716 | 0.0034 | 1.2926 | 201.5738 | 231 | 6727 | cellular response to stimulus |
GO:1900449 | 0.0037 | 5.4419 | 1.0488 | 5 | 35 | regulation of glutamate receptor signaling pathway |
GO:2000826 | 0.0037 | 5.4419 | 1.0488 | 5 | 35 | regulation of heart morphogenesis |
GO:0021521 | 0.0037 | 12.21 | 0.3296 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0043269 | 0.0041 | 1.7606 | 17.889 | 30 | 597 | regulation of ion transport |
GO:0048705 | 0.0041 | 2.3765 | 6.2327 | 14 | 208 | skeletal system morphogenesis |
GO:0048286 | 0.0041 | 5.266 | 1.0787 | 5 | 36 | lung alveolus development |
GO:0048663 | 0.0042 | 3.7552 | 2.0376 | 7 | 68 | neuron fate commitment |
GO:0007626 | 0.0044 | 2.4441 | 5.6334 | 13 | 188 | locomotory behavior |
GO:2000242 | 0.0044 | 4.2634 | 1.5582 | 6 | 52 | negative regulation of reproductive process |
GO:0072078 | 0.0045 | 3.6944 | 2.0676 | 7 | 69 | nephron tubule morphogenesis |
GO:1902476 | 0.0045 | 3.317 | 2.6069 | 8 | 87 | chloride transmembrane transport |
GO:0042659 | 0.0048 | 10.8526 | 0.3596 | 3 | 12 | regulation of cell fate specification |
GO:0090277 | 0.0048 | 3.2753 | 2.6369 | 8 | 88 | positive regulation of peptide hormone secretion |
GO:0070167 | 0.0049 | 3.6355 | 2.0975 | 7 | 70 | regulation of biomineral tissue development |
GO:0043388 | 0.0049 | 4.1725 | 1.5881 | 6 | 53 | positive regulation of DNA binding |
GO:0048513 | 0.0049 | 1.4062 | 62.3455 | 82 | 2207 | animal organ development |
GO:0001655 | 0.005 | 2.0706 | 9.1393 | 18 | 305 | urogenital system development |
GO:0021557 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | oculomotor nerve development |
GO:0034287 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | detection of monosaccharide stimulus |
GO:0035989 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | tendon development |
GO:0036101 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | leukotriene B4 catabolic process |
GO:0042360 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | vitamin E metabolic process |
GO:0051594 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | detection of glucose |
GO:0060486 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | Clara cell differentiation |
GO:0061047 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | positive regulation of branching involved in lung morphogenesis |
GO:0072086 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | specification of loop of Henle identity |
GO:0072095 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:0072125 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | negative regulation of glomerular mesangial cell proliferation |
GO:0072268 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | pattern specification involved in metanephros development |
GO:1900738 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:1904954 | 0.0052 | 32.5042 | 0.1199 | 2 | 4 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation |
GO:0021871 | 0.0053 | 6.5207 | 0.7192 | 4 | 24 | forebrain regionalization |
GO:0061217 | 0.0053 | 6.5207 | 0.7192 | 4 | 24 | regulation of mesonephros development |
GO:0001707 | 0.0053 | 3.5785 | 2.1275 | 7 | 71 | mesoderm formation |
GO:0021536 | 0.0053 | 3.5785 | 2.1275 | 7 | 71 | diencephalon development |
GO:0080090 | 0.0054 | 1.2795 | 170.9797 | 198 | 5706 | regulation of primary metabolic process |
GO:0045980 | 0.0057 | 3.5232 | 2.1575 | 7 | 72 | negative regulation of nucleotide metabolic process |
GO:0022414 | 0.0058 | 1.4971 | 37.2553 | 53 | 1255 | reproductive process |
GO:0001706 | 0.0059 | 4.0016 | 1.6481 | 6 | 55 | endoderm formation |
GO:0021532 | 0.0059 | 4.8004 | 1.1686 | 5 | 39 | neural tube patterning |
GO:0060421 | 0.0059 | 4.8004 | 1.1686 | 5 | 39 | positive regulation of heart growth |
GO:0099601 | 0.0059 | 4.8004 | 1.1686 | 5 | 39 | regulation of neurotransmitter receptor activity |
GO:0030217 | 0.0059 | 2.2698 | 6.5024 | 14 | 217 | T cell differentiation |
GO:0048643 | 0.0061 | 6.2098 | 0.7491 | 4 | 25 | positive regulation of skeletal muscle tissue development |
GO:0060571 | 0.0061 | 6.2098 | 0.7491 | 4 | 25 | morphogenesis of an epithelial fold |
GO:0048934 | 0.0061 | 9.7667 | 0.3895 | 3 | 13 | peripheral nervous system neuron differentiation |
GO:1902358 | 0.0061 | 9.7667 | 0.3895 | 3 | 13 | sulfate transmembrane transport |
GO:0042127 | 0.0061 | 1.4451 | 45.9661 | 63 | 1534 | regulation of cell proliferation |
GO:0072028 | 0.0062 | 3.4696 | 2.1874 | 7 | 73 | nephron morphogenesis |
GO:0072210 | 0.0066 | 4.6629 | 1.1986 | 5 | 40 | metanephric nephron development |
GO:0055024 | 0.0071 | 3.3671 | 2.2474 | 7 | 75 | regulation of cardiac muscle tissue development |
GO:0035850 | 0.0073 | 4.5331 | 1.2286 | 5 | 41 | epithelial cell differentiation involved in kidney development |
GO:0050907 | 0.0075 | 4.4805 | 1.2371 | 5 | 43 | detection of chemical stimulus involved in sensory perception |
GO:0002674 | 0.0076 | 8.8783 | 0.4195 | 3 | 14 | negative regulation of acute inflammatory response |
GO:0032725 | 0.0076 | 8.8783 | 0.4195 | 3 | 14 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0042487 | 0.0076 | 8.8783 | 0.4195 | 3 | 14 | regulation of odontogenesis of dentin-containing tooth |
GO:0071242 | 0.0076 | 3.77 | 1.738 | 6 | 58 | cellular response to ammonium ion |
GO:0035282 | 0.008 | 3.2889 | 2.295 | 7 | 77 | segmentation |
GO:0048483 | 0.0081 | 4.4103 | 1.2585 | 5 | 42 | autonomic nervous system development |
GO:0021602 | 0.0081 | 5.6691 | 0.8091 | 4 | 27 | cranial nerve morphogenesis |
GO:0048645 | 0.0083 | 3.6987 | 1.7679 | 6 | 59 | animal organ formation |
GO:0007356 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | thorax and anterior abdomen determination |
GO:0014050 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | negative regulation of glutamate secretion |
GO:0045110 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | intermediate filament bundle assembly |
GO:0060023 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | soft palate development |
GO:0060510 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | Type II pneumocyte differentiation |
GO:0061743 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | motor learning |
GO:0070172 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | positive regulation of tooth mineralization |
GO:0072047 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:0072179 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | nephric duct formation |
GO:1901523 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | icosanoid catabolic process |
GO:2000359 | 0.0084 | 21.6681 | 0.1498 | 2 | 5 | regulation of binding of sperm to zona pellucida |
GO:0007369 | 0.0085 | 2.3321 | 5.4236 | 12 | 181 | gastrulation |
GO:0042221 | 0.0086 | 1.2834 | 121.8073 | 145 | 4065 | response to chemical |
GO:0042742 | 0.0087 | 2.1618 | 6.802 | 14 | 227 | defense response to bacterium |
GO:0045761 | 0.0088 | 3.2242 | 2.3373 | 7 | 78 | regulation of adenylate cyclase activity |
GO:0002323 | 0.0093 | 8.1379 | 0.4495 | 3 | 15 | natural killer cell activation involved in immune response |
GO:0007379 | 0.0093 | 8.1379 | 0.4495 | 3 | 15 | segment specification |
GO:0060581 | 0.0093 | 8.1379 | 0.4495 | 3 | 15 | cell fate commitment involved in pattern specification |
GO:0072109 | 0.0093 | 8.1379 | 0.4495 | 3 | 15 | glomerular mesangium development |
GO:0045844 | 0.0095 | 4.2135 | 1.3095 | 5 | 44 | positive regulation of striated muscle tissue development |
GO:0051094 | 0.0096 | 1.4675 | 35.6882 | 50 | 1191 | positive regulation of developmental process |
GO:0048701 | 0.0098 | 4.1836 | 1.3185 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0009888 | 0.0098 | 1.7087 | 15.9149 | 26 | 559 | tissue development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038111 | 0 | 14.4079 | 1.0785 | 11 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 14.4079 | 1.0785 | 11 | 37 | response to interleukin-7 |
GO:0006335 | 0 | 15.4496 | 0.9328 | 10 | 32 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 13.0693 | 1.0494 | 10 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 9.989 | 1.2826 | 10 | 44 | protein heterotetramerization |
GO:0045652 | 0 | 6.5905 | 2.1571 | 12 | 74 | regulation of megakaryocyte differentiation |
GO:0034654 | 0 | 1.6022 | 117.6783 | 162 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0097659 | 0 | 1.607 | 104.3277 | 146 | 3579 | nucleic acid-templated transcription |
GO:0045815 | 0 | 5.4939 | 2.3028 | 11 | 79 | positive regulation of gene expression, epigenetic |
GO:0060964 | 1e-04 | 4.3848 | 3.0607 | 12 | 105 | regulation of gene silencing by miRNA |
GO:1901360 | 1e-04 | 1.4472 | 171.7224 | 212 | 5891 | organic cyclic compound metabolic process |
GO:0034645 | 1e-04 | 1.4634 | 141.3481 | 180 | 4849 | cellular macromolecule biosynthetic process |
GO:2001141 | 1e-04 | 1.6112 | 64.6706 | 94 | 2311 | regulation of RNA biosynthetic process |
GO:0007218 | 1e-04 | 4.4967 | 2.7401 | 11 | 94 | neuropeptide signaling pathway |
GO:0060968 | 1e-04 | 3.8445 | 3.7312 | 13 | 128 | regulation of gene silencing |
GO:1901576 | 1e-04 | 1.4228 | 175.3952 | 214 | 6017 | organic substance biosynthetic process |
GO:0045814 | 2e-04 | 3.8438 | 3.4397 | 12 | 118 | negative regulation of gene expression, epigenetic |
GO:0046483 | 2e-04 | 1.4157 | 164.6681 | 202 | 5649 | heterocycle metabolic process |
GO:0007389 | 2e-04 | 2.3356 | 11.9223 | 26 | 409 | pattern specification process |
GO:0009952 | 2e-04 | 3.0475 | 5.6842 | 16 | 195 | anterior/posterior pattern specification |
GO:0048863 | 2e-04 | 2.7295 | 7.4915 | 19 | 257 | stem cell differentiation |
GO:0009889 | 2e-04 | 1.5346 | 74.53 | 103 | 2671 | regulation of biosynthetic process |
GO:0016070 | 2e-04 | 1.4298 | 127.5893 | 162 | 4377 | RNA metabolic process |
GO:0060255 | 3e-04 | 1.3966 | 167.0001 | 203 | 5729 | regulation of macromolecule metabolic process |
GO:0032200 | 3e-04 | 3.1955 | 4.7514 | 14 | 163 | telomere organization |
GO:0034641 | 3e-04 | 1.3869 | 180.9629 | 217 | 6208 | cellular nitrogen compound metabolic process |
GO:0006725 | 4e-04 | 1.3888 | 165.7175 | 201 | 5685 | cellular aromatic compound metabolic process |
GO:0021871 | 6e-04 | 8.849 | 0.6996 | 5 | 24 | forebrain regionalization |
GO:0045934 | 6e-04 | 1.636 | 39.2358 | 60 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0019219 | 6e-04 | 1.4882 | 73.0642 | 99 | 2635 | regulation of nucleobase-containing compound metabolic process |
GO:1902036 | 7e-04 | 3.7184 | 2.9441 | 10 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0070370 | 8e-04 | Inf | 0.0583 | 2 | 2 | cellular heat acclimation |
GO:1904211 | 8e-04 | Inf | 0.0583 | 2 | 2 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol |
GO:0010467 | 9e-04 | 1.3643 | 149.0145 | 181 | 5112 | gene expression |
GO:0045892 | 9e-04 | 1.6771 | 31.7151 | 50 | 1088 | negative regulation of transcription, DNA-templated |
GO:0031497 | 0.0011 | 3.0581 | 4.2267 | 12 | 145 | chromatin assembly |
GO:0003006 | 0.0013 | 1.8759 | 18.0438 | 32 | 619 | developmental process involved in reproduction |
GO:0009653 | 0.0013 | 1.4519 | 69.8141 | 94 | 2395 | anatomical structure morphogenesis |
GO:0006355 | 0.0013 | 1.6304 | 34.8944 | 53 | 1291 | regulation of transcription, DNA-templated |
GO:0050793 | 0.0014 | 1.4556 | 67.3072 | 91 | 2309 | regulation of developmental process |
GO:0006357 | 0.0015 | 1.495 | 54.3938 | 76 | 1866 | regulation of transcription from RNA polymerase II promoter |
GO:0007156 | 0.0017 | 2.9039 | 4.4308 | 12 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:1902679 | 0.0018 | 1.6201 | 32.7062 | 50 | 1122 | negative regulation of RNA biosynthetic process |
GO:0034728 | 0.002 | 2.8424 | 4.5182 | 12 | 155 | nucleosome organization |
GO:0048856 | 0.002 | 1.606 | 35.6778 | 53 | 1330 | anatomical structure development |
GO:0002317 | 0.0025 | 66.8942 | 0.0874 | 2 | 3 | plasma cell differentiation |
GO:0021759 | 0.0025 | 66.8942 | 0.0874 | 2 | 3 | globus pallidus development |
GO:0033563 | 0.0025 | 66.8942 | 0.0874 | 2 | 3 | dorsal/ventral axon guidance |
GO:0051030 | 0.0025 | 66.8942 | 0.0874 | 2 | 3 | snRNA transport |
GO:0070434 | 0.0025 | 66.8942 | 0.0874 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0025 | 66.8942 | 0.0874 | 2 | 3 | positive regulation of microtubule nucleation |
GO:1903237 | 0.0025 | 66.8942 | 0.0874 | 2 | 3 | negative regulation of leukocyte tethering or rolling |
GO:0002430 | 0.0025 | 14.3599 | 0.2915 | 3 | 10 | complement receptor mediated signaling pathway |
GO:0007369 | 0.0025 | 2.6226 | 5.2761 | 13 | 181 | gastrulation |
GO:0009790 | 0.0031 | 1.6363 | 27.0512 | 42 | 928 | embryo development |
GO:0002244 | 0.0032 | 2.5459 | 5.4219 | 13 | 186 | hematopoietic progenitor cell differentiation |
GO:0007631 | 0.0033 | 3.1978 | 3.0316 | 9 | 104 | feeding behavior |
GO:0060856 | 0.0034 | 12.5641 | 0.3206 | 3 | 11 | establishment of blood-brain barrier |
GO:0090009 | 0.0034 | 12.5641 | 0.3206 | 3 | 11 | primitive streak formation |
GO:0090084 | 0.0034 | 12.5641 | 0.3206 | 3 | 11 | negative regulation of inclusion body assembly |
GO:0002092 | 0.0034 | 7.4567 | 0.6413 | 4 | 22 | positive regulation of receptor internalization |
GO:0050995 | 0.0034 | 7.4567 | 0.6413 | 4 | 22 | negative regulation of lipid catabolic process |
GO:0048663 | 0.0036 | 3.8651 | 1.9822 | 7 | 68 | neuron fate commitment |
GO:0030154 | 0.004 | 1.3465 | 99.0612 | 123 | 3487 | cell differentiation |
GO:0009890 | 0.0042 | 1.4698 | 46.0861 | 64 | 1581 | negative regulation of biosynthetic process |
GO:0007188 | 0.0045 | 2.6753 | 4.3725 | 11 | 150 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0048513 | 0.0046 | 1.3449 | 92.8426 | 116 | 3185 | animal organ development |
GO:0030878 | 0.0048 | 6.7102 | 0.6996 | 4 | 24 | thyroid gland development |
GO:0042026 | 0.0048 | 6.7102 | 0.6996 | 4 | 24 | protein refolding |
GO:0001705 | 0.0049 | 33.4449 | 0.1166 | 2 | 4 | ectoderm formation |
GO:0007198 | 0.0049 | 33.4449 | 0.1166 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021615 | 0.0049 | 33.4449 | 0.1166 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0097476 | 0.0049 | 33.4449 | 0.1166 | 2 | 4 | spinal cord motor neuron migration |
GO:1904431 | 0.0049 | 33.4449 | 0.1166 | 2 | 4 | positive regulation of t-circle formation |
GO:0048704 | 0.0054 | 3.21 | 2.6818 | 8 | 92 | embryonic skeletal system morphogenesis |
GO:0001764 | 0.0056 | 2.7453 | 3.8769 | 10 | 133 | neuron migration |
GO:0097485 | 0.0061 | 2.2582 | 6.5296 | 14 | 224 | neuron projection guidance |
GO:0048259 | 0.0062 | 3.4656 | 2.1862 | 7 | 75 | regulation of receptor-mediated endocytosis |
GO:0006837 | 0.007 | 9.1358 | 0.4081 | 3 | 14 | serotonin transport |
GO:0043517 | 0.007 | 9.1358 | 0.4081 | 3 | 14 | positive regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0045761 | 0.0076 | 3.3185 | 2.2737 | 7 | 78 | regulation of adenylate cyclase activity |
GO:0021517 | 0.008 | 4.4191 | 1.2534 | 5 | 43 | ventral spinal cord development |
GO:0014060 | 0.008 | 22.2952 | 0.1457 | 2 | 5 | regulation of epinephrine secretion |
GO:0034137 | 0.008 | 22.2952 | 0.1457 | 2 | 5 | positive regulation of toll-like receptor 2 signaling pathway |
GO:0038007 | 0.008 | 22.2952 | 0.1457 | 2 | 5 | netrin-activated signaling pathway |
GO:0090131 | 0.008 | 22.2952 | 0.1457 | 2 | 5 | mesenchyme migration |
GO:0097070 | 0.008 | 22.2952 | 0.1457 | 2 | 5 | ductus arteriosus closure |
GO:2000851 | 0.008 | 22.2952 | 0.1457 | 2 | 5 | positive regulation of glucocorticoid secretion |
GO:0007498 | 0.0081 | 2.759 | 3.4688 | 9 | 119 | mesoderm development |
GO:0035116 | 0.0084 | 5.5904 | 0.8162 | 4 | 28 | embryonic hindlimb morphogenesis |
GO:0035194 | 0.0086 | 2.1642 | 6.7919 | 14 | 233 | posttranscriptional gene silencing by RNA |
GO:0001708 | 0.0093 | 3.1834 | 2.3611 | 7 | 81 | cell fate specification |
GO:0015837 | 0.0093 | 3.1834 | 2.3611 | 7 | 81 | amine transport |
GO:0030818 | 0.0096 | 4.1976 | 1.3117 | 5 | 45 | negative regulation of cAMP biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 132.6477 | 0.8553 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 131.5352 | 0.7603 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 52.5735 | 1.0454 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 24.2789 | 1.8769 | 28 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 15.8563 | 2.8035 | 31 | 118 | negative regulation of gene expression, epigenetic |
GO:0050911 | 0 | 7.7531 | 7.389 | 45 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:1902036 | 0 | 16.0655 | 2.3996 | 27 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 15.2377 | 2.4947 | 27 | 105 | regulation of gene silencing by miRNA |
GO:0045653 | 0 | 149.2918 | 0.4277 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0050906 | 0 | 6.1038 | 9.5035 | 47 | 400 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 6.152 | 9.2184 | 46 | 388 | detection of chemical stimulus |
GO:0060968 | 0 | 12.3431 | 3.0411 | 28 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 11.0407 | 3.445 | 29 | 145 | chromatin assembly |
GO:0007606 | 0 | 5.8375 | 9.6461 | 46 | 406 | sensory perception of chemical stimulus |
GO:0035194 | 0 | 7.6137 | 5.5358 | 34 | 233 | posttranscriptional gene silencing by RNA |
GO:0017148 | 0 | 5.8452 | 7.6028 | 37 | 320 | negative regulation of translation |
GO:0002244 | 0 | 7.7828 | 4.4191 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 6.2906 | 6.106 | 32 | 257 | stem cell differentiation |
GO:0065004 | 0 | 6.8919 | 5.0844 | 29 | 214 | protein-DNA complex assembly |
GO:0034080 | 0 | 22.9355 | 0.9504 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0032200 | 0 | 7.5067 | 3.8727 | 24 | 163 | telomere organization |
GO:1904837 | 0 | 19.8723 | 1.0454 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0038111 | 0 | 23.012 | 0.8791 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 23.012 | 0.8791 | 13 | 37 | response to interleukin-7 |
GO:0071103 | 0 | 5.4551 | 6.2248 | 29 | 262 | DNA conformation change |
GO:0034724 | 0 | 16.1054 | 1.2117 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0007186 | 0 | 2.8986 | 25.362 | 63 | 1087 | G-protein coupled receptor signaling pathway |
GO:0045652 | 0 | 14.7455 | 1.2828 | 14 | 56 | regulation of megakaryocyte differentiation |
GO:0016233 | 0 | 14.5304 | 1.3067 | 14 | 55 | telomere capping |
GO:0050877 | 0 | 2.7696 | 27.2751 | 65 | 1148 | nervous system process |
GO:0032501 | 0 | 2.9065 | 28.5738 | 65 | 1376 | multicellular organismal process |
GO:0030099 | 0 | 4.0947 | 8.9095 | 32 | 375 | myeloid cell differentiation |
GO:0034248 | 0 | 3.4795 | 12.7347 | 39 | 536 | regulation of cellular amide metabolic process |
GO:0006303 | 0 | 10.2603 | 1.7106 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0043044 | 0 | 9.7538 | 1.7819 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:1903707 | 0 | 6.644 | 3.1837 | 18 | 134 | negative regulation of hemopoiesis |
GO:0034728 | 0 | 7.4384 | 2.3873 | 15 | 104 | nucleosome organization |
GO:0010608 | 0 | 2.9441 | 14.8017 | 39 | 623 | posttranscriptional regulation of gene expression |
GO:0051259 | 0 | 2.8071 | 12.117 | 31 | 510 | protein oligomerization |
GO:0048534 | 0 | 2.329 | 19.7911 | 42 | 833 | hematopoietic or lymphoid organ development |
GO:0043043 | 0 | 2.339 | 18.223 | 39 | 767 | peptide biosynthetic process |
GO:0048869 | 0 | 1.5734 | 94.4411 | 129 | 3975 | cellular developmental process |
GO:0007275 | 1e-04 | 1.5289 | 116.2992 | 152 | 4895 | multicellular organism development |
GO:0009890 | 1e-04 | 1.8096 | 37.5626 | 62 | 1581 | negative regulation of biosynthetic process |
GO:0045892 | 1e-04 | 1.9264 | 25.8495 | 46 | 1088 | negative regulation of transcription, DNA-templated |
GO:1902679 | 1e-04 | 1.9092 | 26.6573 | 47 | 1122 | negative regulation of RNA biosynthetic process |
GO:0006352 | 1e-04 | 3.1635 | 5.4645 | 16 | 230 | DNA-templated transcription, initiation |
GO:0007218 | 4e-04 | 4.4322 | 2.2333 | 9 | 94 | neuropeptide signaling pathway |
GO:0001694 | 6e-04 | Inf | 0.0475 | 2 | 2 | histamine biosynthetic process |
GO:0045934 | 6e-04 | 1.7143 | 31.9793 | 51 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0007154 | 9e-04 | 1.3947 | 142.22 | 172 | 5986 | cell communication |
GO:0023052 | 0.0011 | 1.3872 | 141.7449 | 171 | 5966 | signaling |
GO:0060435 | 0.0017 | 82.6101 | 0.0713 | 2 | 3 | bronchiole development |
GO:0061333 | 0.0017 | 4.4212 | 1.7344 | 7 | 73 | renal tubule morphogenesis |
GO:0051716 | 0.0019 | 1.3599 | 159.8253 | 188 | 6727 | cellular response to stimulus |
GO:0001658 | 0.0019 | 5.0962 | 1.3067 | 6 | 55 | branching involved in ureteric bud morphogenesis |
GO:0015872 | 0.0022 | 6.11 | 0.9266 | 5 | 39 | dopamine transport |
GO:0050793 | 0.0026 | 1.4731 | 54.859 | 75 | 2309 | regulation of developmental process |
GO:0072171 | 0.0032 | 4.5385 | 1.4493 | 6 | 61 | mesonephric tubule morphogenesis |
GO:0021853 | 0.0033 | 41.3024 | 0.095 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
GO:1902261 | 0.0033 | 41.3024 | 0.095 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:1903706 | 0.0033 | 2.3499 | 6.7325 | 15 | 295 | regulation of hemopoiesis |
GO:0014059 | 0.0036 | 7.2116 | 0.6415 | 4 | 27 | regulation of dopamine secretion |
GO:0051239 | 0.0037 | 1.4215 | 64.5526 | 85 | 2717 | regulation of multicellular organismal process |
GO:0050794 | 0.0038 | 1.367 | 216.691 | 241 | 9769 | regulation of cellular process |
GO:0015671 | 0.0049 | 10.3464 | 0.3564 | 3 | 15 | oxygen transport |
GO:0007596 | 0.0052 | 2.163 | 7.7691 | 16 | 327 | blood coagulation |
GO:0061743 | 0.0054 | 27.5332 | 0.1188 | 2 | 5 | motor learning |
GO:0072088 | 0.0068 | 3.8378 | 1.6869 | 6 | 71 | nephron epithelium morphogenesis |
GO:0060249 | 0.0071 | 2.0366 | 8.7432 | 17 | 368 | anatomical structure homeostasis |
GO:0051248 | 0.0072 | 1.5468 | 29.2946 | 43 | 1233 | negative regulation of protein metabolic process |
GO:0021546 | 0.0079 | 20.6485 | 0.1426 | 2 | 6 | rhombomere development |
GO:0045596 | 0.0081 | 1.7593 | 14.873 | 25 | 626 | negative regulation of cell differentiation |
GO:0043270 | 0.0082 | 2.3357 | 5.3932 | 12 | 227 | positive regulation of ion transport |
GO:0048513 | 0.0089 | 1.4096 | 52.4257 | 69 | 2352 | animal organ development |
GO:0061138 | 0.0091 | 2.5307 | 4.1578 | 10 | 175 | morphogenesis of a branching epithelium |
GO:0015718 | 0.0093 | 2.6814 | 3.5401 | 9 | 149 | monocarboxylic acid transport |
GO:0021895 | 0.0097 | 7.7578 | 0.4514 | 3 | 19 | cerebral cortex neuron differentiation |
GO:0048148 | 0.0097 | 7.7578 | 0.4514 | 3 | 19 | behavioral response to cocaine |
GO:0048557 | 0.0097 | 7.7578 | 0.4514 | 3 | 19 | embryonic digestive tract morphogenesis |
GO:0072079 | 0.0097 | 7.7578 | 0.4514 | 3 | 19 | nephron tubule formation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 8.8999 | 3.335 | 24 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0050911 | 0 | 4.707 | 6.8236 | 28 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007186 | 0 | 2.6727 | 25.9121 | 60 | 1181 | G-protein coupled receptor signaling pathway |
GO:0050906 | 0 | 4.0117 | 8.7763 | 31 | 400 | detection of stimulus involved in sensory perception |
GO:0098609 | 0 | 2.9378 | 16.9383 | 44 | 772 | cell-cell adhesion |
GO:0007606 | 0 | 3.6485 | 8.908 | 29 | 406 | sensory perception of chemical stimulus |
GO:0031424 | 0 | 5.0506 | 4.4979 | 20 | 205 | keratinization |
GO:0022610 | 0 | 2.3755 | 28.7425 | 60 | 1310 | biological adhesion |
GO:0009593 | 0 | 3.6816 | 8.513 | 28 | 388 | detection of chemical stimulus |
GO:0009913 | 0 | 3.7172 | 7.1746 | 24 | 327 | epidermal cell differentiation |
GO:0050877 | 0 | 2.2553 | 25.1881 | 51 | 1148 | nervous system process |
GO:0032501 | 0 | 1.6513 | 132.1314 | 171 | 6450 | multicellular organismal process |
GO:0043588 | 0 | 2.8079 | 8.4692 | 22 | 386 | skin development |
GO:0019953 | 3e-04 | 2.056 | 16.675 | 32 | 760 | sexual reproduction |
GO:0070168 | 4e-04 | 13.8631 | 0.373 | 4 | 17 | negative regulation of biomineral tissue development |
GO:0044657 | 5e-04 | Inf | 0.0439 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0052043 | 5e-04 | Inf | 0.0439 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 5e-04 | Inf | 0.0439 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 5e-04 | Inf | 0.0439 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0006959 | 6e-04 | 3.1291 | 4.454 | 13 | 203 | humoral immune response |
GO:0002227 | 8e-04 | 11.2616 | 0.4388 | 4 | 20 | innate immune response in mucosa |
GO:0061844 | 8e-04 | 6.0298 | 1.119 | 6 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0051704 | 0.001 | 1.556 | 49.674 | 71 | 2264 | multi-organism process |
GO:0006968 | 0.0011 | 5.6519 | 1.1848 | 6 | 54 | cellular defense response |
GO:0010738 | 0.0012 | 10.009 | 0.4827 | 4 | 22 | regulation of protein kinase A signaling |
GO:0031640 | 0.0013 | 5.5362 | 1.2067 | 6 | 55 | killing of cells of other organism |
GO:0007267 | 0.0013 | 1.6509 | 33.1745 | 51 | 1512 | cell-cell signaling |
GO:0030802 | 0.0014 | 3.3697 | 3.1814 | 10 | 145 | regulation of cyclic nucleotide biosynthetic process |
GO:0019731 | 0.0014 | 6.8375 | 0.8338 | 5 | 38 | antibacterial humoral response |
GO:0072249 | 0.0014 | 89.6609 | 0.0658 | 2 | 3 | metanephric glomerular visceral epithelial cell development |
GO:0072312 | 0.0014 | 89.6609 | 0.0658 | 2 | 3 | metanephric glomerular epithelial cell differentiation |
GO:1900158 | 0.0014 | 89.6609 | 0.0658 | 2 | 3 | negative regulation of bone mineralization involved in bone maturation |
GO:0001771 | 0.0015 | 16.8523 | 0.2413 | 3 | 11 | immunological synapse formation |
GO:0051349 | 0.0017 | 5.2158 | 1.2726 | 6 | 58 | positive regulation of lyase activity |
GO:0030819 | 0.0019 | 4.3413 | 1.7553 | 7 | 80 | positive regulation of cAMP biosynthetic process |
GO:1900371 | 0.002 | 3.1796 | 3.3569 | 10 | 153 | regulation of purine nucleotide biosynthetic process |
GO:0030810 | 0.0021 | 3.7783 | 2.2818 | 8 | 104 | positive regulation of nucleotide biosynthetic process |
GO:0045087 | 0.0022 | 1.8495 | 17.1784 | 30 | 791 | innate immune response |
GO:0042391 | 0.0022 | 2.2507 | 8.4472 | 18 | 385 | regulation of membrane potential |
GO:0050830 | 0.0023 | 4.1692 | 1.8211 | 7 | 83 | defense response to Gram-positive bacterium |
GO:0046850 | 0.0024 | 5.9359 | 0.9435 | 5 | 43 | regulation of bone remodeling |
GO:0052652 | 0.0025 | 3.0922 | 3.4447 | 10 | 157 | cyclic purine nucleotide metabolic process |
GO:1905952 | 0.0025 | 3.3214 | 2.8962 | 9 | 132 | regulation of lipid localization |
GO:0030500 | 0.0025 | 4.7567 | 1.3823 | 6 | 63 | regulation of bone mineralization |
GO:0061035 | 0.0025 | 4.7567 | 1.3823 | 6 | 63 | regulation of cartilage development |
GO:0048771 | 0.0027 | 3.0503 | 3.4886 | 10 | 159 | tissue remodeling |
GO:0030801 | 0.0028 | 3.5901 | 2.3915 | 8 | 109 | positive regulation of cyclic nucleotide metabolic process |
GO:0001994 | 0.0028 | 44.8276 | 0.0878 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0044245 | 0.0028 | 44.8276 | 0.0878 | 2 | 4 | polysaccharide digestion |
GO:1902714 | 0.0028 | 44.8276 | 0.0878 | 2 | 4 | negative regulation of interferon-gamma secretion |
GO:0050707 | 0.0031 | 2.9896 | 3.5544 | 10 | 162 | regulation of cytokine secretion |
GO:0006909 | 0.0031 | 2.6665 | 4.7612 | 12 | 217 | phagocytosis |
GO:0010919 | 0.0032 | 12.2539 | 0.3072 | 3 | 14 | regulation of inositol phosphate biosynthetic process |
GO:0051852 | 0.0032 | 12.2539 | 0.3072 | 3 | 14 | disruption by host of symbiont cells |
GO:0060080 | 0.0032 | 12.2539 | 0.3072 | 3 | 14 | inhibitory postsynaptic potential |
GO:0045321 | 0.0037 | 1.6658 | 24.1568 | 38 | 1101 | leukocyte activation |
GO:0015850 | 0.0037 | 2.6022 | 4.8709 | 12 | 222 | organic hydroxy compound transport |
GO:0032371 | 0.0039 | 5.244 | 1.0532 | 5 | 48 | regulation of sterol transport |
GO:0046173 | 0.0039 | 5.244 | 1.0532 | 5 | 48 | polyol biosynthetic process |
GO:0030814 | 0.0041 | 3.0697 | 3.1156 | 9 | 142 | regulation of cAMP metabolic process |
GO:0032652 | 0.0043 | 4.2346 | 1.5359 | 6 | 70 | regulation of interleukin-1 production |
GO:1903523 | 0.0045 | 6.6688 | 0.6802 | 4 | 31 | negative regulation of blood circulation |
GO:0008628 | 0.0046 | 29.8831 | 0.1097 | 2 | 5 | hormone-mediated apoptotic signaling pathway |
GO:0051970 | 0.0046 | 29.8831 | 0.1097 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0090289 | 0.0046 | 29.8831 | 0.1097 | 2 | 5 | regulation of osteoclast proliferation |
GO:1900086 | 0.0046 | 29.8831 | 0.1097 | 2 | 5 | positive regulation of peptidyl-tyrosine autophosphorylation |
GO:1903531 | 0.0047 | 2.8032 | 3.7738 | 10 | 172 | negative regulation of secretion by cell |
GO:0043931 | 0.0047 | 10.3673 | 0.3511 | 3 | 16 | ossification involved in bone maturation |
GO:0002251 | 0.005 | 6.4302 | 0.7021 | 4 | 32 | organ or tissue specific immune response |
GO:0002275 | 0.0051 | 1.948 | 11.3215 | 21 | 516 | myeloid cell activation involved in immune response |
GO:0007268 | 0.0051 | 1.8858 | 12.8134 | 23 | 584 | chemical synaptic transmission |
GO:0009620 | 0.0051 | 4.9011 | 1.119 | 5 | 51 | response to fungus |
GO:0099537 | 0.0053 | 1.8788 | 12.8573 | 23 | 586 | trans-synaptic signaling |
GO:0002444 | 0.0056 | 1.9279 | 11.4312 | 21 | 521 | myeloid leukocyte mediated immunity |
GO:0042136 | 0.0057 | 9.6262 | 0.373 | 3 | 17 | neurotransmitter biosynthetic process |
GO:0032940 | 0.0057 | 1.6085 | 25.6401 | 39 | 1190 | secretion by cell |
GO:0042742 | 0.0063 | 3.0979 | 2.74 | 8 | 127 | defense response to bacterium |
GO:0051673 | 0.0068 | 22.4109 | 0.1316 | 2 | 6 | membrane disruption in other organism |
GO:0090237 | 0.0068 | 22.4109 | 0.1316 | 2 | 6 | regulation of arachidonic acid secretion |
GO:0050900 | 0.007 | 2.0395 | 8.7324 | 17 | 398 | leukocyte migration |
GO:0060429 | 0.0072 | 1.5819 | 25.9999 | 39 | 1185 | epithelium development |
GO:0045761 | 0.0073 | 3.7621 | 1.7114 | 6 | 78 | regulation of adenylate cyclase activity |
GO:0032331 | 0.0078 | 8.4218 | 0.4169 | 3 | 19 | negative regulation of chondrocyte differentiation |
GO:0007283 | 0.008 | 1.9284 | 10.3122 | 19 | 470 | spermatogenesis |
GO:0097756 | 0.0082 | 3.66 | 1.7553 | 6 | 80 | negative regulation of blood vessel diameter |
GO:0009988 | 0.0085 | 4.2869 | 1.2625 | 5 | 58 | cell-cell recognition |
GO:0009605 | 0.0085 | 1.4409 | 44.2985 | 60 | 2019 | response to external stimulus |
GO:0031281 | 0.0087 | 4.2518 | 1.2726 | 5 | 58 | positive regulation of cyclase activity |
GO:0043299 | 0.0089 | 1.8731 | 11.1679 | 20 | 509 | leukocyte degranulation |
GO:0070374 | 0.009 | 2.5342 | 4.1468 | 10 | 189 | positive regulation of ERK1 and ERK2 cascade |
GO:0002021 | 0.009 | 7.9259 | 0.4388 | 3 | 20 | response to dietary excess |
GO:0060046 | 0.009 | 7.9259 | 0.4388 | 3 | 20 | regulation of acrosome reaction |
GO:0000160 | 0.0094 | 17.9276 | 0.1536 | 2 | 7 | phosphorelay signal transduction system |
GO:0031340 | 0.0094 | 17.9276 | 0.1536 | 2 | 7 | positive regulation of vesicle fusion |
GO:0032377 | 0.0094 | 17.9276 | 0.1536 | 2 | 7 | regulation of intracellular lipid transport |
GO:0032383 | 0.0094 | 17.9276 | 0.1536 | 2 | 7 | regulation of intracellular cholesterol transport |
GO:0045162 | 0.0094 | 17.9276 | 0.1536 | 2 | 7 | clustering of voltage-gated sodium channels |
GO:2000510 | 0.0094 | 17.9276 | 0.1536 | 2 | 7 | positive regulation of dendritic cell chemotaxis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 108.3287 | 0.9087 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 52.3687 | 1.2495 | 26 | 44 | protein heterotetramerization |
GO:0000183 | 0 | 72.2005 | 1.0223 | 24 | 36 | chromatin silencing at rDNA |
GO:1902036 | 0 | 13.2114 | 2.8682 | 27 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0045653 | 0 | 123.5364 | 0.5112 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 15.7091 | 2.2434 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 11.258 | 2.9818 | 25 | 105 | regulation of gene silencing by miRNA |
GO:0048863 | 0 | 7.3181 | 5.4299 | 32 | 193 | stem cell differentiation |
GO:0031497 | 0 | 8.2615 | 4.1177 | 27 | 145 | chromatin assembly |
GO:0002244 | 0 | 6.9754 | 5.282 | 30 | 186 | hematopoietic progenitor cell differentiation |
GO:0060968 | 0 | 8.7311 | 3.6349 | 25 | 128 | regulation of gene silencing |
GO:0034080 | 0 | 21.1973 | 1.1359 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:0035194 | 0 | 5.344 | 6.6167 | 30 | 233 | posttranscriptional gene silencing by RNA |
GO:0032200 | 0 | 6.5018 | 4.6288 | 25 | 163 | telomere organization |
GO:0034724 | 0 | 14.7099 | 1.4483 | 15 | 51 | DNA replication-independent nucleosome organization |
GO:1904837 | 0 | 16.4439 | 1.2495 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0065004 | 0 | 5.424 | 6.0771 | 28 | 214 | protein-DNA complex assembly |
GO:1903507 | 0 | 2.649 | 31.8338 | 73 | 1121 | negative regulation of nucleic acid-templated transcription |
GO:0051253 | 0 | 2.5043 | 33.9352 | 74 | 1195 | negative regulation of RNA metabolic process |
GO:0043044 | 0 | 9.5815 | 2.1298 | 16 | 75 | ATP-dependent chromatin remodeling |
GO:0016233 | 0 | 12.0236 | 1.5619 | 14 | 55 | telomere capping |
GO:0071103 | 0 | 4.4813 | 7.4402 | 29 | 262 | DNA conformation change |
GO:0030099 | 0 | 3.7332 | 10.6491 | 35 | 375 | myeloid cell differentiation |
GO:0006303 | 0 | 9.2778 | 2.0446 | 15 | 72 | double-strand break repair via nonhomologous end joining |
GO:0009890 | 0 | 2.195 | 44.8968 | 86 | 1581 | negative regulation of biosynthetic process |
GO:2001141 | 0 | 1.8612 | 97.4893 | 151 | 3433 | regulation of RNA biosynthetic process |
GO:0017148 | 0 | 3.8662 | 9.0873 | 31 | 320 | negative regulation of translation |
GO:0006355 | 0 | 1.8615 | 96.7225 | 150 | 3406 | regulation of transcription, DNA-templated |
GO:0032502 | 0 | 1.9677 | 85.3962 | 134 | 3346 | developmental process |
GO:0038111 | 0 | 14.8106 | 1.0507 | 11 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 14.8106 | 1.0507 | 11 | 37 | response to interleukin-7 |
GO:1903707 | 0 | 5.8565 | 3.8053 | 19 | 134 | negative regulation of hemopoiesis |
GO:0048534 | 0 | 2.5574 | 23.6553 | 54 | 833 | hematopoietic or lymphoid organ development |
GO:0007389 | 0 | 3.9212 | 7.7666 | 27 | 278 | pattern specification process |
GO:0051259 | 0 | 3.0057 | 14.4828 | 39 | 510 | protein oligomerization |
GO:0048562 | 0 | 4.1168 | 6.8646 | 25 | 245 | embryonic organ morphogenesis |
GO:0034654 | 0 | 1.7204 | 114.6415 | 165 | 4037 | nucleobase-containing compound biosynthetic process |
GO:0045596 | 0 | 2.6099 | 17.777 | 42 | 626 | negative regulation of cell differentiation |
GO:0045652 | 0 | 8.824 | 1.5429 | 11 | 56 | regulation of megakaryocyte differentiation |
GO:0031324 | 0 | 1.7802 | 71.0226 | 111 | 2501 | negative regulation of cellular metabolic process |
GO:0019219 | 0 | 1.6523 | 113.0512 | 159 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0009952 | 0 | 4.1045 | 5.1826 | 19 | 184 | anterior/posterior pattern specification |
GO:2000026 | 0 | 1.9308 | 42.014 | 73 | 1510 | regulation of multicellular organismal development |
GO:0016331 | 0 | 4.3624 | 4.1177 | 16 | 145 | morphogenesis of embryonic epithelium |
GO:0007156 | 0 | 4.136 | 4.3164 | 16 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0009792 | 0 | 2.4411 | 15.5903 | 35 | 549 | embryo development ending in birth or egg hatching |
GO:0048706 | 0 | 4.6311 | 3.4077 | 14 | 120 | embryonic skeletal system development |
GO:0021902 | 0 | 69.029 | 0.1704 | 4 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0051216 | 0 | 3.7145 | 5.0548 | 17 | 178 | cartilage development |
GO:2000178 | 0 | 14.8466 | 0.568 | 6 | 20 | negative regulation of neural precursor cell proliferation |
GO:0021978 | 0 | 21.6113 | 0.3692 | 5 | 13 | telencephalon regionalization |
GO:0090596 | 0 | 3.1215 | 6.9858 | 20 | 246 | sensory organ morphogenesis |
GO:0007275 | 0 | 1.7076 | 60.9581 | 91 | 2524 | multicellular organism development |
GO:0034728 | 0 | 4.7064 | 2.8647 | 12 | 104 | nucleosome organization |
GO:0002682 | 0 | 1.8076 | 38.5357 | 64 | 1357 | regulation of immune system process |
GO:0048048 | 0 | 8.9939 | 0.9655 | 7 | 34 | embryonic eye morphogenesis |
GO:0045944 | 0 | 1.9089 | 30.0732 | 53 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0060485 | 1e-04 | 3.1689 | 6.1833 | 18 | 219 | mesenchyme development |
GO:0035113 | 1e-04 | 4.0229 | 3.5781 | 13 | 126 | embryonic appendage morphogenesis |
GO:0034248 | 1e-04 | 2.2614 | 15.2212 | 32 | 536 | regulation of cellular amide metabolic process |
GO:0090191 | 1e-04 | 103.32 | 0.1136 | 3 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0040011 | 1e-04 | 1.6946 | 46.203 | 72 | 1627 | locomotion |
GO:0048736 | 1e-04 | 3.4124 | 4.7992 | 15 | 169 | appendage development |
GO:0060255 | 1e-04 | 1.4387 | 162.6904 | 201 | 5729 | regulation of macromolecule metabolic process |
GO:0021983 | 1e-04 | 7.3558 | 1.1359 | 7 | 40 | pituitary gland development |
GO:0051674 | 2e-04 | 1.7111 | 39.7568 | 63 | 1400 | localization of cell |
GO:0021903 | 2e-04 | 19.7162 | 0.3124 | 4 | 11 | rostrocaudal neural tube patterning |
GO:0009893 | 2e-04 | 1.4977 | 88.7712 | 120 | 3126 | positive regulation of metabolic process |
GO:0061333 | 2e-04 | 4.8886 | 2.073 | 9 | 73 | renal tubule morphogenesis |
GO:0043583 | 2e-04 | 2.9818 | 5.7931 | 16 | 204 | ear development |
GO:0035108 | 3e-04 | 3.4396 | 4.1177 | 13 | 145 | limb morphogenesis |
GO:0060021 | 3e-04 | 4.2967 | 2.5842 | 10 | 91 | palate development |
GO:0003337 | 3e-04 | 17.2506 | 0.3408 | 4 | 12 | mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0048729 | 3e-04 | 2.043 | 17.2374 | 33 | 607 | tissue morphogenesis |
GO:0072175 | 3e-04 | 3.6085 | 3.6349 | 12 | 128 | epithelial tube formation |
GO:0032330 | 3e-04 | 6.2217 | 1.3063 | 7 | 46 | regulation of chondrocyte differentiation |
GO:0006352 | 3e-04 | 2.7982 | 6.5315 | 17 | 230 | DNA-templated transcription, initiation |
GO:0042472 | 3e-04 | 4.1425 | 2.6694 | 10 | 94 | inner ear morphogenesis |
GO:0010463 | 3e-04 | 6.0658 | 1.3347 | 7 | 47 | mesenchymal cell proliferation |
GO:0048854 | 3e-04 | 7.4166 | 0.9655 | 6 | 34 | brain morphogenesis |
GO:0098609 | 4e-04 | 1.8977 | 21.923 | 39 | 772 | cell-cell adhesion |
GO:0040034 | 4e-04 | 15.3328 | 0.3692 | 4 | 13 | regulation of development, heterochronic |
GO:0006342 | 4e-04 | 4.969 | 1.8059 | 8 | 67 | chromatin silencing |
GO:0007596 | 5e-04 | 2.4136 | 9.286 | 21 | 327 | blood coagulation |
GO:0010608 | 5e-04 | 1.9855 | 17.6918 | 33 | 623 | posttranscriptional regulation of gene expression |
GO:0001655 | 5e-04 | 2.4657 | 8.6613 | 20 | 305 | urogenital system development |
GO:0061217 | 5e-04 | 9.093 | 0.6815 | 5 | 24 | regulation of mesonephros development |
GO:0048546 | 5e-04 | 5.6415 | 1.4199 | 7 | 50 | digestive tract morphogenesis |
GO:0060688 | 5e-04 | 5.6415 | 1.4199 | 7 | 50 | regulation of morphogenesis of a branching structure |
GO:0070271 | 5e-04 | 1.6509 | 38.9616 | 60 | 1372 | protein complex biogenesis |
GO:0051172 | 5e-04 | 1.7423 | 30.2035 | 49 | 1117 | negative regulation of nitrogen compound metabolic process |
GO:1901576 | 5e-04 | 1.3777 | 170.8689 | 205 | 6017 | organic substance biosynthetic process |
GO:0051248 | 5e-04 | 1.68 | 35.0144 | 55 | 1233 | negative regulation of protein metabolic process |
GO:0010628 | 6e-04 | 1.6048 | 44.973 | 67 | 1664 | positive regulation of gene expression |
GO:0001755 | 6e-04 | 6.6976 | 1.0507 | 6 | 37 | neural crest cell migration |
GO:0050878 | 6e-04 | 2.1099 | 13.6025 | 27 | 479 | regulation of body fluid levels |
GO:0006935 | 6e-04 | 2.0228 | 15.7607 | 30 | 555 | chemotaxis |
GO:0048705 | 6e-04 | 3.5276 | 3.3939 | 11 | 121 | skeletal system morphogenesis |
GO:0009653 | 6e-04 | 1.6539 | 37.7416 | 58 | 1397 | anatomical structure morphogenesis |
GO:0001656 | 6e-04 | 4.1686 | 2.3854 | 9 | 84 | metanephros development |
GO:0006911 | 6e-04 | 6.4878 | 1.0791 | 6 | 38 | phagocytosis, engulfment |
GO:1903508 | 7e-04 | 1.6356 | 38.5925 | 59 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0021798 | 7e-04 | 25.825 | 0.1988 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0060993 | 8e-04 | 4.0075 | 2.4706 | 9 | 87 | kidney morphogenesis |
GO:0072080 | 8e-04 | 4.0075 | 2.4706 | 9 | 87 | nephron tubule development |
GO:0060249 | 9e-04 | 2.2355 | 10.4504 | 22 | 368 | anatomical structure homeostasis |
GO:0007399 | 0.001 | 1.6702 | 32.6521 | 51 | 1192 | nervous system development |
GO:0002886 | 0.001 | 5.9306 | 1.1643 | 6 | 41 | regulation of myeloid leukocyte mediated immunity |
GO:0060322 | 0.001 | 1.8687 | 19.282 | 34 | 679 | head development |
GO:0016339 | 0.001 | 7.5097 | 0.7951 | 5 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0033006 | 0.001 | 7.5097 | 0.7951 | 5 | 28 | regulation of mast cell activation involved in immune response |
GO:0035116 | 0.001 | 7.5097 | 0.7951 | 5 | 28 | embryonic hindlimb morphogenesis |
GO:0060441 | 0.001 | 7.5097 | 0.7951 | 5 | 28 | epithelial tube branching involved in lung morphogenesis |
GO:0043300 | 0.0011 | 5.7655 | 1.1927 | 6 | 42 | regulation of leukocyte degranulation |
GO:0010092 | 0.0012 | 7.1963 | 0.8235 | 5 | 29 | specification of animal organ identity |
GO:2000113 | 0.0012 | 1.6799 | 29.7765 | 47 | 1103 | negative regulation of cellular macromolecule biosynthetic process |
GO:0015701 | 0.0013 | 5.6093 | 1.2211 | 6 | 43 | bicarbonate transport |
GO:0035239 | 0.0013 | 2.3744 | 8.0494 | 18 | 287 | tube morphogenesis |
GO:0051254 | 0.0014 | 1.5745 | 40.6087 | 60 | 1430 | positive regulation of RNA metabolic process |
GO:0072358 | 0.0014 | 1.8616 | 18.1745 | 32 | 640 | cardiovascular system development |
GO:0072077 | 0.0014 | 9.8536 | 0.5112 | 4 | 18 | renal vesicle morphogenesis |
GO:0061138 | 0.0015 | 2.7972 | 4.9696 | 13 | 175 | morphogenesis of a branching epithelium |
GO:0021915 | 0.0016 | 2.922 | 4.4016 | 12 | 155 | neural tube development |
GO:0002448 | 0.0016 | 5.3209 | 1.2779 | 6 | 45 | mast cell mediated immunity |
GO:0009790 | 0.0016 | 2.1612 | 10.2851 | 21 | 379 | embryo development |
GO:0010469 | 0.0017 | 1.9285 | 15.3348 | 28 | 540 | regulation of receptor activity |
GO:0072048 | 0.0017 | 17.2144 | 0.2556 | 3 | 9 | renal system pattern specification |
GO:0071772 | 0.0018 | 2.8814 | 4.4584 | 12 | 157 | response to BMP |
GO:0060216 | 0.0018 | 9.1961 | 0.5396 | 4 | 19 | definitive hemopoiesis |
GO:0072079 | 0.0018 | 9.1961 | 0.5396 | 4 | 19 | nephron tubule formation |
GO:0030183 | 0.0019 | 3.5097 | 2.783 | 9 | 98 | B cell differentiation |
GO:0006928 | 0.0019 | 1.4897 | 53.1037 | 74 | 1870 | movement of cell or subcellular component |
GO:0035115 | 0.0019 | 6.3955 | 0.9087 | 5 | 32 | embryonic forelimb morphogenesis |
GO:0007167 | 0.002 | 1.6697 | 27.2334 | 43 | 959 | enzyme linked receptor protein signaling pathway |
GO:0045766 | 0.0021 | 2.9886 | 3.9473 | 11 | 139 | positive regulation of angiogenesis |
GO:0009611 | 0.0021 | 1.8337 | 17.8338 | 31 | 628 | response to wounding |
GO:0043043 | 0.0022 | 1.7441 | 21.781 | 36 | 767 | peptide biosynthetic process |
GO:2000242 | 0.0022 | 4.9615 | 1.3574 | 6 | 48 | negative regulation of reproductive process |
GO:0003156 | 0.0022 | 6.1667 | 0.9371 | 5 | 33 | regulation of animal organ formation |
GO:0048333 | 0.0022 | 6.1667 | 0.9371 | 5 | 33 | mesodermal cell differentiation |
GO:0050900 | 0.0023 | 2.053 | 11.3023 | 22 | 398 | leukocyte migration |
GO:0003408 | 0.0024 | 68.7273 | 0.0852 | 2 | 3 | optic cup formation involved in camera-type eye development |
GO:0009946 | 0.0024 | 68.7273 | 0.0852 | 2 | 3 | proximal/distal axis specification |
GO:0035880 | 0.0024 | 68.7273 | 0.0852 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0090304 | 0.0025 | 1.3322 | 137.956 | 166 | 4858 | nucleic acid metabolic process |
GO:1901360 | 0.0029 | 1.3129 | 167.2908 | 196 | 5891 | organic cyclic compound metabolic process |
GO:0070374 | 0.003 | 2.5723 | 5.3672 | 13 | 189 | positive regulation of ERK1 and ERK2 cascade |
GO:1901342 | 0.003 | 2.2415 | 8.0081 | 17 | 282 | regulation of vasculature development |
GO:0030509 | 0.003 | 2.8323 | 4.1461 | 11 | 146 | BMP signaling pathway |
GO:0071363 | 0.0031 | 1.7985 | 17.5498 | 30 | 618 | cellular response to growth factor stimulus |
GO:0061081 | 0.0032 | 12.9092 | 0.3124 | 3 | 11 | positive regulation of myeloid leukocyte cytokine production involved in immune response |
GO:0090009 | 0.0032 | 12.9092 | 0.3124 | 3 | 11 | primitive streak formation |
GO:0060349 | 0.0033 | 3.509 | 2.4706 | 8 | 87 | bone morphogenesis |
GO:0050865 | 0.0035 | 1.8927 | 13.8865 | 25 | 489 | regulation of cell activation |
GO:0048513 | 0.0035 | 1.4776 | 49.4136 | 68 | 1974 | animal organ development |
GO:0016477 | 0.0036 | 1.663 | 24.0799 | 38 | 869 | cell migration |
GO:0031076 | 0.0037 | 5.3945 | 1.0507 | 5 | 37 | embryonic camera-type eye development |
GO:0044249 | 0.0038 | 1.3452 | 114.5065 | 139 | 4211 | cellular biosynthetic process |
GO:0010629 | 0.0038 | 1.5188 | 39.0901 | 56 | 1448 | negative regulation of gene expression |
GO:0010557 | 0.0039 | 1.4813 | 45.0671 | 63 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0001837 | 0.004 | 2.893 | 3.6917 | 10 | 130 | epithelial to mesenchymal transition |
GO:0045836 | 0.0041 | 11.4741 | 0.3408 | 3 | 12 | positive regulation of meiotic nuclear division |
GO:0060272 | 0.0041 | 11.4741 | 0.3408 | 3 | 12 | embryonic skeletal joint morphogenesis |
GO:0060900 | 0.0041 | 11.4741 | 0.3408 | 3 | 12 | embryonic camera-type eye formation |
GO:0021879 | 0.0042 | 6.947 | 0.6766 | 4 | 24 | forebrain neuron differentiation |
GO:0035050 | 0.0043 | 3.7267 | 2.0446 | 7 | 72 | embryonic heart tube development |
GO:1900745 | 0.0043 | 6.8949 | 0.6815 | 4 | 24 | positive regulation of p38MAPK cascade |
GO:0010324 | 0.0045 | 4.2323 | 1.5619 | 6 | 55 | membrane invagination |
GO:0007411 | 0.0045 | 2.3444 | 6.3043 | 14 | 222 | axon guidance |
GO:0035282 | 0.0046 | 3.2991 | 2.6126 | 8 | 92 | segmentation |
GO:0021555 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
GO:0021764 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | amygdala development |
GO:0048852 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | diencephalon morphogenesis |
GO:0060164 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | regulation of timing of neuron differentiation |
GO:0060235 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | lens induction in camera-type eye |
GO:0060686 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | negative regulation of prostatic bud formation |
GO:0061325 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
GO:0072086 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | specification of loop of Henle identity |
GO:2000275 | 0.0046 | 34.3614 | 0.1136 | 2 | 4 | regulation of oxidative phosphorylation uncoupler activity |
GO:0030154 | 0.0047 | 1.469 | 47.4446 | 65 | 1867 | cell differentiation |
GO:0048514 | 0.0049 | 1.8153 | 15.0224 | 26 | 529 | blood vessel morphogenesis |
GO:0048667 | 0.005 | 1.8356 | 14.284 | 25 | 503 | cell morphogenesis involved in neuron differentiation |
GO:0072273 | 0.0051 | 6.5661 | 0.7099 | 4 | 25 | metanephric nephron morphogenesis |
GO:0001709 | 0.0052 | 4.9311 | 1.1359 | 5 | 40 | cell fate determination |
GO:0000122 | 0.0052 | 1.6681 | 21.3835 | 34 | 753 | negative regulation of transcription from RNA polymerase II promoter |
GO:0043306 | 0.0053 | 10.326 | 0.3692 | 3 | 13 | positive regulation of mast cell degranulation |
GO:1901213 | 0.0053 | 10.326 | 0.3692 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0001947 | 0.0054 | 4.0658 | 1.6187 | 6 | 57 | heart looping |
GO:0008344 | 0.0058 | 3.5098 | 2.1582 | 7 | 76 | adult locomotory behavior |
GO:0022612 | 0.0058 | 2.9159 | 3.2941 | 9 | 116 | gland morphogenesis |
GO:0021846 | 0.0058 | 6.2673 | 0.7383 | 4 | 26 | cell proliferation in forebrain |
GO:0021884 | 0.0058 | 6.2673 | 0.7383 | 4 | 26 | forebrain neuron development |
GO:0051241 | 0.0059 | 1.6087 | 24.8031 | 38 | 904 | negative regulation of multicellular organismal process |
GO:0065003 | 0.0062 | 1.4343 | 48.6452 | 66 | 1713 | macromolecular complex assembly |
GO:0070663 | 0.0063 | 2.3309 | 5.8783 | 13 | 207 | regulation of leukocyte proliferation |
GO:0090100 | 0.0063 | 3.1127 | 2.7546 | 8 | 97 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0048483 | 0.0065 | 4.664 | 1.1927 | 5 | 42 | autonomic nervous system development |
GO:0038092 | 0.0066 | 9.3867 | 0.3976 | 3 | 14 | nodal signaling pathway |
GO:0042074 | 0.0066 | 9.3867 | 0.3976 | 3 | 14 | cell migration involved in gastrulation |
GO:0048368 | 0.0066 | 9.3867 | 0.3976 | 3 | 14 | lateral mesoderm development |
GO:0046483 | 0.0066 | 1.2798 | 160.4186 | 186 | 5649 | heterocycle metabolic process |
GO:0006725 | 0.0067 | 1.2788 | 161.4409 | 187 | 5685 | cellular aromatic compound metabolic process |
GO:0009435 | 0.0067 | 5.9944 | 0.7667 | 4 | 27 | NAD biosynthetic process |
GO:0061311 | 0.0067 | 5.9944 | 0.7667 | 4 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0031328 | 0.0069 | 1.4266 | 48.8724 | 66 | 1721 | positive regulation of cellular biosynthetic process |
GO:0060675 | 0.007 | 3.8392 | 1.7039 | 6 | 60 | ureteric bud morphogenesis |
GO:0030182 | 0.0071 | 1.5021 | 34.276 | 49 | 1207 | neuron differentiation |
GO:0007212 | 0.0072 | 4.5409 | 1.2211 | 5 | 43 | dopamine receptor signaling pathway |
GO:0007417 | 0.0074 | 1.5922 | 24.3368 | 37 | 857 | central nervous system development |
GO:0002176 | 0.0076 | 22.9061 | 0.142 | 2 | 5 | male germ cell proliferation |
GO:0035609 | 0.0076 | 22.9061 | 0.142 | 2 | 5 | C-terminal protein deglutamylation |
GO:0046874 | 0.0076 | 22.9061 | 0.142 | 2 | 5 | quinolinate metabolic process |
GO:0048382 | 0.0076 | 22.9061 | 0.142 | 2 | 5 | mesendoderm development |
GO:0060455 | 0.0076 | 22.9061 | 0.142 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0072047 | 0.0076 | 22.9061 | 0.142 | 2 | 5 | proximal/distal pattern formation involved in nephron development |
GO:2000609 | 0.0076 | 22.9061 | 0.142 | 2 | 5 | regulation of thyroid hormone generation |
GO:0048701 | 0.0079 | 4.4242 | 1.2495 | 5 | 44 | embryonic cranial skeleton morphogenesis |
GO:0050755 | 0.008 | 8.6039 | 0.426 | 3 | 15 | chemokine metabolic process |
GO:0071822 | 0.008 | 1.4291 | 45.7203 | 62 | 1610 | protein complex subunit organization |
GO:0030324 | 0.0082 | 2.4477 | 4.7424 | 11 | 167 | lung development |
GO:0009799 | 0.0084 | 2.7356 | 3.4929 | 9 | 123 | specification of symmetry |
GO:0042475 | 0.0087 | 3.2277 | 2.3286 | 7 | 82 | odontogenesis of dentin-containing tooth |
GO:0031018 | 0.0087 | 4.3133 | 1.2779 | 5 | 45 | endocrine pancreas development |
GO:0030500 | 0.0088 | 3.6364 | 1.7891 | 6 | 63 | regulation of bone mineralization |
GO:0007166 | 0.0088 | 1.4327 | 44.2612 | 60 | 1621 | cell surface receptor signaling pathway |
GO:1903844 | 0.009 | 2.915 | 2.925 | 8 | 103 | regulation of cellular response to transforming growth factor beta stimulus |
GO:0007179 | 0.0093 | 2.401 | 4.8276 | 11 | 170 | transforming growth factor beta receptor signaling pathway |
GO:0044238 | 0.0094 | 1.2726 | 280.768 | 305 | 9887 | primary metabolic process |
GO:0014031 | 0.0095 | 3.5735 | 1.8175 | 6 | 64 | mesenchymal cell development |
GO:0032418 | 0.0095 | 3.5735 | 1.8175 | 6 | 64 | lysosome localization |
GO:0048864 | 0.0095 | 3.5735 | 1.8175 | 6 | 64 | stem cell development |
GO:0007342 | 0.0097 | 7.9415 | 0.4544 | 3 | 16 | fusion of sperm to egg plasma membrane involved in single fertilization |
GO:0033005 | 0.0097 | 7.9415 | 0.4544 | 3 | 16 | positive regulation of mast cell activation |
GO:0060572 | 0.0097 | 7.9415 | 0.4544 | 3 | 16 | morphogenesis of an epithelial bud |
GO:0046651 | 0.0098 | 2.1265 | 6.9006 | 14 | 243 | lymphocyte proliferation |
GO:0071559 | 0.0099 | 2.1934 | 6.2191 | 13 | 219 | response to transforming growth factor beta |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 107.8121 | 0.9127 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 52.1178 | 1.255 | 26 | 44 | protein heterotetramerization |
GO:0000183 | 0 | 71.8561 | 1.0268 | 24 | 36 | chromatin silencing at rDNA |
GO:0045653 | 0 | 122.9603 | 0.5134 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 15.6342 | 2.2533 | 24 | 79 | positive regulation of gene expression, epigenetic |
GO:1902036 | 0 | 11.797 | 2.8808 | 25 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 10.5979 | 2.9949 | 24 | 105 | regulation of gene silencing by miRNA |
GO:0045814 | 0 | 9.6299 | 3.3657 | 25 | 118 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 8.2418 | 3.651 | 24 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 7.4501 | 4.1358 | 25 | 145 | chromatin assembly |
GO:0032200 | 0 | 6.795 | 4.6493 | 26 | 163 | telomere organization |
GO:0048863 | 0 | 5.1348 | 7.3304 | 32 | 257 | stem cell differentiation |
GO:0034080 | 0 | 18.8901 | 1.1409 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 16.3672 | 1.255 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0002244 | 0 | 5.8095 | 5.3053 | 26 | 186 | hematopoietic progenitor cell differentiation |
GO:0034724 | 0 | 13.2647 | 1.4547 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0038111 | 0 | 16.7642 | 1.0554 | 12 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 16.7642 | 1.0554 | 12 | 37 | response to interleukin-7 |
GO:0016233 | 0 | 11.9675 | 1.5688 | 14 | 55 | telomere capping |
GO:0035194 | 0 | 4.6826 | 6.6459 | 27 | 233 | posttranscriptional gene silencing by RNA |
GO:0051259 | 0 | 3.2658 | 14.5468 | 42 | 510 | protein oligomerization |
GO:0006303 | 0 | 9.2344 | 2.0537 | 15 | 72 | double-strand break repair via nonhomologous end joining |
GO:0065004 | 0 | 4.709 | 6.1039 | 25 | 214 | protein-DNA complex assembly |
GO:0030099 | 0 | 3.5894 | 10.6962 | 34 | 375 | myeloid cell differentiation |
GO:1903707 | 0 | 5.8288 | 3.8221 | 19 | 134 | negative regulation of hemopoiesis |
GO:0043044 | 0 | 8.0333 | 2.1392 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0071103 | 0 | 3.9191 | 7.473 | 26 | 262 | DNA conformation change |
GO:0002682 | 0 | 2.4403 | 25.2232 | 55 | 905 | regulation of immune system process |
GO:0048534 | 0 | 2.3754 | 23.7597 | 51 | 833 | hematopoietic or lymphoid organ development |
GO:0017148 | 0 | 3.2735 | 9.1274 | 27 | 320 | negative regulation of translation |
GO:0060249 | 0 | 2.9232 | 10.4965 | 28 | 368 | anatomical structure homeostasis |
GO:0009913 | 0 | 3.0597 | 9.327 | 26 | 327 | epidermal cell differentiation |
GO:0045652 | 0 | 7.7913 | 1.5499 | 10 | 56 | regulation of megakaryocyte differentiation |
GO:0071345 | 0 | 2.4539 | 16.4614 | 37 | 587 | cellular response to cytokine stimulus |
GO:2000026 | 0 | 1.7725 | 51.1133 | 82 | 1792 | regulation of multicellular organismal development |
GO:0048869 | 0 | 1.5634 | 113.3792 | 154 | 3975 | cellular developmental process |
GO:0060429 | 1e-04 | 1.8244 | 33.7998 | 57 | 1185 | epithelium development |
GO:0048731 | 1e-04 | 1.471 | 124.5032 | 161 | 4365 | system development |
GO:0030155 | 1e-04 | 2.1113 | 18.3118 | 36 | 642 | regulation of cell adhesion |
GO:0006352 | 1e-04 | 2.9698 | 6.5603 | 18 | 230 | DNA-templated transcription, initiation |
GO:0043588 | 1e-04 | 2.4377 | 11.0099 | 25 | 386 | skin development |
GO:0034728 | 1e-04 | 4.227 | 2.8843 | 11 | 104 | nucleosome organization |
GO:0007596 | 2e-04 | 2.5308 | 9.327 | 22 | 327 | blood coagulation |
GO:0090197 | 3e-04 | 17.1718 | 0.3423 | 4 | 12 | positive regulation of chemokine secretion |
GO:0050878 | 3e-04 | 2.1876 | 13.6626 | 28 | 479 | regulation of body fluid levels |
GO:0031424 | 3e-04 | 4.231 | 2.6186 | 10 | 93 | keratinization |
GO:0022408 | 3e-04 | 3.372 | 4.1929 | 13 | 147 | negative regulation of cell-cell adhesion |
GO:0060326 | 4e-04 | 2.6751 | 7.2163 | 18 | 253 | cell chemotaxis |
GO:0060485 | 4e-04 | 2.7458 | 6.6459 | 17 | 233 | mesenchyme development |
GO:0001960 | 4e-04 | 5.7496 | 1.3976 | 7 | 49 | negative regulation of cytokine-mediated signaling pathway |
GO:0060192 | 5e-04 | 13.7357 | 0.3993 | 4 | 14 | negative regulation of lipase activity |
GO:0045596 | 5e-04 | 1.9654 | 17.8554 | 33 | 626 | negative regulation of cell differentiation |
GO:0051248 | 6e-04 | 1.6714 | 35.1689 | 55 | 1233 | negative regulation of protein metabolic process |
GO:0050727 | 7e-04 | 2.3941 | 8.8992 | 20 | 312 | regulation of inflammatory response |
GO:0010604 | 7e-04 | 1.4509 | 82.7739 | 110 | 2902 | positive regulation of macromolecule metabolic process |
GO:0051239 | 7e-04 | 1.8025 | 24.3662 | 41 | 925 | regulation of multicellular organismal process |
GO:0031340 | 7e-04 | 25.7074 | 0.1997 | 3 | 7 | positive regulation of vesicle fusion |
GO:0035754 | 7e-04 | 25.7074 | 0.1997 | 3 | 7 | B cell chemotaxis |
GO:0034248 | 8e-04 | 2.0127 | 15.2884 | 29 | 536 | regulation of cellular amide metabolic process |
GO:0003165 | 8e-04 | Inf | 0.057 | 2 | 2 | Purkinje myocyte development |
GO:0097055 | 8e-04 | Inf | 0.057 | 2 | 2 | agmatine biosynthetic process |
GO:1901383 | 8e-04 | Inf | 0.057 | 2 | 2 | negative regulation of chorionic trophoblast cell proliferation |
GO:0032652 | 8e-04 | 4.4555 | 1.9966 | 8 | 70 | regulation of interleukin-1 production |
GO:0090023 | 9e-04 | 7.8157 | 0.7701 | 5 | 27 | positive regulation of neutrophil chemotaxis |
GO:1903037 | 9e-04 | 2.329 | 9.1274 | 20 | 320 | regulation of leukocyte cell-cell adhesion |
GO:0018149 | 9e-04 | 5.029 | 1.5688 | 7 | 55 | peptide cross-linking |
GO:0045453 | 9e-04 | 5.029 | 1.5688 | 7 | 55 | bone resorption |
GO:0051674 | 9e-04 | 1.6048 | 39.9323 | 60 | 1400 | localization of cell |
GO:0070887 | 0.0011 | 1.4786 | 66.0223 | 90 | 2413 | cellular response to chemical stimulus |
GO:0009611 | 0.0011 | 1.8914 | 17.9125 | 32 | 628 | response to wounding |
GO:0008283 | 0.0011 | 1.511 | 54.7072 | 77 | 1918 | cell proliferation |
GO:0071294 | 0.0012 | 10.5639 | 0.4849 | 4 | 17 | cellular response to zinc ion |
GO:0002072 | 0.0012 | 20.5646 | 0.2282 | 3 | 8 | optic cup morphogenesis involved in camera-type eye development |
GO:0002526 | 0.0012 | 3.037 | 4.2499 | 12 | 149 | acute inflammatory response |
GO:0033993 | 0.0012 | 1.7412 | 24.9577 | 41 | 875 | response to lipid |
GO:0001775 | 0.0013 | 1.6175 | 35.5112 | 54 | 1245 | cell activation |
GO:0045824 | 0.0013 | 5.5836 | 1.2265 | 6 | 43 | negative regulation of innate immune response |
GO:0070098 | 0.0014 | 4.0608 | 2.1678 | 8 | 76 | chemokine-mediated signaling pathway |
GO:0006950 | 0.0014 | 1.4275 | 80.9894 | 106 | 2934 | response to stress |
GO:0022610 | 0.0015 | 1.5941 | 37.3652 | 56 | 1310 | biological adhesion |
GO:0030334 | 0.0016 | 1.7965 | 20.5937 | 35 | 722 | regulation of cell migration |
GO:0048732 | 0.0016 | 2.0787 | 11.6945 | 23 | 410 | gland development |
GO:0071281 | 0.0017 | 17.1361 | 0.2567 | 3 | 9 | cellular response to iron ion |
GO:0045892 | 0.0017 | 1.6394 | 31.0331 | 48 | 1088 | negative regulation of transcription, DNA-templated |
GO:0060759 | 0.0017 | 2.8881 | 4.4496 | 12 | 156 | regulation of response to cytokine stimulus |
GO:0014855 | 0.0019 | 4.3869 | 1.7684 | 7 | 62 | striated muscle cell proliferation |
GO:0010608 | 0.0019 | 1.8408 | 17.7699 | 31 | 623 | posttranscriptional regulation of gene expression |
GO:0045907 | 0.002 | 6.3663 | 0.9127 | 5 | 32 | positive regulation of vasoconstriction |
GO:0032691 | 0.0022 | 8.5815 | 0.5705 | 4 | 20 | negative regulation of interleukin-1 beta production |
GO:0051270 | 0.0022 | 1.7043 | 24.159 | 39 | 847 | regulation of cellular component movement |
GO:0007566 | 0.0023 | 4.9173 | 1.3691 | 6 | 48 | embryo implantation |
GO:0002457 | 0.0024 | 68.415 | 0.0856 | 2 | 3 | T cell antigen processing and presentation |
GO:1900138 | 0.0024 | 68.415 | 0.0856 | 2 | 3 | negative regulation of phospholipase A2 activity |
GO:0070663 | 0.0025 | 2.5173 | 5.9043 | 14 | 207 | regulation of leukocyte proliferation |
GO:1902622 | 0.0026 | 5.9264 | 0.9698 | 5 | 34 | regulation of neutrophil migration |
GO:0051094 | 0.0027 | 1.5833 | 33.4059 | 50 | 1178 | positive regulation of developmental process |
GO:0008219 | 0.0031 | 1.4402 | 58.5293 | 79 | 2052 | cell death |
GO:1902679 | 0.0032 | 1.5838 | 32.0029 | 48 | 1122 | negative regulation of RNA biosynthetic process |
GO:0043374 | 0.0032 | 12.8504 | 0.3138 | 3 | 11 | CD8-positive, alpha-beta T cell differentiation |
GO:0040012 | 0.0033 | 1.6741 | 23.9023 | 38 | 838 | regulation of locomotion |
GO:0006954 | 0.0033 | 2.2193 | 8.083 | 17 | 293 | inflammatory response |
GO:0046649 | 0.0034 | 1.8057 | 16.8857 | 29 | 592 | lymphocyte activation |
GO:0050896 | 0.0035 | 1.3979 | 97.6572 | 120 | 3900 | response to stimulus |
GO:0007166 | 0.0035 | 1.3915 | 73.9888 | 96 | 2594 | cell surface receptor signaling pathway |
GO:0097529 | 0.0037 | 2.6131 | 4.8774 | 12 | 171 | myeloid leukocyte migration |
GO:0031579 | 0.0038 | 7.2251 | 0.656 | 4 | 23 | membrane raft organization |
GO:0009605 | 0.0038 | 1.508 | 40.7908 | 58 | 1464 | response to external stimulus |
GO:0002819 | 0.0039 | 2.904 | 3.6795 | 10 | 129 | regulation of adaptive immune response |
GO:0071241 | 0.0039 | 2.5966 | 4.906 | 12 | 172 | cellular response to inorganic substance |
GO:0070271 | 0.004 | 1.5124 | 39.1337 | 56 | 1372 | protein complex biogenesis |
GO:0003207 | 0.0042 | 11.4218 | 0.3423 | 3 | 12 | cardiac chamber formation |
GO:1901298 | 0.0042 | 11.4218 | 0.3423 | 3 | 12 | regulation of hydrogen peroxide-mediated programmed cell death |
GO:0045934 | 0.0042 | 1.513 | 38.3921 | 55 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0050670 | 0.0044 | 2.4477 | 5.619 | 13 | 197 | regulation of lymphocyte proliferation |
GO:0010803 | 0.0046 | 4.2129 | 1.5688 | 6 | 55 | regulation of tumor necrosis factor-mediated signaling pathway |
GO:0031394 | 0.0047 | 34.2053 | 0.1141 | 2 | 4 | positive regulation of prostaglandin biosynthetic process |
GO:0090403 | 0.0047 | 34.2053 | 0.1141 | 2 | 4 | oxidative stress-induced premature senescence |
GO:0098707 | 0.0047 | 34.2053 | 0.1141 | 2 | 4 | ferrous iron import across plasma membrane |
GO:1901164 | 0.0047 | 34.2053 | 0.1141 | 2 | 4 | negative regulation of trophoblast cell migration |
GO:1904431 | 0.0047 | 34.2053 | 0.1141 | 2 | 4 | positive regulation of t-circle formation |
GO:2001181 | 0.0047 | 34.2053 | 0.1141 | 2 | 4 | positive regulation of interleukin-10 secretion |
GO:0050709 | 0.0048 | 3.0159 | 3.1946 | 9 | 112 | negative regulation of protein secretion |
GO:0070268 | 0.0048 | 3.0159 | 3.1946 | 9 | 112 | cornification |
GO:0051046 | 0.005 | 1.7006 | 19.738 | 32 | 692 | regulation of secretion |
GO:0048596 | 0.0051 | 6.5362 | 0.7131 | 4 | 25 | embryonic camera-type eye morphogenesis |
GO:0001819 | 0.0053 | 1.973 | 10.6363 | 20 | 375 | positive regulation of cytokine production |
GO:0090343 | 0.0053 | 10.279 | 0.3708 | 3 | 13 | positive regulation of cell aging |
GO:0090399 | 0.0053 | 10.279 | 0.3708 | 3 | 13 | replicative senescence |
GO:0042743 | 0.0053 | 4.9086 | 1.1409 | 5 | 40 | hydrogen peroxide metabolic process |
GO:0046006 | 0.0053 | 4.9086 | 1.1409 | 5 | 40 | regulation of activated T cell proliferation |
GO:0006887 | 0.0054 | 1.641 | 23.0181 | 36 | 807 | exocytosis |
GO:0060337 | 0.0055 | 3.5453 | 2.1392 | 7 | 75 | type I interferon signaling pathway |
GO:0002694 | 0.0055 | 1.87 | 12.8924 | 23 | 452 | regulation of leukocyte activation |
GO:0006898 | 0.0055 | 2.1527 | 7.8153 | 16 | 274 | receptor-mediated endocytosis |
GO:0090398 | 0.0055 | 4.0472 | 1.6258 | 6 | 57 | cellular senescence |
GO:0042102 | 0.0057 | 3.17 | 2.7097 | 8 | 95 | positive regulation of T cell proliferation |
GO:0050868 | 0.0057 | 3.17 | 2.7097 | 8 | 95 | negative regulation of T cell activation |
GO:0032602 | 0.0059 | 3.4937 | 2.1678 | 7 | 76 | chemokine production |
GO:0060043 | 0.0059 | 4.7719 | 1.1694 | 5 | 41 | regulation of cardiac muscle cell proliferation |
GO:0048771 | 0.0059 | 2.5694 | 4.5352 | 11 | 159 | tissue remodeling |
GO:0051707 | 0.0062 | 1.6363 | 22.4191 | 35 | 786 | response to other organism |
GO:0002576 | 0.0063 | 2.8754 | 3.3372 | 9 | 117 | platelet degranulation |
GO:0001818 | 0.0064 | 2.2459 | 6.5603 | 14 | 230 | negative regulation of cytokine production |
GO:0045766 | 0.0065 | 2.6771 | 3.9647 | 10 | 139 | positive regulation of angiogenesis |
GO:0021527 | 0.0066 | 9.3439 | 0.3993 | 3 | 14 | spinal cord association neuron differentiation |
GO:0038092 | 0.0066 | 9.3439 | 0.3993 | 3 | 14 | nodal signaling pathway |
GO:0045723 | 0.0066 | 9.3439 | 0.3993 | 3 | 14 | positive regulation of fatty acid biosynthetic process |
GO:0051957 | 0.0066 | 9.3439 | 0.3993 | 3 | 14 | positive regulation of amino acid transport |
GO:0097468 | 0.0066 | 9.3439 | 0.3993 | 3 | 14 | programmed cell death in response to reactive oxygen species |
GO:0002687 | 0.0067 | 2.8488 | 3.3657 | 9 | 118 | positive regulation of leukocyte migration |
GO:0032479 | 0.0067 | 2.8488 | 3.3657 | 9 | 118 | regulation of type I interferon production |
GO:0010469 | 0.0067 | 1.7667 | 15.4025 | 26 | 540 | regulation of receptor activity |
GO:0060706 | 0.0068 | 5.967 | 0.7701 | 4 | 27 | cell differentiation involved in embryonic placenta development |
GO:0001890 | 0.0069 | 2.6564 | 3.9932 | 10 | 140 | placenta development |
GO:0002252 | 0.0071 | 1.5356 | 30.0633 | 44 | 1054 | immune effector process |
GO:0051051 | 0.0073 | 1.8219 | 13.2062 | 23 | 463 | negative regulation of transport |
GO:0043303 | 0.0073 | 4.5202 | 1.2265 | 5 | 43 | mast cell degranulation |
GO:0072330 | 0.0075 | 2.3717 | 5.3338 | 12 | 187 | monocarboxylic acid biosynthetic process |
GO:0048523 | 0.0075 | 1.3143 | 102.9806 | 125 | 3740 | negative regulation of cellular process |
GO:0036037 | 0.0076 | 22.9422 | 0.1418 | 2 | 5 | CD8-positive, alpha-beta T cell activation |
GO:0009446 | 0.0077 | 22.8021 | 0.1426 | 2 | 5 | putrescine biosynthetic process |
GO:0048382 | 0.0077 | 22.8021 | 0.1426 | 2 | 5 | mesendoderm development |
GO:0048859 | 0.0077 | 22.8021 | 0.1426 | 2 | 5 | formation of anatomical boundary |
GO:1903232 | 0.0077 | 22.8021 | 0.1426 | 2 | 5 | melanosome assembly |
GO:2000609 | 0.0077 | 22.8021 | 0.1426 | 2 | 5 | regulation of thyroid hormone generation |
GO:2000147 | 0.0078 | 1.8374 | 12.5216 | 22 | 439 | positive regulation of cell motility |
GO:0034340 | 0.0078 | 3.3014 | 2.2818 | 7 | 80 | response to type I interferon |
GO:0010033 | 0.008 | 1.3973 | 55.4947 | 73 | 2021 | response to organic substance |
GO:0001829 | 0.0081 | 8.5647 | 0.4278 | 3 | 15 | trophectodermal cell differentiation |
GO:0014048 | 0.0081 | 8.5647 | 0.4278 | 3 | 15 | regulation of glutamate secretion |
GO:0015671 | 0.0081 | 8.5647 | 0.4278 | 3 | 15 | oxygen transport |
GO:0007186 | 0.0082 | 1.4952 | 33.6857 | 48 | 1181 | G-protein coupled receptor signaling pathway |
GO:0071356 | 0.0084 | 2.1048 | 7.473 | 15 | 262 | cellular response to tumor necrosis factor |
GO:0023052 | 0.0088 | 1.264 | 170.1686 | 195 | 5966 | signaling |
GO:0043066 | 0.0088 | 1.5938 | 22.9611 | 35 | 805 | negative regulation of apoptotic process |
GO:0045778 | 0.0089 | 3.2129 | 2.3389 | 7 | 82 | positive regulation of ossification |
GO:0050777 | 0.009 | 3.2058 | 2.3425 | 7 | 83 | negative regulation of immune response |
GO:0002790 | 0.0092 | 1.7367 | 15.0317 | 25 | 527 | peptide secretion |
GO:0042330 | 0.0093 | 1.7148 | 15.8303 | 26 | 555 | taxis |
GO:0048518 | 0.0097 | 1.2979 | 111.4957 | 133 | 4094 | positive regulation of biological process |
GO:0071621 | 0.0098 | 2.8712 | 2.9664 | 8 | 104 | granulocyte chemotaxis |
GO:0043651 | 0.0098 | 7.9054 | 0.4564 | 3 | 16 | linoleic acid metabolic process |
GO:0051923 | 0.0098 | 7.9054 | 0.4564 | 3 | 16 | sulfation |
GO:1900017 | 0.0098 | 7.9054 | 0.4564 | 3 | 16 | positive regulation of cytokine production involved in inflammatory response |
GO:0022409 | 0.0098 | 2.126 | 6.9026 | 14 | 242 | positive regulation of cell-cell adhesion |
GO:0045926 | 0.0099 | 2.194 | 6.218 | 13 | 218 | negative regulation of growth |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007218 | 0 | 10.5256 | 2.4572 | 20 | 94 | neuropeptide signaling pathway |
GO:0007606 | 0 | 4.0019 | 10.6132 | 37 | 406 | sensory perception of chemical stimulus |
GO:0050911 | 0 | 4.3755 | 8.1298 | 31 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009952 | 0 | 5.4869 | 5.0975 | 24 | 195 | anterior/posterior pattern specification |
GO:0009593 | 0 | 3.807 | 10.1427 | 34 | 388 | detection of chemical stimulus |
GO:0050877 | 0 | 2.5626 | 27.569 | 62 | 1070 | nervous system process |
GO:0050906 | 0 | 3.6792 | 10.4564 | 34 | 400 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 2.6186 | 21.4912 | 50 | 883 | G-protein coupled receptor signaling pathway |
GO:0007389 | 0 | 3.5743 | 8.4227 | 27 | 326 | pattern specification process |
GO:0001501 | 0 | 3.1444 | 7.6444 | 22 | 297 | skeletal system development |
GO:0050794 | 0 | 1.5674 | 258.7167 | 299 | 9897 | regulation of cellular process |
GO:0048598 | 0 | 2.4002 | 14.9003 | 33 | 570 | embryonic morphogenesis |
GO:0021524 | 0 | Inf | 0.0784 | 3 | 3 | visceral motor neuron differentiation |
GO:0065007 | 0 | 1.606 | 290.1642 | 327 | 11100 | biological regulation |
GO:0048704 | 0 | 5.1692 | 2.405 | 11 | 92 | embryonic skeletal system morphogenesis |
GO:0032501 | 0 | 1.5639 | 129.3129 | 166 | 5469 | multicellular organismal process |
GO:0019935 | 0 | 4.5733 | 2.9278 | 12 | 112 | cyclic-nucleotide-mediated signaling |
GO:0021545 | 0 | 8.8844 | 0.9609 | 7 | 37 | cranial nerve development |
GO:0046877 | 1e-04 | 30.0823 | 0.2353 | 4 | 9 | regulation of saliva secretion |
GO:0009887 | 1e-04 | 1.9788 | 25.1476 | 46 | 962 | animal organ morphogenesis |
GO:0048935 | 1e-04 | 25.1873 | 0.2602 | 4 | 10 | peripheral nervous system neuron development |
GO:0021536 | 1e-04 | 5.5051 | 1.856 | 9 | 71 | diencephalon development |
GO:0097746 | 1e-04 | 4.0438 | 3.2676 | 12 | 125 | regulation of blood vessel diameter |
GO:0009954 | 1e-04 | 9.0569 | 0.8104 | 6 | 31 | proximal/distal pattern formation |
GO:0060173 | 1e-04 | 3.4471 | 4.4178 | 14 | 169 | limb development |
GO:0048880 | 2e-04 | 56.279 | 0.1307 | 3 | 5 | sensory system development |
GO:0071799 | 2e-04 | 56.279 | 0.1307 | 3 | 5 | cellular response to prostaglandin D stimulus |
GO:0007267 | 2e-04 | 1.8337 | 28.2202 | 48 | 1108 | cell-cell signaling |
GO:0035150 | 2e-04 | 3.7433 | 3.5029 | 12 | 134 | regulation of tube size |
GO:0021520 | 3e-04 | 16.7081 | 0.3398 | 4 | 13 | spinal cord motor neuron cell fate specification |
GO:0007268 | 3e-04 | 2.0962 | 15.2663 | 30 | 584 | chemical synaptic transmission |
GO:0007200 | 4e-04 | 4.0797 | 2.6925 | 10 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0099537 | 4e-04 | 2.0884 | 15.3186 | 30 | 586 | trans-synaptic signaling |
GO:0007188 | 4e-04 | 4.4891 | 2.2193 | 9 | 86 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0035107 | 4e-04 | 3.4312 | 3.7904 | 12 | 145 | appendage morphogenesis |
GO:0030326 | 5e-04 | 3.6329 | 3.2938 | 11 | 126 | embryonic limb morphogenesis |
GO:2000542 | 6e-04 | 28.1359 | 0.183 | 3 | 7 | negative regulation of gastrulation |
GO:0098664 | 6e-04 | 12.588 | 0.4164 | 4 | 16 | G-protein coupled serotonin receptor signaling pathway |
GO:0021570 | 7e-04 | Inf | 0.0523 | 2 | 2 | rhombomere 4 development |
GO:0031635 | 7e-04 | Inf | 0.0523 | 2 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
GO:0033693 | 7e-04 | Inf | 0.0523 | 2 | 2 | neurofilament bundle assembly |
GO:0060577 | 7e-04 | Inf | 0.0523 | 2 | 2 | pulmonary vein morphogenesis |
GO:0003018 | 8e-04 | 3.1892 | 4.0518 | 12 | 155 | vascular process in circulatory system |
GO:0045944 | 9e-04 | 1.7323 | 27.6832 | 45 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0051241 | 9e-04 | 1.7422 | 26.9068 | 44 | 1034 | negative regulation of multicellular organismal process |
GO:0008284 | 0.0012 | 1.7958 | 21.8538 | 37 | 836 | positive regulation of cell proliferation |
GO:0048568 | 0.0012 | 2.1686 | 10.7439 | 22 | 411 | embryonic organ development |
GO:0046549 | 0.0013 | 18.7548 | 0.2353 | 3 | 9 | retinal cone cell development |
GO:0007189 | 0.0014 | 4.6361 | 1.673 | 7 | 64 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0033993 | 0.0015 | 1.7607 | 22.8733 | 38 | 875 | response to lipid |
GO:0048665 | 0.0015 | 9.4804 | 0.5182 | 4 | 20 | neuron fate specification |
GO:1905207 | 0.0017 | 5.2595 | 1.2809 | 6 | 49 | regulation of cardiocyte differentiation |
GO:0071695 | 0.0018 | 3.0452 | 3.8689 | 11 | 148 | anatomical structure maturation |
GO:0071805 | 0.0018 | 2.7296 | 5.0713 | 13 | 194 | potassium ion transmembrane transport |
GO:0060346 | 0.0019 | 16.0745 | 0.2614 | 3 | 10 | bone trabecula formation |
GO:0031290 | 0.0019 | 8.8409 | 0.549 | 4 | 21 | retinal ganglion cell axon guidance |
GO:0048936 | 0.002 | 74.8627 | 0.0784 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060435 | 0.002 | 74.8627 | 0.0784 | 2 | 3 | bronchiole development |
GO:0060743 | 0.002 | 74.8627 | 0.0784 | 2 | 3 | epithelial cell maturation involved in prostate gland development |
GO:0060913 | 0.002 | 74.8627 | 0.0784 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 0.002 | 74.8627 | 0.0784 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0045165 | 0.002 | 2.483 | 6.4045 | 15 | 245 | cell fate commitment |
GO:0021515 | 0.0021 | 5.0251 | 1.3332 | 6 | 51 | cell differentiation in spinal cord |
GO:0023061 | 0.0023 | 2.098 | 10.5609 | 21 | 404 | signal release |
GO:0071392 | 0.0023 | 6.0695 | 0.9411 | 5 | 36 | cellular response to estradiol stimulus |
GO:0008306 | 0.0023 | 4.193 | 1.8299 | 7 | 70 | associative learning |
GO:0008015 | 0.0024 | 1.9792 | 12.7829 | 24 | 489 | blood circulation |
GO:0043388 | 0.0025 | 4.8107 | 1.3855 | 6 | 53 | positive regulation of DNA binding |
GO:0002087 | 0.0025 | 14.0643 | 0.2876 | 3 | 11 | regulation of respiratory gaseous exchange by neurological system process |
GO:0021559 | 0.0025 | 14.0643 | 0.2876 | 3 | 11 | trigeminal nerve development |
GO:0060379 | 0.0025 | 14.0643 | 0.2876 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060525 | 0.0025 | 14.0643 | 0.2876 | 3 | 11 | prostate glandular acinus development |
GO:0001755 | 0.0026 | 5.8795 | 0.9672 | 5 | 37 | neural crest cell migration |
GO:0009888 | 0.0026 | 1.4963 | 47.8117 | 67 | 1829 | tissue development |
GO:0006355 | 0.0028 | 1.3819 | 89.036 | 113 | 3406 | regulation of transcription, DNA-templated |
GO:0006813 | 0.003 | 2.4638 | 6.0124 | 14 | 230 | potassium ion transport |
GO:0019233 | 0.003 | 3.5553 | 2.4311 | 8 | 93 | sensory perception of pain |
GO:0048857 | 0.003 | 4.6137 | 1.4378 | 6 | 55 | neural nucleus development |
GO:0003151 | 0.0032 | 3.9416 | 1.9344 | 7 | 74 | outflow tract morphogenesis |
GO:0030878 | 0.0032 | 7.5133 | 0.6274 | 4 | 24 | thyroid gland development |
GO:0046887 | 0.0034 | 3.1806 | 3.0323 | 9 | 116 | positive regulation of hormone secretion |
GO:0007610 | 0.0034 | 2.3428 | 6.7587 | 15 | 266 | behavior |
GO:0055024 | 0.0034 | 3.8834 | 1.9606 | 7 | 75 | regulation of cardiac muscle tissue development |
GO:2001141 | 0.0036 | 1.3676 | 89.7418 | 113 | 3433 | regulation of RNA biosynthetic process |
GO:0060740 | 0.0038 | 7.1551 | 0.6535 | 4 | 25 | prostate gland epithelium morphogenesis |
GO:0007187 | 0.0039 | 7.0433 | 0.6598 | 4 | 26 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0001992 | 0.0039 | 37.4289 | 0.1046 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003257 | 0.0039 | 37.4289 | 0.1046 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0003308 | 0.0039 | 37.4289 | 0.1046 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0007198 | 0.0039 | 37.4289 | 0.1046 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021615 | 0.0039 | 37.4289 | 0.1046 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0021855 | 0.0039 | 37.4289 | 0.1046 | 2 | 4 | hypothalamus cell migration |
GO:0070253 | 0.0039 | 37.4289 | 0.1046 | 2 | 4 | somatostatin secretion |
GO:0050886 | 0.004 | 3.772 | 2.0129 | 7 | 77 | endocrine process |
GO:0042310 | 0.004 | 5.2665 | 1.0636 | 5 | 41 | vasoconstriction |
GO:0045104 | 0.0041 | 5.2249 | 1.0718 | 5 | 41 | intermediate filament cytoskeleton organization |
GO:0045596 | 0.0041 | 1.7979 | 16.3642 | 28 | 626 | negative regulation of cell differentiation |
GO:0030814 | 0.0042 | 2.8671 | 3.712 | 10 | 142 | regulation of cAMP metabolic process |
GO:0007320 | 0.0042 | 11.25 | 0.3398 | 3 | 13 | insemination |
GO:0021984 | 0.0042 | 11.25 | 0.3398 | 3 | 13 | adenohypophysis development |
GO:1901213 | 0.0042 | 11.25 | 0.3398 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:2000726 | 0.0042 | 11.25 | 0.3398 | 3 | 13 | negative regulation of cardiac muscle cell differentiation |
GO:0010469 | 0.0043 | 1.86 | 14.1161 | 25 | 540 | regulation of receptor activity |
GO:0009914 | 0.0044 | 2.2083 | 7.6254 | 16 | 293 | hormone transport |
GO:0003016 | 0.005 | 6.5321 | 0.7058 | 4 | 27 | respiratory system process |
GO:0042634 | 0.005 | 6.5321 | 0.7058 | 4 | 27 | regulation of hair cycle |
GO:0021517 | 0.0051 | 4.9492 | 1.1241 | 5 | 43 | ventral spinal cord development |
GO:0042711 | 0.0052 | 10.2266 | 0.366 | 3 | 14 | maternal behavior |
GO:0045986 | 0.0052 | 10.2266 | 0.366 | 3 | 14 | negative regulation of smooth muscle contraction |
GO:0032502 | 0.0055 | 1.3316 | 113.9291 | 137 | 4543 | developmental process |
GO:0009798 | 0.006 | 3.4728 | 2.1697 | 7 | 83 | axis specification |
GO:0007417 | 0.006 | 1.64 | 22.4028 | 35 | 857 | central nervous system development |
GO:0045471 | 0.0062 | 2.882 | 3.3199 | 9 | 127 | response to ethanol |
GO:0061138 | 0.0064 | 2.5394 | 4.5747 | 11 | 175 | morphogenesis of a branching epithelium |
GO:0008595 | 0.0064 | 9.3738 | 0.3921 | 3 | 15 | anterior/posterior axis specification, embryo |
GO:0048532 | 0.0064 | 9.3738 | 0.3921 | 3 | 15 | anatomical structure arrangement |
GO:0051546 | 0.0064 | 9.3738 | 0.3921 | 3 | 15 | keratinocyte migration |
GO:0060253 | 0.0064 | 9.3738 | 0.3921 | 3 | 15 | negative regulation of glial cell proliferation |
GO:0055008 | 0.0064 | 3.8955 | 1.673 | 6 | 64 | cardiac muscle tissue morphogenesis |
GO:0010841 | 0.0065 | 24.951 | 0.1307 | 2 | 5 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0014060 | 0.0065 | 24.951 | 0.1307 | 2 | 5 | regulation of epinephrine secretion |
GO:0038170 | 0.0065 | 24.951 | 0.1307 | 2 | 5 | somatostatin signaling pathway |
GO:0051970 | 0.0065 | 24.951 | 0.1307 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0061743 | 0.0065 | 24.951 | 0.1307 | 2 | 5 | motor learning |
GO:0003203 | 0.0065 | 6.0087 | 0.7581 | 4 | 29 | endocardial cushion morphogenesis |
GO:0022414 | 0.0066 | 1.5111 | 34.1662 | 49 | 1307 | reproductive process |
GO:0007611 | 0.0066 | 2.3147 | 5.9078 | 13 | 226 | learning or memory |
GO:0048634 | 0.0071 | 2.81 | 3.3983 | 9 | 130 | regulation of muscle organ development |
GO:0051216 | 0.0072 | 2.4933 | 4.6531 | 11 | 178 | cartilage development |
GO:0034765 | 0.0073 | 1.9111 | 10.953 | 20 | 419 | regulation of ion transmembrane transport |
GO:0006874 | 0.0073 | 1.9459 | 10.2211 | 19 | 391 | cellular calcium ion homeostasis |
GO:0019098 | 0.0074 | 5.7772 | 0.7842 | 4 | 30 | reproductive behavior |
GO:0002067 | 0.0074 | 4.4767 | 1.2286 | 5 | 47 | glandular epithelial cell differentiation |
GO:0050795 | 0.0075 | 3.7652 | 1.7253 | 6 | 66 | regulation of behavior |
GO:0019219 | 0.0078 | 1.3119 | 104.067 | 126 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0051094 | 0.008 | 1.5189 | 31.1338 | 45 | 1191 | positive regulation of developmental process |
GO:0033555 | 0.008 | 3.7032 | 1.7514 | 6 | 67 | multicellular organismal response to stress |
GO:0050885 | 0.0081 | 4.3723 | 1.2548 | 5 | 48 | neuromuscular process controlling balance |
GO:0043009 | 0.0091 | 1.7599 | 14.2468 | 24 | 545 | chordate embryonic development |
GO:0048762 | 0.0092 | 2.4058 | 4.8099 | 11 | 184 | mesenchymal cell differentiation |
GO:0001573 | 0.0092 | 8.0336 | 0.4444 | 3 | 17 | ganglioside metabolic process |
GO:0045683 | 0.0092 | 8.0336 | 0.4444 | 3 | 17 | negative regulation of epidermis development |
GO:0048486 | 0.0092 | 8.0336 | 0.4444 | 3 | 17 | parasympathetic nervous system development |
GO:0060219 | 0.0092 | 8.0336 | 0.4444 | 3 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0060644 | 0.0092 | 8.0336 | 0.4444 | 3 | 17 | mammary gland epithelial cell differentiation |
GO:0031644 | 0.0092 | 3.5852 | 1.8037 | 6 | 69 | regulation of neurological system process |
GO:0042755 | 0.0093 | 5.3639 | 0.8365 | 4 | 32 | eating behavior |
GO:0043278 | 0.0093 | 5.3639 | 0.8365 | 4 | 32 | response to morphine |
GO:0045907 | 0.0093 | 5.3639 | 0.8365 | 4 | 32 | positive regulation of vasoconstriction |
GO:0002865 | 0.0095 | 18.712 | 0.1568 | 2 | 6 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0009996 | 0.0095 | 18.712 | 0.1568 | 2 | 6 | negative regulation of cell fate specification |
GO:0032351 | 0.0095 | 18.712 | 0.1568 | 2 | 6 | negative regulation of hormone metabolic process |
GO:0035771 | 0.0095 | 18.712 | 0.1568 | 2 | 6 | interleukin-4-mediated signaling pathway |
GO:0038031 | 0.0095 | 18.712 | 0.1568 | 2 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
GO:0048241 | 0.0095 | 18.712 | 0.1568 | 2 | 6 | epinephrine transport |
GO:0060527 | 0.0095 | 18.712 | 0.1568 | 2 | 6 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0050768 | 0.0097 | 2.1995 | 6.1954 | 13 | 237 | negative regulation of neurogenesis |
GO:0007422 | 0.0099 | 3.529 | 1.8299 | 6 | 70 | peripheral nervous system development |
GO:0030902 | 0.0099 | 2.6552 | 3.5813 | 9 | 137 | hindbrain development |
GO:0097659 | 0.0099 | 1.3106 | 93.5584 | 114 | 3579 | nucleic acid-templated transcription |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 95.6529 | 1.1532 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 95.0698 | 1.0251 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 41.7533 | 1.4095 | 25 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 19.5918 | 2.5307 | 30 | 79 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 10.8814 | 3.78 | 30 | 118 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 12.2041 | 3.2354 | 28 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0045653 | 0 | 108.7113 | 0.5766 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 10.9875 | 3.3635 | 27 | 105 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 8.8933 | 4.1003 | 28 | 128 | regulation of gene silencing |
GO:0006323 | 0 | 6.8984 | 5.9582 | 33 | 186 | DNA packaging |
GO:0002244 | 0 | 6.3692 | 5.9582 | 31 | 186 | hematopoietic progenitor cell differentiation |
GO:0071824 | 0 | 5.333 | 7.8482 | 35 | 245 | protein-DNA complex subunit organization |
GO:0032200 | 0 | 6.2779 | 5.2215 | 27 | 163 | telomere organization |
GO:0038111 | 0 | 18.883 | 1.1852 | 14 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 18.883 | 1.1852 | 14 | 37 | response to interleukin-7 |
GO:0034080 | 0 | 16.701 | 1.2813 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0035194 | 0 | 4.8722 | 7.4638 | 31 | 233 | posttranscriptional gene silencing by RNA |
GO:0030099 | 0 | 3.8295 | 12.0126 | 40 | 375 | myeloid cell differentiation |
GO:1903707 | 0 | 6.5092 | 4.2925 | 23 | 134 | negative regulation of hemopoiesis |
GO:1904837 | 0 | 14.4704 | 1.4095 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 11.7274 | 1.6337 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0016233 | 0 | 10.5806 | 1.7618 | 14 | 55 | telomere capping |
GO:0048534 | 0 | 2.5244 | 26.684 | 60 | 833 | hematopoietic or lymphoid organ development |
GO:0017148 | 0 | 3.6453 | 10.2508 | 33 | 320 | negative regulation of translation |
GO:0006333 | 0 | 6.145 | 3.6882 | 19 | 118 | chromatin assembly or disassembly |
GO:0043044 | 0 | 7.7525 | 2.4025 | 15 | 75 | ATP-dependent chromatin remodeling |
GO:0045652 | 0 | 9.6157 | 1.7467 | 13 | 56 | regulation of megakaryocyte differentiation |
GO:0006303 | 0 | 7.4711 | 2.3064 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0009611 | 0 | 2.5256 | 20.1171 | 46 | 628 | response to wounding |
GO:0071345 | 0 | 2.2734 | 27.1965 | 56 | 849 | cellular response to cytokine stimulus |
GO:0050878 | 0 | 2.4836 | 15.3441 | 35 | 479 | regulation of body fluid levels |
GO:0051239 | 0 | 1.6231 | 87.0353 | 126 | 2717 | regulation of multicellular organismal process |
GO:0048869 | 0 | 1.5386 | 127.3336 | 171 | 3975 | cellular developmental process |
GO:0002376 | 0 | 1.615 | 84.3445 | 122 | 2633 | immune system process |
GO:0034248 | 0 | 2.3374 | 17.17 | 37 | 536 | regulation of cellular amide metabolic process |
GO:0007596 | 0 | 2.8355 | 9.6135 | 25 | 302 | blood coagulation |
GO:0034622 | 0 | 1.9494 | 31.1687 | 56 | 973 | cellular macromolecular complex assembly |
GO:0051259 | 0 | 2.3167 | 16.3371 | 35 | 510 | protein oligomerization |
GO:0045596 | 0 | 2.1529 | 20.053 | 40 | 626 | negative regulation of cell differentiation |
GO:0045892 | 0 | 1.8282 | 34.8526 | 59 | 1088 | negative regulation of transcription, DNA-templated |
GO:0070887 | 0 | 1.5521 | 84.1153 | 118 | 2660 | cellular response to chemical stimulus |
GO:0010608 | 1e-04 | 2.102 | 19.9569 | 39 | 623 | posttranscriptional regulation of gene expression |
GO:0006352 | 1e-04 | 2.9543 | 7.3677 | 20 | 230 | DNA-templated transcription, initiation |
GO:1902679 | 1e-04 | 1.7655 | 35.9417 | 59 | 1122 | negative regulation of RNA biosynthetic process |
GO:1903706 | 1e-04 | 2.6038 | 9.101 | 22 | 295 | regulation of hemopoiesis |
GO:0060337 | 1e-04 | 4.7216 | 2.4025 | 10 | 75 | type I interferon signaling pathway |
GO:0060669 | 1e-04 | 9.161 | 0.8329 | 6 | 26 | embryonic placenta morphogenesis |
GO:0060249 | 1e-04 | 2.3668 | 11.7884 | 26 | 368 | anatomical structure homeostasis |
GO:0071294 | 1e-04 | 12.705 | 0.5446 | 5 | 17 | cellular response to zinc ion |
GO:0045934 | 2e-04 | 1.6709 | 43.1172 | 67 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0048514 | 2e-04 | 2.0802 | 16.9458 | 33 | 529 | blood vessel morphogenesis |
GO:0034340 | 2e-04 | 4.3829 | 2.5627 | 10 | 80 | response to type I interferon |
GO:0010033 | 3e-04 | 1.4644 | 92.7693 | 124 | 2896 | response to organic substance |
GO:0007166 | 3e-04 | 1.4831 | 83.0952 | 113 | 2594 | cell surface receptor signaling pathway |
GO:0090131 | 3e-04 | 45.5876 | 0.1602 | 3 | 5 | mesenchyme migration |
GO:0002227 | 3e-04 | 10.1621 | 0.6407 | 5 | 20 | innate immune response in mucosa |
GO:0072359 | 4e-04 | 1.7482 | 30.496 | 50 | 952 | circulatory system development |
GO:0022607 | 4e-04 | 1.4585 | 85.818 | 115 | 2679 | cellular component assembly |
GO:0048646 | 5e-04 | 1.7103 | 31.7453 | 51 | 991 | anatomical structure formation involved in morphogenesis |
GO:0021978 | 6e-04 | 13.5279 | 0.4164 | 4 | 13 | telencephalon regionalization |
GO:0006584 | 6e-04 | 5.485 | 1.4735 | 7 | 46 | catecholamine metabolic process |
GO:0048519 | 7e-04 | 1.3595 | 154.3059 | 188 | 4817 | negative regulation of biological process |
GO:0051248 | 7e-04 | 1.6182 | 39.4974 | 60 | 1233 | negative regulation of protein metabolic process |
GO:0014855 | 8e-04 | 4.5319 | 1.9861 | 8 | 62 | striated muscle cell proliferation |
GO:0010604 | 9e-04 | 1.4124 | 92.9615 | 121 | 2902 | positive regulation of macromolecule metabolic process |
GO:0016539 | 0.001 | Inf | 0.0641 | 2 | 2 | intein-mediated protein splicing |
GO:0060354 | 0.001 | Inf | 0.0641 | 2 | 2 | negative regulation of cell adhesion molecule production |
GO:1902044 | 0.001 | Inf | 0.0641 | 2 | 2 | regulation of Fas signaling pathway |
GO:1904020 | 0.001 | Inf | 0.0641 | 2 | 2 | regulation of G-protein coupled receptor internalization |
GO:0033083 | 0.001 | 22.7908 | 0.2242 | 3 | 7 | regulation of immature T cell proliferation |
GO:0060710 | 0.001 | 22.7908 | 0.2242 | 3 | 7 | chorio-allantoic fusion |
GO:0045765 | 0.0013 | 2.3728 | 8.0725 | 18 | 252 | regulation of angiogenesis |
GO:0060485 | 0.0014 | 2.4256 | 7.4638 | 17 | 233 | mesenchyme development |
GO:0001944 | 0.0015 | 1.8987 | 16.6953 | 30 | 527 | vasculature development |
GO:0007517 | 0.0015 | 2.0933 | 11.6282 | 23 | 363 | muscle organ development |
GO:0014866 | 0.0016 | 18.2315 | 0.2563 | 3 | 8 | skeletal myofibril assembly |
GO:0018146 | 0.0021 | 6.3476 | 0.929 | 5 | 29 | keratan sulfate biosynthetic process |
GO:0006334 | 0.0023 | 3.3998 | 2.8755 | 9 | 94 | nucleosome assembly |
GO:0048731 | 0.0023 | 1.3616 | 104.8929 | 131 | 3413 | system development |
GO:0034115 | 0.0024 | 15.1919 | 0.2883 | 3 | 9 | negative regulation of heterotypic cell-cell adhesion |
GO:0008347 | 0.003 | 4.6922 | 1.4415 | 6 | 45 | glial cell migration |
GO:0060711 | 0.003 | 4.6922 | 1.4415 | 6 | 45 | labyrinthine layer development |
GO:0002636 | 0.003 | 60.668 | 0.0961 | 2 | 3 | positive regulation of germinal center formation |
GO:0061044 | 0.003 | 60.668 | 0.0961 | 2 | 3 | negative regulation of vascular wound healing |
GO:0072136 | 0.003 | 60.668 | 0.0961 | 2 | 3 | metanephric mesenchymal cell proliferation involved in metanephros development |
GO:0009890 | 0.0032 | 1.4633 | 50.6451 | 70 | 1581 | negative regulation of biosynthetic process |
GO:0002251 | 0.0033 | 5.6412 | 1.0251 | 5 | 32 | organ or tissue specific immune response |
GO:0070586 | 0.0033 | 13.0208 | 0.3203 | 3 | 10 | cell-cell adhesion involved in gastrulation |
GO:0007162 | 0.0035 | 2.2677 | 7.4638 | 16 | 233 | negative regulation of cell adhesion |
GO:0030198 | 0.0038 | 2.0419 | 10.3148 | 20 | 322 | extracellular matrix organization |
GO:0044458 | 0.004 | 7.1581 | 0.6727 | 4 | 21 | motile cilium assembly |
GO:0045581 | 0.0043 | 5.2515 | 1.0891 | 5 | 34 | negative regulation of T cell differentiation |
GO:0002576 | 0.0044 | 2.8604 | 3.7479 | 10 | 117 | platelet degranulation |
GO:0014841 | 0.0044 | 11.3925 | 0.3524 | 3 | 11 | skeletal muscle satellite cell proliferation |
GO:0014857 | 0.0044 | 11.3925 | 0.3524 | 3 | 11 | regulation of skeletal muscle cell proliferation |
GO:0060712 | 0.0044 | 11.3925 | 0.3524 | 3 | 11 | spongiotrophoblast layer development |
GO:2000392 | 0.0044 | 11.3925 | 0.3524 | 3 | 11 | regulation of lamellipodium morphogenesis |
GO:0010469 | 0.0047 | 1.7579 | 17.2981 | 29 | 540 | regulation of receptor activity |
GO:0042596 | 0.0049 | 5.0761 | 1.1212 | 5 | 35 | fear response |
GO:0022407 | 0.0054 | 1.8731 | 12.8775 | 23 | 402 | regulation of cell-cell adhesion |
GO:0070271 | 0.0054 | 1.461 | 43.9501 | 61 | 1372 | protein complex biogenesis |
GO:1903038 | 0.0054 | 2.9587 | 3.2674 | 9 | 102 | negative regulation of leukocyte cell-cell adhesion |
GO:2000736 | 0.0056 | 4.8608 | 1.1579 | 5 | 38 | regulation of stem cell differentiation |
GO:0031579 | 0.0057 | 6.4038 | 0.7368 | 4 | 23 | membrane raft organization |
GO:0017121 | 0.0058 | 10.126 | 0.3844 | 3 | 12 | phospholipid scrambling |
GO:0042340 | 0.0058 | 10.126 | 0.3844 | 3 | 12 | keratan sulfate catabolic process |
GO:0060670 | 0.0058 | 10.126 | 0.3844 | 3 | 12 | branching involved in labyrinthine layer morphogenesis |
GO:2000145 | 0.0059 | 1.6074 | 24.762 | 38 | 773 | regulation of cell motility |
GO:0021764 | 0.0059 | 30.332 | 0.1281 | 2 | 4 | amygdala development |
GO:0030311 | 0.0059 | 30.332 | 0.1281 | 2 | 4 | poly-N-acetyllactosamine biosynthetic process |
GO:0031296 | 0.0059 | 30.332 | 0.1281 | 2 | 4 | B cell costimulation |
GO:0033088 | 0.0059 | 30.332 | 0.1281 | 2 | 4 | negative regulation of immature T cell proliferation in thymus |
GO:0035021 | 0.0059 | 30.332 | 0.1281 | 2 | 4 | negative regulation of Rac protein signal transduction |
GO:1904431 | 0.0059 | 30.332 | 0.1281 | 2 | 4 | positive regulation of t-circle formation |
GO:2001181 | 0.0059 | 30.332 | 0.1281 | 2 | 4 | positive regulation of interleukin-10 secretion |
GO:0043010 | 0.0061 | 2.0286 | 9.3218 | 18 | 291 | camera-type eye development |
GO:0045595 | 0.0062 | 1.5753 | 27.3325 | 41 | 913 | regulation of cell differentiation |
GO:0006790 | 0.0062 | 1.9092 | 11.5321 | 21 | 360 | sulfur compound metabolic process |
GO:0043122 | 0.0066 | 2.1724 | 7.2716 | 15 | 227 | regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0070527 | 0.0067 | 3.8915 | 1.6978 | 6 | 53 | platelet aggregation |
GO:0019731 | 0.0069 | 4.6137 | 1.2173 | 5 | 38 | antibacterial humoral response |
GO:0034105 | 0.0069 | 4.6137 | 1.2173 | 5 | 38 | positive regulation of tissue remodeling |
GO:1901343 | 0.007 | 2.836 | 3.3956 | 9 | 106 | negative regulation of vasculature development |
GO:0042509 | 0.0075 | 3.337 | 2.2744 | 7 | 71 | regulation of tyrosine phosphorylation of STAT protein |
GO:0072378 | 0.0077 | 5.7932 | 0.8008 | 4 | 25 | blood coagulation, fibrin clot formation |
GO:1901031 | 0.0078 | 4.4777 | 1.2493 | 5 | 39 | regulation of response to reactive oxygen species |
GO:0042552 | 0.0078 | 2.7783 | 3.4596 | 9 | 108 | myelination |
GO:0051129 | 0.008 | 1.6697 | 18.7717 | 30 | 586 | negative regulation of cellular component organization |
GO:0043043 | 0.0087 | 1.5731 | 24.5698 | 37 | 767 | peptide biosynthetic process |
GO:0060547 | 0.0091 | 8.2838 | 0.4485 | 3 | 14 | negative regulation of necrotic cell death |
GO:1904994 | 0.0091 | 8.2838 | 0.4485 | 3 | 14 | regulation of leukocyte adhesion to vascular endothelial cell |
GO:0007272 | 0.0093 | 2.6961 | 3.5557 | 9 | 111 | ensheathment of neurons |
GO:0045785 | 0.0094 | 1.8318 | 11.9806 | 21 | 374 | positive regulation of cell adhesion |
GO:0071241 | 0.0095 | 2.2967 | 5.5098 | 12 | 172 | cellular response to inorganic substance |
GO:1902041 | 0.0096 | 3.5853 | 1.8259 | 6 | 57 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0006526 | 0.0096 | 20.22 | 0.1602 | 2 | 5 | arginine biosynthetic process |
GO:0048382 | 0.0096 | 20.22 | 0.1602 | 2 | 5 | mesendoderm development |
GO:0060685 | 0.0096 | 20.22 | 0.1602 | 2 | 5 | regulation of prostatic bud formation |
GO:0070221 | 0.0096 | 20.22 | 0.1602 | 2 | 5 | sulfide oxidation, using sulfide:quinone oxidoreductase |
GO:1903232 | 0.0096 | 20.22 | 0.1602 | 2 | 5 | melanosome assembly |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 126.75 | 0.8914 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 125.7332 | 0.7924 | 24 | 32 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 50.2544 | 1.0895 | 24 | 44 | protein heterotetramerization |
GO:0045815 | 0 | 23.1965 | 1.9562 | 28 | 79 | positive regulation of gene expression, epigenetic |
GO:0050911 | 0 | 8.0441 | 7.7009 | 48 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0045814 | 0 | 15.1437 | 2.9219 | 31 | 118 | negative regulation of gene expression, epigenetic |
GO:0050906 | 0 | 6.4604 | 9.9047 | 51 | 400 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 6.5256 | 9.6076 | 50 | 388 | detection of chemical stimulus |
GO:0007606 | 0 | 6.1883 | 10.0533 | 50 | 406 | sensory perception of chemical stimulus |
GO:1902036 | 0 | 15.3511 | 2.5009 | 27 | 101 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 14.5601 | 2.6 | 27 | 105 | regulation of gene silencing by miRNA |
GO:0045653 | 0 | 142.8753 | 0.4457 | 14 | 18 | negative regulation of megakaryocyte differentiation |
GO:0060968 | 0 | 11.7928 | 3.1695 | 28 | 128 | regulation of gene silencing |
GO:0031497 | 0 | 10.5471 | 3.5905 | 29 | 145 | chromatin assembly |
GO:0035194 | 0 | 6.7348 | 5.7695 | 32 | 233 | posttranscriptional gene silencing by RNA |
GO:0002244 | 0 | 7.4358 | 4.6057 | 28 | 186 | hematopoietic progenitor cell differentiation |
GO:0017148 | 0 | 5.3928 | 7.9238 | 36 | 320 | negative regulation of translation |
GO:0048863 | 0 | 6.007 | 6.3638 | 32 | 257 | stem cell differentiation |
GO:0065004 | 0 | 6.5838 | 5.299 | 29 | 214 | protein-DNA complex assembly |
GO:0032200 | 0 | 7.5495 | 4.0362 | 25 | 163 | telomere organization |
GO:0034080 | 0 | 21.9497 | 0.9905 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 19.0182 | 1.0895 | 14 | 44 | beta-catenin-TCF complex assembly |
GO:0038111 | 0 | 22.0254 | 0.9162 | 13 | 37 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 22.0254 | 0.9162 | 13 | 37 | response to interleukin-7 |
GO:0071103 | 0 | 5.4293 | 6.4876 | 30 | 262 | DNA conformation change |
GO:0007186 | 0 | 2.9007 | 26.5958 | 66 | 1087 | G-protein coupled receptor signaling pathway |
GO:0034724 | 0 | 15.4132 | 1.2629 | 14 | 51 | DNA replication-independent nucleosome organization |
GO:0050877 | 0 | 2.7354 | 28.4265 | 67 | 1148 | nervous system process |
GO:0016233 | 0 | 13.9059 | 1.3619 | 14 | 55 | telomere capping |
GO:0030099 | 0 | 4.0556 | 9.2857 | 33 | 375 | myeloid cell differentiation |
GO:0045652 | 0 | 12.742 | 1.339 | 13 | 56 | regulation of megakaryocyte differentiation |
GO:1903707 | 0 | 6.7853 | 3.3181 | 19 | 134 | negative regulation of hemopoiesis |
GO:0006303 | 0 | 9.8193 | 1.7828 | 14 | 72 | double-strand break repair via nonhomologous end joining |
GO:0032501 | 0 | 1.8323 | 169.123 | 227 | 6830 | multicellular organismal process |
GO:0043044 | 0 | 9.3345 | 1.8571 | 14 | 75 | ATP-dependent chromatin remodeling |
GO:0034248 | 0 | 3.2187 | 13.2723 | 38 | 536 | regulation of cellular amide metabolic process |
GO:0034728 | 0 | 7.1058 | 2.4919 | 15 | 104 | nucleosome organization |
GO:0010608 | 0 | 2.8087 | 15.4266 | 39 | 623 | posttranscriptional regulation of gene expression |
GO:0051259 | 0 | 2.984 | 12.6285 | 34 | 510 | protein oligomerization |
GO:0045892 | 0 | 2.0272 | 26.9408 | 50 | 1088 | negative regulation of transcription, DNA-templated |
GO:0048534 | 0 | 2.1592 | 20.6266 | 41 | 833 | hematopoietic or lymphoid organ development |
GO:1902679 | 0 | 1.9583 | 27.7827 | 50 | 1122 | negative regulation of RNA biosynthetic process |
GO:0043043 | 0 | 2.1651 | 18.9923 | 38 | 767 | peptide biosynthetic process |
GO:0009890 | 1e-04 | 1.755 | 39.1484 | 63 | 1581 | negative regulation of biosynthetic process |
GO:0006352 | 2e-04 | 3.0268 | 5.6952 | 16 | 230 | DNA-templated transcription, initiation |
GO:0015671 | 4e-04 | 14.458 | 0.3714 | 4 | 15 | oxygen transport |
GO:0045934 | 5e-04 | 1.7096 | 33.3294 | 53 | 1346 | negative regulation of nucleobase-containing compound metabolic process |
GO:0051716 | 5e-04 | 1.4043 | 166.5725 | 199 | 6727 | cellular response to stimulus |
GO:0001694 | 6e-04 | Inf | 0.0495 | 2 | 2 | histamine biosynthetic process |
GO:0060675 | 7e-04 | 5.2776 | 1.4857 | 7 | 60 | ureteric bud morphogenesis |
GO:0007154 | 0.0011 | 1.3769 | 148.224 | 178 | 5986 | cell communication |
GO:0072078 | 0.0016 | 4.5089 | 1.7086 | 7 | 69 | nephron tubule morphogenesis |
GO:0061326 | 0.0016 | 3.9496 | 2.2038 | 8 | 89 | renal tubule development |
GO:0060435 | 0.0018 | 79.1654 | 0.0743 | 2 | 3 | bronchiole development |
GO:0023052 | 0.0019 | 1.3557 | 147.7288 | 176 | 5966 | signaling |
GO:0072028 | 0.0022 | 4.2345 | 1.8076 | 7 | 73 | nephron morphogenesis |
GO:0061217 | 0.0027 | 7.9473 | 0.5943 | 4 | 24 | regulation of mesonephros development |
GO:0048754 | 0.003 | 3.0122 | 3.5409 | 10 | 143 | branching morphogenesis of an epithelial tube |
GO:0021853 | 0.0036 | 39.5802 | 0.099 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
GO:0048869 | 0.0039 | 1.3575 | 98.4281 | 122 | 3975 | cellular developmental process |
GO:2000026 | 0.004 | 1.4881 | 44.3731 | 62 | 1792 | regulation of multicellular organismal development |
GO:0048731 | 0.0043 | 1.3427 | 108.0852 | 132 | 4365 | system development |
GO:0002682 | 0.0048 | 1.5428 | 33.6017 | 49 | 1357 | regulation of immune system process |
GO:0060249 | 0.0049 | 2.0745 | 9.1123 | 18 | 368 | anatomical structure homeostasis |
GO:0061743 | 0.0058 | 26.3851 | 0.1238 | 2 | 5 | motor learning |
GO:0045661 | 0.0071 | 4.5201 | 1.2133 | 5 | 49 | regulation of myoblast differentiation |
GO:0045596 | 0.0072 | 1.7565 | 15.5009 | 26 | 626 | negative regulation of cell differentiation |
GO:0007596 | 0.0077 | 2.0696 | 8.0971 | 16 | 327 | blood coagulation |
GO:0046337 | 0.0079 | 8.4965 | 0.421 | 3 | 17 | phosphatidylethanolamine metabolic process |
GO:0090190 | 0.0079 | 8.4965 | 0.421 | 3 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0021546 | 0.0086 | 19.7875 | 0.1486 | 2 | 6 | rhombomere development |
GO:0007218 | 0.0088 | 3.208 | 2.3276 | 7 | 94 | neuropeptide signaling pathway |
GO:0072164 | 0.0088 | 3.208 | 2.3276 | 7 | 94 | mesonephric tubule development |
GO:0051248 | 0.009 | 1.5148 | 30.5313 | 44 | 1233 | negative regulation of protein metabolic process |
GO:0009952 | 0.0094 | 2.3933 | 4.8285 | 11 | 195 | anterior/posterior pattern specification |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.2993 | 35.2689 | 71 | 1421 | receptor activity |
GO:0004871 | 0 | 2.2143 | 37.5772 | 73 | 1514 | signal transducer activity |
GO:0004984 | 0 | 2.9485 | 7.719 | 21 | 311 | olfactory receptor activity |
GO:0004930 | 3e-04 | 2.1304 | 14.5393 | 29 | 598 | G-protein coupled receptor activity |
GO:0048018 | 4e-04 | 2.3249 | 10.5484 | 23 | 425 | receptor ligand activity |
GO:0001968 | 5e-04 | 9.031 | 0.6701 | 5 | 27 | fibronectin binding |
GO:0030246 | 6e-04 | 2.7338 | 6.2546 | 16 | 252 | carbohydrate binding |
GO:0004888 | 9e-04 | 2.3409 | 9.0887 | 20 | 389 | transmembrane signaling receptor activity |
GO:0070051 | 0.0018 | 78.9746 | 0.0745 | 2 | 3 | fibrinogen binding |
GO:0008528 | 0.0021 | 3.4397 | 2.8162 | 9 | 114 | G-protein coupled peptide receptor activity |
GO:0043236 | 0.0054 | 6.3404 | 0.7198 | 4 | 29 | laminin binding |
GO:0098772 | 0.008 | 1.4495 | 42.3178 | 58 | 1705 | molecular function regulator |
GO:0004977 | 0.0086 | 19.7398 | 0.1489 | 2 | 6 | melanocortin receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008191 | 4e-04 | 15.0019 | 0.3668 | 4 | 14 | metalloendopeptidase inhibitor activity |
GO:0016918 | 4e-04 | 15.0019 | 0.3668 | 4 | 14 | retinal binding |
GO:0019841 | 4e-04 | 15.0019 | 0.3668 | 4 | 14 | retinol binding |
GO:0003696 | 6e-04 | 28.0717 | 0.1834 | 3 | 7 | satellite DNA binding |
GO:0016623 | 0.002 | 74.6923 | 0.0786 | 2 | 3 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor |
GO:0031720 | 0.002 | 74.6923 | 0.0786 | 2 | 3 | haptoglobin binding |
GO:0008237 | 0.0028 | 2.7039 | 4.7158 | 12 | 180 | metallopeptidase activity |
GO:0004181 | 0.0038 | 7.1387 | 0.655 | 4 | 25 | metallocarboxypeptidase activity |
GO:0051431 | 0.004 | 37.3438 | 0.1048 | 2 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0004601 | 0.0042 | 5.2129 | 1.0741 | 5 | 41 | peroxidase activity |
GO:0008138 | 0.0046 | 5.0717 | 1.1003 | 5 | 42 | protein tyrosine/serine/threonine phosphatase activity |
GO:0005044 | 0.0089 | 4.2629 | 1.2837 | 5 | 49 | scavenger receptor activity |
GO:0030547 | 0.0092 | 8.0153 | 0.4454 | 3 | 17 | receptor inhibitor activity |
GO:0010997 | 0.0096 | 18.6695 | 0.1572 | 2 | 6 | anaphase-promoting complex binding |
GO:0019237 | 0.0096 | 18.6695 | 0.1572 | 2 | 6 | centromeric DNA binding |
GO:0061578 | 0.0096 | 18.6695 | 0.1572 | 2 | 6 | Lys63-specific deubiquitinase activity |
GO:0046914 | 0.0099 | 1.5419 | 26.4869 | 39 | 1011 | transition metal ion binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 5.5827 | 12.4397 | 56 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 7.5831 | 4.9013 | 30 | 184 | histone binding |
GO:0031492 | 0 | 17.5994 | 1.172 | 14 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 1.6681 | 61.9586 | 93 | 2326 | DNA binding |
GO:0000774 | 1e-04 | 29.5012 | 0.2397 | 4 | 9 | adenyl-nucleotide exchange factor activity |
GO:0102991 | 0.001 | 22.0735 | 0.2131 | 3 | 8 | myristoyl-CoA hydrolase activity |
GO:0016290 | 0.0026 | 13.7932 | 0.293 | 3 | 11 | palmitoyl-CoA hydrolase activity |
GO:0000253 | 0.0041 | 36.7092 | 0.1065 | 2 | 4 | 3-keto sterol reductase activity |
GO:0004984 | 0.0042 | 2.1593 | 8.2842 | 17 | 311 | olfactory receptor activity |
GO:0045504 | 0.0055 | 10.0295 | 0.3729 | 3 | 14 | dynein heavy chain binding |
GO:0008508 | 0.0067 | 24.4712 | 0.1332 | 2 | 5 | bile acid:sodium symporter activity |
GO:0061578 | 0.0099 | 18.3522 | 0.1598 | 2 | 6 | Lys63-specific deubiquitinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 4.4214 | 11.7079 | 44 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 6.7746 | 4.613 | 26 | 184 | histone binding |
GO:0004930 | 0 | 3.4699 | 16.6849 | 50 | 672 | G-protein coupled receptor activity |
GO:0004984 | 0 | 4.5831 | 7.7969 | 31 | 311 | olfactory receptor activity |
GO:0099600 | 0 | 2.3856 | 28.8812 | 61 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 2.3483 | 30.3353 | 63 | 1210 | signaling receptor activity |
GO:0003677 | 0 | 1.9684 | 58.314 | 99 | 2326 | DNA binding |
GO:0031492 | 0 | 11.7051 | 1.1031 | 10 | 44 | nucleosomal DNA binding |
GO:0060089 | 0 | 2.0758 | 36.7283 | 68 | 1465 | molecular transducer activity |
GO:0003682 | 1e-04 | 2.4522 | 11.8584 | 27 | 473 | chromatin binding |
GO:0033872 | 6e-04 | Inf | 0.0501 | 2 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
GO:0052654 | 6e-04 | Inf | 0.0501 | 2 | 2 | L-leucine transaminase activity |
GO:0052655 | 6e-04 | Inf | 0.0501 | 2 | 2 | L-valine transaminase activity |
GO:0052656 | 6e-04 | Inf | 0.0501 | 2 | 2 | L-isoleucine transaminase activity |
GO:0000977 | 0.0035 | 1.8649 | 14.6662 | 26 | 585 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0019904 | 0.0046 | 1.7832 | 16.4964 | 28 | 658 | protein domain specific binding |
GO:0008191 | 0.0046 | 10.6783 | 0.351 | 3 | 14 | metalloendopeptidase inhibitor activity |
GO:0030545 | 0.0051 | 1.9443 | 11.3319 | 21 | 452 | receptor regulator activity |
GO:1990837 | 0.0056 | 1.7366 | 17.5243 | 29 | 699 | sequence-specific double-stranded DNA binding |
GO:0008227 | 0.0057 | 4.7897 | 1.1532 | 5 | 46 | G-protein coupled amine receptor activity |
GO:0030492 | 0.006 | 26.0503 | 0.1254 | 2 | 5 | hemoglobin binding |
GO:0030883 | 0.006 | 26.0503 | 0.1254 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.006 | 26.0503 | 0.1254 | 2 | 5 | exogenous lipid antigen binding |
GO:0005539 | 0.0063 | 2.4236 | 5.2147 | 12 | 208 | glycosaminoglycan binding |
GO:0003700 | 0.007 | 1.5479 | 29.2322 | 43 | 1166 | DNA binding transcription factor activity |
GO:0003705 | 0.0088 | 3.2038 | 2.3316 | 7 | 93 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0001227 | 0.0091 | 2.3044 | 5.4654 | 12 | 218 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 17.359 | 7.524 | 80 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 7.2339 | 17.3706 | 90 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 4.6861 | 27.8704 | 98 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 4.4239 | 29.2736 | 98 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 3.7433 | 35.4428 | 102 | 1465 | molecular transducer activity |
GO:0005549 | 0 | 16.627 | 1.7177 | 20 | 71 | odorant binding |
GO:0031492 | 0 | 12.1519 | 1.0645 | 10 | 44 | nucleosomal DNA binding |
GO:0019825 | 1e-04 | 7.7533 | 1.0645 | 7 | 44 | oxygen binding |
GO:1903231 | 8e-04 | 4.4926 | 1.9596 | 8 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004252 | 0.0012 | 3.0326 | 4.2338 | 12 | 175 | serine-type endopeptidase activity |
GO:0019864 | 0.002 | 15.236 | 0.2661 | 3 | 11 | IgG binding |
GO:0020037 | 0.003 | 3.2364 | 2.9757 | 9 | 123 | heme binding |
GO:0005132 | 0.0034 | 40.5391 | 0.0968 | 2 | 4 | type I interferon receptor binding |
GO:0034875 | 0.0034 | 40.5391 | 0.0968 | 2 | 4 | caffeine oxidase activity |
GO:0050051 | 0.0034 | 40.5391 | 0.0968 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0017171 | 0.0046 | 2.5297 | 5.008 | 12 | 207 | serine hydrolase activity |
GO:0042393 | 0.0052 | 2.6105 | 4.4515 | 11 | 184 | histone binding |
GO:0004497 | 0.0061 | 3.446 | 2.1774 | 7 | 90 | monooxygenase activity |
GO:0008392 | 0.0062 | 9.373 | 0.3871 | 3 | 16 | arachidonic acid epoxygenase activity |
GO:0008146 | 0.007 | 4.5273 | 1.2097 | 5 | 50 | sulfotransferase activity |
GO:0048020 | 0.0098 | 5.2484 | 0.8468 | 4 | 35 | CCR chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 5.1709 | 11.7372 | 50 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 6.7561 | 4.6245 | 26 | 184 | histone binding |
GO:0031492 | 0 | 11.6744 | 1.1059 | 10 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 1.8275 | 58.4598 | 94 | 2326 | DNA binding |
GO:0004459 | 2e-04 | 58.6131 | 0.1257 | 3 | 5 | L-lactate dehydrogenase activity |
GO:0004867 | 4e-04 | 4.4409 | 2.2369 | 9 | 89 | serine-type endopeptidase inhibitor activity |
GO:0004505 | 0.0019 | 77.9599 | 0.0754 | 2 | 3 | phenylalanine 4-monooxygenase activity |
GO:0034714 | 0.0019 | 77.9599 | 0.0754 | 2 | 3 | type III transforming growth factor beta receptor binding |
GO:0004583 | 0.0037 | 38.9774 | 0.1005 | 2 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
GO:0030151 | 0.0037 | 38.9774 | 0.1005 | 2 | 4 | molybdenum ion binding |
GO:0070915 | 0.0037 | 38.9774 | 0.1005 | 2 | 4 | lysophosphatidic acid receptor activity |
GO:0003682 | 0.0043 | 1.9439 | 11.888 | 22 | 473 | chromatin binding |
GO:0019958 | 0.0088 | 19.4862 | 0.1508 | 2 | 6 | C-X-C chemokine binding |
GO:0032027 | 0.0088 | 19.4862 | 0.1508 | 2 | 6 | myosin light chain binding |
GO:0043546 | 0.0088 | 19.4862 | 0.1508 | 2 | 6 | molybdopterin cofactor binding |
GO:0030414 | 0.0097 | 2.5082 | 4.1972 | 10 | 167 | peptidase inhibitor activity |
GO:0061135 | 0.0097 | 2.5082 | 4.1972 | 10 | 167 | endopeptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.6489 | 7.5825 | 50 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 4.3094 | 17.5056 | 62 | 718 | G-protein coupled receptor activity |
GO:0004872 | 0 | 3.2686 | 34.6455 | 91 | 1421 | receptor activity |
GO:0004871 | 0 | 3.0811 | 36.9129 | 92 | 1514 | signal transducer activity |
GO:0005549 | 0 | 9.2445 | 1.7311 | 13 | 71 | odorant binding |
GO:0031492 | 0 | 12.0534 | 1.0728 | 10 | 44 | nucleosomal DNA binding |
GO:0030545 | 0 | 2.5456 | 11.0202 | 26 | 452 | receptor regulator activity |
GO:0042019 | 6e-04 | Inf | 0.0488 | 2 | 2 | interleukin-23 binding |
GO:0042020 | 6e-04 | Inf | 0.0488 | 2 | 2 | interleukin-23 receptor activity |
GO:0019911 | 0.0011 | 20.1554 | 0.2194 | 3 | 9 | structural constituent of myelin sheath |
GO:0005125 | 0.0012 | 2.8589 | 4.8518 | 13 | 199 | cytokine activity |
GO:0030594 | 0.0015 | 4.0141 | 2.1699 | 8 | 89 | neurotransmitter receptor activity |
GO:0004888 | 0.0015 | 2.3358 | 8.1725 | 18 | 383 | transmembrane signaling receptor activity |
GO:0071723 | 0.0015 | 17.275 | 0.2438 | 3 | 10 | lipopeptide binding |
GO:0016934 | 0.0018 | 80.4393 | 0.0731 | 2 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0004062 | 0.0027 | 13.4344 | 0.2926 | 3 | 12 | aryl sulfotransferase activity |
GO:0070851 | 0.0034 | 3.1706 | 3.0329 | 9 | 125 | growth factor receptor binding |
GO:0030197 | 0.0034 | 40.2171 | 0.0975 | 2 | 4 | extracellular matrix constituent, lubricant activity |
GO:0030345 | 0.0034 | 40.2171 | 0.0975 | 2 | 4 | structural constituent of tooth enamel |
GO:0045569 | 0.0034 | 40.2171 | 0.0975 | 2 | 4 | TRAIL binding |
GO:0050294 | 0.0034 | 40.2171 | 0.0975 | 2 | 4 | steroid sulfotransferase activity |
GO:0004252 | 0.0038 | 2.733 | 4.2667 | 11 | 175 | serine-type endopeptidase activity |
GO:0019825 | 0.0042 | 5.184 | 1.0728 | 5 | 44 | oxygen binding |
GO:0008191 | 0.0043 | 10.9903 | 0.3413 | 3 | 14 | metalloendopeptidase inhibitor activity |
GO:0017171 | 0.0049 | 2.509 | 5.0469 | 12 | 207 | serine hydrolase activity |
GO:0042056 | 0.0051 | 6.4586 | 0.7071 | 4 | 29 | chemoattractant activity |
GO:0046982 | 0.0054 | 1.9346 | 11.386 | 21 | 467 | protein heterodimerization activity |
GO:0005143 | 0.0056 | 26.8096 | 0.1219 | 2 | 5 | interleukin-12 receptor binding |
GO:0030883 | 0.0056 | 26.8096 | 0.1219 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0056 | 26.8096 | 0.1219 | 2 | 5 | exogenous lipid antigen binding |
GO:0005201 | 0.0061 | 3.9375 | 1.6498 | 6 | 68 | extracellular matrix structural constituent |
GO:0016782 | 0.0067 | 3.855 | 1.6823 | 6 | 69 | transferase activity, transferring sulfur-containing groups |
GO:0019763 | 0.0083 | 20.1059 | 0.1463 | 2 | 6 | immunoglobulin receptor activity |
GO:0042289 | 0.0083 | 20.1059 | 0.1463 | 2 | 6 | MHC class II protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 10.4132 | 7.8554 | 59 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 5.592 | 18.1356 | 78 | 718 | G-protein coupled receptor activity |
GO:0004872 | 0 | 3.8116 | 35.8924 | 105 | 1421 | receptor activity |
GO:0004871 | 0 | 3.3935 | 38.2414 | 102 | 1514 | signal transducer activity |
GO:0005549 | 0 | 9.7835 | 1.7934 | 14 | 71 | odorant binding |
GO:0046982 | 0 | 2.7819 | 11.7957 | 30 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 4.0574 | 4.6476 | 17 | 184 | histone binding |
GO:0015125 | 4e-04 | 14.1636 | 0.3789 | 4 | 15 | bile acid transmembrane transporter activity |
GO:0017046 | 0.0012 | 7.2236 | 0.8083 | 5 | 32 | peptide hormone binding |
GO:0004888 | 0.0018 | 2.298 | 8.2972 | 18 | 389 | transmembrane signaling receptor activity |
GO:0004980 | 0.0019 | 77.5611 | 0.0758 | 2 | 3 | melanocyte-stimulating hormone receptor activity |
GO:0030172 | 0.0019 | 77.5611 | 0.0758 | 2 | 3 | troponin C binding |
GO:0031720 | 0.0019 | 77.5611 | 0.0758 | 2 | 3 | haptoglobin binding |
GO:0015347 | 0.0029 | 7.7855 | 0.6062 | 4 | 24 | sodium-independent organic anion transmembrane transporter activity |
GO:0050833 | 0.0037 | 38.7781 | 0.101 | 2 | 4 | pyruvate transmembrane transporter activity |
GO:0005344 | 0.0047 | 10.5961 | 0.3536 | 3 | 14 | oxygen carrier activity |
GO:0005272 | 0.0048 | 4.9971 | 1.1114 | 5 | 44 | sodium channel activity |
GO:0019825 | 0.0048 | 4.9971 | 1.1114 | 5 | 44 | oxygen binding |
GO:0004745 | 0.0084 | 8.3239 | 0.4294 | 3 | 17 | retinol dehydrogenase activity |
GO:0034987 | 0.0089 | 19.3865 | 0.1516 | 2 | 6 | immunoglobulin receptor binding |
GO:0047035 | 0.0089 | 19.3865 | 0.1516 | 2 | 6 | testosterone dehydrogenase (NAD+) activity |
GO:0055131 | 0.0089 | 19.3865 | 0.1516 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:1901338 | 0.0098 | 7.7685 | 0.4547 | 3 | 18 | catecholamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 1e-04 | 5.7282 | 1.7667 | 9 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0050840 | 7e-04 | 6.2053 | 1.0906 | 6 | 50 | extracellular matrix binding |
GO:0001875 | 0.0045 | 30.0655 | 0.1091 | 2 | 5 | lipopolysaccharide receptor activity |
GO:0047617 | 0.0056 | 9.6851 | 0.3708 | 3 | 17 | acyl-CoA hydrolase activity |
GO:0008157 | 0.0066 | 9.0388 | 0.3926 | 3 | 18 | protein phosphatase 1 binding |
GO:0016406 | 0.0067 | 22.5477 | 0.1309 | 2 | 6 | carnitine O-acyltransferase activity |
GO:0034987 | 0.0067 | 22.5477 | 0.1309 | 2 | 6 | immunoglobulin receptor binding |
GO:0004872 | 0.0071 | 1.536 | 30.9939 | 45 | 1421 | receptor activity |
GO:0003707 | 0.0074 | 4.4463 | 1.2214 | 5 | 56 | steroid hormone receptor activity |
GO:0008201 | 0.0076 | 2.7731 | 3.4244 | 9 | 157 | heparin binding |
GO:0005347 | 0.0093 | 18.037 | 0.1527 | 2 | 7 | ATP transmembrane transporter activity |
GO:0008430 | 0.0093 | 18.037 | 0.1527 | 2 | 7 | selenium binding |
GO:0015217 | 0.0093 | 18.037 | 0.1527 | 2 | 7 | ADP transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 25.308 | 8.9275 | 113 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 9.3146 | 20.6107 | 124 | 718 | G-protein coupled receptor activity |
GO:0038023 | 0 | 6.1394 | 34.7339 | 143 | 1210 | signaling receptor activity |
GO:0099600 | 0 | 6.2302 | 33.069 | 139 | 1152 | transmembrane receptor activity |
GO:0005549 | 0 | 50.6912 | 2.0381 | 41 | 71 | odorant binding |
GO:0060089 | 0 | 5.085 | 42.0539 | 147 | 1465 | molecular transducer activity |
GO:0031492 | 0 | 14.5747 | 1.2631 | 13 | 44 | nucleosomal DNA binding |
GO:0030414 | 0 | 4.2139 | 4.7939 | 18 | 167 | peptidase inhibitor activity |
GO:0061135 | 0 | 4.2139 | 4.7939 | 18 | 167 | endopeptidase regulator activity |
GO:0004867 | 0 | 4.8646 | 2.5548 | 11 | 89 | serine-type endopeptidase inhibitor activity |
GO:0004024 | 2e-04 | 51.0824 | 0.1435 | 3 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0019825 | 2e-04 | 6.4853 | 1.2631 | 7 | 44 | oxygen binding |
GO:0030246 | 4e-04 | 2.6684 | 7.2338 | 18 | 252 | carbohydrate binding |
GO:0046982 | 0.001 | 2.0548 | 13.4056 | 26 | 467 | protein heterodimerization activity |
GO:0004497 | 0.0011 | 3.8149 | 2.5835 | 9 | 90 | monooxygenase activity |
GO:0046790 | 0.0012 | 20.429 | 0.2296 | 3 | 8 | virion binding |
GO:0030545 | 0.0014 | 2.0377 | 12.975 | 25 | 452 | receptor regulator activity |
GO:0005125 | 0.0019 | 2.6098 | 5.7124 | 14 | 199 | cytokine activity |
GO:0018685 | 0.0024 | 67.9649 | 0.0861 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0042393 | 0.0026 | 2.6183 | 5.2819 | 13 | 184 | histone binding |
GO:0004896 | 0.0026 | 3.6556 | 2.3826 | 8 | 83 | cytokine receptor activity |
GO:0070330 | 0.0027 | 8.0228 | 0.6028 | 4 | 21 | aromatase activity |
GO:0004869 | 0.0044 | 4.2724 | 1.5501 | 6 | 54 | cysteine-type endopeptidase inhibitor activity |
GO:0050051 | 0.0047 | 33.9803 | 0.1148 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0042834 | 0.0054 | 10.2112 | 0.3732 | 3 | 13 | peptidoglycan binding |
GO:0046914 | 0.0063 | 1.5552 | 29.0215 | 43 | 1011 | transition metal ion binding |
GO:0005134 | 0.0078 | 22.652 | 0.1435 | 2 | 5 | interleukin-2 receptor binding |
GO:0005143 | 0.0078 | 22.652 | 0.1435 | 2 | 5 | interleukin-12 receptor binding |
GO:0019103 | 0.0078 | 22.652 | 0.1435 | 2 | 5 | pyrimidine nucleotide binding |
GO:0020037 | 0.009 | 2.7048 | 3.5308 | 9 | 123 | heme binding |
GO:0016705 | 0.01 | 2.5026 | 4.2197 | 10 | 147 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0008392 | 0.01 | 7.8533 | 0.4593 | 3 | 16 | arachidonic acid epoxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 8.7205 | 3.8288 | 27 | 184 | histone binding |
GO:0031492 | 0 | 14.2391 | 0.9156 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.1857 | 9.7176 | 28 | 467 | protein heterodimerization activity |
GO:0004984 | 0 | 3.5702 | 6.4715 | 21 | 311 | olfactory receptor activity |
GO:0004930 | 2e-04 | 2.1564 | 14.9405 | 30 | 718 | G-protein coupled receptor activity |
GO:0099600 | 3e-04 | 1.8936 | 23.9714 | 42 | 1152 | transmembrane receptor activity |
GO:0032394 | 4e-04 | Inf | 0.0416 | 2 | 2 | MHC class Ib receptor activity |
GO:0098641 | 4e-04 | 13.5967 | 0.3746 | 4 | 18 | cadherin binding involved in cell-cell adhesion |
GO:0098631 | 0.001 | 7.4498 | 0.7699 | 5 | 37 | cell adhesion mediator activity |
GO:0038023 | 0.0013 | 1.7421 | 25.1783 | 41 | 1210 | signaling receptor activity |
GO:0019904 | 0.0014 | 2.0154 | 13.692 | 26 | 658 | protein domain specific binding |
GO:0060089 | 0.0018 | 1.652 | 30.4845 | 47 | 1465 | molecular transducer activity |
GO:0004522 | 0.0025 | 47.3364 | 0.0832 | 2 | 4 | ribonuclease A activity |
GO:0004982 | 0.0025 | 47.3364 | 0.0832 | 2 | 4 | N-formyl peptide receptor activity |
GO:0019834 | 0.0025 | 47.3364 | 0.0832 | 2 | 4 | phospholipase A2 inhibitor activity |
GO:0050839 | 0.0029 | 2.1397 | 9.3638 | 19 | 450 | cell adhesion molecule binding |
GO:0055102 | 0.0041 | 10.9493 | 0.3329 | 3 | 16 | lipase inhibitor activity |
GO:0008508 | 0.0041 | 31.5556 | 0.104 | 2 | 5 | bile acid:sodium symporter activity |
GO:0047238 | 0.0041 | 31.5556 | 0.104 | 2 | 5 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity |
GO:0042288 | 0.0058 | 9.4881 | 0.3746 | 3 | 18 | MHC class I protein binding |
GO:0004468 | 0.0061 | 23.6652 | 0.1249 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:1903231 | 0.0068 | 3.8155 | 1.6855 | 6 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004993 | 0.0078 | 8.3708 | 0.4162 | 3 | 20 | G-protein coupled serotonin receptor activity |
GO:1901618 | 0.0093 | 5.2801 | 0.8323 | 4 | 40 | organic hydroxy compound transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.3331 | 4.3708 | 17 | 184 | histone binding |
GO:0046982 | 1e-04 | 2.5278 | 11.0933 | 26 | 467 | protein heterodimerization activity |
GO:0004872 | 1e-04 | 1.805 | 33.7549 | 56 | 1421 | receptor activity |
GO:0004871 | 3e-04 | 1.7154 | 35.964 | 57 | 1514 | signal transducer activity |
GO:0031729 | 6e-04 | Inf | 0.0475 | 2 | 2 | CCR4 chemokine receptor binding |
GO:0004875 | 0.001 | 20.7048 | 0.2138 | 3 | 9 | complement receptor activity |
GO:0004930 | 0.002 | 1.8601 | 17.0556 | 30 | 718 | G-protein coupled receptor activity |
GO:0004984 | 0.0032 | 2.2832 | 7.3876 | 16 | 311 | olfactory receptor activity |
GO:0004982 | 0.0033 | 41.3103 | 0.095 | 2 | 4 | N-formyl peptide receptor activity |
GO:0017040 | 0.0054 | 27.5385 | 0.1188 | 2 | 5 | ceramidase activity |
GO:0001664 | 0.0076 | 2.2697 | 6.0098 | 13 | 253 | G-protein coupled receptor binding |
GO:0015078 | 0.0079 | 3.2744 | 2.2804 | 7 | 96 | hydrogen ion transmembrane transporter activity |
GO:0004111 | 0.0079 | 20.6525 | 0.1425 | 2 | 6 | creatine kinase activity |
GO:0004468 | 0.0079 | 20.6525 | 0.1425 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0031730 | 0.0079 | 20.6525 | 0.1425 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0055131 | 0.0079 | 20.6525 | 0.1425 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0004888 | 0.0081 | 2.0089 | 8.8653 | 17 | 387 | transmembrane signaling receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 10.6654 | 1.2051 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 2.7396 | 12.7909 | 32 | 467 | protein heterodimerization activity |
GO:0030156 | 7e-04 | Inf | 0.0548 | 2 | 2 | benzodiazepine receptor binding |
GO:0042393 | 0.0017 | 2.7517 | 5.0397 | 13 | 184 | histone binding |
GO:0031720 | 0.0022 | 71.3425 | 0.0822 | 2 | 3 | haptoglobin binding |
GO:0003682 | 0.0029 | 1.9503 | 12.9552 | 24 | 473 | chromatin binding |
GO:0005102 | 0.0035 | 1.5259 | 38.8836 | 56 | 1426 | receptor binding |
GO:0005223 | 0.0043 | 35.669 | 0.1096 | 2 | 4 | intracellular cGMP activated cation channel activity |
GO:0032794 | 0.0059 | 9.7447 | 0.3835 | 3 | 14 | GTPase activating protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 22.3473 | 7.9529 | 97 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 8.2951 | 18.1977 | 103 | 715 | G-protein coupled receptor activity |
GO:0099600 | 0 | 5.42 | 29.4589 | 114 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 5.2483 | 30.942 | 116 | 1210 | signaling receptor activity |
GO:0005549 | 0 | 14.5543 | 1.8156 | 19 | 71 | odorant binding |
GO:0004062 | 2e-04 | 19.2314 | 0.3069 | 4 | 12 | aryl sulfotransferase activity |
GO:0001591 | 5e-04 | 28.7833 | 0.179 | 3 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0032393 | 5e-04 | 28.7833 | 0.179 | 3 | 7 | MHC class I receptor activity |
GO:0030109 | 7e-04 | Inf | 0.0511 | 2 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
GO:0046790 | 8e-04 | 23.0252 | 0.2046 | 3 | 8 | virion binding |
GO:0005198 | 0.001 | 1.9247 | 17.082 | 31 | 668 | structural molecule activity |
GO:0016503 | 0.0019 | 76.5813 | 0.0767 | 2 | 3 | pheromone receptor activity |
GO:0018685 | 0.0019 | 76.5813 | 0.0767 | 2 | 3 | alkane 1-monooxygenase activity |
GO:0035240 | 0.0024 | 14.388 | 0.2813 | 3 | 11 | dopamine binding |
GO:0034875 | 0.0038 | 38.2882 | 0.1023 | 2 | 4 | caffeine oxidase activity |
GO:0047961 | 0.0038 | 38.2882 | 0.1023 | 2 | 4 | glycine N-acyltransferase activity |
GO:0050051 | 0.0038 | 38.2882 | 0.1023 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0008009 | 0.0051 | 4.9335 | 1.1252 | 5 | 44 | chemokine activity |
GO:0042056 | 0.006 | 6.1473 | 0.7416 | 4 | 29 | chemoattractant activity |
GO:0004024 | 0.0062 | 25.5238 | 0.1279 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0031727 | 0.0062 | 25.5238 | 0.1279 | 2 | 5 | CCR2 chemokine receptor binding |
GO:0004872 | 0.0062 | 2.8684 | 3.3171 | 9 | 167 | receptor activity |
GO:0048020 | 0.0067 | 5.9388 | 0.7636 | 4 | 30 | CCR chemokine receptor binding |
GO:0008392 | 0.0073 | 8.8513 | 0.4092 | 3 | 16 | arachidonic acid epoxygenase activity |
GO:0004497 | 0.0082 | 3.2524 | 2.3015 | 7 | 90 | monooxygenase activity |
GO:0004866 | 0.0085 | 2.5618 | 4.1171 | 10 | 161 | endopeptidase inhibitor activity |
GO:0004321 | 0.0091 | 19.1416 | 0.1534 | 2 | 6 | fatty-acyl-CoA synthase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 13.4294 | 0.968 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 2.6306 | 10.2737 | 25 | 467 | protein heterodimerization activity |
GO:0042393 | 1e-04 | 3.7716 | 4.0479 | 14 | 184 | histone binding |
GO:1903231 | 4e-04 | 4.9622 | 1.7819 | 8 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004021 | 5e-04 | Inf | 0.044 | 2 | 2 | L-alanine:2-oxoglutarate aminotransferase activity |
GO:0038062 | 5e-04 | Inf | 0.044 | 2 | 2 | protein tyrosine kinase collagen receptor activity |
GO:0004930 | 6e-04 | 2.0262 | 15.7955 | 30 | 718 | G-protein coupled receptor activity |
GO:0008483 | 0.001 | 10.5692 | 0.462 | 4 | 21 | transaminase activity |
GO:0071723 | 0.0011 | 19.2081 | 0.22 | 3 | 10 | lipopeptide binding |
GO:0003682 | 0.0019 | 2.1332 | 10.4057 | 21 | 473 | chromatin binding |
GO:0016783 | 0.002 | 14.9377 | 0.264 | 3 | 12 | sulfurtransferase activity |
GO:0004984 | 0.0038 | 2.3088 | 6.8418 | 15 | 311 | olfactory receptor activity |
GO:0005160 | 0.0039 | 5.2295 | 1.056 | 5 | 48 | transforming growth factor beta receptor binding |
GO:0030883 | 0.0046 | 29.8013 | 0.11 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0046 | 29.8013 | 0.11 | 2 | 5 | exogenous lipid antigen binding |
GO:0030170 | 0.0056 | 4.7832 | 1.144 | 5 | 52 | pyridoxal phosphate binding |
GO:0061578 | 0.0068 | 22.3496 | 0.132 | 2 | 6 | Lys63-specific deubiquitinase activity |
GO:0099600 | 0.008 | 1.5791 | 25.3433 | 38 | 1152 | transmembrane receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.9768 | 5.8585 | 25 | 184 | histone binding |
GO:0046982 | 0 | 2.918 | 14.8691 | 39 | 467 | protein heterodimerization activity |
GO:0031492 | 0 | 10.338 | 1.4009 | 11 | 44 | nucleosomal DNA binding |
GO:0030742 | 7e-04 | 8.5205 | 0.7323 | 5 | 23 | GTP-dependent protein binding |
GO:0008499 | 8e-04 | 12.2516 | 0.4458 | 4 | 14 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0036461 | 0.001 | Inf | 0.0637 | 2 | 2 | BLOC-2 complex binding |
GO:0005123 | 0.001 | 11.1371 | 0.4776 | 4 | 15 | death receptor binding |
GO:0005201 | 0.002 | 3.8457 | 2.2924 | 8 | 72 | extracellular matrix structural constituent |
GO:0005102 | 0.0021 | 1.5161 | 45.4669 | 65 | 1428 | receptor binding |
GO:0017022 | 0.0021 | 4.3026 | 1.8149 | 7 | 57 | myosin binding |
GO:0004602 | 0.0027 | 8.1651 | 0.605 | 4 | 19 | glutathione peroxidase activity |
GO:0004464 | 0.003 | 61.0514 | 0.0955 | 2 | 3 | leukotriene-C4 synthase activity |
GO:0004505 | 0.003 | 61.0514 | 0.0955 | 2 | 3 | phenylalanine 4-monooxygenase activity |
GO:0035651 | 0.003 | 61.0514 | 0.0955 | 2 | 3 | AP-3 adaptor complex binding |
GO:0008378 | 0.0042 | 5.2848 | 1.0825 | 5 | 34 | galactosyltransferase activity |
GO:0050840 | 0.0049 | 4.1841 | 1.592 | 6 | 50 | extracellular matrix binding |
GO:0031685 | 0.0058 | 30.5237 | 0.1274 | 2 | 4 | adenosine receptor binding |
GO:0035650 | 0.0058 | 30.5237 | 0.1274 | 2 | 4 | AP-1 adaptor complex binding |
GO:1901681 | 0.0062 | 2.1865 | 7.2276 | 15 | 227 | sulfur compound binding |
GO:0019904 | 0.0068 | 1.6476 | 20.9504 | 33 | 658 | protein domain specific binding |
GO:0004180 | 0.0084 | 4.3772 | 1.2736 | 5 | 40 | carboxypeptidase activity |
GO:0005528 | 0.009 | 8.3363 | 0.4458 | 3 | 14 | FK506 binding |
GO:0008532 | 0.0095 | 20.3478 | 0.1592 | 2 | 5 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
GO:0008083 | 0.0099 | 2.3855 | 4.8715 | 11 | 153 | growth factor activity |
GO:0004364 | 0.01 | 5.3223 | 0.8597 | 4 | 27 | glutathione transferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 3.6271 | 17.1142 | 53 | 705 | G-protein coupled receptor activity |
GO:0099600 | 0 | 2.7683 | 28.1592 | 67 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 2.3447 | 35.8101 | 73 | 1465 | molecular transducer activity |
GO:0001653 | 0 | 5.8336 | 2.9577 | 15 | 121 | peptide receptor activity |
GO:0003700 | 0 | 2.136 | 28.5014 | 55 | 1166 | DNA binding transcription factor activity |
GO:0043565 | 0 | 2.2036 | 23.9549 | 48 | 980 | sequence-specific DNA binding |
GO:0038023 | 0 | 2.1667 | 23.309 | 46 | 1000 | signaling receptor activity |
GO:0042923 | 0 | 16.1979 | 0.5133 | 6 | 21 | neuropeptide binding |
GO:0008188 | 0 | 9.5122 | 0.9001 | 7 | 37 | neuropeptide receptor activity |
GO:0004984 | 0 | 2.9976 | 7.602 | 21 | 311 | olfactory receptor activity |
GO:0051378 | 1e-04 | 26.8722 | 0.2444 | 4 | 10 | serotonin binding |
GO:0004993 | 1e-04 | 13.4632 | 0.4889 | 5 | 20 | G-protein coupled serotonin receptor activity |
GO:0004985 | 7e-04 | 24.124 | 0.1955 | 3 | 8 | opioid receptor activity |
GO:0030594 | 0.0015 | 4.0034 | 2.1755 | 8 | 89 | neurotransmitter receptor activity |
GO:0005436 | 0.0015 | 17.2292 | 0.2444 | 3 | 10 | sodium:phosphate symporter activity |
GO:0005249 | 0.0016 | 3.9543 | 2.1999 | 8 | 90 | voltage-gated potassium channel activity |
GO:0001228 | 0.0017 | 2.2016 | 9.6064 | 20 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0001601 | 0.0018 | 80.2268 | 0.0733 | 2 | 3 | peptide YY receptor activity |
GO:0019862 | 0.0018 | 80.2268 | 0.0733 | 2 | 3 | IgA binding |
GO:0045125 | 0.0035 | 12.0581 | 0.3178 | 3 | 13 | bioactive lipid receptor activity |
GO:0001602 | 0.0035 | 40.1108 | 0.0978 | 2 | 4 | pancreatic polypeptide receptor activity |
GO:0031728 | 0.0035 | 40.1108 | 0.0978 | 2 | 4 | CCR3 chemokine receptor binding |
GO:1903231 | 0.0036 | 3.826 | 1.9799 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0015294 | 0.004 | 3.3746 | 2.5421 | 8 | 104 | solute:cation symporter activity |
GO:0008009 | 0.0042 | 5.1702 | 1.0755 | 5 | 44 | chemokine activity |
GO:0015079 | 0.0051 | 2.7792 | 3.8132 | 10 | 156 | potassium ion transmembrane transporter activity |
GO:0005184 | 0.0051 | 6.4415 | 0.7089 | 4 | 29 | neuropeptide hormone activity |
GO:0001067 | 0.0052 | 1.6989 | 19.7994 | 32 | 810 | regulatory region nucleic acid binding |
GO:0004994 | 0.0057 | 26.7388 | 0.1222 | 2 | 5 | somatostatin receptor activity |
GO:0048248 | 0.0057 | 26.7388 | 0.1222 | 2 | 5 | CXCR3 chemokine receptor binding |
GO:0003677 | 0.0061 | 1.5527 | 30.74 | 45 | 1346 | DNA binding |
GO:1901677 | 0.0076 | 8.6107 | 0.4155 | 3 | 17 | phosphate transmembrane transporter activity |
GO:0003828 | 0.0084 | 20.0528 | 0.1467 | 2 | 6 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
GO:0005000 | 0.0084 | 20.0528 | 0.1467 | 2 | 6 | vasopressin receptor activity |
GO:0044212 | 0.0087 | 1.6457 | 19.7261 | 31 | 807 | transcription regulatory region DNA binding |
GO:0000977 | 0.0095 | 1.7538 | 14.2996 | 24 | 585 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0001664 | 0.0096 | 2.2019 | 6.1843 | 13 | 253 | G-protein coupled receptor binding |
GO:0022836 | 0.0098 | 2.0634 | 7.602 | 15 | 311 | gated channel activity |
GO:0022890 | 0.0099 | 1.7938 | 12.8085 | 22 | 524 | inorganic cation transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 3.0678 | 10.8006 | 30 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 3.8655 | 4.2555 | 15 | 184 | histone binding |
GO:0004872 | 1e-04 | 1.8234 | 32.8642 | 55 | 1421 | receptor activity |
GO:0004888 | 3e-04 | 1.8551 | 24.9365 | 43 | 1092 | transmembrane signaling receptor activity |
GO:0004871 | 5e-04 | 1.696 | 35.0151 | 55 | 1514 | signal transducer activity |
GO:0004875 | 9e-04 | 21.2842 | 0.2081 | 3 | 9 | complement receptor activity |
GO:1903231 | 0.0027 | 4.0535 | 1.8733 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004982 | 0.0031 | 42.4632 | 0.0925 | 2 | 4 | N-formyl peptide receptor activity |
GO:0004953 | 0.0037 | 11.6058 | 0.3238 | 3 | 14 | icosanoid receptor activity |
GO:0017040 | 0.0051 | 28.307 | 0.1156 | 2 | 5 | ceramidase activity |
GO:0015078 | 0.0069 | 3.367 | 2.2202 | 7 | 96 | hydrogen ion transmembrane transporter activity |
GO:0004111 | 0.0075 | 21.2289 | 0.1388 | 2 | 6 | creatine kinase activity |
GO:0004468 | 0.0075 | 21.2289 | 0.1388 | 2 | 6 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
GO:0004957 | 0.0075 | 21.2289 | 0.1388 | 2 | 6 | prostaglandin E receptor activity |
GO:0019763 | 0.0075 | 21.2289 | 0.1388 | 2 | 6 | immunoglobulin receptor activity |
GO:0031730 | 0.0075 | 21.2289 | 0.1388 | 2 | 6 | CCR5 chemokine receptor binding |
GO:0055131 | 0.0075 | 21.2289 | 0.1388 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0019904 | 0.0089 | 1.7435 | 15.0031 | 25 | 652 | protein domain specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 12.4225 | 1.0424 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.1024 | 11.064 | 31 | 467 | protein heterodimerization activity |
GO:0042393 | 5e-04 | 3.2088 | 4.3593 | 13 | 184 | histone binding |
GO:0099583 | 0.0017 | 82.8511 | 0.0711 | 2 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
GO:0004784 | 0.0033 | 41.4229 | 0.0948 | 2 | 4 | superoxide dismutase activity |
GO:0017018 | 0.0033 | 41.4229 | 0.0948 | 2 | 4 | myosin phosphatase activity |
GO:0047961 | 0.0033 | 41.4229 | 0.0948 | 2 | 4 | glycine N-acyltransferase activity |
GO:0050833 | 0.0033 | 41.4229 | 0.0948 | 2 | 4 | pyruvate transmembrane transporter activity |
GO:0003677 | 0.0065 | 1.4155 | 55.1067 | 73 | 2326 | DNA binding |
GO:0004930 | 0.0069 | 1.726 | 17.0106 | 28 | 718 | G-protein coupled receptor activity |
GO:0038023 | 0.0081 | 1.5421 | 28.6669 | 42 | 1210 | signaling receptor activity |
GO:0099600 | 0.0096 | 1.5394 | 27.2928 | 40 | 1152 | transmembrane receptor activity |
GO:1904315 | 0.0096 | 7.7805 | 0.4501 | 3 | 19 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 23.0886 | 6.9393 | 89 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 8.472 | 16.0206 | 93 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 5.163 | 25.7043 | 97 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 4.8744 | 26.9984 | 97 | 1210 | signaling receptor activity |
GO:0060089 | 0 | 4.1336 | 32.6882 | 101 | 1465 | molecular transducer activity |
GO:0005549 | 0 | 23.92 | 1.5842 | 24 | 71 | odorant binding |
GO:0005198 | 0 | 2.6642 | 14.9049 | 36 | 668 | structural molecule activity |
GO:0030414 | 0 | 4.8143 | 3.7262 | 16 | 167 | peptidase inhibitor activity |
GO:0061135 | 0 | 4.8143 | 3.7262 | 16 | 167 | endopeptidase regulator activity |
GO:0019825 | 0 | 9.9381 | 0.9818 | 8 | 44 | oxygen binding |
GO:0008395 | 0 | 12.4949 | 0.714 | 7 | 32 | steroid hydroxylase activity |
GO:0001591 | 0 | 59.0758 | 0.1562 | 4 | 7 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0008392 | 0 | 20.1865 | 0.357 | 5 | 16 | arachidonic acid epoxygenase activity |
GO:0004867 | 0 | 5.6779 | 1.9858 | 10 | 89 | serine-type endopeptidase inhibitor activity |
GO:0035240 | 1e-04 | 25.3117 | 0.2454 | 4 | 11 | dopamine binding |
GO:0030883 | 1e-04 | 66.2762 | 0.1116 | 3 | 5 | endogenous lipid antigen binding |
GO:0030884 | 1e-04 | 66.2762 | 0.1116 | 3 | 5 | exogenous lipid antigen binding |
GO:0004033 | 2e-04 | 11.0962 | 0.5578 | 5 | 25 | aldo-keto reductase (NADP) activity |
GO:0020037 | 4e-04 | 3.9608 | 2.7445 | 10 | 123 | heme binding |
GO:0005506 | 5e-04 | 3.5462 | 3.3469 | 11 | 150 | iron ion binding |
GO:0030881 | 8e-04 | 22.0864 | 0.2008 | 3 | 9 | beta-2-microglobulin binding |
GO:0071723 | 0.0012 | 18.93 | 0.2231 | 3 | 10 | lipopeptide binding |
GO:0047023 | 0.0015 | 88.1243 | 0.0669 | 2 | 3 | androsterone dehydrogenase activity |
GO:0030246 | 0.0016 | 2.6421 | 5.6228 | 14 | 252 | carbohydrate binding |
GO:0016712 | 0.0018 | 8.8517 | 0.5355 | 4 | 24 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO:0004252 | 0.0019 | 3.0008 | 3.9047 | 11 | 175 | serine-type endopeptidase activity |
GO:0047961 | 0.0029 | 44.0593 | 0.0893 | 2 | 4 | glycine N-acyltransferase activity |
GO:0015125 | 0.0041 | 11.039 | 0.3347 | 3 | 15 | bile acid transmembrane transporter activity |
GO:0004024 | 0.0047 | 29.371 | 0.1116 | 2 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0015020 | 0.0048 | 6.5539 | 0.6917 | 4 | 31 | glucuronosyltransferase activity |
GO:0003823 | 0.0054 | 4.8164 | 1.138 | 5 | 51 | antigen binding |
GO:0004745 | 0.0059 | 9.4607 | 0.3793 | 3 | 17 | retinol dehydrogenase activity |
GO:0005537 | 0.0059 | 9.4607 | 0.3793 | 3 | 17 | mannose binding |
GO:0016705 | 0.006 | 3.1272 | 2.7177 | 8 | 123 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0017171 | 0.0069 | 2.5057 | 4.6187 | 11 | 207 | serine hydrolase activity |
GO:0004869 | 0.0069 | 4.5206 | 1.2049 | 5 | 54 | cysteine-type endopeptidase inhibitor activity |
GO:0016614 | 0.008 | 2.9653 | 2.856 | 8 | 128 | oxidoreductase activity, acting on CH-OH group of donors |
GO:0004032 | 0.0097 | 17.6203 | 0.1562 | 2 | 7 | alditol:NADP+ 1-oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 15.2867 | 7.1732 | 71 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 6.7745 | 16.0311 | 80 | 704 | G-protein coupled receptor activity |
GO:0099600 | 0 | 4.6394 | 26.5707 | 93 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 4.4048 | 25.3649 | 86 | 1121 | signaling receptor activity |
GO:0060089 | 0 | 3.7757 | 33.79 | 98 | 1465 | molecular transducer activity |
GO:0005549 | 0 | 13.9317 | 1.6376 | 17 | 71 | odorant binding |
GO:0004024 | 1e-04 | 64.0479 | 0.1153 | 3 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0016503 | 0.0016 | 85.1694 | 0.0692 | 2 | 3 | pheromone receptor activity |
GO:0035276 | 0.0016 | 85.1694 | 0.0692 | 2 | 3 | ethanol binding |
GO:0004952 | 0.0017 | 16.0058 | 0.2537 | 3 | 11 | dopamine neurotransmitter receptor activity |
GO:1903231 | 0.0026 | 4.0649 | 1.8683 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0033265 | 0.0031 | 42.582 | 0.0923 | 2 | 4 | choline binding |
GO:0004322 | 0.0051 | 28.3862 | 0.1153 | 2 | 5 | ferroxidase activity |
GO:0008106 | 0.0055 | 9.8466 | 0.369 | 3 | 16 | alcohol dehydrogenase (NADP+) activity |
GO:0004745 | 0.0065 | 9.1427 | 0.3921 | 3 | 17 | retinol dehydrogenase activity |
GO:0004321 | 0.0075 | 21.2883 | 0.1384 | 2 | 6 | fatty-acyl-CoA synthase activity |
GO:0034987 | 0.0075 | 21.2883 | 0.1384 | 2 | 6 | immunoglobulin receptor binding |
GO:0061578 | 0.0075 | 21.2883 | 0.1384 | 2 | 6 | Lys63-specific deubiquitinase activity |
GO:0030594 | 0.0089 | 3.5996 | 1.7856 | 6 | 78 | neurotransmitter receptor activity |
GO:0033038 | 0.009 | 7.9988 | 0.4382 | 3 | 19 | bitter taste receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 0 | 2.6019 | 38.1056 | 84 | 1465 | molecular transducer activity |
GO:0038023 | 0 | 2.7516 | 31.4729 | 74 | 1210 | signaling receptor activity |
GO:0099600 | 0 | 2.7112 | 29.9643 | 70 | 1152 | transmembrane receptor activity |
GO:0004984 | 0 | 4.5701 | 8.0893 | 32 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 3.1242 | 18.6757 | 51 | 718 | G-protein coupled receptor activity |
GO:0043565 | 1e-04 | 1.8998 | 25.4904 | 45 | 980 | sequence-specific DNA binding |
GO:0005506 | 2e-04 | 3.6358 | 3.9016 | 13 | 150 | iron ion binding |
GO:0005125 | 2e-04 | 3.1296 | 5.1761 | 15 | 199 | cytokine activity |
GO:0016015 | 6e-04 | 28.2816 | 0.1821 | 3 | 7 | morphogen activity |
GO:0031433 | 6e-04 | 28.2816 | 0.1821 | 3 | 7 | telethonin binding |
GO:0048018 | 6e-04 | 2.8444 | 5.6483 | 15 | 223 | receptor ligand activity |
GO:0001530 | 6e-04 | 8.602 | 0.7023 | 5 | 27 | lipopolysaccharide binding |
GO:0001205 | 7e-04 | 8.2275 | 0.7283 | 5 | 28 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0020037 | 0.0014 | 3.3709 | 3.1993 | 10 | 123 | heme binding |
GO:0039706 | 0.0018 | 16.1578 | 0.2601 | 3 | 10 | co-receptor binding |
GO:0031720 | 0.002 | 75.2494 | 0.078 | 2 | 3 | haptoglobin binding |
GO:0070888 | 0.0023 | 6.1011 | 0.9364 | 5 | 36 | E-box binding |
GO:0005326 | 0.0023 | 8.3925 | 0.5722 | 4 | 22 | neurotransmitter transporter activity |
GO:0035240 | 0.0025 | 14.1371 | 0.2861 | 3 | 11 | dopamine binding |
GO:0004866 | 0.0033 | 2.7936 | 4.1877 | 11 | 161 | endopeptidase inhibitor activity |
GO:0001588 | 0.0039 | 37.6223 | 0.104 | 2 | 4 | dopamine neurotransmitter receptor activity, coupled via Gs |
GO:0008401 | 0.0039 | 37.6223 | 0.104 | 2 | 4 | retinoic acid 4-hydroxylase activity |
GO:0070891 | 0.0039 | 37.6223 | 0.104 | 2 | 4 | lipoteichoic acid binding |
GO:0070696 | 0.0041 | 11.3083 | 0.3381 | 3 | 13 | transmembrane receptor protein serine/threonine kinase binding |
GO:0031072 | 0.0048 | 3.2648 | 2.6271 | 8 | 101 | heat shock protein binding |
GO:0000981 | 0.0049 | 1.7218 | 18.9097 | 31 | 727 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0140110 | 0.0059 | 1.488 | 39.068 | 55 | 1502 | transcription regulator activity |
GO:0005499 | 0.0064 | 25.0799 | 0.1301 | 2 | 5 | vitamin D binding |
GO:0031727 | 0.0064 | 25.0799 | 0.1301 | 2 | 5 | CCR2 chemokine receptor binding |
GO:0051373 | 0.0064 | 25.0799 | 0.1301 | 2 | 5 | FATZ binding |
GO:0061134 | 0.0065 | 2.4185 | 5.2281 | 12 | 201 | peptidase regulator activity |
GO:0001664 | 0.0066 | 2.2351 | 6.5807 | 14 | 253 | G-protein coupled receptor binding |
GO:0022841 | 0.0076 | 8.697 | 0.4162 | 3 | 16 | potassium ion leak channel activity |
GO:0045236 | 0.0076 | 8.697 | 0.4162 | 3 | 16 | CXCR chemokine receptor binding |
GO:0022836 | 0.0076 | 2.0723 | 8.0893 | 16 | 311 | gated channel activity |
GO:0008201 | 0.008 | 2.5855 | 4.0837 | 10 | 157 | heparin binding |
GO:0046625 | 0.0091 | 8.0752 | 0.4422 | 3 | 17 | sphingolipid binding |
GO:0008395 | 0.0091 | 5.3917 | 0.8323 | 4 | 32 | steroid hydroxylase activity |
GO:0055131 | 0.0094 | 18.8087 | 0.1561 | 2 | 6 | C3HC4-type RING finger domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 4.2376 | 11.8543 | 43 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 6.0591 | 4.6706 | 24 | 184 | histone binding |
GO:0031492 | 0 | 13.1277 | 1.1169 | 11 | 44 | nucleosomal DNA binding |
GO:1903231 | 0 | 5.5193 | 2.0561 | 10 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0004984 | 0 | 2.8777 | 7.8944 | 21 | 311 | olfactory receptor activity |
GO:0005549 | 1e-04 | 5.6774 | 1.8023 | 9 | 71 | odorant binding |
GO:0004930 | 2e-04 | 2.0591 | 18.2256 | 35 | 718 | G-protein coupled receptor activity |
GO:0034987 | 3e-04 | 38.6741 | 0.1523 | 3 | 6 | immunoglobulin receptor binding |
GO:0060089 | 7e-04 | 1.6451 | 37.1874 | 57 | 1465 | molecular transducer activity |
GO:0038023 | 0.0013 | 1.6648 | 30.7145 | 48 | 1210 | signaling receptor activity |
GO:0031731 | 0.0019 | 77.1663 | 0.0762 | 2 | 3 | CCR6 chemokine receptor binding |
GO:0019865 | 0.0025 | 8.1538 | 0.5838 | 4 | 23 | immunoglobulin binding |
GO:0099600 | 0.0026 | 1.6309 | 29.2422 | 45 | 1152 | transmembrane receptor activity |
GO:0042379 | 0.0029 | 4.6617 | 1.4215 | 6 | 56 | chemokine receptor binding |
GO:0030280 | 0.0048 | 10.5421 | 0.3554 | 3 | 14 | structural constituent of epidermis |
GO:0031432 | 0.0048 | 10.5421 | 0.3554 | 3 | 14 | titin binding |
GO:0004867 | 0.0075 | 3.3177 | 2.2592 | 7 | 89 | serine-type endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0099600 | 0 | 4.0873 | 26.5707 | 85 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 3.4508 | 33.79 | 92 | 1465 | molecular transducer activity |
GO:0038023 | 0 | 3.8217 | 25.5062 | 78 | 1121 | signaling receptor activity |
GO:0004984 | 0 | 6.6745 | 7.1732 | 39 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 4.9091 | 12.3413 | 50 | 552 | G-protein coupled receptor activity |
GO:0005549 | 0 | 11.785 | 1.6376 | 15 | 71 | odorant binding |
GO:0001847 | 0 | 128.1041 | 0.0923 | 3 | 4 | opsonin receptor activity |
GO:0004966 | 4e-04 | 32.0199 | 0.1615 | 3 | 7 | galanin receptor activity |
GO:0055102 | 4e-04 | 14.2628 | 0.369 | 4 | 16 | lipase inhibitor activity |
GO:0008528 | 5e-04 | 3.9302 | 2.7678 | 10 | 120 | G-protein coupled peptide receptor activity |
GO:0032394 | 5e-04 | Inf | 0.0461 | 2 | 2 | MHC class Ib receptor activity |
GO:1903231 | 6e-04 | 4.7227 | 1.8683 | 8 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0017147 | 6e-04 | 8.5741 | 0.6919 | 5 | 30 | Wnt-protein binding |
GO:0008035 | 9e-04 | 21.3438 | 0.2076 | 3 | 9 | high-density lipoprotein particle binding |
GO:0003823 | 0.0011 | 5.7245 | 1.1763 | 6 | 51 | antigen binding |
GO:0001848 | 0.0012 | 10.0646 | 0.4844 | 4 | 21 | complement binding |
GO:0003876 | 0.0016 | 85.1694 | 0.0692 | 2 | 3 | AMP deaminase activity |
GO:0019862 | 0.0016 | 85.1694 | 0.0692 | 2 | 3 | IgA binding |
GO:0001846 | 0.0037 | 11.6384 | 0.3229 | 3 | 14 | opsonin binding |
GO:0070405 | 0.0038 | 4.3622 | 1.4992 | 6 | 65 | ammonium ion binding |
GO:0008227 | 0.004 | 5.2227 | 1.061 | 5 | 46 | G-protein coupled amine receptor activity |
GO:0030594 | 0.0045 | 3.6665 | 2.0528 | 7 | 89 | neurotransmitter receptor activity |
GO:0016019 | 0.0051 | 28.3862 | 0.1153 | 2 | 5 | peptidoglycan receptor activity |
GO:0031727 | 0.0051 | 28.3862 | 0.1153 | 2 | 5 | CCR2 chemokine receptor binding |
GO:0005509 | 0.0055 | 1.7989 | 15.1767 | 26 | 658 | calcium ion binding |
GO:0019239 | 0.0067 | 5.8954 | 0.7611 | 4 | 33 | deaminase activity |
GO:0060228 | 0.0075 | 21.2883 | 0.1384 | 2 | 6 | phosphatidylcholine-sterol O-acyltransferase activator activity |
GO:0015645 | 0.009 | 7.9988 | 0.4382 | 3 | 19 | fatty acid ligase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003677 | 1e-04 | 1.6071 | 58.8971 | 86 | 2326 | DNA binding |
GO:0097159 | 3e-04 | 1.4249 | 143.7485 | 177 | 5677 | organic cyclic compound binding |
GO:1901363 | 5e-04 | 1.4129 | 141.7228 | 174 | 5597 | heterocyclic compound binding |
GO:0046982 | 0.0019 | 2.054 | 11.825 | 23 | 467 | protein heterodimerization activity |
GO:0001055 | 0.0023 | 14.5352 | 0.2785 | 3 | 11 | RNA polymerase II activity |
GO:0003700 | 0.0031 | 1.6135 | 29.5245 | 45 | 1166 | DNA binding transcription factor activity |
GO:0005132 | 0.0037 | 38.6791 | 0.1013 | 2 | 4 | type I interferon receptor binding |
GO:0004111 | 0.009 | 19.3371 | 0.1519 | 2 | 6 | creatine kinase activity |
GO:0055131 | 0.009 | 19.3371 | 0.1519 | 2 | 6 | C3HC4-type RING finger domain binding |
GO:0003705 | 0.0093 | 3.1707 | 2.3549 | 7 | 93 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 18.6211 | 1.1114 | 14 | 44 | nucleosomal DNA binding |
GO:0003677 | 0 | 1.8417 | 58.7514 | 95 | 2326 | DNA binding |
GO:0046982 | 1e-04 | 2.3631 | 11.7957 | 26 | 467 | protein heterodimerization activity |
GO:0042393 | 8e-04 | 2.9982 | 4.6476 | 13 | 184 | histone binding |
GO:0003682 | 0.0022 | 2.0313 | 11.9473 | 23 | 473 | chromatin binding |
GO:0004954 | 0.0023 | 14.5725 | 0.2778 | 3 | 11 | prostanoid receptor activity |
GO:0003707 | 0.0028 | 4.6857 | 1.4145 | 6 | 56 | steroid hormone receptor activity |
GO:0008131 | 0.0037 | 38.7781 | 0.101 | 2 | 4 | primary amine oxidase activity |
GO:1903231 | 0.0044 | 3.6973 | 2.0459 | 7 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0003700 | 0.0049 | 1.5763 | 29.4515 | 44 | 1166 | DNA binding transcription factor activity |
GO:0004111 | 0.0089 | 19.3865 | 0.1516 | 2 | 6 | creatine kinase activity |
GO:0004957 | 0.0089 | 19.3865 | 0.1516 | 2 | 6 | prostaglandin E receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 2.9426 | 13.1714 | 35 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 4.0984 | 5.1896 | 19 | 184 | histone binding |
GO:0005160 | 4e-04 | 5.9598 | 1.3538 | 7 | 48 | transforming growth factor beta receptor binding |
GO:1903231 | 5e-04 | 4.3744 | 2.2846 | 9 | 81 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005094 | 0.0023 | 69.2143 | 0.0846 | 2 | 3 | Rho GDP-dissociation inhibitor activity |
GO:0008083 | 0.0041 | 2.7109 | 4.3153 | 11 | 153 | growth factor activity |
GO:0035594 | 0.0046 | 34.6049 | 0.1128 | 2 | 4 | ganglioside binding |
GO:0005254 | 0.0048 | 3.6409 | 2.0871 | 7 | 74 | chloride channel activity |
GO:0004364 | 0.0066 | 6.037 | 0.7615 | 4 | 27 | glutathione transferase activity |
GO:0031490 | 0.0069 | 3.0658 | 2.7922 | 8 | 99 | chromatin DNA binding |
GO:0004430 | 0.0075 | 23.0685 | 0.141 | 2 | 5 | 1-phosphatidylinositol 4-kinase activity |
GO:0008503 | 0.0075 | 23.0685 | 0.141 | 2 | 5 | benzodiazepine receptor activity |
GO:0004890 | 0.0095 | 7.9979 | 0.4513 | 3 | 16 | GABA-A receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.0755 | 7.1342 | 45 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 4.0732 | 16.4706 | 56 | 718 | G-protein coupled receptor activity |
GO:0042393 | 0 | 8.1953 | 4.2209 | 28 | 184 | histone binding |
GO:0099600 | 0 | 2.9954 | 26.4263 | 67 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 2.8867 | 27.7568 | 68 | 1210 | signaling receptor activity |
GO:0031492 | 0 | 18.4825 | 1.0093 | 13 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.71 | 10.7128 | 35 | 467 | protein heterodimerization activity |
GO:0060089 | 0 | 2.4062 | 33.6064 | 70 | 1465 | molecular transducer activity |
GO:0031720 | 0.0016 | 85.6484 | 0.0688 | 2 | 3 | haptoglobin binding |
GO:0001228 | 0.0019 | 2.2275 | 9.0152 | 19 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0003682 | 0.0031 | 2.0385 | 10.8504 | 21 | 473 | chromatin binding |
GO:0043565 | 0.0036 | 1.6924 | 22.4807 | 36 | 980 | sequence-specific DNA binding |
GO:0005344 | 0.0036 | 11.704 | 0.3212 | 3 | 14 | oxygen carrier activity |
GO:0015125 | 0.0044 | 10.728 | 0.3441 | 3 | 15 | bile acid transmembrane transporter activity |
GO:0005549 | 0.0057 | 3.9805 | 1.6287 | 6 | 71 | odorant binding |
GO:0008301 | 0.0064 | 9.1942 | 0.39 | 3 | 17 | DNA binding, bending |
GO:0048018 | 0.0095 | 1.9294 | 9.7493 | 18 | 425 | receptor ligand activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 3.6748 | 14.9405 | 47 | 718 | G-protein coupled receptor activity |
GO:0099600 | 0 | 3.0617 | 23.9714 | 62 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 2.994 | 24.9119 | 63 | 1204 | signaling receptor activity |
GO:0060089 | 0 | 2.6738 | 30.4845 | 69 | 1465 | molecular transducer activity |
GO:0004984 | 0 | 4.9926 | 6.4715 | 28 | 311 | olfactory receptor activity |
GO:0005509 | 0 | 3.1277 | 13.692 | 38 | 658 | calcium ion binding |
GO:0019834 | 0 | 142.4498 | 0.0832 | 3 | 4 | phospholipase A2 inhibitor activity |
GO:0055102 | 3e-04 | 15.8648 | 0.3329 | 4 | 16 | lipase inhibitor activity |
GO:0016492 | 4e-04 | Inf | 0.0416 | 2 | 2 | G-protein coupled neurotensin receptor activity |
GO:0005333 | 0.0013 | 94.6788 | 0.0624 | 2 | 3 | norepinephrine transmembrane transporter activity |
GO:0005544 | 0.0021 | 6.1099 | 0.9156 | 5 | 44 | calcium-dependent phospholipid binding |
GO:0033265 | 0.0025 | 47.3364 | 0.0832 | 2 | 4 | choline binding |
GO:0005329 | 0.0041 | 31.5556 | 0.104 | 2 | 5 | dopamine transmembrane transporter activity |
GO:0005267 | 0.0046 | 3.2723 | 2.6011 | 8 | 125 | potassium channel activity |
GO:0098641 | 0.0058 | 9.4881 | 0.3746 | 3 | 18 | cadherin binding involved in cell-cell adhesion |
GO:0000155 | 0.0061 | 23.6652 | 0.1249 | 2 | 6 | phosphorelay sensor kinase activity |
GO:0004565 | 0.0061 | 23.6652 | 0.1249 | 2 | 6 | beta-galactosidase activity |
GO:0030246 | 0.0067 | 2.4036 | 5.2437 | 12 | 252 | carbohydrate binding |
GO:0098631 | 0.0071 | 5.7613 | 0.7699 | 4 | 37 | cell adhesion mediator activity |
GO:0005251 | 0.0078 | 8.3708 | 0.4162 | 3 | 20 | delayed rectifier potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.4426 | 5.155 | 24 | 184 | histone binding |
GO:0046982 | 0 | 3.3679 | 13.0836 | 39 | 467 | protein heterodimerization activity |
GO:0031492 | 0 | 10.4146 | 1.2327 | 10 | 44 | nucleosomal DNA binding |
GO:0030348 | 0 | Inf | 0.084 | 3 | 3 | syntaxin-3 binding |
GO:0048018 | 4e-04 | 2.2376 | 11.9069 | 25 | 425 | receptor ligand activity |
GO:0038100 | 8e-04 | Inf | 0.056 | 2 | 2 | nodal binding |
GO:0055102 | 8e-04 | 11.6599 | 0.4483 | 4 | 16 | lipase inhibitor activity |
GO:0098632 | 0.0013 | 7.0059 | 0.8405 | 5 | 30 | cell-cell adhesion mediator activity |
GO:0031720 | 0.0023 | 69.6944 | 0.084 | 2 | 3 | haptoglobin binding |
GO:0005506 | 0.0034 | 2.7896 | 4.2024 | 11 | 150 | iron ion binding |
GO:0004062 | 0.004 | 11.6359 | 0.3362 | 3 | 12 | aryl sulfotransferase activity |
GO:0019834 | 0.0045 | 34.8449 | 0.1121 | 2 | 4 | phospholipase A2 inhibitor activity |
GO:0005344 | 0.0063 | 9.519 | 0.3922 | 3 | 14 | oxygen carrier activity |
GO:0008310 | 0.0074 | 23.2285 | 0.1401 | 2 | 5 | single-stranded DNA 3'-5' exodeoxyribonuclease activity |
GO:0050544 | 0.0074 | 23.2285 | 0.1401 | 2 | 5 | arachidonic acid binding |
GO:0004896 | 0.0086 | 3.2304 | 2.3254 | 7 | 83 | cytokine receptor activity |
GO:0004890 | 0.0093 | 8.0535 | 0.4483 | 3 | 16 | GABA-A receptor activity |
GO:0045236 | 0.0093 | 8.0535 | 0.4483 | 3 | 16 | CXCR chemokine receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 4.3519 | 17.6449 | 63 | 705 | G-protein coupled receptor activity |
GO:0099600 | 0 | 3.3006 | 29.0256 | 79 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 2.668 | 36.9119 | 83 | 1465 | molecular transducer activity |
GO:0004984 | 0 | 4.5578 | 7.8359 | 31 | 311 | olfactory receptor activity |
GO:0003700 | 0 | 2.6304 | 29.3784 | 67 | 1166 | DNA binding transcription factor activity |
GO:0038023 | 0 | 2.7579 | 24.1346 | 58 | 1000 | signaling receptor activity |
GO:0043565 | 0 | 4.2162 | 6.7045 | 25 | 281 | sequence-specific DNA binding |
GO:0001077 | 0 | 3.5019 | 6.6013 | 21 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0004993 | 0 | 16.8171 | 0.5039 | 6 | 20 | G-protein coupled serotonin receptor activity |
GO:1990837 | 0 | 2.352 | 17.6119 | 38 | 699 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 2.246 | 20.4086 | 42 | 810 | regulatory region nucleic acid binding |
GO:0042923 | 0 | 15.6949 | 0.5291 | 6 | 21 | neuropeptide binding |
GO:0001653 | 0 | 4.7792 | 3.0487 | 13 | 121 | peptide receptor activity |
GO:0000978 | 1e-04 | 2.7127 | 8.743 | 22 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0051378 | 1e-04 | 26.0419 | 0.252 | 4 | 10 | serotonin binding |
GO:0001159 | 1e-04 | 2.5904 | 9.1209 | 22 | 362 | core promoter proximal region DNA binding |
GO:0008188 | 3e-04 | 7.6235 | 0.9279 | 6 | 37 | neuropeptide receptor activity |
GO:0030594 | 4e-04 | 4.4293 | 2.2424 | 9 | 89 | neurotransmitter receptor activity |
GO:0005184 | 7e-04 | 8.1491 | 0.7307 | 5 | 29 | neuropeptide hormone activity |
GO:0004985 | 8e-04 | 23.3805 | 0.2016 | 3 | 8 | opioid receptor activity |
GO:0001601 | 0.0019 | 77.76 | 0.0756 | 2 | 3 | peptide YY receptor activity |
GO:0019862 | 0.0019 | 77.76 | 0.0756 | 2 | 3 | IgA binding |
GO:0005249 | 0.0019 | 3.8309 | 2.2676 | 8 | 90 | voltage-gated potassium channel activity |
GO:0001664 | 0.002 | 2.4941 | 6.3746 | 15 | 253 | G-protein coupled receptor binding |
GO:0005549 | 0.002 | 4.2889 | 1.7889 | 7 | 71 | odorant binding |
GO:0015245 | 0.0029 | 12.9858 | 0.3024 | 3 | 12 | fatty acid transporter activity |
GO:0001602 | 0.0037 | 38.8775 | 0.1008 | 2 | 4 | pancreatic polypeptide receptor activity |
GO:0045125 | 0.0038 | 11.6865 | 0.3275 | 3 | 13 | bioactive lipid receptor activity |
GO:0001228 | 0.0047 | 3.0123 | 3.1805 | 9 | 131 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0008009 | 0.0048 | 5.01 | 1.1086 | 5 | 44 | chemokine activity |
GO:0022836 | 0.0057 | 2.1439 | 7.8359 | 16 | 311 | gated channel activity |
GO:0000977 | 0.0057 | 2.362 | 5.7945 | 13 | 238 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0048018 | 0.0057 | 1.9582 | 10.7082 | 20 | 425 | receptor ligand activity |
GO:0004994 | 0.006 | 25.9167 | 0.126 | 2 | 5 | somatostatin receptor activity |
GO:0008310 | 0.006 | 25.9167 | 0.126 | 2 | 5 | single-stranded DNA 3'-5' exodeoxyribonuclease activity |
GO:0030883 | 0.006 | 25.9167 | 0.126 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.006 | 25.9167 | 0.126 | 2 | 5 | exogenous lipid antigen binding |
GO:0048248 | 0.006 | 25.9167 | 0.126 | 2 | 5 | CXCR3 chemokine receptor binding |
GO:0015079 | 0.0062 | 2.692 | 3.9306 | 10 | 156 | potassium ion transmembrane transporter activity |
GO:0044212 | 0.0065 | 1.9331 | 10.8446 | 20 | 445 | transcription regulatory region DNA binding |
GO:0005539 | 0.0066 | 2.4108 | 5.2407 | 12 | 208 | glycosaminoglycan binding |
GO:0005244 | 0.0076 | 2.4722 | 4.6864 | 11 | 186 | voltage-gated ion channel activity |
GO:0003828 | 0.0089 | 19.4363 | 0.1512 | 2 | 6 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
GO:0003823 | 0.009 | 4.2457 | 1.285 | 5 | 51 | antigen binding |
GO:1901338 | 0.0098 | 7.7885 | 0.4535 | 3 | 18 | catecholamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.6812 | 5.8931 | 28 | 184 | histone binding |
GO:0031492 | 0 | 14.4732 | 1.4092 | 14 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.0753 | 14.9569 | 41 | 467 | protein heterodimerization activity |
GO:0030742 | 7e-04 | 8.4684 | 0.7366 | 5 | 23 | GTP-dependent protein binding |
GO:0008499 | 8e-04 | 12.1767 | 0.4484 | 4 | 14 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0005102 | 9e-04 | 1.5615 | 45.7354 | 67 | 1428 | receptor binding |
GO:0036461 | 0.001 | Inf | 0.0641 | 2 | 2 | BLOC-2 complex binding |
GO:0005123 | 0.0011 | 11.069 | 0.4804 | 4 | 15 | death receptor binding |
GO:0008083 | 0.0013 | 2.8536 | 4.9002 | 13 | 153 | growth factor activity |
GO:0005201 | 0.0021 | 3.8221 | 2.306 | 8 | 72 | extracellular matrix structural constituent |
GO:0017022 | 0.0022 | 4.2761 | 1.8256 | 7 | 57 | myosin binding |
GO:0019904 | 0.0023 | 1.7492 | 21.0741 | 35 | 658 | protein domain specific binding |
GO:0030545 | 0.003 | 1.8899 | 14.4765 | 26 | 452 | receptor regulator activity |
GO:0004464 | 0.003 | 60.6798 | 0.0961 | 2 | 3 | leukotriene-C4 synthase activity |
GO:0004505 | 0.003 | 60.6798 | 0.0961 | 2 | 3 | phenylalanine 4-monooxygenase activity |
GO:0035651 | 0.003 | 60.6798 | 0.0961 | 2 | 3 | AP-3 adaptor complex binding |
GO:0008378 | 0.0043 | 5.2525 | 1.0889 | 5 | 34 | galactosyltransferase activity |
GO:0050840 | 0.005 | 4.1584 | 1.6014 | 6 | 50 | extracellular matrix binding |
GO:0005200 | 0.0054 | 2.9593 | 3.2668 | 9 | 102 | structural constituent of cytoskeleton |
GO:0031685 | 0.0059 | 30.3379 | 0.1281 | 2 | 4 | adenosine receptor binding |
GO:0035650 | 0.0059 | 30.3379 | 0.1281 | 2 | 4 | AP-1 adaptor complex binding |
GO:0004180 | 0.0086 | 4.3504 | 1.2811 | 5 | 40 | carboxypeptidase activity |
GO:0008532 | 0.0096 | 20.224 | 0.1601 | 2 | 5 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.1174 | 7.641 | 48 | 311 | olfactory receptor activity |
GO:0004930 | 0 | 3.836 | 17.6406 | 57 | 718 | G-protein coupled receptor activity |
GO:0042393 | 0 | 7.2587 | 4.5207 | 27 | 184 | histone binding |
GO:0031492 | 0 | 17.1858 | 1.081 | 13 | 44 | nucleosomal DNA binding |
GO:0099600 | 0 | 2.6472 | 28.3036 | 65 | 1152 | transmembrane receptor activity |
GO:0038023 | 0 | 2.5517 | 29.7286 | 66 | 1210 | signaling receptor activity |
GO:0046982 | 0 | 3.4339 | 11.4738 | 35 | 467 | protein heterodimerization activity |
GO:0060089 | 0 | 2.1679 | 35.9937 | 69 | 1465 | molecular transducer activity |
GO:0005344 | 3e-04 | 16.034 | 0.344 | 4 | 14 | oxygen carrier activity |
GO:0005549 | 0.0018 | 4.4031 | 1.7444 | 7 | 71 | odorant binding |
GO:0031720 | 0.0018 | 79.8051 | 0.0737 | 2 | 3 | haptoglobin binding |
GO:0015125 | 0.0054 | 9.9942 | 0.3685 | 3 | 15 | bile acid transmembrane transporter activity |
GO:0043565 | 0.0062 | 1.6159 | 24.0777 | 37 | 980 | sequence-specific DNA binding |
GO:0003682 | 0.0068 | 1.8923 | 11.6212 | 21 | 473 | chromatin binding |
GO:0008301 | 0.0077 | 8.5654 | 0.4177 | 3 | 17 | DNA binding, bending |
GO:0001228 | 0.0087 | 1.9493 | 9.6557 | 18 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0016638 | 0.0091 | 7.9938 | 0.4422 | 3 | 18 | oxidoreductase activity, acting on the CH-NH2 group of donors |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 120.1871 | 0.6503 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 21.1893 | 1.1858 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 16.3679 | 1.3771 | 14 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 13.7977 | 1.6449 | 15 | 43 | protein heterotetramerization |
GO:0034080 | 0 | 13.846 | 1.5301 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 12.8553 | 1.6066 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 9.9931 | 1.9126 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 9.9931 | 1.9126 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0034654 | 0 | 1.6969 | 148.496 | 211 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0007267 | 0 | 2.2267 | 39.4568 | 78 | 1054 | cell-cell signaling |
GO:0048863 | 0 | 3.7902 | 9.3718 | 31 | 245 | stem cell differentiation |
GO:0099537 | 0 | 2.5505 | 21.3449 | 49 | 558 | trans-synaptic signaling |
GO:0032501 | 0 | 1.6565 | 170.2316 | 226 | 4885 | multicellular organismal process |
GO:0007218 | 0 | 5.8398 | 3.5192 | 17 | 92 | neuropeptide signaling pathway |
GO:0045814 | 0 | 5.0048 | 4.4755 | 19 | 117 | negative regulation of gene expression, epigenetic |
GO:0006303 | 0 | 6.9107 | 2.5247 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0045815 | 0 | 6.1177 | 2.9837 | 15 | 78 | positive regulation of gene expression, epigenetic |
GO:0009952 | 0 | 3.8615 | 6.7784 | 23 | 178 | anterior/posterior pattern specification |
GO:0021517 | 0 | 9.0735 | 1.6066 | 11 | 42 | ventral spinal cord development |
GO:0097659 | 0 | 1.7541 | 77.7269 | 120 | 2131 | nucleic acid-templated transcription |
GO:1902679 | 0 | 1.9854 | 41.0831 | 74 | 1074 | negative regulation of RNA biosynthetic process |
GO:0043044 | 0 | 6.0879 | 2.7924 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0006355 | 0 | 1.723 | 80.2456 | 122 | 2234 | regulation of transcription, DNA-templated |
GO:0022008 | 0 | 1.861 | 52.2528 | 88 | 1366 | neurogenesis |
GO:0045934 | 0 | 1.8842 | 49.1926 | 84 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:2001141 | 0 | 1.709 | 80.0592 | 121 | 2228 | regulation of RNA biosynthetic process |
GO:0060255 | 0 | 1.4913 | 211.077 | 265 | 5518 | regulation of macromolecule metabolic process |
GO:0031497 | 0 | 3.9483 | 5.4701 | 19 | 143 | chromatin assembly |
GO:0007268 | 0 | 2.5504 | 15.4835 | 36 | 410 | chemical synaptic transmission |
GO:0009889 | 0 | 1.6404 | 92.8825 | 134 | 2572 | regulation of biosynthetic process |
GO:0045944 | 0 | 1.9072 | 38.9027 | 68 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0035107 | 0 | 3.9254 | 5.2023 | 18 | 136 | appendage morphogenesis |
GO:0060964 | 0 | 4.5817 | 3.787 | 15 | 99 | regulation of gene silencing by miRNA |
GO:0021953 | 0 | 3.5186 | 6.0439 | 19 | 158 | central nervous system neuron differentiation |
GO:0050794 | 0 | 1.4803 | 351.934 | 400 | 9368 | regulation of cellular process |
GO:0007399 | 0 | 2.1655 | 22.1506 | 44 | 625 | nervous system development |
GO:0060173 | 0 | 3.4682 | 6.1204 | 19 | 160 | limb development |
GO:0021515 | 0 | 6.3776 | 1.9126 | 10 | 50 | cell differentiation in spinal cord |
GO:0003151 | 0 | 5.1129 | 2.7542 | 12 | 72 | outflow tract morphogenesis |
GO:0021520 | 0 | 25.4367 | 0.3813 | 5 | 10 | spinal cord motor neuron cell fate specification |
GO:0048869 | 0 | 1.6358 | 71.3555 | 105 | 1981 | cellular developmental process |
GO:0019219 | 0 | 1.5665 | 90.623 | 127 | 2534 | regulation of nucleobase-containing compound metabolic process |
GO:0007188 | 0 | 3.5491 | 5.3553 | 17 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:1902036 | 0 | 4.1689 | 3.8252 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:1903707 | 0 | 3.698 | 4.8581 | 16 | 127 | negative regulation of hemopoiesis |
GO:0051240 | 0 | 1.6844 | 52.7884 | 82 | 1380 | positive regulation of multicellular organismal process |
GO:0034645 | 0 | 1.4237 | 180.2837 | 225 | 4713 | cellular macromolecule biosynthetic process |
GO:0048663 | 0 | 4.9259 | 2.6012 | 11 | 68 | neuron fate commitment |
GO:0051937 | 1e-04 | 5.4252 | 2.1804 | 10 | 57 | catecholamine transport |
GO:0001708 | 1e-04 | 4.8635 | 2.6278 | 11 | 69 | cell fate specification |
GO:0045892 | 1e-04 | 2.4817 | 11.7994 | 27 | 319 | negative regulation of transcription, DNA-templated |
GO:0060968 | 1e-04 | 3.6253 | 4.6285 | 15 | 121 | regulation of gene silencing |
GO:0051584 | 1e-04 | 33.7471 | 0.2678 | 4 | 7 | regulation of dopamine uptake involved in synaptic transmission |
GO:0009890 | 1e-04 | 1.6149 | 59.6738 | 89 | 1560 | negative regulation of biosynthetic process |
GO:0051482 | 1e-04 | 10.8767 | 0.765 | 6 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0009954 | 1e-04 | 8.0847 | 1.1093 | 7 | 29 | proximal/distal pattern formation |
GO:0008344 | 1e-04 | 4.455 | 2.8307 | 11 | 74 | adult locomotory behavior |
GO:0055074 | 1e-04 | 2.2572 | 14.3064 | 30 | 374 | calcium ion homeostasis |
GO:0043009 | 1e-04 | 2.0331 | 20.0443 | 38 | 524 | chordate embryonic development |
GO:0045596 | 1e-04 | 1.9579 | 22.9897 | 42 | 601 | negative regulation of cell differentiation |
GO:0007156 | 1e-04 | 3.1534 | 5.5849 | 16 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0001662 | 2e-04 | 7.1131 | 1.2241 | 7 | 32 | behavioral fear response |
GO:0003018 | 2e-04 | 3.1052 | 5.6614 | 16 | 148 | vascular process in circulatory system |
GO:0060537 | 2e-04 | 2.2389 | 13.4266 | 28 | 351 | muscle tissue development |
GO:0007198 | 2e-04 | 75.8107 | 0.153 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 2e-04 | 75.8107 | 0.153 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 2e-04 | 75.8107 | 0.153 | 3 | 4 | detection of glucose |
GO:0033993 | 2e-04 | 1.7734 | 31.3287 | 52 | 819 | response to lipid |
GO:0015837 | 2e-04 | 4.9026 | 2.1304 | 9 | 56 | amine transport |
GO:0048598 | 3e-04 | 2.4248 | 10.2144 | 23 | 275 | embryonic morphogenesis |
GO:0065007 | 3e-04 | 1.4569 | 254.209 | 288 | 7441 | biological regulation |
GO:1903508 | 3e-04 | 1.6002 | 50.2255 | 75 | 1313 | positive regulation of nucleic acid-templated transcription |
GO:0001501 | 3e-04 | 2.0339 | 17.3284 | 33 | 453 | skeletal system development |
GO:0048646 | 3e-04 | 1.7193 | 33.4971 | 54 | 883 | anatomical structure formation involved in morphogenesis |
GO:0001764 | 4e-04 | 3.1389 | 4.8963 | 14 | 128 | neuron migration |
GO:0007631 | 4e-04 | 3.5197 | 3.787 | 12 | 99 | feeding behavior |
GO:0035150 | 4e-04 | 3.1114 | 4.9346 | 14 | 129 | regulation of tube size |
GO:0008015 | 4e-04 | 1.9947 | 17.6344 | 33 | 461 | blood circulation |
GO:0051094 | 4e-04 | 2.2737 | 11.3158 | 24 | 305 | positive regulation of developmental process |
GO:0000122 | 5e-04 | 1.7716 | 27.6183 | 46 | 722 | negative regulation of transcription from RNA polymerase II promoter |
GO:0030326 | 5e-04 | 3.674 | 3.3382 | 11 | 88 | embryonic limb morphogenesis |
GO:0048468 | 5e-04 | 1.4905 | 69.1604 | 96 | 1808 | cell development |
GO:0065004 | 5e-04 | 2.5381 | 8.0713 | 19 | 211 | protein-DNA complex assembly |
GO:0010628 | 5e-04 | 1.5225 | 59.8257 | 85 | 1597 | positive regulation of gene expression |
GO:0006836 | 5e-04 | 2.7855 | 6.2351 | 16 | 163 | neurotransmitter transport |
GO:0051891 | 5e-04 | 37.9028 | 0.1913 | 3 | 5 | positive regulation of cardioblast differentiation |
GO:0009893 | 5e-04 | 1.3949 | 113.9158 | 146 | 2978 | positive regulation of metabolic process |
GO:0051580 | 6e-04 | 14.4591 | 0.4208 | 4 | 11 | regulation of neurotransmitter uptake |
GO:0051934 | 6e-04 | 14.4591 | 0.4208 | 4 | 11 | catecholamine uptake involved in synaptic transmission |
GO:0090494 | 6e-04 | 14.4591 | 0.4208 | 4 | 11 | dopamine uptake |
GO:0033555 | 6e-04 | 4.2403 | 2.4099 | 9 | 63 | multicellular organismal response to stress |
GO:0042592 | 6e-04 | 1.5209 | 57.6082 | 82 | 1506 | homeostatic process |
GO:0002244 | 7e-04 | 2.622 | 7.0002 | 17 | 183 | hematopoietic progenitor cell differentiation |
GO:0010557 | 7e-04 | 1.5085 | 58.7557 | 83 | 1536 | positive regulation of macromolecule biosynthetic process |
GO:0021761 | 8e-04 | 3.4607 | 3.5192 | 11 | 92 | limbic system development |
GO:0007214 | 8e-04 | 8.4444 | 0.765 | 5 | 20 | gamma-aminobutyric acid signaling pathway |
GO:0051254 | 8e-04 | 1.5311 | 52.9031 | 76 | 1383 | positive regulation of RNA metabolic process |
GO:0097746 | 8e-04 | 3.0441 | 4.6668 | 13 | 122 | regulation of blood vessel diameter |
GO:0035115 | 8e-04 | 6.3404 | 1.1476 | 6 | 30 | embryonic forelimb morphogenesis |
GO:0042391 | 8e-04 | 2.0914 | 13.2345 | 26 | 348 | regulation of membrane potential |
GO:0032200 | 9e-04 | 2.7385 | 5.9291 | 15 | 155 | telomere organization |
GO:0035295 | 9e-04 | 1.9186 | 17.698 | 32 | 467 | tube development |
GO:1901576 | 9e-04 | 1.3087 | 222.4762 | 259 | 5816 | organic substance biosynthetic process |
GO:0002009 | 0.001 | 1.89 | 18.5142 | 33 | 484 | morphogenesis of an epithelium |
GO:0007519 | 0.001 | 2.8151 | 5.3936 | 14 | 141 | skeletal muscle tissue development |
GO:0045637 | 0.0011 | 2.3633 | 8.6068 | 19 | 225 | regulation of myeloid cell differentiation |
GO:0003208 | 0.0011 | 3.8796 | 2.6012 | 9 | 68 | cardiac ventricle morphogenesis |
GO:0021536 | 0.0012 | 3.8147 | 2.6394 | 9 | 69 | diencephalon development |
GO:0001975 | 0.0012 | 7.45 | 0.8416 | 5 | 22 | response to amphetamine |
GO:0019932 | 0.0013 | 2.2165 | 10.0986 | 21 | 264 | second-messenger-mediated signaling |
GO:0031328 | 0.0013 | 1.4631 | 63.346 | 87 | 1656 | positive regulation of cellular biosynthetic process |
GO:0042310 | 0.0013 | 3.7519 | 2.6777 | 9 | 70 | vasoconstriction |
GO:0048562 | 0.0014 | 2.5092 | 6.845 | 16 | 181 | embryonic organ morphogenesis |
GO:0035637 | 0.0014 | 2.5093 | 6.8472 | 16 | 179 | multicellular organismal signaling |
GO:0007493 | 0.0015 | Inf | 0.0765 | 2 | 2 | endodermal cell fate determination |
GO:0046960 | 0.0015 | Inf | 0.0765 | 2 | 2 | sensitization |
GO:0060577 | 0.0015 | Inf | 0.0765 | 2 | 2 | pulmonary vein morphogenesis |
GO:0051960 | 0.0015 | 1.6883 | 27.5418 | 44 | 720 | regulation of nervous system development |
GO:0031018 | 0.0015 | 4.6755 | 1.7214 | 7 | 45 | endocrine pancreas development |
GO:2000026 | 0.0016 | 1.7991 | 20.6048 | 35 | 573 | regulation of multicellular organismal development |
GO:0043279 | 0.0016 | 3.1127 | 3.8635 | 11 | 101 | response to alkaloid |
GO:0007187 | 0.0017 | 6.8089 | 0.8996 | 5 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0007611 | 0.0017 | 2.3147 | 8.3008 | 18 | 217 | learning or memory |
GO:0048514 | 0.0018 | 1.8151 | 19.2027 | 33 | 502 | blood vessel morphogenesis |
GO:0050886 | 0.0018 | 3.5753 | 2.7924 | 9 | 73 | endocrine process |
GO:0072503 | 0.0019 | 1.9396 | 14.7272 | 27 | 385 | cellular divalent inorganic cation homeostasis |
GO:0035137 | 0.0019 | 5.2454 | 1.3388 | 6 | 35 | hindlimb morphogenesis |
GO:0051480 | 0.002 | 2.1274 | 10.4812 | 21 | 274 | regulation of cytosolic calcium ion concentration |
GO:0051969 | 0.0021 | 9.1987 | 0.5738 | 4 | 15 | regulation of transmission of nerve impulse |
GO:0023061 | 0.0021 | 1.9231 | 14.8419 | 27 | 388 | signal release |
GO:0030182 | 0.0021 | 1.575 | 36.2196 | 54 | 972 | neuron differentiation |
GO:0048704 | 0.0021 | 3.2206 | 3.4045 | 10 | 89 | embryonic skeletal system morphogenesis |
GO:0048731 | 0.0022 | 1.5592 | 39.8768 | 58 | 1255 | system development |
GO:0038083 | 0.0022 | 4.3325 | 1.8361 | 7 | 48 | peptidyl-tyrosine autophosphorylation |
GO:0045597 | 0.0022 | 1.6137 | 31.367 | 48 | 820 | positive regulation of cell differentiation |
GO:0008284 | 0.0022 | 1.6214 | 30.5637 | 47 | 799 | positive regulation of cell proliferation |
GO:0048754 | 0.0023 | 2.6731 | 5.2406 | 13 | 137 | branching morphogenesis of an epithelial tube |
GO:0042472 | 0.0025 | 3.1406 | 3.481 | 10 | 91 | inner ear morphogenesis |
GO:0006352 | 0.0026 | 2.224 | 8.6068 | 18 | 225 | DNA-templated transcription, initiation |
GO:0003002 | 0.0026 | 2.908 | 4.0969 | 11 | 111 | regionalization |
GO:0030322 | 0.0027 | 8.4316 | 0.612 | 4 | 16 | stabilization of membrane potential |
GO:0060413 | 0.0027 | 8.4316 | 0.612 | 4 | 16 | atrial septum morphogenesis |
GO:0019933 | 0.0027 | 3.1021 | 3.5192 | 10 | 92 | cAMP-mediated signaling |
GO:0001706 | 0.0028 | 4.1304 | 1.9126 | 7 | 50 | endoderm formation |
GO:0098660 | 0.0028 | 1.6342 | 27.6948 | 43 | 724 | inorganic ion transmembrane transport |
GO:1902476 | 0.0031 | 3.2675 | 3.0219 | 9 | 79 | chloride transmembrane transport |
GO:0044057 | 0.0033 | 1.773 | 18.3994 | 31 | 481 | regulation of system process |
GO:0042053 | 0.0034 | 7.7825 | 0.6503 | 4 | 17 | regulation of dopamine metabolic process |
GO:0048644 | 0.0034 | 3.2213 | 3.0602 | 9 | 80 | muscle organ morphogenesis |
GO:0045995 | 0.0035 | 2.7995 | 4.246 | 11 | 111 | regulation of embryonic development |
GO:0046661 | 0.0035 | 2.5291 | 5.5084 | 13 | 144 | male sex differentiation |
GO:0043270 | 0.0038 | 2.1934 | 8.2243 | 17 | 215 | positive regulation of ion transport |
GO:0009914 | 0.0038 | 2.0063 | 11.055 | 21 | 289 | hormone transport |
GO:0003044 | 0.0039 | 4.4725 | 1.5301 | 6 | 40 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0010579 | 0.0039 | 12.6308 | 0.3443 | 3 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0034776 | 0.0039 | 12.6308 | 0.3443 | 3 | 9 | response to histamine |
GO:0048732 | 0.004 | 1.8486 | 14.8037 | 26 | 387 | gland development |
GO:0015696 | 0.0041 | 3.4127 | 2.5811 | 8 | 68 | ammonium transport |
GO:0032928 | 0.0042 | 7.2261 | 0.6885 | 4 | 18 | regulation of superoxide anion generation |
GO:0048148 | 0.0042 | 7.2261 | 0.6885 | 4 | 18 | behavioral response to cocaine |
GO:0006837 | 0.0042 | 50.6908 | 0.1142 | 2 | 3 | serotonin transport |
GO:0061458 | 0.0042 | 1.8381 | 14.8802 | 26 | 389 | reproductive system development |
GO:0003166 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | bundle of His development |
GO:0010159 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | specification of animal organ position |
GO:0021524 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | visceral motor neuron differentiation |
GO:0021855 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | hypothalamus cell migration |
GO:0021912 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035880 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0045065 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | cytotoxic T cell differentiation |
GO:0060913 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0061364 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | apoptotic process involved in luteolysis |
GO:1905333 | 0.0043 | 50.4536 | 0.1148 | 2 | 3 | regulation of gastric motility |
GO:0008306 | 0.0043 | 3.385 | 2.6012 | 8 | 68 | associative learning |
GO:0035050 | 0.0043 | 3.385 | 2.6012 | 8 | 68 | embryonic heart tube development |
GO:0031175 | 0.0043 | 1.5664 | 30.8315 | 46 | 806 | neuron projection development |
GO:0071103 | 0.0044 | 2.0586 | 9.7544 | 19 | 255 | DNA conformation change |
GO:0045766 | 0.0044 | 2.5676 | 5.0111 | 12 | 131 | positive regulation of angiogenesis |
GO:0099531 | 0.0044 | 2.5676 | 5.0111 | 12 | 131 | presynaptic process involved in chemical synaptic transmission |
GO:0006325 | 0.0045 | 1.616 | 25.9734 | 40 | 679 | chromatin organization |
GO:0046883 | 0.0045 | 2.1004 | 9.0658 | 18 | 237 | regulation of hormone secretion |
GO:0048534 | 0.0045 | 1.562 | 30.908 | 46 | 808 | hematopoietic or lymphoid organ development |
GO:0001667 | 0.0048 | 1.9293 | 12.0113 | 22 | 314 | ameboidal-type cell migration |
GO:0035051 | 0.005 | 2.5248 | 5.0876 | 12 | 133 | cardiocyte differentiation |
GO:0065008 | 0.0051 | 1.4307 | 52.6002 | 71 | 1474 | regulation of biological quality |
GO:0051384 | 0.0052 | 2.5123 | 5.1096 | 12 | 134 | response to glucocorticoid |
GO:0001963 | 0.0052 | 5.0632 | 1.1476 | 5 | 30 | synaptic transmission, dopaminergic |
GO:0007210 | 0.0052 | 6.7439 | 0.7268 | 4 | 19 | serotonin receptor signaling pathway |
GO:0015698 | 0.0053 | 2.3996 | 5.7761 | 13 | 151 | inorganic anion transport |
GO:0001820 | 0.0055 | 10.8257 | 0.3825 | 3 | 10 | serotonin secretion |
GO:0021903 | 0.0055 | 10.8257 | 0.3825 | 3 | 10 | rostrocaudal neural tube patterning |
GO:0007626 | 0.0055 | 2.7745 | 3.8846 | 10 | 103 | locomotory behavior |
GO:0032655 | 0.0056 | 4.109 | 1.6449 | 6 | 43 | regulation of interleukin-12 production |
GO:0050433 | 0.0056 | 4.109 | 1.6449 | 6 | 43 | regulation of catecholamine secretion |
GO:0006813 | 0.0057 | 2.0967 | 8.5685 | 17 | 224 | potassium ion transport |
GO:0061061 | 0.0057 | 1.6444 | 22.3012 | 35 | 583 | muscle structure development |
GO:0009887 | 0.0057 | 1.771 | 16.0023 | 27 | 434 | animal organ morphogenesis |
GO:0048645 | 0.0058 | 3.5505 | 2.1804 | 7 | 57 | animal organ formation |
GO:0048771 | 0.0059 | 2.365 | 5.8526 | 13 | 153 | tissue remodeling |
GO:0051930 | 0.006 | 4.8681 | 1.1858 | 5 | 31 | regulation of sensory perception of pain |
GO:0071869 | 0.006 | 4.8681 | 1.1858 | 5 | 31 | response to catecholamine |
GO:0048332 | 0.0061 | 3.1725 | 2.7542 | 8 | 72 | mesoderm morphogenesis |
GO:0003012 | 0.0063 | 1.7778 | 15.3392 | 26 | 401 | muscle system process |
GO:0046483 | 0.0064 | 1.2452 | 208.0168 | 237 | 5438 | heterocycle metabolic process |
GO:0071805 | 0.0064 | 2.1855 | 7.268 | 15 | 190 | potassium ion transmembrane transport |
GO:0050905 | 0.0064 | 2.8935 | 3.3662 | 9 | 88 | neuromuscular process |
GO:0030072 | 0.0065 | 2.0664 | 8.6833 | 17 | 227 | peptide hormone secretion |
GO:0009725 | 0.0067 | 1.5396 | 29.9134 | 44 | 782 | response to hormone |
GO:0060079 | 0.0069 | 2.8571 | 3.4045 | 9 | 89 | excitatory postsynaptic potential |
GO:0032890 | 0.007 | 3.8978 | 1.7214 | 6 | 45 | regulation of organic acid transport |
GO:0003093 | 0.0073 | 9.4718 | 0.4208 | 3 | 11 | regulation of glomerular filtration |
GO:0035723 | 0.0073 | 9.4718 | 0.4208 | 3 | 11 | interleukin-15-mediated signaling pathway |
GO:0055062 | 0.0073 | 9.4718 | 0.4208 | 3 | 11 | phosphate ion homeostasis |
GO:0060379 | 0.0073 | 9.4718 | 0.4208 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060573 | 0.0073 | 9.4718 | 0.4208 | 3 | 11 | cell fate specification involved in pattern specification |
GO:0070672 | 0.0073 | 9.4718 | 0.4208 | 3 | 11 | response to interleukin-15 |
GO:1904064 | 0.0074 | 2.6472 | 4.0548 | 10 | 106 | positive regulation of cation transmembrane transport |
GO:0014821 | 0.0075 | 5.9497 | 0.8033 | 4 | 21 | phasic smooth muscle contraction |
GO:0051953 | 0.0075 | 5.9497 | 0.8033 | 4 | 21 | negative regulation of amine transport |
GO:0035194 | 0.0077 | 1.9414 | 10.2899 | 19 | 269 | posttranscriptional gene silencing by RNA |
GO:2000027 | 0.0077 | 2.0272 | 8.8363 | 17 | 231 | regulation of organ morphogenesis |
GO:0051259 | 0.0077 | 1.6743 | 18.7437 | 30 | 490 | protein oligomerization |
GO:0097305 | 0.0078 | 2.2016 | 6.7324 | 14 | 176 | response to alcohol |
GO:0001960 | 0.0078 | 3.8001 | 1.7596 | 6 | 46 | negative regulation of cytokine-mediated signaling pathway |
GO:0060795 | 0.0079 | 4.5198 | 1.2623 | 5 | 33 | cell fate commitment involved in formation of primary germ layer |
GO:0001763 | 0.0081 | 2.1879 | 6.7707 | 14 | 177 | morphogenesis of a branching structure |
GO:1901342 | 0.0083 | 1.9258 | 10.3664 | 19 | 271 | regulation of vasculature development |
GO:0003205 | 0.0083 | 3.7419 | 1.7821 | 6 | 47 | cardiac chamber development |
GO:0001992 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0002865 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0003257 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0021913 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0032100 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | positive regulation of appetite |
GO:0048105 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | establishment of body hair planar orientation |
GO:0051414 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | response to cortisol |
GO:0090027 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:0097070 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | ductus arteriosus closure |
GO:0097476 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | spinal cord motor neuron migration |
GO:1900133 | 0.0083 | 25.2251 | 0.153 | 2 | 4 | regulation of renin secretion into blood stream |
GO:0055008 | 0.0084 | 3.2866 | 2.3334 | 7 | 61 | cardiac muscle tissue morphogenesis |
GO:0010594 | 0.0085 | 2.4534 | 4.7816 | 11 | 125 | regulation of endothelial cell migration |
GO:0050801 | 0.0085 | 1.5654 | 25.3614 | 38 | 663 | ion homeostasis |
GO:0006725 | 0.0086 | 1.2334 | 209.2408 | 237 | 5470 | cellular aromatic compound metabolic process |
GO:0040011 | 0.0087 | 1.3703 | 58.9853 | 77 | 1542 | locomotion |
GO:0055082 | 0.0089 | 1.5602 | 25.4379 | 38 | 665 | cellular chemical homeostasis |
GO:0003230 | 0.0089 | 4.3636 | 1.3006 | 5 | 34 | cardiac atrium development |
GO:0031960 | 0.0091 | 8.5538 | 0.4521 | 3 | 12 | response to corticosteroid |
GO:0048856 | 0.0093 | 1.6471 | 19.8999 | 31 | 666 | anatomical structure development |
GO:0072359 | 0.0093 | 1.474 | 34.7332 | 49 | 908 | circulatory system development |
GO:0034765 | 0.0094 | 1.7349 | 15.0715 | 25 | 394 | regulation of ion transmembrane transport |
GO:0034331 | 0.0095 | 8.4188 | 0.459 | 3 | 12 | cell junction maintenance |
GO:0048935 | 0.0095 | 8.4188 | 0.459 | 3 | 12 | peripheral nervous system neuron development |
GO:0070493 | 0.0095 | 8.4188 | 0.459 | 3 | 12 | thrombin-activated receptor signaling pathway |
GO:0043524 | 0.0095 | 2.4107 | 4.8581 | 11 | 127 | negative regulation of neuron apoptotic process |
GO:0016070 | 0.0095 | 1.2917 | 104.161 | 126 | 2847 | RNA metabolic process |
GO:1903670 | 0.0096 | 3.6186 | 1.8361 | 6 | 48 | regulation of sprouting angiogenesis |
GO:0003279 | 0.0098 | 2.6881 | 3.5957 | 9 | 94 | cardiac septum development |
GO:0050796 | 0.0099 | 2.2058 | 6.2351 | 13 | 163 | regulation of insulin secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009952 | 0 | 7.5682 | 4.7849 | 28 | 125 | anterior/posterior pattern specification |
GO:0006355 | 0 | 1.9867 | 126.9929 | 204 | 3275 | regulation of transcription, DNA-templated |
GO:2001141 | 0 | 1.9803 | 128.0398 | 205 | 3302 | regulation of RNA biosynthetic process |
GO:0045944 | 0 | 2.5462 | 39.4356 | 87 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0032502 | 0 | 1.9588 | 133.4985 | 203 | 3812 | developmental process |
GO:0019219 | 0 | 1.8332 | 148.126 | 221 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0009792 | 0 | 3.0752 | 20.474 | 55 | 528 | embryo development ending in birth or egg hatching |
GO:0034654 | 0 | 1.7384 | 150.5302 | 217 | 3882 | nucleobase-containing compound biosynthetic process |
GO:1903508 | 0 | 2.1119 | 50.9135 | 95 | 1313 | positive regulation of nucleic acid-templated transcription |
GO:0051254 | 0 | 2.0402 | 53.6278 | 97 | 1383 | positive regulation of RNA metabolic process |
GO:0003151 | 0 | 7.2515 | 2.7919 | 16 | 72 | outflow tract morphogenesis |
GO:0007275 | 0 | 1.914 | 74.8143 | 121 | 2279 | multicellular organism development |
GO:0035113 | 0 | 5.2009 | 4.5756 | 20 | 118 | embryonic appendage morphogenesis |
GO:0060255 | 0 | 1.5829 | 213.9684 | 277 | 5518 | regulation of macromolecule metabolic process |
GO:0048736 | 0 | 4.2894 | 6.2042 | 23 | 160 | appendage development |
GO:0007267 | 0 | 2.0982 | 39.811 | 75 | 1054 | cell-cell signaling |
GO:0021510 | 0 | 5.6051 | 3.645 | 17 | 94 | spinal cord development |
GO:0010557 | 0 | 1.8739 | 59.5606 | 100 | 1536 | positive regulation of macromolecule biosynthetic process |
GO:0010628 | 0 | 1.8219 | 64.9505 | 106 | 1675 | positive regulation of gene expression |
GO:0031328 | 0 | 1.8244 | 64.2138 | 105 | 1656 | positive regulation of cellular biosynthetic process |
GO:0009889 | 0 | 1.7114 | 94.9465 | 141 | 2572 | regulation of biosynthetic process |
GO:0035108 | 0 | 5.1794 | 3.8856 | 17 | 101 | limb morphogenesis |
GO:0048332 | 0 | 6.1042 | 2.7919 | 14 | 72 | mesoderm morphogenesis |
GO:0051173 | 0 | 1.6239 | 103.4168 | 149 | 2667 | positive regulation of nitrogen compound metabolic process |
GO:0099537 | 0 | 2.3305 | 21.6373 | 46 | 558 | trans-synaptic signaling |
GO:0001708 | 0 | 6.1288 | 2.5783 | 13 | 67 | cell fate specification |
GO:0001763 | 0 | 3.6156 | 6.8634 | 22 | 177 | morphogenesis of a branching structure |
GO:1903507 | 0 | 1.9235 | 41.6071 | 73 | 1073 | negative regulation of nucleic acid-templated transcription |
GO:0072001 | 0 | 3.0416 | 9.8492 | 27 | 254 | renal system development |
GO:0007399 | 0 | 2.3247 | 20.8013 | 44 | 589 | nervous system development |
GO:0048646 | 0 | 2.0462 | 31.5172 | 59 | 837 | anatomical structure formation involved in morphogenesis |
GO:0003002 | 0 | 4.5213 | 4.0748 | 16 | 111 | regionalization |
GO:0051253 | 0 | 1.8427 | 44.4378 | 75 | 1146 | negative regulation of RNA metabolic process |
GO:0048562 | 0 | 3.5192 | 6.3629 | 20 | 169 | embryonic organ morphogenesis |
GO:0000122 | 0 | 2.0586 | 27.9966 | 53 | 722 | negative regulation of transcription from RNA polymerase II promoter |
GO:0051094 | 0 | 2.7936 | 11.0251 | 28 | 297 | positive regulation of developmental process |
GO:0009790 | 0 | 2.5995 | 13.0434 | 31 | 358 | embryo development |
GO:0042472 | 0 | 4.592 | 3.5287 | 14 | 91 | inner ear morphogenesis |
GO:0048704 | 0 | 6.6954 | 1.8411 | 10 | 48 | embryonic skeletal system morphogenesis |
GO:0007218 | 0 | 4.5328 | 3.5674 | 14 | 92 | neuropeptide signaling pathway |
GO:0035295 | 0 | 3.5925 | 5.6066 | 18 | 152 | tube development |
GO:0048468 | 0 | 1.6535 | 66.9251 | 101 | 1742 | cell development |
GO:0007156 | 0 | 3.5639 | 5.6614 | 18 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0060537 | 0 | 2.4789 | 13.6105 | 31 | 351 | muscle tissue development |
GO:0060021 | 0 | 4.4911 | 3.3348 | 13 | 86 | palate development |
GO:0043583 | 0 | 3.0298 | 7.639 | 21 | 197 | ear development |
GO:0060795 | 0 | 8.0274 | 1.2796 | 8 | 33 | cell fate commitment involved in formation of primary germ layer |
GO:0007268 | 0 | 2.1713 | 18.9007 | 38 | 492 | chemical synaptic transmission |
GO:0009887 | 0 | 2.6009 | 10.8727 | 26 | 304 | animal organ morphogenesis |
GO:0048699 | 0 | 2.0139 | 24.1191 | 45 | 638 | generation of neurons |
GO:0048565 | 1e-04 | 3.6779 | 4.5756 | 15 | 118 | digestive tract development |
GO:0090596 | 1e-04 | 2.7186 | 9.2288 | 23 | 238 | sensory organ morphogenesis |
GO:0010454 | 1e-04 | 17.8486 | 0.4653 | 5 | 12 | negative regulation of cell fate commitment |
GO:0048935 | 1e-04 | 17.8486 | 0.4653 | 5 | 12 | peripheral nervous system neuron development |
GO:0042733 | 1e-04 | 5.3657 | 2.2032 | 10 | 57 | embryonic digit morphogenesis |
GO:1901576 | 1e-04 | 1.3901 | 225.5238 | 271 | 5816 | organic substance biosynthetic process |
GO:0016477 | 1e-04 | 1.6892 | 46.5705 | 73 | 1201 | cell migration |
GO:0003214 | 1e-04 | 15.6165 | 0.5041 | 5 | 13 | cardiac left ventricle morphogenesis |
GO:0008595 | 1e-04 | 15.6165 | 0.5041 | 5 | 13 | anterior/posterior axis specification, embryo |
GO:0045597 | 1e-04 | 1.8225 | 31.7967 | 54 | 820 | positive regulation of cell differentiation |
GO:0090304 | 1e-04 | 1.3923 | 181.784 | 224 | 4688 | nucleic acid metabolic process |
GO:0007188 | 1e-04 | 3.2596 | 5.4287 | 16 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0035115 | 1e-04 | 7.6227 | 1.1633 | 7 | 30 | embryonic forelimb morphogenesis |
GO:0001756 | 1e-04 | 4.7403 | 2.4429 | 10 | 63 | somitogenesis |
GO:0048701 | 2e-04 | 6.078 | 1.5898 | 8 | 41 | embryonic cranial skeleton morphogenesis |
GO:0048732 | 2e-04 | 2.1959 | 14.6671 | 30 | 380 | gland development |
GO:0007350 | 2e-04 | 12.4915 | 0.5816 | 5 | 15 | blastoderm segmentation |
GO:0060581 | 2e-04 | 12.4915 | 0.5816 | 5 | 15 | cell fate commitment involved in pattern specification |
GO:0097659 | 2e-04 | 1.6152 | 52.5145 | 78 | 1509 | nucleic acid-templated transcription |
GO:0034645 | 2e-04 | 1.4301 | 122.267 | 157 | 3311 | cellular macromolecule biosynthetic process |
GO:0034287 | 2e-04 | 74.7402 | 0.1551 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 2e-04 | 74.7402 | 0.1551 | 3 | 4 | detection of glucose |
GO:0051240 | 2e-04 | 1.6173 | 49.0934 | 74 | 1289 | positive regulation of multicellular organismal process |
GO:0040011 | 2e-04 | 1.8146 | 28.3125 | 48 | 755 | locomotion |
GO:0021915 | 2e-04 | 3.0143 | 5.8165 | 16 | 150 | neural tube development |
GO:0048333 | 2e-04 | 8.3768 | 0.9265 | 6 | 24 | mesodermal cell differentiation |
GO:0023061 | 3e-04 | 2.1348 | 15.0453 | 30 | 388 | signal release |
GO:0035050 | 3e-04 | 4.3302 | 2.6368 | 10 | 68 | embryonic heart tube development |
GO:0048663 | 3e-04 | 4.3302 | 2.6368 | 10 | 68 | neuron fate commitment |
GO:0042127 | 3e-04 | 1.8641 | 24.6626 | 43 | 662 | regulation of cell proliferation |
GO:0007519 | 3e-04 | 3.0861 | 5.3341 | 15 | 138 | skeletal muscle tissue development |
GO:0001945 | 3e-04 | 7.898 | 0.9694 | 6 | 25 | lymph vessel development |
GO:0060429 | 3e-04 | 2.3342 | 11.0503 | 24 | 299 | epithelium development |
GO:0048754 | 3e-04 | 3.8743 | 3.1917 | 11 | 83 | branching morphogenesis of an epithelial tube |
GO:0048286 | 3e-04 | 6.2594 | 1.3572 | 7 | 35 | lung alveolus development |
GO:2000113 | 3e-04 | 1.5652 | 54.7523 | 80 | 1412 | negative regulation of cellular macromolecule biosynthetic process |
GO:0051674 | 3e-04 | 1.5819 | 51.4176 | 76 | 1326 | localization of cell |
GO:0021514 | 4e-04 | 10.4081 | 0.6592 | 5 | 17 | ventral spinal cord interneuron differentiation |
GO:0048514 | 4e-04 | 2.0332 | 16.7963 | 32 | 438 | blood vessel morphogenesis |
GO:0016331 | 4e-04 | 3.0018 | 5.4675 | 15 | 141 | morphogenesis of embryonic epithelium |
GO:0072080 | 4e-04 | 3.7871 | 3.2572 | 11 | 84 | nephron tubule development |
GO:0035270 | 4e-04 | 3.2886 | 4.3615 | 13 | 113 | endocrine system development |
GO:0060541 | 4e-04 | 2.7479 | 6.7151 | 17 | 174 | respiratory system development |
GO:0071805 | 4e-04 | 2.6442 | 7.3675 | 18 | 190 | potassium ion transmembrane transport |
GO:0021953 | 5e-04 | 3.0841 | 4.9734 | 14 | 130 | central nervous system neuron differentiation |
GO:0009890 | 5e-04 | 1.5221 | 60.4913 | 86 | 1560 | negative regulation of biosynthetic process |
GO:0031016 | 5e-04 | 3.9852 | 2.8307 | 10 | 73 | pancreas development |
GO:0007517 | 5e-04 | 2.1375 | 13.4899 | 27 | 349 | muscle organ development |
GO:0048729 | 5e-04 | 2.045 | 15.6373 | 30 | 418 | tissue morphogenesis |
GO:0048608 | 5e-04 | 2.0659 | 14.9677 | 29 | 386 | reproductive structure development |
GO:0060539 | 5e-04 | 37.3676 | 0.1939 | 3 | 5 | diaphragm development |
GO:0045766 | 6e-04 | 3.0138 | 5.0797 | 14 | 131 | positive regulation of angiogenesis |
GO:0045778 | 7e-04 | 3.8032 | 2.947 | 10 | 76 | positive regulation of ossification |
GO:0001657 | 7e-04 | 3.498 | 3.4899 | 11 | 90 | ureteric bud development |
GO:0040012 | 7e-04 | 1.7042 | 30.5171 | 49 | 787 | regulation of locomotion |
GO:0098609 | 7e-04 | 1.7339 | 28.1517 | 46 | 726 | cell-cell adhesion |
GO:0003203 | 7e-04 | 6.5226 | 1.1245 | 6 | 29 | endocardial cushion morphogenesis |
GO:0072163 | 8e-04 | 3.4541 | 3.5287 | 11 | 91 | mesonephric epithelium development |
GO:0030539 | 8e-04 | 8.3248 | 0.7755 | 5 | 20 | male genitalia development |
GO:0060411 | 9e-04 | 4.03 | 2.5205 | 9 | 65 | cardiac septum morphogenesis |
GO:0030509 | 9e-04 | 2.8656 | 5.3124 | 14 | 137 | BMP signaling pathway |
GO:0022414 | 9e-04 | 1.5479 | 48.0828 | 70 | 1240 | reproductive process |
GO:1901342 | 9e-04 | 2.2361 | 10.5084 | 22 | 271 | regulation of vasculature development |
GO:0009914 | 9e-04 | 2.1896 | 11.2064 | 23 | 289 | hormone transport |
GO:0060052 | 0.0011 | 24.91 | 0.2327 | 3 | 6 | neurofilament cytoskeleton organization |
GO:0086073 | 0.0011 | 24.91 | 0.2327 | 3 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0030154 | 0.0012 | 1.6791 | 30.5738 | 48 | 907 | cell differentiation |
GO:0065008 | 0.0012 | 1.3609 | 116.1599 | 146 | 3034 | regulation of biological quality |
GO:0060349 | 0.0012 | 3.4849 | 3.1797 | 10 | 82 | bone morphogenesis |
GO:0018212 | 0.0013 | 2.0283 | 13.6105 | 26 | 351 | peptidyl-tyrosine modification |
GO:0030323 | 0.0013 | 2.6322 | 6.1458 | 15 | 159 | respiratory tube development |
GO:0030534 | 0.0013 | 2.8678 | 4.9246 | 13 | 127 | adult behavior |
GO:0021513 | 0.0013 | 7.3444 | 0.8531 | 5 | 22 | spinal cord dorsal/ventral patterning |
GO:0046483 | 0.0013 | 1.2986 | 210.8663 | 246 | 5438 | heterocycle metabolic process |
GO:0007167 | 0.0014 | 1.6084 | 35.5192 | 54 | 916 | enzyme linked receptor protein signaling pathway |
GO:0006725 | 0.0014 | 1.2956 | 212.1072 | 247 | 5470 | cellular aromatic compound metabolic process |
GO:0072088 | 0.0015 | 3.6984 | 2.7144 | 9 | 70 | nephron epithelium morphogenesis |
GO:0046777 | 0.0015 | 2.3531 | 8.1818 | 18 | 211 | protein autophosphorylation |
GO:0050789 | 0.0015 | 1.3572 | 239.7844 | 270 | 6655 | regulation of biological process |
GO:0098815 | 0.0015 | 5.5548 | 1.2796 | 6 | 33 | modulation of excitatory postsynaptic potential |
GO:0007493 | 0.0015 | Inf | 0.0776 | 2 | 2 | endodermal cell fate determination |
GO:0021560 | 0.0015 | Inf | 0.0776 | 2 | 2 | abducens nerve development |
GO:0021599 | 0.0015 | Inf | 0.0776 | 2 | 2 | abducens nerve formation |
GO:0032759 | 0.0015 | Inf | 0.0776 | 2 | 2 | positive regulation of TRAIL production |
GO:0048343 | 0.0015 | Inf | 0.0776 | 2 | 2 | paraxial mesodermal cell fate commitment |
GO:0051729 | 0.0015 | Inf | 0.0776 | 2 | 2 | germline cell cycle switching, mitotic to meiotic cell cycle |
GO:0051892 | 0.0015 | Inf | 0.0776 | 2 | 2 | negative regulation of cardioblast differentiation |
GO:0060184 | 0.0015 | Inf | 0.0776 | 2 | 2 | cell cycle switching |
GO:0061032 | 0.0015 | Inf | 0.0776 | 2 | 2 | visceral serous pericardium development |
GO:2000043 | 0.0015 | Inf | 0.0776 | 2 | 2 | regulation of cardiac cell fate specification |
GO:2000027 | 0.0015 | 2.4942 | 6.8849 | 16 | 180 | regulation of organ morphogenesis |
GO:0071363 | 0.0016 | 1.8883 | 16.8089 | 30 | 442 | cellular response to growth factor stimulus |
GO:0001964 | 0.0016 | 6.9359 | 0.8919 | 5 | 23 | startle response |
GO:0061333 | 0.0016 | 3.6385 | 2.7531 | 9 | 71 | renal tubule morphogenesis |
GO:0021527 | 0.0016 | 9.9762 | 0.5429 | 4 | 14 | spinal cord association neuron differentiation |
GO:0035637 | 0.0016 | 2.4731 | 6.941 | 16 | 179 | multicellular organismal signaling |
GO:0008284 | 0.0017 | 1.72 | 24.5641 | 40 | 641 | positive regulation of cell proliferation |
GO:0007507 | 0.0017 | 1.9764 | 13.9318 | 26 | 367 | heart development |
GO:0071542 | 0.0018 | 5.356 | 1.3184 | 6 | 34 | dopaminergic neuron differentiation |
GO:0010002 | 0.0018 | 18.7987 | 0.2698 | 3 | 7 | cardioblast differentiation |
GO:0021521 | 0.0018 | 18.7423 | 0.2706 | 3 | 7 | ventral spinal cord interneuron specification |
GO:0014827 | 0.0018 | 18.6812 | 0.2714 | 3 | 7 | intestine smooth muscle contraction |
GO:0031622 | 0.0018 | 18.6812 | 0.2714 | 3 | 7 | positive regulation of fever generation |
GO:0048341 | 0.0018 | 18.6812 | 0.2714 | 3 | 7 | paraxial mesoderm formation |
GO:0060017 | 0.0018 | 18.6812 | 0.2714 | 3 | 7 | parathyroid gland development |
GO:0010463 | 0.0018 | 4.4906 | 1.7837 | 7 | 46 | mesenchymal cell proliferation |
GO:0060425 | 0.0018 | 4.4906 | 1.7837 | 7 | 46 | lung morphogenesis |
GO:0043279 | 0.0018 | 3.0682 | 3.9164 | 11 | 101 | response to alkaloid |
GO:0022610 | 0.0018 | 1.5077 | 47.7338 | 68 | 1231 | biological adhesion |
GO:0061448 | 0.0019 | 4.4619 | 1.7901 | 7 | 47 | connective tissue development |
GO:0060562 | 0.002 | 4.4197 | 1.8019 | 7 | 48 | epithelial tube morphogenesis |
GO:0007611 | 0.002 | 2.2812 | 8.4145 | 18 | 217 | learning or memory |
GO:0030855 | 0.002 | 1.6774 | 26.4068 | 42 | 681 | epithelial cell differentiation |
GO:0007389 | 0.002 | 6.4551 | 0.932 | 5 | 26 | pattern specification process |
GO:0001755 | 0.0021 | 5.171 | 1.3572 | 6 | 35 | neural crest cell migration |
GO:0035137 | 0.0021 | 5.171 | 1.3572 | 6 | 35 | hindlimb morphogenesis |
GO:2000826 | 0.0021 | 5.171 | 1.3572 | 6 | 35 | regulation of heart morphogenesis |
GO:0072171 | 0.0021 | 3.8522 | 2.3266 | 8 | 60 | mesonephric tubule morphogenesis |
GO:0019233 | 0.0021 | 3.2155 | 3.4123 | 10 | 88 | sensory perception of pain |
GO:0003156 | 0.0021 | 9.122 | 0.5784 | 4 | 15 | regulation of animal organ formation |
GO:0072359 | 0.0022 | 1.8923 | 15.638 | 28 | 421 | circulatory system development |
GO:0061377 | 0.0022 | 9.0686 | 0.5816 | 4 | 15 | mammary gland lobule development |
GO:0098911 | 0.0022 | 9.0686 | 0.5816 | 4 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0022603 | 0.0023 | 1.6874 | 24.9949 | 40 | 664 | regulation of anatomical structure morphogenesis |
GO:0045596 | 0.0024 | 1.7203 | 22.6642 | 37 | 589 | negative regulation of cell differentiation |
GO:1901360 | 0.0024 | 1.2766 | 219.7461 | 253 | 5667 | organic cyclic compound metabolic process |
GO:0060322 | 0.0024 | 1.6823 | 25.0496 | 40 | 646 | head development |
GO:0003309 | 0.0024 | 6.2415 | 0.9694 | 5 | 25 | type B pancreatic cell differentiation |
GO:0001944 | 0.0024 | 2.0164 | 12.0743 | 23 | 319 | vasculature development |
GO:0006935 | 0.0025 | 1.7602 | 20.3576 | 34 | 525 | chemotaxis |
GO:0051270 | 0.0026 | 1.6079 | 30.7885 | 47 | 794 | regulation of cellular component movement |
GO:0014031 | 0.0026 | 3.709 | 2.4041 | 8 | 62 | mesenchymal cell development |
GO:0001946 | 0.0028 | 8.3124 | 0.6204 | 4 | 16 | lymphangiogenesis |
GO:0033278 | 0.0028 | 14.944 | 0.3102 | 3 | 8 | cell proliferation in midbrain |
GO:0006813 | 0.0029 | 2.2026 | 8.6859 | 18 | 224 | potassium ion transport |
GO:0007368 | 0.0029 | 2.8752 | 4.1491 | 11 | 107 | determination of left/right symmetry |
GO:0008584 | 0.003 | 2.7146 | 4.7695 | 12 | 123 | male gonad development |
GO:0046661 | 0.003 | 2.7108 | 4.7739 | 12 | 124 | male sex differentiation |
GO:0048706 | 0.0031 | 5.8244 | 1.0211 | 5 | 27 | embryonic skeletal system development |
GO:0009798 | 0.0031 | 3.2678 | 3.0246 | 9 | 78 | axis specification |
GO:0045103 | 0.0032 | 4.6853 | 1.4735 | 6 | 38 | intermediate filament-based process |
GO:0048483 | 0.0032 | 4.6853 | 1.4735 | 6 | 38 | autonomic nervous system development |
GO:0015844 | 0.0032 | 3.5761 | 2.4817 | 8 | 64 | monoamine transport |
GO:0038084 | 0.0034 | 5.6733 | 1.047 | 5 | 27 | vascular endothelial growth factor signaling pathway |
GO:0061311 | 0.0034 | 5.6733 | 1.047 | 5 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0051216 | 0.0035 | 2.4385 | 6.1386 | 14 | 159 | cartilage development |
GO:0072132 | 0.0035 | 7.7394 | 0.6538 | 4 | 17 | mesenchyme morphogenesis |
GO:0050767 | 0.0035 | 1.6544 | 24.7781 | 39 | 639 | regulation of neurogenesis |
GO:0050805 | 0.0035 | 3.5131 | 2.5205 | 8 | 65 | negative regulation of synaptic transmission |
GO:0072074 | 0.0036 | 7.6724 | 0.6592 | 4 | 17 | kidney mesenchyme development |
GO:0045665 | 0.0036 | 2.3436 | 6.8247 | 15 | 176 | negative regulation of neuron differentiation |
GO:0072175 | 0.0036 | 2.6426 | 4.8858 | 12 | 126 | epithelial tube formation |
GO:0032496 | 0.0036 | 2.0154 | 11.0125 | 21 | 284 | response to lipopolysaccharide |
GO:0048762 | 0.0038 | 2.7598 | 4.3017 | 11 | 112 | mesenchymal cell differentiation |
GO:0023051 | 0.0039 | 1.3085 | 120.4009 | 147 | 3105 | regulation of signaling |
GO:0048167 | 0.004 | 2.4927 | 5.5838 | 13 | 144 | regulation of synaptic plasticity |
GO:0008015 | 0.004 | 1.7642 | 17.8759 | 30 | 461 | blood circulation |
GO:0007501 | 0.0041 | 12.4932 | 0.3479 | 3 | 9 | mesodermal cell fate specification |
GO:0001701 | 0.0041 | 1.9922 | 11.1288 | 21 | 287 | in utero embryonic development |
GO:0002934 | 0.0041 | 12.4525 | 0.349 | 3 | 9 | desmosome organization |
GO:0003266 | 0.0041 | 12.4525 | 0.349 | 3 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0042473 | 0.0041 | 12.4525 | 0.349 | 3 | 9 | outer ear morphogenesis |
GO:0060923 | 0.0041 | 12.4525 | 0.349 | 3 | 9 | cardiac muscle cell fate commitment |
GO:0090009 | 0.0041 | 12.4525 | 0.349 | 3 | 9 | primitive streak formation |
GO:1905770 | 0.0041 | 12.4525 | 0.349 | 3 | 9 | regulation of mesodermal cell differentiation |
GO:2000543 | 0.0041 | 12.4525 | 0.349 | 3 | 9 | positive regulation of gastrulation |
GO:0046887 | 0.0041 | 2.732 | 4.343 | 11 | 112 | positive regulation of hormone secretion |
GO:0072210 | 0.0041 | 4.4091 | 1.5511 | 6 | 40 | metanephric nephron development |
GO:0050730 | 0.0043 | 2.1617 | 8.3369 | 17 | 215 | regulation of peptidyl-tyrosine phosphorylation |
GO:0003166 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | bundle of His development |
GO:0014707 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0021912 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035880 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0042270 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | protection from natural killer cell mediated cytotoxicity |
GO:0044691 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | tooth eruption |
GO:0060435 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | bronchiole development |
GO:0060913 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | cardiac cell fate determination |
GO:1904349 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | positive regulation of small intestine smooth muscle contraction |
GO:1905333 | 0.0044 | 49.7424 | 0.1163 | 2 | 3 | regulation of gastric motility |
GO:2000026 | 0.0044 | 1.464 | 46.0839 | 64 | 1242 | regulation of multicellular organismal development |
GO:0060993 | 0.0044 | 3.0879 | 3.1797 | 9 | 82 | kidney morphogenesis |
GO:0001759 | 0.0044 | 7.1239 | 0.698 | 4 | 18 | organ induction |
GO:0010884 | 0.0044 | 7.1239 | 0.698 | 4 | 18 | positive regulation of lipid storage |
GO:0001656 | 0.0045 | 4.317 | 1.5779 | 6 | 41 | metanephros development |
GO:2000147 | 0.0046 | 1.8026 | 15.7432 | 27 | 406 | positive regulation of cell motility |
GO:0001658 | 0.0046 | 3.7242 | 2.0939 | 7 | 54 | branching involved in ureteric bud morphogenesis |
GO:0001947 | 0.0046 | 3.7242 | 2.0939 | 7 | 54 | heart looping |
GO:0008306 | 0.0046 | 3.3368 | 2.6368 | 8 | 68 | associative learning |
GO:0034641 | 0.0047 | 1.2504 | 233.0852 | 264 | 6011 | cellular nitrogen compound metabolic process |
GO:0009954 | 0.0047 | 5.1998 | 1.1245 | 5 | 29 | proximal/distal pattern formation |
GO:0048384 | 0.0047 | 5.1998 | 1.1245 | 5 | 29 | retinoic acid receptor signaling pathway |
GO:0003208 | 0.0049 | 3.6758 | 2.1165 | 7 | 55 | cardiac ventricle morphogenesis |
GO:0022008 | 0.0049 | 3.0215 | 3.2317 | 9 | 89 | neurogenesis |
GO:0009719 | 0.0052 | 1.4237 | 52.4645 | 71 | 1353 | response to endogenous stimulus |
GO:0060976 | 0.0053 | 4.1635 | 1.6286 | 6 | 42 | coronary vasculature development |
GO:0010646 | 0.0054 | 1.2962 | 118.6559 | 144 | 3060 | regulation of cell communication |
GO:0071773 | 0.0054 | 10.841 | 0.382 | 3 | 10 | cellular response to BMP stimulus |
GO:0034505 | 0.0054 | 6.6485 | 0.7368 | 4 | 19 | tooth mineralization |
GO:0048557 | 0.0054 | 6.6485 | 0.7368 | 4 | 19 | embryonic digestive tract morphogenesis |
GO:0042755 | 0.0055 | 4.9915 | 1.1633 | 5 | 30 | eating behavior |
GO:0021520 | 0.0056 | 10.7084 | 0.3865 | 3 | 10 | spinal cord motor neuron cell fate specification |
GO:0003263 | 0.0057 | 10.6728 | 0.3878 | 3 | 10 | cardioblast proliferation |
GO:0031650 | 0.0057 | 10.6728 | 0.3878 | 3 | 10 | regulation of heat generation |
GO:0032275 | 0.0057 | 10.6728 | 0.3878 | 3 | 10 | luteinizing hormone secretion |
GO:0032769 | 0.0057 | 10.6728 | 0.3878 | 3 | 10 | negative regulation of monooxygenase activity |
GO:0009799 | 0.0057 | 2.6022 | 4.5368 | 11 | 117 | specification of symmetry |
GO:0010629 | 0.0058 | 1.3699 | 67.7425 | 88 | 1747 | negative regulation of gene expression |
GO:0002448 | 0.006 | 4.0507 | 1.6674 | 6 | 43 | mast cell mediated immunity |
GO:0035094 | 0.006 | 4.0507 | 1.6674 | 6 | 43 | response to nicotine |
GO:0060317 | 0.0063 | 4.7992 | 1.2021 | 5 | 31 | cardiac epithelial to mesenchymal transition |
GO:0030900 | 0.0066 | 1.8427 | 13.1064 | 23 | 338 | forebrain development |
GO:0031290 | 0.0066 | 6.2326 | 0.7755 | 4 | 20 | retinal ganglion cell axon guidance |
GO:0043586 | 0.0066 | 6.2326 | 0.7755 | 4 | 20 | tongue development |
GO:0060986 | 0.0067 | 3.9439 | 1.7062 | 6 | 44 | endocrine hormone secretion |
GO:0098900 | 0.0067 | 3.9439 | 1.7062 | 6 | 44 | regulation of action potential |
GO:0006812 | 0.007 | 1.4716 | 38.4275 | 54 | 991 | cation transport |
GO:1903530 | 0.007 | 1.6081 | 23.421 | 36 | 604 | regulation of secretion by cell |
GO:0048593 | 0.0071 | 2.6652 | 4.0328 | 10 | 104 | camera-type eye morphogenesis |
GO:0072089 | 0.0071 | 2.6652 | 4.0328 | 10 | 104 | stem cell proliferation |
GO:0003206 | 0.0071 | 9.5746 | 0.4165 | 3 | 11 | cardiac chamber morphogenesis |
GO:0044057 | 0.0072 | 1.6836 | 18.6515 | 30 | 481 | regulation of system process |
GO:0000902 | 0.0073 | 1.5097 | 32.5722 | 47 | 840 | cell morphogenesis |
GO:0019932 | 0.0073 | 1.953 | 10.237 | 19 | 264 | second-messenger-mediated signaling |
GO:0010039 | 0.0073 | 4.6211 | 1.2408 | 5 | 32 | response to iron ion |
GO:0002067 | 0.0075 | 3.8425 | 1.7449 | 6 | 45 | glandular epithelial cell differentiation |
GO:0006584 | 0.0075 | 3.8425 | 1.7449 | 6 | 45 | catecholamine metabolic process |
GO:0051961 | 0.0075 | 1.987 | 9.539 | 18 | 246 | negative regulation of nervous system development |
GO:0003161 | 0.0076 | 9.3381 | 0.4265 | 3 | 11 | cardiac conduction system development |
GO:0021889 | 0.0076 | 9.3381 | 0.4265 | 3 | 11 | olfactory bulb interneuron differentiation |
GO:0060379 | 0.0076 | 9.3381 | 0.4265 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060536 | 0.0076 | 9.3381 | 0.4265 | 3 | 11 | cartilage morphogenesis |
GO:0060415 | 0.0077 | 3.0322 | 2.8695 | 8 | 74 | muscle tissue morphogenesis |
GO:0010842 | 0.0079 | 5.8655 | 0.8143 | 4 | 21 | retina layer formation |
GO:0001654 | 0.0079 | 1.8369 | 12.5636 | 22 | 324 | eye development |
GO:0014020 | 0.0081 | 2.7814 | 3.4899 | 9 | 90 | primary neural tube formation |
GO:0048844 | 0.0081 | 3.3121 | 2.3193 | 7 | 60 | artery morphogenesis |
GO:0070830 | 0.0083 | 3.7462 | 1.7837 | 6 | 46 | bicellular tight junction assembly |
GO:0007198 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021913 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0032100 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | positive regulation of appetite |
GO:0042662 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0048105 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | establishment of body hair planar orientation |
GO:0060214 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | endocardium formation |
GO:0061030 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | epithelial cell differentiation involved in mammary gland alveolus development |
GO:0061056 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | sclerotome development |
GO:0061183 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | regulation of dermatome development |
GO:0097070 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | ductus arteriosus closure |
GO:0097476 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | spinal cord motor neuron migration |
GO:1905903 | 0.0085 | 24.8695 | 0.1551 | 2 | 4 | negative regulation of mesoderm formation |
GO:0050679 | 0.0086 | 2.2499 | 6.1267 | 13 | 158 | positive regulation of epithelial cell proliferation |
GO:0007610 | 0.0087 | 2.5739 | 4.1557 | 10 | 111 | behavior |
GO:0031175 | 0.0089 | 1.5042 | 31.2538 | 45 | 806 | neuron projection development |
GO:0006940 | 0.0091 | 3.2399 | 2.3654 | 7 | 61 | regulation of smooth muscle contraction |
GO:0050795 | 0.0091 | 3.2399 | 2.3654 | 7 | 61 | regulation of behavior |
GO:0061180 | 0.0091 | 3.2399 | 2.3654 | 7 | 61 | mammary gland epithelium development |
GO:0007626 | 0.0091 | 2.1565 | 6.8634 | 14 | 177 | locomotory behavior |
GO:0019933 | 0.0093 | 2.714 | 3.5674 | 9 | 92 | cAMP-mediated signaling |
GO:2000679 | 0.0094 | 5.5393 | 0.8531 | 4 | 22 | positive regulation of transcription regulatory region DNA binding |
GO:0033003 | 0.0095 | 4.3018 | 1.3184 | 5 | 34 | regulation of mast cell activation |
GO:0060428 | 0.0095 | 4.3018 | 1.3184 | 5 | 34 | lung epithelium development |
GO:0048638 | 0.0095 | 1.8978 | 10.5084 | 19 | 271 | regulation of developmental growth |
GO:0048522 | 0.0095 | 1.2851 | 111.6991 | 134 | 3103 | positive regulation of cellular process |
GO:0033604 | 0.0098 | 8.2999 | 0.4653 | 3 | 12 | negative regulation of catecholamine secretion |
GO:0043518 | 0.0098 | 8.2999 | 0.4653 | 3 | 12 | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO:0048864 | 0.0099 | 3.1807 | 2.4041 | 7 | 62 | stem cell development |
GO:0007200 | 0.0099 | 2.6815 | 3.6062 | 9 | 93 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 15.9013 | 0.9198 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 11.4962 | 1.2759 | 11 | 43 | protein heterotetramerization |
GO:0000183 | 0 | 12.839 | 1.0682 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 12.839 | 1.0682 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 12.839 | 1.0682 | 10 | 36 | response to interleukin-7 |
GO:0050906 | 0 | 3.1159 | 12.1655 | 34 | 410 | detection of stimulus involved in sensory perception |
GO:0050911 | 0 | 3.2092 | 9.673 | 28 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0002376 | 0 | 1.8646 | 56.6119 | 93 | 1977 | immune system process |
GO:0007186 | 0 | 2.123 | 30.1881 | 58 | 1030 | G-protein coupled receptor signaling pathway |
GO:0031497 | 0 | 4.5452 | 4.2431 | 17 | 143 | chromatin assembly |
GO:0007606 | 0 | 2.7385 | 12.4028 | 31 | 418 | sensory perception of chemical stimulus |
GO:0034728 | 0 | 4.2081 | 4.5398 | 17 | 153 | nucleosome organization |
GO:0009593 | 0 | 2.761 | 11.8984 | 30 | 401 | detection of chemical stimulus |
GO:0050830 | 0 | 5.9008 | 2.3737 | 12 | 80 | defense response to Gram-positive bacterium |
GO:0045652 | 0 | 6.1197 | 2.1067 | 11 | 71 | regulation of megakaryocyte differentiation |
GO:0016339 | 0 | 11.6096 | 0.8011 | 7 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0061844 | 0 | 7.5911 | 1.2759 | 8 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0048486 | 0 | 18.3594 | 0.4154 | 5 | 14 | parasympathetic nervous system development |
GO:0023052 | 0 | 1.4724 | 168.8031 | 210 | 5689 | signaling |
GO:0098542 | 0 | 2.4957 | 12.1358 | 28 | 409 | defense response to other organism |
GO:0007154 | 0 | 1.4643 | 169.3669 | 210 | 5708 | cell communication |
GO:0065004 | 1e-04 | 3.1348 | 6.2608 | 18 | 211 | protein-DNA complex assembly |
GO:0030099 | 1e-04 | 2.5401 | 10.6225 | 25 | 358 | myeloid cell differentiation |
GO:0009617 | 1e-04 | 2.3169 | 13.9458 | 30 | 470 | response to bacterium |
GO:0048534 | 1e-04 | 1.9784 | 23.9748 | 44 | 808 | hematopoietic or lymphoid organ development |
GO:0045815 | 1e-04 | 4.8951 | 2.3144 | 10 | 78 | positive regulation of gene expression, epigenetic |
GO:0050877 | 1e-04 | 1.813 | 32.7707 | 55 | 1111 | nervous system process |
GO:0002227 | 1e-04 | 12.7069 | 0.5341 | 5 | 18 | innate immune response in mucosa |
GO:0002251 | 1e-04 | 9.025 | 0.8308 | 6 | 28 | organ or tissue specific immune response |
GO:0060964 | 2e-04 | 4.1646 | 2.9375 | 11 | 99 | regulation of gene silencing by miRNA |
GO:0045814 | 2e-04 | 3.8119 | 3.4716 | 12 | 117 | negative regulation of gene expression, epigenetic |
GO:0019731 | 2e-04 | 8.3079 | 0.8865 | 6 | 30 | antibacterial humoral response |
GO:0007596 | 3e-04 | 2.496 | 9.0202 | 21 | 304 | blood coagulation |
GO:1903039 | 4e-04 | 2.8639 | 6.0234 | 16 | 203 | positive regulation of leukocyte cell-cell adhesion |
GO:0046903 | 4e-04 | 1.6618 | 38.7915 | 60 | 1321 | secretion |
GO:0002443 | 6e-04 | 1.9073 | 19.5241 | 35 | 658 | leukocyte mediated immunity |
GO:1902036 | 8e-04 | 3.693 | 2.9672 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0050829 | 8e-04 | 4.4959 | 1.988 | 8 | 67 | defense response to Gram-negative bacterium |
GO:0021561 | 8e-04 | 24.6833 | 0.2077 | 3 | 7 | facial nerve development |
GO:0021570 | 9e-04 | Inf | 0.0593 | 2 | 2 | rhombomere 4 development |
GO:0050863 | 9e-04 | 2.3943 | 8.4565 | 19 | 285 | regulation of T cell activation |
GO:0050900 | 9e-04 | 2.1849 | 11.1863 | 23 | 377 | leukocyte migration |
GO:0060968 | 9e-04 | 3.3267 | 3.5903 | 11 | 121 | regulation of gene silencing |
GO:0045582 | 0.001 | 4.3479 | 2.0474 | 8 | 69 | positive regulation of T cell differentiation |
GO:0051952 | 0.001 | 4.3479 | 2.0474 | 8 | 69 | regulation of amine transport |
GO:0050896 | 0.001 | 1.7065 | 33.3303 | 51 | 1260 | response to stimulus |
GO:0045055 | 0.001 | 1.864 | 19.346 | 34 | 652 | regulated exocytosis |
GO:0032753 | 0.001 | 10.9889 | 0.4747 | 4 | 16 | positive regulation of interleukin-4 production |
GO:0045087 | 0.0011 | 1.8081 | 21.7111 | 37 | 739 | innate immune response |
GO:0002263 | 0.0011 | 1.8925 | 17.9218 | 32 | 604 | cell activation involved in immune response |
GO:0002244 | 0.0011 | 2.7635 | 5.4299 | 14 | 183 | hematopoietic progenitor cell differentiation |
GO:0001816 | 0.0013 | 1.8789 | 18.0405 | 32 | 608 | cytokine production |
GO:0032729 | 0.0013 | 4.7293 | 1.6616 | 7 | 56 | positive regulation of interferon-gamma production |
GO:0043380 | 0.0013 | 19.7453 | 0.2374 | 3 | 8 | regulation of memory T cell differentiation |
GO:1904628 | 0.0013 | 19.7453 | 0.2374 | 3 | 8 | cellular response to phorbol 13-acetate 12-myristate |
GO:0007155 | 0.0013 | 1.6085 | 36.4073 | 55 | 1227 | cell adhesion |
GO:0098751 | 0.0015 | 6.8778 | 0.8605 | 5 | 29 | bone cell development |
GO:0006959 | 0.0016 | 2.7755 | 5.0147 | 13 | 170 | humoral immune response |
GO:0071103 | 0.0016 | 2.3879 | 7.5663 | 17 | 255 | DNA conformation change |
GO:0006954 | 0.0016 | 1.8455 | 18.3372 | 32 | 618 | inflammatory response |
GO:0002369 | 0.0017 | 6.6022 | 0.8902 | 5 | 30 | T cell cytokine production |
GO:0002250 | 0.0018 | 2.6273 | 5.6859 | 14 | 194 | adaptive immune response |
GO:0015698 | 0.0018 | 2.8728 | 4.4804 | 12 | 151 | inorganic anion transport |
GO:0070255 | 0.0019 | 16.4533 | 0.267 | 3 | 9 | regulation of mucus secretion |
GO:0090715 | 0.0019 | 16.4533 | 0.267 | 3 | 9 | immunological memory formation process |
GO:0015711 | 0.0019 | 2.0539 | 11.8391 | 23 | 399 | organic anion transport |
GO:1903708 | 0.0019 | 2.8521 | 4.5101 | 12 | 152 | positive regulation of hemopoiesis |
GO:0002694 | 0.002 | 2.0108 | 12.6105 | 24 | 425 | regulation of leukocyte activation |
GO:0022407 | 0.002 | 2.079 | 11.1863 | 22 | 377 | regulation of cell-cell adhesion |
GO:1903706 | 0.0021 | 2.3323 | 7.7317 | 17 | 265 | regulation of hemopoiesis |
GO:0002763 | 0.0023 | 4.9577 | 1.3649 | 6 | 46 | positive regulation of myeloid leukocyte differentiation |
GO:0002673 | 0.0023 | 3.733 | 2.3441 | 8 | 79 | regulation of acute inflammatory response |
GO:0002215 | 0.0026 | 65.6896 | 0.089 | 2 | 3 | defense response to nematode |
GO:0035879 | 0.0026 | 65.6896 | 0.089 | 2 | 3 | plasma membrane lactate transport |
GO:0006069 | 0.0027 | 14.1019 | 0.2967 | 3 | 10 | ethanol oxidation |
GO:0030432 | 0.0027 | 14.1019 | 0.2967 | 3 | 10 | peristalsis |
GO:0009611 | 0.003 | 1.8019 | 17.5361 | 30 | 591 | response to wounding |
GO:0045619 | 0.003 | 2.8331 | 4.1541 | 11 | 140 | regulation of lymphocyte differentiation |
GO:0051716 | 0.0036 | 1.2996 | 190.5229 | 219 | 6421 | cellular response to stimulus |
GO:0002087 | 0.0036 | 12.3383 | 0.3264 | 3 | 11 | regulation of respiratory gaseous exchange by neurological system process |
GO:0051580 | 0.0036 | 12.3383 | 0.3264 | 3 | 11 | regulation of neurotransmitter uptake |
GO:1903531 | 0.0038 | 2.6074 | 4.8959 | 12 | 165 | negative regulation of secretion by cell |
GO:0032941 | 0.004 | 5.3222 | 1.0682 | 5 | 36 | secretion by tissue |
GO:0007156 | 0.0042 | 2.706 | 4.3321 | 11 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0050776 | 0.0044 | 1.7046 | 20.3557 | 33 | 696 | regulation of immune response |
GO:0006501 | 0.0046 | 3.6749 | 2.077 | 7 | 70 | C-terminal protein lipidation |
GO:0002922 | 0.0047 | 10.9667 | 0.3561 | 3 | 12 | positive regulation of humoral immune response |
GO:0038092 | 0.0047 | 10.9667 | 0.3561 | 3 | 12 | nodal signaling pathway |
GO:0051967 | 0.0047 | 10.9667 | 0.3561 | 3 | 12 | negative regulation of synaptic transmission, glutamatergic |
GO:0002521 | 0.0047 | 1.8982 | 12.7292 | 23 | 429 | leukocyte differentiation |
GO:0007599 | 0.0048 | 33.7884 | 0.1155 | 2 | 4 | hemostasis |
GO:0032943 | 0.0049 | 2.251 | 7.0322 | 15 | 237 | mononuclear cell proliferation |
GO:0045595 | 0.0049 | 1.4603 | 46.4068 | 64 | 1564 | regulation of cell differentiation |
GO:0002778 | 0.0051 | 32.8426 | 0.1187 | 2 | 4 | antibacterial peptide production |
GO:0030321 | 0.0051 | 32.8426 | 0.1187 | 2 | 4 | transepithelial chloride transport |
GO:0032714 | 0.0051 | 32.8426 | 0.1187 | 2 | 4 | negative regulation of interleukin-5 production |
GO:0072095 | 0.0051 | 32.8426 | 0.1187 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:0014059 | 0.0051 | 6.5898 | 0.7121 | 4 | 24 | regulation of dopamine secretion |
GO:0002440 | 0.0051 | 2.6274 | 4.4508 | 11 | 150 | production of molecular mediator of immune response |
GO:0051239 | 0.0052 | 1.3686 | 75.8848 | 97 | 2573 | regulation of multicellular organismal process |
GO:0010469 | 0.0053 | 1.8028 | 15.1326 | 26 | 510 | regulation of receptor activity |
GO:0002824 | 0.0054 | 3.5613 | 2.1364 | 7 | 72 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0002706 | 0.0054 | 2.9528 | 3.2639 | 9 | 110 | regulation of lymphocyte mediated immunity |
GO:0009914 | 0.0059 | 2.0846 | 8.5752 | 17 | 289 | hormone transport |
GO:0098656 | 0.0059 | 2.2007 | 7.1806 | 15 | 242 | anion transmembrane transport |
GO:0002830 | 0.0059 | 9.8693 | 0.3857 | 3 | 13 | positive regulation of type 2 immune response |
GO:0042116 | 0.0061 | 3.9635 | 1.6616 | 6 | 56 | macrophage activation |
GO:0006811 | 0.0065 | 1.4632 | 41.8076 | 58 | 1409 | ion transport |
GO:0042119 | 0.0065 | 1.8421 | 13.0853 | 23 | 441 | neutrophil activation |
GO:0045670 | 0.0067 | 3.8855 | 1.6913 | 6 | 57 | regulation of osteoclast differentiation |
GO:0051251 | 0.0068 | 2.162 | 7.2993 | 15 | 246 | positive regulation of lymphocyte activation |
GO:0007628 | 0.0068 | 5.9899 | 0.7715 | 4 | 26 | adult walking behavior |
GO:0002792 | 0.0068 | 2.8396 | 3.3826 | 9 | 114 | negative regulation of peptide secretion |
GO:0098810 | 0.0074 | 8.9715 | 0.4154 | 3 | 14 | neurotransmitter reuptake |
GO:0015849 | 0.0076 | 2.0738 | 8.1004 | 16 | 273 | organic acid transport |
GO:0035587 | 0.0078 | 5.7291 | 0.8011 | 4 | 27 | purinergic receptor signaling pathway |
GO:0030072 | 0.008 | 2.1861 | 6.7355 | 14 | 227 | peptide hormone secretion |
GO:0008544 | 0.0081 | 1.83 | 12.5809 | 22 | 424 | epidermis development |
GO:0021612 | 0.0083 | 21.8936 | 0.1484 | 2 | 5 | facial nerve structural organization |
GO:0042321 | 0.0083 | 21.8936 | 0.1484 | 2 | 5 | negative regulation of circadian sleep/wake cycle, sleep |
GO:0060696 | 0.0083 | 21.8936 | 0.1484 | 2 | 5 | regulation of phospholipid catabolic process |
GO:0002819 | 0.0085 | 2.7346 | 3.5013 | 9 | 118 | regulation of adaptive immune response |
GO:0002275 | 0.0089 | 1.7655 | 14.2128 | 24 | 479 | myeloid cell activation involved in immune response |
GO:0007589 | 0.0089 | 3.2136 | 2.3441 | 7 | 79 | body fluid secretion |
GO:0050673 | 0.0093 | 1.936 | 9.7324 | 18 | 328 | epithelial cell proliferation |
GO:0008277 | 0.0095 | 2.685 | 3.5606 | 9 | 120 | regulation of G-protein coupled receptor protein signaling pathway |
GO:0043312 | 0.0098 | 1.7978 | 12.7886 | 22 | 431 | neutrophil degranulation |
GO:0042098 | 0.0098 | 2.3847 | 4.8662 | 11 | 164 | T cell proliferation |
GO:0032101 | 0.01 | 1.6402 | 19.1087 | 30 | 644 | regulation of response to external stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 152.0881 | 0.5211 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0009593 | 0 | 4.5554 | 12.2924 | 47 | 401 | detection of chemical stimulus |
GO:0050911 | 0 | 5.0389 | 9.9933 | 42 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 4.3416 | 12.8135 | 47 | 418 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 4.3228 | 12.5683 | 46 | 410 | detection of stimulus involved in sensory perception |
GO:0006335 | 0 | 26.8137 | 0.9503 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 20.7127 | 1.1036 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 17.5213 | 1.2262 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 16.2676 | 1.2875 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0051290 | 0 | 15.7056 | 1.3181 | 14 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 9.1071 | 2.391 | 17 | 78 | positive regulation of gene expression, epigenetic |
GO:0016233 | 0 | 12.6457 | 1.5327 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 12.6457 | 1.5327 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0050877 | 0 | 2.4644 | 34.3942 | 74 | 1122 | nervous system process |
GO:0045814 | 0 | 6.7664 | 3.5866 | 20 | 117 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 6.6832 | 3.0654 | 17 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0006303 | 0 | 8.7453 | 2.0232 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0007186 | 0 | 2.2386 | 35.1912 | 70 | 1148 | G-protein coupled receptor signaling pathway |
GO:0043044 | 0 | 7.704 | 2.2378 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:1903707 | 0 | 5.3908 | 3.8931 | 18 | 127 | negative regulation of hemopoiesis |
GO:0060964 | 0 | 5.8006 | 3.0348 | 15 | 99 | regulation of gene silencing by miRNA |
GO:0060968 | 0 | 4.9537 | 3.7092 | 16 | 121 | regulation of gene silencing |
GO:0002244 | 0 | 4.0085 | 5.6097 | 20 | 183 | hematopoietic progenitor cell differentiation |
GO:0032501 | 0 | 1.5934 | 170.4645 | 218 | 5815 | multicellular organismal process |
GO:0045919 | 0 | 26.6253 | 0.3372 | 5 | 11 | positive regulation of cytolysis |
GO:0051707 | 0 | 2.1155 | 22.5616 | 44 | 736 | response to other organism |
GO:0048863 | 0 | 3.0568 | 7.5103 | 21 | 245 | stem cell differentiation |
GO:0015844 | 0 | 5.9619 | 1.9619 | 10 | 64 | monoamine transport |
GO:0002682 | 0 | 2.8376 | 8.4336 | 22 | 293 | regulation of immune system process |
GO:0051952 | 0 | 5.4548 | 2.1152 | 10 | 69 | regulation of amine transport |
GO:0050670 | 1e-04 | 3.2437 | 5.7324 | 17 | 187 | regulation of lymphocyte proliferation |
GO:0031497 | 1e-04 | 3.5068 | 4.3836 | 14 | 143 | chromatin assembly |
GO:0070663 | 1e-04 | 3.0443 | 6.0696 | 17 | 198 | regulation of leukocyte proliferation |
GO:0051716 | 2e-04 | 1.4133 | 188.254 | 226 | 6243 | cellular response to stimulus |
GO:0045637 | 2e-04 | 2.8197 | 6.8972 | 18 | 225 | regulation of myeloid cell differentiation |
GO:0042755 | 3e-04 | 7.9951 | 0.9196 | 6 | 30 | eating behavior |
GO:2000821 | 3e-04 | 47.7323 | 0.1533 | 3 | 5 | regulation of grooming behavior |
GO:0002694 | 3e-04 | 2.2153 | 13.0281 | 27 | 425 | regulation of leukocyte activation |
GO:0032200 | 3e-04 | 3.2057 | 4.7514 | 14 | 155 | telomere organization |
GO:0048534 | 3e-04 | 1.8561 | 24.7687 | 43 | 808 | hematopoietic or lymphoid organ development |
GO:0009607 | 3e-04 | 2.011 | 18.0625 | 34 | 599 | response to biotic stimulus |
GO:0007155 | 4e-04 | 1.6835 | 37.6129 | 59 | 1227 | cell adhesion |
GO:0032943 | 4e-04 | 2.663 | 7.2651 | 18 | 237 | mononuclear cell proliferation |
GO:0002709 | 5e-04 | 5.7467 | 1.4101 | 7 | 46 | regulation of T cell mediated immunity |
GO:0031341 | 6e-04 | 4.7488 | 1.9006 | 8 | 62 | regulation of cell killing |
GO:0015872 | 6e-04 | 6.6144 | 1.0729 | 6 | 35 | dopamine transport |
GO:0014059 | 7e-04 | 8.4006 | 0.7357 | 5 | 24 | regulation of dopamine secretion |
GO:0065004 | 8e-04 | 2.6511 | 6.4681 | 16 | 211 | protein-DNA complex assembly |
GO:0002449 | 9e-04 | 2.7354 | 5.8856 | 15 | 192 | lymphocyte mediated immunity |
GO:0007610 | 9e-04 | 1.971 | 16.1548 | 30 | 527 | behavior |
GO:0045596 | 9e-04 | 1.9007 | 18.4233 | 33 | 601 | negative regulation of cell differentiation |
GO:0031622 | 9e-04 | 23.8629 | 0.2146 | 3 | 7 | positive regulation of fever generation |
GO:0018003 | 9e-04 | Inf | 0.0613 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0051729 | 9e-04 | Inf | 0.0613 | 2 | 2 | germline cell cycle switching, mitotic to meiotic cell cycle |
GO:0060184 | 9e-04 | Inf | 0.0613 | 2 | 2 | cell cycle switching |
GO:0070488 | 9e-04 | Inf | 0.0613 | 2 | 2 | neutrophil aggregation |
GO:0002237 | 9e-04 | 2.3233 | 9.1657 | 20 | 299 | response to molecule of bacterial origin |
GO:0002819 | 0.001 | 3.305 | 3.6172 | 11 | 118 | regulation of adaptive immune response |
GO:0023052 | 0.001 | 1.3479 | 174.3926 | 207 | 5689 | signaling |
GO:0001816 | 0.0011 | 1.8766 | 18.6378 | 33 | 608 | cytokine production |
GO:0002526 | 0.0011 | 3.0645 | 4.2303 | 12 | 138 | acute inflammatory response |
GO:0018108 | 0.0012 | 2.1831 | 10.6984 | 22 | 349 | peptidyl-tyrosine phosphorylation |
GO:2000252 | 0.0014 | 19.089 | 0.2452 | 3 | 8 | negative regulation of feeding behavior |
GO:0009636 | 0.0014 | 2.5874 | 6.1922 | 15 | 202 | response to toxic substance |
GO:0015850 | 0.0015 | 2.5734 | 6.2228 | 15 | 203 | organic hydroxy compound transport |
GO:0007154 | 0.0017 | 1.3286 | 174.975 | 206 | 5708 | cell communication |
GO:0035194 | 0.0017 | 2.3184 | 8.246 | 18 | 269 | posttranscriptional gene silencing by RNA |
GO:0050778 | 0.0019 | 3.5103 | 2.7939 | 9 | 93 | positive regulation of immune response |
GO:0002263 | 0.0019 | 1.8255 | 18.5152 | 32 | 604 | cell activation involved in immune response |
GO:0001963 | 0.002 | 6.3819 | 0.9196 | 5 | 30 | synaptic transmission, dopaminergic |
GO:0050794 | 0.002 | 1.3441 | 279.5679 | 309 | 9368 | regulation of cellular process |
GO:0002758 | 0.002 | 2.3361 | 7.7249 | 17 | 252 | innate immune response-activating signal transduction |
GO:0002703 | 0.0021 | 2.8164 | 4.5675 | 12 | 149 | regulation of leukocyte mediated immunity |
GO:0032649 | 0.0024 | 3.7127 | 2.3604 | 8 | 77 | regulation of interferon-gamma production |
GO:0002460 | 0.0025 | 2.5186 | 5.9163 | 14 | 193 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0045402 | 0.0028 | 63.5107 | 0.092 | 2 | 3 | regulation of interleukin-4 biosynthetic process |
GO:0071673 | 0.0028 | 63.5107 | 0.092 | 2 | 3 | positive regulation of smooth muscle cell chemotaxis |
GO:0090292 | 0.0028 | 63.5107 | 0.092 | 2 | 3 | nuclear matrix anchoring at nuclear membrane |
GO:1905333 | 0.0028 | 63.5107 | 0.092 | 2 | 3 | regulation of gastric motility |
GO:0042592 | 0.0029 | 1.4952 | 46.1655 | 65 | 1506 | homeostatic process |
GO:0031650 | 0.0029 | 13.6332 | 0.3065 | 3 | 10 | regulation of heat generation |
GO:0002285 | 0.0029 | 2.8486 | 4.1383 | 11 | 135 | lymphocyte activation involved in immune response |
GO:0045089 | 0.0031 | 2.1246 | 9.4415 | 19 | 308 | positive regulation of innate immune response |
GO:0071216 | 0.0034 | 2.534 | 5.4565 | 13 | 178 | cellular response to biotic stimulus |
GO:0043588 | 0.0039 | 1.9617 | 11.8019 | 22 | 385 | skin development |
GO:0002517 | 0.0039 | 11.9282 | 0.3372 | 3 | 11 | T cell tolerance induction |
GO:0002864 | 0.0039 | 11.9282 | 0.3372 | 3 | 11 | regulation of acute inflammatory response to antigenic stimulus |
GO:0006068 | 0.0039 | 11.9282 | 0.3372 | 3 | 11 | ethanol catabolic process |
GO:0006911 | 0.004 | 5.3164 | 1.0729 | 5 | 35 | phagocytosis, engulfment |
GO:0051046 | 0.004 | 1.7147 | 20.2319 | 33 | 660 | regulation of secretion |
GO:0006352 | 0.0041 | 2.3004 | 6.8972 | 15 | 225 | DNA-templated transcription, initiation |
GO:0006959 | 0.0041 | 2.4734 | 5.5791 | 13 | 182 | humoral immune response |
GO:0042107 | 0.0041 | 3.1006 | 3.1267 | 9 | 102 | cytokine metabolic process |
GO:0010469 | 0.0042 | 1.8147 | 15.6337 | 27 | 510 | regulation of receptor activity |
GO:0048869 | 0.0043 | 1.3214 | 116.8237 | 142 | 3811 | cellular developmental process |
GO:0045471 | 0.0046 | 2.8377 | 3.7705 | 10 | 123 | response to ethanol |
GO:0007586 | 0.0046 | 2.6745 | 4.3836 | 11 | 143 | digestion |
GO:0050793 | 0.0046 | 1.3919 | 67.4089 | 88 | 2199 | regulation of developmental process |
GO:0065007 | 0.0048 | 1.3238 | 325.5186 | 351 | 10619 | biological regulation |
GO:0030878 | 0.0049 | 6.706 | 0.7051 | 4 | 23 | thyroid gland development |
GO:0042742 | 0.005 | 2.3215 | 6.3761 | 14 | 208 | defense response to bacterium |
GO:0050776 | 0.005 | 2.6378 | 4.4363 | 11 | 151 | regulation of immune response |
GO:0033604 | 0.0051 | 10.6022 | 0.3679 | 3 | 12 | negative regulation of catecholamine secretion |
GO:0034374 | 0.0051 | 10.6022 | 0.3679 | 3 | 12 | low-density lipoprotein particle remodeling |
GO:0051481 | 0.0051 | 10.6022 | 0.3679 | 3 | 12 | negative regulation of cytosolic calcium ion concentration |
GO:0071318 | 0.0051 | 10.6022 | 0.3679 | 3 | 12 | cellular response to ATP |
GO:0050896 | 0.0054 | 1.6238 | 27.5321 | 41 | 1074 | response to stimulus |
GO:0007356 | 0.0054 | 31.7532 | 0.1226 | 2 | 4 | thorax and anterior abdomen determination |
GO:0014050 | 0.0054 | 31.7532 | 0.1226 | 2 | 4 | negative regulation of glutamate secretion |
GO:0021615 | 0.0054 | 31.7532 | 0.1226 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0036101 | 0.0054 | 31.7532 | 0.1226 | 2 | 4 | leukotriene B4 catabolic process |
GO:2001188 | 0.0054 | 31.7532 | 0.1226 | 2 | 4 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0002691 | 0.0057 | 6.3703 | 0.7357 | 4 | 24 | regulation of cellular extravasation |
GO:0034698 | 0.0057 | 6.3703 | 0.7357 | 4 | 24 | response to gonadotropin |
GO:0002764 | 0.0059 | 1.8326 | 13.7331 | 24 | 448 | immune response-regulating signaling pathway |
GO:0048661 | 0.006 | 3.496 | 2.1765 | 7 | 71 | positive regulation of smooth muscle cell proliferation |
GO:0022407 | 0.0063 | 1.906 | 11.5567 | 21 | 377 | regulation of cell-cell adhesion |
GO:0002437 | 0.0065 | 4.6897 | 1.1955 | 5 | 39 | inflammatory response to antigenic stimulus |
GO:0046006 | 0.0065 | 4.6897 | 1.1955 | 5 | 39 | regulation of activated T cell proliferation |
GO:0050866 | 0.0069 | 2.5203 | 4.6288 | 11 | 151 | negative regulation of cell activation |
GO:0071222 | 0.0069 | 2.5203 | 4.6288 | 11 | 151 | cellular response to lipopolysaccharide |
GO:0045429 | 0.0072 | 4.5554 | 1.2262 | 5 | 40 | positive regulation of nitric oxide biosynthetic process |
GO:0002253 | 0.0077 | 1.7671 | 14.8061 | 25 | 483 | activation of immune response |
GO:0006910 | 0.0081 | 8.6733 | 0.4292 | 3 | 14 | phagocytosis, recognition |
GO:0014744 | 0.0081 | 8.6733 | 0.4292 | 3 | 14 | positive regulation of muscle adaptation |
GO:0048705 | 0.0081 | 2.257 | 6.0696 | 13 | 198 | skeletal system morphogenesis |
GO:0031347 | 0.0083 | 1.6501 | 19.6494 | 31 | 641 | regulation of defense response |
GO:1903038 | 0.0087 | 2.9409 | 2.9122 | 8 | 95 | negative regulation of leukocyte cell-cell adhesion |
GO:0045321 | 0.0087 | 1.6743 | 18.1249 | 29 | 610 | leukocyte activation |
GO:0002249 | 0.0088 | 21.1674 | 0.1533 | 2 | 5 | lymphocyte anergy |
GO:0002309 | 0.0088 | 21.1674 | 0.1533 | 2 | 5 | T cell proliferation involved in immune response |
GO:0002667 | 0.0088 | 21.1674 | 0.1533 | 2 | 5 | regulation of T cell anergy |
GO:0006824 | 0.0088 | 21.1674 | 0.1533 | 2 | 5 | cobalt ion transport |
GO:0014805 | 0.0088 | 21.1674 | 0.1533 | 2 | 5 | smooth muscle adaptation |
GO:0019509 | 0.0088 | 21.1674 | 0.1533 | 2 | 5 | L-methionine salvage from methylthioadenosine |
GO:1901523 | 0.0088 | 21.1674 | 0.1533 | 2 | 5 | icosanoid catabolic process |
GO:0051250 | 0.0089 | 2.7179 | 3.5253 | 9 | 115 | negative regulation of lymphocyte activation |
GO:0042110 | 0.009 | 1.8129 | 12.6909 | 22 | 414 | T cell activation |
GO:0032103 | 0.009 | 2.0882 | 7.541 | 15 | 246 | positive regulation of response to external stimulus |
GO:0051259 | 0.0091 | 1.7396 | 15.0206 | 25 | 490 | protein oligomerization |
GO:0030101 | 0.0092 | 3.6133 | 1.8086 | 6 | 59 | natural killer cell activation |
GO:0002224 | 0.0099 | 2.6672 | 3.5866 | 9 | 117 | toll-like receptor signaling pathway |
GO:0001909 | 0.0099 | 3.1498 | 2.391 | 7 | 78 | leukocyte mediated cytotoxicity |
GO:0002643 | 0.0099 | 7.95 | 0.4598 | 3 | 15 | regulation of tolerance induction |
GO:0031338 | 0.0099 | 3.5462 | 1.8393 | 6 | 60 | regulation of vesicle fusion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0010595 | 0 | 6.253 | 2.0679 | 11 | 70 | positive regulation of endothelial cell migration |
GO:0070434 | 0 | Inf | 0.0886 | 3 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0007166 | 0 | 1.6057 | 72.6705 | 105 | 2460 | cell surface receptor signaling pathway |
GO:1901750 | 0 | 33.1365 | 0.2363 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:2000145 | 1e-04 | 2.0598 | 21.4762 | 41 | 727 | regulation of cell motility |
GO:0090132 | 1e-04 | 3.001 | 6.883 | 19 | 233 | epithelium migration |
GO:0006751 | 1e-04 | 26.5074 | 0.2659 | 4 | 9 | glutathione catabolic process |
GO:2000741 | 1e-04 | 99.2076 | 0.1182 | 3 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0030335 | 1e-04 | 2.4153 | 11.58 | 26 | 392 | positive regulation of cell migration |
GO:0043114 | 1e-04 | 9.0668 | 0.8271 | 6 | 28 | regulation of vascular permeability |
GO:0060429 | 2e-04 | 1.7507 | 33.7947 | 55 | 1144 | epithelium development |
GO:0009310 | 2e-04 | 11.062 | 0.5908 | 5 | 20 | amine catabolic process |
GO:0040017 | 2e-04 | 2.2488 | 12.8503 | 27 | 435 | positive regulation of locomotion |
GO:0019441 | 2e-04 | 49.6004 | 0.1477 | 3 | 5 | tryptophan catabolic process to kynurenine |
GO:1901343 | 3e-04 | 3.9154 | 3.1018 | 11 | 105 | negative regulation of vasculature development |
GO:0051272 | 3e-04 | 2.251 | 12.3481 | 26 | 418 | positive regulation of cellular component movement |
GO:0051674 | 3e-04 | 1.6755 | 39.1712 | 61 | 1326 | localization of cell |
GO:0016525 | 5e-04 | 3.9769 | 2.7768 | 10 | 94 | negative regulation of angiogenesis |
GO:0001937 | 5e-04 | 6.875 | 1.0339 | 6 | 35 | negative regulation of endothelial cell proliferation |
GO:0001667 | 6e-04 | 2.4154 | 8.8402 | 20 | 301 | ameboidal-type cell migration |
GO:0010633 | 6e-04 | 4.6759 | 1.9202 | 8 | 65 | negative regulation of epithelial cell migration |
GO:0001822 | 7e-04 | 2.5868 | 7.0307 | 17 | 238 | kidney development |
GO:0021852 | 9e-04 | Inf | 0.0591 | 2 | 2 | pyramidal neuron migration |
GO:0070370 | 9e-04 | Inf | 0.0591 | 2 | 2 | cellular heat acclimation |
GO:1905438 | 9e-04 | Inf | 0.0591 | 2 | 2 | non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation |
GO:0003012 | 9e-04 | 2.1527 | 11.8459 | 24 | 401 | muscle system process |
GO:2000026 | 0.001 | 1.5382 | 50.2485 | 72 | 1708 | regulation of multicellular organismal development |
GO:0023052 | 0.001 | 1.354 | 168.0578 | 200 | 5689 | signaling |
GO:0046218 | 0.0013 | 19.8362 | 0.2363 | 3 | 8 | indolalkylamine catabolic process |
GO:0070424 | 0.0013 | 19.8362 | 0.2363 | 3 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:2000544 | 0.0013 | 19.8362 | 0.2363 | 3 | 8 | regulation of endothelial cell chemotaxis to fibroblast growth factor |
GO:1901606 | 0.0015 | 3.6587 | 2.6882 | 9 | 91 | alpha-amino acid catabolic process |
GO:0060602 | 0.0017 | 9.4612 | 0.5317 | 4 | 18 | branch elongation of an epithelium |
GO:0048646 | 0.0017 | 1.6795 | 27.7684 | 44 | 940 | anatomical structure formation involved in morphogenesis |
GO:0006568 | 0.0019 | 16.529 | 0.2659 | 3 | 9 | tryptophan metabolic process |
GO:0035766 | 0.0019 | 16.529 | 0.2659 | 3 | 9 | cell chemotaxis to fibroblast growth factor |
GO:0042330 | 0.0019 | 1.9071 | 15.5089 | 28 | 525 | taxis |
GO:0010632 | 0.0019 | 3.2231 | 3.3512 | 10 | 115 | regulation of epithelial cell migration |
GO:0006955 | 0.002 | 1.5018 | 49.7763 | 70 | 1685 | immune response |
GO:0043537 | 0.002 | 6.3772 | 0.9158 | 5 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0022603 | 0.002 | 1.681 | 26.4391 | 42 | 895 | regulation of anatomical structure morphogenesis |
GO:0007178 | 0.0021 | 2.8254 | 4.547 | 12 | 156 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0001655 | 0.0023 | 2.248 | 8.4782 | 18 | 287 | urogenital system development |
GO:0007154 | 0.0023 | 1.3218 | 168.6191 | 198 | 5708 | cell communication |
GO:0042430 | 0.0025 | 8.2774 | 0.5908 | 4 | 20 | indole-containing compound metabolic process |
GO:0014043 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | negative regulation of neuron maturation |
GO:0032497 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | detection of lipopolysaccharide |
GO:0035582 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | sequestering of BMP in extracellular matrix |
GO:0048014 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | Tie signaling pathway |
GO:0060936 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | cardiac fibroblast cell development |
GO:0060938 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | epicardium-derived cardiac fibroblast cell differentiation |
GO:0060940 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | epithelial to mesenchymal transition involved in cardiac fibroblast development |
GO:0090063 | 0.0026 | 65.9911 | 0.0886 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0035329 | 0.0026 | 5.9209 | 0.9748 | 5 | 33 | hippo signaling |
GO:0002252 | 0.0027 | 1.6232 | 29.3045 | 45 | 992 | immune effector process |
GO:0050729 | 0.003 | 3.2588 | 2.9836 | 9 | 101 | positive regulation of inflammatory response |
GO:0050920 | 0.003 | 2.6907 | 4.7561 | 12 | 161 | regulation of chemotaxis |
GO:0006928 | 0.0031 | 1.5373 | 38.6962 | 56 | 1352 | movement of cell or subcellular component |
GO:0030049 | 0.0034 | 5.5254 | 1.0339 | 5 | 35 | muscle filament sliding |
GO:0030029 | 0.0035 | 1.7641 | 18.4926 | 31 | 626 | actin filament-based process |
GO:0030207 | 0.0035 | 12.3951 | 0.3249 | 3 | 11 | chondroitin sulfate catabolic process |
GO:0099068 | 0.0035 | 12.3951 | 0.3249 | 3 | 11 | postsynapse assembly |
GO:0042221 | 0.0036 | 1.3331 | 114.6185 | 140 | 3880 | response to chemical |
GO:0042692 | 0.0037 | 2.0068 | 11.0187 | 21 | 373 | muscle cell differentiation |
GO:0030198 | 0.0037 | 2.1348 | 8.8918 | 18 | 301 | extracellular matrix organization |
GO:0042346 | 0.0043 | 6.969 | 0.6794 | 4 | 23 | positive regulation of NF-kappaB import into nucleus |
GO:0090103 | 0.0043 | 6.969 | 0.6794 | 4 | 23 | cochlea morphogenesis |
GO:0071772 | 0.0043 | 2.6985 | 4.3425 | 11 | 147 | response to BMP |
GO:0040007 | 0.0049 | 1.6199 | 25.3165 | 39 | 857 | growth |
GO:0032613 | 0.0049 | 5.0221 | 1.1226 | 5 | 38 | interleukin-10 production |
GO:0006379 | 0.005 | 6.6201 | 0.709 | 4 | 24 | mRNA cleavage |
GO:0031112 | 0.005 | 6.6201 | 0.709 | 4 | 24 | positive regulation of microtubule polymerization or depolymerization |
GO:0006026 | 0.005 | 4.1483 | 1.5952 | 6 | 54 | aminoglycan catabolic process |
GO:0001692 | 0.005 | 32.9933 | 0.1182 | 2 | 4 | histamine metabolic process |
GO:0048295 | 0.005 | 32.9933 | 0.1182 | 2 | 4 | positive regulation of isotype switching to IgE isotypes |
GO:0060699 | 0.005 | 32.9933 | 0.1182 | 2 | 4 | regulation of endoribonuclease activity |
GO:0071692 | 0.005 | 32.9933 | 0.1182 | 2 | 4 | protein localization to extracellular region |
GO:0045165 | 0.005 | 2.2412 | 7.0603 | 15 | 239 | cell fate commitment |
GO:0044106 | 0.0053 | 2.9666 | 3.2495 | 9 | 110 | cellular amine metabolic process |
GO:0045766 | 0.0055 | 2.7539 | 3.8699 | 10 | 131 | positive regulation of angiogenesis |
GO:0060337 | 0.0057 | 3.5234 | 2.1565 | 7 | 73 | type I interferon signaling pathway |
GO:0002685 | 0.0058 | 2.5835 | 4.5197 | 11 | 153 | regulation of leukocyte migration |
GO:0003002 | 0.0058 | 2.0392 | 9.2758 | 18 | 314 | regionalization |
GO:0021884 | 0.0058 | 6.3045 | 0.7385 | 4 | 25 | forebrain neuron development |
GO:0001973 | 0.0059 | 9.9147 | 0.384 | 3 | 13 | adenosine receptor signaling pathway |
GO:0042074 | 0.0059 | 9.9147 | 0.384 | 3 | 13 | cell migration involved in gastrulation |
GO:0045598 | 0.0059 | 2.9086 | 3.3086 | 9 | 112 | regulation of fat cell differentiation |
GO:0009653 | 0.006 | 1.6111 | 24.8692 | 38 | 880 | anatomical structure morphogenesis |
GO:0045446 | 0.0062 | 3.1297 | 2.7473 | 8 | 93 | endothelial cell differentiation |
GO:0090066 | 0.0063 | 1.8771 | 12.289 | 22 | 416 | regulation of anatomical structure size |
GO:0032835 | 0.0065 | 3.9035 | 1.6838 | 6 | 57 | glomerulus development |
GO:0002366 | 0.0065 | 1.7144 | 17.7245 | 29 | 600 | leukocyte activation involved in immune response |
GO:0045664 | 0.0066 | 1.7699 | 15.3908 | 26 | 521 | regulation of neuron differentiation |
GO:0061036 | 0.0067 | 6.0175 | 0.7681 | 4 | 26 | positive regulation of cartilage development |
GO:0031345 | 0.0068 | 2.665 | 3.988 | 10 | 135 | negative regulation of cell projection organization |
GO:0045597 | 0.0069 | 1.6017 | 24.2235 | 37 | 820 | positive regulation of cell differentiation |
GO:0006952 | 0.0071 | 1.4653 | 40.2642 | 56 | 1363 | defense response |
GO:0002312 | 0.0071 | 3.8282 | 1.7134 | 6 | 58 | B cell activation involved in immune response |
GO:0071560 | 0.0071 | 2.297 | 5.9672 | 13 | 202 | cellular response to transforming growth factor beta stimulus |
GO:0044331 | 0.0073 | 9.0128 | 0.4136 | 3 | 14 | cell-cell adhesion mediated by cadherin |
GO:0050768 | 0.0074 | 2.2069 | 6.6762 | 14 | 226 | negative regulation of neurogenesis |
GO:1900180 | 0.0074 | 2.2848 | 5.9968 | 13 | 203 | regulation of protein localization to nucleus |
GO:0030509 | 0.0075 | 2.6227 | 4.0471 | 10 | 137 | BMP signaling pathway |
GO:0009154 | 0.0077 | 5.7555 | 0.7976 | 4 | 27 | purine ribonucleotide catabolic process |
GO:0090287 | 0.008 | 2.186 | 6.7353 | 14 | 228 | regulation of cellular response to growth factor stimulus |
GO:0032501 | 0.008 | 1.2651 | 193.4925 | 219 | 6550 | multicellular organismal process |
GO:0007155 | 0.0081 | 1.4788 | 36.2466 | 51 | 1227 | cell adhesion |
GO:0071310 | 0.0082 | 1.3654 | 65.3148 | 84 | 2211 | cellular response to organic substance |
GO:0034340 | 0.0082 | 3.2742 | 2.3042 | 7 | 78 | response to type I interferon |
GO:0009169 | 0.0082 | 21.9941 | 0.1477 | 2 | 5 | purine ribonucleoside monophosphate catabolic process |
GO:0033591 | 0.0082 | 21.9941 | 0.1477 | 2 | 5 | response to L-ascorbic acid |
GO:0060591 | 0.0082 | 21.9941 | 0.1477 | 2 | 5 | chondroblast differentiation |
GO:0060729 | 0.0082 | 21.9941 | 0.1477 | 2 | 5 | intestinal epithelial structure maintenance |
GO:1900020 | 0.0082 | 21.9941 | 0.1477 | 2 | 5 | positive regulation of protein kinase C activity |
GO:1901509 | 0.0082 | 21.9941 | 0.1477 | 2 | 5 | regulation of endothelial tube morphogenesis |
GO:0050798 | 0.0084 | 4.3598 | 1.2703 | 5 | 43 | activated T cell proliferation |
GO:0035988 | 0.0089 | 8.2612 | 0.4431 | 3 | 15 | chondrocyte proliferation |
GO:0040037 | 0.0089 | 8.2612 | 0.4431 | 3 | 15 | negative regulation of fibroblast growth factor receptor signaling pathway |
GO:0090083 | 0.0089 | 8.2612 | 0.4431 | 3 | 15 | regulation of inclusion body assembly |
GO:0035306 | 0.0093 | 4.2477 | 1.2998 | 5 | 44 | positive regulation of dephosphorylation |
GO:0043647 | 0.0098 | 3.5538 | 1.8315 | 6 | 62 | inositol phosphate metabolic process |
GO:0006691 | 0.0099 | 5.2943 | 0.8567 | 4 | 29 | leukotriene metabolic process |
GO:0055002 | 0.01 | 2.5034 | 4.2243 | 10 | 143 | striated muscle cell development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 12.5377 | 11.0183 | 88 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 10.0796 | 14.1277 | 95 | 418 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 10.1753 | 13.8573 | 94 | 410 | detection of stimulus involved in sensory perception |
GO:0009593 | 0 | 9.9744 | 13.5532 | 91 | 401 | detection of chemical stimulus |
GO:0007186 | 0 | 4.0452 | 38.8006 | 120 | 1148 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.8188 | 37.9218 | 113 | 1122 | nervous system process |
GO:0000183 | 0 | 16.5497 | 1.2167 | 13 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 16.5497 | 1.2167 | 13 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 16.5497 | 1.2167 | 13 | 36 | response to interleukin-7 |
GO:0032501 | 0 | 1.7885 | 205.022 | 273 | 6338 | multicellular organismal process |
GO:0043588 | 0 | 3.3 | 13.0124 | 38 | 385 | skin development |
GO:0045814 | 0 | 5.7161 | 3.9544 | 19 | 117 | negative regulation of gene expression, epigenetic |
GO:0009913 | 0 | 3.395 | 10.9507 | 33 | 324 | epidermal cell differentiation |
GO:0006335 | 0 | 13.8622 | 1.0478 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0031424 | 0 | 5.7139 | 3.5238 | 17 | 106 | keratinization |
GO:0018149 | 0 | 8.5424 | 1.7913 | 12 | 53 | peptide cross-linking |
GO:0045815 | 0 | 6.4 | 2.6363 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0050829 | 0 | 7.0341 | 2.2645 | 13 | 67 | defense response to Gram-negative bacterium |
GO:0007154 | 0 | 1.562 | 192.9212 | 247 | 5708 | cell communication |
GO:0045652 | 0 | 6.5472 | 2.3997 | 13 | 71 | regulation of megakaryocyte differentiation |
GO:0051290 | 0 | 8.8142 | 1.4533 | 10 | 43 | protein heterotetramerization |
GO:0023052 | 0 | 1.5332 | 192.279 | 244 | 5689 | signaling |
GO:0052696 | 0 | 36.0739 | 0.3042 | 5 | 9 | flavonoid glucuronidation |
GO:0052697 | 0 | 36.0739 | 0.3042 | 5 | 9 | xenobiotic glucuronidation |
GO:0050896 | 0 | 2.0255 | 35.7518 | 62 | 1260 | response to stimulus |
GO:1902036 | 0 | 4.7556 | 3.3798 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0051716 | 0 | 1.4741 | 217.0195 | 265 | 6421 | cellular response to stimulus |
GO:0031497 | 0 | 3.6848 | 4.8332 | 16 | 143 | chromatin assembly |
GO:0060964 | 0 | 4.4072 | 3.346 | 13 | 99 | regulation of gene silencing by miRNA |
GO:0022610 | 0 | 1.7734 | 41.6058 | 68 | 1231 | biological adhesion |
GO:0002244 | 0 | 3.1952 | 6.1851 | 18 | 183 | hematopoietic progenitor cell differentiation |
GO:0034728 | 1e-04 | 3.4135 | 5.1712 | 16 | 153 | nucleosome organization |
GO:0002682 | 1e-04 | 1.7244 | 43.2957 | 69 | 1281 | regulation of immune system process |
GO:2000360 | 1e-04 | 86.2573 | 0.1352 | 3 | 4 | negative regulation of binding of sperm to zona pellucida |
GO:0060968 | 2e-04 | 3.5041 | 4.0896 | 13 | 121 | regulation of gene silencing |
GO:0070268 | 2e-04 | 3.7125 | 3.5826 | 12 | 106 | cornification |
GO:0050830 | 4e-04 | 4.1448 | 2.7039 | 10 | 80 | defense response to Gram-positive bacterium |
GO:0051552 | 4e-04 | 43.1257 | 0.169 | 3 | 5 | flavone metabolic process |
GO:0019585 | 4e-04 | 9.6125 | 0.676 | 5 | 20 | glucuronate metabolic process |
GO:0071466 | 5e-04 | 3.6714 | 3.3122 | 11 | 98 | cellular response to xenobiotic stimulus |
GO:0045087 | 5e-04 | 1.8052 | 25.3582 | 43 | 753 | innate immune response |
GO:0048863 | 7e-04 | 2.457 | 8.2806 | 19 | 245 | stem cell differentiation |
GO:0006953 | 7e-04 | 5.3247 | 1.5209 | 7 | 45 | acute-phase response |
GO:0065004 | 8e-04 | 2.5563 | 7.1315 | 17 | 211 | protein-DNA complex assembly |
GO:0036017 | 0.0012 | 21.5599 | 0.2366 | 3 | 7 | response to erythropoietin |
GO:0080154 | 0.0013 | 7.2069 | 0.845 | 5 | 25 | regulation of fertilization |
GO:0098542 | 0.0016 | 1.9906 | 13.8235 | 26 | 409 | defense response to other organism |
GO:0007596 | 0.0016 | 2.1689 | 10.2747 | 21 | 304 | blood coagulation |
GO:0050878 | 0.0024 | 1.898 | 15.0065 | 27 | 444 | regulation of body fluid levels |
GO:0001906 | 0.0026 | 2.8992 | 4.0896 | 11 | 121 | cell killing |
GO:0001542 | 0.0028 | 14.3713 | 0.3042 | 3 | 9 | ovulation from ovarian follicle |
GO:0060837 | 0.0028 | 14.3713 | 0.3042 | 3 | 9 | blood vessel endothelial cell differentiation |
GO:0098609 | 0.0029 | 1.6738 | 24.5376 | 39 | 726 | cell-cell adhesion |
GO:0061844 | 0.0031 | 4.6785 | 1.4533 | 6 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0009611 | 0.0033 | 1.7378 | 19.9748 | 33 | 591 | response to wounding |
GO:0018879 | 0.0033 | 57.393 | 0.1014 | 2 | 3 | biphenyl metabolic process |
GO:0038162 | 0.0033 | 57.393 | 0.1014 | 2 | 3 | erythropoietin-mediated signaling pathway |
GO:0006768 | 0.0039 | 12.3175 | 0.338 | 3 | 10 | biotin metabolic process |
GO:0030155 | 0.004 | 1.7155 | 20.2114 | 33 | 598 | regulation of cell adhesion |
GO:0050900 | 0.0047 | 1.8974 | 12.742 | 23 | 377 | leukocyte migration |
GO:0008210 | 0.0049 | 6.7711 | 0.7098 | 4 | 21 | estrogen metabolic process |
GO:0042573 | 0.0049 | 6.7711 | 0.7098 | 4 | 21 | retinoic acid metabolic process |
GO:0045919 | 0.0052 | 10.777 | 0.3718 | 3 | 11 | positive regulation of cytolysis |
GO:2000344 | 0.0052 | 10.777 | 0.3718 | 3 | 11 | positive regulation of acrosome reaction |
GO:2000242 | 0.0059 | 4.0241 | 1.6561 | 6 | 49 | negative regulation of reproductive process |
GO:0043029 | 0.0061 | 4.8014 | 1.1829 | 5 | 35 | T cell homeostasis |
GO:0035910 | 0.0065 | 28.6946 | 0.1352 | 2 | 4 | ascending aorta morphogenesis |
GO:0061760 | 0.0065 | 28.6946 | 0.1352 | 2 | 4 | antifungal innate immune response |
GO:0019730 | 0.0066 | 4.6896 | 1.206 | 5 | 36 | antimicrobial humoral response |
GO:0042448 | 0.0067 | 9.5789 | 0.4056 | 3 | 12 | progesterone metabolic process |
GO:0045835 | 0.0067 | 9.5789 | 0.4056 | 3 | 12 | negative regulation of meiotic nuclear division |
GO:2001212 | 0.0067 | 9.5789 | 0.4056 | 3 | 12 | regulation of vasculogenesis |
GO:0060343 | 0.0069 | 6.0576 | 0.7774 | 4 | 23 | trabecula formation |
GO:0007292 | 0.0075 | 2.6304 | 4.0558 | 10 | 120 | female gamete generation |
GO:0032609 | 0.0085 | 2.9624 | 2.9067 | 8 | 86 | interferon-gamma production |
GO:0033033 | 0.0085 | 8.6205 | 0.4394 | 3 | 13 | negative regulation of myeloid cell apoptotic process |
GO:0042737 | 0.0085 | 8.6205 | 0.4394 | 3 | 13 | drug catabolic process |
GO:0009617 | 0.0097 | 1.7098 | 15.8852 | 26 | 470 | response to bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 107.9525 | 1.001 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 71.6929 | 1.1625 | 25 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 43.7915 | 1.3886 | 25 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 143.9068 | 0.549 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045814 | 0 | 10.4304 | 3.7781 | 29 | 117 | negative regulation of gene expression, epigenetic |
GO:0045815 | 0 | 13.9493 | 2.5188 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 11.2119 | 3.1969 | 26 | 99 | regulation of gene silencing by miRNA |
GO:0006323 | 0 | 7.2707 | 5.9094 | 34 | 183 | DNA packaging |
GO:0060968 | 0 | 9.5056 | 3.9073 | 28 | 121 | regulation of gene silencing |
GO:1902036 | 0 | 10.4694 | 3.2292 | 25 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0032200 | 0 | 7.2659 | 5.0052 | 29 | 155 | telomere organization |
GO:0071824 | 0 | 5.5708 | 7.8146 | 36 | 242 | protein-DNA complex subunit organization |
GO:0002244 | 0 | 6.1919 | 5.9094 | 30 | 183 | hematopoietic progenitor cell differentiation |
GO:0048863 | 0 | 5.1125 | 7.9115 | 34 | 245 | stem cell differentiation |
GO:1904837 | 0 | 17.1397 | 1.3563 | 15 | 42 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 14.5419 | 1.6146 | 16 | 50 | telomere capping |
GO:0034080 | 0 | 16.5788 | 1.2917 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0030099 | 0 | 4.5106 | 8.5329 | 33 | 267 | myeloid cell differentiation |
GO:0035194 | 0 | 4.4193 | 8.6865 | 33 | 269 | posttranscriptional gene silencing by RNA |
GO:0002376 | 0 | 2.2261 | 49.793 | 95 | 1608 | immune system process |
GO:0034724 | 0 | 11.9654 | 1.6146 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0048534 | 0 | 2.6515 | 26.0918 | 61 | 808 | hematopoietic or lymphoid organ development |
GO:0006333 | 0 | 6.6458 | 3.6514 | 20 | 116 | chromatin assembly or disassembly |
GO:0043044 | 0 | 7.9621 | 2.3573 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 8.2748 | 2.1313 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0017148 | 0 | 3.23 | 11.4313 | 33 | 354 | negative regulation of translation |
GO:0051259 | 0 | 2.8107 | 15.823 | 40 | 490 | protein oligomerization |
GO:0038111 | 0 | 11.7439 | 1.1625 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 11.7439 | 1.1625 | 10 | 36 | response to interleukin-7 |
GO:1903707 | 0 | 5.0984 | 4.1011 | 18 | 127 | negative regulation of hemopoiesis |
GO:0045652 | 0 | 8.0505 | 1.6961 | 11 | 54 | regulation of megakaryocyte differentiation |
GO:0034248 | 0 | 2.3871 | 18.3095 | 40 | 567 | regulation of cellular amide metabolic process |
GO:0034622 | 0 | 2.0419 | 30.5481 | 57 | 946 | cellular macromolecular complex assembly |
GO:0045892 | 0 | 1.9093 | 33.6158 | 59 | 1041 | negative regulation of transcription, DNA-templated |
GO:0051246 | 0 | 1.5859 | 82.7964 | 118 | 2564 | regulation of protein metabolic process |
GO:0006950 | 0 | 1.5741 | 87.6722 | 123 | 2779 | response to stress |
GO:1901360 | 0 | 1.4519 | 182.998 | 226 | 5667 | organic cyclic compound metabolic process |
GO:0071360 | 0 | 18.9114 | 0.4198 | 5 | 13 | cellular response to exogenous dsRNA |
GO:1902679 | 0 | 1.8428 | 34.6815 | 59 | 1074 | negative regulation of RNA biosynthetic process |
GO:0006352 | 0 | 3.005 | 7.2657 | 20 | 225 | DNA-templated transcription, initiation |
GO:0090304 | 0 | 1.4582 | 151.3843 | 192 | 4688 | nucleic acid metabolic process |
GO:0060249 | 1e-04 | 2.5228 | 11.1407 | 26 | 345 | anatomical structure homeostasis |
GO:0046483 | 1e-04 | 1.4264 | 175.6032 | 216 | 5438 | heterocycle metabolic process |
GO:0006725 | 1e-04 | 1.425 | 176.6365 | 217 | 5470 | cellular aromatic compound metabolic process |
GO:0010604 | 1e-04 | 1.5059 | 89.4485 | 122 | 2770 | positive regulation of macromolecule metabolic process |
GO:0034641 | 1e-04 | 1.4071 | 194.1064 | 234 | 6011 | cellular nitrogen compound metabolic process |
GO:0045596 | 1e-04 | 2.0443 | 19.4074 | 37 | 601 | negative regulation of cell differentiation |
GO:0045934 | 2e-04 | 1.6857 | 41.5273 | 65 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0002227 | 2e-04 | 11.6338 | 0.5813 | 5 | 18 | innate immune response in mucosa |
GO:0071675 | 2e-04 | 6.6354 | 1.2594 | 7 | 39 | regulation of mononuclear cell migration |
GO:1903506 | 3e-04 | 1.4455 | 106.4017 | 139 | 3295 | regulation of nucleic acid-templated transcription |
GO:0009890 | 3e-04 | 1.6056 | 50.3753 | 75 | 1560 | negative regulation of biosynthetic process |
GO:0006959 | 3e-04 | 2.9518 | 5.8771 | 16 | 182 | humoral immune response |
GO:0097529 | 3e-04 | 3.0802 | 5.2959 | 15 | 164 | myeloid leukocyte migration |
GO:0060326 | 3e-04 | 2.6518 | 7.7178 | 19 | 239 | cell chemotaxis |
GO:0043043 | 3e-04 | 1.8401 | 25.5429 | 44 | 791 | peptide biosynthetic process |
GO:0048625 | 3e-04 | 45.2204 | 0.1615 | 3 | 5 | myoblast fate commitment |
GO:0010608 | 3e-04 | 1.9228 | 21.0866 | 38 | 653 | posttranscriptional regulation of gene expression |
GO:0002443 | 4e-04 | 1.9066 | 21.2481 | 38 | 658 | leukocyte mediated immunity |
GO:0001775 | 4e-04 | 1.6735 | 37.7492 | 59 | 1169 | cell activation |
GO:0048869 | 4e-04 | 1.4082 | 123.0643 | 156 | 3811 | cellular developmental process |
GO:1903555 | 4e-04 | 3.6823 | 3.2938 | 11 | 102 | regulation of tumor necrosis factor superfamily cytokine production |
GO:0071345 | 5e-04 | 1.8166 | 25.2348 | 43 | 790 | cellular response to cytokine stimulus |
GO:0050793 | 5e-04 | 1.4965 | 71.0098 | 98 | 2199 | regulation of developmental process |
GO:0006996 | 6e-04 | 1.4096 | 109.2757 | 140 | 3384 | organelle organization |
GO:0050776 | 6e-04 | 1.7774 | 26.3502 | 44 | 816 | regulation of immune response |
GO:0051252 | 6e-04 | 1.4025 | 112.2465 | 143 | 3476 | regulation of RNA metabolic process |
GO:0019731 | 7e-04 | 6.4884 | 1.0979 | 6 | 34 | antibacterial humoral response |
GO:2000112 | 7e-04 | 1.3855 | 122.7737 | 154 | 3802 | regulation of cellular macromolecule biosynthetic process |
GO:0098542 | 8e-04 | 2.0919 | 13.2074 | 26 | 409 | defense response to other organism |
GO:0044260 | 9e-04 | 1.3378 | 251.6183 | 286 | 7792 | cellular macromolecule metabolic process |
GO:0051239 | 0.001 | 1.4293 | 83.3776 | 110 | 2582 | regulation of multicellular organismal process |
GO:0002434 | 0.001 | Inf | 0.0646 | 2 | 2 | immune complex clearance |
GO:0090265 | 0.001 | Inf | 0.0646 | 2 | 2 | positive regulation of immune complex clearance by monocytes and macrophages |
GO:1904057 | 0.001 | Inf | 0.0646 | 2 | 2 | negative regulation of sensory perception of pain |
GO:2000439 | 0.001 | Inf | 0.0646 | 2 | 2 | positive regulation of monocyte extravasation |
GO:2000866 | 0.001 | Inf | 0.0646 | 2 | 2 | positive regulation of estradiol secretion |
GO:0044238 | 0.0011 | 1.3522 | 306.4822 | 339 | 9491 | primary metabolic process |
GO:0009435 | 0.0013 | 7.198 | 0.8396 | 5 | 26 | NAD biosynthetic process |
GO:0034654 | 0.0013 | 1.3593 | 125.357 | 155 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0019222 | 0.0014 | 1.3242 | 193.3314 | 226 | 5987 | regulation of metabolic process |
GO:1901564 | 0.0015 | 1.3205 | 198.4658 | 231 | 6146 | organonitrogen compound metabolic process |
GO:0030888 | 0.0017 | 4.5131 | 1.7438 | 7 | 54 | regulation of B cell proliferation |
GO:0002251 | 0.0018 | 6.5712 | 0.9042 | 5 | 28 | organ or tissue specific immune response |
GO:0090026 | 0.0018 | 9.288 | 0.549 | 4 | 17 | positive regulation of monocyte chemotaxis |
GO:1903706 | 0.0021 | 2.2131 | 9.0984 | 19 | 290 | regulation of hemopoiesis |
GO:0048731 | 0.0021 | 1.333 | 135.1415 | 164 | 4185 | system development |
GO:0042987 | 0.0022 | 6.297 | 0.9365 | 5 | 29 | amyloid precursor protein catabolic process |
GO:0032269 | 0.0023 | 1.6901 | 25.0158 | 40 | 811 | negative regulation of cellular protein metabolic process |
GO:0071840 | 0.0023 | 1.3069 | 183.3532 | 214 | 5678 | cellular component organization or biogenesis |
GO:0035457 | 0.0024 | 15.0694 | 0.2906 | 3 | 9 | cellular response to interferon-alpha |
GO:0042535 | 0.0024 | 15.0694 | 0.2906 | 3 | 9 | positive regulation of tumor necrosis factor biosynthetic process |
GO:0061844 | 0.0024 | 4.9072 | 1.3886 | 6 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0019363 | 0.0025 | 6.0447 | 0.9688 | 5 | 30 | pyridine nucleotide biosynthetic process |
GO:0009595 | 0.0028 | 8.0485 | 0.6135 | 4 | 19 | detection of biotic stimulus |
GO:0002250 | 0.0029 | 2.0971 | 10.0751 | 20 | 312 | adaptive immune response |
GO:0010573 | 0.0029 | 5.8118 | 1.001 | 5 | 31 | vascular endothelial growth factor production |
GO:0010629 | 0.003 | 1.9805 | 12.2711 | 23 | 401 | negative regulation of gene expression |
GO:0034344 | 0.0031 | 60.1752 | 0.0969 | 2 | 3 | regulation of type III interferon production |
GO:0045658 | 0.0031 | 60.1752 | 0.0969 | 2 | 3 | regulation of neutrophil differentiation |
GO:0055099 | 0.0031 | 60.1752 | 0.0969 | 2 | 3 | response to high density lipoprotein particle |
GO:0070340 | 0.0031 | 60.1752 | 0.0969 | 2 | 3 | detection of bacterial lipopeptide |
GO:0043207 | 0.0031 | 1.6792 | 23.8314 | 38 | 738 | response to external biotic stimulus |
GO:0002687 | 0.0032 | 3.0078 | 3.5844 | 10 | 111 | positive regulation of leukocyte migration |
GO:0070661 | 0.0033 | 2.2192 | 8.1053 | 17 | 251 | leukocyte proliferation |
GO:0032490 | 0.0034 | 12.9157 | 0.3229 | 3 | 10 | detection of molecule of bacterial origin |
GO:0045351 | 0.0034 | 12.9157 | 0.3229 | 3 | 10 | type I interferon biosynthetic process |
GO:0022607 | 0.0035 | 1.3711 | 82.8609 | 106 | 2566 | cellular component assembly |
GO:0033673 | 0.0037 | 2.1906 | 8.2021 | 17 | 254 | negative regulation of kinase activity |
GO:0007166 | 0.0038 | 1.3736 | 79.438 | 102 | 2460 | cell surface receptor signaling pathway |
GO:0009617 | 0.0038 | 1.8548 | 14.7424 | 26 | 459 | response to bacterium |
GO:0002366 | 0.0038 | 1.7361 | 19.3751 | 32 | 600 | leukocyte activation involved in immune response |
GO:0070271 | 0.0038 | 1.494 | 42.4315 | 60 | 1314 | protein complex biogenesis |
GO:0048519 | 0.0041 | 1.2974 | 149.5759 | 177 | 4632 | negative regulation of biological process |
GO:0046651 | 0.0041 | 2.2293 | 7.5886 | 16 | 235 | lymphocyte proliferation |
GO:0033077 | 0.0044 | 3.7188 | 2.0667 | 7 | 64 | T cell differentiation in thymus |
GO:0016045 | 0.0046 | 11.3005 | 0.3552 | 3 | 11 | detection of bacterium |
GO:0051091 | 0.0047 | 2.2638 | 7.0073 | 15 | 217 | positive regulation of DNA binding transcription factor activity |
GO:0007596 | 0.0048 | 2.0378 | 9.8167 | 19 | 304 | blood coagulation |
GO:0050921 | 0.0049 | 2.8115 | 3.8104 | 10 | 118 | positive regulation of chemotaxis |
GO:0002407 | 0.0049 | 6.7057 | 0.7104 | 4 | 22 | dendritic cell chemotaxis |
GO:0032675 | 0.005 | 3.0003 | 3.2292 | 9 | 100 | regulation of interleukin-6 production |
GO:0006911 | 0.005 | 5.0355 | 1.1302 | 5 | 35 | phagocytosis, engulfment |
GO:0002757 | 0.0051 | 1.858 | 13.5626 | 24 | 420 | immune response-activating signal transduction |
GO:0032760 | 0.0051 | 4.1484 | 1.6057 | 6 | 50 | positive regulation of tumor necrosis factor production |
GO:0050878 | 0.0052 | 1.8301 | 14.3376 | 25 | 444 | regulation of body fluid levels |
GO:0046209 | 0.0053 | 3.5923 | 2.1313 | 7 | 66 | nitric oxide metabolic process |
GO:0050729 | 0.0054 | 2.9675 | 3.2615 | 9 | 101 | positive regulation of inflammatory response |
GO:0031347 | 0.0057 | 1.6715 | 20.6991 | 33 | 641 | regulation of defense response |
GO:0015671 | 0.0059 | 10.0442 | 0.3875 | 3 | 12 | oxygen transport |
GO:0033160 | 0.0059 | 10.0442 | 0.3875 | 3 | 12 | positive regulation of protein import into nucleus, translocation |
GO:0035458 | 0.0059 | 10.0442 | 0.3875 | 3 | 12 | cellular response to interferon-beta |
GO:0002051 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | osteoblast fate commitment |
GO:0006710 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | androgen catabolic process |
GO:0009786 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | regulation of asymmetric cell division |
GO:0043553 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | negative regulation of phosphatidylinositol 3-kinase activity |
GO:0045354 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | regulation of interferon-alpha biosynthetic process |
GO:0046874 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | quinolinate metabolic process |
GO:0061484 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | hematopoietic stem cell homeostasis |
GO:0070213 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | protein auto-ADP-ribosylation |
GO:0071225 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | cellular response to muramyl dipeptide |
GO:0072683 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | T cell extravasation |
GO:0072716 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | response to actinomycin D |
GO:1990511 | 0.006 | 30.0855 | 0.1292 | 2 | 4 | piRNA biosynthetic process |
GO:0002684 | 0.006 | 1.6171 | 23.997 | 37 | 753 | positive regulation of immune system process |
GO:0032101 | 0.0061 | 1.6629 | 20.796 | 33 | 644 | regulation of response to external stimulus |
GO:0032481 | 0.0062 | 3.474 | 2.1958 | 7 | 68 | positive regulation of type I interferon production |
GO:0050871 | 0.0062 | 3.474 | 2.1958 | 7 | 68 | positive regulation of B cell activation |
GO:0051172 | 0.0063 | 1.543 | 30.7354 | 45 | 1004 | negative regulation of nitrogen compound metabolic process |
GO:0043281 | 0.0065 | 2.3266 | 5.9094 | 13 | 183 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0009059 | 0.0068 | 1.2771 | 150.5078 | 176 | 4736 | macromolecule biosynthetic process |
GO:0002691 | 0.0068 | 6.0344 | 0.775 | 4 | 24 | regulation of cellular extravasation |
GO:0032091 | 0.007 | 3.0683 | 2.8094 | 8 | 87 | negative regulation of protein binding |
GO:0045838 | 0.0075 | 9.0392 | 0.4198 | 3 | 13 | positive regulation of membrane potential |
GO:0048518 | 0.0075 | 1.295 | 123.6478 | 147 | 4029 | positive regulation of biological process |
GO:0006334 | 0.0079 | 2.9975 | 2.8628 | 8 | 93 | nucleosome assembly |
GO:0030851 | 0.0079 | 5.7466 | 0.8073 | 4 | 25 | granulocyte differentiation |
GO:0044092 | 0.0079 | 1.497 | 33.6158 | 48 | 1041 | negative regulation of molecular function |
GO:0002437 | 0.008 | 4.4419 | 1.2594 | 5 | 39 | inflammatory response to antigenic stimulus |
GO:1990266 | 0.008 | 2.9921 | 2.874 | 8 | 89 | neutrophil migration |
GO:0045087 | 0.0081 | 1.5927 | 23.6496 | 36 | 739 | innate immune response |
GO:0032944 | 0.0081 | 2.2594 | 6.0709 | 13 | 188 | regulation of mononuclear cell proliferation |
GO:0042089 | 0.0083 | 2.9724 | 2.8905 | 8 | 90 | cytokine biosynthetic process |
GO:0042110 | 0.0083 | 1.8001 | 13.3688 | 23 | 414 | T cell activation |
GO:0045429 | 0.0089 | 4.3147 | 1.2917 | 5 | 40 | positive regulation of nitric oxide biosynthetic process |
GO:0006919 | 0.0091 | 3.2098 | 2.3573 | 7 | 73 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0032677 | 0.0091 | 3.6281 | 1.8083 | 6 | 56 | regulation of interleukin-8 production |
GO:0030218 | 0.0091 | 2.9196 | 2.9386 | 8 | 91 | erythrocyte differentiation |
GO:0002689 | 0.0093 | 8.2169 | 0.4521 | 3 | 14 | negative regulation of leukocyte chemotaxis |
GO:0051770 | 0.0093 | 8.2169 | 0.4521 | 3 | 14 | positive regulation of nitric-oxide synthase biosynthetic process |
GO:0000963 | 0.0098 | 20.0557 | 0.1615 | 2 | 5 | mitochondrial RNA processing |
GO:0002677 | 0.0098 | 20.0557 | 0.1615 | 2 | 5 | negative regulation of chronic inflammatory response |
GO:0009597 | 0.0098 | 20.0557 | 0.1615 | 2 | 5 | detection of virus |
GO:0019441 | 0.0098 | 20.0557 | 0.1615 | 2 | 5 | tryptophan catabolic process to kynurenine |
GO:0035701 | 0.0098 | 20.0557 | 0.1615 | 2 | 5 | hematopoietic stem cell migration |
GO:1900223 | 0.0098 | 20.0557 | 0.1615 | 2 | 5 | positive regulation of amyloid-beta clearance |
GO:1900748 | 0.0098 | 20.0557 | 0.1615 | 2 | 5 | positive regulation of vascular endothelial growth factor signaling pathway |
GO:0070098 | 0.0098 | 3.1616 | 2.3896 | 7 | 74 | chemokine-mediated signaling pathway |
GO:0009611 | 0.0098 | 1.6416 | 19.0845 | 30 | 591 | response to wounding |
GO:0042692 | 0.0099 | 1.8229 | 12.0449 | 21 | 373 | muscle cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 4.1292 | 4.0452 | 15 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:1902622 | 2e-04 | 8.5289 | 0.8589 | 6 | 31 | regulation of neutrophil migration |
GO:0035609 | 2e-04 | 53.0071 | 0.1385 | 3 | 5 | C-terminal protein deglutamylation |
GO:0045409 | 2e-04 | 53.0071 | 0.1385 | 3 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0002376 | 3e-04 | 1.5405 | 68.4913 | 96 | 2472 | immune system process |
GO:0045087 | 3e-04 | 1.939 | 20.9741 | 38 | 757 | innate immune response |
GO:0050776 | 3e-04 | 3.0027 | 5.3902 | 15 | 202 | regulation of immune response |
GO:0006952 | 4e-04 | 2.0636 | 16.0793 | 31 | 606 | defense response |
GO:0050778 | 5e-04 | 2.0055 | 17.012 | 32 | 614 | positive regulation of immune response |
GO:0050727 | 5e-04 | 2.5195 | 8.0627 | 19 | 291 | regulation of inflammatory response |
GO:0002675 | 5e-04 | 8.866 | 0.6927 | 5 | 25 | positive regulation of acute inflammatory response |
GO:0090023 | 5e-04 | 8.866 | 0.6927 | 5 | 25 | positive regulation of neutrophil chemotaxis |
GO:0002282 | 8e-04 | Inf | 0.0554 | 2 | 2 | microglial cell activation involved in immune response |
GO:0018003 | 8e-04 | Inf | 0.0554 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0044663 | 8e-04 | Inf | 0.0554 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0007585 | 0.001 | 4.9787 | 1.5793 | 7 | 57 | respiratory gaseous exchange |
GO:0097530 | 0.001 | 3.5344 | 3.0755 | 10 | 111 | granulocyte migration |
GO:0034587 | 0.001 | 10.8911 | 0.471 | 4 | 17 | piRNA metabolic process |
GO:0098609 | 0.001 | 1.8476 | 20.1152 | 35 | 726 | cell-cell adhesion |
GO:0071622 | 0.0011 | 5.7581 | 1.1914 | 6 | 43 | regulation of granulocyte chemotaxis |
GO:0051607 | 0.0015 | 2.6829 | 5.5691 | 14 | 201 | defense response to virus |
GO:0022610 | 0.0015 | 1.6245 | 34.1071 | 52 | 1231 | biological adhesion |
GO:0032675 | 0.0018 | 3.5244 | 2.7707 | 9 | 100 | regulation of interleukin-6 production |
GO:0080134 | 0.0019 | 1.6024 | 34.5227 | 52 | 1246 | regulation of response to stress |
GO:1901223 | 0.0022 | 15.1398 | 0.2771 | 3 | 10 | negative regulation of NIK/NF-kappaB signaling |
GO:0045085 | 0.0023 | 70.5131 | 0.0831 | 2 | 3 | negative regulation of interleukin-2 biosynthetic process |
GO:0045658 | 0.0023 | 70.5131 | 0.0831 | 2 | 3 | regulation of neutrophil differentiation |
GO:0060244 | 0.0023 | 70.5131 | 0.0831 | 2 | 3 | negative regulation of cell proliferation involved in contact inhibition |
GO:1904637 | 0.0023 | 70.5131 | 0.0831 | 2 | 3 | cellular response to ionomycin |
GO:2000297 | 0.0023 | 70.5131 | 0.0831 | 2 | 3 | negative regulation of synapse maturation |
GO:0043124 | 0.0025 | 4.8398 | 1.3853 | 6 | 50 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0032103 | 0.0037 | 2.3257 | 6.8159 | 15 | 246 | positive regulation of response to external stimulus |
GO:0050711 | 0.0039 | 11.7738 | 0.3325 | 3 | 12 | negative regulation of interleukin-1 secretion |
GO:0030311 | 0.0044 | 35.2542 | 0.1108 | 2 | 4 | poly-N-acetyllactosamine biosynthetic process |
GO:0045354 | 0.0044 | 35.2542 | 0.1108 | 2 | 4 | regulation of interferon-alpha biosynthetic process |
GO:0030851 | 0.0046 | 6.7385 | 0.6927 | 4 | 25 | granulocyte differentiation |
GO:0002367 | 0.0047 | 3.6564 | 2.078 | 7 | 75 | cytokine production involved in immune response |
GO:0030595 | 0.0051 | 2.5053 | 5.0703 | 12 | 183 | leukocyte chemotaxis |
GO:0009607 | 0.0057 | 1.6588 | 21.5282 | 34 | 777 | response to biotic stimulus |
GO:0001818 | 0.0059 | 2.5707 | 4.5315 | 11 | 165 | negative regulation of cytokine production |
GO:0002274 | 0.0062 | 1.7792 | 15.3219 | 26 | 553 | myeloid leukocyte activation |
GO:0002429 | 0.0067 | 2.1061 | 7.9796 | 16 | 288 | immune response-activating cell surface receptor signaling pathway |
GO:0032648 | 0.0071 | 4.5409 | 1.2191 | 5 | 44 | regulation of interferon-beta production |
GO:0002730 | 0.0072 | 23.5012 | 0.1385 | 2 | 5 | regulation of dendritic cell cytokine production |
GO:0002885 | 0.0072 | 23.5012 | 0.1385 | 2 | 5 | positive regulation of hypersensitivity |
GO:0032792 | 0.0072 | 23.5012 | 0.1385 | 2 | 5 | negative regulation of CREB transcription factor activity |
GO:0060414 | 0.0072 | 23.5012 | 0.1385 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0032611 | 0.0073 | 3.7996 | 1.7178 | 6 | 62 | interleukin-1 beta production |
GO:0007127 | 0.0074 | 3.0249 | 2.8261 | 8 | 102 | meiosis I |
GO:0051707 | 0.0079 | 1.6438 | 20.3922 | 32 | 736 | response to other organism |
GO:0051321 | 0.0082 | 2.2531 | 6.0678 | 13 | 219 | meiotic cell cycle |
GO:1904018 | 0.009 | 2.5431 | 4.156 | 10 | 150 | positive regulation of vasculature development |
GO:0032480 | 0.0094 | 4.2157 | 1.3022 | 5 | 47 | negative regulation of type I interferon production |
GO:0002443 | 0.0094 | 1.6634 | 18.2311 | 29 | 658 | leukocyte mediated immunity |
GO:0002757 | 0.01 | 2.6564 | 3.5866 | 9 | 132 | immune response-activating signal transduction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038111 | 0 | 13.8188 | 1.1342 | 11 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 13.8188 | 1.1342 | 11 | 36 | response to interleukin-7 |
GO:0006335 | 0 | 14.9277 | 0.9767 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 10.7908 | 1.3548 | 11 | 43 | protein heterotetramerization |
GO:0000183 | 0 | 12.0529 | 1.1342 | 10 | 36 | chromatin silencing at rDNA |
GO:0045814 | 0 | 5.0029 | 3.6862 | 16 | 117 | negative regulation of gene expression, epigenetic |
GO:0031497 | 0 | 4.2628 | 4.5053 | 17 | 143 | chromatin assembly |
GO:0034728 | 0 | 3.9467 | 4.8204 | 17 | 153 | nucleosome organization |
GO:0019731 | 0 | 9.6016 | 1.0712 | 8 | 34 | antibacterial humoral response |
GO:0030198 | 0 | 2.7508 | 9.4833 | 24 | 301 | extracellular matrix organization |
GO:0045815 | 0 | 5.1416 | 2.4575 | 11 | 78 | positive regulation of gene expression, epigenetic |
GO:1901750 | 1e-04 | 30.9895 | 0.252 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006941 | 1e-04 | 3.5734 | 4.6314 | 15 | 147 | striated muscle contraction |
GO:0045652 | 1e-04 | 5.1251 | 2.2369 | 10 | 71 | regulation of megakaryocyte differentiation |
GO:0006751 | 1e-04 | 24.7899 | 0.2836 | 4 | 9 | glutathione catabolic process |
GO:0007218 | 1e-04 | 4.2489 | 2.8985 | 11 | 92 | neuropeptide signaling pathway |
GO:0035637 | 2e-04 | 3.0869 | 5.6395 | 16 | 179 | multicellular organismal signaling |
GO:0002227 | 2e-04 | 11.9368 | 0.5671 | 5 | 18 | innate immune response in mucosa |
GO:0060047 | 2e-04 | 2.7355 | 7.4984 | 19 | 238 | heart contraction |
GO:1903779 | 2e-04 | 4.9272 | 2.0794 | 9 | 66 | regulation of cardiac conduction |
GO:0065004 | 4e-04 | 2.7558 | 6.6477 | 17 | 211 | protein-DNA complex assembly |
GO:0003012 | 4e-04 | 2.196 | 12.6339 | 26 | 401 | muscle system process |
GO:0014706 | 4e-04 | 2.3221 | 10.586 | 23 | 336 | striated muscle tissue development |
GO:0001964 | 6e-04 | 8.6181 | 0.7246 | 5 | 23 | startle response |
GO:1903265 | 0.001 | 23.1935 | 0.2205 | 3 | 7 | positive regulation of tumor necrosis factor-mediated signaling pathway |
GO:0002663 | 0.001 | Inf | 0.063 | 2 | 2 | positive regulation of B cell tolerance induction |
GO:0006742 | 0.001 | Inf | 0.063 | 2 | 2 | NADP catabolic process |
GO:0070370 | 0.001 | Inf | 0.063 | 2 | 2 | cellular heat acclimation |
GO:0060964 | 0.0011 | 3.506 | 3.1191 | 10 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0.0012 | 3.4669 | 3.1506 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0010959 | 0.0013 | 2.2119 | 10.0819 | 21 | 320 | regulation of metal ion transport |
GO:0043010 | 0.0014 | 2.2977 | 8.7901 | 19 | 279 | camera-type eye development |
GO:0006776 | 0.0015 | 18.5536 | 0.252 | 3 | 8 | vitamin A metabolic process |
GO:0002251 | 0.0016 | 6.7423 | 0.8822 | 5 | 28 | organ or tissue specific immune response |
GO:0007517 | 0.0018 | 2.0996 | 11.0901 | 22 | 352 | muscle organ development |
GO:0071345 | 0.0019 | 1.6962 | 25.5513 | 41 | 811 | cellular response to cytokine stimulus |
GO:0048704 | 0.0019 | 3.5051 | 2.804 | 9 | 89 | embryonic skeletal system morphogenesis |
GO:0061844 | 0.0021 | 5.0352 | 1.3548 | 6 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0003407 | 0.0022 | 4.2668 | 1.8273 | 7 | 58 | neural retina development |
GO:0001501 | 0.0025 | 1.9216 | 14.2722 | 26 | 453 | skeletal system development |
GO:0050885 | 0.0027 | 4.7764 | 1.4178 | 6 | 45 | neuromuscular process controlling balance |
GO:0014722 | 0.0029 | 61.7328 | 0.0945 | 2 | 3 | regulation of skeletal muscle contraction by calcium ion signaling |
GO:0070434 | 0.0029 | 61.7328 | 0.0945 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0029 | 61.7328 | 0.0945 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0051239 | 0.0029 | 1.6573 | 26.2226 | 41 | 869 | regulation of multicellular organismal process |
GO:0071103 | 0.003 | 2.2395 | 8.034 | 17 | 255 | DNA conformation change |
GO:1903522 | 0.0034 | 2.2112 | 8.1285 | 17 | 258 | regulation of blood circulation |
GO:0055117 | 0.0036 | 3.8845 | 1.9849 | 7 | 63 | regulation of cardiac muscle contraction |
GO:0061448 | 0.0037 | 2.324 | 6.8368 | 15 | 217 | connective tissue development |
GO:0010880 | 0.0038 | 7.2852 | 0.6616 | 4 | 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO:0055013 | 0.0039 | 3.8161 | 2.0164 | 7 | 64 | cardiac muscle cell development |
GO:0007626 | 0.004 | 2.4766 | 5.5765 | 13 | 177 | locomotory behavior |
GO:0007423 | 0.0041 | 1.8195 | 15.5954 | 27 | 495 | sensory organ development |
GO:0009109 | 0.0042 | 11.5936 | 0.3466 | 3 | 11 | coenzyme catabolic process |
GO:0051580 | 0.0042 | 11.5936 | 0.3466 | 3 | 11 | regulation of neurotransmitter uptake |
GO:0030049 | 0.0045 | 5.1667 | 1.1027 | 5 | 35 | muscle filament sliding |
GO:0090169 | 0.0045 | 6.88 | 0.6931 | 4 | 22 | regulation of spindle assembly |
GO:0055017 | 0.0046 | 3.3175 | 2.615 | 8 | 83 | cardiac muscle tissue growth |
GO:0048863 | 0.0048 | 2.1873 | 7.7189 | 16 | 245 | stem cell differentiation |
GO:0060968 | 0.0049 | 2.8069 | 3.8122 | 10 | 121 | regulation of gene silencing |
GO:0048731 | 0.005 | 1.318 | 114.6254 | 139 | 3732 | system development |
GO:0048869 | 0.0051 | 1.309 | 120.0688 | 145 | 3811 | cellular developmental process |
GO:0007601 | 0.0051 | 2.4025 | 5.7341 | 13 | 182 | visual perception |
GO:0002523 | 0.0055 | 10.3047 | 0.3781 | 3 | 12 | leukocyte migration involved in inflammatory response |
GO:0006703 | 0.0055 | 10.3047 | 0.3781 | 3 | 12 | estrogen biosynthetic process |
GO:0010958 | 0.0057 | 30.8643 | 0.126 | 2 | 4 | regulation of amino acid import |
GO:0021615 | 0.0057 | 30.8643 | 0.126 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:1902261 | 0.0057 | 30.8643 | 0.126 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:2000741 | 0.0057 | 30.8643 | 0.126 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0031113 | 0.0058 | 4.8431 | 1.1657 | 5 | 37 | regulation of microtubule polymerization |
GO:0006937 | 0.0062 | 2.5591 | 4.5684 | 11 | 145 | regulation of muscle contraction |
GO:0031112 | 0.0063 | 6.1912 | 0.7561 | 4 | 24 | positive regulation of microtubule polymerization or depolymerization |
GO:2000026 | 0.0064 | 1.4101 | 53.9695 | 72 | 1713 | regulation of multicellular organismal development |
GO:0050808 | 0.0066 | 2.1713 | 7.2779 | 15 | 231 | synapse organization |
GO:0050872 | 0.007 | 9.2736 | 0.4096 | 3 | 13 | white fat cell differentiation |
GO:0045926 | 0.0071 | 2.2201 | 6.6477 | 14 | 211 | negative regulation of growth |
GO:0050878 | 0.0074 | 1.7963 | 13.9886 | 24 | 444 | regulation of body fluid levels |
GO:0032886 | 0.0077 | 2.3688 | 5.356 | 12 | 170 | regulation of microtubule-based process |
GO:0009408 | 0.0079 | 2.4662 | 4.7259 | 11 | 150 | response to heat |
GO:0050877 | 0.0081 | 1.4841 | 35.3496 | 50 | 1122 | nervous system process |
GO:1903514 | 0.0084 | 5.6276 | 0.8192 | 4 | 26 | release of sequestered calcium ion into cytosol by endoplasmic reticulum |
GO:0010666 | 0.0087 | 8.43 | 0.4411 | 3 | 14 | positive regulation of cardiac muscle cell apoptotic process |
GO:0089711 | 0.0087 | 8.43 | 0.4411 | 3 | 14 | L-glutamate transmembrane transport |
GO:0044060 | 0.0089 | 4.3038 | 1.2917 | 5 | 41 | regulation of endocrine process |
GO:0046604 | 0.0093 | 20.5748 | 0.1575 | 2 | 5 | positive regulation of mitotic centrosome separation |
GO:0061743 | 0.0093 | 20.5748 | 0.1575 | 2 | 5 | motor learning |
GO:0072526 | 0.0093 | 20.5748 | 0.1575 | 2 | 5 | pyridine-containing compound catabolic process |
GO:1903789 | 0.0093 | 20.5748 | 0.1575 | 2 | 5 | regulation of amino acid transmembrane transport |
GO:0007605 | 0.0094 | 2.531 | 4.1903 | 10 | 133 | sensory perception of sound |
GO:0070296 | 0.0096 | 5.3826 | 0.8507 | 4 | 27 | sarcoplasmic reticulum calcium ion transport |
GO:0006029 | 0.0099 | 3.1499 | 2.3944 | 7 | 76 | proteoglycan metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 16.4358 | 0.8914 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 13.2706 | 1.0352 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 13.2706 | 1.0352 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 13.2706 | 1.0352 | 10 | 36 | response to interleukin-7 |
GO:0051290 | 0 | 10.4507 | 1.2365 | 10 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 5.6623 | 2.2429 | 11 | 78 | positive regulation of gene expression, epigenetic |
GO:0045652 | 0 | 5.6429 | 2.0416 | 10 | 71 | regulation of megakaryocyte differentiation |
GO:1901750 | 0 | 34.0782 | 0.23 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0051239 | 1e-04 | 1.588 | 74.245 | 106 | 2582 | regulation of multicellular organismal process |
GO:0006751 | 1e-04 | 27.2607 | 0.2588 | 4 | 9 | glutathione catabolic process |
GO:0035194 | 1e-04 | 2.7948 | 7.735 | 20 | 269 | posttranscriptional gene silencing by RNA |
GO:0060964 | 1e-04 | 4.3049 | 2.8467 | 11 | 99 | regulation of gene silencing by miRNA |
GO:0007186 | 2e-04 | 1.7608 | 33.0105 | 54 | 1148 | G-protein coupled receptor signaling pathway |
GO:0002244 | 3e-04 | 3.0871 | 5.2621 | 15 | 183 | hematopoietic progenitor cell differentiation |
GO:0003008 | 3e-04 | 1.6008 | 51.4999 | 76 | 1791 | system process |
GO:0007596 | 5e-04 | 2.4445 | 8.7415 | 20 | 304 | blood coagulation |
GO:1902036 | 6e-04 | 3.8171 | 2.8755 | 10 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 7e-04 | 3.4388 | 3.4793 | 11 | 121 | regulation of gene silencing |
GO:0006742 | 8e-04 | Inf | 0.0575 | 2 | 2 | NADP catabolic process |
GO:0014809 | 8e-04 | Inf | 0.0575 | 2 | 2 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
GO:0007275 | 0.0011 | 1.3707 | 134.8889 | 165 | 4691 | multicellular organism development |
GO:0050878 | 0.0011 | 2.0766 | 12.7671 | 25 | 444 | regulation of body fluid levels |
GO:2000304 | 0.0012 | 20.3986 | 0.23 | 3 | 8 | positive regulation of ceramide biosynthetic process |
GO:0048513 | 0.0013 | 1.4153 | 87.961 | 114 | 3059 | animal organ development |
GO:0010612 | 0.0015 | 9.73 | 0.5176 | 4 | 18 | regulation of cardiac muscle adaptation |
GO:0060326 | 0.0015 | 2.4773 | 6.8724 | 16 | 239 | cell chemotaxis |
GO:0035023 | 0.0017 | 3.3002 | 3.2781 | 10 | 114 | regulation of Rho protein signal transduction |
GO:0032200 | 0.0018 | 2.886 | 4.457 | 12 | 155 | telomere organization |
GO:0045814 | 0.002 | 3.207 | 3.3643 | 10 | 117 | negative regulation of gene expression, epigenetic |
GO:0030817 | 0.0021 | 3.1771 | 3.3931 | 10 | 118 | regulation of cAMP biosynthetic process |
GO:0045595 | 0.0023 | 1.5164 | 44.9726 | 64 | 1564 | regulation of cell differentiation |
GO:0010636 | 0.0024 | 67.8581 | 0.0863 | 2 | 3 | positive regulation of mitochondrial fusion |
GO:0038091 | 0.0024 | 67.8581 | 0.0863 | 2 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
GO:0051480 | 0.0025 | 2.284 | 7.8788 | 17 | 274 | regulation of cytosolic calcium ion concentration |
GO:0010524 | 0.0027 | 4.7645 | 1.409 | 6 | 49 | positive regulation of calcium ion transport into cytosol |
GO:0032502 | 0.0028 | 1.3213 | 157.7778 | 186 | 5487 | developmental process |
GO:0031497 | 0.0028 | 2.8614 | 4.1119 | 11 | 143 | chromatin assembly |
GO:0065004 | 0.0032 | 2.4465 | 6.0673 | 14 | 211 | protein-DNA complex assembly |
GO:0017148 | 0.0033 | 2.0714 | 10.1792 | 20 | 354 | negative regulation of translation |
GO:1903244 | 0.0033 | 12.7466 | 0.3163 | 3 | 11 | positive regulation of cardiac muscle hypertrophy in response to stress |
GO:0052652 | 0.0035 | 2.7765 | 4.227 | 11 | 147 | cyclic purine nucleotide metabolic process |
GO:0009611 | 0.0037 | 1.7955 | 16.9941 | 29 | 591 | response to wounding |
GO:0030099 | 0.0037 | 2.0463 | 10.2942 | 20 | 358 | myeloid cell differentiation |
GO:0008015 | 0.0038 | 1.9045 | 13.256 | 24 | 461 | blood circulation |
GO:0071346 | 0.0041 | 2.8812 | 3.7094 | 10 | 129 | cellular response to interferon-gamma |
GO:0030799 | 0.0045 | 2.6771 | 4.3707 | 11 | 152 | regulation of cyclic nucleotide metabolic process |
GO:0071604 | 0.0045 | 6.8083 | 0.6901 | 4 | 24 | transforming growth factor beta production |
GO:0034728 | 0.0047 | 2.6581 | 4.3995 | 11 | 153 | nucleosome organization |
GO:0032430 | 0.0048 | 33.9268 | 0.115 | 2 | 4 | positive regulation of phospholipase A2 activity |
GO:0032914 | 0.0048 | 33.9268 | 0.115 | 2 | 4 | positive regulation of transforming growth factor beta1 production |
GO:2000741 | 0.0048 | 33.9268 | 0.115 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0048863 | 0.005 | 2.2454 | 7.0449 | 15 | 245 | stem cell differentiation |
GO:0023052 | 0.005 | 1.2945 | 163.5862 | 190 | 5689 | signaling |
GO:0014808 | 0.0053 | 6.4836 | 0.7189 | 4 | 25 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO:0090153 | 0.0054 | 10.1959 | 0.3738 | 3 | 13 | regulation of sphingolipid biosynthetic process |
GO:0006805 | 0.006 | 3.145 | 2.7317 | 8 | 95 | xenobiotic metabolic process |
GO:0044060 | 0.0061 | 4.7337 | 1.1789 | 5 | 41 | regulation of endocrine process |
GO:0002790 | 0.0062 | 1.8012 | 14.5499 | 25 | 506 | peptide secretion |
GO:0072507 | 0.0065 | 1.8999 | 11.5882 | 21 | 403 | divalent inorganic cation homeostasis |
GO:0014744 | 0.0068 | 9.2683 | 0.4026 | 3 | 14 | positive regulation of muscle adaptation |
GO:0032930 | 0.0068 | 9.2683 | 0.4026 | 3 | 14 | positive regulation of superoxide anion generation |
GO:0034433 | 0.0068 | 9.2683 | 0.4026 | 3 | 14 | steroid esterification |
GO:0034435 | 0.0068 | 9.2683 | 0.4026 | 3 | 14 | cholesterol esterification |
GO:0014743 | 0.0068 | 3.8629 | 1.6965 | 6 | 59 | regulation of muscle hypertrophy |
GO:0006812 | 0.0075 | 1.5472 | 28.496 | 42 | 991 | cation transport |
GO:0007154 | 0.0077 | 1.2752 | 164.1326 | 189 | 5708 | cell communication |
GO:0046604 | 0.0078 | 22.6163 | 0.1438 | 2 | 5 | positive regulation of mitotic centrosome separation |
GO:0072526 | 0.0078 | 22.6163 | 0.1438 | 2 | 5 | pyridine-containing compound catabolic process |
GO:0090131 | 0.0078 | 22.6163 | 0.1438 | 2 | 5 | mesenchyme migration |
GO:0008347 | 0.0083 | 4.3687 | 1.2652 | 5 | 44 | glial cell migration |
GO:0060749 | 0.0083 | 8.4954 | 0.4313 | 3 | 15 | mammary gland alveolus development |
GO:0019722 | 0.0084 | 2.5755 | 4.1119 | 10 | 143 | calcium-mediated signaling |
GO:0030808 | 0.0088 | 2.5561 | 4.1407 | 10 | 144 | regulation of nucleotide biosynthetic process |
GO:0046883 | 0.0088 | 2.1574 | 6.8149 | 14 | 237 | regulation of hormone secretion |
GO:0006691 | 0.0091 | 5.4448 | 0.8339 | 4 | 29 | leukotriene metabolic process |
GO:0046058 | 0.0092 | 2.537 | 4.1695 | 10 | 145 | cAMP metabolic process |
GO:0043270 | 0.0095 | 2.2096 | 6.1823 | 13 | 215 | positive regulation of ion transport |
GO:0009914 | 0.0096 | 2.0166 | 8.3101 | 16 | 289 | hormone transport |
GO:0009410 | 0.0097 | 2.8786 | 2.9617 | 8 | 103 | response to xenobiotic stimulus |
GO:2000179 | 0.01 | 4.1551 | 1.3227 | 5 | 46 | positive regulation of neural precursor cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 94.9475 | 1.1269 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 55.3672 | 1.3087 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 38.5063 | 1.5632 | 25 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 126.8799 | 0.618 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 13.0465 | 2.8355 | 25 | 78 | positive regulation of gene expression, epigenetic |
GO:0031497 | 0 | 8.0484 | 5.1985 | 32 | 143 | chromatin assembly |
GO:0060964 | 0 | 9.3307 | 3.5989 | 25 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 9.2057 | 3.6353 | 25 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0065004 | 0 | 5.359 | 7.6705 | 34 | 211 | protein-DNA complex assembly |
GO:1904837 | 0 | 16.7672 | 1.5268 | 16 | 42 | beta-catenin-TCF complex assembly |
GO:0060968 | 0 | 7.1816 | 4.3987 | 25 | 121 | regulation of gene silencing |
GO:0045814 | 0 | 7.1048 | 4.2533 | 24 | 117 | negative regulation of gene expression, epigenetic |
GO:0034080 | 0 | 14.6171 | 1.4541 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0071103 | 0 | 4.1263 | 9.27 | 33 | 255 | DNA conformation change |
GO:0030099 | 0 | 3.5157 | 13.0143 | 40 | 358 | myeloid cell differentiation |
GO:0002244 | 0 | 4.7714 | 6.6526 | 27 | 183 | hematopoietic progenitor cell differentiation |
GO:0016233 | 0 | 10.5496 | 1.8176 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 10.5496 | 1.8176 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0032200 | 0 | 5.0307 | 5.6347 | 24 | 155 | telomere organization |
GO:0034728 | 0 | 5.908 | 3.6619 | 18 | 103 | nucleosome organization |
GO:0048863 | 0 | 3.7 | 8.9065 | 29 | 245 | stem cell differentiation |
GO:1903707 | 0 | 5.1026 | 4.6168 | 20 | 127 | negative regulation of hemopoiesis |
GO:0043044 | 0 | 7.0182 | 2.6538 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 7.2956 | 2.3993 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0045596 | 0 | 2.4841 | 21.8481 | 49 | 601 | negative regulation of cell differentiation |
GO:0051259 | 0 | 2.6067 | 17.8129 | 42 | 490 | protein oligomerization |
GO:0045652 | 0 | 7.9217 | 1.9157 | 12 | 54 | regulation of megakaryocyte differentiation |
GO:0038111 | 0 | 10.3641 | 1.3087 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 10.3641 | 1.3087 | 10 | 36 | response to interleukin-7 |
GO:0048534 | 0 | 2.1725 | 29.3732 | 58 | 808 | hematopoietic or lymphoid organ development |
GO:0035194 | 0 | 3.1903 | 9.7789 | 28 | 269 | posttranscriptional gene silencing by RNA |
GO:0017148 | 0 | 2.5376 | 12.8689 | 30 | 354 | negative regulation of translation |
GO:0045595 | 0 | 1.8931 | 30.8712 | 54 | 896 | regulation of cell differentiation |
GO:0048869 | 1e-04 | 1.4535 | 134.3818 | 174 | 3731 | cellular developmental process |
GO:0010812 | 1e-04 | 5.6232 | 1.8904 | 9 | 52 | negative regulation of cell-substrate adhesion |
GO:0035987 | 1e-04 | 6.5056 | 1.4905 | 8 | 41 | endodermal cell differentiation |
GO:0007166 | 1e-04 | 1.6242 | 54.1305 | 81 | 1541 | cell surface receptor signaling pathway |
GO:0071294 | 1e-04 | 13.3655 | 0.5453 | 5 | 15 | cellular response to zinc ion |
GO:0051248 | 2e-04 | 1.6482 | 44.2415 | 68 | 1217 | negative regulation of protein metabolic process |
GO:0002376 | 3e-04 | 1.4659 | 89.8644 | 121 | 2472 | immune system process |
GO:0002227 | 4e-04 | 10.279 | 0.6544 | 5 | 18 | innate immune response in mucosa |
GO:0006352 | 6e-04 | 2.4961 | 8.1794 | 19 | 225 | DNA-templated transcription, initiation |
GO:0040007 | 6e-04 | 1.706 | 31.1545 | 50 | 857 | growth |
GO:0071241 | 7e-04 | 2.8102 | 5.7801 | 15 | 159 | cellular response to inorganic substance |
GO:1903844 | 7e-04 | 3.4796 | 3.4899 | 11 | 96 | regulation of cellular response to transforming growth factor beta stimulus |
GO:0070271 | 7e-04 | 1.5626 | 47.7677 | 70 | 1314 | protein complex biogenesis |
GO:0007492 | 7e-04 | 4.1083 | 2.4637 | 9 | 68 | endoderm development |
GO:0048663 | 8e-04 | 4.0938 | 2.472 | 9 | 68 | neuron fate commitment |
GO:0043537 | 8e-04 | 6.4205 | 1.1269 | 6 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0010720 | 8e-04 | 1.9834 | 16.068 | 30 | 442 | positive regulation of cell development |
GO:0050896 | 8e-04 | 1.3189 | 279.2268 | 316 | 7681 | response to stimulus |
GO:0034248 | 8e-04 | 1.8525 | 20.6121 | 36 | 567 | regulation of cellular amide metabolic process |
GO:0050878 | 9e-04 | 1.9735 | 16.1407 | 30 | 444 | regulation of body fluid levels |
GO:0051962 | 9e-04 | 1.9931 | 15.45 | 29 | 425 | positive regulation of nervous system development |
GO:0009611 | 9e-04 | 1.8254 | 21.4846 | 37 | 591 | response to wounding |
GO:0060547 | 0.001 | 11.8596 | 0.4726 | 4 | 13 | negative regulation of necrotic cell death |
GO:0048731 | 0.0012 | 1.3572 | 126.7799 | 157 | 3573 | system development |
GO:0051895 | 0.0013 | 10.673 | 0.5089 | 4 | 14 | negative regulation of focal adhesion assembly |
GO:0019285 | 0.0013 | Inf | 0.0727 | 2 | 2 | glycine betaine biosynthetic process from choline |
GO:0031455 | 0.0013 | Inf | 0.0727 | 2 | 2 | glycine betaine metabolic process |
GO:0070370 | 0.0013 | Inf | 0.0727 | 2 | 2 | cellular heat acclimation |
GO:0097213 | 0.0013 | Inf | 0.0727 | 2 | 2 | regulation of lysosomal membrane permeability |
GO:1901731 | 0.0013 | Inf | 0.0727 | 2 | 2 | positive regulation of platelet aggregation |
GO:0001766 | 0.0015 | 19.9837 | 0.2545 | 3 | 7 | membrane raft polarization |
GO:0043652 | 0.0015 | 19.9837 | 0.2545 | 3 | 7 | engulfment of apoptotic cell |
GO:0030198 | 0.0015 | 2.1352 | 10.9422 | 22 | 301 | extracellular matrix organization |
GO:0030574 | 0.0016 | 4.0451 | 2.2175 | 8 | 61 | collagen catabolic process |
GO:0071276 | 0.0018 | 6.6782 | 0.9088 | 5 | 25 | cellular response to cadmium ion |
GO:2000108 | 0.0018 | 6.6782 | 0.9088 | 5 | 25 | positive regulation of leukocyte apoptotic process |
GO:0021879 | 0.0018 | 4.4617 | 1.7813 | 7 | 49 | forebrain neuron differentiation |
GO:0030308 | 0.002 | 2.7114 | 5.1621 | 13 | 142 | negative regulation of cell growth |
GO:0043524 | 0.0023 | 2.8051 | 4.6168 | 12 | 127 | negative regulation of neuron apoptotic process |
GO:0051665 | 0.0023 | 15.9859 | 0.2908 | 3 | 8 | membrane raft localization |
GO:0070424 | 0.0023 | 15.9859 | 0.2908 | 3 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0045666 | 0.0025 | 2.0875 | 10.652 | 21 | 294 | positive regulation of neuron differentiation |
GO:0014013 | 0.0025 | 3.1205 | 3.4899 | 10 | 96 | regulation of gliogenesis |
GO:0015696 | 0.0026 | 3.3516 | 2.9446 | 9 | 81 | ammonium transport |
GO:0010608 | 0.0029 | 1.6848 | 23.7385 | 38 | 653 | posttranscriptional regulation of gene expression |
GO:0002251 | 0.0031 | 5.8059 | 1.0179 | 5 | 28 | organ or tissue specific immune response |
GO:0010038 | 0.0032 | 2.0344 | 10.9059 | 21 | 300 | response to metal ion |
GO:0045892 | 0.0033 | 1.5313 | 37.8434 | 55 | 1041 | negative regulation of transcription, DNA-templated |
GO:0010033 | 0.0034 | 1.341 | 99.8251 | 125 | 2746 | response to organic substance |
GO:0045602 | 0.0034 | 13.3207 | 0.3272 | 3 | 9 | negative regulation of endothelial cell differentiation |
GO:1903706 | 0.0035 | 2.0618 | 10.2477 | 20 | 290 | regulation of hemopoiesis |
GO:0060602 | 0.0035 | 7.6215 | 0.6544 | 4 | 18 | branch elongation of an epithelium |
GO:1902667 | 0.0035 | 7.6215 | 0.6544 | 4 | 18 | regulation of axon guidance |
GO:0001704 | 0.0036 | 2.7862 | 4.2533 | 11 | 117 | formation of primary germ layer |
GO:0070887 | 0.0038 | 1.3507 | 90.1787 | 114 | 2523 | cellular response to chemical stimulus |
GO:0048878 | 0.0039 | 1.542 | 34.7897 | 51 | 957 | chemical homeostasis |
GO:0036337 | 0.0039 | 53.2043 | 0.1091 | 2 | 3 | Fas signaling pathway |
GO:0046110 | 0.0039 | 53.2043 | 0.1091 | 2 | 3 | xanthine metabolic process |
GO:0070434 | 0.0039 | 53.2043 | 0.1091 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0039 | 53.2043 | 0.1091 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0009612 | 0.004 | 2.3075 | 6.9071 | 15 | 190 | response to mechanical stimulus |
GO:0050767 | 0.0042 | 1.723 | 19.5066 | 32 | 543 | regulation of neurogenesis |
GO:0007167 | 0.0043 | 1.5464 | 33.2993 | 49 | 916 | enzyme linked receptor protein signaling pathway |
GO:0043032 | 0.0043 | 7.1129 | 0.6907 | 4 | 19 | positive regulation of macrophage activation |
GO:0007411 | 0.0044 | 2.2828 | 6.9738 | 15 | 193 | axon guidance |
GO:2000026 | 0.0045 | 1.4902 | 41.0468 | 58 | 1194 | regulation of multicellular organismal development |
GO:0006600 | 0.0047 | 11.4169 | 0.3635 | 3 | 10 | creatine metabolic process |
GO:0006853 | 0.0047 | 11.4169 | 0.3635 | 3 | 10 | carnitine shuttle |
GO:0090084 | 0.0047 | 11.4169 | 0.3635 | 3 | 10 | negative regulation of inclusion body assembly |
GO:0001504 | 0.0053 | 6.6679 | 0.7271 | 4 | 20 | neurotransmitter uptake |
GO:0031579 | 0.0053 | 6.6679 | 0.7271 | 4 | 20 | membrane raft organization |
GO:0090092 | 0.0054 | 2.23 | 7.1252 | 15 | 196 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0071822 | 0.0055 | 1.4086 | 56.1289 | 75 | 1544 | protein complex subunit organization |
GO:0072358 | 0.0055 | 1.6489 | 22.248 | 35 | 612 | cardiovascular system development |
GO:0042330 | 0.0056 | 1.7027 | 19.0853 | 31 | 525 | taxis |
GO:0006790 | 0.0058 | 1.8926 | 12.2146 | 22 | 336 | sulfur compound metabolic process |
GO:0090288 | 0.0059 | 2.5893 | 4.5441 | 11 | 125 | negative regulation of cellular response to growth factor stimulus |
GO:0042531 | 0.0059 | 3.533 | 2.1812 | 7 | 60 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0070373 | 0.0059 | 3.533 | 2.1812 | 7 | 60 | negative regulation of ERK1 and ERK2 cascade |
GO:1902679 | 0.0062 | 1.4781 | 39.043 | 55 | 1074 | negative regulation of RNA biosynthetic process |
GO:0001952 | 0.0062 | 2.9053 | 3.3445 | 9 | 92 | regulation of cell-matrix adhesion |
GO:0007039 | 0.0063 | 9.9891 | 0.3999 | 3 | 11 | protein catabolic process in the vacuole |
GO:0045687 | 0.0064 | 4.7675 | 1.1996 | 5 | 33 | positive regulation of glial cell differentiation |
GO:1901566 | 0.0064 | 1.3616 | 69.834 | 90 | 1921 | organonitrogen compound biosynthetic process |
GO:0061564 | 0.0067 | 1.7676 | 15.4136 | 26 | 424 | axon development |
GO:0030155 | 0.0067 | 1.637 | 21.739 | 34 | 598 | regulation of cell adhesion |
GO:0022603 | 0.0071 | 1.5126 | 32.5359 | 47 | 895 | regulation of anatomical structure morphogenesis |
GO:2001237 | 0.0071 | 2.8365 | 3.4172 | 9 | 94 | negative regulation of extrinsic apoptotic signaling pathway |
GO:0019731 | 0.0073 | 4.6028 | 1.236 | 5 | 34 | antibacterial humoral response |
GO:0045773 | 0.0073 | 4.6028 | 1.236 | 5 | 34 | positive regulation of axon extension |
GO:0050922 | 0.0073 | 4.6028 | 1.236 | 5 | 34 | negative regulation of chemotaxis |
GO:0001568 | 0.0073 | 1.6402 | 21.0483 | 33 | 579 | blood vessel development |
GO:0030856 | 0.0074 | 2.5008 | 4.6895 | 11 | 129 | regulation of epithelial cell differentiation |
GO:0034112 | 0.0075 | 26.6969 | 0.1449 | 2 | 4 | positive regulation of homotypic cell-cell adhesion |
GO:0042663 | 0.0075 | 26.6004 | 0.1454 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0044571 | 0.0075 | 26.6004 | 0.1454 | 2 | 4 | [2Fe-2S] cluster assembly |
GO:0048382 | 0.0075 | 26.6004 | 0.1454 | 2 | 4 | mesendoderm development |
GO:0060167 | 0.0075 | 26.6004 | 0.1454 | 2 | 4 | regulation of adenosine receptor signaling pathway |
GO:0060708 | 0.0075 | 26.6004 | 0.1454 | 2 | 4 | spongiotrophoblast differentiation |
GO:0072095 | 0.0075 | 26.6004 | 0.1454 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:1904340 | 0.0075 | 26.6004 | 0.1454 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0070228 | 0.0075 | 3.8173 | 1.7449 | 6 | 48 | regulation of lymphocyte apoptotic process |
GO:1905039 | 0.0076 | 2.8033 | 3.4535 | 9 | 95 | carboxylic acid transmembrane transport |
GO:0120035 | 0.0076 | 1.6762 | 18.7218 | 30 | 515 | regulation of plasma membrane bounded cell projection organization |
GO:0007596 | 0.0079 | 1.8992 | 11.0513 | 20 | 304 | blood coagulation |
GO:0071559 | 0.008 | 2.1231 | 7.4523 | 15 | 205 | response to transforming growth factor beta |
GO:0046903 | 0.0081 | 1.4026 | 50.8941 | 68 | 1400 | secretion |
GO:0010839 | 0.0082 | 8.8786 | 0.4362 | 3 | 12 | negative regulation of keratinocyte proliferation |
GO:0070243 | 0.0082 | 8.8786 | 0.4362 | 3 | 12 | regulation of thymocyte apoptotic process |
GO:0046068 | 0.0083 | 3.7283 | 1.7813 | 6 | 49 | cGMP metabolic process |
GO:0030512 | 0.0084 | 3.2842 | 2.3266 | 7 | 64 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0048844 | 0.0084 | 3.2842 | 2.3266 | 7 | 64 | artery morphogenesis |
GO:0071345 | 0.0084 | 1.5248 | 29.4822 | 43 | 811 | cellular response to cytokine stimulus |
GO:0001708 | 0.0085 | 2.9738 | 2.9082 | 8 | 80 | cell fate specification |
GO:0070997 | 0.0086 | 1.9178 | 10.3969 | 19 | 286 | neuron death |
GO:0006928 | 0.0086 | 1.3577 | 64.3447 | 83 | 1770 | movement of cell or subcellular component |
GO:0090103 | 0.0088 | 5.6139 | 0.8361 | 4 | 23 | cochlea morphogenesis |
GO:0065003 | 0.0089 | 1.3678 | 59.946 | 78 | 1649 | macromolecular complex assembly |
GO:0010769 | 0.0089 | 2.0401 | 8.2521 | 16 | 227 | regulation of cell morphogenesis involved in differentiation |
GO:0045934 | 0.009 | 1.4123 | 46.7499 | 63 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0010633 | 0.0091 | 3.2273 | 2.3629 | 7 | 65 | negative regulation of epithelial cell migration |
GO:0048708 | 0.0091 | 3.2273 | 2.3629 | 7 | 65 | astrocyte differentiation |
GO:0001558 | 0.0091 | 2.0893 | 7.5611 | 15 | 211 | regulation of cell growth |
GO:0016043 | 0.0095 | 1.2358 | 199.2867 | 226 | 5482 | cellular component organization |
GO:0001666 | 0.01 | 1.8526 | 11.3058 | 20 | 311 | response to hypoxia |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007218 | 0 | 6.9114 | 2.5972 | 15 | 92 | neuropeptide signaling pathway |
GO:0099537 | 0 | 2.8277 | 15.7528 | 40 | 558 | trans-synaptic signaling |
GO:0050877 | 0 | 2.2486 | 29.298 | 59 | 1058 | nervous system process |
GO:0042391 | 0 | 3.2872 | 8.7557 | 26 | 315 | regulation of membrane potential |
GO:0051480 | 0 | 3.2757 | 7.7352 | 23 | 274 | regulation of cytosolic calcium ion concentration |
GO:0065007 | 0 | 1.6803 | 299.7831 | 341 | 10619 | biological regulation |
GO:0007186 | 0 | 2.1957 | 22.9834 | 46 | 863 | G-protein coupled receptor signaling pathway |
GO:0023061 | 0 | 2.7938 | 10.9536 | 28 | 388 | signal release |
GO:0007268 | 0 | 2.5756 | 13.5554 | 32 | 487 | chemical synaptic transmission |
GO:0055074 | 0 | 2.7906 | 10.5583 | 27 | 374 | calcium ion homeostasis |
GO:0007188 | 0 | 4.2436 | 3.9523 | 15 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0031644 | 0 | 6.5022 | 1.8068 | 10 | 64 | regulation of neurological system process |
GO:0072503 | 0 | 2.7028 | 10.8689 | 27 | 385 | cellular divalent inorganic cation homeostasis |
GO:0060322 | 0 | 2.2627 | 18.2371 | 38 | 646 | head development |
GO:0008015 | 0 | 2.5004 | 13.0144 | 30 | 461 | blood circulation |
GO:0061364 | 0 | Inf | 0.0847 | 3 | 3 | apoptotic process involved in luteolysis |
GO:0060079 | 0 | 6.7784 | 1.566 | 9 | 56 | excitatory postsynaptic potential |
GO:0048665 | 0 | 9.404 | 0.9316 | 7 | 33 | neuron fate specification |
GO:0048699 | 0 | 1.8466 | 36.0508 | 61 | 1277 | generation of neurons |
GO:0035637 | 0 | 3.4706 | 5.0533 | 16 | 179 | multicellular organismal signaling |
GO:0050794 | 1e-04 | 1.5151 | 257.4354 | 295 | 9322 | regulation of cellular process |
GO:0009593 | 1e-04 | 2.4756 | 11.3206 | 26 | 401 | detection of chemical stimulus |
GO:0048644 | 1e-04 | 5.0105 | 2.2585 | 10 | 80 | muscle organ morphogenesis |
GO:0060219 | 1e-04 | 14.4992 | 0.4799 | 5 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0007198 | 1e-04 | 103.9836 | 0.1129 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 1e-04 | 103.9836 | 0.1129 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 1e-04 | 103.9836 | 0.1129 | 3 | 4 | detection of glucose |
GO:0007267 | 1e-04 | 2.2239 | 15.0259 | 31 | 563 | cell-cell signaling |
GO:0003206 | 1e-04 | 4.018 | 3.303 | 12 | 117 | cardiac chamber morphogenesis |
GO:0006875 | 1e-04 | 2.3166 | 12.9862 | 28 | 460 | cellular metal ion homeostasis |
GO:0007210 | 1e-04 | 12.4262 | 0.5364 | 5 | 19 | serotonin receptor signaling pathway |
GO:0007611 | 1e-04 | 3.005 | 6.1261 | 17 | 217 | learning or memory |
GO:0035270 | 1e-04 | 3.9056 | 3.3877 | 12 | 120 | endocrine system development |
GO:0051240 | 2e-04 | 1.7233 | 38.9585 | 62 | 1380 | positive regulation of multicellular organismal process |
GO:0097746 | 2e-04 | 3.8341 | 3.4442 | 12 | 122 | regulation of blood vessel diameter |
GO:0019233 | 2e-04 | 4.4942 | 2.4843 | 10 | 88 | sensory perception of pain |
GO:0019932 | 2e-04 | 2.7465 | 7.4529 | 19 | 264 | second-messenger-mediated signaling |
GO:0051970 | 2e-04 | 51.9883 | 0.1412 | 3 | 5 | negative regulation of transmission of nerve impulse |
GO:0071502 | 2e-04 | 51.9883 | 0.1412 | 3 | 5 | cellular response to temperature stimulus |
GO:0009914 | 2e-04 | 2.6352 | 8.1587 | 20 | 289 | hormone transport |
GO:0050885 | 2e-04 | 6.4291 | 1.2704 | 7 | 45 | neuromuscular process controlling balance |
GO:0007389 | 2e-04 | 2.5384 | 8.877 | 21 | 318 | pattern specification process |
GO:0045597 | 3e-04 | 1.897 | 23.1493 | 41 | 820 | positive regulation of cell differentiation |
GO:0003018 | 3e-04 | 3.3867 | 4.1782 | 13 | 148 | vascular process in circulatory system |
GO:0035150 | 3e-04 | 3.603 | 3.6418 | 12 | 129 | regulation of tube size |
GO:0071804 | 3e-04 | 3.0208 | 5.3639 | 15 | 190 | cellular potassium ion transport |
GO:0031960 | 3e-04 | 3.3368 | 4.2346 | 13 | 150 | response to corticosteroid |
GO:0046883 | 4e-04 | 2.7281 | 6.6907 | 17 | 237 | regulation of hormone secretion |
GO:0021891 | 4e-04 | 34.6565 | 0.1694 | 3 | 6 | olfactory bulb interneuron development |
GO:0007631 | 4e-04 | 4.9648 | 1.8135 | 8 | 65 | feeding behavior |
GO:0048666 | 4e-04 | 1.8097 | 26.0006 | 44 | 921 | neuron development |
GO:0030900 | 4e-04 | 3.6681 | 3.278 | 11 | 118 | forebrain development |
GO:0007417 | 5e-04 | 2.0116 | 16.9764 | 32 | 621 | central nervous system development |
GO:0050906 | 6e-04 | 2.2075 | 11.5746 | 24 | 410 | detection of stimulus involved in sensory perception |
GO:0050768 | 7e-04 | 2.6852 | 6.3802 | 16 | 226 | negative regulation of neurogenesis |
GO:0035385 | 7e-04 | 25.9907 | 0.1976 | 3 | 7 | Roundabout signaling pathway |
GO:0032502 | 7e-04 | 1.3789 | 154.9025 | 187 | 5487 | developmental process |
GO:0021510 | 7e-04 | 4.5435 | 1.9609 | 8 | 70 | spinal cord development |
GO:0007586 | 7e-04 | 3.2149 | 4.037 | 12 | 143 | digestion |
GO:0042310 | 8e-04 | 4.5067 | 1.9762 | 8 | 70 | vasoconstriction |
GO:0032501 | 8e-04 | 1.4545 | 104.7833 | 132 | 4205 | multicellular organismal process |
GO:2000054 | 8e-04 | Inf | 0.0565 | 2 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
GO:0006811 | 8e-04 | 1.6169 | 39.7772 | 60 | 1409 | ion transport |
GO:0007606 | 8e-04 | 2.1615 | 11.8005 | 24 | 418 | sensory perception of chemical stimulus |
GO:0021522 | 8e-04 | 7.9401 | 0.7588 | 5 | 27 | spinal cord motor neuron differentiation |
GO:0009952 | 9e-04 | 2.829 | 5.3074 | 14 | 188 | anterior/posterior pattern specification |
GO:0050911 | 0.001 | 2.3106 | 9.2032 | 20 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0031016 | 0.001 | 4.2978 | 2.0609 | 8 | 73 | pancreas development |
GO:0008343 | 0.0011 | 20.7911 | 0.2258 | 3 | 8 | adult feeding behavior |
GO:0045924 | 0.0011 | 20.7911 | 0.2258 | 3 | 8 | regulation of female receptivity |
GO:0019098 | 0.0012 | 7.2437 | 0.8187 | 5 | 29 | reproductive behavior |
GO:0015672 | 0.0013 | 2.0245 | 13.6073 | 26 | 482 | monovalent inorganic cation transport |
GO:0071396 | 0.0013 | 1.986 | 14.3977 | 27 | 510 | cellular response to lipid |
GO:0060485 | 0.0015 | 2.5735 | 6.2108 | 15 | 220 | mesenchyme development |
GO:0048705 | 0.0015 | 2.6734 | 5.5897 | 14 | 198 | skeletal system morphogenesis |
GO:0002067 | 0.0016 | 5.3564 | 1.2704 | 6 | 45 | glandular epithelial cell differentiation |
GO:0050795 | 0.0016 | 4.5193 | 1.7221 | 7 | 61 | regulation of behavior |
GO:0044848 | 0.0017 | 17.3248 | 0.2541 | 3 | 9 | biological phase |
GO:0046549 | 0.0017 | 17.3248 | 0.2541 | 3 | 9 | retinal cone cell development |
GO:0046877 | 0.0017 | 17.3248 | 0.2541 | 3 | 9 | regulation of saliva secretion |
GO:0048878 | 0.0017 | 1.6881 | 27.0169 | 43 | 957 | chemical homeostasis |
GO:0055010 | 0.0018 | 5.2221 | 1.2986 | 6 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0006873 | 0.0019 | 1.9128 | 15.4705 | 28 | 548 | cellular ion homeostasis |
GO:0051482 | 0.0021 | 8.6768 | 0.5646 | 4 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0098815 | 0.0022 | 6.2072 | 0.9316 | 5 | 33 | modulation of excitatory postsynaptic potential |
GO:0021559 | 0.0023 | 14.8488 | 0.2823 | 3 | 10 | trigeminal nerve development |
GO:0071280 | 0.0023 | 14.8488 | 0.2823 | 3 | 10 | cellular response to copper ion |
GO:0010159 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | specification of animal organ position |
GO:0021524 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | visceral motor neuron differentiation |
GO:0021912 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0055014 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | atrial cardiac muscle cell development |
GO:2000312 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | regulation of kainate selective glutamate receptor activity |
GO:2000721 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0014821 | 0.0026 | 8.1659 | 0.5928 | 4 | 21 | phasic smooth muscle contraction |
GO:0060487 | 0.0026 | 8.1659 | 0.5928 | 4 | 21 | lung epithelial cell differentiation |
GO:0098660 | 0.0026 | 1.7558 | 20.4391 | 34 | 724 | inorganic ion transmembrane transport |
GO:0048593 | 0.0027 | 3.3093 | 2.936 | 9 | 104 | camera-type eye morphogenesis |
GO:1905114 | 0.0028 | 1.8773 | 15.16 | 27 | 537 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0008306 | 0.003 | 3.9988 | 1.9197 | 7 | 68 | associative learning |
GO:0044057 | 0.003 | 2.0083 | 11.5475 | 22 | 417 | regulation of system process |
GO:0060573 | 0.0031 | 12.9918 | 0.3105 | 3 | 11 | cell fate specification involved in pattern specification |
GO:1905065 | 0.0031 | 12.9918 | 0.3105 | 3 | 11 | positive regulation of vascular smooth muscle cell differentiation |
GO:0055080 | 0.0032 | 1.8154 | 16.8256 | 29 | 596 | cation homeostasis |
GO:0090596 | 0.0032 | 2.3628 | 6.7189 | 15 | 238 | sensory organ morphogenesis |
GO:0014706 | 0.0033 | 2.1122 | 9.4856 | 19 | 336 | striated muscle tissue development |
GO:0046530 | 0.0033 | 4.5391 | 1.468 | 6 | 52 | photoreceptor cell differentiation |
GO:0060402 | 0.0034 | 2.9627 | 3.6135 | 10 | 128 | calcium ion transport into cytosol |
GO:0010460 | 0.0036 | 7.3053 | 0.6493 | 4 | 23 | positive regulation of heart rate |
GO:0007215 | 0.0038 | 3.8106 | 2.0044 | 7 | 71 | glutamate receptor signaling pathway |
GO:0007187 | 0.0039 | 7.1316 | 0.66 | 4 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0006047 | 0.0041 | 11.5475 | 0.3388 | 3 | 12 | UDP-N-acetylglucosamine metabolic process |
GO:0021511 | 0.0043 | 6.9396 | 0.6775 | 4 | 24 | spinal cord patterning |
GO:0007200 | 0.0043 | 3.7258 | 2.0444 | 7 | 73 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0098771 | 0.0043 | 1.7731 | 17.1926 | 29 | 609 | inorganic ion homeostasis |
GO:0030072 | 0.0043 | 2.3606 | 6.2679 | 14 | 223 | peptide hormone secretion |
GO:0051960 | 0.0043 | 1.7077 | 20.3262 | 33 | 720 | regulation of nervous system development |
GO:0010959 | 0.0044 | 2.0975 | 9.0339 | 18 | 320 | regulation of metal ion transport |
GO:1901701 | 0.0044 | 1.6207 | 25.9991 | 40 | 925 | cellular response to oxygen-containing compound |
GO:0003231 | 0.0044 | 3.0506 | 3.1619 | 9 | 112 | cardiac ventricle development |
GO:0019933 | 0.0044 | 3.3214 | 2.5972 | 8 | 92 | cAMP-mediated signaling |
GO:0050886 | 0.0045 | 3.6946 | 2.0609 | 7 | 73 | endocrine process |
GO:1901379 | 0.0045 | 3.6946 | 2.0609 | 7 | 73 | regulation of potassium ion transmembrane transport |
GO:0051241 | 0.0046 | 1.5989 | 27.682 | 42 | 985 | negative regulation of multicellular organismal process |
GO:0032309 | 0.0046 | 5.1098 | 1.101 | 5 | 39 | icosanoid secretion |
GO:0001992 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0021913 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0032100 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | positive regulation of appetite |
GO:0048880 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | sensory system development |
GO:0050923 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | regulation of negative chemotaxis |
GO:0051414 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | response to cortisol |
GO:0070253 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | somatostatin secretion |
GO:0071504 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | cellular response to heparin |
GO:0035725 | 0.0047 | 2.8182 | 3.7829 | 10 | 134 | sodium ion transmembrane transport |
GO:0045165 | 0.0048 | 2.3311 | 6.3412 | 14 | 226 | cell fate commitment |
GO:0003148 | 0.0049 | 6.6087 | 0.7058 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0049 | 6.6087 | 0.7058 | 4 | 25 | type B pancreatic cell differentiation |
GO:0007205 | 0.0049 | 6.6087 | 0.7058 | 4 | 25 | protein kinase C-activating G-protein coupled receptor signaling pathway |
GO:0034767 | 0.005 | 2.9921 | 3.2183 | 9 | 114 | positive regulation of ion transmembrane transport |
GO:0003012 | 0.005 | 1.9485 | 11.3206 | 21 | 401 | muscle system process |
GO:0048812 | 0.005 | 1.8107 | 15.0753 | 26 | 534 | neuron projection morphogenesis |
GO:0009953 | 0.0051 | 3.2437 | 2.6537 | 8 | 94 | dorsal/ventral pattern formation |
GO:0032101 | 0.0051 | 1.7329 | 18.1807 | 30 | 644 | regulation of response to external stimulus |
GO:0006837 | 0.0052 | 10.3921 | 0.367 | 3 | 13 | serotonin transport |
GO:0008595 | 0.0052 | 10.3921 | 0.367 | 3 | 13 | anterior/posterior axis specification, embryo |
GO:0021781 | 0.0052 | 10.3921 | 0.367 | 3 | 13 | glial cell fate commitment |
GO:0021819 | 0.0052 | 10.3921 | 0.367 | 3 | 13 | layer formation in cerebral cortex |
GO:0036149 | 0.0052 | 10.3921 | 0.367 | 3 | 13 | phosphatidylinositol acyl-chain remodeling |
GO:0046851 | 0.0052 | 10.3921 | 0.367 | 3 | 13 | negative regulation of bone remodeling |
GO:0051046 | 0.0054 | 1.7247 | 18.2611 | 30 | 651 | regulation of secretion |
GO:0042493 | 0.0055 | 1.9679 | 10.6713 | 20 | 378 | response to drug |
GO:1901571 | 0.0057 | 4.8252 | 1.1575 | 5 | 41 | fatty acid derivative transport |
GO:0071385 | 0.0057 | 4.0138 | 1.6374 | 6 | 58 | cellular response to glucocorticoid stimulus |
GO:0016042 | 0.0061 | 2.1281 | 7.9046 | 16 | 280 | lipid catabolic process |
GO:0034762 | 0.0063 | 1.9073 | 11.5464 | 21 | 409 | regulation of transmembrane transport |
GO:0009798 | 0.0064 | 3.4333 | 2.202 | 7 | 78 | axis specification |
GO:0001573 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | ganglioside metabolic process |
GO:0002070 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | epithelial cell maturation |
GO:0014048 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | regulation of glutamate secretion |
GO:0021794 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | thalamus development |
GO:0042711 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | maternal behavior |
GO:0050884 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | neuromuscular process controlling posture |
GO:0071625 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | vocalization behavior |
GO:0086069 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | bundle of His cell to Purkinje myocyte communication |
GO:0051209 | 0.0065 | 3.0987 | 2.7666 | 8 | 98 | release of sequestered calcium ion into cytosol |
GO:0003016 | 0.0066 | 6.0332 | 0.7622 | 4 | 27 | respiratory system process |
GO:0050796 | 0.0066 | 2.5301 | 4.6016 | 11 | 163 | regulation of insulin secretion |
GO:0045596 | 0.0067 | 1.7295 | 16.9667 | 28 | 601 | negative regulation of cell differentiation |
GO:0051282 | 0.0069 | 3.0645 | 2.7949 | 8 | 99 | regulation of sequestering of calcium ion |
GO:0050433 | 0.007 | 4.5707 | 1.2139 | 5 | 43 | regulation of catecholamine secretion |
GO:0048858 | 0.0075 | 1.75 | 15.5552 | 26 | 551 | cell projection morphogenesis |
GO:0010040 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | response to iron(II) ion |
GO:0021778 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | oligodendrocyte cell fate specification |
GO:0032730 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | positive regulation of interleukin-1 alpha production |
GO:0035609 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | C-terminal protein deglutamylation |
GO:0060012 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | synaptic transmission, glycinergic |
GO:0070100 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:0071205 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0090131 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | mesenchyme migration |
GO:0090259 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | regulation of retinal ganglion cell axon guidance |
GO:0055008 | 0.0077 | 8.7583 | 0.4188 | 3 | 15 | cardiac muscle tissue morphogenesis |
GO:0007269 | 0.0077 | 2.7787 | 3.4442 | 9 | 122 | neurotransmitter secretion |
GO:0048167 | 0.0077 | 2.6061 | 4.0652 | 10 | 144 | regulation of synaptic plasticity |
GO:0031290 | 0.0078 | 8.6978 | 0.4216 | 3 | 15 | retinal ganglion cell axon guidance |
GO:0008016 | 0.0079 | 2.2645 | 6.0414 | 13 | 214 | regulation of heart contraction |
GO:0007350 | 0.0079 | 8.6589 | 0.4235 | 3 | 15 | blastoderm segmentation |
GO:0010642 | 0.0079 | 8.6589 | 0.4235 | 3 | 15 | negative regulation of platelet-derived growth factor receptor signaling pathway |
GO:0060579 | 0.0079 | 8.6589 | 0.4235 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0060749 | 0.0079 | 8.6589 | 0.4235 | 3 | 15 | mammary gland alveolus development |
GO:0071380 | 0.0079 | 8.6589 | 0.4235 | 3 | 15 | cellular response to prostaglandin E stimulus |
GO:0098911 | 0.0079 | 8.6589 | 0.4235 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0043647 | 0.0079 | 3.7261 | 1.7503 | 6 | 62 | inositol phosphate metabolic process |
GO:0032879 | 0.0081 | 1.3727 | 63.5839 | 82 | 2280 | regulation of localization |
GO:0006937 | 0.0081 | 2.5866 | 4.0935 | 10 | 145 | regulation of muscle contraction |
GO:0032355 | 0.0081 | 2.7542 | 3.4724 | 9 | 123 | response to estradiol |
GO:0045471 | 0.0081 | 2.7542 | 3.4724 | 9 | 123 | response to ethanol |
GO:0098655 | 0.0082 | 1.6392 | 20.4391 | 32 | 724 | cation transmembrane transport |
GO:0051716 | 0.0085 | 1.27 | 181.2701 | 206 | 6421 | cellular response to stimulus |
GO:0086002 | 0.0085 | 4.3415 | 1.2704 | 5 | 45 | cardiac muscle cell action potential involved in contraction |
GO:0061448 | 0.0088 | 2.2307 | 6.1261 | 13 | 217 | connective tissue development |
GO:0003015 | 0.009 | 2.151 | 6.8319 | 14 | 242 | heart process |
GO:0030322 | 0.0095 | 7.9923 | 0.4517 | 3 | 16 | stabilization of membrane potential |
GO:0035584 | 0.0095 | 7.9923 | 0.4517 | 3 | 16 | calcium-mediated signaling using intracellular calcium source |
GO:0036148 | 0.0095 | 7.9923 | 0.4517 | 3 | 16 | phosphatidylglycerol acyl-chain remodeling |
GO:0045986 | 0.0095 | 7.9923 | 0.4517 | 3 | 16 | negative regulation of smooth muscle contraction |
GO:0055012 | 0.0095 | 7.9923 | 0.4517 | 3 | 16 | ventricular cardiac muscle cell differentiation |
GO:0021953 | 0.0095 | 2.6779 | 3.5619 | 9 | 128 | central nervous system neuron differentiation |
GO:0042417 | 0.0096 | 5.336 | 0.8469 | 4 | 30 | dopamine metabolic process |
GO:0042755 | 0.0096 | 5.336 | 0.8469 | 4 | 30 | eating behavior |
GO:0051954 | 0.0096 | 5.336 | 0.8469 | 4 | 30 | positive regulation of amine transport |
GO:0072359 | 0.0098 | 1.5522 | 25.6336 | 38 | 908 | circulatory system development |
GO:0021537 | 0.0098 | 2.1979 | 6.2108 | 13 | 220 | telencephalon development |
GO:0042692 | 0.0098 | 1.8866 | 10.5301 | 19 | 373 | muscle cell differentiation |
GO:0014033 | 0.0099 | 3.5359 | 1.835 | 6 | 65 | neural crest cell differentiation |
GO:0050805 | 0.0099 | 3.5359 | 1.835 | 6 | 65 | negative regulation of synaptic transmission |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045653 | 0 | 172.8063 | 0.4621 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0051290 | 0 | 22.018 | 1.1689 | 16 | 43 | protein heterotetramerization |
GO:0006335 | 0 | 30.4665 | 0.8427 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0034080 | 0 | 22.2405 | 1.0873 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 20.5903 | 1.1417 | 15 | 42 | beta-catenin-TCF complex assembly |
GO:0000183 | 0 | 23.5343 | 0.9786 | 14 | 36 | chromatin silencing at rDNA |
GO:0034724 | 0 | 15.8754 | 1.3591 | 15 | 50 | DNA replication-independent nucleosome organization |
GO:0060964 | 0 | 8.8595 | 2.6911 | 19 | 99 | regulation of gene silencing by miRNA |
GO:0016233 | 0 | 14.3685 | 1.3591 | 14 | 50 | telomere capping |
GO:0043044 | 0 | 10.4085 | 1.9843 | 16 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 10.8831 | 1.7941 | 15 | 66 | double-strand break repair via nonhomologous end joining |
GO:0045815 | 0 | 9.5659 | 2.1203 | 16 | 78 | positive regulation of gene expression, epigenetic |
GO:0060968 | 0 | 6.9383 | 3.2891 | 19 | 121 | regulation of gene silencing |
GO:1903707 | 0 | 6.1326 | 3.4522 | 18 | 127 | negative regulation of hemopoiesis |
GO:0045637 | 0 | 4.2553 | 6.1161 | 23 | 225 | regulation of myeloid cell differentiation |
GO:0045814 | 0 | 5.8566 | 3.1804 | 16 | 117 | negative regulation of gene expression, epigenetic |
GO:0065004 | 0 | 4.113 | 5.7356 | 21 | 211 | protein-DNA complex assembly |
GO:1902036 | 0 | 5.9944 | 2.7183 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0035194 | 0 | 3.4837 | 7.3122 | 23 | 269 | posttranscriptional gene silencing by RNA |
GO:0032200 | 0 | 4.2446 | 4.2133 | 16 | 155 | telomere organization |
GO:0006952 | 0 | 2.4527 | 15.6198 | 35 | 606 | defense response |
GO:0031497 | 0 | 4.3137 | 3.8871 | 15 | 143 | chromatin assembly |
GO:0007156 | 0 | 4.214 | 3.9687 | 15 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0006352 | 0 | 3.4112 | 6.1161 | 19 | 225 | DNA-templated transcription, initiation |
GO:0017148 | 0 | 2.8297 | 9.6227 | 25 | 354 | negative regulation of translation |
GO:0045087 | 0 | 2.1643 | 20.5774 | 41 | 757 | innate immune response |
GO:0071103 | 0 | 3.1494 | 6.9316 | 20 | 255 | DNA conformation change |
GO:0002682 | 0 | 2.5716 | 11.8414 | 28 | 465 | regulation of immune system process |
GO:0001816 | 1e-04 | 2.2198 | 16.5272 | 34 | 608 | cytokine production |
GO:0006281 | 1e-04 | 2.3719 | 13.1837 | 29 | 485 | DNA repair |
GO:0034248 | 1e-04 | 2.2359 | 15.4127 | 32 | 567 | regulation of cellular amide metabolic process |
GO:0050727 | 1e-04 | 2.7243 | 7.9102 | 20 | 291 | regulation of inflammatory response |
GO:1902622 | 2e-04 | 8.7004 | 0.8427 | 6 | 31 | regulation of neutrophil migration |
GO:0097530 | 2e-04 | 4.0166 | 3.0173 | 11 | 111 | granulocyte migration |
GO:0050776 | 3e-04 | 3.0697 | 5.2799 | 15 | 202 | regulation of immune response |
GO:0022610 | 3e-04 | 1.738 | 33.462 | 54 | 1231 | biological adhesion |
GO:0098609 | 4e-04 | 1.9496 | 19.7347 | 36 | 726 | cell-cell adhesion |
GO:0051607 | 4e-04 | 2.9569 | 5.4637 | 15 | 201 | defense response to virus |
GO:0051259 | 4e-04 | 2.1626 | 13.3196 | 27 | 490 | protein oligomerization |
GO:0010608 | 5e-04 | 1.983 | 17.7504 | 33 | 653 | posttranscriptional regulation of gene expression |
GO:0002244 | 5e-04 | 3.0333 | 4.9745 | 14 | 183 | hematopoietic progenitor cell differentiation |
GO:0002675 | 5e-04 | 9.0439 | 0.6796 | 5 | 25 | positive regulation of acute inflammatory response |
GO:0090023 | 5e-04 | 9.0439 | 0.6796 | 5 | 25 | positive regulation of neutrophil chemotaxis |
GO:0043207 | 5e-04 | 1.9146 | 20.0609 | 36 | 738 | response to external biotic stimulus |
GO:0060249 | 5e-04 | 2.3899 | 9.3781 | 21 | 345 | anatomical structure homeostasis |
GO:0051256 | 6e-04 | 27.0291 | 0.1903 | 3 | 7 | mitotic spindle midzone assembly |
GO:0080134 | 7e-04 | 1.6763 | 33.8698 | 53 | 1246 | regulation of response to stress |
GO:0002282 | 7e-04 | Inf | 0.0544 | 2 | 2 | microglial cell activation involved in immune response |
GO:0018003 | 7e-04 | Inf | 0.0544 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:0044663 | 7e-04 | Inf | 0.0544 | 2 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
GO:0007585 | 9e-04 | 5.0791 | 1.5494 | 7 | 57 | respiratory gaseous exchange |
GO:0071622 | 0.001 | 5.8739 | 1.1689 | 6 | 43 | regulation of granulocyte chemotaxis |
GO:0048863 | 0.0011 | 2.5606 | 6.6598 | 16 | 245 | stem cell differentiation |
GO:0032103 | 0.0012 | 2.5493 | 6.687 | 16 | 246 | positive regulation of response to external stimulus |
GO:0051248 | 0.0013 | 1.6445 | 33.0815 | 51 | 1217 | negative regulation of protein metabolic process |
GO:0045472 | 0.0021 | 15.4421 | 0.2718 | 3 | 10 | response to ether |
GO:0051231 | 0.0021 | 15.4421 | 0.2718 | 3 | 10 | spindle elongation |
GO:0072672 | 0.0021 | 15.4421 | 0.2718 | 3 | 10 | neutrophil extravasation |
GO:0045085 | 0.0022 | 71.9177 | 0.0815 | 2 | 3 | negative regulation of interleukin-2 biosynthetic process |
GO:0045658 | 0.0022 | 71.9177 | 0.0815 | 2 | 3 | regulation of neutrophil differentiation |
GO:0060244 | 0.0022 | 71.9177 | 0.0815 | 2 | 3 | negative regulation of cell proliferation involved in contact inhibition |
GO:1904637 | 0.0022 | 71.9177 | 0.0815 | 2 | 3 | cellular response to ionomycin |
GO:2000297 | 0.0022 | 71.9177 | 0.0815 | 2 | 3 | negative regulation of synapse maturation |
GO:0050778 | 0.0024 | 1.8797 | 15.7268 | 28 | 583 | positive regulation of immune response |
GO:0002407 | 0.0027 | 8.0205 | 0.598 | 4 | 22 | dendritic cell chemotaxis |
GO:1905954 | 0.0029 | 4.0275 | 1.9028 | 7 | 70 | positive regulation of lipid localization |
GO:0043043 | 0.0032 | 1.7173 | 21.5016 | 35 | 791 | peptide biosynthetic process |
GO:0030593 | 0.0035 | 4.4806 | 1.4795 | 6 | 55 | neutrophil chemotaxis |
GO:0050865 | 0.0036 | 1.9446 | 12.4497 | 23 | 458 | regulation of cell activation |
GO:1900003 | 0.0037 | 12.0089 | 0.3262 | 3 | 12 | regulation of serine-type endopeptidase activity |
GO:0002443 | 0.004 | 1.7649 | 17.8863 | 30 | 658 | leukocyte mediated immunity |
GO:0006959 | 0.0042 | 2.5717 | 4.9473 | 12 | 182 | humoral immune response |
GO:0010701 | 0.0043 | 35.9564 | 0.1087 | 2 | 4 | positive regulation of norepinephrine secretion |
GO:0045354 | 0.0043 | 35.9564 | 0.1087 | 2 | 4 | regulation of interferon-alpha biosynthetic process |
GO:0046874 | 0.0043 | 35.9564 | 0.1087 | 2 | 4 | quinolinate metabolic process |
GO:0030595 | 0.0043 | 2.6921 | 4.3405 | 11 | 161 | leukocyte chemotaxis |
GO:0030851 | 0.0043 | 6.8734 | 0.6796 | 4 | 25 | granulocyte differentiation |
GO:0042110 | 0.0047 | 1.961 | 11.2537 | 21 | 414 | T cell activation |
GO:0002274 | 0.0049 | 1.8168 | 15.0321 | 26 | 553 | myeloid leukocyte activation |
GO:0002429 | 0.0056 | 2.1495 | 7.8287 | 16 | 288 | immune response-activating cell surface receptor signaling pathway |
GO:1902107 | 0.0058 | 2.9174 | 3.2891 | 9 | 121 | positive regulation of leukocyte differentiation |
GO:0051249 | 0.0058 | 1.9938 | 10.0033 | 19 | 368 | regulation of lymphocyte activation |
GO:0032675 | 0.0059 | 3.1535 | 2.7183 | 8 | 100 | regulation of interleukin-6 production |
GO:0060255 | 0.0059 | 1.2977 | 149.9948 | 175 | 5518 | regulation of macromolecule metabolic process |
GO:0043122 | 0.0063 | 2.3336 | 5.8715 | 13 | 216 | regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0032648 | 0.0066 | 4.632 | 1.196 | 5 | 44 | regulation of interferon-beta production |
GO:0007127 | 0.0066 | 3.086 | 2.7726 | 8 | 102 | meiosis I |
GO:0044703 | 0.0068 | 1.615 | 23.4044 | 36 | 861 | multi-organism reproductive process |
GO:0002730 | 0.007 | 23.9693 | 0.1359 | 2 | 5 | regulation of dendritic cell cytokine production |
GO:0002885 | 0.007 | 23.9693 | 0.1359 | 2 | 5 | positive regulation of hypersensitivity |
GO:0009744 | 0.007 | 23.9693 | 0.1359 | 2 | 5 | response to sucrose |
GO:0045409 | 0.007 | 23.9693 | 0.1359 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0060414 | 0.007 | 23.9693 | 0.1359 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0043900 | 0.0071 | 1.9952 | 9.4596 | 18 | 348 | regulation of multi-organism process |
GO:0006950 | 0.0071 | 1.5091 | 35.3253 | 50 | 1466 | response to stress |
GO:0008272 | 0.0071 | 9.0049 | 0.4077 | 3 | 15 | sulfate transport |
GO:0045596 | 0.0075 | 1.731 | 16.3369 | 27 | 601 | negative regulation of cell differentiation |
GO:2000026 | 0.0077 | 1.432 | 46.5642 | 63 | 1713 | regulation of multicellular organismal development |
GO:0048534 | 0.0077 | 1.6231 | 21.9637 | 34 | 808 | hematopoietic or lymphoid organ development |
GO:0048518 | 0.0086 | 1.2891 | 133.002 | 156 | 4954 | positive regulation of biological process |
GO:0009566 | 0.0087 | 2.5578 | 4.1318 | 10 | 152 | fertilization |
GO:0032480 | 0.0087 | 4.3002 | 1.2776 | 5 | 47 | negative regulation of type I interferon production |
GO:0002757 | 0.0088 | 2.7124 | 3.5161 | 9 | 132 | immune response-activating signal transduction |
GO:0080090 | 0.009 | 1.2782 | 149.5055 | 173 | 5500 | regulation of primary metabolic process |
GO:0002720 | 0.0095 | 5.3438 | 0.8427 | 4 | 31 | positive regulation of cytokine production involved in immune response |
GO:0009617 | 0.0096 | 1.7998 | 12.7759 | 22 | 470 | response to bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006333 | 0 | 7.5658 | 4.7842 | 29 | 166 | chromatin assembly or disassembly |
GO:0006323 | 0 | 6.7229 | 5.2741 | 29 | 183 | DNA packaging |
GO:0038111 | 0 | 22.1159 | 1.0375 | 14 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 22.1159 | 1.0375 | 14 | 36 | response to interleukin-7 |
GO:0071824 | 0 | 5.4592 | 6.9745 | 32 | 242 | protein-DNA complex subunit organization |
GO:0000183 | 0 | 19.596 | 1.0375 | 13 | 36 | chromatin silencing at rDNA |
GO:0006334 | 0 | 9.2033 | 2.6247 | 19 | 93 | nucleosome assembly |
GO:0045652 | 0 | 10.1352 | 2.0462 | 16 | 71 | regulation of megakaryocyte differentiation |
GO:0006335 | 0 | 16.3965 | 0.8934 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0060964 | 0 | 6.1945 | 2.8532 | 15 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 6.1212 | 2.882 | 15 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0051290 | 0 | 10.4257 | 1.2393 | 10 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 6.9143 | 2.248 | 13 | 78 | positive regulation of gene expression, epigenetic |
GO:0002244 | 0 | 4.0351 | 5.2741 | 19 | 183 | hematopoietic progenitor cell differentiation |
GO:0030099 | 0 | 2.9856 | 10.3177 | 28 | 358 | myeloid cell differentiation |
GO:0060968 | 0 | 4.9016 | 3.4873 | 15 | 121 | regulation of gene silencing |
GO:0051276 | 0 | 2.1003 | 26.0561 | 50 | 920 | chromosome organization |
GO:0007596 | 1e-04 | 2.7146 | 8.7614 | 22 | 304 | blood coagulation |
GO:1903706 | 1e-04 | 2.4201 | 12.0181 | 27 | 417 | regulation of hemopoiesis |
GO:0006342 | 1e-04 | 5.5705 | 1.8503 | 9 | 66 | chromatin silencing |
GO:0048863 | 1e-04 | 2.9157 | 7.061 | 19 | 245 | stem cell differentiation |
GO:0035194 | 1e-04 | 2.7879 | 7.7527 | 20 | 269 | posttranscriptional gene silencing by RNA |
GO:0002227 | 1e-04 | 13.0981 | 0.5188 | 5 | 18 | innate immune response in mucosa |
GO:0051253 | 1e-04 | 1.7986 | 33.0281 | 55 | 1146 | negative regulation of RNA metabolic process |
GO:1903507 | 2e-04 | 1.8122 | 30.9242 | 52 | 1073 | negative regulation of nucleic acid-templated transcription |
GO:0021902 | 4e-04 | 33.9222 | 0.1729 | 3 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0009611 | 5e-04 | 2.0019 | 17.0328 | 32 | 591 | response to wounding |
GO:0050878 | 5e-04 | 2.1649 | 12.7962 | 26 | 444 | regulation of body fluid levels |
GO:0097274 | 8e-04 | Inf | 0.0576 | 2 | 2 | urea homeostasis |
GO:0002251 | 0.0011 | 7.3983 | 0.807 | 5 | 28 | organ or tissue specific immune response |
GO:0017148 | 0.0015 | 2.1815 | 10.2024 | 21 | 354 | negative regulation of translation |
GO:0072507 | 0.0015 | 2.0969 | 11.6146 | 23 | 403 | divalent inorganic cation homeostasis |
GO:0045595 | 0.0016 | 1.5412 | 45.075 | 65 | 1564 | regulation of cell differentiation |
GO:0032200 | 0.0018 | 2.879 | 4.4672 | 12 | 155 | telomere organization |
GO:0010558 | 0.0022 | 1.5339 | 42.3371 | 61 | 1469 | negative regulation of macromolecule biosynthetic process |
GO:0002019 | 0.0024 | 67.6986 | 0.0865 | 2 | 3 | regulation of renal output by angiotensin |
GO:0071373 | 0.0024 | 67.6986 | 0.0865 | 2 | 3 | cellular response to luteinizing hormone stimulus |
GO:0019731 | 0.0027 | 5.8652 | 0.9799 | 5 | 34 | antibacterial humoral response |
GO:0055062 | 0.0033 | 12.7165 | 0.317 | 3 | 11 | phosphate ion homeostasis |
GO:0048534 | 0.0037 | 1.6738 | 23.2868 | 37 | 808 | hematopoietic or lymphoid organ development |
GO:0006874 | 0.0044 | 2.0108 | 10.4618 | 20 | 363 | cellular calcium ion homeostasis |
GO:0055065 | 0.0047 | 1.8221 | 14.9866 | 26 | 520 | metal ion homeostasis |
GO:0060745 | 0.0048 | 33.847 | 0.1153 | 2 | 4 | mammary gland branching involved in pregnancy |
GO:0051172 | 0.0052 | 1.3914 | 65.9986 | 86 | 2290 | negative regulation of nitrogen compound metabolic process |
GO:0009649 | 0.0053 | 6.4683 | 0.7205 | 4 | 25 | entrainment of circadian clock |
GO:1905476 | 0.0053 | 6.4683 | 0.7205 | 4 | 25 | negative regulation of protein localization to membrane |
GO:1904754 | 0.0055 | 10.1719 | 0.3747 | 3 | 13 | positive regulation of vascular associated smooth muscle cell migration |
GO:0034622 | 0.0059 | 1.5808 | 27.264 | 41 | 946 | cellular macromolecular complex assembly |
GO:0071345 | 0.0067 | 1.6157 | 23.3733 | 36 | 811 | cellular response to cytokine stimulus |
GO:0031327 | 0.0067 | 1.4482 | 44.4986 | 61 | 1544 | negative regulation of cellular biosynthetic process |
GO:2001275 | 0.0068 | 9.2465 | 0.4035 | 3 | 14 | positive regulation of glucose import in response to insulin stimulus |
GO:0061844 | 0.0076 | 4.4734 | 1.2393 | 5 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0033864 | 0.0078 | 22.5632 | 0.1441 | 2 | 5 | positive regulation of NAD(P)H oxidase activity |
GO:0044828 | 0.0078 | 22.5632 | 0.1441 | 2 | 5 | negative regulation by host of viral genome replication |
GO:0010863 | 0.0081 | 5.6586 | 0.807 | 4 | 28 | positive regulation of phospholipase C activity |
GO:0043552 | 0.0081 | 5.6586 | 0.807 | 4 | 28 | positive regulation of phosphatidylinositol 3-kinase activity |
GO:0010042 | 0.0084 | 8.4754 | 0.4323 | 3 | 15 | response to manganese ion |
GO:0046661 | 0.0089 | 2.55 | 4.1501 | 10 | 144 | male sex differentiation |
GO:0006873 | 0.009 | 1.721 | 15.7935 | 26 | 548 | cellular ion homeostasis |
GO:0008584 | 0.0092 | 2.695 | 3.5449 | 9 | 123 | male gonad development |
GO:0044264 | 0.0094 | 3.1798 | 2.3633 | 7 | 82 | cellular polysaccharide metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009952 | 0 | 4.6829 | 5.3813 | 22 | 188 | anterior/posterior pattern specification |
GO:0007156 | 0 | 5.2623 | 4.1791 | 19 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0009888 | 0 | 1.8251 | 50.0345 | 82 | 1748 | tissue development |
GO:0007389 | 0 | 3.0477 | 9.0026 | 25 | 318 | pattern specification process |
GO:0009790 | 0 | 2.2091 | 22.794 | 46 | 805 | embryo development |
GO:0032502 | 0 | 1.5881 | 119.9843 | 160 | 4362 | developmental process |
GO:0098609 | 0 | 2.199 | 20.7809 | 42 | 726 | cell-cell adhesion |
GO:0022610 | 0 | 1.8941 | 35.2359 | 61 | 1231 | biological adhesion |
GO:0044851 | 0 | 45.6567 | 0.2004 | 4 | 7 | hair cycle phase |
GO:0048704 | 0 | 4.8836 | 2.5475 | 11 | 89 | embryonic skeletal system morphogenesis |
GO:0007267 | 0 | 1.772 | 41.2756 | 67 | 1442 | cell-cell signaling |
GO:0042634 | 1e-04 | 10.3086 | 0.7442 | 6 | 26 | regulation of hair cycle |
GO:0015844 | 1e-04 | 5.6489 | 1.8319 | 9 | 64 | monoamine transport |
GO:0001501 | 1e-04 | 2.3204 | 12.9666 | 28 | 453 | skeletal system development |
GO:0022405 | 1e-04 | 4.7342 | 2.3758 | 10 | 83 | hair cycle process |
GO:0098773 | 1e-04 | 4.7342 | 2.3758 | 10 | 83 | skin epidermis development |
GO:0009889 | 1e-04 | 1.4692 | 118.2737 | 153 | 4132 | regulation of biosynthetic process |
GO:0030326 | 1e-04 | 3.922 | 3.3776 | 12 | 118 | embryonic limb morphogenesis |
GO:0035107 | 1e-04 | 3.666 | 3.8928 | 13 | 136 | appendage morphogenesis |
GO:0042303 | 2e-04 | 4.0918 | 2.9769 | 11 | 104 | molting cycle |
GO:0050433 | 2e-04 | 6.6898 | 1.2308 | 7 | 43 | regulation of catecholamine secretion |
GO:0015874 | 2e-04 | 11.4313 | 0.5725 | 5 | 20 | norepinephrine transport |
GO:0051953 | 3e-04 | 10.7161 | 0.6011 | 5 | 21 | negative regulation of amine transport |
GO:0051798 | 3e-04 | 17.1155 | 0.3435 | 4 | 12 | positive regulation of hair follicle development |
GO:2000406 | 3e-04 | 10.0851 | 0.6297 | 5 | 22 | positive regulation of T cell migration |
GO:0045668 | 4e-04 | 7.105 | 1.0018 | 6 | 35 | negative regulation of osteoblast differentiation |
GO:0051674 | 4e-04 | 1.6709 | 37.9552 | 59 | 1326 | localization of cell |
GO:2001141 | 5e-04 | 1.4525 | 94.5159 | 124 | 3302 | regulation of RNA biosynthetic process |
GO:0060173 | 7e-04 | 3.0625 | 4.5798 | 13 | 160 | limb development |
GO:0018149 | 7e-04 | 5.232 | 1.5171 | 7 | 53 | peptide cross-linking |
GO:0010700 | 7e-04 | 25.621 | 0.2004 | 3 | 7 | negative regulation of norepinephrine secretion |
GO:0060907 | 7e-04 | 25.621 | 0.2004 | 3 | 7 | positive regulation of macrophage cytokine production |
GO:2000049 | 7e-04 | 25.621 | 0.2004 | 3 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0015850 | 8e-04 | 2.7684 | 5.8106 | 15 | 203 | organic hydroxy compound transport |
GO:0060255 | 8e-04 | 1.3719 | 157.9463 | 190 | 5518 | regulation of macromolecule metabolic process |
GO:0043134 | 8e-04 | Inf | 0.0572 | 2 | 2 | regulation of hindgut contraction |
GO:0044657 | 8e-04 | Inf | 0.0572 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0046960 | 8e-04 | Inf | 0.0572 | 2 | 2 | sensitization |
GO:0052043 | 8e-04 | Inf | 0.0572 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 8e-04 | Inf | 0.0572 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 8e-04 | Inf | 0.0572 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0060809 | 8e-04 | Inf | 0.0572 | 2 | 2 | mesodermal to mesenchymal transition involved in gastrulation |
GO:0099553 | 8e-04 | Inf | 0.0572 | 2 | 2 | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission |
GO:1902957 | 8e-04 | Inf | 0.0572 | 2 | 2 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
GO:1904106 | 8e-04 | Inf | 0.0572 | 2 | 2 | protein localization to microvillus |
GO:0050905 | 9e-04 | 3.9264 | 2.5189 | 9 | 88 | neuromuscular process |
GO:0042472 | 0.0012 | 3.782 | 2.6048 | 9 | 91 | inner ear morphogenesis |
GO:0060346 | 0.0012 | 20.4954 | 0.229 | 3 | 8 | bone trabecula formation |
GO:0016048 | 0.0012 | 10.529 | 0.4866 | 4 | 17 | detection of temperature stimulus |
GO:0090026 | 0.0012 | 10.529 | 0.4866 | 4 | 17 | positive regulation of monocyte chemotaxis |
GO:0002694 | 0.0013 | 2.091 | 12.1651 | 24 | 425 | regulation of leukocyte activation |
GO:0050866 | 0.0013 | 2.9842 | 4.3222 | 12 | 151 | negative regulation of cell activation |
GO:0032496 | 0.0014 | 2.3521 | 8.1292 | 18 | 284 | response to lipopolysaccharide |
GO:0007268 | 0.0014 | 1.9253 | 15.9435 | 29 | 557 | chemical synaptic transmission |
GO:0019219 | 0.0014 | 1.3822 | 109.343 | 137 | 3820 | regulation of nucleobase-containing compound metabolic process |
GO:0051445 | 0.0015 | 5.419 | 1.2594 | 6 | 44 | regulation of meiotic cell cycle |
GO:0007416 | 0.0016 | 4.5079 | 1.7263 | 7 | 61 | synapse assembly |
GO:0097659 | 0.0016 | 1.39 | 98.5518 | 125 | 3443 | nucleic acid-templated transcription |
GO:0001714 | 0.0017 | 17.0783 | 0.2576 | 3 | 9 | endodermal cell fate specification |
GO:0048147 | 0.0017 | 6.5901 | 0.8873 | 5 | 31 | negative regulation of fibroblast proliferation |
GO:0071867 | 0.0017 | 6.5901 | 0.8873 | 5 | 31 | response to monoamine |
GO:0048562 | 0.0018 | 2.7325 | 5.0801 | 13 | 181 | embryonic organ morphogenesis |
GO:0050776 | 0.0022 | 1.7202 | 23.357 | 38 | 816 | regulation of immune response |
GO:0030278 | 0.0022 | 2.801 | 4.5798 | 12 | 160 | regulation of ossification |
GO:0050951 | 0.0022 | 8.5531 | 0.5725 | 4 | 20 | sensory perception of temperature stimulus |
GO:0009617 | 0.0023 | 1.9615 | 13.4532 | 25 | 470 | response to bacterium |
GO:0048513 | 0.0023 | 1.3896 | 87.5603 | 112 | 3059 | animal organ development |
GO:0043433 | 0.0023 | 3.1339 | 3.4349 | 10 | 120 | negative regulation of DNA binding transcription factor activity |
GO:0060688 | 0.0024 | 4.9016 | 1.3739 | 6 | 48 | regulation of morphogenesis of a branching structure |
GO:0048819 | 0.0024 | 68.485 | 0.0855 | 2 | 3 | regulation of hair follicle maturation |
GO:0010819 | 0.0024 | 14.6376 | 0.2862 | 3 | 10 | regulation of T cell chemotaxis |
GO:2001044 | 0.0024 | 14.6376 | 0.2862 | 3 | 10 | regulation of integrin-mediated signaling pathway |
GO:0035880 | 0.0024 | 68.1793 | 0.0859 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0051795 | 0.0024 | 68.1793 | 0.0859 | 2 | 3 | positive regulation of timing of catagen |
GO:0099541 | 0.0024 | 68.1793 | 0.0859 | 2 | 3 | trans-synaptic signaling by lipid |
GO:1901856 | 0.0024 | 68.1793 | 0.0859 | 2 | 3 | negative regulation of cellular respiration |
GO:2000562 | 0.0024 | 68.1793 | 0.0859 | 2 | 3 | negative regulation of CD4-positive, alpha-beta T cell proliferation |
GO:0043009 | 0.0024 | 1.8992 | 14.9989 | 27 | 524 | chordate embryonic development |
GO:0018958 | 0.0026 | 3.6687 | 2.3758 | 8 | 83 | phenol-containing compound metabolic process |
GO:0042220 | 0.0026 | 4.7872 | 1.4026 | 6 | 49 | response to cocaine |
GO:0014821 | 0.0027 | 8.0494 | 0.6011 | 4 | 21 | phasic smooth muscle contraction |
GO:0061082 | 0.0027 | 8.0494 | 0.6011 | 4 | 21 | myeloid leukocyte cytokine production |
GO:0097529 | 0.0027 | 2.7266 | 4.6943 | 12 | 164 | myeloid leukocyte migration |
GO:0008284 | 0.0027 | 1.7077 | 22.8704 | 37 | 799 | positive regulation of cell proliferation |
GO:0061138 | 0.0028 | 2.7086 | 4.7229 | 12 | 165 | morphogenesis of a branching epithelium |
GO:0050900 | 0.0029 | 2.4784 | 5.9938 | 14 | 213 | leukocyte migration |
GO:0007399 | 0.0029 | 1.4671 | 53.2209 | 73 | 1904 | nervous system development |
GO:0001775 | 0.0029 | 1.6264 | 28.622 | 44 | 1018 | cell activation |
GO:0015872 | 0.003 | 5.7099 | 1.0018 | 5 | 35 | dopamine transport |
GO:0051281 | 0.003 | 5.7099 | 1.0018 | 5 | 35 | positive regulation of release of sequestered calcium ion into cytosol |
GO:0045807 | 0.0032 | 3.2274 | 3.0055 | 9 | 105 | positive regulation of endocytosis |
GO:0060021 | 0.0032 | 3.5269 | 2.4616 | 8 | 86 | palate development |
GO:0035295 | 0.0032 | 1.8566 | 15.3137 | 27 | 535 | tube development |
GO:0051583 | 0.0032 | 12.807 | 0.3149 | 3 | 11 | dopamine uptake involved in synaptic transmission |
GO:0090493 | 0.0032 | 12.807 | 0.3149 | 3 | 11 | catecholamine uptake |
GO:0032101 | 0.0034 | 1.7709 | 18.4337 | 31 | 644 | regulation of response to external stimulus |
GO:0006954 | 0.0034 | 1.7853 | 17.6895 | 30 | 618 | inflammatory response |
GO:0051094 | 0.0035 | 1.5757 | 32.2018 | 48 | 1125 | positive regulation of developmental process |
GO:0030154 | 0.0036 | 1.3589 | 96.1517 | 120 | 3416 | cell differentiation |
GO:0040017 | 0.0036 | 1.9442 | 12.4514 | 23 | 435 | positive regulation of locomotion |
GO:0043270 | 0.0037 | 2.4088 | 6.1541 | 14 | 215 | positive regulation of ion transport |
GO:0021602 | 0.0038 | 7.2012 | 0.6583 | 4 | 23 | cranial nerve morphogenesis |
GO:0007618 | 0.0038 | 5.3523 | 1.0591 | 5 | 37 | mating |
GO:0051241 | 0.0039 | 1.6054 | 28.2517 | 43 | 987 | negative regulation of multicellular organismal process |
GO:0043406 | 0.0039 | 2.3073 | 6.8697 | 15 | 240 | positive regulation of MAP kinase activity |
GO:0032940 | 0.004 | 1.5302 | 36.6385 | 53 | 1280 | secretion by cell |
GO:0098657 | 0.004 | 1.7635 | 17.8899 | 30 | 625 | import into cell |
GO:0035019 | 0.0041 | 3.7559 | 2.0323 | 7 | 71 | somatic stem cell population maintenance |
GO:0051272 | 0.0046 | 1.9323 | 11.9648 | 22 | 418 | positive regulation of cellular component movement |
GO:0099537 | 0.0047 | 1.7992 | 15.7617 | 27 | 553 | trans-synaptic signaling |
GO:0048105 | 0.0047 | 34.0874 | 0.1145 | 2 | 4 | establishment of body hair planar orientation |
GO:0051884 | 0.0047 | 34.0874 | 0.1145 | 2 | 4 | regulation of timing of anagen |
GO:0099550 | 0.0047 | 34.0874 | 0.1145 | 2 | 4 | trans-synaptic signaling, modulating synaptic transmission |
GO:0051963 | 0.0048 | 3.6416 | 2.0895 | 7 | 73 | regulation of synapse assembly |
GO:0071675 | 0.0048 | 5.0368 | 1.1163 | 5 | 39 | regulation of mononuclear cell migration |
GO:0051924 | 0.0051 | 2.4009 | 5.7248 | 13 | 200 | regulation of calcium ion transport |
GO:0007200 | 0.0052 | 3.2349 | 2.662 | 8 | 93 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0002683 | 0.0052 | 1.9785 | 10.6194 | 20 | 371 | negative regulation of immune system process |
GO:0034654 | 0.0052 | 1.3222 | 111.1177 | 135 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0001973 | 0.0054 | 10.2442 | 0.3721 | 3 | 13 | adenosine receptor signaling pathway |
GO:0008595 | 0.0054 | 10.2442 | 0.3721 | 3 | 13 | anterior/posterior axis specification, embryo |
GO:0046851 | 0.0054 | 10.2442 | 0.3721 | 3 | 13 | negative regulation of bone remodeling |
GO:0060456 | 0.0054 | 10.2442 | 0.3721 | 3 | 13 | positive regulation of digestive system process |
GO:0071871 | 0.0054 | 10.2442 | 0.3721 | 3 | 13 | response to epinephrine |
GO:0090179 | 0.0054 | 10.2442 | 0.3721 | 3 | 13 | planar cell polarity pathway involved in neural tube closure |
GO:0007275 | 0.0056 | 1.418 | 60.3931 | 79 | 2343 | multicellular organism development |
GO:0002684 | 0.0056 | 1.6147 | 24.731 | 38 | 864 | positive regulation of immune system process |
GO:0051250 | 0.0058 | 2.9209 | 3.2917 | 9 | 115 | negative regulation of lymphocyte activation |
GO:0002385 | 0.006 | 6.2179 | 0.7442 | 4 | 26 | mucosal immune response |
GO:2000145 | 0.0061 | 1.6638 | 20.8095 | 33 | 727 | regulation of cell motility |
GO:0002688 | 0.0062 | 3.124 | 2.7479 | 8 | 96 | regulation of leukocyte chemotaxis |
GO:0045087 | 0.0063 | 1.6462 | 21.6682 | 34 | 757 | innate immune response |
GO:0071695 | 0.0064 | 2.6899 | 3.9501 | 10 | 138 | anatomical structure maturation |
GO:0001704 | 0.0064 | 2.8664 | 3.349 | 9 | 117 | formation of primary germ layer |
GO:0006910 | 0.0067 | 9.3123 | 0.4007 | 3 | 14 | phagocytosis, recognition |
GO:0050965 | 0.0067 | 9.3123 | 0.4007 | 3 | 14 | detection of temperature stimulus involved in sensory perception of pain |
GO:0098810 | 0.0067 | 9.3123 | 0.4007 | 3 | 14 | neurotransmitter reuptake |
GO:0030216 | 0.0067 | 2.105 | 7.986 | 16 | 279 | keratinocyte differentiation |
GO:0001825 | 0.0069 | 5.9472 | 0.7728 | 4 | 27 | blastocyst formation |
GO:0016339 | 0.0069 | 5.9472 | 0.7728 | 4 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0046636 | 0.0069 | 5.9472 | 0.7728 | 4 | 27 | negative regulation of alpha-beta T cell activation |
GO:0009798 | 0.0069 | 3.384 | 2.2327 | 7 | 78 | axis specification |
GO:0051283 | 0.007 | 3.0541 | 2.8051 | 8 | 98 | negative regulation of sequestering of calcium ion |
GO:2000021 | 0.0071 | 2.3922 | 5.2954 | 12 | 185 | regulation of ion homeostasis |
GO:0048584 | 0.0071 | 1.4066 | 54.2708 | 72 | 1896 | positive regulation of response to stimulus |
GO:2000026 | 0.0072 | 1.4239 | 49.0326 | 66 | 1713 | regulation of multicellular organismal development |
GO:2000401 | 0.0074 | 4.5054 | 1.2308 | 5 | 43 | regulation of lymphocyte migration |
GO:0007631 | 0.0075 | 3.0204 | 2.8338 | 8 | 99 | feeding behavior |
GO:0010511 | 0.0077 | 22.7234 | 0.1431 | 2 | 5 | regulation of phosphatidylinositol biosynthetic process |
GO:0035609 | 0.0077 | 22.7234 | 0.1431 | 2 | 5 | C-terminal protein deglutamylation |
GO:0045409 | 0.0077 | 22.7234 | 0.1431 | 2 | 5 | negative regulation of interleukin-6 biosynthetic process |
GO:0051673 | 0.0077 | 22.7234 | 0.1431 | 2 | 5 | membrane disruption in other organism |
GO:0071502 | 0.0077 | 22.7234 | 0.1431 | 2 | 5 | cellular response to temperature stimulus |
GO:1904970 | 0.0077 | 22.7234 | 0.1431 | 2 | 5 | brush border assembly |
GO:2000851 | 0.0077 | 22.7234 | 0.1431 | 2 | 5 | positive regulation of glucocorticoid secretion |
GO:0050795 | 0.0078 | 3.7397 | 1.7461 | 6 | 61 | regulation of behavior |
GO:1904888 | 0.0078 | 3.7397 | 1.7461 | 6 | 61 | cranial skeletal system development |
GO:0006355 | 0.008 | 1.4622 | 40.6593 | 56 | 1485 | regulation of transcription, DNA-templated |
GO:0007350 | 0.0082 | 8.5357 | 0.4294 | 3 | 15 | blastoderm segmentation |
GO:0036037 | 0.0082 | 8.5357 | 0.4294 | 3 | 15 | CD8-positive, alpha-beta T cell activation |
GO:0048670 | 0.0082 | 8.5357 | 0.4294 | 3 | 15 | regulation of collateral sprouting |
GO:0090177 | 0.0082 | 8.5357 | 0.4294 | 3 | 15 | establishment of planar polarity involved in neural tube closure |
GO:0061053 | 0.0085 | 3.2461 | 2.3185 | 7 | 81 | somite development |
GO:0006357 | 0.0088 | 1.4028 | 51.2367 | 68 | 1790 | regulation of transcription from RNA polymerase II promoter |
GO:0071870 | 0.0089 | 5.4707 | 0.8301 | 4 | 29 | cellular response to catecholamine stimulus |
GO:0006584 | 0.009 | 4.2795 | 1.2881 | 5 | 45 | catecholamine metabolic process |
GO:0060349 | 0.009 | 3.2026 | 2.3472 | 7 | 82 | bone morphogenesis |
GO:0045165 | 0.0091 | 2.1484 | 6.8411 | 14 | 239 | cell fate commitment |
GO:0070664 | 0.0091 | 3.608 | 1.8033 | 6 | 63 | negative regulation of leukocyte proliferation |
GO:0002274 | 0.0093 | 1.7169 | 15.829 | 26 | 553 | myeloid leukocyte activation |
GO:0030335 | 0.0093 | 1.8641 | 11.2205 | 20 | 392 | positive regulation of cell migration |
GO:0030514 | 0.0098 | 4.1749 | 1.3167 | 5 | 46 | negative regulation of BMP signaling pathway |
GO:0060562 | 0.0098 | 2.0115 | 8.3295 | 16 | 291 | epithelial tube morphogenesis |
GO:0002076 | 0.0099 | 7.8786 | 0.458 | 3 | 16 | osteoblast development |
GO:0032225 | 0.0099 | 7.8786 | 0.458 | 3 | 16 | regulation of synaptic transmission, dopaminergic |
GO:0045683 | 0.0099 | 7.8786 | 0.458 | 3 | 16 | negative regulation of epidermis development |
GO:0090280 | 0.0099 | 7.8786 | 0.458 | 3 | 16 | positive regulation of calcium ion import |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 9.6465 | 9.246 | 64 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 8.4493 | 11.3731 | 70 | 401 | detection of chemical stimulus |
GO:0007606 | 0 | 8.8478 | 10.0798 | 65 | 359 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 8.0566 | 11.6283 | 69 | 410 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 3.6158 | 31.822 | 92 | 1122 | nervous system process |
GO:0045653 | 0 | 165.1822 | 0.4822 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0007186 | 0 | 3.3653 | 32.5594 | 89 | 1148 | G-protein coupled receptor signaling pathway |
GO:0006335 | 0 | 29.1223 | 0.8792 | 14 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 18.9756 | 1.2196 | 15 | 43 | protein heterotetramerization |
GO:0000183 | 0 | 22.496 | 1.021 | 14 | 36 | chromatin silencing at rDNA |
GO:0034080 | 0 | 19.0299 | 1.1345 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 17.6683 | 1.1912 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0016233 | 0 | 13.7346 | 1.4181 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 13.7346 | 1.4181 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0043044 | 0 | 9.1421 | 2.0704 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 9.4983 | 1.8719 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0045815 | 0 | 7.7111 | 2.2122 | 14 | 78 | positive regulation of gene expression, epigenetic |
GO:0016441 | 0 | 3.6487 | 7.6577 | 25 | 270 | posttranscriptional gene silencing |
GO:0031047 | 0 | 3.4986 | 8.2817 | 26 | 292 | gene silencing by RNA |
GO:1903707 | 0 | 5.0893 | 3.602 | 16 | 127 | negative regulation of hemopoiesis |
GO:0060964 | 0 | 5.7977 | 2.8078 | 14 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 5.7299 | 2.8362 | 14 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0032501 | 0 | 1.6011 | 176.3947 | 224 | 6338 | multicellular organismal process |
GO:0051716 | 0 | 1.5667 | 182.1113 | 229 | 6421 | cellular response to stimulus |
GO:0045814 | 0 | 4.7787 | 3.3183 | 14 | 117 | negative regulation of gene expression, epigenetic |
GO:0034249 | 0 | 2.8265 | 10.4372 | 27 | 368 | negative regulation of cellular amide metabolic process |
GO:0060968 | 0 | 4.5988 | 3.4318 | 14 | 121 | regulation of gene silencing |
GO:0032200 | 0 | 3.7664 | 4.3961 | 15 | 155 | telomere organization |
GO:0060249 | 1e-04 | 2.653 | 9.7848 | 24 | 345 | anatomical structure homeostasis |
GO:0050896 | 1e-04 | 2.2204 | 19.0837 | 37 | 852 | response to stimulus |
GO:0031497 | 1e-04 | 3.8088 | 4.0557 | 14 | 143 | chromatin assembly |
GO:0002244 | 1e-04 | 3.3698 | 5.1902 | 16 | 183 | hematopoietic progenitor cell differentiation |
GO:0045637 | 1e-04 | 3.0649 | 6.3814 | 18 | 225 | regulation of myeloid cell differentiation |
GO:0007154 | 2e-04 | 1.4258 | 161.8893 | 198 | 5708 | cell communication |
GO:0023052 | 2e-04 | 1.4199 | 161.3504 | 197 | 5689 | signaling |
GO:0045596 | 2e-04 | 2.0721 | 17.0455 | 33 | 601 | negative regulation of cell differentiation |
GO:0006352 | 2e-04 | 2.8735 | 6.3814 | 17 | 225 | DNA-templated transcription, initiation |
GO:0051967 | 3e-04 | 17.2797 | 0.3403 | 4 | 12 | negative regulation of synaptic transmission, glutamatergic |
GO:0042221 | 6e-04 | 1.4758 | 84.9507 | 112 | 3479 | response to chemical |
GO:0043588 | 7e-04 | 2.2427 | 10.9193 | 23 | 385 | skin development |
GO:1901386 | 7e-04 | 12.5645 | 0.4254 | 4 | 15 | negative regulation of voltage-gated calcium channel activity |
GO:1905438 | 8e-04 | Inf | 0.0567 | 2 | 2 | non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation |
GO:0065004 | 0.001 | 2.68 | 5.9843 | 15 | 211 | protein-DNA complex assembly |
GO:0007195 | 0.0011 | 20.6916 | 0.2269 | 3 | 8 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0015889 | 0.0011 | 20.6916 | 0.2269 | 3 | 8 | cobalamin transport |
GO:0061303 | 0.0011 | 20.6916 | 0.2269 | 3 | 8 | cornea development in camera-type eye |
GO:0007194 | 0.0014 | 6.9201 | 0.8509 | 5 | 30 | negative regulation of adenylate cyclase activity |
GO:0060513 | 0.0017 | 17.2419 | 0.2553 | 3 | 9 | prostatic bud formation |
GO:1904847 | 0.0017 | 17.2419 | 0.2553 | 3 | 9 | regulation of cell chemotaxis to fibroblast growth factor |
GO:0048863 | 0.0017 | 2.4471 | 6.9486 | 16 | 245 | stem cell differentiation |
GO:0009913 | 0.0023 | 2.1862 | 9.1892 | 19 | 324 | epidermal cell differentiation |
GO:0014722 | 0.0024 | 68.8306 | 0.0851 | 2 | 3 | regulation of skeletal muscle contraction by calcium ion signaling |
GO:0048807 | 0.0024 | 68.8306 | 0.0851 | 2 | 3 | female genitalia morphogenesis |
GO:0060750 | 0.0024 | 68.8306 | 0.0851 | 2 | 3 | epithelial cell proliferation involved in mammary gland duct elongation |
GO:2000410 | 0.0024 | 68.8306 | 0.0851 | 2 | 3 | regulation of thymocyte migration |
GO:2000545 | 0.0024 | 68.8306 | 0.0851 | 2 | 3 | negative regulation of endothelial cell chemotaxis to fibroblast growth factor |
GO:0042742 | 0.0025 | 2.5215 | 5.8993 | 14 | 208 | defense response to bacterium |
GO:0050922 | 0.0025 | 5.964 | 0.9643 | 5 | 34 | negative regulation of chemotaxis |
GO:0009235 | 0.0026 | 8.1267 | 0.5956 | 4 | 21 | cobalamin metabolic process |
GO:0031424 | 0.003 | 2.4699 | 6.0127 | 14 | 212 | keratinization |
GO:0031279 | 0.0032 | 3.5157 | 2.4675 | 8 | 87 | regulation of cyclase activity |
GO:0051339 | 0.0037 | 3.4284 | 2.5242 | 8 | 89 | regulation of lyase activity |
GO:0006936 | 0.0039 | 2.123 | 8.934 | 18 | 315 | muscle contraction |
GO:0030799 | 0.0041 | 2.7163 | 4.311 | 11 | 152 | regulation of cyclic nucleotide metabolic process |
GO:0051481 | 0.0041 | 11.4922 | 0.3403 | 3 | 12 | negative regulation of cytosolic calcium ion concentration |
GO:0060158 | 0.0041 | 11.4922 | 0.3403 | 3 | 12 | phospholipase C-activating dopamine receptor signaling pathway |
GO:0002376 | 0.0044 | 1.3916 | 70.1104 | 91 | 2472 | immune system process |
GO:0032714 | 0.0046 | 34.413 | 0.1134 | 2 | 4 | negative regulation of interleukin-5 production |
GO:0048534 | 0.0049 | 1.6517 | 22.9164 | 36 | 808 | hematopoietic or lymphoid organ development |
GO:0035767 | 0.005 | 6.577 | 0.709 | 4 | 25 | endothelial cell chemotaxis |
GO:0031272 | 0.0052 | 10.3423 | 0.3687 | 3 | 13 | regulation of pseudopodium assembly |
GO:0048149 | 0.0052 | 10.3423 | 0.3687 | 3 | 13 | behavioral response to ethanol |
GO:0035195 | 0.0059 | 2.572 | 4.5303 | 11 | 164 | gene silencing by miRNA |
GO:0002526 | 0.006 | 2.7161 | 3.9139 | 10 | 138 | acute inflammatory response |
GO:0050909 | 0.0064 | 3.9188 | 1.6733 | 6 | 59 | sensory perception of taste |
GO:0030817 | 0.0064 | 2.8675 | 3.3467 | 9 | 118 | regulation of cAMP biosynthetic process |
GO:1900542 | 0.0068 | 2.2298 | 6.6083 | 14 | 233 | regulation of purine nucleotide metabolic process |
GO:0051259 | 0.0068 | 1.8092 | 13.8973 | 24 | 490 | protein oligomerization |
GO:0030803 | 0.0071 | 4.5487 | 1.2196 | 5 | 43 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0006824 | 0.0076 | 22.9404 | 0.1418 | 2 | 5 | cobalt ion transport |
GO:0033625 | 0.0076 | 22.9404 | 0.1418 | 2 | 5 | positive regulation of integrin activation |
GO:0060157 | 0.0076 | 22.9404 | 0.1418 | 2 | 5 | urinary bladder development |
GO:0060744 | 0.0076 | 22.9404 | 0.1418 | 2 | 5 | mammary gland branching involved in thelarche |
GO:0070245 | 0.0076 | 22.9404 | 0.1418 | 2 | 5 | positive regulation of thymocyte apoptotic process |
GO:0090257 | 0.0076 | 2.2763 | 6.0127 | 13 | 212 | regulation of muscle system process |
GO:0060603 | 0.0076 | 5.7537 | 0.7941 | 4 | 28 | mammary gland duct morphogenesis |
GO:0030808 | 0.008 | 2.5934 | 4.0841 | 10 | 144 | regulation of nucleotide biosynthetic process |
GO:0030815 | 0.0086 | 4.3207 | 1.2763 | 5 | 45 | negative regulation of cAMP metabolic process |
GO:0009954 | 0.0086 | 5.5232 | 0.8225 | 4 | 29 | proximal/distal pattern formation |
GO:0052652 | 0.0092 | 2.5361 | 4.1692 | 10 | 147 | cyclic purine nucleotide metabolic process |
GO:1900372 | 0.0095 | 4.215 | 1.3046 | 5 | 46 | negative regulation of purine nucleotide biosynthetic process |
GO:0042633 | 0.0095 | 2.8898 | 2.9496 | 8 | 104 | hair cycle |
GO:0045087 | 0.0095 | 1.6078 | 21.4699 | 33 | 757 | innate immune response |
GO:0010447 | 0.0096 | 7.954 | 0.4538 | 3 | 16 | response to acidic pH |
GO:0031268 | 0.0096 | 7.954 | 0.4538 | 3 | 16 | pseudopodium organization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006935 | 0 | 2.3109 | 16.403 | 35 | 525 | chemotaxis |
GO:0048513 | 0 | 1.5594 | 88.2696 | 123 | 2868 | animal organ development |
GO:0097530 | 0 | 4.2003 | 3.4681 | 13 | 111 | granulocyte migration |
GO:0006811 | 1e-04 | 1.7277 | 44.0226 | 70 | 1409 | ion transport |
GO:0099537 | 1e-04 | 2.1601 | 17.4341 | 35 | 558 | trans-synaptic signaling |
GO:0051240 | 1e-04 | 1.708 | 43.1165 | 68 | 1380 | positive regulation of multicellular organismal process |
GO:0016477 | 1e-04 | 1.7558 | 37.5239 | 61 | 1201 | cell migration |
GO:0048869 | 1e-04 | 1.4671 | 114.9739 | 150 | 3731 | cellular developmental process |
GO:0007267 | 1e-04 | 1.682 | 45.0536 | 70 | 1442 | cell-cell signaling |
GO:0015844 | 2e-04 | 5.1521 | 1.9996 | 9 | 64 | monoamine transport |
GO:0032501 | 2e-04 | 1.4703 | 132.9441 | 167 | 4616 | multicellular organismal process |
GO:2000516 | 2e-04 | 8.5512 | 0.8748 | 6 | 28 | positive regulation of CD4-positive, alpha-beta T cell activation |
GO:0050793 | 2e-04 | 1.5408 | 68.7052 | 97 | 2199 | regulation of developmental process |
GO:0002711 | 2e-04 | 8.1789 | 0.9061 | 6 | 29 | positive regulation of T cell mediated immunity |
GO:0055085 | 2e-04 | 1.6873 | 39.5235 | 62 | 1265 | transmembrane transport |
GO:0007268 | 3e-04 | 2.0525 | 17.1799 | 33 | 552 | chemical synaptic transmission |
GO:0051674 | 3e-04 | 1.6611 | 41.4294 | 64 | 1326 | localization of cell |
GO:0045597 | 3e-04 | 1.8351 | 25.62 | 44 | 820 | positive regulation of cell differentiation |
GO:1902622 | 3e-04 | 7.5236 | 0.9686 | 6 | 31 | regulation of neutrophil migration |
GO:0040011 | 4e-04 | 1.8781 | 22.7856 | 40 | 755 | locomotion |
GO:0014821 | 4e-04 | 9.7815 | 0.6561 | 5 | 21 | phasic smooth muscle contraction |
GO:0002822 | 6e-04 | 3.5756 | 3.3743 | 11 | 108 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0043382 | 6e-04 | 31.1962 | 0.1875 | 3 | 6 | positive regulation of memory T cell differentiation |
GO:0006928 | 6e-04 | 1.5376 | 55.3016 | 79 | 1770 | movement of cell or subcellular component |
GO:0098655 | 7e-04 | 1.8335 | 22.6206 | 39 | 724 | cation transmembrane transport |
GO:0098660 | 7e-04 | 1.8335 | 22.6206 | 39 | 724 | inorganic ion transmembrane transport |
GO:0015872 | 7e-04 | 6.4841 | 1.0935 | 6 | 35 | dopamine transport |
GO:0002687 | 7e-04 | 3.4676 | 3.4681 | 11 | 111 | positive regulation of leukocyte migration |
GO:0030001 | 7e-04 | 1.7956 | 24.2765 | 41 | 777 | metal ion transport |
GO:0009653 | 7e-04 | 1.5146 | 59.9083 | 84 | 1955 | anatomical structure morphogenesis |
GO:0042711 | 7e-04 | 12.4989 | 0.4374 | 4 | 14 | maternal behavior |
GO:0046638 | 8e-04 | 6.2675 | 1.1248 | 6 | 36 | positive regulation of alpha-beta T cell differentiation |
GO:0001708 | 9e-04 | 3.9867 | 2.4995 | 9 | 80 | cell fate specification |
GO:0051241 | 9e-04 | 1.6907 | 30.8377 | 49 | 987 | negative regulation of multicellular organismal process |
GO:0043370 | 9e-04 | 6.0649 | 1.156 | 6 | 37 | regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0021884 | 9e-04 | 7.8231 | 0.7811 | 5 | 25 | forebrain neuron development |
GO:0071805 | 9e-04 | 2.7115 | 5.9363 | 15 | 190 | potassium ion transmembrane transport |
GO:0001826 | 0.001 | 23.3956 | 0.2187 | 3 | 7 | inner cell mass cell differentiation |
GO:0021843 | 0.001 | 23.3956 | 0.2187 | 3 | 7 | substrate-independent telencephalic tangential interneuron migration |
GO:2000318 | 0.001 | 23.3956 | 0.2187 | 3 | 7 | positive regulation of T-helper 17 type immune response |
GO:0070370 | 0.001 | Inf | 0.0625 | 2 | 2 | cellular heat acclimation |
GO:0032526 | 0.001 | 3.537 | 3.0931 | 10 | 99 | response to retinoic acid |
GO:0032753 | 0.0013 | 10.4144 | 0.4999 | 4 | 16 | positive regulation of interleukin-4 production |
GO:0045986 | 0.0013 | 10.4144 | 0.4999 | 4 | 16 | negative regulation of smooth muscle contraction |
GO:0051952 | 0.0013 | 4.1187 | 2.1558 | 8 | 69 | regulation of amine transport |
GO:0007626 | 0.0013 | 2.7134 | 5.5302 | 14 | 177 | locomotory behavior |
GO:0030593 | 0.0015 | 4.6069 | 1.7068 | 7 | 55 | neutrophil chemotaxis |
GO:0045630 | 0.0015 | 18.7152 | 0.25 | 3 | 8 | positive regulation of T-helper 2 cell differentiation |
GO:1903715 | 0.0015 | 18.7152 | 0.25 | 3 | 8 | regulation of aerobic respiration |
GO:0035296 | 0.0015 | 3.1216 | 3.8118 | 11 | 122 | regulation of tube diameter |
GO:0019229 | 0.0015 | 4.5742 | 1.7184 | 7 | 55 | regulation of vasoconstriction |
GO:0009790 | 0.0016 | 1.6833 | 27.6821 | 44 | 886 | embryo development |
GO:0060008 | 0.0016 | 9.6126 | 0.5311 | 4 | 17 | Sertoli cell differentiation |
GO:0045944 | 0.0016 | 1.6347 | 31.775 | 49 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0040012 | 0.0017 | 1.7208 | 24.5889 | 40 | 787 | regulation of locomotion |
GO:0032729 | 0.0017 | 4.4805 | 1.7497 | 7 | 56 | positive regulation of interferon-gamma production |
GO:0007165 | 0.0018 | 1.3265 | 163.4991 | 194 | 5233 | signal transduction |
GO:0030595 | 0.0018 | 2.616 | 5.7176 | 14 | 183 | leukocyte chemotaxis |
GO:0032103 | 0.0019 | 2.3499 | 7.686 | 17 | 246 | positive regulation of response to external stimulus |
GO:0050886 | 0.0019 | 3.8642 | 2.2808 | 8 | 73 | endocrine process |
GO:0048148 | 0.002 | 8.9254 | 0.5624 | 4 | 18 | behavioral response to cocaine |
GO:0071622 | 0.0021 | 5.0794 | 1.3435 | 6 | 43 | regulation of granulocyte chemotaxis |
GO:0051960 | 0.0021 | 1.7369 | 22.4956 | 37 | 720 | regulation of nervous system development |
GO:0050890 | 0.0021 | 2.3292 | 7.7485 | 17 | 248 | cognition |
GO:0048562 | 0.0021 | 2.2624 | 8.4358 | 18 | 270 | embryonic organ morphogenesis |
GO:0042127 | 0.0022 | 1.5137 | 45.6473 | 65 | 1461 | regulation of cell proliferation |
GO:0046877 | 0.0022 | 15.5949 | 0.2812 | 3 | 9 | regulation of saliva secretion |
GO:0090715 | 0.0022 | 15.5949 | 0.2812 | 3 | 9 | immunological memory formation process |
GO:0050880 | 0.0022 | 2.9603 | 3.9992 | 11 | 128 | regulation of blood vessel size |
GO:0007218 | 0.0023 | 3.4076 | 2.8744 | 9 | 92 | neuropeptide signaling pathway |
GO:0002706 | 0.0023 | 3.1456 | 3.4368 | 10 | 110 | regulation of lymphocyte mediated immunity |
GO:0098609 | 0.0024 | 1.721 | 22.683 | 37 | 726 | cell-cell adhesion |
GO:0007200 | 0.0025 | 3.3668 | 2.9057 | 9 | 93 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0002821 | 0.0025 | 3.693 | 2.3745 | 8 | 76 | positive regulation of adaptive immune response |
GO:0060284 | 0.0026 | 1.699 | 23.5891 | 38 | 755 | regulation of cell development |
GO:0002291 | 0.0028 | 62.5243 | 0.0934 | 2 | 3 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0014707 | 0.0029 | 62.2695 | 0.0937 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0035106 | 0.0029 | 62.2695 | 0.0937 | 2 | 3 | operant conditioning |
GO:0045163 | 0.0029 | 62.2695 | 0.0937 | 2 | 3 | clustering of voltage-gated potassium channels |
GO:0061364 | 0.0029 | 62.2695 | 0.0937 | 2 | 3 | apoptotic process involved in luteolysis |
GO:0070434 | 0.0029 | 62.2695 | 0.0937 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0029 | 62.2695 | 0.0937 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0032101 | 0.0031 | 2.3697 | 6.7143 | 15 | 220 | regulation of response to external stimulus |
GO:0010453 | 0.0034 | 5.5849 | 1.031 | 5 | 33 | regulation of cell fate commitment |
GO:0001914 | 0.0037 | 7.3488 | 0.6561 | 4 | 21 | regulation of T cell mediated cytotoxicity |
GO:0031644 | 0.0037 | 3.8496 | 1.9996 | 7 | 64 | regulation of neurological system process |
GO:0045785 | 0.0041 | 1.9871 | 11.1228 | 21 | 356 | positive regulation of cell adhesion |
GO:0051583 | 0.0041 | 11.6946 | 0.3437 | 3 | 11 | dopamine uptake involved in synaptic transmission |
GO:0090493 | 0.0041 | 11.6946 | 0.3437 | 3 | 11 | catecholamine uptake |
GO:2000344 | 0.0041 | 11.6946 | 0.3437 | 3 | 11 | positive regulation of acrosome reaction |
GO:0001755 | 0.0044 | 5.2119 | 1.0935 | 5 | 35 | neural crest cell migration |
GO:0002230 | 0.0044 | 6.9401 | 0.6874 | 4 | 22 | positive regulation of defense response to virus by host |
GO:0009605 | 0.0046 | 1.5134 | 37.7405 | 54 | 1260 | response to external stimulus |
GO:0050727 | 0.0047 | 2.0853 | 9.092 | 18 | 291 | regulation of inflammatory response |
GO:0015850 | 0.0047 | 2.336 | 6.3425 | 14 | 203 | organic hydroxy compound transport |
GO:1903039 | 0.0047 | 2.336 | 6.3425 | 14 | 203 | positive regulation of leukocyte cell-cell adhesion |
GO:0007613 | 0.0049 | 3.0065 | 3.2181 | 9 | 103 | memory |
GO:0002294 | 0.0049 | 4.1741 | 1.5934 | 6 | 51 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
GO:0002042 | 0.0049 | 5.0434 | 1.1248 | 5 | 36 | cell migration involved in sprouting angiogenesis |
GO:0006836 | 0.0052 | 2.5019 | 5.0927 | 12 | 163 | neurotransmitter transport |
GO:0008306 | 0.0052 | 3.5962 | 2.1246 | 7 | 68 | associative learning |
GO:0022008 | 0.0053 | 1.558 | 30.402 | 45 | 993 | neurogenesis |
GO:0002922 | 0.0054 | 10.3945 | 0.3749 | 3 | 12 | positive regulation of humoral immune response |
GO:0006957 | 0.0054 | 10.3945 | 0.3749 | 3 | 12 | complement activation, alternative pathway |
GO:0032736 | 0.0054 | 10.3945 | 0.3749 | 3 | 12 | positive regulation of interleukin-13 production |
GO:0060134 | 0.0054 | 10.3945 | 0.3749 | 3 | 12 | prepulse inhibition |
GO:2000319 | 0.0054 | 10.3945 | 0.3749 | 3 | 12 | regulation of T-helper 17 cell differentiation |
GO:0002287 | 0.0054 | 4.0831 | 1.6247 | 6 | 52 | alpha-beta T cell activation involved in immune response |
GO:0044057 | 0.0055 | 1.8726 | 12.8915 | 23 | 417 | regulation of system process |
GO:0015849 | 0.0055 | 2.0981 | 8.5296 | 17 | 273 | organic acid transport |
GO:0055078 | 0.0056 | 4.8855 | 1.156 | 5 | 37 | sodium ion homeostasis |
GO:0021853 | 0.0056 | 31.1326 | 0.125 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
GO:0050923 | 0.0056 | 31.1326 | 0.125 | 2 | 4 | regulation of negative chemotaxis |
GO:0051142 | 0.0056 | 31.1326 | 0.125 | 2 | 4 | positive regulation of NK T cell proliferation |
GO:0051414 | 0.0056 | 31.1326 | 0.125 | 2 | 4 | response to cortisol |
GO:2000330 | 0.0056 | 31.1326 | 0.125 | 2 | 4 | positive regulation of T-helper 17 cell lineage commitment |
GO:2000360 | 0.0056 | 31.1326 | 0.125 | 2 | 4 | negative regulation of binding of sperm to zona pellucida |
GO:2001188 | 0.0056 | 31.1326 | 0.125 | 2 | 4 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO:0021536 | 0.0056 | 3.538 | 2.1558 | 7 | 69 | diencephalon development |
GO:0007155 | 0.0057 | 1.8953 | 12.1963 | 22 | 405 | cell adhesion |
GO:0009888 | 0.0058 | 1.4148 | 54.6143 | 73 | 1748 | tissue development |
GO:0006937 | 0.0058 | 2.5818 | 4.5304 | 11 | 145 | regulation of muscle contraction |
GO:0032879 | 0.0059 | 1.3617 | 74.3291 | 95 | 2379 | regulation of localization |
GO:0035239 | 0.006 | 1.9902 | 10.0293 | 19 | 321 | tube morphogenesis |
GO:0014059 | 0.0061 | 6.2452 | 0.7499 | 4 | 24 | regulation of dopamine secretion |
GO:0031112 | 0.0061 | 6.2452 | 0.7499 | 4 | 24 | positive regulation of microtubule polymerization or depolymerization |
GO:0046633 | 0.0061 | 6.2452 | 0.7499 | 4 | 24 | alpha-beta T cell proliferation |
GO:0050905 | 0.0062 | 3.1365 | 2.7495 | 8 | 88 | neuromuscular process |
GO:0002237 | 0.0062 | 2.0248 | 9.3419 | 18 | 299 | response to molecule of bacterial origin |
GO:0009952 | 0.0062 | 2.3398 | 5.8738 | 13 | 188 | anterior/posterior pattern specification |
GO:0043268 | 0.0063 | 4.7371 | 1.1873 | 5 | 38 | positive regulation of potassium ion transport |
GO:0032940 | 0.0063 | 1.4743 | 39.9921 | 56 | 1280 | secretion by cell |
GO:0006952 | 0.0063 | 1.4598 | 42.5854 | 59 | 1363 | defense response |
GO:0034765 | 0.0064 | 1.874 | 12.3101 | 22 | 394 | regulation of ion transmembrane transport |
GO:0007411 | 0.0066 | 2.2399 | 6.5925 | 14 | 211 | axon guidance |
GO:0045624 | 0.0068 | 9.4108 | 0.4038 | 3 | 13 | positive regulation of T-helper cell differentiation |
GO:0008595 | 0.0069 | 9.3544 | 0.4062 | 3 | 13 | anterior/posterior axis specification, embryo |
GO:0050769 | 0.0069 | 1.8889 | 11.654 | 21 | 373 | positive regulation of neurogenesis |
GO:0001961 | 0.007 | 4.5975 | 1.2185 | 5 | 39 | positive regulation of cytokine-mediated signaling pathway |
GO:0030182 | 0.007 | 1.6743 | 19.4087 | 31 | 636 | neuron differentiation |
GO:0002675 | 0.0071 | 5.9474 | 0.7811 | 4 | 25 | positive regulation of acute inflammatory response |
GO:0080154 | 0.0071 | 5.9474 | 0.7811 | 4 | 25 | regulation of fertilization |
GO:0090023 | 0.0071 | 5.9474 | 0.7811 | 4 | 25 | positive regulation of neutrophil chemotaxis |
GO:0002705 | 0.0071 | 3.0595 | 2.8119 | 8 | 90 | positive regulation of leukocyte mediated immunity |
GO:0008406 | 0.0071 | 2.2999 | 5.9676 | 13 | 191 | gonad development |
GO:0051046 | 0.0071 | 1.6567 | 20.2238 | 32 | 651 | regulation of secretion |
GO:0045664 | 0.0072 | 1.7364 | 16.2781 | 27 | 521 | regulation of neuron differentiation |
GO:0055123 | 0.0072 | 2.64 | 4.0305 | 10 | 129 | digestive system development |
GO:0050776 | 0.0072 | 1.5955 | 24.2965 | 37 | 786 | regulation of immune response |
GO:0015711 | 0.0074 | 1.8485 | 12.4663 | 22 | 399 | organic anion transport |
GO:0046634 | 0.0077 | 3.3226 | 2.2808 | 7 | 73 | regulation of alpha-beta T cell activation |
GO:0071222 | 0.0079 | 2.4701 | 4.7178 | 11 | 151 | cellular response to lipopolysaccharide |
GO:0048731 | 0.0079 | 1.5282 | 31.249 | 45 | 1118 | system development |
GO:0045596 | 0.0079 | 1.6713 | 18.7776 | 30 | 601 | negative regulation of cell differentiation |
GO:0007548 | 0.008 | 2.1209 | 7.436 | 15 | 238 | sex differentiation |
GO:0002828 | 0.0082 | 5.6767 | 0.8123 | 4 | 26 | regulation of type 2 immune response |
GO:0002263 | 0.0085 | 1.6622 | 18.8713 | 30 | 604 | cell activation involved in immune response |
GO:0002827 | 0.0085 | 8.5035 | 0.4374 | 3 | 14 | positive regulation of T-helper 1 type immune response |
GO:0021527 | 0.0085 | 8.5035 | 0.4374 | 3 | 14 | spinal cord association neuron differentiation |
GO:0032693 | 0.0085 | 8.5035 | 0.4374 | 3 | 14 | negative regulation of interleukin-10 production |
GO:0032725 | 0.0085 | 8.5035 | 0.4374 | 3 | 14 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0051883 | 0.0085 | 8.5035 | 0.4374 | 3 | 14 | killing of cells in other organism involved in symbiotic interaction |
GO:0071625 | 0.0085 | 8.5035 | 0.4374 | 3 | 14 | vocalization behavior |
GO:0098810 | 0.0085 | 8.5035 | 0.4374 | 3 | 14 | neurotransmitter reuptake |
GO:0048762 | 0.0086 | 2.3302 | 5.4364 | 12 | 174 | mesenchymal cell differentiation |
GO:0042102 | 0.0086 | 2.951 | 2.9057 | 8 | 93 | positive regulation of T cell proliferation |
GO:0008217 | 0.009 | 2.4178 | 4.8116 | 11 | 154 | regulation of blood pressure |
GO:0002176 | 0.0091 | 20.7537 | 0.1562 | 2 | 5 | male germ cell proliferation |
GO:0015870 | 0.0091 | 20.7537 | 0.1562 | 2 | 5 | acetylcholine transport |
GO:0051970 | 0.0091 | 20.7537 | 0.1562 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060012 | 0.0091 | 20.7537 | 0.1562 | 2 | 5 | synaptic transmission, glycinergic |
GO:0060023 | 0.0091 | 20.7537 | 0.1562 | 2 | 5 | soft palate development |
GO:0060478 | 0.0091 | 20.7537 | 0.1562 | 2 | 5 | acrosomal vesicle exocytosis |
GO:0071205 | 0.0091 | 20.7537 | 0.1562 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0002292 | 0.0092 | 3.6105 | 1.8121 | 6 | 58 | T cell differentiation involved in immune response |
GO:0021872 | 0.0092 | 3.6105 | 1.8121 | 6 | 58 | forebrain generation of neurons |
GO:0070665 | 0.0094 | 2.5326 | 4.1867 | 10 | 134 | positive regulation of leukocyte proliferation |
GO:0048705 | 0.0095 | 2.2118 | 6.1863 | 13 | 198 | skeletal system morphogenesis |
GO:0002285 | 0.0098 | 2.5122 | 4.2179 | 10 | 135 | lymphocyte activation involved in immune response |
GO:0045321 | 0.0099 | 1.4893 | 32.3374 | 46 | 1035 | leukocyte activation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 95.1793 | 1.0163 | 26 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 124.9196 | 0.8752 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 50.691 | 1.2139 | 25 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 19.3746 | 2.202 | 27 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 165.9968 | 0.4799 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:1902036 | 0 | 13.5156 | 2.8231 | 27 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 12.9829 | 2.7949 | 26 | 99 | regulation of gene silencing by miRNA |
GO:0031497 | 0 | 9.7475 | 4.037 | 30 | 143 | chromatin assembly |
GO:0045814 | 0 | 10.4021 | 3.303 | 26 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 9.9614 | 3.4159 | 26 | 121 | regulation of gene silencing |
GO:0065004 | 0 | 6.3102 | 5.9567 | 31 | 211 | protein-DNA complex assembly |
GO:0048863 | 0 | 5.7195 | 6.9166 | 33 | 245 | stem cell differentiation |
GO:0034724 | 0 | 16.7847 | 1.4115 | 16 | 50 | DNA replication-independent nucleosome organization |
GO:0002244 | 0 | 6.5808 | 5.1662 | 28 | 183 | hematopoietic progenitor cell differentiation |
GO:0035194 | 0 | 5.1295 | 7.5941 | 33 | 269 | posttranscriptional gene silencing by RNA |
GO:0034080 | 0 | 19.1238 | 1.1292 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0030099 | 0 | 4.3862 | 10.1066 | 38 | 358 | myeloid cell differentiation |
GO:1904837 | 0 | 17.7554 | 1.1857 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0032200 | 0 | 6.8088 | 4.272 | 24 | 152 | telomere organization |
GO:0071103 | 0 | 5.0555 | 7.1989 | 31 | 255 | DNA conformation change |
GO:0017148 | 0 | 4.1609 | 9.9937 | 36 | 354 | negative regulation of translation |
GO:0016233 | 0 | 13.8023 | 1.4115 | 14 | 50 | telomere capping |
GO:1903707 | 0 | 6.6985 | 3.5853 | 20 | 127 | negative regulation of hemopoiesis |
GO:0043044 | 0 | 9.1873 | 2.0609 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0045652 | 0 | 11.6093 | 1.4766 | 13 | 54 | regulation of megakaryocyte differentiation |
GO:0006303 | 0 | 9.5451 | 1.8632 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0051259 | 0 | 3.077 | 13.8331 | 38 | 490 | protein oligomerization |
GO:0034248 | 0 | 2.86 | 16.0069 | 41 | 567 | regulation of cellular amide metabolic process |
GO:0038111 | 0 | 13.5301 | 1.0163 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 13.5301 | 1.0163 | 10 | 36 | response to interleukin-7 |
GO:0048534 | 0 | 2.4961 | 22.8105 | 51 | 808 | hematopoietic or lymphoid organ development |
GO:0010608 | 0 | 2.5846 | 18.4347 | 43 | 653 | posttranscriptional regulation of gene expression |
GO:0048869 | 0 | 1.6995 | 107.5877 | 154 | 3811 | cellular developmental process |
GO:0045596 | 0 | 2.6031 | 16.9667 | 40 | 601 | negative regulation of cell differentiation |
GO:0034728 | 0 | 5.7716 | 2.809 | 14 | 103 | nucleosome organization |
GO:0022610 | 0 | 2.0426 | 34.7521 | 64 | 1231 | biological adhesion |
GO:0048518 | 0 | 1.5536 | 141.8317 | 185 | 5024 | positive regulation of biological process |
GO:0007596 | 0 | 2.9199 | 8.5822 | 23 | 304 | blood coagulation |
GO:0002263 | 0 | 2.2894 | 17.0514 | 36 | 604 | cell activation involved in immune response |
GO:0045892 | 0 | 1.9652 | 29.3883 | 53 | 1041 | negative regulation of transcription, DNA-templated |
GO:0046640 | 0 | 13.0765 | 0.6211 | 6 | 22 | regulation of alpha-beta T cell proliferation |
GO:0006950 | 0 | 1.6241 | 75.1746 | 108 | 2779 | response to stress |
GO:1903706 | 0 | 2.8945 | 7.8725 | 21 | 290 | regulation of hemopoiesis |
GO:1902679 | 0 | 1.8972 | 30.3199 | 53 | 1074 | negative regulation of RNA biosynthetic process |
GO:0048731 | 0 | 1.5455 | 98.3792 | 133 | 3579 | system development |
GO:0051248 | 1e-04 | 1.835 | 34.3569 | 58 | 1217 | negative regulation of protein metabolic process |
GO:0032753 | 1e-04 | 15.8184 | 0.4517 | 5 | 16 | positive regulation of interleukin-4 production |
GO:0009611 | 1e-04 | 2.1955 | 16.6844 | 34 | 591 | response to wounding |
GO:0043043 | 1e-04 | 1.9744 | 22.3306 | 41 | 791 | peptide biosynthetic process |
GO:0007166 | 2e-04 | 1.5542 | 69.4478 | 98 | 2460 | cell surface receptor signaling pathway |
GO:0098657 | 2e-04 | 2.0643 | 17.6443 | 34 | 625 | import into cell |
GO:0006352 | 2e-04 | 2.8878 | 6.3519 | 17 | 225 | DNA-templated transcription, initiation |
GO:0010604 | 3e-04 | 1.5096 | 78.1994 | 107 | 2770 | positive regulation of macromolecule metabolic process |
GO:0046635 | 4e-04 | 5.9575 | 1.3551 | 7 | 48 | positive regulation of alpha-beta T cell activation |
GO:0050878 | 4e-04 | 2.2144 | 12.5345 | 26 | 444 | regulation of body fluid levels |
GO:0032616 | 4e-04 | 34.88 | 0.1683 | 3 | 6 | interleukin-13 production |
GO:0045055 | 4e-04 | 1.9703 | 18.4065 | 34 | 652 | regulated exocytosis |
GO:0048856 | 7e-04 | 1.8617 | 22.8533 | 39 | 938 | anatomical structure development |
GO:0002699 | 7e-04 | 3.0865 | 4.5452 | 13 | 161 | positive regulation of immune effector process |
GO:0098609 | 7e-04 | 2.2803 | 10.2791 | 22 | 373 | cell-cell adhesion |
GO:0070271 | 7e-04 | 1.6464 | 37.0953 | 57 | 1314 | protein complex biogenesis |
GO:0042119 | 8e-04 | 2.1344 | 12.4498 | 25 | 441 | neutrophil activation |
GO:0018003 | 8e-04 | Inf | 0.0565 | 2 | 2 | peptidyl-lysine N6-acetylation |
GO:1902340 | 8e-04 | Inf | 0.0565 | 2 | 2 | negative regulation of chromosome condensation |
GO:0002279 | 0.001 | 5.9702 | 1.1575 | 6 | 41 | mast cell activation involved in immune response |
GO:0032729 | 0.001 | 4.9821 | 1.5809 | 7 | 56 | positive regulation of interferon-gamma production |
GO:0023052 | 0.001 | 1.3648 | 160.6052 | 192 | 5689 | signaling |
GO:0002694 | 0.001 | 2.1227 | 11.9981 | 24 | 425 | regulation of leukocyte activation |
GO:0045595 | 0.0011 | 1.7449 | 25.6739 | 42 | 963 | regulation of cell differentiation |
GO:0045630 | 0.0011 | 20.7911 | 0.2258 | 3 | 8 | positive regulation of T-helper 2 cell differentiation |
GO:0051133 | 0.0011 | 20.7911 | 0.2258 | 3 | 8 | regulation of NK T cell activation |
GO:0032268 | 0.0011 | 1.4693 | 67.8951 | 92 | 2405 | regulation of cellular protein metabolic process |
GO:0051241 | 0.0012 | 1.776 | 23.3461 | 39 | 860 | negative regulation of multicellular organismal process |
GO:0002711 | 0.0012 | 7.2437 | 0.8187 | 5 | 29 | positive regulation of T cell mediated immunity |
GO:0048646 | 0.0012 | 1.7222 | 26.537 | 43 | 940 | anatomical structure formation involved in morphogenesis |
GO:0007286 | 0.0012 | 3.2118 | 3.6982 | 11 | 131 | spermatid development |
GO:0002448 | 0.0012 | 5.6467 | 1.2139 | 6 | 43 | mast cell mediated immunity |
GO:0045934 | 0.0012 | 1.6166 | 36.3048 | 55 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0043312 | 0.0013 | 2.0905 | 12.1675 | 24 | 431 | neutrophil degranulation |
GO:0035115 | 0.0014 | 6.9535 | 0.8469 | 5 | 30 | embryonic forelimb morphogenesis |
GO:0009890 | 0.0014 | 1.555 | 44.0401 | 64 | 1560 | negative regulation of biosynthetic process |
GO:0046649 | 0.0014 | 1.9283 | 15.9222 | 29 | 564 | lymphocyte activation |
GO:0007154 | 0.0016 | 1.3443 | 161.1415 | 191 | 5708 | cell communication |
GO:0045602 | 0.0017 | 17.3248 | 0.2541 | 3 | 9 | negative regulation of endothelial cell differentiation |
GO:0097398 | 0.0017 | 17.3248 | 0.2541 | 3 | 9 | cellular response to interleukin-17 |
GO:0008283 | 0.002 | 1.4968 | 51.5213 | 72 | 1825 | cell proliferation |
GO:0060249 | 0.002 | 2.1727 | 9.7396 | 20 | 345 | anatomical structure homeostasis |
GO:0006928 | 0.0021 | 1.4983 | 49.9686 | 70 | 1770 | movement of cell or subcellular component |
GO:0065003 | 0.0022 | 1.5139 | 46.5526 | 66 | 1649 | macromolecular complex assembly |
GO:0016477 | 0.0022 | 1.5972 | 33.9052 | 51 | 1201 | cell migration |
GO:0090109 | 0.0022 | 4.9728 | 1.3551 | 6 | 48 | regulation of cell-substrate junction assembly |
GO:0048514 | 0.0022 | 1.9367 | 14.1719 | 26 | 502 | blood vessel morphogenesis |
GO:0031509 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | telomeric heterochromatin assembly |
GO:2000566 | 0.0023 | 69.1608 | 0.0847 | 2 | 3 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
GO:0016192 | 0.0025 | 1.5043 | 46.8067 | 66 | 1658 | vesicle-mediated transport |
GO:0050778 | 0.0026 | 1.8257 | 17.3337 | 30 | 614 | positive regulation of immune response |
GO:0045321 | 0.0027 | 2.031 | 11.4395 | 22 | 419 | leukocyte activation |
GO:0070527 | 0.0027 | 4.7461 | 1.4115 | 6 | 50 | platelet aggregation |
GO:0002275 | 0.0029 | 1.9833 | 12.2258 | 23 | 438 | myeloid cell activation involved in immune response |
GO:0045087 | 0.0029 | 1.7278 | 21.3707 | 35 | 757 | innate immune response |
GO:1903391 | 0.003 | 4.6403 | 1.4398 | 6 | 51 | regulation of adherens junction organization |
GO:0051674 | 0.0039 | 1.5274 | 37.4341 | 54 | 1326 | localization of cell |
GO:0002523 | 0.0041 | 11.5475 | 0.3388 | 3 | 12 | leukocyte migration involved in inflammatory response |
GO:0032736 | 0.0041 | 11.5475 | 0.3388 | 3 | 12 | positive regulation of interleukin-13 production |
GO:0070663 | 0.0042 | 2.463 | 5.5897 | 13 | 198 | regulation of leukocyte proliferation |
GO:0001952 | 0.0044 | 3.3214 | 2.5972 | 8 | 92 | regulation of cell-matrix adhesion |
GO:0003164 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | His-Purkinje system development |
GO:0010716 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | negative regulation of extracellular matrix disassembly |
GO:0031508 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | pericentric heterochromatin assembly |
GO:0051142 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | positive regulation of NK T cell proliferation |
GO:2000360 | 0.0046 | 34.5781 | 0.1129 | 2 | 4 | negative regulation of binding of sperm to zona pellucida |
GO:0022603 | 0.0047 | 1.6248 | 25.2666 | 39 | 895 | regulation of anatomical structure morphogenesis |
GO:0042102 | 0.0048 | 3.2821 | 2.6255 | 8 | 93 | positive regulation of T cell proliferation |
GO:0051716 | 0.0049 | 1.2945 | 181.2701 | 208 | 6421 | cellular response to stimulus |
GO:0030155 | 0.005 | 1.9865 | 10.5819 | 20 | 381 | regulation of cell adhesion |
GO:0006909 | 0.0053 | 2.3846 | 5.7591 | 13 | 204 | phagocytosis |
GO:0007159 | 0.0053 | 2.0558 | 9.2032 | 18 | 326 | leukocyte cell-cell adhesion |
GO:0030198 | 0.0054 | 2.104 | 8.4975 | 17 | 301 | extracellular matrix organization |
GO:0002828 | 0.0057 | 6.3079 | 0.734 | 4 | 26 | regulation of type 2 immune response |
GO:1903671 | 0.0057 | 6.3079 | 0.734 | 4 | 26 | negative regulation of sprouting angiogenesis |
GO:0060429 | 0.006 | 1.5329 | 32.2961 | 47 | 1144 | epithelium development |
GO:0040011 | 0.0064 | 1.4573 | 43.5319 | 60 | 1542 | locomotion |
GO:0002444 | 0.0064 | 1.8735 | 12.3112 | 22 | 441 | myeloid leukocyte mediated immunity |
GO:0051895 | 0.0064 | 9.4467 | 0.3952 | 3 | 14 | negative regulation of focal adhesion assembly |
GO:0022412 | 0.0065 | 2.0597 | 8.6669 | 17 | 307 | cellular process involved in reproduction in multicellular organism |
GO:0022409 | 0.0065 | 2.2408 | 6.5778 | 14 | 233 | positive regulation of cell-cell adhesion |
GO:0043304 | 0.0066 | 6.0332 | 0.7622 | 4 | 27 | regulation of mast cell degranulation |
GO:0002682 | 0.0068 | 1.7668 | 15.4504 | 26 | 601 | regulation of immune system process |
GO:0006954 | 0.0068 | 1.7257 | 17.0022 | 28 | 606 | inflammatory response |
GO:0019730 | 0.0069 | 3.3854 | 2.2302 | 7 | 79 | antimicrobial humoral response |
GO:0050670 | 0.0069 | 2.3993 | 5.2792 | 12 | 187 | regulation of lymphocyte proliferation |
GO:0032418 | 0.0073 | 3.7941 | 1.7221 | 6 | 61 | lysosome localization |
GO:0001944 | 0.0074 | 1.7139 | 17.1079 | 28 | 606 | vasculature development |
GO:0015840 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | urea transport |
GO:0051891 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0060414 | 0.0075 | 23.0505 | 0.1412 | 2 | 5 | aorta smooth muscle tissue morphogenesis |
GO:0001942 | 0.0079 | 3.2934 | 2.2867 | 7 | 81 | hair follicle development |
GO:0032634 | 0.0079 | 8.6589 | 0.4235 | 3 | 15 | interleukin-5 production |
GO:0008584 | 0.0081 | 2.7542 | 3.4724 | 9 | 123 | male gonad development |
GO:0006968 | 0.0085 | 4.3415 | 1.2704 | 5 | 45 | cellular defense response |
GO:0007156 | 0.0085 | 2.5674 | 4.1217 | 10 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0009954 | 0.0085 | 5.5498 | 0.8187 | 4 | 29 | proximal/distal pattern formation |
GO:1901890 | 0.0085 | 5.5498 | 0.8187 | 4 | 29 | positive regulation of cell junction assembly |
GO:0007162 | 0.0088 | 2.2307 | 6.1261 | 13 | 217 | negative regulation of cell adhesion |
GO:0022404 | 0.009 | 3.2063 | 2.3432 | 7 | 83 | molting cycle process |
GO:0045137 | 0.0095 | 2.2932 | 5.505 | 12 | 195 | development of primary sexual characteristics |
GO:1905939 | 0.0095 | 7.9923 | 0.4517 | 3 | 16 | regulation of gonad development |
GO:0002369 | 0.0096 | 5.336 | 0.8469 | 4 | 30 | T cell cytokine production |
GO:0002703 | 0.0097 | 2.5115 | 4.2064 | 10 | 149 | regulation of leukocyte mediated immunity |
GO:0071822 | 0.0099 | 1.4259 | 43.5884 | 59 | 1544 | protein complex subunit organization |
GO:0032946 | 0.0099 | 2.6601 | 3.5853 | 9 | 127 | positive regulation of mononuclear cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 100.6306 | 1.0681 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 58.6813 | 1.2403 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 37.0442 | 1.4815 | 24 | 43 | protein heterotetramerization |
GO:0060964 | 0 | 12.2293 | 3.4109 | 29 | 99 | regulation of gene silencing by miRNA |
GO:0045815 | 0 | 14.689 | 2.6874 | 26 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 134.3307 | 0.5857 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060968 | 0 | 9.291 | 4.1689 | 29 | 121 | regulation of gene silencing |
GO:1902036 | 0 | 10.3065 | 3.4453 | 26 | 100 | regulation of hematopoietic stem cell differentiation |
GO:1904837 | 0 | 19.6599 | 1.447 | 17 | 42 | beta-catenin-TCF complex assembly |
GO:0031497 | 0 | 7.1508 | 4.9268 | 28 | 143 | chromatin assembly |
GO:0045814 | 0 | 7.9455 | 4.031 | 25 | 117 | negative regulation of gene expression, epigenetic |
GO:0048863 | 0 | 4.9325 | 8.4411 | 35 | 245 | stem cell differentiation |
GO:0002244 | 0 | 5.7669 | 6.305 | 30 | 183 | hematopoietic progenitor cell differentiation |
GO:0035194 | 0 | 4.5747 | 9.268 | 36 | 269 | posttranscriptional gene silencing by RNA |
GO:0065004 | 0 | 5.0661 | 7.2697 | 31 | 211 | protein-DNA complex assembly |
GO:0034080 | 0 | 15.4755 | 1.3781 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0030099 | 0 | 3.733 | 12.3343 | 40 | 358 | myeloid cell differentiation |
GO:0032200 | 0 | 5.6084 | 5.3403 | 25 | 155 | telomere organization |
GO:0006303 | 0 | 9.2179 | 2.2739 | 16 | 66 | double-strand break repair via nonhomologous end joining |
GO:0016233 | 0 | 11.1692 | 1.7227 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 11.1692 | 1.7227 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0017148 | 0 | 3.4429 | 12.1965 | 37 | 354 | negative regulation of translation |
GO:0051259 | 0 | 3.0055 | 16.8822 | 45 | 490 | protein oligomerization |
GO:0048534 | 0 | 2.5552 | 26.4399 | 60 | 773 | hematopoietic or lymphoid organ development |
GO:1903707 | 0 | 5.7414 | 4.3756 | 21 | 127 | negative regulation of hemopoiesis |
GO:0071103 | 0 | 3.7476 | 8.7856 | 29 | 255 | DNA conformation change |
GO:0038111 | 0 | 12.5729 | 1.2403 | 11 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 12.5729 | 1.2403 | 11 | 36 | response to interleukin-7 |
GO:0043044 | 0 | 7.4312 | 2.5151 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0051239 | 0 | 2.1185 | 39.928 | 75 | 1200 | regulation of multicellular organismal process |
GO:1902679 | 0 | 2.1003 | 37.0029 | 70 | 1074 | negative regulation of RNA biosynthetic process |
GO:0045652 | 0 | 8.3977 | 1.813 | 12 | 54 | regulation of megakaryocyte differentiation |
GO:0045892 | 0 | 2.1009 | 35.866 | 68 | 1041 | negative regulation of transcription, DNA-templated |
GO:0007156 | 0 | 4.3123 | 5.0302 | 19 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0022610 | 0 | 1.9543 | 42.4121 | 75 | 1231 | biological adhesion |
GO:0034248 | 0 | 2.4154 | 19.5351 | 43 | 567 | regulation of cellular amide metabolic process |
GO:0048731 | 0 | 1.8553 | 54.5956 | 89 | 1767 | system development |
GO:0009890 | 0 | 1.8111 | 53.7473 | 88 | 1560 | negative regulation of biosynthetic process |
GO:0045596 | 0 | 2.3246 | 20.7065 | 44 | 601 | negative regulation of cell differentiation |
GO:0032502 | 0 | 1.8787 | 48.0626 | 79 | 1583 | developmental process |
GO:0045934 | 0 | 1.858 | 44.3071 | 75 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0032268 | 0 | 1.6295 | 82.8604 | 121 | 2405 | regulation of cellular protein metabolic process |
GO:0051248 | 0 | 1.8511 | 41.9298 | 71 | 1217 | negative regulation of protein metabolic process |
GO:0098609 | 0 | 2.0564 | 23.1092 | 44 | 679 | cell-cell adhesion |
GO:0009893 | 0 | 1.5212 | 102.6022 | 140 | 2978 | positive regulation of metabolic process |
GO:0006352 | 0 | 2.9633 | 7.752 | 21 | 225 | DNA-templated transcription, initiation |
GO:0034654 | 0 | 1.4708 | 133.7481 | 174 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0034728 | 0 | 4.2306 | 3.4656 | 13 | 103 | nucleosome organization |
GO:0070271 | 1e-04 | 1.7237 | 45.2718 | 72 | 1314 | protein complex biogenesis |
GO:0010608 | 1e-04 | 2.0068 | 22.4981 | 42 | 653 | posttranscriptional regulation of gene expression |
GO:0007399 | 1e-04 | 1.58 | 64.7961 | 94 | 1904 | nervous system development |
GO:1903506 | 1e-04 | 1.4567 | 113.5239 | 149 | 3295 | regulation of nucleic acid-templated transcription |
GO:0060173 | 1e-04 | 3.1802 | 5.5125 | 16 | 160 | limb development |
GO:2000811 | 2e-04 | 12.8512 | 0.5513 | 5 | 16 | negative regulation of anoikis |
GO:0007154 | 2e-04 | 1.4366 | 140.0914 | 176 | 4266 | cell communication |
GO:0060037 | 2e-04 | 8.9405 | 0.8613 | 6 | 25 | pharyngeal system development |
GO:0051252 | 2e-04 | 1.4367 | 119.76 | 155 | 3476 | regulation of RNA metabolic process |
GO:0034113 | 2e-04 | 5.822 | 1.6193 | 8 | 47 | heterotypic cell-cell adhesion |
GO:0080090 | 2e-04 | 1.3853 | 189.4937 | 229 | 5500 | regulation of primary metabolic process |
GO:0030326 | 2e-04 | 3.5323 | 4.0655 | 13 | 118 | embryonic limb morphogenesis |
GO:0065003 | 2e-04 | 1.5763 | 56.8137 | 83 | 1649 | macromolecular complex assembly |
GO:0035107 | 3e-04 | 3.2765 | 4.6857 | 14 | 136 | appendage morphogenesis |
GO:0023052 | 3e-04 | 1.4186 | 139.4675 | 174 | 4247 | signaling |
GO:1903706 | 3e-04 | 2.4418 | 9.6731 | 22 | 290 | regulation of hemopoiesis |
GO:0051716 | 3e-04 | 1.3612 | 221.2253 | 260 | 6421 | cellular response to stimulus |
GO:0001952 | 3e-04 | 3.8658 | 3.1697 | 11 | 92 | regulation of cell-matrix adhesion |
GO:0048869 | 3e-04 | 1.4158 | 119.7956 | 153 | 3572 | cellular developmental process |
GO:0009611 | 3e-04 | 1.9376 | 20.362 | 37 | 591 | response to wounding |
GO:0001568 | 5e-04 | 1.921 | 19.9485 | 36 | 579 | blood vessel development |
GO:0002376 | 5e-04 | 1.4531 | 85.1688 | 114 | 2472 | immune system process |
GO:2000112 | 5e-04 | 1.3827 | 130.9918 | 164 | 3802 | regulation of cellular macromolecule biosynthetic process |
GO:0072358 | 7e-04 | 1.8641 | 21.0855 | 37 | 612 | cardiovascular system development |
GO:0048589 | 7e-04 | 1.9305 | 18.1569 | 33 | 527 | developmental growth |
GO:0007267 | 8e-04 | 1.5478 | 49.6818 | 72 | 1442 | cell-cell signaling |
GO:0071822 | 9e-04 | 1.5348 | 51.5218 | 74 | 1506 | protein complex subunit organization |
GO:0007596 | 9e-04 | 2.2381 | 10.4738 | 22 | 304 | blood coagulation |
GO:0050878 | 0.0011 | 1.9913 | 14.9105 | 28 | 435 | regulation of body fluid levels |
GO:0022414 | 0.0011 | 1.5681 | 42.7222 | 63 | 1240 | reproductive process |
GO:0042133 | 0.0012 | 7.4361 | 0.8269 | 5 | 24 | neurotransmitter metabolic process |
GO:0003165 | 0.0012 | Inf | 0.0689 | 2 | 2 | Purkinje myocyte development |
GO:1902963 | 0.0012 | Inf | 0.0689 | 2 | 2 | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
GO:0048598 | 0.0013 | 1.8565 | 18.8116 | 33 | 546 | embryonic morphogenesis |
GO:0036037 | 0.0014 | 10.2612 | 0.5168 | 4 | 15 | CD8-positive, alpha-beta T cell activation |
GO:0021884 | 0.0014 | 7.0638 | 0.8613 | 5 | 25 | forebrain neuron development |
GO:0060561 | 0.0014 | 7.0638 | 0.8613 | 5 | 25 | apoptotic process involved in morphogenesis |
GO:0048699 | 0.0015 | 1.5449 | 43.997 | 64 | 1277 | generation of neurons |
GO:0042475 | 0.0015 | 3.6485 | 2.7218 | 9 | 79 | odontogenesis of dentin-containing tooth |
GO:0001708 | 0.0017 | 3.5969 | 2.7563 | 9 | 80 | cell fate specification |
GO:0071772 | 0.0017 | 2.7624 | 5.0646 | 13 | 147 | response to BMP |
GO:0043043 | 0.0021 | 1.6654 | 27.2526 | 43 | 791 | peptide biosynthetic process |
GO:0007631 | 0.0022 | 3.1905 | 3.4109 | 10 | 99 | feeding behavior |
GO:0045597 | 0.0024 | 1.6428 | 28.2518 | 44 | 820 | positive regulation of cell differentiation |
GO:0009966 | 0.0025 | 1.3621 | 96.3661 | 122 | 2797 | regulation of signal transduction |
GO:0018212 | 0.0025 | 2.0093 | 12.0931 | 23 | 351 | peptidyl-tyrosine modification |
GO:0007517 | 0.0026 | 2.003 | 12.1276 | 23 | 352 | muscle organ development |
GO:0065008 | 0.0027 | 1.369 | 91.2993 | 116 | 2734 | regulation of biological quality |
GO:0007389 | 0.0027 | 1.9328 | 13.6435 | 25 | 396 | pattern specification process |
GO:0030509 | 0.0028 | 2.7298 | 4.7201 | 12 | 137 | BMP signaling pathway |
GO:0019935 | 0.0029 | 3.0524 | 3.5487 | 10 | 103 | cyclic-nucleotide-mediated signaling |
GO:0043496 | 0.0029 | 8.0608 | 0.6202 | 4 | 18 | regulation of protein homodimerization activity |
GO:0002934 | 0.0029 | 14.087 | 0.3101 | 3 | 9 | desmosome organization |
GO:0033089 | 0.0029 | 14.087 | 0.3101 | 3 | 9 | positive regulation of T cell differentiation in thymus |
GO:0070255 | 0.0029 | 14.087 | 0.3101 | 3 | 9 | regulation of mucus secretion |
GO:0072172 | 0.0029 | 14.087 | 0.3101 | 3 | 9 | mesonephric tubule formation |
GO:0030155 | 0.003 | 1.7371 | 20.6031 | 34 | 598 | regulation of cell adhesion |
GO:0045165 | 0.0031 | 2.5659 | 5.4127 | 13 | 159 | cell fate commitment |
GO:0061564 | 0.0033 | 1.874 | 14.6082 | 26 | 424 | axon development |
GO:0003350 | 0.0035 | 56.2595 | 0.1034 | 2 | 3 | pulmonary myocardium development |
GO:0060988 | 0.0035 | 56.2595 | 0.1034 | 2 | 3 | lipid tube assembly |
GO:0045595 | 0.0036 | 2.0165 | 10.9957 | 21 | 344 | regulation of cell differentiation |
GO:0007189 | 0.0036 | 3.8849 | 1.9983 | 7 | 58 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0007166 | 0.0038 | 1.361 | 84.7554 | 108 | 2460 | cell surface receptor signaling pathway |
GO:0001569 | 0.0039 | 5.4315 | 1.0681 | 5 | 31 | branching involved in blood vessel morphogenesis |
GO:0008344 | 0.0039 | 3.434 | 2.5496 | 8 | 74 | adult locomotory behavior |
GO:0032501 | 0.004 | 1.3461 | 114.798 | 139 | 3802 | multicellular organismal process |
GO:0060081 | 0.0041 | 12.0738 | 0.3445 | 3 | 10 | membrane hyperpolarization |
GO:0048599 | 0.0042 | 4.3497 | 1.5504 | 6 | 45 | oocyte development |
GO:0060249 | 0.0042 | 1.9485 | 11.8864 | 22 | 345 | anatomical structure homeostasis |
GO:0043069 | 0.0043 | 1.6109 | 26.7358 | 41 | 776 | negative regulation of programmed cell death |
GO:0001504 | 0.0043 | 7.0522 | 0.6891 | 4 | 20 | neurotransmitter uptake |
GO:0045944 | 0.0044 | 1.5311 | 35.0391 | 51 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0048666 | 0.0045 | 1.5568 | 31.7316 | 47 | 921 | neuron development |
GO:0003281 | 0.0048 | 3.6683 | 2.1017 | 7 | 61 | ventricular septum development |
GO:0031623 | 0.0049 | 3.284 | 2.6529 | 8 | 77 | receptor internalization |
GO:0070997 | 0.0049 | 2.0315 | 9.8537 | 19 | 286 | neuron death |
GO:0060537 | 0.0052 | 1.9121 | 12.0931 | 22 | 351 | muscle tissue development |
GO:0010628 | 0.0052 | 1.4276 | 52.5709 | 71 | 1597 | positive regulation of gene expression |
GO:0007565 | 0.0052 | 2.4003 | 5.7537 | 13 | 167 | female pregnancy |
GO:0008015 | 0.0052 | 1.7837 | 15.883 | 27 | 461 | blood circulation |
GO:0051953 | 0.0052 | 6.6369 | 0.7235 | 4 | 21 | negative regulation of amine transport |
GO:0048523 | 0.0053 | 1.3084 | 118.3473 | 143 | 3601 | negative regulation of cellular process |
GO:0051583 | 0.0055 | 10.5638 | 0.379 | 3 | 11 | dopamine uptake involved in synaptic transmission |
GO:0090493 | 0.0055 | 10.5638 | 0.379 | 3 | 11 | catecholamine uptake |
GO:0018209 | 0.0057 | 2.0455 | 9.268 | 18 | 269 | peptidyl-serine modification |
GO:0048477 | 0.0058 | 3.191 | 2.7218 | 8 | 79 | oogenesis |
GO:0038083 | 0.0058 | 4.0382 | 1.6538 | 6 | 48 | peptidyl-tyrosine autophosphorylation |
GO:0001932 | 0.006 | 1.4613 | 42.4466 | 59 | 1232 | regulation of protein phosphorylation |
GO:0035295 | 0.0062 | 1.705 | 18.4326 | 30 | 535 | tube development |
GO:0009887 | 0.0065 | 1.5358 | 30.716 | 45 | 897 | animal organ morphogenesis |
GO:0015872 | 0.0066 | 4.706 | 1.2059 | 5 | 35 | dopamine transport |
GO:0035137 | 0.0066 | 4.706 | 1.2059 | 5 | 35 | hindlimb morphogenesis |
GO:0048536 | 0.0066 | 4.706 | 1.2059 | 5 | 35 | spleen development |
GO:0007416 | 0.0066 | 2.5384 | 4.6168 | 11 | 134 | synapse assembly |
GO:0006931 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | substrate-dependent cell migration, cell attachment to substrate |
GO:0014050 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | negative regulation of glutamate secretion |
GO:0021853 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
GO:0051454 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | intracellular pH elevation |
GO:0060167 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | regulation of adenosine receptor signaling pathway |
GO:0072107 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0090191 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | negative regulation of branching involved in ureteric bud morphogenesis |
GO:0099550 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | trans-synaptic signaling, modulating synaptic transmission |
GO:1900194 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | negative regulation of oocyte maturation |
GO:1902953 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | positive regulation of ER to Golgi vesicle-mediated transport |
GO:2000275 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | regulation of oxidative phosphorylation uncoupler activity |
GO:2000664 | 0.0068 | 28.1279 | 0.1378 | 2 | 4 | positive regulation of interleukin-5 secretion |
GO:0060411 | 0.0069 | 3.4144 | 2.2395 | 7 | 65 | cardiac septum morphogenesis |
GO:0002726 | 0.0071 | 9.3894 | 0.4134 | 3 | 12 | positive regulation of T cell cytokine production |
GO:0043173 | 0.0071 | 9.3894 | 0.4134 | 3 | 12 | nucleotide salvage |
GO:0042481 | 0.0073 | 5.9375 | 0.7924 | 4 | 23 | regulation of odontogenesis |
GO:0060343 | 0.0073 | 5.9375 | 0.7924 | 4 | 23 | trabecula formation |
GO:0031589 | 0.0076 | 1.981 | 9.5441 | 18 | 278 | cell-substrate adhesion |
GO:0045664 | 0.0078 | 1.6899 | 17.9502 | 29 | 521 | regulation of neuron differentiation |
GO:0035556 | 0.0078 | 1.3258 | 84.0318 | 105 | 2439 | intracellular signal transduction |
GO:0001525 | 0.0078 | 1.8107 | 13.302 | 23 | 389 | angiogenesis |
GO:0046637 | 0.0079 | 3.7682 | 1.7571 | 6 | 51 | regulation of alpha-beta T cell differentiation |
GO:0048870 | 0.0082 | 1.4247 | 45.6852 | 62 | 1326 | cell motility |
GO:0071695 | 0.0082 | 2.4578 | 4.7546 | 11 | 138 | anatomical structure maturation |
GO:0007618 | 0.0084 | 4.4113 | 1.2748 | 5 | 37 | mating |
GO:0045777 | 0.0084 | 4.4113 | 1.2748 | 5 | 37 | positive regulation of blood pressure |
GO:0021953 | 0.0086 | 2.3338 | 5.4436 | 12 | 158 | central nervous system neuron differentiation |
GO:0051240 | 0.0086 | 1.4132 | 47.5457 | 64 | 1380 | positive regulation of multicellular organismal process |
GO:0002293 | 0.0086 | 3.686 | 1.7916 | 6 | 52 | alpha-beta T cell differentiation involved in immune response |
GO:0033138 | 0.0089 | 2.9412 | 2.9285 | 8 | 85 | positive regulation of peptidyl-serine phosphorylation |
GO:0046500 | 0.009 | 8.4499 | 0.4479 | 3 | 13 | S-adenosylmethionine metabolic process |
GO:0010033 | 0.009 | 1.3029 | 94.609 | 116 | 2746 | response to organic substance |
GO:0009792 | 0.0092 | 1.6654 | 18.1914 | 29 | 528 | embryo development ending in birth or egg hatching |
GO:0030199 | 0.0094 | 4.2773 | 1.3092 | 5 | 38 | collagen fibril organization |
GO:0071417 | 0.0097 | 1.6912 | 16.6754 | 27 | 484 | cellular response to organonitrogen compound |
GO:0006281 | 0.01 | 1.6874 | 16.7099 | 27 | 485 | DNA repair |
GO:0043523 | 0.01 | 2.1982 | 6.2361 | 13 | 181 | regulation of neuron apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051290 | 0 | 11.5424 | 1.4252 | 12 | 43 | protein heterotetramerization |
GO:0006335 | 0 | 14.1513 | 1.0274 | 10 | 31 | DNA replication-dependent nucleosome assembly |
GO:0002227 | 0 | 23.6964 | 0.5966 | 8 | 18 | innate immune response in mucosa |
GO:0019731 | 0 | 12.3799 | 1.1269 | 10 | 34 | antibacterial humoral response |
GO:0006333 | 0 | 4.3645 | 5.5018 | 21 | 166 | chromatin assembly or disassembly |
GO:0000183 | 0 | 11.426 | 1.1932 | 10 | 36 | chromatin silencing at rDNA |
GO:0038111 | 0 | 11.426 | 1.1932 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 11.426 | 1.1932 | 10 | 36 | response to interleukin-7 |
GO:0006323 | 0 | 3.902 | 6.0652 | 21 | 183 | DNA packaging |
GO:0045814 | 0 | 4.7395 | 3.8778 | 16 | 117 | negative regulation of gene expression, epigenetic |
GO:0002251 | 0 | 11.8402 | 0.928 | 8 | 28 | organ or tissue specific immune response |
GO:0045652 | 0 | 6.0531 | 2.3532 | 12 | 71 | regulation of megakaryocyte differentiation |
GO:0061844 | 0 | 7.8437 | 1.4252 | 9 | 43 | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO:0071824 | 0 | 3.0043 | 8.0207 | 22 | 242 | protein-DNA complex subunit organization |
GO:0060964 | 1e-04 | 4.0972 | 3.2812 | 12 | 99 | regulation of gene silencing by miRNA |
GO:0045815 | 2e-04 | 4.3563 | 2.5852 | 10 | 78 | positive regulation of gene expression, epigenetic |
GO:0006664 | 3e-04 | 3.6346 | 3.6458 | 12 | 110 | glycolipid metabolic process |
GO:1902036 | 5e-04 | 3.6634 | 3.3143 | 11 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0008542 | 6e-04 | 5.5824 | 1.4583 | 7 | 44 | visual learning |
GO:0060968 | 7e-04 | 3.2653 | 4.0103 | 12 | 121 | regulation of gene silencing |
GO:0006334 | 9e-04 | 3.6335 | 3.0276 | 10 | 93 | nucleosome assembly |
GO:0006959 | 0.0011 | 2.6697 | 6.0321 | 15 | 182 | humoral immune response |
GO:0001575 | 0.0011 | Inf | 0.0663 | 2 | 2 | globoside metabolic process |
GO:0002337 | 0.0011 | Inf | 0.0663 | 2 | 2 | B-1a B cell differentiation |
GO:0031444 | 0.0011 | Inf | 0.0663 | 2 | 2 | slow-twitch skeletal muscle fiber contraction |
GO:0036215 | 0.0011 | Inf | 0.0663 | 2 | 2 | response to stem cell factor |
GO:0038109 | 0.0011 | Inf | 0.0663 | 2 | 2 | Kit signaling pathway |
GO:0044657 | 0.0011 | Inf | 0.0663 | 2 | 2 | pore formation in membrane of other organism during symbiotic interaction |
GO:0052043 | 0.0011 | Inf | 0.0663 | 2 | 2 | modification by symbiont of host cellular component |
GO:0052185 | 0.0011 | Inf | 0.0663 | 2 | 2 | modification of structure of other organism involved in symbiotic interaction |
GO:0052332 | 0.0011 | Inf | 0.0663 | 2 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
GO:0098609 | 0.0011 | 1.7612 | 24.0621 | 40 | 726 | cell-cell adhesion |
GO:0072148 | 0.0012 | 10.6845 | 0.4972 | 4 | 15 | epithelial cell fate commitment |
GO:0050830 | 0.0013 | 3.7467 | 2.6515 | 9 | 80 | defense response to Gram-positive bacterium |
GO:1903706 | 0.0016 | 1.9907 | 13.8208 | 26 | 417 | regulation of hemopoiesis |
GO:0002890 | 0.0018 | 17.6016 | 0.2651 | 3 | 8 | negative regulation of immunoglobulin mediated immune response |
GO:0009414 | 0.0018 | 17.6016 | 0.2651 | 3 | 8 | response to water deprivation |
GO:0051259 | 0.0019 | 1.8859 | 16.2403 | 29 | 490 | protein oligomerization |
GO:0032200 | 0.002 | 2.7147 | 5.1372 | 13 | 155 | telomere organization |
GO:0090331 | 0.0026 | 14.667 | 0.2983 | 3 | 9 | negative regulation of platelet aggregation |
GO:0042330 | 0.0027 | 1.8164 | 17.4003 | 30 | 525 | taxis |
GO:0050771 | 0.0028 | 4.7754 | 1.4252 | 6 | 43 | negative regulation of axonogenesis |
GO:0007612 | 0.0031 | 2.8301 | 4.1761 | 11 | 126 | learning |
GO:0003010 | 0.0032 | 58.5714 | 0.0994 | 2 | 3 | voluntary skeletal muscle contraction |
GO:0110023 | 0.0032 | 58.5714 | 0.0994 | 2 | 3 | negative regulation of cardiac muscle myoblast proliferation |
GO:0048863 | 0.0034 | 2.216 | 8.1201 | 17 | 245 | stem cell differentiation |
GO:0000381 | 0.0038 | 5.4461 | 1.0606 | 5 | 32 | regulation of alternative mRNA splicing, via spliceosome |
GO:0043586 | 0.0038 | 7.3431 | 0.6629 | 4 | 20 | tongue development |
GO:0051968 | 0.0038 | 7.3431 | 0.6629 | 4 | 20 | positive regulation of synaptic transmission, glutamatergic |
GO:0032048 | 0.0049 | 10.9988 | 0.3646 | 3 | 11 | cardiolipin metabolic process |
GO:0042118 | 0.0049 | 10.9988 | 0.3646 | 3 | 11 | endothelial cell activation |
GO:0051580 | 0.0049 | 10.9988 | 0.3646 | 3 | 11 | regulation of neurotransmitter uptake |
GO:0097485 | 0.005 | 2.247 | 7.0595 | 15 | 213 | neuron projection guidance |
GO:0010517 | 0.0059 | 4.0137 | 1.6572 | 6 | 50 | regulation of phospholipase activity |
GO:0042760 | 0.0063 | 29.2837 | 0.1326 | 2 | 4 | very long-chain fatty acid catabolic process |
GO:0051142 | 0.0063 | 29.2837 | 0.1326 | 2 | 4 | positive regulation of NK T cell proliferation |
GO:0072592 | 0.0063 | 29.2837 | 0.1326 | 2 | 4 | oxygen metabolic process |
GO:0045086 | 0.0064 | 9.776 | 0.3977 | 3 | 12 | positive regulation of interleukin-2 biosynthetic process |
GO:0034110 | 0.0064 | 6.1824 | 0.7623 | 4 | 23 | regulation of homotypic cell-cell adhesion |
GO:0042832 | 0.0064 | 6.1824 | 0.7623 | 4 | 23 | defense response to protozoan |
GO:0002244 | 0.008 | 2.2633 | 6.0652 | 13 | 183 | hematopoietic progenitor cell differentiation |
GO:0030099 | 0.0084 | 1.8532 | 11.8653 | 21 | 358 | myeloid cell differentiation |
GO:0022610 | 0.0094 | 1.4389 | 40.7995 | 56 | 1231 | biological adhesion |
GO:0006665 | 0.0098 | 2.3897 | 4.8721 | 11 | 147 | sphingolipid metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 99.808 | 1.0762 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 58.2016 | 1.2498 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 40.4813 | 1.4928 | 25 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 133.2532 | 0.5902 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045814 | 0 | 10.1034 | 4.0617 | 30 | 117 | negative regulation of gene expression, epigenetic |
GO:0045815 | 0 | 12.8968 | 2.7078 | 24 | 78 | positive regulation of gene expression, epigenetic |
GO:0048863 | 0 | 5.6029 | 8.5053 | 39 | 245 | stem cell differentiation |
GO:0060964 | 0 | 9.8093 | 3.4368 | 25 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 9.1498 | 3.4715 | 24 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 7.55 | 4.2006 | 25 | 121 | regulation of gene silencing |
GO:0031497 | 0 | 6.4462 | 4.9643 | 26 | 143 | chromatin assembly |
GO:0099537 | 0 | 3.2037 | 19.3712 | 54 | 558 | trans-synaptic signaling |
GO:0034080 | 0 | 15.3514 | 1.3886 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:1904837 | 0 | 14.2529 | 1.458 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0032200 | 0 | 5.5625 | 5.3809 | 25 | 155 | telomere organization |
GO:0007268 | 0 | 3.1583 | 16.9265 | 47 | 492 | chemical synaptic transmission |
GO:0016233 | 0 | 11.0796 | 1.7358 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 11.0796 | 1.7358 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0002244 | 0 | 4.7907 | 6.3529 | 26 | 183 | hematopoietic progenitor cell differentiation |
GO:0030099 | 0 | 3.3705 | 12.4281 | 37 | 358 | myeloid cell differentiation |
GO:0007389 | 0 | 3.0058 | 13.7473 | 37 | 396 | pattern specification process |
GO:0006303 | 0 | 7.6621 | 2.2912 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0045892 | 0 | 2.1574 | 36.1387 | 70 | 1041 | negative regulation of transcription, DNA-templated |
GO:0035194 | 0 | 3.4964 | 9.3384 | 29 | 269 | posttranscriptional gene silencing by RNA |
GO:0065004 | 0 | 3.8728 | 7.3249 | 25 | 211 | protein-DNA complex assembly |
GO:0007218 | 0 | 6.0049 | 3.1938 | 16 | 92 | neuropeptide signaling pathway |
GO:1902679 | 0 | 2.1181 | 37.2843 | 71 | 1074 | negative regulation of RNA biosynthetic process |
GO:0048731 | 0 | 1.9241 | 59.4932 | 99 | 1881 | system development |
GO:0043044 | 0 | 6.7498 | 2.5342 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0038111 | 0 | 10.8809 | 1.2498 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 10.8809 | 1.2498 | 10 | 36 | response to interleukin-7 |
GO:0045934 | 0 | 1.9635 | 44.644 | 79 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0003008 | 0 | 1.9597 | 44.8808 | 79 | 1326 | system process |
GO:0007267 | 0 | 2.0612 | 35.419 | 66 | 1054 | cell-cell signaling |
GO:0071103 | 0 | 3.2682 | 8.8524 | 26 | 255 | DNA conformation change |
GO:0051259 | 0 | 2.516 | 17.0105 | 39 | 490 | protein oligomerization |
GO:0045652 | 0 | 7.4419 | 1.8271 | 11 | 54 | regulation of megakaryocyte differentiation |
GO:1903707 | 0 | 4.4065 | 4.4089 | 17 | 127 | negative regulation of hemopoiesis |
GO:0017148 | 0 | 2.7723 | 12.2893 | 31 | 354 | negative regulation of translation |
GO:0048534 | 0 | 2.1039 | 28.05 | 54 | 808 | hematopoietic or lymphoid organ development |
GO:2000026 | 0 | 1.7469 | 59.4675 | 94 | 1713 | regulation of multicellular organismal development |
GO:0045596 | 0 | 2.1829 | 20.864 | 42 | 601 | negative regulation of cell differentiation |
GO:0007187 | 0 | 3.5135 | 5.6933 | 18 | 164 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0042391 | 0 | 2.6711 | 11.0149 | 27 | 320 | regulation of membrane potential |
GO:0050896 | 0 | 1.4426 | 266.649 | 313 | 7681 | response to stimulus |
GO:0007610 | 0 | 2.5342 | 11.9914 | 28 | 350 | behavior |
GO:0045944 | 0 | 1.8382 | 35.3056 | 60 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0023061 | 0 | 2.4099 | 13.4696 | 30 | 388 | signal release |
GO:0009890 | 0 | 1.667 | 54.156 | 83 | 1560 | negative regulation of biosynthetic process |
GO:0032501 | 1e-04 | 1.5487 | 105.5897 | 140 | 3521 | multicellular organismal process |
GO:0021761 | 1e-04 | 4.2443 | 3.1938 | 12 | 92 | limbic system development |
GO:0032502 | 1e-04 | 1.7163 | 45.3106 | 70 | 1464 | developmental process |
GO:0009893 | 1e-04 | 1.4747 | 103.3825 | 138 | 2978 | positive regulation of metabolic process |
GO:0060173 | 1e-04 | 3.1546 | 5.5545 | 16 | 160 | limb development |
GO:0007215 | 2e-04 | 4.6267 | 2.4648 | 10 | 71 | glutamate receptor signaling pathway |
GO:0009952 | 2e-04 | 2.9021 | 6.3652 | 17 | 184 | anterior/posterior pattern specification |
GO:0007416 | 2e-04 | 3.3049 | 4.6519 | 14 | 134 | synapse assembly |
GO:0007548 | 2e-04 | 2.6118 | 8.2623 | 20 | 238 | sex differentiation |
GO:0007154 | 3e-04 | 4.3335 | 2.593 | 10 | 90 | cell communication |
GO:0002682 | 3e-04 | 1.641 | 44.4704 | 68 | 1281 | regulation of immune system process |
GO:0021515 | 3e-04 | 5.3622 | 1.7358 | 8 | 50 | cell differentiation in spinal cord |
GO:0006352 | 3e-04 | 2.6228 | 7.811 | 19 | 225 | DNA-templated transcription, initiation |
GO:0019932 | 4e-04 | 2.4608 | 9.1649 | 21 | 264 | second-messenger-mediated signaling |
GO:0003161 | 4e-04 | 16.0022 | 0.3819 | 4 | 11 | cardiac conduction system development |
GO:0060379 | 4e-04 | 16.0022 | 0.3819 | 4 | 11 | cardiac muscle cell myoblast differentiation |
GO:0050890 | 4e-04 | 2.4955 | 8.6094 | 20 | 248 | cognition |
GO:0007612 | 4e-04 | 3.2542 | 4.3741 | 13 | 126 | learning |
GO:0065007 | 5e-04 | 1.4605 | 228.3573 | 259 | 7441 | biological regulation |
GO:0048167 | 5e-04 | 3.0486 | 4.999 | 14 | 144 | regulation of synaptic plasticity |
GO:0009914 | 5e-04 | 2.347 | 10.0328 | 22 | 289 | hormone transport |
GO:0030539 | 5e-04 | 9.3473 | 0.6943 | 5 | 20 | male genitalia development |
GO:0021517 | 5e-04 | 5.6222 | 1.458 | 7 | 42 | ventral spinal cord development |
GO:0060537 | 6e-04 | 2.1884 | 12.1851 | 25 | 351 | muscle tissue development |
GO:0048869 | 6e-04 | 1.3913 | 121.2217 | 153 | 3572 | cellular developmental process |
GO:0065008 | 6e-04 | 1.4373 | 89.5729 | 118 | 2711 | regulation of biological quality |
GO:0060485 | 7e-04 | 2.5297 | 7.6374 | 18 | 220 | mesenchyme development |
GO:0034728 | 7e-04 | 3.4589 | 3.4927 | 11 | 103 | nucleosome organization |
GO:0060430 | 8e-04 | 27.9583 | 0.2083 | 3 | 6 | lung saccule development |
GO:0086073 | 8e-04 | 27.9583 | 0.2083 | 3 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0060080 | 8e-04 | 12.4444 | 0.4513 | 4 | 13 | inhibitory postsynaptic potential |
GO:0045844 | 8e-04 | 4.0236 | 2.4995 | 9 | 72 | positive regulation of striated muscle tissue development |
GO:0003156 | 8e-04 | 6.2383 | 1.1456 | 6 | 33 | regulation of animal organ formation |
GO:1903508 | 9e-04 | 1.5668 | 45.5813 | 67 | 1313 | positive regulation of nucleic acid-templated transcription |
GO:0035107 | 9e-04 | 2.9876 | 4.7213 | 13 | 136 | appendage morphogenesis |
GO:0007165 | 9e-04 | 1.3327 | 181.6657 | 216 | 5233 | signal transduction |
GO:0023052 | 9e-04 | 4.3777 | 2.0456 | 8 | 71 | signaling |
GO:0001964 | 0.001 | 7.7878 | 0.7985 | 5 | 23 | startle response |
GO:2000463 | 0.001 | 7.7878 | 0.7985 | 5 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0007269 | 0.0011 | 3.0804 | 4.2353 | 12 | 122 | neurotransmitter secretion |
GO:0003218 | 0.0012 | Inf | 0.0694 | 2 | 2 | cardiac left ventricle formation |
GO:0007493 | 0.0012 | Inf | 0.0694 | 2 | 2 | endodermal cell fate determination |
GO:0070352 | 0.0012 | Inf | 0.0694 | 2 | 2 | positive regulation of white fat cell proliferation |
GO:2000043 | 0.0012 | Inf | 0.0694 | 2 | 2 | regulation of cardiac cell fate specification |
GO:0021953 | 0.0012 | 2.7495 | 5.485 | 14 | 158 | central nervous system neuron differentiation |
GO:0051890 | 0.0013 | 20.9673 | 0.243 | 3 | 7 | regulation of cardioblast differentiation |
GO:2000049 | 0.0013 | 20.9673 | 0.243 | 3 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0042136 | 0.0014 | 10.1804 | 0.5207 | 4 | 15 | neurotransmitter biosynthetic process |
GO:0098911 | 0.0014 | 10.1804 | 0.5207 | 4 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0009790 | 0.0015 | 1.6517 | 30.7578 | 48 | 886 | embryo development |
GO:0003148 | 0.0015 | 7.0081 | 0.8679 | 5 | 25 | outflow tract septum morphogenesis |
GO:0007420 | 0.0015 | 1.7884 | 21.2805 | 36 | 613 | brain development |
GO:0009611 | 0.0015 | 1.8034 | 20.5168 | 35 | 591 | response to wounding |
GO:0061448 | 0.0015 | 2.4087 | 7.5332 | 17 | 217 | connective tissue development |
GO:0003013 | 0.0017 | 1.8986 | 16.1427 | 29 | 465 | circulatory system process |
GO:0003231 | 0.0018 | 3.0713 | 3.8881 | 11 | 112 | cardiac ventricle development |
GO:0060079 | 0.0019 | 3.9114 | 2.273 | 8 | 66 | excitatory postsynaptic potential |
GO:0007193 | 0.0019 | 3.8931 | 2.2832 | 8 | 66 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0015696 | 0.0019 | 3.5185 | 2.8119 | 9 | 81 | ammonium transport |
GO:0051240 | 0.0019 | 1.5061 | 47.9073 | 68 | 1380 | positive regulation of multicellular organismal process |
GO:0010628 | 0.0021 | 1.4801 | 53.2018 | 74 | 1597 | positive regulation of gene expression |
GO:0021983 | 0.0021 | 5.102 | 1.3539 | 6 | 39 | pituitary gland development |
GO:2000112 | 0.0021 | 1.3297 | 131.9879 | 161 | 3802 | regulation of cellular macromolecule biosynthetic process |
GO:0007596 | 0.0022 | 2.1072 | 10.5535 | 21 | 304 | blood coagulation |
GO:0035051 | 0.0023 | 2.7983 | 4.6171 | 12 | 133 | cardiocyte differentiation |
GO:0001501 | 0.0024 | 1.8783 | 15.7261 | 28 | 453 | skeletal system development |
GO:0072210 | 0.0024 | 4.9516 | 1.3886 | 6 | 40 | metanephric nephron development |
GO:0032102 | 0.0026 | 2.2174 | 8.6094 | 18 | 248 | negative regulation of response to external stimulus |
GO:0080090 | 0.0026 | 1.2917 | 190.9347 | 222 | 5500 | regulation of primary metabolic process |
GO:0030326 | 0.0027 | 2.8979 | 4.0964 | 11 | 118 | embryonic limb morphogenesis |
GO:0051252 | 0.0027 | 1.4152 | 69.7968 | 92 | 2093 | regulation of RNA metabolic process |
GO:0034654 | 0.0028 | 1.3158 | 134.7652 | 163 | 3882 | nucleobase-containing compound biosynthetic process |
GO:0007517 | 0.0028 | 1.9867 | 12.2198 | 23 | 352 | muscle organ development |
GO:0009954 | 0.0029 | 5.8385 | 1.0067 | 5 | 29 | proximal/distal pattern formation |
GO:0002934 | 0.003 | 13.9763 | 0.3124 | 3 | 9 | desmosome organization |
GO:0060923 | 0.003 | 13.9763 | 0.3124 | 3 | 9 | cardiac muscle cell fate commitment |
GO:0051254 | 0.0032 | 1.4758 | 48.0114 | 67 | 1383 | positive regulation of RNA metabolic process |
GO:0030879 | 0.0033 | 2.8183 | 4.2006 | 11 | 121 | mammary gland development |
GO:1903506 | 0.0033 | 1.4159 | 65.7637 | 87 | 1982 | regulation of nucleic acid-templated transcription |
GO:0021536 | 0.0033 | 5.6566 | 1.0323 | 5 | 30 | diencephalon development |
GO:0048646 | 0.0034 | 1.5751 | 32.0912 | 48 | 929 | anatomical structure formation involved in morphogenesis |
GO:0035282 | 0.0034 | 3.2052 | 3.055 | 9 | 88 | segmentation |
GO:0001560 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | regulation of cell growth by extracellular stimulus |
GO:0003166 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | bundle of His development |
GO:0021524 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | visceral motor neuron differentiation |
GO:0030538 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | embryonic genitalia morphogenesis |
GO:0035880 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0045213 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | neurotransmitter receptor metabolic process |
GO:0060913 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | cardiac cell fate determination |
GO:0061364 | 0.0035 | 55.8182 | 0.1041 | 2 | 3 | apoptotic process involved in luteolysis |
GO:0007600 | 0.0036 | 1.621 | 27.2539 | 42 | 790 | sensory perception |
GO:0003206 | 0.0036 | 2.9483 | 3.6616 | 10 | 106 | cardiac chamber morphogenesis |
GO:0098900 | 0.0039 | 4.4292 | 1.5275 | 6 | 44 | regulation of action potential |
GO:0060415 | 0.004 | 3.4067 | 2.5689 | 8 | 74 | muscle tissue morphogenesis |
GO:0060996 | 0.004 | 3.4067 | 2.5689 | 8 | 74 | dendritic spine development |
GO:0042472 | 0.0043 | 3.0873 | 3.1591 | 9 | 91 | inner ear morphogenesis |
GO:0050794 | 0.0043 | 1.3924 | 108.3561 | 130 | 3757 | regulation of cellular process |
GO:0001502 | 0.0045 | 6.9967 | 0.6943 | 4 | 20 | cartilage condensation |
GO:0002861 | 0.0045 | 6.9967 | 0.6943 | 4 | 20 | regulation of inflammatory response to antigenic stimulus |
GO:0050951 | 0.0045 | 6.9967 | 0.6943 | 4 | 20 | sensory perception of temperature stimulus |
GO:0060039 | 0.0045 | 6.9967 | 0.6943 | 4 | 20 | pericardium development |
GO:0043269 | 0.0046 | 1.7124 | 19.6142 | 32 | 565 | regulation of ion transport |
GO:0019933 | 0.0046 | 3.0499 | 3.1938 | 9 | 92 | cAMP-mediated signaling |
GO:0007399 | 0.0048 | 1.6954 | 20.4854 | 33 | 618 | nervous system development |
GO:0034248 | 0.0048 | 1.7058 | 19.6836 | 32 | 567 | regulation of cellular amide metabolic process |
GO:0055010 | 0.0049 | 4.2072 | 1.5969 | 6 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0009887 | 0.005 | 1.662 | 22.1044 | 35 | 650 | animal organ morphogenesis |
GO:0042127 | 0.005 | 1.4349 | 50.7192 | 69 | 1461 | regulation of cell proliferation |
GO:0006935 | 0.0053 | 1.7263 | 18.2256 | 30 | 525 | chemotaxis |
GO:0003279 | 0.0053 | 2.9777 | 3.2632 | 9 | 94 | cardiac septum development |
GO:0045956 | 0.0054 | 6.5847 | 0.729 | 4 | 21 | positive regulation of calcium ion-dependent exocytosis |
GO:0097120 | 0.0054 | 6.5847 | 0.729 | 4 | 21 | receptor localization to synapse |
GO:0030800 | 0.0055 | 4.1043 | 1.6316 | 6 | 47 | negative regulation of cyclic nucleotide metabolic process |
GO:0048562 | 0.0055 | 2.0534 | 9.2358 | 18 | 267 | embryonic organ morphogenesis |
GO:0003207 | 0.0056 | 10.4808 | 0.3819 | 3 | 11 | cardiac chamber formation |
GO:0021521 | 0.0056 | 10.4808 | 0.3819 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0046887 | 0.0056 | 2.7592 | 3.8881 | 10 | 112 | positive regulation of hormone secretion |
GO:0043410 | 0.0056 | 1.7732 | 15.9691 | 27 | 460 | positive regulation of MAPK cascade |
GO:0090276 | 0.0057 | 2.2841 | 6.4918 | 14 | 187 | regulation of peptide hormone secretion |
GO:0002673 | 0.006 | 3.1657 | 2.7425 | 8 | 79 | regulation of acute inflammatory response |
GO:0007589 | 0.006 | 3.1657 | 2.7425 | 8 | 79 | body fluid secretion |
GO:0034220 | 0.0062 | 1.5185 | 33.1532 | 48 | 955 | ion transmembrane transport |
GO:0071157 | 0.0064 | 6.2184 | 0.7637 | 4 | 22 | negative regulation of cell cycle arrest |
GO:0001708 | 0.0065 | 3.1215 | 2.7772 | 8 | 80 | cell fate specification |
GO:0031644 | 0.0066 | 3.447 | 2.2218 | 7 | 64 | regulation of neurological system process |
GO:0031328 | 0.0066 | 1.394 | 57.4887 | 76 | 1656 | positive regulation of cellular biosynthetic process |
GO:0048639 | 0.0068 | 2.4154 | 5.2767 | 12 | 152 | positive regulation of developmental growth |
GO:0001755 | 0.0068 | 4.6689 | 1.215 | 5 | 35 | neural crest cell migration |
GO:0015695 | 0.0068 | 4.6689 | 1.215 | 5 | 35 | organic cation transport |
GO:0002865 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | negative regulation of acute inflammatory response to antigenic stimulus |
GO:0003257 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0007198 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0007356 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | thorax and anterior abdomen determination |
GO:0008291 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | acetylcholine metabolic process |
GO:0034287 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | detection of monosaccharide stimulus |
GO:0048880 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | sensory system development |
GO:0051414 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | response to cortisol |
GO:0051594 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | detection of glucose |
GO:0060510 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | Type II pneumocyte differentiation |
GO:0070253 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | somatostatin secretion |
GO:0072268 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | pattern specification involved in metanephros development |
GO:0090027 | 0.0069 | 27.9072 | 0.1389 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:0035725 | 0.007 | 2.5182 | 4.6519 | 11 | 134 | sodium ion transmembrane transport |
GO:0050805 | 0.0071 | 3.3874 | 2.2565 | 7 | 65 | negative regulation of synaptic transmission |
GO:0030073 | 0.0072 | 2.2192 | 6.6654 | 14 | 192 | insulin secretion |
GO:0032736 | 0.0072 | 9.3156 | 0.4166 | 3 | 12 | positive regulation of interleukin-13 production |
GO:0010557 | 0.0074 | 1.4013 | 53.3229 | 71 | 1536 | positive regulation of macromolecule biosynthetic process |
GO:0060914 | 0.0075 | 5.8907 | 0.7985 | 4 | 23 | heart formation |
GO:0032941 | 0.0077 | 4.518 | 1.2498 | 5 | 36 | secretion by tissue |
GO:0035136 | 0.0077 | 4.518 | 1.2498 | 5 | 36 | forelimb morphogenesis |
GO:1900543 | 0.0078 | 3.3297 | 2.2912 | 7 | 66 | negative regulation of purine nucleotide metabolic process |
GO:0022008 | 0.0082 | 1.4172 | 47.4212 | 64 | 1366 | neurogenesis |
GO:0048754 | 0.0082 | 2.4577 | 4.756 | 11 | 137 | branching morphogenesis of an epithelial tube |
GO:0051046 | 0.0085 | 1.5965 | 22.9122 | 35 | 660 | regulation of secretion |
GO:0021511 | 0.0088 | 5.5958 | 0.8332 | 4 | 24 | spinal cord patterning |
GO:2000727 | 0.0088 | 5.5958 | 0.8332 | 4 | 24 | positive regulation of cardiac muscle cell differentiation |
GO:1903522 | 0.0088 | 1.9933 | 8.9566 | 17 | 258 | regulation of blood circulation |
GO:0045165 | 0.0089 | 2.3238 | 5.4651 | 12 | 159 | cell fate commitment |
GO:0001763 | 0.0089 | 2.2344 | 6.1446 | 13 | 177 | morphogenesis of a branching structure |
GO:0007626 | 0.0089 | 2.2344 | 6.1446 | 13 | 177 | locomotory behavior |
GO:0035050 | 0.0091 | 3.2201 | 2.3606 | 7 | 68 | embryonic heart tube development |
GO:0008595 | 0.0092 | 8.3835 | 0.4513 | 3 | 13 | anterior/posterior axis specification, embryo |
GO:0046851 | 0.0092 | 8.3835 | 0.4513 | 3 | 13 | negative regulation of bone remodeling |
GO:0051284 | 0.0092 | 8.3835 | 0.4513 | 3 | 13 | positive regulation of sequestering of calcium ion |
GO:1901213 | 0.0092 | 8.3835 | 0.4513 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0007613 | 0.0096 | 2.691 | 3.5757 | 9 | 103 | memory |
GO:0007155 | 0.0098 | 1.4262 | 42.5958 | 58 | 1227 | cell adhesion |
GO:0051171 | 0.0099 | 1.2531 | 162.3412 | 187 | 4792 | regulation of nitrogen compound metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1901750 | 1e-04 | 31.6047 | 0.2473 | 4 | 8 | leukotriene D4 biosynthetic process |
GO:0006751 | 1e-04 | 25.2821 | 0.2782 | 4 | 9 | glutathione catabolic process |
GO:0006691 | 2e-04 | 8.2695 | 0.8966 | 6 | 29 | leukotriene metabolic process |
GO:0016338 | 2e-04 | 11.3039 | 0.5874 | 5 | 19 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO:0007214 | 3e-04 | 10.5496 | 0.6183 | 5 | 20 | gamma-aminobutyric acid signaling pathway |
GO:0060042 | 5e-04 | 5.6957 | 1.4222 | 7 | 46 | retina morphogenesis in camera-type eye |
GO:0006813 | 6e-04 | 2.6331 | 6.9253 | 17 | 224 | potassium ion transport |
GO:0055065 | 8e-04 | 1.9815 | 16.0765 | 30 | 520 | metal ion homeostasis |
GO:0099093 | 0.001 | Inf | 0.0618 | 2 | 2 | mitochondrial calcium release |
GO:0061448 | 0.0012 | 2.5476 | 6.7088 | 16 | 217 | connective tissue development |
GO:0030322 | 0.0012 | 10.5292 | 0.4947 | 4 | 16 | stabilization of membrane potential |
GO:0007204 | 0.0016 | 2.3978 | 7.5436 | 17 | 244 | positive regulation of cytosolic calcium ion concentration |
GO:0098660 | 0.0019 | 1.7467 | 22.3834 | 37 | 724 | inorganic ion transmembrane transport |
GO:0006936 | 0.0019 | 2.1749 | 9.7387 | 20 | 315 | muscle contraction |
GO:0003407 | 0.002 | 4.352 | 1.7931 | 7 | 58 | neural retina development |
GO:0007268 | 0.0023 | 1.8376 | 17.2204 | 30 | 557 | chemical synaptic transmission |
GO:0071805 | 0.0024 | 2.539 | 5.8741 | 14 | 190 | potassium ion transmembrane transport |
GO:0099537 | 0.0024 | 1.834 | 17.2513 | 30 | 558 | trans-synaptic signaling |
GO:0032890 | 0.0025 | 4.8716 | 1.3912 | 6 | 45 | regulation of organic acid transport |
GO:0050801 | 0.0027 | 1.7482 | 20.4975 | 34 | 663 | ion homeostasis |
GO:0071284 | 0.0028 | 62.9532 | 0.0927 | 2 | 3 | cellular response to lead ion |
GO:0055013 | 0.0035 | 3.8923 | 1.9786 | 7 | 64 | cardiac muscle cell development |
GO:0009109 | 0.004 | 11.8233 | 0.3401 | 3 | 11 | coenzyme catabolic process |
GO:0055017 | 0.0041 | 3.3839 | 2.5661 | 8 | 83 | cardiac muscle tissue growth |
GO:0048169 | 0.0042 | 7.0166 | 0.6802 | 4 | 22 | regulation of long-term neuronal synaptic plasticity |
GO:1990776 | 0.0042 | 7.0166 | 0.6802 | 4 | 22 | response to angiotensin |
GO:0003300 | 0.0044 | 3.3392 | 2.597 | 8 | 84 | cardiac muscle hypertrophy |
GO:0006874 | 0.0046 | 1.9678 | 11.2226 | 21 | 363 | cellular calcium ion homeostasis |
GO:0048167 | 0.0051 | 2.6305 | 4.452 | 11 | 144 | regulation of synaptic plasticity |
GO:0051967 | 0.0052 | 10.5089 | 0.371 | 3 | 12 | negative regulation of synaptic transmission, glutamatergic |
GO:0010958 | 0.0055 | 31.4745 | 0.1237 | 2 | 4 | regulation of amino acid import |
GO:0015842 | 0.0055 | 31.4745 | 0.1237 | 2 | 4 | aminergic neurotransmitter loading into synaptic vesicle |
GO:0032914 | 0.0055 | 31.4745 | 0.1237 | 2 | 4 | positive regulation of transforming growth factor beta1 production |
GO:1902261 | 0.0055 | 31.4745 | 0.1237 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:2000741 | 0.0055 | 31.4745 | 0.1237 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0051965 | 0.0057 | 4.0402 | 1.6386 | 6 | 53 | positive regulation of synapse assembly |
GO:0071604 | 0.0059 | 6.3141 | 0.742 | 4 | 24 | transforming growth factor beta production |
GO:0001658 | 0.0062 | 3.9557 | 1.6695 | 6 | 54 | branching involved in ureteric bud morphogenesis |
GO:0015893 | 0.0068 | 6.013 | 0.7729 | 4 | 25 | drug transport |
GO:0043270 | 0.0071 | 2.2194 | 6.647 | 14 | 215 | positive regulation of ion transport |
GO:0072507 | 0.0073 | 1.8496 | 12.4593 | 22 | 403 | divalent inorganic cation homeostasis |
GO:0006821 | 0.0076 | 3.0195 | 2.8443 | 8 | 92 | chloride transport |
GO:0009435 | 0.0079 | 5.7393 | 0.8038 | 4 | 26 | NAD biosynthetic process |
GO:0007200 | 0.0081 | 2.9838 | 2.8752 | 8 | 93 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0010666 | 0.0083 | 8.597 | 0.4328 | 3 | 14 | positive regulation of cardiac muscle cell apoptotic process |
GO:0008652 | 0.0084 | 3.2602 | 2.3187 | 7 | 75 | cellular amino acid biosynthetic process |
GO:0055129 | 0.009 | 20.9816 | 0.1546 | 2 | 5 | L-proline biosynthetic process |
GO:0060591 | 0.009 | 20.9816 | 0.1546 | 2 | 5 | chondroblast differentiation |
GO:1903789 | 0.009 | 20.9816 | 0.1546 | 2 | 5 | regulation of amino acid transmembrane transport |
GO:1903961 | 0.009 | 20.9816 | 0.1546 | 2 | 5 | positive regulation of anion transmembrane transport |
GO:0014743 | 0.0095 | 3.5813 | 1.8241 | 6 | 59 | regulation of muscle hypertrophy |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 100.1445 | 1.1083 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 113.6963 | 0.9543 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 41.8541 | 1.3238 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 17.6224 | 2.4013 | 27 | 78 | positive regulation of gene expression, epigenetic |
GO:0045653 | 0 | 151.4006 | 0.5234 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0060964 | 0 | 12.4647 | 3.0478 | 27 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 12.2931 | 3.0785 | 27 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0045814 | 0 | 10.4689 | 3.6019 | 28 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 9.5332 | 3.725 | 27 | 121 | regulation of gene silencing |
GO:0031497 | 0 | 7.7136 | 4.4023 | 27 | 143 | chromatin assembly |
GO:0002244 | 0 | 6.2527 | 5.6337 | 29 | 183 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 6.6584 | 4.7717 | 26 | 155 | telomere organization |
GO:0034080 | 0 | 17.4421 | 1.2314 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0065004 | 0 | 5.2806 | 6.4957 | 29 | 211 | protein-DNA complex assembly |
GO:1904837 | 0 | 16.1941 | 1.293 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0038111 | 0 | 18.2725 | 1.1083 | 13 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 18.2725 | 1.1083 | 13 | 36 | response to interleukin-7 |
GO:0048863 | 0 | 4.8121 | 7.5424 | 31 | 245 | stem cell differentiation |
GO:0030099 | 0 | 3.9795 | 11.0212 | 38 | 358 | myeloid cell differentiation |
GO:0016233 | 0 | 12.5886 | 1.5393 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 12.5886 | 1.5393 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0050906 | 0 | 3.5185 | 12.622 | 39 | 410 | detection of stimulus involved in sensory perception |
GO:0050911 | 0 | 3.8737 | 10.036 | 34 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051259 | 0 | 3.2328 | 15.0848 | 43 | 490 | protein oligomerization |
GO:0035194 | 0 | 3.9886 | 8.2813 | 29 | 269 | posttranscriptional gene silencing by RNA |
GO:0045652 | 0 | 10.5593 | 1.6147 | 13 | 54 | regulation of megakaryocyte differentiation |
GO:0007606 | 0 | 3.2332 | 12.8683 | 37 | 418 | sensory perception of chemical stimulus |
GO:0009593 | 0 | 3.2798 | 12.3449 | 36 | 401 | detection of chemical stimulus |
GO:0050877 | 0 | 2.2865 | 34.5412 | 70 | 1122 | nervous system process |
GO:0006303 | 0 | 8.7057 | 2.0318 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0071103 | 0 | 3.8945 | 7.8503 | 27 | 255 | DNA conformation change |
GO:0043044 | 0 | 7.6692 | 2.2473 | 14 | 73 | ATP-dependent chromatin remodeling |
GO:0051239 | 0 | 1.8197 | 79.4878 | 125 | 2582 | regulation of multicellular organismal process |
GO:0032501 | 0 | 1.8015 | 107.957 | 154 | 3970 | multicellular organismal process |
GO:1903707 | 0 | 5.0106 | 3.9097 | 17 | 127 | negative regulation of hemopoiesis |
GO:0017148 | 0 | 3.0457 | 10.898 | 30 | 354 | negative regulation of translation |
GO:0045596 | 0 | 2.3606 | 18.502 | 40 | 601 | negative regulation of cell differentiation |
GO:0007186 | 0 | 1.9932 | 31.8714 | 58 | 1056 | G-protein coupled receptor signaling pathway |
GO:0048731 | 0 | 1.551 | 128.8367 | 172 | 4185 | system development |
GO:0048869 | 0 | 1.5449 | 117.323 | 158 | 3811 | cellular developmental process |
GO:0034728 | 0 | 4.7836 | 3.0865 | 13 | 103 | nucleosome organization |
GO:0007218 | 0 | 4.82 | 2.8323 | 12 | 92 | neuropeptide signaling pathway |
GO:0006352 | 2e-04 | 2.8068 | 6.9267 | 18 | 225 | DNA-templated transcription, initiation |
GO:0071804 | 3e-04 | 2.9618 | 5.8492 | 16 | 190 | cellular potassium ion transport |
GO:0034248 | 4e-04 | 2.017 | 17.4553 | 33 | 567 | regulation of cellular amide metabolic process |
GO:0048534 | 6e-04 | 1.7975 | 24.8746 | 42 | 808 | hematopoietic or lymphoid organ development |
GO:0045892 | 7e-04 | 1.6975 | 32.0476 | 51 | 1041 | negative regulation of transcription, DNA-templated |
GO:0023052 | 7e-04 | 1.3614 | 175.1379 | 209 | 5689 | signaling |
GO:0045595 | 7e-04 | 1.7399 | 28.2347 | 46 | 963 | regulation of cell differentiation |
GO:1902679 | 8e-04 | 1.6767 | 33.0635 | 52 | 1074 | negative regulation of RNA biosynthetic process |
GO:0070271 | 8e-04 | 1.6121 | 40.452 | 61 | 1314 | protein complex biogenesis |
GO:0007154 | 8e-04 | 1.354 | 175.7228 | 209 | 5708 | cell communication |
GO:0010107 | 9e-04 | 7.9446 | 0.7696 | 5 | 25 | potassium ion import |
GO:0065007 | 0.0011 | 1.3962 | 326.9097 | 357 | 10619 | biological regulation |
GO:0001714 | 0.0021 | 15.8362 | 0.2771 | 3 | 9 | endodermal cell fate specification |
GO:0060249 | 0.0024 | 2.0892 | 10.6209 | 21 | 345 | anatomical structure homeostasis |
GO:0051716 | 0.0024 | 1.3089 | 197.6728 | 228 | 6421 | cellular response to stimulus |
GO:0006687 | 0.0026 | 4.1277 | 1.8779 | 7 | 61 | glycosphingolipid metabolic process |
GO:0035106 | 0.0028 | 63.2308 | 0.0924 | 2 | 3 | operant conditioning |
GO:0007596 | 0.0028 | 2.1452 | 9.3587 | 19 | 304 | blood coagulation |
GO:0042359 | 0.0029 | 7.9297 | 0.6157 | 4 | 20 | vitamin D metabolic process |
GO:0015672 | 0.0041 | 1.8416 | 14.8385 | 26 | 482 | monovalent inorganic cation transport |
GO:0045934 | 0.0051 | 1.492 | 39.59 | 56 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0042659 | 0.0052 | 10.5553 | 0.3694 | 3 | 12 | regulation of cell fate specification |
GO:0034765 | 0.0054 | 1.9042 | 12.1294 | 22 | 394 | regulation of ion transmembrane transport |
GO:0015803 | 0.0054 | 31.6132 | 0.1231 | 2 | 4 | branched-chain amino acid transport |
GO:1901842 | 0.0054 | 31.6132 | 0.1231 | 2 | 4 | negative regulation of high voltage-gated calcium channel activity |
GO:1902261 | 0.0054 | 31.6132 | 0.1231 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:2000741 | 0.0054 | 31.6132 | 0.1231 | 2 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0071822 | 0.0056 | 1.4452 | 47.5326 | 65 | 1544 | protein complex subunit organization |
GO:0030001 | 0.0057 | 1.6232 | 23.9202 | 37 | 777 | metal ion transport |
GO:0061337 | 0.0062 | 2.7043 | 3.9405 | 10 | 128 | cardiac conduction |
GO:1903706 | 0.0066 | 2.0587 | 8.677 | 17 | 290 | regulation of hemopoiesis |
GO:0022008 | 0.0074 | 1.4518 | 42.0528 | 58 | 1366 | neurogenesis |
GO:0007268 | 0.0077 | 1.7086 | 17.1474 | 28 | 557 | chemical synaptic transmission |
GO:0002828 | 0.0077 | 5.7647 | 0.8004 | 4 | 26 | regulation of type 2 immune response |
GO:0099537 | 0.0078 | 1.7053 | 17.1782 | 28 | 558 | trans-synaptic signaling |
GO:0098662 | 0.0088 | 1.6423 | 19.7334 | 31 | 641 | inorganic cation transmembrane transport |
GO:0019800 | 0.0089 | 21.0741 | 0.1539 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0060591 | 0.0089 | 21.0741 | 0.1539 | 2 | 5 | chondroblast differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 6.4351 | 3.6722 | 20 | 146 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0031424 | 0 | 4.45 | 5.3323 | 21 | 212 | keratinization |
GO:0009913 | 0 | 3.2407 | 8.1493 | 24 | 324 | epidermal cell differentiation |
GO:0098609 | 0 | 2.4064 | 18.2606 | 40 | 726 | cell-cell adhesion |
GO:0045087 | 0 | 2.2561 | 18.846 | 39 | 753 | innate immune response |
GO:0001787 | 1e-04 | 22.3699 | 0.2767 | 4 | 11 | natural killer cell proliferation |
GO:0043588 | 1e-04 | 2.5557 | 9.6836 | 23 | 385 | skin development |
GO:0035609 | 2e-04 | 58.5866 | 0.1258 | 3 | 5 | C-terminal protein deglutamylation |
GO:0002407 | 2e-04 | 11.5366 | 0.5534 | 5 | 22 | dendritic cell chemotaxis |
GO:1902715 | 5e-04 | 29.2894 | 0.1761 | 3 | 7 | positive regulation of interferon-gamma secretion |
GO:0050900 | 6e-04 | 2.3607 | 9.4824 | 21 | 377 | leukocyte migration |
GO:2000458 | 6e-04 | Inf | 0.0503 | 2 | 2 | regulation of astrocyte chemotaxis |
GO:0050829 | 9e-04 | 5.0315 | 1.5518 | 7 | 62 | defense response to Gram-negative bacterium |
GO:0002374 | 0.0011 | 10.4337 | 0.4779 | 4 | 19 | cytokine secretion involved in immune response |
GO:0002376 | 0.0013 | 1.7573 | 24.4062 | 40 | 1032 | immune system process |
GO:0031640 | 0.0014 | 5.478 | 1.2325 | 6 | 49 | killing of cells of other organism |
GO:0002440 | 0.0015 | 3.1281 | 3.7728 | 11 | 150 | production of molecular mediator of immune response |
GO:0050710 | 0.0017 | 5.2339 | 1.2828 | 6 | 51 | negative regulation of cytokine secretion |
GO:0043309 | 0.0019 | 77.9162 | 0.0755 | 2 | 3 | regulation of eosinophil degranulation |
GO:0060988 | 0.0019 | 77.9162 | 0.0755 | 2 | 3 | lipid tube assembly |
GO:0009617 | 0.0019 | 2.0576 | 11.8216 | 23 | 470 | response to bacterium |
GO:0032501 | 0.0021 | 1.3631 | 152.8193 | 180 | 6338 | multicellular organismal process |
GO:0002792 | 0.0023 | 3.3778 | 2.8674 | 9 | 114 | negative regulation of peptide secretion |
GO:0045577 | 0.0024 | 8.2349 | 0.5785 | 4 | 23 | regulation of B cell differentiation |
GO:0022610 | 0.0026 | 1.6136 | 30.9625 | 47 | 1231 | biological adhesion |
GO:0048856 | 0.0028 | 1.3509 | 128.8552 | 155 | 5123 | anatomical structure development |
GO:1903531 | 0.0031 | 2.8206 | 4.1501 | 11 | 165 | negative regulation of secretion by cell |
GO:0021797 | 0.0037 | 38.9555 | 0.1006 | 2 | 4 | forebrain anterior/posterior pattern specification |
GO:0044571 | 0.0037 | 38.9555 | 0.1006 | 2 | 4 | [2Fe-2S] cluster assembly |
GO:0045542 | 0.0037 | 38.9555 | 0.1006 | 2 | 4 | positive regulation of cholesterol biosynthetic process |
GO:0051790 | 0.0037 | 38.9555 | 0.1006 | 2 | 4 | short-chain fatty acid biosynthetic process |
GO:0061760 | 0.0037 | 38.9555 | 0.1006 | 2 | 4 | antifungal innate immune response |
GO:2001187 | 0.0037 | 38.9555 | 0.1006 | 2 | 4 | positive regulation of CD8-positive, alpha-beta T cell activation |
GO:0098542 | 0.0037 | 2.0472 | 10.2873 | 20 | 409 | defense response to other organism |
GO:0050911 | 0.0038 | 2.1848 | 8.1996 | 17 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050830 | 0.004 | 3.7669 | 2.0122 | 7 | 80 | defense response to Gram-positive bacterium |
GO:0070661 | 0.0046 | 2.3383 | 6.3132 | 14 | 251 | leukocyte proliferation |
GO:0007606 | 0.0047 | 1.9997 | 10.5137 | 20 | 418 | sensory perception of chemical stimulus |
GO:0002443 | 0.0048 | 1.7794 | 16.5502 | 28 | 658 | leukocyte mediated immunity |
GO:0099024 | 0.0048 | 5.0213 | 1.1067 | 5 | 44 | plasma membrane invagination |
GO:0006641 | 0.0049 | 3.6175 | 2.0876 | 7 | 83 | triglyceride metabolic process |
GO:0007267 | 0.005 | 1.5204 | 36.2696 | 52 | 1442 | cell-cell signaling |
GO:0009620 | 0.0052 | 4.8954 | 1.1319 | 5 | 45 | response to fungus |
GO:0006970 | 0.0053 | 4.0572 | 1.6097 | 6 | 64 | response to osmotic stress |
GO:0030502 | 0.0057 | 9.7579 | 0.3773 | 3 | 15 | negative regulation of bone mineralization |
GO:0002278 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | eosinophil activation involved in immune response |
GO:0002447 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | eosinophil mediated immunity |
GO:0032482 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | Rab protein signal transduction |
GO:0042420 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | dopamine catabolic process |
GO:0060455 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | negative regulation of gastric acid secretion |
GO:0070945 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | neutrophil mediated killing of gram-negative bacterium |
GO:1903753 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | negative regulation of p38MAPK cascade |
GO:2001199 | 0.006 | 25.9686 | 0.1258 | 2 | 5 | negative regulation of dendritic cell differentiation |
GO:0002521 | 0.0062 | 1.9444 | 10.7903 | 20 | 429 | leukocyte differentiation |
GO:0070374 | 0.0067 | 2.5223 | 4.6029 | 11 | 183 | positive regulation of ERK1 and ERK2 cascade |
GO:0002076 | 0.0069 | 9.0067 | 0.4024 | 3 | 16 | osteoblast development |
GO:0010804 | 0.0069 | 9.0067 | 0.4024 | 3 | 16 | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO:0006066 | 0.007 | 2.1514 | 7.3193 | 15 | 291 | alcohol metabolic process |
GO:0001775 | 0.0076 | 1.5406 | 29.403 | 43 | 1169 | cell activation |
GO:0006085 | 0.0083 | 8.3628 | 0.4276 | 3 | 17 | acetyl-CoA biosynthetic process |
GO:0035459 | 0.0083 | 8.3628 | 0.4276 | 3 | 17 | cargo loading into vesicle |
GO:0035743 | 0.0083 | 8.3628 | 0.4276 | 3 | 17 | CD4-positive, alpha-beta T cell cytokine production |
GO:0043123 | 0.0086 | 2.5573 | 4.125 | 10 | 164 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0046649 | 0.0086 | 1.7707 | 14.1859 | 24 | 564 | lymphocyte activation |
GO:0019614 | 0.0089 | 19.4751 | 0.1509 | 2 | 6 | catechol-containing compound catabolic process |
GO:0036289 | 0.0089 | 19.4751 | 0.1509 | 2 | 6 | peptidyl-serine autophosphorylation |
GO:0002682 | 0.0089 | 1.504 | 32.2201 | 46 | 1281 | regulation of immune system process |
GO:0042092 | 0.0091 | 5.3917 | 0.83 | 4 | 33 | type 2 immune response |
GO:0010818 | 0.0097 | 7.8047 | 0.4527 | 3 | 18 | T cell chemotaxis |
GO:0001959 | 0.0098 | 2.6617 | 3.5716 | 9 | 142 | regulation of cytokine-mediated signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007154 | 0 | 1.5281 | 183.9481 | 233 | 5708 | cell communication |
GO:0023052 | 0 | 1.5236 | 183.3358 | 232 | 5689 | signaling |
GO:0030155 | 0 | 2.2547 | 19.2714 | 40 | 598 | regulation of cell adhesion |
GO:1901700 | 0 | 1.7803 | 44.7947 | 73 | 1390 | response to oxygen-containing compound |
GO:0040013 | 0 | 2.8964 | 8.6689 | 23 | 269 | negative regulation of locomotion |
GO:0051271 | 0 | 2.8962 | 8.2822 | 22 | 257 | negative regulation of cellular component movement |
GO:2000145 | 0 | 2.0264 | 23.4286 | 44 | 727 | regulation of cell motility |
GO:1902622 | 0 | 8.8709 | 0.999 | 7 | 31 | regulation of neutrophil migration |
GO:0009719 | 0 | 1.7444 | 43.6023 | 70 | 1353 | response to endogenous stimulus |
GO:0022610 | 0 | 1.7767 | 39.6707 | 65 | 1231 | biological adhesion |
GO:0030308 | 1e-04 | 3.627 | 4.5761 | 15 | 142 | negative regulation of cell growth |
GO:0048732 | 1e-04 | 2.4232 | 12.4716 | 28 | 387 | gland development |
GO:0050727 | 1e-04 | 2.6546 | 9.3779 | 23 | 291 | regulation of inflammatory response |
GO:0002675 | 1e-04 | 9.588 | 0.8057 | 6 | 25 | positive regulation of acute inflammatory response |
GO:0046903 | 1e-04 | 1.6769 | 45.1169 | 70 | 1400 | secretion |
GO:0051674 | 1e-04 | 1.6924 | 42.7322 | 67 | 1326 | localization of cell |
GO:1901343 | 1e-04 | 3.9468 | 3.3838 | 12 | 105 | negative regulation of vasculature development |
GO:0010596 | 2e-04 | 5.9399 | 1.5791 | 8 | 49 | negative regulation of endothelial cell migration |
GO:0001952 | 2e-04 | 4.1486 | 2.9648 | 11 | 92 | regulation of cell-matrix adhesion |
GO:0006952 | 2e-04 | 1.6694 | 43.9245 | 68 | 1363 | defense response |
GO:0030336 | 2e-04 | 2.9268 | 6.2985 | 17 | 197 | negative regulation of cell migration |
GO:0016525 | 2e-04 | 4.0481 | 3.0293 | 11 | 94 | negative regulation of angiogenesis |
GO:0051897 | 2e-04 | 3.3253 | 4.6084 | 14 | 143 | positive regulation of protein kinase B signaling |
GO:0042345 | 3e-04 | 6.2576 | 1.3213 | 7 | 41 | regulation of NF-kappaB import into nucleus |
GO:0061061 | 3e-04 | 1.9883 | 18.788 | 35 | 583 | muscle structure development |
GO:0051716 | 4e-04 | 1.3695 | 206.9255 | 244 | 6421 | cellular response to stimulus |
GO:0030855 | 4e-04 | 1.8952 | 21.9462 | 39 | 681 | epithelial cell differentiation |
GO:2000026 | 4e-04 | 1.5627 | 55.2038 | 80 | 1713 | regulation of multicellular organismal development |
GO:0007275 | 4e-04 | 1.4897 | 82.7924 | 111 | 2726 | multicellular organism development |
GO:0032103 | 4e-04 | 2.5744 | 7.9277 | 19 | 246 | positive regulation of response to external stimulus |
GO:0071622 | 4e-04 | 5.9091 | 1.3857 | 7 | 43 | regulation of granulocyte chemotaxis |
GO:0048514 | 4e-04 | 2.0422 | 16.1776 | 31 | 502 | blood vessel morphogenesis |
GO:0009612 | 4e-04 | 2.8206 | 6.123 | 16 | 190 | response to mechanical stimulus |
GO:0007417 | 6e-04 | 1.779 | 26.3289 | 44 | 817 | central nervous system development |
GO:0007166 | 6e-04 | 1.5797 | 47.7384 | 70 | 1539 | cell surface receptor signaling pathway |
GO:0010038 | 7e-04 | 2.3166 | 9.6679 | 21 | 300 | response to metal ion |
GO:0051241 | 9e-04 | 1.7276 | 27.6873 | 45 | 878 | negative regulation of multicellular organismal process |
GO:0002687 | 9e-04 | 3.356 | 3.5771 | 11 | 111 | positive regulation of leukocyte migration |
GO:0061138 | 9e-04 | 2.8365 | 5.3174 | 14 | 165 | morphogenesis of a branching epithelium |
GO:0046638 | 9e-04 | 6.0679 | 1.1601 | 6 | 36 | positive regulation of alpha-beta T cell differentiation |
GO:0002731 | 0.001 | Inf | 0.0645 | 2 | 2 | negative regulation of dendritic cell cytokine production |
GO:0090134 | 0.001 | Inf | 0.0645 | 2 | 2 | cell migration involved in mesendoderm migration |
GO:0097498 | 0.001 | Inf | 0.0645 | 2 | 2 | endothelial tube lumen extension |
GO:0001766 | 0.0011 | 22.6549 | 0.2256 | 3 | 7 | membrane raft polarization |
GO:0021843 | 0.0011 | 22.6549 | 0.2256 | 3 | 7 | substrate-independent telencephalic tangential interneuron migration |
GO:0035385 | 0.0011 | 22.6549 | 0.2256 | 3 | 7 | Roundabout signaling pathway |
GO:0072102 | 0.0011 | 22.6549 | 0.2256 | 3 | 7 | glomerulus morphogenesis |
GO:0090023 | 0.0011 | 7.5744 | 0.8057 | 5 | 25 | positive regulation of neutrophil chemotaxis |
GO:0071310 | 0.0012 | 1.4511 | 71.2525 | 96 | 2211 | cellular response to organic substance |
GO:0051094 | 0.0012 | 1.612 | 36.2547 | 55 | 1125 | positive regulation of developmental process |
GO:0018958 | 0.0014 | 3.7018 | 2.6748 | 9 | 83 | phenol-containing compound metabolic process |
GO:0042454 | 0.0014 | 10.084 | 0.5156 | 4 | 16 | ribonucleoside catabolic process |
GO:0045410 | 0.0017 | 18.1227 | 0.2578 | 3 | 8 | positive regulation of interleukin-6 biosynthetic process |
GO:0051665 | 0.0017 | 18.1227 | 0.2578 | 3 | 8 | membrane raft localization |
GO:0043114 | 0.0018 | 6.5851 | 0.9023 | 5 | 28 | regulation of vascular permeability |
GO:0048646 | 0.0018 | 1.6419 | 30.2928 | 47 | 940 | anatomical structure formation involved in morphogenesis |
GO:0002040 | 0.0019 | 3.511 | 2.8037 | 9 | 87 | sprouting angiogenesis |
GO:0010817 | 0.002 | 1.9548 | 14.0507 | 26 | 436 | regulation of hormone levels |
GO:0002366 | 0.002 | 1.8016 | 19.3358 | 33 | 600 | leukocyte activation involved in immune response |
GO:0002274 | 0.002 | 1.8361 | 17.8212 | 31 | 553 | myeloid leukocyte activation |
GO:0030029 | 0.0021 | 1.7785 | 20.1737 | 34 | 626 | actin filament-based process |
GO:1903530 | 0.0022 | 1.7884 | 19.4647 | 33 | 604 | regulation of secretion by cell |
GO:0043434 | 0.0022 | 2.0271 | 11.9882 | 23 | 372 | response to peptide hormone |
GO:0043496 | 0.0023 | 8.6423 | 0.5801 | 4 | 18 | regulation of protein homodimerization activity |
GO:0030182 | 0.0023 | 1.5616 | 37.2859 | 55 | 1157 | neuron differentiation |
GO:0046634 | 0.0024 | 3.7406 | 2.3525 | 8 | 73 | regulation of alpha-beta T cell activation |
GO:0007566 | 0.0024 | 4.9176 | 1.3857 | 6 | 43 | embryo implantation |
GO:0034776 | 0.0024 | 15.1012 | 0.29 | 3 | 9 | response to histamine |
GO:0009653 | 0.0024 | 1.676 | 25.9302 | 41 | 842 | anatomical structure morphogenesis |
GO:0072006 | 0.0027 | 2.89 | 4.0927 | 11 | 127 | nephron development |
GO:0048545 | 0.0027 | 2.0301 | 11.4404 | 22 | 355 | response to steroid hormone |
GO:0072358 | 0.0027 | 1.7627 | 19.7225 | 33 | 612 | cardiovascular system development |
GO:0042493 | 0.0027 | 1.992 | 12.1816 | 23 | 378 | response to drug |
GO:0046849 | 0.0028 | 3.6285 | 2.417 | 8 | 75 | bone remodeling |
GO:0032956 | 0.0028 | 2.1974 | 8.6689 | 18 | 269 | regulation of actin cytoskeleton organization |
GO:0014706 | 0.003 | 2.0467 | 10.8281 | 21 | 336 | striated muscle tissue development |
GO:0014707 | 0.003 | 60.302 | 0.0967 | 2 | 3 | branchiomeric skeletal muscle development |
GO:0035803 | 0.003 | 60.302 | 0.0967 | 2 | 3 | egg coat formation |
GO:0051586 | 0.003 | 60.302 | 0.0967 | 2 | 3 | positive regulation of dopamine uptake involved in synaptic transmission |
GO:0070340 | 0.003 | 60.302 | 0.0967 | 2 | 3 | detection of bacterial lipopeptide |
GO:0006584 | 0.003 | 4.6648 | 1.4502 | 6 | 45 | catecholamine metabolic process |
GO:0048638 | 0.0031 | 2.1797 | 8.7333 | 18 | 271 | regulation of developmental growth |
GO:0007167 | 0.0032 | 1.607 | 29.5194 | 45 | 916 | enzyme linked receptor protein signaling pathway |
GO:0002863 | 0.0034 | 12.943 | 0.3223 | 3 | 10 | positive regulation of inflammatory response to antigenic stimulus |
GO:0071888 | 0.0034 | 12.943 | 0.3223 | 3 | 10 | macrophage apoptotic process |
GO:0033993 | 0.0034 | 1.8723 | 14.6245 | 26 | 464 | response to lipid |
GO:0060425 | 0.0034 | 4.5478 | 1.4824 | 6 | 46 | lung morphogenesis |
GO:0021544 | 0.0034 | 7.561 | 0.6445 | 4 | 20 | subpallium development |
GO:0046697 | 0.0034 | 7.561 | 0.6445 | 4 | 20 | decidualization |
GO:0048608 | 0.0036 | 1.947 | 12.4394 | 23 | 386 | reproductive structure development |
GO:0007610 | 0.0036 | 1.7957 | 16.9833 | 29 | 527 | behavior |
GO:0090132 | 0.0037 | 2.255 | 7.5087 | 16 | 233 | epithelium migration |
GO:0007264 | 0.0037 | 1.8569 | 14.7275 | 26 | 457 | small GTPase mediated signal transduction |
GO:0030073 | 0.0038 | 2.4018 | 6.1875 | 14 | 192 | insulin secretion |
GO:0046626 | 0.0038 | 4.4366 | 1.5146 | 6 | 47 | regulation of insulin receptor signaling pathway |
GO:0048168 | 0.0038 | 4.4366 | 1.5146 | 6 | 47 | regulation of neuronal synaptic plasticity |
GO:0050919 | 0.0038 | 5.4074 | 1.0635 | 5 | 33 | negative chemotaxis |
GO:1901658 | 0.0038 | 5.4074 | 1.0635 | 5 | 33 | glycosyl compound catabolic process |
GO:0002237 | 0.0039 | 2.0795 | 9.6357 | 19 | 299 | response to molecule of bacterial origin |
GO:0048513 | 0.004 | 1.3674 | 83.3204 | 106 | 2672 | animal organ development |
GO:0009966 | 0.004 | 1.3566 | 87.8121 | 111 | 2750 | regulation of signal transduction |
GO:0060333 | 0.0042 | 3.3753 | 2.5781 | 8 | 80 | interferon-gamma-mediated signaling pathway |
GO:0046879 | 0.0042 | 2.1117 | 8.9912 | 18 | 279 | hormone secretion |
GO:0048468 | 0.0042 | 1.4207 | 58.2653 | 78 | 1808 | cell development |
GO:0098916 | 0.0043 | 1.7556 | 17.9501 | 30 | 557 | anterograde trans-synaptic signaling |
GO:0099536 | 0.0044 | 1.7521 | 17.9823 | 30 | 558 | synaptic signaling |
GO:0045124 | 0.0044 | 5.2206 | 1.0957 | 5 | 34 | regulation of bone resorption |
GO:0048566 | 0.0044 | 5.2206 | 1.0957 | 5 | 34 | embryonic digestive tract development |
GO:0033077 | 0.0044 | 3.7267 | 2.0625 | 7 | 64 | T cell differentiation in thymus |
GO:0031175 | 0.0044 | 1.6185 | 25.9745 | 40 | 806 | neuron projection development |
GO:0015696 | 0.0045 | 3.3289 | 2.6103 | 8 | 81 | ammonium transport |
GO:0002864 | 0.0045 | 11.3244 | 0.3545 | 3 | 11 | regulation of acute inflammatory response to antigenic stimulus |
GO:0007039 | 0.0045 | 11.3244 | 0.3545 | 3 | 11 | protein catabolic process in the vacuole |
GO:0032536 | 0.0045 | 11.3244 | 0.3545 | 3 | 11 | regulation of cell projection size |
GO:0051934 | 0.0045 | 11.3244 | 0.3545 | 3 | 11 | catecholamine uptake involved in synaptic transmission |
GO:0090494 | 0.0045 | 11.3244 | 0.3545 | 3 | 11 | dopamine uptake |
GO:2000774 | 0.0045 | 11.3244 | 0.3545 | 3 | 11 | positive regulation of cellular senescence |
GO:0098609 | 0.0047 | 1.6562 | 22.8262 | 36 | 712 | cell-cell adhesion |
GO:0045165 | 0.0047 | 2.1935 | 7.7021 | 16 | 239 | cell fate commitment |
GO:0060993 | 0.0049 | 3.2837 | 2.6426 | 8 | 82 | kidney morphogenesis |
GO:0002686 | 0.005 | 5.0462 | 1.1279 | 5 | 35 | negative regulation of leukocyte migration |
GO:0051384 | 0.0051 | 2.6377 | 4.4472 | 11 | 138 | response to glucocorticoid |
GO:0022029 | 0.0052 | 4.1333 | 1.6113 | 6 | 50 | telencephalon cell migration |
GO:0042093 | 0.0052 | 4.1333 | 1.6113 | 6 | 50 | T-helper cell differentiation |
GO:0006637 | 0.0052 | 3.2397 | 2.6748 | 8 | 83 | acyl-CoA metabolic process |
GO:0043534 | 0.0052 | 3.2397 | 2.6748 | 8 | 83 | blood vessel endothelial cell migration |
GO:0050767 | 0.0053 | 1.681 | 20.5927 | 33 | 639 | regulation of neurogenesis |
GO:0051051 | 0.0053 | 1.8252 | 14.373 | 25 | 446 | negative regulation of transport |
GO:0035270 | 0.0054 | 2.7659 | 3.8672 | 10 | 120 | endocrine system development |
GO:0050776 | 0.0055 | 1.5965 | 26.2967 | 40 | 816 | regulation of immune response |
GO:0022617 | 0.0056 | 3.1968 | 2.707 | 8 | 84 | extracellular matrix disassembly |
GO:0072080 | 0.0056 | 3.1968 | 2.707 | 8 | 84 | nephron tubule development |
GO:0022603 | 0.0057 | 1.565 | 28.8426 | 43 | 895 | regulation of anatomical structure morphogenesis |
GO:0090103 | 0.0058 | 6.3658 | 0.7412 | 4 | 23 | cochlea morphogenesis |
GO:0045060 | 0.0059 | 10.0654 | 0.3867 | 3 | 12 | negative thymic T cell selection |
GO:2000319 | 0.0059 | 10.0654 | 0.3867 | 3 | 12 | regulation of T-helper 17 cell differentiation |
GO:0001666 | 0.0059 | 1.9924 | 10.0224 | 19 | 311 | response to hypoxia |
GO:0045926 | 0.0059 | 3.5038 | 2.1761 | 7 | 69 | negative regulation of growth |
GO:0021853 | 0.006 | 30.149 | 0.1289 | 2 | 4 | cerebral cortex GABAergic interneuron migration |
GO:0044571 | 0.006 | 30.149 | 0.1289 | 2 | 4 | [2Fe-2S] cluster assembly |
GO:0048382 | 0.006 | 30.149 | 0.1289 | 2 | 4 | mesendoderm development |
GO:0051582 | 0.006 | 30.149 | 0.1289 | 2 | 4 | positive regulation of neurotransmitter uptake |
GO:0060167 | 0.006 | 30.149 | 0.1289 | 2 | 4 | regulation of adenosine receptor signaling pathway |
GO:0060708 | 0.006 | 30.149 | 0.1289 | 2 | 4 | spongiotrophoblast differentiation |
GO:0090027 | 0.006 | 30.149 | 0.1289 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:1901668 | 0.006 | 30.149 | 0.1289 | 2 | 4 | regulation of superoxide dismutase activity |
GO:1902731 | 0.006 | 30.149 | 0.1289 | 2 | 4 | negative regulation of chondrocyte proliferation |
GO:1902744 | 0.006 | 30.149 | 0.1289 | 2 | 4 | negative regulation of lamellipodium organization |
GO:0002699 | 0.006 | 2.454 | 5.1884 | 12 | 161 | positive regulation of immune effector process |
GO:0060538 | 0.0061 | 2.5666 | 4.559 | 11 | 142 | skeletal muscle organ development |
GO:0060322 | 0.0062 | 1.661 | 20.8182 | 33 | 646 | head development |
GO:0002293 | 0.0063 | 3.953 | 1.6758 | 6 | 52 | alpha-beta T cell differentiation involved in immune response |
GO:0010812 | 0.0063 | 3.953 | 1.6758 | 6 | 52 | negative regulation of cell-substrate adhesion |
GO:0043370 | 0.0063 | 4.7302 | 1.1924 | 5 | 37 | regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0006790 | 0.0064 | 1.9388 | 10.8281 | 20 | 336 | sulfur compound metabolic process |
GO:0070482 | 0.0064 | 1.9388 | 10.8281 | 20 | 336 | response to oxygen levels |
GO:0051149 | 0.0064 | 2.8794 | 3.3515 | 9 | 104 | positive regulation of muscle cell differentiation |
GO:0060562 | 0.0064 | 2.0172 | 9.3779 | 18 | 291 | epithelial tube morphogenesis |
GO:0042330 | 0.0064 | 1.7336 | 16.9188 | 28 | 525 | taxis |
GO:0006836 | 0.0066 | 2.4212 | 5.2529 | 12 | 163 | neurotransmitter transport |
GO:0031344 | 0.0066 | 1.73 | 16.9511 | 28 | 526 | regulation of cell projection organization |
GO:0032102 | 0.0067 | 2.1071 | 7.9921 | 16 | 248 | negative regulation of response to external stimulus |
GO:0002691 | 0.0068 | 6.0471 | 0.7734 | 4 | 24 | regulation of cellular extravasation |
GO:0021871 | 0.0068 | 6.0471 | 0.7734 | 4 | 24 | forebrain regionalization |
GO:0072012 | 0.0068 | 6.0471 | 0.7734 | 4 | 24 | glomerulus vasculature development |
GO:0010243 | 0.0068 | 1.5722 | 26.6646 | 40 | 832 | response to organonitrogen compound |
GO:0060135 | 0.0069 | 3.8687 | 1.708 | 6 | 53 | maternal process involved in female pregnancy |
GO:0048585 | 0.007 | 1.4975 | 35.0844 | 50 | 1107 | negative regulation of response to stimulus |
GO:0035710 | 0.0072 | 3.3704 | 2.2558 | 7 | 70 | CD4-positive, alpha-beta T cell activation |
GO:0072088 | 0.0072 | 3.3704 | 2.2558 | 7 | 70 | nephron epithelium morphogenesis |
GO:0031667 | 0.0074 | 1.848 | 12.4716 | 22 | 387 | response to nutrient levels |
GO:0001819 | 0.0074 | 1.876 | 11.7304 | 21 | 364 | positive regulation of cytokine production |
GO:0070307 | 0.0075 | 9.0583 | 0.4189 | 3 | 13 | lens fiber cell development |
GO:0090051 | 0.0075 | 9.0583 | 0.4189 | 3 | 13 | negative regulation of cell migration involved in sprouting angiogenesis |
GO:0001658 | 0.0076 | 3.7878 | 1.7402 | 6 | 54 | branching involved in ureteric bud morphogenesis |
GO:0035082 | 0.0076 | 3.7878 | 1.7402 | 6 | 54 | axoneme assembly |
GO:1902105 | 0.0077 | 2.1296 | 7.4121 | 15 | 230 | regulation of leukocyte differentiation |
GO:0021884 | 0.0079 | 5.7588 | 0.8057 | 4 | 25 | forebrain neuron development |
GO:0045824 | 0.0079 | 4.4513 | 1.2568 | 5 | 39 | negative regulation of innate immune response |
GO:0071675 | 0.0079 | 4.4513 | 1.2568 | 5 | 39 | regulation of mononuclear cell migration |
GO:0035295 | 0.0082 | 1.6982 | 17.2411 | 28 | 535 | tube development |
GO:0007010 | 0.0082 | 1.4817 | 35.3846 | 50 | 1098 | cytoskeleton organization |
GO:1902041 | 0.0083 | 3.7103 | 1.7725 | 6 | 55 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0051707 | 0.0085 | 1.5874 | 23.7186 | 36 | 736 | response to other organism |
GO:0090066 | 0.0086 | 1.7947 | 13.4062 | 23 | 416 | regulation of anatomical structure size |
GO:0043066 | 0.0087 | 1.5736 | 24.5887 | 37 | 763 | negative regulation of apoptotic process |
GO:0002703 | 0.0089 | 2.4256 | 4.8017 | 11 | 149 | regulation of leukocyte mediated immunity |
GO:2000106 | 0.009 | 3.2166 | 2.3525 | 7 | 73 | regulation of leukocyte apoptotic process |
GO:0061437 | 0.0091 | 5.4966 | 0.8379 | 4 | 26 | renal system vasculature development |
GO:0003158 | 0.0091 | 2.7072 | 3.5449 | 9 | 110 | endothelium development |
GO:0043010 | 0.0092 | 1.9825 | 8.9912 | 17 | 279 | camera-type eye development |
GO:0009888 | 0.0092 | 1.3901 | 53.0514 | 70 | 1672 | tissue development |
GO:0021527 | 0.0093 | 8.2342 | 0.4512 | 3 | 14 | spinal cord association neuron differentiation |
GO:0044331 | 0.0093 | 8.2342 | 0.4512 | 3 | 14 | cell-cell adhesion mediated by cadherin |
GO:0046885 | 0.0093 | 8.2342 | 0.4512 | 3 | 14 | regulation of hormone biosynthetic process |
GO:0086069 | 0.0093 | 8.2342 | 0.4512 | 3 | 14 | bundle of His cell to Purkinje myocyte communication |
GO:1902532 | 0.0093 | 1.736 | 15.0497 | 25 | 467 | negative regulation of intracellular signal transduction |
GO:1903034 | 0.0093 | 2.408 | 4.834 | 11 | 150 | regulation of response to wounding |
GO:0002252 | 0.0096 | 1.5447 | 26.4054 | 39 | 831 | immune effector process |
GO:0008585 | 0.0096 | 2.8908 | 2.9648 | 8 | 92 | female gonad development |
GO:0097530 | 0.0097 | 2.6805 | 3.5771 | 9 | 111 | granulocyte migration |
GO:0008344 | 0.0097 | 3.1684 | 2.3848 | 7 | 74 | adult locomotory behavior |
GO:0007249 | 0.0097 | 2.0709 | 7.6054 | 15 | 236 | I-kappaB kinase/NF-kappaB signaling |
GO:0001547 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | antral ovarian follicle growth |
GO:0002885 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | positive regulation of hypersensitivity |
GO:0009438 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | methylglyoxal metabolic process |
GO:0042321 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | negative regulation of circadian sleep/wake cycle, sleep |
GO:0060426 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | lung vasculature development |
GO:0060478 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | acrosomal vesicle exocytosis |
GO:0060539 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | diaphragm development |
GO:0072104 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | glomerular capillary formation |
GO:0140052 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | cellular response to oxidised low-density lipoprotein particle stimulus |
GO:1900223 | 0.0097 | 20.098 | 0.1611 | 2 | 5 | positive regulation of amyloid-beta clearance |
GO:0042246 | 0.0098 | 3.5643 | 1.8369 | 6 | 57 | tissue regeneration |
GO:0051937 | 0.0098 | 3.5643 | 1.8369 | 6 | 57 | catecholamine transport |
GO:0002460 | 0.0098 | 2.2006 | 6.2197 | 13 | 193 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0099531 | 0.0099 | 2.5126 | 4.2217 | 10 | 131 | presynaptic process involved in chemical synaptic transmission |
GO:0030198 | 0.0099 | 2.1271 | 6.9175 | 14 | 217 | extracellular matrix organization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 3.8749 | 10.9528 | 37 | 401 | detection of chemical stimulus |
GO:0050911 | 0 | 3.9625 | 8.9043 | 31 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 3.4609 | 11.4172 | 35 | 418 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 2.6223 | 23.8093 | 55 | 918 | G-protein coupled receptor signaling pathway |
GO:0050906 | 0 | 3.4173 | 11.1987 | 34 | 410 | detection of stimulus involved in sensory perception |
GO:0007389 | 0 | 3.5098 | 8.5838 | 27 | 318 | pattern specification process |
GO:0007218 | 0 | 6.5791 | 2.5129 | 14 | 92 | neuropeptide signaling pathway |
GO:0065007 | 0 | 1.759 | 290.0454 | 333 | 10619 | biological regulation |
GO:0050794 | 0 | 1.6801 | 259.1808 | 305 | 9489 | regulation of cellular process |
GO:0009952 | 0 | 4.0101 | 5.0029 | 18 | 184 | anterior/posterior pattern specification |
GO:0007154 | 0 | 1.5174 | 155.9073 | 197 | 5708 | cell communication |
GO:0061364 | 0 | Inf | 0.0819 | 3 | 3 | apoptotic process involved in luteolysis |
GO:0042391 | 0 | 2.7299 | 9.9422 | 25 | 364 | regulation of membrane potential |
GO:0023052 | 0 | 1.5107 | 155.3883 | 196 | 5689 | signaling |
GO:0048665 | 0 | 9.7343 | 0.9014 | 7 | 33 | neuron fate specification |
GO:0007188 | 0 | 4.0596 | 3.8239 | 14 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0007631 | 0 | 5.0377 | 2.469 | 11 | 91 | feeding behavior |
GO:0060322 | 0 | 2.2058 | 17.6447 | 36 | 646 | head development |
GO:0031644 | 1e-04 | 5.9338 | 1.7481 | 9 | 64 | regulation of neurological system process |
GO:0099537 | 1e-04 | 2.2634 | 15.2411 | 32 | 558 | trans-synaptic signaling |
GO:0060219 | 1e-04 | 15.0061 | 0.4643 | 5 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0007198 | 1e-04 | 107.6014 | 0.1093 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 1e-04 | 107.6014 | 0.1093 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 1e-04 | 107.6014 | 0.1093 | 3 | 4 | detection of glucose |
GO:0046883 | 1e-04 | 3.0139 | 6.4734 | 18 | 237 | regulation of hormone secretion |
GO:0021559 | 1e-04 | 23.9613 | 0.2731 | 4 | 10 | trigeminal nerve development |
GO:0021953 | 1e-04 | 3.5478 | 4.3156 | 14 | 158 | central nervous system neuron differentiation |
GO:0021517 | 1e-04 | 7.2268 | 1.1472 | 7 | 42 | ventral spinal cord development |
GO:0009914 | 1e-04 | 2.7307 | 7.8937 | 20 | 289 | hormone transport |
GO:0030900 | 2e-04 | 2.5617 | 9.2321 | 22 | 338 | forebrain development |
GO:0050885 | 2e-04 | 6.6549 | 1.2291 | 7 | 45 | neuromuscular process controlling balance |
GO:0031960 | 2e-04 | 3.4558 | 4.0971 | 13 | 150 | response to corticosteroid |
GO:0007268 | 3e-04 | 2.1384 | 15.0098 | 30 | 552 | chemical synaptic transmission |
GO:0001501 | 3e-04 | 2.2461 | 12.3732 | 26 | 453 | skeletal system development |
GO:0008595 | 3e-04 | 15.9709 | 0.3551 | 4 | 13 | anterior/posterior axis specification, embryo |
GO:0003206 | 4e-04 | 3.7686 | 3.1957 | 11 | 117 | cardiac chamber morphogenesis |
GO:0021891 | 4e-04 | 35.8623 | 0.1639 | 3 | 6 | olfactory bulb interneuron development |
GO:0021675 | 4e-04 | 4.9884 | 1.8027 | 8 | 66 | nerve development |
GO:0023061 | 4e-04 | 2.3166 | 10.5978 | 23 | 388 | signal release |
GO:0048699 | 5e-04 | 1.7374 | 30.89 | 50 | 1149 | generation of neurons |
GO:0008306 | 5e-04 | 4.8215 | 1.8573 | 8 | 68 | associative learning |
GO:0045597 | 5e-04 | 1.8586 | 22.3973 | 39 | 820 | positive regulation of cell differentiation |
GO:0045471 | 5e-04 | 3.5652 | 3.3596 | 11 | 123 | response to ethanol |
GO:0007350 | 6e-04 | 13.0654 | 0.4097 | 4 | 15 | blastoderm segmentation |
GO:0048646 | 6e-04 | 1.7884 | 25.675 | 43 | 940 | anatomical structure formation involved in morphogenesis |
GO:0035385 | 7e-04 | 26.8949 | 0.1912 | 3 | 7 | Roundabout signaling pathway |
GO:0048704 | 7e-04 | 4.0726 | 2.4309 | 9 | 89 | embryonic skeletal system morphogenesis |
GO:0003016 | 7e-04 | 8.1796 | 0.7375 | 5 | 27 | respiratory system process |
GO:2000054 | 7e-04 | Inf | 0.0546 | 2 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
GO:0003018 | 8e-04 | 3.2057 | 4.0424 | 12 | 148 | vascular process in circulatory system |
GO:0007417 | 8e-04 | 1.9368 | 17.5774 | 32 | 659 | central nervous system development |
GO:0007611 | 9e-04 | 2.7058 | 5.9271 | 15 | 217 | learning or memory |
GO:0090190 | 0.001 | 11.0538 | 0.4643 | 4 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0008343 | 0.001 | 21.5145 | 0.2185 | 3 | 8 | adult feeding behavior |
GO:0060346 | 0.001 | 21.5145 | 0.2185 | 3 | 8 | bone trabecula formation |
GO:0009953 | 0.0011 | 3.8317 | 2.5675 | 9 | 94 | dorsal/ventral pattern formation |
GO:0048598 | 0.0011 | 1.9915 | 14.9133 | 28 | 546 | embryonic morphogenesis |
GO:0002067 | 0.0013 | 5.5441 | 1.2291 | 6 | 45 | glandular epithelial cell differentiation |
GO:0048754 | 0.0013 | 3.1661 | 3.742 | 11 | 137 | branching morphogenesis of an epithelial tube |
GO:0061061 | 0.0014 | 1.9287 | 15.924 | 29 | 583 | muscle structure development |
GO:0021562 | 0.0015 | 17.9275 | 0.2458 | 3 | 9 | vestibulocochlear nerve development |
GO:0044848 | 0.0015 | 17.9275 | 0.2458 | 3 | 9 | biological phase |
GO:0046549 | 0.0015 | 17.9275 | 0.2458 | 3 | 9 | retinal cone cell development |
GO:0007210 | 0.0015 | 9.5787 | 0.519 | 4 | 19 | serotonin receptor signaling pathway |
GO:0060688 | 0.0019 | 5.147 | 1.3111 | 6 | 48 | regulation of morphogenesis of a branching structure |
GO:0051482 | 0.0019 | 8.9794 | 0.5463 | 4 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0097746 | 0.0019 | 3.2332 | 3.3323 | 10 | 122 | regulation of blood vessel diameter |
GO:0008015 | 0.002 | 2.0141 | 12.5917 | 24 | 461 | blood circulation |
GO:0019935 | 0.002 | 3.4628 | 2.8133 | 9 | 103 | cyclic-nucleotide-mediated signaling |
GO:0007600 | 0.002 | 2.2149 | 9.0812 | 19 | 353 | sensory perception |
GO:0055025 | 0.0021 | 5.027 | 1.3384 | 6 | 49 | positive regulation of cardiac muscle tissue development |
GO:0071392 | 0.0021 | 6.2023 | 0.9287 | 5 | 34 | cellular response to estradiol stimulus |
GO:0010159 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | specification of animal organ position |
GO:0021524 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | visceral motor neuron differentiation |
GO:0021912 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0071626 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | mastication |
GO:0098583 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | learned vocalization behavior |
GO:0110023 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | negative regulation of cardiac muscle myoblast proliferation |
GO:1905747 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | negative regulation of saliva secretion |
GO:1905748 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | hard palate morphogenesis |
GO:2000312 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | regulation of kainate selective glutamate receptor activity |
GO:2000721 | 0.0022 | 71.5614 | 0.0819 | 2 | 3 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0014821 | 0.0023 | 8.4506 | 0.5736 | 4 | 21 | phasic smooth muscle contraction |
GO:2000291 | 0.0023 | 8.4506 | 0.5736 | 4 | 21 | regulation of myoblast proliferation |
GO:0006355 | 0.0023 | 1.3913 | 89.4527 | 114 | 3275 | regulation of transcription, DNA-templated |
GO:0021515 | 0.0023 | 4.9124 | 1.3657 | 6 | 50 | cell differentiation in spinal cord |
GO:0003008 | 0.0026 | 1.8721 | 15.852 | 28 | 657 | system process |
GO:0001764 | 0.0027 | 3.0675 | 3.4962 | 10 | 128 | neuron migration |
GO:0046530 | 0.0028 | 4.6982 | 1.4203 | 6 | 52 | photoreceptor cell differentiation |
GO:0060379 | 0.0028 | 13.4438 | 0.3005 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060573 | 0.0028 | 13.4438 | 0.3005 | 3 | 11 | cell fate specification involved in pattern specification |
GO:0035150 | 0.0028 | 3.0415 | 3.5235 | 10 | 129 | regulation of tube size |
GO:2001141 | 0.003 | 1.3763 | 90.1902 | 114 | 3302 | regulation of RNA biosynthetic process |
GO:0048639 | 0.0031 | 2.8264 | 4.1517 | 11 | 152 | positive regulation of developmental growth |
GO:0048869 | 0.0032 | 1.3705 | 95.0759 | 119 | 3572 | cellular developmental process |
GO:0007215 | 0.0032 | 3.9444 | 1.9393 | 7 | 71 | glutamate receptor signaling pathway |
GO:0030072 | 0.0032 | 2.4454 | 6.0634 | 14 | 223 | peptide hormone secretion |
GO:0001964 | 0.0032 | 7.5601 | 0.6282 | 4 | 23 | startle response |
GO:0010460 | 0.0032 | 7.5601 | 0.6282 | 4 | 23 | positive regulation of heart rate |
GO:0030878 | 0.0032 | 7.5601 | 0.6282 | 4 | 23 | thyroid gland development |
GO:0061217 | 0.0032 | 7.5601 | 0.6282 | 4 | 23 | regulation of mesonephros development |
GO:2000463 | 0.0032 | 7.5601 | 0.6282 | 4 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0033993 | 0.0033 | 1.6975 | 22.37 | 36 | 819 | response to lipid |
GO:0055074 | 0.0034 | 2.0629 | 10.2154 | 20 | 374 | calcium ion homeostasis |
GO:0048636 | 0.0035 | 3.8835 | 1.9666 | 7 | 72 | positive regulation of muscle organ development |
GO:1901863 | 0.0035 | 3.8835 | 1.9666 | 7 | 72 | positive regulation of muscle tissue development |
GO:0007187 | 0.0035 | 7.3704 | 0.6394 | 4 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0003231 | 0.0036 | 3.1583 | 3.0591 | 9 | 112 | cardiac ventricle development |
GO:0051480 | 0.0036 | 2.2567 | 7.484 | 16 | 274 | regulation of cytosolic calcium ion concentration |
GO:0031223 | 0.0037 | 11.9493 | 0.3278 | 3 | 12 | auditory behavior |
GO:0048666 | 0.0037 | 1.6617 | 24.1251 | 38 | 890 | neuron development |
GO:0031016 | 0.0037 | 3.8244 | 1.9939 | 7 | 73 | pancreas development |
GO:0021511 | 0.0038 | 7.1816 | 0.6555 | 4 | 24 | spinal cord patterning |
GO:0050793 | 0.0039 | 1.4262 | 60.0631 | 80 | 2199 | regulation of developmental process |
GO:0001709 | 0.004 | 5.2884 | 1.0652 | 5 | 39 | cell fate determination |
GO:0044058 | 0.004 | 5.2884 | 1.0652 | 5 | 39 | regulation of digestive system process |
GO:0060415 | 0.004 | 3.7671 | 2.0212 | 7 | 74 | muscle tissue morphogenesis |
GO:0001992 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003257 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0007356 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | thorax and anterior abdomen determination |
GO:0021615 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0021913 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0032100 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | positive regulation of appetite |
GO:0048880 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | sensory system development |
GO:0050923 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | regulation of negative chemotaxis |
GO:0051414 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | response to cortisol |
GO:0070253 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | somatostatin secretion |
GO:0071504 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | cellular response to heparin |
GO:0072289 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | metanephric nephron tubule formation |
GO:0090027 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:1901078 | 0.0043 | 35.7783 | 0.1093 | 2 | 4 | negative regulation of relaxation of muscle |
GO:0003148 | 0.0044 | 6.8392 | 0.6828 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0044 | 6.8392 | 0.6828 | 4 | 25 | type B pancreatic cell differentiation |
GO:0072503 | 0.0047 | 1.9992 | 10.5158 | 20 | 385 | cellular divalent inorganic cation homeostasis |
GO:0046851 | 0.0047 | 10.7536 | 0.3551 | 3 | 13 | negative regulation of bone remodeling |
GO:1901213 | 0.0047 | 10.7536 | 0.3551 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0051960 | 0.0047 | 1.7109 | 19.6659 | 32 | 720 | regulation of nervous system development |
GO:0035270 | 0.0048 | 3.2719 | 2.628 | 8 | 97 | endocrine system development |
GO:0050877 | 0.0048 | 2.2522 | 7.022 | 15 | 283 | nervous system process |
GO:0071385 | 0.0049 | 4.1544 | 1.5842 | 6 | 58 | cellular response to glucocorticoid stimulus |
GO:1901700 | 0.0052 | 1.5048 | 37.9662 | 54 | 1390 | response to oxygen-containing compound |
GO:0050796 | 0.0052 | 2.6199 | 4.4522 | 11 | 163 | regulation of insulin secretion |
GO:0014706 | 0.0052 | 2.0616 | 9.1774 | 18 | 336 | striated muscle tissue development |
GO:0009798 | 0.0054 | 3.5539 | 2.1305 | 7 | 78 | axis specification |
GO:0002070 | 0.0059 | 9.7754 | 0.3824 | 3 | 14 | epithelial cell maturation |
GO:0021794 | 0.0059 | 9.7754 | 0.3824 | 3 | 14 | thalamus development |
GO:0050884 | 0.0059 | 9.7754 | 0.3824 | 3 | 14 | neuromuscular process controlling posture |
GO:0090596 | 0.0059 | 2.2683 | 6.5007 | 14 | 238 | sensory organ morphogenesis |
GO:0051241 | 0.0062 | 1.5849 | 26.5483 | 40 | 981 | negative regulation of multicellular organismal process |
GO:0050795 | 0.0063 | 3.927 | 1.6661 | 6 | 61 | regulation of behavior |
GO:0048812 | 0.0064 | 1.7969 | 14.5856 | 25 | 534 | neuron projection morphogenesis |
GO:0010092 | 0.0067 | 5.9831 | 0.7648 | 4 | 28 | specification of animal organ identity |
GO:0060045 | 0.0067 | 5.9831 | 0.7648 | 4 | 28 | positive regulation of cardiac muscle cell proliferation |
GO:1905114 | 0.0068 | 1.786 | 14.6675 | 25 | 537 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0021546 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | rhombomere development |
GO:0021650 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | vestibulocochlear nerve formation |
GO:0035609 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | C-terminal protein deglutamylation |
GO:0051970 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060012 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | synaptic transmission, glycinergic |
GO:0070100 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:0071205 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0071502 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | cellular response to temperature stimulus |
GO:0090259 | 0.007 | 23.8506 | 0.1366 | 2 | 5 | regulation of retinal ganglion cell axon guidance |
GO:0031290 | 0.0071 | 9.0018 | 0.4079 | 3 | 15 | retinal ganglion cell axon guidance |
GO:0060579 | 0.0072 | 8.9601 | 0.4097 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0071380 | 0.0072 | 8.9601 | 0.4097 | 3 | 15 | cellular response to prostaglandin E stimulus |
GO:0098911 | 0.0072 | 8.9601 | 0.4097 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0060485 | 0.0076 | 2.2763 | 6.009 | 13 | 220 | mesenchyme development |
GO:0019098 | 0.0076 | 5.7433 | 0.7921 | 4 | 29 | reproductive behavior |
GO:0051716 | 0.0078 | 1.2784 | 175.382 | 200 | 6421 | cellular response to stimulus |
GO:0055010 | 0.0081 | 4.3834 | 1.2564 | 5 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0045165 | 0.0084 | 2.3343 | 5.4111 | 12 | 200 | cell fate commitment |
GO:0032102 | 0.0084 | 2.1699 | 6.7738 | 14 | 248 | negative regulation of response to external stimulus |
GO:0045986 | 0.0087 | 8.2703 | 0.437 | 3 | 16 | negative regulation of smooth muscle contraction |
GO:0060079 | 0.0088 | 3.6292 | 1.7881 | 6 | 66 | excitatory postsynaptic potential |
GO:0009887 | 0.0088 | 1.6735 | 18.146 | 29 | 680 | animal organ morphogenesis |
GO:0045661 | 0.0089 | 4.2788 | 1.2837 | 5 | 47 | regulation of myoblast differentiation |
GO:0048858 | 0.0093 | 1.7367 | 15.0499 | 25 | 551 | cell projection morphogenesis |
GO:0050768 | 0.0094 | 2.2112 | 6.1729 | 13 | 226 | negative regulation of neurogenesis |
GO:0008038 | 0.0096 | 5.3172 | 0.8467 | 4 | 31 | neuron recognition |
GO:0051930 | 0.0096 | 5.3172 | 0.8467 | 4 | 31 | regulation of sensory perception of pain |
GO:0048675 | 0.0097 | 3.1521 | 2.3763 | 7 | 87 | axon extension |
GO:0010769 | 0.0097 | 2.2007 | 6.2002 | 13 | 227 | regulation of cell morphogenesis involved in differentiation |
GO:0032870 | 0.0098 | 1.7095 | 15.8966 | 26 | 582 | cellular response to hormone stimulus |
GO:0048259 | 0.0098 | 3.5393 | 1.83 | 6 | 67 | regulation of receptor-mediated endocytosis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 94.7626 | 1.129 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 55.2594 | 1.3111 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 38.4312 | 1.566 | 25 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 126.6371 | 0.6191 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 13.021 | 2.8406 | 25 | 78 | positive regulation of gene expression, epigenetic |
GO:0031497 | 0 | 8.0325 | 5.2078 | 32 | 143 | chromatin assembly |
GO:1902036 | 0 | 9.7033 | 3.6418 | 26 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060964 | 0 | 9.3125 | 3.6054 | 25 | 99 | regulation of gene silencing by miRNA |
GO:0065004 | 0 | 5.3484 | 7.6843 | 34 | 211 | protein-DNA complex assembly |
GO:0045814 | 0 | 7.4813 | 4.261 | 25 | 117 | negative regulation of gene expression, epigenetic |
GO:0060968 | 0 | 7.1676 | 4.4066 | 25 | 121 | regulation of gene silencing |
GO:1904837 | 0 | 15.0791 | 1.5296 | 15 | 42 | beta-catenin-TCF complex assembly |
GO:0034080 | 0 | 14.5891 | 1.4567 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0071103 | 0 | 4.1181 | 9.2867 | 33 | 255 | DNA conformation change |
GO:0048863 | 0 | 4.1567 | 8.9225 | 32 | 245 | stem cell differentiation |
GO:0002244 | 0 | 4.7621 | 6.6646 | 27 | 183 | hematopoietic progenitor cell differentiation |
GO:0016233 | 0 | 10.5294 | 1.8209 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 10.5294 | 1.8209 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0032200 | 0 | 5.0209 | 5.6449 | 24 | 155 | telomere organization |
GO:0030099 | 0 | 3.2991 | 13.0378 | 38 | 358 | myeloid cell differentiation |
GO:0034728 | 0 | 5.8963 | 3.6687 | 18 | 103 | nucleosome organization |
GO:0051259 | 0 | 2.7487 | 17.845 | 44 | 490 | protein oligomerization |
GO:0043044 | 0 | 7.0047 | 2.6585 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 7.2816 | 2.4036 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:1903707 | 0 | 4.7841 | 4.6251 | 19 | 127 | negative regulation of hemopoiesis |
GO:0045652 | 0 | 7.9062 | 1.9192 | 12 | 54 | regulation of megakaryocyte differentiation |
GO:0038111 | 0 | 10.3445 | 1.3111 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 10.3445 | 1.3111 | 10 | 36 | response to interleukin-7 |
GO:0035194 | 0 | 3.184 | 9.7966 | 28 | 269 | posttranscriptional gene silencing by RNA |
GO:0051239 | 0 | 1.6403 | 94.0324 | 137 | 2582 | regulation of multicellular organismal process |
GO:0045596 | 0 | 2.3006 | 21.8875 | 46 | 601 | negative regulation of cell differentiation |
GO:0048534 | 0 | 2.0349 | 29.4261 | 55 | 808 | hematopoietic or lymphoid organ development |
GO:0017148 | 0 | 2.5326 | 12.8921 | 30 | 354 | negative regulation of translation |
GO:0030198 | 0 | 2.5752 | 10.9619 | 26 | 301 | extracellular matrix organization |
GO:0048869 | 1e-04 | 1.4483 | 138.7906 | 179 | 3811 | cellular developmental process |
GO:0035987 | 1e-04 | 6.4933 | 1.4932 | 8 | 41 | endodermal cell differentiation |
GO:0030574 | 3e-04 | 4.6383 | 2.2215 | 9 | 61 | collagen catabolic process |
GO:0002227 | 4e-04 | 10.2597 | 0.6555 | 5 | 18 | innate immune response in mucosa |
GO:0070271 | 5e-04 | 1.5862 | 47.8538 | 71 | 1314 | protein complex biogenesis |
GO:0009611 | 5e-04 | 1.8782 | 21.5233 | 38 | 591 | response to wounding |
GO:0045595 | 5e-04 | 2.5261 | 8.0921 | 19 | 238 | regulation of cell differentiation |
GO:0010812 | 5e-04 | 4.8663 | 1.8938 | 8 | 52 | negative regulation of cell-substrate adhesion |
GO:0006352 | 6e-04 | 2.4913 | 8.1941 | 19 | 225 | DNA-templated transcription, initiation |
GO:0007166 | 6e-04 | 1.4314 | 89.1757 | 118 | 2457 | cell surface receptor signaling pathway |
GO:0048731 | 7e-04 | 1.3792 | 127.0237 | 159 | 3573 | system development |
GO:0065008 | 7e-04 | 1.385 | 115.7377 | 147 | 3178 | regulation of biological quality |
GO:0007492 | 7e-04 | 4.1005 | 2.4682 | 9 | 68 | endoderm development |
GO:0060284 | 8e-04 | 1.7366 | 27.4959 | 45 | 755 | regulation of cell development |
GO:0034248 | 9e-04 | 1.8488 | 20.6492 | 36 | 567 | regulation of cellular amide metabolic process |
GO:0051960 | 0.001 | 1.7376 | 26.2213 | 43 | 720 | regulation of nervous system development |
GO:0001704 | 0.0011 | 3.0685 | 4.261 | 12 | 117 | formation of primary germ layer |
GO:0050769 | 0.0012 | 2.0307 | 13.5841 | 26 | 373 | positive regulation of neurogenesis |
GO:0051895 | 0.0013 | 10.6529 | 0.5099 | 4 | 14 | negative regulation of focal adhesion assembly |
GO:0019285 | 0.0013 | Inf | 0.0728 | 2 | 2 | glycine betaine biosynthetic process from choline |
GO:0031455 | 0.0013 | Inf | 0.0728 | 2 | 2 | glycine betaine metabolic process |
GO:1901731 | 0.0013 | Inf | 0.0728 | 2 | 2 | positive regulation of platelet aggregation |
GO:0001766 | 0.0015 | 19.9462 | 0.2549 | 3 | 7 | membrane raft polarization |
GO:0010692 | 0.0015 | 19.9462 | 0.2549 | 3 | 7 | regulation of alkaline phosphatase activity |
GO:0043652 | 0.0015 | 19.9462 | 0.2549 | 3 | 7 | engulfment of apoptotic cell |
GO:0010608 | 0.0017 | 1.7319 | 23.7812 | 39 | 653 | posttranscriptional regulation of gene expression |
GO:0071294 | 0.0017 | 9.6838 | 0.5463 | 4 | 15 | cellular response to zinc ion |
GO:2000108 | 0.0018 | 6.6656 | 0.9105 | 5 | 25 | positive regulation of leukocyte apoptotic process |
GO:0001952 | 0.0019 | 3.2674 | 3.3505 | 10 | 92 | regulation of cell-matrix adhesion |
GO:0007411 | 0.0019 | 2.3601 | 7.6843 | 17 | 211 | axon guidance |
GO:0051716 | 0.0022 | 1.2846 | 233.8427 | 267 | 6421 | cellular response to stimulus |
GO:0051665 | 0.0023 | 15.9559 | 0.2913 | 3 | 8 | membrane raft localization |
GO:1905039 | 0.0024 | 3.1515 | 3.4597 | 10 | 95 | carboxylic acid transmembrane transport |
GO:0014013 | 0.0026 | 3.1146 | 3.4962 | 10 | 96 | regulation of gliogenesis |
GO:0045664 | 0.0028 | 1.7761 | 18.974 | 32 | 521 | regulation of neuron differentiation |
GO:0002251 | 0.0031 | 5.795 | 1.0197 | 5 | 28 | organ or tissue specific immune response |
GO:0048663 | 0.0032 | 3.5647 | 2.4765 | 8 | 68 | neuron fate commitment |
GO:0009653 | 0.0033 | 1.3702 | 82.4666 | 106 | 2272 | anatomical structure morphogenesis |
GO:0044848 | 0.0034 | 13.2957 | 0.3278 | 3 | 9 | biological phase |
GO:0045602 | 0.0034 | 13.2957 | 0.3278 | 3 | 9 | negative regulation of endothelial cell differentiation |
GO:0060602 | 0.0035 | 7.6071 | 0.6555 | 4 | 18 | branch elongation of an epithelium |
GO:1903706 | 0.0036 | 2.0536 | 10.286 | 20 | 290 | regulation of hemopoiesis |
GO:0070286 | 0.0036 | 5.5532 | 1.0561 | 5 | 29 | axonemal dynein complex assembly |
GO:0030047 | 0.0039 | 53.1047 | 0.1093 | 2 | 3 | actin modification |
GO:0036337 | 0.0039 | 53.1047 | 0.1093 | 2 | 3 | Fas signaling pathway |
GO:0046110 | 0.0039 | 53.1047 | 0.1093 | 2 | 3 | xanthine metabolic process |
GO:0071822 | 0.0039 | 1.4283 | 56.23 | 76 | 1544 | protein complex subunit organization |
GO:0030155 | 0.004 | 1.6882 | 21.7782 | 35 | 598 | regulation of cell adhesion |
GO:0043032 | 0.0044 | 7.0995 | 0.6919 | 4 | 19 | positive regulation of macrophage activation |
GO:0006928 | 0.0044 | 1.3951 | 64.4606 | 85 | 1770 | movement of cell or subcellular component |
GO:0045926 | 0.0046 | 2.2057 | 7.6843 | 16 | 211 | negative regulation of growth |
GO:0006600 | 0.0048 | 11.3955 | 0.3642 | 3 | 10 | creatine metabolic process |
GO:0006853 | 0.0048 | 11.3955 | 0.3642 | 3 | 10 | carnitine shuttle |
GO:0048839 | 0.0049 | 2.3343 | 6.3732 | 14 | 175 | inner ear development |
GO:0043537 | 0.0049 | 5.1253 | 1.129 | 5 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:2000677 | 0.0049 | 4.2123 | 1.6024 | 6 | 44 | regulation of transcription regulatory region DNA binding |
GO:0001666 | 0.005 | 1.9519 | 11.3261 | 21 | 311 | response to hypoxia |
GO:0009306 | 0.0051 | 1.7479 | 17.408 | 29 | 478 | protein secretion |
GO:0001504 | 0.0053 | 6.6553 | 0.7284 | 4 | 20 | neurotransmitter uptake |
GO:0031579 | 0.0053 | 6.6553 | 0.7284 | 4 | 20 | membrane raft organization |
GO:0006584 | 0.0055 | 4.1041 | 1.6388 | 6 | 45 | catecholamine metabolic process |
GO:0022610 | 0.0055 | 1.4539 | 44.8311 | 62 | 1231 | biological adhesion |
GO:0072358 | 0.0057 | 1.6456 | 22.2881 | 35 | 612 | cardiovascular system development |
GO:0006790 | 0.0059 | 1.889 | 12.2366 | 22 | 336 | sulfur compound metabolic process |
GO:0070482 | 0.0059 | 1.889 | 12.2366 | 22 | 336 | response to oxygen levels |
GO:0051046 | 0.0062 | 1.6121 | 24.0362 | 37 | 660 | regulation of secretion |
GO:0045687 | 0.0064 | 4.7586 | 1.2018 | 5 | 33 | positive regulation of glial cell differentiation |
GO:0045597 | 0.0065 | 1.5432 | 29.8631 | 44 | 820 | positive regulation of cell differentiation |
GO:0065003 | 0.0065 | 1.3862 | 60.054 | 79 | 1649 | macromolecular complex assembly |
GO:0051248 | 0.0066 | 1.445 | 44.3212 | 61 | 1217 | negative regulation of protein metabolic process |
GO:1901566 | 0.0067 | 1.3586 | 69.9598 | 90 | 1921 | organonitrogen compound biosynthetic process |
GO:0001578 | 0.0068 | 3.0979 | 2.8042 | 8 | 77 | microtubule bundle formation |
GO:0017015 | 0.0072 | 2.8311 | 3.4233 | 9 | 94 | regulation of transforming growth factor beta receptor signaling pathway |
GO:0019731 | 0.0073 | 4.5942 | 1.2382 | 5 | 34 | antibacterial humoral response |
GO:0007599 | 0.0073 | 27.0131 | 0.1433 | 2 | 4 | hemostasis |
GO:0001568 | 0.0075 | 1.637 | 21.0863 | 33 | 579 | blood vessel development |
GO:0034112 | 0.0075 | 26.6467 | 0.1452 | 2 | 4 | positive regulation of homotypic cell-cell adhesion |
GO:0035910 | 0.0076 | 26.5505 | 0.1457 | 2 | 4 | ascending aorta morphogenesis |
GO:0042663 | 0.0076 | 26.5505 | 0.1457 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0044571 | 0.0076 | 26.5505 | 0.1457 | 2 | 4 | [2Fe-2S] cluster assembly |
GO:0048382 | 0.0076 | 26.5505 | 0.1457 | 2 | 4 | mesendoderm development |
GO:0060167 | 0.0076 | 26.5505 | 0.1457 | 2 | 4 | regulation of adenosine receptor signaling pathway |
GO:0072095 | 0.0076 | 26.5505 | 0.1457 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:1904340 | 0.0076 | 26.5505 | 0.1457 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0060249 | 0.008 | 1.8352 | 12.5644 | 22 | 345 | anatomical structure homeostasis |
GO:0007596 | 0.008 | 1.8955 | 11.0712 | 20 | 304 | blood coagulation |
GO:0044259 | 0.0082 | 2.5975 | 4.1153 | 10 | 113 | multicellular organismal macromolecule metabolic process |
GO:0045892 | 0.0082 | 1.4635 | 37.9116 | 53 | 1041 | negative regulation of transcription, DNA-templated |
GO:0070243 | 0.0083 | 8.862 | 0.437 | 3 | 12 | regulation of thymocyte apoptotic process |
GO:0070365 | 0.0083 | 8.862 | 0.437 | 3 | 12 | hepatocyte differentiation |
GO:0021879 | 0.0084 | 3.7213 | 1.7845 | 6 | 49 | forebrain neuron differentiation |
GO:0046068 | 0.0084 | 3.7213 | 1.7845 | 6 | 49 | cGMP metabolic process |
GO:0048844 | 0.0084 | 3.278 | 2.3308 | 7 | 64 | artery morphogenesis |
GO:0120036 | 0.0088 | 1.4182 | 45.8144 | 62 | 1258 | plasma membrane bounded cell projection organization |
GO:0002440 | 0.0088 | 2.3294 | 5.4628 | 12 | 150 | production of molecular mediator of immune response |
GO:0090103 | 0.0089 | 5.6034 | 0.8376 | 4 | 23 | cochlea morphogenesis |
GO:0015696 | 0.0092 | 2.9273 | 2.9499 | 8 | 81 | ammonium transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 95.689 | 1.1554 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 108.6695 | 0.995 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 40.0036 | 1.3801 | 24 | 43 | protein heterotetramerization |
GO:0045815 | 0 | 16.8383 | 2.5034 | 27 | 78 | positive regulation of gene expression, epigenetic |
GO:0060964 | 0 | 12.5531 | 3.1774 | 28 | 99 | regulation of gene silencing by miRNA |
GO:0045653 | 0 | 144.8431 | 0.5456 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045814 | 0 | 10.5004 | 3.7552 | 29 | 117 | negative regulation of gene expression, epigenetic |
GO:1902036 | 0 | 11.7461 | 3.2095 | 27 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0060968 | 0 | 9.5692 | 3.8835 | 28 | 121 | regulation of gene silencing |
GO:0031497 | 0 | 7.727 | 4.5896 | 28 | 143 | chromatin assembly |
GO:0034080 | 0 | 18.6341 | 1.2838 | 15 | 40 | CENP-A containing nucleosome assembly |
GO:0002244 | 0 | 5.9733 | 5.8735 | 29 | 183 | hematopoietic progenitor cell differentiation |
GO:0032200 | 0 | 6.3627 | 4.9748 | 26 | 155 | telomere organization |
GO:0030099 | 0 | 4.0416 | 11.4901 | 40 | 358 | myeloid cell differentiation |
GO:1904837 | 0 | 15.4926 | 1.348 | 14 | 42 | beta-catenin-TCF complex assembly |
GO:0034724 | 0 | 13.3011 | 1.6048 | 15 | 50 | DNA replication-independent nucleosome organization |
GO:0065004 | 0 | 5.0446 | 6.7721 | 29 | 211 | protein-DNA complex assembly |
GO:0038111 | 0 | 17.4826 | 1.1554 | 13 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 17.4826 | 1.1554 | 13 | 36 | response to interleukin-7 |
GO:0048863 | 0 | 4.5961 | 7.8634 | 31 | 245 | stem cell differentiation |
GO:0016233 | 0 | 12.0433 | 1.6048 | 14 | 50 | telomere capping |
GO:0043044 | 0 | 8.7172 | 2.343 | 16 | 73 | ATP-dependent chromatin remodeling |
GO:0051259 | 0 | 3.0839 | 15.7267 | 43 | 490 | protein oligomerization |
GO:0045652 | 0 | 10.0895 | 1.6855 | 13 | 54 | regulation of megakaryocyte differentiation |
GO:0035194 | 0 | 3.8103 | 8.6337 | 29 | 269 | posttranscriptional gene silencing by RNA |
GO:0071103 | 0 | 3.8847 | 8.1843 | 28 | 255 | DNA conformation change |
GO:0006303 | 0 | 8.3286 | 2.1183 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0050911 | 0 | 3.3155 | 10.4631 | 31 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 3.0288 | 12.8702 | 35 | 401 | detection of chemical stimulus |
GO:1903707 | 0 | 5.1319 | 4.0761 | 18 | 127 | negative regulation of hemopoiesis |
GO:0050906 | 0 | 2.9543 | 13.1591 | 35 | 410 | detection of stimulus involved in sensory perception |
GO:0050877 | 0 | 2.098 | 36.011 | 68 | 1122 | nervous system process |
GO:0051239 | 0 | 1.7365 | 82.8702 | 126 | 2582 | regulation of multicellular organismal process |
GO:0007606 | 0 | 2.7947 | 13.4159 | 34 | 418 | sensory perception of chemical stimulus |
GO:0017148 | 0 | 2.9092 | 11.3618 | 30 | 354 | negative regulation of translation |
GO:0034728 | 0 | 4.9999 | 3.2152 | 14 | 103 | nucleosome organization |
GO:0045596 | 0 | 2.3182 | 19.2893 | 41 | 601 | negative regulation of cell differentiation |
GO:0032501 | 0 | 1.5786 | 113.9024 | 151 | 3970 | multicellular organismal process |
GO:0007186 | 0 | 1.8909 | 33.3327 | 58 | 1056 | G-protein coupled receptor signaling pathway |
GO:0071804 | 0 | 3.2382 | 6.0981 | 18 | 190 | cellular potassium ion transport |
GO:0048869 | 1e-04 | 1.4633 | 122.3155 | 159 | 3811 | cellular developmental process |
GO:0007218 | 2e-04 | 4.1665 | 2.9528 | 11 | 92 | neuropeptide signaling pathway |
GO:0030001 | 4e-04 | 1.8405 | 24.9381 | 43 | 777 | metal ion transport |
GO:0048534 | 4e-04 | 1.8095 | 25.9331 | 44 | 808 | hematopoietic or lymphoid organ development |
GO:0034765 | 4e-04 | 2.194 | 12.6456 | 26 | 394 | regulation of ion transmembrane transport |
GO:0048731 | 6e-04 | 1.5129 | 65.8918 | 91 | 2147 | system development |
GO:0065007 | 6e-04 | 1.4098 | 340.8207 | 373 | 10619 | biological regulation |
GO:0030574 | 7e-04 | 4.611 | 1.9578 | 8 | 61 | collagen catabolic process |
GO:0034248 | 7e-04 | 1.926 | 18.1981 | 33 | 567 | regulation of cellular amide metabolic process |
GO:0070271 | 8e-04 | 1.5952 | 42.1733 | 63 | 1314 | protein complex biogenesis |
GO:0015672 | 9e-04 | 1.9891 | 15.47 | 29 | 482 | monovalent inorganic cation transport |
GO:0006352 | 0.001 | 2.5174 | 7.2215 | 17 | 225 | DNA-templated transcription, initiation |
GO:0010107 | 0.001 | 7.6067 | 0.8024 | 5 | 25 | potassium ion import |
GO:0098662 | 0.0016 | 1.7988 | 20.5731 | 35 | 641 | inorganic cation transmembrane transport |
GO:0045892 | 0.0016 | 1.6179 | 33.4113 | 51 | 1041 | negative regulation of transcription, DNA-templated |
GO:0006811 | 0.0018 | 1.5286 | 45.2224 | 65 | 1409 | ion transport |
GO:1902679 | 0.0019 | 1.5979 | 34.4704 | 52 | 1074 | negative regulation of RNA biosynthetic process |
GO:0007168 | 0.0024 | 15.1653 | 0.2889 | 3 | 9 | receptor guanylyl cyclase signaling pathway |
GO:0051716 | 0.0024 | 1.3017 | 206.0844 | 237 | 6421 | cellular response to stimulus |
GO:0061337 | 0.0028 | 2.8774 | 4.1082 | 11 | 128 | cardiac conduction |
GO:0023052 | 0.0032 | 1.2949 | 182.5906 | 212 | 5689 | signaling |
GO:0042359 | 0.0034 | 7.5931 | 0.6419 | 4 | 20 | vitamin D metabolic process |
GO:0007154 | 0.0038 | 1.2878 | 183.2004 | 212 | 5708 | cell communication |
GO:0045595 | 0.005 | 1.5721 | 29.4823 | 44 | 963 | regulation of cell differentiation |
GO:0051481 | 0.0058 | 10.1081 | 0.3851 | 3 | 12 | negative regulation of cytosolic calcium ion concentration |
GO:0015803 | 0.0059 | 30.2766 | 0.1284 | 2 | 4 | branched-chain amino acid transport |
GO:1901842 | 0.0059 | 30.2766 | 0.1284 | 2 | 4 | negative regulation of high voltage-gated calcium channel activity |
GO:1902261 | 0.0059 | 30.2766 | 0.1284 | 2 | 4 | positive regulation of delayed rectifier potassium channel activity |
GO:0071435 | 0.0074 | 9.0967 | 0.4172 | 3 | 13 | potassium ion export |
GO:0045934 | 0.0078 | 1.4511 | 41.2746 | 57 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0060249 | 0.0081 | 1.8922 | 11.0729 | 20 | 345 | anatomical structure homeostasis |
GO:1901019 | 0.0082 | 3.2803 | 2.3109 | 7 | 72 | regulation of calcium ion transmembrane transporter activity |
GO:0007399 | 0.0088 | 1.3577 | 65.4104 | 84 | 2038 | nervous system development |
GO:0002828 | 0.0089 | 5.52 | 0.8345 | 4 | 26 | regulation of type 2 immune response |
GO:0002115 | 0.0092 | 8.2692 | 0.4493 | 3 | 14 | store-operated calcium entry |
GO:0071822 | 0.0094 | 1.4006 | 49.5552 | 66 | 1544 | protein complex subunit organization |
GO:0007596 | 0.0095 | 1.9322 | 9.757 | 18 | 304 | blood coagulation |
GO:0009446 | 0.0096 | 20.1831 | 0.1605 | 2 | 5 | putrescine biosynthetic process |
GO:0019800 | 0.0096 | 20.1831 | 0.1605 | 2 | 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan |
GO:0021546 | 0.0096 | 20.1831 | 0.1605 | 2 | 5 | rhombomere development |
GO:0060591 | 0.0096 | 20.1831 | 0.1605 | 2 | 5 | chondroblast differentiation |
GO:1903706 | 0.0097 | 1.9701 | 9.041 | 17 | 290 | regulation of hemopoiesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 2.0908 | 41.4113 | 77 | 1351 | receptor activity |
GO:0004871 | 0 | 1.7901 | 44.6911 | 73 | 1458 | signal transducer activity |
GO:0004888 | 1e-04 | 2.4927 | 10.3757 | 24 | 352 | transmembrane signaling receptor activity |
GO:0022836 | 6e-04 | 2.4207 | 8.8279 | 20 | 288 | gated channel activity |
GO:0005245 | 6e-04 | 6.6149 | 1.0728 | 6 | 35 | voltage-gated calcium channel activity |
GO:0022838 | 8e-04 | 2.1744 | 11.7398 | 24 | 383 | substrate-specific channel activity |
GO:0004930 | 0.0011 | 1.8048 | 21.7325 | 37 | 709 | G-protein coupled receptor activity |
GO:0022803 | 0.0021 | 2.0025 | 12.6594 | 24 | 413 | passive transmembrane transporter activity |
GO:0005261 | 0.0026 | 2.2195 | 8.5827 | 18 | 280 | cation channel activity |
GO:0005244 | 0.0034 | 2.5342 | 5.4561 | 13 | 178 | voltage-gated ion channel activity |
GO:0015276 | 0.0034 | 2.9702 | 3.617 | 10 | 118 | ligand-gated ion channel activity |
GO:0046934 | 0.0037 | 3.8595 | 1.9924 | 7 | 65 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
GO:0015085 | 0.0038 | 2.9158 | 3.6783 | 10 | 120 | calcium ion transmembrane transporter activity |
GO:0017034 | 0.0054 | 31.7554 | 0.1226 | 2 | 4 | Rap guanyl-nucleotide exchange factor activity |
GO:0032190 | 0.0054 | 31.7554 | 0.1226 | 2 | 4 | acrosin binding |
GO:0005104 | 0.0066 | 6.0669 | 0.7663 | 4 | 25 | fibroblast growth factor receptor binding |
GO:0030414 | 0.0068 | 2.5205 | 4.6285 | 11 | 151 | peptidase inhibitor activity |
GO:0008188 | 0.008 | 4.4288 | 1.2567 | 5 | 41 | neuropeptide receptor activity |
GO:0005499 | 0.0088 | 21.1688 | 0.1533 | 2 | 5 | vitamin D binding |
GO:0023029 | 0.0088 | 21.1688 | 0.1533 | 2 | 5 | MHC class Ib protein binding |
GO:0032393 | 0.0088 | 21.1688 | 0.1533 | 2 | 5 | MHC class I receptor activity |
GO:0001653 | 0.0099 | 2.6674 | 3.5863 | 9 | 117 | peptide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019904 | 2e-04 | 1.9484 | 21.3942 | 39 | 621 | protein domain specific binding |
GO:0042393 | 5e-04 | 2.7887 | 6.2012 | 16 | 180 | histone binding |
GO:0016418 | 0.0012 | Inf | 0.0689 | 2 | 2 | S-acetyltransferase activity |
GO:0005231 | 0.0026 | 4.8485 | 1.4125 | 6 | 41 | excitatory extracellular ligand-gated ion channel activity |
GO:0043027 | 0.0062 | 6.2682 | 0.7579 | 4 | 22 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:0051431 | 0.0068 | 28.1298 | 0.1378 | 2 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0050839 | 0.0079 | 1.762 | 14.8484 | 25 | 431 | cell adhesion molecule binding |
GO:0046982 | 0.0087 | 1.7266 | 15.7442 | 26 | 457 | protein heterodimerization activity |
GO:0016918 | 0.009 | 8.4505 | 0.4479 | 3 | 13 | retinal binding |
GO:0019841 | 0.009 | 8.4505 | 0.4479 | 3 | 13 | retinol binding |
GO:0008066 | 0.0099 | 5.3716 | 0.8613 | 4 | 25 | glutamate receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 5.0112 | 12.6313 | 52 | 457 | protein heterodimerization activity |
GO:0042393 | 0 | 5.6784 | 4.9751 | 24 | 180 | histone binding |
GO:0031492 | 0 | 12.3901 | 1.1885 | 11 | 43 | nucleosomal DNA binding |
GO:0003677 | 0 | 1.7361 | 62.1613 | 96 | 2249 | DNA binding |
GO:1901363 | 9e-04 | 1.3752 | 149.9443 | 181 | 5425 | heterocyclic compound binding |
GO:0097159 | 0.0013 | 1.3591 | 151.9897 | 182 | 5499 | organic cyclic compound binding |
GO:0004165 | 0.0022 | 70.6905 | 0.0829 | 2 | 3 | dodecenoyl-CoA delta-isomerase activity |
GO:0005088 | 0.0049 | 2.3241 | 6.3571 | 14 | 230 | Ras guanyl-nucleotide exchange factor activity |
GO:0017048 | 0.0058 | 2.7264 | 3.8972 | 10 | 141 | Rho GTPase binding |
GO:0035250 | 0.007 | 5.9099 | 0.7739 | 4 | 28 | UDP-galactosyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 3.4592 | 13.8585 | 42 | 457 | protein heterodimerization activity |
GO:0042393 | 0 | 5.3948 | 5.4585 | 25 | 180 | histone binding |
GO:0031492 | 0 | 9.8816 | 1.304 | 10 | 43 | nucleosomal DNA binding |
GO:0001228 | 1e-04 | 2.4644 | 11.3718 | 26 | 375 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0099600 | 1e-04 | 1.8025 | 33.5393 | 56 | 1106 | transmembrane receptor activity |
GO:0060089 | 2e-04 | 1.6913 | 42.1819 | 66 | 1391 | molecular transducer activity |
GO:0038023 | 2e-04 | 1.7524 | 35.0341 | 57 | 1160 | signaling receptor activity |
GO:0030883 | 3e-04 | 48.2707 | 0.1516 | 3 | 5 | endogenous lipid antigen binding |
GO:0030884 | 3e-04 | 48.2707 | 0.1516 | 3 | 5 | exogenous lipid antigen binding |
GO:0003700 | 5e-04 | 1.6965 | 34.0548 | 54 | 1123 | DNA binding transcription factor activity |
GO:0004692 | 9e-04 | Inf | 0.0606 | 2 | 2 | cGMP-dependent protein kinase activity |
GO:0004882 | 9e-04 | Inf | 0.0606 | 2 | 2 | androgen receptor activity |
GO:0034189 | 9e-04 | Inf | 0.0606 | 2 | 2 | very-low-density lipoprotein particle binding |
GO:0004930 | 9e-04 | 1.8267 | 21.5003 | 37 | 709 | G-protein coupled receptor activity |
GO:0019904 | 0.0013 | 1.8556 | 18.8317 | 33 | 621 | protein domain specific binding |
GO:0030881 | 0.0014 | 19.3043 | 0.2426 | 3 | 8 | beta-2-microglobulin binding |
GO:0051428 | 0.0023 | 8.5926 | 0.5762 | 4 | 19 | peptide hormone receptor binding |
GO:0016508 | 0.0027 | 64.2256 | 0.091 | 2 | 3 | long-chain-enoyl-CoA hydratase activity |
GO:0071723 | 0.0028 | 13.787 | 0.3032 | 3 | 10 | lipopeptide binding |
GO:0015267 | 0.0038 | 1.9372 | 12.4938 | 23 | 412 | channel activity |
GO:0031490 | 0.0047 | 4.2053 | 1.5769 | 6 | 53 | chromatin DNA binding |
GO:0005216 | 0.005 | 1.9508 | 11.3112 | 21 | 373 | ion channel activity |
GO:0001602 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | pancreatic polypeptide receptor activity |
GO:0001640 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity |
GO:0005030 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | neurotrophin receptor activity |
GO:0005237 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | inhibitory extracellular ligand-gated ion channel activity |
GO:0030284 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | estrogen receptor activity |
GO:0044323 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | retinoic acid-responsive element binding |
GO:0051431 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0070915 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | lysophosphatidic acid receptor activity |
GO:0003705 | 0.0059 | 3.1569 | 2.7292 | 8 | 90 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding |
GO:0034185 | 0.0063 | 9.6489 | 0.3942 | 3 | 13 | apolipoprotein binding |
GO:0000977 | 0.0071 | 1.7202 | 17.0426 | 28 | 562 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0071855 | 0.0073 | 5.8558 | 0.7884 | 4 | 26 | neuropeptide receptor binding |
GO:0008188 | 0.0077 | 4.4787 | 1.2433 | 5 | 41 | neuropeptide receptor activity |
GO:0043565 | 0.0084 | 1.5341 | 28.6873 | 42 | 946 | sequence-specific DNA binding |
GO:0003677 | 0.0086 | 1.4772 | 36.4039 | 51 | 1272 | DNA binding |
GO:0015277 | 0.0086 | 21.4056 | 0.1516 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0000982 | 0.0091 | 1.87 | 11.1899 | 20 | 369 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0022857 | 0.0097 | 1.5352 | 27.2621 | 40 | 899 | transmembrane transporter activity |
GO:0008201 | 0.0098 | 2.5114 | 4.2152 | 10 | 139 | heparin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 12.0785 | 9.6083 | 77 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 6.1907 | 20.8966 | 95 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 4.5489 | 32.5976 | 111 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 3.8286 | 40.9975 | 119 | 1391 | molecular transducer activity |
GO:0038023 | 0 | 4.1975 | 31.2518 | 101 | 1081 | signaling receptor activity |
GO:0005549 | 0 | 11.8364 | 2.2989 | 20 | 78 | odorant binding |
GO:0031492 | 0 | 10.1825 | 1.2674 | 10 | 43 | nucleosomal DNA binding |
GO:0005506 | 0 | 4.2646 | 4.2147 | 16 | 143 | iron ion binding |
GO:0019825 | 0 | 8.6335 | 1.1495 | 8 | 39 | oxygen binding |
GO:0004497 | 0 | 7.0808 | 1.5186 | 9 | 52 | monooxygenase activity |
GO:0030594 | 0 | 5.1318 | 2.4463 | 11 | 83 | neurotransmitter receptor activity |
GO:0020037 | 0 | 4.3347 | 3.36 | 13 | 114 | heme binding |
GO:0001567 | 9e-04 | Inf | 0.0589 | 2 | 2 | cholesterol 25-hydroxylase activity |
GO:0004507 | 9e-04 | Inf | 0.0589 | 2 | 2 | steroid 11-beta-monooxygenase activity |
GO:0047783 | 9e-04 | Inf | 0.0589 | 2 | 2 | corticosterone 18-monooxygenase activity |
GO:0008392 | 0.001 | 11.0658 | 0.4716 | 4 | 16 | arachidonic acid epoxygenase activity |
GO:0016709 | 0.0017 | 6.6485 | 0.8842 | 5 | 30 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0035240 | 0.0026 | 14.2004 | 0.2947 | 3 | 10 | dopamine binding |
GO:0000146 | 0.0036 | 7.3742 | 0.6484 | 4 | 22 | microfilament motor activity |
GO:0015333 | 0.005 | 33.0714 | 0.1179 | 2 | 4 | peptide:proton symporter activity |
GO:0033265 | 0.005 | 33.0714 | 0.1179 | 2 | 4 | choline binding |
GO:0099589 | 0.0058 | 6.3195 | 0.7368 | 4 | 25 | serotonin receptor activity |
GO:0004435 | 0.0067 | 6.0318 | 0.7663 | 4 | 26 | phosphatidylinositol phospholipase C activity |
GO:0015198 | 0.0082 | 22.0461 | 0.1474 | 2 | 5 | oligopeptide transporter activity |
GO:0016907 | 0.0082 | 22.0461 | 0.1474 | 2 | 5 | G-protein coupled acetylcholine receptor activity |
GO:1903231 | 0.0086 | 2.7288 | 3.5073 | 9 | 119 | mRNA binding involved in posttranscriptional gene silencing |
GO:0005230 | 0.009 | 3.6273 | 1.7979 | 6 | 61 | extracellular ligand-gated ion channel activity |
GO:0050839 | 0.0091 | 1.8109 | 12.703 | 22 | 431 | cell adhesion molecule binding |
GO:0005160 | 0.0092 | 4.2579 | 1.2968 | 5 | 44 | transforming growth factor beta receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 4.3994 | 14.1278 | 52 | 457 | protein heterodimerization activity |
GO:0042393 | 0 | 5.5427 | 5.5646 | 26 | 180 | histone binding |
GO:0031492 | 0 | 9.6832 | 1.3293 | 10 | 43 | nucleosomal DNA binding |
GO:0004459 | 1e-04 | 94.6375 | 0.1237 | 3 | 4 | L-lactate dehydrogenase activity |
GO:0030151 | 1e-04 | 94.6375 | 0.1237 | 3 | 4 | molybdenum ion binding |
GO:0003677 | 2e-04 | 1.5404 | 69.5263 | 98 | 2249 | DNA binding |
GO:0005178 | 4e-04 | 3.6925 | 3.2769 | 11 | 106 | integrin binding |
GO:0043546 | 5e-04 | 31.5416 | 0.1855 | 3 | 6 | molybdopterin cofactor binding |
GO:0008294 | 0.001 | Inf | 0.0618 | 2 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
GO:0016614 | 0.0011 | 3.2451 | 3.6788 | 11 | 119 | oxidoreductase activity, acting on CH-OH group of donors |
GO:0045296 | 0.0016 | 2.2651 | 8.9033 | 19 | 288 | cadherin binding |
GO:0019904 | 0.0018 | 1.8164 | 19.1978 | 33 | 621 | protein domain specific binding |
GO:0008940 | 0.0028 | 62.9574 | 0.0927 | 2 | 3 | nitrate reductase activity |
GO:0016836 | 0.0035 | 4.523 | 1.4839 | 6 | 48 | hydro-lyase activity |
GO:0030170 | 0.0038 | 4.4175 | 1.5148 | 6 | 49 | pyridoxal phosphate binding |
GO:0004583 | 0.0055 | 31.4766 | 0.1237 | 2 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
GO:0019955 | 0.0076 | 3.0197 | 2.8441 | 8 | 92 | cytokine binding |
GO:0005499 | 0.009 | 20.983 | 0.1546 | 2 | 5 | vitamin D binding |
GO:0008508 | 0.009 | 20.983 | 0.1546 | 2 | 5 | bile acid:sodium symporter activity |
GO:0050072 | 0.009 | 20.983 | 0.1546 | 2 | 5 | m7G(5')pppN diphosphatase activity |
GO:0004867 | 0.0096 | 3.1669 | 2.3804 | 7 | 77 | serine-type endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 2.5003 | 20.8502 | 47 | 709 | G-protein coupled receptor activity |
GO:0031492 | 0 | 10.2064 | 1.2645 | 10 | 43 | nucleosomal DNA binding |
GO:0004984 | 0 | 3.2408 | 9.587 | 28 | 326 | olfactory receptor activity |
GO:0099600 | 0 | 2.1138 | 32.5252 | 62 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 2.0336 | 34.2308 | 63 | 1164 | signaling receptor activity |
GO:0005509 | 1e-04 | 2.1209 | 18.2623 | 36 | 621 | calcium ion binding |
GO:0046982 | 2e-04 | 2.2309 | 13.4394 | 28 | 457 | protein heterodimerization activity |
GO:0004024 | 2e-04 | 49.833 | 0.147 | 3 | 5 | alcohol dehydrogenase activity, zinc-dependent |
GO:0005549 | 5e-04 | 4.3725 | 2.2938 | 9 | 78 | odorant binding |
GO:0005164 | 8e-04 | 7.9354 | 0.7646 | 5 | 26 | tumor necrosis factor receptor binding |
GO:0030545 | 0.001 | 2.0932 | 12.6748 | 25 | 431 | receptor regulator activity |
GO:0005125 | 0.0015 | 2.6777 | 5.5875 | 14 | 190 | cytokine activity |
GO:0035586 | 0.0025 | 8.3163 | 0.5882 | 4 | 20 | purinergic receptor activity |
GO:0004872 | 0.0025 | 2.9075 | 4.0512 | 11 | 148 | receptor activity |
GO:0030345 | 0.0025 | 66.2998 | 0.0882 | 2 | 3 | structural constituent of tooth enamel |
GO:0042393 | 0.0026 | 2.616 | 5.2934 | 13 | 180 | histone binding |
GO:0005201 | 0.0032 | 3.962 | 1.9409 | 7 | 66 | extracellular matrix structural constituent |
GO:0015075 | 0.0035 | 1.6896 | 22.4382 | 36 | 763 | ion transmembrane transporter activity |
GO:0008028 | 0.0038 | 5.372 | 1.0587 | 5 | 36 | monocarboxylic acid transmembrane transporter activity |
GO:0008514 | 0.0049 | 2.5158 | 5.0582 | 12 | 172 | organic anion transmembrane transporter activity |
GO:0042806 | 0.005 | 33.1477 | 0.1176 | 2 | 4 | fucose binding |
GO:0030414 | 0.0051 | 2.6332 | 4.4406 | 11 | 151 | peptidase inhibitor activity |
GO:0005229 | 0.0072 | 9.055 | 0.4117 | 3 | 14 | intracellular calcium activated chloride channel activity |
GO:0015103 | 0.0081 | 2.7604 | 3.4701 | 9 | 118 | inorganic anion transmembrane transporter activity |
GO:0005149 | 0.0088 | 8.2999 | 0.4411 | 3 | 15 | interleukin-1 receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 5.2026 | 9.7151 | 42 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 3.1106 | 21.1288 | 57 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 2.5492 | 32.9598 | 73 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 2.4996 | 34.0489 | 74 | 1149 | signaling receptor activity |
GO:0042393 | 0 | 3.4884 | 5.3642 | 17 | 180 | histone binding |
GO:0030545 | 2e-04 | 2.2499 | 12.8442 | 27 | 431 | receptor regulator activity |
GO:0004806 | 0.0011 | 10.9394 | 0.4768 | 4 | 16 | triglyceride lipase activity |
GO:0046982 | 0.0013 | 2.0224 | 13.619 | 26 | 457 | protein heterodimerization activity |
GO:0003823 | 0.0018 | 5.1958 | 1.3112 | 6 | 44 | antigen binding |
GO:0004872 | 0.0021 | 2.9728 | 3.967 | 11 | 148 | receptor activity |
GO:0035662 | 0.0026 | 65.3951 | 0.0894 | 2 | 3 | Toll-like receptor 4 binding |
GO:0042834 | 0.0036 | 12.2829 | 0.3278 | 3 | 11 | peptidoglycan binding |
GO:0008083 | 0.0043 | 2.6937 | 4.3509 | 11 | 146 | growth factor activity |
GO:0016411 | 0.0044 | 6.9058 | 0.6854 | 4 | 23 | acylglycerol O-acyltransferase activity |
GO:0050051 | 0.0051 | 32.6954 | 0.1192 | 2 | 4 | leukotriene-B4 20-monooxygenase activity |
GO:0005179 | 0.0063 | 2.8819 | 3.3377 | 9 | 112 | hormone activity |
GO:0071855 | 0.0069 | 5.9629 | 0.7748 | 4 | 26 | neuropeptide receptor binding |
GO:0034987 | 0.0083 | 21.7954 | 0.149 | 2 | 5 | immunoglobulin receptor binding |
GO:0046870 | 0.0083 | 21.7954 | 0.149 | 2 | 5 | cadmium ion binding |
GO:0050544 | 0.0083 | 21.7954 | 0.149 | 2 | 5 | arachidonic acid binding |
GO:0008329 | 0.0092 | 8.1864 | 0.447 | 3 | 15 | signaling pattern recognition receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008081 | 2e-04 | 4.4261 | 2.5275 | 10 | 85 | phosphoric diester hydrolase activity |
GO:0036374 | 5e-04 | 32.8404 | 0.1784 | 3 | 6 | glutathione hydrolase activity |
GO:0036505 | 9e-04 | Inf | 0.0595 | 2 | 2 | prosaposin receptor activity |
GO:0050840 | 0.0023 | 4.9467 | 1.3678 | 6 | 46 | extracellular matrix binding |
GO:0005178 | 0.0043 | 3.0685 | 3.152 | 9 | 106 | integrin binding |
GO:0001875 | 0.0051 | 32.7699 | 0.1189 | 2 | 4 | lipopolysaccharide receptor activity |
GO:0030023 | 0.0051 | 32.7699 | 0.1189 | 2 | 4 | extracellular matrix constituent conferring elasticity |
GO:0004620 | 0.0053 | 3.2226 | 2.6762 | 8 | 90 | phospholipase activity |
GO:0003779 | 0.0055 | 1.9677 | 10.675 | 20 | 359 | actin binding |
GO:0022848 | 0.006 | 9.8475 | 0.3866 | 3 | 13 | acetylcholine-gated cation-selective channel activity |
GO:0004435 | 0.0069 | 5.9766 | 0.7731 | 4 | 26 | phosphatidylinositol phospholipase C activity |
GO:0005102 | 0.0073 | 1.4837 | 36.8926 | 52 | 1257 | receptor binding |
GO:0004046 | 0.0083 | 21.8451 | 0.1487 | 2 | 5 | aminoacylase activity |
GO:0005201 | 0.0099 | 3.5448 | 1.836 | 6 | 62 | extracellular matrix structural constituent |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 12.8791 | 10.7827 | 88 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 6.2385 | 23.4507 | 106 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 4.3029 | 36.5817 | 119 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 4.1945 | 38.5001 | 122 | 1164 | signaling receptor activity |
GO:0060089 | 0 | 3.5474 | 46.0083 | 126 | 1391 | molecular transducer activity |
GO:0005549 | 0 | 15.3559 | 2.5799 | 26 | 78 | odorant binding |
GO:0031492 | 0 | 12.9762 | 1.4223 | 13 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.0474 | 15.1156 | 41 | 457 | protein heterodimerization activity |
GO:0009374 | 3e-04 | 44.1066 | 0.1654 | 3 | 5 | biotin binding |
GO:0015020 | 4e-04 | 7.3843 | 0.9923 | 6 | 30 | glucuronosyltransferase activity |
GO:0001530 | 6e-04 | 8.6741 | 0.7277 | 5 | 22 | lipopolysaccharide binding |
GO:0001972 | 0.0025 | 8.4112 | 0.5954 | 4 | 18 | retinoic acid binding |
GO:0070330 | 0.0025 | 8.4112 | 0.5954 | 4 | 18 | aromatase activity |
GO:0031419 | 0.0026 | 14.6982 | 0.2977 | 3 | 9 | cobalamin binding |
GO:0004869 | 0.0059 | 4.0223 | 1.6538 | 6 | 50 | cysteine-type endopeptidase inhibitor activity |
GO:0032190 | 0.0063 | 29.3459 | 0.1323 | 2 | 4 | acrosin binding |
GO:0005198 | 0.0064 | 1.6561 | 20.8708 | 33 | 631 | structural molecule activity |
GO:0008201 | 0.0065 | 2.5459 | 4.5975 | 11 | 139 | heparin binding |
GO:0042393 | 0.0069 | 2.3094 | 5.9536 | 13 | 180 | histone binding |
GO:0031406 | 0.008 | 2.3554 | 5.3913 | 12 | 163 | carboxylic acid binding |
GO:0005229 | 0.01 | 8.0145 | 0.4631 | 3 | 14 | intracellular calcium activated chloride channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 6.2473 | 5.6471 | 29 | 180 | histone binding |
GO:0046982 | 0 | 3.8156 | 14.3374 | 47 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 12.2329 | 1.349 | 12 | 43 | nucleosomal DNA binding |
GO:0003677 | 0 | 1.6983 | 70.5574 | 107 | 2249 | DNA binding |
GO:0004514 | 0 | Inf | 0.0941 | 3 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:1901363 | 3e-04 | 1.3959 | 170.1975 | 207 | 5425 | heterocyclic compound binding |
GO:0016493 | 4e-04 | 15.5589 | 0.3765 | 4 | 12 | C-C chemokine receptor activity |
GO:0097159 | 6e-04 | 1.3657 | 172.5191 | 207 | 5499 | organic cyclic compound binding |
GO:0031720 | 0.001 | Inf | 0.0627 | 2 | 2 | haptoglobin binding |
GO:0071791 | 0.001 | Inf | 0.0627 | 2 | 2 | chemokine (C-C motif) ligand 5 binding |
GO:0019904 | 0.0012 | 1.8485 | 19.4825 | 34 | 621 | protein domain specific binding |
GO:0070410 | 0.0022 | 15.5284 | 0.2824 | 3 | 9 | co-SMAD binding |
GO:0035663 | 0.0029 | 62.0042 | 0.0941 | 2 | 3 | Toll-like receptor 2 binding |
GO:0043325 | 0.0037 | 7.3174 | 0.6588 | 4 | 21 | phosphatidylinositol-3,4-bisphosphate binding |
GO:0005344 | 0.0042 | 11.6447 | 0.3451 | 3 | 11 | oxygen carrier activity |
GO:0045296 | 0.0044 | 2.0996 | 9.0354 | 18 | 288 | cadherin binding |
GO:0030229 | 0.0057 | 31 | 0.1255 | 2 | 4 | very-low-density lipoprotein particle receptor activity |
GO:0001637 | 0.0062 | 6.2185 | 0.7529 | 4 | 24 | G-protein coupled chemoattractant receptor activity |
GO:0019825 | 0.0071 | 4.5777 | 1.2235 | 5 | 39 | oxygen binding |
GO:0044877 | 0.0071 | 1.5509 | 28.3924 | 42 | 905 | macromolecular complex binding |
GO:0001227 | 0.008 | 2.1851 | 6.7452 | 14 | 215 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0003723 | 0.0081 | 1.4164 | 48.3573 | 65 | 1555 | RNA binding |
GO:0031727 | 0.0092 | 20.6653 | 0.1569 | 2 | 5 | CCR2 chemokine receptor binding |
GO:0003725 | 0.0094 | 3.595 | 1.8196 | 6 | 58 | double-stranded RNA binding |
GO:0020037 | 0.0097 | 2.6779 | 3.5765 | 9 | 114 | heme binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004063 | 7e-04 | Inf | 0.0548 | 2 | 2 | aryldialkylphosphatase activity |
GO:0102007 | 0.0022 | 71.3894 | 0.0821 | 2 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
GO:0004181 | 0.0027 | 7.9614 | 0.6023 | 4 | 22 | metallocarboxypeptidase activity |
GO:0000978 | 0.0042 | 2.1106 | 8.9798 | 18 | 328 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0004583 | 0.0043 | 35.6923 | 0.1095 | 2 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
GO:0004839 | 0.0043 | 35.6923 | 0.1095 | 2 | 4 | ubiquitin activating enzyme activity |
GO:0030492 | 0.0043 | 35.6923 | 0.1095 | 2 | 4 | hemoglobin binding |
GO:0034584 | 0.0043 | 35.6923 | 0.1095 | 2 | 4 | piRNA binding |
GO:0004707 | 0.0047 | 10.7277 | 0.3559 | 3 | 13 | MAP kinase activity |
GO:0001159 | 0.0066 | 2.0112 | 9.3905 | 18 | 343 | core promoter proximal region DNA binding |
GO:0019534 | 0.0071 | 23.7933 | 0.1369 | 2 | 5 | toxin transmembrane transporter activity |
GO:1901682 | 0.0076 | 5.7295 | 0.7939 | 4 | 29 | sulfur compound transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 11.184 | 1.3096 | 11 | 43 | nucleosomal DNA binding |
GO:0046982 | 1e-04 | 2.3219 | 13.9183 | 30 | 457 | protein heterodimerization activity |
GO:0036374 | 5e-04 | 32.0346 | 0.1827 | 3 | 6 | glutathione hydrolase activity |
GO:0005201 | 9e-04 | 4.4503 | 2.0101 | 8 | 66 | extracellular matrix structural constituent |
GO:0050839 | 0.0016 | 2.0148 | 13.1265 | 25 | 431 | cell adhesion molecule binding |
GO:0008528 | 0.0029 | 3.0473 | 3.5329 | 10 | 116 | G-protein coupled peptide receptor activity |
GO:0004303 | 0.0029 | 13.7254 | 0.3046 | 3 | 10 | estradiol 17-beta-dehydrogenase activity |
GO:0031072 | 0.003 | 3.263 | 2.9847 | 9 | 98 | heat shock protein binding |
GO:0004683 | 0.0047 | 6.7515 | 0.7005 | 4 | 23 | calmodulin-dependent protein kinase activity |
GO:0016641 | 0.005 | 10.6739 | 0.3655 | 3 | 12 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GO:0004687 | 0.0053 | 31.9676 | 0.1218 | 2 | 4 | myosin light chain kinase activity |
GO:0031014 | 0.0053 | 31.9676 | 0.1218 | 2 | 4 | troponin T binding |
GO:0090722 | 0.0053 | 31.9676 | 0.1218 | 2 | 4 | receptor-receptor interaction |
GO:0022839 | 0.0063 | 4.7215 | 1.1878 | 5 | 39 | ion gated channel activity |
GO:0048018 | 0.0063 | 1.8748 | 12.3042 | 22 | 404 | receptor ligand activity |
GO:0005313 | 0.008 | 8.732 | 0.4264 | 3 | 14 | L-glutamate transmembrane transporter activity |
GO:0004028 | 0.0087 | 21.3103 | 0.1523 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0004030 | 0.0087 | 21.3103 | 0.1523 | 2 | 5 | aldehyde dehydrogenase [NAD(P)+] activity |
GO:0005499 | 0.0087 | 21.3103 | 0.1523 | 2 | 5 | vitamin D binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 16.2871 | 9.8859 | 95 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 7.8011 | 21.5003 | 114 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 5.0252 | 33.5393 | 122 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 4.7255 | 35.2981 | 122 | 1164 | signaling receptor activity |
GO:0005549 | 0 | 18.9949 | 2.3653 | 28 | 78 | odorant binding |
GO:0001591 | 5e-04 | 32.1783 | 0.1819 | 3 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0036374 | 5e-04 | 32.1783 | 0.1819 | 3 | 6 | glutathione hydrolase activity |
GO:0008392 | 0.0011 | 10.7429 | 0.4852 | 4 | 16 | arachidonic acid epoxygenase activity |
GO:0004252 | 0.0012 | 2.8806 | 4.852 | 13 | 160 | serine-type endopeptidase activity |
GO:0005198 | 0.0017 | 1.8233 | 19.135 | 33 | 631 | structural molecule activity |
GO:0070330 | 0.0018 | 9.207 | 0.5458 | 4 | 18 | aromatase activity |
GO:0048020 | 0.0022 | 6.2314 | 0.9363 | 5 | 31 | CCR chemokine receptor binding |
GO:0008395 | 0.0026 | 5.9753 | 0.9704 | 5 | 32 | steroid hydroxylase activity |
GO:0004982 | 0.0027 | 64.2256 | 0.091 | 2 | 3 | N-formyl peptide receptor activity |
GO:0035240 | 0.0028 | 13.787 | 0.3032 | 3 | 10 | dopamine binding |
GO:0016705 | 0.003 | 2.8352 | 4.1545 | 11 | 137 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
GO:0017171 | 0.0051 | 2.4012 | 5.7314 | 13 | 189 | serine hydrolase activity |
GO:0001640 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity |
GO:0034875 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | caffeine oxidase activity |
GO:0050294 | 0.0053 | 32.1106 | 0.1213 | 2 | 4 | steroid sulfotransferase activity |
GO:0019825 | 0.0062 | 4.7428 | 1.1827 | 5 | 39 | oxygen binding |
GO:0030414 | 0.0063 | 2.5492 | 4.5791 | 11 | 151 | peptidase inhibitor activity |
GO:0031727 | 0.0086 | 21.4056 | 0.1516 | 2 | 5 | CCR2 chemokine receptor binding |
GO:0008009 | 0.0094 | 4.2424 | 1.304 | 5 | 43 | chemokine activity |
GO:0042056 | 0.0096 | 5.3671 | 0.8491 | 4 | 28 | chemoattractant activity |
GO:0005149 | 0.0096 | 8.0397 | 0.4549 | 3 | 15 | interleukin-1 receptor binding |
GO:0004872 | 0.0097 | 2.6659 | 3.5672 | 9 | 148 | receptor activity |
GO:0008233 | 0.01 | 1.6877 | 16.709 | 27 | 551 | peptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 12.4211 | 1.1857 | 11 | 43 | nucleosomal DNA binding |
GO:0004888 | 0 | 1.9225 | 29.3939 | 52 | 1066 | transmembrane signaling receptor activity |
GO:0004872 | 1e-04 | 1.7807 | 37.2525 | 61 | 1351 | receptor activity |
GO:0036374 | 4e-04 | 35.512 | 0.1654 | 3 | 6 | glutathione hydrolase activity |
GO:0004871 | 6e-04 | 1.6314 | 40.2029 | 61 | 1458 | signal transducer activity |
GO:0004689 | 0.0022 | 70.864 | 0.0827 | 2 | 3 | phosphorylase kinase activity |
GO:0030550 | 0.0022 | 70.864 | 0.0827 | 2 | 3 | acetylcholine receptor inhibitor activity |
GO:0008528 | 0.0043 | 3.7107 | 2.049 | 7 | 75 | G-protein coupled peptide receptor activity |
GO:0051731 | 0.0044 | 35.4296 | 0.1103 | 2 | 4 | polynucleotide 5'-hydroxyl-kinase activity |
GO:0015295 | 0.0046 | 6.7722 | 0.6894 | 4 | 25 | solute:proton symporter activity |
GO:0008188 | 0.0052 | 4.9449 | 1.1305 | 5 | 41 | neuropeptide receptor activity |
GO:0015267 | 0.0052 | 1.941 | 11.3605 | 21 | 412 | channel activity |
GO:0045296 | 0.0064 | 2.1169 | 7.9413 | 16 | 288 | cadherin binding |
GO:0015277 | 0.0072 | 23.6181 | 0.1379 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0004497 | 0.0074 | 3.3302 | 2.2611 | 7 | 82 | monooxygenase activity |
GO:0005216 | 0.0078 | 1.935 | 10.2851 | 19 | 373 | ion channel activity |
GO:0005201 | 0.0096 | 3.5631 | 1.8199 | 6 | 66 | extracellular matrix structural constituent |
GO:0017080 | 0.0099 | 5.2651 | 0.8548 | 4 | 31 | sodium channel regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.8378 | 6.5785 | 27 | 180 | histone binding |
GO:0031492 | 0 | 8.116 | 1.5715 | 10 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 2.3407 | 16.702 | 36 | 457 | protein heterodimerization activity |
GO:0050431 | 0 | 13.3134 | 0.6578 | 6 | 18 | transforming growth factor beta binding |
GO:0045296 | 2e-04 | 2.4593 | 10.5255 | 24 | 288 | cadherin binding |
GO:0004111 | 9e-04 | 26.4991 | 0.2193 | 3 | 6 | creatine kinase activity |
GO:0008499 | 0.001 | 11.7938 | 0.4751 | 4 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0030306 | 0.0015 | 19.873 | 0.2558 | 3 | 7 | ADP-ribosylation factor binding |
GO:0019911 | 0.0024 | 15.8973 | 0.2924 | 3 | 8 | structural constituent of myelin sheath |
GO:0030368 | 0.0024 | 15.8973 | 0.2924 | 3 | 8 | interleukin-17 receptor activity |
GO:0016595 | 0.0035 | 13.2468 | 0.3289 | 3 | 9 | glutamate binding |
GO:0004351 | 0.0039 | 52.9101 | 0.1096 | 2 | 3 | glutamate decarboxylase activity |
GO:0019904 | 0.0043 | 1.6652 | 22.6957 | 36 | 621 | protein domain specific binding |
GO:0008378 | 0.005 | 5.1064 | 1.133 | 5 | 31 | galactosyltransferase activity |
GO:0001540 | 0.0063 | 3.9864 | 1.6812 | 6 | 46 | amyloid-beta binding |
GO:0030169 | 0.0064 | 9.9338 | 0.402 | 3 | 11 | low-density lipoprotein particle binding |
GO:0008237 | 0.0069 | 2.3154 | 5.9572 | 13 | 163 | metallopeptidase activity |
GO:0005025 | 0.0076 | 26.4532 | 0.1462 | 2 | 4 | transforming growth factor beta receptor activity, type I |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060089 | 0 | 2.7725 | 38.0821 | 88 | 1391 | molecular transducer activity |
GO:0099600 | 0 | 2.9663 | 26.4771 | 67 | 988 | transmembrane receptor activity |
GO:0038023 | 0 | 2.7423 | 28.8314 | 68 | 1081 | signaling receptor activity |
GO:0004930 | 0 | 3.1784 | 15.7344 | 44 | 590 | G-protein coupled receptor activity |
GO:0030594 | 0 | 6.7774 | 2.2723 | 13 | 83 | neurotransmitter receptor activity |
GO:0051378 | 0 | 35.9443 | 0.2738 | 5 | 10 | serotonin binding |
GO:0000981 | 0 | 2.1398 | 19.1916 | 38 | 701 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0008528 | 1e-04 | 4.1908 | 3.1758 | 12 | 116 | G-protein coupled peptide receptor activity |
GO:0022834 | 1e-04 | 4.1112 | 3.2305 | 12 | 118 | ligand-gated channel activity |
GO:0005184 | 1e-04 | 9.3881 | 0.7939 | 6 | 29 | neuropeptide hormone activity |
GO:0004993 | 1e-04 | 12.8295 | 0.5202 | 5 | 19 | G-protein coupled serotonin receptor activity |
GO:0022838 | 1e-04 | 2.4588 | 10.4856 | 24 | 383 | substrate-specific channel activity |
GO:0043565 | 2e-04 | 1.8678 | 25.8991 | 45 | 946 | sequence-specific DNA binding |
GO:0022803 | 5e-04 | 2.2645 | 11.3069 | 24 | 413 | passive transmembrane transporter activity |
GO:0004984 | 7e-04 | 2.3884 | 8.9251 | 20 | 326 | olfactory receptor activity |
GO:0005217 | 7e-04 | 8.1598 | 0.7392 | 5 | 27 | intracellular ligand-gated ion channel activity |
GO:0005231 | 8e-04 | 6.1644 | 1.1225 | 6 | 41 | excitatory extracellular ligand-gated ion channel activity |
GO:0001159 | 0.0013 | 2.2601 | 9.3905 | 20 | 343 | core promoter proximal region DNA binding |
GO:0000976 | 0.0015 | 1.8764 | 17.4942 | 31 | 639 | transcription regulatory region sequence-specific DNA binding |
GO:0003700 | 0.0017 | 2.1181 | 11.0084 | 22 | 422 | DNA binding transcription factor activity |
GO:0001012 | 0.0018 | 1.921 | 15.4135 | 28 | 563 | RNA polymerase II regulatory region DNA binding |
GO:0000978 | 0.0018 | 2.2409 | 8.9798 | 19 | 328 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0016520 | 0.0022 | 71.3894 | 0.0821 | 2 | 3 | growth hormone-releasing hormone receptor activity |
GO:0016934 | 0.0022 | 71.3894 | 0.0821 | 2 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0005261 | 0.0024 | 2.4439 | 6.5091 | 15 | 240 | cation channel activity |
GO:0000975 | 0.0029 | 1.7277 | 21.3818 | 35 | 781 | regulatory region DNA binding |
GO:0001664 | 0.003 | 2.3764 | 6.6801 | 15 | 244 | G-protein coupled receptor binding |
GO:0099604 | 0.0032 | 7.5418 | 0.6297 | 4 | 23 | ligand-gated calcium channel activity |
GO:0001077 | 0.0034 | 2.3452 | 6.7622 | 15 | 247 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0005244 | 0.0037 | 2.6145 | 4.8732 | 12 | 178 | voltage-gated ion channel activity |
GO:0016594 | 0.0037 | 11.9205 | 0.3285 | 3 | 12 | glycine binding |
GO:0004983 | 0.0043 | 35.8599 | 0.109 | 2 | 4 | neuropeptide Y receptor activity |
GO:0001602 | 0.0043 | 35.6923 | 0.1095 | 2 | 4 | pancreatic polypeptide receptor activity |
GO:0047961 | 0.0043 | 35.6923 | 0.1095 | 2 | 4 | glycine N-acyltransferase activity |
GO:0008066 | 0.0044 | 6.8226 | 0.6844 | 4 | 25 | glutamate receptor activity |
GO:0005272 | 0.0045 | 5.1245 | 1.0951 | 5 | 40 | sodium channel activity |
GO:0022824 | 0.005 | 4.9818 | 1.1225 | 5 | 41 | transmitter-gated ion channel activity |
GO:0003828 | 0.0071 | 23.7933 | 0.1369 | 2 | 5 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
GO:0005280 | 0.0071 | 23.7933 | 0.1369 | 2 | 5 | hydrogen:amino acid symporter activity |
GO:0048495 | 0.0071 | 23.7933 | 0.1369 | 2 | 5 | Roundabout binding |
GO:0071837 | 0.0073 | 8.9386 | 0.4107 | 3 | 15 | HMG box domain binding |
GO:0015079 | 0.0079 | 2.594 | 4.0793 | 10 | 149 | potassium ion transmembrane transporter activity |
GO:0003690 | 0.0086 | 1.6341 | 20.5058 | 32 | 749 | double-stranded DNA binding |
GO:0022841 | 0.0087 | 8.2504 | 0.438 | 3 | 16 | potassium ion leak channel activity |
GO:0005249 | 0.0098 | 3.1445 | 2.3818 | 7 | 87 | voltage-gated potassium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 3.8795 | 4.8572 | 17 | 180 | histone binding |
GO:0004063 | 7e-04 | Inf | 0.054 | 2 | 2 | aryldialkylphosphatase activity |
GO:0003677 | 0.001 | 1.5012 | 60.6882 | 84 | 2249 | DNA binding |
GO:0102007 | 0.0021 | 72.4634 | 0.081 | 2 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
GO:0005092 | 0.0036 | 12.1002 | 0.3238 | 3 | 12 | GDP-dissociation inhibitor activity |
GO:0004950 | 0.0036 | 7.2725 | 0.6476 | 4 | 24 | chemokine receptor activity |
GO:0004839 | 0.0042 | 36.2293 | 0.1079 | 2 | 4 | ubiquitin activating enzyme activity |
GO:0030492 | 0.0042 | 36.2293 | 0.1079 | 2 | 4 | hemoglobin binding |
GO:0034584 | 0.0042 | 36.2293 | 0.1079 | 2 | 4 | piRNA binding |
GO:0043015 | 0.0042 | 6.9258 | 0.6746 | 4 | 25 | gamma-tubulin binding |
GO:0004707 | 0.0046 | 10.8895 | 0.3508 | 3 | 13 | MAP kinase activity |
GO:0019534 | 0.0069 | 24.1512 | 0.1349 | 2 | 5 | toxin transmembrane transporter activity |
GO:0034987 | 0.0069 | 24.1512 | 0.1349 | 2 | 5 | immunoglobulin receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 3.7324 | 13.2898 | 43 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 14.8741 | 1.2505 | 13 | 43 | nucleosomal DNA binding |
GO:0042393 | 0 | 4.3231 | 5.2345 | 20 | 180 | histone binding |
GO:0003677 | 0 | 1.6687 | 65.4019 | 98 | 2249 | DNA binding |
GO:0003682 | 0.0019 | 1.9878 | 13.2898 | 25 | 457 | chromatin binding |
GO:0004165 | 0.0025 | 67.0724 | 0.0872 | 2 | 3 | dodecenoyl-CoA delta-isomerase activity |
GO:0033130 | 0.0025 | 14.3994 | 0.2908 | 3 | 10 | acetylcholine receptor binding |
GO:0086006 | 0.008 | 22.3544 | 0.1454 | 2 | 5 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential |
GO:0042169 | 0.0083 | 5.6061 | 0.8143 | 4 | 28 | SH2 domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 16.4747 | 9.0105 | 89 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 7.9232 | 19.5964 | 106 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 5.2371 | 30.5693 | 115 | 1106 | transmembrane receptor activity |
GO:0038023 | 0 | 4.9536 | 29.4009 | 107 | 1081 | signaling receptor activity |
GO:0060089 | 0 | 4.2439 | 38.4466 | 120 | 1391 | molecular transducer activity |
GO:0005549 | 0 | 18.6793 | 2.1559 | 26 | 78 | odorant binding |
GO:0008392 | 0 | 21.3981 | 0.4422 | 6 | 16 | arachidonic acid epoxygenase activity |
GO:0005198 | 0 | 2.3058 | 17.4405 | 37 | 631 | structural molecule activity |
GO:0008395 | 2e-04 | 8.2212 | 0.8845 | 6 | 32 | steroid hydroxylase activity |
GO:0070405 | 2e-04 | 5.4976 | 1.6584 | 8 | 60 | ammonium ion binding |
GO:0036374 | 4e-04 | 35.4248 | 0.1658 | 3 | 6 | glutathione hydrolase activity |
GO:0030594 | 5e-04 | 4.3501 | 2.2941 | 9 | 83 | neurotransmitter receptor activity |
GO:0008389 | 8e-04 | Inf | 0.0553 | 2 | 2 | coumarin 7-hydroxylase activity |
GO:0004867 | 0.0013 | 4.1383 | 2.1282 | 8 | 77 | serine-type endopeptidase inhibitor activity |
GO:0004252 | 0.0016 | 2.9067 | 4.4223 | 12 | 160 | serine-type endopeptidase activity |
GO:0005506 | 0.0021 | 2.9834 | 3.9524 | 11 | 143 | iron ion binding |
GO:0016712 | 0.0024 | 8.3473 | 0.5804 | 4 | 21 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
GO:0030414 | 0.0032 | 2.8114 | 4.1736 | 11 | 151 | peptidase inhibitor activity |
GO:0015125 | 0.0038 | 11.8035 | 0.3317 | 3 | 12 | bile acid transmembrane transporter activity |
GO:0019825 | 0.0042 | 5.2236 | 1.0779 | 5 | 39 | oxygen binding |
GO:0020037 | 0.0043 | 3.0594 | 3.1509 | 9 | 114 | heme binding |
GO:0022848 | 0.0049 | 10.6224 | 0.3593 | 3 | 13 | acetylcholine-gated cation-selective channel activity |
GO:0022824 | 0.0052 | 4.9327 | 1.1332 | 5 | 41 | transmitter-gated ion channel activity |
GO:0003779 | 0.0054 | 2.0115 | 9.9226 | 19 | 359 | actin binding |
GO:0017171 | 0.0064 | 2.4256 | 5.2239 | 12 | 189 | serine hydrolase activity |
GO:0008422 | 0.0072 | 23.5603 | 0.1382 | 2 | 5 | beta-glucosidase activity |
GO:0019863 | 0.0072 | 23.5603 | 0.1382 | 2 | 5 | IgE binding |
GO:0030883 | 0.0072 | 23.5603 | 0.1382 | 2 | 5 | endogenous lipid antigen binding |
GO:0030884 | 0.0072 | 23.5603 | 0.1382 | 2 | 5 | exogenous lipid antigen binding |
GO:0004629 | 0.0079 | 5.6731 | 0.8015 | 4 | 29 | phospholipase C activity |
GO:0048018 | 0.0089 | 1.8737 | 11.1664 | 20 | 404 | receptor ligand activity |
GO:0016709 | 0.0089 | 5.4545 | 0.8292 | 4 | 30 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen |
GO:0099529 | 0.009 | 8.1695 | 0.4422 | 3 | 16 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential |
GO:0061135 | 0.0097 | 2.5133 | 4.2012 | 10 | 152 | endopeptidase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.9511 | 9.0105 | 64 | 326 | olfactory receptor activity |
GO:0004930 | 0 | 4.7589 | 19.5964 | 74 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 3.7463 | 30.5693 | 91 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 3.3524 | 38.4466 | 102 | 1391 | molecular transducer activity |
GO:0038023 | 0 | 3.511 | 28.7405 | 82 | 1066 | signaling receptor activity |
GO:0005549 | 0 | 11.8162 | 2.1559 | 19 | 78 | odorant binding |
GO:0042393 | 0 | 3.5281 | 4.9751 | 16 | 180 | histone binding |
GO:0001591 | 4e-04 | 35.4248 | 0.1658 | 3 | 6 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0022850 | 4e-04 | 35.4248 | 0.1658 | 3 | 6 | serotonin-gated cation-selective channel activity |
GO:0035240 | 0.0022 | 15.178 | 0.2764 | 3 | 10 | dopamine binding |
GO:0005509 | 0.0042 | 1.7767 | 17.1641 | 29 | 621 | calcium ion binding |
GO:0048018 | 0.0043 | 1.9776 | 11.1664 | 21 | 404 | receptor ligand activity |
GO:0005223 | 0.0044 | 35.3429 | 0.1106 | 2 | 4 | intracellular cGMP activated cation channel activity |
GO:0004252 | 0.0049 | 2.6399 | 4.4223 | 11 | 160 | serine-type endopeptidase activity |
GO:0008307 | 0.0052 | 4.9327 | 1.1332 | 5 | 41 | structural constituent of muscle |
GO:0022835 | 0.0052 | 4.9327 | 1.1332 | 5 | 41 | transmitter-gated channel activity |
GO:0030594 | 0.0056 | 4.8455 | 1.1502 | 5 | 42 | neurotransmitter receptor activity |
GO:0004028 | 0.0072 | 23.5603 | 0.1382 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0015198 | 0.0072 | 23.5603 | 0.1382 | 2 | 5 | oligopeptide transporter activity |
GO:0008329 | 0.0074 | 8.8508 | 0.4146 | 3 | 15 | signaling pattern recognition receptor activity |
GO:0097493 | 0.0074 | 8.8508 | 0.4146 | 3 | 15 | structural molecule activity conferring elasticity |
GO:0051371 | 0.009 | 8.1695 | 0.4422 | 3 | 16 | muscle alpha-actinin binding |
GO:0005201 | 0.0097 | 3.5543 | 1.8242 | 6 | 66 | extracellular matrix structural constituent |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 6.628 | 5.1402 | 28 | 180 | histone binding |
GO:0031492 | 0 | 15.1636 | 1.2279 | 13 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.2843 | 13.0503 | 38 | 457 | protein heterodimerization activity |
GO:0050839 | 7e-04 | 3.256 | 3.9903 | 12 | 143 | cell adhesion molecule binding |
GO:0045296 | 0.0016 | 2.3225 | 8.2243 | 18 | 288 | cadherin binding |
GO:0030492 | 0.0047 | 34.1705 | 0.1142 | 2 | 4 | hemoglobin binding |
GO:0005044 | 0.006 | 4.768 | 1.1708 | 5 | 41 | scavenger receptor activity |
GO:0022857 | 0.0061 | 1.596 | 25.6723 | 39 | 899 | transmembrane transporter activity |
GO:0004252 | 0.0063 | 2.5505 | 4.569 | 11 | 160 | serine-type endopeptidase activity |
GO:0003682 | 0.0063 | 1.8475 | 13.0503 | 23 | 457 | chromatin binding |
GO:0004867 | 0.0064 | 3.441 | 2.1988 | 7 | 77 | serine-type endopeptidase inhibitor activity |
GO:0044877 | 0.0068 | 1.5843 | 25.8436 | 39 | 905 | macromolecular complex binding |
GO:0030246 | 0.0077 | 2.1933 | 6.7108 | 14 | 235 | carbohydrate binding |
GO:0017171 | 0.0082 | 2.3433 | 5.3972 | 12 | 189 | serine hydrolase activity |
GO:0005102 | 0.0085 | 1.4604 | 38.9225 | 54 | 1363 | receptor binding |
GO:0005125 | 0.0085 | 2.33 | 5.4257 | 12 | 190 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.5229 | 6.0715 | 28 | 180 | histone binding |
GO:0046982 | 0 | 2.7253 | 15.4149 | 38 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 8.8329 | 1.4504 | 10 | 43 | nucleosomal DNA binding |
GO:0045296 | 1e-04 | 2.5558 | 9.7144 | 23 | 288 | cadherin binding |
GO:0019904 | 1e-04 | 1.995 | 20.9468 | 39 | 621 | protein domain specific binding |
GO:0003677 | 6e-04 | 1.4687 | 75.8603 | 103 | 2249 | DNA binding |
GO:0005488 | 7e-04 | 1.6157 | 417.1278 | 441 | 12660 | binding |
GO:0004063 | 0.0011 | Inf | 0.0675 | 2 | 2 | aryldialkylphosphatase activity |
GO:0000981 | 0.0027 | 1.693 | 23.6452 | 38 | 701 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0000987 | 0.0028 | 2.0257 | 11.4684 | 22 | 340 | core promoter proximal region sequence-specific DNA binding |
GO:0102007 | 0.0033 | 57.5127 | 0.1012 | 2 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
GO:0003682 | 0.0035 | 1.8429 | 15.4149 | 27 | 457 | chromatin binding |
GO:0001784 | 0.0041 | 5.3471 | 1.0794 | 5 | 32 | phosphotyrosine residue binding |
GO:0140110 | 0.0041 | 1.4574 | 48.5722 | 67 | 1440 | transcription regulator activity |
GO:0004713 | 0.0051 | 2.4075 | 5.7342 | 13 | 170 | protein tyrosine kinase activity |
GO:0001191 | 0.006 | 4.8114 | 1.1806 | 5 | 35 | transcriptional repressor activity, RNA polymerase II transcription factor binding |
GO:0005329 | 0.0065 | 28.7544 | 0.1349 | 2 | 4 | dopamine transmembrane transporter activity |
GO:0017016 | 0.0073 | 1.7542 | 15.5161 | 26 | 460 | Ras GTPase binding |
GO:1990837 | 0.0079 | 1.6053 | 22.8019 | 35 | 676 | sequence-specific double-stranded DNA binding |
GO:0000977 | 0.009 | 1.6535 | 18.9566 | 30 | 562 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0051020 | 0.009 | 1.6535 | 18.9566 | 30 | 562 | GTPase binding |
GO:0001077 | 0.0098 | 2.0157 | 8.3315 | 16 | 247 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 2.871 | 19.3178 | 49 | 709 | G-protein coupled receptor activity |
GO:0099600 | 0 | 2.4569 | 30.1347 | 65 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 2.2623 | 37.8999 | 75 | 1391 | molecular transducer activity |
GO:0004984 | 0 | 3.0909 | 8.8824 | 25 | 326 | olfactory receptor activity |
GO:0038023 | 0 | 2.0653 | 25.3987 | 48 | 964 | signaling receptor activity |
GO:0046982 | 1e-04 | 2.4262 | 12.4517 | 28 | 457 | protein heterodimerization activity |
GO:0001653 | 1e-04 | 4.1717 | 3.1878 | 12 | 117 | peptide receptor activity |
GO:0042393 | 1e-04 | 3.3296 | 4.9044 | 15 | 180 | histone binding |
GO:0004467 | 2e-04 | 20.5895 | 0.2997 | 4 | 11 | long-chain fatty acid-CoA ligase activity |
GO:0031957 | 6e-04 | 26.9637 | 0.1907 | 3 | 7 | very long-chain fatty acid-CoA ligase activity |
GO:0102391 | 6e-04 | 26.9637 | 0.1907 | 3 | 7 | decanoate--CoA ligase activity |
GO:0008188 | 8e-04 | 6.1953 | 1.1171 | 6 | 41 | neuropeptide receptor activity |
GO:0000981 | 8e-04 | 1.8929 | 19.0998 | 34 | 701 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0043565 | 0.0012 | 1.7327 | 25.7752 | 42 | 946 | sequence-specific DNA binding |
GO:0016934 | 0.0022 | 71.744 | 0.0817 | 2 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0016594 | 0.0037 | 11.9798 | 0.327 | 3 | 12 | glycine binding |
GO:0047961 | 0.0043 | 35.8696 | 0.109 | 2 | 4 | glycine N-acyltransferase activity |
GO:0031406 | 0.0051 | 2.6267 | 4.4412 | 11 | 163 | carboxylic acid binding |
GO:0005549 | 0.0053 | 3.563 | 2.1252 | 7 | 78 | odorant binding |
GO:0003823 | 0.0066 | 4.6207 | 1.1988 | 5 | 44 | antigen binding |
GO:0048495 | 0.007 | 23.9114 | 0.1362 | 2 | 5 | Roundabout binding |
GO:0030594 | 0.0074 | 3.3275 | 2.2615 | 7 | 83 | neurotransmitter receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001601 | 0.0021 | 73.9453 | 0.0794 | 2 | 3 | peptide YY receptor activity |
GO:0046982 | 0.0025 | 2.0071 | 12.0925 | 23 | 457 | protein heterodimerization activity |
GO:0015293 | 0.0028 | 3.0418 | 3.5193 | 10 | 133 | symporter activity |
GO:0001602 | 0.004 | 36.9701 | 0.1058 | 2 | 4 | pancreatic polypeptide receptor activity |
GO:0004656 | 0.004 | 36.9701 | 0.1058 | 2 | 4 | procollagen-proline 4-dioxygenase activity |
GO:0004687 | 0.004 | 36.9701 | 0.1058 | 2 | 4 | myosin light chain kinase activity |
GO:0046943 | 0.0043 | 3.0561 | 3.1488 | 9 | 119 | carboxylic acid transmembrane transporter activity |
GO:0005102 | 0.0046 | 1.5272 | 36.0658 | 52 | 1363 | receptor binding |
GO:0019838 | 0.0046 | 3.0283 | 3.1753 | 9 | 120 | growth factor binding |
GO:0008509 | 0.0058 | 2.2004 | 7.1708 | 15 | 271 | anion transmembrane transporter activity |
GO:0015129 | 0.0066 | 24.6451 | 0.1323 | 2 | 5 | lactate transmembrane transporter activity |
GO:0017049 | 0.008 | 8.5465 | 0.4234 | 3 | 16 | GTP-Rho binding |
GO:0022857 | 0.0087 | 1.5871 | 23.7881 | 36 | 899 | transmembrane transporter activity |
GO:0005132 | 0.0098 | 18.4826 | 0.1588 | 2 | 6 | type I interferon receptor binding |
GO:0055131 | 0.0098 | 18.4826 | 0.1588 | 2 | 6 | C3HC4-type RING finger domain binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 10.0404 | 1.4504 | 11 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 2.3946 | 15.4149 | 34 | 457 | protein heterodimerization activity |
GO:0042393 | 4e-04 | 2.8523 | 6.0715 | 16 | 180 | histone binding |
GO:0003677 | 0.0013 | 1.4316 | 75.8603 | 101 | 2249 | DNA binding |
GO:0019199 | 0.004 | 3.4076 | 2.5635 | 8 | 76 | transmembrane receptor protein kinase activity |
GO:0005025 | 0.0065 | 28.7544 | 0.1349 | 2 | 4 | transforming growth factor beta receptor activity, type I |
GO:0043422 | 0.0067 | 9.599 | 0.4048 | 3 | 12 | protein kinase B binding |
GO:0097159 | 0.0079 | 1.2527 | 185.485 | 212 | 5499 | organic cyclic compound binding |
GO:0000978 | 0.008 | 1.8949 | 11.0637 | 20 | 328 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:1901363 | 0.0089 | 1.2488 | 182.9889 | 209 | 5425 | heterocyclic compound binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031492 | 0 | 9.8383 | 1.4786 | 11 | 43 | nucleosomal DNA binding |
GO:0003700 | 0 | 1.8277 | 38.6151 | 65 | 1123 | DNA binding transcription factor activity |
GO:0005509 | 4e-04 | 1.8952 | 21.3535 | 38 | 621 | calcium ion binding |
GO:0042923 | 5e-04 | 9.441 | 0.6877 | 5 | 20 | neuropeptide binding |
GO:0003677 | 5e-04 | 1.4691 | 77.3333 | 105 | 2249 | DNA binding |
GO:0001653 | 7e-04 | 3.261 | 4.0231 | 12 | 117 | peptide receptor activity |
GO:0004966 | 0.0013 | 21.1767 | 0.2407 | 3 | 7 | galanin receptor activity |
GO:0004983 | 0.002 | 16.9402 | 0.2751 | 3 | 8 | neuropeptide Y receptor activity |
GO:0004985 | 0.002 | 16.9402 | 0.2751 | 3 | 8 | opioid receptor activity |
GO:0004090 | 0.0035 | 56.3748 | 0.1032 | 2 | 3 | carbonyl reductase (NADPH) activity |
GO:0004938 | 0.0035 | 56.3748 | 0.1032 | 2 | 3 | alpha2-adrenergic receptor activity |
GO:0005275 | 0.0035 | 56.3748 | 0.1032 | 2 | 3 | amine transmembrane transporter activity |
GO:0046848 | 0.0035 | 56.3748 | 0.1032 | 2 | 3 | hydroxyapatite binding |
GO:0045296 | 0.0052 | 2.0204 | 9.9031 | 19 | 288 | cadherin binding |
GO:0001228 | 0.0055 | 1.8731 | 12.8946 | 23 | 375 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0030295 | 0.0062 | 3.4817 | 2.2007 | 7 | 64 | protein kinase activator activity |
GO:0004095 | 0.0068 | 28.1855 | 0.1375 | 2 | 4 | carnitine O-palmitoyltransferase activity |
GO:0046982 | 0.0085 | 1.7302 | 15.7142 | 26 | 457 | protein heterodimerization activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004890 | 5e-04 | 14.359 | 0.3934 | 4 | 13 | GABA-A receptor activity |
GO:0036374 | 5e-04 | 32.2505 | 0.1816 | 3 | 6 | glutathione hydrolase activity |
GO:0005201 | 8e-04 | 4.4806 | 1.9971 | 8 | 66 | extracellular matrix structural constituent |
GO:0004458 | 9e-04 | Inf | 0.0605 | 2 | 2 | D-lactate dehydrogenase (cytochrome) activity |
GO:0015238 | 0.0011 | 10.7671 | 0.4841 | 4 | 16 | drug transmembrane transporter activity |
GO:0022841 | 0.0011 | 10.7671 | 0.4841 | 4 | 16 | potassium ion leak channel activity |
GO:0022842 | 0.0022 | 8.6119 | 0.5749 | 4 | 19 | narrow pore channel activity |
GO:0004965 | 0.0027 | 64.3696 | 0.0908 | 2 | 3 | G-protein coupled GABA receptor activity |
GO:0015222 | 0.0027 | 64.3696 | 0.0908 | 2 | 3 | serotonin transmembrane transporter activity |
GO:0030345 | 0.0027 | 64.3696 | 0.0908 | 2 | 3 | structural constituent of tooth enamel |
GO:0004687 | 0.0053 | 32.1826 | 0.121 | 2 | 4 | myosin light chain kinase activity |
GO:0005030 | 0.0053 | 32.1826 | 0.121 | 2 | 4 | neurotrophin receptor activity |
GO:0008503 | 0.0053 | 32.1826 | 0.121 | 2 | 4 | benzodiazepine receptor activity |
GO:0015079 | 0.0057 | 2.5924 | 4.5086 | 11 | 149 | potassium ion transmembrane transporter activity |
GO:0008066 | 0.0063 | 6.1489 | 0.7565 | 4 | 25 | glutamate receptor activity |
GO:0022836 | 0.0068 | 2.049 | 8.7147 | 17 | 288 | gated channel activity |
GO:0015277 | 0.0086 | 21.4536 | 0.1513 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0030594 | 0.0097 | 3.1618 | 2.3808 | 7 | 79 | neurotransmitter receptor activity |
GO:0140110 | 0.01 | 1.4232 | 43.5735 | 59 | 1440 | transcription regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 6.1469 | 5.5056 | 28 | 180 | histone binding |
GO:0004930 | 0 | 2.8877 | 21.6861 | 55 | 709 | G-protein coupled receptor activity |
GO:0031492 | 0 | 14.0986 | 1.3152 | 13 | 43 | nucleosomal DNA binding |
GO:0004984 | 0 | 3.9016 | 9.9713 | 34 | 326 | olfactory receptor activity |
GO:0099600 | 0 | 2.3011 | 33.8291 | 69 | 1106 | transmembrane receptor activity |
GO:0060089 | 0 | 2.1271 | 42.5463 | 80 | 1391 | molecular transducer activity |
GO:0046982 | 0 | 2.669 | 13.9782 | 34 | 457 | protein heterodimerization activity |
GO:0038023 | 0 | 2.0512 | 31.6498 | 59 | 1047 | signaling receptor activity |
GO:0015079 | 1e-04 | 3.6324 | 4.5574 | 15 | 149 | potassium ion transmembrane transporter activity |
GO:0005244 | 1e-04 | 3.2058 | 5.4445 | 16 | 178 | voltage-gated ion channel activity |
GO:0005261 | 1e-04 | 2.6437 | 8.5643 | 21 | 280 | cation channel activity |
GO:0022836 | 2e-04 | 2.5631 | 8.809 | 21 | 288 | gated channel activity |
GO:0022803 | 4e-04 | 2.1959 | 12.6324 | 26 | 413 | passive transmembrane transporter activity |
GO:0005539 | 5e-04 | 2.8732 | 5.628 | 15 | 184 | glycosaminoglycan binding |
GO:0022838 | 7e-04 | 2.1794 | 11.7148 | 24 | 383 | substrate-specific channel activity |
GO:0005298 | 9e-04 | Inf | 0.0612 | 2 | 2 | proline:sodium symporter activity |
GO:0005249 | 0.001 | 4.3153 | 2.0647 | 8 | 68 | voltage-gated potassium channel activity |
GO:0008188 | 0.0014 | 5.4909 | 1.2541 | 6 | 41 | neuropeptide receptor activity |
GO:0005416 | 0.0015 | 9.8275 | 0.52 | 4 | 17 | cation:amino acid symporter activity |
GO:0005184 | 0.0017 | 6.6635 | 0.887 | 5 | 29 | neuropeptide hormone activity |
GO:0098960 | 0.0019 | 9.125 | 0.5506 | 4 | 18 | postsynaptic neurotransmitter receptor activity |
GO:0022890 | 0.0022 | 1.9131 | 14.8958 | 27 | 487 | inorganic cation transmembrane transporter activity |
GO:0005242 | 0.0023 | 8.5161 | 0.5812 | 4 | 19 | inward rectifier potassium channel activity |
GO:0045296 | 0.0034 | 2.1575 | 8.809 | 18 | 288 | cadherin binding |
GO:0005248 | 0.0034 | 7.5131 | 0.6423 | 4 | 21 | voltage-gated sodium channel activity |
GO:0005201 | 0.0039 | 3.8023 | 2.0187 | 7 | 66 | extracellular matrix structural constituent |
GO:0004683 | 0.0048 | 6.7214 | 0.7035 | 4 | 23 | calmodulin-dependent protein kinase activity |
GO:0005222 | 0.0054 | 31.8258 | 0.1223 | 2 | 4 | intracellular cAMP activated cation channel activity |
GO:0090722 | 0.0054 | 31.8258 | 0.1223 | 2 | 4 | receptor-receptor interaction |
GO:0022848 | 0.0065 | 9.5631 | 0.3976 | 3 | 13 | acetylcholine-gated cation-selective channel activity |
GO:0009374 | 0.0088 | 21.2158 | 0.1529 | 2 | 5 | biotin binding |
GO:0005518 | 0.0091 | 3.6217 | 1.8046 | 6 | 59 | collagen binding |
GO:0019904 | 0.0092 | 1.6506 | 18.9944 | 30 | 621 | protein domain specific binding |
GO:0001653 | 0.0097 | 2.6734 | 3.5787 | 9 | 117 | peptide receptor activity |
GO:0070405 | 0.0098 | 3.5544 | 1.8352 | 6 | 60 | ammonium ion binding |
GO:0015175 | 0.0099 | 5.3193 | 0.8564 | 4 | 28 | neutral amino acid transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031727 | 1e-04 | 62.6303 | 0.1179 | 3 | 5 | CCR2 chemokine receptor binding |
GO:0030295 | 7e-04 | 5.1666 | 1.509 | 7 | 64 | protein kinase activator activity |
GO:0004181 | 0.0016 | 9.2946 | 0.5187 | 4 | 22 | metallocarboxypeptidase activity |
GO:0005509 | 0.0017 | 1.9539 | 14.6424 | 27 | 621 | calcium ion binding |
GO:0004984 | 0.0019 | 2.3416 | 7.6867 | 17 | 326 | olfactory receptor activity |
GO:0004930 | 0.0029 | 1.8332 | 16.7173 | 29 | 709 | G-protein coupled receptor activity |
GO:0005105 | 0.0032 | 41.6369 | 0.0943 | 2 | 4 | type 1 fibroblast growth factor receptor binding |
GO:0005545 | 0.0039 | 11.3804 | 0.3301 | 3 | 14 | 1-phosphatidylinositol binding |
GO:0005123 | 0.0048 | 10.4314 | 0.3537 | 3 | 15 | death receptor binding |
GO:0004871 | 0.0071 | 1.5095 | 34.3778 | 49 | 1458 | signal transducer activity |
GO:0060089 | 0.0076 | 1.5155 | 32.798 | 47 | 1391 | molecular transducer activity |
GO:0004867 | 0.0096 | 3.5419 | 1.8156 | 6 | 77 | serine-type endopeptidase inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.0192 | 6.0951 | 26 | 180 | histone binding |
GO:0046982 | 0 | 3.1416 | 15.4748 | 43 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 9.9993 | 1.4561 | 11 | 43 | nucleosomal DNA binding |
GO:0003677 | 0 | 1.6129 | 76.1549 | 111 | 2249 | DNA binding |
GO:0000981 | 0 | 2.0485 | 23.737 | 45 | 701 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0001067 | 1e-04 | 1.9097 | 26.446 | 47 | 781 | regulatory region nucleic acid binding |
GO:1990837 | 2e-04 | 1.9488 | 22.5323 | 41 | 669 | sequence-specific double-stranded DNA binding |
GO:0003680 | 0.0012 | 21.518 | 0.237 | 3 | 7 | AT DNA binding |
GO:0140110 | 0.0019 | 1.5031 | 48.7608 | 69 | 1440 | transcription regulator activity |
GO:0044212 | 0.003 | 1.8915 | 14.4895 | 26 | 436 | transcription regulatory region DNA binding |
GO:0048403 | 0.0034 | 57.2816 | 0.1016 | 2 | 3 | brain-derived neurotrophic factor binding |
GO:0001965 | 0.0034 | 7.66 | 0.6434 | 4 | 19 | G-protein alpha-subunit binding |
GO:0019904 | 0.0041 | 1.6986 | 21.0281 | 34 | 621 | protein domain specific binding |
GO:0001077 | 0.0045 | 2.1466 | 8.3638 | 17 | 247 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0000977 | 0.0052 | 2.1706 | 7.7843 | 16 | 234 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0048018 | 0.0056 | 1.8411 | 13.6801 | 24 | 404 | receptor ligand activity |
GO:0005031 | 0.0059 | 6.3821 | 0.745 | 4 | 22 | tumor necrosis factor-activated receptor activity |
GO:0015106 | 0.0059 | 6.3821 | 0.745 | 4 | 22 | bicarbonate transmembrane transporter activity |
GO:0000253 | 0.0066 | 28.6388 | 0.1354 | 2 | 4 | 3-keto sterol reductase activity |
GO:0030492 | 0.0066 | 28.6388 | 0.1354 | 2 | 4 | hemoglobin binding |
GO:0001159 | 0.0067 | 1.8972 | 11.6146 | 21 | 343 | core promoter proximal region DNA binding |
GO:0005509 | 0.0072 | 1.6423 | 21.0281 | 33 | 621 | calcium ion binding |
GO:0015296 | 0.0072 | 3.8372 | 1.7269 | 6 | 51 | anion:cation symporter activity |
GO:0000978 | 0.0083 | 1.887 | 11.1066 | 20 | 328 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0005104 | 0.0093 | 5.4692 | 0.8465 | 4 | 25 | fibroblast growth factor receptor binding |
GO:0032813 | 0.0097 | 4.2271 | 1.3206 | 5 | 39 | tumor necrosis factor receptor superfamily binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050840 | 1e-04 | 6.5361 | 1.4552 | 8 | 46 | extracellular matrix binding |
GO:0098632 | 0.0017 | 6.7137 | 0.8858 | 5 | 28 | cell-cell adhesion mediator activity |
GO:0005088 | 0.0027 | 2.3328 | 7.276 | 16 | 230 | Ras guanyl-nucleotide exchange factor activity |
GO:0004090 | 0.0029 | 61.4719 | 0.0949 | 2 | 3 | carbonyl reductase (NADPH) activity |
GO:0031781 | 0.0029 | 61.4719 | 0.0949 | 2 | 3 | type 3 melanocortin receptor binding |
GO:0031782 | 0.0029 | 61.4719 | 0.0949 | 2 | 3 | type 4 melanocortin receptor binding |
GO:0035663 | 0.0029 | 61.4719 | 0.0949 | 2 | 3 | Toll-like receptor 2 binding |
GO:0043120 | 0.0029 | 61.4719 | 0.0949 | 2 | 3 | tumor necrosis factor binding |
GO:0070996 | 0.0029 | 61.4719 | 0.0949 | 2 | 3 | type 1 melanocortin receptor binding |
GO:0048018 | 0.0049 | 1.8903 | 12.7805 | 23 | 404 | receptor ligand activity |
GO:0008574 | 0.0085 | 5.6037 | 0.8225 | 4 | 26 | ATP-dependent microtubule motor activity, plus-end-directed |
GO:0045236 | 0.0088 | 8.3943 | 0.4429 | 3 | 14 | CXCR chemokine receptor binding |
GO:0017124 | 0.0091 | 2.7065 | 3.5431 | 9 | 112 | SH3 domain binding |
GO:0003996 | 0.0094 | 20.4879 | 0.1582 | 2 | 5 | acyl-CoA ligase activity |
GO:0022849 | 0.0094 | 20.4879 | 0.1582 | 2 | 5 | glutamate-gated calcium ion channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.8284 | 6.5903 | 27 | 180 | histone binding |
GO:0046982 | 0 | 2.5642 | 16.7319 | 39 | 457 | protein heterodimerization activity |
GO:0031492 | 0 | 8.1007 | 1.5743 | 10 | 43 | nucleosomal DNA binding |
GO:0001540 | 2e-04 | 5.6055 | 1.6842 | 8 | 46 | amyloid-beta binding |
GO:0050431 | 4e-04 | 10.2027 | 0.659 | 5 | 18 | transforming growth factor beta binding |
GO:0045296 | 4e-04 | 2.3389 | 10.5444 | 23 | 288 | cadherin binding |
GO:0004111 | 9e-04 | 26.4496 | 0.2197 | 3 | 6 | creatine kinase activity |
GO:0008499 | 0.001 | 11.7718 | 0.476 | 4 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0016723 | 0.0015 | 19.8359 | 0.2563 | 3 | 7 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
GO:0043395 | 0.0023 | 8.827 | 0.5858 | 4 | 16 | heparan sulfate proteoglycan binding |
GO:0019911 | 0.0024 | 15.8676 | 0.2929 | 3 | 8 | structural constituent of myelin sheath |
GO:0005201 | 0.0027 | 3.6676 | 2.4164 | 8 | 66 | extracellular matrix structural constituent |
GO:0033218 | 0.003 | 2.1393 | 9.4094 | 19 | 257 | amide binding |
GO:0016595 | 0.0035 | 13.2221 | 0.3295 | 3 | 9 | glutamate binding |
GO:0004351 | 0.0039 | 52.8115 | 0.1098 | 2 | 3 | glutamate decarboxylase activity |
GO:0008378 | 0.005 | 5.0968 | 1.135 | 5 | 31 | galactosyltransferase activity |
GO:0004222 | 0.0055 | 2.7727 | 3.8809 | 10 | 106 | metalloendopeptidase activity |
GO:0030169 | 0.0065 | 9.9152 | 0.4027 | 3 | 11 | low-density lipoprotein particle binding |
GO:0086089 | 0.0076 | 26.4039 | 0.1465 | 2 | 4 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization |
GO:0016879 | 0.0078 | 3.7889 | 1.7574 | 6 | 48 | ligase activity, forming carbon-nitrogen bonds |
GO:0044548 | 0.0084 | 8.8129 | 0.4394 | 3 | 12 | S100 protein binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 6.1348 | 5.7414 | 29 | 180 | histone binding |
GO:0031492 | 0 | 13.4854 | 1.3716 | 13 | 43 | nucleosomal DNA binding |
GO:0004930 | 0 | 2.5106 | 22.6148 | 51 | 709 | G-protein coupled receptor activity |
GO:0004984 | 0 | 3.3383 | 10.3983 | 31 | 326 | olfactory receptor activity |
GO:0005244 | 0 | 3.7335 | 5.6776 | 19 | 178 | voltage-gated ion channel activity |
GO:0046982 | 0 | 2.5476 | 14.5768 | 34 | 457 | protein heterodimerization activity |
GO:0099600 | 0 | 1.9571 | 35.2778 | 63 | 1106 | transmembrane receptor activity |
GO:0005261 | 0 | 2.9411 | 8.9311 | 24 | 280 | cation channel activity |
GO:0060089 | 0 | 1.8011 | 44.3684 | 73 | 1391 | molecular transducer activity |
GO:0015079 | 0 | 3.7413 | 4.7526 | 16 | 149 | potassium ion transmembrane transporter activity |
GO:0022803 | 0 | 2.4678 | 13.1734 | 30 | 413 | passive transmembrane transporter activity |
GO:0022838 | 0 | 2.4789 | 12.2165 | 28 | 383 | substrate-specific channel activity |
GO:0038023 | 0 | 1.8108 | 37.1278 | 62 | 1164 | signaling receptor activity |
GO:0022836 | 1e-04 | 2.7153 | 9.1863 | 23 | 288 | gated channel activity |
GO:0005248 | 4e-04 | 9.5727 | 0.6698 | 5 | 21 | voltage-gated sodium channel activity |
GO:0022890 | 0.001 | 1.9802 | 15.5337 | 29 | 487 | inorganic cation transmembrane transporter activity |
GO:0005298 | 0.001 | Inf | 0.0638 | 2 | 2 | proline:sodium symporter activity |
GO:0005184 | 0.002 | 6.3784 | 0.925 | 5 | 29 | neuropeptide hormone activity |
GO:0015075 | 0.0025 | 1.6902 | 24.3372 | 39 | 763 | ion transmembrane transporter activity |
GO:0005242 | 0.0027 | 8.1524 | 0.606 | 4 | 19 | inward rectifier potassium channel activity |
GO:0015271 | 0.0044 | 11.446 | 0.3509 | 3 | 11 | outward rectifier potassium channel activity |
GO:0005201 | 0.0049 | 3.6389 | 2.1052 | 7 | 66 | extracellular matrix structural constituent |
GO:0008201 | 0.005 | 2.6455 | 4.4337 | 11 | 139 | heparin binding |
GO:0045296 | 0.0052 | 2.0627 | 9.1863 | 18 | 288 | cadherin binding |
GO:0004683 | 0.0056 | 6.4343 | 0.7336 | 4 | 23 | calmodulin-dependent protein kinase activity |
GO:0004634 | 0.0058 | 30.4722 | 0.1276 | 2 | 4 | phosphopyruvate hydratase activity |
GO:0005222 | 0.0058 | 30.4722 | 0.1276 | 2 | 4 | intracellular cAMP activated cation channel activity |
GO:0015183 | 0.0058 | 30.4722 | 0.1276 | 2 | 4 | L-aspartate transmembrane transporter activity |
GO:0090722 | 0.0058 | 30.4722 | 0.1276 | 2 | 4 | receptor-receptor interaction |
GO:0005249 | 0.0088 | 3.6503 | 1.7955 | 6 | 57 | voltage-gated potassium channel activity |
GO:0008188 | 0.0094 | 4.2488 | 1.3078 | 5 | 41 | neuropeptide receptor activity |
GO:0009374 | 0.0095 | 20.3134 | 0.1595 | 2 | 5 | biotin binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006450 | 0.0011 | Inf | 0.0011 | 1 | 17 | regulation of translational fidelity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006957 | 0.0045 | 289.7273 | 0.0045 | 1 | 12 | complement activation, alternative pathway |
GO:0030150 | 0.006 | 212.4133 | 0.006 | 1 | 16 | protein import into mitochondrial matrix |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007218 | 0 | 11.9591 | 1.3141 | 13 | 94 | neuropeptide signaling pathway |
GO:0007187 | 0 | 6.9732 | 2.4604 | 15 | 176 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0050877 | 0 | 2.6174 | 16.0484 | 37 | 1148 | nervous system process |
GO:0021524 | 0 | Inf | 0.0419 | 3 | 3 | visceral motor neuron differentiation |
GO:0051241 | 0 | 2.4881 | 14.3287 | 32 | 1034 | negative regulation of multicellular organismal process |
GO:0007268 | 1e-04 | 2.8005 | 8.164 | 21 | 584 | chemical synaptic transmission |
GO:0099537 | 1e-04 | 2.7902 | 8.192 | 21 | 586 | trans-synaptic signaling |
GO:0007267 | 1e-04 | 2.2932 | 14.9653 | 31 | 1108 | cell-cell signaling |
GO:0009952 | 1e-04 | 4.3836 | 2.726 | 11 | 195 | anterior/posterior pattern specification |
GO:0031290 | 2e-04 | 16.881 | 0.2936 | 4 | 21 | retinal ganglion cell axon guidance |
GO:0007389 | 2e-04 | 3.0163 | 5.7176 | 16 | 409 | pattern specification process |
GO:0046877 | 2e-04 | 35.7341 | 0.1258 | 3 | 9 | regulation of saliva secretion |
GO:0033555 | 3e-04 | 7.1019 | 0.9366 | 6 | 67 | multicellular organismal response to stress |
GO:0097746 | 4e-04 | 4.9651 | 1.7474 | 8 | 125 | regulation of blood vessel diameter |
GO:0009593 | 4e-04 | 2.9689 | 5.424 | 15 | 388 | detection of chemical stimulus |
GO:0021559 | 4e-04 | 26.7972 | 0.1538 | 3 | 11 | trigeminal nerve development |
GO:0072507 | 4e-04 | 2.8312 | 6.0671 | 16 | 434 | divalent inorganic cation homeostasis |
GO:0006874 | 4e-04 | 2.9446 | 5.466 | 15 | 391 | cellular calcium ion homeostasis |
GO:0045596 | 5e-04 | 2.4587 | 8.7511 | 20 | 626 | negative regulation of cell differentiation |
GO:0050768 | 5e-04 | 3.5593 | 3.3131 | 11 | 237 | negative regulation of neurogenesis |
GO:0050906 | 5e-04 | 2.8741 | 5.5918 | 15 | 400 | detection of stimulus involved in sensory perception |
GO:0050885 | 5e-04 | 8.3668 | 0.671 | 5 | 48 | neuromuscular process controlling balance |
GO:0042310 | 5e-04 | 6.4634 | 1.0205 | 6 | 73 | vasoconstriction |
GO:0030799 | 6e-04 | 4.1447 | 2.3346 | 9 | 167 | regulation of cyclic nucleotide metabolic process |
GO:0060913 | 6e-04 | 142.3348 | 0.0419 | 2 | 3 | cardiac cell fate determination |
GO:0035150 | 6e-04 | 4.6078 | 1.8732 | 8 | 134 | regulation of tube size |
GO:0007200 | 6e-04 | 5.2773 | 1.4399 | 7 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0065007 | 6e-04 | 1.693 | 155.1718 | 177 | 11100 | biological regulation |
GO:0007631 | 6e-04 | 5.2226 | 1.4539 | 7 | 104 | feeding behavior |
GO:0003203 | 7e-04 | 11.4732 | 0.4054 | 4 | 29 | endocardial cushion morphogenesis |
GO:0021520 | 7e-04 | 21.435 | 0.1817 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0048935 | 7e-04 | 21.435 | 0.1817 | 3 | 13 | peripheral nervous system neuron development |
GO:0019098 | 8e-04 | 11.0313 | 0.4194 | 4 | 30 | reproductive behavior |
GO:0042711 | 9e-04 | 19.4851 | 0.1957 | 3 | 14 | maternal behavior |
GO:0021545 | 9e-04 | 10.4246 | 0.4398 | 4 | 32 | cranial nerve development |
GO:0060253 | 0.0011 | 17.8602 | 0.2097 | 3 | 15 | negative regulation of glial cell proliferation |
GO:0001662 | 0.0011 | 9.8882 | 0.4613 | 4 | 33 | behavioral fear response |
GO:0001992 | 0.0011 | 71.1629 | 0.0559 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003308 | 0.0011 | 71.1629 | 0.0559 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0007198 | 0.0011 | 71.1629 | 0.0559 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021615 | 0.0011 | 71.1629 | 0.0559 | 2 | 4 | glossopharyngeal nerve morphogenesis |
GO:0070253 | 0.0011 | 71.1629 | 0.0559 | 2 | 4 | somatostatin secretion |
GO:0050794 | 0.0012 | 1.7604 | 49.8596 | 67 | 4072 | regulation of cellular process |
GO:0098664 | 0.0013 | 16.6344 | 0.2217 | 3 | 16 | G-protein coupled serotonin receptor signaling pathway |
GO:0007204 | 0.0014 | 3.1237 | 3.7465 | 11 | 268 | positive regulation of cytosolic calcium ion concentration |
GO:0050911 | 0.0015 | 2.9349 | 4.3476 | 12 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0003018 | 0.0015 | 3.9442 | 2.1668 | 8 | 155 | vascular process in circulatory system |
GO:0071392 | 0.0015 | 8.9595 | 0.5033 | 4 | 36 | cellular response to estradiol stimulus |
GO:0030816 | 0.0015 | 5.2121 | 1.2442 | 6 | 89 | positive regulation of cAMP metabolic process |
GO:0045683 | 0.0016 | 15.3068 | 0.2377 | 3 | 17 | negative regulation of epidermis development |
GO:0060193 | 0.0016 | 6.4192 | 0.8527 | 5 | 61 | positive regulation of lipase activity |
GO:0007186 | 0.0017 | 2.1386 | 11.0766 | 22 | 880 | G-protein coupled receptor signaling pathway |
GO:0035270 | 0.0018 | 4.3243 | 1.7335 | 7 | 124 | endocrine system development |
GO:0045777 | 0.0019 | 8.4314 | 0.5312 | 4 | 38 | positive regulation of blood pressure |
GO:0038170 | 0.0019 | 47.4389 | 0.0699 | 2 | 5 | somatostatin signaling pathway |
GO:0048880 | 0.0019 | 47.4389 | 0.0699 | 2 | 5 | sensory system development |
GO:0051970 | 0.0019 | 47.4389 | 0.0699 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0050795 | 0.0023 | 5.8911 | 0.9226 | 5 | 66 | regulation of behavior |
GO:0019932 | 0.0025 | 2.8944 | 4.0261 | 11 | 288 | second-messenger-mediated signaling |
GO:0048665 | 0.0025 | 12.7693 | 0.2761 | 3 | 20 | neuron fate specification |
GO:0035813 | 0.0026 | 12.6032 | 0.2796 | 3 | 20 | regulation of renal sodium excretion |
GO:0007193 | 0.0027 | 5.6651 | 0.9562 | 5 | 69 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0010840 | 0.0028 | 35.5769 | 0.0839 | 2 | 6 | regulation of circadian sleep/wake cycle, wakefulness |
GO:0021546 | 0.0028 | 35.5769 | 0.0839 | 2 | 6 | rhombomere development |
GO:0007399 | 0.0029 | 1.821 | 18.4521 | 31 | 1381 | nervous system development |
GO:0008306 | 0.003 | 5.5272 | 0.9786 | 5 | 70 | associative learning |
GO:0014821 | 0.003 | 11.9023 | 0.2936 | 3 | 21 | phasic smooth muscle contraction |
GO:0050951 | 0.003 | 11.9023 | 0.2936 | 3 | 21 | sensory perception of temperature stimulus |
GO:0021517 | 0.003 | 7.3481 | 0.6011 | 4 | 43 | ventral spinal cord development |
GO:0021536 | 0.0031 | 5.4431 | 0.9925 | 5 | 71 | diencephalon development |
GO:0009914 | 0.0033 | 2.7819 | 4.1799 | 11 | 299 | hormone transport |
GO:0014070 | 0.0034 | 1.9665 | 12.4697 | 23 | 892 | response to organic cyclic compound |
GO:0060052 | 0.0039 | 28.4597 | 0.0979 | 2 | 7 | neurofilament cytoskeleton organization |
GO:2000542 | 0.0039 | 28.4597 | 0.0979 | 2 | 7 | negative regulation of gastrulation |
GO:0002067 | 0.0041 | 6.6628 | 0.657 | 4 | 47 | glandular epithelial cell differentiation |
GO:0007202 | 0.0044 | 10.2 | 0.3355 | 3 | 24 | activation of phospholipase C activity |
GO:0035640 | 0.0044 | 10.2 | 0.3355 | 3 | 24 | exploration behavior |
GO:0050886 | 0.0045 | 4.9876 | 1.0764 | 5 | 77 | endocrine process |
GO:0007608 | 0.0045 | 10.1014 | 0.3373 | 3 | 25 | sensory perception of smell |
GO:0023061 | 0.0046 | 2.4284 | 5.6477 | 13 | 404 | signal release |
GO:0007611 | 0.0046 | 3.0063 | 3.1594 | 9 | 226 | learning or memory |
GO:0003148 | 0.0049 | 9.7357 | 0.3495 | 3 | 25 | outflow tract septum morphogenesis |
GO:0051960 | 0.0049 | 1.9984 | 10.6104 | 20 | 759 | regulation of nervous system development |
GO:0002118 | 0.0052 | 23.7149 | 0.1118 | 2 | 8 | aggressive behavior |
GO:0045924 | 0.0052 | 23.7149 | 0.1118 | 2 | 8 | regulation of female receptivity |
GO:0048819 | 0.0052 | 23.7149 | 0.1118 | 2 | 8 | regulation of hair follicle maturation |
GO:0055065 | 0.0054 | 2.1617 | 7.8145 | 16 | 559 | metal ion homeostasis |
GO:0003073 | 0.0055 | 4.7239 | 1.1323 | 5 | 81 | regulation of systemic arterial blood pressure |
GO:0021515 | 0.0056 | 6.0942 | 0.713 | 4 | 51 | cell differentiation in spinal cord |
GO:0046887 | 0.0058 | 3.926 | 1.6216 | 6 | 116 | positive regulation of hormone secretion |
GO:0048562 | 0.006 | 2.6982 | 3.9003 | 10 | 279 | embryonic organ morphogenesis |
GO:0042634 | 0.0062 | 8.9233 | 0.3774 | 3 | 27 | regulation of hair cycle |
GO:0061311 | 0.0062 | 8.9233 | 0.3774 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
GO:0001993 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0010579 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0021562 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | vestibulocochlear nerve development |
GO:0038003 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | opioid receptor signaling pathway |
GO:0043950 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | positive regulation of cAMP-mediated signaling |
GO:0044851 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | hair cycle phase |
GO:0046549 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | retinal cone cell development |
GO:0060837 | 0.0066 | 20.3258 | 0.1258 | 2 | 9 | blood vessel endothelial cell differentiation |
GO:0080090 | 0.0068 | 1.4149 | 79.7667 | 98 | 5706 | regulation of primary metabolic process |
GO:0030003 | 0.0069 | 2.1015 | 8.0242 | 16 | 574 | cellular cation homeostasis |
GO:0034767 | 0.0079 | 3.658 | 1.7335 | 6 | 124 | positive regulation of ion transmembrane transport |
GO:0051006 | 0.0081 | 17.7839 | 0.1398 | 2 | 10 | positive regulation of lipoprotein lipase activity |
GO:0051954 | 0.0083 | 7.9303 | 0.4194 | 3 | 30 | positive regulation of amine transport |
GO:0042063 | 0.0085 | 2.7142 | 3.4809 | 9 | 249 | gliogenesis |
GO:0043266 | 0.0086 | 4.2213 | 1.2581 | 5 | 90 | regulation of potassium ion transport |
GO:0051094 | 0.0087 | 1.7237 | 16.6495 | 27 | 1191 | positive regulation of developmental process |
GO:0045471 | 0.0089 | 3.5666 | 1.7754 | 6 | 127 | response to ethanol |
GO:0031323 | 0.009 | 1.3947 | 81.4302 | 99 | 5825 | regulation of cellular metabolic process |
GO:0007420 | 0.009 | 1.991 | 8.9888 | 17 | 643 | brain development |
GO:0019933 | 0.0091 | 4.16 | 1.2753 | 5 | 92 | cAMP-mediated signaling |
GO:1900542 | 0.0094 | 2.669 | 3.5368 | 9 | 253 | regulation of purine nucleotide metabolic process |
GO:0051171 | 0.0096 | 1.3931 | 77.7536 | 95 | 5562 | regulation of nitrogen compound metabolic process |
GO:0001525 | 0.0098 | 2.1973 | 6.2069 | 13 | 444 | angiogenesis |
GO:0019233 | 0.0098 | 4.0766 | 1.3001 | 5 | 93 | sensory perception of pain |
GO:0043278 | 0.0099 | 7.3824 | 0.4473 | 3 | 32 | response to morphine |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031424 | 0 | 77.9406 | 0.0771 | 3 | 205 | keratinization |
GO:0009913 | 2e-04 | 48.216 | 0.123 | 3 | 327 | epidermal cell differentiation |
GO:0043588 | 3e-04 | 40.6345 | 0.1452 | 3 | 386 | skin development |
GO:1903243 | 0.0026 | 531.3333 | 0.0026 | 1 | 7 | negative regulation of cardiac muscle hypertrophy in response to stress |
GO:0035195 | 0.0029 | 34.9356 | 0.0854 | 2 | 227 | gene silencing by miRNA |
GO:0016441 | 0.0031 | 33.8664 | 0.088 | 2 | 234 | posttranscriptional gene silencing |
GO:0031047 | 0.0037 | 30.7667 | 0.0967 | 2 | 257 | gene silencing by RNA |
GO:0014745 | 0.0045 | 289.7273 | 0.0045 | 1 | 12 | negative regulation of muscle adaptation |
GO:1904262 | 0.0053 | 245.1231 | 0.0053 | 1 | 14 | negative regulation of TORC1 signaling |
GO:0034249 | 0.0062 | 23.5151 | 0.1256 | 2 | 334 | negative regulation of cellular amide metabolic process |
GO:0060429 | 0.0069 | 12.4907 | 0.4457 | 3 | 1185 | epithelium development |
GO:0010612 | 0.0071 | 176.9778 | 0.0071 | 1 | 19 | regulation of cardiac muscle adaptation |
GO:0055022 | 0.0075 | 167.6526 | 0.0075 | 1 | 20 | negative regulation of cardiac muscle tissue growth |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0098706 | 3e-04 | Inf | 3e-04 | 1 | 4 | ferric iron import across plasma membrane |
GO:0015677 | 3e-04 | Inf | 3e-04 | 1 | 5 | copper ion import |
GO:0097286 | 8e-04 | Inf | 8e-04 | 1 | 12 | iron ion import |
GO:0034755 | 0.0011 | Inf | 0.0011 | 1 | 18 | iron ion transmembrane transport |
GO:0015682 | 0.0024 | Inf | 0.0024 | 1 | 38 | ferric iron transport |
GO:0098659 | 0.0025 | Inf | 0.0025 | 1 | 40 | inorganic cation import across plasma membrane |
GO:0098739 | 0.0034 | Inf | 0.0034 | 1 | 54 | import across plasma membrane |
GO:0055072 | 0.0051 | Inf | 0.0051 | 1 | 81 | iron ion homeostasis |
GO:0000041 | 0.0064 | Inf | 0.0064 | 1 | 102 | transition metal ion transport |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 3.9434 | 18.5827 | 61 | 388 | detection of chemical stimulus |
GO:0050911 | 0 | 4.3137 | 14.8949 | 53 | 311 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050877 | 0 | 2.4831 | 54.9819 | 117 | 1148 | nervous system process |
GO:0050906 | 0 | 3.6437 | 19.1575 | 59 | 400 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 2.6689 | 40.444 | 93 | 883 | G-protein coupled receptor signaling pathway |
GO:0007218 | 0 | 7.4126 | 4.502 | 25 | 94 | neuropeptide signaling pathway |
GO:0009952 | 0 | 4.6742 | 9.3393 | 36 | 195 | anterior/posterior pattern specification |
GO:0007389 | 0 | 3.0805 | 15.4896 | 42 | 326 | pattern specification process |
GO:0032501 | 0 | 1.4413 | 289.1398 | 350 | 6312 | multicellular organismal process |
GO:0060173 | 0 | 3.1979 | 8.094 | 23 | 169 | limb development |
GO:0009954 | 0 | 8.2176 | 1.4847 | 9 | 31 | proximal/distal pattern formation |
GO:0098664 | 0 | 10.7941 | 0.9579 | 7 | 20 | G-protein coupled serotonin receptor signaling pathway |
GO:0046883 | 0 | 2.5157 | 11.734 | 27 | 245 | regulation of hormone secretion |
GO:0045944 | 1e-04 | 1.672 | 50.7194 | 79 | 1059 | positive regulation of transcription from RNA polymerase II promoter |
GO:0070098 | 1e-04 | 4.1558 | 3.6399 | 13 | 76 | chemokine-mediated signaling pathway |
GO:0035107 | 1e-04 | 3.0487 | 6.9446 | 19 | 145 | appendage morphogenesis |
GO:0048663 | 1e-04 | 4.3119 | 3.2568 | 12 | 68 | neuron fate commitment |
GO:0050794 | 1e-04 | 1.346 | 474.0038 | 523 | 9897 | regulation of cellular process |
GO:0009914 | 1e-04 | 2.2668 | 14.3202 | 30 | 299 | hormone transport |
GO:0021524 | 1e-04 | Inf | 0.1437 | 3 | 3 | visceral motor neuron differentiation |
GO:0048704 | 1e-04 | 3.6161 | 4.4062 | 14 | 92 | embryonic skeletal system morphogenesis |
GO:0023061 | 1e-04 | 2.0553 | 19.349 | 37 | 404 | signal release |
GO:0021536 | 1e-04 | 4.0919 | 3.4005 | 12 | 71 | diencephalon development |
GO:0021515 | 1e-04 | 4.8997 | 2.4426 | 10 | 51 | cell differentiation in spinal cord |
GO:0002862 | 1e-04 | 14.2867 | 0.5747 | 5 | 12 | negative regulation of inflammatory response to antigenic stimulus |
GO:0001708 | 2e-04 | 3.8456 | 3.5793 | 12 | 75 | cell fate specification |
GO:0003016 | 2e-04 | 7.0129 | 1.2931 | 7 | 27 | respiratory system process |
GO:0065007 | 2e-04 | 1.3479 | 531.6199 | 575 | 11100 | biological regulation |
GO:0006355 | 2e-04 | 1.354 | 163.1259 | 203 | 3406 | regulation of transcription, DNA-templated |
GO:0001763 | 3e-04 | 2.5422 | 9.004 | 21 | 188 | morphogenesis of a branching structure |
GO:2001141 | 3e-04 | 1.3492 | 164.419 | 204 | 3433 | regulation of RNA biosynthetic process |
GO:0019935 | 3e-04 | 3.1157 | 5.3641 | 15 | 112 | cyclic-nucleotide-mediated signaling |
GO:0030326 | 3e-04 | 2.932 | 6.0346 | 16 | 126 | embryonic limb morphogenesis |
GO:0007200 | 4e-04 | 3.1668 | 4.933 | 14 | 103 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0097756 | 4e-04 | 3.5482 | 3.8315 | 12 | 80 | negative regulation of blood vessel diameter |
GO:0003257 | 4e-04 | 59.8699 | 0.1916 | 3 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0034287 | 4e-04 | 59.8699 | 0.1916 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 4e-04 | 59.8699 | 0.1916 | 3 | 4 | detection of glucose |
GO:0007631 | 4e-04 | 3.1314 | 4.9809 | 14 | 104 | feeding behavior |
GO:0019233 | 5e-04 | 3.269 | 4.4541 | 13 | 93 | sensory perception of pain |
GO:0046877 | 5e-04 | 15.9821 | 0.431 | 4 | 9 | regulation of saliva secretion |
GO:0048562 | 6e-04 | 2.4515 | 8.843 | 20 | 187 | embryonic organ morphogenesis |
GO:0050880 | 6e-04 | 2.7553 | 6.3699 | 16 | 133 | regulation of blood vessel size |
GO:0070374 | 8e-04 | 2.389 | 9.0519 | 20 | 189 | positive regulation of ERK1 and ERK2 cascade |
GO:0043388 | 8e-04 | 4.1028 | 2.5384 | 9 | 53 | positive regulation of DNA binding |
GO:0021520 | 9e-04 | 13.3518 | 0.4778 | 4 | 10 | spinal cord motor neuron cell fate specification |
GO:0048935 | 9e-04 | 13.3518 | 0.4778 | 4 | 10 | peripheral nervous system neuron development |
GO:0007189 | 9e-04 | 3.717 | 3.0652 | 10 | 64 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0060346 | 9e-04 | 13.3175 | 0.4789 | 4 | 10 | bone trabecula formation |
GO:0035296 | 9e-04 | 2.7451 | 5.9867 | 15 | 125 | regulation of tube diameter |
GO:0090277 | 0.001 | 3.173 | 4.2146 | 12 | 88 | positive regulation of peptide hormone secretion |
GO:2000725 | 0.001 | 5.1924 | 1.6284 | 7 | 34 | regulation of cardiac muscle cell differentiation |
GO:0048880 | 0.001 | 29.933 | 0.2395 | 3 | 5 | sensory system development |
GO:0071799 | 0.001 | 29.933 | 0.2395 | 3 | 5 | cellular response to prostaglandin D stimulus |
GO:0007187 | 0.0011 | 6.1217 | 1.2225 | 6 | 26 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0008284 | 0.0011 | 1.5829 | 40.0391 | 60 | 836 | positive regulation of cell proliferation |
GO:0001759 | 0.0013 | 7.6898 | 0.8621 | 5 | 18 | organ induction |
GO:0060379 | 0.0013 | 11.4143 | 0.5268 | 4 | 11 | cardiac muscle cell myoblast differentiation |
GO:0032101 | 0.0015 | 1.6233 | 33.1424 | 51 | 692 | regulation of response to external stimulus |
GO:0021602 | 0.0015 | 5.7169 | 1.2931 | 6 | 27 | cranial nerve morphogenesis |
GO:0032502 | 0.0016 | 1.2591 | 259.8584 | 298 | 5492 | developmental process |
GO:0002548 | 0.0016 | 3.683 | 2.7778 | 9 | 58 | monocyte chemotaxis |
GO:0048706 | 0.0017 | 5.5308 | 1.3241 | 6 | 28 | embryonic skeletal system development |
GO:0090596 | 0.0017 | 2.083 | 11.7818 | 23 | 246 | sensory organ morphogenesis |
GO:0042472 | 0.0017 | 2.9397 | 4.502 | 12 | 94 | inner ear morphogenesis |
GO:0048754 | 0.0018 | 2.6456 | 5.7652 | 14 | 121 | branching morphogenesis of an epithelial tube |
GO:0002070 | 0.0019 | 10.0125 | 0.5733 | 4 | 12 | epithelial cell maturation |
GO:0019731 | 0.0019 | 4.5212 | 1.82 | 7 | 38 | antibacterial humoral response |
GO:0009996 | 0.002 | 19.954 | 0.2874 | 3 | 6 | negative regulation of cell fate specification |
GO:0010840 | 0.002 | 19.954 | 0.2874 | 3 | 6 | regulation of circadian sleep/wake cycle, wakefulness |
GO:0038031 | 0.002 | 19.954 | 0.2874 | 3 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
GO:0009790 | 0.002 | 1.8394 | 17.8391 | 31 | 379 | embryo development |
GO:0071346 | 0.002 | 2.5147 | 6.4656 | 15 | 135 | cellular response to interferon-gamma |
GO:1903508 | 0.0021 | 1.4254 | 65.0875 | 88 | 1359 | positive regulation of nucleic acid-templated transcription |
GO:0002227 | 0.0021 | 6.6636 | 0.9579 | 5 | 20 | innate immune response in mucosa |
GO:0019219 | 0.0021 | 1.2705 | 190.6647 | 225 | 3981 | regulation of nucleobase-containing compound metabolic process |
GO:0021546 | 0.0023 | Inf | 0.0954 | 2 | 2 | rhombomere development |
GO:0002506 | 0.0023 | Inf | 0.0958 | 2 | 2 | polysaccharide assembly with MHC class II protein complex |
GO:0021570 | 0.0023 | Inf | 0.0958 | 2 | 2 | rhombomere 4 development |
GO:0031635 | 0.0023 | Inf | 0.0958 | 2 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
GO:0033693 | 0.0023 | Inf | 0.0958 | 2 | 2 | neurofilament bundle assembly |
GO:0036345 | 0.0023 | Inf | 0.0958 | 2 | 2 | platelet maturation |
GO:0060577 | 0.0023 | Inf | 0.0958 | 2 | 2 | pulmonary vein morphogenesis |
GO:0071823 | 0.0023 | Inf | 0.0958 | 2 | 2 | protein-carbohydrate complex subunit organization |
GO:2000043 | 0.0023 | Inf | 0.0958 | 2 | 2 | regulation of cardiac cell fate specification |
GO:0007188 | 0.0024 | 2.9726 | 4.0813 | 11 | 86 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0060326 | 0.0025 | 2.0186 | 12.1171 | 23 | 253 | cell chemotaxis |
GO:0071805 | 0.0025 | 2.1879 | 9.2914 | 19 | 194 | potassium ion transmembrane transport |
GO:0021545 | 0.0026 | 6.2878 | 0.9996 | 5 | 21 | cranial nerve development |
GO:1901213 | 0.0026 | 8.8766 | 0.6226 | 4 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0031328 | 0.0027 | 1.3697 | 82.425 | 107 | 1721 | positive regulation of cellular biosynthetic process |
GO:0031290 | 0.0027 | 6.2467 | 1.0058 | 5 | 21 | retinal ganglion cell axon guidance |
GO:0035270 | 0.0028 | 2.753 | 4.7652 | 12 | 100 | endocrine system development |
GO:0009889 | 0.0033 | 1.2515 | 203.6439 | 237 | 4252 | regulation of biosynthetic process |
GO:2000049 | 0.0033 | 14.9645 | 0.3353 | 3 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:2000542 | 0.0033 | 14.9645 | 0.3353 | 3 | 7 | negative regulation of gastrulation |
GO:0060444 | 0.0033 | 5.8789 | 1.0537 | 5 | 22 | branching involved in mammary gland duct morphogenesis |
GO:0098916 | 0.0034 | 1.6147 | 27.9699 | 43 | 584 | anterograde trans-synaptic signaling |
GO:0042737 | 0.0036 | 7.9884 | 0.6705 | 4 | 14 | drug catabolic process |
GO:0099536 | 0.0036 | 1.6085 | 28.0657 | 43 | 586 | synaptic signaling |
GO:0021517 | 0.004 | 3.892 | 2.0594 | 7 | 43 | ventral spinal cord development |
GO:0045672 | 0.0041 | 5.5519 | 1.1016 | 5 | 23 | positive regulation of osteoclast differentiation |
GO:0051254 | 0.0042 | 1.38 | 68.488 | 90 | 1430 | positive regulation of RNA metabolic process |
GO:0008595 | 0.0047 | 7.2617 | 0.7184 | 4 | 15 | anterior/posterior axis specification, embryo |
GO:0002791 | 0.0047 | 1.6951 | 20.4506 | 33 | 427 | regulation of peptide secretion |
GO:0007608 | 0.0048 | 5.2797 | 1.1364 | 5 | 25 | sensory perception of smell |
GO:0009888 | 0.0048 | 1.3328 | 87.5975 | 111 | 1829 | tissue development |
GO:0030878 | 0.0049 | 5.2593 | 1.1494 | 5 | 24 | thyroid gland development |
GO:0060054 | 0.0051 | 11.9708 | 0.3831 | 3 | 8 | positive regulation of epithelial cell proliferation involved in wound healing |
GO:0001501 | 0.0053 | 1.7653 | 16.6827 | 28 | 355 | skeletal system development |
GO:0048513 | 0.0054 | 1.2592 | 152.5414 | 181 | 3185 | animal organ development |
GO:0019229 | 0.0055 | 3.2694 | 2.7299 | 8 | 57 | regulation of vasoconstriction |
GO:0021953 | 0.0058 | 2.159 | 7.9025 | 16 | 165 | central nervous system neuron differentiation |
GO:0007267 | 0.0059 | 1.5292 | 32.1842 | 47 | 698 | cell-cell signaling |
GO:0010642 | 0.006 | 6.6561 | 0.7663 | 4 | 16 | negative regulation of platelet-derived growth factor receptor signaling pathway |
GO:0035313 | 0.006 | 6.6561 | 0.7663 | 4 | 16 | wound healing, spreading of epidermal cells |
GO:0008306 | 0.006 | 2.9561 | 3.3526 | 9 | 70 | associative learning |
GO:0009798 | 0.0062 | 2.7461 | 3.9752 | 10 | 83 | axis specification |
GO:0034767 | 0.0065 | 2.3512 | 5.9388 | 13 | 124 | positive regulation of ion transmembrane transport |
GO:0002009 | 0.0066 | 1.6043 | 24.1384 | 37 | 504 | morphogenesis of an epithelium |
GO:0010159 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | specification of animal organ position |
GO:0021571 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | rhombomere 5 development |
GO:0021912 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0048936 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060435 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | bronchiole development |
GO:0060743 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | epithelial cell maturation involved in prostate gland development |
GO:0060913 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | cardiac cell fate determination |
GO:0061031 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | endodermal digestive tract morphogenesis |
GO:0061184 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | positive regulation of dermatome development |
GO:2001201 | 0.0067 | 39.8609 | 0.1437 | 2 | 3 | regulation of transforming growth factor-beta secretion |
GO:0048645 | 0.0068 | 3.1408 | 2.8257 | 8 | 59 | animal organ formation |
GO:0048762 | 0.0073 | 2.047 | 8.8124 | 17 | 184 | mesenchymal cell differentiation |
GO:0061180 | 0.0073 | 3.4314 | 2.2893 | 7 | 48 | mammary gland epithelium development |
GO:0050921 | 0.0074 | 2.3093 | 6.0346 | 13 | 126 | positive regulation of chemotaxis |
GO:0014807 | 0.0074 | 9.975 | 0.431 | 3 | 9 | regulation of somitogenesis |
GO:0046549 | 0.0074 | 9.975 | 0.431 | 3 | 9 | retinal cone cell development |
GO:0060837 | 0.0074 | 9.975 | 0.431 | 3 | 9 | blood vessel endothelial cell differentiation |
GO:0006813 | 0.0074 | 1.9173 | 11.0155 | 20 | 230 | potassium ion transport |
GO:0050885 | 0.0075 | 3.4162 | 2.2989 | 7 | 48 | neuromuscular process controlling balance |
GO:0060644 | 0.0075 | 6.1437 | 0.8142 | 4 | 17 | mammary gland epithelial cell differentiation |
GO:0060749 | 0.0075 | 6.1437 | 0.8142 | 4 | 17 | mammary gland alveolus development |
GO:1905208 | 0.0075 | 6.1437 | 0.8142 | 4 | 17 | negative regulation of cardiocyte differentiation |
GO:0045087 | 0.0076 | 1.4684 | 37.6832 | 53 | 791 | innate immune response |
GO:0001755 | 0.0077 | 3.8702 | 1.7721 | 6 | 37 | neural crest cell migration |
GO:0043269 | 0.0082 | 1.5337 | 28.5925 | 42 | 597 | regulation of ion transport |
GO:0030814 | 0.0082 | 2.1963 | 6.8009 | 14 | 142 | regulation of cAMP metabolic process |
GO:0032355 | 0.0084 | 2.2688 | 6.1304 | 13 | 128 | response to estradiol |
GO:0050673 | 0.0085 | 1.7131 | 16.5233 | 27 | 345 | epithelial cell proliferation |
GO:0003151 | 0.0086 | 2.7734 | 3.5441 | 9 | 74 | outflow tract morphogenesis |
GO:0021700 | 0.0087 | 1.8545 | 11.9255 | 21 | 249 | developmental maturation |
GO:0051932 | 0.0088 | 3.749 | 1.82 | 6 | 38 | synaptic transmission, GABAergic |
GO:0009792 | 0.0091 | 1.5482 | 26.2936 | 39 | 549 | embryo development ending in birth or egg hatching |
GO:0030154 | 0.0093 | 1.2313 | 167.9748 | 195 | 3578 | cell differentiation |
GO:0007350 | 0.0093 | 5.7045 | 0.8621 | 4 | 18 | blastoderm segmentation |
GO:0010544 | 0.0093 | 5.7045 | 0.8621 | 4 | 18 | negative regulation of platelet activation |
GO:0032026 | 0.0093 | 5.7045 | 0.8621 | 4 | 18 | response to magnesium ion |
GO:0010557 | 0.0094 | 1.3202 | 76.0073 | 96 | 1587 | positive regulation of macromolecule biosynthetic process |
GO:0061061 | 0.0094 | 1.5195 | 28.832 | 42 | 602 | muscle structure development |
GO:0007204 | 0.0099 | 1.8009 | 12.8355 | 22 | 268 | positive regulation of cytosolic calcium ion concentration |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002161 | 8e-04 | Inf | 8e-04 | 1 | 12 | aminoacyl-tRNA editing activity |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | Inf | 0.1756 | 6 | 467 | protein heterodimerization activity |
GO:0003677 | 0 | Inf | 0.8747 | 6 | 2326 | DNA binding |
GO:0019899 | 2e-04 | 33.487 | 0.7811 | 5 | 2077 | enzyme binding |
GO:1901363 | 0.0019 | Inf | 2.1048 | 6 | 5597 | heterocyclic compound binding |
GO:0097159 | 0.002 | Inf | 2.1349 | 6 | 5677 | organic cyclic compound binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015450 | 0.003 | 455.4857 | 0.003 | 1 | 8 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity |
GO:0015266 | 0.0041 | 318.78 | 0.0041 | 1 | 11 | protein channel activity |
GO:0022884 | 0.0075 | 167.6842 | 0.0075 | 1 | 20 | macromolecule transmembrane transporter activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 201.5662 | 0.2049 | 6 | 467 | protein heterodimerization activity |
GO:0003677 | 1e-04 | 35.2448 | 1.0205 | 6 | 2326 | DNA binding |
GO:0019899 | 6e-04 | 16.7423 | 0.9113 | 5 | 2077 | enzyme binding |
GO:1901363 | 0.0091 | 11.1146 | 2.4556 | 6 | 5597 | heterocyclic compound binding |
GO:0097159 | 0.0099 | 10.8732 | 2.4907 | 6 | 5677 | organic cyclic compound binding |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046982 | 0 | 2.1659 | 26.3136 | 52 | 467 | protein heterodimerization activity |
GO:0042393 | 0 | 2.8082 | 10.3677 | 26 | 184 | histone binding |
GO:0031492 | 0 | 5.6393 | 2.4792 | 11 | 44 | nucleosomal DNA binding |
GO:0070051 | 2e-04 | Inf | 0.169 | 3 | 3 | fibrinogen binding |
GO:0050431 | 5e-04 | 7.7748 | 1.0706 | 6 | 19 | transforming growth factor beta binding |
GO:0005507 | 5e-04 | 4.1195 | 2.8736 | 10 | 51 | copper ion binding |
GO:0005123 | 0.001 | 8.415 | 0.8452 | 5 | 15 | death receptor binding |
GO:0019904 | 0.0022 | 1.5619 | 37.0757 | 55 | 658 | protein domain specific binding |
GO:0036461 | 0.0032 | Inf | 0.1127 | 2 | 2 | BLOC-2 complex binding |
GO:0043236 | 0.0049 | 4.3915 | 1.634 | 6 | 29 | laminin binding |
GO:0042609 | 0.0053 | 12.5993 | 0.3944 | 3 | 7 | CD4 receptor binding |
GO:0008499 | 0.0064 | 6.7245 | 0.7888 | 4 | 14 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0019956 | 0.0066 | 4.9477 | 1.2396 | 5 | 22 | chemokine binding |
GO:0000982 | 0.0066 | 1.6419 | 21.7495 | 34 | 386 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0005201 | 0.0069 | 2.7203 | 4.0569 | 10 | 72 | extracellular matrix structural constituent |
GO:0005005 | 0.0081 | 10.0788 | 0.4508 | 3 | 8 | transmembrane-ephrin receptor activity |
GO:0008381 | 0.0081 | 10.0788 | 0.4508 | 3 | 8 | mechanically-gated ion channel activity |
GO:0019869 | 0.0081 | 10.0788 | 0.4508 | 3 | 8 | chloride channel inhibitor activity |
GO:0030742 | 0.0081 | 4.6725 | 1.296 | 5 | 23 | GTP-dependent protein binding |
GO:0097153 | 0.0083 | 6.1127 | 0.8452 | 4 | 15 | cysteine-type endopeptidase activity involved in apoptotic process |
GO:0050839 | 0.0084 | 1.5687 | 25.3557 | 38 | 450 | cell adhesion molecule binding |
GO:0001730 | 0.0092 | 33.5674 | 0.169 | 2 | 3 | 2'-5'-oligoadenylate synthetase activity |
GO:0003987 | 0.0092 | 33.5674 | 0.169 | 2 | 3 | acetate-CoA ligase activity |
GO:0004464 | 0.0092 | 33.5674 | 0.169 | 2 | 3 | leukotriene-C4 synthase activity |
GO:0004505 | 0.0092 | 33.5674 | 0.169 | 2 | 3 | phenylalanine 4-monooxygenase activity |
GO:0035651 | 0.0092 | 33.5674 | 0.169 | 2 | 3 | AP-3 adaptor complex binding |
GO:0048030 | 0.0092 | 33.5674 | 0.169 | 2 | 3 | disaccharide binding |
GO:0070404 | 0.0092 | 33.5674 | 0.169 | 2 | 3 | NADH binding |
GO:0048018 | 0.0097 | 1.5728 | 23.947 | 36 | 425 | receptor ligand activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0099600 | 0 | 3.3982 | 15.1626 | 43 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 2.6719 | 19.2824 | 44 | 1465 | molecular transducer activity |
GO:0004930 | 0 | 3.7336 | 7.5907 | 25 | 598 | G-protein coupled receptor activity |
GO:0038023 | 0 | 2.714 | 14.2722 | 34 | 1121 | signaling receptor activity |
GO:0004993 | 0 | 25.5772 | 0.2632 | 5 | 20 | G-protein coupled serotonin receptor activity |
GO:0051378 | 0 | 50.9353 | 0.1316 | 4 | 10 | serotonin binding |
GO:0042923 | 0 | 23.9771 | 0.2764 | 5 | 21 | neuropeptide binding |
GO:0030594 | 0 | 7.6587 | 1.1714 | 8 | 89 | neurotransmitter receptor activity |
GO:0043565 | 0 | 2.4924 | 12.8988 | 29 | 980 | sequence-specific DNA binding |
GO:0003700 | 3e-04 | 2.1433 | 15.3469 | 30 | 1166 | DNA binding transcription factor activity |
GO:0005184 | 5e-04 | 12.2097 | 0.3817 | 4 | 29 | neuropeptide hormone activity |
GO:0008528 | 7e-04 | 5.1854 | 1.4608 | 7 | 112 | G-protein coupled peptide receptor activity |
GO:0004984 | 9e-04 | 3.1308 | 4.0934 | 12 | 311 | olfactory receptor activity |
GO:0004994 | 0.0017 | 50.4551 | 0.0658 | 2 | 5 | somatostatin receptor activity |
GO:0048248 | 0.0017 | 50.4551 | 0.0658 | 2 | 5 | CXCR3 chemokine receptor binding |
GO:0008009 | 0.0026 | 7.6238 | 0.5791 | 4 | 44 | chemokine activity |
GO:0001664 | 0.0028 | 3.2626 | 2.9243 | 9 | 225 | G-protein coupled receptor binding |
GO:0004985 | 0.0046 | 25.2228 | 0.1053 | 2 | 8 | opioid receptor activity |
GO:0003676 | 0.0049 | 1.5008 | 50.1868 | 67 | 3813 | nucleic acid binding |
GO:0070405 | 0.0055 | 6.0912 | 0.7106 | 4 | 55 | ammonium ion binding |
GO:0071855 | 0.0058 | 9.113 | 0.3685 | 3 | 28 | neuropeptide receptor binding |
GO:0001228 | 0.006 | 2.444 | 5.1727 | 12 | 393 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0039706 | 0.0072 | 18.9147 | 0.1316 | 2 | 10 | co-receptor binding |
GO:0005319 | 0.0099 | 3.4788 | 1.8164 | 6 | 138 | lipid transporter activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:1903231 | 2e-04 | 200.9114 | 0.0203 | 2 | 81 | mRNA binding involved in posttranscriptional gene silencing |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008823 | 2e-04 | Inf | 2e-04 | 1 | 3 | cupric reductase activity |
GO:0052851 | 2e-04 | Inf | 2e-04 | 1 | 3 | ferric-chelate reductase (NADPH) activity |
GO:0016722 | 9e-04 | Inf | 9e-04 | 1 | 14 | oxidoreductase activity, oxidizing metal ions |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 3.8708 | 33.0787 | 103 | 705 | G-protein coupled receptor activity |
GO:0099600 | 0 | 3.0829 | 54.2967 | 136 | 1152 | transmembrane receptor activity |
GO:0060089 | 0 | 2.536 | 69.0492 | 146 | 1465 | molecular transducer activity |
GO:0038023 | 0 | 2.7288 | 45.7288 | 106 | 1000 | signaling receptor activity |
GO:0004984 | 0 | 4.3921 | 14.6582 | 53 | 311 | olfactory receptor activity |
GO:0043565 | 0 | 2.5282 | 46.1899 | 101 | 980 | sequence-specific DNA binding |
GO:0001077 | 0 | 3.2205 | 12.3487 | 35 | 262 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0000975 | 0 | 2.1133 | 38.1302 | 73 | 809 | regulatory region DNA binding |
GO:0001012 | 0 | 2.3228 | 27.6197 | 58 | 586 | RNA polymerase II regulatory region DNA binding |
GO:0042923 | 0 | 15.3341 | 0.9898 | 9 | 21 | neuropeptide binding |
GO:0000978 | 0 | 2.6452 | 16.355 | 39 | 347 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001159 | 0 | 2.5963 | 17.062 | 40 | 362 | core promoter proximal region DNA binding |
GO:0000976 | 0 | 2.103 | 31.2018 | 60 | 662 | transcription regulatory region sequence-specific DNA binding |
GO:0001653 | 0 | 4.0854 | 5.703 | 20 | 121 | peptide receptor activity |
GO:0008188 | 0 | 7.2653 | 1.9796 | 11 | 42 | neuropeptide receptor activity |
GO:0003690 | 0 | 1.9285 | 36.5749 | 65 | 776 | double-stranded DNA binding |
GO:0005549 | 0 | 5.0407 | 3.3464 | 14 | 71 | odorant binding |
GO:0004993 | 0 | 10.9788 | 0.9427 | 7 | 20 | G-protein coupled serotonin receptor activity |
GO:0008009 | 0 | 6.0128 | 2.0738 | 10 | 44 | chemokine activity |
GO:0004985 | 3e-04 | 20.3195 | 0.3771 | 4 | 8 | opioid receptor activity |
GO:0001664 | 4e-04 | 2.2586 | 11.9245 | 25 | 253 | G-protein coupled receptor binding |
GO:0051378 | 8e-04 | 13.5446 | 0.4713 | 4 | 10 | serotonin binding |
GO:0030594 | 9e-04 | 3.1855 | 4.1948 | 12 | 89 | neurotransmitter receptor activity |
GO:0001228 | 9e-04 | 2.7373 | 5.9853 | 15 | 131 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
GO:0001965 | 0.0015 | 7.2619 | 0.8955 | 5 | 19 | G-protein alpha-subunit binding |
GO:0005000 | 0.0019 | 20.2937 | 0.2828 | 3 | 6 | vasopressin receptor activity |
GO:0003823 | 0.0025 | 3.7909 | 2.4038 | 8 | 51 | antigen binding |
GO:0045125 | 0.0025 | 9.0279 | 0.6127 | 4 | 13 | bioactive lipid receptor activity |
GO:0015103 | 0.0031 | 2.4889 | 6.0801 | 14 | 129 | inorganic anion transmembrane transporter activity |
GO:0005249 | 0.0033 | 2.8419 | 4.2419 | 11 | 90 | voltage-gated potassium channel activity |
GO:0048018 | 0.0035 | 1.7341 | 20.0313 | 33 | 425 | receptor ligand activity |
GO:0003700 | 0.0042 | 1.7241 | 19.5169 | 32 | 439 | DNA binding transcription factor activity |
GO:0048020 | 0.0054 | 4.2084 | 1.6496 | 6 | 35 | CCR chemokine receptor binding |
GO:0045236 | 0.0057 | 6.7696 | 0.7541 | 4 | 16 | CXCR chemokine receptor binding |
GO:0001601 | 0.0064 | 40.5387 | 0.1414 | 2 | 3 | peptide YY receptor activity |
GO:0019862 | 0.0064 | 40.5387 | 0.1414 | 2 | 3 | IgA binding |
GO:0046703 | 0.0071 | 10.1449 | 0.4242 | 3 | 9 | natural killer cell lectin-like receptor binding |
GO:0046873 | 0.0071 | 1.6575 | 20.2199 | 32 | 429 | metal ion transmembrane transporter activity |
GO:0003676 | 0.0081 | 1.2301 | 179.7165 | 208 | 3813 | nucleic acid binding |
GO:0005200 | 0.0085 | 2.4652 | 4.8075 | 11 | 102 | structural constituent of cytoskeleton |
GO:0071837 | 0.0088 | 5.8018 | 0.8484 | 4 | 18 | HMG box domain binding |
GO:0000981 | 0.0093 | 1.7389 | 15.0667 | 25 | 334 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0005436 | 0.0098 | 8.695 | 0.4713 | 3 | 10 | sodium:phosphate symporter activity |
GO:0015143 | 0.0098 | 8.695 | 0.4713 | 3 | 10 | urate transmembrane transporter activity |
GO:0039706 | 0.0098 | 8.695 | 0.4713 | 3 | 10 | co-receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 9.5671 | 3.2291 | 25 | 184 | histone binding |
GO:0031492 | 0 | 17.0381 | 0.7722 | 10 | 44 | nucleosomal DNA binding |
GO:0046982 | 0 | 3.536 | 8.1955 | 26 | 467 | protein heterodimerization activity |
GO:0005123 | 1e-04 | 20.6377 | 0.2632 | 4 | 15 | death receptor binding |
GO:0019904 | 6e-04 | 2.2241 | 11.5475 | 24 | 658 | protein domain specific binding |
GO:0003682 | 7e-04 | 2.4406 | 8.3008 | 19 | 473 | chromatin binding |
GO:0047617 | 0.003 | 12.1153 | 0.2983 | 3 | 17 | acyl-CoA hydrolase activity |
GO:0017108 | 0.0044 | 28.1853 | 0.1053 | 2 | 6 | 5'-flap endonuclease activity |
GO:0043546 | 0.0044 | 28.1853 | 0.1053 | 2 | 6 | molybdopterin cofactor binding |
GO:0045296 | 0.0067 | 2.4007 | 5.2473 | 12 | 299 | cadherin binding |
GO:0030742 | 0.0073 | 8.4774 | 0.4036 | 3 | 23 | GTP-dependent protein binding |
GO:0003677 | 0.0078 | 1.4763 | 40.8198 | 56 | 2326 | DNA binding |
GO:0102991 | 0.008 | 18.7878 | 0.1404 | 2 | 8 | myristoyl-CoA hydrolase activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008652 | 0.0049 | Inf | 0.0049 | 1 | 75 | cellular amino acid biosynthetic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006450 | 0.0011 | Inf | 0.0011 | 1 | 17 | regulation of translational fidelity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036297 | 0.003 | Inf | 0.003 | 1 | 46 | interstrand cross-link repair |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007274 | 0.0065 | 211.6528 | 0.0066 | 1 | 25 | neuromuscular synaptic transmission |
GO:0021522 | 0.0078 | 175.1034 | 0.0079 | 1 | 30 | spinal cord motor neuron differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006600 | 0.0039 | 338.9333 | 0.0039 | 1 | 10 | creatine metabolic process |
GO:0044331 | 0.0055 | 234.5846 | 0.0055 | 1 | 14 | cell-cell adhesion mediated by cadherin |
GO:0050965 | 0.0055 | 234.5846 | 0.0055 | 1 | 14 | detection of temperature stimulus involved in sensory perception of pain |
GO:0016048 | 0.0067 | 190.5625 | 0.0067 | 1 | 17 | detection of temperature stimulus |
GO:0045663 | 0.0071 | 179.3412 | 0.0071 | 1 | 18 | positive regulation of myoblast differentiation |
GO:0050951 | 0.0078 | 160.4421 | 0.0079 | 1 | 20 | sensory perception of temperature stimulus |
GO:0097150 | 0.0086 | 145.1429 | 0.0086 | 1 | 22 | neuronal stem cell population maintenance |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048477 | 0.0052 | Inf | 0.0052 | 1 | 79 | oogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005981 | 4e-04 | Inf | 4e-04 | 1 | 6 | regulation of glycogen catabolic process |
GO:0009251 | 0.0014 | Inf | 0.0014 | 1 | 21 | glucan catabolic process |
GO:0044247 | 0.0014 | Inf | 0.0014 | 1 | 21 | cellular polysaccharide catabolic process |
GO:0005979 | 0.0016 | Inf | 0.0016 | 1 | 24 | regulation of glycogen biosynthetic process |
GO:0032885 | 0.002 | Inf | 0.002 | 1 | 31 | regulation of polysaccharide biosynthetic process |
GO:0009250 | 0.0029 | Inf | 0.0029 | 1 | 44 | glucan biosynthetic process |
GO:0005977 | 0.0045 | Inf | 0.0045 | 1 | 68 | glycogen metabolic process |
GO:0043470 | 0.0045 | Inf | 0.0045 | 1 | 68 | regulation of carbohydrate catabolic process |
GO:0034637 | 0.0047 | Inf | 0.0047 | 1 | 71 | cellular carbohydrate biosynthetic process |
GO:0010906 | 0.0056 | Inf | 0.0056 | 1 | 86 | regulation of glucose metabolic process |
GO:0005976 | 0.0061 | Inf | 0.0061 | 1 | 93 | polysaccharide metabolic process |
GO:0043467 | 0.0074 | Inf | 0.0074 | 1 | 113 | regulation of generation of precursor metabolites and energy |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001994 | 0.0044 | 317.6458 | 0.0045 | 1 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0060040 | 0.0044 | 317.6458 | 0.0045 | 1 | 4 | retinal bipolar neuron differentiation |
GO:1901653 | 0.0051 | 10.0298 | 0.3586 | 3 | 322 | cellular response to peptide |
GO:0055074 | 0.0077 | 8.594 | 0.4165 | 3 | 374 | calcium ion homeostasis |
GO:0001993 | 0.0089 | 136.0982 | 0.0089 | 1 | 8 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:2000480 | 0.01 | 119.0781 | 0.01 | 1 | 9 | negative regulation of cAMP-dependent protein kinase activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006335 | 0 | 99.4016 | 1.0802 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0000183 | 0 | 57.9646 | 1.2545 | 24 | 36 | chromatin silencing at rDNA |
GO:0051290 | 0 | 40.3161 | 1.4984 | 25 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 132.7207 | 0.5924 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 13.6597 | 2.718 | 25 | 78 | positive regulation of gene expression, epigenetic |
GO:0031497 | 0 | 8.4319 | 4.983 | 32 | 143 | chromatin assembly |
GO:0060964 | 0 | 9.7693 | 3.4498 | 25 | 99 | regulation of gene silencing by miRNA |
GO:1902036 | 0 | 9.6384 | 3.4846 | 25 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0065004 | 0 | 5.6154 | 7.3526 | 34 | 211 | protein-DNA complex assembly |
GO:1904837 | 0 | 17.542 | 1.4635 | 16 | 42 | beta-catenin-TCF complex assembly |
GO:0060968 | 0 | 7.5192 | 4.2164 | 25 | 121 | regulation of gene silencing |
GO:0045814 | 0 | 7.4382 | 4.077 | 24 | 117 | negative regulation of gene expression, epigenetic |
GO:0034080 | 0 | 15.29 | 1.3939 | 14 | 40 | CENP-A containing nucleosome assembly |
GO:0071103 | 0 | 4.3233 | 8.8858 | 33 | 255 | DNA conformation change |
GO:0002244 | 0 | 4.9966 | 6.3769 | 27 | 183 | hematopoietic progenitor cell differentiation |
GO:0030099 | 0 | 3.575 | 12.475 | 39 | 358 | myeloid cell differentiation |
GO:0032200 | 0 | 5.2668 | 5.4012 | 24 | 155 | telomere organization |
GO:0016233 | 0 | 11.0353 | 1.7423 | 14 | 50 | telomere capping |
GO:0034724 | 0 | 11.0353 | 1.7423 | 14 | 50 | DNA replication-independent nucleosome organization |
GO:0048863 | 0 | 3.8754 | 8.5374 | 29 | 245 | stem cell differentiation |
GO:0034728 | 0 | 6.1895 | 3.5062 | 18 | 103 | nucleosome organization |
GO:1903707 | 0 | 5.3402 | 4.4255 | 20 | 127 | negative regulation of hemopoiesis |
GO:0043044 | 0 | 7.3419 | 2.5438 | 15 | 73 | ATP-dependent chromatin remodeling |
GO:0006303 | 0 | 7.6315 | 2.2999 | 14 | 66 | double-strand break repair via nonhomologous end joining |
GO:0051259 | 0 | 2.7335 | 17.0747 | 42 | 490 | protein oligomerization |
GO:0045596 | 0 | 2.5434 | 20.9427 | 48 | 601 | negative regulation of cell differentiation |
GO:0045652 | 0 | 8.2947 | 1.8342 | 12 | 54 | regulation of megakaryocyte differentiation |
GO:0035194 | 0 | 3.3412 | 9.3737 | 28 | 269 | posttranscriptional gene silencing by RNA |
GO:0038111 | 0 | 10.8378 | 1.2545 | 10 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 10.8378 | 1.2545 | 10 | 36 | response to interleukin-7 |
GO:0048534 | 0 | 2.2345 | 28.1559 | 57 | 808 | hematopoietic or lymphoid organ development |
GO:0017148 | 0 | 2.6581 | 12.3356 | 30 | 354 | negative regulation of translation |
GO:0048869 | 0 | 1.4831 | 132.7996 | 174 | 3811 | cellular developmental process |
GO:0040008 | 0 | 2.1208 | 20.3503 | 40 | 584 | regulation of growth |
GO:0045595 | 0 | 1.8742 | 31.7804 | 55 | 963 | regulation of cell differentiation |
GO:0010812 | 1e-04 | 5.8797 | 1.812 | 9 | 52 | negative regulation of cell-substrate adhesion |
GO:0035987 | 1e-04 | 6.8018 | 1.4287 | 8 | 41 | endodermal cell differentiation |
GO:0071294 | 1e-04 | 13.9706 | 0.5227 | 5 | 15 | cellular response to zinc ion |
GO:0051248 | 1e-04 | 1.7021 | 42.4081 | 67 | 1217 | negative regulation of protein metabolic process |
GO:0051716 | 2e-04 | 1.3724 | 223.7487 | 264 | 6421 | cellular response to stimulus |
GO:0070271 | 2e-04 | 1.6432 | 45.7882 | 70 | 1314 | protein complex biogenesis |
GO:0007166 | 2e-04 | 1.6065 | 51.875 | 77 | 1541 | cell surface receptor signaling pathway |
GO:0002227 | 3e-04 | 10.7444 | 0.6272 | 5 | 18 | innate immune response in mucosa |
GO:0006352 | 3e-04 | 2.6122 | 7.8404 | 19 | 225 | DNA-templated transcription, initiation |
GO:0050878 | 4e-04 | 2.0672 | 15.4718 | 30 | 444 | regulation of body fluid levels |
GO:0071241 | 4e-04 | 2.9398 | 5.5406 | 15 | 159 | cellular response to inorganic substance |
GO:1903844 | 5e-04 | 3.6389 | 3.3453 | 11 | 96 | regulation of cellular response to transforming growth factor beta stimulus |
GO:0007492 | 5e-04 | 4.2964 | 2.3613 | 9 | 68 | endoderm development |
GO:0048663 | 6e-04 | 4.2805 | 2.3696 | 9 | 68 | neuron fate commitment |
GO:0043537 | 6e-04 | 6.7118 | 1.0802 | 6 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:0002376 | 8e-04 | 1.4315 | 86.1403 | 114 | 2472 | immune system process |
GO:0034248 | 8e-04 | 1.8801 | 19.7579 | 35 | 567 | regulation of cellular amide metabolic process |
GO:0060547 | 8e-04 | 12.3956 | 0.453 | 4 | 13 | negative regulation of necrotic cell death |
GO:2000026 | 8e-04 | 1.5893 | 43.0255 | 64 | 1296 | regulation of multicellular organismal development |
GO:0009611 | 8e-04 | 1.8544 | 20.5942 | 36 | 591 | response to wounding |
GO:0010720 | 9e-04 | 1.9993 | 15.4021 | 29 | 442 | positive regulation of cell development |
GO:0030198 | 9e-04 | 2.2351 | 10.4888 | 22 | 301 | extracellular matrix organization |
GO:0051962 | 0.001 | 2.0064 | 14.8097 | 28 | 425 | positive regulation of nervous system development |
GO:0051895 | 0.0011 | 11.1553 | 0.4878 | 4 | 14 | negative regulation of focal adhesion assembly |
GO:0007411 | 0.0012 | 2.4742 | 7.3526 | 17 | 211 | axon guidance |
GO:0030574 | 0.0012 | 4.2293 | 2.1256 | 8 | 61 | collagen catabolic process |
GO:0019285 | 0.0012 | Inf | 0.0697 | 2 | 2 | glycine betaine biosynthetic process from choline |
GO:0031455 | 0.0012 | Inf | 0.0697 | 2 | 2 | glycine betaine metabolic process |
GO:0070370 | 0.0012 | Inf | 0.0697 | 2 | 2 | cellular heat acclimation |
GO:0097213 | 0.0012 | Inf | 0.0697 | 2 | 2 | regulation of lysosomal membrane permeability |
GO:1901731 | 0.0012 | Inf | 0.0697 | 2 | 2 | positive regulation of platelet aggregation |
GO:0001766 | 0.0013 | 20.8852 | 0.2439 | 3 | 7 | membrane raft polarization |
GO:0043652 | 0.0013 | 20.8852 | 0.2439 | 3 | 7 | engulfment of apoptotic cell |
GO:0030308 | 0.0014 | 2.8361 | 4.9482 | 13 | 142 | negative regulation of cell growth |
GO:0010608 | 0.0014 | 1.7661 | 22.7547 | 38 | 653 | posttranscriptional regulation of gene expression |
GO:0021879 | 0.0014 | 4.6644 | 1.7075 | 7 | 49 | forebrain neuron differentiation |
GO:0071276 | 0.0015 | 6.9806 | 0.8712 | 5 | 25 | cellular response to cadmium ion |
GO:2000108 | 0.0015 | 6.9806 | 0.8712 | 5 | 25 | positive regulation of leukocyte apoptotic process |
GO:0043524 | 0.0016 | 2.9338 | 4.4255 | 12 | 127 | negative regulation of neuron apoptotic process |
GO:0071822 | 0.0018 | 1.4821 | 53.8028 | 75 | 1544 | protein complex subunit organization |
GO:0014013 | 0.0019 | 3.2632 | 3.3453 | 10 | 96 | regulation of gliogenesis |
GO:1901566 | 0.0019 | 1.435 | 66.9399 | 90 | 1921 | organonitrogen compound biosynthetic process |
GO:0010038 | 0.002 | 2.1293 | 10.4539 | 21 | 300 | response to metal ion |
GO:0051665 | 0.0021 | 16.707 | 0.2788 | 3 | 8 | membrane raft localization |
GO:0070424 | 0.0021 | 16.707 | 0.2788 | 3 | 8 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0048731 | 0.0024 | 1.343 | 117.7228 | 145 | 3495 | system development |
GO:0002251 | 0.0025 | 6.0688 | 0.9757 | 5 | 28 | organ or tissue specific immune response |
GO:0001704 | 0.0026 | 2.9138 | 4.077 | 11 | 117 | formation of primary germ layer |
GO:0072358 | 0.0028 | 1.728 | 21.326 | 35 | 612 | cardiovascular system development |
GO:0045602 | 0.003 | 13.9216 | 0.3136 | 3 | 9 | negative regulation of endothelial cell differentiation |
GO:0060602 | 0.003 | 7.9659 | 0.6272 | 4 | 18 | branch elongation of an epithelium |
GO:0065003 | 0.003 | 1.4396 | 57.4617 | 78 | 1649 | macromolecular complex assembly |
GO:0045666 | 0.0033 | 2.0694 | 10.209 | 20 | 294 | positive regulation of neuron differentiation |
GO:0045892 | 0.0034 | 1.5395 | 36.2751 | 53 | 1041 | negative regulation of transcription, DNA-templated |
GO:0036337 | 0.0036 | 55.6 | 0.1045 | 2 | 3 | Fas signaling pathway |
GO:0046110 | 0.0036 | 55.6 | 0.1045 | 2 | 3 | xanthine metabolic process |
GO:0070434 | 0.0036 | 55.6 | 0.1045 | 2 | 3 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO:0090063 | 0.0036 | 55.6 | 0.1045 | 2 | 3 | positive regulation of microtubule nucleation |
GO:0090092 | 0.0037 | 2.3329 | 6.8299 | 15 | 196 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0043032 | 0.0037 | 7.4343 | 0.6621 | 4 | 19 | positive regulation of macrophage activation |
GO:0001568 | 0.0039 | 1.7186 | 20.1761 | 33 | 579 | blood vessel development |
GO:0050767 | 0.0041 | 1.7433 | 18.6834 | 31 | 543 | regulation of neurogenesis |
GO:0006600 | 0.0042 | 11.9319 | 0.3485 | 3 | 10 | creatine metabolic process |
GO:0006853 | 0.0042 | 11.9319 | 0.3485 | 3 | 10 | carnitine shuttle |
GO:0090084 | 0.0042 | 11.9319 | 0.3485 | 3 | 10 | negative regulation of inclusion body assembly |
GO:0090288 | 0.0043 | 2.7079 | 4.3558 | 11 | 125 | negative regulation of cellular response to growth factor stimulus |
GO:0048878 | 0.0044 | 1.5449 | 33.348 | 49 | 957 | chemical homeostasis |
GO:0001504 | 0.0045 | 6.9692 | 0.6969 | 4 | 20 | neurotransmitter uptake |
GO:0031579 | 0.0045 | 6.9692 | 0.6969 | 4 | 20 | membrane raft organization |
GO:0042531 | 0.0047 | 3.6936 | 2.0908 | 7 | 60 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0070373 | 0.0047 | 3.6936 | 2.0908 | 7 | 60 | negative regulation of ERK1 and ERK2 cascade |
GO:1903706 | 0.0047 | 2.0417 | 9.8071 | 19 | 290 | regulation of hemopoiesis |
GO:0001952 | 0.0047 | 3.0378 | 3.2059 | 9 | 92 | regulation of cell-matrix adhesion |
GO:0007167 | 0.005 | 1.5463 | 31.9193 | 47 | 916 | enzyme linked receptor protein signaling pathway |
GO:0007596 | 0.005 | 1.9876 | 10.5933 | 20 | 304 | blood coagulation |
GO:0009653 | 0.0053 | 1.3532 | 79.3104 | 101 | 2276 | anatomical structure morphogenesis |
GO:0045687 | 0.0053 | 4.9834 | 1.1499 | 5 | 33 | positive regulation of glial cell differentiation |
GO:0071559 | 0.0055 | 2.2211 | 7.1435 | 15 | 205 | response to transforming growth factor beta |
GO:0007039 | 0.0056 | 10.4397 | 0.3833 | 3 | 11 | protein catabolic process in the vacuole |
GO:1905039 | 0.0058 | 2.9312 | 3.3104 | 9 | 95 | carboxylic acid transmembrane transport |
GO:0065008 | 0.0061 | 1.3277 | 92.5904 | 115 | 2734 | regulation of biological quality |
GO:0019731 | 0.0061 | 4.8112 | 1.1848 | 5 | 34 | antibacterial humoral response |
GO:0050922 | 0.0061 | 4.8112 | 1.1848 | 5 | 34 | negative regulation of chemotaxis |
GO:0071310 | 0.0063 | 1.3489 | 77.0454 | 98 | 2211 | cellular response to organic substance |
GO:1902679 | 0.0064 | 1.4862 | 37.425 | 53 | 1074 | negative regulation of RNA biosynthetic process |
GO:0051241 | 0.0066 | 1.5499 | 29.0832 | 43 | 860 | negative regulation of multicellular organismal process |
GO:0030512 | 0.0067 | 3.4335 | 2.2302 | 7 | 64 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0048844 | 0.0067 | 3.4335 | 2.2302 | 7 | 64 | artery morphogenesis |
GO:0046068 | 0.0068 | 3.8974 | 1.7075 | 6 | 49 | cGMP metabolic process |
GO:0034112 | 0.0069 | 27.9034 | 0.1389 | 2 | 4 | positive regulation of homotypic cell-cell adhesion |
GO:0042663 | 0.0069 | 27.7981 | 0.1394 | 2 | 4 | regulation of endodermal cell fate specification |
GO:0044571 | 0.0069 | 27.7981 | 0.1394 | 2 | 4 | [2Fe-2S] cluster assembly |
GO:0048382 | 0.0069 | 27.7981 | 0.1394 | 2 | 4 | mesendoderm development |
GO:0060167 | 0.0069 | 27.7981 | 0.1394 | 2 | 4 | regulation of adenosine receptor signaling pathway |
GO:0060708 | 0.0069 | 27.7981 | 0.1394 | 2 | 4 | spongiotrophoblast differentiation |
GO:0072095 | 0.0069 | 27.7981 | 0.1394 | 2 | 4 | regulation of branch elongation involved in ureteric bud branching |
GO:1904340 | 0.0069 | 27.7981 | 0.1394 | 2 | 4 | positive regulation of dopaminergic neuron differentiation |
GO:0015696 | 0.0071 | 3.0664 | 2.8226 | 8 | 81 | ammonium transport |
GO:0006790 | 0.0073 | 1.8813 | 11.7084 | 21 | 336 | sulfur compound metabolic process |
GO:0048708 | 0.0073 | 3.374 | 2.265 | 7 | 65 | astrocyte differentiation |
GO:0070243 | 0.0073 | 9.2791 | 0.4182 | 3 | 12 | regulation of thymocyte apoptotic process |
GO:0001890 | 0.0076 | 2.4878 | 4.7043 | 11 | 135 | placenta development |
GO:0090103 | 0.0076 | 5.8676 | 0.8015 | 4 | 23 | cochlea morphogenesis |
GO:0120035 | 0.0077 | 1.6904 | 17.9459 | 29 | 515 | regulation of plasma membrane bounded cell projection organization |
GO:1901214 | 0.0079 | 2.0193 | 8.851 | 17 | 254 | regulation of neuron death |
GO:0045934 | 0.0082 | 1.4283 | 44.8125 | 61 | 1286 | negative regulation of nucleobase-containing compound metabolic process |
GO:0022604 | 0.0086 | 1.7941 | 13.4159 | 23 | 385 | regulation of cell morphogenesis |
GO:0035270 | 0.0092 | 2.547 | 4.1816 | 10 | 120 | endocrine system development |
GO:0009743 | 0.0096 | 2.1373 | 6.8996 | 14 | 198 | response to carbohydrate |
GO:0042221 | 0.0099 | 1.2618 | 135.204 | 159 | 3880 | response to chemical |
GO:0016043 | 0.01 | 1.2391 | 191.028 | 217 | 5482 | cellular component organization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 2.6446 | 27.8418 | 64 | 401 | detection of chemical stimulus |
GO:0007606 | 0 | 2.4656 | 29.0221 | 63 | 418 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 2.4741 | 28.4666 | 62 | 410 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 1.9522 | 59.316 | 104 | 880 | G-protein coupled receptor signaling pathway |
GO:0007218 | 0 | 4.8168 | 6.3876 | 24 | 92 | neuropeptide signaling pathway |
GO:0050911 | 0 | 2.6232 | 22.6344 | 52 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050877 | 0 | 1.8447 | 66.5469 | 111 | 976 | nervous system process |
GO:0007187 | 0 | 3.188 | 11.3867 | 31 | 164 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0060079 | 0 | 5.4546 | 3.8708 | 16 | 56 | excitatory postsynaptic potential |
GO:0007268 | 0 | 1.992 | 38.673 | 70 | 557 | chemical synaptic transmission |
GO:0099537 | 0 | 1.9878 | 38.7424 | 70 | 558 | trans-synaptic signaling |
GO:0007389 | 0 | 2.1274 | 27.4946 | 53 | 396 | pattern specification process |
GO:0042391 | 0 | 2.2038 | 20.0142 | 40 | 291 | regulation of membrane potential |
GO:0009952 | 0 | 2.4852 | 13.053 | 29 | 188 | anterior/posterior pattern specification |
GO:0007631 | 0 | 3.223 | 6.8736 | 19 | 99 | feeding behavior |
GO:0071805 | 0 | 2.454 | 13.1919 | 29 | 190 | potassium ion transmembrane transport |
GO:0048663 | 1e-04 | 3.8333 | 4.7213 | 15 | 68 | neuron fate commitment |
GO:0006813 | 1e-04 | 2.2722 | 15.5525 | 32 | 224 | potassium ion transport |
GO:0021517 | 1e-04 | 4.7952 | 2.9161 | 11 | 42 | ventral spinal cord development |
GO:0031644 | 1e-04 | 3.7896 | 4.4436 | 14 | 64 | regulation of neurological system process |
GO:0001708 | 1e-04 | 3.3867 | 5.5545 | 16 | 80 | cell fate specification |
GO:0060080 | 1e-04 | 11.5478 | 0.9026 | 6 | 13 | inhibitory postsynaptic potential |
GO:0046877 | 2e-04 | 16.8282 | 0.6249 | 5 | 9 | regulation of saliva secretion |
GO:0007210 | 2e-04 | 7.8636 | 1.3192 | 7 | 19 | serotonin receptor signaling pathway |
GO:0021953 | 2e-04 | 2.433 | 10.9701 | 24 | 158 | central nervous system neuron differentiation |
GO:0003008 | 3e-04 | 1.647 | 43.5122 | 67 | 669 | system process |
GO:0023061 | 3e-04 | 1.8391 | 26.9391 | 46 | 388 | signal release |
GO:0072210 | 3e-04 | 4.5006 | 2.7772 | 10 | 40 | metanephric nephron development |
GO:0061364 | 3e-04 | Inf | 0.2083 | 3 | 3 | apoptotic process involved in luteolysis |
GO:0007586 | 3e-04 | 2.4673 | 9.9286 | 22 | 143 | digestion |
GO:0048704 | 4e-04 | 2.9673 | 6.1793 | 16 | 89 | embryonic skeletal system morphogenesis |
GO:0055074 | 4e-04 | 1.8211 | 25.9671 | 44 | 374 | calcium ion homeostasis |
GO:0030534 | 5e-04 | 2.5341 | 8.8177 | 20 | 127 | adult behavior |
GO:0048699 | 5e-04 | 1.425 | 88.6631 | 119 | 1277 | generation of neurons |
GO:0060379 | 5e-04 | 11.2172 | 0.7637 | 5 | 11 | cardiac muscle cell myoblast differentiation |
GO:0021515 | 5e-04 | 3.8094 | 3.4715 | 11 | 50 | cell differentiation in spinal cord |
GO:0060322 | 6e-04 | 1.5881 | 44.8523 | 67 | 646 | head development |
GO:0035637 | 6e-04 | 2.2042 | 12.4281 | 25 | 179 | multicellular organismal signaling |
GO:0006355 | 7e-04 | 1.2741 | 227.3859 | 270 | 3275 | regulation of transcription, DNA-templated |
GO:0048007 | 7e-04 | 17.9343 | 0.486 | 4 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0019935 | 7e-04 | 2.6763 | 7.1514 | 17 | 103 | cyclic-nucleotide-mediated signaling |
GO:0001964 | 7e-04 | 5.8961 | 1.5969 | 7 | 23 | startle response |
GO:0045944 | 8e-04 | 1.4547 | 70.6111 | 97 | 1017 | positive regulation of transcription from RNA polymerase II promoter |
GO:0031223 | 8e-04 | 9.6141 | 0.8332 | 5 | 12 | auditory behavior |
GO:0055008 | 9e-04 | 3.3085 | 4.2353 | 12 | 61 | cardiac muscle tissue morphogenesis |
GO:0035725 | 9e-04 | 2.3774 | 9.3037 | 20 | 134 | sodium ion transmembrane transport |
GO:0065007 | 0.001 | 1.2496 | 737.2856 | 782 | 10619 | biological regulation |
GO:2001141 | 0.0011 | 1.2597 | 229.2605 | 270 | 3302 | regulation of RNA biosynthetic process |
GO:0098660 | 0.0012 | 1.5151 | 50.2679 | 72 | 724 | inorganic ion transmembrane transport |
GO:0006939 | 0.0012 | 2.6079 | 6.8736 | 16 | 99 | smooth muscle contraction |
GO:0007198 | 0.0013 | 40.3198 | 0.2777 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 0.0013 | 40.3198 | 0.2777 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 0.0013 | 40.3198 | 0.2777 | 3 | 4 | detection of glucose |
GO:2000741 | 0.0013 | 40.3198 | 0.2777 | 3 | 4 | positive regulation of mesenchymal stem cell differentiation |
GO:0006837 | 0.0013 | 8.4117 | 0.9026 | 5 | 13 | serotonin transport |
GO:0021520 | 0.0013 | 8.4117 | 0.9026 | 5 | 13 | spinal cord motor neuron cell fate specification |
GO:0072503 | 0.0014 | 1.7141 | 26.7309 | 43 | 385 | cellular divalent inorganic cation homeostasis |
GO:0072079 | 0.0014 | 6.2154 | 1.3192 | 6 | 19 | nephron tubule formation |
GO:0032502 | 0.0017 | 1.2143 | 380.9668 | 426 | 5487 | developmental process |
GO:0030539 | 0.0018 | 5.7711 | 1.3886 | 6 | 20 | male genitalia development |
GO:0031290 | 0.0018 | 5.7711 | 1.3886 | 6 | 20 | retinal ganglion cell axon guidance |
GO:0071625 | 0.0019 | 7.4766 | 0.972 | 5 | 14 | vocalization behavior |
GO:0008015 | 0.0019 | 1.6228 | 32.0076 | 49 | 461 | blood circulation |
GO:0014706 | 0.002 | 1.7355 | 23.3287 | 38 | 336 | striated muscle tissue development |
GO:0021562 | 0.0022 | 10.7591 | 0.6249 | 4 | 9 | vestibulocochlear nerve development |
GO:0048245 | 0.0022 | 10.7591 | 0.6249 | 4 | 9 | eosinophil chemotaxis |
GO:0098598 | 0.0022 | 10.7591 | 0.6249 | 4 | 9 | learned vocalization behavior or vocal learning |
GO:1902414 | 0.0022 | 10.7591 | 0.6249 | 4 | 9 | protein localization to cell junction |
GO:0051928 | 0.0022 | 2.5347 | 6.5959 | 15 | 95 | positive regulation of calcium ion transport |
GO:0001501 | 0.0022 | 1.6164 | 31.4522 | 48 | 453 | skeletal system development |
GO:0048167 | 0.0023 | 2.1841 | 9.998 | 20 | 144 | regulation of synaptic plasticity |
GO:0007416 | 0.0023 | 2.2365 | 9.3037 | 19 | 134 | synapse assembly |
GO:0042692 | 0.0023 | 1.6815 | 25.8977 | 41 | 373 | muscle cell differentiation |
GO:0060986 | 0.0028 | 3.4674 | 3.055 | 9 | 44 | endocrine hormone secretion |
GO:0010959 | 0.0028 | 1.7235 | 22.2179 | 36 | 320 | regulation of metal ion transport |
GO:0052652 | 0.0029 | 2.132 | 10.2063 | 20 | 147 | cyclic purine nucleotide metabolic process |
GO:0051970 | 0.003 | 20.1585 | 0.3472 | 3 | 5 | negative regulation of transmission of nerve impulse |
GO:0071502 | 0.003 | 20.1585 | 0.3472 | 3 | 5 | cellular response to temperature stimulus |
GO:0097659 | 0.0031 | 1.2272 | 239.0502 | 276 | 3443 | nucleic acid-templated transcription |
GO:0051384 | 0.0032 | 2.1608 | 9.5815 | 19 | 138 | response to glucocorticoid |
GO:0007204 | 0.0032 | 1.8305 | 16.9411 | 29 | 244 | positive regulation of cytosolic calcium ion concentration |
GO:0048644 | 0.0033 | 2.6204 | 5.5545 | 13 | 80 | muscle organ morphogenesis |
GO:0009914 | 0.0033 | 1.7511 | 20.0655 | 33 | 289 | hormone transport |
GO:0031018 | 0.0033 | 3.3708 | 3.1244 | 9 | 45 | endocrine pancreas development |
GO:0002475 | 0.0035 | 8.9653 | 0.6943 | 4 | 10 | antigen processing and presentation via MHC class Ib |
GO:0021559 | 0.0035 | 8.9653 | 0.6943 | 4 | 10 | trigeminal nerve development |
GO:0030432 | 0.0035 | 8.9653 | 0.6943 | 4 | 10 | peristalsis |
GO:0032275 | 0.0035 | 8.9653 | 0.6943 | 4 | 10 | luteinizing hormone secretion |
GO:0060525 | 0.0035 | 8.9653 | 0.6943 | 4 | 10 | prostate glandular acinus development |
GO:0051480 | 0.0035 | 4.1518 | 2.0588 | 7 | 30 | regulation of cytosolic calcium ion concentration |
GO:0034765 | 0.0036 | 1.6239 | 27.3557 | 42 | 394 | regulation of ion transmembrane transport |
GO:2001222 | 0.0038 | 4.0996 | 2.0829 | 7 | 30 | regulation of neuron migration |
GO:1905114 | 0.0038 | 1.5252 | 37.2843 | 54 | 537 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0021602 | 0.004 | 4.7516 | 1.5969 | 6 | 23 | cranial nerve morphogenesis |
GO:0030878 | 0.004 | 4.7516 | 1.5969 | 6 | 23 | thyroid gland development |
GO:0050768 | 0.004 | 1.8399 | 15.6914 | 27 | 226 | negative regulation of neurogenesis |
GO:0046889 | 0.0042 | 2.9972 | 3.8187 | 10 | 55 | positive regulation of lipid biosynthetic process |
GO:0030799 | 0.0043 | 2.0506 | 10.5535 | 20 | 152 | regulation of cyclic nucleotide metabolic process |
GO:0050794 | 0.0043 | 1.1947 | 652.8107 | 693 | 9449 | regulation of cellular process |
GO:0098655 | 0.0044 | 1.4406 | 50.2679 | 69 | 724 | cation transmembrane transport |
GO:0046887 | 0.0045 | 2.2527 | 7.7762 | 16 | 112 | positive regulation of hormone secretion |
GO:0050905 | 0.0046 | 2.7637 | 4.49 | 11 | 65 | neuromuscular process |
GO:0090092 | 0.0048 | 1.8903 | 13.6084 | 24 | 196 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0007200 | 0.0048 | 2.3936 | 6.4571 | 14 | 93 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0006649 | 0.0048 | Inf | 0.1389 | 2 | 2 | phospholipid transfer to membrane |
GO:0007493 | 0.0048 | Inf | 0.1389 | 2 | 2 | endodermal cell fate determination |
GO:0021570 | 0.0048 | Inf | 0.1389 | 2 | 2 | rhombomere 4 development |
GO:0048696 | 0.0048 | Inf | 0.1389 | 2 | 2 | regulation of collateral sprouting in absence of injury |
GO:0051892 | 0.0048 | Inf | 0.1389 | 2 | 2 | negative regulation of cardioblast differentiation |
GO:0070352 | 0.0048 | Inf | 0.1389 | 2 | 2 | positive regulation of white fat cell proliferation |
GO:2000043 | 0.0048 | Inf | 0.1389 | 2 | 2 | regulation of cardiac cell fate specification |
GO:2000054 | 0.0048 | Inf | 0.1389 | 2 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
GO:2000079 | 0.0048 | Inf | 0.1389 | 2 | 2 | regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
GO:0060219 | 0.0049 | 5.6062 | 1.1803 | 5 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0090190 | 0.0049 | 5.6062 | 1.1803 | 5 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0006875 | 0.0049 | 1.5496 | 31.9382 | 47 | 460 | cellular metal ion homeostasis |
GO:2000727 | 0.005 | 4.4873 | 1.6663 | 6 | 24 | positive regulation of cardiac muscle cell differentiation |
GO:0021521 | 0.0051 | 7.684 | 0.7637 | 4 | 11 | ventral spinal cord interneuron specification |
GO:0009584 | 0.0052 | 3.1109 | 3.3327 | 9 | 48 | detection of visible light |
GO:0009953 | 0.0052 | 2.3635 | 6.5265 | 14 | 94 | dorsal/ventral pattern formation |
GO:0007193 | 0.0053 | 2.7057 | 4.5707 | 11 | 66 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0048645 | 0.0054 | 2.8693 | 3.9576 | 10 | 57 | animal organ formation |
GO:0021675 | 0.0054 | 2.6982 | 4.5824 | 11 | 66 | nerve development |
GO:0060485 | 0.0054 | 1.8163 | 15.2748 | 26 | 220 | mesenchyme development |
GO:0003254 | 0.0055 | 3.3686 | 2.7772 | 8 | 40 | regulation of membrane depolarization |
GO:0014062 | 0.0057 | 13.438 | 0.4166 | 3 | 6 | regulation of serotonin secretion |
GO:0021891 | 0.0057 | 13.438 | 0.4166 | 3 | 6 | olfactory bulb interneuron development |
GO:0060430 | 0.0057 | 13.438 | 0.4166 | 3 | 6 | lung saccule development |
GO:0060687 | 0.0057 | 13.438 | 0.4166 | 3 | 6 | regulation of branching involved in prostate gland morphogenesis |
GO:0072174 | 0.0057 | 13.438 | 0.4166 | 3 | 6 | metanephric tubule formation |
GO:2000848 | 0.0057 | 13.438 | 0.4166 | 3 | 6 | positive regulation of corticosteroid hormone secretion |
GO:0007189 | 0.0061 | 2.8093 | 4.027 | 10 | 58 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0001562 | 0.0062 | 4.2509 | 1.7358 | 6 | 25 | response to protozoan |
GO:0035235 | 0.0062 | 4.2509 | 1.7358 | 6 | 25 | ionotropic glutamate receptor signaling pathway |
GO:0007612 | 0.0063 | 2.1081 | 8.7483 | 17 | 126 | learning |
GO:0030900 | 0.0063 | 1.7135 | 18.567 | 30 | 269 | forebrain development |
GO:0001759 | 0.0064 | 5.1746 | 1.2498 | 5 | 18 | organ induction |
GO:0031664 | 0.0064 | 5.1746 | 1.2498 | 5 | 18 | regulation of lipopolysaccharide-mediated signaling pathway |
GO:0051004 | 0.0064 | 5.1746 | 1.2498 | 5 | 18 | regulation of lipoprotein lipase activity |
GO:0060231 | 0.0064 | 5.1746 | 1.2498 | 5 | 18 | mesenchymal to epithelial transition |
GO:0072077 | 0.0064 | 5.1746 | 1.2498 | 5 | 18 | renal vesicle morphogenesis |
GO:0097094 | 0.0064 | 5.1746 | 1.2498 | 5 | 18 | craniofacial suture morphogenesis |
GO:0031424 | 0.0065 | 1.8109 | 14.7193 | 25 | 212 | keratinization |
GO:0015837 | 0.0065 | 2.4913 | 5.3462 | 12 | 77 | amine transport |
GO:0048754 | 0.0066 | 2.0451 | 9.512 | 18 | 137 | branching morphogenesis of an epithelial tube |
GO:0050919 | 0.0066 | 3.6258 | 2.2912 | 7 | 33 | negative chemotaxis |
GO:0098815 | 0.0066 | 3.6258 | 2.2912 | 7 | 33 | modulation of excitatory postsynaptic potential |
GO:0045596 | 0.0066 | 1.4566 | 41.7279 | 58 | 601 | negative regulation of cell differentiation |
GO:0007417 | 0.0067 | 1.4369 | 45.1866 | 62 | 659 | central nervous system development |
GO:1905207 | 0.0068 | 2.9644 | 3.4654 | 9 | 50 | regulation of cardiocyte differentiation |
GO:0051705 | 0.0069 | 2.7518 | 4.0964 | 10 | 59 | multi-organism behavior |
GO:0048935 | 0.0073 | 6.723 | 0.8332 | 4 | 12 | peripheral nervous system neuron development |
GO:0051967 | 0.0073 | 6.723 | 0.8332 | 4 | 12 | negative regulation of synaptic transmission, glutamatergic |
GO:0098703 | 0.0073 | 6.723 | 0.8332 | 4 | 12 | calcium ion import across plasma membrane |
GO:0060688 | 0.0074 | 3.1784 | 2.909 | 8 | 42 | regulation of morphogenesis of a branching structure |
GO:0030817 | 0.0075 | 2.1193 | 8.1928 | 16 | 118 | regulation of cAMP biosynthetic process |
GO:0019233 | 0.0075 | 2.3396 | 6.1099 | 13 | 88 | sensory perception of pain |
GO:0021536 | 0.0076 | 2.5581 | 4.7907 | 11 | 69 | diencephalon development |
GO:0003229 | 0.0078 | 2.8881 | 3.541 | 9 | 51 | ventricular cardiac muscle tissue development |
GO:0035150 | 0.0079 | 2.0512 | 8.9566 | 17 | 129 | regulation of tube size |
GO:0009887 | 0.0084 | 1.3837 | 54.3555 | 72 | 792 | animal organ morphogenesis |
GO:0010469 | 0.0084 | 1.4794 | 35.4097 | 50 | 510 | regulation of receptor activity |
GO:0007267 | 0.0085 | 1.4611 | 37.9951 | 53 | 563 | cell-cell signaling |
GO:0006812 | 0.0086 | 1.6864 | 18.1941 | 29 | 267 | cation transport |
GO:0060560 | 0.0088 | 1.8375 | 12.7753 | 22 | 184 | developmental growth involved in morphogenesis |
GO:0061180 | 0.0088 | 2.6435 | 4.2353 | 10 | 61 | mammary gland epithelium development |
GO:0014902 | 0.0091 | 2.1977 | 6.9431 | 14 | 100 | myotube differentiation |
GO:0038084 | 0.0092 | 3.8455 | 1.8746 | 6 | 27 | vascular endothelial growth factor signaling pathway |
GO:0046471 | 0.0092 | 3.8455 | 1.8746 | 6 | 27 | phosphatidylglycerol metabolic process |
GO:0051240 | 0.0093 | 1.2895 | 93.0559 | 115 | 1349 | positive regulation of multicellular organismal process |
GO:0009888 | 0.0094 | 1.2728 | 105.0011 | 128 | 1528 | tissue development |
GO:0003339 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0031017 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | exocrine pancreas development |
GO:0032277 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | negative regulation of gonadotropin secretion |
GO:0035385 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | Roundabout signaling pathway |
GO:0098969 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | neurotransmitter receptor transport to postsynaptic membrane |
GO:0099612 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | protein localization to axon |
GO:1902902 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | negative regulation of autophagosome assembly |
GO:1903539 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | protein localization to postsynaptic membrane |
GO:2000049 | 0.0095 | 10.0778 | 0.486 | 3 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0055007 | 0.0095 | 2.3567 | 5.6009 | 12 | 81 | cardiac muscle cell differentiation |
GO:0030816 | 0.0098 | 2.3462 | 5.6239 | 12 | 81 | positive regulation of cAMP metabolic process |
GO:0051047 | 0.0099 | 1.5646 | 24.8562 | 37 | 358 | positive regulation of secretion |
GO:0008595 | 0.01 | 5.9756 | 0.9026 | 4 | 13 | anterior/posterior axis specification, embryo |
GO:0021781 | 0.01 | 5.9756 | 0.9026 | 4 | 13 | glial cell fate commitment |
GO:0021819 | 0.01 | 5.9756 | 0.9026 | 4 | 13 | layer formation in cerebral cortex |
GO:0036149 | 0.01 | 5.9756 | 0.9026 | 4 | 13 | phosphatidylinositol acyl-chain remodeling |
GO:0046851 | 0.01 | 5.9756 | 0.9026 | 4 | 13 | negative regulation of bone remodeling |
GO:0060456 | 0.01 | 5.9756 | 0.9026 | 4 | 13 | positive regulation of digestive system process |
GO:0060911 | 0.01 | 5.9756 | 0.9026 | 4 | 13 | cardiac cell fate commitment |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007600 | 0.0028 | Inf | 0.1061 | 2 | 810 | sensory perception |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061485 | 9e-04 | Inf | 9e-04 | 1 | 1 | memory T cell proliferation |
GO:0003220 | 0.0017 | 1271.0833 | 0.0017 | 1 | 2 | left ventricular cardiac muscle tissue morphogenesis |
GO:0098735 | 0.0017 | 1271.0833 | 0.0017 | 1 | 2 | positive regulation of the force of heart contraction |
GO:0098907 | 0.0017 | 1271.0833 | 0.0017 | 1 | 2 | regulation of SA node cell action potential |
GO:1903905 | 0.0017 | 1271.0833 | 0.0017 | 1 | 2 | positive regulation of establishment of T cell polarity |
GO:1901896 | 0.0026 | 635.5 | 0.0026 | 1 | 3 | positive regulation of calcium-transporting ATPase activity |
GO:0098904 | 0.0034 | 423.6389 | 0.0034 | 1 | 4 | regulation of AV node cell action potential |
GO:0002318 | 0.0051 | 254.15 | 0.0051 | 1 | 6 | myeloid progenitor cell differentiation |
GO:0035672 | 0.0051 | 254.15 | 0.0051 | 1 | 6 | oligopeptide transmembrane transport |
GO:0035726 | 0.0051 | 254.15 | 0.0051 | 1 | 6 | common myeloid progenitor cell proliferation |
GO:0071313 | 0.0051 | 254.15 | 0.0051 | 1 | 6 | cellular response to caffeine |
GO:0086029 | 0.0051 | 254.15 | 0.0051 | 1 | 6 | Purkinje myocyte to ventricular cardiac muscle cell signaling |
GO:0098910 | 0.0051 | 254.15 | 0.0051 | 1 | 6 | regulation of atrial cardiac muscle cell action potential |
GO:1990869 | 0.0051 | 254.15 | 0.0051 | 1 | 6 | cellular response to chemokine |
GO:0061337 | 0.0051 | 21.8297 | 0.109 | 2 | 128 | cardiac conduction |
GO:0060075 | 0.0059 | 211.7778 | 0.006 | 1 | 7 | regulation of resting membrane potential |
GO:0034728 | 0.0072 | 18.1854 | 0.1303 | 2 | 153 | nucleosome organization |
GO:0038003 | 0.0076 | 158.8125 | 0.0077 | 1 | 9 | opioid receptor signaling pathway |
GO:0070914 | 0.0076 | 158.8125 | 0.0077 | 1 | 9 | UV-damage excision repair |
GO:0086018 | 0.0076 | 158.8125 | 0.0077 | 1 | 9 | SA node cell to atrial cardiac muscle cell signaling |
GO:0006333 | 0.0085 | 16.7295 | 0.1414 | 2 | 166 | chromatin assembly or disassembly |
GO:0001767 | 0.0085 | 141.1574 | 0.0085 | 1 | 10 | establishment of lymphocyte polarity |
GO:0002328 | 0.0085 | 141.1574 | 0.0085 | 1 | 10 | pro-B cell differentiation |
GO:0003376 | 0.0085 | 141.1574 | 0.0085 | 1 | 10 | sphingosine-1-phosphate signaling pathway |
GO:0086027 | 0.0085 | 141.1574 | 0.0085 | 1 | 10 | AV node cell to bundle of His cell signaling |
GO:0097050 | 0.0085 | 141.1574 | 0.0085 | 1 | 10 | type B pancreatic cell apoptotic process |
GO:0001771 | 0.0093 | 127.0333 | 0.0094 | 1 | 11 | immunological synapse formation |
GO:0006995 | 0.0093 | 127.0333 | 0.0094 | 1 | 11 | cellular response to nitrogen starvation |
GO:0071872 | 0.0093 | 127.0333 | 0.0094 | 1 | 11 | cellular response to epinephrine stimulus |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0060716 | 0.0013 | Inf | 0.0013 | 1 | 20 | labyrinthine layer blood vessel development |
GO:0043647 | 0.0041 | Inf | 0.0041 | 1 | 62 | inositol phosphate metabolic process |
GO:0001892 | 0.0054 | Inf | 0.0054 | 1 | 83 | embryonic placenta development |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003167 | 1e-04 | Inf | 1e-04 | 1 | 1 | atrioventricular bundle cell differentiation |
GO:0060931 | 1e-04 | Inf | 1e-04 | 1 | 1 | sinoatrial node cell development |
GO:0003163 | 1e-04 | Inf | 1e-04 | 1 | 2 | sinoatrial node development |
GO:0010159 | 2e-04 | Inf | 2e-04 | 1 | 3 | specification of animal organ position |
GO:0060596 | 2e-04 | Inf | 2e-04 | 1 | 3 | mammary placode formation |
GO:0003164 | 3e-04 | Inf | 3e-04 | 1 | 4 | His-Purkinje system development |
GO:0060920 | 3e-04 | Inf | 3e-04 | 1 | 4 | cardiac pacemaker cell differentiation |
GO:0046884 | 5e-04 | Inf | 5e-04 | 1 | 7 | follicle-stimulating hormone secretion |
GO:0060923 | 6e-04 | Inf | 6e-04 | 1 | 9 | cardiac muscle cell fate commitment |
GO:0032275 | 7e-04 | Inf | 7e-04 | 1 | 10 | luteinizing hormone secretion |
GO:0008595 | 9e-04 | Inf | 9e-04 | 1 | 13 | anterior/posterior axis specification, embryo |
GO:0071697 | 9e-04 | Inf | 9e-04 | 1 | 13 | ectodermal placode morphogenesis |
GO:0007350 | 0.001 | Inf | 0.001 | 1 | 15 | blastoderm segmentation |
GO:0030540 | 0.001 | Inf | 0.001 | 1 | 15 | female genitalia development |
GO:0030539 | 0.0013 | Inf | 0.0013 | 1 | 20 | male genitalia development |
GO:0060444 | 0.0013 | Inf | 0.0013 | 1 | 20 | branching involved in mammary gland duct morphogenesis |
GO:0045662 | 0.0015 | Inf | 0.0015 | 1 | 23 | negative regulation of myoblast differentiation |
GO:0035116 | 0.0018 | Inf | 0.0018 | 1 | 27 | embryonic hindlimb morphogenesis |
GO:0035115 | 0.002 | Inf | 0.002 | 1 | 30 | embryonic forelimb morphogenesis |
GO:0060412 | 0.0024 | Inf | 0.0024 | 1 | 36 | ventricular septum morphogenesis |
GO:2000648 | 0.0024 | Inf | 0.0024 | 1 | 36 | positive regulation of stem cell proliferation |
GO:0030857 | 0.0025 | Inf | 0.0025 | 1 | 38 | negative regulation of epithelial cell differentiation |
GO:0060443 | 0.0028 | Inf | 0.0028 | 1 | 42 | mammary gland morphogenesis |
GO:0060986 | 0.0029 | Inf | 0.0029 | 1 | 44 | endocrine hormone secretion |
GO:0001947 | 0.0035 | Inf | 0.0035 | 1 | 54 | heart looping |
GO:0090398 | 0.0037 | Inf | 0.0037 | 1 | 57 | cellular senescence |
GO:0042733 | 0.0039 | Inf | 0.0039 | 1 | 60 | embryonic digit morphogenesis |
GO:0061180 | 0.004 | Inf | 0.004 | 1 | 61 | mammary gland epithelium development |
GO:0055013 | 0.0042 | Inf | 0.0042 | 1 | 64 | cardiac muscle cell development |
GO:0035050 | 0.0045 | Inf | 0.0045 | 1 | 68 | embryonic heart tube development |
GO:0003151 | 0.0047 | Inf | 0.0047 | 1 | 72 | outflow tract morphogenesis |
GO:0048332 | 0.0047 | Inf | 0.0047 | 1 | 72 | mesoderm morphogenesis |
GO:0009798 | 0.0051 | Inf | 0.0051 | 1 | 78 | axis specification |
GO:0060021 | 0.0056 | Inf | 0.0056 | 1 | 86 | palate development |
GO:0021761 | 0.006 | Inf | 0.006 | 1 | 92 | limbic system development |
GO:0003279 | 0.0062 | Inf | 0.0062 | 1 | 94 | cardiac septum development |
GO:0007368 | 0.007 | Inf | 0.007 | 1 | 107 | determination of left/right symmetry |
GO:0003231 | 0.0073 | Inf | 0.0073 | 1 | 112 | cardiac ventricle development |
GO:0003206 | 0.0077 | Inf | 0.0077 | 1 | 117 | cardiac chamber morphogenesis |
GO:0009799 | 0.0077 | Inf | 0.0077 | 1 | 117 | specification of symmetry |
GO:0035113 | 0.0077 | Inf | 0.0077 | 1 | 118 | embryonic appendage morphogenesis |
GO:0035051 | 0.0087 | Inf | 0.0087 | 1 | 133 | cardiocyte differentiation |
GO:0035108 | 0.0089 | Inf | 0.0089 | 1 | 136 | limb morphogenesis |
GO:0019827 | 0.0094 | Inf | 0.0094 | 1 | 144 | stem cell population maintenance |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0038001 | 0.0012 | 1525.9 | 0.0012 | 1 | 6 | paracrine signaling |
GO:2000774 | 0.0022 | 762.7 | 0.0022 | 1 | 11 | positive regulation of cellular senescence |
GO:0071360 | 0.0026 | 635.5 | 0.0026 | 1 | 13 | cellular response to exogenous dsRNA |
GO:2000311 | 0.0035 | 448.4412 | 0.0035 | 1 | 18 | regulation of AMPA receptor activity |
GO:0002230 | 0.0043 | 362.9286 | 0.0043 | 1 | 22 | positive regulation of defense response to virus by host |
GO:0016339 | 0.0053 | 293.0385 | 0.0053 | 1 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0090342 | 0.008 | 190.3 | 0.0081 | 1 | 41 | regulation of cell aging |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045660 | 8e-04 | Inf | 8e-04 | 1 | 1 | positive regulation of neutrophil differentiation |
GO:0046470 | 0.0013 | 44.6676 | 0.055 | 2 | 70 | phosphatidylcholine metabolic process |
GO:0070973 | 0.0024 | 693.3182 | 0.0024 | 1 | 3 | protein localization to endoplasmic reticulum exit site |
GO:0098706 | 0.0024 | 693.3182 | 0.0024 | 1 | 3 | ferric iron import across plasma membrane |
GO:0015677 | 0.0031 | 462.1818 | 0.0031 | 1 | 4 | copper ion import |
GO:0090073 | 0.0047 | 277.2727 | 0.0047 | 1 | 6 | positive regulation of protein homodimerization activity |
GO:2000035 | 0.0055 | 231.0455 | 0.0055 | 1 | 7 | regulation of stem cell division |
GO:0097286 | 0.0086 | 138.5909 | 0.0086 | 1 | 11 | iron ion import |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019805 | 2e-04 | Inf | 2e-04 | 1 | 3 | quinolinate biosynthetic process |
GO:0006569 | 5e-04 | Inf | 5e-04 | 1 | 8 | tryptophan catabolic process |
GO:0042436 | 5e-04 | Inf | 5e-04 | 1 | 8 | indole-containing compound catabolic process |
GO:0070050 | 5e-04 | Inf | 5e-04 | 1 | 8 | neuron cellular homeostasis |
GO:0006586 | 9e-04 | Inf | 9e-04 | 1 | 13 | indolalkylamine metabolic process |
GO:0042402 | 0.0012 | Inf | 0.0012 | 1 | 18 | cellular biogenic amine catabolic process |
GO:0009072 | 0.0016 | Inf | 0.0016 | 1 | 24 | aromatic amino acid family metabolic process |
GO:0009435 | 0.0017 | Inf | 0.0017 | 1 | 26 | NAD biosynthetic process |
GO:0019363 | 0.002 | Inf | 0.002 | 1 | 30 | pyridine nucleotide biosynthetic process |
GO:0010043 | 0.0029 | Inf | 0.0029 | 1 | 45 | response to zinc ion |
GO:0046686 | 0.0032 | Inf | 0.0032 | 1 | 49 | response to cadmium ion |
GO:0043648 | 0.006 | Inf | 0.006 | 1 | 91 | dicarboxylic acid metabolic process |
GO:0009063 | 0.0068 | Inf | 0.0068 | 1 | 104 | cellular amino acid catabolic process |
GO:0044106 | 0.0072 | Inf | 0.0072 | 1 | 110 | cellular amine metabolic process |
GO:0022900 | 0.0098 | Inf | 0.0098 | 1 | 150 | electron transport chain |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 3.5527 | 10.4801 | 33 | 401 | detection of chemical stimulus |
GO:0050911 | 0 | 3.5365 | 8.5199 | 27 | 326 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007606 | 0 | 3.1521 | 10.9243 | 31 | 418 | sensory perception of chemical stimulus |
GO:0050906 | 0 | 3.0997 | 10.7153 | 30 | 410 | detection of stimulus involved in sensory perception |
GO:0007186 | 0 | 2.3417 | 22.7714 | 48 | 918 | G-protein coupled receptor signaling pathway |
GO:0007218 | 0 | 6.3047 | 2.4044 | 13 | 92 | neuropeptide signaling pathway |
GO:0007389 | 0 | 3.3721 | 8.207 | 25 | 318 | pattern specification process |
GO:0065007 | 0 | 1.7134 | 277.5254 | 317 | 10619 | biological regulation |
GO:0050794 | 0 | 1.6396 | 247.9931 | 290 | 9489 | regulation of cellular process |
GO:0009952 | 0 | 3.9376 | 4.786 | 17 | 184 | anterior/posterior pattern specification |
GO:0061364 | 0 | Inf | 0.0784 | 3 | 3 | apoptotic process involved in luteolysis |
GO:0007188 | 0 | 4.2545 | 3.6589 | 14 | 140 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0007631 | 0 | 5.2796 | 2.3616 | 11 | 91 | feeding behavior |
GO:0042391 | 0 | 2.7347 | 9.5131 | 24 | 364 | regulation of membrane potential |
GO:0060322 | 0 | 2.2436 | 16.8831 | 35 | 646 | head development |
GO:0031644 | 0 | 6.2152 | 1.6726 | 9 | 64 | regulation of neurological system process |
GO:0060219 | 1e-04 | 15.7107 | 0.4443 | 5 | 17 | camera-type eye photoreceptor cell differentiation |
GO:0099537 | 1e-04 | 2.2924 | 14.5832 | 31 | 558 | trans-synaptic signaling |
GO:0007198 | 1e-04 | 112.6288 | 0.1045 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0034287 | 1e-04 | 112.6288 | 0.1045 | 3 | 4 | detection of monosaccharide stimulus |
GO:0051594 | 1e-04 | 112.6288 | 0.1045 | 3 | 4 | detection of glucose |
GO:0021953 | 1e-04 | 3.7182 | 4.1293 | 14 | 158 | central nervous system neuron differentiation |
GO:0030900 | 1e-04 | 2.6873 | 8.8336 | 22 | 338 | forebrain development |
GO:0021559 | 1e-04 | 25.0835 | 0.2613 | 4 | 10 | trigeminal nerve development |
GO:0021517 | 1e-04 | 7.5679 | 1.0977 | 7 | 42 | ventral spinal cord development |
GO:0007154 | 1e-04 | 1.4627 | 149.1774 | 185 | 5708 | cell communication |
GO:0050885 | 2e-04 | 6.969 | 1.1761 | 7 | 45 | neuromuscular process controlling balance |
GO:0031960 | 2e-04 | 3.6213 | 3.9202 | 13 | 150 | response to corticosteroid |
GO:0048665 | 2e-04 | 8.3919 | 0.8624 | 6 | 33 | neuron fate specification |
GO:0003206 | 2e-04 | 3.9482 | 3.0578 | 11 | 117 | cardiac chamber morphogenesis |
GO:0008595 | 3e-04 | 16.719 | 0.3398 | 4 | 13 | anterior/posterior axis specification, embryo |
GO:0007268 | 3e-04 | 2.161 | 14.3588 | 29 | 552 | chemical synaptic transmission |
GO:0021891 | 3e-04 | 37.5379 | 0.1568 | 3 | 6 | olfactory bulb interneuron development |
GO:0001501 | 4e-04 | 2.2552 | 11.8391 | 25 | 453 | skeletal system development |
GO:0045471 | 4e-04 | 3.7352 | 3.2146 | 11 | 123 | response to ethanol |
GO:0008306 | 4e-04 | 5.0496 | 1.7772 | 8 | 68 | associative learning |
GO:0048869 | 4e-04 | 1.4601 | 97.5944 | 127 | 3772 | cellular developmental process |
GO:0045597 | 4e-04 | 1.8961 | 21.4305 | 38 | 820 | positive regulation of cell differentiation |
GO:0007350 | 5e-04 | 13.6773 | 0.392 | 4 | 15 | blastoderm segmentation |
GO:0003018 | 5e-04 | 3.3589 | 3.868 | 12 | 148 | vascular process in circulatory system |
GO:0023052 | 6e-04 | 1.4116 | 141.6941 | 173 | 5510 | signaling |
GO:0035385 | 6e-04 | 28.1515 | 0.1829 | 3 | 7 | Roundabout signaling pathway |
GO:0007611 | 6e-04 | 2.8361 | 5.6713 | 15 | 217 | learning or memory |
GO:2000054 | 7e-04 | Inf | 0.0523 | 2 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
GO:0009953 | 8e-04 | 4.0135 | 2.4567 | 9 | 94 | dorsal/ventral pattern formation |
GO:0048646 | 9e-04 | 1.7795 | 24.5667 | 41 | 940 | anatomical structure formation involved in morphogenesis |
GO:0008343 | 9e-04 | 22.5197 | 0.2091 | 3 | 8 | adult feeding behavior |
GO:0060346 | 9e-04 | 22.5197 | 0.2091 | 3 | 8 | bone trabecula formation |
GO:0071695 | 0.001 | 3.2907 | 3.6066 | 11 | 138 | anatomical structure maturation |
GO:0002067 | 0.0011 | 5.805 | 1.1761 | 6 | 45 | glandular epithelial cell differentiation |
GO:0008015 | 0.0011 | 2.1135 | 12.0481 | 24 | 461 | blood circulation |
GO:0035270 | 0.0012 | 3.4489 | 3.1362 | 10 | 120 | endocrine system development |
GO:0007210 | 0.0013 | 10.0273 | 0.4966 | 4 | 19 | serotonin receptor signaling pathway |
GO:0021562 | 0.0013 | 18.7652 | 0.2352 | 3 | 9 | vestibulocochlear nerve development |
GO:0044848 | 0.0013 | 18.7652 | 0.2352 | 3 | 9 | biological phase |
GO:0046549 | 0.0013 | 18.7652 | 0.2352 | 3 | 9 | retinal cone cell development |
GO:0097746 | 0.0014 | 3.3869 | 3.1884 | 10 | 122 | regulation of blood vessel diameter |
GO:0046883 | 0.0015 | 2.5771 | 6.1939 | 15 | 237 | regulation of hormone secretion |
GO:0061061 | 0.0015 | 1.9464 | 15.2366 | 28 | 583 | muscle structure development |
GO:0019935 | 0.0015 | 3.627 | 2.6919 | 9 | 103 | cyclic-nucleotide-mediated signaling |
GO:0033993 | 0.0016 | 1.784 | 21.4044 | 36 | 819 | response to lipid |
GO:0051482 | 0.0016 | 9.4 | 0.5227 | 4 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0009914 | 0.0016 | 2.3881 | 7.553 | 17 | 289 | hormone transport |
GO:0021675 | 0.0016 | 4.4821 | 1.7249 | 7 | 66 | nerve development |
GO:0055025 | 0.0017 | 5.2636 | 1.2806 | 6 | 49 | positive regulation of cardiac muscle tissue development |
GO:0048699 | 0.0017 | 1.9543 | 14.6493 | 27 | 580 | generation of neurons |
GO:0048666 | 0.0017 | 1.7477 | 23.0736 | 38 | 890 | neuron development |
GO:0071392 | 0.0018 | 6.4935 | 0.8886 | 5 | 34 | cellular response to estradiol stimulus |
GO:0021515 | 0.0018 | 5.1437 | 1.3067 | 6 | 50 | cell differentiation in spinal cord |
GO:0051239 | 0.0019 | 1.4554 | 65.6019 | 88 | 2534 | regulation of multicellular organismal process |
GO:0014821 | 0.0019 | 8.8465 | 0.5488 | 4 | 21 | phasic smooth muscle contraction |
GO:2000291 | 0.0019 | 8.8465 | 0.5488 | 4 | 21 | regulation of myoblast proliferation |
GO:0006355 | 0.002 | 1.4074 | 85.5915 | 110 | 3275 | regulation of transcription, DNA-templated |
GO:0010159 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | specification of animal organ position |
GO:0021524 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | visceral motor neuron differentiation |
GO:0021912 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0071626 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | mastication |
GO:0098583 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | learned vocalization behavior |
GO:0110023 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | negative regulation of cardiac muscle myoblast proliferation |
GO:1905747 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | negative regulation of saliva secretion |
GO:1905748 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | hard palate morphogenesis |
GO:2000312 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | regulation of kainate selective glutamate receptor activity |
GO:2000721 | 0.002 | 74.8967 | 0.0784 | 2 | 3 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:1901700 | 0.002 | 1.5854 | 36.3274 | 54 | 1390 | response to oxygen-containing compound |
GO:0055074 | 0.002 | 2.1636 | 9.7744 | 20 | 374 | calcium ion homeostasis |
GO:0035150 | 0.0021 | 3.1861 | 3.3714 | 10 | 129 | regulation of tube size |
GO:0048639 | 0.0022 | 2.9611 | 3.9725 | 11 | 152 | positive regulation of developmental growth |
GO:0046530 | 0.0023 | 4.9193 | 1.359 | 6 | 52 | photoreceptor cell differentiation |
GO:0048704 | 0.0023 | 3.7352 | 2.326 | 8 | 89 | embryonic skeletal system morphogenesis |
GO:0051480 | 0.0024 | 2.3657 | 7.1609 | 16 | 274 | regulation of cytosolic calcium ion concentration |
GO:0048598 | 0.0024 | 1.9233 | 14.2696 | 26 | 546 | embryonic morphogenesis |
GO:0007215 | 0.0025 | 4.1306 | 1.8556 | 7 | 71 | glutamate receptor signaling pathway |
GO:0060379 | 0.0025 | 14.072 | 0.2875 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060573 | 0.0025 | 14.072 | 0.2875 | 3 | 11 | cell fate specification involved in pattern specification |
GO:2001141 | 0.0026 | 1.3923 | 86.2971 | 110 | 3302 | regulation of RNA biosynthetic process |
GO:0048636 | 0.0027 | 4.0668 | 1.8817 | 7 | 72 | positive regulation of muscle organ development |
GO:1901863 | 0.0027 | 4.0668 | 1.8817 | 7 | 72 | positive regulation of muscle tissue development |
GO:0001964 | 0.0027 | 7.9142 | 0.6011 | 4 | 23 | startle response |
GO:0010460 | 0.0027 | 7.9142 | 0.6011 | 4 | 23 | positive regulation of heart rate |
GO:0021602 | 0.0027 | 7.9142 | 0.6011 | 4 | 23 | cranial nerve morphogenesis |
GO:2000463 | 0.0027 | 7.9142 | 0.6011 | 4 | 23 | positive regulation of excitatory postsynaptic potential |
GO:0072503 | 0.0029 | 2.0968 | 10.0619 | 20 | 385 | cellular divalent inorganic cation homeostasis |
GO:0031016 | 0.0029 | 4.0049 | 1.9078 | 7 | 73 | pancreas development |
GO:0007187 | 0.0029 | 7.7281 | 0.6108 | 4 | 24 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0003008 | 0.0031 | 1.8695 | 15.2942 | 27 | 657 | system process |
GO:0007417 | 0.0031 | 1.8224 | 16.7923 | 29 | 659 | central nervous system development |
GO:0023061 | 0.0031 | 2.0793 | 10.1403 | 20 | 388 | signal release |
GO:0060415 | 0.0032 | 3.9448 | 1.934 | 7 | 74 | muscle tissue morphogenesis |
GO:0007600 | 0.0032 | 2.172 | 8.7475 | 18 | 353 | sensory perception |
GO:0048754 | 0.0032 | 2.9838 | 3.5805 | 10 | 137 | branching morphogenesis of an epithelial tube |
GO:0021511 | 0.0032 | 7.518 | 0.6272 | 4 | 24 | spinal cord patterning |
GO:0031223 | 0.0033 | 12.5076 | 0.3136 | 3 | 12 | auditory behavior |
GO:0001709 | 0.0033 | 5.5367 | 1.0193 | 5 | 39 | cell fate determination |
GO:0044058 | 0.0033 | 5.5367 | 1.0193 | 5 | 39 | regulation of digestive system process |
GO:0014706 | 0.0033 | 2.1616 | 8.7813 | 18 | 336 | striated muscle tissue development |
GO:0048513 | 0.0035 | 1.411 | 70.6892 | 92 | 2781 | animal organ development |
GO:0048812 | 0.0037 | 1.8857 | 13.956 | 25 | 534 | neuron projection morphogenesis |
GO:0003148 | 0.0038 | 7.1595 | 0.6534 | 4 | 25 | outflow tract septum morphogenesis |
GO:0003309 | 0.0038 | 7.1595 | 0.6534 | 4 | 25 | type B pancreatic cell differentiation |
GO:0050793 | 0.0039 | 1.4364 | 57.4704 | 77 | 2199 | regulation of developmental process |
GO:0071385 | 0.0039 | 4.35 | 1.5158 | 6 | 58 | cellular response to glucocorticoid stimulus |
GO:0001992 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0003257 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
GO:0007356 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | thorax and anterior abdomen determination |
GO:0021913 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0032100 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | positive regulation of appetite |
GO:0048880 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | sensory system development |
GO:0050923 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | regulation of negative chemotaxis |
GO:0051414 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | response to cortisol |
GO:0070253 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | somatostatin secretion |
GO:0071504 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | cellular response to heparin |
GO:0090027 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | negative regulation of monocyte chemotaxis |
GO:1901078 | 0.0039 | 37.4458 | 0.1045 | 2 | 4 | negative regulation of relaxation of muscle |
GO:0046851 | 0.0042 | 11.2561 | 0.3398 | 3 | 13 | negative regulation of bone remodeling |
GO:1901213 | 0.0042 | 11.2561 | 0.3398 | 3 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0009798 | 0.0042 | 3.7216 | 2.0385 | 7 | 78 | axis specification |
GO:0030073 | 0.0047 | 2.5302 | 5.0179 | 12 | 192 | insulin secretion |
GO:0003016 | 0.005 | 6.536 | 0.7056 | 4 | 27 | respiratory system process |
GO:0050795 | 0.0051 | 4.1119 | 1.5942 | 6 | 61 | regulation of behavior |
GO:0021794 | 0.0052 | 10.2321 | 0.3659 | 3 | 14 | thalamus development |
GO:0050884 | 0.0052 | 10.2321 | 0.3659 | 3 | 14 | neuromuscular process controlling posture |
GO:0060485 | 0.0053 | 2.3853 | 5.7497 | 13 | 220 | mesenchyme development |
GO:0051961 | 0.0054 | 2.294 | 6.4292 | 14 | 246 | negative regulation of nervous system development |
GO:0048858 | 0.0054 | 1.8226 | 14.4003 | 25 | 551 | cell projection morphogenesis |
GO:0060045 | 0.0057 | 6.2633 | 0.7318 | 4 | 28 | positive regulation of cardiac muscle cell proliferation |
GO:0032102 | 0.0058 | 2.2741 | 6.4814 | 14 | 248 | negative regulation of response to external stimulus |
GO:0022604 | 0.0062 | 1.9811 | 10.0619 | 19 | 385 | regulation of cell morphogenesis |
GO:0031290 | 0.0063 | 9.4245 | 0.3902 | 3 | 15 | retinal ganglion cell axon guidance |
GO:0060579 | 0.0064 | 9.3788 | 0.392 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0071380 | 0.0064 | 9.3788 | 0.392 | 3 | 15 | cellular response to prostaglandin E stimulus |
GO:0098911 | 0.0064 | 9.3788 | 0.392 | 3 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0001764 | 0.0065 | 2.8602 | 3.3453 | 9 | 128 | neuron migration |
GO:0021650 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | vestibulocochlear nerve formation |
GO:0035609 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | C-terminal protein deglutamylation |
GO:0051970 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060012 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | synaptic transmission, glycinergic |
GO:0070100 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:0071205 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | protein localization to juxtaparanode region of axon |
GO:0071502 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | cellular response to temperature stimulus |
GO:0090259 | 0.0065 | 24.9622 | 0.1307 | 2 | 5 | regulation of retinal ganglion cell axon guidance |
GO:0019098 | 0.0065 | 6.0124 | 0.7579 | 4 | 29 | reproductive behavior |
GO:0055010 | 0.0068 | 4.5893 | 1.2022 | 5 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0060079 | 0.0072 | 3.8018 | 1.7102 | 6 | 66 | excitatory postsynaptic potential |
GO:0045661 | 0.0074 | 4.4797 | 1.2283 | 5 | 47 | regulation of myoblast differentiation |
GO:0035637 | 0.0075 | 2.4807 | 4.6781 | 11 | 179 | multicellular organismal signaling |
GO:1905114 | 0.0076 | 1.7909 | 14.0344 | 24 | 537 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0048675 | 0.0077 | 3.3009 | 2.2737 | 7 | 87 | axon extension |
GO:0045986 | 0.0077 | 8.6568 | 0.4182 | 3 | 16 | negative regulation of smooth muscle contraction |
GO:0048259 | 0.008 | 3.7059 | 1.751 | 6 | 67 | regulation of receptor-mediated endocytosis |
GO:0060688 | 0.0081 | 4.3752 | 1.2545 | 5 | 48 | regulation of morphogenesis of a branching structure |
GO:0061564 | 0.0082 | 1.8893 | 11.0812 | 20 | 424 | axon development |
GO:0008038 | 0.0083 | 5.5662 | 0.8102 | 4 | 31 | neuron recognition |
GO:0051930 | 0.0083 | 5.5662 | 0.8102 | 4 | 31 | regulation of sensory perception of pain |
GO:0050877 | 0.0083 | 2.172 | 6.7671 | 14 | 283 | nervous system process |
GO:0050770 | 0.009 | 2.7 | 3.5282 | 9 | 135 | regulation of axonogenesis |
GO:0003231 | 0.0091 | 2.9046 | 2.9271 | 8 | 112 | cardiac ventricle development |
GO:0090190 | 0.0092 | 8.0379 | 0.4443 | 3 | 17 | positive regulation of branching involved in ureteric bud morphogenesis |
GO:0043266 | 0.0092 | 3.1809 | 2.3521 | 7 | 90 | regulation of potassium ion transport |
GO:0000381 | 0.0093 | 5.3671 | 0.8363 | 4 | 32 | regulation of alternative mRNA splicing, via spliceosome |
GO:0002069 | 0.0095 | 18.7204 | 0.1568 | 2 | 6 | columnar/cuboidal epithelial cell maturation |
GO:0014062 | 0.0095 | 18.7204 | 0.1568 | 2 | 6 | regulation of serotonin secretion |
GO:0021800 | 0.0095 | 18.7204 | 0.1568 | 2 | 6 | cerebral cortex tangential migration |
GO:0032109 | 0.0095 | 18.7204 | 0.1568 | 2 | 6 | positive regulation of response to nutrient levels |
GO:0060430 | 0.0095 | 18.7204 | 0.1568 | 2 | 6 | lung saccule development |
GO:0086073 | 0.0095 | 18.7204 | 0.1568 | 2 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0006875 | 0.0097 | 1.826 | 12.022 | 21 | 460 | cellular metal ion homeostasis |
GO:0050767 | 0.0098 | 1.6907 | 16.7001 | 27 | 639 | regulation of neurogenesis |
GO:0042310 | 0.0099 | 3.5315 | 1.8294 | 6 | 70 | vasoconstriction |
GO:0090596 | 0.01 | 2.1918 | 6.2201 | 13 | 238 | sensory organ morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000183 | 0 | 33.0924 | 3.0489 | 27 | 36 | chromatin silencing at rDNA |
GO:0006335 | 0 | 37.7359 | 2.6255 | 24 | 31 | DNA replication-dependent nucleosome assembly |
GO:0051290 | 0 | 20.5983 | 3.6418 | 28 | 43 | protein heterotetramerization |
GO:0045653 | 0 | 50.9758 | 1.4398 | 14 | 17 | negative regulation of megakaryocyte differentiation |
GO:0045815 | 0 | 6.52 | 6.606 | 29 | 78 | positive regulation of gene expression, epigenetic |
GO:0045814 | 0 | 4.9122 | 9.909 | 36 | 117 | negative regulation of gene expression, epigenetic |
GO:0006323 | 0 | 3.7257 | 15.4987 | 46 | 183 | DNA packaging |
GO:1902036 | 0 | 5.1895 | 8.4692 | 32 | 100 | regulation of hematopoietic stem cell differentiation |
GO:0071824 | 0 | 3.0399 | 20.4956 | 52 | 242 | protein-DNA complex subunit organization |
GO:0060964 | 0 | 4.7867 | 8.3846 | 30 | 99 | regulation of gene silencing by miRNA |
GO:0030099 | 0 | 2.5696 | 30.3199 | 67 | 358 | myeloid cell differentiation |
GO:0051674 | 0 | 1.7307 | 112.3022 | 174 | 1326 | localization of cell |
GO:0048534 | 0 | 1.9334 | 68.4315 | 118 | 808 | hematopoietic or lymphoid organ development |
GO:0006333 | 0 | 4.0554 | 9.7346 | 31 | 116 | chromatin assembly or disassembly |
GO:0034080 | 0 | 7.2827 | 3.3877 | 16 | 40 | CENP-A containing nucleosome assembly |
GO:0060968 | 0 | 3.6238 | 10.2478 | 30 | 121 | regulation of gene silencing |
GO:1904837 | 0 | 6.7215 | 3.5571 | 16 | 42 | beta-catenin-TCF complex assembly |
GO:0002244 | 0 | 2.8878 | 15.4987 | 38 | 183 | hematopoietic progenitor cell differentiation |
GO:1903707 | 0 | 3.3981 | 10.7559 | 30 | 127 | negative regulation of hemopoiesis |
GO:0051259 | 0 | 2.0595 | 39.5909 | 73 | 469 | protein oligomerization |
GO:0051272 | 0 | 2.121 | 35.4015 | 67 | 418 | positive regulation of cellular component movement |
GO:0022610 | 0 | 1.6055 | 104.2564 | 153 | 1231 | biological adhesion |
GO:2000145 | 0 | 2.0011 | 40.542 | 73 | 483 | regulation of cell motility |
GO:0048863 | 0 | 2.4833 | 20.7497 | 45 | 245 | stem cell differentiation |
GO:0038111 | 0 | 6.9418 | 3.0489 | 14 | 36 | interleukin-7-mediated signaling pathway |
GO:0098760 | 0 | 6.9418 | 3.0489 | 14 | 36 | response to interleukin-7 |
GO:0030198 | 0 | 2.415 | 22.1743 | 47 | 263 | extracellular matrix organization |
GO:0071294 | 0 | 16.3178 | 1.2704 | 9 | 15 | cellular response to zinc ion |
GO:0045652 | 0 | 5.073 | 4.5289 | 17 | 54 | regulation of megakaryocyte differentiation |
GO:0034724 | 0 | 5.137 | 4.2346 | 16 | 50 | DNA replication-independent nucleosome organization |
GO:0001890 | 0 | 3.0016 | 11.4335 | 29 | 135 | placenta development |
GO:0006928 | 0 | 1.54 | 111.6272 | 158 | 1352 | movement of cell or subcellular component |
GO:0048731 | 0 | 1.3754 | 258.0138 | 321 | 3163 | system development |
GO:0051716 | 0 | 1.3024 | 543.8104 | 621 | 6421 | cellular response to stimulus |
GO:0001568 | 0 | 1.8085 | 49.0369 | 81 | 579 | blood vessel development |
GO:0072358 | 0 | 1.7693 | 51.8318 | 84 | 612 | cardiovascular system development |
GO:0045596 | 0 | 2.0755 | 28.3619 | 53 | 338 | negative regulation of cell differentiation |
GO:0032879 | 0 | 1.3855 | 201.4834 | 257 | 2379 | regulation of localization |
GO:0040017 | 0 | 2.082 | 26.6591 | 50 | 317 | positive regulation of locomotion |
GO:0071345 | 0 | 1.6417 | 67.9933 | 103 | 805 | cellular response to cytokine stimulus |
GO:0048869 | 0 | 1.367 | 223.1085 | 279 | 2705 | cellular developmental process |
GO:0043044 | 0 | 3.5728 | 6.1826 | 18 | 73 | ATP-dependent chromatin remodeling |
GO:0045926 | 0 | 2.2583 | 17.8701 | 36 | 211 | negative regulation of growth |
GO:0045597 | 0 | 1.5812 | 69.4478 | 102 | 820 | positive regulation of cell differentiation |
GO:0016233 | 0 | 4.2379 | 4.2346 | 14 | 50 | telomere capping |
GO:0042330 | 1e-04 | 1.7302 | 44.4635 | 71 | 525 | taxis |
GO:0051241 | 1e-04 | 1.568 | 66.4191 | 97 | 800 | negative regulation of multicellular organismal process |
GO:0006303 | 1e-04 | 3.4892 | 5.5897 | 16 | 66 | double-strand break repair via nonhomologous end joining |
GO:0032200 | 1e-04 | 2.4133 | 13.1273 | 28 | 155 | telomere organization |
GO:0061458 | 1e-04 | 1.8143 | 32.9454 | 55 | 389 | reproductive system development |
GO:0030574 | 1e-04 | 3.5538 | 5.1662 | 15 | 61 | collagen catabolic process |
GO:0060548 | 1e-04 | 1.5317 | 70.5892 | 101 | 836 | negative regulation of cell death |
GO:0060317 | 2e-04 | 5.1787 | 2.6255 | 10 | 31 | cardiac epithelial to mesenchymal transition |
GO:0007162 | 2e-04 | 2.1084 | 18.3783 | 35 | 217 | negative regulation of cell adhesion |
GO:0098609 | 2e-04 | 1.5667 | 60.861 | 89 | 720 | cell-cell adhesion |
GO:0035194 | 2e-04 | 1.9743 | 22.7823 | 41 | 269 | posttranscriptional gene silencing by RNA |
GO:0043067 | 2e-04 | 1.4101 | 114.2501 | 151 | 1349 | regulation of programmed cell death |
GO:0070231 | 2e-04 | 4.0814 | 3.7265 | 12 | 44 | T cell apoptotic process |
GO:0071887 | 2e-04 | 2.8399 | 7.7917 | 19 | 92 | leukocyte apoptotic process |
GO:0007166 | 2e-04 | 1.3956 | 117.0689 | 153 | 1428 | cell surface receptor signaling pathway |
GO:0007492 | 3e-04 | 3.114 | 6.0979 | 16 | 72 | endoderm development |
GO:0023052 | 3e-04 | 1.2556 | 344.2142 | 396 | 4185 | signaling |
GO:0030335 | 4e-04 | 2.1372 | 15.536 | 30 | 186 | positive regulation of cell migration |
GO:0010810 | 4e-04 | 5.8629 | 1.9271 | 8 | 23 | regulation of cell-substrate adhesion |
GO:0010038 | 4e-04 | 1.836 | 25.4077 | 43 | 300 | response to metal ion |
GO:0035987 | 5e-04 | 4.3581 | 2.9585 | 10 | 35 | endodermal cell differentiation |
GO:0001666 | 5e-04 | 1.8085 | 26.3394 | 44 | 311 | response to hypoxia |
GO:0045892 | 6e-04 | 1.42 | 88.1649 | 118 | 1041 | negative regulation of transcription, DNA-templated |
GO:0060443 | 6e-04 | 3.8592 | 3.5571 | 11 | 42 | mammary gland morphogenesis |
GO:0006334 | 6e-04 | 2.6651 | 7.7459 | 18 | 93 | nucleosome assembly |
GO:0007596 | 6e-04 | 1.8074 | 25.7465 | 43 | 304 | blood coagulation |
GO:0001952 | 6e-04 | 2.6518 | 7.7917 | 18 | 92 | regulation of cell-matrix adhesion |
GO:0007154 | 6e-04 | 1.2405 | 341.4 | 390 | 4170 | cell communication |
GO:0009653 | 7e-04 | 1.6604 | 36.1792 | 56 | 446 | anatomical structure morphogenesis |
GO:0036018 | 7e-04 | 21.6788 | 0.5082 | 4 | 6 | cellular response to erythropoietin |
GO:0071635 | 7e-04 | 21.6788 | 0.5082 | 4 | 6 | negative regulation of transforming growth factor beta production |
GO:0050729 | 7e-04 | 2.5266 | 8.5539 | 19 | 101 | positive regulation of inflammatory response |
GO:0010647 | 8e-04 | 1.3421 | 127.0387 | 161 | 1500 | positive regulation of cell communication |
GO:0071276 | 8e-04 | 5.1113 | 2.1173 | 8 | 25 | cellular response to cadmium ion |
GO:0001704 | 8e-04 | 2.3866 | 9.909 | 21 | 117 | formation of primary germ layer |
GO:0033077 | 8e-04 | 3.0483 | 5.4203 | 14 | 64 | T cell differentiation in thymus |
GO:0023056 | 8e-04 | 1.3376 | 127.3775 | 161 | 1504 | positive regulation of signaling |
GO:1902679 | 9e-04 | 1.3962 | 90.9597 | 120 | 1074 | negative regulation of RNA biosynthetic process |
GO:0031579 | 9e-04 | 5.8456 | 1.6938 | 7 | 20 | membrane raft organization |
GO:0060333 | 0.001 | 2.7232 | 6.7754 | 16 | 80 | interferon-gamma-mediated signaling pathway |
GO:0060326 | 0.001 | 1.878 | 20.2415 | 35 | 239 | cell chemotaxis |
GO:1903844 | 0.001 | 2.5151 | 8.1305 | 18 | 96 | regulation of cellular response to transforming growth factor beta stimulus |
GO:0009063 | 0.0011 | 2.4369 | 8.808 | 19 | 104 | cellular amino acid catabolic process |
GO:0040011 | 0.0011 | 1.4717 | 61.9673 | 86 | 758 | locomotion |
GO:0065008 | 0.0011 | 1.3203 | 138.2702 | 172 | 1672 | regulation of biological quality |
GO:0009968 | 0.0011 | 1.3826 | 92.4842 | 121 | 1092 | negative regulation of signal transduction |
GO:0070271 | 0.0012 | 1.3476 | 111.2859 | 142 | 1314 | protein complex biogenesis |
GO:0090132 | 0.0012 | 1.8694 | 19.7333 | 34 | 233 | epithelium migration |
GO:0086013 | 0.0012 | 5.4277 | 1.7785 | 7 | 21 | membrane repolarization during cardiac muscle cell action potential |
GO:0002521 | 0.0013 | 1.6155 | 36.3331 | 55 | 429 | leukocyte differentiation |
GO:0098901 | 0.0013 | 4.5726 | 2.2867 | 8 | 27 | regulation of cardiac muscle cell action potential |
GO:0043066 | 0.0013 | 1.5026 | 52.2221 | 74 | 623 | negative regulation of apoptotic process |
GO:0097529 | 0.0013 | 2.0574 | 13.8896 | 26 | 164 | myeloid leukocyte migration |
GO:2000811 | 0.0014 | 6.51 | 1.3551 | 6 | 16 | negative regulation of anoikis |
GO:0070482 | 0.0014 | 1.6955 | 28.4567 | 45 | 336 | response to oxygen levels |
GO:0002682 | 0.0015 | 1.4235 | 71.2727 | 96 | 864 | regulation of immune system process |
GO:0001658 | 0.0016 | 3.1074 | 4.5734 | 12 | 54 | branching involved in ureteric bud morphogenesis |
GO:0035082 | 0.0016 | 3.1074 | 4.5734 | 12 | 54 | axoneme assembly |
GO:0048584 | 0.0017 | 1.2814 | 160.5769 | 195 | 1896 | positive regulation of response to stimulus |
GO:0010594 | 0.0018 | 2.2018 | 10.5866 | 21 | 125 | regulation of endothelial cell migration |
GO:0071241 | 0.0019 | 2.0363 | 13.4661 | 25 | 159 | cellular response to inorganic substance |
GO:0070228 | 0.0019 | 3.232 | 4.0652 | 11 | 48 | regulation of lymphocyte apoptotic process |
GO:0002376 | 0.0019 | 1.5905 | 36.159 | 54 | 451 | immune system process |
GO:0009605 | 0.0019 | 1.3969 | 77.0992 | 102 | 935 | response to external stimulus |
GO:0045165 | 0.0019 | 1.8139 | 20.2415 | 34 | 239 | cell fate commitment |
GO:0070665 | 0.0019 | 2.1423 | 11.3488 | 22 | 134 | positive regulation of leukocyte proliferation |
GO:0001937 | 0.002 | 3.7602 | 2.9642 | 9 | 35 | negative regulation of endothelial cell proliferation |
GO:0051897 | 0.0021 | 2.0908 | 12.111 | 23 | 143 | positive regulation of protein kinase B signaling |
GO:0070243 | 0.0021 | 7.7457 | 1.0163 | 5 | 12 | regulation of thymocyte apoptotic process |
GO:0042060 | 0.0021 | 1.9287 | 15.7889 | 28 | 189 | wound healing |
GO:0007599 | 0.0022 | 32.988 | 0.3342 | 3 | 4 | hemostasis |
GO:0043524 | 0.0022 | 2.1599 | 10.7559 | 21 | 127 | negative regulation of neuron apoptotic process |
GO:0072006 | 0.0022 | 2.1599 | 10.7559 | 21 | 127 | nephron development |
GO:0003199 | 0.0023 | 32.4953 | 0.3388 | 3 | 4 | endocardial cushion to mesenchymal transition involved in heart valve formation |
GO:2000391 | 0.0023 | 32.4953 | 0.3388 | 3 | 4 | positive regulation of neutrophil extravasation |
GO:2001137 | 0.0023 | 32.4953 | 0.3388 | 3 | 4 | positive regulation of endocytic recycling |
GO:0051216 | 0.0023 | 1.9709 | 14.3977 | 26 | 170 | cartilage development |
GO:0000003 | 0.0023 | 1.3314 | 105.1034 | 133 | 1241 | reproduction |
GO:0017148 | 0.0023 | 1.6367 | 29.9811 | 46 | 354 | negative regulation of translation |
GO:0051046 | 0.0024 | 1.4545 | 55.897 | 77 | 660 | regulation of secretion |
GO:0002088 | 0.0024 | 2.7727 | 5.4203 | 13 | 64 | lens development in camera-type eye |
GO:1901607 | 0.0025 | 2.9041 | 4.8206 | 12 | 57 | alpha-amino acid biosynthetic process |
GO:0048699 | 0.0026 | 1.3221 | 108.1523 | 136 | 1277 | generation of neurons |
GO:0002687 | 0.0026 | 2.3508 | 8.107 | 17 | 96 | positive regulation of leukocyte migration |
GO:0016477 | 0.0026 | 1.5126 | 43.3856 | 62 | 529 | cell migration |
GO:0007566 | 0.0026 | 3.2927 | 3.6418 | 10 | 43 | embryo implantation |
GO:0006952 | 0.0027 | 1.3114 | 115.4358 | 144 | 1363 | defense response |
GO:0034135 | 0.0027 | 10.8379 | 0.6775 | 4 | 8 | regulation of toll-like receptor 2 signaling pathway |
GO:0071805 | 0.0027 | 1.8872 | 16.0916 | 28 | 190 | potassium ion transmembrane transport |
GO:0010633 | 0.0028 | 2.7191 | 5.505 | 13 | 65 | negative regulation of epithelial cell migration |
GO:0060602 | 0.0028 | 5.4242 | 1.5245 | 6 | 18 | branch elongation of an epithelium |
GO:0008285 | 0.0028 | 1.4541 | 53.695 | 74 | 634 | negative regulation of cell proliferation |
GO:0032940 | 0.0028 | 1.3183 | 108.4064 | 136 | 1280 | secretion by cell |
GO:0044259 | 0.0029 | 2.2021 | 9.5702 | 19 | 113 | multicellular organismal macromolecule metabolic process |
GO:0002691 | 0.0029 | 4.4689 | 2.0326 | 7 | 24 | regulation of cellular extravasation |
GO:0033598 | 0.0029 | 4.4689 | 2.0326 | 7 | 24 | mammary gland epithelial cell proliferation |
GO:0030183 | 0.003 | 2.3139 | 8.2152 | 17 | 97 | B cell differentiation |
GO:0060547 | 0.0031 | 6.777 | 1.101 | 5 | 13 | negative regulation of necrotic cell death |
GO:0070307 | 0.0031 | 6.777 | 1.101 | 5 | 13 | lens fiber cell development |
GO:1900025 | 0.0031 | 6.777 | 1.101 | 5 | 13 | negative regulation of substrate adhesion-dependent cell spreading |
GO:0035556 | 0.0032 | 1.2343 | 206.5649 | 242 | 2439 | intracellular signal transduction |
GO:0097164 | 0.0033 | 1.9373 | 14.039 | 25 | 166 | ammonium ion metabolic process |
GO:0050865 | 0.0033 | 1.5284 | 38.7892 | 56 | 458 | regulation of cell activation |
GO:0043537 | 0.0035 | 3.7763 | 2.6255 | 8 | 31 | negative regulation of blood vessel endothelial cell migration |
GO:1902622 | 0.0035 | 3.7763 | 2.6255 | 8 | 31 | regulation of neutrophil migration |
GO:0001667 | 0.0036 | 1.6435 | 26.5934 | 41 | 314 | ameboidal-type cell migration |
GO:0045765 | 0.0036 | 1.7504 | 20.2415 | 33 | 239 | regulation of angiogenesis |
GO:1903706 | 0.0036 | 1.6772 | 24.1922 | 38 | 290 | regulation of hemopoiesis |
GO:0048041 | 0.0037 | 2.6181 | 5.6744 | 13 | 67 | focal adhesion assembly |
GO:0001558 | 0.0037 | 1.5999 | 29.8964 | 45 | 353 | regulation of cell growth |
GO:0030199 | 0.0037 | 3.3705 | 3.2183 | 9 | 38 | collagen fibril organization |
GO:0009712 | 0.0038 | 3.1041 | 3.8112 | 10 | 45 | catechol-containing compound metabolic process |
GO:0090102 | 0.0038 | 3.1041 | 3.8112 | 10 | 45 | cochlea development |
GO:0042423 | 0.0038 | 5.0066 | 1.6092 | 6 | 19 | catecholamine biosynthetic process |
GO:0045109 | 0.0038 | 5.0066 | 1.6092 | 6 | 19 | intermediate filament organization |
GO:0009065 | 0.0038 | 4.2203 | 2.1173 | 7 | 25 | glutamine family amino acid catabolic process |
GO:0060706 | 0.0038 | 4.2203 | 2.1173 | 7 | 25 | cell differentiation involved in embryonic placenta development |
GO:0045664 | 0.0039 | 1.483 | 44.1248 | 62 | 521 | regulation of neuron differentiation |
GO:0045595 | 0.0039 | 1.6233 | 27.5158 | 42 | 342 | regulation of cell differentiation |
GO:0071310 | 0.0039 | 1.2987 | 114.8589 | 142 | 1400 | cellular response to organic substance |
GO:0001819 | 0.004 | 1.5841 | 30.8281 | 46 | 364 | positive regulation of cytokine production |
GO:0042531 | 0.004 | 2.7178 | 5.0815 | 12 | 60 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0070373 | 0.004 | 2.7178 | 5.0815 | 12 | 60 | negative regulation of ERK1 and ERK2 cascade |
GO:0072171 | 0.004 | 2.7178 | 5.0815 | 12 | 60 | mesonephric tubule morphogenesis |
GO:0001763 | 0.004 | 1.8785 | 14.9906 | 26 | 177 | morphogenesis of a branching structure |
GO:2000026 | 0.004 | 1.4449 | 51.0455 | 70 | 629 | regulation of multicellular organismal development |
GO:0048545 | 0.0041 | 1.5893 | 30.0658 | 45 | 355 | response to steroid hormone |
GO:0090288 | 0.0041 | 2.0752 | 10.5866 | 20 | 125 | negative regulation of cellular response to growth factor stimulus |
GO:0007219 | 0.0042 | 1.9243 | 13.5508 | 24 | 160 | Notch signaling pathway |
GO:0030278 | 0.0042 | 1.9243 | 13.5508 | 24 | 160 | regulation of ossification |
GO:2001235 | 0.0042 | 1.9243 | 13.5508 | 24 | 160 | positive regulation of apoptotic signaling pathway |
GO:0034220 | 0.0042 | 1.3488 | 80.8813 | 104 | 955 | ion transmembrane transport |
GO:0071559 | 0.0043 | 1.7987 | 17.362 | 29 | 205 | response to transforming growth factor beta |
GO:0072080 | 0.0043 | 2.3653 | 7.1142 | 15 | 84 | nephron tubule development |
GO:0001961 | 0.0045 | 3.2579 | 3.303 | 9 | 39 | positive regulation of cytokine-mediated signaling pathway |
GO:1902743 | 0.0045 | 3.2579 | 3.303 | 9 | 39 | regulation of lamellipodium organization |
GO:0021527 | 0.0045 | 6.0236 | 1.1857 | 5 | 14 | spinal cord association neuron differentiation |
GO:0050671 | 0.0045 | 2.0555 | 10.6713 | 20 | 126 | positive regulation of lymphocyte proliferation |
GO:0045216 | 0.0045 | 1.7704 | 18.2089 | 30 | 215 | cell-cell junction organization |
GO:0008354 | 0.0046 | 8.6697 | 0.7622 | 4 | 9 | germ cell migration |
GO:0034776 | 0.0046 | 8.6697 | 0.7622 | 4 | 9 | response to histamine |
GO:0098903 | 0.0046 | 8.6697 | 0.7622 | 4 | 9 | regulation of membrane repolarization during action potential |
GO:0043583 | 0.0046 | 1.8081 | 16.6844 | 28 | 197 | ear development |
GO:0032944 | 0.0046 | 1.8298 | 15.9222 | 27 | 188 | regulation of mononuclear cell proliferation |
GO:0003006 | 0.0047 | 1.4591 | 46.1978 | 64 | 549 | developmental process involved in reproduction |
GO:0050921 | 0.0048 | 2.0902 | 9.9937 | 19 | 118 | positive regulation of chemotaxis |
GO:0031667 | 0.0048 | 1.5507 | 32.776 | 48 | 387 | response to nutrient levels |
GO:0031344 | 0.0048 | 1.4665 | 44.5482 | 62 | 526 | regulation of cell projection organization |
GO:0060285 | 0.0048 | 3.9979 | 2.202 | 7 | 26 | cilium-dependent cell motility |
GO:2001242 | 0.0048 | 1.9653 | 12.1957 | 22 | 144 | regulation of intrinsic apoptotic signaling pathway |
GO:0008283 | 0.0048 | 1.3104 | 99.2161 | 124 | 1191 | cell proliferation |
GO:0032649 | 0.0048 | 2.417 | 6.5213 | 14 | 77 | regulation of interferon-gamma production |
GO:0051249 | 0.0049 | 1.564 | 31.1668 | 46 | 368 | regulation of lymphocyte activation |
GO:0042493 | 0.0049 | 1.5548 | 32.0138 | 47 | 378 | response to drug |
GO:0046697 | 0.005 | 4.6487 | 1.6938 | 6 | 20 | decidualization |
GO:0042592 | 0.0051 | 1.2726 | 127.5469 | 155 | 1506 | homeostatic process |
GO:1901658 | 0.0053 | 3.4737 | 2.7949 | 8 | 33 | glycosyl compound catabolic process |
GO:2001237 | 0.0053 | 2.2322 | 7.9611 | 16 | 94 | negative regulation of extrinsic apoptotic signaling pathway |
GO:0006526 | 0.0053 | 16.2465 | 0.4235 | 3 | 5 | arginine biosynthetic process |
GO:0035771 | 0.0053 | 16.2465 | 0.4235 | 3 | 5 | interleukin-4-mediated signaling pathway |
GO:0051410 | 0.0053 | 16.2465 | 0.4235 | 3 | 5 | detoxification of nitrogen compound |
GO:1905007 | 0.0053 | 16.2465 | 0.4235 | 3 | 5 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:2001268 | 0.0053 | 16.2465 | 0.4235 | 3 | 5 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0071260 | 0.0054 | 2.4797 | 5.9285 | 13 | 70 | cellular response to mechanical stimulus |
GO:0072088 | 0.0054 | 2.4797 | 5.9285 | 13 | 70 | nephron epithelium morphogenesis |
GO:0010769 | 0.0054 | 1.7268 | 19.2252 | 31 | 227 | regulation of cell morphogenesis involved in differentiation |
GO:0007178 | 0.0055 | 1.629 | 24.8149 | 38 | 293 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0002696 | 0.0055 | 1.6529 | 23.2057 | 36 | 274 | positive regulation of leukocyte activation |
GO:0032989 | 0.0055 | 1.3401 | 78.9334 | 101 | 932 | cellular component morphogenesis |
GO:0050918 | 0.0057 | 2.7165 | 4.6581 | 11 | 55 | positive chemotaxis |
GO:1902041 | 0.0057 | 2.7165 | 4.6581 | 11 | 55 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO:0001101 | 0.0058 | 1.6225 | 24.8996 | 38 | 294 | response to acid chemical |
GO:0003341 | 0.006 | 2.5574 | 5.3356 | 12 | 63 | cilium movement |
GO:0033555 | 0.006 | 2.5574 | 5.3356 | 12 | 63 | multicellular organismal response to stress |
GO:0018146 | 0.006 | 3.7977 | 2.2867 | 7 | 27 | keratan sulfate biosynthetic process |
GO:0120036 | 0.0061 | 1.2898 | 106.2231 | 131 | 1256 | plasma membrane bounded cell projection organization |
GO:0032101 | 0.0061 | 1.4045 | 54.542 | 73 | 644 | regulation of response to external stimulus |
GO:0048661 | 0.0061 | 2.4368 | 6.0132 | 13 | 71 | positive regulation of smooth muscle cell proliferation |
GO:0009719 | 0.0062 | 1.303 | 96.3399 | 120 | 1148 | response to endogenous stimulus |
GO:0140115 | 0.0063 | 5.4208 | 1.2704 | 5 | 15 | export across plasma membrane |
GO:1905523 | 0.0063 | 5.4208 | 1.2704 | 5 | 15 | positive regulation of macrophage migration |
GO:0048598 | 0.0064 | 1.4391 | 46.0075 | 63 | 544 | embryonic morphogenesis |
GO:0046189 | 0.0064 | 3.3398 | 2.8795 | 8 | 34 | phenol-containing compound biosynthetic process |
GO:0007411 | 0.0064 | 1.7386 | 17.8701 | 29 | 211 | axon guidance |
GO:0032461 | 0.0065 | 4.3385 | 1.7785 | 6 | 21 | positive regulation of protein oligomerization |
GO:1903206 | 0.0065 | 4.3385 | 1.7785 | 6 | 21 | negative regulation of hydrogen peroxide-induced cell death |
GO:0032677 | 0.0066 | 2.6559 | 4.7428 | 11 | 56 | regulation of interleukin-8 production |
GO:0033135 | 0.0066 | 2.0625 | 9.5702 | 18 | 113 | regulation of peptidyl-serine phosphorylation |
GO:0006812 | 0.0067 | 1.3207 | 83.9302 | 106 | 991 | cation transport |
GO:0009887 | 0.0067 | 1.3494 | 70.5829 | 91 | 838 | animal organ morphogenesis |
GO:0061564 | 0.0067 | 1.4973 | 35.9096 | 51 | 424 | axon development |
GO:0030512 | 0.0068 | 2.508 | 5.4203 | 12 | 64 | negative regulation of transforming growth factor beta receptor signaling pathway |
GO:0007173 | 0.0068 | 2.0084 | 10.3325 | 19 | 122 | epidermal growth factor receptor signaling pathway |
GO:0065003 | 0.0069 | 1.2501 | 139.6579 | 167 | 1649 | macromolecular complex assembly |
GO:0050678 | 0.0069 | 1.6251 | 23.5445 | 36 | 278 | regulation of epithelial cell proliferation |
GO:0007167 | 0.0069 | 1.4064 | 52.2148 | 70 | 623 | enzyme linked receptor protein signaling pathway |
GO:0007265 | 0.007 | 1.5905 | 26.0006 | 39 | 307 | Ras protein signal transduction |
GO:0032970 | 0.007 | 1.5905 | 26.0006 | 39 | 307 | regulation of actin filament-based process |
GO:0051960 | 0.007 | 1.3741 | 60.9786 | 80 | 720 | regulation of nervous system development |
GO:0051248 | 0.0071 | 1.2874 | 103.0707 | 127 | 1217 | negative regulation of protein metabolic process |
GO:0006600 | 0.0071 | 7.2242 | 0.8469 | 4 | 10 | creatine metabolic process |
GO:0060433 | 0.0071 | 7.2242 | 0.8469 | 4 | 10 | bronchus development |
GO:0086065 | 0.0071 | 2.7849 | 4.1499 | 10 | 49 | cell communication involved in cardiac conduction |
GO:2000242 | 0.0071 | 2.7849 | 4.1499 | 10 | 49 | negative regulation of reproductive process |
GO:0010604 | 0.0071 | 1.1988 | 234.5982 | 268 | 2770 | positive regulation of macromolecule metabolic process |
GO:0002636 | 0.0072 | Inf | 0.1694 | 2 | 2 | positive regulation of germinal center formation |
GO:0002731 | 0.0072 | Inf | 0.1694 | 2 | 2 | negative regulation of dendritic cell cytokine production |
GO:0009098 | 0.0072 | Inf | 0.1694 | 2 | 2 | leucine biosynthetic process |
GO:0009099 | 0.0072 | Inf | 0.1694 | 2 | 2 | valine biosynthetic process |
GO:0019285 | 0.0072 | Inf | 0.1694 | 2 | 2 | glycine betaine biosynthetic process from choline |
GO:0030237 | 0.0072 | Inf | 0.1694 | 2 | 2 | female sex determination |
GO:0031455 | 0.0072 | Inf | 0.1694 | 2 | 2 | glycine betaine metabolic process |
GO:0033693 | 0.0072 | Inf | 0.1694 | 2 | 2 | neurofilament bundle assembly |
GO:0045082 | 0.0072 | Inf | 0.1694 | 2 | 2 | positive regulation of interleukin-10 biosynthetic process |
GO:0060545 | 0.0072 | Inf | 0.1694 | 2 | 2 | positive regulation of necroptotic process |
GO:0060809 | 0.0072 | Inf | 0.1694 | 2 | 2 | mesodermal to mesenchymal transition involved in gastrulation |
GO:0070370 | 0.0072 | Inf | 0.1694 | 2 | 2 | cellular heat acclimation |
GO:0097055 | 0.0072 | Inf | 0.1694 | 2 | 2 | agmatine biosynthetic process |
GO:0097213 | 0.0072 | Inf | 0.1694 | 2 | 2 | regulation of lysosomal membrane permeability |
GO:1901731 | 0.0072 | Inf | 0.1694 | 2 | 2 | positive regulation of platelet aggregation |
GO:1902044 | 0.0072 | Inf | 0.1694 | 2 | 2 | regulation of Fas signaling pathway |
GO:1905863 | 0.0072 | Inf | 0.1694 | 2 | 2 | invadopodium organization |
GO:0006955 | 0.0072 | 1.2483 | 139.8321 | 167 | 1657 | immune response |
GO:0042221 | 0.0072 | 1.1975 | 245.4309 | 279 | 2984 | response to chemical |
GO:0010035 | 0.0073 | 1.9174 | 11.8737 | 21 | 142 | response to inorganic substance |
GO:0002251 | 0.0075 | 3.6166 | 2.3714 | 7 | 28 | organ or tissue specific immune response |
GO:0006536 | 0.0075 | 3.6166 | 2.3714 | 7 | 28 | glutamate metabolic process |
GO:1902230 | 0.0075 | 3.6166 | 2.3714 | 7 | 28 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0048666 | 0.0075 | 1.3266 | 78.0018 | 99 | 921 | neuron development |
GO:0048732 | 0.0076 | 1.5126 | 32.776 | 47 | 387 | gland development |
GO:0009116 | 0.0076 | 2.0785 | 8.9774 | 17 | 106 | nucleoside metabolic process |
GO:0042398 | 0.0077 | 3.2159 | 2.9642 | 8 | 35 | cellular modified amino acid biosynthetic process |
GO:0060337 | 0.0078 | 2.3552 | 6.1826 | 13 | 73 | type I interferon signaling pathway |
GO:0008016 | 0.0078 | 1.7101 | 18.1242 | 29 | 214 | regulation of heart contraction |
GO:1903034 | 0.0078 | 1.8724 | 12.7039 | 22 | 150 | regulation of response to wounding |
GO:0010811 | 0.008 | 2.1227 | 8.2999 | 16 | 98 | positive regulation of cell-substrate adhesion |
GO:0006813 | 0.0081 | 1.6872 | 18.9711 | 30 | 224 | potassium ion transport |
GO:0048518 | 0.0081 | 1.201 | 233.0643 | 265 | 2873 | positive regulation of biological process |
GO:0002230 | 0.0083 | 4.067 | 1.8632 | 6 | 22 | positive regulation of defense response to virus by host |
GO:0051354 | 0.0083 | 4.067 | 1.8632 | 6 | 22 | negative regulation of oxidoreductase activity |
GO:0002576 | 0.0084 | 2.0553 | 9.0621 | 17 | 107 | platelet degranulation |
GO:0010634 | 0.0084 | 2.0553 | 9.0621 | 17 | 107 | positive regulation of epithelial cell migration |
GO:0051707 | 0.0084 | 1.359 | 62.3337 | 81 | 736 | response to other organism |
GO:0001946 | 0.0086 | 4.9277 | 1.3551 | 5 | 16 | lymphangiogenesis |
GO:0019372 | 0.0086 | 4.9277 | 1.3551 | 5 | 16 | lipoxygenase pathway |
GO:0042454 | 0.0086 | 4.9277 | 1.3551 | 5 | 16 | ribonucleoside catabolic process |
GO:0072488 | 0.0086 | 4.9277 | 1.3551 | 5 | 16 | ammonium transmembrane transport |
GO:0060993 | 0.0086 | 2.2385 | 6.9448 | 14 | 82 | kidney morphogenesis |
GO:0048858 | 0.0087 | 1.4155 | 46.6656 | 63 | 551 | cell projection morphogenesis |
GO:0010721 | 0.0087 | 1.6209 | 22.2741 | 34 | 263 | negative regulation of cell development |
GO:0035239 | 0.0087 | 1.5556 | 27.1863 | 40 | 321 | tube morphogenesis |
GO:2000146 | 0.0087 | 1.6473 | 20.665 | 32 | 244 | negative regulation of cell motility |
GO:0001570 | 0.0088 | 2.4148 | 5.5897 | 12 | 66 | vasculogenesis |
GO:0043393 | 0.0088 | 1.7496 | 15.9222 | 26 | 188 | regulation of protein binding |
GO:0002448 | 0.0088 | 2.8738 | 3.6418 | 9 | 43 | mast cell mediated immunity |
GO:0060711 | 0.0088 | 2.8738 | 3.6418 | 9 | 43 | labyrinthine layer development |
GO:1903037 | 0.0089 | 1.5724 | 25.5771 | 38 | 302 | regulation of leukocyte cell-cell adhesion |
GO:0072001 | 0.0089 | 1.6299 | 21.5119 | 33 | 254 | renal system development |
GO:0001525 | 0.009 | 1.7663 | 15.1757 | 25 | 181 | angiogenesis |
GO:0001934 | 0.0091 | 1.3311 | 71.3958 | 91 | 843 | positive regulation of protein phosphorylation |
GO:0061061 | 0.0091 | 1.4001 | 49.3757 | 66 | 583 | muscle structure development |
GO:0010942 | 0.0091 | 1.3999 | 49.3794 | 66 | 585 | positive regulation of cell death |
GO:1901031 | 0.0092 | 3.1008 | 3.0489 | 8 | 36 | regulation of response to reactive oxygen species |
GO:0009743 | 0.0092 | 1.7215 | 16.7691 | 27 | 198 | response to carbohydrate |
GO:0002224 | 0.0094 | 1.9786 | 9.909 | 18 | 117 | toll-like receptor signaling pathway |
GO:0051058 | 0.0095 | 2.6487 | 4.3193 | 10 | 51 | negative regulation of small GTPase mediated signal transduction |
GO:0007044 | 0.0095 | 2.2059 | 7.0295 | 14 | 83 | cell-substrate junction assembly |
GO:0051239 | 0.0097 | 1.4191 | 44.3472 | 60 | 565 | regulation of multicellular organismal process |
GO:0010940 | 0.0099 | 10.847 | 0.5074 | 3 | 6 | positive regulation of necrotic cell death |
GO:0050769 | 0.0099 | 1.5001 | 31.5903 | 45 | 373 | positive regulation of neurogenesis |
GO:0006578 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | amino-acid betaine biosynthetic process |
GO:0046498 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | S-adenosylhomocysteine metabolic process |
GO:0060710 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | chorio-allantoic fusion |
GO:0060753 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | regulation of mast cell chemotaxis |
GO:0061218 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | negative regulation of mesonephros development |
GO:0070257 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | positive regulation of mucus secretion |
GO:1902302 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | regulation of potassium ion export |
GO:1902947 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | regulation of tau-protein kinase activity |
GO:1902959 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
GO:1903224 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | regulation of endodermal cell differentiation |
GO:1905024 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | regulation of membrane repolarization during ventricular cardiac muscle cell action potential |
GO:2000535 | 0.01 | 10.8302 | 0.5082 | 3 | 6 | regulation of entry of bacterium into host cell |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004068 | 1e-04 | Inf | 1e-04 | 1 | 1 | aspartate 1-decarboxylase activity |
GO:0004782 | 1e-04 | Inf | 1e-04 | 1 | 2 | sulfinoalanine decarboxylase activity |
GO:0030170 | 0.0032 | Inf | 0.0032 | 1 | 49 | pyridoxal phosphate binding |
GO:0016830 | 0.0033 | Inf | 0.0033 | 1 | 50 | carbon-carbon lyase activity |
GO:0019842 | 0.0081 | Inf | 0.0081 | 1 | 123 | vitamin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002161 | 8e-04 | Inf | 8e-04 | 1 | 12 | aminoacyl-tRNA editing activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045145 | 1e-04 | Inf | 1e-04 | 1 | 2 | single-stranded DNA 5'-3' exodeoxyribonuclease activity |
GO:0008310 | 3e-04 | Inf | 3e-04 | 1 | 4 | single-stranded DNA 3'-5' exodeoxyribonuclease activity |
GO:0008409 | 9e-04 | Inf | 9e-04 | 1 | 14 | 5'-3' exonuclease activity |
GO:0016895 | 0.001 | Inf | 0.001 | 1 | 16 | exodeoxyribonuclease activity, producing 5'-phosphomonoesters |
GO:0051539 | 0.0024 | Inf | 0.0024 | 1 | 36 | 4 iron, 4 sulfur cluster binding |
GO:0008408 | 0.0029 | Inf | 0.0029 | 1 | 45 | 3'-5' exonuclease activity |
GO:0004536 | 0.0033 | Inf | 0.0033 | 1 | 51 | deoxyribonuclease activity |
GO:0051540 | 0.0038 | Inf | 0.0038 | 1 | 58 | metal cluster binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004111 | 0.0027 | 508.5333 | 0.0028 | 1 | 6 | creatine kinase activity |
GO:0045296 | 0.007 | 20.9441 | 0.132 | 2 | 288 | cadherin binding |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005184 | 0.0019 | Inf | 0.0019 | 1 | 29 | neuropeptide hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005184 | 0.0019 | Inf | 0.0019 | 1 | 29 | neuropeptide hormone activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001046 | 0.0069 | Inf | 0.0069 | 1 | 106 | core promoter sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 50.8149 | 0.4598 | 14 | 180 | histone binding |
GO:0046982 | 0 | 18.6911 | 1.1673 | 14 | 457 | protein heterodimerization activity |
GO:0019904 | 0 | 13.4898 | 1.5863 | 14 | 621 | protein domain specific binding |
GO:0003723 | 0 | 8.1263 | 4.1202 | 19 | 1613 | RNA binding |
GO:0003677 | 0 | 4.9938 | 5.7448 | 18 | 2249 | DNA binding |
GO:1901363 | 1e-04 | 3.6414 | 13.8574 | 26 | 5425 | heterocyclic compound binding |
GO:0097159 | 1e-04 | 3.5651 | 14.0464 | 26 | 5499 | organic cyclic compound binding |
GO:0004909 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | interleukin-1, Type I, activating receptor activity |
GO:0071791 | 0.0051 | 400.7368 | 0.0051 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019888 | 0.0045 | Inf | 0.0045 | 1 | 68 | protein phosphatase regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000224 | 0.0012 | Inf | 0.0012 | 1 | 1 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity |
GO:0004937 | 0.0037 | 423.5278 | 0.0037 | 1 | 3 | alpha1-adrenergic receptor activity |
GO:0005432 | 0.0062 | 211.7361 | 0.0062 | 1 | 5 | calcium:sodium antiporter activity |
GO:0005499 | 0.0062 | 211.7361 | 0.0062 | 1 | 5 | vitamin D binding |
GO:0008603 | 0.0087 | 141.1389 | 0.0087 | 1 | 7 | cAMP-dependent protein kinase regulator activity |
GO:0015085 | 0.0096 | 15.0857 | 0.1493 | 2 | 120 | calcium ion transmembrane transporter activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0047499 | 4e-04 | Inf | 4e-04 | 1 | 6 | calcium-independent phospholipase A2 activity |
GO:0043008 | 5e-04 | Inf | 5e-04 | 1 | 8 | ATP-dependent protein binding |
GO:0102567 | 0.0012 | Inf | 0.0012 | 1 | 18 | phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) |
GO:0102568 | 0.0012 | Inf | 0.0012 | 1 | 18 | phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) |
GO:0004620 | 0.0059 | Inf | 0.0059 | 1 | 90 | phospholipase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 5.0545 | 6.3191 | 27 | 180 | histone binding |
GO:0031492 | 0 | 8.4681 | 1.5096 | 10 | 43 | nucleosomal DNA binding |
GO:0046982 | 0 | 2.4475 | 16.0435 | 36 | 457 | protein heterodimerization activity |
GO:0050431 | 0 | 13.8868 | 0.6319 | 6 | 18 | transforming growth factor beta binding |
GO:0045296 | 1e-04 | 2.5689 | 10.1106 | 24 | 288 | cadherin binding |
GO:0004111 | 8e-04 | 27.6341 | 0.2106 | 3 | 6 | creatine kinase activity |
GO:0008499 | 8e-04 | 12.2999 | 0.4564 | 4 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0030306 | 0.0014 | 20.7242 | 0.2457 | 3 | 7 | ADP-ribosylation factor binding |
GO:0019911 | 0.0021 | 16.5782 | 0.2808 | 3 | 8 | structural constituent of myelin sheath |
GO:0016595 | 0.0031 | 13.8143 | 0.316 | 3 | 9 | glutamate binding |
GO:0004351 | 0.0036 | 55.1723 | 0.1053 | 2 | 3 | glutamate decarboxylase activity |
GO:0019904 | 0.004 | 1.6864 | 21.8009 | 35 | 621 | protein domain specific binding |
GO:0008378 | 0.0042 | 5.3259 | 1.0883 | 5 | 31 | galactosyltransferase activity |
GO:0008237 | 0.005 | 2.4164 | 5.7223 | 13 | 163 | metallopeptidase activity |
GO:0001540 | 0.0052 | 4.1581 | 1.6149 | 6 | 46 | amyloid-beta binding |
GO:0030169 | 0.0057 | 10.3593 | 0.3862 | 3 | 11 | low-density lipoprotein particle binding |
GO:0005025 | 0.007 | 27.5843 | 0.1404 | 2 | 4 | transforming growth factor beta receptor activity, type I |
GO:0005201 | 0.0082 | 3.2909 | 2.317 | 7 | 66 | extracellular matrix structural constituent |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0 | 2.9107 | 47.505 | 115 | 709 | G-protein coupled receptor activity |
GO:0004872 | 0 | 2.2755 | 90.5209 | 174 | 1351 | receptor activity |
GO:0004871 | 0 | 2.1174 | 97.6902 | 177 | 1458 | signal transducer activity |
GO:0030594 | 0 | 5.7764 | 5.5612 | 24 | 83 | neurotransmitter receptor activity |
GO:0004984 | 0 | 2.7306 | 21.8429 | 52 | 326 | olfactory receptor activity |
GO:0022834 | 0 | 3.6166 | 7.9063 | 24 | 118 | ligand-gated channel activity |
GO:0008188 | 0 | 6.5354 | 2.7471 | 13 | 41 | neuropeptide receptor activity |
GO:0005216 | 0 | 2.1615 | 24.9921 | 49 | 373 | ion channel activity |
GO:0043565 | 0 | 1.6738 | 63.3847 | 98 | 946 | sequence-specific DNA binding |
GO:0022824 | 1e-04 | 5.1504 | 2.7471 | 11 | 41 | transmitter-gated ion channel activity |
GO:0015267 | 1e-04 | 1.9239 | 27.6052 | 49 | 412 | channel activity |
GO:0001653 | 1e-04 | 2.9084 | 7.8393 | 20 | 117 | peptide receptor activity |
GO:0030883 | 1e-04 | 55.9136 | 0.335 | 4 | 5 | endogenous lipid antigen binding |
GO:0030884 | 1e-04 | 55.9136 | 0.335 | 4 | 5 | exogenous lipid antigen binding |
GO:0001077 | 1e-04 | 2.1855 | 16.5497 | 33 | 247 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0004993 | 1e-04 | 8.1718 | 1.2731 | 7 | 19 | G-protein coupled serotonin receptor activity |
GO:0008066 | 2e-04 | 6.5966 | 1.6751 | 8 | 25 | glutamate receptor activity |
GO:0003700 | 2e-04 | 1.8577 | 27.2604 | 47 | 422 | DNA binding transcription factor activity |
GO:0001012 | 2e-04 | 1.7022 | 37.7226 | 60 | 563 | RNA polymerase II regulatory region DNA binding |
GO:0005267 | 2e-04 | 2.7681 | 7.7521 | 19 | 116 | potassium channel activity |
GO:0051378 | 3e-04 | 13.9882 | 0.67 | 5 | 10 | serotonin binding |
GO:0000976 | 3e-04 | 1.6455 | 42.8148 | 66 | 639 | transcription regulatory region sequence-specific DNA binding |
GO:0000978 | 3e-04 | 1.914 | 21.9769 | 39 | 328 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001159 | 4e-04 | 1.8724 | 22.982 | 40 | 343 | core promoter proximal region DNA binding |
GO:0005184 | 5e-04 | 5.3386 | 1.9431 | 8 | 29 | neuropeptide hormone activity |
GO:0022832 | 8e-04 | 2.1982 | 11.9265 | 24 | 178 | voltage-gated channel activity |
GO:0005234 | 8e-04 | 6.9975 | 1.2061 | 6 | 18 | extracellularly glutamate-gated ion channel activity |
GO:0005125 | 9e-04 | 2.1376 | 12.7305 | 25 | 190 | cytokine activity |
GO:0000975 | 0.001 | 1.5172 | 52.3293 | 75 | 781 | regulatory region DNA binding |
GO:0030881 | 0.0011 | 13.9755 | 0.536 | 4 | 8 | beta-2-microglobulin binding |
GO:0001602 | 0.0011 | 41.8941 | 0.268 | 3 | 4 | pancreatic polypeptide receptor activity |
GO:0042562 | 0.0012 | 3.3552 | 3.8192 | 11 | 57 | hormone binding |
GO:0005251 | 0.0015 | 5.9971 | 1.3401 | 6 | 20 | delayed rectifier potassium channel activity |
GO:0005221 | 0.0019 | 11.1796 | 0.603 | 4 | 9 | intracellular cyclic nucleotide activated cation channel activity |
GO:0005102 | 0.002 | 1.3615 | 91.3249 | 118 | 1363 | receptor binding |
GO:0030545 | 0.002 | 1.652 | 28.8782 | 45 | 431 | receptor regulator activity |
GO:0015277 | 0.0027 | 20.9456 | 0.335 | 3 | 5 | kainate selective glutamate receptor activity |
GO:0003690 | 0.0028 | 1.4675 | 50.1852 | 70 | 749 | double-stranded DNA binding |
GO:0022843 | 0.0029 | 2.2977 | 8.1073 | 17 | 121 | voltage-gated cation channel activity |
GO:0071723 | 0.003 | 9.3157 | 0.67 | 4 | 10 | lipopeptide binding |
GO:0004888 | 0.0041 | 1.7048 | 21.1126 | 34 | 340 | transmembrane signaling receptor activity |
GO:0102567 | 0.0055 | 5.3771 | 1.2061 | 5 | 18 | phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) |
GO:0102568 | 0.0055 | 5.3771 | 1.2061 | 5 | 18 | phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) |
GO:0005549 | 0.0055 | 2.55 | 5.2262 | 12 | 78 | odorant binding |
GO:0015081 | 0.0062 | 2.0564 | 9.4474 | 18 | 141 | sodium ion transmembrane transporter activity |
GO:0016594 | 0.0064 | 6.9858 | 0.804 | 4 | 12 | glycine binding |
GO:0005215 | 0.0073 | 1.3185 | 82.4135 | 104 | 1230 | transporter activity |
GO:0022890 | 0.0074 | 1.5109 | 32.6304 | 47 | 487 | inorganic cation transmembrane transporter activity |
GO:0000981 | 0.0083 | 1.6309 | 21.3204 | 33 | 326 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0004972 | 0.0086 | 10.4713 | 0.469 | 3 | 7 | NMDA glutamate receptor activity |
GO:0005021 | 0.0086 | 10.4713 | 0.469 | 3 | 7 | vascular endothelial growth factor-activated receptor activity |
GO:0099095 | 0.0086 | 10.4713 | 0.469 | 3 | 7 | ligand-gated anion channel activity |
GO:0005230 | 0.0086 | 4.7004 | 1.3292 | 5 | 20 | extracellular ligand-gated ion channel activity |
GO:0004890 | 0.0088 | 6.2091 | 0.871 | 4 | 13 | GABA-A receptor activity |
GO:0004866 | 0.0088 | 1.9753 | 9.7824 | 18 | 146 | endopeptidase inhibitor activity |
GO:0003677 | 0.0096 | 1.3206 | 75.1621 | 95 | 1161 | DNA binding |
GO:0001228 | 0.01 | 2.0415 | 8.4362 | 16 | 128 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070840 | 0.0013 | Inf | 0.0013 | 1 | 20 | dynein complex binding |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005201 | 0.0086 | 233.8615 | 0.0086 | 1 | 66 | extracellular matrix structural constituent |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005154 | 0.002 | Inf | 0.002 | 1 | 31 | epidermal growth factor receptor binding |
GO:0008083 | 0.0096 | Inf | 0.0096 | 1 | 146 | growth factor activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043621 | 7e-04 | 62.0694 | 0.0401 | 2 | 51 | protein self-association |
GO:0043924 | 8e-04 | Inf | 8e-04 | 1 | 1 | suramin binding |
GO:0099094 | 0.0014 | 44.0203 | 0.0558 | 2 | 71 | ligand-gated cation channel activity |
GO:0005427 | 0.0016 | 1386.8182 | 0.0016 | 1 | 2 | proton-dependent oligopeptide secondary active transmembrane transporter activity |
GO:0004872 | 0.0025 | 7.3817 | 1.0618 | 5 | 1351 | receptor activity |
GO:0005219 | 0.0031 | 462.2121 | 0.0031 | 1 | 4 | ryanodine-sensitive calcium-release channel activity |
GO:0015333 | 0.0031 | 462.2121 | 0.0031 | 1 | 4 | peptide:proton symporter activity |
GO:0035673 | 0.0031 | 462.2121 | 0.0031 | 1 | 4 | oligopeptide transmembrane transporter activity |
GO:0048763 | 0.0031 | 462.2121 | 0.0031 | 1 | 4 | calcium-induced calcium release activity |
GO:0022834 | 0.0037 | 26.1034 | 0.0927 | 2 | 118 | ligand-gated channel activity |
GO:0038036 | 0.0047 | 277.2909 | 0.0047 | 1 | 6 | sphingosine-1-phosphate receptor activity |
GO:0046982 | 0.0048 | 10.8678 | 0.3592 | 3 | 457 | protein heterodimerization activity |
GO:0005021 | 0.0055 | 231.0606 | 0.0055 | 1 | 7 | vascular endothelial growth factor-activated receptor activity |
GO:0004985 | 0.0063 | 198.039 | 0.0063 | 1 | 8 | opioid receptor activity |
GO:0004888 | 0.0074 | 6.6827 | 0.8378 | 4 | 1066 | transmembrane signaling receptor activity |
GO:0008324 | 0.0094 | 8.4345 | 0.4582 | 3 | 583 | cation transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004435 | 0.0017 | Inf | 0.0017 | 1 | 26 | phosphatidylinositol phospholipase C activity |
GO:0008081 | 0.0056 | Inf | 0.0056 | 1 | 85 | phosphoric diester hydrolase activity |
GO:0004620 | 0.0059 | Inf | 0.0059 | 1 | 90 | phospholipase activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001102 | 0.0022 | Inf | 0.0022 | 1 | 34 | RNA polymerase II activating transcription factor binding |
GO:0001078 | 0.0084 | Inf | 0.0084 | 1 | 128 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0061501 | 2e-04 | Inf | 2e-04 | 1 | 1 | cyclic-GMP-AMP synthase activity |
GO:0005245 | 0.0069 | 223.9853 | 0.0069 | 1 | 35 | voltage-gated calcium channel activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031737 | 0.002 | Inf | 0.002 | 1 | 1 | CX3C chemokine receptor binding |
GO:0036393 | 0.002 | Inf | 0.002 | 1 | 1 | thiocyanate peroxidase activity |
GO:0102797 | 0.002 | Inf | 0.002 | 1 | 1 | geranial:oxygen oxidoreductase activity |
GO:0102798 | 0.002 | Inf | 0.002 | 1 | 1 | heptaldehyde:oxygen oxidoreductase activity |
GO:0003989 | 0.0039 | 525.4138 | 0.0039 | 1 | 2 | acetyl-CoA carboxylase activity |
GO:0004021 | 0.0039 | 525.4138 | 0.0039 | 1 | 2 | L-alanine:2-oxoglutarate aminotransferase activity |
GO:0004031 | 0.0039 | 525.4138 | 0.0039 | 1 | 2 | aldehyde oxidase activity |
GO:0005230 | 0.0064 | 18.3765 | 0.1199 | 2 | 61 | extracellular ligand-gated ion channel activity |
GO:0008503 | 0.0078 | 175.1149 | 0.0079 | 1 | 4 | benzodiazepine receptor activity |
GO:0004075 | 0.0098 | 131.3276 | 0.0098 | 1 | 5 | biotin carboxylase activity |
GO:0004568 | 0.0098 | 131.3276 | 0.0098 | 1 | 5 | chitinase activity |
GO:0009374 | 0.0098 | 131.3276 | 0.0098 | 1 | 5 | biotin binding |
GO:0015277 | 0.0098 | 131.3276 | 0.0098 | 1 | 5 | kainate selective glutamate receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001641 | 1e-04 | Inf | 1e-04 | 1 | 2 | group II metabotropic glutamate receptor activity |
GO:0098988 | 3e-04 | Inf | 3e-04 | 1 | 4 | G-protein coupled glutamate receptor activity |
GO:0005246 | 0.0022 | Inf | 0.0022 | 1 | 33 | calcium channel regulator activity |
GO:0016247 | 0.0076 | Inf | 0.0076 | 1 | 116 | channel regulator activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050023 | 8e-04 | Inf | 8e-04 | 1 | 1 | L-fuconate dehydratase activity |
GO:0008823 | 0.0016 | 1386.8182 | 0.0016 | 1 | 2 | cupric reductase activity |
GO:0033872 | 0.0016 | 1386.8182 | 0.0016 | 1 | 2 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity |
GO:0052851 | 0.0016 | 1386.8182 | 0.0016 | 1 | 2 | ferric-chelate reductase (NADPH) activity |
GO:0008467 | 0.0055 | 231.0606 | 0.0055 | 1 | 7 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000334 | 1e-04 | Inf | 1e-04 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0008198 | 0.0014 | Inf | 0.0014 | 1 | 21 | ferrous iron binding |
GO:0016701 | 0.0014 | Inf | 0.0014 | 1 | 22 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
GO:0051213 | 0.005 | Inf | 0.005 | 1 | 76 | dioxygenase activity |
GO:0009055 | 0.0062 | Inf | 0.0062 | 1 | 94 | electron transfer activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 2.6353 | 15.338 | 35 | 180 | histone binding |
GO:0031492 | 0 | 4.6889 | 3.6641 | 13 | 43 | nucleosomal DNA binding |
GO:0046982 | 1e-04 | 1.7531 | 38.9414 | 63 | 457 | protein heterodimerization activity |
GO:0005102 | 1e-04 | 1.4168 | 116.1425 | 154 | 1363 | receptor binding |
GO:0004896 | 3e-04 | 2.9694 | 6.7317 | 17 | 79 | cytokine receptor activity |
GO:0043236 | 4e-04 | 5.1137 | 2.3859 | 9 | 28 | laminin binding |
GO:0008499 | 4e-04 | 9.2399 | 1.1077 | 6 | 13 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0050431 | 4e-04 | 6.8633 | 1.5338 | 7 | 18 | transforming growth factor beta binding |
GO:0004111 | 7e-04 | 21.5343 | 0.5113 | 4 | 6 | creatine kinase activity |
GO:0030020 | 7e-04 | 21.5343 | 0.5113 | 4 | 6 | extracellular matrix structural constituent conferring tensile strength |
GO:0005518 | 0.0012 | 3.0545 | 5.0274 | 13 | 59 | collagen binding |
GO:0019956 | 0.0013 | 5.3914 | 1.7894 | 7 | 21 | chemokine binding |
GO:0005201 | 0.0013 | 2.9982 | 5.0989 | 13 | 60 | extracellular matrix structural constituent |
GO:0030306 | 0.0015 | 14.3552 | 0.5965 | 4 | 7 | ADP-ribosylation factor binding |
GO:0022857 | 0.0022 | 1.389 | 76.6046 | 101 | 899 | transmembrane transporter activity |
GO:0005332 | 0.0023 | 32.2789 | 0.3408 | 3 | 4 | gamma-aminobutyric acid:sodium symporter activity |
GO:0030151 | 0.0023 | 32.2789 | 0.3408 | 3 | 4 | molybdenum ion binding |
GO:0045296 | 0.0026 | 1.7025 | 24.5407 | 39 | 288 | cadherin binding |
GO:0005024 | 0.0028 | 10.7656 | 0.6817 | 4 | 8 | transforming growth factor beta-activated receptor activity |
GO:0019911 | 0.0028 | 10.7656 | 0.6817 | 4 | 8 | structural constituent of myelin sheath |
GO:0050840 | 0.0028 | 5.4184 | 1.526 | 6 | 18 | extracellular matrix binding |
GO:0015079 | 0.0038 | 1.9769 | 12.6964 | 23 | 149 | potassium ion transmembrane transporter activity |
GO:0033218 | 0.0038 | 1.7117 | 21.8992 | 35 | 257 | amide binding |
GO:0001968 | 0.0039 | 4.1921 | 2.1303 | 7 | 25 | fibronectin binding |
GO:0005088 | 0.004 | 1.7536 | 19.5985 | 32 | 230 | Ras guanyl-nucleotide exchange factor activity |
GO:0042802 | 0.004 | 1.2844 | 124.9192 | 153 | 1466 | identical protein binding |
GO:0015293 | 0.0042 | 2.0295 | 11.333 | 21 | 133 | symporter activity |
GO:0015075 | 0.0042 | 1.3895 | 65.0159 | 86 | 763 | ion transmembrane transporter activity |
GO:0005509 | 0.0043 | 1.4318 | 52.916 | 72 | 621 | calcium ion binding |
GO:0001540 | 0.0046 | 2.9975 | 3.9197 | 10 | 46 | amyloid-beta binding |
GO:0016723 | 0.0054 | 16.1632 | 0.4255 | 3 | 5 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor |
GO:0016661 | 0.0054 | 16.1383 | 0.4261 | 3 | 5 | oxidoreductase activity, acting on other nitrogenous compounds as donors |
GO:0008514 | 0.0058 | 1.842 | 14.6563 | 25 | 172 | organic anion transmembrane transporter activity |
GO:0008519 | 0.0062 | 3.7724 | 2.3007 | 7 | 27 | ammonium transmembrane transporter activity |
GO:0016879 | 0.0064 | 2.8393 | 4.0901 | 10 | 48 | ligase activity, forming carbon-nitrogen bonds |
GO:0017124 | 0.0064 | 2.0706 | 9.5436 | 18 | 112 | SH3 domain binding |
GO:0016702 | 0.0067 | 4.3095 | 1.7894 | 6 | 21 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
GO:0005146 | 0.0073 | Inf | 0.1704 | 2 | 2 | leukemia inhibitory factor receptor binding |
GO:0008147 | 0.0073 | Inf | 0.1704 | 2 | 2 | structural constituent of bone |
GO:0008294 | 0.0073 | Inf | 0.1704 | 2 | 2 | calcium- and calmodulin-responsive adenylate cyclase activity |
GO:0008823 | 0.0073 | Inf | 0.1704 | 2 | 2 | cupric reductase activity |
GO:0016401 | 0.0073 | Inf | 0.1704 | 2 | 2 | palmitoyl-CoA oxidase activity |
GO:0052654 | 0.0073 | Inf | 0.1704 | 2 | 2 | L-leucine transaminase activity |
GO:0052655 | 0.0073 | Inf | 0.1704 | 2 | 2 | L-valine transaminase activity |
GO:0052656 | 0.0073 | Inf | 0.1704 | 2 | 2 | L-isoleucine transaminase activity |
GO:0052851 | 0.0073 | Inf | 0.1704 | 2 | 2 | ferric-chelate reductase (NADPH) activity |
GO:0004383 | 0.0088 | 4.8948 | 1.3634 | 5 | 16 | guanylate cyclase activity |
GO:0033613 | 0.009 | 2.5255 | 4.9422 | 11 | 58 | activating transcription factor binding |
GO:0008028 | 0.0095 | 3.0801 | 3.0676 | 8 | 36 | monocarboxylic acid transmembrane transporter activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
No LOLA Enrichment Analysis was conducted